PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Endo, S; Suganami, A; Fukushima, K; Senoo, K; Araki, Y; Regan, JW; Mashimo, M; Tamura, Y; Fujino, H				Endo, Suzu; Suganami, Akiko; Fukushima, Keijo; Senoo, Kanaho; Araki, Yumi; Regan, John W.; Mashimo, Masato; Tamura, Yutaka; Fujino, Hiromichi			15-Keto-PGE(2)acts as a biased/partial agonist to terminate PGE(2)-evoked signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						EP4 prostanoid receptors; EP2 prostanoid receptors; PGE2; 15-keto-PGE2; biased agonist; switched agonist; Schild regression; pharmacology; G-protein-coupled receptor (GPCR); prostaglandin; cancer biology; bioinformatics; biased ligand; switched ligand	EP4 PROSTANOID RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-GROWTH; E-2; EXPRESSION; CYCLOOXYGENASE-2; PROSTAGLANDINS; STIMULATION; ACTIVATION; PATHWAY	Prostaglandin E-2(PGE(2)) is well-known as an endogenous proinflammatory prostanoid synthesized from arachidonic acid by the activation of cyclooxygenase-2. E type prostanoid (EP) receptors are cognates for PGE(2)that have four main subtypes: EP1 to EP4. Of these, the EP2 and EP4 prostanoid receptors have been shown to couple to G alpha(s)-protein and can activate adenylyl cyclase to form cAMP. Studies suggest that EP4 receptors are involved in colorectal homeostasis and cancer development, but further work is needed to identify the roles of EP2 receptors in these functions. After sufficient inflammation has been evoked by PGE(2), it is metabolized to 15-keto-PGE(2). Thus, 15-keto-PGE(2)has long been considered an inactive metabolite of PGE(2). However, it may have an additional role as a biased and/or partial agonist capable of taking over the actions of PGE(2)to gradually terminate reactions. Here, using cell-based experiments andin silicosimulations, we show that PGE(2)-activated EP4 receptor-mediated signaling may evoke the primary initiating reaction of the cells, which would take over the 15-keto-PGE(2)-activated EP2 receptor-mediated signaling after PGE(2)is metabolized to 15-keto-PGE(2). The present results shed light on new aspects of 15-keto-PGE(2), which may have important roles in passing on activities to EP2 receptors from PGE(2)-stimulated EP4 receptors as a "switched agonist." This novel mechanism may be significant for gradually terminating PGE(2)-evoked inflammation and/or maintaining homeostasis of colorectal tissues/cells functions.	[Endo, Suzu; Fukushima, Keijo; Senoo, Kanaho; Araki, Yumi; Fujino, Hiromichi] Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Pharmacol Life Sci, Tokushima, Japan; [Endo, Suzu; Fukushima, Keijo; Senoo, Kanaho; Araki, Yumi; Fujino, Hiromichi] Univ Tokushima, Grad Sch Biomed Sci, Tokushima, Japan; [Suganami, Akiko; Tamura, Yutaka] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba, Japan; [Regan, John W.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Mashimo, Masato] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Lab Pharmacol, Kyoto, Japan	Tokushima University; Tokushima University; Chiba University; University of Arizona	Fujino, H (corresponding author), Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Pharmacol Life Sci, Tokushima, Japan.; Fujino, H (corresponding author), Univ Tokushima, Grad Sch Biomed Sci, Tokushima, Japan.; Tamura, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba, Japan.	hfujino@tokushima-u.ac.jp; yutaka_tamura@faculty.chiba-u.jp		Fujino, Hiromichi/0000-0002-5899-2095	MEXT KAKENHI (JAPAN) [17K08308, 20K07084, 19K16374]	MEXT KAKENHI (JAPAN)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by MEXT KAKENHI Grants 17K08308 (JAPAN) (to H.F.), 20K07084 (JAPAN) (to H. F.), and 19K16374 (JAPAN) (to K. F.).	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Aoki T, 2017, INFLAMM REGEN, V37, DOI 10.1186/s41232-017-0036-7; Araki Y, 2017, FEBS LETT, V591, P3771, DOI 10.1002/1873-3468.12878; Black JW, 2010, BRIT J PHARMACOL, V160, pS54, DOI 10.1111/j.1476-5381.2010.00855.x; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Eisinger AL, 2007, PROSTAG OTH LIPID M, V82, P147, DOI 10.1016/j.prostaglandins.2006.05.026; Fujino H, 2006, MOL PHARMACOL, V69, P13, DOI 10.1124/mol.105.017749; Fujino H, 2003, TRENDS PHARMACOL SCI, V24, P335, DOI 10.1016/S0165-6147(03)00162-7; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Fujino H, 2016, BIOL PHARM BULL, V39, P149, DOI 10.1248/bpb.b15-00840; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kenakin T, 2019, ACS PHARMACOL TRANSL, V2, P9, DOI 10.1021/acsptsci.8b00057; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P43, DOI 10.1016/B978-0-12-374585-9.00003-7; Kishore AH, 2014, J CLIN ENDOCR METAB, V99, P1006, DOI 10.1210/jc.2013-3392; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Schmitt JM, 2001, MOL CELL BIOL, V21, P3671, DOI 10.1128/MCB.21.11.3671-3683.2001; Srivastava S, 2001, CLIN CANCER RES, V7, P1118; Suganami A, 2016, FEBS J, V283, P3931, DOI 10.1111/febs.13899; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Takafuji V, 2000, PROSTAG LEUKOTR ESS, V63, P223, DOI 10.1054/plef.2000.0144; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Yoshida K, 2013, EUR J PHARMACOL, V718, P408, DOI 10.1016/j.ejphar.2013.08.002	31	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13338	13352		10.1074/jbc.RA120.013988	http://dx.doi.org/10.1074/jbc.RA120.013988			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32727851	hybrid, Green Published			2022-12-26	WOS:000574483500017
J	Wang, T; Young, S; Krenz, H; Tuttelmann, F; Ropke, A; Krallmann, C; Kliesch, S; Zeng, XH; Brenker, C; Strunker, T				Wang, Tao; Young, Samuel; Krenz, Henrike; Tuettelmann, Frank; Roepke, Albrecht; Krallmann, Claudia; Kliesch, Sabine; Zeng, Xu-Hui; Brenker, Christoph; Struenker, Timo			The Ca(2+)channel CatSper is not activated by cAMP/PKA signaling but directly affected by chemicals used to probe the action of cAMP and PKA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CatSper; Ca(2+)signaling; cAMP; sperm; ion channel; calcium channel; pharmacology; cyclic AMP (cAMP)	SOLUBLE ADENYLYL-CYCLASE; PROTEIN-TYROSINE PHOSPHORYLATION; CHANNEL CONTROLS CHEMOSENSATION; MALE-INFERTILITY; SPERM-MOTILITY; ACROSOME REACTION; HUMAN SPERMATOZOA; CA2+ CHANNEL; BICARBONATE; CAPACITATION	The sperm-specific Ca(2+)channel CatSper (cation channel of sperm) controls the influx of Ca(2+)into the flagellum and, thereby, the swimming behavior of sperm. A hallmark of human CatSper is its polymodal activation by membrane voltage, intracellular pH, and oviductal hormones. Whether CatSper is also activated by signaling pathways involving an increase of cAMP and ensuing activation of PKA is, however, a matter of controversy. To shed light on this question, we used kinetic ion-sensitive fluorometry, patch-clamp recordings, and optochemistry to study transmembrane Ca(2+)flux and membrane currents in human sperm from healthy donors and from patients that lack functional CatSper channels. We found that human CatSper is neither activated by intracellular cAMP directly nor indirectly by the cAMP/PKA-signaling pathway. Instead, we show that nonphysiological concentrations of cAMP and membrane-permeable cAMP analogs used to mimic the action of intracellular cAMP activate human CatSper from the outside via a hitherto-unknown extracellular binding site. Finally, we demonstrate that the effects of common PKA inhibitors on human CatSper rest predominantly, if not exclusively, on off-target drug actions on CatSper itself rather than on inhibition of PKA. We conclude that the concept of an intracellular cAMP/PKA-activation of CatSper is primarily based on unspecific effects of chemical probes used to interfere with cAMP signaling. Altogether, our findings solve several controversial issues and reveal a novel ligand-binding site controlling the activity of CatSper, which has important bearings on future studies of cAMP and Ca(2+)signaling in sperm.	[Wang, Tao; Zeng, Xu-Hui] Nanchang Univ, Inst Life Sci, Nanchang, Jiangxi, Peoples R China; [Wang, Tao; Zeng, Xu-Hui] Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China; [Wang, Tao; Young, Samuel; Krallmann, Claudia; Kliesch, Sabine; Brenker, Christoph; Struenker, Timo] Univ Munster, Ctr Reprod Med & Androl, Munster, Germany; [Krenz, Henrike] Univ Munster, Inst Med Informat, Munster, Germany; [Tuettelmann, Frank; Roepke, Albrecht] Univ Munster, Inst Human Genet, Munster, Germany; [Struenker, Timo] Univ Munster, Cells Mot Interfac Ctr, Munster, Germany	Nanchang University; Nanchang University; University of Munster; University of Munster; University of Munster; University of Munster	Zeng, XH (corresponding author), Nanchang Univ, Inst Life Sci, Nanchang, Jiangxi, Peoples R China.; Zeng, XH (corresponding author), Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China.; Brenker, C; Strunker, T (corresponding author), Univ Munster, Ctr Reprod Med & Androl, Munster, Germany.; Strunker, T (corresponding author), Univ Munster, Cells Mot Interfac Ctr, Munster, Germany.	zengxuhui@ncu.edu.cn; christoph.brenker@ukmuenster.de; timo.struenker@ukmuenster.de	Tüttelmann, Frank/ABH-8185-2020	Tüttelmann, Frank/0000-0003-2745-9965; Young, Samuel/0000-0002-0950-4112; , wang tao/0000-0002-2952-134X	German Research Foundation [CRU326, GRK 2515]; National Basic Research Program of China, 973 Program [2015CB943003]; National Natural Science Foundation of China [31671204]; Ph.D. Overseas Study Program of Nanchang University	German Research Foundation(German Research Foundation (DFG)); National Basic Research Program of China, 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Overseas Study Program of Nanchang University	This work was supported by the German Research Foundation Grants CRU326 (to F. T., C. B., and T. S.) and GRK 2515 (to T. S.); the National Basic Research Program of China, 973 Program Grant 2015CB943003 (to X.-H. Z.); and National Natural Science Foundation of China Grant 31671204 (to X.-H. Z.). T. W. received funding from the Ph.D. Overseas Study Program of Nanchang University.	Achikanu C, 2018, HUM REPROD, V33, P1802, DOI 10.1093/humrep/dey280; Akbari A, 2019, HUM REPROD, V34, P1155, DOI 10.1093/humrep/dez048; Alasmari W, 2013, J BIOL CHEM, V288, P6248, DOI 10.1074/jbc.M112.439356; Avenarius MR, 2009, AM J HUM GENET, V84, P505, DOI 10.1016/j.ajhg.2009.03.004; Avidan N, 2003, EUR J HUM GENET, V11, P497, DOI 10.1038/sj.ejhg.5200991; Balbach M, 2018, MOL CELL ENDOCRINOL, V468, P111, DOI 10.1016/j.mce.2017.11.008; Baron L, 2016, ANDROLOGY-US, V4, P1063, DOI 10.1111/andr.12234; Battistone MA, 2013, MOL HUM REPROD, V19, P570, DOI 10.1093/molehr/gat033; Bedu-Addo K, 2005, MOL HUM REPROD, V11, P683, DOI 10.1093/molehr/gah226; Bonigk W, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000516; Brenker C, 2018, HUM REPROD, V33, P1915, DOI 10.1093/humrep/dey275; Brenker C, 2018, P NATL ACAD SCI USA, V115, pE344, DOI 10.1073/pnas.1717929115; Brenker C, 2014, ELIFE, V3, DOI 10.7554/eLife.01438; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Cohen J.E., 1988, STAT POWER ANAL BEHA; Diao RY, 2017, ONCOTARGET, V8, P91445, DOI 10.18632/oncotarget.20651; Diao RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009071; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Hagen V, 2003, CHEMBIOCHEM, V4, P434, DOI 10.1002/cbic.200300561; Hagen V, 2001, ANGEW CHEM INT EDIT, V40, P1046; Hagen V, 2002, ANGEW CHEM INT EDIT, V41, P3625, DOI 10.1002/1521-3773(20021004)41:19<3625::AID-ANIE3625>3.0.CO;2-J; Hamzeh H, 2019, METHOD CELL BIOL, V151, P487, DOI 10.1016/bs.mcb.2018.12.001; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Hwang JY, 2019, CELL, V177, P1480, DOI 10.1016/j.cell.2019.03.047; Itzhakov D, 2019, ASIAN J ANDROL, V21, P337, DOI 10.4103/aja.aja_99_18; Jansen V, 2015, ELIFE, V4, DOI 10.7554/eLife.05161; Kawai T, 2019, P NATL ACAD SCI USA, V116, P26020, DOI 10.1073/pnas.1916867116; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kleinboelting S, 2014, FEBS J, V281, P4151, DOI 10.1111/febs.12913; Kohn RA, 1998, J ANIM SCI, V76, P1702; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Loux SC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111708; Lucchesi O, 2016, BBA-MOL CELL RES, V1863, P544, DOI 10.1016/j.bbamcr.2015.12.007; Luo T, 2019, HUM REPROD, V34, P414, DOI 10.1093/humrep/dey377; McBrinn RC, 2019, BRIT J PHARMACOL, V176, P4521, DOI 10.1111/bph.14814; Miller MR, 2016, SCIENCE, V352, P555, DOI 10.1126/science.aad6887; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; Moseley FLC, 2005, MOL HUM REPROD, V11, P523, DOI 10.1093/molehr/gah188; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; Orta G, 2018, J BIOL CHEM, V293, P16830, DOI 10.1074/jbc.RA117.001566; Molina LCP, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00072; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rennhack A, 2018, BRIT J PHARMACOL, V175, P3144, DOI 10.1111/bph.14355; Schaefer M, 1998, P NATL ACAD SCI USA, V95, P3008, DOI 10.1073/pnas.95.6.3008; Schiffer C, 2020, EMBO J, V39, DOI 10.15252/embj.2019102363; Schiffer C, 2014, EMBO REP, V15, P758, DOI 10.15252/embr.201438869; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Schuh SM, 2006, BIOL REPROD, V74, P492, DOI 10.1095/biolreprod.105.047837; Seifert R, 2015, EMBO J, V34, P379, DOI 10.15252/embj.201489376; Smith JF, 2013, P NATL ACAD SCI USA, V110, P6823, DOI 10.1073/pnas.1216588110; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Stival C, 2018, J BIOL CHEM, V293, P9435, DOI 10.1074/jbc.RA118.002286; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Sumigama S, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129783; Tamburrino L, 2015, HUM REPROD, V30, P1532, DOI 10.1093/humrep/dev103; Tamburrino L, 2014, HUM REPROD, V29, P418, DOI 10.1093/humrep/det454; Tavares RS, 2013, HUM REPROD, V28, P3167, DOI 10.1093/humrep/det372; Trotschel C, 2020, EMBO J, V39, DOI 10.15252/embj.2019102723; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Williams HL, 2015, HUM REPROD, V30, P2737, DOI 10.1093/humrep/dev243; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yanagimachi R., 1994, Zygote, V2, P371; Zhang Y, 2007, J MED GENET, V44, P233, DOI 10.1136/jmg.2006.045765	74	12	12	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13181	13193		10.1074/jbc.RA120.013218	http://dx.doi.org/10.1074/jbc.RA120.013218			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32703901	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000574483500004
J	Swaggerty, CL; Arsenault, RJ; Johnson, C; Piva, A; Grilli, E				Swaggerty, Christina L.; Arsenault, Ryan J.; Johnson, Casey; Piva, Andrea; Grilli, Ester			Dietary supplementation with a microencapsulated blend of organic acids and botanicals alters the kinome in the ileum and jejunum ofGallus gallus	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNALING PATHWAY; IMMUNE; PERFORMANCE; ANTIBIOTICS; HETEROPHILS; ACTIVATION; COMPONENTS; NETWORKS; RECEPTOR	The use of natural products as feed additives in the poultry industry is increasing; however, most studies focus on performance and growth with little regard for determining mechanism. Our laboratory designed a chicken (Gallus gallus)-specific immunometabolic kinome peptide array. Using this tool to examine the active enzymes responsible for phosphorylation events (kinases) provides important information on host and cellular functions. The objective of this project was to determine if feeding a microencapsulated product comprised of a blend of organic acids and botanicals (AviPlus(R)P) impacts the intestinal kinome of broiler chickens (Gallus gallus). Day-of-hatch chicks were provided 0 or 500g/MT of the additive and jejunal and ileal segments collected for kinome analysis to determine the mode-of-action of the additive. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed by uploading the statistically significant peptides to the Search Tool for the Retrieval of Interacting Genes database. As a whole, GO and KEGG analysis showed similar activities in the ileum and jejunum. However, there were a small number of KEGG pathways that were only activated in either the ileum or jejunum, but not both. Analysis of the adipocytokine and PI3K-AKT signaling pathways showed differences between ileal and jejunal activity that were controlled, in part, by AKT3. Additionally, cytokine/chemokine evaluation showed the ileum had higher IL1 beta, IL6, IL10, TNF alpha, IFN gamma, CXCL8, and CCL4 mRNA expression levels (P<0.05). As a whole, the data showed the addition of microencapsulated organic acids and botanicals to a broiler diet activated many of the same signaling pathways in the ileum and jejunum; however, distinctions were observed. Taken together, the findings of this study begin to define the mode-of-action that microencapsulated organic acids and botanicals have on two important intestinal segments responsible for nutrient digestion and absorption in chickens.	[Swaggerty, Christina L.] ARS, USDA, Southern Plains Agr Res Serv, College Stn, TX 77845 USA; [Arsenault, Ryan J.; Johnson, Casey] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA; [Piva, Andrea; Grilli, Ester] Univ Bologna, DIMEVET, Bologna, Italy; [Piva, Andrea] Vetagro SpA, Reggio Emilia, Italy; [Grilli, Ester] Vetagro Inc, Chicago, IL USA	United States Department of Agriculture (USDA); University of Delaware; University of Bologna	Swaggerty, CL (corresponding author), ARS, USDA, Southern Plains Agr Res Serv, College Stn, TX 77845 USA.	christi.swaggerty@usda.gov		Swaggerty, Christina/0000-0001-5057-8175; Grilli, Ester/0000-0001-8351-9542	Vetagro [58-3091-8-005]; USDA/ARS [3091-32000-035-00D]	Vetagro; USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported, in part, by Vetagro ([CLS] Agreement number 58-3091-8-005; https://www.vetagro.com) and the USDA/ARS (3091-32000-035-00D; https://www.ars.usda.gov/research/project/?accnNo=430283).There was no additional external funding received for this study. Vetagro provided support in the form of salaries for AP and EG, and supplied the AviPlus feed amendment, but did not have any additional role in data collection and analysis, decision to publish, or preparation of the manuscript. USDA/ARS provided support in the form of salary for CLS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. All other authors declare no conflict of interest.	Abers HMHG, 2014, ACS CHEM BIOL, V9, P414, DOI 10.1021/cb400421a; Arsenault RJ, 2017, POULTRY SCI, V96, P4307, DOI 10.3382/ps/pex246; Arsenault R. J., 2012, CURR TOP BIOTECHNOL, V7, P79; Arsenault RJ, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-35; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Bedford A, 2018, ANIM NUTR, V4, P151, DOI 10.1016/j.aninu.2017.08.010; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Cherbut C, 2003, P NUTR SOC, V62, P95, DOI 10.1079/PNS2002213; Cox CM, 2010, POULTRY SCI, V89, P2597, DOI 10.3382/ps.2010-00987; Gadde U, 2017, PROBIOTICS ANTIMICRO, V9, P397, DOI 10.1007/s12602-017-9275-9; Gessner DK, 2017, J ANIM PHYSIOL AN N, V101, P605, DOI 10.1111/jpn.12579; Grilli E, 2016, J ANIM SCI, V94, P433, DOI 10.2527/jas.2015-9787; Grilli E, 2007, P 16 EUR S POULT NUT; Grilli E, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0410-0; Hashim MM, 2018, POULTRY SCI, V97, P203, DOI 10.3382/ps/pex290; Jalal S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pl1; Kaiser P, 2000, MICROBIOL-UK, V146, P3217, DOI 10.1099/00221287-146-12-3217; Kogut MH, 2003, J INTERF CYTOK RES, V23, P319, DOI 10.1089/107999003766628160; Kogut MH, 2013, CLIN VACCINE IMMUNOL, V20, P1440, DOI 10.1128/CVI.00322-13; Li YP, 2011, VET MICROBIOL, V148, P75, DOI 10.1016/j.vetmic.2010.08.009; Li Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002429; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Micciche AC, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00191; National Research Council, 1994, NUTR REQ CHICK NUTR, V9th ed., P19; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Ouyang Z, 2003, SCIENCE, V301, P1351, DOI 10.1126/science.1088776; Piva A, 2007, J ANIM SCI, V85, P486, DOI 10.2527/jas.2006-323; Research AM, 2019, GLOB AN FEED ADD MAR; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Suresh G, 2018, CRIT REV MICROBIOL, V44, P318, DOI 10.1080/1040841X.2017.1373062; Svihus B, 2014, J APPL POULTRY RES, V23, P306, DOI 10.3382/japr.2014-00937; Swaggerty CL, 2020, POULTRY SCI, V99, P3428, DOI 10.1016/j.psj.2020.03.031; Swaggerty CL, 2004, IMMUNOLOGY, V113, P139, DOI 10.1111/j.1365-2567.2004.01939.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trost B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080837; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Wang AH, 2012, J NUTR, V142, P1, DOI 10.3945/jn.111.148155; [王红霞 Wang Hongxia], 2014, [国际药学研究杂志, Journal of International Pharmaceutical Research], V41, P259; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yadav S, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-018-0310-9; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yitbarek A, 2013, POULTRY SCI, V92, P2299, DOI 10.3382/ps.2013-03141; Zeng ZK, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0004-5; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zimonja O, 2009, ANIM FEED SCI TECH, V149, P287, DOI 10.1016/j.anifeedsci.2008.06.010	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236950	10.1371/journal.pone.0236950	http://dx.doi.org/10.1371/journal.pone.0236950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730335	Green Published, gold			2022-12-26	WOS:000556884700047
J	Mahar, AL; Kurdyak, P; Hanna, TP; Coburn, NG; Groome, PA				Mahar, Alyson L.; Kurdyak, Paul; Hanna, Timothy P.; Coburn, Natalie G.; Groome, Patti A.			The effect of a severe psychiatric illness on colorectal cancer treatment and survival: A population-based retrospective cohort study	PLOS ONE			English	Article							MENTAL-ILLNESS; BREAST-CANCER; PHYSICAL ILLNESS; HEALTH-CARE; MORTALITY; DIAGNOSIS; SCHIZOPHRENIA; DEPRESSION; WOMEN; INDIVIDUALS	Objectives To identify inequalities in cancer survival rates for patients with a history of severe psychiatric illness (SPI) compared to those with no history of mental illness and explore differences in the provision of recommended cancer treatment as a potential explanation. Design Population-based retrospective cohort study using linked cancer registry and administrative data at ICES. Setting The universal healthcare system in Ontario, Canada. Participants Colorectal cancer (CRC) patients diagnosed between April 1st, 2007 and December 31st, 2012. SPI history (schizophrenia, schizoaffective disorders, other psychotic disorders, bipolar disorders or major depressive disorders) was determined using hospitalization, emergency department, and psychiatrist visit data and categorized as 'no history of mental illness, 'outpatient SPI history', and 'inpatient SPI history'. Main outcome measures Cancer-specific survival, non-receipt of surgical resection, and non-receipt of adjuvant chemotherapy or radiation. Results 24,507 CRC patients were included; 482 (2.0%) had an outpatient SPI history and 258 (1.0%) had an inpatient SPI history. Individuals with an SPI history had significantly lower survival rates and were significantly less likely to receive guideline recommended treatment than CRC patients with no history of mental illness. The adjusted HR for cancer-specific death was 1.69 times higher for individuals with an inpatient SPI (95% CI 1.36-2.09) and 1.24 times higher for individuals with an outpatient SPI history (95% CI 1.04-1.48). Stage II and III CRC patients with an inpatient SPI history were 2.15 times less likely (95% CI 1.07-4.33) to receive potentially curative surgical resection and 2.07 times less likely (95% CI 1.72-2.50) to receive adjuvant radiation or chemotherapy. These findings were consistent across multiple sensitivity analyses. Conclusions Individuals with an SPI history experience inequalities in colorectal cancer care and survival within a universal healthcare system. Increasing advocacy and the availability of resources to support individuals with an SPI within the cancer system are warranted to reduce the potential for unnecessary harm.	[Mahar, Alyson L.] Univ Manitoba, Dept Community Hlth Sci, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Mahar, Alyson L.; Kurdyak, Paul; Hanna, Timothy P.; Coburn, Natalie G.; Groome, Patti A.] ICES, Toronto, ON, Canada; [Kurdyak, Paul] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Hanna, Timothy P.] Queens Univ, Div Canc Care & Epidemiol, Dept Oncol, Kingston, ON, Canada; [Coburn, Natalie G.] Univ Toronto, Dept Surg, Div Gen Surg, Toronto, ON, Canada; [Groome, Patti A.] Queens Univ, Div Canc Care & Epidemiol, Dept Publ Hlth Sci, Kingston, ON, Canada	University of Manitoba; University of Toronto; University of Toronto; Queens University - Canada; University of Toronto; Queens University - Canada	Mahar, AL (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada.; Mahar, AL (corresponding author), ICES, Toronto, ON, Canada.	alyson_mahar@cpe.umanitoba.ca		Hanna, Timothy/0000-0003-3228-6042	Frederick Banting and Charles Best Canadian Graduate Studentship from the Canadian Institutes of Health Research (CIHR); CIHR [MOP-119370]; ICES; Ontario Ministry of Health and Long-Term Care (MOHLTC)	Frederick Banting and Charles Best Canadian Graduate Studentship from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); ICES; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	AL Mahar was supported by a Frederick Banting and Charles Best Canadian Graduate Studentship from the Canadian Institutes of Health Research (CIHR). The studies were supported in part by CIHR under operating grant MOP-119370 (PA Groome). This study was supported in part by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by CIHI. However, the analyses, conclusions, opinions and statements expressed in the material are those of the author (s), and not necessarily those of CIHI. Parts of this material are based on data and information provided by Cancer Care Ontario (CCO). The opinions, results, view, and conclusions reported in this paper are those of the authors and do not necessarily reflect those of CCO. No endorsement by CCO is intended or should be inferred.	Abdullah KN, 2015, AM J SURG, V209, P378, DOI 10.1016/j.amjsurg.2014.07.004; [Anonymous], 2014, SOC PSYCH PSYCH EPID, DOI DOI 10.1007/S00127-013-0765-0; [Anonymous], 2020, J EPIDEMIOL COMMUN H, DOI DOI 10.1136/JECH-2019-212311; Baillargeon J, 2011, J AM GERIATR SOC, V59, P1268, DOI 10.1111/j.1532-5415.2011.03481.x; Batty GD, 2012, BRIT J CANCER, V106, P1842, DOI 10.1038/bjc.2012.150; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bergamo C, 2014, PSYCHOSOM MED, V76, P215, DOI 10.1097/PSY.0000000000000050; Booth CM, 2016, J NATL COMPR CANC NE, V14, P47, DOI 10.6004/jnccn.2016.0006; Boyd CA, 2012, SURGERY, V152, P403, DOI 10.1016/j.surg.2012.06.010; Bushe CJ, 2010, CAN J PSYCHIAT, V55, P761, DOI 10.1177/070674371005501203; Cancer Care Ontario, 2014, CANC CAR ONT DIS PAT; Chang CK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004295; Chang TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070883; Charlwood P., 1999, HLTH OUTCOME INDICAT; Clarke E A, 1991, IARC Sci Publ, P246; Cole M, 2012, J CANCER EDUC, V27, P774, DOI 10.1007/s13187-012-0391-7; De Hert M, 2011, WORLD PSYCHIATRY, V10, P138; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Division HSIMaI, 2012, HLTH AN TOOKL; Edge S B, 2010, AJCC CANC STAGING MA; Farasatpour M, 2013, AM J SURG, V206, P798, DOI 10.1016/j.amjsurg.2012.06.013; Fox JP, 2013, BREAST J, V19, P276, DOI 10.1111/tbj.12096; Glimelius B, 2013, ANN ONCOL, V24, P81, DOI 10.1093/annonc/mdt240; Goering PN, 2012, MAKING DIFFERENCE ON; Goodwin JS, 2004, J AM GERIATR SOC, V52, P106, DOI 10.1111/j.1532-5415.2004.52018.x; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Heggestad T, 2011, SOC PSYCH PSYCH EPID, V46, P1275, DOI 10.1007/s00127-010-0295-y; Hjerl K, 2003, PSYCHOSOMATICS, V44, P24, DOI 10.1176/appi.psy.44.1.24; Howard LM, 2010, LANCET ONCOL, V11, P797, DOI 10.1016/S1470-2045(10)70085-1; Inagaki T, 2006, PSYCHIAT CLIN NEUROS, V60, P327, DOI 10.1111/j.1440-1819.2006.01509.x; Irwin KE, 2014, CANCER-AM CANCER SOC, V120, P323, DOI 10.1002/cncr.28431; Johns Hopkins University, 2014, J HOPK ACG SYST VERS; Kisely S, 2013, JAMA PSYCHIAT, V70, P209, DOI 10.1001/jamapsychiatry.2013.278; Kisely S, 2012, CAN J PSYCHIAT, V57, P389, DOI 10.1177/070674371205700609; Kisely S, 2008, CAN J PSYCHIAT, V53, P753, DOI 10.1177/070674370805301107; Kisely S, 2016, AUST NZ J PSYCHIAT, V50, P254, DOI 10.1177/0004867415577979; Klein JP., 2003, SURVIVAL ANAL TECHNI; Kleinbaum DG, 2005, COMPETING RISKS SURV, P391; Kralj B, 2000, ONTARIO MED REV, V67, P33; Kralj B., 2009, MEASURING RURALITY R; Kurdyak P, 2015, CAN J PSYCHIAT, V60, P362, DOI 10.1177/070674371506000805; Kurdyak P, 2012, SCHIZOPHR RES, V142, P52, DOI 10.1016/j.schres.2012.09.003; Labianca R, 2010, ANN ONCOL, V21, pv70, DOI 10.1093/annonc/mdq168; Lin J, 2016, CANCER EPIDEM BIOMAR, V25, P1564, DOI 10.1158/1055-9965.EPI-16-0316; Lora A, 2007, COMMUNITY MENT HLT J, V43, P341, DOI 10.1007/s10597-006-9078-z; Maddison AR, 2011, CANCER CAUSE CONTROL, V22, P359, DOI 10.1007/s10552-010-9722-3; Matheson FI, 2012, MARG ONTARIO MARGINA; Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823; Musuuza JS, 2013, CANCER-AM CANCER SOC, V119, P2469, DOI 10.1002/cncr.28091; Obuchi T, 2014, SURG TODAY, V44, P855, DOI 10.1007/s00595-013-0599-0; Prasad SM, 2014, J CLIN ONCOL, V32, P2471, DOI 10.1200/JCO.2013.51.1048; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Ruggeri M, 2000, BRIT J PSYCHIAT, V177, P149, DOI 10.1192/bjp.177.2.149; Safdieh JJ, 2017, AM J MENS HEALTH, V11, P5, DOI 10.1177/1557988315610626; Sharma A, 2010, BREAST, V19, P410, DOI 10.1016/j.breast.2010.04.001; Sinding C, 2013, SOC WORK MENT HEALTH, V11, P288, DOI 10.1080/15332985.2012.758075; Sinding C, 2014, SUPPORT CARE CANCER, V22, P3101, DOI 10.1007/s00520-014-2348-3; Steele LS, 2006, PSYCHIAT SERV, V57, P317, DOI 10.1176/appi.ps.57.3.317; Sun YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138134; Thompson JM, 2014, HLTH WELL BEING CANA; Tran E, 2009, CANCER-AM CANCER SOC, V115, P3555, DOI 10.1002/cncr.24383; Vigod S., 2016, ANTIPSYCHOTIC MEDICA; Vigod SN, 2014, BJOG-INT J OBSTET GY, V121, P566, DOI 10.1111/1471-0528.12567; Vigod SN, 2014, PEDIATRICS, V133, pE585, DOI 10.1542/peds.2013-1761; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weinstein LC, 2016, CA-CANCER J CLIN, V66, P134, DOI 10.3322/caac.21334	68	7	7	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235409	10.1371/journal.pone.0235409	http://dx.doi.org/10.1371/journal.pone.0235409			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2YL	32726314	Green Published, gold			2022-12-26	WOS:000556908900005
J	Wu, F; Seib, M; Mauel, S; Klinzing, S; Hicks, AL				Wu, Fan; Seib, Matt; Mauel, Samantha; Klinzing, Sydney; Hicks, Andrea L.			A citizen science approach estimating titanium dioxide released from personal care products	PLOS ONE			English	Article							WASTE-WATER; ENGINEERED NANOMATERIALS; TIO2 NANOPARTICLES; EXPOSURE DATA; OXIDE NANOPARTICLES; COSMETIC PRODUCTS; ACTIVATED-SLUDGE; FOOD-PRODUCTS; SUNSCREENS; TOXICITY	Titanium dioxide (TiO2) is a common component in personal care products (PCP), which through use enters the wastewater treatment plant (WWTP) and ultimately the environment. A citizen science approach is utilized here to inform the prevalence and usage of TiO(2)containing PCP on a household scale, which generates information as to the quantity of TiO(2)entering the WWTP, and the portion ultimately discharged to the environment. Meanwhile, citizen science sourced inventories were generated to estimate the quantity of TiO2, and potentially nanoscale TiO(2)entering the WWTP from consumer products and to determine which products had the greatest contribution. The estimated values were compared with water samples from the WWTP which quantified the amount of total titanium present using ICP-AES. These values were at a similar level with other top-down estimation approaches and suggest that a citizen science approach is valid to estimate the loading of TiO2, and potentially other emerging contaminants, while at the same time engaging with community stakeholders.	[Wu, Fan] Jinan Univ, Guangdong Key Lab Environm Pollut & Hlth, Sch Environm, Guangzhou, Peoples R China; [Wu, Fan; Mauel, Samantha; Klinzing, Sydney; Hicks, Andrea L.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Seib, Matt] Madison Metropolitan Sewerage Dist, Madison, WI USA	Jinan University; University of Wisconsin System; University of Wisconsin Madison	Hicks, AL (corresponding author), Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA.	Hicks5@wisc.edu	Wu, Fan/Q-2346-2019	Wu, Fan/0000-0001-8621-9449; Hicks, Andrea/0000-0002-6426-9717	National Science Foundation (NSF) [1743891]; Wisconsin Alumni Research Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Wisconsin Alumni Research Foundation	This work is supported by the National Science Foundation (NSF #1743891) and Wisconsin Alumni Research Foundation.	Arsenic A. M, 1996, METHOD 3050B ACID DI; Benn T, 2010, J ENVIRON QUAL, V39, P1875, DOI 10.2134/jeq2009.0363; Bernauer U, 2018, OPINION TITANIUM DIO, P53; Biesterbos JWH, 2013, FOOD CHEM TOXICOL, V55, P8, DOI 10.1016/j.fct.2012.11.014; Boxall ABA, 2007, SCI TOTAL ENVIRON, V390, P396, DOI [10.1016/j.scitotenv.2007.10.01018031795, DOI 10.1016/J.SCITOTENV.2007.10.01018031795]; Boxall AB, 2007, NANOMEDICINE-UK, V2, P919, DOI 10.2217/17435889.2.6.919; Chen XX, 2013, SMALL, V9, P1765, DOI 10.1002/smll.201201506; El Badawy AM, 2010, ENVIRON SCI TECHNOL, V44, P1260, DOI 10.1021/es902240k; Gondikas AP, 2014, ENVIRON SCI TECHNOL, V48, P5415, DOI 10.1021/es405596y; Gottschalk F, 2013, ENVIRON POLLUT, V181, P287, DOI 10.1016/j.envpol.2013.06.003; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Hall B, 2011, FOOD CHEM TOXICOL, V49, P408, DOI 10.1016/j.fct.2010.11.016; Heigl F, 2019, P NATL ACAD SCI USA, V116, P8089, DOI 10.1073/pnas.1903393116; Hou J, 2019, J ENVIRON SCI, V75, P40, DOI 10.1016/j.jes.2018.06.010; Jarvie HP, 2009, ENVIRON SCI TECHNOL, V43, P8622, DOI 10.1021/es901399q; Johnson AC, 2011, SCI TOTAL ENVIRON, V409, P2503, DOI 10.1016/j.scitotenv.2011.03.040; Keller AA, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2489-9; Keller AA, 2014, ENVIRON SCI TECH LET, V1, P65, DOI 10.1021/ez400106t; Keller AA, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1692-4; Khosravi K, 2012, ANAL CHIM ACTA, V713, P86, DOI 10.1016/j.aca.2011.11.048; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Lazareva A, 2014, ACS SUSTAIN CHEM ENG, V2, P1656, DOI 10.1021/sc500121w; Lehtonen M, 2004, ECOL ECON, V49, P199, DOI 10.1016/j.ecolecon.2004.03.019; Lewicka ZA, 2011, J NANOPART RES, V13, P3607, DOI 10.1007/s11051-011-0438-4; Limbach LK, 2008, ENVIRON SCI TECHNOL, V42, P5828, DOI 10.1021/es800091f; Lomer MCE, 2001, EUR J GASTROEN HEPAT, V13, P101, DOI 10.1097/00042737-200102000-00003; Loretz LJ, 2008, FOOD CHEM TOXICOL, V46, P1516, DOI 10.1016/j.fct.2007.12.011; Loretz L, 2006, FOOD CHEM TOXICOL, V44, P2008, DOI 10.1016/j.fct.2006.06.029; Loretz LJ, 2005, FOOD CHEM TOXICOL, V43, P279, DOI 10.1016/j.fct.2004.09.016; ltd R and M, TIT DIOX TIO2 A GLOB; Mahlalela LC, 2017, J ENVIRON SCI HEAL A, V52, P794, DOI 10.1080/10934529.2017.1305176; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Musee N, 2011, HUM EXP TOXICOL, V30, P1181, DOI 10.1177/0960327110391387; Nowack B, 2012, HDB GREEN CHEM, P227, DOI [10.1002/9783527628698.hgc102, DOI 10.1002/9783527628698.HGC102]; Peters RJB, 2014, J AGR FOOD CHEM, V62, P6285, DOI 10.1021/jf5011885; Rompelberg C, 2016, NANOTOXICOLOGY, V10, P1404, DOI 10.1080/17435390.2016.1222457; Sanchez-Quiles D, 2014, ENVIRON SCI TECHNOL, V48, P9037, DOI 10.1021/es5020696; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Shandilya N, 2015, ENVIRON SCI TECHNOL, V49, P2163, DOI 10.1021/es504710p; Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15; Shi XM, 2016, NANOIMPACT, V3-4, P96, DOI 10.1016/j.impact.2016.09.002; Shukla RK, 2011, TOXICOL IN VITRO, V25, P231, DOI 10.1016/j.tiv.2010.11.008; Smijs TG, 2011, NANOTECHNOL SCI APPL, V4, P95, DOI 10.2147/NSA.S19419; Sun TY, 2016, ENVIRON SCI TECHNOL, V50, P4701, DOI 10.1021/acs.est.5b05828; Tiede K., 2012, REV RISKS POSED DRIN; Warheit DB, 2015, FOOD CHEM TOXICOL, V84, P208, DOI 10.1016/j.fct.2015.08.026; Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d; Westerhoff P, 2011, J ENVIRON MONITOR, V13, P1195, DOI 10.1039/c1em10017c; Windler L, 2012, ENVIRON SCI TECHNOL, V46, P8181, DOI 10.1021/es301633b; Wu F, 2020, INTEGR ENVIRON ASSES, V16, P10, DOI 10.1002/ieam.4197; Wu XM, 2010, FOOD CHEM TOXICOL, V48, P3109, DOI 10.1016/j.fct.2010.08.004; Yang XN, 2013, WATER RES, V47, P3947, DOI 10.1016/j.watres.2013.01.056; Yang Y, 2014, ENVIRON SCI TECHNOL, V48, P6391, DOI 10.1021/es500436x; Zheng X, 2011, ENVIRON SCI TECHNOL, V45, P7284, DOI 10.1021/es2008598; Zhou XH, 2015, CHEMOSPHERE, V119, P568, DOI 10.1016/j.chemosphere.2014.07.037	55	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235988	10.1371/journal.pone.0235988	http://dx.doi.org/10.1371/journal.pone.0235988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726346	Green Published, gold			2022-12-26	WOS:000556908900035
J	Munoz-Perez, I; Mecias-Calvo, M; Crespo-Alvarez, J; Samano-Celorio, ML; Agudo-Toyos, P; Lago-Fuentes, C				Munoz-Perez, Iker; Mecias-Calvo, Marcos; Crespo-Alvarez, Jorge; Samano-Celorio, Maria Luisa; Agudo-Toyos, Pablo; Lago-Fuentes, Carlos			Different race pacing strategies among runners covering the 2017 Berlin Marathon under 3 hours and 30 minutes	PLOS ONE			English	Article							DECISION-MAKING; PERFORMANCE; PERCEPTION; EXERCISE; SEX; AGE	The purposes of this study were 1) to analyse the different pacing behaviours based on athlete's performance and 2) to determine whether significant differences in each race split and the runner's performance implied different race profiles. A total of 2295 runners, which took part in Berlin's marathon (2017), met the inclusion criteria. 4 different groups were created based on sex and performance. Men: Elite (<02:19:00 h), Top 1 (<02:30:00 h), Top 2 (<02:45:00 h) and Top 3 (<03:00:00 h); women: Elite (02:45:00 h), Top 1 (<03:00:00 h), Top 2 (<03:15:00 h), Top 3 (<03:30:00 h). With the aim of comparing the pacing between sex and performance the average speed was normalized. In men, no statistically significant changes were found between performance group and splits. A large number of significant differences between splits and groups were found amongst women: 5-10 km Top 2 vs Top 3 (P = 0.0178), 10-15 km Top1 vs Top 2 (P = 0.0211), 15-20 km Top1 vs Top 2 (P = 0.0382), 20-21.1 km Elite vs Top 2 (P = 0.0129); Elite vs Top 3 (P = 0.0020); Top1 vs Top 2 (P = 0.0233); Top 1 vs Top 3 (P = 0.0007), 25-30 km Elite vs Top 2 (P = 0.0273); Elite vs Top 3 (P = 0.0156), 30-35 km Elite vs Top 2 (P = 0.0096); Top 1 vs Top 2 (P = 0.0198); Top2 vs Top3 (P = 0.0069). In men there were little significant differences based on athletes' performance which implied a similar pacing behaviour. Women presented numerous differences based on their performance which suggested different pacing behaviours.	[Munoz-Perez, Iker; Mecias-Calvo, Marcos; Crespo-Alvarez, Jorge; Agudo-Toyos, Pablo; Lago-Fuentes, Carlos] Univ Europea Atlantico UNEATLANTICO, Fac Ciencias Salud, Santander, Spain; [Munoz-Perez, Iker] Runnea, Baracaldo, Spain; [Mecias-Calvo, Marcos] Ctr Invest & Tecnol Ind Cantabria CITICAN, Santander, Spain; [Crespo-Alvarez, Jorge] Recursos Obras Montajes & Asistencias ROMA, Santa Cruz De Bezana, Spain; [Samano-Celorio, Maria Luisa] Univ Int Iberoamer, Campeche, Mexico		Mecias-Calvo, M (corresponding author), Univ Europea Atlantico UNEATLANTICO, Fac Ciencias Salud, Santander, Spain.; Mecias-Calvo, M (corresponding author), Ctr Invest & Tecnol Ind Cantabria CITICAN, Santander, Spain.	marcos.mecias@uneatlantico.es	Muñoz, Iker/HDN-8895-2022; Celorio, María Luisa Sámano/I-3399-2015; CALVO, MARCOS MECÍAS/AAS-3394-2020; Lago-Fuentes, Carlos/J-4361-2019; Alvarez, Jorge Crespo/AAT-1988-2021	Muñoz, Iker/0000-0001-5480-1581; Celorio, María Luisa Sámano/0000-0002-7097-9352; CALVO, MARCOS MECÍAS/0000-0002-4719-7686; Lago-Fuentes, Carlos/0000-0003-4139-9911; Alvarez, Jorge Crespo/0000-0001-7589-5337				Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Angus SD, 2014, J SPORT SCI, V32, P31, DOI 10.1080/02640414.2013.803592; Angus SD, 2011, MED SCI SPORT EXER, V43, P2405, DOI 10.1249/MSS.0b013e3182245367; Breen D, 2017, INT J SPORT PHYSIOL, P1; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Deaner RO, 2015, MED SCI SPORT EXER, V47, P607, DOI 10.1249/MSS.0000000000000432; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Diaz JJ., 2018, EUR J SPORT SCI, V4, P1, DOI [10.17979/sportis.2018.4.1.3243, DOI 10.17979/SPORTIS.2018.4.1.3243]; Diaz-Castro J, 2020, EUR J NUTR, V59, P1577, DOI 10.1007/s00394-019-02013-5; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; Foster C., 2012, ENDUR TRAIN SCI PRAC, V1, P85; Gordon D, 2017, OPEN ACCESS J SPORTS, V8, P231, DOI 10.2147/OAJSM.S141657; Hanley B, 2016, J SPORT SCI, V34, P1675, DOI 10.1080/02640414.2015.1132841; Lucia A, 2006, APPL PHYSIOL NUTR ME, V31, P530, DOI 10.1139/H06-029; March DS, 2011, J STRENGTH COND RES, V25, P386, DOI 10.1519/JSC.0b013e3181bffd0f; Maughan R J, 1985, Br J Sports Med, V19, P192; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Nikolaidis PT, 2019, J STRENGTH COND RES, V33, P3423, DOI 10.1519/JSC.0000000000002159; Nikolaidis PT, 2018, RES SPORTS MED, V26, P86, DOI 10.1080/15438627.2017.1393752; Nikolaidis PT, 2017, OPEN ACCESS J SPORTS, V8, P171, DOI 10.2147/OAJSM.S141649; Nikolaidis PT, 2019, MED, V55; Rauch HGL, 2005, BRIT J SPORT MED, V39, P34, DOI 10.1136/bjsm.2003.010645; Renfree A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01432; Renfree A, 2014, SPORTS MED, V44, P147, DOI 10.1007/s40279-013-0107-0; Renfree A, 2013, INT J SPORT PHYSIOL, V8, P279, DOI 10.1123/ijspp.8.3.279; Roepstorff C, 2002, AM J PHYSL ENDOCRINO, V282; Santos-Lozano A, 2014, INT J SPORTS MED, V35, P933, DOI 10.1055/s-0034-1367048; Seiler S, 2010, INT J SPORT PHYSIOL, V5, P276, DOI 10.1123/ijspp.5.3.276; Smits BLM, 2014, SPORTS MED, V44, P763, DOI 10.1007/s40279-014-0163-0; Stoggl TL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00295; Swain P, 2020, EUR J SPORT SCI, V20, P880, DOI 10.1080/17461391.2019.1688396; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236658	10.1371/journal.pone.0236658	http://dx.doi.org/10.1371/journal.pone.0236658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722683	gold, Green Published			2022-12-26	WOS:000556916000005
J	Palayew, A; Stumo, SR; Cooke, GS; Hutchinson, SJ; Jauffret-Roustide, M; Maticic, M; Harris, M; Metwally, AM; Razavi, H; Lazarus, JV				Palayew, Adam; Stumo, Samya R.; Cooke, Graham S.; Hutchinson, Sharon J.; Jauffret-Roustide, Marie; Maticic, Mojca; Harris, Magdalena; Metwally, Ammal M.; Razavi, Homie; Lazarus, Jeffrey V.		Hep-CORE Study Grp	The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data	PLOS ONE			English	Article							VIRAL-HEPATITIS; RESTRICTIONS; INFECTION; DRUGS	Background New hepatitis C virus (HCV) treatments spurred the World Health Organization (WHO) in 2016 to adopt a strategy to eliminate HCV as a public health threat by 2030. To achieve this, key policies must be implemented. In the absence of monitoring mechanisms, this study aims to assess the extent of policy implementation from the perspective of liver patient groups. Methods Thirty liver patient organisations, each representing a country, were surveyed in October 2018 to assess implementation of HCV policies in practice. Respondents received two sets of questions based on: 1) WHO recommendations; and 2) validated data sources verifying an existing policy in their country. Academic experts selected key variables from each set for inclusion into policy scores. The similarity scores were calculated for each set with a multiple joint correspondence analysis. Proxy reference countries were included as the baseline to contextualize results. We extracted scores for each country and standardized them from 0 to 10 (best). Results Twenty-five countries responded. For the score based on WHO recommendations, Bulgaria had the lowest score whereas five countries (Cyprus, Netherlands, Portugal, Slovenia, and Sweden) had the highest scores. For the verified policy score, a two-dimensional solution was identified; first dimension scores pertained to whether verified policies were in place and second dimension scores pertained to the proportion of verified policies in-place that were implemented. Spain, UK, and Sweden had high scores for both dimensions. Conclusions Patient groups reported that the European region is not on track to meet WHO 2030 HCV goals. More action should be taken to implement and monitor HCV policies.	[Palayew, Adam] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Stumo, Samya R.; Lazarus, Jeffrey V.] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain; [Cooke, Graham S.] Imperial Coll, Div Infect Dis, London, England; [Hutchinson, Sharon J.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Jauffret-Roustide, Marie] Paris Descartes Univ, Ecole Hautes Etud Sci Sociales, Cermes3, INSERM,CNRS,U988,UMR 8211, Paris, France; [Maticic, Mojca] Univ Med Ctr Ljubljana, Clin Infect Dis & Febrile Illnesses, Ljubljana, Slovenia; [Maticic, Mojca] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Harris, Magdalena] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England; [Metwally, Ammal M.] Natl Res Ctr, Med Res Div, Community Med Res Dept, Giza, Egypt; [Metwally, Ammal M.] Assoc Liver Patient Care, Dakhlyia, Egypt; [Razavi, Homie] Ctr Dis Anal Fdn, Lafayette, CO USA	McGill University; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Imperial College London; Glasgow Caledonian University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University Medical Centre Ljubljana; University of Ljubljana; University of London; London School of Hygiene & Tropical Medicine; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Lazarus, JV (corresponding author), Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain.	Jeffrey.lazarus@isglobal.org	Metwally, Ammal M/A-1531-2016; Lazarus, Jeffrey V./R-6248-2018; Jauffret-Roustide, Marie/AAF-4983-2021	Metwally, Ammal M/0000-0003-0575-5202; Lazarus, Jeffrey V./0000-0001-9618-2299; Jauffret-Roustide, Marie/0000-0001-8563-5395; Palayew, Adam/0000-0002-1904-5730; Harris, Magdalena/0000-0001-8718-8226; Razavi, Homie/0000-0002-2658-6930	AbbVie; Gilead Sciences; MSD; BRC of Imperial College NHS Trust; NIHR Professorship; Spanish Ministry of Science, Innovation and Universities Miguel Servet grant (Instituto de Salud Carlos III/ESF, European Union) [CP18/00074]; Spanish Ministry of Science, Innovation and Universities through the "Severo Ochoa Centre of Excellence 2019-2023" [CEX2018000806-S]; Government of Catalonia, Spain, through the CERCA Program; MRC [MR/P025064/1] Funding Source: UKRI	AbbVie(AbbVie); Gilead Sciences(Gilead Sciences); MSD; BRC of Imperial College NHS Trust; NIHR Professorship; Spanish Ministry of Science, Innovation and Universities Miguel Servet grant (Instituto de Salud Carlos III/ESF, European Union); Spanish Ministry of Science, Innovation and Universities through the "Severo Ochoa Centre of Excellence 2019-2023"; Government of Catalonia, Spain, through the CERCA Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The European Liver Patients' Association received funding from AbbVie, Gilead Sciences and MSD to carry out this study. GC is supported in part by the BRC of Imperial College NHS Trust and an NIHR Professorship and that JVL is supported by a Spanish Ministry of Science, Innovation and Universities Miguel Servet grant (Instituto de Salud Carlos III/ESF, European Union (CP18/00074)). JVL further acknowledges support from the Spanish Ministry of Science, Innovation and Universities through the "Severo Ochoa Centre of Excellence 2019-2023" Program (CEX2018000806-S), and support from the Government of Catalonia, Spain, through the CERCA Program. ICMJE forms have been provided by all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker W, 2017, ECOL INDIC, V80, P12, DOI 10.1016/j.ecolind.2017.03.056; Bielen R, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0230-1; Centre for Disease Analysis, 2018, POL OBS; Cooke GS, 2019, LANCET GASTROENTEROL, V4, P135, DOI 10.1016/S2468-1253(18)30270-X; Di Franco G, 2016, QUAL QUANT, V50, P1299, DOI 10.1007/s11135-015-0206-0; ECDC, 2018, ANT CONS ANN EP REP; European Liver Patients Associtation, 2017, 2016 HEP COR REP MON; European Monitoring Center for Drugs and Drug Additction, 2018, COUNTR DRUG REP EUR; Greenacre M., 2017, CORRES ANAL PRACTICE, V2, DOI [10.1201/9781420011234, DOI 10.1201/9781315369983]; Hofstraat SHI, 2017, EPIDEMIOL INFECT, V145, P2873, DOI [10.1017/S0950268817001947, 10.1017/s0950268817001947]; Lazarus JV, 2017, INT J DRUG POLICY, V47, P47, DOI 10.1016/j.drugpo.2017.05.054; Lazarus JV, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25052; Lazarus JV, 2017, J HEPATOL, V67, P665, DOI 10.1016/j.jhep.2017.06.033; Lazarus JV, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S6-S18; Lazarus JV, 2013, LANCET GLOB HEALTH, V1, pE127, DOI 10.1016/S2214-109X(13)70038-X; Lazarus JV, 2018, MICROELIMINATION APR; Likert R., 1932, ARCH PSYCHOL, V22, P16; Marshall AD, 2018, J HEPATOL, V69, P1188, DOI 10.1016/j.jhep.2018.06.016; Marshall AD, 2018, LANCET GASTROENTEROL, V3, P125, DOI 10.1016/S2468-1253(17)30284-4; Mazziotta M, 2013, RIV ITALIANA EC DEMO, V67; Palayew A, 2020, LANCET GASTROENTEROL; Paruolo P, 2013, J ROY STAT SOC, V176, P24; Petruzziello A, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0099-0; Smith J, 2017, AIDS BEHAV, V21, pS44, DOI 10.1007/s10461-016-1579-3; Sourial N, 2010, J CLIN EPIDEMIOL, V63, P638, DOI 10.1016/j.jclinepi.2009.08.008; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Torres MA, 2017, AIDS BEHAV, V21, pS51, DOI 10.1007/s10461-016-1621-5; WHO, 2016, ASS VIR HEP RESP KYR; World Health Organization, 2016, GLOB HLTH SECT STRAT	29	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0235715	10.1371/journal.pone.0235715	http://dx.doi.org/10.1371/journal.pone.0235715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722701	gold, Green Published			2022-12-26	WOS:000556916000044
J	Almoughrabie, S; Ngari, C; Guillier, L; Briandet, R; Poulet, V; Dubois-Brissonnet, F				Almoughrabie, Samia; Ngari, Chrisse; Guillier, Laurent; Briandet, Romain; Poulet, Valerie; Dubois-Brissonnet, Florence			Rapid assessment and prediction of the efficiency of two preservatives againstS.aureusin cosmetic products using High Content Screening-Confocal Laser Scanning Microscopy	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; VIABILITY ASSESSMENT; FLUORESCENT-PROBES; TEMPORAL PATTERNS; MODEL; OIL; INFECTIONS; BIOCIDES; BACTERIA; EFFICACY	Most cosmetic products are susceptible to microbiological spoilage due to contaminations that could happen during fabrication or by consumer's repetitive manipulation. The composition of cosmetic products must guarantee efficient bacterial inactivation all along with the product shelf life, which is usually assessed by challenge-tests. A challenge-test consists in inoculating specific bacteria, i.e.Staphylococcus aureus, in the formula and then investigating the bacterial log reduction over time. The main limitation of this method is relative to the time-consuming protocol, where 30 days are needed to obtain results. In this study, we have proposed a rapid alternative method coupling High Content Screening-Confocal Laser Scanning Microscopy (HCS-CLSM), image analysis and modeling. It consists in acquiring real-timeS.aureusinactivation kinetics on short-time periods (typically 4h) and in predicting the efficiency of preservatives on longer scale periods (up to 7 days). The action of two preservatives, chlorphenesin and benzyl alcohol, was evaluated againstS.aureusat several concentrations in a cosmetic matrix. From these datasets, we compared two secondary models to determine the logarithm reduction time (Dc) for each preservative concentration. Afterwards, we used two primary inactivation models to predict log reductions for up to 7 days and we compared them to observed log reductions. The IQ model better fits datasets and the Q value gives information about the matrix level of interference.	[Almoughrabie, Samia; Briandet, Romain; Dubois-Brissonnet, Florence] Univ Paris Saclay, Micalis Inst, INRAE, AgroParisTech, Jouy En Josas, France; [Ngari, Chrisse; Poulet, Valerie] Labs Clarins, Pontoise, France; [Guillier, Laurent] Agence Natl Secur Alimentat Environm & Travail, Direct Evaluat Risques, ANSES, Maisons Alfort, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Dubois-Brissonnet, F (corresponding author), Univ Paris Saclay, Micalis Inst, INRAE, AgroParisTech, Jouy En Josas, France.	florence.dubois-brissonnet@agroparistech.fr	Guillier, Laurent/K-9644-2016; Briandet, Romain/AAD-2102-2020	Guillier, Laurent/0000-0002-7867-2937; Briandet, Romain/0000-0002-8123-3492; Almoughrabie, Samia/0000-0003-0334-1866; Dubois-Brissonnet, Florence/0000-0003-2998-7518	Laboratoires Clarins; Micalis Institute	Laboratoires Clarins; Micalis Institute	The funds for the laboratory experiments were provided by both Micalis Institute and Laboratoires Clarins. Additionally, Laboratoires Clarins provided support in the form of salaries for authors VP and CN. The specific roles of each authors are articulated in the `author contributions' section.	AFSSA, 2007, AV AG FRANC SEC SAN; Al-Adham I., 2013, TYPES MICROBICIDAL M, P5; [Anonymous], 2020, AGENCE NATL SECURITE; Augustin JC, 2006, FOOD MICROBIOL, V23, P1, DOI 10.1016/j.fm.2005.01.010; Auty MAE, 2001, APPL ENVIRON MICROB, V67, P420, DOI 10.1128/AEM.67.1.420-425.2001; Baty F, 2015, J STAT SOFTW, V66, P1; Berthele H, 2014, INT J COSMETIC SCI, V36, P54, DOI 10.1111/ics.12094; Bigelow WD, 1920, J INFECT DIS, V27, P602, DOI 10.1093/infdis/27.6.602; Bouarab-Chibane L, 2018, FOOD CONTROL, V90, P189, DOI 10.1016/j.foodcont.2018.03.006; Bridier A, 2011, ANTIMICROB AGENTS CH, V55, P2648, DOI 10.1128/AAC.01760-10; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Bukowski M, 2010, TOXINS, V2, P1148, DOI 10.3390/toxins2051148; Campana R, 2006, LETT APPL MICROBIOL, V43, P301, DOI 10.1111/j.1472-765X.2006.01952.x; Canette A, 2019, METHODS MOL BIOL, V1918, P171, DOI 10.1007/978-1-4939-9000-9_14; Chen CY, 2003, J MICROBIOL METH, V55, P475, DOI 10.1016/S0167-7012(03)00194-5; Chitarra L. G., 2006, Fitopatologia Brasileira, V31, P349, DOI 10.1590/S0100-41582006000400004; Comas-Riu J, 1999, J MICROBIOL METH, V34, P215, DOI 10.1016/S0167-7012(98)00091-8; Davison WM, 2010, ANTIMICROB AGENTS CH, V54, P2920, DOI 10.1128/AAC.01734-09; Doherty SB, 2010, J MICROBIOL METH, V80, P231, DOI 10.1016/j.mimet.2009.12.009; Dorobantu LS, 2004, APPL ENVIRON MICROB, V70, P6333, DOI 10.1128/AEM.70.10.6333-6336.2004; Feuilloley MO, 2018, EVALUATION PRODUITS; Findley K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004436; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Halla N, 2018, MOLECULES, V23, DOI 10.3390/molecules23071571; Hedges AJ, 2002, INT J FOOD MICROBIOL, V76, P207, DOI 10.1016/S0168-1605(02)00022-3; Herrera AG, 2004, METH MOL B, V268, P293; Hugbo P, 2005, TROPICAL J PHARM RES, V2, DOI [10.4314/tjpr.v2i2.14604, DOI 10.4314/TJPR.V2I2.14604]; Jeanson S, 2011, APPL ENVIRON MICROB, V77, P1493, DOI 10.1128/AEM.02233-10; Johnson W, 2014, INT J TOXICOL, V33, p5S, DOI 10.1177/1091581814526893; Johnston MD, 2002, J APPL MICROBIOL, V92, P784, DOI 10.1046/j.1365-2672.2002.01584.x; Joux F, 2000, MICROBES INFECT, V2, P1523, DOI 10.1016/S1286-4579(00)01307-1; JUVEN BJ, 1994, J APPL BACTERIOL, V76, P626, DOI 10.1111/j.1365-2672.1994.tb01661.x; KANESHIRO ES, 1993, J MICROBIOL METH, V17, P1, DOI 10.1016/S0167-7012(93)80010-4; Karampoula F, 2016, APPL ENVIRON MICROB, V82, P5309, DOI 10.1128/AEM.01351-16; Kirk-Othmer, 2013, CHEM TECHNOLOGY COSM; Lambert RJW, 2000, J APPL MICROBIOL, V88, P907, DOI 10.1046/j.1365-2672.2000.01060.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lundov M. D., 2008, International Journal of Cosmetic Science, V30, P471, DOI 10.1111/j.1468-2494.2008.00475.x; Lundov MD, 2009, CONTACT DERMATITIS, V60, P70, DOI 10.1111/j.1600-0536.2008.01501.x; Mafart P, 2001, INT J FOOD MICROBIOL, V63, P51, DOI 10.1016/S0168-1605(00)00397-4; Pernin A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00137; Pernin A, 2018, J SCI FOOD AGR, V98, P5401, DOI 10.1002/jsfa.9082; Rawlinson LAB, 2010, BIOMACROMOLECULES, V11, P443, DOI 10.1021/bm901166y; Russell A. D., 2003, International Journal of Cosmetic Science, V25, P147, DOI 10.1046/j.1467-2494.2003.00179.x; Ryu S, 2014, INT J MOL SCI, V15, P8753, DOI 10.3390/ijms15058753; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholtyssek R., 2005, DIRECTORY MICROBICID, P263; SHIMAMOTO T, 1979, CHEM PHARM BULL, V27, P2743; STEPHENS PJ, 2003, PROG IND MICROBIOL, V37, P25; Takenaka S, 2008, APPL ENVIRON MICROB, V74, P1869, DOI 10.1128/AEM.02218-07; Tan ASB, 2013, PAK J PHARM SCI, V26, P153; The Good Scents Compagny information system, 2020, CHLORPH; The Good Scents Compagny information system, 2020, BENZ ALC; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Tran T. T., 1994, International Journal of Cosmetic Science, V16, P61, DOI 10.1111/j.1467-2494.1994.tb00084.x; Weiss J, 2015, CURR OPIN FOOD SCI, V4, P69, DOI 10.1016/j.cofs.2015.05.008; 2001, INT J TOXICOL, V20, P23, DOI DOI 10.1080/10915810152630729	57	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236059	10.1371/journal.pone.0236059	http://dx.doi.org/10.1371/journal.pone.0236059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716948	Green Submitted, Green Published, gold			2022-12-26	WOS:000556674500013
J	Schnitzler, F; Friedrich, M; Angelberger, M; Diegelmann, J; Stallhofer, J; Wolf, C; Dutschler, J; Truniger, S; Olszak, T; Beigel, F; Tillack, C; Lohse, P; Brand, S				Schnitzler, Fabian; Friedrich, Matthias; Angelberger, Marianne; Diegelmann, Julia; Stallhofer, Johannes; Wolf, Christiane; Duetschler, Joel; Truniger, Samuel; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Lohse, Peter; Brand, Stephan			Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn's disease and active smoking status resulting in ileal stenosis requiring surgery	PLOS ONE			English	Article							ULCERATIVE-COLITIS; FRAMESHIFT MUTATION; SUSCEPTIBILITY LOCI; INSERTION MUTATION; CLINICAL-COURSE; GENE-MUTATIONS; ASSOCIATION; RISK; VARIANTS; METAANALYSIS	Background NOD2variants are the strongest genetic predictors for susceptibility to Crohn's disease (CD). However, the clinical value ofNOD2on an individual patient level remains controversial. We aimed to define the predictive power of the majorNOD2mutations regarding complicated CD in a large single center cohort. Methods 1076 CD patients were prospectively genotyped for the three common CD-associatedNOD2mutations rs2066844, rs2066845, and rs2066847, followed by detailed genotype-phenotype analyses. Results Overall, 434 CD patients (40.3%) carried at least one of the three mainNOD2mutations. A significantly higher minor allele frequency (15.6%) of theNOD2frameshift mutation p.Leu1007fsX1008 (rs2066847) was seen in patients with aggressive disease compared to 8.2% in patients with mild disease (p = 2.6 x 10(-5)). Moreover, a total of 54 CD patients (5.0%) were homozygous for thisNOD2frameshift mutation. 100% of these patients had ileal disease compared to 82% ofNOD2wild-type carriers (p<0.0001). In homozygous carriers of theNOD2frameshift mutation, 87% presented with ileal stenosis, 68.5% had fistulas, and 72.2% required CD-related surgery despite immunosuppressive therapy in 87% of these patients. All homozygous carriers of the 1007fs mutation who were active smokers had ileal stenosis and required CD-related surgery. Conclusion Homozygosity for Leu1007fsX1008 is an excellent biomarker for predicting complicated CD on an individual patient level. Active smoking and homozygosity for this mutation is associated with a 100% risk for developing ileal stenosis requiring CD-related surgery. In these patients, smoking cessation and early initiation of immunosuppressive strategies may be beneficial.	[Schnitzler, Fabian; Angelberger, Marianne; Stallhofer, Johannes; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Brand, Stephan] Ludwig Maximilians Univ LMU Munich, Dept Med Grosshadern 2, Munich, Germany; [Friedrich, Matthias] Univ Oxford, Kennedy Inst Rheumatol Rheumatol & Musculoskeleta, Nuffield Dept Orthopaed, Oxford, England; [Diegelmann, Julia] Ludwig Maximilians Univ Munchen, Dept Prevent Dent & Periodontol, Munich, Germany; [Stallhofer, Johannes] Friedrich Schiller Univ, Dept Med 4, Univ Hosp, Jena, Germany; [Wolf, Christiane] Max Planck Inst Psychiat, Munich, Germany; [Duetschler, Joel; Truniger, Samuel; Brand, Stephan] Kantonsspital St Gallen, Dept Gastroenterol & Hepatol, St Gallen, Switzerland; [Lohse, Peter] Inst Lab Med & Human Genet, Singen, Germany	University of Munich; University of Oxford; University of Munich; Friedrich Schiller University of Jena; Max Planck Society; Kantonsspital St. Gallen	Schnitzler, F; Brand, S (corresponding author), Ludwig Maximilians Univ LMU Munich, Dept Med Grosshadern 2, Munich, Germany.; Brand, S (corresponding author), Kantonsspital St Gallen, Dept Gastroenterol & Hepatol, St Gallen, Switzerland.	fabian.schnitzler@gmail.com; stephan.brand@kssg.ch		Schnitzler, Fabian/0000-0001-8260-8594; Truniger, Samuel/0000-0002-5708-0975; Stallhofer, Johannes/0000-0001-8698-6103	Deutsche Forschungsgemeinschaft (DFG) [BR 1912/6-1]; Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium) [2010_EKES.32]; DFG [BE 4490/2-1]; Ludwig-Maximilians-University Munich (FoFoLe program); German Research Council (Deutsche Forschungsgemeinschaft/DFG) [OL/324-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium); DFG(German Research Foundation (DFG)); Ludwig-Maximilians-University Munich (FoFoLe program); German Research Council (Deutsche Forschungsgemeinschaft/DFG)(German Research Foundation (DFG))	S. Brand was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BR 1912/6-1) and the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32). F. Beigel was supported by the DFG (BE 4490/2-1). C. Tillack was supported by a grant of the Ludwig-Maximilians-University Munich (FoFoLe program). T. Olszak was supported by a grant of the German Research Council (Deutsche Forschungsgemeinschaft/DFG, OL/324-1).	Annese V, 2005, AM J GASTROENTEROL, V100, P84, DOI 10.1111/j.1572-0241.2005.40705.x; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Berkowitz L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02289; Brand S, 2013, GUT, V62, P1531, DOI 10.1136/gutjnl-2012-304151; Chen HY, 2011, DIS COLON RECTUM, V54, P1020, DOI 10.1007/DCR.0b013e31821b94b3; Chen YY, 2019, INT J COLORECTAL DIS, V34, P2023, DOI 10.1007/s00384-019-03441-9; Chivese T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139597; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hirano A, 2013, INFLAMM BOWEL DIS, V19, P526, DOI 10.1097/MIB.0b013e31828075e7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, J GASTROENTEROL, V45, P721, DOI 10.1007/s00535-010-0231-7; Lakatos PL, 2005, WORLD J GASTROENTERO, V11, P1489; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Lindoso L, 2018, AM J GASTROENTEROL, V113, P1524, DOI 10.1038/s41395-018-0239-9; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Momozawa Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04365-8; Nunes T, 2016, AM J GASTROENTEROL, V111, P411, DOI 10.1038/ajg.2015.401; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Opstelten JL, 2016, INFLAMM BOWEL DIS, V22, P2070, DOI 10.1097/MIB.0000000000000875; Parkes GC, 2014, J CROHNS COLITIS, V8, P717, DOI 10.1016/j.crohns.2014.02.002; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Pugazhendhi S, 2013, GENE, V512, P309, DOI 10.1016/j.gene.2012.10.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radlmayr M, 2002, GASTROENTEROLOGY, V122, P2091, DOI 10.1053/gast.2002.34020; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Schnitzler F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108503; Schnitzler F, 2012, INFLAMM BOWEL DIS, V18, P395, DOI 10.1002/ibd.21882; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Severs M, 2016, J CROHNS COLITIS, V10, P455, DOI 10.1093/ecco-jcc/jjv238; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; To N, 2016, ALIMENT PHARM THER, V43, P549, DOI 10.1111/apt.13511; van der Heide F, 2010, AM J GASTROENTEROL, V105, P1165, DOI 10.1038/ajg.2009.659; Vavassori P, 2004, INFLAMM BOWEL DIS, V10, P116, DOI 10.1097/00054725-200403000-00009	45	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236421	10.1371/journal.pone.0236421	http://dx.doi.org/10.1371/journal.pone.0236421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716958	gold, Green Published			2022-12-26	WOS:000556674500023
J	Shu, Z; Li, Z; Huang, HH; Chen, Y; Fan, J; Yu, L; Wu, ZH; Tian, L; Qi, Q; Peng, S; Wei, CY; Xie, ZQ; Li, XB; Feng, Q; Sheng, H; Li, GQ; Wei, DP; Shan, CL; Chen, G				Shu, Zhen; Li, Zhen; Huang, Huanhuan; Chen, Yan; Fan, Jun; Yu, Li; Wu, Zhihui; Tian, Ling; Qi, Qi; Peng, Shuang; Wei, Changyong; Xie, Zhongqiu; Li, Xiaobo; Feng, Qi; Sheng, Hao; Li, Guangqiang; Wei, Dongping; Shan, Changliang; Chen, Guo			Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition	ONCOGENE			English	Article							RIBONUCLEOTIDE REDUCTASE; GENOME INTEGRITY; SUBUNIT P53R2; S-PHASE; KINASE; ACTIVATION; STRESS; PROTEIN; SAMHD1; REPAIR	Ribonucleotide reductase (RNR) catalyzes the rate-limiting step of de novo synthesis of deoxyribonucleotide triphosphates (dNTPs) building blocks for DNA synthesis, and is a well-recognized target for cancer therapy. RNR is a heterotetramer consisting of two large RRM1 subunits and two small RRM2 subunits. RNR activity is greatly stimulated by transcriptional activation of RRM2 during S/G2 phase to ensure adequate dNTP supply for DNA replication. However, little is known about the cell-cycle-dependent regulation of RNR activity through RRM1. Here, we report that RRM1 is phosphorylated at Ser 559 by CDK2/cyclin A during S/G2 phase. And this S559 phosphorylation of RRM1enhances RNR enzymatic activity and is required for maintaining sufficient dNTPs during normal DNA replication. Defective RRM1 S559 phosphorylation causes DNA replication stress, double-strand break, and genomic instability. Moreover, combined targeting of RRM1 S559 phosphorylation and ATR triggers lethal replication stress and profound antitumor effects. Thus, this posttranslational phosphorylation of RRM1 provides an alternative mechanism to finely regulating RNR and therapeutic opportunities for cancer treatment.	[Shu, Zhen; Li, Zhen; Chen, Yan; Fan, Jun; Yu, Li; Wu, Zhihui; Tian, Ling; Chen, Guo] Jinan Univ, Sch Med, Dept Med Biochem & Mol Biol, Guangzhou 510632, Peoples R China; [Shu, Zhen; Wei, Changyong; Xie, Zhongqiu] Emory Univ, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA; [Li, Zhen; Feng, Qi; Sheng, Hao; Li, Guangqiang; Shan, Changliang] Jinan Univ, Biomed Translat Res Inst, Guangzhou 510632, Peoples R China; [Huang, Huanhuan; Wei, Dongping] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing 210006, Peoples R China; [Qi, Qi; Peng, Shuang] Jinan Univ, Sch Med, Dept Pathophysiol & Pharmacol, Guangzhou 510632, Peoples R China; [Li, Xiaobo] Tianjin Med Univ, Minist Educ, Key Lab Immune Microenvironm & Dis, Tianjin 300070, Peoples R China; [Shan, Changliang] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300350, Peoples R China; [Shan, Changliang] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300350, Peoples R China	Jinan University; Emory University; Jinan University; Nanjing Medical University; Jinan University; Tianjin Medical University; Nankai University; Nankai University	Chen, G (corresponding author), Jinan Univ, Sch Med, Dept Med Biochem & Mol Biol, Guangzhou 510632, Peoples R China.	gchen84@jnu.edu.cn	Peng, shuang/GPX-0999-2022; Chen, Guo/HGE-9902-2022; Xie, Zhongqiu/AAZ-9680-2020; Qi, Qi/J-3508-2013	Chen, Guo/0000-0001-8886-1873; Xie, Zhongqiu/0000-0002-2869-7669; Li, Guangqiang/0000-0003-2447-1803; Qi, Qi/0000-0003-4460-0713; Peng, Shuang/0000-0002-0163-9047	Natural Science Foundation of Guangdong Province of China [2019A1515011247]; Guangzhou Municipal Science and Technology Program of China [202002030451]; Fundamental Research Funds for the Central Universities [21620421]; National Natural Science Foundation of China [81472793, 81672895]	Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Guangzhou Municipal Science and Technology Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of Guangdong Province of China (2019A1515011247 to GC), Guangzhou Municipal Science and Technology Program of China (202002030451 to GC), Fundamental Research Funds for the Central Universities (21620421 to GC) and National Natural Science Foundation of China (81472793 and 81672895 to DW).	Arnaoutov A, 2014, SCIENCE, V345, P1512, DOI 10.1126/science.1251550; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Buckland RJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004846; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Chabes A, 1999, J BIOL CHEM, V274, P36679, DOI 10.1074/jbc.274.51.36679; Chang LF, 2008, P NATL ACAD SCI USA, V105, P18519, DOI 10.1073/pnas.0803313105; Chen G, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2994; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Chung G, 2015, GENE DEV, V29, P1969, DOI 10.1101/gad.266056.115; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Grinberg IR, 2018, J BIOL CHEM, V293, P15889, DOI 10.1074/jbc.RA118.004991; Grinberg IR, 2018, ELIFE, V7, DOI 10.7554/eLife.31529; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Le TM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00221-3; Lin YF, 2018, NUCLEIC ACIDS RES, V46, P59; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Logan DT, 2011, NAT STRUCT MOL BIOL, V18, P251, DOI 10.1038/nsmb0311-251; Ma K, 2012, INT J MOL SCI, V13, P11974, DOI 10.3390/ijms130911974; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maya-Mendoza A, 2018, NATURE, V559, P279, DOI 10.1038/s41586-018-0261-5; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Puigvert JC, 2016, FEBS J, V283, P232, DOI 10.1111/febs.13574; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Schmidt TT, 2019, NUCLEIC ACIDS RES, V47, P237, DOI 10.1093/nar/gky1154; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Schwab RAV, 2011, JOVE-J VIS EXP, DOI 10.3791/3255; Sopko R, 2014, DEV CELL, V31, P114, DOI 10.1016/j.devcel.2014.07.027; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tang CX, 2015, J BIOL CHEM, V290, P26352, DOI 10.1074/jbc.M115.677435; Tuli R, 2019, EBIOMEDICINE, V40, P375, DOI 10.1016/j.ebiom.2018.12.060; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Xie MH, 2014, CANCER RES, V74, P212, DOI 10.1158/0008-5472.CAN-13-1536-T; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Zhang JF, 2018, NATURE, V553, P91, DOI 10.1038/nature25015; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; Zhou BS, 2013, CANCER RES, V73, P6484, DOI 10.1158/0008-5472.CAN-13-1094; Zhu YH, 2004, MOL CELL BIOL, V24, P6268, DOI 10.1128/MCB.24.14.6268-6277.2004; Zimanyi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.07141	47	10	11	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2020	39	35					5721	5733		10.1038/s41388-020-01403-y	http://dx.doi.org/10.1038/s41388-020-01403-y		JUL 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NF2QB	32712628				2022-12-26	WOS:000552667700001
J	Kobayashi, Y; Higa, M; Higashiyama, K; Nakamura, F				Kobayashi, Yoshiko; Higa, Motoki; Higashiyama, Kan; Nakamura, Futoshi			Drivers of land-use changes in societies with decreasing populations: A comparison of the factors affecting farmland abandonment in a food production area in Japan	PLOS ONE			English	Article							COMMUNITY; COVER; RESTORATION; SUCCESSION; ECOLOGY; POLICY; MODEL	The extraordinary population growth of the 20th century will subside in the 21st century, followed by depopulation, constituting the first population decline phase in human history in Japan and other developed countries. The drivers of land-use change during the population decline phase are expected to differ from those of the population growth phase; however, research on land-use drivers during the decline phase is limited. Identifying these drivers is necessary to develop effective management plans for biodiversity and ecosystem services in the decline phase. First, we calculated the probability of farmland abandonment in Hokkaido, a Japanese food production area, from 1973-2009 and divided the period into the population growth phase (1978-1997) and the decline phase (1997-2009). We examined various geographical and social factors that were assumed to alter the land use during these two phases. Geographical and social conditions are key factors in determining the probability of farmland abandonment, but their influences varied between the two phases. The farmlands located on geographically uncultivable sites, such as marginal, underproductive, narrow, and steep land, were abandoned during these phases; however, social conditions, such as the distance from densely inhabited districts (DIDs) and the population, exerted opposite effects during these two phases. Farmland abandonment occurred near DIDs (i.e., urban areas) during the population growth phase, whereas farmland abandonment occurred far from DIDs and sparsely populated farmlands during the decline phase. Farmland abandonment was strongly affected by government policy during the population growth phase, but the policy weakened during the decline phase, which triggered farmland abandonment throughout Hokkaido. The geographical and social drivers found in the present study may provide new insights for other developed countries experiencing depopulation problems.	[Kobayashi, Yoshiko; Higashiyama, Kan; Nakamura, Futoshi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan; [Higa, Motoki] Kochi Univ, Fac Sci, Kochi, Kochi, Japan; [Kobayashi, Yoshiko] Natl Agr & Food Res Org NARO, Western Reg Agr Res Ctr, Zentsuji, Kagawa, Japan	Hokkaido University; Kochi University; National Agriculture & Food Research Organization - Japan	Kobayashi, Y (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan.; Kobayashi, Y (corresponding author), Natl Agr & Food Res Org NARO, Western Reg Agr Res Ctr, Zentsuji, Kagawa, Japan.	mail.yoshikob@gmail.com	Nakamura, Futoshi/A-6696-2012	Nakamura, Futoshi/0000-0003-4351-2578; Higa, Motoki/0000-0003-3406-999X	Environmental Research and Technology Development Fund [4-1504, 4-1805]; Ministry of the Environment of Japan	Environmental Research and Technology Development Fund; Ministry of the Environment of Japan(Ministry of the Environment, Japan)	Our study was supported by the Environmental Research and Technology Development Fund (4-1504, 4-1805) of the Ministry of the Environment of Japan.	Aide TM, 2004, SCIENCE, V305, P1915, DOI 10.1126/science.1103179; [Anonymous], 2012, ENCY US CENSUS; [Anonymous], 2014, R LANG ENV STAT COMP; Bellemare J, 2002, J BIOGEOGR, V29, P1401, DOI 10.1046/j.1365-2699.2002.00762.x; BERRY D, 1978, GROWTH CHANGE, V9, P2, DOI 10.1111/j.1468-2257.1978.tb01024.x; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; DUANE S, 1987, PHYS LETT B, V195, P216, DOI 10.1016/0370-2693(87)91197-X; Endo C, 2013, BIRD CONSERV INT, V23, P445, DOI 10.1017/S0959270912000457; Garcia-Ruiz JM, 2011, AGR ECOSYST ENVIRON, V140, P317, DOI 10.1016/j.agee.2011.01.003; Gellrich M, 2007, LANDSCAPE URBAN PLAN, V79, P65, DOI 10.1016/j.landurbplan.2006.03.004; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geospatial Information Authority of Japan, 2008, FUND GEOSP DAT ROAD; Geospatial Information Authority of Japan, 2009, FUND GEOSP DAT 10 M; GRASS Development Team, 2014, GEOGR RES AN SUPP SY; Hanioka M, 2018, AGR ECOSYST ENVIRON, V265, P217, DOI 10.1016/j.agee.2018.06.014; Hanioka M, 2018, BIODIVERS CONSERV, V27, P1831, DOI 10.1007/s10531-018-1510-5; Hashiguchi T., 2011, J RURAL EC, V82, P258; Hashiguchi T, 2014, ECOL RES MONOGR, P3, DOI 10.1007/978-4-431-55330-4_1; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Hokkaido Development Agency, 1978, 4 TERM HOKK COMPR DE; Hokkaido Development Agency, 1988, 5 TERM HOKK COMPR DE; Hokkaido Development Agency, 1998, 6 TERM HOKK COMPR DE; Hokkaido Development Agency, 2016, 8 TERM HOKK COMPR DE; Hokkaido Research Organization, 2003, WETL RES ENV DATABAS; Holmes MA, 2018, J ECOL, V106, P2121, DOI 10.1111/1365-2745.12970; Diaz GI, 2011, LANDSCAPE URBAN PLAN, V99, P207, DOI 10.1016/j.landurbplan.2010.11.005; Japan Soil Association, 2007, CHIRY HOZ DOJY DAT C; Kamp J, 2018, AGR ECOSYST ENVIRON, V268, P61, DOI 10.1016/j.agee.2018.09.009; Keenleyside C, 2010, FARMLAND ABANDONMENT; Koshida C, 2018, CONSERV BIOL, V32, P1392, DOI 10.1111/cobi.13156; Kosmas C, 2015, CATENA, V128, P252, DOI 10.1016/j.catena.2014.02.006; Lasanta T, 2017, CATENA, V149, P810, DOI 10.1016/j.catena.2016.02.024; Lasanta T, 2015, ENVIRON SCI POLICY, V52, P99, DOI 10.1016/j.envsci.2015.05.012; Levers C, 2018, SCI TOTAL ENVIRON, V644, P95, DOI 10.1016/j.scitotenv.2018.06.326; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Maimaitijiang M, 2015, INT J APPL EARTH OBS, V35, P161, DOI 10.1016/j.jag.2014.08.020; Mattison EHA, 2005, TRENDS ECOL EVOL, V20, P610, DOI 10.1016/j.tree.2005.08.011; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MEYER WB, 1992, ANNU REV ECOL SYST, V23, P39, DOI 10.1146/annurev.es.23.110192.000351; Morimoto J, 2017, RESTOR ECOL, V25, P1005, DOI 10.1111/rec.12516; Nakamura F, 2020, RIVER RES APPL, V36, P921, DOI 10.1002/rra.3576; National Institute of Population and Social Security Research, 2013, POP RES SER, V330; National Land Information Division, 1997, NAT NUM INF LAND UT; National Land Information Division, 2009, NAT LAND NUM INF LAN; National Land Information Division, 2000, NAT LAND NUM INF DEN; National Land Information Division, 1980, NAT LAND NUM INF DEN; National Land Information Division, 2005, NAT LAND NUM INF DEN; National Land Information Division, 2006, NAT LAND NUM INF LAN; National Land Information Division, 1976, NAT LAND NUM INF LAN; National Land Information Division, 1987, NAT NUM INF LAND UT; National Land Information Division, 1990, NAT LAND NUM INF DEN; National Land Information Division, 1970, NAT LAND NUM INF DEN; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Neal RM, 2011, CH CRC HANDB MOD STA, P113; NEAL RM, 1994, J COMPUT PHYS, V111, P194, DOI 10.1006/jcph.1994.1054; Nelson GC, 2006, ECOL SOC, V11; Nigi T., 1998, Research Bulletin of the Hokkaido University Forests, V55, P97; Nishihiro J., 2020, JAPAN ECOL CIVIL ENG, V22, P175; Ohashi H, 2019, T GIS, V23, P786, DOI 10.1111/tgis.12525; Ohwaki A, 2013, ENTOMOL SCI, V16, P379, DOI 10.1111/ens.12021; Osawa T, 2016, SCI TOTAL ENVIRON, V542, P478, DOI 10.1016/j.scitotenv.2015.10.067; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Perpina Castillo C., 2018, JRC113718; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rey Benayas J. M., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072057; Saizen I, 2006, LANDSCAPE URBAN PLAN, V78, P411, DOI 10.1016/j.landurbplan.2005.12.002; Shin MW, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010334; Sluis T.V.D., 2014, J LANDSC ECOL CZECH, V7, P23, DOI [10.2478/jlecol-2014-0008, DOI 10.2478/JLECOL-2014-0008]; Stan Development Team, 2014, STAN A C LIB PROB SA; Statics Department MAFF of Japan, 2015, STAT CULT LAND PLANT; Statistics Bureau MIC of Japan, 2000, GRID SQUAR STAT 2000, V1; Statistics Bureau MIC of Japan, 1970, GRID SQUAR STAT 1970; Statistics Bureau MIC of Japan, 1980, GRID SQUAR STAT 1980; Statistics Bureau MIC of Japan, TIM SER 2000 2010; Statistics Bureau MIC of Japan, POP EST JAP 1920 200; Statistics Bureau MIC of Japan, 2005, GRID SQUAR STAT 2005, V1; Statistics Bureau MIC of Japan, 1990, GRID SQUAR STAT 1990, V1; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tognetti PM, 2010, BIOL CONSERV, V143, P2494, DOI 10.1016/j.biocon.2010.06.016; Turley NE, 2017, J APPL ECOL, V54, P1100, DOI 10.1111/1365-2664.12903; Turner BL, 2008, ANNU REV ENV RESOUR, V33, P295, DOI 10.1146/annurev.environ.33.022207.104943; Uchida K, 2019, J APPL ECOL, V56, P1419, DOI 10.1111/1365-2664.13386; United Nations, 2019, STESASERA430 UN DEP; United Nations, 1999, 154 EASPWP UN; Usami S., 1968, REV SOC AGR EC, V24, P155; Yamanaka S, 2017, AGR ECOSYST ENVIRON, V249, P31, DOI 10.1016/j.agee.2017.07.027; Yanagida R., 2009, J ARCHITECTURE PLANN, V74, P99; Zhang Y, 2016, J RURAL STUD, V47, P524, DOI 10.1016/j.jrurstud.2016.06.019	91	12	12	11	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0235846	10.1371/journal.pone.0235846	http://dx.doi.org/10.1371/journal.pone.0235846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OD5ZL	32706787	gold, Green Published			2022-12-26	WOS:000579931700010
J	Moor, MB; Ramakrishnan, SK; Legrand, F; Bachtler, M; Koesters, R; Hynes, NE; Pasch, A; Bonny, O				Moor, Matthias B.; Ramakrishnan, Suresh K.; Legrand, Finola; Bachtler, Matthias; Koesters, Robert; Hynes, Nancy E.; Pasch, Andreas; Bonny, Olivier			Elevated serum magnesium lowers calcification propensity in Memo1-deficient mice	PLOS ONE			English	Article							P-I COTRANSPORT; ASCORBIC-ACID; KLOTHO; KIDNEY; PHOSPHATE; DIETARY; MEMO; PROGRESSION; HOMEOSTASIS; IMPAIRMENT	MEdiator of cell MOtility1 (MEMO1) is a ubiquitously expressed redox protein involved in extracellular ligand-induced cell signaling. We previously reported that inducible whole-body Memo1 KO (cKO) mice displayed a syndrome of premature aging and disturbed mineral metabolism partially recapitulating the phenotype observed in Klotho or Fgf23-deficient mouse models. Here, we aimed at delineating the contribution of systemic mineral load on the Memo1 cKO mouse phenotype. We attempted to rescue the Memo1 cKO phenotype by depleting phosphate or vitamin D from the diet, but did not observe any effect on survival. However, we noticed that, by contrast to Klotho or Fgf23-deficient mouse models, Memo1 cKO mice did not present any soft-tissue calcifications and displayed even a decreased serum calcification propensity. We identified higher serum magnesium levels as the main cause of protection against calcifications. Expression of genes encoding intestinal and renal magnesium channels and the regulator epidermal growth factor were increased in Memo1 cKO. In order to check whether magnesium reabsorption in the kidney alone was driving the higher magnesemia, we generated a kidney-specific Memo1 KO (kKO) mouse model. Memo1 kKO mice also displayed higher magnesemia and increased renal magnesium channel gene expression. Collectively, these data identify MEMO1 as a novel regulator of magnesium homeostasis and systemic calcification propensity, by regulating expression of the main magnesium channels.	[Moor, Matthias B.; Ramakrishnan, Suresh K.; Legrand, Finola; Bonny, Olivier] Univ Lausanne, Dept Med Biosci, Lausanne, Switzerland; [Moor, Matthias B.; Ramakrishnan, Suresh K.; Bonny, Olivier] Natl Ctr Competence Res NCCR Kidney CH Kidney Con, Zurich, Switzerland; [Bachtler, Matthias; Pasch, Andreas] Calciscon AG, Nidau, Switzerland; [Bachtler, Matthias; Pasch, Andreas] Johannes Kepler Univ Linz, Inst Physiol & Pathophysiol, Linz, Austria; [Koesters, Robert] Univ Paris 06, Dept Nephrol, Hop Tenon, Paris, France; [Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Hynes, Nancy E.] Univ Basel, Basel, Switzerland; [Bonny, Olivier] Lausanne Univ Hosp, Dept Med, Serv Nephrol, Lausanne, Switzerland; [Moor, Matthias B.] Bern Univ Hosp, Dept Nephrol & Hypertens, Bern, Switzerland	University of Lausanne; Johannes Kepler University Linz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern	Bonny, O (corresponding author), Univ Lausanne, Dept Med Biosci, Lausanne, Switzerland.; Bonny, O (corresponding author), Natl Ctr Competence Res NCCR Kidney CH Kidney Con, Zurich, Switzerland.; Bonny, O (corresponding author), Lausanne Univ Hosp, Dept Med, Serv Nephrol, Lausanne, Switzerland.	Olivier.Bonny@unil.ch		Moor, Matthias/0000-0002-7717-651X; bonny, olivier/0000-0003-4123-4279	Swiss National Science Foundation through the program NCCR-Kidney.CH [183774]; patient association "Association pour l'Information et la Recherche sur les maladies renales Genetiques (AIRG)-Suisse"	Swiss National Science Foundation through the program NCCR-Kidney.CH; patient association "Association pour l'Information et la Recherche sur les maladies renales Genetiques (AIRG)-Suisse"	The study was sponsored by the Swiss National Science Foundation through the program NCCR-Kidney.CH (183774) and by an unrestricted grant from the patient association "Association pour l'Information et la Recherche sur les maladies renales Genetiques (AIRG)-Suisse". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiria SA, 2017, P NATL ACAD SCI USA, V114, pE6079, DOI 10.1073/pnas.1707380114; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Anour R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031376; ARAR M, 1995, AM J PHYSIOL-RENAL, V268, pF309, DOI 10.1152/ajprenal.1995.268.2.F309; Arar M, 1999, AM J PHYSIOL-RENAL, V276, pF72, DOI 10.1152/ajprenal.1999.276.1.F72; Cao G, 2010, J BIOL CHEM, V285, P26081, DOI 10.1074/jbc.M110.103655; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Diaz-Tocados JM, 2017, KIDNEY INT, V92, P1084, DOI 10.1016/j.kint.2017.04.011; Gao HX, 2011, CELL CALCIUM, V50, P559, DOI 10.1016/j.ceca.2011.09.003; Gess B, 2010, GLIA, V58, P287, DOI 10.1002/glia.20923; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Haenzi B, 2014, FASEB J, V28, P327, DOI 10.1096/fj.13-228320; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Hesse M, 2007, MATRIX BIOL, V26, P75, DOI 10.1016/j.matbio.2006.10.003; HSU JM, 1983, J NUTR, V113, P2041, DOI 10.1093/jn/113.10.2041; Ju WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7071; Kawaguchi H, 1999, J CLIN INVEST, V104, P229, DOI 10.1172/JCI5705; Kim BJ, 2007, MOL CELLS, V23, P363; Kondo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094114; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; MacDonald G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004870; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Moor MB, 2018, JBMR PLUS, V2, P195, DOI 10.1002/jbm4.10034; Moor MB, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00874; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; MORTON RK, 1955, BIOCHEM J, V60, P573, DOI 10.1042/bj0600573; Nishida K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14471; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Ortega B, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13176; Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Sakaguchi Y, 2019, J AM SOC NEPHROL, V30, P1073, DOI 10.1681/ASN.2018111150; Sakaguchi Y, 2015, KIDNEY INT, V88, P833, DOI 10.1038/ki.2015.165; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Song MY, 2011, ANTIOXID REDOX SIGN, V15, P1549, DOI 10.1089/ars.2010.3648; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Thurneysen T, 2002, ANN NY ACAD SCI, V976, P367; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; van der Hagen EAE, 2014, PFLUG ARCH EUR J PHY, V466, P2077, DOI 10.1007/s00424-014-1470-x; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Yamashita T, 1998, J ENDOCRINOL, V159, P1, DOI 10.1677/joe.0.1590001; Zheltova AA, 2016, BIOMEDICINE-TAIWAN, V6, P8, DOI 10.7603/s40681-016-0020-6	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236361	10.1371/journal.pone.0236361	http://dx.doi.org/10.1371/journal.pone.0236361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706793	Green Published, gold			2022-12-26	WOS:000579931700031
J	Sievers, W; Rathner, JA; Green, RA; Kettle, C; Irving, HR; Whelan, DR; Fernandez, RGD; Zacharias, A				Sievers, Will; Rathner, Joseph A.; Green, Rodney A.; Kettle, Christine; Irving, Helen R.; Whelan, Donna R.; Fernandez, Richard G. D.; Zacharias, Anita			Innervation of supraclavicular adipose tissue: A human cadaveric study	PLOS ONE			English	Article							COLD-ACTIVATED BROWN; SYMPATHETIC-NERVE ACTIVITY; OBESITY; FAT; THERMOGENESIS; OUTFLOW	Functional brown adipose tissue (BAT) was identified in adult humans only in 2007 with the use of fluorodeoxyglucose positron emission tomography imaging. Previous studies have demonstrated a negative correlation between obesity and BAT presence in humans. It is proposed that BAT possesses the capacity to increase metabolism and aid weight loss. In rodents it is well established that BAT is stimulated by the sympathetic nervous system with the interscapular BAT being innervated via branches of intercostal nerves. Whilst there is evidence to suggest that BAT possesses beta-3 adrenoceptors, no studies have identified the specific nerve branch that carries sympathetic innervation to BAT in humans. The aim of this study was to identify and trace the peripheral nerve or nerves that innervate human BAT in the supraclavicular region. The posterior triangle region of the neck of cadaveric specimens were dissected in order to identify any peripheral nerve branches piercing and/or terminating in supraclavicular BAT. A previously undescribed branch of the cervical plexus terminating in a supraclavicular adipose depot was identified in all specimens. This was typically an independent branch of the plexus, from the third cervical spinal nerve, but in one specimen was a branch of the supraclavicular nerve. Histological analysis revealed the supraclavicular adipose depot contained tyrosine hydroxylase immunoreactive structures, which likely represent sympathetic axons. This is the first study that identifies a nerve branch to supraclavicular BAT-like tissue. This finding opens new avenues for the investigation of neural regulation of fat metabolism in humans.	[Sievers, Will; Rathner, Joseph A.; Green, Rodney A.; Kettle, Christine; Irving, Helen R.; Whelan, Donna R.; Zacharias, Anita] La Trobe Univ, La Trobe Inst Mol Sci, Dept Pharm & Biomed Sci, Bendigo, Vic, Australia; [Rathner, Joseph A.] Univ Melbourne, Dept Physiol, Sch Biomed Sci, Parkville, Vic, Australia; [Fernandez, Richard G. D.] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia	La Trobe University; University of Melbourne; La Trobe University	Sievers, W (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Pharm & Biomed Sci, Bendigo, Vic, Australia.	W.Sievers@latrobe.edu.au	; Irving, Helen/B-4425-2019	Zacharias, Anita/0000-0001-6100-9429; Rathner, Joseph/0000-0002-8734-9402; Irving, Helen/0000-0002-1514-0909; Kettle, Christine/0000-0003-3223-4090	Australian Research Council Australian Discovery Early Career Research Award [DE200100584]; Australian Government	Australian Research Council Australian Discovery Early Career Research Award(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	Dr. Whelan is the recipient of an Australian Research Council Australian Discovery Early Career Research Award (DE200100584) funded by the Australian Government. The Australian Government had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Institute of Health and Welfare, 2019, OV OB CAN AIHW2019; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Blaszkiewicz M, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010010; Bohlender J, 2015, Ann Cardiol Angeiol (Paris), V64, P175, DOI 10.1016/j.ancard.2015.04.015; Bujalska IJ, 2007, J ENDOCRINOL, V192, P279, DOI 10.1677/JOE-06-0042; Burgi K, 2011, AM J PHYSIOL-REG I, V300, pR264, DOI 10.1152/ajpregu.00687.2009; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen KY, 2020, J BIOL CHEM, V295, P1926, DOI 10.1074/jbc.REV119.007363; Chen YCI, 2013, J NUCL MED, V54, P1584, DOI 10.2967/jnumed.112.117275; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4; FAWCETT DW, 1952, J MORPHOL, V90, P363, DOI 10.1002/jmor.1050900208; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4989; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; FOSTER DO, 1982, CAN J PHYSIOL PHARM, V60, P107, DOI 10.1139/y82-018; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Hwang JJ, 2015, METABOLISM, V64, P747, DOI 10.1016/j.metabol.2015.03.001; Iwami M, 2013, BIOMED RES-TOKYO, V34, P173; Jameson J.L., 2016, ENDOCRINOLOGY ADULT, Vseventh; Kaisanlahti A, 2019, J PHYSIOL BIOCHEM, V75, P1, DOI 10.1007/s13105-018-0658-5; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Keiichiro S, 2010, NATURE ED, V9, P59; King NA, 2007, OBESITY, V15, P1373, DOI 10.1038/oby.2007.164; Koba S, 2018, J PHYSIOL-LONDON, V596, P4581, DOI 10.1113/JP276223; Lee P, 2013, ENDOCR REV, V34, P413, DOI 10.1210/er.2012-1081; Lee P, 2011, J CLIN ENDOCR METAB, V96, P2450, DOI 10.1210/jc.2011-0487; Leitner BP, 2017, P NATL ACAD SCI USA, V114, P8649, DOI 10.1073/pnas.1705287114; Loh RKC, 2017, OBES REV, V18, P1227, DOI 10.1111/obr.12584; Macefield VG, 2013, INT J PSYCHOPHYSIOL, V89, P451, DOI 10.1016/j.ijpsycho.2013.06.002; Madden CJ, 2008, NEUROPHARMACOLOGY, V54, P487, DOI 10.1016/j.neuropharm.2007.10.019; Madden CJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE287, DOI 10.1152/ajpendo.00081.2016; McLaughlin T, 2014, OBESITY, V22, P673, DOI 10.1002/oby.20209; Mihalopoulos NL, 2020, OBESITY, V28, P916, DOI 10.1002/oby.22767; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Muzik O, 2017, J NUCL MED, V58, P799, DOI 10.2967/jnumed.116.180992; Park Anna, 2014, World J Stem Cells, V6, P33, DOI 10.4252/wjsc.v6.i1.33; Perdikari A, 2018, CELL REP, V25, P784, DOI 10.1016/j.celrep.2018.09.044; Rathner JA, 2006, BRAIN RES, V1077, P99, DOI 10.1016/j.brainres.2006.01.035; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; SALANS LB, 1971, J CLIN INVEST, V50, P1005, DOI 10.1172/JCI106570; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sievers W, 2019, OBES SCI PRACT, V5, P592, DOI 10.1002/osp4.368; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Standring S., 2016, GRAYS ANATOMY ANATOM; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; World Health Organization, OB OV 2018; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125	51	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236286	10.1371/journal.pone.0236286	http://dx.doi.org/10.1371/journal.pone.0236286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702004	gold, Green Published			2022-12-26	WOS:000575913700069
J	Will, PA; Rafiei, A; Pretze, M; Gazyakan, E; Ziegler, B; Kneser, U; Engel, H; Wangler, B; Kzhyshkowska, J; Hirche, C				Will, P. A.; Rafiei, A.; Pretze, M.; Gazyakan, E.; Ziegler, B.; Kneser, U.; Engel, H.; Waengler, B.; Kzhyshkowska, J.; Hirche, C.			Evidence of stage progression in a novel, validated fluorescence-navigated and microsurgical-assisted secondary lymphedema rodent model	PLOS ONE			English	Article							SHOCK-PROTEIN 47; VEGF-C; BREAST-CANCER; NODE TRANSFER; PROMOTES LYMPHANGIOGENESIS; MOUSE TAIL; FIBROSIS; INFLAMMATION; LYMPHADENECTOMY; LYMPHOGRAPHY	Secondary lymphedema (SL)is a frequent and devastating complication of modern oncological therapy and filarial infections. A lack of a reliable preclinical model to investigate the underlying mechanism of clinical stage progression has limited the development of new therapeutic strategies. Current first line treatment has shown to be merely symptomatic and relies on lifetime use of compression garments and decongestive physiotherapy. In this study, we present the development of a secondary lymphedema model in 35 rats using pre- and intraoperative fluorescence-guided mapping of the lymphatics and microsurgical induction. In contrast to the few models reported so far, we decided to avoid the use of radiation for lymphedema induction. It turned out, that the model is nearly free of complications and capable of generating a statistically significant limb volume increase by water displacement measurements, sustained for at least 48 days. A translational, accurate lymphatic dysfunction was visualized by a novel VIS-NIR X-ray ICG-Clearance-Capacity imaging technology. For the first-time SL stage progression was validated by characteristic histological alterations, such as subdermal mast cell infiltration, adipose tissue deposition, and fibrosis by increased skin collagen content. Immunofluorescence confocal microscopy analysis suggested that stage progression is related to the presence of a characteristic a SMA(+)/HSP-47(+)/vimentin(+) fibroblast subpopulation phenotype. These findings demonstrate that the in-vivo model is a reliable and clinically relevant SL model for the development of further secondary lymphedema therapeutic strategies and the analysis of the veiled molecular mechanisms of lymphatic dysfunction.	[Will, P. A.; Rafiei, A.; Gazyakan, E.; Ziegler, B.; Kneser, U.; Engel, H.; Hirche, C.] BG Trauma Hosp Ludwigshafen, Burn Ctr, Dept Hand Plast & Reconstruct Surg Microsurg, Microsurg, Ludwigshafen, Germany; [Pretze, M.; Waengler, B.] Heidelberg Univ, Med Fac Mannheim, Dept Clin Radiol & Nucl Med, Mannheim, Germany; [Engel, H.] Ethianum Klin Heidelberg, Heidelberg, Germany; [Kzhyshkowska, J.] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, Mannheim, Germany; [Kzhyshkowska, J.] German Red Cross Blood Serv Baden Wurttemberg Hes, Frankfurt, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Will, PA (corresponding author), BG Trauma Hosp Ludwigshafen, Burn Ctr, Dept Hand Plast & Reconstruct Surg Microsurg, Microsurg, Ludwigshafen, Germany.	Patrick.will-marks@bgu-ludwigshafen.de		Wangler, Bjorn/0000-0003-3877-5576				Aghasafari P, 2019, INFLAMM RES, V68, P59, DOI 10.1007/s00011-018-1191-2; Al Kattan WM, 2017, JCPSP-J COLL PHYSICI, V27, P38, DOI 2519; Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b; Basta MN, 2015, PLAST RECONSTR SURG, V136, p134E, DOI 10.1097/PRS.0000000000001417; Basta MN, 2014, PLAST RECONSTR SURG, V133, P905, DOI 10.1097/PRS.0000000000000010; Chang DW, 2016, PLAST RECONSTR SURG, V138, p209S, DOI 10.1097/PRS.0000000000002683; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Cuzzone DA, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.01019.2013; Di S, 2016, LYMPHAT RES BIOL, V14, P162, DOI 10.1089/lrb.2016.0010; DiSipio T, 2013, LANCET ONCOL, V14, P500, DOI 10.1016/S1470-2045(13)70076-7; Duarte BD, 2018, J CANCER RES CLIN, V144, P2319, DOI 10.1007/s00432-018-2739-9; Fabregat I, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00357; Frueh FS, 2016, J SURG RES, V200, P208, DOI 10.1016/j.jss.2015.07.005; Gardenier JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14345; Ghanta S, 2015, AM J PHYSIOL-HEART C, V308, pH1065, DOI 10.1152/ajpheart.00598.2014; Gousopoulos E, 2017, J INVEST DERMATOL, V137, P1995, DOI 10.1016/j.jid.2017.04.033; Gousopoulos E, 2016, AM J PATHOL, V186, P2193, DOI 10.1016/j.ajpath.2016.04.006; Grada AA, 2017, J AM ACAD DERMATOL, V77, P1009, DOI 10.1016/j.jaad.2017.03.022; Hirche C, 2010, ANN SURG ONCOL, V17, P2357, DOI 10.1245/s10434-010-1010-7; Hirche C, 2012, J SURG ONCOL, V105, P162, DOI 10.1002/jso.22075; Honkonen KM, 2013, ANN SURG, V257, P961, DOI 10.1097/SLA.0b013e31826ed043; Huang TW, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-15; Ito R, 2014, PLAST RECONSTR SURG, V134, P548, DOI 10.1097/PRS.0000000000000383; Ito S, 2019, J BIOL CHEM, V294, P2133, DOI 10.1074/jbc.TM118.002812; Jiang XC, 2017, ACS CHEM NEUROSCI, V8, P128, DOI 10.1021/acschemneuro.6b00253; Kanter M., 1989, PLAST RECONSTR SURG; Kawai Y, 2014, J SURG RES, V189, P184, DOI 10.1016/j.jss.2013.11.1116; Kimura T, 2013, J LEUKOCYTE BIOL, V94, P137, DOI 10.1189/jlb.0812408; Kinashi H, 2013, J AM SOC NEPHROL, V24, P1627, DOI 10.1681/ASN.2012030226; Knopp S, 2012, INFECT DIS CLIN N AM, V26, P359, DOI 10.1016/j.idc.2012.02.005; Ly CL, 2019, TRANSL RES, V206, P57, DOI 10.1016/j.trsl.2018.12.003; Mishima T, 2017, J SURG RES, V219, P50, DOI 10.1016/j.jss.2017.05.124; Moldobaeva A, 2017, ANGIOGENESIS, V20, P73, DOI 10.1007/s10456-016-9529-2; Mori K, 2017, INT J CANCER, V140, P1425, DOI 10.1002/ijc.30557; Murdaca G, 2012, AM J MED, V125, P134, DOI 10.1016/j.amjmed.2011.06.032; Nguyen TT, 2017, ANN SURG ONCOL, V24, P2972, DOI 10.1245/s10434-017-5960-x; Nores GDG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04418-y; NUTMAN TB, 1991, REV INFECT DIS, V13, P1018; Pereira ACPR, 2017, BREAST, V36, P67, DOI 10.1016/j.breast.2017.09.006; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Raju A, 2015, ANN SURG, V261, P1013, DOI 10.1097/SLA.0000000000000763; Rizk FH, 2018, IUBMB LIFE, V70, P795, DOI 10.1002/iub.1884; Rockson SG, 2008, ANN NY ACAD SCI, V1131, P147, DOI 10.1196/annals.1413.014; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Savetsky IL, 2014, AM J PHYSIOL-HEART C, V307, pH165, DOI 10.1152/ajpheart.00244.2014; Scaglioni MF, 2017, MICROSURG, V37, P947, DOI 10.1002/micr.30246; Schwager S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124850; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shah C, 2012, INT J RADIAT ONCOL, V83, P1095, DOI 10.1016/j.ijrobp.2011.09.058; Sharma A, 2012, J AM ACAD DERMATOL, V67, P1342, DOI 10.1016/j.jaad.2012.04.028; Society TI Document C Congress XI Inter- XVI Icl X Committee E, 2013, DIAGN TREATM PER LY, V46, P1; Staszyk C, 2003, LAB ANIM-UK, V37, P121, DOI 10.1258/00236770360563750; Sulo E, 2015, J PLAST RECONSTR AES, V68, P551, DOI 10.1016/j.bjps.2014.11.016; Swartz MA, 1999, J BIOMECH, V32, P1297, DOI 10.1016/S0021-9290(99)00125-6; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Triacca V, 2019, EUR J VASC ENDOVASC, V57, P859, DOI 10.1016/j.ejvs.2018.04.014; Turner NA, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-5; Uzarski J, 2008, AM J PHYSIOL-HEART C, V294, pH1326, DOI 10.1152/ajpheart.00900.2007; van Caam A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02452; Vogel B, 2015, METHODSX, V2, P124, DOI 10.1016/j.mex.2015.02.007; Wang YY, 2017, J AM SOC NEPHROL, V28, P2053, DOI 10.1681/ASN.2016050573; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; Weiler MJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46797-2; Williams SK, 2011, UROL CLIN N AM, V38, P507, DOI 10.1016/j.ucl.2011.07.013; Yamakawa T, 2018, BLOOD, V131, P1476, DOI 10.1182/blood-2017-04-779934; Yamamoto T, 2014, ANN PLAS SURG, V73, P706, DOI 10.1097/SAP.0b013e318285875f; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yang CY, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000064; Yang GH, 2017, CLIN EXP HYPERTENS, V39, P740, DOI 10.1080/10641963.2017.1324478; Yazdani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050209; Yoon Y, 2003, J CLIN INVEST, V111, P717, DOI 10.1172/JCI200315830; Yost KJ, 2014, OBSTET GYNECOL, V124, P307, DOI 10.1097/AOG.0000000000000372; Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC709, DOI 10.1152/ajpcell.00284.2011; Zhu YM, 2016, TRANSL RES, V178, P38, DOI 10.1016/j.trsl.2016.07.001	76	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235965	10.1371/journal.pone.0235965	http://dx.doi.org/10.1371/journal.pone.0235965			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701960	Green Published, gold			2022-12-26	WOS:000575913700034
J	Xiong, XH; Rao, G; Roy, RV; Zhang, YS; Means, N; Dey, A; Tsaliki, M; Saha, S; Bhattacharyya, S; Dwivedi, SKD; Rao, CV; McCormick, DJ; Dhanasekaran, D; Ding, K; Gillies, E; Zhang, M; Yang, D; Bhattacharya, R; Mukherjee, P				Xiong, Xunhao; Rao, Geeta; Roy, Ram Vinod; Zhang, Yushan; Means, Nicolas; Dey, Anindya; Tsaliki, Martha; Saha, Sounik; Bhattacharyya, Sanjib; Dwivedi, Shailendra Kumar Dhar; Rao, Chinthalapally, V; McCormick, Daniel J.; Dhanasekaran, Danny; Ding, Kai; Gillies, Elizabeth; Zhang, Min; Yang, Da; Bhattacharya, Resham; Mukherjee, Priyabrata			Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer	FASEB JOURNAL			English	Article						KRAS; macropinocytosis; pancreatic cancer; small GTPases; therapeutic target; UBAP2	RAS; GLUTAMINE; ANTIBODY; BIOLOGY; GROWTH	Macropinocytosis supports the metabolic requirement of RAS-transformed pancreatic ductal adenocarcinoma cells (PDACs). However, regulators of RAS-transformation (activation) that lead to macropinocytosis have not been identified. Herein, we report that UBAP2 (ubiquitin-binding associated protein 2), regulates the activation of KRAS and macropinocytosis in pancreatic cancer. We demonstrate that UBAP2 is highly expressed in both pancreatic cancer cell lines and tumor tissues of PDAC patients. The expression of UBAP2 is associated with poor overall survival in several cancers, including PDAC. Silencing UBAP2 decreases the levels of activated KRAS, and inhibits macropinocytosis, and tumor growth in vivo. Using a UBAP2-deletion construct, we demonstrate that the UBA-domain of UBAP2 is critical for the regulation of macropinocytosis and maintaining the levels of activated KRAS. In addition, UBAP2 regulates RAS downstream signaling and helps maintain RAS in the GTP-bound form. However, the exact mechanism by which UBAP2 regulates KRAS activation is unknown and needs further investigation. Thus, UBAP2 may be exploited as a potential therapeutic target to inhibit macropinocytosis and tumor growth in activated KRAS-driven cancers.	[Xiong, Xunhao; Rao, Geeta; Roy, Ram Vinod; Zhang, Yushan; Means, Nicolas; Dey, Anindya; Tsaliki, Martha; Saha, Sounik; Dwivedi, Shailendra Kumar Dhar; Dhanasekaran, Danny; Bhattacharya, Resham; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St, Oklahoma City, OK 73104 USA; [Xiong, Xunhao; Rao, Geeta; Roy, Ram Vinod; Zhang, Yushan; Means, Nicolas; Dey, Anindya; Tsaliki, Martha; Saha, Sounik; Dwivedi, Shailendra Kumar Dhar; Gillies, Elizabeth; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Bhattacharyya, Sanjib; McCormick, Daniel J.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN USA; [Rao, Chinthalapally, V] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Stephenson Canc Ctr,Ctr Canc Prevent & Drug Dev, Oklahoma City, OK 73104 USA; [Dhanasekaran, Danny] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Ding, Kai] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA; [Zhang, Min; Yang, Da] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Bhattacharya, Resham] Univ Oklahoma, Dept Obstet & Gynecol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma Health Sciences Center	Mukherjee, P (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St, Oklahoma City, OK 73104 USA.	Priyabrata-Mukherjee@ouhsc.edu	Chinthalapally, Rao V/B-3633-2010	Chinthalapally, Rao V/0000-0002-5715-7979; Bhattacharyya, Sanjib/0000-0001-8738-7188	National Institutes of Health (NIH) [2CA136494, CA213278, CA220237]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health (NIH), Grant/Award Number: 2CA136494, CA213278 and CA220237	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Arvizo RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033650; Bai DS, 2016, ONCOTARGET, V7, P32946, DOI 10.18632/oncotarget.8783; Bhattacharyya S, 2012, ANGEW CHEM INT EDIT, V51, P1563, DOI 10.1002/anie.201105432; Bhattacharyya S, 2010, P NATL ACAD SCI USA, V107, P14541, DOI 10.1073/pnas.1006507107; Chi XJ, 2013, INT J MOL SCI, V14, P7089, DOI 10.3390/ijms14047089; Commisso C, 2014, NAT PROTOC, V9, P182, DOI 10.1038/nprot.2014.004; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Finicle BT, 2018, NAT REV CANCER, V18, P619, DOI 10.1038/s41568-018-0048-x; Giri K, 2014, BIOCONJUGATE CHEM, V25, P1078, DOI 10.1021/bc500084f; Gwinn DM, 2018, CANCER CELL, V33, P91, DOI 10.1016/j.ccell.2017.12.003; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Latonen L, 2016, GENE CHROMOSOME CANC, V55, P617, DOI 10.1002/gcc.22364; Logsdon CD, 2016, INT J BIOL SCI, V12, P338, DOI 10.7150/ijbs.15020; Malik R, 2019, MATRIX BIOL, V81, P50, DOI 10.1016/j.matbio.2018.11.001; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sousa CM, 2014, CARCINOGENESIS, V35, P1441, DOI 10.1093/carcin/bgu097; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Thompson H, 2013, NAT MED, V19, P949, DOI 10.1038/nm0813-949; Torrence ME, 2018, ANNU REV CANC BIOL, V2, P251, DOI 10.1146/annurev-cancerbio-030617-050329; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Zhou BY, 2016, SEMIN CELL DEV BIOL, V58, P60, DOI 10.1016/j.semcdb.2016.07.012	31	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12024	12039		10.1096/fj.201902826RR	http://dx.doi.org/10.1096/fj.201902826RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32692445	Green Accepted			2022-12-26	WOS:000554624400001
J	Davidson, RK; Himes, ER; Takigawa, S; Chen, A; Horn, MR; Meijome, T; Wallace, JM; Kacena, MA; Yokota, H; Nguyen, AV; Li, JL				Davidson, Rebecca K.; Himes, Evan R.; Takigawa, Shinya; Chen, Andy; Horn, M. Ryne; Meijome, Tomas; Wallace, Joseph M.; Kacena, Melissa A.; Yokota, Hiroki; Nguyen, Andrew, V; Li, Jiliang			The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure	PLOS ONE			English	Article							OSTEOBLASTIC CELLS; DIFFERENTIATION; RECEPTOR; EXPRESSION; OSTEOPOROSIS; INDUCTION; LIGAND; SUSCEPTIBILITY; INTERLEUKIN-6; DISRUPTION	Signal Transducer and Activator of Transcription 3 (STAT3) has recently been shown to be involved in bone development and has been implicated in bone diseases, such as Job's Syndrome. Bone growth and changes have been known for many years to differ between sexes with male bones tending to have higher bone mass than female bones and older females tending to lose bone mass at faster rates than older males. Previous studies using conditional knock mice withStat3specifically deleted from the osteoblasts showed both sexes exhibited decreased bone mineral density (BMD) and strength. Using the Cre-Lox system with Cathepsin K promotor driving Cre to target the deletion of theStat3gene in mature osteoclasts (STAT3-cKO mice), we observed that 8-week old STAT3-cKO female femurs exhibited significantly lower BMD and bone mineral content (BMC) compared to littermate control (CN) females. There were no differences in BMD and BMC observed between male knock-out and male CN femurs. However, micro-computed tomography (mu CT) analysis showed that both male and female STAT3-cKO mice had significant decreases in bone volume/tissue volume (BV/TV). Bone histomorphometry analysis of the distal femur, further revealed a decrease in bone formation rate and mineralizing surface/bone surface (MS/BS) with a significant decrease in osteoclast surface in female, but not male, STAT3-cKO mice. Profiling gene expression in an osteoclastic cell line with a knockdown of STAT3 showed an upregulation of a number of genes that are directly regulated by estrogen receptors. These data collectively suggest that regulation of STAT3 differs in male and female osteoclasts and that inactivation of STAT3 in osteoclasts affects bone turnover more in females than males, demonstrating the complicated nature of STAT3 signaling pathways in osteoclastogenesis. Drugs targeting the STAT3 pathway may be used for treatment of diseases such as Job's Syndrome and osteoporosis.	[Davidson, Rebecca K.; Himes, Evan R.; Li, Jiliang] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA; [Takigawa, Shinya; Chen, Andy; Horn, M. Ryne; Wallace, Joseph M.; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46205 USA; [Meijome, Tomas; Kacena, Melissa A.] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46205 USA; [Nguyen, Andrew, V] CUNY Queensborough Community Coll, Dept Biol Sci & Geol, Bayside, NY 11364 USA; [Takigawa, Shinya] Mie Univ, Dept Orthopaed Surg, Grad Sch Med, Tsu, Mie, Japan	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; City University of New York (CUNY) System; Mie University	Li, JL (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA.; Nguyen, AV (corresponding author), CUNY Queensborough Community Coll, Dept Biol Sci & Geol, Bayside, NY 11364 USA.	anguyen@qcc.cuny.edu; jilili@iupui.edu		Horn, Michael/0000-0002-1066-6303; Davidson, Rebecca/0000-0002-7337-9416; Wallace, Joseph/0000-0001-6077-8058	Biomechanics and Biomaterials Research Center; Release Time for Research 2018; Research Support Funds Grant 2016; Indiana University Purdue University Indianapolis; PSC-CUNY Grant	Biomechanics and Biomaterials Research Center; Release Time for Research 2018; Research Support Funds Grant 2016; Indiana University Purdue University Indianapolis; PSC-CUNY Grant	This study was supported by the research funds from Biomechanics and Biomaterials Research Center 2014 (JL), Release Time for Research 2018 (JL) and Research Support Funds Grant 2016 (JL), Indiana University Purdue University Indianapolis (JL). AVN was supported by the PSC-CUNY Grant (2018-2019).	Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; ARNOLD J. S., 1966, CLIN ORTHOP RELATED RES, V49, P17; Bellido T, 2015, BASIC APPL BONE BIOL, P27; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; Callewaert F, 2010, J BONE MINER RES, V25, P124, DOI 10.1359/jbmr.091001; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Charles JF, 2012, BONE, V51, P902, DOI 10.1016/j.bone.2012.08.113; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Choi HK, 2013, CELL RES, V23, P524, DOI 10.1038/cr.2013.33; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; Corry KA, 2019, BONE REP, V11, DOI 10.1016/j.bonr.2019.100218; DAVIS SD, 1966, LANCET, V1, P1013; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Freeman AF, 2008, IMMUNOL ALLERGY CLIN, V28, P277, DOI 10.1016/j.iac.2008.01.005; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; GIMBLE JM, 1994, J CELL BIOCHEM, V54, P122, DOI 10.1002/jcb.240540113; Goettsch C, 2011, ENDOCRINOLOGY, V152, P4915, DOI 10.1210/en.2011-1282; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Jules J, 2018, J BIOL CHEM, V293, P1480, DOI 10.1074/jbc.M116.736009; Jules J, 2016, J BIOL CHEM, V291, P16390, DOI 10.1074/jbc.M115.674598; Kim JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep38526; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kim T, 2010, BIOCHEM BIOPH RES CO, V403, P73, DOI 10.1016/j.bbrc.2010.10.117; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Li CH, 2013, BIOCHEM BIOPH RES CO, V435, P533, DOI 10.1016/j.bbrc.2013.04.084; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; O'Brien CA, 2000, J CELL BIOCHEM, V79, P532, DOI 10.1002/1097-4644(20001215)79:4<532::AID-JCB20>3.0.CO;2-U; Panchanathan R, 2009, J IMMUNOL, V183, P7031, DOI 10.4049/jimmunol.0802665; Pang MH, 2019, J CELL BIOCHEM, V120, P12382, DOI 10.1002/jcb.28504; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park GB, 2019, NEOPLASIA, V21, P206, DOI 10.1016/j.neo.2018.12.005; Pramanik R, 2004, J BIOL CHEM, V279, P16121, DOI 10.1074/jbc.M313140200; Puissant E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165004; Rybaczyk Leszek A, 2005, BMC Womens Health, V5, P12, DOI 10.1186/1472-6874-5-12; Scarff KL, 2004, MOL CELL BIOL, V24, P4075, DOI 10.1128/MCB.24.9.4075-4082.2004; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; TROTTER M, 1970, AM J PHYS ANTHROPOL, V33, P313, DOI 10.1002/ajpa.1330330305; UDAGAWA N, 1995, J EXP MED, V182, P1461, DOI 10.1084/jem.182.5.1461; Wallace JM, 2010, ANN BIOMED ENG, V38, P1607, DOI 10.1007/s10439-009-9881-0; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Won HY, 2016, ARTHRITIS RHEUMATOL, V68, P1301, DOI 10.1002/art.39538; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Yamada T, 2004, J BONE MINER RES, V19, P1452, DOI 10.1359/JBMR.040515; Yang YL, 2019, J BIOL CHEM, V294, P15395, DOI 10.1074/jbc.RA119.010139; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0; Zhang ZY, 2005, BIOCHEM BIOPH RES CO, V328, P800, DOI 10.1016/j.bbrc.2005.01.019; Zhou HK, 2011, BONE, V49, P404, DOI 10.1016/j.bone.2011.04.020	57	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236891	10.1371/journal.pone.0236891	http://dx.doi.org/10.1371/journal.pone.0236891			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730332	Green Published, gold			2022-12-26	WOS:000556884700057
J	Filatova, OA				Filatova, Olga A.			Independent acoustic variation of the higher- and lower-frequency components of biphonic calls can facilitate call recognition and social affiliation in killer whales	PLOS ONE			English	Article							ORCINUS-ORCA; NONLINEAR PHENOMENA; STEREOTYPED CALLS; CULTURAL TRANSMISSION; AVACHA GULF; EVOLUTION; VOCALIZATIONS; BIPHONATION; KAMCHATKA; DIALECTS	Each resident-type (R-type) killer whale pod has a set of stereotyped calls that are culturally transmitted from mother to offspring. The functions of particular call types are not yet clearly understood, but it is believed that calls with two independently modulated frequency components (biphonic calls) play an important role in pod communication and cohesion at long ranges. In this study we examined the possible functions of biphonic calls in R-type killer whales. First, we tested the hypothesis that the additional component enhances the potential of a call to identify the family affiliation. We found that the similarity patterns of the lower- and higher frequency components across the families were largely unrelated. Calls were classified more accurately to their respective family when both lower- and higher-frequency components were considered. Second, we tested the long-range detectability of the lower- and higher-frequency components. After adjusting the received levels by the killer whale hearing sensitivity to different frequency ranges, the sensation level of the higher-frequency component was higher than the amplitude of the lower-frequency component. Our results suggest that the higher-frequency component of killer whale biphonic calls varies independently of the lower-frequency component, which enhances the efficiency of these calls as family markers. The acoustic variation of the higher-frequency component allows the recognition of family identity of a caller even if the shape of the lower-frequency component accidentally becomes similar in unrelated families. The higher-frequency component can also facilitate family recognition when the lower-frequency component is masked by low-frequency noise.	[Filatova, Olga A.] Lomonosov Moscow State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia	Lomonosov Moscow State University	Filatova, OA (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia.	alazorro@gmail.com		Filatova, Olga/0000-0003-1533-4807	Russian Science Foundation [19-14-00037]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation (http://www.rscf.ru/) funding to OAF, grant number 19-14-00037. This research received no additional funding from any public, commercial or not-for-profit sectors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JZ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2171; Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Bigg M., 1983, Whalewatcher, V17, P3; Branstetter BK, 2017, J ACOUST SOC AM, V141, P2387, DOI 10.1121/1.4979116; Branstetter BK, 2012, J ACOUST SOC AM, V131, P1613, DOI 10.1121/1.3676694; Brown CH, 2003, J ACOUST SOC AM, V113, P2114, DOI 10.1121/1.1528930; Brown JC, 2008, J ACOUST SOC AM, V123, P2875, DOI 10.1121/1.2890745; Burdin AM, 2006, KILLER WHALES E KAMC; Deecke VB, 2006, J ACOUST SOC AM, V119, P645, DOI 10.1121/1.2139067; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Deecke VB, 2010, NATURWISSENSCHAFTEN, V97, P513, DOI 10.1007/s00114-010-0657-z; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Filatova OA, 2009, ACTA ETHOL, V12, P37, DOI 10.1007/s10211-009-0056-7; Filatova OA, 2004, ZOOL ZH, V83, P1169; Filatova OA, 2017, BEHAVIOUR, V154, P171, DOI 10.1163/1568539X-00003417; Filatova OA, 2016, J ACOUST SOC AM, V140, P3755, DOI 10.1121/1.4967369; Filatova OA, 2015, BEHAVIOUR, V152, P2001, DOI 10.1163/1568539X-00003317; Filatova OA, 2015, J ACOUST SOC AM, V138, P251, DOI 10.1121/1.4922704; Filatova OA, 2013, BEHAV PROCESS, V99, P34, DOI 10.1016/j.beproc.2013.06.008; Filatova OA, 2012, ANIM BEHAV, V83, P595, DOI 10.1016/j.anbehav.2011.12.013; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Fllatova OA, 2007, BIOACOUSTICS, V16, P261; Foote AD, 2008, ETHOLOGY, V114, P599, DOI 10.1111/j.1439-0310.2008.01496.x; Foote AD, 2006, BIOL LETT-UK, V2, P509, DOI 10.1098/rsbl.2006.0525; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; Hodges R.P., 2011, UNDERWATER ACOUSTICS; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Ivkovich T, 2010, MAMM BIOL, V75, P198, DOI 10.1016/j.mambio.2009.03.006; Kriesell HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106317; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; LUMSDEN CJ, 1985, J SOC BIOL STRUCT, V8, P343, DOI 10.1016/0140-1750(85)90042-9; McKenna MF, 2012, J ACOUST SOC AM, V131, P92, DOI 10.1121/1.3664100; Miller PJO, 2007, J ACOUST SOC AM, V121, P3932, DOI 10.1121/1.2722056; Miller PJO, 2006, J COMP PHYSIOL A, V192, P449, DOI 10.1007/s00359-005-0085-2; Miller PJO, 2002, BEHAV ECOL SOCIOBIOL, V52, P262, DOI 10.1007/s00265-002-0508-9; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; MUNDINGER PC, 1980, ETHOL SOCIOBIOL, V1, P183, DOI 10.1016/0162-3095(80)90008-4; Nousek AE, 2006, BIOL LETT-UK, V2, P481, DOI 10.1098/rsbl.2006.0517; Papale E, 2015, BIOACOUSTICS, V24, P223, DOI 10.1080/09524622.2015.1041158; Quick N, 2018, MAR MAMMAL SCI, V34, P155, DOI 10.1111/mms.12452; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Riede T, 2004, AM J PRIMATOL, V64, P277, DOI 10.1002/ajp.20078; Riede T, 2000, J ACOUST SOC AM, V108, P1435, DOI 10.1121/1.1289208; STRAGER H, 1995, CAN J ZOOL, V73, P1037, DOI 10.1139/z95-124; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; Tyson RB, 2007, J ACOUST SOC AM, V122, P1365, DOI 10.1121/1.2756263; Veirs S, 2016, PEERJ, V4, DOI 10.7717/peerj.1657; Volodin Ilya A., 2002, Bioacoustics, V13, P105; Volodina EV, 2006, ETHOLOGY, V112, P815, DOI 10.1111/j.1439-0310.2006.01231.x; Weib BM, 2007, J ACOUST SOC AM, V122, P3710, DOI 10.1121/1.2799907; Wellard R, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.191228; Wilden I., 1998, Bioacoustics, V9, P171; Yurk H, 2002, ANIM BEHAV, V63, P1103, DOI 10.1006/anbe.2002.3012; Yurk H., 2005, THESIS	55	3	3	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236749	10.1371/journal.pone.0236749	http://dx.doi.org/10.1371/journal.pone.0236749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730308	gold, Green Published			2022-12-26	WOS:000556884700023
J	Marzolla, V; Feraco, A; Gorini, S; Mammi, C; Marrese, C; Mularoni, V; Boitani, C; Lombes, M; Kolkhof, P; Ciriolo, MR; Armani, A; Caprio, M				Marzolla, Vincenzo; Feraco, Alessandra; Gorini, Stefania; Mammi, Caterina; Marrese, Carmen; Mularoni, Valentina; Boitani, Carla; Lombes, Marc; Kolkhof, Peter; Ciriolo, Maria Rosa; Armani, Andrea; Caprio, Massimiliano			The novel non-steroidal MR antagonist finerenone improves metabolic parameters in high-fat diet-fed mice and activates brown adipose tissue via AMPK-ATGL pathway	FASEB JOURNAL			English	Article						aldosterone; adipocyte; metabolic syndrome; obesity	CHRONIC KIDNEY-DISEASE; MINERALOCORTICOID RECEPTOR ANTAGONIST; CHRONIC HEART-FAILURE; INSULIN-RESISTANCE; ADIPOCYTE DYSFUNCTION; UNCOUPLING PROTEIN-1; PLASMA-ALDOSTERONE; ACID OXIDATION; LIPOLYSIS; EXPRESSION	Mineralocorticoid receptor antagonists (MRAs) are recommended for the treatment of heart failure and hypertension, mainly due to their natriuretic and anti-fibrotic mode of action. Rodent studies have shown that MRAs can prevent adverse metabolic consequences of obesity but an elucidation of underlying molecular mechanisms is missing. Here, we investigated metabolic effects of the novel non-steroidal MRA finerenone (FIN) in a mouse model of high-fat diet (HFD)-induced obesity and the signaling pathways activated by MR antagonism at level of interscapular brown adipose tissue (iBAT). C57BL/6J male mice were fed a normal diet or a HFD (with60% kcal from fat) containing or not FIN for 3 months. Metabolic parameters, adipose tissue morphology, gene and protein expression analysis were assessed. We also used brown adipocyte cultures (T37i cells) to investigate the effects of FIN-mediated MR antagonism upon lipid and mitochondrial metabolism. HFD + FIN-treated mice showed improved glucose tolerance together with increased multilocularity and higher expression of thermogenic markers at the level of iBAT, without differences in white adipose depots, suggesting an iBAT-specific effect of FIN. Mechanistically, FIN increased activation of AMP-activated protein kinase which, in turn, stimulated adipose triglyceride lipase activation, with subsequent increased expression of uncoupling protein-1 in brown adipocytes.	[Marzolla, Vincenzo; Feraco, Alessandra; Gorini, Stefania; Mammi, Caterina; Marrese, Carmen; Armani, Andrea; Caprio, Massimiliano] IRCCS San Raffaele Pisana, Lab Cardiovasc Endocrinol, Rome, Italy; [Mularoni, Valentina; Boitani, Carla] Sapienza Univ Rome, Dept Anat Histol Forens & Orthoped Sci, Sect Histol & Med Embryol, Rome, Italy; [Lombes, Marc] Univ Paris Saclay, Univ Paris Sud, Fac Med Paris Sud, INSERM UMR S U1185, Orsay, France; [Kolkhof, Peter] Bayer AG, R&D Preclin Res Cardiovasc, Wuppertal, Germany; [Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Ciriolo, Maria Rosa] IRCCS San Raffaele Pisana, Rome, Italy; [Armani, Andrea; Caprio, Massimiliano] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy	IRCCS San Raffaele Pisana; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Bayer AG; University of Rome Tor Vergata; IRCCS San Raffaele Pisana	Caprio, M (corresponding author), IRCCS San Raffaele Pisana, San Raffaele Res Inst, Lab Cardiovasc Endocrinol, Via Val Cannuta 247, I-00166 Rome, Italy.	massimiliano.caprio@sanraffaele.it	Feraco, Alessandra/K-5920-2016; Mularoni, Valentina/AAC-2947-2020; Marzolla, Vincenzo/AAB-2300-2019; Caprio, Massimiliano/J-3020-2012; gorini, stefania/ABI-6853-2020	Feraco, Alessandra/0000-0002-7074-0480; Marzolla, Vincenzo/0000-0002-2943-7631; Caprio, Massimiliano/0000-0003-0722-7163; Ciriolo, Maria Rosa/0000-0002-7863-9029; MULARONI, VALENTINA/0000-0002-9996-3725; mammi, caterina/0000-0002-2687-4422	Ministry of Health, Italy \ Agenzia Italiana del Farmaco, Ministero della Salute (AIFA) [GR-2013-02357959]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2017A5TXC3]	Ministry of Health, Italy \ Agenzia Italiana del Farmaco, Ministero della Salute (AIFA); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	Ministry of Health, Italy vertical bar Agenzia Italiana del Farmaco, Ministero della Salute (AIFA), Grant/Award Number: GR-2013-02357959 and Ricerca Corrente; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Grant/Award Number: 2017A5TXC3	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Anders HJ, 2018, NAT REV NEPHROL, V14, P361, DOI 10.1038/s41581-018-0001-y; Anthony NM, 2009, OBESITY, V17, P1312, DOI 10.1038/oby.2008.645; Armani A, 2014, INT J OBESITY, V38, P1580, DOI 10.1038/ijo.2014.68; Armani A, 2019, DIABETES OBES METAB, V21, P2024, DOI 10.1111/dom.13756; Armani A, 2015, J MOL ENDOCRINOL, V55, pR1, DOI 10.1530/JME-15-0122; Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415; Arner P, 2018, CELL METAB, V28, P45, DOI 10.1016/j.cmet.2018.05.004; Bakris GL, 2015, JAMA-J AM MED ASSOC, V314, P884, DOI 10.1001/jama.2015.10081; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Bochud M, 2006, HYPERTENSION, V48, P239, DOI 10.1161/01.HYP.0000231338.41548.fc; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Celi FS, 2017, RES PERSPECT END INT, P1, DOI 10.1007/978-3-319-72790-5_1; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feraco A, 2020, TRENDS ENDOCRIN MET, V31, P205, DOI 10.1016/j.tem.2019.11.006; Filippatos G, 2016, EUR HEART J, V37, P2105, DOI 10.1093/eurheartj/ehw132; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Hankir MK, 2018, EMBO REP, V19, DOI 10.15252/embr.201846404; Hirata A, 2012, BIOCHEM BIOPH RES CO, V419, P182, DOI 10.1016/j.bbrc.2012.01.139; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Kim SJ, 2016, MOL CELL BIOL, V36, P1961, DOI 10.1128/MCB.00244-16; Kolkhof P, 2017, J ENDOCRINOL, V234, pT125, DOI 10.1530/JOE-16-0600; Kolkhof P, 2017, HANDB EXP PHARMACOL, V243, P271, DOI 10.1007/164_2016_76; Kolkhof P, 2015, CURR OPIN NEPHROL HY, V24, P417, DOI 10.1097/MNH.0000000000000147; Kovesdy CP, 2017, AFR J PRIM HEALTH CA, V9, DOI 10.4102/phcfm.v9i1.1435; Kraus D, 2005, HORM METAB RES, V37, P455, DOI 10.1055/s-2005-870240; Kuhn E, 2019, ANN ENDOCRINOL-PARIS, V80, P1, DOI 10.1016/j.ando.2018.04.018; Lainscak M, 2015, INT J CARDIOL, V200, P25, DOI 10.1016/j.ijcard.2015.05.127; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu LCY, 2015, EXPERT OPIN INV DRUG, V24, P1123, DOI 10.1517/13543784.2015.1059819; Loutradis C, 2015, AM J NEPHROL, V42, P351, DOI 10.1159/000442393; Modica S, 2016, CELL REP, V16, P2243, DOI 10.1016/j.celrep.2016.07.048; Mottillo EP, 2016, CELL METAB, V24, P118, DOI 10.1016/j.cmet.2016.06.006; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Mummidi S, 2016, J MOL CELL CARDIOL, V98, P95, DOI 10.1016/j.yjmcc.2016.07.006; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P542, DOI 10.2215/CJN.04750908; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Penfornis P, 2000, AM J PHYSIOL-ENDOC M, V279, pE386, DOI 10.1152/ajpendo.2000.279.2.E386; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Rossi GP, 2008, J CLIN ENDOCR METAB, V93, P2566, DOI 10.1210/jc.2008-0251; Schweiger M, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14859, 10.1038/ncomms15490]; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Thuzar M, 2019, DIABETES OBES METAB, V21, P509, DOI 10.1111/dom.13539; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; Urbanet R, 2015, HYPERTENSION, V66, P149, DOI 10.1161/HYPERTENSIONAHA.114.04981; Viengchareun S, 2001, AM J PHYSIOL-ENDOC M, V280, pE640, DOI 10.1152/ajpendo.2001.280.4.E640; Wada T, 2017, J ENDOCRINOL, V235, P179, DOI 10.1530/JOE-17-0351; Wu CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113742; Wu LY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1706-y; Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zennaro MC, 1998, J CLIN INVEST, V101, P1254, DOI 10.1172/JCI1915	63	21	22	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12450	12465		10.1096/fj.202000164R	http://dx.doi.org/10.1096/fj.202000164R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729974				2022-12-26	WOS:000556800100001
J	Turek, C; Wrobel, S; Piwowar, M				Turek, Cezary; Wrobel, Sonia; Piwowar, Monika			OmicsON - Integration of omics data with molecular networks and statistical procedures	PLOS ONE			English	Article								A huge amount of atomized biological data collected in various databases and the need for a description of their relation by theoretical methods causes the development of data integration methods. The omics data analysis by integration of biological knowledge with mathematical procedures implemented in the OmicsON R library is presented in the paper. OmicsON is a tool for the integration of two sets of data: transcriptomics and metabolomics. In the workflow of the library, the functional grouping and statistical analysis are applied. Subgroups among the transcriptomic and metabolomics sets are created based on the biological knowledge stored in Reactome and String databases. It gives the possibility to analyze such sets of data by multivariate statistical procedures like Canonical Correlation Analysis (CCA) or Partial Least Squares (PLS). The integration of metabolomic and transcriptomic data based on the methodology contained in OmicsON helps to easily obtain information on the connection of data from two different sets. This information can significantly help in assessing the relationship between gene expression and metabolite concentrations, which in turn facilitates the biological interpretation of the analyzed process.	[Turek, Cezary; Piwowar, Monika] Jagiellonian Univ Med Coll, Dept Bioinformat & Telemed, Krakow, Poland; [Wrobel, Sonia] Jagiellonian Univ, Marian Smoluchowski Inst Phys, Dept Med Phys, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University	Piwowar, M (corresponding author), Jagiellonian Univ Med Coll, Dept Bioinformat & Telemed, Krakow, Poland.	mpiwowar@cm-uj.krakow.pl	; Piwowar, Monika Weronika/L-5452-2013	Wrobel, Sonia/0000-0002-7921-2334; Piwowar, Monika Weronika/0000-0003-4645-8730	Jagiellonian University, Collegium Medicum [K/ZDS/006364]	Jagiellonian University, Collegium Medicum	The scientific activity of the authors is financed by the Jagiellonian University, Collegium Medicum under grant K/ZDS/006364. The University gives researchers the freedom to create research directions as well as the way of result publication. It only requires that the journals to which the papers are sent they are important in the scientific community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Chadeau-Hyam M, 2013, ENVIRON MOL MUTAGEN, V54, P542, DOI 10.1002/em.21797; Chung D., 2013, SPLS SPARSE PARTIAL; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cruz-Cano R., 2012, FRCC FAST REGULARIZE; Cruz-Cano R, 2014, COMPUT STAT DATA AN, V70, P88, DOI 10.1016/j.csda.2013.09.020; Dai MW, 2017, BIOINFORMATICS, V33, P2882, DOI 10.1093/bioinformatics/btx314; Delaigle A, 2012, ANN STAT, V40, P322, DOI 10.1214/11-AOS958; Dunkler D, 2011, METHODS MOL BIOL, V719, P113, DOI 10.1007/978-1-61779-027-0_5; Gligorijevic V, 2016, PROTEOMICS, V16, P741, DOI 10.1002/pmic.201500396; Gottardo R, 2003, BIOSTATISTICS, V4, P597, DOI 10.1093/biostatistics/4.4.597; Hardle WK, 2015, CANONICAL CORRELATIO, P281, DOI [10.1007/978-3-642-36005-3_16, DOI 10.1007/978-3-642-36005-3_16]; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510; Merrick B Alex, 2011, IARC Sci Publ, P121; Piwowar M, 2019, J COMPUT BIOL, V26, P235, DOI 10.1089/cmb.2018.0202; Piwowar M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206608; Piwowar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128854; Schafer M, 2017, BIOINFORMATICS, V33, P3220, DOI 10.1093/bioinformatics/btx356; Schneider MV, 2011, METHODS MOL BIOL, V719, P3, DOI 10.1007/978-1-61779-027-0_1; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tebani A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091555; Tebani A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071167; The R Core Team, 2017, R LANG ENV STAT COMP, P342; Waller T, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0052-6	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235398	10.1371/journal.pone.0235398	http://dx.doi.org/10.1371/journal.pone.0235398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726348	Green Published, gold			2022-12-26	WOS:000556908900066
J	Xiong, CL; Liu, XP; Kong, LZ; Yan, J				Xiong, Colin; Liu, Xiuping; Kong, Lingzhi; Yan, Jun			Thalamic gating contributes to forward suppression in the auditory cortex	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; 2-TONE SUPPRESSION; TEMPORAL-MODULATION; STREAM SEGREGATION; RECEPTIVE-FIELDS; FREQUENCY; MASKING; AMPLITUDE; NEURONS; RESPONSES	The neural mechanisms underlying forward suppression in the auditory cortex remain a puzzle. Little attention is paid to thalamic contribution despite the important fact that the thalamus gates upstreaming information to the auditory cortex. This study compared the time courses of forward suppression in the auditory thalamus, thalamocortical inputs and cortex using the two-tone stimulus paradigm. The preceding and succeeding tones were 20-ms long. Their frequency and amplitude were set at the characteristic frequency and 20 dB above the minimum threshold of given neurons, respectively. In the ventral division of the medial geniculate body of the thalamus, we found that the duration of complete forward suppression was about 75 ms and the duration of partial suppression was from 75 ms to about 300 ms after the onset of the preceding tone. We also found that during the partial suppression period, the responses to the succeeding tone were further suppressed in the primary auditory cortex. The forward suppression of thalamocortical field excitatory postsynaptic potentials was between those of thalamic and cortical neurons but much closer to that of thalamic ones. Our results indicate that early suppression in the cortex could result from complete suppression in the thalamus whereas later suppression may involve thalamocortical and intracortical circuitry. This suggests that the complete suppression that occurs in the thalamus provides the cortex with a "silence" window that could potentially benefit cortical processing and/or perception of the information carried by the preceding sound.	[Xiong, Colin; Liu, Xiuping; Kong, Lingzhi; Yan, Jun] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Xiong, Colin] Univ Calgary, Cumming Sch Med, Dept Family Med, Calgary, AB, Canada; [Kong, Lingzhi] Beijing Language & Culture Univ, Sch Commun Sci, Language Pathol & Brain Sci MEG Lab, Beijing, Peoples R China	University of Calgary; University of Calgary; Beijing Language & Culture University	Yan, J (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada.	juyan@ucalgary.ca		Yan, Jun/0000-0002-1548-7208	Canadian Institutes of Health Research [MOP274494]; Natural Sciences and Engineering Research Council of Canada [DG261338]; Campbell McLaurin Chair for Hearing Deficiencies, University of Calgary	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Campbell McLaurin Chair for Hearing Deficiencies, University of Calgary	JY 1. Canadian Institutes of Health Research (MOP274494) - https://cihr-irsc.gc.ca/e/193.html 2. Natural Sciences and Engineering Research Council of Canada (DG261338) - https://www.nserc-crsng.gc.ca/index_eng.asp 3. Campbell McLaurin Chair for Hearing Deficiencies, University of Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS PJ, 1978, J ACOUST SOC AM, V63, P1878, DOI 10.1121/1.381929; Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2014, BRAIN TOPOGR, V27, P480, DOI 10.1007/s10548-013-0342-6; Ayala Y, 2018, BRAIN STRUCT FUNCT, V223, P1391, DOI 10.1007/s00429-017-1546-4; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Bayazitov IT, 2013, J NEUROSCI, V33, P18940, DOI 10.1523/JNEUROSCI.3335-13.2013; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Carbajal GV, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518784822; CHEATHAM MA, 1992, HEARING RES, V60, P1, DOI 10.1016/0378-5955(92)90052-O; EGGERMONT JJ, 1991, HEARING RES, V56, P153, DOI 10.1016/0378-5955(91)90165-6; EGGERMONT JJ, 1985, HEARING RES, V18, P57, DOI 10.1016/0378-5955(85)90110-8; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; Jafari MR, 2007, CEREB CORTEX, V17, P71, DOI 10.1093/cercor/bhj125; JESTEADT W, 1982, J ACOUST SOC AM, V71, P950, DOI 10.1121/1.387576; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; KIDD G, 1982, J ACOUST SOC AM, V72, P1384, DOI 10.1121/1.388443; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Li LY, 2014, J NEUROSCI, V34, P13670, DOI 10.1523/JNEUROSCI.1516-14.2014; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Liu XP, 2015, EUR J NEUROSCI, V42, P2289, DOI 10.1111/ejn.13003; Liu XP, 2015, CEREB CORTEX, V25, P545, DOI 10.1093/cercor/bht259; Liu XP, 2011, NEUROSCI BIOBEHAV R, V35, P2155, DOI 10.1016/j.neubiorev.2011.02.010; Luo F, 2009, HEARING RES, V257, P75, DOI 10.1016/j.heares.2009.08.002; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; Moore BC, 2012, INTRO PSYCHOL HEARIN; MOORE BCJ, 1983, J ACOUST SOC AM, V73, P1249, DOI 10.1121/1.389273; Nelson PC, 2009, J NEUROSCI, V29, P2553, DOI 10.1523/JNEUROSCI.5359-08.2009; Nieto-Diego J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002397; Oxenham AJ, 2000, HEARING RES, V150, P258, DOI 10.1016/S0378-5955(00)00206-9; PALMER AR, 1982, ARCH OTO-RHINO-LARYN, V236, P197, DOI 10.1007/BF00454039; Phillips EAK, 2017, J NEUROPHYSIOL, V118, P1376, DOI 10.1152/jn.00094.2017; Phillips EAK, 2017, CELL REP, V20, P771, DOI 10.1016/j.celrep.2017.07.001; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; RHODE WS, 1994, J NEUROPHYSIOL, V71, P1797, DOI 10.1152/jn.1994.71.5.1797; Riecke L, 2009, NEURON, V64, P550, DOI 10.1016/j.neuron.2009.10.016; ROUILLER E, 1981, HEARING RES, V5, P81, DOI 10.1016/0378-5955(81)90028-9; Rui YY, 2018, NEUROSCIENCE, V392, P13, DOI 10.1016/j.neuroscience.2018.09.015; Scholes C, 2011, EUR J NEUROSCI, V33, P1240, DOI 10.1111/j.1460-9568.2010.07568.x; SCHREINER CE, 1981, NEURONAL MECH HEARIN, P191, DOI DOI 10.1007/978-1-4684-3908-320; Song L, 2008, J NEUROPHYSIOL, V99, P344, DOI 10.1152/jn.00983.2007; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Villalobos C, 2004, J NEUROSCI, V24, P3537, DOI 10.1523/JNEUROSCI.0380-04.2004; von Bekesy G, 1967, SENSORY INHIBITION; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Werner LA, 1999, J ACOUST SOC AM, V105, P2445, DOI 10.1121/1.426849; Wu Y, 2007, J NEUROSCI, V27, P10651, DOI 10.1523/JNEUROSCI.1320-07.2007; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; Yao JD, 2015, J NEUROSCI, V35, P16199, DOI 10.1523/JNEUROSCI.3116-15.2015; Zhang YF, 2005, HEARING RES, V201, P145, DOI 10.1016/j.heares.2004.10.003; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P4423, DOI 10.1073/pnas.0800009105; Zhou Y, 2014, EUR J NEUROSCI, V39, P919, DOI 10.1111/ejn.12460; ZWISLOCKI J, 1959, J ACOUST SOC AM, V31, P9, DOI 10.1121/1.1907619	59	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236760	10.1371/journal.pone.0236760	http://dx.doi.org/10.1371/journal.pone.0236760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726372	gold, Green Published			2022-12-26	WOS:000556908900060
J	Yu, Q; Si, S; Zhang, S; Zhang, JH				Yu, Qi; Si, Si; Zhang, Shun; Zhang, Jinghuan			Paternal indifference and neglect in early life and creativity: Exploring the moderating role of TPH1 genotype and offspring gender	PLOS ONE			English	Article							PARENTAL ACCEPTANCE-REJECTION; MESSENGER-RNA; PERSONALITY-TRAITS; BEHAVIOR; FATHERS; IDENTIFICATION; ASSOCIATION; EXPRESSION; MOTHERS; ABILITIES	For further understanding the joint contribution of environment, heredity and gender to creativity, the present research examined the prospective impact of paternal indifference & neglect in early life,TPH1rs623580, offspring gender, and the interaction effects thereof on creativity in five hundred and thirty-nine unrelated healthy Chinese undergraduate students. Paternal indifference & neglect in early life was assessed on the Parental Bonding Instrument (PBI) and creativity on the Runco Creativity Assessment Battery (rCAB). Two primary findings emerged. Firstly, significant paternal indifference & neglect xTPH1genotype interaction effects were identified in predicting all three dimensions of creativity (fluency, originality, and flexibility). Paternal indifference & neglect in early life negatively predicted fluency, originality, and flexibility when individuals carry A allele ofTPH1(rs623580). Secondly, there was a significant interaction effect ofTPH1genotype by offspring gender on flexibility. Only in males, individuals who carry A allele were linked with lower level of flexibility compared to TT homozygote individuals. No significant three-way interaction was found. In conclusion, the current findings provided the first preliminary evidence for the moderation effect ofTPH1on the relationship between parenting and creativity, andTPH1- offspring gender interaction on creativity; future studies are needed to validate these findings.	[Yu, Qi; Si, Si; Zhang, Shun; Zhang, Jinghuan] Shandong Normal Univ, Dept Psychol, Jinan, Peoples R China	Shandong Normal University	Zhang, JH (corresponding author), Shandong Normal Univ, Dept Psychol, Jinan, Peoples R China.	zhangjinghuan@126.com			National Natural Science Foundation of China [31470999, 31771235]; Key special project of national key research and development program of China [SQ2017YFB1400102]; Shandong Provincial Institute of Qilu Cultural Studies	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key special project of national key research and development program of China; Shandong Provincial Institute of Qilu Cultural Studies	This research was supported by National Natural Science Foundation of China (31470999, 31771235), Key special project of national key research and development program of China (SQ2017YFB1400102) and Shandong Provincial Institute of Qilu Cultural Studies to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRA J, 1991, GENET SOC GEN PSYCH, V117, P233; Abumaria N, 2008, CELL MOL NEUROBIOL, V28, P331, DOI 10.1007/s10571-007-9259-5; Albert RS, 1992, GENIUS EMINENCE; Asghari R, 2011, NEUROSCIENCE, V199, P429, DOI 10.1016/j.neuroscience.2011.10.036; Badran I, 2007, EUR J ENG EDUC, V32, P573, DOI 10.1080/03043790701433061; Belsky J, 2010, CURRENT DIRECTIONS P, V16, P300; Cabrera NJ, 2000, CHILD DEV, V71, P127, DOI 10.1111/1467-8624.00126; Caldera Y.M., 2004, FATHERING, V2, P191, DOI [10.3149/fth.0202.191, DOI 10.3149/FTH.0202.191]; Chavez-Eakle RA, 2012, CREATIVITY RES J, V24, P76, DOI 10.1080/10400419.2012.649233; Chuang SS, 2009, J FAM PSYCHOL, V23, P331, DOI 10.1037/a0016015; Creativity Testing Services, 2011, RUNC CREAT ASS BATT; Ehnvall A, 2008, ACTA PSYCHIAT SCAND, V117, P50, DOI 10.1111/j.1600-0447.2007.01124.x; Fishbein D, 2009, CHILD MALTREATMENT, V14, P299, DOI 10.1177/1077559508326355; Fox NA, 2011, J CHILD PSYCHOL PSYC, V52, P919, DOI 10.1111/j.1469-7610.2010.02355.x; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; GUILFORD JP, 1979, J CREATIVE BEHAV, V13, P1; Handa H, 2009, PSYCHIAT CLIN NEUROS, V63, P721, DOI 10.1111/j.1440-1819.2009.02018.x; Herrmannpillath C., 2015, ARE CHINESE COLLECTI; Holman WD, 1998, CHILD ADOLESC SOC WO, V15, P101; Horwitz AV, 2001, J HEALTH SOC BEHAV, V42, P184, DOI 10.2307/3090177; Jager A. O., 1982, BERLINER INTELLIGENZ; [蒋奖 Jiang Jiang], 2009, [心理科学, Psychological Science], V32, P193; Jokela M, 2007, J AFFECT DISORDERS, V100, P191, DOI 10.1016/j.jad.2006.10.016; Kandler C, 2016, J PERS SOC PSYCHOL, V111, P230, DOI 10.1037/pspp0000087; Kantor GK, 2004, CHILD MALTREATMENT, V9, P409, DOI 10.1177/1077559504269530; KAUFMAN J, 1994, J FAM VIOLENCE, V9, P227, DOI 10.1007/BF01531949; Kemple K. M., 2000, EARLY CHILDHOOD EDUC, V28, P67, DOI DOI 10.1023/A:1009555805909; Khaleque A, 2015, J CHILD FAM STUD, V24, P1419, DOI 10.1007/s10826-014-9948-x; Korat O, 2008, J COGN EDUC PSYCHOL, V7, P223, DOI 10.1891/194589508787381872; Kwak SH, 2012, OBESITY, V20, P233, DOI 10.1038/oby.2011.253; Lai TJ, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-14; LECHANU M, 1994, EUR J PSYCHOL EDUC, V9, P3, DOI 10.1007/BF03172881; Levant RF., 1992, J FAM PSYCHOL, P379, DOI DOI 10.1037/0893-3200.5.3-4.379; Liu GR, 2013, CREATIVITY RES J, V25, P446, DOI 10.1080/10400419.2013.843401; Mackey W.C., 2000, J MENS STUDIES, V8, P349, DOI DOI 10.3149/JMS.0803.349; Madore KP, 2015, PSYCHOL SCI, V26, P1461, DOI 10.1177/0956797615591863; Morawska A, 2008, AUST NZ J PSYCHIAT, V42, P819, DOI 10.1080/00048670802277271; Mulyadi S., 2010, INT J BUSINESS SOCIA, V1, P72; NICHOLS RC, 1978, HOMO, V29, P158; Paoloni-Giacobino A, 2000, MOL PSYCHIATR, V5, P49, DOI 10.1038/sj.mp.4000647; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Plucker JA, 2004, EDUC PSYCHOL-US, V39, P83, DOI 10.1207/s15326985ep3902_1; Ren FF, 2017, PSYCHOL AESTHET CREA, V11, P34, DOI 10.1037/aca0000078; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; REZNIKOFF M, 1973, BEHAV GENET, V3, P365, DOI 10.1007/BF01070219; Rogers CR, 1954, ETC REV GEN SEMANTIC, V11, P240; Rohner R. P., 2016, ONLINE READING PSYCH, V6, DOI [DOI 10.9707/2307-0919.1055, 10.9707/2307-0919.1055]; Rohner RP, 2005, ETHOS, V33, P299, DOI 10.1525/eth.2005.33.3.299; Rohner RP, 2004, AM PSYCHOL, V59, P830, DOI 10.1037/0003-066X.59.8.830; Rohner RP, 1986, WARMTH DIMENSION FDN; Runco MA, 2007, CREATIVITY: THEORIES AND THEMES: RESEARCH, DEVELOPMENT, AND PRACTICE, P1; Runco MA, 2011, CREATIVITY RES J, V23, P376, DOI 10.1080/10400419.2011.621859; Schumacher JA, 2001, AGGRESS VIOLENT BEH, V6, P231, DOI 10.1016/S1359-1789(00)00024-0; Shannon JD, 2002, PARENT-SCI PRACT, V2, P77, DOI 10.1207/S15327922PAR0202_01; SIEGELMAN M, 1973, J CONSULT CLIN PSYCH, V40, P43, DOI 10.1037/h0033981; Silver E.A., 1997, ZDM-MATH EDUC, V29, P75, DOI [https://doi.org/10.1007/s11858-997-0003-x, DOI 10.1007/S11858-997-0003-X]; Simonton DK, 2003, PSYCHOL BULL, V129, P475, DOI 10.1037/0033-2909.129.4.475; Sonuga-Barke EJS, 2008, AM J MED GENET B, V147B, P1359, DOI 10.1002/ajmg.b.30860; Sternberg R.J., 1999, HDB CREAT, V1, P3; Stewart C., 2006, J CHILD FAM STUD, V15, P542; Tamis-LeMonda CS, 2004, CHILD DEV, V75, P1806, DOI 10.1111/j.1467-8624.2004.00818.x; Uji M, 2006, CHILD PSYCHIAT HUM D, V37, P115, DOI 10.1007/s10578-006-0027-4; Waller N.G., 1993, PSYCHOL INQ, V4, P235, DOI [10.1207/s15327965pli0403_18, DOI 10.1207/S15327965PLI0403_18]; Windle M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01322; Youngblade LM, 1990, CHILDREN RISK EVALUA, P109; Zhang JH, 2014, STUD PSYCHOL BEHAV, V12, P145; Zhang S, 2017, PSYCHOL AESTHET CREA, V11, P2, DOI 10.1037/aca0000073; Zhang S, 2014, CREATIVITY RES J, V26, P115, DOI 10.1080/10400419.2014.874267; Zhang S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00216; Zhao Z, 2013, CHINA J HLTH PSYCHOL, V21, P1135; Zill P, 2009, NEUROSCIENCE, V159, P1274, DOI 10.1016/j.neuroscience.2009.01.006; Zill P, 2007, J PSYCHIATR RES, V41, P168, DOI 10.1016/j.jpsychires.2005.05.004; 张景焕, 2016, [心理学报, Acta Psychologica Sinica], V48, P1551	73	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0221383	10.1371/journal.pone.0221383	http://dx.doi.org/10.1371/journal.pone.0221383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2YL	32726303	Green Published, gold			2022-12-26	WOS:000556908900013
J	Aguiar, M; Van-Dierdonck, JB; Stollenwerk, N				Aguiar, Maira; Van-Dierdonck, Joseba Bidaurrazaga; Stollenwerk, Nico			Reproduction ratio and growth rates: Measures for an unfolding pandemic	PLOS ONE			English	Article							COVID-19; MODEL	The initial exponential growth rate of an epidemic is an important measure that follows directly from data at hand, commonly used to infer the basic reproduction number. As the growth rates lambda(t) of tested positive COVID-19 cases have crossed the threshold in many countries, with negative numbers as surrogate for disease transmission deceleration, lockdowns lifting are linked to the behavior of the momentary reproduction numbers r(t), often called R-0. Important to note that this concept alone can be easily misinterpreted as it is bound to many internal assumptions of the underlying model and significantly affected by the assumed recovery period. Here we present our experience, as part of the Basque Country Modeling Task Force (BMTF), in monitoring the development of the COVID-19 epidemic, by considering not only the behaviour of r(t) estimated for the new tested positive cases-significantly affected by the increased testing capacities, but also the momentary growth rates for hospitalizations, ICU admissions, deceased and recovered cases, in assisting the Basque Health Managers and the Basque Government during the lockdown lifting measures. Two different data sets, collected and then refined during the COVID-19 responses, are used as an exercise to estimate the momentary growth rates and reproduction numbers over time in the Basque Country, and the implications of using those concepts to make decisions about easing lockdown and relaxing social distancing measures are discussed. These results are potentially helpful for task forces around the globe which are now struggling to provide real scientific advice for health managers and governments while the lockdown measures are relaxed.	[Aguiar, Maira; Stollenwerk, Nico] Univ Trento, Dipartimento Matemat, Trento, Italy; [Aguiar, Maira] Basque Ctr Appl Math BCAM, Bilbao, Spain; [Aguiar, Maira] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Van-Dierdonck, Joseba Bidaurrazaga] Gobierno Vasco, Basque Hlth Dept, Publ Hlth, Bilbao, Spain; [Stollenwerk, Nico] Lisbon Univ, Ctr Math Fundamental Applicat & Operat Res, Lisbon, Portugal	University of Trento; Basque Center for Applied Mathematics (BCAM); Basque Foundation for Science; Universidade de Lisboa	Aguiar, M (corresponding author), Univ Trento, Dipartimento Matemat, Trento, Italy.; Aguiar, M (corresponding author), Basque Ctr Appl Math BCAM, Bilbao, Spain.; Aguiar, M (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	m.aguiar@unitn.it	Aguiar, Maira/E-5448-2018; Aguiar, Maira/ABD-6780-2020	Aguiar, Maira/0000-0001-8354-9944; Aguiar, Maira/0000-0001-8354-9944	European Union [792494]	European Union(European Commission)	Maira Aguiar has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 792494.	Aguiar M, 2013, ECOL COMPLEX, V16, P31, DOI 10.1016/j.ecocom.2012.09.001; Aguiar M, 2011, J THEOR BIOL, V289, P181, DOI 10.1016/j.jtbi.2011.08.043; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, PLAN TRANSICION HACI; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Flaxman S., 2020, IMPACT NONPHARMACEUT; Fu YJ, 2020, VIROL SIN, V35, P266, DOI 10.1007/s12250-020-00207-4; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Heesterbeek JAP, 1996, STAT NEERL, V50, P89, DOI [10.1111/j.1467-9574.1996.tb01482.x, DOI 10.1111/J.1467-9574.1996.TB01482.X]; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kramer M., 2020, EPIDEMIOLOGICAL DATA; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Stollenwerk Nico, 2010, Journal of Biological Dynamics, V4, P634, DOI 10.1080/17513758.2010.487159; Tetro JA, 2020, MICROBES INFECT, V22, P72, DOI 10.1016/j.micinf.2020.02.006; World Health Organization, 2019, 2 WHO; WorldHealth Organization, 2020, 113 WHO; Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044; Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134	21	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236620	10.1371/journal.pone.0236620	http://dx.doi.org/10.1371/journal.pone.0236620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702051	Green Published, gold, Green Submitted			2022-12-26	WOS:000575913700102
J	Nagar, P; Kumar, A; Jain, M; Kumari, S; Mustafiz, A				Nagar, Preeti; Kumar, Ashish; Jain, Muskan; Kumari, Sumita; Mustafiz, Ananda			Genome-wide analysis and transcript profiling of PSKR gene family members in Oryza sativa	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; ABIOTIC STRESS TOLERANCE; PHYTOSULFOKINE RECEPTOR; IMPROVES DROUGHT; ARABIDOPSIS; GROWTH; MEMBRANE; OVEREXPRESSION; IDENTIFICATION; PROLIFERATION	Peptide signalling is an integral part of cell-to-cell communication which helps to relay the information responsible for coordinating cell proliferation and differentiation. Phytosulfokine Receptor (PSKR) is a transmembrane LRR-RLK family protein with a binding site for small signalling peptide, phytosulfokine (PSK). PSK signalling through PSKR promotes normal growth and development and also plays a role in defense responses. Like other RLKs, these PSKRs might have a role in signal transduction pathways related to abiotic stress responses. Genome-wide analysis of phytosulfokine receptor gene family has led to the identification of fifteen putative members in the Oryza sativa genome. The expression analysis of OsPSKR genes done using RNA-seq data, showed that these genes were differentially expressed in different tissues and responded specifically to heat, salt, drought and cold stress. Furthermore, the real-time quantitative PCR for fifteen OsPSKR genes revealed temporally and spatially regulated gene expression corresponding to salinity and drought stress. Our results provide useful information for a better understanding of OsPSKR genes and provide the foundation for additional functional exploration of the rice PSKR gene family in development and stress response.	[Nagar, Preeti; Kumar, Ashish; Jain, Muskan; Mustafiz, Ananda] South Asian Univ, Fac Life Sci & Biotechnol, Plant Mol Biol Lab, New Delhi, India; [Kumari, Sumita] Sher E Kashmir Univ Agr Sci & Technol, Sch Biotechnol, Jammu, JK, India	South Asian University (SAU); Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu)	Mustafiz, A (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, Plant Mol Biol Lab, New Delhi, India.	amustafiz@sau.ac.in		NAGAR, PREETI/0000-0002-7427-0092; Kumar, Ashish/0000-0003-2544-0240	Department of Biotechnology (DBT), Government of India [BT/PR22673/BPA/118/251/2017]; South Asian University (SAU), New Delhi; University Grant Commission (UGC), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); South Asian University (SAU), New Delhi; University Grant Commission (UGC), Government of India(University Grants Commission, India)	This study received support from the Department of Biotechnology (DBT) (Grant No. BT/PR22673/BPA/118/251/2017), Government of India and the South Asian University (SAU), New Delhi. PN was supported by a fellowship from the University Grant Commission (UGC), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2015, PLANT CELL; Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; [Anonymous], 2012, NUCLEIC ACIDS RES; [Anonymous], 2018, PLANT J CELL MOL BIO; Batth R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00198; Castelan-Munoz N, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00853/full; Chen J, 2016, P NATL ACAD SCI; Chen LJ, 2013, PLANT PHYSIOL, V163, P1752, DOI 10.1104/pp.113.224881; Cheng ZJ, 2014, PLANT CELL, V26, P1053, DOI 10.1105/tpc.113.121566; Chong YT, 2010, NEW PHYTOL, V185, P401, DOI 10.1111/j.1469-8137.2009.03070.x; Czyzewicz N, 2013, J EXP BOT, V64, P5281, DOI 10.1093/jxb/ert283; Deshmukh RK, 2016, J PLANT BIOCHEM BIOT, V25, P142, DOI 10.1007/s13562-015-0319-5; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Fujisaki K, 2015, PLANT J, V83, P875, DOI 10.1111/tpj.12934; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hartmann J, 2015, BIOCHEM J, V472; Hartmann J, 2014, PLANT J, V78, P192, DOI 10.1111/tpj.12460; Hartmann J, 2013, PLANT J, V73, P579, DOI 10.1111/tpj.12056; Hohmann U, 2017, ANNU REV PLANT BIOL, V68, P109, DOI 10.1146/annurev-arplant-042916-040957; Holzwart E, 2018, P NATL ACAD SCI USA, V115, P11838, DOI 10.1073/pnas.1814434115; Hou X, 2009, P NATL ACAD SCI; Houde M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-149; Huang ZN, 2016, GENOME BIOL EVOL, V8, P302, DOI 10.1093/gbe/evv259; Igarashi D, 2012, PLANT J, V71, P194, DOI 10.1111/j.1365-313X.2012.04950.x; Igasaki T, 2003, PLANT CELL PHYSIOL, V44, P1412, DOI 10.1093/pcp/pcg161; Kanaoka MM, 2015, CURR OPIN PLANT BIOL, V28, P127, DOI 10.1016/j.pbi.2015.10.006; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DY, 2010, PHYSIOL PLANTARUM, V139, P170, DOI 10.1111/j.1399-3054.2010.01353.x; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Kumari S, 2009, FUNCT INTEGR GENOMIC, V9, P109, DOI 10.1007/s10142-008-0088-5; Kutschmar A, 2009, NEW PHYTOL, V181, P820, DOI 10.1111/j.1469-8137.2008.02710.x; Ladwig F, 2015, PLANT CELL, V27, P1718, DOI 10.1105/tpc.15.00306; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loivamaki M, 2010, PHYSIOL PLANTARUM, V139, P348, DOI 10.1111/j.1399-3054.2010.01371.x; Lorbiecke R, 2005, J EXP BOT, V56, P1805, DOI 10.1093/jxb/eri169; Markovic V, 2019, EX070A2 CRITICAL EXO; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 2006, PLANT PHYSIOL, V142, P45, DOI 10.1104/pp.106.081109; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mosher S, 2013, PLANT J, V73, P469, DOI 10.1111/tpj.12050; Muleya V, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0060-z; Najafi S, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Ofori PA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200854; Osakabe Y, 2010, J BIOL CHEM, V285, P9190, DOI 10.1074/jbc.M109.051938; Ouyang SQ, 2010, PLANT J, V62, P316, DOI 10.1111/j.1365-313X.2010.04146.x; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Park S, 2014, J PLANT PHYSIOL, V171, P1645, DOI 10.1016/j.jplph.2014.08.002; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Phukan UJ, 2016, FRONT PLANT SCI, V7; Pj W., 2017, P NATL ACAD SCI USA; Planas-Riverola A, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.151894; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sauter M, 2015, J EXP BOT, V66, P5160, DOI 10.1093/jxb/erv071; Sekeres J, 2017, PLANT PHYSIOL, V173, P1659, DOI 10.1104/pp.16.01709; Shang Y, 2016, MOL PLANT, V9, P447, DOI 10.1016/j.molp.2015.12.014; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen YP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003525; Shinohara H, 2007, J BIOL CHEM, V282, P124, DOI 10.1074/jbc.M604558200; Stuhrwohldt N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021054; ten Hove CA, 2011, PLANT MOL BIOL, V76, P69, DOI 10.1007/s11103-011-9769-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JZ, 2015, NATURE, V525, P265, DOI 10.1038/nature14858; Wang L, 2016, INT J RADIAT BIOL, P1, DOI DOI 10.18632/0NC0TARGET.7405; Wu T, 2015, J EXP BOT, V66, P3657, DOI 10.1093/jxb/erv105; Yang W, 2019, PLANTA, V250, P1603, DOI 10.1007/s00425-019-03238-8; Ye YY, 2017, PLANT CELL REP, V36, P235, DOI 10.1007/s00299-016-2084-x; Yoshida S, 1971, LAB MANUAL PHYSIOLOG; Yu ZP, 2019, J EXP BOT, V70, P5457, DOI 10.1093/jxb/erz302; Zhang H, 2018, PLANT CELL, V30, P652, DOI 10.1105/tpc.17.00537	73	5	5	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236349	10.1371/journal.pone.0236349	http://dx.doi.org/10.1371/journal.pone.0236349			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701993	Green Published, gold			2022-12-26	WOS:000575913700079
J	Yang, S; Wu, LF; Wu, B; Zhang, YZ; Wang, HY; Tan, XM				Yang, Sheng; Wu, Linfeng; Wu, Bin; Zhang, Yizheng; Wang, Haiyan; Tan, Xuemei			Diversity and structure of soil microbiota of the Jinsha earthen relic	PLOS ONE			English	Article							ALTAMIRA CAVE; FUNCTIONAL REDUNDANCY; WALL PAINTINGS; COMMUNITIES; BACTERIAL; FUNGAL; BIODETERIORATION; IDENTIFICATION; BIODIVERSITY	In order to define the diversity and composition of the microbial communities colonizing of the soil microbiome of the Jinsha earthen relic, we used high-throughput sequencing technology to identify and characterize the microbiota in 22 samples collected from the Jinsha earthen relic in China during 2017 and 2018. We compared the taxonomy of the microbial communities from samples taken at different times and different sites. Our results showed that the identity of the dominant bacterial phyla differed among the samples.Proteobacteria(23-86.2%) were the predominant bacterial phylum in all samples taken from site A in both 2017 and 2018. However,Actinobacteria(21-92.3%) were the most popular bacterial phylum in samples from sites B and C in 2017 and 2018.Ascomycotawere identified as the only fungal phyla in samples in 2017. However, the group varied drastically in relative abundance between 2017 and 2018. Functional analysis of the soil bacterial community suggested that abundant members of the microbiota may be associated with metabolism and the specific environment. This report was the first high-throughput sequencing study of the soil of the Jinsha earthen relic microbiome. Since soil microbiota can damage soil and archeological structures, comprehensive analyses of the microbiomes at archeological sites may contribute to the understand of the influence of microorganisms on the degradation of soil, as well as to the identification of potentially beneficial or undesirable members of these microbial communities in archeological sites. The study will be helpful to provide effective data and guidance for the prevention and control of microbial corrosion of the Jinsha earthen relic.	[Yang, Sheng] Chengdu Inst Cultural Rel, Chengdu, Peoples R China; [Wu, Linfeng; Zhang, Yizheng; Wang, Haiyan; Tan, Xuemei] Sichuan Univ, Sichuan Key Lab Mol Biol & Biotechnol, Key Lab Bioresources & Ecoenvironm, Coll Life Sci,Minist Educ, Chengdu, Peoples R China; [Wu, Bin] Jinsha Site Museum, Chengdu, Peoples R China	Sichuan University	Tan, XM (corresponding author), Sichuan Univ, Sichuan Key Lab Mol Biol & Biotechnol, Key Lab Bioresources & Ecoenvironm, Coll Life Sci,Minist Educ, Chengdu, Peoples R China.	txmyyf@scu.edu.cn			Chengdu Institute of Cultural Relics [16H1189]	Chengdu Institute of Cultural Relics	This study was financially supported by the Chengdu Institute of Cultural Relics (16H1189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahram M, 2018, NATURE, V560, P233, DOI 10.1038/s41586-018-0386-6; Bahrndorff S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20967-0; Biswas J, 2013, IRAN J MICROBIOL, V5, P309; Capodicasa S, 2010, INT BIODETER BIODEGR, V64, P727, DOI 10.1016/j.ibiod.2010.08.006; Cuezva S, 2012, FEMS MICROBIOL ECOL, V81, P281, DOI 10.1111/j.1574-6941.2012.01391.x; Dakal Tikam Chand, 2012, Environmental Sciences Europe, V24, P1, DOI 10.1186/2190-4715-24-36; Dehler CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13249-8; Douglas G.M., 2020, PICURUST2 IMPROVED E, DOI [10.1101/672295, 672295, 10.1101/672295, DOI 10.1101/672295]; Duan YL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179718; Elshahawi SI, 2013, P NATL ACAD SCI USA, V110, pE295, DOI 10.1073/pnas.1213892110; Forstner C, 2019, SCI TOTAL ENVIRON, V671, P140, DOI 10.1016/j.scitotenv.2019.03.360; Fraczek K, 2009, ECOL CHEM ENG A, V16, P1117; Gong W, 2019, J CULT HERIT, V35, P116, DOI 10.1016/j.culher.2018.06.002; Gulotta D, 2018, SCI TOTAL ENVIRON, V639, P1480, DOI 10.1016/j.scitotenv.2018.05.277; Gutarowska B, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.00979, 10.3389/fmicb.2015.00979]; Hui DAN, 2006, J CHENGDU U TECHNOLO, V33, P541; Hujslova M, 2017, MICROB ECOL, V73, P321, DOI 10.1007/s00248-016-0860-3; Itcus C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34106-2; Jiang XY, 2014, SOIL RES, V52, P97, DOI 10.1071/SR13210; Jroundi F, 2010, MICROB ECOL, V60, P39, DOI 10.1007/s00248-010-9665-y; Jurado V, 2008, INT J SYST EVOL MICR, V58, P2210, DOI 10.1099/ijs.0.65482-0; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Lan WS, 2010, MICROB ECOL, V60, P105, DOI 10.1007/s00248-010-9707-5; [李静 Li Jing], 2019, [微生物学通报, Microbiology China], V46, P3205; Li Q, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02680-17; Li Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163287; Li YM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01705; Liu ZP, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00096; Liu ZJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00802; Louca S, 2018, NAT ECOL EVOL, V2, P936, DOI 10.1038/s41559-018-0519-1; MA YT, 2015, SCI REP, V5, P25435, DOI DOI 10.1038/SREP0775225583346; Macedo MF, 2009, MICROBIOL-SGM, V155, P3476, DOI 10.1099/mic.0.032508-0; Margesin R, 2017, MICROB ECOL, V73, P925, DOI 10.1007/s00248-016-0904-8; Maza F, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00010; Mihajlovski A, 2017, INT BIODETER BIODEGR, V120, P161, DOI 10.1016/j.ibiod.2017.02.019; Mosier AC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00238; Negi A, 2019, MICROB ECOL, V78, P1014, DOI 10.1007/s00248-019-01366-y; Nowicka KP, 2014, SCI TOTAL ENVIRON, V493, P116, DOI [10.1016/j.scitotenv.2014.05.11324937497, DOI 10.1016/J.SCITOTENV.2014.05.11324937497]; Pasic L, 2010, FEMS MICROBIOL ECOL, V71, P50, DOI 10.1111/j.1574-6941.2009.00789.x; Pepe O, 2010, MICROBIOL RES, V165, P21, DOI 10.1016/j.micres.2008.03.005; Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Sauro F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35532-y; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Tyler HL, 2019, J APPL MICROBIOL, V126, P1797, DOI 10.1111/jam.14267; Wei YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193097; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; XU JJ, 2017, SCI REP, V7, P25435, DOI DOI 10.1038/SREP4169128169321; Zhang H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40819; Zhou JZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12083; Zhu B, 2019, HARMFUL ALGAE, V82, P9, DOI 10.1016/j.hal.2018.12.006; Zhu Lidong, 2009, 2009 1st International Conference on Information Science and Engineering (ICISE 2009), P5406, DOI 10.1109/ICISE.2009.999; Zhu Z. Y., 2003, J E ASIAN ARCHAEOL, V5, P247; Zimmermann J, 2005, GEOMICROBIOL J, V22, P379, DOI 10.1080/01490450500248986; Zucconi L, 2012, INT BIODETER BIODEGR, V70, P40, DOI 10.1016/j.ibiod.2011.11.018	55	0	0	7	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236165	10.1371/journal.pone.0236165	http://dx.doi.org/10.1371/journal.pone.0236165			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697804	Green Published, gold			2022-12-26	WOS:000555392700028
J	Fokam, J; Takou, D; Teto, G; Nforbih, SE; Kome, OP; Santoro, MM; Ngoufack, ES; Eyongetah, M; Palmer, D; Fokunang, ET; Fokunang, CN; Colizzi, V; Perno, CF; Ndjolo, A				Fokam, Joseph; Takou, Desire; Teto, Georges; Nforbih, Shu E.; Kome, Odine P.; Santoro, Maria M.; Ngoufack, Ezechiel S.; Eyongetah, Mbuh; Palmer, Denis; Fokunang, Estella T.; Fokunang, Charles N.; Colizzi, Vittorio; Perno, Carlo-Federico; Ndjolo, Alexis			Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon	PLOS ONE			English	Article							NEWLY-DIAGNOSED PATIENTS; REVERSE-TRANSCRIPTASE; NAIVE PATIENTS; MUTATIONS; INDIVIDUALS; PREVALENCE; YAOUNDE; SUSCEPTIBILITY; LAMIVUDINE; EVOLUTION	Background With the scale-up of antiretroviral therapy (ART), pre-treatment drug resistance (PDR) appears >= 10% amongst ART-initiators in many developing countries, including Cameroon. Northwest region-Cameroon having the second epidemiological burden of HIV infection, generating data on PDR in these geographical settings, will enhance evidence-based decision-making. Objectives We sought to ascertain levels of PDR and HIV-1 clade dispersal in rural and urban settings, and their potential association with subtype distribution and CD4-staging. Methods A cross-sectional study was conducted from February to May 2017 among patients recently diagnosed with HIV-infection and initiating ART at the Bamenda regional Hospital (urban setting) and the Mbingo Baptist hospital (rural setting). Protease and reverse transcriptase sequencing was performed using an in-house protocol and pre-treatment drug resistance mutations were interpreted using StanfordHIVdb.v8.3. Phylogeny was performed for subtype assignation. Results A total of 61 patient sequences were generated from ART initiators (median age: 37 years old; 57.4% female; median CD4 cell count: 184 [IQR: 35-387] in urban vs. 161 [IQR: 96-322] cells/mm(3)in rural). Overall, the level of PDR was 9.8% (6/61). Of note, burden of PDR was almost doubled in urban (12.9% [4/31]) compared to rural setting 6.7% (2/30),p= 0.352). Fifteen (15) PDR mutations were found among four patients the urban settings [6 resistance mutations to NRTIs:[M41L (2), E44D (1), K65R (1), K70E (1), M184V/I (2), K219R (1)] and 6 resistance mutations to NNRTIs: K103N (1), E138A/G (2), V179E (1), M230L (1), K238T (1), P225H (1)] against two (02) mutations found in two patients in the rural setting[2 resistant mutations to NNRTIs: E138A (1) and Y188H (1)]. The rural setting showed more genetic diversity (8 subtypes) than the urban setting (5 subtypes), with CRF02_AG being the most prevalent clade (72.1% [44/61]). Of note, level of PDR was similar between patients infected with CRF02_AG and non-CRF02_AG infected (9.1% [4/44]) vs. 11.8% [2/17]),p= 1.000). Moreover, PDR appeared higher in patients with CD4 cell count <200 cells/mm(3)compared to those with CD4 cell count >= 200 cells/mm(3)(14.7% [5/34]) vs. 3.7% [1/27]),p= 0.214). Conclusions PDR is at a moderate rate in the Northwest region of Cameroon, with higher burden within urban populations. CRF02_AG is the most predominant clade in both urban and rural settings. No effect of HIV molecular epidemiology and CD4-staging on the presence of PDR in patients living in these settings was found. Our findings suggest close monitoring, NNRTI-sparing regimens or sequencing for patients initiating ART, especially in urban settings.	[Fokam, Joseph; Takou, Desire; Teto, Georges; Ngoufack, Ezechiel S.; Colizzi, Vittorio; Perno, Carlo-Federico; Ndjolo, Alexis] Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon; [Fokam, Joseph; Nforbih, Shu E.; Kome, Odine P.; Fokunang, Estella T.; Fokunang, Charles N.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Fokam, Joseph; Ndjolo, Alexis] Minist Publ Hlth, Natl HIV Drug Resistance Prevent & Surveillance W, Yaounde, Cameroon; [Nforbih, Shu E.] Univ Lagos, Dept Community Hlth & Primary Care, Lagos, Nigeria; [Santoro, Maria M.; Perno, Carlo-Federico] Univ Roma Tor Vergata, Rome, Italy; [Eyongetah, Mbuh] Bamenda Reg Hosp, Day Care Ctr, Bamenda, Cameroon; [Palmer, Denis] Mbingo Baptist Hosp, Care & Treatment Ctr, Mbingo, Cameroon; [Colizzi, Vittorio] UNESCO Chair Multidisciplinary Biotechnol & Eurob, Rome, Italy; [Colizzi, Vittorio; Perno, Carlo-Federico] Univ Milan, Milan, Italy	University of Yaounde I; University of Lagos; University of Rome Tor Vergata; University of Milan	Fokam, J (corresponding author), Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon.; Fokam, J (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.; Fokam, J (corresponding author), Minist Publ Hlth, Natl HIV Drug Resistance Prevent & Surveillance W, Yaounde, Cameroon.	josephfokam@gmail.com	; santoro, maria/K-3250-2018	PERNO, CARLO FEDERICO/0000-0002-0825-5388; santoro, maria/0000-0002-6228-1114; Fokam, Joseph/0000-0002-1501-2763	Chantal BIYA International Reference Center for research on HIV/AIDS prevention and management, in Yaounde, Cameroon; EDCTP2, the European and Developing Countries Clinical Trial Partnership [CDF-TMA 1027]	Chantal BIYA International Reference Center for research on HIV/AIDS prevention and management, in Yaounde, Cameroon; EDCTP2, the European and Developing Countries Clinical Trial Partnership	This study was financially supported by the Chantal BIYA International Reference Center for research on HIV/AIDS prevention and management, in Yaounde, Cameroon. The study was partly supported by EDCTP2, the European and Developing Countries Clinical Trial Partnership, CDF-TMA 1027, which facilitated the relocation at CIRCB of the principal investigator: Dr. Joseph Fokam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Agyingi L, 2014, J MED VIROL, V86, P385, DOI 10.1002/jmv.23846; [Anonymous], 2011, DERMOGRAPHIC HLTH SU; Bakhouch K, 2009, J INFECT DEV COUNTR, V3, P380, DOI 10.3855/jidc.247; Billong SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072680; Brenner B, 2000, INT J ANTIMICROB AG, V16, P429, DOI 10.1016/S0924-8579(00)00270-3; Burda ST, 2010, J MED VIROL, V82, P187, DOI 10.1002/jmv.21677; Cameroon MoPH, 2011, REP 1 SEM ACT FIGHT; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; Ceccarelli L, 2012, J MED VIROL, V84, P721, DOI 10.1002/jmv.23244; Derache A, 2008, J ANTIMICROB CHEMOTH, V62, P456, DOI 10.1093/jac/dkn234; Duwe S, 2001, J ACQ IMMUN DEF SYND, V26, P266, DOI 10.1097/00126334-200103010-00010; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; FAghokeng A, 2009, ANTIVIR THER, V14, P401; Fokam J, 2011, ARCH VIROL, V156, P1235, DOI 10.1007/s00705-011-0982-3; Fokam J, 2016, AIDS RES HUM RETROV, V32, P329, DOI [10.1089/aid.2015.0065, 10.1089/AID.2015.0065]; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassan AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210559; Koizumi Y, 2006, JAIDS-J ACQ IMM DEF, V43, P15, DOI 10.1097/01.qai.0000226793.16216.55; Konings FAJ, 2004, AIDS RES HUM RETROV, V20, P105, DOI 10.1089/088922204322749558; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Mbanya Dora, 2008, Int J Environ Res Public Health, V5, P378; Mbunkah HA, 2018, J ANTIMICROB CHEMOTH, V73, P1917, DOI 10.1093/jac/dky103; Melikian GL, 2014, J ANTIMICROB CHEMOTH, V69, P12, DOI 10.1093/jac/dkt316; Miller MD, 1999, J INFECT DIS, V179, P92, DOI 10.1086/314560; National AIDS Control Committee, 2015, NATL AIDS CONTROL CO, P18; Ndembi N, 2008, J CLIN MICROBIOL, V46, P177, DOI 10.1128/JCM.00428-07; Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40; Novak RM, 2005, CLIN INFECT DIS, V40, P468, DOI 10.1086/427212; Nwobegahay JM, 2011, J HEALTH POPUL NUTR, V29, P303, DOI 10.3329/jhpn.v29i4.8444; Onywera H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171124; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Parikh U, 2003, 12 INT HIV DRUG RES; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Rios M, 2007, J MED VIROL, V79, P647, DOI 10.1002/jmv.20881; Smith D, 2007, CLIN INFECT DIS, V44, P456, DOI 10.1086/510748; Tambuyzer L, 2011, JAIDS-J ACQ IMM DEF, V58, P18, DOI 10.1097/QAI.0b013e3182237f74; Tchouwa GF, 2018, J ANTIMICROB CHEMOTH, V73, P2468, DOI 10.1093/jac/dky221; Theys K, 2016, AIDS RES HUM RETROV, V32, P427, DOI [10.1089/aid.2015.0095, 10.1089/AID.2015.0095]; Turner D, 2004, ANTIMICROB AGENTS CH, V48, P2993, DOI 10.1128/AAC.48.8.2993-2998.2004; UNAIDS, FAST TRACK END AIDS; United Nations, FAST TRACK END AIDS; Vergne L, 2006, ANTIVIR THER, V11, P575; Vessiere A, 2006, JAIDS-J ACQ IMM DEF, V42, P256, DOI 10.1097/01.qai.0000209909.20373.3b; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; WHO, 2014, SURV HIV DRUG RES PO; World Health Organisation, 2016, WHO CONSOLIDATION GU; World Health Organisation (WHO), 2017, HIV DRUG RES REP 201	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0235958	10.1371/journal.pone.0235958	http://dx.doi.org/10.1371/journal.pone.0235958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692778	gold, Green Published			2022-12-26	WOS:000554606400019
J	Kim, GW; Imam, H; Khan, M; Siddiqui, A				Kim, Geon-Woo; Imam, Hasan; Khan, Mohsin; Siddiqui, Aleem			N-6-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						m6A modification; immune evasion; RIG-I sensing; innate immunity; viral immunology; cellular immune response; hepatitis B virus (HBV; Hep B); hepatitis C virus (HCV; Hep C)	MOLECULAR-BIOLOGY; VIRUS; METHYLATION; PSEUDOURIDINE; RECOGNITION; TRANSLATION; SUPPRESSION; ACTIVATION; REVEALS; PROTEIN	N-6-Methyladenosine (m(6)A), the methylation of the adenosine base at the nitrogen 6 position, is the most common epitranscriptomic modification of mRNA that affects a wide variety of biological functions. We have previously reported that hepatitis B viral RNAs are m(6)A-modified, displaying a dual functional role in the viral life cycle. Here, we show that cellular m(6)A machinery regulates host innate immunity against hepatitis B and C viral infections by inducing m(6)A modification of viral transcripts. The depletion of the m(6)A writer enzymes (METTL3 and METTL14) leads to an increase in viral RNA recognition by retinoic acid-inducible gene I (RIG-I), thereby stimulating type I interferon production. This is reversed in cells in which m(6)A METTL3 and METTL14 are overexpressed. The m(6)A modification of viral RNAs renders RIG-I signaling less effective, whereas single nucleotide mutation of m(6)A consensus motif of viral RNAs enhances RIG-I sensing activity. Importantly, m(6)A reader proteins (YTHDF2 and YTHDF3) inhibit RIG-I-transduced signaling activated by viral RNAs by occupying m(6)A-modified RNAs and inhibiting RIG-I recognition. Collectively, our results provide new insights into the mechanism of immune evasion via m(6)A modification of viral RNAs.	[Kim, Geon-Woo; Imam, Hasan; Khan, Mohsin; Siddiqui, Aleem] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Siddiqui, A (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.	asiddiqui@health.ucsd.edu	Kim, Geon-Woo/AAL-3260-2021	KIM, GEON-WOO/0000-0003-0432-8268	National Institutes of Health [AI125350, AI139234, AI085087]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health Grants AI125350, AI139234, and AI085087 (to A. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barth H, 2011, HEPATOLOGY, V54, P1135, DOI 10.1002/hep.24489; Braciale TJ, 2013, IMMUNOL REV, V255, P5, DOI 10.1111/imr.12109; de Martel C, 2015, HEPATOLOGY, V62, P1190, DOI 10.1002/hep.27969; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Durbin AF, 2016, MBIO, V7, DOI 10.1128/mBio.00833-16; Flamme M, 2019, METHODS, V161, P64, DOI 10.1016/j.ymeth.2019.03.018; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; George CX, 2014, J INTERF CYTOK RES, V34, P437, DOI 10.1089/jir.2014.0001; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Gonzales-van Horn SR, 2017, CELL HOST MICROBE, V21, P661, DOI 10.1016/j.chom.2017.05.008; Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Imam H, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008338; Imam H, 2018, P NATL ACAD SCI USA, V115, P8829, DOI 10.1073/pnas.1808319115; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Khan M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005693; Kim GW, 2021, HEPATOLOGY, V73, P533, DOI 10.1002/hep.31313; Kim GW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005714; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Li S, 2016, NAT IMMUNOL, V17, P241, DOI 10.1038/ni.3311; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Li XY, 2016, CURR OPIN CHEM BIOL, V33, P108, DOI 10.1016/j.cbpa.2016.06.014; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lu MJ, 2020, NAT MICROBIOL, V5, P584, DOI 10.1038/s41564-019-0653-9; Manners O, 2019, BBA-GENE REGUL MECH, V1862, P370, DOI 10.1016/j.bbagrm.2018.10.015; McIntyre W, 2018, NUCLEIC ACIDS RES, V46, P5776, DOI 10.1093/nar/gky029; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Sioud M, 2007, BIOCHEM BIOPH RES CO, V361, P122, DOI 10.1016/j.bbrc.2007.06.177; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Wang XM, 2010, CELL MOL IMMUNOL, V7, P341, DOI 10.1038/cmi.2010.36; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Yang DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027552; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhong L, 2019, CANCER LETT, V442, P252, DOI 10.1016/j.canlet.2018.11.006	52	53	54	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					13123	13133		10.1074/jbc.RA120.014260	http://dx.doi.org/10.1074/jbc.RA120.014260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32719095	hybrid, Green Published			2022-12-26	WOS:000572412900020
J	Chen, YS; Tseng, WC; Chen, CH; Bezerra, P; Ye, X				Chen, Yung-Sheng; Tseng, Wei-Chin; Chen, Che-Hsiu; Bezerra, Pedro; Ye, Xin			Acute effects of kinesiology tape tension on soleus muscle h-reflex modulations during lying and standing postures	PLOS ONE			English	Article							TRICEPS SURAE; TAPING APPLICATION; EXCITABILITY; IMMEDIATE; STRENGTH; SWAY; PAIN	Kinesiology tape (KT) has been widely used in the areas of sports and rehabilitation. However, there is no gold standard for the tape tension used during a KT application. The purpose of this study was to examine the effects of KT application with different tension intensities on soleus muscle Hoffmann-reflex (H-reflex) modulation during lying and standing postures. Fifteen healthy university students were tested with 3 tape tension intensities during separate visits with a randomized sequence: tape-on no tension (0KT), moderate (about 50% of the maximal tape tension: (ModKT), and maximal tape tension (MaxKT). During each experimental visit, the H-reflex measurements on the soleus muscle were taken before, during, and after the KT application for both lying and standing postures. The H-wave and M-wave recruitment curves were generated using surface electromyography (EMG). There was a main effect for posture (p= 0.001) for the maximal peak-to-peak amplitude of the H-wave and M-wave (H-max/M-max) ratio, showing the depressed H-max/M(max)ratio during standing, when compared to the lying posture. Even though the tension factor had a large effect (eta(2)(p)= 0.165), different tape tensions showed no significant differential effects for the H-max/M(max)ratio. The spinal motoneuron excitability was not altered, even during the maximal tension KT application on the soleus muscle. Thus, the tension used during a KT application should not be a concern in terms of modulating the sensorimotor activity ascribed to elastic taping during lying and standing postures.	[Chen, Yung-Sheng; Tseng, Wei-Chin] Univ Taipei, Dept Exercise & Hlth Sci, Taipei, Taiwan; [Chen, Che-Hsiu] Natl Taiwan Univ Sports, Dept Sport Performance, Taichung, Taiwan; [Bezerra, Pedro] Inst Politecn Viana Castelo, Escola Super Desporto & Lazer, Melgaco, Portugal; [Bezerra, Pedro] Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal; [Ye, Xin] Univ Mississippi, Dept Hlth Exercise Sci & Recreat Management, Oxford, MS 38677 USA; [Ye, Xin] Univ Hartford, Dept Rehabil Sci, Hartford, CT 06134 USA	University of Taipei; Polytechnic Institute of Viana do Castelo; University of Mississippi; University of Hartford	Ye, X (corresponding author), Univ Mississippi, Dept Hlth Exercise Sci & Recreat Management, Oxford, MS 38677 USA.; Ye, X (corresponding author), Univ Hartford, Dept Rehabil Sci, Hartford, CT 06134 USA.	xye@hartford.edu	; Ye, Xin/J-5745-2015	Chen, Yung-Sheng/0000-0002-1013-3822; Ye, Xin/0000-0002-6028-2295	Ministry of Science and Technology, R.O.C. (Taiwan) [MOST 107-2410-H-845-021]	Ministry of Science and Technology, R.O.C. (Taiwan)	This study was supported by a research grant MOST 107-2410-H-845-021 from the Ministry of Science and Technology, R.O.C. (Taiwan).	Alexander CM, 2008, MANUAL THER, V13, P57, DOI 10.1016/j.math.2006.08.003; Alexander CM, 2003, MANUAL THER, V8, P37, DOI 10.1054/math.2002.0485; Alrowayeh HN, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-65; Bagheri R, 2018, J BODYW MOV THER, V22, P266, DOI 10.1016/j.jbmt.2017.06.018; Bravi R, 2016, INT J SPORTS MED, V37, P909, DOI 10.1055/s-0042-109777; Bravi R, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00181; Chen YS, 2011, GAIT POSTURE, V33, P169, DOI 10.1016/j.gaitpost.2010.12.008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cools AM, 2002, MANUAL THER, V7, P154, DOI 10.1054/math.2002.0464; de Jesus JF, 2017, INT J SPORTS PHYS TH, V12, P85; Deliagina TG, 2006, PHYSIOLOGY, V21, P216, DOI 10.1152/physiol.00001.2006; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Firth BL, 2010, CLIN J SPORT MED, V20, P416, DOI 10.1097/JSM.0b013e3181f479b0; Fu TC, 2008, J SCI MED SPORT, V11, P198, DOI 10.1016/j.jsams.2007.02.011; Halseth T, 2004, J SPORT SCI MED, V3, P1; Hanna-Boutros B, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12276; Hermens HJ., 1999, ROESSINGH RES DEV, V8, P13; Kim MK, 2017, MED SCI MONITOR, V23, P5534, DOI 10.12659/MSM.905385; KOCEJA DM, 1993, BRAIN RES, V629, P155, DOI 10.1016/0006-8993(93)90495-9; Magalhaes IEJ, 2021, J SPORT REHABIL, V30, P22, DOI 10.1123/jsr.2018-0435; Mynark RG, 2005, CLIN NEUROPHYSIOL, V116, P1400, DOI 10.1016/j.clinph.2005.02.001; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; PierrotDeseilligny E, 1997, J NEUROSCI METH, V74, P189, DOI 10.1016/S0165-0270(97)02249-8; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; Tokuno CD, 2007, ACTA PHYSIOL, V191, P229, DOI 10.1111/j.1748-1716.2007.01727.x; Tokuno CD, 2008, J APPL PHYSIOL, V104, P1359, DOI 10.1152/japplphysiol.00857.2007; Tremblay F, 2015, J ATHL TRAINING, V50, P840, DOI 10.4085/1062-6050-50.5.08; Velasco-Roldan O, 2018, PM&R, V10, P28, DOI 10.1016/j.pmrj.2017.05.003; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	29	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236587	10.1371/journal.pone.0236587	http://dx.doi.org/10.1371/journal.pone.0236587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730289	gold, Green Published			2022-12-26	WOS:000556884700032
J	Foligne, B; George, F; Standaert, A; Garat, A; Poiret, S; Peucelle, V; Ferreira, S; Sobry, H; Muharram, G; Lucau-Danila, A; Daniel, C				Foligne, Benoit; George, Fanny; Standaert, Annie; Garat, Anne; Poiret, Sabine; Peucelle, Veronique; Ferreira, Stephanie; Sobry, Helene; Muharram, Ghaffar; Lucau-Danila, Anca; Daniel, Catherine			High-dose dietary supplementation with zinc prevents gut inflammation: Investigation of the role of metallothioneins and beyond by transcriptomic and metagenomic studies	FASEB JOURNAL			English	Article						colitis; dietary zinc; metallothionein; microbiota; mouse; transcriptomics	DEXTRAN SULFATE SODIUM; EXPERIMENTAL COLITIS; IN-VITRO; INTESTINAL MICROBIOTA; REGIONAL-DISTRIBUTION; RESISTANCE; EXPRESSION; OXIDE; ACID; ACCUMULATION	Although it is known that zinc has several beneficial roles in the context of gut inflammation, the underlying mechanisms have not been extensively characterized. Zinc (Zn) is known to be the primary physiological inducer of the expression of the metallothionein (MT) superfamily of small stress-responsive proteins. The expression of MTs in various tissues is induced or enhanced (including the gastrointestinal tract (GIT)) by a variety of stimuli, including infection and inflammation. However, the MTs' exact role in inflammation is still subject to debate. In order to establish whether or not MTs are the sole vectors in the Zn-based modulation of intestinal inflammation, we used transcriptomic and metagenomic approaches to assess the potential effect of dietary Zn, the mechanisms underlying the MTs' beneficial effects, and the induction of previously unidentified mediators. We found that the expression of endogenous MTs in the mouse GIT was stimulated by an optimized dietary supplementation with Zn. The protective effects of dietary supplementation with Zn were then evaluated in mouse models of chemically induced colitis. The potential contribution of MTs and other pathways was explored via transcriptomic analyses of the ileum and colon in Zn-treated mice. The microbiota's role was also assessed via fecal 16S rRNA sequencing. We found that high-dose dietary supplementation with Zn induced the expression of MT-encoding genes in the colon of healthy mice. We next demonstrated that the Zn diet significantly protected mice in the two models of induced colitis. When comparing Zn-treated and control mice, various genes were found to be differentially expressed in the colon and the ileum. Finally, we found that Zn supplementation did not modify the overall structure of the fecal microbiota, with the exception of (i) a significant increase in endogenousClostridiaceae, and (ii) some subtle but specific changes at the family and genus levels. Our results emphasize the beneficial effects of excess dietary Zn on the prevention of colitis and inflammatory events in mouse models. The main underlying mechanisms were driven by the multifaceted roles of MTs and the other potential molecular mediators highlighted by our transcriptomic analyses although we cannot rule out contributions by other factors from the host and/or the microbiota.	[Foligne, Benoit; George, Fanny; Standaert, Annie] Univ Lille, CHU Lille, INSERM, U1286,Infinite,Inst Translat Res Inflammat, Lille, France; [George, Fanny; Garat, Anne] Univ Lille, CHU Lille, Inst Pasteur Lille, ULR 4483,IMPECS,IMPact Environm Chim Sante Humain, Lille, France; [Garat, Anne] CHU Lille, Unite Fonct Toxicol, Lille, France; [Poiret, Sabine; Peucelle, Veronique; Sobry, Helene; Muharram, Ghaffar; Daniel, Catherine] Univ Lille, CNRS, INSERM,Ctr Infect & Immun Lille, CHU Lille,Inst Pasteur Lille,U1019,UMR 9017,CIIL, Lille, France; [Ferreira, Stephanie] GenoScreen, Lille, France; [Lucau-Danila, Anca] ULille, ULiege, UArtois, BIOECOAGRO INRAe,ULCO,UPJV,YNCREA,Inst Charles Vi, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; INRAE; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale	Daniel, C (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, Team Cellular Microbiol & Phys Infect, INSERM U1019,CNRS UMR 8204, 1 Rue Prof Calmette, F-59019 Lille, France.	catherine.daniel@ibl.cnrs.fr	Standaert, Annie/R-5826-2018; poiret, sabine/GLQ-5349-2022; Garat, Anne/AAC-6868-2022; George, Fanny FG/M-3667-2018; Lucau-Danila, Anca/AAE-7674-2021; daniel, catherine/C-3051-2012; Muharram, Ghaffar/I-6686-2017; Foligne, Benoit/B-2754-2014	Standaert, Annie/0000-0002-7752-3964; George, Fanny FG/0000-0003-2727-5680; daniel, catherine/0000-0002-5299-2799; LUCAU-DANILA, Anca/0000-0002-9379-6241; Muharram, Ghaffar/0000-0003-4309-8450; Foligne, Benoit/0000-0001-9263-9706	Institut National de la Sante et de la Recherche Medicale (INSERM); Center National de la Recherche Scientifique (CNRS); Lille University via the "Romarin" grant, as part of the Infectious, Inflammatory, and Immune Diseases Research Federation (SF3I) program	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Center National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Lille University via the "Romarin" grant, as part of the Infectious, Inflammatory, and Immune Diseases Research Federation (SF3I) program	This work was funded by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Center National de la Recherche Scientifique (CNRS), and Lille University via the "Romarin" grant, as part of the Infectious, Inflammatory, and Immune Diseases Research Federation (SF3I) program.	Ameho CK, 1997, GUT, V41, P487, DOI 10.1136/gut.41.4.487; Arab HH, 2014, FOOD CHEM TOXICOL, V69, P294, DOI 10.1016/j.fct.2014.04.032; Barada KA, 2007, CYTOKINE, V37, P236, DOI 10.1016/j.cyto.2007.04.005; Beaugerie L, 2020, CLIN GASTROENTEROL H, V18, P1324, DOI 10.1016/j.cgh.2020.02.009; Beaumont M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3514-z; Blindauer CA, 2010, NAT PROD REP, V27, P720, DOI 10.1039/b906685n; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Breton J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19200; Breton J, 2013, TOXICOL LETT, V222, P132, DOI 10.1016/j.toxlet.2013.07.021; Bruwer M, 2001, INFLAMM RES, V50, P289, DOI 10.1007/PL00000246; Castillo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137463; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Chen PR, 2008, CURR OPIN CHEM BIOL, V12, P214, DOI 10.1016/j.cbpa.2007.12.010; Choi EK, 2020, FASEB J, V34, P2929, DOI 10.1096/fj.201902396R; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Click Benjamin, 2019, Curr Gastroenterol Rep, V21, P1, DOI 10.1007/s11894-019-0669-6; COOPER HS, 1993, LAB INVEST, V69, P238; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Danese Silvio, 2017, Gastroenterology, V153, P603, DOI 10.1053/j.gastro.2017.06.040; de Queiroz CAA, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-136; Devisscher L, 2014, J PATHOL, V233, P89, DOI 10.1002/path.4330; Di Leo V, 2001, DIGEST LIVER DIS, V33, P135, DOI 10.1016/S1590-8658(01)80068-2; Dostie KE, 2018, CURR PHARM DESIGN, V24, P3155, DOI 10.2174/1381612824666180717110236; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dziegiel P, 2016, ADV ANAT EMBRYOL CEL, V218, P1, DOI 10.1007/978-3-319-27472-0_1; Foligne B, 2007, GASTROENTEROLOGY, V133, P862, DOI 10.1053/j.gastro.2007.06.018; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Foligne B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060577; FORTINA MG, 1993, LETT APPL MICROBIOL, V17, P303, DOI 10.1111/j.1472-765X.1993.tb01473.x; Gericke A, 2013, ADV EXP MED BIOL, V991, P85, DOI 10.1007/978-94-007-6331-9_6; Gielda LM, 2012, MBIO, V3, DOI 10.1128/mBio.00171-12; Giles DA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02585; Gopalsamy GL, 2015, NUTRIENTS, V7, P572, DOI 10.3390/nu7010572; Hamouda HE, 2011, WORLD J GASTROENTERO, V17, P2417, DOI 10.3748/wjg.v17.i19.2417; Hardyman JEJ, 2016, METALLOMICS, V8, P337, DOI 10.1039/c5mt00305a; Hedblom GA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01991; Hennigar SR, 2019, COMPR PHYSIOL, V9, P59, DOI 10.1002/cphy.c180001; Higashimura Y, 2019, J CROHNS COLITIS, V14, P856; Hill GM, 2019, BIOL TRACE ELEM RES, V188, P148, DOI 10.1007/s12011-018-1578-5; Hojberg O, 2005, APPL ENVIRON MICROB, V71, P2267, DOI 10.1128/AEM.71.5.2267-2277.2005; Iwaya H, 2011, J NUTR, V141, P1077, DOI 10.3945/jn.111.138180; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kanai T, 2015, J GASTROENTEROL, V50, P928, DOI 10.1007/s00535-015-1084-x; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kimura T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030336; King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S; Kondaiah P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081885; Kumari MVR, 1998, FREE RADICAL RES, V29, P93, DOI 10.1080/10715769800300111; Lahiri A, 2014, GASTROENTEROLOGY, V147, P835, DOI 10.1053/j.gastro.2014.06.024; Li Weimin, 2013, Advances in Biological Regulation, V53, P64, DOI 10.1016/j.jbior.2012.10.004; Liedtke J, 2012, VET MICROBIOL, V160, P251, DOI 10.1016/j.vetmic.2012.05.013; Lim Wee-Chian, 2004, Rev Gastroenterol Disord, V4, P104; Liu HS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131273; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Liu JH, 2017, TOXICOL RES-UK, V6, P134, DOI 10.1039/c6tx00370b; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Lopez CA, 2018, CELL HOST MICROBE, V23, P737, DOI 10.1016/j.chom.2018.05.008; Martin L, 2013, J NUTR, V143, P1205, DOI 10.3945/jn.113.177881; Mascaraque C, 2015, BRIT J NUTR, V113, P618, DOI 10.1017/S0007114514004292; Maxwell Joseph R, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0558s47; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; Miyoshi Y, 2016, AM J PHYSIOL-GASTR L, V311, pG105, DOI 10.1152/ajpgi.00405.2015; Mizoguchi E, 2020, INTEST RES, V18, P151, DOI 10.5217/ir.2019.09154; MORRIS GP, 1989, AM J MED, V86, P10, DOI 10.1016/0002-9343(89)90150-2; Nakase H, 2020, IMMUNOL MED, V43, P1; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; O'Brien FG, 2002, J ANTIMICROB CHEMOTH, V50, P313, DOI 10.1093/jac/dkf153; Ohashi W, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/8396878; Owczarek D, 2016, WORLD J GASTROENTERO, V22, P895, DOI 10.3748/wjg.v22.i3.895; Oz HS, 2005, MED SCI MONITOR, V11, pBR69; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Podany A, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800947; Podany AB, 2016, CELL MOL GASTROENTER, V2, P369, DOI 10.1016/j.jcmgh.2015.12.006; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Raudenska M, 2014, METALLOMICS, V6, P55, DOI 10.1039/c3mt00132f; Reed S, 2018, J AGR FOOD CHEM, V66, P6291, DOI 10.1021/acs.jafc.8b01481; Reed S, 2015, NUTRIENTS, V7, P9768, DOI 10.3390/nu7125497; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Sauer AK, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01295; SILVER S, 1992, MICROBIOL REV, V56, P195, DOI 10.1128/MMBR.56.1.195-228.1992; Skrypnik K, 2018, J SCI FOOD AGR, V98, P2449, DOI 10.1002/jsfa.8724; Star L, 2012, POULTRY SCI, V91, P3115, DOI 10.3382/ps.2012-02314; Starke IC, 2014, FEMS MICROBIOL ECOL, V87, P416, DOI 10.1111/1574-6941.12233; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Suwendi E, 2012, BIOMED RES-TOKYO, V33, P329, DOI 10.2220/biomedres.33.329; Takagishi T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122708; Tran CD, 2007, DIGEST DIS SCI, V52, P2113, DOI 10.1007/s10620-007-9765-9; Tran CD, 1998, BIOL TRACE ELEM RES, V63, P239, DOI 10.1007/BF02778942; Tran CD, 1999, SCAND J GASTROENTERO, V34, P689, DOI 10.1080/003655299750025895; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tsuji T, 2013, INT J MOL MED, V31, P1037, DOI 10.3892/ijmm.2013.1294; Vagianos K, 2007, JPEN-PARENTER ENTER, V31, P311, DOI 10.1177/0148607107031004311; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; Van Acker A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110015; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; Vignesh KS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102197; Vowinkel T, 2004, DIGEST DIS SCI, V49, P556, DOI 10.1023/B:DDAS.0000026298.72088.f7; Waeytens A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/729172; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Wang XX, 2010, IUBMB LIFE, V62, P176, DOI 10.1002/iub.291; Weisshof R, 2015, CURR OPIN CLIN NUTR, V18, P576, DOI 10.1097/MCO.0000000000000226; Wessels I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121286; Wiegand S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45649; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Xia T, 2017, ONCOTARGET, V8, P64878, DOI 10.18632/oncotarget.17612; Yeshi K, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051273; Zackular JP, 2016, NAT MED, V22, P1330, DOI 10.1038/nm.4174	110	9	9	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12615	12633		10.1096/fj.202000562RR	http://dx.doi.org/10.1096/fj.202000562RR		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729971				2022-12-26	WOS:000556799500001
J	Han, BG; Lee, JY; Kim, MR; Shin, H; Kim, JS; Yang, JW; Kim, JY				Han, Byoung-Geun; Lee, Jun Young; Kim, Mi Ryung; Shin, Hanwul; Kim, Jae-Seok; Yang, Jae-Won; Kim, Jong Yeon			Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; HEART-FAILURE; EJECTION FRACTION; VOLUME OVERLOAD; CLINICAL IMPACT; RISK-FACTORS; CARDIOMYOPATHY; HYPERTROPHY; ASSOCIATION; MORTALITY	Background Fluid overload is common in patients with diabetes and chronic kidney disease (DM and CKD; DMCKD) and can lead to structural and functional cardiac abnormalities including left ventricular hypertrophy (LVH) and left ventricular diastolic dysfunction (LVDD). Fluid overload represents a crucial step in the pathophysiological pathways to chronic heart failure in patients with end-stage renal disease. We evaluated the impact of fluid overload on cardiac alterations in patients with diabetes and non-dialysis-dependent CKD stage 5 (DMCKD5-ND) without intrinsic heart disease. Methods Bioimpedance spectroscopy, echocardiography, and N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) measurement were performed in 135 consecutive patients on the same day. Patients were divided into groups by tertiles of overhydration/extracellular water (OH/ECW) per bioimpedance spectroscopy. Results Fluid balance markers including OH/ECW and NT-proBNP were significantly higher in the LVDD+LVH group. OH/ECW and its exacerbation were positively associated with the ratio between early mitral inflow and annular early diastolic velocities (E/e ' ratio) and left ventricular mass index (LVMI). The prevalence of LVH progressively increased across increasing tertiles of OH/ECW. In multiple regression analyses, OH/ECW as a continuous and categorical variable was independently associated with the E/e ' ratio and LVMI after adjustment for multiple confounding factors. Conclusions Fluid overload was independently associated with LVDD and LVH in patients with DMCKD5-ND. Our study suggests that structural and functional cardiac abnormalities and volume status should be evaluated simultaneously in patients with early-stage DMCKD rather than only DMCKD5-ND, in addition to intensive blood pressure and glycemic control, regardless of evident cardiovascular disease.	[Han, Byoung-Geun; Lee, Jun Young; Kim, Mi Ryung; Shin, Hanwul; Kim, Jae-Seok; Yang, Jae-Won] Yonsei Univ, Dept Nephrol, Wonju Coll Med, Wonju, Kang Won, South Korea; [Kim, Jong Yeon] Yonsei Univ, Dept Neurosurg, Wonju Coll Med, Wonju, Kang Won, South Korea	Yonsei University; Yonsei University	Kim, JY (corresponding author), Yonsei Univ, Dept Neurosurg, Wonju Coll Med, Wonju, Kang Won, South Korea.	jjongse@yonsei.ac.kr	Lee, Jun Young/CAI-2335-2022; Lee, Jun Young/CAF-6397-2022	Lee, Jun Young/0000-0001-8047-4190; Lee, Jun Young/0000-0001-8047-4190; Kim, Jongyeon/0000-0002-9407-0127				Artham SM, 2009, PROG CARDIOVASC DIS, V52, P153, DOI 10.1016/j.pcad.2009.05.002; Asp AM, 2015, CLIN PHYSIOL FUNCT I, V35, P223, DOI 10.1111/cpf.12154; Athithtan L, 2019, WORLD J DIABETES, V10, P490, DOI 10.4239/wjd.v10.i10.490; Borghetti G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01514; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Ciftel S, 2012, DIABETES RES CLIN PR, V96, P179, DOI 10.1016/j.diabres.2011.12.021; Dawson A, 2005, DIABETOLOGIA, V48, P1971, DOI 10.1007/s00125-005-1896-y; Dillmann WH, 2019, CIRC RES, V124, P1160, DOI 10.1161/CIRCRESAHA.118.314665; Farshid A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-280; Fontes-Carvalho R, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-014-0168-x; Grigorescu ED, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9030121; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Houston BA, 2015, MAYO CLIN PROC, V90, P1247, DOI 10.1016/j.mayocp.2015.05.002; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Jia GH, 2016, NAT REV ENDOCRINOL, V12, P144, DOI 10.1038/nrendo.2015.216; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Lahnwong S, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0745-5; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lee WS, 2017, KOREAN J INTERN MED, V32, P404, DOI 10.3904/kjim.2016.208; Mishra RK, 2013, AM J CARDIOL, V111, P432, DOI 10.1016/j.amjcard.2012.10.019; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nardi E, 2009, J HYPERTENS, V27, P633, DOI 10.1097/HJH.0b013e3283220ecd; Ogawa T, 2018, CONTRIB NEPHROL, V195, P81, DOI 10.1159/000486938; Otsuka T, 2009, J CARDIOL, V54, P199, DOI 10.1016/j.jjcc.2009.05.002; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Rawshani A, 2018, NEW ENGL J MED, V379, P633, DOI 10.1056/NEJMoa1800256; Romano S, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-89; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Sattar N, 2016, DIABETOLOGIA, V59, P1333, DOI 10.1007/s00125-016-3956-x; Tentolouris A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162965; Tuegel C, 2017, HEART, V103, P1848, DOI 10.1136/heartjnl-2016-310794; Vetrone LM, 2019, ACTA DIABETOL, V56, P331, DOI 10.1007/s00592-018-1253-5; Vidal-Petiot E, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010278; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; Zabalgoitia M, 2001, AM J CARDIOL, V87, P320, DOI 10.1016/S0002-9149(00)01366-7; Zoccali C, 2017, J AM SOC NEPHROL, V28, P2491, DOI 10.1681/ASN.2016121341	39	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0235640	10.1371/journal.pone.0235640	http://dx.doi.org/10.1371/journal.pone.0235640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730268	gold, Green Published			2022-12-26	WOS:000556884700014
J	Jiang, KY; Kessler, H; Park, Y; Sudman, M; Thompson, SD; Jarvis, JN				Jiang, Kaiyu; Kessler, Haeja; Park, Yungki; Sudman, Marc; Thompson, Susan D.; Jarvis, James N.			Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci	PLOS ONE			English	Article							HI-C; MULTIPLE-SCLEROSIS; HUMAN NEUTROPHILS; GENOME; IL2RA; SUSCEPTIBILITY; ANNOTATION; ENHANCERS; DISEASES; REGIONS	Objective The risk loci for juvenile idiopathic arthritis (JIA) consist of extended haplotypes that include functional elements in addition to canonical coding genes. As with most autoimmune diseases, the risk haplotypes for JIA are highly enriched for H3K4me1/H3K27ac histone marks, epigenetic signatures that typically identify poised or active enhancers. In this study, we test the hypothesis that genetic risk for JIA is exerted through altered enhancer-mediated gene regulation. Methods We mined publically available HiC and other chromatin conformation data to determine whether H3K27ac-marked regions in 25 JIA risk loci showed physical evidence of contact with gene promoters. We also usedin vitroreporter assays to establish as proof-of-concept the idea that genetic variants in linkage disequilibrium with GWAS-identified tag SNPs alter enhancer function. Results All 25 loci examined showed multiple contact sites in the 4 different cell lines that we queried. These regions were characterized by HiC-defined loop structures that included 237 immune-related genes. Usingin vitroassays, we found that a 657 bp, H3K4me1/H3K27-marked region within the first intron ofIL2RAshows enhancer activity in reporter assays, and this activity is attenuated by SNPs on the IL2RA haplotype that we identified using whole genome sequencing of children with JIA. Similarly, we identified a 1,669 bp sequence in an intergenic region of theIL6Rlocus where SNPs identified in children with JIA increase enhancer function in reporter assays. Conclusions These studies provide evidence that altered enhancer function contributes to genetic risk in JIA. Further studies to identify the specific target genes of genetically altered enhancers are warranted.	[Jiang, Kaiyu; Kessler, Haeja; Jarvis, James N.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pediat, Pediat Rheumatol Res, Buffalo, NY 14203 USA; [Park, Yungki] Univ Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Park, Yungki; Jarvis, James N.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Genet Genom & Bioinformat Program, Buffalo, NY 14203 USA; [Sudman, Marc; Thompson, Susan D.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genet & Epigenet, Cincinnati, OH 45229 USA; [Thompson, Susan D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Jarvis, JN (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pediat, Pediat Rheumatol Res, Buffalo, NY 14203 USA.; Jarvis, JN (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Genet Genom & Bioinformat Program, Buffalo, NY 14203 USA.	jamesjar@buffalo.edu	Sudman, Marc/ABA-4655-2020	Sudman, Marc/0000-0001-9061-8274; Jarvis, James/0000-0002-1878-0717	National Institutes of Health [R21-AR-071878]; Arthritis Foundation [6490]; Rheumatology Research Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001412]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Rheumatology Research Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	R21-AR-071878 from the National Institutes of Health (JNJ). Arthritis Foundation #6490 (JNJ) Rheumatology Research Foundation -No number (JNJ) Rheumatology Research Foundation -No number (HK). UL1TR001412 National Center for Advancing Translational Sciences of the National Institutes of Health (Institutional award to the University at Buffalo).	Arnold M, 2015, BIOINFORMATICS, V31, P1334, DOI 10.1093/bioinformatics/btu779; Belton JM, 2012, METHODS, V58, P268, DOI 10.1016/j.ymeth.2012.05.001; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Brodie A, 2016, NUCLEIC ACIDS RES, V44, P6046, DOI 10.1093/nar/gkw500; Brunner HI, 2015, ANN RHEUM DIS, V74, P1110, DOI 10.1136/annrheumdis-2014-205351; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gasperini M, 2019, CELL, V176, P377, DOI 10.1016/j.cell.2018.11.029; GORTMAKER SL, 1984, PEDIATR CLIN N AM, V31, P3; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hersh AO, 2017, RHEUM DIS CLIN N AM, V43, P435, DOI 10.1016/j.rdc.2017.04.007; Hersh AO, 2015, J AUTOIMMUN, V64, P113, DOI 10.1016/j.jaut.2015.08.002; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Hinks A, 2009, ARTHRITIS RHEUM, V60, P251, DOI 10.1002/art.24187; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hui-Yuen JS, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1169-9; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jeong MH, 2017, BIORXIV, DOI [10.1101/212928, DOI 10.1101/212928]; Jiang KY, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1059-1; Jiang KY, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0128-7; Jiang KY, 2015, ARTHRITIS RHEUMATOL, V67, P1966, DOI 10.1002/art.39135; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kessler H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02964; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Pal Koustav, 2019, Biophys Rev, V11, P67, DOI 10.1007/s12551-018-0489-1; Pelikan RC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05328-9; Pesenacker AM, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.14; Phanstiel DH, 2017, MOL CELL, V67, P1037, DOI 10.1016/j.molcel.2017.08.006; Prahalad S, 2010, ARTHRITIS RHEUM-US, V62, P2525, DOI 10.1002/art.27516; Qu HQ, 2009, GENES IMMUN, V10, pS42, DOI 10.1038/gene.2009.90; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Shaul O, 2017, INT J BIOCHEM CELL B, V91, P145, DOI 10.1016/j.biocel.2017.06.016; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; SINGSEN BH, 1990, RHEUM DIS CLIN N AM, V16, P581; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Wang YL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1519-9; Weber F, 2008, GENES IMMUN, V9, P259, DOI 10.1038/gene.2008.14; Wong LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02966-9; Zhu LS, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1260-x	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0235857	10.1371/journal.pone.0235857	http://dx.doi.org/10.1371/journal.pone.0235857			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730263	Green Published, gold			2022-12-26	WOS:000556884700067
J	Mao, Y; Lv, M; Cao, WH; Liu, XY; Cui, J; Wang, YM; Wang, YY; Nie, G; Liu, XP; Wang, HB				Mao, Yan; Lv, Meng; Cao, Weihong; Liu, Xiaoyi; Cui, Jian; Wang, Yongmei; Wang, Yuanyuan; Nie, Gang; Liu, Xiangping; Wang, Haibo			Circular RNA 000554 represses epithelial-mesenchymal transition in breast cancer by regulating microRNA-182/ZFP36 axis	FASEB JOURNAL			English	Article						breast cancer; circular RNA 000554; epithelial-to-mesenchymal transition; microRNA-182; ZFP36	CELL-CYCLE; METASTASIS; INVASION; PROLIFERATION; PROGRESSION; BIOMARKERS; MICRORNAS; AUTOPHAGY; THERAPY	Increasing evidence indicates that circular RNAs (circRNAs) play a crucial role in regulating microRNAs (miRs) and mRNAs during breast cancer (BC) progression. Based on the in silico analysis of circRNA/miR/mRNA in BC, we aim to define an important role of circRNA_000554 in BC in relation to miR-182 and zinc finger protein 36 (ZFP36). Low expression of circRNA_000554 and ZFP36, and high miR-182 expression were determined in the clinical BC tissues. CircRNA_000554 acted as a sponge of miR-182, and miR-182 directly targeted ZFP36. After that, in order to evaluate the effects of circRNA_000554, miR-182, and ZFP36 on cellular process, we evaluated in vitro epithelial-mesenchymal transition (EMT) and in vivo tumor growth after delivering a series of overexpression plasmids, mimic, inhibitor, or shRNAs into BC cells. Increasing circRNA_000554 suppressed EMT, cell invasion and migration during BC by depleting miR-182 and increasing ZFP36. The inhibitory effect of circRNA_000554 on tumor growth was validated in vivo. Taken together, the present study confirms that circRNA_000554 functioned as an inhibitor of EMT in BC and suggests a molecular mechanism that circRNA_000554 bound to miR-182 to upregulate ZFP36 in this process.	[Mao, Yan; Lv, Meng; Cao, Weihong; Liu, Xiaoyi; Cui, Jian; Wang, Yongmei; Wang, Yuanyuan; Nie, Gang; Wang, Haibo] Qingdao Univ, Breast Dis Ctr, Affiliated Hosp, 59 Haier Rd, Qingdao 266071, Shandong, Peoples R China; [Liu, Xiangping] Qingdao Univ, Cent Lab Mol Biol, Affiliated Hosp, Qingdao, Peoples R China	Qingdao University; Qingdao University	Mao, Y; Wang, HB (corresponding author), Qingdao Univ, Breast Dis Ctr, Affiliated Hosp, 59 Haier Rd, Qingdao 266071, Shandong, Peoples R China.	nancyelin@yeah.net; hbwang66@126.com	wangwangwang, yuanyaun/HHN-6432-2022; Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; Wang, Yu/GZL-9655-2022		Natural Science Doctoral Funding of Shandong Province [ZR2017BH061, ZR2018BH023, ZR2019BH013]; Qingdao Science and Technology Innovation Plan [17-1-1-54-jch]; Qingdao University; Qingdao University Affiliated Hospital	Natural Science Doctoral Funding of Shandong Province; Qingdao Science and Technology Innovation Plan; Qingdao University; Qingdao University Affiliated Hospital	This study was supported by the Natural Science Doctoral Funding of Shandong Province (ZR2017BH061, ZR2018BH023 and ZR2019BH013), Funding from Qingdao Science and Technology Innovation Plan (17-1-1-54-jch), Postdoctoral Funding from Qingdao City, Youth Funding from Qingdao University, and Excellent Funding from Qingdao University Affiliated Hospital	Barrios-Garcia T, 2014, J BIOL CHEM, V289, P15554, DOI 10.1074/jbc.M114.548552; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Chen YN, 2018, ADV SCI, V5, DOI 10.1002/advs.201700964; Cheng Z, 2017, ONCOTARGET, V8, P67933, DOI 10.18632/oncotarget.18913; Chiang CH, 2016, AM J CANCER RES, V6, P1785; Dai XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0485-1; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Ding JJ, 2019, LIFE SCI, V228, P112, DOI 10.1016/j.lfs.2019.04.069; Dittmer J, 2018, SEMIN CANCER BIOL, V53, P59, DOI 10.1016/j.semcancer.2018.07.007; Dong F, 2018, EXP CELL RES, V367, P89, DOI 10.1016/j.yexcr.2018.03.028; Du WW, 2018, ONCOGENE, V37, P5829, DOI 10.1038/s41388-018-0369-y; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Fu B, 2018, EPIGENOMICS-UK, V10, P1619, DOI 10.2217/epi-2018-0090; Garcia-Estevez L, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1124-1; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Hsieh TH, 2015, ONCOTARGET, V6, P494, DOI 10.18632/oncotarget.2674; Li P, 2018, CELL PHYSIOL BIOCHEM, V46, P1606, DOI 10.1159/000489208; Li X, 2018, MOL CELL, V71, P428, DOI 10.1016/j.molcel.2018.06.034; Liguori M, 2018, HUM MOL GENET, V27, P66, DOI 10.1093/hmg/ddx385; Liu ZH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1287-1; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Nassar FJ, 2017, PHARMACOL THERAPEUT, V172, P34, DOI 10.1016/j.pharmthera.2016.11.012; Nicolini A, 2018, SEMIN CANCER BIOL, V52, P56, DOI 10.1016/j.semcancer.2017.08.010; Ponde NF, 2019, NAT REV CLIN ONCOL, V16, P27, DOI 10.1038/s41571-018-0089-9; Ren CN, 2018, MOL ONCOL, V12, P690, DOI 10.1002/1878-0261.12192; Su M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1002-6; Szabo L, 2016, NAT REV GENET, V17, P679, DOI 10.1038/nrg.2016.114; Wang XH, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0870-8; Wu X, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0382-1; Xu JZ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1382-y; Xu L, 2015, ONCOTARGET, V6, P41679, DOI 10.18632/oncotarget.6149; Yang R, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0933-7; Yin RT, 2013, J VASC RES, V50, P157, DOI 10.1159/000345697; Yoon NA, 2016, ONCOTARGET, V7, P8931, DOI 10.18632/oncotarget.7094; Yu JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13884; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhang WJ, 2015, J BIOL CHEM, V290, P13812, DOI 10.1074/jbc.M115.653261; Zhang XZ, 2017, ONCOL LETT, V14, P4805, DOI 10.3892/ol.2017.6778; Zhao JZ, 2018, CELL CYCLE, V17, P2731, DOI 10.1080/15384101.2018.1556058; Zhao YS, 2019, YONSEI MED J, V60, P148, DOI 10.3349/ymj.2019.60.2.148	40	16	17	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11405	11420		10.1096/fj.201903047R	http://dx.doi.org/10.1096/fj.201903047R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729957				2022-12-26	WOS:000556800900001
J	Schuz, J; Bukhtiyarov, I; Olsson, A; Moissonnier, M; Ostroumova, E; Feletto, E; Schonfeld, SJ; Byrnes, G; Tskhomariia, I; McCormack, V; Straif, K; Kashanskiy, S; Morozova, T; Kromhout, H; Kovalevskiy, E				Schuz, Joachim; Bukhtiyarov, Igor; Olsson, Ann; Moissonnier, Monika; Ostroumova, Evgenia; Feletto, Eleonora; Schonfeld, Sara J.; Byrnes, Graham; Tskhomariia, Iraklii; McCormack, Valerie; Straif, Kurt; Kashanskiy, Sergey; Morozova, Tatiana; Kromhout, Hans; Kovalevskiy, Evgeny			Occupational cohort study of current and former workers exposed to chrysotile in mine and processing facilities in Asbest, the Russian Federation: Cohort profile of the Asbest Chrysotile Cohort study	PLOS ONE			English	Article							CANCER-MORTALITY; MESOTHELIOMA; DUST; FACTORIES; MILLERS	A historical cohort study in workers occupationally exposed to chrysotile was set up in the town of Asbest, the Russian Federation, to study their cause-specific mortality, with a focus on cancer. Chrysotile has different chemical and physical properties compared with other asbestos fibres; therefore it is important to conduct studies specifically of chrysotile and in different geographical regions to improve the knowledge about its carcinogenicity. Setting was the town of Asbest, Sverdlovsk oblast, the Russian Federation. Participants were all current and former employees with at least one year of employment between 1/1/1975 and 31/12/2010 in the mine, enrichment factories, auto-transport and external rail transportation departments, the central laboratory, and the explosives unit of the company. Of the 35,837 cohort members, 12,729 (35.5%) had died (2,373 of them of cancer, including 10 of mesothelioma), 18,799 (52.5%) were known to be alive at the end of the observation period (2015), and 4,309 (12.0%) were censored before the end of 2015. Mean follow-up duration was 21.7 years in men and 25.9 years in women. The mean age at death was 59.4 years in men and 66.5 years in women. This is the largest occupational cohort of chrysotile workers to date, and the only one with a large proportion of exposed female workers.	[Schuz, Joachim; Olsson, Ann; Moissonnier, Monika; Ostroumova, Evgenia; Feletto, Eleonora; Schonfeld, Sara J.; Byrnes, Graham; McCormack, Valerie; Straif, Kurt] Int Agcy Res Canc IARC WHO, Lyon, France; [Bukhtiyarov, Igor; Tskhomariia, Iraklii; Kovalevskiy, Evgeny] Fed State Budgetary Sci Inst, Izmerov Res Inst Occupat Hlth IRIOH, Moscow, Russia; [Bukhtiyarov, Igor; Morozova, Tatiana; Kovalevskiy, Evgeny] IM Sechenov First Moscow State Med Univ Sechenov, Moscow, Russia; [Feletto, Eleonora] Canc Council New South Wales, Canc Res Div, Woolloomooloo, Australia; [Schonfeld, Sara J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Kashanskiy, Sergey] Yekaterinburg Med Res Ctr Prophylaxis & Hlth Prot, Ekaterinburg, Russia; [Kromhout, Hans] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands	World Health Organization; International Agency for Research on Cancer (IARC); Sechenov First Moscow State Medical University; Cancer Council New South Wales; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yekaterinburg Medical Research Center for Prophylaxis & Health Protection in Industrial Workers; Utrecht University	Schuz, J (corresponding author), Int Agcy Res Canc IARC WHO, Lyon, France.	schuzj@iarc.fr	Olsson, Ann/HHM-2587-2022; Kromhout, Hans/A-9159-2008	Kromhout, Hans/0000-0002-4233-1890; McCormack, Valerie/0000-0001-7397-3442; Schuz, Joachim/0000-0001-9687-2134; Kovalevskiy, Evgeny/0000-0001-5166-6871; Ostroumova, Evgenia/0000-0003-4729-1733	Ministry of Health of the Russian Federation; International Agency for Research on Cancer (IARC/WHO)	Ministry of Health of the Russian Federation; International Agency for Research on Cancer (IARC/WHO)	IB, EK, JS: The work was supported by the Ministry of Health of the Russian Federation in the framework of the Federal target programme "National System of Chemical and Biological Safety of the Russian Federation" of 2009-2014 and of 2015-2020 under a general framework of action between the Federal state budgetary scientific institution "Izmerov Research Institute of Occupational Health" (IRIOH) and the International Agency for Research on Cancer (IARC/WHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, OUTL DEV NAT PROGR E; Domnin SG, 2001, CAN MINERAL, P199; Erokhin YV, 1998, URAL GEOLOGICAL J, V3; Feletto E, 2017, INT J HYG ENVIR HEAL, V220, P857, DOI 10.1016/j.ijheh.2017.04.001; Ferrante D, 2020, AM J IND MED, V63, P135, DOI 10.1002/ajim.23071; Gilham C, 2016, OCCUP ENVIRON MED, V73, P290, DOI 10.1136/oemed-2015-103074; Institute of Medicine, 2006, ASB SEL CANC; Jarnik H, 2005, SCI DIRECT, P141, DOI [10.1016/B0-12-369397-7/00023-6, DOI 10.1016/B0-12-369397-7/00023-6]; Kashansky SV, 2001, IND HEALTH, V39, P51, DOI 10.2486/indhealth.39.51; Kovalevskiy EV, 2014, INT C MON SURV ASB R, pP74; Liddell FDK, 1997, ANN OCCUP HYG, V41, P13, DOI 10.1016/S0003-4878(96)00044-0; Lin SH, 2014, OCCUP ENVIRON MED, V71, P323, DOI 10.1136/oemed-2013-101360; McCormack V, 2012, BRIT J CANCER, V106, P575, DOI 10.1038/bjc.2011.563; McDonald AD, 1997, ANN OCCUP HYG, V41, P707, DOI 10.1016/S0003-4878(97)00020-3; Olsson AC, 2017, EPIDEMIOLOGY, V28, P288, DOI 10.1097/EDE.0000000000000604; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; SASS W, 2020, OCCUP ENVIRON MED, DOI DOI 10.1136/OEMED-2019-10626332398292; Schonfeld SJ, 2017, ANN WORK EXPOS HEAL, V61, P797, DOI 10.1093/annweh/wxx051; Schonfeld SJ, 2014, CANCER CAUSE CONTROL, V25, P615, DOI 10.1007/s10552-014-0368-4; Schuz J, 2013, CANCER EPIDEMIOL, V37, P440, DOI 10.1016/j.canep.2013.03.001; Schuz J, 2020, METHOD INFORM MED; Soeberg MJ, 2016, J TOXICOL ENV HEAL B, V19, P173, DOI 10.1080/10937404.2016.1194254; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Tossavainen A, 1999, AM J IND MED, P142; Tossavainen A, 2000, AM J IND MED, V37, P327, DOI 10.1002/(SICI)1097-0274(200004)37:4<327::AID-AJIM1>3.0.CO;2-1; Virta Robert L., 2002, ASBESTOS GEOLOGY MIN; Wang XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071899; WHO (World Health Organization), 2006, ASB HIST; World Health Organization, 2007, WHA 60 26 60 WORLD H; Zorina L KS, 1999, PREVENTING ASBESTOS	30	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236475	10.1371/journal.pone.0236475	http://dx.doi.org/10.1371/journal.pone.0236475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726334	gold, Green Published			2022-12-26	WOS:000556908900041
J	Naoi, T; Kitabayashi, S; Kasai, A; Sugawara, K; Adkar-Purushothama, CR; Senda, M; Hataya, T; Sano, T				Naoi, Takashi; Kitabayashi, Syoya; Kasai, Atsushi; Sugawara, Kohei; Adkar-Purushothama, Charith Raj; Senda, Mineo; Hataya, Tatsuji; Sano, Teruo			Suppression of RNA-dependent RNA polymerase 6 in tomatoes allows potato spindle tuber viroid to invade basal part but not apical part including pluripotent stem cells of shoot apical meristem	PLOS ONE			English	Article							SEED TRANSMISSION; GENE-EXPRESSION; VIRUS; ARABIDOPSIS; INVASION; DEFENSE; PLANTS; ACCUMULATION; INHIBITION; INFECTION	RNA-dependent RNA polymerase 6 (RDR6) is one of the key factors in plant defense responses and suppresses virus or viroid invasion into shoot apical meristem (SAM) inNicotiana benthamiana. To evaluate the role ofSolanum lycopersicum(Sl) RDR6 upon viroid infection, SlRDR6-suppressed (SlRDR6i) 'Moneymaker' tomatoes were generated by RNA interference and inoculated with intermediate or lethal strain of potato spindle tuber viroid (PSTVd). Suppression of SlRDR6 did not change disease symptoms of both PSTVd strains in 'Moneymaker' tomatoes. Analysis of PSTVd distribution in shoot apices byin situhybridization revealed that both PSTVd strains similarly invade the basal part but not apical part including pluripotent stem cells of SAM in SlRDR6i plants at a low rate unlike a previous report inN.benthamiana. In addition, unexpectedly, amount of PSTVd accumulation was apparently lower in SlRDR6i plants than in control tomatoes transformed with empty cassette in early infection especially in the lethal strain. Meanwhile, SlRDR6 suppression did not affect the seed transmission rates of PSTVd. These results indicate that RDR6 generally suppresses PSTVd invasion into SAM in plants, while suppression of RDR6 does not necessarily elevate amount of PSTVd accumulation. Additionally, our results suggest that host factors such as RDR1 other than RDR6 may also be involved in the protection of SAM including pluripotent stem cells from PSTVd invasion and effective RNA silencing causing the decrease of PSTVd accumulation during early infection in tomato plants.	[Naoi, Takashi; Hataya, Tatsuji] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Kitabayashi, Syoya; Kasai, Atsushi; Sugawara, Kohei; Senda, Mineo; Sano, Teruo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Adkar-Purushothama, Charith Raj] Univ Sherbrooke, Dept Biochim, Fac Med Sci Sante, Pavillon Rech Appl Canc, Sherbrooke, PQ, Canada; [Hataya, Tatsuji] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan	Hokkaido University; Hirosaki University; University of Sherbrooke; Hokkaido University	Hataya, T (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.; Sano, T (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan.; Hataya, T (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan.	hataya@res.agr.hokudai.ac.jp; sano@hirosaki-u.ac.jp	Adkar-Purushothama, Charith Raj/AAR-2159-2020	Adkar-Purushothama, Charith Raj/0000-0001-8868-6008; bei lin, jiang ye/0000-0001-9416-1734	Japan Society for the Promotion of Science (JSPS) KAKENHI [15H04455, 18H0221]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI grant no. 15H04455 and 18H0221 to T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkar-Purushothama CR, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040345; Adkar-Purushothama CR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08823-z; Adkar-Purushothama CR, 2015, PLANT CELL, V27, P2178, DOI 10.1105/tpc.15.00523; Boccara M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003883; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Dadami E, 2013, MOL PLANT, V6, P232, DOI 10.1093/mp/sss118; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Daros JA, 2004, P NATL ACAD SCI USA, V101, P6792, DOI 10.1073/pnas.0401090101; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Di Serio F, 2014, ARCH VIROL, V159, P3467, DOI 10.1007/s00705-014-2200-6; Di Serio F, 2017, VIROIDS AND SATELLITES, P135, DOI 10.1016/B978-0-12-801498-1.00013-9; Di Serio F, 2010, J VIROL, V84, P2477, DOI 10.1128/JVI.02336-09; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Fletcher JC, 2018, PLANTS-BASEL, V7, DOI 10.3390/plants7040087; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Flores R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00052; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Gomez G, 2008, PLANT PHYSIOL, V148, P414, DOI 10.1104/pp.108.120808; Gora A, 1996, ARCH VIROL, V141, P2045, DOI 10.1007/BF01718214; Hong W, 2015, SCI REP-UK, V5, DOI 10.1038/srep11324; HUNTER DE, 1969, AM POTATO J, V46, P247, DOI 10.1007/BF02863021; Iglesias VA, 2000, PLANT J, V21, P157, DOI 10.1046/j.1365-313x.2000.00658.x; Itaya A, 2001, MOL PLANT MICROBE IN, V14, P1332, DOI 10.1094/MPMI.2001.14.11.1332; Jiang FW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01028; Jiang L, 2012, VIRUS RES, V163, P512, DOI 10.1016/j.virusres.2011.11.016; Katsarou K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005936; Korner CJ, 2013, MOL PLANT MICROBE IN, V26, P1271, DOI 10.1094/MPMI-06-13-0179-R; Kovalskaya N, 2014, PLANT SCI, V228, P48, DOI 10.1016/j.plantsci.2014.05.006; KRYCZYNSKI S, 1988, J PHYTOPATHOL, V121, P51, DOI 10.1111/j.1439-0434.1988.tb00952.x; Lee WS, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0705-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez de Alba AE, 2002, J VIROL, V76, P13094, DOI 10.1128/JVI.76.24.13094-13096.2002; Matsushita Y, 2016, EUR J PLANT PATHOL, V145, P1007, DOI 10.1007/s10658-016-0868-z; Matsushita Y, 2011, EUR J PLANT PATHOL, V130, P441, DOI 10.1007/s10658-011-9766-6; Mochizuki Tomofumi, 2004, Journal of General Plant Pathology, V70, P363, DOI 10.1007/s10327-004-0140-9; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Navarro B, 2012, PLANT J, V70, P991, DOI 10.1111/j.1365-313X.2012.04940.x; Niehl A, 2019, MOL PLANT PATHOL, V20, P1203, DOI 10.1111/mpp.12798; Niehl A, 2016, NEW PHYTOL, V211, P1008, DOI 10.1111/nph.13944; Owens RA, 1996, VIROLOGY, V222, P144, DOI 10.1006/viro.1996.0405; Owens RA, 2012, MOL PLANT MICROBE IN, V25, P582, DOI 10.1094/MPMI-09-11-0258; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Qi YJ, 2003, PLANT CELL, V15, P1360, DOI 10.1105/tpc.011585; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; Roberts IM, 2003, PROTOPLASMA, V222, P31, DOI 10.1007/s00709-003-0015-5; Rodio ME, 2007, PLANT CELL, V19, P3610, DOI 10.1105/tpc.106.049775; Sablowski R, 2004, TRENDS CELL BIOL, V14, P605, DOI 10.1016/j.tcb.2004.09.011; SANGER HL, 1982, ENCY PLANT PHYSL B, V14, P368; Sano Teruo, 2004, Journal of General Plant Pathology, V70, P181, DOI 10.1007/s10327-004-0105-z; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; SINGH RP, 1970, AM POTATO J, V47, P289, DOI [10.1007/BF02863004, 10.1007/BF02872303]; SINGH RP, 1973, AM POTATO J, V50, P111, DOI 10.1007/BF02857207; Spano R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141319; Suzuki T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040344; Tabler M, 2004, TRENDS PLANT SCI, V9, P339, DOI 10.1016/j.tplants.2004.05.007; Tsushima D, 2015, J GEN PLANT PATHOL, V81, P49, DOI 10.1007/s10327-014-0566-7; Tsushima T, 2011, J GEN PLANT PATHOL, V77, P253, DOI 10.1007/s10327-011-0316-z; Vaistij FE, 2009, PLANT PHYSIOL, V149, P1399, DOI 10.1104/pp.108.132688; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wang Y, 2011, VIROLOGY, V413, P72, DOI 10.1016/j.virol.2011.01.021; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Xia CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02427; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Zhang ZB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00053; Zheng Y, 2017, J VIROL, V91, DOI 10.1128/JVI.00247-17; Zhu J, 2017, INT J STEM CELL RES, V3; Zhu YL, 2001, VIROLOGY, V279, P69, DOI 10.1006/viro.2000.0724	75	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236481	10.1371/journal.pone.0236481	http://dx.doi.org/10.1371/journal.pone.0236481			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716919	Green Published, gold			2022-12-26	WOS:000556674500042
J	Hasan, MR; Mirza, F; Al-Hail, H; Sundararaju, S; Xaba, T; Iqbal, M; Alhussain, H; Yassine, HM; Perez-Lopez, A; Tang, P				Hasan, Mohammad Rubayet; Mirza, Faheem; Al-Hail, Hamad; Sundararaju, Sathyavathi; Xaba, Thabisile; Iqbal, Muhammad; Alhussain, Hashim; Yassine, Hadi Mohamad; Perez-Lopez, Andres; Tang, Patrick			Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA	PLOS ONE			English	Article							PCR	To circumvent the limited availability of RNA extraction reagents, we aimed to develop a protocol for direct RT-qPCR to detect SARS-CoV-2 in nasopharyngeal swabs without RNA extraction. Nasopharyngeal specimens positive for SARS-CoV-2 and other coronaviruses collected in universal viral transport (UVT) medium were pre-processed by several commercial and laboratory-developed methods and tested by RT-qPCR assays without RNA extraction using different RT-qPCR master mixes. The results were compared to that of standard approach that involves RNA extraction. Incubation of specimens at 65 degrees C for 10 minutes along with the use of TaqPathT 1-Step RT-qPCR Master Mix provides higher analytical sensitivity for detection of SARS-CoV-2 RNA than many other conditions tested. The optimized direct RT-qPCR approach demonstrated a limit of detection of 6.6x10(3) copy/ml and high reproducibility (co-efficient of variation = 1.2%). In 132 nasopharyngeal specimens submitted for SARS-CoV-2 testing, the sensitivity, specificity and accuracy of our optimized approach were 95%, 99% and 98.5%, respectively, with reference to the standard approach. Also, the RT-qPCR C-T values obtained by the two methods were positively correlated (Pearson correlation coefficient r = 0.6971, p = 0.0013). The rate of PCR inhibition by the direct approach was 8% compared to 9% by the standard approach. Our simple approach to detect SARS-CoV-2 RNA by direct RT-qPCR may help laboratories continue testing for the virus despite reagent shortages or expand their testing capacity in resource limited settings.	[Hasan, Mohammad Rubayet; Mirza, Faheem; Al-Hail, Hamad; Sundararaju, Sathyavathi; Xaba, Thabisile; Iqbal, Muhammad; Perez-Lopez, Andres; Tang, Patrick] Sidra Med, Dept Pathol, Doha, Qatar; [Hasan, Mohammad Rubayet; Perez-Lopez, Andres; Tang, Patrick] Weill Cornell Med Coll Qatar, Doha, Qatar; [Alhussain, Hashim; Yassine, Hadi Mohamad] Qatar Univ, Doha, Qatar	Sidra Medical & Research Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar University	Hasan, MR (corresponding author), Sidra Med, Dept Pathol, Doha, Qatar.; Hasan, MR (corresponding author), Weill Cornell Med Coll Qatar, Doha, Qatar.	mhasan@sidra.org	Sundararaju, Sathyavathi/AFV-3150-2022; Hasan, Mohammad/AAR-2093-2020; YASSINE, HADI M./AAW-6475-2020	Hasan, Mohammad/0000-0002-4658-7949; YASSINE, HADI M./0000-0001-7592-2788				Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Hasan MR, 2019, J VIROL METHODS, V265, P42, DOI 10.1016/j.jviromet.2018.12.013; Herraez-Hernandez E, 2013, J VIROL METHODS, V193, P9, DOI 10.1016/j.jviromet.2013.04.018; Li L, 2019, INT J INFECT DIS, V85, P167, DOI 10.1016/j.ijid.2019.06.007; Nishimura N, 2010, J VIROL METHODS, V163, P282, DOI 10.1016/j.jviromet.2009.10.011; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Slabodkin G., FDA CHIEF WARNS SUPP; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Steffens I., 100 DAYS CORONAVIRUS, DOI [10.2807/1560-7917.ES.2020.25.14.2000550#r8, DOI 10.2807/1560-7917.ES.2020.25.14.2000550#R8]; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; World Health Organization, COR DIS COVID 19 PAN; Yan Y, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2106; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	15	34	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236564	10.1371/journal.pone.0236564	http://dx.doi.org/10.1371/journal.pone.0236564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706827	Green Published, gold, Green Submitted			2022-12-26	WOS:000579931700054
J	Reza, MM; Rana, AKMM; Azim, T; Chowdhury, EI; Gourab, G; Al Imran, MS; Islam, MA; Khan, SI				Reza, Md Masud; Rana, A. K. M. Masud; Azim, Tasnim; Chowdhury, Ezazul Islam; Gourab, Gorkey; Al Imran, Md Sha; Islam, Md Aminul; Khan, Sharful Islam			Changes in condom use among males who have sex with males (MSM): Measuring the effect of HIV prevention programme in Dhaka city	PLOS ONE			English	Article							MEN; INTERVENTION; RISK; REDUCTION; PROVINCE; IMPACT	Background A systematic assessment was done to examine the effect of HIV interventions among MSM in Dhaka, Bangladesh. MSM were defined as males having sex with males but did not sell sex in the last year. MSM are hidden, marginalized and stigmatized population groups not only in Bangladesh but also globally. In 2010, HIV interventions for MSM were expanded in 40 districts of Bangladesh through 65 drop-in-centres (DICs) and peer outreach workers. Methods Data from two surveys on MSM in Dhaka in 2010 (baseline) and 2013 (midline) were used to analyse the effect of ongoing HIV prevention services. Both surveys used time location sampling to randomly select MSM for risk behaviour interviews. Two outcome variables were considered; condom use in the last anal sex act and consistent condom use during anal sex in the last month. Univariate and multivariate logistic regression methods were used to determine factors associated with condom use. Results Condom use significantly increased at the midline than baseline (p<0.001 for both). Multivariate analysis showed that having comprehensive knowledge of HIV and participation in HIV prevention programme were positively associated with both last time and consistent condom use. MSM who had comprehensive knowledge of HIV were 1.9 times (95% CI: 1.3-2.8, p = 0.002) and 2.1 times (95% CI: 1.4-3.2, p<0.001) more likely to use condoms than those who did not have comprehensive knowledge of HIV. The likelihood of using condoms among MSM was more than double at the midline than the baseline (p<0.01 for both). However, odds of condom use was significantly lower among those who perceived themselves to be at risk or were not able to assess their own risk of HIV. Conclusion To sustain positive changes in HIV risk behaviours, HIV prevention programmes for MSM need to be continued and strengthened.	[Reza, Md Masud; Rana, A. K. M. Masud; Gourab, Gorkey; Al Imran, Md Sha; Islam, Md Aminul; Khan, Sharful Islam] Int Ctr Diarrhoea Dis Res Bangladesh Icddr B, Infect Dis Div, Programme HIV & AIDS, Dhaka, Bangladesh; [Azim, Tasnim] WHO, Dept Communicable Dis, Res Policy & Cooperat RPC, South East Asia Reg Off, Delhi, India; [Chowdhury, Ezazul Islam] Save Children Int, HIV AIDS Program, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); World Health Organization; Save the Children	Khan, SI (corresponding author), Int Ctr Diarrhoea Dis Res Bangladesh Icddr B, Infect Dis Div, Programme HIV & AIDS, Dhaka, Bangladesh.	sharful@icddrb.org		Imran, Mohammad Sha Al/0000-0002-9643-0632; Khan, MBBS, MHSS, PhD, Sharful Islam/0000-0002-7319-1333	Global Fund through the Grant 'Expanding HIV/AIDS Prevention in Bangladesh' [BAN-202-G13-H-00]; icddr,b	Global Fund through the Grant 'Expanding HIV/AIDS Prevention in Bangladesh'; icddr,b	The surveys were funded by The Global Fund through the Grant `Expanding HIV/AIDS Prevention in Bangladesh' under the terms of Grant Agreement NO. BAN-202-G13-H-00 with icddr,b. We acknowledge with gratitude the commitment of the Global Fund to its research efforts. icddr,b is also grateful to the governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support.	AIDS/STD Programme (ASP), 2017, TECHNICAL REPORT; AIDS/STD Programme (ASP), 2017, FACTS FIG HIV BANGL; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Amin A., 2004, CRIMINAL RESPONSIBIL; Amirkhanian YA, 2015, AIDS, V29, P583, DOI 10.1097/QAD.0000000000000558; Amon J., 2000, BEHAV SURVEILLANCE S; [Anonymous], 1860, PAKISTAN PENAL CODE; Baral S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-36; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Duan YW, 2013, AIDS EDUC PREV, V25, P38, DOI 10.1521/aeap.2013.25.1.38; Dupont WD., 2009, STAT MODELING BIOMED, V2, DOI [10.1017/CBO9780511575884, DOI 10.1017/CBO9780511575884]; Forthofer R. N., 2006, BIOSTATISTICS GUIDE; Gill K, 2005, GUIDE PARTICIPATORY; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; Hao C, 2012, AIDS BEHAV, V16, P1138, DOI 10.1007/s10461-012-0141-1; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Holtz TH, 2015, ARCH SEX BEHAV, V44, P341, DOI 10.1007/s10508-014-0427-7; Huang ZH, 2013, AIDS RES HUM RETROV, V29, P441, DOI [10.1089/aid.2012.0151, 10.1089/AID.2012.0151]; Huq MN, 2017, HIV AIDS REV, V16, P112, DOI 10.5114/hivar.2017.66898; Jin MH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1101; Khosla N, 2009, J HEALTH POPUL NUTR, V27, P587, DOI 10.3329/jhpn.v27i4.3404; Kumar GA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-64; Liu HX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0111175, 10.1371/journal.pone.0110887]; Ma N, 2012, AIDS RES HUM RETROV, V28, P1273, DOI 10.1089/aid.2011.0294; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mimiaga MJ, 2016, ARCH SEX BEHAV, V45, P1493, DOI 10.1007/s10508-015-0663-5; Mokter A, 2010, RURAL HLTH MANAGEMEN; National AIDS/STD Control Programme (NASP), 2016, MAPP SIZ EST KEY POP; National AIDS/STD Programme (NASP), 2003, NAT HIV SER BEH SURV; National AIDS/STD Programme (NASP), 2012, COUNT NUMB MAL WHO H; National AIDS/STD Programme (NASP), 2009, BEH SURV SURV 2006 0; National AIDS/STD Programme (NASP), 2002, NAT HIV SER BEH SURV; National AIDS/STD Programme (NASP), 2017, 4 NAT STRAT PLAN HIV; Ramanathan S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-784; Reza MM, 2014, SURVEY HIV SYPHILIS; Safren SA, 2014, AIDS BEHAV, V18, P1904, DOI 10.1007/s10461-014-0773-4; Stata, 2011, STATA SURV DAT REF M; Subramanian T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-857; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2015, GLOB AIDS RRESPONSE; UNAIDS, 2015, COUNTR PROGR REP JAN; UNAIDS, 2014, INT GLOB AIDS RESP P; UNAIDS, 2014, GLOB AIDS RESP PROGR; UNAIDS, 2015, COUNTR PROGR REP; UNAIDS, 2015, AIDS RESP PROGR REP; UNAIDS, 2006, HIV MEN WHO HAV SEX; UNDP, 2012, GLOB COMM HIV LAW SE; Veazie M., 2004, STATA LISTSERVER; Wade AS, 2010, AIDS CARE, V22, P409, DOI 10.1080/09540120903253973; Wirtz AL, 2013, INT J STD AIDS, V24, P18, DOI 10.1177/0956462412472291; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050873; Zhang HB, 2010, JAIDS-J ACQ IMM DEF, V53, pS88, DOI 10.1097/QAI.0b013e3181c7de63	54	0	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236557	10.1371/journal.pone.0236557	http://dx.doi.org/10.1371/journal.pone.0236557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OD5ZL	32706840	Green Published, gold			2022-12-26	WOS:000579931700053
J	Rousseau, R; Weisberg, DF; Gorero, J; Parwani, V; Bozzo, J; Kenyon, K; Smith, C; Cole, J; Curtis, S; Forray, A; Roberts, JD				Rousseau, Robert; Weisberg, Daniel F.; Gorero, Jack; Parwani, Vivek; Bozzo, Janis; Kenyon, Kathleen; Smith, Constance; Cole, Joanna; Curtis, Susanna; Forray, Ariadna; Roberts, John D.			Utilization, financial outcomes and stakeholder perspectives of a re-organized adult sickle cell program	PLOS ONE			English	Article							HIGH HOSPITAL UTILIZATION; ACUTE-CARE UTILIZATION; DISEASE PATIENTS; CORD BLOOD; PAIN; ATTITUDES; ANEMIA; IMMUNIZATION; PERCEPTIONS; PREVENTION	In 2011 Yale New Haven Hospital, in response to high utilization of acute care services and widespread patient and health care personnel dissatisfaction, set out to improve its care of adults living with sickle cell disease. Re-organization components included recruitment of additional personnel; re-locating inpatients to a single nursing unit; reducing the number of involved providers; personalized care plans for pain management; setting limits upon access to parenteral opioids; and an emphasis upon clinic visits focused upon home management of pain as well as specialty and primary care. Outcomes included dramatic reductions in inpatient days (79%), emergency department visits (63%), and hospitalizations (53%); an increase in outpatient visits (31%); and a decrease in costs (49%). Providers and nurses viewed the re-organization and outcomes positively. Most patients reported improvements in pain control and life style; many patients thought the re-organization process was unfair. Their primary complaint was a lack of shared decision-making. We attribute the contrast in these perspectives to the inherent difficulties of managing recurrent acute and chronic pain with opioids, especially within the context of the imbalance in wellness, power, and privilege between persons living with sickle cell disease, predominantly persons of color and poor socio-economic status, and health care organizations and their personnel.	[Rousseau, Robert] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Weisberg, Daniel F.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Gorero, Jack] Hartford Hosp, Hartford, CT 06115 USA; [Parwani, Vivek; Curtis, Susanna; Forray, Ariadna; Roberts, John D.] Yale Sch Med, New Haven, CT 06510 USA; [Bozzo, Janis] Yale New Haven Hlth, New Haven, CT USA; [Kenyon, Kathleen; Smith, Constance; Cole, Joanna] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA	Northeastern University; Icahn School of Medicine at Mount Sinai; Hartford Hospital; Yale University; Yale University; Yale University	Roberts, JD (corresponding author), Yale Sch Med, New Haven, CT 06510 USA.	john.d.roberts@yale.edu		Curtis, Susanna/0000-0002-2281-0843				Andemariam B, 2016, J RACIAL ETHN HEALTH, V3, P176, DOI 10.1007/s40615-015-0142-7; Artz N, 2010, J NATL MED ASSOC, V102, P1009, DOI 10.1016/S0027-9684(15)30727-6; ATWEH GF, 1987, AM J HEMATOL, V24, P31, DOI 10.1002/ajh.2830240105; Carroll CP, 2011, J HOSP MED, V6, P248, DOI 10.1002/jhm.850; Carroll CP, 2009, AM J HEMATOL, V84, P666, DOI 10.1002/ajh.21515; Castaneda AM, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100354; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Connecticut Hospital Association, 2010, CHIME DAT; Flory DA, 2001, ORTHOPEDICS, V24, P243; Freiermuth CE, 2016, ADV EMERG NURS J, V38, P199, DOI 10.1097/TME.0000000000000106; Freiermuth CE, 2014, ADV EMERG NURS J, V36, P335, DOI 10.1097/TME.0000000000000036; Gallagher PG, 2017, BLOOD, V130, P2699, DOI 10.1182/blood-2017-04-590810; Haywood C, 2015, J NATL MED ASSOC, V107, P89, DOI 10.1016/S0027-9684(15)30029-8; Jenerette CM, 2015, PAIN MANAG NURS, V16, P173, DOI 10.1016/j.pmn.2014.06.007; Kirsh Kenneth L, 2007, Palliat Support Care, V5, P219; Knisely JS, 2008, J SUBST ABUSE TREAT, V35, P380, DOI 10.1016/j.jsat.2008.02.001; Koch KL, 2015, AM J HEMATOL, V90, P215, DOI 10.1002/ajh.23912; KRAMER MS, 1979, JAMA-J AM MED ASSOC, V241, P485, DOI 10.1001/jama.241.5.485; KRAMER MS, 1980, J PEDIATR-US, V96, P857, DOI 10.1016/S0022-3476(80)80557-9; KRAMER MS, 1978, NEW ENGL J MED, V299, P686, DOI 10.1056/NEJM197809282991303; Kwon JH, 2015, J PALLIAT MED, V18, P703, DOI 10.1089/jpm.2014.0446; Kwon JH, 2015, ONCOLOGIST, V20, P692, DOI 10.1634/theoncologist.2015-0012; Lanzkron S, 2006, AM J HEMATOL, V81, P927, DOI 10.1002/ajh.20703; Lanzkron S, 2018, BLOOD ADV, V2, P2412, DOI 10.1182/bloodadvances.2018018382; Lanzkron S, 2010, AM J HEMATOL, V85, P797, DOI 10.1002/ajh.21807; Mager Amy, 2017, J Opioid Manag, V13, P143, DOI 10.5055/jom.2017.0382; Marcus E., 2016, WASHINGTON POST; McCormack J P, 1990, Can J Anaesth, V37, pS57; MCCORMACK JP, 1993, CAN J ANAESTH, V40, P819, DOI 10.1007/BF03009251; MCINTOSH S, 1980, J PEDIATR-US, V96, P199, DOI 10.1016/S0022-3476(80)80802-X; Mercer T, 2015, J HOSP MED, V10, P419, DOI 10.1002/jhm.2351; OBRIEN RT, 1976, J PEDIATR-US, V89, P205, DOI 10.1016/S0022-3476(76)80449-0; PEARSON HA, 1964, J LAB CLIN MED, V64, P913; Pearson HA, 1996, J PEDIATR-US, V129, P788; PEARSON HA, 1974, JAMA-J AM MED ASSOC, V227, P420, DOI 10.1001/jama.227.4.420; PEARSON HA, 1979, BLOOD, V53, P358; PEARSON HA, 1985, PEDIATRICS, V76, P392; PEARSON HA, 1969, NEW ENGL J MED, V281, P923, DOI 10.1056/NEJM196910232811703; PEARSON HA, 1977, J INFECT DIS, V136, pS25, DOI 10.1093/infdis/136.Supplement.S25; Pereira J, 2001, J PAIN SYMPTOM MANAG, V22, P672, DOI 10.1016/S0885-3924(01)00294-9; Poole KG, 2019, NEW ENGL J MED, V380, P801, DOI 10.1056/NEJMp1813418; Porter J, 2012, J NATL MED ASSOC, V104, P449, DOI 10.1016/S0027-9684(15)30199-1; Powell RE, 2018, AM J MED QUAL, V33, P127, DOI 10.1177/1062860617707262; ROBBINS JB, 1965, J PEDIATR-US, V66, P877, DOI 10.1016/S0022-3476(65)80062-2; Roberts JD, 2018, CANNABIS CANNABINOID, V3, P162, DOI 10.1089/can.2018.0001; SCHWARTZ AD, 1972, PEDIATR RES, V6, P145, DOI 10.1203/00006450-197202000-00008; Shapiro BS, 1997, J PAIN SYMPTOM MANAG, V14, P168, DOI 10.1016/S0885-3924(97)00019-5; Singh AP, 2016, J PAIN SYMPTOM MANAG, V51, P628, DOI 10.1016/j.jpainsymman.2015.11.004; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Solomon LR, 2008, BLOOD, V111, P997, DOI 10.1182/blood-2007-07-089144; Telfer P, 2017, HEMATOL-AM SOC HEMAT, P525, DOI 10.1182/asheducation-2017.1.525; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Weisberg D, 2013, J HOSP MED, V8, P42, DOI 10.1002/jhm.1987; YNHH, 2017, ANN REP; Zassman SM, 2019, AM J HEALTH-SYST PH, V76, P1965, DOI 10.1093/ajhp/zxz228	55	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236360	10.1371/journal.pone.0236360	http://dx.doi.org/10.1371/journal.pone.0236360			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706825	Green Published, gold			2022-12-26	WOS:000579931700030
J	Barros, CHN; Fulaz, S; Vitale, S; Casey, E; Quinn, L				Barros, Caio H. N.; Fulaz, Stephanie; Vitale, Stefania; Casey, Eoin; Quinn, Laura			Interactions between functionalised silica nanoparticles and Pseudomonas fluorescens biofilm matrix: A focus on the protein corona	PLOS ONE			English	Article							POLYMERIC SUBSTANCES EPS; ADSORPTION; EXTRACTION; STRENGTH; PH	Biofilms are microbial communities embedded in an extracellular polymeric matrix and display an enhanced tolerance to the action of antimicrobials. The emergence of novel functionalised nanoparticles is considered a promising avenue for the development of biofilm-specific antimicrobial technologies. However, there is a gap in the understanding of interactions between nanoparticles and the biofilm matrix. Particularly, questions are raised on how nanoparticle charge and surface groups play a role in aggregation when in contact with biofilm components. Herein we present the synthesis of four types of silica nanoparticles and undertake an analysis of their interactions with Pseudomonas fluorescens biofilm matrix. The effect of the biofilm matrix components on the charge and aggregation of the nanoparticles was assessed. Additionally, the study focused on the role of matrix proteins, with the in-depth characterisation of the protein corona of each nanoparticle by Liquid Chromatography with Tandem Mass Spectrometry experiments. The protein corona composition is dependent on the nanoparticle type; non-functionalised nanoparticles show less protein selectivity, whereas carboxylate-functionalised nanoparticles prefer proteins with a higher isoelectric point. These outcomes provide insights into the field of biofilm-nanoparticle interactions that can be valuable for the design of new nano-based targeting systems in future anti-biofilm applications.	[Barros, Caio H. N.; Fulaz, Stephanie; Vitale, Stefania; Casey, Eoin; Quinn, Laura] Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin, Ireland	University College Dublin	Quinn, L (corresponding author), Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin, Ireland.	laura.quinn@ucdconnect.ie	Casey, Eoin/C-5384-2008	Casey, Eoin/0000-0002-6471-7356; Fulaz, Stephanie/0000-0002-0152-2754; Quinn, Laura/0000-0001-6563-3800; Vitale, Stefania/0000-0002-7039-9470	Science Foundation Ireland [15/IA/3008]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by Science Foundation Ireland (https://www.sfi.ie/) under grant number 15/IA/3008 and awarded to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif AAH, 2019, J PHARM INNOV, V14, P112, DOI 10.1007/s12247-018-9335-z; Al-fattani MA, 2018, J MED MICROBIOL, P999; Basnet M, 2016, ENVIRON SCI-NANO, V3, P127, DOI 10.1039/c5en00109a; Bharti B, 2014, SOFT MATTER, V10, P718, DOI 10.1039/c3sm52401a; Bradford SA, 2017, LANGMUIR, V33, P10094, DOI 10.1021/acs.langmuir.7b02445; BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1111/j.1574-6968.1995.tb07529.x; Das T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091935; Devlin H, 2020, COLLOID SURFACE B, V193, DOI 10.1016/j.colsurfb.2020.111123; Ding YD, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673549; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duran N, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0114-4; Flemming HC, 2019, NAT REV MICROBIOL, V17, P247, DOI 10.1038/s41579-019-0158-9; Flemming HC, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4040041; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fulaz S, 2019, TRENDS MICROBIOL, P1; Gasteiger E, 2015, PROTEOMICS PROTOCOLS; Gounani Z, 2019, COLLOID SURFACE B, V175, P498, DOI 10.1016/j.colsurfb.2018.12.035; Han Y, 2017, ENVIRON SCI-NANO, V4, P800, DOI 10.1039/c6en00530f; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hwang G, 2018, COLLOID SURFACE A, V554, P306, DOI 10.1016/j.colsurfa.2018.06.049; Jahn A, 1995, WATER SCI TECHNOL, V32, P157, DOI 10.2166/wst.1995.0287; Lara S, 2018, ACS NANO, V12, P4930, DOI 10.1021/acsnano.8b02014; Lawrence JR, 2016, ENVIRON SCI-NANO, V3, P181, DOI 10.1039/c5en00229j; Li XN, 2015, CHEM COMMUN, V51, P282, DOI 10.1039/c4cc07737g; Lim YH, 2016, WIRES NANOMED NANOBI, V8, P842, DOI 10.1002/wnan.1401; Lin FM, 2017, NANOSCALE, V9, P9056, DOI 10.1039/c7nr01975k; Liu Y, 2018, ACTA BIOMATER, V79, P331, DOI 10.1016/j.actbio.2018.08.038; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meder F, 2016, ACS NANO, V10, P4660, DOI 10.1021/acsnano.6b01001; Meissner J, 2015, COLLOID POLYM SCI, V293, P3381, DOI 10.1007/s00396-015-3754-x; Mortensen NP, 2013, NANOSCALE, V5, P6372, DOI 10.1039/c3nr33280b; Pan XL, 2010, WATER SA, V36, P111; Paula AJ, 2014, ACS APPL MATER INTER, V6, P3437, DOI 10.1021/am405594q; Pederzoli F, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1467; Peulen TO, 2011, ENVIRON SCI TECHNOL, V45, P3367, DOI 10.1021/es103450g; Puddu V, 2012, ACS NANO, V6, P6356, DOI 10.1021/nn301866q; SINGH AK, 2017, FRONT MICROBIOL, V8, P26295, DOI DOI 10.3389/FMICB.2017; Song B, 2006, MICROBIOL RES, V161, P355, DOI 10.1016/j.micres.2006.01.004; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Vert M, 2012, PURE APPL CHEM, V84, P377, DOI 10.1351/PAC-REC-10-12-04; Wu JF, 2009, APPL ENVIRON MICROB, V75, P5390, DOI 10.1128/AEM.00400-09; Zhang HY, 2018, COLLOID SURFACE B, V167, P220, DOI 10.1016/j.colsurfb.2018.04.021	46	5	5	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236441	10.1371/journal.pone.0236441	http://dx.doi.org/10.1371/journal.pone.0236441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701973	gold, Green Published			2022-12-26	WOS:000575913700093
J	Grazette, N; McAllister, S; Ong, CW; Sunderland, C; Nevill, ME; Morris, JG				Grazette, Neval; McAllister, Scot; Ong, Chin Wei; Sunderland, Caroline; Nevill, Mary E.; Morris, John G.			Reliability of a musculoskeletal profiling test battery in elite academy soccer players	PLOS ONE			English	Article							STATISTICAL-METHODS; ASSESSING AGREEMENT; SPORTS-MEDICINE; SHOULDER RANGE; VALIDITY; FLEXIBILITY; MOTION; INJURIES; STRENGTH; ISSUES	The study aimed to quantify the measurement error / reliability of a musculoskeletal profiling test battery administered in young, elite academy soccer players, and to examine if the order in which the test battery was administered, and who it was administered by, influenced reliability. Players (n = 75; age 12-20 years; stature 1.47-1.95 m; body mass 36-89 kg) from U-12 to U-23 age groups were assigned to either: 1) intra-rater-fixed order; 2) intra-rater-non-fixed order; 3) inter-rater-fixed order; or, 4) inter-rater-non-fixed order groups. On two separate occasions separated by 3 to 7 days, 12 raters conducted a musculoskeletal profiling test battery comprising 10 tests (Supine Medial Hip Rotation, Supine Lateral Hip Rotation, Hamstring 90/90, Prone Medial Hip Rotation [degrees]; Combined Elevation, Thoracic Rotation, Weight-Bearing Dorsiflexion, Y-Balance [centimetres]; Beighton, Lumbar Quadrant [categorical]). The measurement error / reliability for tests measured in degrees and centimetres was evaluated using the intraclass correlation (relative reliability), coefficient of variation and ratio limits of agreement (absolute reliability). Intraclass correlations varied from 0.04 ("poor") to 0.95 ("excellent"), coefficient of variation from 2.9 to 43.4%, and the ratio limits of agreement from 1.058 (*/divided by 1.020) to 2.026 (*/divided by 1.319) for the tests measured in degrees and centimetres. The intraclass correlation, coefficient of variation and ratio limits of agreement were smallest for five out of eight tests measured in degrees and centimetres when the tests were administered in an intra-rater-fixed test order. These findings emphasise that different testing methods, and the administration of a musculoskeletal profiling test battery using a less than optimal design, will influence measurement error and hence test reliability. These observations need to be considered when investigating musculoskeletal function and age, injury, training or asymmetry in young, elite academy soccer players.	[Grazette, Neval; Sunderland, Caroline; Nevill, Mary E.; Morris, John G.] Nottingham Trent Univ, Sport Hlth & Performance Enhancement Res Ctr, Sch Sci & Technol, Dept Sport Sci, Nottingham, Notts, England; [McAllister, Scot; Ong, Chin Wei] City Football Grp, Global Football, Performance Serv & Appl Res, Manchester, Lancs, England	Nottingham Trent University	Morris, JG (corresponding author), Nottingham Trent Univ, Sport Hlth & Performance Enhancement Res Ctr, Sch Sci & Technol, Dept Sport Sci, Nottingham, Notts, England.	john.morris@ntu.ac.uk		Ong, Chin Wei/0000-0002-3003-0919; Grazette, Neval/0000-0001-7555-9974	City Football Group	City Football Group	JGM, MEN and CS received funding from City Football Group (www.cityfootballgroup.com) as part of a Ph.D. studentship agreement to conduct research, and the funders also agreed to have research conducted on their premises. NG was appointed to the PhD studentship. As part of the research, CWO and SM as salaried members of staff of the funder, contributed to the research as articulated in the `author contributions' section. Apart from the aforementioned, the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aefsky B, 2016, J SPORT REHABIL, V25, P330, DOI 10.1123/jsr.2015-0013; Allen S, 2017, PHYS THER SPORT, V25, P1, DOI 10.1016/j.ptsp.2016.11.001; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Baker RT, 2013, INT J ATHL THER TRAI, V18, P30, DOI 10.1123/ijatt.18.1.30; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cejudo A, 2019, PEERJ, V7, DOI 10.7717/peerj.6236; Chisholm MD, 2012, PHYSIOTHER CAN, V64, P347, DOI 10.3138/ptc.2011-41; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Deehan DJ, 2007, J BONE JOINT SURG BR, V89B, P5, DOI 10.1302/0301-620X.89B1.18427; Denegar Craig R, 1993, J SPORT REHAB, V2, P35, DOI [10.1123/jsr.2.1.35, DOI 10.1123/JSR.2.1.35]; Dennis RJ, 2008, PHYS THER SPORT, V9, P25, DOI 10.1016/j.ptsp.2007.09.004; Deshefy-Longhi T, 2009, South Online J Nurs Res, V9, P6; Dickson Danelle, 2012, J Dance Med Sci, V16, P116; Evans AM, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-1; Fourchet F, 2013, PHYS THER SPORT, V14, P28, DOI 10.1016/j.ptsp.2012.02.004; Gabbe BJ, 2004, PHYS THER SPORT, V5, P90, DOI 10.1016/j.ptsp.2004.01.003; Gradoz MC, 2018, J SPORT REHABIL, V27, DOI 10.1123/jsr.2017-0243; Hidalgo B, 2014, J MANIP PHYSIOL THER, V37, P105, DOI 10.1016/j.jmpt.2013.09.006; Johnson A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b490; Johnson KD, 2012, J ATHL TRAINING, V47, P52; Junge T, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-214; Karim A, 2011, WORK, V40, P281, DOI 10.3233/WOR-2011-1231; Kenny SJ, 2018, J DANCE MED SCI, V22, P54, DOI 10.12678/1089-313X.22.1.54; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lees A, 1998, J SPORT SCI, V16, P211, DOI 10.1080/026404198366740; Linek P, 2017, MUSCULOSKEL SCI PRAC, V31, P72, DOI 10.1016/j.msksp.2017.03.011; Malina RM, 2015, BRIT J SPORT MED, V49, P852, DOI 10.1136/bjsports-2015-094623; Malliaras P, 2009, BRIT J SPORT MED, V43, P739, DOI 10.1136/bjsm.2008.055749; Moller M, 2018, PHYS THER SPORT, V32, P212, DOI 10.1016/j.ptsp.2018.04.005; Mulligan BR., 1993, J MAN MANIP THER, V1, P154, DOI DOI 10.1179/JMT.1993.1.4.154; Nevill AM, 1997, BRIT J SPORT MED, V31, P314, DOI 10.1136/bjsm.31.4.314; Nussbaumer S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-194; Pearsall AW, 2005, CLIN ORTHOP RELAT R, P50, DOI 10.1097/01.blo.0000159896.64176.72; Price RJ, 2004, BRIT J SPORT MED, V38, P466, DOI 10.1136/bjsm.2003.005165; Shultz SJ, 2006, CLIN J SPORT MED, V16, P155, DOI 10.1097/00042752-200603000-00012; Sporis G, 2011, J STRENGTH COND RES, V25, P1168, DOI 10.1519/JSC.0b013e3181cc2334; Swann C, 2015, PSYCHOL SPORT EXERC, V16, P3, DOI 10.1016/j.psychsport.2014.07.004; Toivo K, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000376; Viera AJ, 2005, FAM MED, V37, P360; Walker H, 2016, PHYS THER SPORT, V21, P26, DOI 10.1016/j.ptsp.2016.03.002; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Williams AG., 2017, SPORT EXERC SCI, V51, P6; Wollin M, 2018, PHYS THER SPORT, V29, P14, DOI 10.1016/j.ptsp.2017.09.001	46	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236341	10.1371/journal.pone.0236341	http://dx.doi.org/10.1371/journal.pone.0236341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702027	Green Published, Green Accepted, gold			2022-12-26	WOS:000575913700077
J	Monamele, CG; Kengne-Nde, C; Njifon, HLM; Njankouo, MR; Kenmoe, S; Njouom, R				Monamele, Chavely Gwladys; Kengne-Nde, Cyprien; Njifon, Hermann Landry Munshili; Njankouo, Mohamadou Ripa; Kenmoe, Sebastien; Njouom, Richard			Clinical signs predictive of influenza virus infection in Cameroon	PLOS ONE			English	Article							CASE DEFINITIONS	Influenza virus accounts for majority of respiratory virus infections in Cameroon. According to the World Health Organization (WHO), influenza-like illnesses (ILI) are identified by a measured temperature of >= 38 degrees C and cough, with onset within the past 10 days. Other symptoms could as well be observed however, none of these are specific to influenza alone. This study aimed to determine symptom based predictors of influenza virus infection in Cameroon. Individuals with ILI were recruited from 2009-2018 in sentinel sites of the influenza surveillance system in Cameroon according to the WHO case definition. Individual data collection forms accompanied each respiratory sample and contained clinical data. Samples were analyzed for influenza using the gold standard assay. Two statistical methods were compared to determine the most reliable clinical predictors of influenza virus activity in Cameroon: binomial logistic predictive model and random forest model. Analyses were performed in R version 3.5.2. A total of 11816 participants were recruited, of which, 24.0% were positive for influenza virus. Binomial logistic predictive model revealed that the presence of cough, rhinorrhoea, headache and myalgia are significant predictors of influenza positivity. The prediction model had a sensitivity of 75.6%, specificity of 46.6% and AUC of 66.7%. The random forest model categorized the reported symptoms according to their degree of importance in predicting influenza virus infection. Myalgia had a 2-fold higher value in predicting influenza virus infection compared to any other symptom followed by arthralgia, head ache, rhinorrhoea and sore throat. The model had a OOB error rate of 25.86%. Analysis showed that the random forest model had a better performance over the binomial regression model in predicting influenza infection. Rhinorrhoea, headache and myalgia were symptoms reported by both models as significant predictors of influenza infection in Cameroon. These symptoms could be used by clinicians in their decision to treat patients.	[Monamele, Chavely Gwladys; Njifon, Hermann Landry Munshili; Njankouo, Mohamadou Ripa; Kenmoe, Sebastien; Njouom, Richard] Ctr Pasteur Cameroon, Virol Dept, Yaounde, Cameroon; [Kengne-Nde, Cyprien] Natl AIDS Control Comm, Evaluat & Res Unit, Yaounde, Cameroon		Njouom, R (corresponding author), Ctr Pasteur Cameroon, Virol Dept, Yaounde, Cameroon.	njouom@pasteur-yaounde.org	NDE, Cyprien KENGNE/AAM-7309-2020	NDE, Cyprien KENGNE/0000-0002-8338-2221; Hermann Landry, Munshili Njifon/0000-0002-7181-9836; KENMOE, SEBASTIEN/0000-0002-5536-080X	U.S. Department of Health and Human Services, DHHS [6 DESP060001-01-01]; WHO PIP Implementation project in Cameroon	U.S. Department of Health and Human Services, DHHS; WHO PIP Implementation project in Cameroon	This work received grant fom the U.S. Department of Health and Human Services, DHHS (grant number 6 DESP060001-01-01). This work also benefited from the WHO PIP Implementation project in Cameroon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193050; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Casalegno J.S, 2017, EURO SURVEILL, V22; Chokshi A, 2019, J GLOB INFECT DIS, V11, P36, DOI 10.4103/jgid.jgid_110_18; Falsey AR, 2015, INFLUENZA OTHER RESP, V9, P23, DOI 10.1111/irv.12316; Fitzner J, 2018, B WORLD HEALTH ORGAN, V96, P122, DOI 10.2471/BLT.17.194514; Monamele C.G., 2019, MOL CHARACTERIZATION, V14; Monamele C.G, 2018, J MED VIROL; Monamele GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184411; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Njifon H.L.M, 2019, GENETIC DIVERSITY IN; Njouom R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225793; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Shah SC, 2015, INFECT CONT HOSP EP, V36, P241, DOI 10.1017/ice.2014.64; Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4; Vemula SV, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040096; Vuichard-Gysin D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212050; Woolpert T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-129	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236267	10.1371/journal.pone.0236267	http://dx.doi.org/10.1371/journal.pone.0236267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701976	gold, Green Published			2022-12-26	WOS:000575913700066
J	Nishino, M; Matsuzaki, I; Musangile, FY; Takahashi, Y; Iwahashi, Y; Warigaya, K; Kinoshita, Y; Kojima, F; Murata, S				Nishino, Masaru; Matsuzaki, Ibu; Musangile, Fidele Y.; Takahashi, Yuichi; Iwahashi, Yoshifumi; Warigaya, Kenji; Kinoshita, Yuichi; Kojima, Fumiyoshi; Murata, Shin-ichi			Measurement and visualization of cell membrane surface charge in fixed cultured cells related with cell morphology	PLOS ONE			English	Article							CANCER-CELLS; SIALIC-ACID; CHANNELS; PROLIFERATION; VOLTAGE	The diagnosis of patients with malignancies relies on the results of a clinical cytological examination. To enhance the diagnostic qualities of cytological examinations, it is important to have a detailed analysis of the cell's characteristics. There is, therefore, a need for developing a new auxiliary method for cytological diagnosis. In this study, we focused on studying the charge of the cell membrane surface of fixed cells, which is one of important cell's characteristics. Although fixed cells lose membrane potential which is observed in living cells owing to ion dynamics, we hypothesized that fixed cells still have a cell membrane surface charge due to cell membrane components and structure. We used 5 cell lines in this study (ARO, C32TG, RT4, TK, UM-UC-14). After fixation with CytoRich Red, we measured the cell membrane surface charge of fixed cells in solution using zeta potential measurements and fixed cells on glass slides, visualizing it using antibody-labeled beads and positively-charged beads. Furthermore, we measured the cell membrane surface charge of fixed cells under different conditions, such as different solution of fixative, ion concentration, pH, and pepsin treatments. The zeta potential measurements and visualization using the beads indicated that the cell membrane surface of fixed cells was negatively charged, and also that the charge varied among fixed cells. The charge state was affected by the different treatments. Moreover, the number of cell-bound beads was small in interphase, anaphase, and apoptotic cells. We concluded that the negative cell membrane surface charge was influenced by the three-dimensional structure of proteins as well as the different types of amino acids and lipids on the cell membrane. Thus, cell surface charge visualization can be applied as a new auxiliary method for clinical cytological diagnosis. This is the first systematic report of the cell membrane surface charge of fixed cells.	[Nishino, Masaru; Matsuzaki, Ibu; Musangile, Fidele Y.; Takahashi, Yuichi; Iwahashi, Yoshifumi; Warigaya, Kenji; Kinoshita, Yuichi; Kojima, Fumiyoshi; Murata, Shin-ichi] Wakayama Med Univ, Dept Human Pathol, Wakayama, Japan; [Nishino, Masaru] Osaka Univ, Dept Pathol, Osaka, Japan	Wakayama Medical University; Osaka University	Murata, S (corresponding author), Wakayama Med Univ, Dept Human Pathol, Wakayama, Japan.	smurata@wakayama-med.ac.jp		Nishino, Masaru/0000-0001-7080-8329				Adams Dany S, 2012, Cold Spring Harb Protoc, V2012, P385, DOI 10.1101/pdb.top067710; Bautista W, 2017, ANN HEPATOL, V16, P297, DOI 10.5604/16652681.1231590; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Benarroch JM, 2020, TRENDS MICROBIOL, V28, P304, DOI 10.1016/j.tim.2019.12.008; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Bocian S, 2015, J SEP SCI, V38, P2625, DOI 10.1002/jssc.201500072; Chen BD, 2016, THERANOSTICS, V6, P1887, DOI 10.7150/thno.16358; Cook GMW, 2016, ELECTROPHORESIS, V37, P1399, DOI 10.1002/elps.201500476; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; Fuhs T, 2018, NANOSCALE, V10, P4538, DOI 10.1039/c7nr09522h; Gerencser AA, 2016, MOL CELL, V61, P642, DOI 10.1016/j.molcel.2016.02.026; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hodeify R, 2018, CALCIUM ENTRY CHANNE, P215, DOI DOI 10.1201/9781315152592-12; Jangsiriwitayakorn Porntip, 2018, Asian Pac J Cancer Prev, V19, P1571; Koss LG., 2006, KOSSDIAGNOSTIC CYTOL; Lodish H., 2007, MOL CELL BIOL; MAYHEW E, 1966, J GEN PHYSIOL, V49, P717, DOI 10.1085/jgp.49.4.717; NAITOH Y, 1969, SCIENCE, V164, P963, DOI 10.1126/science.164.3882.963; NILIUS B, 1992, J PHYSIOL-LONDON, V445, P537, DOI 10.1113/jphysiol.1992.sp018938; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Perry D, 2016, J AM CHEM SOC, V138, P3152, DOI 10.1021/jacs.5b13153; Purves D., 2001, NEUROSCIENCE; RAY PK, 1973, CANCER RES, V33, P936; RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255, DOI 10.1128/AEM.59.10.3255-3265.1993; Shohani S, 2017, CURR HIV RES, V15, P56, DOI 10.2174/1570162X14666161216142806; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Surma MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111341; VanderWal A, 1997, J COLLOID INTERF SCI, V186, P71, DOI 10.1006/jcis.1996.4615; Wright SH, 2004, ADV PHYSIOL EDUC, V28, P139, DOI 10.1152/advan.00029.2004	31	13	13	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236373	10.1371/journal.pone.0236373	http://dx.doi.org/10.1371/journal.pone.0236373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702063	Green Published, gold			2022-12-26	WOS:000575913700084
J	Alhabib, KF; Gamra, H; Almahmeed, W; Hammoudeh, A; Benkheddah, S; Al Jarallah, M; Al-Motarreb, A; Alquraishi, M; Sobhy, M; Yousif, MG; Alkindi, F; Fellat, N; Amin, MI; Ali, M; Al Saleh, A; Ullah, A; Zannad, F				Alhabib, Khalid F.; Gamra, Habib; Almahmeed, Wael; Hammoudeh, Ayman; Benkheddah, Salim; Al Jarallah, Mohammad; Al-Motarreb, Ahmed; Alquraishi, Mothanna; Sobhy, Mohamed; Yousif, Magdi G.; Alkindi, Fahad; Fellat, Nadia; Amin, Mohammad, I; Ali, Muhammad; Al Saleh, Ayman; Ullah, Anhar; Zannad, Faiez			Acute myocardial infarction and acute heart failure in the Middle East and North Africa: Study design and pilot phase study results from the PEACE MENA registry	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; BASE-LINE CHARACTERISTICS; ST-SEGMENT ELEVATION; LONG-TERM OUTCOMES; TASK-FORCE; CARDIOVASCULAR-DISEASES; MANAGEMENT-PRACTICES; EUROPEAN-SOCIETY; GULF REGISTRY; GLOBAL BURDEN	Background This pilot study describes the overall design and results of the Program for the Evaluation and Management of the Cardiac Events registry for the Middle East and North Africa (MENA) Region. Methods This prospective, multi-center, multi-country study included patients hospitalized with acute myocardial infarction (AMI) and/or acute heart failure (AHF). We evaluated the clinical characteristics, socioeconomic and educational levels, management, in-hospital outcomes, and 30-day mortality rate of patients that were admitted to one tertiary-care center in each of 14 Arab countries in the MENA region. Results Between 22 April and 28 August 2018, 543 AMI and 381AHF patients were enrolled from 14 Arab countries (mean age, 57 +/- 12 years, 82.5% men). Over half of the patients in both study groups had low incomes with limited health care coverage, and limited education. Nearly half of the cohort had a history of diabetes mellitus, hypertension, or hypercholesterolemia. Among patients with ST-elevation myocardial infarctions, 56.4% received primary percutaneous interventions, 24% received thrombolysis, and 19.5% received no acute reperfusion therapy. The main causes of AHF were ischemic heart diseases (55%) and primary valvular heart diseases (15%). The in-hospital and 30-day mortality rates were 2.0% and 3.5%, respectively, for AMI, and 5.4% and 7.0%, respectively, for AHF. Conclusions This pilot study revealed a high prevalence of cardiovascular risk factors in patients with AMI and AHF in Arab countries, and low levels of socioeconomic and educational status. Future phases of the study will improve our understanding of the impact that these factors have on the management and outcomes of cardiac events in these patient populations.	[Alhabib, Khalid F.; Al Saleh, Ayman; Ullah, Anhar] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh, Saudi Arabia; [Gamra, Habib] Univ Monastir, Fattouma Bourguiba Univ Hosp, Res Lab LR 12SP16, Monastir, Tunisia; [Almahmeed, Wael] Cleveland Clin Abu Dhabi, Heart & Vasc Inst, Abu Dhabi, U Arab Emirates; [Hammoudeh, Ayman] Istishari Hosp, Cardiol Dept, Amman, Jordan; [Benkheddah, Salim] Univ Benyoucef Benkhedda, Mustapha Hosp, Cardiol Dept, Alger Ctre, Algeria; [Al Jarallah, Mohammad] Sabah Al Ahmad Cardia Ctr, Kuwait, Kuwait; [Al-Motarreb, Ahmed] Sanaa Univ, Fac Med, Sanaa, Yemen; [Alquraishi, Mothanna] Ibn Albitar Hosp Cardiac Surg, Baghdad, Iraq; [Sobhy, Mohamed] Int Cardiac Ctr ICC, Alexandria, Egypt; [Yousif, Magdi G.] Sudan Heart Ctr, Khartoum, Sudan; [Alkindi, Fahad] Heart Hosp, Hamad Med Corp, Doha, Qatar; [Fellat, Nadia] IBN SINA Univ Hosp, Rabat, Morocco; [Amin, Mohammad, I] Sh Mohammad Bin Khalifa Cardiac Ctr, Awali, Bahrain; [Ali, Muhammad] Saudi Heart Assoc, Riyadh, Saudi Arabia; [Zannad, Faiez] Univ Lorraine, Ctr Invest Clin Inserm, Inst Lorrain Coeur & Vaisseaux, CHU, Nancy, France	King Saud University; Universite de Monastir; Hopital Fattouma Bourguiba; Cleveland Clinic Foundation; Hamad Medical Corporation; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Alhabib, KF (corresponding author), King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh, Saudi Arabia.	khalidalhabib13@hotmail.com	alkindi, fahad/ABI-6820-2020; Ullah, Anhar/CAJ-2116-2022	Gamra, Habib/0000-0001-8758-5766; Ullah, Anhar/0000-0001-6768-2112; Alhabib, Khalid/0000-0002-6692-3874	Roche Diagnostic Middle East FZCO	Roche Diagnostic Middle East FZCO	HG, WA, AH, SB, MJ, AM, MS, MGY, FA, NF, MIA, AS. 30 $ for each submitted online CRF for data collection. funder name: by Roche Diagnostic Middle East FZCO. https://www.rochemiddleeast.com/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhabib KF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216551; AlHabib KF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147385; AlHabib KF, 2014, EUR J HEART FAIL, V16, P461, DOI 10.1002/ejhf.57; AlHabib KF, 2011, J SAUDI HEART ASSOC, V23, P233, DOI 10.1016/j.jsha.2011.05.004; AlHabib KF, 2012, ANN SAUDI MED, V32, P9, DOI 10.5144/0256-4947.2012.9; Belle L, 2017, ARCH CARDIOVASC DIS, V110, P366, DOI 10.1016/j.acvd.2017.05.001; Dewan P, 2019, JACC-HEART FAIL, V7, P336, DOI 10.1016/j.jchf.2018.11.005; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dokainish H, 2017, LANCET GLOB HEALTH, V5, pE665, DOI [10.1016/s2214-109x(17)30196-1, 10.1016/S2214-109X(17)30196-1]; Ferreira JP, 2019, AM HEART J, V218, P66, DOI 10.1016/j.ahj.2019.08.019; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Moustaghfir A, 2012, ARCH CARDIOVASC DIS, V105, P566, DOI 10.1016/j.acvd.2012.07.002; Najafi F, 2009, EUR J HEART FAIL, V11, P472, DOI 10.1093/eurjhf/hfp029; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Puymirat E, 2012, JAMA-J AM MED ASSOC, V308, P998, DOI 10.1001/2012.jama.11348; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Rossello X, 2017, INT J CARDIOL, V245, P27, DOI 10.1016/j.ijcard.2017.07.039; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zubaid M, 2009, ACTA CARDIOL, V64, P439, DOI 10.2143/AC.64.4.2041607	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236292	10.1371/journal.pone.0236292	http://dx.doi.org/10.1371/journal.pone.0236292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697793	Green Published, gold			2022-12-26	WOS:000555392700001
J	Mallahid, N; Badro, DA; Figueiras, A; Takkouche, B				Mallahid, Narmeen; Badro, Danielle A.; Figueiras, Adolfo; Takkouche, Bahi			Association of knowledge and beliefs with the misuse of antibiotics in parents: A study in Beirut (Lebanon)	PLOS ONE			English	Article							SELF-MEDICATION; PUBLIC KNOWLEDGE; ATTITUDES; POPULATION; RESPONDENTS; COMMUNITY; BEHAVIOR; ADULTS	Background Antibiotic resistance is a major public health concern. It has been associated with factors such as uncontrolled consumption, lack of knowledge, beliefs, and sociodemographic characteristics. Lebanon is characterized by high levels of antibiotic misuse, as almost half of the population self-medicates with antibiotics and over 30% of the antibiotics are dispensed without prescription. To-date, no studies determined adequately the association between knowledge, beliefs and antibiotic misuse in Lebanon. Objective To assess the association between level of knowledge and beliefs about antibiotics, and antibiotic misuse in Lebanon. Methods We conducted a cross-sectional study among 1,421 parents of schoolchildren using an anonymous self-administered Knowledge, Attitude and Practices questionnaire. The participants level of agreement with each item of knowledge and beliefs was measured using a Likert-type (0-10) scale. Misuse practices in the last month were detected through a series of questions aimed at determining the level of compliance with physicians instructions in terms of dosage and duration. Data were analyzed using logistic regression. Results 277 participants (16%) acknowledged using antibiotics in the previous month, 41% of whom showed at least one misuse behavior. Misconceptions and beliefs about antibiotics substantially increased the odds of their misuse. For instance, participants who believed that antibiotics were effective in treating viruses, cold, or sore throat infections were twice as likely to misuse antibiotics [Adjusted Interquartile Odds Ratio (aIqOR): 2.08 (95%CI: 1.32, 3.19), aIqOR: 1.81 (95%CI: 1.41, 2.29), aIqOR: 2.19 (95%CI: 1.61, 2.93), respectively]. Parents who usually keep antibiotics at home antibiotics for future use were more likely to misuse antibiotics [aIqOR: 2.44 (95%CI: 1.68, 3.46)]. Conclusions Our findings indicate that the low level of knowledge and the existence of erroneous beliefs about antibiotics are associated with increased odds of antibiotic misuse. Key elements including rationale prescription and control of dispensing should be addressed when designing educational campaigns against antibiotic misuse.	[Mallahid, Narmeen; Figueiras, Adolfo; Takkouche, Bahi] Univ Santiago de Compostela, Dept Prevent Med, Santiago De Compostela, Spain; [Mallahid, Narmeen; Figueiras, Adolfo; Takkouche, Bahi] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain; [Badro, Danielle A.] Amer Univ Sci & Technol, Fac Hlth Sci, Beirut, Lebanon; [Figueiras, Adolfo; Takkouche, Bahi] Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; American University of Science & Technology - Lebanon; Complexo Hospitalario Universitario de Santiago de Compostela	Takkouche, B (corresponding author), Univ Santiago de Compostela, Dept Prevent Med, Santiago De Compostela, Spain.; Takkouche, B (corresponding author), Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain.; Takkouche, B (corresponding author), Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain.	bahi.takkouche@usc.es	Mallah, Narmeen/O-3696-2019; Figueiras Guzman, Adolfo/K-8563-2015	Mallah, Narmeen/0000-0002-3711-3792; Badro, Danielle A/0000-0003-4487-9144; Takkouche, Bahi/0000-0002-0739-2241; Figueiras Guzman, Adolfo/0000-0002-5766-8672	Regional Ministry of Education, Universities and Vocational Training, Santiago de Compostela, Spain [ED431C 2018/20]; American University of Science and Technology in Lebanon	Regional Ministry of Education, Universities and Vocational Training, Santiago de Compostela, Spain; American University of Science and Technology in Lebanon	This study was funded by a grant from the Regional Ministry of Education, Universities and Vocational Training, Santiago de Compostela, Spain, (ED431C 2018/20), and by the American University of Science and Technology in Lebanon.	Anderson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204878; [Anonymous], 2020, LEBANON IMMIGRATION; Awad AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117910; Barah F., 2010, Eastern Mediterranean Health Journal, V16, P516; Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; BUTLER CC, 2009, BRIT MED J, V338; Cheaito L, 2014, INT J PUBLIC HEALTH, V59, P319, DOI 10.1007/s00038-013-0493-y; European Commission, 2017, EUR COMM LAST VISIT; Farah R, 2015, J INFECT PUBLIC HEAL, V8, P37, DOI 10.1016/j.jiph.2014.07.003; Frost I, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz036; Institute of Health Management and Social Protection, 2012, NAT HLTH STAT REP LE; Jamhour A, 2017, AM J INFECT CONTROL, V45, P384, DOI 10.1016/j.ajic.2016.11.026; Jassim Abdul-Mohsin, 2010, Oman Med J, V25, P79, DOI 10.5001/omj.2010.25; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Lopez-Vazquez P, 2012, J EVAL CLIN PRACT, V18, P473, DOI 10.1111/j.1365-2753.2010.01610.x; Moienzadeh A, 2017, INT J PHARM PRACT, V25, P133, DOI 10.1111/ijpp.12233; Mor A, 2015, INFECTION, V43, P453, DOI 10.1007/s15010-015-0768-8; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Mouhieddine TH, 2015, J INFECT PUBLIC HEAL, V8, P20, DOI 10.1016/j.jiph.2014.07.010; Ocan M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2109-3; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; ONeill J., 2016, TACKLING DRUG RESIST; Purdie DM, 2002, J EPIDEMIOL COMMUN H, V56, P748, DOI 10.1136/jech.56.10.748; Ramalhinho I, 2014, INT J CLIN PHARM-NET, V36, P1039, DOI 10.1007/s11096-014-9992-z; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Rouusounides A, 2011, INT J ENV RES PUB HE, V8, P3246, DOI 10.3390/ijerph8083246; Saleh Nadine, 2015, Infection Ecology & Epidemiology, V5, P27094, DOI 10.3402/iee.v5.27094; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Tolonen H, 2005, EUR J EPIDEMIOL, V20, P887, DOI 10.1007/s10654-005-2672-5; von Wintersdorff CJH, 2014, EMERG INFECT DIS, V20, P649, DOI [10.3201/eid2004.131718, 10.3201/eid.2004.131718]; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5; Zahreddine L, 2018, PHARM PRACT-GRANADA, V16, DOI [10.18549/PharmPract.2018.03.1194, 10.18549/pharmpract.2018.03.1194]	32	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0232464	10.1371/journal.pone.0232464	http://dx.doi.org/10.1371/journal.pone.0232464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7SC	32697808	Green Published, gold			2022-12-26	WOS:000575905100001
J	Musyimi, CW; Mutiso, VN; Nyamai, DN; Ebuenyi, I; Ndetei, DM				Musyimi, Christine W.; Mutiso, Victoria N.; Nyamai, Darius N.; Ebuenyi, Ikenna; Ndetei, David M.			Suicidal behavior risks during adolescent pregnancy in a low-resource setting: A qualitative study	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; DEPRESSION; TEENAGERS	Background Suicide is one of the most common causes of death among female adolescents. A greater risk is seen among adolescent mothers who become pregnant outside marriage and consider suicide as the solution to unresolved problems. We aimed to investigate the factors associated with suicidal behavior among adolescent pregnant mothers in Kenya. Methods A total of 27 Focus Group Discussions (FGDs) and 8 Key Informant Interviews (KIIs) were conducted in a rural setting (Makueni County) in Kenya. The study participants consisted of formal health care workers and informal health care providers (traditional birth attendants and community health workers), adolescent and adult pregnant and post-natal (up to six weeks post-delivery) women including first-time adolescent mothers, and caregivers (husbands and/or mothers-in-law of pregnant women) and local key opinion leaders. The qualitative data was analyzed using Qualitative Solution for Research (QSR) NVivo version 10. Results Five themes associated with suicidal behavior risk among adolescent mothers emerged from this study. These included: (i) poverty, (ii) intimate partner violence (IPV), (iii) family rejection, (iv) social isolation and stigma from the community, and (v) chronic physical illnesses. Low economic status was associated with hopelessness and suicidal ideation. IPV was related to drug abuse (especially alcohol) by the male partner, predisposing the adolescent mothers to suicidal ideation. Rejection by parents and isolation by peers at school; and diagnosis of a chronic illness such as HIV/AIDS were other contributing factors to suicidal behavior in adolescent mothers. Conclusion Improved social relations, economic and health circumstances of adolescent mothers can lead to reduction of suicidal behaviour. Therefore, concerted efforts by stakeholders including family members, community leaders, health care workers and policy makers should explore ways of addressing IPV, economic empowerment and access to youth friendly health care centers for chronic physical illnesses. Prevention strategies should include monitoring for suicidal behavior risks during pregnancy in both community and health care settings. Additionally, utilizing lay workers in conducting dialogue discussions and early screening could address some of the risk factors and reduce pregnancy- related suicide mortality in LMICs.	[Musyimi, Christine W.; Mutiso, Victoria N.; Nyamai, Darius N.; Ndetei, David M.] Africa Mental Hlth Res & Training Fdn, Nairobi, Kenya; [Ebuenyi, Ikenna] Maynooth Univ, Dept Psychol, Maynooth, Kildare, Ireland; [Ebuenyi, Ikenna] Maynooth Univ, Assisting Living & Learning Inst, Maynooth, Kildare, Ireland; [Ndetei, David M.] Univ Nairobi, Nairobi, Kenya	Maynooth University; Maynooth University; University of Nairobi	Musyimi, CW (corresponding author), Africa Mental Hlth Res & Training Fdn, Nairobi, Kenya.	dmndetei@amhf.or.ke		Ebuenyi, Ikenna/0000-0002-3329-6296; Musyimi, Christine/0000-0002-8828-2959	Grand Challenges Africa, a scheme of the Alliance for Accelerating Excellence in Science in Africa (AESA) [GCA/ISG/rnd1/135]; African Academy of Sciences	Grand Challenges Africa, a scheme of the Alliance for Accelerating Excellence in Science in Africa (AESA); African Academy of Sciences	This study was supported through Grand Challenges Africa [#GCA/ISG/rnd1/135], a scheme of the Alliance for Accelerating Excellence in Science in Africa (AESA). AESA is an initiative of the African Academy of Sciences (AAS)'s the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency). The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report, or the decision to submit for publication. African Academy of Sciences: https://www.aasciences.africa/.	Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bryan CJ, 2006, J CLIN PSYCHOL, V62, P185, DOI 10.1002/jclp.20222; Cramer RJ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01756; Darroch JE, 2016, COSTS BENEFITS M CON, V1, P1; Freitas GVS, 2008, EUR CHILD ADOLES PSY, V17, P336, DOI 10.1007/s00787-007-0668-2; Gavin AR, 2011, ARCH WOMEN MENT HLTH, V14, P239, DOI 10.1007/s00737-011-0207-5; Gibbs A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194885; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Gunnell D, 2005, BRIT J PSYCHIAT, V187, P206, DOI 10.1192/bjp.187.3.206; Halim N, 2018, CLIN PSYCHOL REV, V66, P117, DOI 10.1016/j.cpr.2017.11.004; Harris Allyssa L, 2016, Nurs Womens Health, V20, P211, DOI 10.1016/j.nwh.2016.01.002; Joiner T, 2007, WHY PEOPLE DIE SUICI, DOI DOI 10.2307/J.CTVJGHV2F; Kapungu C, 2018, LANCET CHILD ADOLESC, V2, P85, DOI 10.1016/S2352-4642(17)30152-9; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lund C, 2018, J AFFECT DISORDERS, V229, P396, DOI 10.1016/j.jad.2017.12.050; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Musyimi CW, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8195267; Musyimi CW, 2018, COMMUNITY MENT HLT J, V54, P84, DOI 10.1007/s10597-016-0072-9; Musyimi CW, 2017, CULT MED PSYCHIAT, P1, DOI [10.1007/s11013-017-9525-z, DOI 10.1007/S11013-017-9525-Z]; National Academies of Sciences and Medicine E, 2018, ADDR SOC CULT NORMS; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; Palladino CL, 2011, OBSTET GYNECOL, V118, P1056, DOI 10.1097/AOG.0b013e31823294da; Pinheiro RT, 2012, J AFFECT DISORDERS, V136, P520, DOI 10.1016/j.jad.2011.10.037; Raneri LG, 2007, PERSPECT SEX REPRO H, V39, P39, DOI 10.1363/3903907; Rice JL, 2017, CHILD YOUTH SERV REV, V73, P79, DOI 10.1016/j.childyouth.2016.12.006; Shamu S, 2016, GEN HOSP PSYCHIAT, V38, P109, DOI 10.1016/j.genhosppsych.2015.10.005; Straub DM, 2018, LANCET CHILD ADOLESC, V2, P214, DOI 10.1016/S2352-4642(18)30005-1; Sukhawaha S, 2016, ARCH PSYCHIAT NURS, V30, P334, DOI 10.1016/j.apnu.2015.12.005; World Health Organization, 2012, WHO APPL ICD 10 DEAT	32	10	10	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236269	10.1371/journal.pone.0236269	http://dx.doi.org/10.1371/journal.pone.0236269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU0WZ	32697791	Green Published, Green Accepted, gold			2022-12-26	WOS:000555392700030
J	Shahzad, N; Munir, T; Javed, M; Tasneem, F; Aslam, B; Ali, M; Mutahir, Z; Ali, MA; Umer, M; Ahmad, M; Farooq, K; Hassan, U; Mustafa, T; Anjum, RS; Shakoori, AR				Shahzad, Naveed; Munir, Tehreem; Javed, Mariam; Tasneem, Fareeda; Aslam, Bilal; Ali, Moazzam; Mutahir, Zeeshan; Akhtar Ali, Muhammad; Umer, Muhammad; Ahmad, Munir; Farooq, Kokab; Hassan, Umair; Mustafa, Tanveer; Anjum, Rana Salman; Shakoori, Abdul Rauf			SHISA3, an antagonist of the Wnt/beta-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer	PLOS ONE			English	Article							DNA METHYLATION; WNT; PROGRESSION; PATHWAY; GENES	Breast cancer (BC) is the foremost cause of cancer related deaths in women globally. Currently there is a scarcity of reliable biomarkers for its early stage diagnosis and theranostics monitoring. Altered DNA methylation patterns leading to the silencing of tumor suppressor genes are considered as an important mechanism underlying tumor development and progression in various cancer types, including BC. Very recently, epigenetic silencing ofSHISA3, an antagonist of beta-catenin, has been reported in various types of tumor. However, the role ofSHISA3in BC has not been investigated yet. Therefore, we aimed at evaluating the contribution ofSHISA3in BC causation by analyzing its expression and methylation levels in BC cell lines (MDA-MB231, MCF-7 and BT-474) and in 103 paired BC tissue samples. TheSHISA3expression and methylation status was determined by qPCR and methylation specific PCR (MSP) respectively. The role ofSHISA3in BC tumorigenesis was evaluated by proliferation and migration assays after ectopic expression ofSHISA3. The association betweenSHISA3hypermethylation and clinicopathological parameters of BC patients was also studied. The downregulation ofSHISA3expression was found in three BC cell lines used and in all BC tissue samples. However,SHISA3promoter region was hypermethylated in 61% (63/103) tumorous tissues in comparison to the 18% of their matched normal tissues. The 5-aza-2'-deoxycytidine treatment restoredSHISA3expression by reversing promoter hypermethylation in both MDA-MB231 and MCF-7 cells. Furthermore, ectopic expression ofSHISA3significantly reduced the proliferation and migration ability of these cells. Taken together, our findings for the first time reveal epigenetic silencing and tumor suppressing role ofSHISA3in BC. Henceforth, this study has identifiedSHISA3as potentially powerful target for the development of new therapies against BC, as well as novel diagnostic and therapy response monitoring approaches.	[Shahzad, Naveed; Munir, Tehreem; Javed, Mariam; Akhtar Ali, Muhammad; Ahmad, Munir; Farooq, Kokab; Hassan, Umair; Shakoori, Abdul Rauf] Univ Punjab, Sch Biol Sci, Lahore, Pakistan; [Tasneem, Fareeda] Univ Punjab, Dept Zool, Lahore, Pakistan; [Aslam, Bilal] Govt Coll Univ, Dept Microbiol, Faisalabad, Pakistan; [Ali, Moazzam; Mutahir, Zeeshan] Univ Punjab, Inst Biochem & Biotechnol, Lahore, Pakistan; [Umer, Muhammad] Griffith Univ, Queensland Micro & Nanotechnol Ctr, Nathan, Qld, Australia; [Mustafa, Tanveer] Fatima Jinnah Med Univ, Dept Histopathol, Lahore, Pakistan; [Anjum, Rana Salman] Forman Christian Coll Univ, Sch Life Sci, Lahore, Pakistan	University of Punjab; University of Punjab; Government College University Faisalabad; University of Punjab; Griffith University	Shahzad, N (corresponding author), Univ Punjab, Sch Biol Sci, Lahore, Pakistan.; Umer, M (corresponding author), Griffith Univ, Queensland Micro & Nanotechnol Ctr, Nathan, Qld, Australia.	hnaveed.shahzad@gmail.com; m.umer@griffith.edu.au	Ali, Muhammad Akhtar/AAA-9583-2020; Ali, Muhammad Akhtar/AAQ-3209-2021; Umer, Muhammad/D-7072-2011; ASLAM, BILAL/AAX-6227-2020	Ali, Muhammad Akhtar/0000-0003-4883-3506; Umer, Muhammad/0000-0001-9983-0087; ASLAM, BILAL/0000-0002-5568-5049; Shakoori, Abdul Rauf/0000-0002-3950-9870; ANJUM, RANA SALMAN/0000-0002-7891-4553; Mutahir, Zeeshan/0000-0001-9550-8170	Higher Education Commission, Pakistan [8461/Punjab/NRPU/RD/HEC/2017]; School of Biological Sciences, University of the Punjab, Lahore, Pakistan	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan); School of Biological Sciences, University of the Punjab, Lahore, Pakistan	This work was supported by Higher Education Commission, Pakistan vide grant No: 8461/Punjab/NRPU/R&D/HEC/2017 to NS and funding and research facilities provided by School of Biological Sciences, University of the Punjab, Lahore, Pakistan.	Boras-Granic Kata, 2008, Organogenesis, V4, P116; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Byler S, 2014, ANTICANCER RES, V34, P1071; Chatterjee A, 2018, SEMIN CANCER BIOL, V51, P149, DOI 10.1016/j.semcancer.2017.08.004; Chen CC, 2014, AM J RESP CRIT CARE, V190, P433, DOI 10.1164/rccm.201312-2256OC; Chiang KC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08686; Flavahan WA, 2017, SCIENCE, V357, DOI 10.1126/science.aal2380; Fu DY, 2010, BREAST CANCER RES TR, V119, P601, DOI 10.1007/s10549-009-0339-8; Furushima K, 2007, DEV BIOL, V306, P480, DOI 10.1016/j.ydbio.2007.03.028; Galamb O, 2016, EPIGENETICS-US, V11, P588, DOI 10.1080/15592294.2016.1190894; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43; Gorgannezhad L, 2018, LAB CHIP, V18, P1174, DOI [10.1039/c8lc00100f, 10.1039/C8LC00100F]; Guo Y, 2011, NEOPLASMA, V58, P110, DOI 10.4149/neo_2011_02_110; Haldrup C, 2016, MOL ONCOL, V10, P825, DOI 10.1016/j.molonc.2016.02.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedge TA, 2008, INT J DEV BIOL, V52, P81, DOI 10.1387/ijdb.072355th; Heywang-Kobrunner SH, 2011, BREAST CARE, V6, P199, DOI 10.1159/000329005; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Karsli-Ceppioglu S, 2014, EPIGENOMICS-UK, V6, P651, DOI [10.2217/EPI.14.59, 10.2217/epi.14.59]; Koval A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25672-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Nebbioso A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007362; Pei JM, 2012, CELL SIGNAL, V24, P758, DOI 10.1016/j.cellsig.2011.11.011; Perri F, 2017, CRIT REV ONCOL HEMAT, V111, P166, DOI 10.1016/j.critrevonc.2017.01.020; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Shan M, 2016, ONCOTARGET, V7, P18485, DOI 10.18632/oncotarget.7608; Shen ZS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9058749; Shen ZS, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0461-y; Tsai MH, 2015, ANN SURG ONCOL, V22, pS1481, DOI 10.1245/s10434-015-4593-1; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Umer M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-117; Xiang TX, 2013, J CELL MOL MED, V17, P1236, DOI 10.1111/jcmm.12099; Xu JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117097; Yamamoto A, 2005, CELL, V120, P223, DOI 10.1016/j.cell.2004.11.051; Yin P, 2018, CANCER SCI, V109, P3368, DOI 10.1111/cas.13771; Yin XD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3399; Yu QC, 2016, CANCERS, V8, DOI 10.3390/cancers8070065; Zhang J, 2019, CANCER RES, V79, P747, DOI 10.1158/0008-5472.CAN-18-1754; Zhang X, 2014, ONCOL LETT, V8, P1745, DOI 10.3892/ol.2014.2410; Zhang Z, 2013, BIOMED MICRODEVICES, V15, P595, DOI 10.1007/s10544-012-9734-8	41	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236192	10.1371/journal.pone.0236192	http://dx.doi.org/10.1371/journal.pone.0236192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692756	Green Published, gold			2022-12-26	WOS:000554606400001
J	Zheng, F; Dong, FF; Yu, S; Li, TP; Jian, YZ; Nie, LY; Fu, CH				Zheng, Fan; Dong, Fenfen; Yu, Shuo; Li, Tianpeng; Jian, Yanze; Nie, Lingyun; Fu, Chuanhai			Klp2 and Ase1 synergize to maintain meiotic spindle stability during metaphase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinesin; meiosis; mitosis; Schizosaccharomyces pombe; spindle; microtubule-associated protein (MAP)	MICROTUBULE MOTOR PROTEIN; KINESIN-RELATED PROTEIN; FISSION YEAST; CROSS-LINKERS; CHROMOSOME SEGREGATION; SELF-ORGANIZATION; FORCE BALANCE; DROSOPHILA; MECHANISMS; MEIOSIS	The spindle apparatus segregates bi-oriented sister chromatids during mitosis but mono-oriented homologous chromosomes during meiosis I. It has remained unclear if similar molecular mechanisms operate to regulate spindle dynamics during mitosis and meiosis I. Here, we employed live-cell microscopy to compare the spindle dynamics of mitosis and meiosis I in fission yeast cells and demonstrated that the conserved kinesin-14 motor Klp2 plays a specific role in maintaining metaphase spindle length during meiosis I but not during mitosis. Moreover, the maintenance of metaphase spindle stability during meiosis I requires the synergism between Klp2 and the conserved microtubule cross-linker Ase1, as the absence of both proteins causes exacerbated defects in metaphase spindle stability. The synergism is not necessary for regulating mitotic spindle dynamics. Hence, our work reveals a new molecular mechanism underlying meiotic spindle dynamics and provides insights into understanding differential regulation of meiotic and mitotic events.	[Zheng, Fan; Dong, Fenfen; Yu, Shuo; Li, Tianpeng; Jian, Yanze; Nie, Lingyun; Fu, Chuanhai] Univ Sci & Technol China, Sch Life Sci,Div Life Sci & Med, Minist Educ,Key Lab Membraneless Organelles & Cel, CAS Ctr Excellence Mol Cell Sci,Hefei Natl Lab Ph, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Fu, CH (corresponding author), Univ Sci & Technol China, Sch Life Sci,Div Life Sci & Med, Minist Educ,Key Lab Membraneless Organelles & Cel, CAS Ctr Excellence Mol Cell Sci,Hefei Natl Lab Ph, Hefei, Peoples R China.	chuanhai@ustc.edu.cn	Fu, Chuanhai/G-8303-2016; Dong, Fenfen/ABG-9400-2021	Fu, Chuanhai/0000-0003-4354-3796; 	National Key Research and Development Program of China [2017YFA0503600]; National Natural Science Foundation of China [31671406, 91754106, 31871350, 31621002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040101]; China's 1000 Young Talents Recruitment Program	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China's 1000 Young Talents Recruitment Program	This work is supported by grants from National Key Research and Development Program of China 2017YFA0503600 (to C. F.), National Natural Science Foundation of China 31671406, 91754106, 31871350, and 31621002 (to C. F.), the Strategic Priority Research Program of the Chinese Academy of Sciences XDB19040101 (to C. F.), and China's 1000 Young Talents Recruitment Program.	Blackwell R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601603; Braun M, 2017, NAT CHEM BIOL, V13, P1245, DOI [10.1038/nchembio.2495, 10.1038/NCHEMBIO.2495]; Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Civelekoglu-Scholey G, 2010, J CELL BIOL, V188, P49, DOI 10.1083/jcb.200908150; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; ENDOW SA, 1994, J CELL SCI, V107, P859; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Gachet Y, 2008, MOL BIOL CELL, V19, P1646, DOI 10.1091/mbc.E07-09-0910; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; Hallen MA, 2008, J CELL SCI, V121, P3834, DOI 10.1242/jcs.038497; HATSUMI M, 1992, J CELL SCI, V103, P1013; HATSUMI M, 1992, J CELL SCI, V101, P547; Hepperla AJ, 2014, DEV CELL, V31, P61, DOI 10.1016/j.devcel.2014.07.023; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; KOMMA DJ, 1991, EMBO J, V10, P419, DOI 10.1002/j.1460-2075.1991.tb07963.x; Lansky Z, 2015, CELL, V160, P1159, DOI 10.1016/j.cell.2015.01.051; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Ludecke A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04656-0; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Ohkura H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015859; Olmsted ZT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6339; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; Petry S, 2016, ANNU REV BIOCHEM, V85, P659, DOI 10.1146/annurev-biochem-060815-014528; Pidoux AL, 1996, MOL BIOL CELL, V7, P1639, DOI 10.1091/mbc.7.10.1639; Reber S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015784; Reinemann DN, 2018, CURR BIOL, V28, P2356, DOI 10.1016/j.cub.2018.06.055; Rincon SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15286; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; She ZY, 2017, J CELL SCI, V130, P2097, DOI 10.1242/jcs.200261; Shen J, 2019, MOL BIOL CELL, V30, P256, DOI 10.1091/mbc.E18-05-0279; Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304; Syrovatkina V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8322; Syrovatkina V, 2013, CURR BIOL, V23, P2423, DOI 10.1016/j.cub.2013.10.023; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; van Heesbeen RGHP, 2014, CELL REP, V8, P948, DOI 10.1016/j.celrep.2014.07.015; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Yamamoto A, 2008, J CELL BIOL, V182, P277, DOI 10.1083/jcb.200802053; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Yamashita Akira, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.top079855; Yukawa M, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210740; Yukawa M, 2017, MOL BIOL CELL, V28, P3647, DOI 10.1091/mbc.E17-08-0497; Yukawa M, 2015, J CELL BIOL, V209, P549, DOI 10.1083/jcb.201412111	54	2	2	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13287	13298		10.1074/jbc.RA120.012905	http://dx.doi.org/10.1074/jbc.RA120.012905			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32723864	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000574483500013
J	Blount, A; Coppola, DM				Blount, Alyson; Coppola, David M.			The effect of odor enrichment on olfactory acuity: Olfactometric testing in mice using two mirror-molecular pairs	PLOS ONE			English	Article							RECEPTOR SENSITIVITY; SENSORY NEURONS; EXPOSURE; PLASTICITY; DISCRIMINATION; ENHANCEMENT; EPITHELIUM; CONTOURS; BULB	Intelligent systems in nature like the mammalian nervous system benefit from adaptable inputs that can tailor response profiles to their environment that varies in time and space. Study of such plasticity, in all its manifestations, forms a pillar of classical and modern neuroscience. This study is concerned with a novel form of plasticity in the olfactory system referred to as induction. In this process, subjects unable to smell a particular odor, or unable to differentiate similar odors, gain these abilities through mere exposure to the odor(s) over time without the need for attention or feedback (reward or punishment). However, few studies of induction have rigorously documented changes in olfactory threshold for the odor(s) used for "enrichment." We trained 36 CD-1 mice in an operant-olfactometer (go/no go task) to discriminate a mixture of stereoisomers from a lone stereoisomer using two enantiomeric pairs: limonene and carvone. We also measured each subject's ability to detect one of the stereoisomers of each odor. In order to assess the effect of odor enrichment on enantiomer discrimination and detection, mice were exposed to both stereoisomers of limonene or carvone for 2 to 12 weeks. Enrichment was effected by adulterating a subject's food (passive enrichment) with one pair of enantiomers or by exposing a subject to the enantiomers in daily operant discrimination testing (active enrichment). We found that neither form of enrichment altered discrimination nor detection. And this result pertained using either within-subject or between-subject experimental designs. Unexpectedly, our threshold measurements were among the lowest ever recorded for any species, which we attributed to the relatively greater amount of practice (task replication) we allowed our mice compared to other reports. Interestingly, discrimination thresholds were no greater (limonene) or only modestly greater (carvone) from detection thresholds suggesting chiral-specific olfactory receptors determine thresholds for these compounds. The super-sensitivity of mice, shown in this study, to the limonene and carvone enantiomers, compared to the much lesser acuity of humans for these compounds, reported elsewhere, may resolve the mystery of why the former group with four-fold more olfactory receptors have tended, in previous studies, to have similar thresholds to the latter group. Finally, our results are consistent with the conclusion that supervised-perceptual learning i.e. that involving repeated feedback for correct and incorrect decisions, rather than induction, is the form of plasticity that allows animals to fully realize the capabilities of their olfactory system.	[Blount, Alyson; Coppola, David M.] Randolph Macon Coll, Dept Biol, Ashland, VA 23005 USA		Coppola, DM (corresponding author), Randolph Macon Coll, Dept Biol, Ashland, VA 23005 USA.	dcoppola@rmc.edu		Blount, Alyson/0000-0001-9501-8163	National Science Foundation (USA) [DMC IOS-1655113]	National Science Foundation (USA)(National Science Foundation (NSF))	DMC IOS-1655113. National Science Foundation (USA) NSF.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angely CJ, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-26; Barbour J, 2008, J PROTEOME RES, V7, P1594, DOI 10.1021/pr7005796; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Buonviso N, 2000, NEUROSCIENCE, V95, P325; Cadiou H, 2014, J NEUROSCI, V34, P4857, DOI 10.1523/JNEUROSCI.0688-13.2014; Cavallin MA, 2010, NEUROSCI LETT, V483, P90, DOI 10.1016/j.neulet.2010.07.059; Chan Wilson, 2017, Front Synaptic Neurosci, V9, P4, DOI 10.3389/fnsyn.2017.00004; Clarin T, 2010, BEHAV BRAIN RES, V206, P229, DOI 10.1016/j.bbr.2009.09.022; Clevenger AC, 2006, CHEM SENSES, V31, P9, DOI 10.1093/chemse/bjj001; Cometto-Muniz JE, 2003, CHEM SENSES, V28, P467, DOI 10.1093/chemse/28.6.467; Coppola DM, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/351752; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; CUNZEMAN PJ, 1984, CHEM SENSES, V9, P229, DOI 10.1093/chemse/9.3.229; Dewaele A, 2018, BEHAV BRAIN RES, V347, P414, DOI 10.1016/j.bbr.2018.02.026; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Escanilla O, 2008, PHYSIOL BEHAV, V94, P621, DOI 10.1016/j.physbeh.2008.03.008; Fahey P. G., 2019, GLOBAL MAP ORIENTATI, DOI [10.1101/745323, DOI 10.1101/745323]; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Francois A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00271; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hamana H, 2003, CHEM SENSES, V28, P87, DOI 10.1093/chemse/28.2.87; Hochenberger R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061278; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; Hubel DH., 2005, BRAIN VISUAL PERCEPT; Ibarra-Soria X, 2017, ELIFE, V6, DOI 10.7554/eLife.21476; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Joshi D, 2006, CHEM SENSES, V31, P655, DOI 10.1093/chemse/bjl006; Kass MD, 2013, SCIENCE, V342, P1389, DOI 10.1126/science.1244916; Kerr MA, 2006, NAT NEUROSCI, V9, P484, DOI 10.1038/nn1673; LAING DG, 1980, PHYSIOL BEHAV, V25, P555, DOI 10.1016/0031-9384(80)90121-3; LAING DG, 1978, J COMP PHYSIOL, V124, P259, DOI 10.1007/BF00657057; Laska M, 2006, BEHAV BRAIN RES, V167, P349, DOI 10.1016/j.bbr.2005.09.022; Laska M, 2017, SPRINGER HBK, P675; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; LEITEREG TJ, 1971, J AGR FOOD CHEM, V19, P785, DOI 10.1021/jf60176a035; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; Liu AN, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0129-17.2017; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Mandairon N, 2006, BEHAV NEUROSCI, V120, P173, DOI 10.1037/0735-7044.120.1.173; Martel G, 2015, NEUROBIOL AGING, V36, P1013, DOI 10.1016/j.neurobiolaging.2014.10.033; Ohloff G., 1994, FASCINATION ODORS TH; OTTOSON D, 1956, ACTA PHYSIOL SCAND, V35, P7; PELOSI P, 1978, CHEM SENS FLAV, V3, P331, DOI 10.1093/chemse/3.3.331; Santoro SW, 2012, ELIFE, V1, DOI 10.7554/eLife.00070; Sato T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14073; Schellinck H, 2018, BEHAV PROCESS, V155, P19, DOI 10.1016/j.beproc.2017.08.009; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; SEMKE E, 1995, NATURWISSENSCHAFTEN, V82, P148; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Slotnick B, 2005, CURR PROTOC NEUROSCI, V33; Slotnick B, 2015, CHEM SENSES, V40, P269, DOI 10.1093/chemse/bjv005; Smith DW, 2008, PHYSIOL BEHAV, V93, P44, DOI 10.1016/j.physbeh.2007.07.011; STEVENS JC, 1988, CHEM SENSES, V13, P643, DOI 10.1093/chemse/13.4.643; Todrank J, 2011, P ROY SOC B-BIOL SCI, V278, P1949, DOI 10.1098/rspb.2010.2314; Vinera J, 2015, LEARN MEMORY, V22, P192, DOI 10.1101/lm.036608.114; Voznessenskaya VV, 1995, ADV BIOSCI, V93, P399; Voznessenskaya VV, 1999, ADV CHEM SIGNALS VER, P563, DOI DOI 10.1007/978-1-4615-4733-4_50; Wackermannova M, 2016, PHYSIOL RES, V65, P369, DOI 10.33549/physiolres.932955; WALKER JC, 1986, CHEM SENSES, V11, P439, DOI 10.1093/chemse/11.4.439; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; Watanabe T, 2015, ANNU REV PSYCHOL, V66, P197, DOI 10.1146/annurev-psych-010814-015214; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; Webster Michael A, 2012, F1000 Biol Rep, V4, P21, DOI 10.3410/B4-21; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; Yee KK, 2001, PHYSIOL BEHAV, V72, P705, DOI 10.1016/S0031-9384(01)00428-0; YOUNGENTOB SL, 1995, BRAIN RES, V670, P82, DOI 10.1016/0006-8993(94)01275-M; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	70	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0233250	10.1371/journal.pone.0233250	http://dx.doi.org/10.1371/journal.pone.0233250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730274	gold, Green Submitted, Green Published			2022-12-26	WOS:000556884700100
J	Frazao, DR; Maia, CSF; Chemelo, VD; Monteiro, D; Ferreira, RD; Bittencourt, LO; Balbinot, GD; Collares, FM; Rosing, CK; Martins, MD; Lima, RR				Frazao, Deborah Ribeiro; Ferraz Maia, Cristiane Socorro; Chemelo, Victoria dos Santos; Monteiro, Deiweson; Ferreira, Railson de Oliveira; Bittencourt, Leonardo Oliveira; Balbinot, Gabriela de Souza; Collares, Fabricio Mezzomo; Rosing, Cassiano Kuchenbecker; Martins, Manoela Domingues; Lima, Rafael Rodrigues			Ethanol binge drinking exposure affects alveolar bone quality and aggravates bone loss in experimentally-induced periodontitis	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; DISEASES; DENSITY	Background Periodontitis is a multifactorial inflammatory disease of tooth supporting tissues caused by oral biofilms, influenced by environmental and genetic factors, among others. Ethanol consumption has been considered a factor that enhances alveolar bone loss, especially in high doses. The present study aims to investigate the changes promoted by ethanol binge drinking per se or associated with ligature-induced periodontal breakdown on alveolar bone loss. Materials and methods Thirty-two Wistar rats were randomly allocated into four groups: control (C), ethanol (3g/kg/day; 3 days On-4 days Off protocol by gavage for 28 days, EtOH), experimental periodontitis (EP) and experimental periodontitis plus ethanol administration (EP+EtOH). On day 14(th), periodontitis was induced by ligatures that were placed around the lower first molars. On day 28(th), the animals were euthanized and mandibles were submitted to stereomicroscopy for exposed root area analysis and micro-computed tomography (micro-CT) for the evaluation of alveolar bone loss and microstructural parameters. Results The results revealed that ligature-induced alveolar bone loss is aggravated by ethanol binge drinking compared to controls (1.06 +/- 0.10 vs 0.77 +/- 0.04; p<0.0001). In addition, binge drinkingper sealtered the alveolar bone quality and density demonstrating a reduction in trabecular thickness, trabecular number parameter and bone density percentual. Periodontal disorder plus ethanol binge drinking group also demonstrated reduction of the quality of bone measured by trabecular thickness. Conclusions In conclusion, intense and episodic ethanol intake decreased alveolar bone quality in all microstructural parameters analyzed which may be considered a modifying factor of periodontitis, intensifying the already installed disease.	[Frazao, Deborah Ribeiro; Chemelo, Victoria dos Santos; Monteiro, Deiweson; Ferreira, Railson de Oliveira; Bittencourt, Leonardo Oliveira; Lima, Rafael Rodrigues] Fed Univ Para UFPA, Inst Biol Sci, Lab Funct & Struct Biol, Belem, Para, Brazil; [Ferraz Maia, Cristiane Socorro] Fed Univ Para UFPA, Pharm Fac, Inst Hlth Sci, Lab Inflammat & Behav Pharmacol, Belem, Para, Brazil; [Balbinot, Gabriela de Souza; Collares, Fabricio Mezzomo] Fed Univ Rio Grande do Sul UFRGS, Sch Dent, Dent Mat Lab, Porto Alegre, RS, Brazil; [Rosing, Cassiano Kuchenbecker] Fed Univ Rio Grande do Sul UFRGS, Sch Dent, Dept Periodontol, Porto Alegre, RS, Brazil; [Martins, Manoela Domingues] Fed Univ Rio Grande do Sul UFRGS, Sch Dent, Dept Oral Pathol, Porto Alegre, RS, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Lima, RR (corresponding author), Fed Univ Para UFPA, Inst Biol Sci, Lab Funct & Struct Biol, Belem, Para, Brazil.	rafalima@ufpa.br	Souza-Monteiro, Deiweson/AAF-6076-2022; Souza-Monteiro, Deiweson/AFJ-9037-2022; Rösing, Cassiano/AAR-7060-2021; Lima, Rafael Rodrigues/M-7726-2019; Chemelo, Victória/AAZ-6047-2021; Maia, Cristiane/E-7217-2016; Martins, Manoela Domingues/G-8209-2012; Frazão, Deborah Ribeiro/T-7212-2017; Bittencourt, Leonardo O/N-4526-2017; Collares, Fabricio m/J-1752-2015; Souza-Monteiro, Deiweson/HGA-7549-2022; Balbinot, Gabriela/AAE-9736-2021	Souza-Monteiro, Deiweson/0000-0003-1843-4184; Souza-Monteiro, Deiweson/0000-0003-1843-4184; Lima, Rafael Rodrigues/0000-0003-1486-4013; Maia, Cristiane/0000-0003-4493-7375; Martins, Manoela Domingues/0000-0001-8662-5965; Bittencourt, Leonardo O/0000-0002-9525-2723; Collares, Fabricio m/0000-0002-1382-0150; Frazao, Deborah/0000-0001-9168-2606; Balbinot, Gabriela de Souza/0000-0001-9076-2460; Ferreira, Railson/0000-0001-8718-9341	CNPq -Brazilian National Council for Scientific and Technological Development [435093/2018-5]; CAPES/PROCAD -Higher Education Improvement Coordination [23038.005350/2018-78]; CAPES [001]; Pro - Reitoria de Pesquisa e Posgraduacao from Federal University of Para (PROPESP-UFPA)	CNPq -Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PROCAD -Higher Education Improvement Coordination; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro - Reitoria de Pesquisa e Posgraduacao from Federal University of Para (PROPESP-UFPA)	This study was partially supported by a grant provided by CNPq -Brazilian National Council for Scientific and Technological Development-435093/2018-5 (DF, VC, RO, DF, LB, RL), CAPES/PROCAD -Higher Education Improvement Coordination -23038.005350/2018-78 (CM, GB, FC, CR, MD, RL) and (CAPES) - Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The APC was funded by Pro - Reitoria de Pesquisa e Posgraduacao from Federal University of Para (PROPESP-UFPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2018, J PERIODONTOL, V89, pS183, DOI 10.1002/JPER.16-0480; Bannach SV, 2015, INDIAN J EXP BIOL, V53, P93; Bastos MF, 2014, ARCH ORAL BIOL, V59, P82, DOI 10.1016/j.archoralbio.2013.10.002; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Callaci JJ, 2004, ALCOHOL CLIN EXP RES, V28, P182, DOI 10.1097/01.ALC.0000108661.41560.BF; Callaci JJ, 2009, CALCIFIED TISSUE INT, V84, P474, DOI 10.1007/s00223-009-9240-z; Cavagni Juliano, 2017, Acta odontol. latinoam., V30, P39; Centro de informacao sobre saude e alcool (CISA), 2018, REL GLOB ALC SAUD 20; Chakkalakal DA, 2005, ALCOHOL CLIN EXP RES, V29, P2077, DOI 10.1097/01.alc.0000192039.21305.55; Chen MM, 2019, J CLIN PERIODONTOL, V46, P608, DOI 10.1111/jcpe.13112; Correa MG, 2016, J PERIODONTAL RES, V51, P60, DOI 10.1111/jre.12279; Dahiya Parveen, 2013, J Indian Soc Periodontol, V17, P411, DOI 10.4103/0972-124X.118306; Dai J, 2016, CLIN ORAL INVEST, V20, P581, DOI 10.1007/s00784-015-1531-3; Dal-Fabbro R, 2019, ARCH ORAL BIOL, V108, DOI 10.1016/j.archoralbio.2019.104538; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; Araujo Cristiano Miranda de, 2014, Dental Press J. Orthod., V19, P93, DOI 10.1590/2176-9451.19.6.093-098.oar; Fagundes NCF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7323627; Fernandez-Sola J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101651; Ferreira RD, 2019, THER ADV MUSCULOSKEL, V11, DOI 10.1177/1759720X19858514; Amaral CDF, 2009, J DENT, V37, P643, DOI 10.1016/j.jdent.2009.04.011; Hassumi JS, 2018, J APPL ORAL SCI, V26, DOI 10.1590/1678-7757-2017-0326; Hernandez-Rios P, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00869; Lamarao-Vieira K, 2019, OXID MED CELL LONGEV, V2019, DOI [10.1155/2019/6802421, 10.1155/2019/6802424]; Lang NP, 2018, J PERIODONTOL, V89, pS9, DOI 10.1002/JPER.16-0517; Liberman DN, 2011, ARCH ORAL BIOL, V56, P109, DOI 10.1016/j.archoralbio.2010.09.012; Lisboa MRP, 2015, J PERIODONTOL, V86, P801, DOI 10.1902/jop.2015.140630; Castro MML, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9187978; Dantas AM, 2012, ARCH ORAL BIOL, V57, P1211, DOI 10.1016/j.archoralbio.2012.02.008; Martiniakova M, 2018, J BIOL RES-THESSALON, V25, DOI 10.1186/s40709-018-0079-1; Mikosch P, 2014, WIEN MED WOCHENSCHR, V164, P15, DOI 10.1007/s10354-013-0258-5; NIAAA-National Institute on Alcohol Abuse and Alcoholism, 2019, ALC EFF HLTH; Papapanou PN, 2018, J PERIODONTOL, V89, pS173, DOI 10.1002/JPER.17-0721; Fernandes LMP, 2015, HISTOL HISTOPATHOL, V30, P1069, DOI 10.14670/HH-11-604; Rocco A, 2014, WORLD J GASTROENTERO, V20, P14652, DOI 10.3748/wjg.v20.i40.14652; Schmidt APG, 2019, DIMORFISMO SEXUAL CA; Souza Daniela Martins de, 2009, Braz. oral res., V23, P326, DOI 10.1590/S1806-83242009000300017; Vargas-Sanchez PK, 2017, J APPL ORAL SCI, V25, P490, DOI 10.1590/1678-7757-2016-0517; Virto L, 2018, J PERIODONTAL RES, V53, P825, DOI 10.1111/jre.12571; Wagner MC, 2017, J PERIODONTOL, V88, P1271, DOI 10.1902/jop.2017.170231; Wagner Marcius Comparsi, 2016, Braz. Dent. J., V27, P135, DOI 10.1590/0103-6440201600545; Wang JT, 2016, J CLIN PERIODONTOL, V43, P572, DOI 10.1111/jcpe.12556	42	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236161	10.1371/journal.pone.0236161	http://dx.doi.org/10.1371/journal.pone.0236161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730269	Green Published, gold			2022-12-26	WOS:000556884700048
J	Gu, YL; Chen, J; Zhang, H; Shen, ZY; Liu, H; Lv, SQ; Yu, XX; Zhang, D; Ding, XQ; Zhang, XY				Gu, Yulu; Chen, Jing; Zhang, Han; Shen, Ziyan; Liu, Hong; Lv, Shiqi; Yu, Xixi; Zhang, Di; Ding, Xiaoqiang; Zhang, Xiaoyan			Hydrogen sulfide attenuates renal fibrosis by inducing TET-dependent DNA demethylation on Klotho promoter	FASEB JOURNAL			English	Article						CKD; Fe2+; hypoxia; ROS	FIBROBLAST ACTIVATION; GENE-EXPRESSION; KIDNEY INJURY; METHYLATION; HYDROXYMETHYLATION; HYPOXIA; H2S; VASORELAXANT; FIBROGENESIS; CONTRIBUTES	Hypoxia is a key pathogenetic characteristic of chronic kidney disease (CKD). Klotho has renoprotective effect and its expression is commonly suppressed in CKD patients. We showed that chronic hypoxia in unilateral ureteral obstruction model mice is associated with renal Klotho promoter methylation and expression silencing. Administration of low-dose of sodium hydrosulfide (NaHS) effectively ameliorated renal tubulointerstitial fibrosis in the mouse model by demethylating Klotho promoter and restoring its expression. Mechanistically, hypoxia microenvironment in CKD reduced cellular oxygen availability and Fe(2+)concentration, and led to impaired activity of ten-eleven translocation (TET), which is critical in maintaining Klotho promoter demethylation status. NaHS treatment greatly improved hypoxia condition, restored TET activity, reversed DNA methylation, and thus, increased Klotho expression. Our results strongly suggested that correcting hypoxia condition to restore TET activity could be a promising therapeutic strategy against CKD.	[Gu, Yulu; Chen, Jing; Zhang, Han; Shen, Ziyan; Liu, Hong; Lv, Shiqi; Yu, Xixi; Zhang, Di; Ding, Xiaoqiang; Zhang, Xiaoyan] Fudan Univ, Zhongshan Hosp, Dept Nephrol, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Gu, Yulu; Lv, Shiqi; Yu, Xixi; Zhang, Di; Ding, Xiaoqiang; Zhang, Xiaoyan] Shanghai Key Lab Kidney & Blood Purificat, Shanghai, Peoples R China; [Chen, Jing; Zhang, Han; Shen, Ziyan; Liu, Hong; Ding, Xiaoqiang; Zhang, Xiaoyan] Shanghai Med Ctr Kidney Dis, Shanghai, Peoples R China; [Ding, Xiaoqiang; Zhang, Xiaoyan] Shanghai Inst Kidney & Dialysis, 136 Med Coll Rd, Shanghai 200032, Peoples R China	Fudan University	Ding, XQ; Zhang, XY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Nephrol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Ding, XQ; Zhang, XY (corresponding author), Shanghai Inst Kidney & Dialysis, 136 Med Coll Rd, Shanghai 200032, Peoples R China.	ding.xiaoqiang@zs-hospital.sh.cn; zhang.xiaoyan@zs-hospital.sh.cn			Ministry of Science and Technology of People's Republic of China [2016YFC1305500]; Shanghai Municipal Health Commission [2017ZZ01015]; Innovation Program of Shanghai Municipal Education Commission [2017-01-07-0007-E00009]; National Natural Science Foundation of China [81700646, 81970637]	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Shanghai Municipal Health Commission; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Ministry of Science and Technology of People's Republic of China (2016YFC1305500), Shanghai Municipal Health Commission (2017ZZ01015), Innovation Program of Shanghai Municipal Education Commission (2017-01-07-0007-E00009), and National Natural Science Foundation of China (81700646 and 81970637)	Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Dressler GR, 2008, J AM SOC NEPHROL, V19, P2060, DOI 10.1681/ASN.2008010119; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hore TA, 2016, P NATL ACAD SCI USA, V113, P12202, DOI 10.1073/pnas.1608679113; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuang Q, 2018, AM J NEPHROL, V47, P361, DOI 10.1159/000489606; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Morgado-Pascual JL, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2931049; Madala HR, 2018, CANCERS, V10, DOI 10.3390/cancers10020049; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; Olson KR, 2006, J EXP BIOL, V209, P4011, DOI 10.1242/jeb.02480; Ploumakis A, 2015, MOL CELL, V58, P729, DOI 10.1016/j.molcel.2015.05.026; Salminen A, 2014, AGEING RES REV, V16, P45, DOI 10.1016/j.arr.2014.05.004; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Sun Y, 2015, J MOL MED, V93, P439, DOI 10.1007/s00109-014-1227-1; Tampe B, 2017, KIDNEY INT, V91, P157, DOI 10.1016/j.kint.2016.07.042; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xia M, 2009, J PHARMACOL EXP THER, V329, P1056, DOI 10.1124/jpet.108.149963; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu XB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05766-5; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Yin WJ, 2012, EUR J RADIOL, V81, P1426, DOI 10.1016/j.ejrad.2011.03.045; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893; Zhang Q, 2017, KIDNEY INT, V91, P144, DOI 10.1016/j.kint.2016.07.040; Zhao BL, 2014, NUCLEIC ACIDS RES, V42, P1593, DOI 10.1093/nar/gkt1090; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	42	12	12	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11474	11487		10.1096/fj.201902957RR	http://dx.doi.org/10.1096/fj.201902957RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729950				2022-12-26	WOS:000556805800001
J	Kim, JJ; Jang, EJ; Park, J; Sohn, HS				Kim, Jong Joo; Jang, Eun Jin; Park, Jiwon; Sohn, Hyun Soon			Association between proton pump inhibitor use and risk of fracture: A population-based case-control study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HIP FRACTURE; THERAPY; BISPHOSPHONATES; COMBINATION; RESORPTION	Objectives The purpose of this study was to reconfirm the association between the risk of fracture and proton pump inhibitor use and to establish evidence for defining a high-risk group of patients among proton pump inhibitor users. Methods A nested case-control study was performed using data from the National Health Insurance Sharing Service database from the period January 2007 to December 2017. The study population included elderly women aged >= 65 years with claims for peptic ulcer or gastro-esophageal reflux disease. The cases were all incidental osteoporotic fractures, and up to two controls were matched to each case by age, osteoporosis, and Charlson comorbidity index. Conditional logistic regression was used to calculate the adjusted odds ratio and 95% confidence interval (CI). Results A total of 21,754 cases were identified, and 43,508 controls were matched to the cases. The adjusted odds ratio of osteoporotic fractures related to the use of proton pump inhibitors was 1.15 (95% CI: 1.11-1.20). There was a statistically significant interaction between proton pump inhibitor and bisphosphonate use (p<0.01). The risk of fracture in patients using proton pump inhibitors was 1.15 (95% CI: 1.08-1.92) in bisphosphonate users and 1.11 (95% CI: 1.03-1.20) in bisphosphonate non-users. Conclusion Concomitant use of bisphosphonates and proton pump inhibitors will likely increase the risk of osteoporotic fractures in women aged 65 and over, and caution should be exercised in this high-risk group of patients.	[Kim, Jong Joo] Cha Univ, Pharmaceut Informat Res Inst, Gyeonggi Do, South Korea; [Jang, Eun Jin] Andong Natl Univ, Coll Nat Sci, Gyeongsangbuk Do, South Korea; [Park, Jiwon] Kyungpook Natl Univ, Coll Nat Sci, Daegu Si, South Korea; [Sohn, Hyun Soon] Cha Univ, Coll Pharm, Gyeonggi Do, South Korea	Pochon Cha University; Andong National University; Kyungpook National University; Pochon Cha University	Sohn, HS (corresponding author), Cha Univ, Coll Pharm, Gyeonggi Do, South Korea.	sohn64@cha.ac.kr		Sohn, Hyun Soon/0000-0003-1360-1895				Abrahamsen B, 2011, ARCH INTERN MED, V171, P998, DOI 10.1001/archinternmed.2011.20; AGGART HT, 2002, MAYO CLIN P, V77, P262, DOI DOI 10.4065/77.3.262; Arana A, 2011, EPIDEMIOLOGY, V22, P876, DOI [10.1097/EDE.0b013e3182093a0f, 10.1097/EDE.0b013e31823198fc]; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Biswas PN, 2003, OSTEOPOROSIS INT, V14, P507, DOI 10.1007/s00198-003-1399-y; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Blackie R., 2020, PRESCRIBER, V31, P14, DOI 10.1002/psb.1815; de Vries F, 2009, OSTEOPOROSIS INT, V20, P1989, DOI 10.1007/s00198-009-0891-4; Eom CS, 2011, ANN FAM MED, V9, P257, DOI 10.1370/afm.1243; Eslick GD, 2009, J CLIN GASTROENTEROL, V43, P111, DOI 10.1097/MCG.0b013e31815ea27b; Ettinger B., 1998, J MANAGE CARE PHARM, V4, P488, DOI [10.18553/jmcp.1998.4.5.488, DOI 10.18553/jmcp.1998.4.5.488]; Gray SL, 2010, ARCH INTERN MED, V170, P765, DOI 10.1001/archinternmed.2010.94; Health Insurance Review and Assessment Service, HEALTHC BIGD HUB STA; Hinson AM, 2015, J AM GERIATR SOC, V63, P2070, DOI 10.1111/jgs.13661; Itoh S, 2013, J BONE MINER METAB, V31, P206, DOI 10.1007/s00774-012-0406-9; Kim Jong Joo, 2018, Yakhak Hoeji, V62, P171, DOI 10.17480/psk.2018.62.3.171; Kwok CS, 2011, BONE, V48, P768, DOI 10.1016/j.bone.2010.12.015; Lee J, 2013, J GASTROENTEROL, V48, P1016, DOI 10.1007/s00535-012-0722-9; Malfertheiner P, 2017, NAT REV GASTRO HEPAT, V14, P697, DOI 10.1038/nrgastro.2017.117; Nassar Yousef, 2018, J Bone Metab, V25, P141, DOI 10.11005/jbm.2018.25.3.141; Prieto-Alhambra D, 2014, J BONE MINER RES, V29, P268, DOI 10.1002/jbmr.2011; Roughead EE, 2004, BRIT J CLIN PHARMACO, V57, P813, DOI 10.1111/j.1365-2125.2004.02078.x; Rzeszutek K, 2003, J CRANIOFAC SURG, V14, P301, DOI 10.1097/00001665-200305000-00007; Targownik LE, 2010, GASTROENTEROLOGY, V138, P896, DOI 10.1053/j.gastro.2009.11.014; TUUKKANEN J, 1986, CALCIFIED TISSUE INT, V38, P123, DOI 10.1007/BF02556841; van Pinxteren B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002095.pub3; Yang SD, 2015, INT J CLIN EXP MED, V8, P4899; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Zhou B, 2016, OSTEOPOROSIS INT, V27, P339, DOI 10.1007/s00198-015-3365-x	29	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0235163	10.1371/journal.pone.0235163	http://dx.doi.org/10.1371/journal.pone.0235163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730257	Green Published, gold			2022-12-26	WOS:000556884700058
J	Liu, YX; Toet, A; Krone, T; van Stokkum, R; Eijsman, S; van Erp, JBF				Liu, Yingxuan; Toet, Alexander; Krone, Tanja; van Stokkum, Robin; Eijsman, Sophia; van Erp, Jan B. F.			A network model of affective odor perception	PLOS ONE			English	Article							STARTLE REFLEX MODULATION; TEST-RETEST RELIABILITY; UNPLEASANT ODORS; OLFACTORY PERFORMANCE; NEURAL REPRESENTATIONS; DETECTION THRESHOLDS; AUTONOMIC RESPONSES; COGNITIVE JUDGMENTS; EVERYDAY ODORS; HUMAN AMYGDALA	The affective appraisal of odors is known to depend on their intensity (I), familiarity (F), detection threshold (T), and on the baseline affective state of the observer. However, the exact nature of these relations is still largely unknown. We therefore performed an observer experiment in which participants (N = 52) smelled 40 different odors (varying widely in hedonic valence) and reported the intensity, familiarity and their affective appraisal (valence and arousal: V and A) for each odor. Also, we measured the baseline affective state (valence and arousal: BV and BA) and odor detection threshold of the participants. Analyzing the results for pleasant and unpleasant odors separately, we obtained two models through network analysis. Several relations that have previously been reported in the literature also emerge in both models (the relations between F and I, F and V, I and A; I and V, BV and T). However, there are also relations that do not emerge (between BA and V, BV and I, and T and I) or that appear with a different polarity (the relation between F and A for pleasant odors). Intensity (I) has the largest impact on the affective appraisal of unpleasant odors, while F significantly contributes to the appraisal of pleasant odors. T is only affected by BV and has no effect on other variables. This study is a first step towards an integral study of the affective appraisal of odors through network analysis. Future studies should also include other factors that are known to influence odor appraisal, such as age, gender, personality, and culture.	[Liu, Yingxuan; Toet, Alexander; Eijsman, Sophia; van Erp, Jan B. F.] TNO, Perceptual & Cognit Syst, Soesterberg, Netherlands; [Krone, Tanja; van Stokkum, Robin] TNO, Risk Anal Prod Dev RAPID, Zeist, Netherlands; [van Erp, Jan B. F.] Univ Twente, Res Grp Human Media Interact, Enschede, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; University of Twente	Toet, A (corresponding author), TNO, Perceptual & Cognit Syst, Soesterberg, Netherlands.	lex.toet@tno.nl	Toet, Alexander/E-6733-2016	Toet, Alexander/0000-0003-1051-5422; Krone, Tanja/0000-0003-4902-9907; van Stokkum, Robin Mischa/0000-0002-1988-9896; van Erp, Jan/0000-0002-6511-2850				AlaouiIsmaili O, 1997, CHEM SENSES, V22, P237, DOI 10.1093/chemse/22.3.237; AlaouiIsmaili O, 1997, PHYSIOL BEHAV, V62, P713, DOI 10.1016/S0031-9384(97)90016-0; Albrecht J, 2009, RHINOLOGY, V47, P160; Albrecht J, 2008, CHEM SENSES, V33, P461, DOI 10.1093/chemse/bjn013; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Ayabe-Kanamura S, 1998, CHEM SENSES, V23, P31, DOI 10.1093/chemse/23.1.31; Beard C, 2016, PSYCHOL MED, V46, P3359, DOI 10.1017/S0033291716002300; Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; Bensafi M, 2002, NEUROPHYSIOL CLIN, V32, P326, DOI 10.1016/S0987-7053(02)00339-8; Bensafi M, 2002, NEUROSCI LETT, V319, P162, DOI 10.1016/S0304-3940(01)02572-1; Bensafi M, 2002, NEUROSCI LETT, V328, P309, DOI 10.1016/S0304-3940(02)00548-7; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Bensafi M, 2003, BRAIN COGNITION, V51, P270, DOI 10.1016/S0278-2626(03)00019-8; Bensafi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038358; Berridge KC, 2019, NAT REV NEUROSCI, V20, P225, DOI 10.1038/s41583-019-0122-8; Blackford JU, 2010, NEUROIMAGE, V50, P1188, DOI 10.1016/j.neuroimage.2009.12.083; Borsboom D, 2017, J ABNORM PSYCHOL, V126, P989, DOI 10.1037/abn0000306; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Braden R, 2009, J PERIANESTH NURS, V24, P348, DOI 10.1016/j.jopan.2009.10.002; Brainerd CJ, 2018, PSYCHOL SCI, V29, P1706, DOI 10.1177/0956797618780353; BRAUCHLI P, 1995, CHEM SENSES, V20, P505, DOI 10.1093/chemse/20.5.505; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; BUSH LK, 1993, PSYCHOL BULL, V113, P566, DOI 10.1037/0033-2909.113.3.566; Cacioppo JT, 1999, J PERS SOC PSYCHOL, V76, P839, DOI 10.1037/0022-3514.76.5.839; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; CAIN WS, 1970, PERCEPT PSYCHOPHYS, V7, P271, DOI 10.3758/BF03210163; Chebat JC, 2003, J BUS RES, V56, P529, DOI 10.1016/S0148-2963(01)00247-8; Chen D, 2005, CHEM SENSES, V30, P345, DOI 10.1093/chemse/bji029; Chen D, 1999, PHYSIOL BEHAV, V68, P241, DOI 10.1016/S0031-9384(99)00147-X; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Chrea C, 2009, CHEM SENSES, V34, P49, DOI 10.1093/chemse/bjn052; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costantini G, 2019, PERS INDIV DIFFER, V136, P68, DOI 10.1016/j.paid.2017.06.011; Costantini G, 2015, EUR J PERSONALITY, V29, P548, DOI 10.1002/per.2014; Costantini G, 2015, J RES PERS, V54, P13, DOI 10.1016/j.jrp.2014.07.003; Costenbader E, 2003, SOC NETWORKS, V25, P283, DOI 10.1016/S0378-8733(03)00012-1; Cramer AOJ, 2012, EUR J PERSONALITY, V26, P414, DOI 10.1002/per.1866; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Croy I, 2013, INT J PSYCHOPHYSIOL, V88, P104, DOI 10.1016/j.ijpsycho.2013.02.005; Croy I, 2011, EMOTION, V11, P1331, DOI 10.1037/a0024437; Dalege J, 2017, SOC PSYCHOL PERS SCI, V8, P528, DOI 10.1177/1948550617709827; Dalton P, 1997, AM J IND MED, V31, P558, DOI 10.1002/(SICI)1097-0274(199705)31:5<558::AID-AJIM10>3.3.CO;2-J; Dalton P, 2000, CHEM SENSES, V25, P487, DOI 10.1093/chemse/25.4.487; de Lange MA, 2012, SOC INFLUENCE, V7, P90, DOI 10.1080/15534510.2012.659509; Delplanque S, 2008, CHEM SENSES, V33, P469, DOI 10.1093/chemse/bjn014; Distel H, 1999, CHEM SENSES, V24, P191, DOI 10.1093/chemse/24.2.191; Distel H, 2001, CHEM SENSES, V26, P247, DOI 10.1093/chemse/26.3.247; Djordjevic J, 2012, CHEMOSENS PERCEPT, V5, P11, DOI 10.1007/s12078-011-9107-3; DOTY RL, 1975, PERCEPT PSYCHOPHYS, V17, P492, DOI 10.3758/BF03203300; Douce L, 2013, ENVIRON BEHAV, V45, P215, DOI 10.1177/0013916511410421; EHRLICHMAN H, 1995, PSYCHOPHYSIOLOGY, V32, P150, DOI 10.1111/j.1469-8986.1995.tb03306.x; EHRLICHMAN H, 1988, J PERS SOC PSYCHOL, V55, P769, DOI 10.1037/0022-3514.55.5.769; Ehrlichman H, 1997, PSYCHOPHYSIOLOGY, V34, P726, DOI 10.1111/j.1469-8986.1997.tb02149.x; Ehrlichman H., 1992, SCIENCE OLFACTION, P410; Ekman P., 2003, UNMASKING FACE GUIDE; ENGEN T, 1973, J EXP PSYCHOL, V100, P221, DOI 10.1037/h0035492; Epskamp S, 2018, PSYCHOL METHODS, V23, P617, DOI 10.1037/met0000167; Epskamp S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179891; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Faelens L, 2019, COMPUT HUM BEHAV, V96, P13, DOI 10.1016/j.chb.2019.02.002; Faraji-Rad A, 2017, J CONSUM RES, V44, P1, DOI 10.1093/jcr/ucw073; Ferdenzi C, 2013, CHEM SENSES, V38, P175, DOI 10.1093/chemse/bjs083; Flohr ELR, 2017, EMOTION, V17, P369, DOI 10.1037/emo0000224; Foygel R., 2010, ARXIV10116640; Frank RA, 2003, PHYSIOL BEHAV, V78, P195, DOI 10.1016/S0031-9384(02)00965-4; Fried EI, 2018, CLIN PSYCHOL SCI, V6, P335, DOI 10.1177/2167702617745092; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fulbright RK, 1998, AM J NEURORADIOL, V19, P1721; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Grabenhorst F, 2007, J NEUROSCI, V27, P13532, DOI 10.1523/JNEUROSCI.3337-07.2007; Grosofsky A, 2011, PERCEPT MOTOR SKILL, V112, P536, DOI 10.2466/24.PMS.112.2.536-538; Haj-Ali H, 2020, SOC COGN AFFECT NEUR, V15, P1, DOI 10.1093/scan/nsaa012; Heeren A, 2018, COGNITIVE THER RES, V42, P103, DOI 10.1007/s10608-017-9876-3; HENION KE, 1971, J EXP PSYCHOL, V90, P275, DOI 10.1037/h0031549; Hermans D, 2002, OLFACTION TASTE COGN; Herz RS, 2009, INT J NEUROSCI, V119, P263, DOI 10.1080/00207450802333953; Herz RS, 2002, OLFACTION, TASTE, AND COGNITION, P160, DOI 10.1017/CBO9780511546389.016; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Hevey D, 2018, HEALTH PSYCHOL BEHAV, V6, P301, DOI 10.1080/21642850.2018.1521283; Hoenen M, 2017, PERCEPTION, V46, P366, DOI 10.1177/0301006616688707; Hsieh JW, 2017, P NATL ACAD SCI USA, V114, P11275, DOI 10.1073/pnas.1711415114; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Itkes O, 2019, COGNITION EMOTION, V33, P1356, DOI 10.1080/02699931.2018.1564249; Ito T, 1998, PERS SOC PSYCHOL B, V24, P855, DOI 10.1177/0146167298248006; Jacob TJC, 2006, PHYSIOL BEHAV, V87, P500, DOI 10.1016/j.physbeh.2005.11.018; Johnson BN, 2006, CHEM SENSES, V31, P795, DOI 10.1093/chemse/bjl021; Jones PJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01742; Kadohisa M, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00066; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Knaapila A, 2017, APPETITE, V109, P190, DOI 10.1016/j.appet.2016.11.025; Kolaczyk ED., 2014, STAT ANAL NETWORK DA; Kontaris I, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00035; Koster EP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00064; Kritsidima M, 2010, COMMUNITY DENT ORAL, V38, P83, DOI 10.1111/j.1600-0528.2009.00511.x; Kron A, 2013, PSYCHOL SCI, V24, P1503, DOI 10.1177/0956797613475456; Krusemark EA, 2013, J NEUROSCI, V33, P587, DOI [10.1523/JNEUROSCI.1379-12.2013, 10.1523/JNEUROSCI.1835-13.2013]; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; Lauritzen S.L.., 1996, GRAPHICAL MODELS; LAWLESS HT, 1975, CHEM SENS FLAV, V1, P331, DOI 10.1093/chemse/1.3.331; Lehrner J, 2000, PHYSIOL BEHAV, V71, P83, DOI 10.1016/S0031-9384(00)00308-5; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Li W, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00098; Liu H, 2009, J MACH LEARN RES, V10, P2295; Luisier A-C, 2019, AUTISM; Mandairon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004209; Manesse C, 2020, CHEM SENSES, V45, P211, DOI 10.1093/chemse/bjaa008; Mattek A, 2018, UNCOVERING REPRESENT; Mattek AM, 2017, PERSPECT PSYCHOL SCI, V12, P508, DOI 10.1177/1745691616685863; Mattsson MT, 2019, PEERJ, V6, DOI 10.7717/peerj.6119; McNally RJ, 2017, PSYCHOL MED, V47, P1204, DOI 10.1017/S0033291716003287; McNally RJ, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1341276; MILTNER W, 1994, PSYCHOPHYSIOLOGY, V31, P107, DOI 10.1111/j.1469-8986.1994.tb01030.x; Mingo SA, 2007, PERCEPTION, V36, P931, DOI 10.1068/p5624; MOSKOWITZ HR, 1974, J EXP PSYCHOL, V103, P216, DOI 10.1037/h0036793; MOSKOWITZ HR, 1976, PERCEPT PSYCHOPHYS, V19, P122, DOI 10.3758/BF03204218; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Nigri A, 2013, NEUROREPORT, V24, P171, DOI 10.1097/WNR.0b013e32835d5d2b; Novakova LM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00607; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Oleszkiewicz A, 2018, J SENS STUD, V33, DOI 10.1111/joss.12440; Oleszkiewicz A, 2017, SCI REP-UK, V7, DOI 10.1038/srep39977; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Pichon AM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01821; Pollatos O, 2007, CHEM SENSES, V32, P583, DOI 10.1093/chemse/bjm027; Retiveau AN, 2004, J SENS STUD, V19, P373, DOI 10.1111/j.1745-459x.2004.102803.x; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rouby C, 2009, FOOD QUAL PREFER, V20, P545, DOI 10.1016/j.foodqual.2009.05.004; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Rumeau C, 2016, EUR ANN OTORHINOLARY, V133, P203, DOI 10.1016/j.anorl.2015.08.004; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schreuder E, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016630591; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Schwarz N., 1990, MOTIVATION COGNITION, V2, P527, DOI [10.2307/, DOI 10.2307/2072281]; Seo HS, 2008, J FOOD SCI, V73, pS273, DOI 10.1111/j.1750-3841.2008.00818.x; Sorokowska A, 2015, J NEUROSCI METH, V243, P111, DOI 10.1016/j.jneumeth.2015.01.034; Sorokowski P, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00242; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Sulmont C, 2002, CHEM SENSES, V27, P307, DOI 10.1093/chemse/27.4.307; The International Fragrance Association (IFRA), 2019, IFRA COD PRACT 49 AM; Toet A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02396; Tonacci A, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8121481; van Borkulo C., 2017, COMP NETWORK STRUCTU, DOI [10.13140/RG.2.2.29455.38569, DOI 10.13140/RG.2.2.29455.38569]; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; Warrenburg S, 2005, CHEM SENSES, V30, pI248, DOI 10.1093/chemse/bjh208; Wilson D. A., 2006, LEARNING SMELL; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Wysocki CJ, 1997, AM IND HYG ASSOC J, V58, P704, DOI 10.1202/0002-8894(1997)058<0704:AOAITO>2.0.CO;2; Xiao W, 2019, CHEMOSENS PERCEPT, DOI [10.1007/s12078-019-09265-9y 31827664, DOI 10.1007/S12078-019-09265-9Y 31827664]; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zelano C, 2007, J NEUROPHYSIOL, V97, P1969, DOI 10.1152/jn.01122.2006; Zernecke R, 2011, RHINOLOGY, V49, P331, DOI 10.4193/Rhino10.263; Zhao P, 2006, J MACH LEARN RES, V7, P2541; Zhao T, 2012, J MACH LEARN RES, V13, P1059; ZILLMANN D, 1971, J EXP SOC PSYCHOL, V7, P419, DOI 10.1016/0022-1031(71)90075-8; 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.28105324141714	163	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236468	10.1371/journal.pone.0236468	http://dx.doi.org/10.1371/journal.pone.0236468			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730278	Green Published, gold			2022-12-26	WOS:000556884700028
J	Lo, KJ; Lee, SK; Liu, CT				Lo, Kai-Jiun; Lee, Sook-Kuan; Liu, Chi-Te			Development of a low-cost culture medium for the rapid production of plant growth-promotingRhodopseudomonas palustrisstrain PS3	PLOS ONE			English	Article							CORN STEEP LIQUOR; BIOMASS PRODUCTION; OPTIMIZATION; PURPLE; FERMENTATION; METABOLISM; COMPONENTS; FERTILIZER; INOCULANT; MOLASSES	Rhodopseudomonas palustrisPS3 is one of the purple phototrophic non-sulfur bacteria (PNSB), which have plant growth-promoting effects on various plants. To expand the scale of PS3 fermentation in a time- and cost-effective fashion, the purpose of this work was to evaluate the use of low-cost materials as culture media and to optimize the culture conditions via response surface methodology. Corn steep liquor (CSL) and molasses were identified as potential materials to replace the nitrogen and carbon sources, respectively, in the conventional growth medium. The optimum culture conditions identified through central composite design were CSL, 39.41 mL/L; molasses, 32.35 g/L; temperature, 37.9 degrees C; pH, 7.0; and DO 30%. Under the optimized conditions, the biomass yield reached 2.18 +/- 0.01 g/L at 24 hours, which was 7.8-fold higher than that under the original medium (0.28 +/- 0.01 g/L). The correlation between the predicted and experimental values of the model was over 98%, which verified the validity of the response models. Furthermore, we verified the effectiveness of theR.palustrisPS3 inoculant grown under the newly developed culture conditions for plant growth promotion. This study provides a potential strategy for improving the fermentation ofR.palustrisPS3 in low-cost media for large-scale industrial production.	[Lo, Kai-Jiun; Lee, Sook-Kuan; Liu, Chi-Te] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Liu, Chi-Te] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Liu, CT (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Liu, CT (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	chiteliu@ntu.edu.tw		Liu, Chi-Te/0000-0001-8656-5050	Ministry of Science and Technology; National Taiwan University (NTU), Taiwan; Ministry of Science and Technology, Taiwan [MOST 108-2313-B-002058-MY3, 108-2321-B-005 -018 -]; National Taiwan University under the Excellence Improvement Program for Doctoral Students	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University (NTU), Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University under the Excellence Improvement Program for Doctoral Students	This article was subsidized by Ministry of Science and Technology and National Taiwan University (NTU), Taiwan. This study was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 108-2313-B-002058-MY3 and 108-2321-B-005 -018 -).; We thank Prof. Yan-Zhang Sun (Department of Plant Pathology and Microbiology, National Taiwan University) for kindly providing the 5-L stirred tank bioreactor. This article was subsidized by National Taiwan University under the Excellence Improvement Program for Doctoral Students (sponsored by Ministry of Science and Technology).	[Anonymous], 2019, R LANG ENV STAT COMP; Austin S, 2015, ENVIRON SCI TECHNOL, V49, P8914, DOI 10.1021/acs.est.5b02062; Bagheri B, 2021, ENVIRON TECHNOL, V42, P764, DOI 10.1080/09593330.2019.1645215; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Carlozzi P, 2001, J BIOTECHNOL, V88, P239, DOI 10.1016/S0168-1656(01)00280-2; Cetinkaya Donmez Gonul, 1999, Turkish Journal of Biology, V23, P457; Cha SH, 2007, BIORESOURCE TECHNOL, V98, P165, DOI 10.1016/j.biortech.2005.11.007; Chang TH, 2020, CHEMOSPHERE, V246, DOI 10.1016/j.chemosphere.2019.125621; Chinta YD, 2014, J SCI FOOD AGR, V94, P2317, DOI 10.1002/jsfa.6561; Comelli RN, 2016, NEW BIOTECHNOL, V33, P107, DOI 10.1016/j.nbt.2015.09.001; Crater JS, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny138; Dhaliwal SS, 2011, BIORESOURCE TECHNOL, V102, P5968, DOI 10.1016/j.biortech.2011.02.015; Du CH, 2003, FEMS MICROBIOL LETT, V225, P69, DOI 10.1016/S0378-1097(03)00482-8; Gobbetti M, 1996, Z LEBENSM UNTERS FOR, V203, P82, DOI 10.1007/BF01267775; Govindaraju A, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00048-19; Hermsen R, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145537; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Hsu ShuHua, 2015, Crop, Environment & Bioinformatics, V12, P30; Hull SR, 1996, J AGR FOOD CHEM, V44, P1857, DOI 10.1021/jf950353v; Idi A, 2015, REV ENVIRON SCI BIO, V14, P271, DOI 10.1007/s11157-014-9355-1; Imhoff J. F., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol. III., P2141; Kleijn RJ, 2010, J BIOL CHEM, V285, P1587, DOI 10.1074/jbc.M109.061747; Kornochalert N, 2014, ANN MICROBIOL, V64, P1021, DOI 10.1007/s13213-013-0739-1; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lee SK, 2016, APPL MICROBIOL BIOT, V100, P7977, DOI 10.1007/s00253-016-7582-9; Lenth RV, 2009, J STAT SOFTW, V32, P1; Li KX, 2014, INT J ENERG RES, V38, P965, DOI 10.1002/er.3164; LIGGETT RW, 1948, BACTERIOL REV, V12, P297, DOI 10.1128/MMBR.12.4.297-311.1948; Liu BB, 2010, BIOCHEM ENG J, V52, P212, DOI 10.1016/j.bej.2010.08.013; Liu SJ, 2017, BIOPROCESS ENGINEERING: KINETICS, SUSTAINABILITY, AND REACTOR DESIGN, 2ND EDITION, P21, DOI 10.1016/B978-0-444-63783-3.00002-2; Liu Y, 2015, BIORESOURCE TECHNOL, V176, P189, DOI 10.1016/j.biortech.2014.11.047; Lo KJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31128-8; Navarrete-Bolanos JL, 2012, ENG LIFE SCI, V12, P410, DOI 10.1002/elsc.201100128; McKinlay JB, 2011, MBIO, V2, DOI 10.1128/mBio.00323-10; Merugu R, 2011, ISRN RENEWABLE ENERG, V2011, DOI [10.5402/2011/328984, DOI 10.5402/2011/328984, 10.502/2011/328984]; Mirmiran P, 2020, NUTR METAB, V17, DOI 10.1186/s12986-019-0421-0; Moraes IO, 1991, MULTIPLICACAO AGENTE, P253; Najafpour GD, 2003, BIORESOURCE TECHNOL, V86, P91, DOI 10.1016/S0960-8524(02)00103-7; Nelson EK, 1929, J AM CHEM SOC, V51, P2808, DOI 10.1021/ja01384a030; Nunkaew T, 2014, ELECTRON J BIOTECHN, V17, DOI 10.1016/j.ejbt.2013.12.004; Oda Y, 2003, APPL ENVIRON MICROB, V69, P5186, DOI 10.1128/AEM.69.9.5186-5191.2003; Pyakurel A, 2019, INT J APPL SCI BIOTE, V7, P49, DOI [10.3126/ijasbt.v7i1.23301, DOI 10.3126/IJASBT.V7I1.23301]; Ruiz B, 2010, CRIT REV MICROBIOL, V36, P146, DOI 10.3109/10408410903489576; Samavat S., 2014, International Research Journal of Applied and Basic Sciences, V8, P266; Sanl A, 2015, TARLA BITKILERI MERK, V24, P103; Shamala TR, 2012, BRAZ J MICROBIOL, V43, P1094, DOI 10.1590/S1517-838220120003000036; Shen NK, 2016, SUGAR TECH, V18, P292, DOI 10.1007/s12355-015-0401-2; Shi XY, 2014, INT J HYDROGEN ENERG, V39, P4244, DOI 10.1016/j.ijhydene.2014.01.016; Shinohara M, 2011, SOIL SCI PLANT NUTR, V57, P190, DOI 10.1080/00380768.2011.554223; Silveira MM, 2001, APPL MICROBIOL BIOT, V55, P442, DOI 10.1007/s002530000569; Singh V, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02087; Thomsen MH, 2005, APPL MICROBIOL BIOT, V68, P598, DOI 10.1007/s00253-005-0056-0; van Niel CB, 1944, BACTERIOL REV, V8, P1; Waites M.J., 2001, IND MICROBIOLOGY INT; Wong WT, 2014, MICROBES ENVIRON, V29, P303, DOI 10.1264/jsme2.ME14056; Xiao X, 2012, J AGR FOOD CHEM, V60, P7830, DOI 10.1021/jf3012823; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Xu J, 2013, LETT APPL MICROBIOL, V57, P420, DOI 10.1111/lam.12129; Yang TW, 2013, PROCESS BIOCHEM, V48, P1610, DOI 10.1016/j.procbio.2013.07.027; Yang XM, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P669; Yolmeh M, 2017, FOOD BIOPROCESS TECH, V10, P413, DOI 10.1007/s11947-016-1855-2; Zhang BoWen, 2017, Acta Universitatis Cibiniensis - Series E: Food Technology, V21, P3; Zhang D, 2015, CHEM ENG SCI, V130, P68, DOI 10.1016/j.ces.2015.02.045; Zhu MM, 2019, PLANT GROWTH REGUL, V87, P29, DOI 10.1007/s10725-018-0449-6	64	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236739	10.1371/journal.pone.0236739	http://dx.doi.org/10.1371/journal.pone.0236739			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730333	Green Published, gold			2022-12-26	WOS:000556884700004
J	Merg, ML; Dezerald, O; Kreutzenberger, K; Demski, S; Reyjol, Y; Usseglio-Polatera, P; Belliard, J				Merg, Marie-Line; Dezerald, Olivier; Kreutzenberger, Karl; Demski, Samuel; Reyjol, Yorick; Usseglio-Polatera, Philippe; Belliard, Jerome			Modeling diadromous fish loss from historical data: Identification of anthropogenic drivers and testing of mitigation scenarios	PLOS ONE			English	Article							SALMON SALMO-SALAR; FRESH-WATER FISH; ATLANTIC SALMON; UPSTREAM MIGRATION; ANADROMOUS FISH; RIVER; IMPACTS; HABITAT; DAMS; CONSERVATION	Diadromous fishes have drastically declined over the last century, especially in Europe. Several authors have highlighted the role of large dams in this decline, but in fact, its causes are potentially multiple and cumulative, including degradation of local environmental conditions and widespread fragmentation of hydrographic networks associated with the pervasive establishment of smaller barriers. Consequently, there is a need to improve the identification and prioritization of the drivers of diadromous species loss in order to identify and apply the most appropriate conservation and restoration measures. In this study, we used both historical sources (from mid-18(th)to early 20(th)century) and current data to quantify the long-term loss of diadromous taxa over 555 sites throughout the French river network. Then, we modeled the effects of several anthropogenic pressures (e.g. barriers, water quality, hydrological and river morphological alterations) on diadromous taxon loss. Lastly, we assessed the potential consequences of four different scenarios of anthropogenic pressure reduction. Due to uncertainties in historical sources, some species were grouped into taxa leading to a potential underestimation of actual species extinctions. Despite this limitation, our results showed that the decline in diadromous assemblages is widespread but with contrasting magnitudes depending on site locations. The maximum height and density of barriers appeared as the major factors of taxon loss. Over the scenarios tested, we observed that exclusively improving local conditions have much more limited effects than restoring river continuity. Focusing actions on large dam removal did not show the strongest responses compared to removing medium and small-sized barriers. For effective and sustainable restoration of diadromous fish assemblage, (1) historical occurrences of diadromous fishes should be used as an indicator for assessing recovery, and (2) undertaken measures must be adapted to each basin to target and limit the number of barriers to remove while allowing diadromous fish recovery.	[Merg, Marie-Line; Belliard, Jerome] Univ Paris Saclay, INRAE, UR HYCAR, Antony, France; [Dezerald, Olivier] ESE, Ecol & Ecosyst Hlth, INRAE, Agrocampus Ouest, Rennes, France; [Kreutzenberger, Karl; Demski, Samuel] Off Francais Biodivers, Direct Rech Expertise & Donnees, Vincennes, France; [Reyjol, Yorick] UMS Patrinat OFB CNRS MNHN, Museum Natl Hist Nat CP41, Paris, France; [Usseglio-Polatera, Philippe] LIEC, CNRS, UMR 7360, Campus Bridoux, Metz, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut Agro; Agrocampus Ouest; Office Francais de la Biodiversite OFB; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine	Merg, ML (corresponding author), Univ Paris Saclay, INRAE, UR HYCAR, Antony, France.	marie-line.merg@inrae.fr		Kreutzenberger, Karl/0000-0001-9266-1663	OFB [21]; French Office of Biodiversity (OFB)	OFB; French Office of Biodiversity (OFB)	To carry out this study, MLM and JB received funding from the OFB under the 2016/2018 Programme - Theme Etat, fonctionnement et services des ecosystemes aquatiques - Action No. 21. The funder also played a role in the data collection.; This work was supported by the French Office of Biodiversity (OFB). It was based on a long-term effort to collect historical data regarding diadromous fishes initiated as part of the European EFI+ project. We are particularly indebted to Sarah Beslagic, Marie Bunel, Vanessa Demougin, Guillaume Gorges, Alexis Guilpart and Amandine Zahm for their contribution to the collection and compilation of historical data. We are grateful to the regional directions and departmental services of the OFB who have provided data on the current distribution of species. A special thanks to Cedric Mondy, Pierre Steinbach, Maxime Logez, Laurent Beaulaton and Alienor Jeliazkov whose fruitful discussions were particularly useful in advancing this work.	Aarestrup K, 2003, ECOL FRESHW FISH, V12, P169, DOI 10.1034/j.1600-0633.2003.00027.x; Agence de l'Eau Seine Normandie, 1976, BES UT EAU POLL FASC, V2, P140; Agostinho AA, 2005, CONSERV BIOL, V19, P646, DOI 10.1111/j.1523-1739.2005.00701.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alin A, 2010, WIRES COMPUT STAT, V2, P370, DOI 10.1002/wics.84; ANGERMEIER PL, 1995, CONSERV BIOL, V9, P143, DOI 10.1046/j.1523-1739.1995.09010143.x; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Antonio RR, 2007, NEOTROP ICHTHYOL, V5, P177, DOI 10.1590/S1679-62252007000200012; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bachelier R., 1964, Bulletin Francais de Pisciculture, V36, P49; Bachelier R., 1964, B FRANCAIS PISCICULT, V212, P86; Baisez A, 2005, B FR PECHE PISCIC, P115, DOI 10.1051/kmae:2005007; BANKS JW, 1969, J FISH BIOL, V1, P85, DOI 10.1111/j.1095-8649.1969.tb03847.x; Barton, 2019, PACKAGE MUMIN VERSIO; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; Beguer M, 2007, ECOL FRESHW FISH, V16, P221, DOI 10.1111/j.1600-0633.2006.00214.x; Belliard J, 2009, PEUPLEMENT POISSONS; Berthier C, 2016, METHODE CALCUL TAUX; Boet P, 1999, HYDROBIOLOGIA, V410, P59, DOI 10.1023/A:1003747528595; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bordes J-L, 2010, POUR MEMOIRE, V9, P70; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chalant A., 2016, VULNERABILITY DIVERS; Chanseau M, 1999, B FR PECHE PISCIC, P99, DOI 10.1051/kmae:1999008; Commission internationale de la Meuse, 2011, POISS MIGR MEUS; Costa-Dias S, 2009, DECLINE DIADROMOUS F, P67; de Groot SJ, 2002, HYDROBIOLOGIA, V478, P205, DOI 10.1023/A:1021038916271; EFI+ Consortium, 2009, MAN APPL NEW EUR FIS; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Fenkes M, 2016, COMP BIOCHEM PHYS A, V193, P11, DOI 10.1016/j.cbpa.2015.11.012; Feunteun E, 2002, ECOL ENG, V18, P575, DOI 10.1016/S0925-8574(02)00021-6; Fielding AH, 1995, CONSERV BIOL, V9, P1466, DOI 10.1046/j.1523-1739.1995.09061466.x; Fortin MJ, 2012, SPAT STAT-NETH, V1, P100, DOI 10.1016/j.spasta.2012.02.004; Fox J, 2006, SOCIOL METHODOL, V36, P225, DOI 10.1111/j.1467-9531.2006.00180.x; Froese R, 1999, ICLARM C P; Fukushima M, 2007, FRESHWATER BIOL, V52, P1511, DOI 10.1111/j.1365-2427.2007.01783.x; Fuller MR, 2015, ANN NY ACAD SCI, V1355, P31, DOI 10.1111/nyas.12853; Gerlier M, 1998, HYDROBIOLOGIA, V372, P283, DOI 10.1023/A:1017061608281; Gowans ARD, 2003, ECOL FRESHW FISH, V12, P177, DOI 10.1034/j.1600-0633.2003.00018.x; Haidvogl G, 2018, AQUAT ECOL SER, V8, P19, DOI 10.1007/978-3-319-73250-3_2; Hall CJ, 2011, LANDSCAPE ECOL, V26, P95, DOI 10.1007/s10980-010-9539-1; Hensen M., 2019, INLAND NAVIGATION; Hoffmann RC, 1996, AM HIST REV, V101, P631, DOI 10.2307/2169418; Humphries P, 2009, BIOSCIENCE, V59, P673, DOI 10.1525/bio.2009.59.8.9; International Commission for the Protection of the Rhine, 2015, CART K 7 LARG TRANSV; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Jonsson B, 1999, ICES J MAR SCI, V56, P405, DOI 10.1006/jmsc.1999.0483; Joy MK, 2001, FRESHWATER BIOL, V46, P417, DOI 10.1046/j.1365-2427.2001.00681.x; Larinier M, 2002, B FR PECHE PISCIC, P39, DOI 10.1051/kmae/2002106; Larinier M, 1998, FISH MIGRATION AND FISH BYPASSES, P127; Larinier M., 2001, DAMS FISH MIGRATION; Larinier M., 2004, P 2 INT S MANAGEMENT, P183; Larinier M., 2001, ENV ISSUES DAMS FISH, V419, P45; Lassalle G, 2009, GLOBAL CHANGE BIOL, V15, P1072, DOI 10.1111/j.1365-2486.2008.01794.x; Lassalle G, 2009, FRESHWATER BIOL, V54, P587, DOI 10.1111/j.1365-2427.2008.02135.x; Lenders HJR, 2016, SCI REP-UK, V6, DOI 10.1038/srep29269; Lenhardt M, 2006, BIODIVERS CONSERV, V15, P1967, DOI 10.1007/s10531-005-4317-0; Limburg KE, 2009, BIOSCIENCE, V59, P955, DOI 10.1525/bio.2009.59.11.7; Lundqvist H, 2008, HYDROBIOLOGIA, V602, P111, DOI 10.1007/s10750-008-9282-7; Marzin A, 2013, HYDROBIOLOGIA, V704, P375, DOI 10.1007/s10750-012-1254-2; Marzin A, 2012, ECOL INDIC, V23, P56, DOI 10.1016/j.ecolind.2012.03.010; MCDOWALL RM, 1992, AQUAT CONSERV, V2, P351, DOI 10.1002/aqc.3270020405; MEDD Agences de l'eau, 2003, AG EAU SYST EV QUAL; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Miguet P., 2017, VERS INDICATEURS CON; Mollenhauer R, 2018, CAN J FISH AQUAT SCI, V75, P1614, DOI 10.1139/cjfas-2016-0422; Muller T, 2009, ETAT LIEUX CONTINUIT; O'Hanley JR, 2005, ENVIRON MODEL ASSESS, V10, P85, DOI 10.1007/s10666-004-4268-y; Oberdorff T, 2001, FRESHWATER BIOL, V46, P399, DOI 10.1046/j.1365-2427.2001.00669.x; Ovidio M, 2002, HYDROBIOLOGIA, V483, P55, DOI 10.1023/A:1021398605520; RAYMOND HL, 1979, T AM FISH SOC, V108, P505, DOI 10.1577/1548-8659(1979)108<505:EODAIO>2.0.CO;2; Rivinoja P, 2001, REGUL RIVER, V17, P101, DOI 10.1002/rrr.607; ROCHARD E, 1990, J FISH BIOL, V37, P123, DOI 10.1111/j.1095-8649.1990.tb05028.x; Rochard E, 2007, CEMAGREF EPBX RENNES; Rochard E, 2009, IDENTIFICATION DIADR, P69; Rougier T, 2012, ICES J MAR SCI, V69, P1802, DOI 10.1093/icesjms/fss149; Rouillard J, 2011, EAU CAMPAGNES BASSIN; Royet P, 2013, PARC BARRAGES FRANCA; Schmutz S., 2018, RIVERINE ECOSYSTEM M; Scruton DA, 2007, HYDROBIOLOGIA, V582, P67, DOI 10.1007/s10750-006-0558-5; Segurado P, 2015, AQUAT SCI, V77, P427, DOI 10.1007/s00027-014-0371-6; Sheppard J.J., 2014, TR56 MASS DIV MAR FI; Silva AT, 2018, FISH FISH, V19, P340, DOI 10.1111/faf.12258; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Taverny C, 2000, HYDRO AQUA, P227; TENENHAUS M, 1985, PSYCHOMETRIKA, V50, P91, DOI 10.1007/BF02294151; Thorstad E.B., 2005, P111; Thorstad EB, 2003, FISHERIES MANAG ECOL, V10, P139, DOI 10.1046/j.1365-2400.2003.00335.x; Thorstad EB, 2008, REV FISH BIOL FISHER, V18, P345, DOI 10.1007/s11160-007-9076-4; UICN MNHN AFB, 2019, LIST ROUG ESP MEN FR; van Puijenbroek PJTM, 2019, RIVER RES APPL, V35, P68, DOI 10.1002/rra.3386; VANDAMME PA, 1994, BELG J ZOOL, V124, P93; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; Wasson J. G., 2002, HYDROECOREGIONS FRAN; Welcomme R.L, 1985, 262 FAO; Williams RN, 1999, FISHERIES, V24, P10, DOI 10.1577/1548-8446(1999)024<0010:RTTRSI>2.0.CO;2; Williot P, 2002, INT REV HYDROBIOL, V87, P483, DOI 10.1002/1522-2632(200211)87:5/6<483::AID-IROH483>3.0.CO;2-K; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; Zhong Y., 1996, IMPACT ASSESS, V14, P285, DOI [10.1080/07349165.1996.9725905, DOI 10.1080/07349165.1996.9725905]	100	12	12	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236575	10.1371/journal.pone.0236575	http://dx.doi.org/10.1371/journal.pone.0236575			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722713	gold, Green Published			2022-12-26	WOS:000556916000013
J	Kassa, G; Dougherty, G; Madevu-Matson, C; Egesimba, G; Sartie, K; Akinjeji, A; Tamba, F; Gleason, B; Toure, M; Rabkin, M				Kassa, Getachew; Dougherty, Gillian; Madevu-Matson, Caitlin; Egesimba, Ginika; Sartie, Kenneh; Akinjeji, Adewale; Tamba, Francis; Gleason, Brigette; Toure, Mame; Rabkin, Miriam			Improving inpatient provider-initiated HIV testing and counseling in Sierra Leone	PLOS ONE			English	Article							IMPROVEMENT; PREVENTION; ACCEPTABILITY	Background/setting Only 47% of HIV-positive Sierra Leoneans knew their status in 2017, making expanded HIV testing a priority. National guidelines endorse provider-initiated HIV testing and counselling (PITC) to increase testing coverage, but PITC is rarely provided in Sierra Leone. In response, a Quality Improvement Collaborative (QIC) was implemented to improve PITC coverage amongst adult inpatients. Methods Ten hospitals received the intervention between October 2017 and August 2018; there were no control facilites. Each hospital aimed to improve PITC coverage to >= 95% of eligible patients. Staff received training on PITC and QIC methods and a package of PITC best practices and tools. They then worked to identify additional contextually-appropriate interventions, conducted rapid tests of change, and tracked performance using shared indicators and time-series data. Supportive supervision bolstered QI skills, and quarterly meetings enabled diffusion of innovations while spurring friendly competition. Results Baseline PITC coverage was 4%. The hospital teams tested diverse interventions using QI methods, including staff training; data review meetings; enhanced workflow processes and supervision; and patient education and sensitization activities Nine hospitals reached and sustained the 95% target, and all saw rapid and durable improvement, which was sustained for a median of six months. Of the 5,238 patients tested for HIV, 311 (6%) were found to be HIV-positive and were referred for treatment. HIV rapid test kit stockouts occurred during the project period, limiting PITC services in some cases. Conclusions The intervention led to swift and sustained improvement in inpatient PITC coverage and to the diagnosis of hundreds of people living with HIV. Sierra Leone's Ministry of Health and Sanitation plans to take the initiative to national scale, with close attention to the issue of test kit stockouts.	[Kassa, Getachew; Dougherty, Gillian; Madevu-Matson, Caitlin; Rabkin, Miriam] Columbia Univ, ICAP, New York, NY 10027 USA; [Egesimba, Ginika; Akinjeji, Adewale; Toure, Mame] Columbia Univ, ICAP, Freetown, Sierra Leone; [Sartie, Kenneh; Tamba, Francis] Sierra Leone Minist Hlth & Sanitat, Freetown, Sierra Leone; [Gleason, Brigette] US Ctr Dis Control & Prevent CDC, Freetown, Sierra Leone; [Rabkin, Miriam] Columbia Univ, Dept Med & Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Ministry of Health & Sanitation Sierra Leone; Columbia University	Kassa, G (corresponding author), Columbia Univ, ICAP, New York, NY 10027 USA.	gk2353@cumc.columbia.edu		Rabkin, Miriam/0000-0002-2342-4362	U.S. President's Emergency Plan for AIDS Relief (PEPFAR), through CDC [U2GGH000994]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR), through CDC(United States Agency for International Development (USAID))	ICAP at Columbia University received the award: This project was supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), through CDC cooperative agreement number U2GGH000994. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. URL: https://www.cdc.gov/	Ahmed S, 2016, TROP MED INT HEALTH, V21, P479, DOI 10.1111/tmi.12671; Catsambas TT, 2008, COLLABORATIVE EVALUA; Cham HJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215654; Cohen J, 2016, SCIENCE, V354, P1213, DOI 10.1126/science.354.6317.1213; Cohn J, 2016, LANCET HIV, V3, pE473, DOI 10.1016/S2352-3018(16)30050-9; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; Dougherty G, 2019, J ASSOC NURSE AIDS C, V30, P682, DOI 10.1097/JNC.0000000000000066; Franco LM, 2011, BMJ QUAL SAF, V20, P658, DOI 10.1136/bmjqs.2010.044388; Gaolathe T, 2016, LANCET HIV, V3, pE221, DOI 10.1016/S2352-3018(16)00037-0; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Hamilton D, 2018, BMJ OPEN QUAL, V8, DOI [10.1136/6963-15-S1-S4, DOI 10.1136/6963-15-S1-S4]; Heiby J, 2014, INT J QUAL HEALTH C, V26, P117, DOI 10.1093/intqhc/mzt093; Higgins-Steele A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/1472-6963-15-S1-S4; Huerga H, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5208-0; Institute for Healthcare Improvement, 2003, BREAKTHR SER IHIS CO; Justman JE, 2018, NEW ENGL J MED, V378, P1859, DOI 10.1056/NEJMp1801934; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Kiene SM, 2015, J HEALTH PSYCHOL, V20, P173, DOI 10.1177/1359105313500685; Langley G.J., 1996, IMPROVEMENT GUIDE PR; Nsirim R, 2018, INT J STD AIDS, V29, P1362, DOI 10.1177/0956462418783533; Rabkin M, 2020, J ASSOC NURSE AIDS C, V31, P566, DOI 10.1097/JNC.0000000000000158; Rondinelli I, 2020, INT J QUAL HEALTH C, V32, P85, DOI 10.1093/intqhc/mzz137; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Tabb Zachary, 2017, R I Med J (2013), V100, P19; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; UNAIDS, 2018, GLOB AIDS UPD MIL GO; UNAIDS, 2014, 90 90 90 AMB TREATM; World Health Organization/United Nations Program on HIV/AIDS, 2007, GUID INT HIV TEST CO	29	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236358	10.1371/journal.pone.0236358	http://dx.doi.org/10.1371/journal.pone.0236358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OD5ZL	32706810	gold, Green Published			2022-12-26	WOS:000579931700029
J	Katz, TK; Regev, T; Lavie, S; Porat, H; Avraham, R				Katz, Tamar Kricheli; Regev, Tali; Lavie, Shay; Porat, Haggai; Avraham, Ronen			Those who tan and those who don't: A natural experiment on colorism	PLOS ONE			English	Article							LABOR-MARKET; SKIN-TONE; DISCRIMINATION; PERCEPTIONS; PREJUDICE; SELECTION	Are darker-skinned workers discriminated against in the labor market? Studies using survey data have shown that darker skin tone is associated with increased labor market disadvantages. However, it is hard to refute the possibility that other factors correlated with skin tones might affect employment outcomes. To overcome this inherent limitation, we use a natural experiment: we utilize changes in one's own skin tone, generated by exposure to the sun, to explore the effect of skin tone on the tendency to be employed. We find that those people whose skin tone becomes darker by exposure to the sun (but not others) are less likely to be employed when the UV radiation in the previous three weeks in the area in which they reside is greater. These within-person findings hold even when controlling for the week, the year, the region, demographic characteristics and the occupation and industry one is employed in.	[Katz, Tamar Kricheli; Lavie, Shay; Avraham, Ronen] Tel Aviv Univ, Buchmann Fac Law, Tel Aviv, Israel; [Regev, Tali] Interdisciplinary Ctr Herzelyia, Tel Aviv, Israel; [Porat, Haggai] Harvard Univ, Cambridge, MA 02138 USA	Tel Aviv University; Harvard University	Katz, TK (corresponding author), Tel Aviv Univ, Buchmann Fac Law, Tel Aviv, Israel.	tamarkk@taux.tau.ac.il						Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; CHARDON A, 1991, INT J COSMETIC SCI, V13, P191, DOI 10.1111/j.1467-2494.1991.tb00561.x; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; Eckstein Z, 1999, REV ECON STAT, V81, P384, DOI 10.1162/003465399558319; Fitzpatrick T. B., 1975, J MED ESTHETIQUE, V2, P33, DOI DOI 10.1159/000251345; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Goldsmith AH, 2006, AM ECON REV, V96, P242, DOI 10.1257/000282806777212152; Harrison MS, 2009, J APPL SOC PSYCHOL, V39, P134, DOI 10.1111/j.1559-1816.2008.00433.x; Hersch J, 2006, AM ECON REV, V96, P251, DOI 10.1257/000282806777212071; Holman DM, 2015, J AM ACAD DERMATOL, V73, P83, DOI 10.1016/j.jaad.2015.02.1112; Holzer Harry, 1999, WHAT EMPLOYERS WANT; HUGHES M, 1990, SOC FORCES, V68, P1105, DOI 10.2307/2579136; KEITH VM, 1991, AM J SOCIOL, V97, P760, DOI 10.1086/229819; KIRSCHENMAN J, 1991, URBAN UNDERCLASS, P203; Kreisman D, 2015, REV ECON STAT, V97, P1, DOI 10.1162/REST_a_00464; Lang K, 2011, AM ECON REV, V101, P1467, DOI 10.1257/aer.101.4.1467; Mandel H, 2016, AM SOCIOL REV, V81, P1039, DOI 10.1177/0003122416662958; MILL R., 2016, RACE SKIN COLOR EC O; MONK EP, 2015, AM J SOCIOLOGY, V0121, P00001; Moss P., 2001, STORIES EMPLOYERS TE; Navarrete CD, 2010, J PERS SOC PSYCHOL, V98, P933, DOI 10.1037/a0017931; Neal DA, 1996, J POLIT ECON, V104, P869, DOI 10.1086/262045; Pager D, 2003, AM J SOCIOL, V108, P937, DOI 10.1086/374403; Pager D, 2009, AM SOCIOL REV, V74, P777, DOI 10.1177/000312240907400505; Ritter JA, 2011, REV ECON STAT, V93, P30, DOI 10.1162/REST_a_00063; Shi JY, 2015, ECON INQ, V53, P388, DOI 10.1111/ecin.12109; Waldinger R, 2003, OTHER HALF WORKS IMM	28	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0235438	10.1371/journal.pone.0235438	http://dx.doi.org/10.1371/journal.pone.0235438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OD5ZL	32706822	Green Published, gold			2022-12-26	WOS:000579931700008
J	Virani, NA; Kelada, OJ; Kunjachan, S; Detappe, A; Kwon, JH; Hayashi, J; Vazquez-Pagan, A; Biancur, DE; Ireland, T; Kumar, R; Sridhar, S; Makrigiorgos, GM; Berbeco, RI				Virani, Needa A.; Kelada, Olivia J.; Kunjachan, Sijumon; Detappe, Alexandre; Kwon, Jihun; Hayashi, Jennifer; Vazquez-Pagan, Ana; Biancur, Douglas E.; Ireland, Thomas; Kumar, Rajiv; Sridhar, Srinivas; Makrigiorgos, G. Mike; Berbeco, Ross, I			Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption	PLOS ONE			English	Article							GOLD NANOPARTICLES; RADIATION RESPONSE; LUNG-CANCER; RADIOTHERAPY; ENHANCEMENT; THERAPY; AGENTS; PROGRESSION; BEVACIZUMAB; TOMOGRAPHY	We have previously demonstrated that endothelial targeting of gold nanoparticles followed by external beam irradiation can cause specific tumor vascular disruption in mouse models of cancer. The induced vascular damage may lead to changes in tumor physiology, including tumor hypoxia, thereby compromising future therapeutic interventions. In this study, we investigate the dynamic changes in tumor hypoxia mediated by targeted gold nanoparticles and clinical radiation therapy (RT). By using noninvasive whole-body fluorescence imaging, tumor hypoxia was measured at baseline, on day 2 and day 13, post-tumor vascular disruption. A 2.5-fold increase (P<0.05) in tumor hypoxia was measured two days after combined therapy, resolving by day 13. In addition, the combination of vascular-targeted gold nanoparticles and radiation therapy resulted in a significant (P<0.05) suppression of tumor growth. This is the first study to demonstrate the tumor hypoxic physiological response and recovery after delivery of vascular-targeted gold nanoparticles followed by clinical radiation therapy in a human non-small cell lung cancer athymic Foxn1(nu) mouse model.	[Virani, Needa A.; Kelada, Olivia J.; Kunjachan, Sijumon; Detappe, Alexandre; Kwon, Jihun; Hayashi, Jennifer; Vazquez-Pagan, Ana; Kumar, Rajiv; Sridhar, Srinivas; Makrigiorgos, G. Mike; Berbeco, Ross, I] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA; [Virani, Needa A.; Kelada, Olivia J.; Kunjachan, Sijumon; Detappe, Alexandre; Kwon, Jihun; Hayashi, Jennifer; Vazquez-Pagan, Ana; Biancur, Douglas E.; Kumar, Rajiv; Sridhar, Srinivas; Makrigiorgos, G. Mike; Berbeco, Ross, I] Harvard Med Sch, Boston, MA 02115 USA; [Detappe, Alexandre; Biancur, Douglas E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kwon, Jihun] Hokkaido Univ, Dept Radiat Oncol, Sapporo, Hokkaido, Japan; [Hayashi, Jennifer; Vazquez-Pagan, Ana; Kumar, Rajiv; Sridhar, Srinivas] Northeastern Univ, Nanomed Innovat Ctr, Boston, MA 02115 USA; [Hayashi, Jennifer; Vazquez-Pagan, Ana; Kumar, Rajiv; Sridhar, Srinivas] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Ireland, Thomas] Boston Univ, LA ICP MS & ICP ES Labs, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Hokkaido University; Northeastern University; Northeastern University; Boston University	Virani, NA (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA.; Virani, NA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	navirani@bwh.harvard.edu	Detappe, Alexandre/HGC-4905-2022; Kwon, Jihun/Q-6259-2017; Makrigiorgos, Mike/AFC-4575-2022	Kwon, Jihun/0000-0003-1810-0205; Brown (Virani), Needa/0000-0003-3355-1354; Kelada, Olivia/0000-0003-1007-2801; Detappe, Alexandre/0000-0001-9364-1621; Vazquez-Pagan, Ana/0000-0001-9984-7129	National Cancer Institute (NCI) [R21CA188833]; Research Fellowship of the Japanese Society for the Promotion of Science (JSPS); JSPS Overseas Challenge Program for Young Researchers; JSPS KAKENHI [JP17J03616]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research Fellowship of the Japanese Society for the Promotion of Science (JSPS); JSPS Overseas Challenge Program for Young Researchers; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was supported, in part, by award number R21CA188833 from the National Cancer Institute (NCI). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or NIH. J.K. would like to acknowledge support from a Research Fellowship of the Japanese Society for the Promotion of Science (JSPS), and the JSPS Overseas Challenge Program for Young Researchers. This work was supported by JSPS KAKENHI Grant Number JP17J03616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JPM, 2011, NANOMEDICINE-UK, V6, P815, DOI [10.2217/nnm.11.79, 10.2217/NNM.11.79]; Berbeco RI, 2016, MED PHYS, V43, P436, DOI 10.1118/1.4938410; Berbeco RI, 2012, RADIAT RES, V178, P604, DOI 10.1667/RR3001.1; Berbeco RI, 2011, INT J RADIAT ONCOL, V81, P270, DOI 10.1016/j.ijrobp.2010.10.022; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; BREM S, 1976, CANCER RES, V36, P2807; Brown SL, 2015, RADIAT RES, V183, P713, DOI 10.1667/RR13458.1; Bussink J, 2000, RADIAT RES, V153, P398, DOI 10.1667/0033-7587(2000)153[0398:CIBPAH]2.0.CO;2; Cao C, 2012, ACTA ONCOL, V51, P151, DOI 10.3109/0284186X.2011.631579; Castle KD, 2019, CANCER RES, V79, P5685, DOI 10.1158/0008-5472.CAN-19-1323; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Danhier F, 2009, J CONTROL RELEASE, V140, P166, DOI 10.1016/j.jconrel.2009.08.011; Detappe A, 2017, NANO LETT, V17, P1733, DOI 10.1021/acs.nanolett.6b05055; Detappe A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34040; Detappe A, 2016, J CONTROL RELEASE, V238, P103, DOI 10.1016/j.jconrel.2016.07.021; Detappe A, 2013, MED PHYS, V40, DOI 10.1118/1.4791671; Diagaradjane P, 2008, NANO LETT, V8, P1492, DOI 10.1021/nl080496z; FOLKMAN J, 1986, CANCER RES, V46, P467; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Hahnfeldt P, 1999, CANCER RES, V59, P4770; Hainfeld JF, 2008, J PHARM PHARMACOL, V60, P977, DOI 10.1211/jpp.60.8.0005; Hallac RR, 2014, MAGN RESON MED, V71, P1863, DOI 10.1002/mrm.24846; Hinnen P, 2007, BRIT J CANCER, V96, P1159, DOI 10.1038/sj.bjc.6603694; Hockel M, 1996, SEMIN RADIAT ONCOL, V6, P3, DOI 10.1016/S1053-4296(96)80031-2; Hockel M, 1996, CANCER RES, V56, P4509; Hofer S, 2011, ACTA ONCOL, V50, P630, DOI 10.3109/0284186X.2011.572913; Horsman MR, 2016, J RADIAT RES, V57, pI90, DOI 10.1093/jrr/rrw007; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Ilie M, 2010, BRIT J CANCER, V102, P1627, DOI 10.1038/sj.bjc.6605690; Jelveh Salomeh, 2011, Cancers (Basel), V3, P1081, DOI 10.3390/cancers3011081; Kelada OJ, 2017, MOL IMAGING BIOL, V19, P893, DOI 10.1007/s11307-017-1083-9; Kelada OJ, 2014, RADIAT RES, V181, P335, DOI 10.1667/RR13590.1; Kolosnjaj-Tabi J, 2015, ACS NANO, V9, P7925, DOI 10.1021/acsnano.5b00042; Kumar R, 2013, TRANSL CANCER RES, V2, P228, DOI 10.3978/j.issn.2218-676X.2013.07.02; KUNJACHAN S, 2019, SCI REPORTS, V9, DOI DOI 10.1038/S41598-018-37186-2; Kunjachan S, 2015, NANO LETT, V15, P7488, DOI 10.1021/acs.nanolett.5b03073; Kwon J, 2020, ULTRASOUND MED BIOL, V46, P369, DOI 10.1016/j.ultrasmedbio.2019.09.019; Lindblom EK, 2019, MED PHYS, V46, P2512, DOI 10.1002/mp.13514; Ljungkvist ASE, 2007, RADIAT RES, V167, P127, DOI 10.1667/RR0719.1; Mauceri HJ, 1996, CANCER RES, V56, P4311; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Patterson DA, 2007, CLIN ONCOL-UK, V19, P443, DOI 10.1016/j.clon.2007.03.014; Rahman WN, 2009, NANOMED-NANOTECHNOL, V5, P136, DOI 10.1016/j.nano.2009.01.014; Rich LJ, 2018, THERANOSTICS, V8, P2064, DOI 10.7150/thno.21708; Rockwell S, 2009, CURR MOL MED, V9, P442, DOI 10.2174/156652409788167087; Siemann DW, 2017, CANCER INVEST, V35, P519, DOI 10.1080/07357907.2017.1364745; Siemann DW, 2009, CELL TISSUE RES, V335, P241, DOI 10.1007/s00441-008-0646-0; Siemann DW, 2000, RADIOTHER ONCOL, V57, P5, DOI 10.1016/S0167-8140(00)00243-7; Siemann DW, 2005, CLIN CANCER RES, V11, P416; Siemann DW, 2005, INT J RADIAT ONCOL, V62, P846, DOI 10.1016/j.ijrobp.2005.02.048; Siemann DW, 2004, HEMATOL ONCOL CLIN N, V18, P1023, DOI 10.1016/j.hoc.2004.06.012; Singh P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071979; Song CW, 2019, RADIAT RES, V192, P159, DOI 10.1667/RR15346.1; Taylor E, 2020, SCI REPORTS, P10; Thakor AS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001963; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vilalta M, 2017, MOL IMAGING BIOL, V19, P215, DOI 10.1007/s11307-016-1010-5; Wang XD, 2019, ACS NANO, V13, P5720, DOI 10.1021/acsnano.9b01154; Wenzl T, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-171; White DA, 2016, CANCER LETT, V380, P69, DOI 10.1016/j.canlet.2016.06.003; WONG HH, 1973, RADIOLOGY, V108, P429, DOI 10.1148/108.2.429; Yang YS, 2014, ACS NANO, V8, P8992, DOI 10.1021/nn502146r; Zhou HL, 2017, ONCOTARGET, V8, P37464, DOI 10.18632/oncotarget.16395	66	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236245	10.1371/journal.pone.0236245	http://dx.doi.org/10.1371/journal.pone.0236245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706818	Green Published, gold			2022-12-26	WOS:000579931700020
J	Wolfe, AE; Moskowitz, JE; Franklin, CL; Wiemken, TL; Ericsson, AC				Wolfe, Annie E.; Moskowitz, Jacob E.; Franklin, Craig L.; Wiemken, Timothy L.; Ericsson, Aaron C.			Interactions of Segmented Filamentous Bacteria (Candidatus Savagella) and bacterial drivers in colitis-associated colorectal cancer development	PLOS ONE			English	Article							T-CELL RESPONSES; ALPHA-HEMOLYSIN; HELICOBACTER-BILIS; ULCERATIVE-COLITIS; T(H)17 CELLS; COLON-CANCER; INFLAMMATION; SEQUENCES; MICROBIOME; INTESTINE	Colorectal cancer (CRC) risk is influenced by host genetics, sex, and the gut microbiota. Using a genetically susceptible mouse model of CRC induced via inoculation with pathobiont Helicobacter spp. and demonstrating variable tumor incidence, we tested the ability of the Th17-enhancing commensal Candidatus Savagella, more commonly denoted as Segmented Filamentous Bacteria (SFB), to influence the incidence and severity of colitis-associated CRC in male and female mice. To document the composition of the gut microbiota during CRC development and identify taxa associated with disease, fecal samples were collected before and throughout disease development and characterized via 16S rRNA sequencing. While there were no significant SFB-dependent effects on disease incidence or severity, SFB was found to exert a sex-dependent protective effect in male mice. Furthermore, SFB stabilized the GM against Helicobacter-induced changes post-inoculation, resulting in a shift in disease association from Helicobacter spp. to Escherichia coli. These data support sex-dependent SFB-mediated effects on CRC risk, and highlight the complex community dynamics within the GM during exposure to inflammatory pathobionts.	[Wolfe, Annie E.; Franklin, Craig L.; Ericsson, Aaron C.] Univ Missouri, Mol Pathogenesis & Therapeut, Columbia, MO 65211 USA; [Moskowitz, Jacob E.; Franklin, Craig L.; Ericsson, Aaron C.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Franklin, Craig L.; Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA; [Franklin, Craig L.; Ericsson, Aaron C.] Univ Missouri, Mutant Mouse Resource & Res Ctr, Columbia, MO 65211 USA; [Franklin, Craig L.; Ericsson, Aaron C.] Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA; [Wiemken, Timothy L.] St Louis Univ, Ctr Hlth Outcomes Res, St Louis, MO 63103 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Saint Louis University	Ericsson, AC (corresponding author), Univ Missouri, Mol Pathogenesis & Therapeut, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Mutant Mouse Resource & Res Ctr, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA.	ericssona@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021	Ericsson, Aaron C./0000-0002-3053-7269	National Institutes of Health (NIH) [U42 OD010918]; NIH [K01 OD019924]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C.F. received funding (Grant#: U42 OD010918) from National Institutes of Health (NIH), Office of the Director (https://www.nih.gov/institutes-nih/nih-office-director).A.E.received funding (grant#: K01 OD019924) from NIH, Office of the Director (https://www.nih.gov/institutes-nih/nih-office-director).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caselli M, 2013, AM J GASTROENTEROL, V108, P860, DOI 10.1038/ajg.2013.61; CAVALIERI SJ, 1984, MICROBIOL REV, V48, P326, DOI 10.1128/MMBR.48.4.326-343.1984; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chen B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01403; Dalmasso G, 2014, GUT MICROBES, V5, P675, DOI 10.4161/19490976.2014.969989; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericsson AC, 2015, ONCOTARGET, V6, P33689, DOI 10.18632/oncotarget.5604; Ericsson AC, 2015, BIOTECHNIQUES, V59, P94, DOI 10.2144/000114319; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Ericsson AC, 2014, COMPARATIVE MED, V64, P90; Ericsson AC, 2010, NEOPLASIA, V12, P1054, DOI 10.1593/neo.10940; Fichtner-Feigl S, 2015, TRENDS IMMUNOL, V36, P451, DOI 10.1016/j.it.2015.06.007; Finotti A, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000172; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Fox JG, 2007, GUT, V56, P898, DOI 10.1136/gut.2006.115428; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hart ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28448-0; Hart ML, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00792; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; Jin S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43662; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lakatos PL, 2008, WORLD J GASTROENTERO, V14, P3937, DOI 10.3748/wjg.14.3937; Lee Sun Min, 2016, J Cancer Prev, V21, P271, DOI 10.15430/JCP.2016.21.4.271; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Makino S, 1981, Jikken Dobutsu, V30, P137; Markle JGM, 2014, GUT MICROBES, V5, P485, DOI 10.4161/gmic.29795; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; May AK, 2000, INFECT IMMUN, V68, P176, DOI 10.1128/IAI.68.1.176-183.2000; Moulton VR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02279; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Ording AG, 2013, INFLAMM BOWEL DIS, V19, P800, DOI 10.1097/MIB.0b013e3182802af7; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Roncucci L, 2015, EUR J INTERN MED, V26, P752, DOI 10.1016/j.ejim.2015.08.019; Samadder NJ, 2017, DIGEST DIS SCI, V62, P2126, DOI 10.1007/s10620-016-4435-4; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Snel J, 1998, CAN J MICROBIOL, V44, P1177, DOI 10.1139/cjm-44-12-1177; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Traish A, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120549; Urdaci MC, 2001, RES MICROBIOL, V152, P67, DOI 10.1016/S0923-2508(00)01169-4; Watanabe T, 2011, INFLAMM BOWEL DIS, V17, P802, DOI 10.1002/ibd.21365; Weisberg JFHS., 2019, R COMPANION APPL REG; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yoshida N, 2016, ANN SURG ONCOL, V23, P919, DOI 10.1245/s10434-015-4923-3; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	64	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236595	10.1371/journal.pone.0236595	http://dx.doi.org/10.1371/journal.pone.0236595			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706816	Green Published, gold			2022-12-26	WOS:000579931700056
J	Bitew, ZW; Alebel, A; Worku, T; Alemu, A				Bitew, Zebenay Workneh; Alebel, Animut; Worku, Teshager; Alemu, Ayinalem			Recovery rate and its predictors among children with severe acute malnutrition in Addis Ababa, Ethiopia: A retrospective cohort study	PLOS ONE			English	Article							MORTALITY	Introduction Malnutrition is a public health problem in under-five children in several parts of the world even after decades of the implementation of management protocols. An estimated 17 million children under the age of five years are living with severe acute malnutrition and the majorities are found in Asia and Africa, including Ethiopia. Objective The main objective of this study was to determine the recovery rate and its predictors among under-five children who were admitted to St. Paul's Hospital Millennium Medical College from 2012 to 2019. Methods An institution based retrospective cohort study was employed at St. Paul's Hospital Millennium Medical College from May 20, 2019 to June 28, 2019. Data were collected by reviewing children's' medical records using a structured checklist. A total of 534 charts were selected using a simple random sampling method and 515 of them were used for the final analysis. Ep-info version 7 software was used for data entry and STATA Version 15 for analysis. The Kaplan Meier failure estimate with Log-rank test was used to determine the survival estimates. Bi-variable and multivariable Cox proportional hazards regression model were fitted to identify predictors of mortality. Finally, variables with p-values less than 0.05 in the multivariable Cox regression were considered as independent predictors. The proportional hazards assumption was checked using the Schoenfeld residuals test and the final model fitness was checked using the Cox-Snail residual test. Result In this study, a total of 515 subjects were followed for 8672 child-days and 79% of the subjects recovered from SAM with the median time of 17 days. The incidence density rate of recovery was 46 per 1000 child-days. Tuberculosis (AHR(Adjusted Hazard Ratio) 0.44 & 95% CI: 0.32, 0.62), pale conjunctiva (AHR,0.67 & 95% CI: 0.52, 0.88), IV fluid infusion (AHR, 0.71 & 95 CI: 0.51, 0.98), feeding F100 (AHR, 1.63 & 95% CI:1.04,2.54), Vitamin A supplementation (AHR, 1.3 & 95% CI:1.07, 1.59) and bottle feeding (AHR, 0.79 & 95CI%: 0.64-0.98) were the independent predictors of time to recovery from SAM. Conclusion In conclusion, the recovery rate was relatively higher than the Sphere standard and the national SAM management protocol. Co-morbidities and the treatments given were the main determinants of recovery of children. Co-morbidities must be managed as early as possible and the treatments given during the SAM management process need to be given with precaution.	[Bitew, Zebenay Workneh] St Pauls Hosp, Dept Pediat Nursing, Sch Nursing, Millennium Med Coll, Addis Ababa, Ethiopia; [Alebel, Animut] Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia; [Worku, Teshager] Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia; [Alemu, Ayinalem] Ethipian Publ Hlth Inst, Dept Med Microbiol, Addis Ababa, Ethiopia	Haramaya University	Bitew, ZW (corresponding author), St Pauls Hosp, Dept Pediat Nursing, Sch Nursing, Millennium Med Coll, Addis Ababa, Ethiopia.	zedo2015@gmail.com	Alebel, Animut/L-4278-2019	Alebel, Animut/0000-0003-2822-2062				Abate HK, 2019, CLIN NUTR ESPEN, V33, P98, DOI 10.1016/j.clnesp.2019.07.001; Adal TG, 2016, INCIDENCE PREDICTORS, V6; Admasu A, 2017, J NUTR HLTH FOOD SCI; Amsalu Solomon, 2006, Ethiop Med J, V44, P151; Asres DT, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0224-0; Derseh B, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0423-1; Desalegn M., 2016, INT J NUTR METAB, V8, P12, DOI [10.5897/IJNAM2015.0193, DOI 10.5897/IJNAM2015.0193]; Desta K., 2015, J NUTR DISORD THER, V5, P160, DOI DOI 10.4172/2161-0509.1000160; Dubale S, 2019, BIOMEDICAL J SCI TEC, V20, P14888; Federal democratic Republic of Ethiopia MoH, 2013, TRAIN COURS MAN SEV; Fikrie A, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0642-x; FMOH/Ethiopia, 2019, KEY IND MIN HLTH SUR; Gebremichael DY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2593-5; Gebrezgi D, 2019, INT J NUTR, V3, P1; Girum T, 2017, THER CLIN RISK MANAG, V13, P101, DOI 10.2147/TCRM.S119826; GLOBALNUTRITIONREPORT.ORG, 2018, BURD MALN; Golden M., 2011, GUIDELINES INTEGRATE; Gordon DM, 2013, J TROP PEDIATRICS, V59, P350, DOI 10.1093/tropej/fmt031; Guesh Gebremicael, 2018, BMC Res Notes, V11, P832, DOI 10.1186/s13104-018-3937-x; Hassen SL, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/2643531; Hayashi C, 2017, UNICEF WHO WORLD BAN; Jarso H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0398-4; Mekuria Getnet, 2017, BMC Nutr, V3, P42, DOI 10.1186/s40795-017-0161-3; Melaku G, 2014, OPEN ACCESS LIB J, V1, P1, DOI DOI 10.4236/OALIB.1100446; Mena MB, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/8686501; Mengesha MM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30704; Misganaw C, 2014, J DIAGN, V1, P18, DOI [10.18488/journal.98.1.1/98.1.18.27, DOI 10.18488/JOURNAL.98.1.1/98.1.18.27, DOI 10.18488/journal.98/2014.1.1/98.1.18.27]; Munthali Tendai, 2017, BMC Res Notes, V10, P206, DOI 10.1186/s13104-017-2529-5; Oumer A, 2016, E AFR J HLTH BIOMED, V1, P13; Pravana NK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017084; Shanka N., 2015, J NUTR DISORD THER, V5, P155, DOI [10.4172/2161-0509.1000155, DOI 10.4172/2161-0509.1000155]; Sheshukov, 2019, ENVIRON GEOCHEM HLTH, P1; Shiferaw W, 2015, ETHIOP J PEDIAT CHIL, V11, P29; Shoham MMJ, 2019, FIELD EXCHANGE, V60, P2; Tefera Chane, 2014, Journal of Nutrition and Food Sciences, V4, P329; Tekeste Asayehegn, 2012, Cost Eff Resour Alloc, V10, P4, DOI 10.1186/1478-7547-10-4; Teshome G, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1407-9; Thurstans S., 2011, FIELD EXCHANGE, V41, P36; Tirore Mengistu Girma, 2017, BMC Nutr, V3, P66, DOI 10.1186/s40795-017-0186-7; UNICEF, 2019, STATE WORLDS CHILDRE; UNICEF-WHO-The World Bank Joint Child Malnutrition Estimates, LEV TRENDS CHILD MAL; USAID, 2018, ETH NUTR PROF PDF; Wagnew F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211628; Webb P, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2238	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235259	10.1371/journal.pone.0235259	http://dx.doi.org/10.1371/journal.pone.0235259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701985	Green Published, gold			2022-12-26	WOS:000575913700013
J	Bilbao-Malave, V; Recalde, S; Bezunartea, J; Hernandez-Sanchez, M; Gonzalez-Zamora, J; Maestre-Rellan, L; Ruiz-Moreno, JM; Araiz-Iribarren, J; Arias, L; Ruiz-Medrano, J; Flores-Moreno, I; Llorente-Gonzalez, S; Fernandez-Sanz, G; Berrozpe-Villabona, C; Velazquez-Villoria, A; Carreno, E; Fernandez-Robredo, P; Garcia-Layana, A				Bilbao-Malave, Valentina; Recalde, Sergio; Bezunartea, Jaione; Hernandez-Sanchez, Maria; Gonzalez-Zamora, Jorge; Maestre-Rellan, Leyre; Maria Ruiz-Moreno, Jose; Araiz-Iribarren, Javier; Arias, Luis; Ruiz-Medrano, Jorge; Flores-Moreno, Ignacio; Llorente-Gonzalez, Sara; Fernandez-Sanz, Guillermo; Berrozpe-Villabona, Clara; Velazquez-Villoria, Alvaro; Carreno, Ester; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo			Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients	PLOS ONE			English	Article							CONJUNCTIVAL ULTRAVIOLET AUTOFLUORESCENCE; GENOME-WIDE ASSOCIATION; VISUAL IMPAIRMENT; PAX6 GENE; CHOROIDAL NEOVASCULARIZATION; EXTREME MYOPIA; AXIAL LENGTH; RISK-FACTORS; LOW-VISION; POPULATION	High myopia and the subsequent degenerative changes of the retina, choroid, and sclera, known as myopic maculopathy (MM), are a serious visual problem in many Asian countries, and are beginning to be so in the south of Europe, especially in the Mediterranean. It is therefore necessary to carry out genetic and environmental studies to determine the possible causes of this disease. This study aims to verify if the genetic factors that have been most related to Asian populations are also associated in two Spanish cohorts. Eight SNPs from six genes (PAX6,SCO2,CCDC102B,BLID,chromosome 15q14, andCOL8A1) along with demographic, ophthalmic and environmental factors were analysed in two cohorts from a total of 365 highly myopic subjects and 177 control subjects. The genetic analysis showed thatCOL8A1SNP rs13095226 was associated with the development of choroidal neovascularization (CNV) and also seems to play an important role in the increase of axial length. The SNP rs634990 ofchromosome 15q14also showed a significant association with MM, although this was lost after the Bonferroni correction. Additional demographic and environmental factors, namely age, sex, smoking status, and pregnancy history, were also found to be associated with MM and CNV in this population.	[Bilbao-Malave, Valentina; Recalde, Sergio; Bezunartea, Jaione; Hernandez-Sanchez, Maria; Gonzalez-Zamora, Jorge; Maestre-Rellan, Leyre; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo] Clin Univ Navarra, Ophthalmol Expt Lab, Pamplona, Spain; [Bilbao-Malave, Valentina; Recalde, Sergio; Bezunartea, Jaione; Hernandez-Sanchez, Maria; Gonzalez-Zamora, Jorge; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo] Clin Univ Navarra, Dept Ophthalmol, Pamplona, Spain; [Recalde, Sergio; Bezunartea, Jaione; Hernandez-Sanchez, Maria; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo] Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain; [Recalde, Sergio; Hernandez-Sanchez, Maria; Maria Ruiz-Moreno, Jose; Arias, Luis; Flores-Moreno, Ignacio; Llorente-Gonzalez, Sara; Fernandez-Sanz, Guillermo; Berrozpe-Villabona, Clara; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo] Inst Salud Carlos III, Minist Ciencia Innovac & Univ, Red Temat Invest Cooperat Salud Prevent Early Det, Madrid, Spain; [Maria Ruiz-Moreno, Jose; Araiz-Iribarren, Javier] Univ Castilla La Mancha, Dept Ophthalmol, Ciudad Real, Spain; [Maria Ruiz-Moreno, Jose; Ruiz-Medrano, Jorge; Flores-Moreno, Ignacio] Hosp Univ Puerta de Hierro Majadahonda, Dept Ophthalmol, Madrid, Spain; [Maria Ruiz-Moreno, Jose] Vissum Corp Oftalmol, Alicante, Spain; [Araiz-Iribarren, Javier] Inst Clin Quirurg Oftalmol, Bilbao, Spain; [Araiz-Iribarren, Javier] Hosp San Eloy, Dept Ophthalmol, Bilbao, Spain; [Arias, Luis] Hosp Univ Bellvitge, Barcelona, Spain; [Llorente-Gonzalez, Sara; Fernandez-Sanz, Guillermo; Berrozpe-Villabona, Clara] Clin Univ Navarra, Dept Ophthalmol, Madrid, Spain; [Velazquez-Villoria, Alvaro] Clin Villoria, Pontevedra, Spain; [Carreno, Ester] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain	University of Navarra; University of Navarra; Instituto de Salud Carlos III; Universidad de Castilla-La Mancha; Hospital Puerta de Hierro-Majadahonda; VISSUM; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Navarra	Bilbao-Malave, V (corresponding author), Clin Univ Navarra, Ophthalmol Expt Lab, Pamplona, Spain.; Bilbao-Malave, V (corresponding author), Clin Univ Navarra, Dept Ophthalmol, Pamplona, Spain.	vbilbao@unav.es	Carreño, Ester/AAD-6863-2020; Ruiz-Medrano, Jorge/N-6256-2016	Carreño, Ester/0000-0002-0055-9547; LLORENTE GONZALEZ, SARA/0000-0001-8815-4757; Ruiz-Medrano, Jorge/0000-0002-1105-9265; Gonzalez Zamora, Jorge/0000-0002-2826-6842; Ruiz-Moreno, Jose M/0000-0001-9636-0788	Fundacion Jesus de Gangoiti Barrera; Fundacion Multiopticas CUN 2019	Fundacion Jesus de Gangoiti Barrera; Fundacion Multiopticas CUN 2019	This work has been developed by members the RETICS OFTARED (RD16/0008/0021) "Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology'' from the Instituto de Salud Carlos III from the Ministerio de Ciencia, Innovacion y Universidades, Spain (SR, MHS, JMRM, JAI, LA, IFM, SLG, GFS, CBV, PFR, AGL). This work has been partly funded by the Fundacion Jesus de Gangoiti Barrera (VBM personal grant) and Fundacion Multiopticas CUN 2019 (SR, JB, MHS, PFR, AGL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, BRIEN HOLD VIS I GLO; Asakuma T, 2012, OPHTHALMOLOGY, V119, P1760, DOI 10.1016/j.ophtha.2012.02.034; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Cedrone C, 2003, OPHTHALMOLOGY, V110, P584, DOI 10.1016/S0161-6420(02)01898-5; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Fang YX, 2018, OPHTHALMOLOGY, V125, P863, DOI 10.1016/j.ophtha.2017.12.005; Fernandez-Montero A, 2017, EYE, V31, P1085, DOI 10.1038/eye.2017.24; Flitcroft DI, 2019, INVEST OPHTH VIS SCI, V60, pM20, DOI 10.1167/iovs.18-25957; Gong JF, 2015, CHINESE MED J-PEKING, V128, P666, DOI 10.4103/0366-6999.151669; Hayashi H, 2011, INVEST OPHTH VIS SCI, V52, P4853, DOI 10.1167/iovs.11-7311; Hosoda Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03649-3; Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011; Hwang HS, 2018, CURR EYE RES, V43, P1052, DOI 10.1080/02713683.2018.1472286; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Iyer JV, 2012, EYE, V26, P1324, DOI 10.1038/eye.2012.160; Jiang D, 2015, INVEST OPHTH VIS SCI, V56, P339, DOI 10.1167/iovs.14-14850; Jiao XD, 2012, MOL VIS, V18, P2633; Jonas JB, 2017, ACTA OPHTHALMOL, V95, pE399, DOI 10.1111/aos.13301; Kearney S, 2019, CLIN EXP OPTOM, V102, P43, DOI 10.1111/cxo.12825; Kearney S, 2016, OPHTHAL PHYSL OPT, V36, P359, DOI 10.1111/opo.12309; Klaver CC, 1998, ARCH OPHTHALMOL, V116; Krumpaszky HG, 1999, OPHTHALMOLOGICA, V213, P176, DOI 10.1159/000027415; Liang CL, 2011, INVEST OPHTH VIS SCI, V52, P3500, DOI 10.1167/iovs.10-5859; Meng WH, 2011, OPHTHALMOLOGICA, V225, P127, DOI 10.1159/000317072; Miyake M, 2012, MOL VIS, V18, P2726; Morgan Ian G, 2003, Clin Exp Optom, V86, P276; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Nirmalan PK, 2004, INVEST OPHTH VIS SCI, V45, P4273, DOI 10.1167/iovs.04-0285; Ohno-Matsui K, 2015, AM J OPHTHALMOL, V159, P877, DOI 10.1016/j.ajo.2015.01.022; Ooi JL, 2006, AM J OPHTHALMOL, V141, P294, DOI 10.1016/j.ajo.2005.09.006; Organizacion Nacional de Ciegos Espanoles, 2019, DAT AF ONCE; QIANG Y, 2014, BMC GENET, V15, DOI DOI 10.1186/1471-2156-15-1; Ruiz-Medrano J, 2019, PROG RETIN EYE RES, V69, P80, DOI 10.1016/j.preteyeres.2018.10.005; Sainz-Gomez C, 2010, EUR J OPHTHALMOL, V20, P442, DOI 10.1177/112067211002000228; Saw SM, 2004, BRIT J OPHTHALMOL, V88, P934, DOI 10.1136/bjo.2003.033175; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Stone RA, 2001, INVEST OPHTH VIS SCI, V42, P557; Stone RA, 2006, INVEST OPHTH VIS SCI, V47, P4277, DOI 10.1167/iovs.05-1625; Sun C, 2017, CANCER EPIDEM BIOMAR, V26, P1146, DOI [10.1158/1055-9965.EPI-16-0846, 10.1158/1055-9965.epi-16-0846]; Tang SM, 2019, BRIT J OPHTHALMOL, V103, P8, DOI 10.1136/bjophthalmol-2018-312159; Tang SM, 2014, OPTOMETRY VISION SCI, V91, P419, DOI 10.1097/OPX.0000000000000224; Tedja MS, 2019, INVEST OPHTH VIS SCI, V60, pM89, DOI 10.1167/iovs.18-25965; Tran-Viet KN, 2013, AM J HUM GENET, V92, P820, DOI 10.1016/j.ajhg.2013.04.005; Tsai YY, 2008, EYE, V22, P576, DOI 10.1038/sj.eye.6702982; Velazquez-Villoria A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162296; Wakazono T, 2016, JPN J OPHTHALMOL, V60, P319, DOI 10.1007/s10384-016-0442-4; Wojciechowski R, 2018, RETINA-J RET VIT DIS, V38, P91, DOI 10.1097/IAE.0000000000001518; Wong TY, 2015, BRIT J OPHTHALMOL, V99, P289, DOI 10.1136/bjophthalmol-2014-305131; Wong YL, 2018, INVEST OPHTH VIS SCI, V59, P4603, DOI 10.1167/iovs.18-24032; Xu L, 2006, BEIJING EYE STUDY OP, V113, P1, DOI [10.1016/j.ophtha.2005.09.01516389103, DOI 10.1016/J.OPHTHA.2005.09.01516389103]; Yan YN, 2018, OPHTHALMOLOGY, V125, P1253, DOI 10.1016/j.ophtha.2018.01.035	54	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236071	10.1371/journal.pone.0236071	http://dx.doi.org/10.1371/journal.pone.0236071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730261	Green Published, gold			2022-12-26	WOS:000556884700075
J	Kim, JY; Ko, I; Park, KJ; Kim, DK				Kim, Jong-Yeup; Ko, Inseok; Park, Ki Joon; Kim, Dong-Kyu			Association of adenotonsillectomy with asthma and upper respiratory infection: A nationwide cohort study	PLOS ONE			English	Article							EARLY-LIFE; TRACT INFECTIONS; TONSILLECTOMY; CHILDREN; ADENOIDECTOMY; EXPOSURE; RISK	Adenotonsillectomy is a common paediatric surgery for treating obstructed breathing or recurrent inflammation; however, the long-term health consequences on the developing immune system are unknown. This study investigated the potential association between adenotonsillectomy and the development of asthma and upper respiratory infections (URI). This propensity score-matched retrospective cohort study utilized data from the National Sample Cohort 2002-2013. In the asthma cohort, we used a Cox-proportional hazards model to analyze the hazard ratio (HR) of adenotonsillectomy for asthma events. In the URI cohort, equivalence testing of postoperative visits for URI was performed. The margin of equivalence of the difference was set at -0.5-0.5. Asthma incidence was 66.97/1000 person-years in children who underwent adenotonsillectomy and 30.43/1000 person-years in those who did not. Adjusted asthma HRs were 2.25 (95% confidence interval, 1.96-2.57) in the adenotonsillectomy vs. non-adenotonsillectomy groups. In a subgroup analysis, children aged 5-9 years living in metropolitan areas showed a higher incidence of subsequent asthma than those of other ages and areas. However, any significant difference between the groups in terms of URI events in the 1-11-year postoperative period was not identified. Adenotonsillectomy in children is associated with an increased incidence of asthma, with no significant impact on postoperative visits for URI.	[Kim, Jong-Yeup] Konyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Daejeon, South Korea; [Kim, Jong-Yeup; Ko, Inseok] Konyang Univ, Coll Med, Dept Biomed Informat, Daejeon, South Korea; [Park, Ki Joon; Kim, Dong-Kyu] Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Big Data & Artificial Intelligence,Coll Med, Chunchon, South Korea; [Kim, Dong-Kyu] Hallym Univ, Inst New Frontier Res, Coll Med, Chunchon, South Korea	Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Hallym University; Hallym University	Kim, DK (corresponding author), Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Big Data & Artificial Intelligence,Coll Med, Chunchon, South Korea.; Kim, DK (corresponding author), Hallym Univ, Inst New Frontier Res, Coll Med, Chunchon, South Korea.	doctordk@naver.com	Ko, Inseok/AFN-5296-2022; Ko, Inseok/E-6217-2018	Ko, Inseok/0000-0002-6348-7392; Kim, Dong-Kyu/0000-0003-4917-0177; Kim, Jong-Yeup/0000-0003-1230-9307	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C2412]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT) [NRF-2017M3A9E8033231]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C2412). This research was also supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF), funded by the Korean government (MSIT) (NRF-2017M3A9E8033231 to Dong-Kyu Kim). These funding sources had no role in the design of this study, and did not have any role during its execution, analyses, interpretation of the data, or decision to submit results.	Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Bhattacharjee R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001753; Brandtzaeg P, 2003, INT J PEDIATR OTORHI, V67, pS69, DOI 10.1016/j.ijporl.2003.08.018; Busino RS, 2010, LARYNGOSCOPE, V120, pS221, DOI 10.1002/lary.21688; Byars SG, 2018, JAMA OTOLARYNGOL, V144, P594, DOI 10.1001/jamaoto.2018.0614; Choi HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169264; Dayyat E, 2009, CHEST, V135, P1142, DOI 10.1378/chest.08-2102; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Johansson E, 2003, INT J PEDIATR OTORHI, V67, P981, DOI 10.1016/S0165-5876(03)00196-4; Kaditis AG, 2010, PEDIATR PULM, V45, P275, DOI 10.1002/ppul.21174; Kato A, 2013, J ALLERGY CLIN IMMUN, V131, P933, DOI 10.1016/j.jaci.2013.02.023; Ko I, 2017, HEALTHC INFORM RES, V23, P349, DOI 10.4258/hir.2017.23.4.349; Kohli N, 2016, INT J PEDIATR OTORHI, V90, P107, DOI 10.1016/j.ijporl.2016.08.030; Kvaerner KJ, 2002, ANN OTO RHINOL LARYN, V111, P1034, DOI 10.1177/000348940211101115; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Levin JC, 2014, PEDIATR RES, V75, P403, DOI 10.1038/pr.2013.237; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Mattila PS, 2009, ARCH DIS CHILD, V94, P366, DOI 10.1136/adc.2008.145664; Mattila PS, 2003, PEDIATR ALLERGY IMMU, V14, P358, DOI 10.1034/j.1399-3038.2003.00070.x; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Ramos SD, 2013, PEDIATR CLIN N AM, V60, P793, DOI 10.1016/j.pcl.2013.04.015; Rubner FJ, 2017, J ALLERGY CLIN IMMUN, V139, P501, DOI 10.1016/j.jaci.2016.03.049; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Saito H, 1996, ACTA OTO-LARYNGOL, P212; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; STJERNQUISTDESATNIK A, 1992, ADV OTO-RHINO-LARYNG, V47, P186; Tsou YA, 2013, INT J PEDIATR OTORHI, V77, P677, DOI 10.1016/j.ijporl.2013.01.011; van Kempen MJP, 2000, INT ARCH ALLERGY IMM, V122, P8, DOI 10.1159/000024354; van Staaij BK, 2005, ARCH DIS CHILD, V90, P19, DOI 10.1136/adc.2003.047530	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236806	10.1371/journal.pone.0236806	http://dx.doi.org/10.1371/journal.pone.0236806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730318	gold, Green Published			2022-12-26	WOS:000556884700096
J	Jabbarzare, M; Njie, M; Jaworowski, A; Umbers, AJ; Ome-Kaius, M; Hasang, W; Randall, LM; Kalionis, B; Rogerson, SJ				Jabbarzare, Marzieh; Njie, Madi; Jaworowski, Anthony; Umbers, Alexandra J.; Ome-Kaius, Maria; Hasang, Wina; Randall, Louise M.; Kalionis, Bill; Rogerson, Stephen J.			Innate immune responses to malaria-infected erythrocytes in pregnant women: Effects of gravidity, malaria infection, and geographic location	PLOS ONE			English	Article							V-GAMMA-2V-DELTA-2 T-CELLS; NATURAL-KILLER-CELLS; LOW-BIRTH-WEIGHT; PLASMODIUM-FALCIPARUM; PLACENTAL MALARIA; IFN-GAMMA; INTERFERON-GAMMA; RISK-FACTORS; TNF-ALPHA; ASSOCIATION	Background Malaria in pregnancy causes maternal, fetal and neonatal morbidity and mortality, and maternal innate immune responses are implicated in pathogenesis of these complications. The effects of malaria exposure and obstetric and demographic factors on the early maternal immune response are poorly understood. Methods Peripheral blood mononuclear cell responses toPlasmodium falciparum-infected erythrocytes and phytohemagglutinin were compared between pregnant women from Papua New Guinea (malaria-exposed) with and without current malaria infection and from Australia (unexposed). Elicited levels of inflammatory cytokines at 48 h and 24 h (interferon gamma, IFN-gamma only) and the cellular sources of IFN-gamma were analysed. Results Among Papua New Guinean women, microscopic malaria at enrolment did not alter peripheral blood mononuclear cell responses. Compared to samples from Australia, cells from Papua New Guinean women secreted more inflammatory cytokines tumor necrosis factor-alpha, interleukin 1 beta, interleukin 6 and IFN-gamma; p<0.001 for all assays, and more natural killer cells produced IFN-gamma in response to infected erythrocytes and phytohemagglutinin. In both populations, cytokine responses were not affected by gravidity, except that in the Papua New Guinean cohort multigravid women had higher IFN-gamma secretion at 24 h (p = 0.029) and an increased proportion of IFN-gamma V+delta 2 gamma delta T cells (p = 0.003). Cytokine levels elicited by a pregnancy malaria-specific CSA binding parasite line, CS2, were broadly similar to those elicited by CD36-binding line P6A1. Conclusions Geographic location and, to some extent, gravidity influence maternal innate immunity to malaria.	[Jabbarzare, Marzieh; Njie, Madi; Hasang, Wina; Randall, Louise M.; Rogerson, Stephen J.] Univ Melbourne, Dept Med, Doherty Inst, Melbourne, Vic, Australia; [Jaworowski, Anthony] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Umbers, Alexandra J.; Ome-Kaius, Maria] Papua New Guinea Inst Med Res, Vector Borne Dis Unit, Madang, Papua N Guinea; [Kalionis, Bill] Univ Melbourne, Royal Womens Hosp, Dept Maternal Fetal Med, Pregnancy Res Ctr,Dept Obstet & Gynaecol, Parkville, Vic, Australia	University of Melbourne; Royal Melbourne Institute of Technology (RMIT); PNG Institute Of Medical Research; University of Melbourne	Jabbarzare, M (corresponding author), Univ Melbourne, Dept Med, Doherty Inst, Melbourne, Vic, Australia.	marzieh.jabbarzare@gmail.com	KALIONIS, BILL/B-4766-2011	Hasang, Wina/0000-0001-8664-7558; jaworowski, anthony/0000-0002-3844-805X	National Health and Medical Research Council of Australia [APP1092789]; Bill and Melinda Gates Foundation [46099]; Pregvax Consortium through European Union [PREGVAX 201588]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Pregvax Consortium through European Union	This work was supported by funds from a Program Grant from the National Health and Medical Research Council of Australia, APP1092789. Sample collection in Papua New Guinea was supported by the Malaria in Pregnancy Consortium, which is funded through a grant (46099) from the Bill and Melinda Gates Foundation to the Liverpool School of Tropical Medicine; the Pregvax Consortium, through a grant from the European Union's Seventh Framework Programme FP7-2007-HEALTH (PREGVAX 201588). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Agerbaek MO, 2018, NATURE COMMUNICATION, V9, P1, DOI [10.1038/s41467-017-02088-w, DOI 10.1038/S41467-017-02088-W]; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Bouyou-Akotet MK, 2009, EXP PARASITOL, V123, P265, DOI 10.1016/j.exppara.2009.07.011; Bouyou-Akotet MK, 2004, CLIN INFECT DIS, V38, P342, DOI 10.1086/380646; BRABIN BJ, 1990, ANN TROP MED PARASIT, V84, P1; Chen ZW, 2003, TRENDS IMMUNOL, V24, P213, DOI 10.1016/S1471-4906(03)00032-2; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Duffy MF, 2009, J MOL BIOL, V389, P453, DOI 10.1016/j.jmb.2009.04.032; Engelmann I, 2005, J INFECT DIS, V191, P1612, DOI 10.1086/429336; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2015, VACCINE, V33, P7483, DOI 10.1016/j.vaccine.2015.10.011; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Hensmann M, 2001, INFECT IMMUN, V69, P2364, DOI 10.1128/IAI.69.4.2364-2371.2001; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Kline K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001755; KUTNER S, 1985, J CELL PHYSIOL, V125, P521, DOI 10.1002/jcp.1041250323; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Ludlow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086160; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737; Moore Kerryn A, 2017, Lancet Glob Health, V5, pe1101, DOI 10.1016/S2214-109X(17)30340-6; Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Othoro C, 2008, INFECT IMMUN, V76, P1678, DOI 10.1128/IAI.01420-07; Parham P, 2014, IMMUNE SYSTEM; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Riccio EKP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0688-1; Riedhammer C, 2014, PERIPHERAL BLOOD MON, P53; Roetynck S, 2006, IMMUNOL REV, V214, P251, DOI 10.1111/j.1600-065X.2006.00446.x; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Sakowicz A, 2018, BJOG-INT J OBSTET GY, V125, P1379, DOI 10.1111/1471-0528.15172; Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186; Schrum JE, 2018, J IMMUNOL, V200, P1243, DOI 10.4049/jimmunol.1701010; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; Senn N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001195; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Stanisic DI, 2015, T ROY SOC TROP MED H, V109, P313, DOI 10.1093/trstmh/trv019; Stanisic DI, 2014, J INFECT DIS, V210, P295, DOI 10.1093/infdis/jiu083; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Tako EA, 2005, AM J TROP MED HYG, V72, P236, DOI 10.4269/ajtmh.2005.72.236; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; Van Geertruyden JP, 2005, TROP MED INT HEALTH, V10, P681, DOI 10.1111/j.1365-3156.2005.01431.x; Wang LS, 2001, J IMMUNOL, V167, P6195, DOI 10.4049/jimmunol.167.11.6195; Winkler S, 1998, INFECT IMMUN, V66, P6040, DOI 10.1128/IAI.66.12.6040-6044.1998; Zhou JL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-343	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236375	10.1371/journal.pone.0236375	http://dx.doi.org/10.1371/journal.pone.0236375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726331	Green Published, gold			2022-12-26	WOS:000556908900008
J	Lee, SY; Lei, BW; Mallick, B				Lee, Se Yoon; Lei, Bowen; Mallick, Bani			Estimation of COVID-19 spread curves integrating global data and borrowing information	PLOS ONE			English	Article							REPRODUCTION NUMBER; GROWTH-CURVES; MODELS; EPIDEMIOLOGY; HORSESHOE; INFLUENZA; INFERENCE; VARIANCE; DENGUE; SEIR	Currently, novel coronavirus disease 2019 (COVID-19) is a big threat to global health. The rapid spread of the virus has created pandemic, and countries all over the world are struggling with a surge in COVID-19 infected cases. There are no drugs or other therapeutics approved by the US Food and Drug Administration to prevent or treat COVID-19: information on the disease is very limited and scattered even if it exists. This motivates the use of data integration, combining data from diverse sources and eliciting useful information with a unified view of them. In this paper, we propose a Bayesian hierarchical model that integrates global data for real-time prediction of infection trajectory for multiple countries. Because the proposed model takes advantage of borrowing information across multiple countries, it outperforms an existing individual country-based model. As fully Bayesian way has been adopted, the model provides a powerful predictive tool endowed with uncertainty quantification. Additionally, a joint variable selection technique has been integrated into the proposed modeling scheme, which aimed to identify possible country-level risk factors for severe disease due to COVID-19.	[Lee, Se Yoon; Lei, Bowen; Mallick, Bani] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Lee, SY (corresponding author), Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA.	seyoonlee@stat.tamu.edu	Lee, Se Yoon/AAS-8427-2021	Lee, Se Yoon/0000-0002-9551-5562; Lei, Bowen/0000-0001-7141-7485	National Cancer Institute of the National Institutes of Health [R01CA194391]; NSF [CCF-1934904]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF))	Research reported in this publication was supported by National Cancer Institute of the National Institutes of Health under award number R01CA194391, and NSF grant no. NSF CCF-1934904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton H., 1988, CALCULUS ANAL GEOMET; Armagan A, 2013, STAT SINICA, V23, P119, DOI 10.5705/ss.2011.048; Bhadra A, 2019, STAT SCI, V34, P405, DOI 10.1214/19-STS700; Birch CPD, 1999, ANN BOT-LONDON, V83, P713, DOI 10.1006/anbo.1999.0877; Browne WJ, 2006, BAYESIAN ANAL, V1, P473, DOI 10.1214/06-BA117; Cao J, 2016, J MATER CHEM A, V4, P10223, DOI 10.1039/c6ta03121h; Cao LY, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11020204; Carvalho C.M., 2009, ARTIF INTELL; Carvalho CM, 2010, BIOMETRIKA, V97, P465, DOI 10.1093/biomet/asq017; CAUSTON DR, 1969, BIOMETRICS, V25, P401, DOI 10.2307/2528797; Clayton D., 2013, STAT MODELS EPIDEMIO; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dowd J.B., 2020, P NATL ACAD SCI US; Efron B, 2010, STAT SCI, V25, P145, DOI 10.1214/09-STS308; Fineberg HV, 2009, EPIDEMIC SCI REAL TI; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gelman A., 2004, BAYESIAN DATA ANAL; Giltinan DM, 1995, NONLINEAR MODELS REP, V62; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; He ZR, 2018, INT J INFECT DIS, V74, P61, DOI 10.1016/j.ijid.2018.07.003; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HILL BM, 1965, J AM STAT ASSOC, V60, P806, DOI 10.2307/2283247; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023; Hsieh YH, 2009, SERIES CONT APPL MAT, V11, P216, DOI DOI 10.1142/9789814261265_; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Hsieh YH, 2009, AM J TROP MED HYG, V80, P66, DOI 10.4269/ajtmh.2009.80.66; Hu WB, 2006, ECOL MODEL, V196, P505, DOI 10.1016/j.ecolmodel.2006.02.028; Huttenhower Curtis, 2006, Comput Syst Bioinformatics Conf, P341; James W., 1992, BREAKTHROUGHS STAT, P443, DOI [10.1007/978-1-4612-0919-5_30, DOI 10.1007/978-1-4612-0919-5_30]; Jia L., 2020, PREDICTION ANAL CORO; Kahm M, 2010, J STAT SOFTW, V33, P1; Korobeinikov A, 2004, MATH MED BIOL, V21, P75; Lenzerini Maurizio, 2002, PROC ACM SIGMOD SIGA, P233; Li Q, 2020, J INFECTION, V80, P472, DOI 10.1016/j.jinf.2020.02.014; Li YS, 2010, BIOMETRICS, V66, P70, DOI 10.1111/j.1541-0420.2009.01227.x; Lindley D.V., 1972, BAYESIAN STAT REV, V2; Liu Z, 2020, PREDICTING CUMULATIV; Malinverno A, 2004, GEOPHYSICS, V69, P1005, DOI 10.1190/1.1778243; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Murray I., 2010, ELLIPTICAL SLICE SAM; NELDER JA, 1962, BIOMETRICS, V18, P614, DOI 10.2307/2527907; Pell B, 2018, EPIDEMICS-NETH, V22, P62, DOI 10.1016/j.epidem.2016.11.002; Peng L., 2020, EPIDEMIC ANAL COVID; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rushton SP, 2006, EPIDEMIOL INFECT, V134, P521, DOI 10.1017/S0950268805005303; Seber G.A., 2003, NONLINEAR REGRESSION, V62, P63; Shen XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060601; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; STONE M, 1965, BIOMETRIKA, V52, P623; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; TIAO GC, 1965, BIOMETRIKA, V52, P37, DOI 10.1093/biomet/52.1-2.37; Tiberiu H., 2014, APPL MATH COMPUT, V236, P184; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Wang XS, 2012, J THEOR BIOL, V313, P12, DOI 10.1016/j.jtbi.2012.07.024; Wasserman L., 2013, ALL STAT CONCISE COU; Werker AR, 1997, ANN BOT-LONDON, V79, P657, DOI 10.1006/anbo.1997.0387; Wu K., 2020, ARXIV200305681; Yaesoubi R, 2011, EUR J OPER RES, V215, P679, DOI 10.1016/j.ejor.2011.07.016; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033	64	33	33	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236860	10.1371/journal.pone.0236860	http://dx.doi.org/10.1371/journal.pone.0236860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726361	Green Submitted, Green Published, gold			2022-12-26	WOS:000556908900019
J	Wu, ZH; Fang, M; Zhou, Y				Wu, Zeng-Hong; Fang, Ming; Zhou, Yan			Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; POOR-PROGNOSIS; DRUG TARGET; WEB SERVER; CANCER; APOPTOSIS; PROLIFERATION; PATHWAY; CBX2; AKT	Head and neck squamous cell carcinoma (HNSCC), a tumor included oral cavity, lips, larynx, oropharynx, and the nasopharynx et al. The cell division cycle-associated (CDCA) protein family (CDCA1-8) critical for normal cell function and cancer cell proliferation. We explored the mutation signatures and expression levels of variousCDCAsin detail in HNSCC. A comprehensive bioinformatics analysis pipeline based on copy number and gene expressions data from patients with HNSCC in order to given new insights into the possible functions and distinct prognostics that underlieCDCAsregulation. We compared the transcriptional expression ofCDCAsin HNSCC and found significantly elevated mRNA expression ofCDCA1-8in HNSCC tissues across multiple datasets. We also foundCDCA5/6/8are over-expressed both transcriptionally and translationally in patients with HNSCC. Our results suggested that that mRNA levels ofCDCA1/2/4/7related to the prognosis and can be used as a new useful biomarker for predicting the survival of HNSCC patients. The top 5CDCAsneighboring gene alterations in HNSCCs were found inMYC,STAG1,RAD21,KLHL9andNDC80. Multivariable Cox proportional hazard model also showed that CD8+ T cells were higher (P<0.05) in HNSCC-HPV-pos patients and that this was related toCDCA1/2/3/4/5/7. This study utilizes online tools to conduct specific gene analyses from free open databases, but our study requires more large-scale genomics research and basic research.	[Wu, Zeng-Hong; Fang, Ming; Zhou, Yan] Huazhong Univ Sci & Technol, Union Hosp, Dept Otorhinolaryngol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Wu, Zeng-Hong] Huazhong Univ Sci & Technol, Union Hosp, Dept Infect Dis, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhou, Y (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Otorhinolaryngol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	wzhs134@163.com						Abdullah J M, 2001, BLOOD CELL MOL DIS, V27; Asplund A, 2012, PROTEOMICS, V12, P2067, DOI 10.1002/pmic.201100504; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bressan V, 2016, CANCER TREAT REV, V45, P105, DOI 10.1016/j.ctrv.2016.03.006; Bu YH, 2019, GENE, V703, P1, DOI 10.1016/j.gene.2019.04.006; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chang IW, 2015, AM J TRANSL RES, V7, P710; Chen H, 2019, J CANCER, V10, P1846, DOI 10.7150/jca.28809; Chen J, 2013, CANCER LETT, V330, P217, DOI 10.1016/j.canlet.2012.11.051; Chin D, 2005, INT J CANCER, V113, P789, DOI 10.1002/ijc.20608; Ci C, 2019, INT J MOL MED, V43, P404, DOI 10.3892/ijmm.2018.3985; Clermont PL, 2014, BRIT J CANCER, V111, P1663, DOI 10.1038/bjc.2014.474; Clermont PL, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0182-9; Coskun HH, 2015, HEAD NECK-J SCI SPEC, V37, P915, DOI 10.1002/hed.23689; Fang XN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28957-y; Feng YF, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5793-z; Gill RM, 2013, MOL CELL BIOL, V33, P498, DOI 10.1128/MCB.00276-12; Giordano TJ, 2006, CLIN CANCER RES, V12, P1983, DOI 10.1158/1078-0432.CCR-05-2039; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Jenness C, 2018, P NATL ACAD SCI USA, V115; Jimenez R, 2018, HAEMATOLOGICA, V103, P1669, DOI 10.3324/haematol.2018.188961; Kaneko N, 2009, BIOCHEM BIOPH RES CO, V390, P1235, DOI 10.1016/j.bbrc.2009.10.127; Krasnoselsky AL, 2005, ONCOGENE, V24, P1533, DOI 10.1038/sj.onc.1208341; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Magnes T, 2017, MEMO-MAG EUR MED ONC, V10, P220, DOI 10.1007/s12254-017-0358-9; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Ni GY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221045; Obara W, 2017, CANCER SCI, V108, P1452, DOI 10.1111/cas.13278; Pang S, 2019, ONCOL LETT, V17, P4393, DOI 10.3892/ol.2019.10077; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Phan Nam Nhut, 2018, Oncotarget, V9, P6977, DOI 10.18632/oncotarget.24059; Thang PM, 2016, INT J ONCOL, V49, P1385, DOI 10.3892/ijo.2016.3649; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Shi R, 2017, ONCOTARGET, V8, P19768, DOI 10.18632/oncotarget.15519; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Thijssen PE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8870; Tokuzumi A, 2016, J DERMATOL, V43, P1399, DOI 10.1111/1346-8138.13436; Tomita Y, 2014, INT J CANCER, V134, P352, DOI 10.1002/ijc.28376; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Vagnarelli P, 2014, ADV EXP MED BIOL, V773, P401, DOI 10.1007/978-1-4899-8032-8_18; Valenti F, 2019, CANCERS, V11, DOI 10.3390/cancers11091347; Walker MG, 2001, CURR CANCER DRUG TAR, V1, P73, DOI 10.2174/1568009013334241; Wang L, 2017, CELL BIOL INT, V41, P833, DOI 10.1002/cbin.10786; Wang Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0248-5; Xu J, 2019, EBIOMEDICINE, V46, P54, DOI 10.1016/j.ebiom.2019.07.030; Xu YJ, 2018, MOL MED REP, V17, P1507, DOI 10.3892/mmr.2017.8095; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Ye LP, 2018, INT J CANCER, V143, P2602, DOI 10.1002/ijc.31766; Yu JW, 2020, J CELL BIOCHEM, V121, P142, DOI 10.1002/jcb.28993; Zhang W, 2018, BIOCHEM BIOPH RES CO, V500, P196, DOI 10.1016/j.bbrc.2018.04.034; Zhang Y, 2019, ONCOL REP, V41, P2471, DOI 10.3892/or.2019.7008; Zhao MH, 2019, INT J ONCOL, V55, P1165, DOI 10.3892/ijo.2019.4880	56	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236678	10.1371/journal.pone.0236678	http://dx.doi.org/10.1371/journal.pone.0236678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716971	gold, Green Published			2022-12-26	WOS:000556674500027
J	Choudhary, MI; Shaikh, M; Atia-tul-Wahab; Atta-ur-Rahman				Choudhary, M. Iqbal; Shaikh, Muniza; Atia-tul-Wahab; Atta-ur-Rahman			In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation	PLOS ONE			English	Article							DIMETHYL LITHOSPERMATE-B; LIPID-PEROXIDATION; ACCURATE DOCKING; DANSHEN; GLIDE	The incidence of 2019 novel corona virus (SARS-CoV-2) has created a medical emergency throughout the world. Various efforts have been made to develop the vaccine or effective treatments against the disease. The discovery of crystal structure of SARS-CoV-2 main protease has made the in silico identification of its inhibitors possible. Based on its critical role in viral replication, the viral protease can prove to be a promising "target" for antiviral drug therapy. We have systematically screened an in-house library of 15,754 natural and synthetic compounds, established at International Center for Chemical and Biological Sciences, University of Karachi. The in silico search for potential viral protease inhibitors resulted in nine top ranked ligands (compounds 1-9) against SARS-CoV-2 main protease (PDB ID: 6LU7) based on docking scores, and predictive binding energies. The in silico studies were updated via carrying out the docking, and predictive binding energy estimation, with a recently reported crystal structure of main protease (PDB ID: 6Y2F) at a better resolution i.e., 1.95 A. Compound 2 (molecular bank code AAA396) was found to have highest negative binding energy of -71.63 kcal/mol for 6LU7. While compound 3 (molecular bank code AAD146) exhibited highest negative binding energy of -81.92 kcal/mol for 6Y2F. The stability of the compounds- in complex with viral protease was analyzed by Molecular Dynamics simulation studies, and was found to be stable over the course of 20 ns simulation time. Compound 2, and 3 were predicted to be the significant inhibitors of SARS-CoV-2 3CL hydrolase (Mpro) among the nine short listed compounds.	[Choudhary, M. Iqbal; Shaikh, Muniza; Atia-tul-Wahab; Atta-ur-Rahman] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan; [Choudhary, M. Iqbal; Atta-ur-Rahman] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Pakistan	University of Karachi; University of Karachi	Choudhary, MI; Shaikh, M; Atia-tul-Wahab (corresponding author), Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan.; Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Pakistan.	iqbal.choudhary@iccs.edu; shaikhmuniza2016@gmail.com; atia.tulwahab@iccs.edu	Shaikh, Muniza/ABE-5751-2020; , Atia-tul-Wahab/C-5839-2018; Choudhary, M. Iqbal/C-8633-2012	Shaikh, Muniza/0000-0002-4956-9877; , Atia-tul-Wahab/0000-0002-2730-5547; Choudhary, M. Iqbal/0000-0001-5356-3585	Searle Company, Pakistan	Searle Company, Pakistan	The study has financial support of the Searle Company, Pakistan through a research project funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; AFFANY A, 1987, FUND CLIN PHARMACOL, V1, P451, DOI 10.1111/j.1472-8206.1987.tb00578.x; Ahmad S, 2019, INTERDISCIP SCI, V11, P508, DOI 10.1007/s12539-018-0299-y; [Anonymous], 2020, SCHROD REL 2020 2 QI; [Anonymous], 2020, SCHROD REL 2020 1 DE; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Choi HG, 2018, ARCH PHARM RES, V41, P64, DOI 10.1007/s12272-017-0983-1; Fish JM, 2006, CIRCULATION, V113, P1393, DOI 10.1161/CIRCULATIONAHA.105.601690; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hashemzadeh S, 2019, INTERDISCIP SCI, V11, P115, DOI 10.1007/s12539-018-0305-4; Hassan M, 2018, INTERDISCIP SCI, V10, P68, DOI 10.1007/s12539-016-0171-x; Hayes JM, 2012, MOL DYNAMICS STUDIES; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Khan KM, 2008, LETT DRUG DES DISCOV, V5, P152, DOI 10.2174/157018008784083974; Lamberton J N, 1965, Bull Soc Fr Dermatol Syphiligr, V72, P808; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mbwambo ZH, 2004, PLANTA MED, V70, P706, DOI 10.1055/s-2004-827199; Mesaik MA, 2012, CHEM BIOL DRUG DES, V79, P290, DOI 10.1111/j.1747-0285.2011.01310.x; National Health Commission of the People's Republic of China, 2020, UPD NOV COR PNEUM OU; Oh SH, 2006, ARCH PHARM RES, V29, P762, DOI 10.1007/BF02974077; Richman D., 2016, CLIN VIROLOGY, V4th, DOI DOI 10.1128/9781555819439; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schrodinger, 2020, SCHROD REL 2020 1 PR; Schrodinger, 2020, SCHROD REL 2020 1 GL; Schrodinger LLC, 2020, SCHRODINGER RELEASE; Tchinda AT, 2007, CHEM PHARM BULL, V55, P1402, DOI 10.1248/cpb.55.1402; Vinothkumar R, 2014, ENVIRON TOXICOL PHAR, V37, P174, DOI 10.1016/j.etap.2013.11.022; WACKER A, 1978, ARZNEIMITTEL-FORSCH, V28-1, P347; World Health Organization, 2020, MENT HLTH PSYCH CONS; Yoon JY, 2004, BRIT J PHARMACOL, V143, P765, DOI 10.1038/sj.bjp.0705969; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	34	51	51	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0235030	10.1371/journal.pone.0235030	http://dx.doi.org/10.1371/journal.pone.0235030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706783	Green Published, gold			2022-12-26	WOS:000579931700005
J	Ramaraju, S; Roula, MA; McCarthy, PW				Ramaraju, Sriharsha; Roula, Mohammed A.; McCarthy, Peter W.			Transcranial direct current stimulation and working memory: Comparison of effect on learning shapes and English letters	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PREFRONTAL CORTEX; BRAIN-STIMULATION; MOTOR CORTEX; MAGNETIC STIMULATION; NEGATIVE SYMPTOMS; TDCS; HEALTHY; SCHIZOPHRENIA; FACILITATION	We present the results of a study investigating whether there is an effect of Anodal-Transcranial Direct Current Stimulation (A-tDCS) on working memory (WM) performance. The relative effectiveness of A-tDCS onWM is investigated using a 2-back test protocol using two commonly used memory visual stimuli (shapes and letters). In a double-blinded, randomised, crossover, sham-controlled experiment, real A-tDCS and sham A-tDCS were applied separately to the left dorsolateral prefrontal cortex (L-DLPFC) of twenty healthy subjects. There was a minimal interval of one week between sham and real A-tDCS sessions. For the letters based stimulus experiment, 2-back test recall accuracy was measured for a set of English letters (A-L) which were presented individually in a randomised order where each was separated by a blank interval. A similar 2-back protocol was used for the shapes based stimuli experiment where instead of letters, a set of 12 geometric shapes were used. The working memory accuracy scores measured appeared to be significantly affected by memory stimulus type used and by the application of A-tDCS (repeated measures ANOVA p< 0.05). A large effect size (d = 0.98) and statistical significance between sham and real A-tDCSWM scores (p = 0.01) was found when shapes were used as a visual testing stimulus, while low (d = 0.38) effect size and insignificant difference (p = 0.15) was found when letters were used. This results are important as they show that recollection different stimuli used in working memory can be affected differently by A-tDCS application. This highlights the importance of considering using multiple methods ofWM testing when assessing the effectiveness of A-tDCS.	[Ramaraju, Sriharsha] Newcastle Univ, Interdisciplinary Comp & Complex Bio Syst ICOS Fa, Newcastle Upon Tyne, Tyne & Wear, England; [Roula, Mohammed A.] Univ South Wales, Med Elect & Signal Proc Res Unit, Treforest, Wales; [McCarthy, Peter W.] Univ South Wales, Clin Technol & Diagnost Res Unit, Treforest, Wales	Newcastle University - UK; University of South Wales; University of South Wales	Roula, MA (corresponding author), Univ South Wales, Med Elect & Signal Proc Res Unit, Treforest, Wales.	ali.roula@southwales.ac.uk		Ramaraju, Sriharsha/0000-0001-5958-0976	SR University of South Wales centenary PhD Scholarship University of South Wales	SR University of South Wales centenary PhD Scholarship University of South Wales	SR University of South Wales centenary PhD Scholarship University of South Wales https://www.southwales.ac.uk/No, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2004, EUR J NEUROSCI, V19, P2888, DOI 10.1111/j.1460-9568.2004.03367.x; Berryhill ME, 2012, NEUROSCI LETT, V521, P148, DOI 10.1016/j.neulet.2012.05.074; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Brunye TT, 2015, NEUROREPORT, V26, P296, DOI 10.1097/WNR.0000000000000348; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Courtney SM, 1998, PHILOS T R SOC B, V353, P1819, DOI 10.1098/rstb.1998.0334; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DYMOND AM, 1975, BIOL PSYCHIAT, V10, P101; Fiori V, 2011, J COGNITIVE NEUROSCI, V23, P2309, DOI 10.1162/jocn.2010.21579; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Floel A, 2007, BRAIN RES REV, V53, P250, DOI 10.1016/j.brainresrev.2006.08.006; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Goldman-Rakic PS, 1994, J NEUROPSYCHIATRY CL; GRAFMAN J, 1994, NEUROREPORT, V5, P1157, DOI 10.1097/00001756-199405000-00034; Harvey PD, 2001, AM J PSYCHIAT, V158, P176, DOI 10.1176/appi.ajp.158.2.176; Hautzel H, 2002, NEUROSCI LETT, V323, P156, DOI 10.1016/S0304-3940(02)00125-8; Hoy KE, 2013, NEUROPSYCHOLOGIA, V51, P1777, DOI 10.1016/j.neuropsychologia.2013.05.018; Hur J, 2017, COGNITION EMOTION, V31, P1294, DOI 10.1080/02699931.2016.1213703; Izzidien A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1584947; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jahanshahi M, 1998, BRAIN, V121, P1533, DOI 10.1093/brain/121.8.1533; Jones KT, 2015, NEUROIMAGE, V105, P238, DOI 10.1016/j.neuroimage.2014.11.012; Keshvari F, 2013, BASIC CLIN NEUROSCI, V4, P224; Klencklen G, 2017, LEARN MOTIV, V57, P48, DOI 10.1016/j.lmot.2017.01.007; Lindenmayer JP, 2007, J CLIN PSYCHIAT, V68, P368, DOI 10.4088/JCP.v68n0303; Martin DM, 2013, INT J NEUROPSYCHOPH, V16, P1927, DOI 10.1017/S1461145713000539; Matsumoto H, 2017, CLIN NEUROPHYS PRACT, V2, P19, DOI 10.1016/j.cnp.2016.12.003; Miller KM, 2009, ARCH CLIN NEUROPSYCH, V24, P711, DOI 10.1093/arclin/acp063; Morris R.G., 1994, NEUROPSYCHOLOGY, V8, P544; Mottaghy FM, 2000, NEUROSCI LETT, V280, P167, DOI 10.1016/S0304-3940(00)00798-9; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; Nilsson J, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00230; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nozari N, 2013, NEUROPSYCHOLOGIA, V51, P2770, DOI 10.1016/j.neuropsychologia.2013.08.019; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Oliveira JF, 2013, NEUROSCI LETT, V537, P60, DOI 10.1016/j.neulet.2013.01.023; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park SH, 2014, NEUROREPORT, V25, P122, DOI 10.1097/WNR.0000000000000080; Reiser B, 1999, CONFIDENCE INTERVALS; Riedel M, 2007, EUR ARCH PSY CLIN N, V257, P360, DOI 10.1007/s00406-007-0739-x; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Slaby I, 2015, NEUROREPORT, V26, P988, DOI 10.1097/WNR.0000000000000456; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Tsuchida A, 2009, J COGNITIVE NEUROSCI, V21, P2263, DOI 10.1162/jocn.2008.21172; Winograd-Gurvich C, 2006, BRAIN RES BULL, V70, P312, DOI 10.1016/j.brainresbull.2006.06.007; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012; Wykes T, 1999, SCHIZOPHRENIA BULL, V25, P291, DOI 10.1093/oxfordjournals.schbul.a033379; Wykes T, 2007, BRIT J PSYCHIAT, V190, P421, DOI 10.1192/bjp.bp.106.026575; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2; Zimmer HD, 2008, NEUROSCI BIOBEHAV R, V32, P1373, DOI 10.1016/j.neubiorev.2008.05.016	56	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0222688	10.1371/journal.pone.0222688	http://dx.doi.org/10.1371/journal.pone.0222688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706780	Green Published, gold			2022-12-26	WOS:000579931700002
J	Carter, KM; Lu, M; Luo, QW; Jiang, HM; An, LL				Carter, Kyle M.; Lu, Meng; Luo, Qianwen; Jiang, Hongmei; An, Lingling			Microbial community dissimilarity for source tracking with application in forensic studies	PLOS ONE			English	Article							DNA; IDENTIFICATION	Microbial source-tracking is a useful tool for trace evidence analysis in Forensics. Community-wide massively parallel sequencing profiles can bypass the need for satellite microbes or marker sets, which are unreliable when handling unstable samples. We propose a novel method utilizing Aitchison distance to select important suspects/sources, and then integrate it with existing algorithms in source tracking to estimate the proportions of microbial sample coming from important suspects/sources. A series of comprehensive simulation studies show that the proposed method is capable of accurate selection and therefore improves the performance of current methods such as Bayesian SourceTracker and FEAST in the presence of noise microbial sources.	[Carter, Kyle M.; Lu, Meng; An, Lingling] Univ Arizona, Interdisciplinary Program Stat & Data Sci, Tucson, AZ 85715 USA; [Luo, Qianwen; An, Lingling] Univ Arizona, Dept Biosyst Engn, Tucson, AZ 85715 USA; [Jiang, Hongmei] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [An, Lingling] Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ 85715 USA	University of Arizona; University of Arizona; Northwestern University; University of Arizona	An, LL (corresponding author), Univ Arizona, Interdisciplinary Program Stat & Data Sci, Tucson, AZ 85715 USA.; An, LL (corresponding author), Univ Arizona, Dept Biosyst Engn, Tucson, AZ 85715 USA.; An, LL (corresponding author), Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ 85715 USA.	anling@email.arizona.edu	Jiang, Hongmei/AAU-2911-2021	An, Lingling/0000-0001-8273-0776	National Science Foundation [DMS-1222592]; United States Department of Agriculture [ARZT-1360830-H22-138, ARZT1361620-H22-149]	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was partially supported by the National Science Foundation [DMS-1222592 to L. A.]; and the United States Department of Agriculture [ARZT-1360830-H22-138 and ARZT1361620-H22-149 to L.A.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TRAC EV; Brooke JS, 2009, J ENVIRON HEALTH, V71, P17; Brown CM, 2019, ENVIRON SCI TECHNOL, V53, P60, DOI 10.1021/acs.est.8b04707; Choi A, 2014, INT J LEGAL MED, V128, P33, DOI 10.1007/s00414-013-0918-4; Dawson P, 2007, J APPL MICROBIOL, V102, P945, DOI 10.1111/j.1365-2672.2006.03171.x; Doi M, 2014, FORENSIC SCI INT-GEN, V12, P93, DOI 10.1016/j.fsigen.2014.05.005; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Hagedorn C, 2011, MICROBIAL SOURCE TRACKING: METHODS, APPLICATIONS, AND CASE STUDIES, P515, DOI 10.1007/978-1-4419-9386-1_22; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Lax S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0082-9; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Martin-Fernandez A, MEASURES DIFFERENCE; ROEDER K, 1994, STAT SCI, V9, P222, DOI 10.1214/ss/1177010488; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Shenhav L, 2019, NATURE METHODS, V3, P21; Tims S, 2010, INT J LEGAL MED, V124, P477, DOI 10.1007/s00414-009-0352-9	17	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236082	10.1371/journal.pone.0236082	http://dx.doi.org/10.1371/journal.pone.0236082			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702000	Green Published, Green Submitted, gold			2022-12-26	WOS:000575913700046
J	Elmer, T; Mepham, K; Stadtfeld, C				Elmer, Timon; Mepham, Kieran; Stadtfeld, Christoph			Students under lockdown: Comparisons of students' social networks and mental health before and during the COVID-19 crisis in Switzerland	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; DEPRESSIVE SYMPTOMS; LONELINESS; VALIDITY; NEED	This study investigates students' social networks and mental health before and at the time of the COVID-19 pandemic in April 2020, using longitudinal data collected since 2018. We analyze change on multiple dimensions of social networks (interaction, friendship, social support, co-studying) and mental health indicators (depression, anxiety, stress, loneliness) within two cohorts of Swiss undergraduate students experiencing the crisis (N = 212), and make additional comparisons to an earlier cohort which did not experience the crisis (N = 54). In within-person comparisons we find that interaction and co-studying networks had become sparser, and more students were studying alone. Furthermore, students' levels of stress, anxiety, loneliness, and depressive symptoms got worse, compared to measures before the crisis. Stressors shifted from fears of missing out on social life to worries about health, family, friends, and their future. Exploratory analyses suggest that COVID-19 specific worries, isolation in social networks, lack of interaction and emotional support, and physical isolation were associated with negative mental health trajectories. Female students appeared to have worse mental health trajectories when controlling for different levels of social integration and COVID-19 related stressors. As universities and researchers discuss future strategies on how to combine on-site teaching with online courses, our results indicate the importance of considering social contacts in students' mental health and offer starting points to identify and support students at higher risk of social isolation and negative psychological effects during the COVID-19 pandemic.	[Elmer, Timon; Mepham, Kieran; Stadtfeld, Christoph] Swiss Fed Inst Technol, Social Networks Lab, Dept Humanities Social & Polit Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Elmer, T; Stadtfeld, C (corresponding author), Swiss Fed Inst Technol, Social Networks Lab, Dept Humanities Social & Polit Sci, Zurich, Switzerland.	timon.elmer@gess.ethz.ch; christoph.stadtfeld@ethz.ch	Elmer, Timon/P-7520-2019	Elmer, Timon/0000-0003-4354-4457	Swiss National Science Foundation [10001A_169965, 10DL17_183008]; rectorate of ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); rectorate of ETH Zurich(ETH Zurich)	The Swiss StudentLife Study (PI: Christoph Stadtfeld) was supported by Swiss National Science Foundation Grants 10001A_169965 and 10DL17_183008; and the rectorate of ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2009, STAT METHODS SOCIAL; Anderson RM, 2020, LANCET; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Boda Zsofia, 2020, SCI REPORTS, V10, P1, DOI DOI 10.1038/S41598-019-56847-4; BOLGER N, 1991, J PERS SOC PSYCHOL, V61, P440, DOI 10.1037/0022-3514.61.3.440; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Cohen S, 2000, SOCIAL SUPPORT MEASU; Crossley N., 2015, SOCIAL NETWORK ANAL; DiCiccio TJ, 1996, STAT SCI, V11, P189; Doreian P, 2012, SOC NETWORKS, V34, P32, DOI 10.1016/j.socnet.2010.09.002; Doring N., 1993, PSYCHOMETRISCHE EINS; Draper N.R., 1998, APPL REGRESSION ANAL; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Elmer T., 2020, INTERTWINED DYNAMICS; Elmer T, 2017, NETW SCI, V5, P278, DOI 10.1017/nws.2017.20; Festinger L., 1950, SOCIAL PRESSURES INF; Fried E, 2020, MENTAL HLTH SOCIAL C; Fuhrer R, 1999, SOC SCI MED, V48, P77, DOI 10.1016/S0277-9536(98)00290-1; GIBBONS RD, 1993, J EDUC STAT, V18, P271, DOI 10.3102/10769986018003271; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Hefner J, 2009, AM J ORTHOPSYCHIAT, V79, P491, DOI 10.1037/a0016918; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Klein EM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0875-9; Lang FR, 2001, DIAGNOSTICA, V47, P111, DOI 10.1026//0012-1924.47.3.111; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Luhmann M, 2016, J RES PERS, V61, P50, DOI 10.1016/j.jrp.2016.02.002; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Mikolajczyk RT, 2008, SOC PSYCH PSYCH EPID, V43, P105, DOI 10.1007/s00127-007-0282-0; Odriozola-Gonzalez P, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113108; Okamoto J, 2011, RES HUM DEV, V8, P67, DOI 10.1080/15427609.2011.549711; Przybylski AK, 2013, COMPUT HUM BEHAV, V29, P1841, DOI 10.1016/j.chb.2013.02.014; Robins G., 2015, DOING SOCIAL NETWORK; Rosa H, 2014, BESCHLEUNIGUNG VERAN; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stadtfeld C, 2019, P NATL ACAD SCI USA, V116, P792, DOI 10.1073/pnas.1811388115; THOMPSON B, 1995, EDUC PSYCHOL MEAS, V55, P525, DOI 10.1177/0013164495055004001; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van Os J, 2001, BRIT J PSYCHIAT, V178, pS72, DOI 10.1192/bjp.178.40.s72; Voros A, 2017, SOC NETWORKS, V49, P93, DOI 10.1016/j.socnet.2017.01.002	46	470	477	46	209	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236337	10.1371/journal.pone.0236337	http://dx.doi.org/10.1371/journal.pone.0236337			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32702065	Green Published, gold			2022-12-26	WOS:000575913700076
J	Leon, LA; Brandao, ML; Cardenas, FP; Parra, D; Krahe, TE; Cruz, APM; Landeira-Fernandez, J				Leon, Laura A.; Brandao, Marcus L.; Cardenas, Fernando P.; Parra, Diana; Krahe, Thomas E.; Mello Cruz, Antonio Pedro; Landeira-Fernandez, J.			Distinct patterns of brain Fos expression in Carioca High- and Low-conditioned Freezing Rats	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR ANTAGONISM; BASOLATERAL AMYGDALA; PERIRHINAL CORTEX; PREFRONTAL CORTEX; C-FOS; PRELIMBIC CORTEX; CINGULATE CORTEX; PARABRACHIAL NUCLEUS; VENTRAL HIPPOCAMPUS; GENERALIZED ANXIETY	Background The bidirectional selection of high and low anxiety-like behavior is a valuable tool for understanding the neurocircuits that are responsible for anxiety disorders. Our group developed two breeding lines of rats, known as Carioca High- and Low-conditioned Freezing (CHF and CLF), based on defensive freezing in the contextual fear conditioning paradigm. A random selected line was employed as a control (CTL) comparison group for both CHF and CLF lines of animals. The present study performed Fos immunochemistry to investigate changes in neural activity in different brain structures among CHF and CLF rats when they were exposed to contextual cues that were previously associated with footshock. Results The study indicated that CHF rats expressed high Fos expression in the locus coeruleus, periventricular nucleus of the hypothalamus (PVN), and lateral portion of the septal area and low Fos expression in the medial portion of the septal area, dentate gyrus, and prelimbic cortex (PL) compared to CTL animals. CLF rats exhibited a decrease in Fos expression in the PVN, PL, and basolateral nucleus of the amygdala and increase in the cingulate and perirhinal cortices compared to CTL animals. Conclusions Both CHF and CLF rats displayed Fos expression changes key regions of the anxiety brain circuitry. The two bidirectional lines exhibit different pattern of neural activation and inhibition with opposing influences on the PVN, the main structure involved in regulating the hypothalamic-pituitary-adrenal neuroendocrine responses observed in anxiety disorders.	[Leon, Laura A.; Brandao, Marcus L.] Univ Sao Paulo, Behav Neurosci Inst INeC, Lab Neuropsychopharmacol, FFCLRP, Campus USP, Ribeirao Preto, SP, Brazil; [Leon, Laura A.; Krahe, Thomas E.; Landeira-Fernandez, J.] Pontifical Catholic Univ Rio de Janeiro, Dept Psychol, Rio De Janeiro, Brazil; [Leon, Laura A.] Univ Sergio Arboleda, Programa Psicol, Bogota, Colombia; [Cardenas, Fernando P.; Parra, Diana] Univ Andes, Lab Neurociencia & Comportamiento, Bogota, Colombia; [Mello Cruz, Antonio Pedro] Univ Brasilia, Inst Psychol, Brasilia, DF, Brazil	Universidade de Sao Paulo; Pontificia Universidade Catolica do Rio de Janeiro; University Sergio Arboleda; Universidad de los Andes (Colombia); Universidade de Brasilia	Landeira-Fernandez, J (corresponding author), Pontifical Catholic Univ Rio de Janeiro, Dept Psychol, Rio De Janeiro, Brazil.	landeira@puc-rio.br	Anhuamán, Laura Andrea León/AAH-2780-2019; Cruz, Antonio Pedro Mello/AAO-7861-2020; Krahe, Thomas E/H-1695-2013; Landeira-Fernandez, J./F-6818-2012	Anhuamán, Laura Andrea León/0000-0002-5573-7750; Krahe, Thomas E/0000-0002-4686-9284; Landeira-Fernandez, J./0000-0002-8395-8008; Cardenas, Fernando/0000-0002-8826-6211	National Council for Scientific and Technological Development (CNPq); Rio de Janeiro State Research Foundation (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the National Council for Scientific and Technological Development (CNPq) and Rio de Janeiro State Research Foundation (FAPERJ) to JLF. This study was also financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) - Finance Code 001. LAL had a doctoral fellowship from CAPES.	Albrechet-Souza L, 2009, NEUROSCIENCE, V164, P387, DOI 10.1016/j.neuroscience.2009.08.038; Angeli E, 2018, PSYCHONEUROENDOCRINO, V90, P174, DOI 10.1016/j.psyneuen.2018.02.026; [Anonymous], 2014, TRENDS PSYCHOL, DOI [10.9788/tp2014.3-11, DOI 10.9788/TP2014.3-11]; [Anonymous], 2011, ANXIETY DISORDERS; BECK CHM, 1995, J NEUROSCI, V15, P709; Bhatnagar S, 2004, ANN NY ACAD SCI, V1032, P315, DOI 10.1196/annals.1314.050; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P761; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; Bucci DJ, 2000, BEHAV NEUROSCI, V114, P882, DOI 10.1037//0735-7044.114.5.882; BULLITT E, 1992, BRAIN RES, V580, P172, DOI 10.1016/0006-8993(92)90941-2; Burwell RD, 2004, J NEUROSCI, V24, P11023, DOI 10.1523/JNEUROSCI.3781-04.2004; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CACERES A, 1981, NEUROENDOCRINOLOGY, V32, P317, DOI 10.1159/000123180; Calandreau L, 2007, LEARN MEMORY, V14, P422, DOI 10.1101/lm.531407; Canteras NS, 2010, CURR TOP BEHAV NEURO, V2, P77, DOI 10.1007/7854_2009_7; Cavaliere DR, 2020, NEUROSCI LETT, V715, DOI 10.1016/j.neulet.2019.134632; CHAMBERLIN NL, 1994, J NEUROSCI, V14, P6500; Conrad CD, 2004, NEUROBIOL LEARN MEM, V81, P185, DOI 10.1016/j.nlm.2004.01.002; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; Dampney RAL, 2003, PROG NEUROBIOL, V71, P359, DOI 10.1016/j.pneurobio.2003.11.001; DEACON TW, 1983, J COMP NEUROL, V220, P168, DOI 10.1002/cne.902200205; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dias GP, 2014, BEHAV BRAIN RES, V263, P34, DOI 10.1016/j.bbr.2014.01.012; Dias GP, 2009, BEHAV BRAIN RES, V205, P342, DOI 10.1016/j.bbr.2009.06.038; DIORIO D, 1993, J NEUROSCI, V13, P3839; Donley MP, 2005, BEHAV BRAIN RES, V164, P197, DOI 10.1016/j.bbr.2005.06.020; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; French PJ, 2001, EUR J NEUROSCI, V13, P968, DOI 10.1046/j.0953-816x.2001.01467.x; Galvão Bruno de Oliveira, 2011, Psychol. Neurosci., V4, P205, DOI 10.3922/j.psns.2011.2.005; Gilmartin MR, 2012, NEUROBIOL LEARN MEM, V97, P452, DOI 10.1016/j.nlm.2012.03.009; Gomes VD, 2008, BRAIN RES, V1233, P137, DOI 10.1016/j.brainres.2008.07.044; Gonzalez F, 2003, J EXP PSYCHOL-ANIM B, V29, P78, DOI 10.1037//0097-7403.29.1.78; Graeff Frederico Guilherme, 2010, Psychol. Neurosci., V3, P3, DOI 10.3922/j.psns.2010.1.002; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Haller J, 2012, CURR OPIN PSYCHIATR, V25, P59, DOI 10.1097/YCO.0b013e32834de34f; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; He QY, 2019, NEUROSCI BULL, V35, P369, DOI 10.1007/s12264-018-0291-x; Herman JP, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00137; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Holmes NM, 2013, J NEUROSCI, V33, P13112, DOI 10.1523/JNEUROSCI.1998-13.2013; Indovina I, 2011, NEURON, V69, P563, DOI 10.1016/j.neuron.2010.12.034; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Jhang J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05090-y; Jones BF, 2007, HIPPOCAMPUS, V17, P957, DOI 10.1002/hipo.20330; Jones KR, 2011, PHYSIOL BEHAV, V104, P266, DOI 10.1016/j.physbeh.2011.03.021; Kalisch R, 2004, NEUROIMAGE, V23, P382, DOI 10.1016/j.neuroimage.2004.06.012; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Koo JW, 2004, J NEUROSCI, V24, P7654, DOI 10.1523/JNEUROSCI.1644-04.2004; LandeiraFernandez J, 1996, BRAZ J MED BIOL RES, V29, P149; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leon LA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00117; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; LIMA D, 1994, NEUROREPORT, V5, P1853, DOI 10.1097/00001756-199410000-00003; Maren S, 1996, BEHAV NEUROSCI, V110, P718, DOI 10.1037/0735-7044.110.4.718; Maren S, 1999, J NEUROSCI, V19, P8696; Misslin R, 2003, NEUROPHYSIOL CLIN, V33, P55, DOI 10.1016/S0987-7053(03)00009-1; MORGAN JI, 1991, TRENDS PHARMACOL SCI, V12, P343, DOI 10.1016/0165-6147(91)90594-I; Mousovich-Neto F, 2015, PHYSIOL BEHAV, V142, P90, DOI 10.1016/j.physbeh.2015.01.028; Nakamura K, 2010, P NATL ACAD SCI USA, V107, P8848, DOI 10.1073/pnas.0913358107; NYAKAS C, 1987, BRAIN RES BULL, V18, P533, DOI 10.1016/0361-9230(87)90117-1; Onishi BKA, 2010, NEUROBIOL LEARN MEM, V93, P165, DOI 10.1016/j.nlm.2009.09.007; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perusini JN, 2015, LEARN MEMORY, V22, P417, DOI 10.1101/lm.039180.115; Reis FMCV, 2016, CEREB CORTEX, V26, P2639, DOI 10.1093/cercor/bhv103; Ressler RL, 2019, CURR OPIN NEUROBIOL, V54, P54, DOI 10.1016/j.conb.2018.08.012; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Robinson-Drummer PA, 2017, NEUROBIOL LEARN MEM, V143, P27, DOI 10.1016/j.nlm.2017.04.003; Roozendaal B, 1997, NEUROBIOL LEARN MEM, V67, P176, DOI 10.1006/nlme.1996.3765; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Saleh TM, 1998, NEUROSCIENCE, V87, P135, DOI 10.1016/S0306-4522(98)00149-3; Salome N, 2004, BIOL PSYCHIAT, V55, P715, DOI 10.1016/j.biopsych.2003.10.021; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; Schloss S, 2018, DEV PSYCHOBIOL, V60, P722, DOI 10.1002/dev.21627; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; Sparks Peter D., 2000, P234; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; Stein DJ, 2017, DIALOGUES CLIN NEURO, V19, P127; Sullivan GM, 1999, BIOL PSYCHIAT, V46, P1205, DOI 10.1016/S0006-3223(99)00246-2; SWANSON LW, 1979, J COMP NEUROL, V186, P621, DOI 10.1002/cne.901860408; Tsanov M, 2018, EUR J NEUROSCI, V48, P2783, DOI 10.1111/ejn.13746; Twining RC, 2020, J NEUROSCI, V40, P3217, DOI 10.1523/JNEUROSCI.1453-19.2020; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; West-Eberhard MJ, 2005, J EXP ZOOL PART B, V304B, P610, DOI 10.1002/jez.b.21071; Wislowska-Stanek A, 2013, NEUROSCI LETT, V533, P17, DOI 10.1016/j.neulet.2012.11.012; Yang ST, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0061-2; Yen YC, 2011, PHARMACOPSYCHIATRY, V21, pA124; Yen YC, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00103; YOSHIDA K, 1995, NEUROSCI RES, V21, P199, DOI 10.1016/0168-0102(94)00852-7; Zhou TL, 1999, HIPPOCAMPUS, V9, P220, DOI 10.1002/(SICI)1098-1063(1999)9:3<220::AID-HIPO3>3.0.CO;2-E; Ziegler DR, 1999, J NEUROENDOCRINOL, V11, P361	97	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236039	10.1371/journal.pone.0236039	http://dx.doi.org/10.1371/journal.pone.0236039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702030	Green Published, gold			2022-12-26	WOS:000575913700043
J	Liang, SH; Walther, BA; Shieh, BS				Liang, Shih-Hsiung; Walther, Bruno Andreas; Shieh, Bao-Sen			Determinants of establishment success: Comparing alien and native freshwater fishes in Taiwan	PLOS ONE			English	Article							RISK-ASSESSMENT; AQUACULTURE; FRAMEWORK; INVADERS; PERFORMANCE; IMPACTS; TRADE	Many parts of Asia, including Taiwan, have suffered severely from freshwater fish invasions. However, few studies using an assemblage approach have been conducted in the region so far that would help to prioritize suitable preventive actions. In this study, we focused on the invasion process from the import stage to the establishment stage, and defined establishment success as the success during this predefined process. We used datasets of freshwater fish assemblages in Taiwan to (1) compare established versus non-established alien species to distinguish the determinants of establishment success, and (2) to use these determinants to test a life history hypothesis which predicts that the magnitudes of the determinants should be significantly different between established alien species and native species. We collated a dataset for freshwater fish species which were imported into Taiwan (n = 118) of which some successfully established (n = 26), and another dataset for freshwater fish species native to Taiwan (n = 77). For each imported species, we collected data for 17 variables, including two phylogenetic, two human-use, two invasion history, and 11 life history variables. We then used decision tree methods, which have advantages in analyzing datasets with many variables of mixed types without the need to make assumptions about data distributions and input data for missing values. Our results showed that aquaculture use and maximum body length were the most important determinants for predicting establishment success of alien freshwater fish in Taiwan. Comparing five important determinants between established alien versus native species showed that the established alien species were significantly more often used in aquaculture, were associated with a higher number of established countries, and had a larger body length and greater highest water temperature tolerance than the native species. We thus conclude that our results provided evidence to support our stated hypothesis. We suggest that aquaculture use, measures of body size, and the number of previously invaded countries may alert researchers and conservation managers to species with a high establishment potential, especially for countries with similar conditions as those in Taiwan.	[Liang, Shih-Hsiung] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Walther, Bruno Andreas] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Shieh, Bao-Sen] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Shieh, Bao-Sen] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	National Kaohsiung Normal University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Shieh, BS (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.; Shieh, BS (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	bsshieh@kmu.edu.tw		Shieh, Bao-Sen/0000-0002-5438-3735	Ministry of Science and Technology, Taiwan, R.O.C.; MOST [108-2621-B-017-001-MY3]; Taiwan Forestry Bureau	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); MOST; Taiwan Forestry Bureau	This work was supported by the Ministry of Science and Technology, Taiwan, R.O.C. (grant no. MOST 108-2621-B-017-001-MY3) and the Taiwan Forestry Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adikari Y, 2010, J FLOOD RISK MANAG, V3, P185, DOI 10.1111/j.1753-318X.2010.01068.x; Ahmed N, 2019, ENVIRON MANAGE, V63, P159, DOI 10.1007/s00267-018-1117-3; Ahmed N, 2019, SCI TOTAL ENVIRON, V652, P851, DOI 10.1016/j.scitotenv.2018.10.163; Blanchet S, 2010, ECOL LETT, V13, P421, DOI 10.1111/j.1461-0248.2009.01432.x; Chan FKS, 2018, J CLEAN PROD, V187, P576, DOI 10.1016/j.jclepro.2018.03.217; Chen CL, 2014, MAR POLICY, V48, P152, DOI 10.1016/j.marpol.2014.03.026; Chen I. S., 2010, SURVEY CONSERVATION; Chiu YW, 2012, ZOOL STUD, V51, P1438; Cucherousset J, 2011, FISHERIES, V36, P215, DOI 10.1080/03632415.2011.574578; Dana ED, 2014, ORYX, V48, P56, DOI 10.1017/S0030605312001263; De Silva SS, 2009, AMBIO, V38, P24, DOI 10.1579/0044-7447-38.1.24; Fridley JD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1157, DOI 10.1111/geb.12221; GJEDREM T, 1983, AQUACULTURE, V33, P51, DOI 10.1016/0044-8486(83)90386-1; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Gozlan RE, 2008, FISH FISH, V9, P106, DOI 10.1111/j.1467-2979.2007.00267.x; Hall P, 2014, OVERVIEW MACHINE LEA; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hou Ping-Chun Lucy, 2006, Taiwania, V51, P87; Huang KT, 2016, APPL ENERG, V184, P1230, DOI 10.1016/j.apenergy.2015.11.008; Kalous L, 2015, ACTA ICHTHYOL PISCAT, V45, P239, DOI 10.3750/AIP2015.45.3.03; Keller RP, 2011, DIVERS DISTRIB, V17, P451, DOI 10.1111/j.1472-4642.2011.00748.x; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Li KC, 2016, ZOOL STUD, V55, DOI 10.6620/ZS.2016.55-53; Liang S. H., 2011, ESTABLISHMENT LIFE H; Liang S. H., 2008, COMP ASSESSMENT INVA; Liang S. H., 2015, APPL ANAL LIFE HIST; Liang SH, 2005, ZOOL STUD, V44, P252; Liang Shih-Hisung, 2006, Taiwania, V51, P93; Liang SH, 2017, PEERJ, V5, DOI 10.7717/peerj.3092; Lin Yu-Hsung, 2006, Taiwania, V51, P99; Little DC, 2018, AQUACULTURE, V493, P338, DOI 10.1016/j.aquaculture.2017.12.033; Liu CL, 2017, AQUAT CONSERV, V27, P773, DOI 10.1002/aqc.2740; Milardi M, 2018, SCI TOTAL ENVIRON, V624, P1325, DOI 10.1016/j.scitotenv.2017.12.237; Moyle PB, 2006, BIOSCIENCE, V56, P515, DOI 10.1641/0006-3568(2006)56[515:PISFFI]2.0.CO;2; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; Nguyen N. H, 2016, FISH FISHERIES, V17, P483; Olinsky A, 2014, MAT DEP J ARTICL, V5, P12; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pimentel D, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P1, DOI 10.1201/b10938; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Casimiro ACR, 2018, ZOOLOGIA-CURITIBA, V35, DOI 10.3897/zoologia.35.e14638; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; SAS Institute Inc, 2013, SAS ENT MIN 131 EXT; Severinghaus LL, 1999, BIOL CONSERV, V89, P301, DOI 10.1016/S0006-3207(98)00155-4; Shao K.T., 2008, TAIWAN SPECIES DIVER; Shiau Tsu-Way, 2006, Taiwania, V51, P71; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Vitule JRS, 2009, FISH FISH, V10, P98, DOI 10.1111/j.1467-2979.2008.00312.x; Sogard SM, 1997, B MAR SCI, V60, P1129; Tecco PA, 2010, J ECOL, V98, P17, DOI 10.1111/j.1365-2745.2009.01592.x; Toussaint A, 2016, BIOL INVASIONS, V18, P1295, DOI 10.1007/s10530-016-1067-8; Toussaint A, 2014, GLOBAL ECOL BIOGEOGR, V23, P574, DOI 10.1111/geb.12141; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Williamson MA, 2020, BIOL INVASIONS, V22, P663, DOI 10.1007/s10530-019-02120-8; Xiong W, 2015, REV FISH BIOL FISHER, V25, P651, DOI 10.1007/s11160-015-9396-8	58	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236427	10.1371/journal.pone.0236427	http://dx.doi.org/10.1371/journal.pone.0236427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702074	gold, Green Published			2022-12-26	WOS:000575913700092
J	Toonkomdang, S; Phinyo, P; Phetsuksiri, B; Patumanond, J; Rudeeaneksin, J; Klayut, W; Lin, BC				Toonkomdang, Sarawut; Phinyo, Phichayut; Phetsuksiri, Benjawan; Patumanond, Jayanton; Rudeeaneksin, Janisara; Klayut, Wiphat; Lin, Baochuan			Pragmatic accuracy of an in-house loop-mediated isothermal amplification (LAMP) for diagnosis of pulmonary tuberculosis in a Thai community hospital	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RAPID IDENTIFICATION; ASSAY; PERFORMANCE; COMPLEX	Background To improve the quality of diagnosing pulmonary tuberculosis (TB), WHO recommends the use of rapid molecular testing as an alternative to conventional microscopic methods. Loop-mediated isothermal amplification assay (LAMP test) is a practical and cost-effective nucleic amplification technique. We evaluated the pragmatic accuracy of an in-house LAMP assay for the diagnosis of TB in a remote health care setting where an advanced rapid molecular test is not available. Methods A prospective diagnostic accuracy study was conducted. Patients with clinical symptoms suggestive of TB were consecutively enrolled from April to August 2016. Sputum samples were collected from each patient and were sent for microscopic examination (both acid-fast stain and fluorescence stain), in-house LAMP test, and TB culture. Results One hundred and seven patients with TB symptoms were used in the final analysis. This included 50 (46.7%) culture-positive TB patients and 57 (53.3%) culture-negative patients. The overall sensitivity of the in-house LAMP based on culture positivity was 88.8% (95/107) with a 95%CI of 81.2-94.1. The sensitivity was 90.9% (40/44) with a 95%CI of 78.3-97.5 for smear-positive, culture-positive patients, and was 16.7% (1/6) with a 95%CI of 0.4-64.1 for smear-negative, culture-positive patients. The overall sensitivity of the in-house LAMP test compared to smear microscopy methods were not significantly different (p = 0.375). The specificity of the in-house LAMP based on non-TB patients (smear-negative, culture-negative) was 94.7% (54/57) with a 95%CI of 85.4-98.9. Conclusions The diagnostic accuracy of the in-house LAMP test in a community hospital was comparable to other previous reports in terms of specificity. The sensitivity of the in-house assay could be improved with better sputum processing and DNA extraction method.	[Toonkomdang, Sarawut] Maesot Gen Hosp, Dept Med Technol, Tak, Thailand; [Phinyo, Phichayut] Chiang Mai Univ, Fac Med, Dept Family Med, Chiang Mai, Thailand; [Phinyo, Phichayut; Patumanond, Jayanton] Chiang Mai Univ, Fac Med, Ctr Clin Epidemiol & Clin Stat, Chiang Mai, Thailand; [Phetsuksiri, Benjawan; Rudeeaneksin, Janisara; Klayut, Wiphat; Lin, Baochuan] Natl Inst Hlth, Dept Med Sci, Minist Publ Hlth, Nonthaburi, Thailand	Chiang Mai University; Chiang Mai University; Ministry of Public Health - Thailand	Phinyo, P (corresponding author), Chiang Mai Univ, Fac Med, Dept Family Med, Chiang Mai, Thailand.; Phinyo, P (corresponding author), Chiang Mai Univ, Fac Med, Ctr Clin Epidemiol & Clin Stat, Chiang Mai, Thailand.	phichayutphinyo@gmail.com	Phetsuksiri, Benjawan/AAE-7721-2022	Phinyo, Phichayut/0000-0002-8543-6254				[Anonymous], 2016, US LOOP MED IS AMPL; Cudahy P, 2016, POSTGRAD MED J, V92, P187, DOI 10.1136/postgradmedj-2015-133278; Eddabra R, 2018, PNEUMONIA, V10, DOI 10.1186/s41479-018-0049-2; Geojith G, 2011, J MICROBIOL METH, V84, P71, DOI 10.1016/j.mimet.2010.10.015; George G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021007; Gray CM, 2016, J CLIN MICROBIOL, V54, P1984, DOI 10.1128/JCM.03036-15; Habeenzu C, 2017, J INFECT DEV COUNTR, V11, P440, DOI 10.3855/jidc.7730; Ho J, 2015, INT J TUBERC LUNG D, V19, P537, DOI 10.5588/ijtld.14.0798; Kadioglu EE, 2014, EURASIAN J MED, V46, P74, DOI 10.5152/eajm.2014.19; Kaku T, 2016, JPN J INFECT DIS, V69, P488, DOI 10.7883/yoken.JJID.2015.519; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim CK, 2018, ANN LAB MED, V38, P119, DOI 10.3343/alm.2018.38.2.119; Kohan L, 2011, AFR J BIOTECHNOL, V10, P5096; Lee MF, 2009, J MICROBIOL METH, V76, P174, DOI 10.1016/j.mimet.2008.10.005; Li YM, 2014, J MICROBIOL METH, V104, P55, DOI 10.1016/j.mimet.2014.06.011; Nagai K, 2016, SCI REP-UK, V6, DOI 10.1038/srep39090; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; Pandey BD, 2008, J MED MICROBIOL, V57, P439, DOI 10.1099/jmm.0.47499-0; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Pathak D, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-83; Phetsuksiri B, 2020, JPN J INFECT DIS, V73, P272, DOI 10.7883/yoken.JJID.2019.335; Phetsuksiri B, 2013, JPN J INFECT DIS, V66, P249, DOI 10.7883/yoken.66.249; Poudel A, 2009, Kathmandu Univ Med J (KUMJ), V7, P109; Rafati A, 2015, MICROCHIM ACTA, V182, P523, DOI 10.1007/s00604-014-1354-y; Rudeeaneksin J., 2017, J HEALTH SCI, V19, P300; Rudeeaneksin J, 2012, JPN J INFECT DIS, V65, P306, DOI 10.7883/yoken.65.306; Sethi SK, 2013, J CLIN LAB ANAL, V27, P272, DOI 10.1002/jcla.21596; Shea YR, 2009, J CLIN MICROBIOL, V47, P1553, DOI 10.1128/JCM.00348-09; Shete PB, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3881-y; Shi J, 2018, BIOMED RES INT; Sohn H, 2019, J GLOB HLTH SCI, V1, pe22, DOI [10.35500/jghs.2019.1.e22, DOI 10.35500/JGHS.2019.1.E22]; Pham TH, 2018, INT J INFECT DIS, V68, P44, DOI 10.1016/j.ijid.2018.01.005; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Yan LP, 2016, TUBERCULOSIS, V96, P75, DOI 10.1016/j.tube.2015.11.005; Yoon SH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-172	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236496	10.1371/journal.pone.0236496	http://dx.doi.org/10.1371/journal.pone.0236496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702008	Green Published, gold			2022-12-26	WOS:000575913700096
J	Vasconcelos, NG; Queiroz, JHFD; da Silva, KE; Vasconcelos, PCD; Croda, J; Simionatto, S				Vasconcelos, Nathalie Gaebler; Ferreira de Sa Queiroz, Julio Henrique; da Silva, Kesia Esther; de Paula Vasconcelos, Paulo Cesar; Croda, Julio; Simionatto, Simone			Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens	PLOS ONE			English	Article							IN-VITRO; ANTIMICROBIAL ACTIVITY; TRANS-CINNAMALDEHYDE; MULTIPLEX PCR; ANTIBACTERIAL; OUTBREAK; COLISTIN; TIME	Multidrug resistance prompts the search for new sources of antibiotics with new targets at bacteria cell. To investigate the antibacterial activity of Cinnamomum cassia L. essential oil (CCeo) alone and in combination with antibiotics against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens. The antimicrobial susceptibility of the strains was determined by Vitek (R) 2 and confirmed by MALDI-TOF/TOF. The antibacterial activity of CCeo and its synergism with antibiotics was determined using agar disk diffusion, broth microdilution, time-kill, and checkboard methods. The integrity of the bacterial cell membrane in S. marcescens was monitored by protein leakage assay. CCeo exhibited inhibitory effects with MIC = 281.25 mu g.mL(-1). The association between CCeo and polymyxin B showed a decrease in terms of viable cell counts on survival curves over time after a 4 hour-treatment with a FIC index value of 0.006. Protein leakage was observed with increasing concentrations for CCeo and CCeo + polymyxin B treatments. CCeo showed antibacterial activity against the studied strains. When associated with polymyxin B, a synergistic effect was able to inhibit bacterial growth rapidly and consistently, making it a potential candidate for the development of an alternative treatment and drug delivery system for carbapenemase-producing strains.	[Vasconcelos, Nathalie Gaebler; Ferreira de Sa Queiroz, Julio Henrique; da Silva, Kesia Esther; Croda, Julio; Simionatto, Simone] Univ Fed Grande Dourados UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil; [Vasconcelos, Nathalie Gaebler; de Paula Vasconcelos, Paulo Cesar] Univ Fed Grande Dourados UFGD, Hosp Univ Dourados, Dourados, MS, Brazil; [Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil; [Croda, Julio] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso do Sul	Simionatto, S (corresponding author), Univ Fed Grande Dourados UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.	simonesimionatto@ufgd.edu.br	Croda, Julio/I-5172-2013	Croda, Julio/0000-0002-6665-6825	National Council for Scientific and Technological Development (CNPq) [480949/2013-1, 407791/2013-2]; Support Foundation for the Development of Education, Science and Technology in the State of Mato Grosso do Sul (FUNDECT) [05/2011, 04/2012]; Coordination for the Improvement of Higher Education Personnel (CAPES); Federal University of Grande Dourados (UFGD); CAPES; FUNDECT; Laboratorio de Pesquisa em Ciencia da Saude (LPCS); Universidade Federal da Grande Dourados (UFGD); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Support Foundation for the Development of Education, Science and Technology in the State of Mato Grosso do Sul (FUNDECT)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Support Foundation for the Development of Education, Science and Technology in the State of Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Federal University of Grande Dourados (UFGD); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Laboratorio de Pesquisa em Ciencia da Saude (LPCS); Universidade Federal da Grande Dourados (UFGD); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Support Foundation for the Development of Education, Science and Technology in the State of Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	This work was partially supported by the National Council for Scientific and Technological Development (CNPq grants 480949/2013-1 and 407791/2013-2) - www.cnpq.br; the Support Foundation for the Development of Education, Science and Technology in the State of Mato Grosso do Sul (FUNDECT grants 05/2011 and 04/2012) - www.fundect.ms.gov.br; Coordination for the Improvement of Higher Education Personnel (CAPES) and Federal University of Grande Dourados (UFGD). K.E.S. received a scholarship from CAPES and J.H.F.S.Q from FUNDECT. The sponsors had no role in the collection, analysis and interpretation of data or the writing of the manuscript. There was no additional external funding received for this study.; The authors thank the financial support and infrastructure provided by the Laboratorio de Pesquisa em Ciencia da Saude (LPCS) and Universidade Federal da Grande Dourados (UFGD) which made this study possible, thank the Hospital Universitario da Universidade Federal da Grande Dourados (HU-UFGD) for the strains of the study. K.E.S. received a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and J.H. F.S.Q. from Support Foundation for the Development of Education, Science and Technology in the State of Mato Grosso do Sul (FUNDECT).	Adukwu EC, 2016, APPL MICROBIOL BIOT, V100, P9619, DOI 10.1007/s00253-016-7807-y; Albano M, 2016, INNOV FOOD SCI EMERG, V38, P83, DOI 10.1016/j.ifset.2016.09.003; Barbosa LN, 2015, J OLEO SCI, V64, P289, DOI 10.5650/jos.ess14209; Bialvaei AZ, 2015, CURR MED RES OPIN, V31, P707, DOI 10.1185/03007995.2015.1018989; Bickers D, 2005, FOOD CHEM TOXICOL, V43, P799, DOI 10.1016/j.fct.2004.09.013; Brasiliense D, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190020; Campos AC, 2016, AM J INFECT CONTROL, V44, P1374, DOI 10.1016/j.ajic.2016.03.022; Carvalhaes CG, 2013, J CLIN MICROBIOL, V51, P287, DOI 10.1128/JCM.02365-12; Cavalcanti Y.W., 2011, REV ODONTOL BRAS CEN, V20, P68; CLSI, C28A3 CLSI, V29th; Cole JM, 2009, J CLIN MICROBIOL, V47, P322, DOI 10.1128/JCM.01550-08; da Silva KE, 2016, J MED MICROBIOL, V65, P547, DOI 10.1099/jmm.0.000254; Dave VS, 2015, J PHARM SCI-US, V104, P906, DOI 10.1002/jps.24299; Franklyne J, 2016, LETT APPL MICROBIOL, V63, P322, DOI 10.1111/lam.12631; Gheorghe I, 2014, J MED MICROBIOL, V63, P1303, DOI 10.1099/jmm.0.074039-0; Hammoudi D, 2014, J MICROBIOL METH, V107, P106, DOI 10.1016/j.mimet.2014.09.009; HAYASHI M, 1988, FOOD CHEM TOXICOL, V26, P487, DOI 10.1016/0278-6915(88)90001-4; Helal A, 2014, J FUNCT FOODS, V7, P506, DOI 10.1016/j.jff.2014.01.005; Javan AO, 2015, EUR J CLIN PHARMACOL, V71, P801, DOI 10.1007/s00228-015-1865-4; Lammari N, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12050431; Liang QQ, 2019, BRAZ J INFECT DIS, V23, P60, DOI 10.1016/j.bjid.2018.12.004; Lin QY, 2014, ANTIMICROB AGENTS CH, V58, P5181, DOI 10.1128/AAC.00013-14; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Marto JM, 2018, J MICROENCAPSUL, V35, P344, DOI 10.1080/02652048.2018.1487472; Mlynarcik Patrik, 2016, Jundishapur J Microbiol, V9, pe29314, DOI 10.5812/jjm.29314; Morinaka A, 2016, ANTIMICROB AGENTS CH, V60, P3001, DOI 10.1128/AAC.02704-15; Andrade BFMT, 2014, J ESSENT OIL RES, V26, P34, DOI 10.1080/10412905.2013.860409; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Trinh NTT, 2015, CAN J MICROBIOL, V61, P263, DOI 10.1139/cjm-2014-0481; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; Peters M, 1993, THESIS; PETERS MMCG, 1994, FOOD CHEM TOXICOL, V32, P869, DOI 10.1016/0278-6915(94)90084-1; Quarto di Palo FM, 1961, ATTI ACCAD MED LOMB, V16, P180; Silva KE, 2015, J CLIN MICROBIOL, V53, P2324, DOI 10.1128/JCM.00727-15; van Vuuren S, 2011, PLANTA MED, V77, P1168, DOI 10.1055/s-0030-1250736; Vasconcelos NG, 2018, MICROB PATHOGENESIS, V120, P198, DOI 10.1016/j.micpath.2018.04.036; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; WONG-LEUNG Y L, 1988, Fitoterapia, V59, P11; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Yap PSX, 2015, J MICROBIOL BIOTECHN, V25, P1299, DOI 10.4014/jmb.1407.07054	42	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236505	10.1371/journal.pone.0236505	http://dx.doi.org/10.1371/journal.pone.0236505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701970	Green Published, gold			2022-12-26	WOS:000575913700098
J	Besaw, JE; Ou, WL; Morizumi, T; Eger, BT; Vasquez, JDS; Chu, JHY; Harris, A; Brown, LS; Miller, RJD; Ernst, OP				Besaw, Jessica E.; Ou, Wei-Lin; Morizumi, Takefumi; Eger, Bryan T.; Sanchez Vasquez, Juan D.; Chu, Jessica H. Y.; Harris, Andrew; Brown, Leonid S.; Miller, R. J. Dwayne; Ernst, Oliver P.			The crystal structures of a chloride-pumping microbial rhodopsin and its proton-pumping mutant illuminate proton transfer determinants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mastigocladopsis repens; microbial rhodopsin; cyanobacterial rhodopsin; chloride pump; proton pump; retinal protein; membrane protein; functional interconversion; bicelle crystallization; structure&#8211; function; chloride transport; X-ray crystallography; protein structure; bacteriorhodopsin; functional conversion	TRANSPORT MECHANISM; MEMBRANE-PROTEIN; ION PUMP; BACTERIORHODOPSIN; HALORHODOPSIN; CONVERSION; DIVERSITY; BINDING	Microbial rhodopsins are versatile and ubiquitous retinal-binding proteins that function as light-driven ion pumps, light-gated ion channels, and photosensors, with potential utility as optogenetic tools for altering membrane potential in target cells. Insights from crystal structures have been central for understanding proton, sodium, and chloride transport mechanisms of microbial rhodopsins. Two of three known groups of anion pumps, the archaeal halorhodopsins (HRs) and bacterial chloride-pumping rhodopsins, have been structurally characterized. Here we report the structure of a representative of a recently discovered third group consisting of cyanobacterial chloride and sulfate ion-pumping rhodopsins, the Mastigocladopsis repens rhodopsin (MastR). Chloride-pumping MastR contains in its ion transport pathway a unique Thr-Ser-Asp (TSD) motif, which is involved in the binding of a chloride ion. The structure reveals that the chloride-binding mode is more similar to HRs than chloride-pumping rhodopsins, but the overall structure most closely resembles bacteriorhodopsin (BR), an archaeal proton pump. The MastR structure shows a trimer arrangement reminiscent of BR-like proton pumps and shows features at the extracellular side more similar to BR than the other chloride pumps. We further solved the structure of the MastR-T74D mutant, which contains a single amino acid replacement in the TSD motif. We provide insights into why this point mutation can convert the MastR chloride pump into a proton pump but cannot in HRs. Our study points at the importance of precise coordination and exact location of the water molecule in the active center of proton pumps, which serves as a bridge for the key proton transfer.	[Besaw, Jessica E.; Ou, Wei-Lin; Morizumi, Takefumi; Eger, Bryan T.; Sanchez Vasquez, Juan D.; Chu, Jessica H. Y.; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Besaw, Jessica E.; Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON, Canada; [Sanchez Vasquez, Juan D.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Harris, Andrew; Brown, Leonid S.] Univ Guelph, Dept Phys, Guelph, ON, Canada; [Harris, Andrew; Brown, Leonid S.] Univ Guelph, Biophys Interdept Grp, Guelph, ON, Canada; [Ou, Wei-Lin] High Q Technol Inc, Waterloo, ON, Canada; [Chu, Jessica H. Y.] Univ Western Ontario, Dept Med Sci, London, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Guelph; University of Guelph; Western University (University of Western Ontario)	Ernst, OP (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.; Ernst, OP (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	oliver.ernst@utoronto.ca	Morizumi, Takefumi/AAA-2063-2021; Brown, Leonid/X-7445-2019	Morizumi, Takefumi/0000-0002-2785-209X; Brown, Leonid/0000-0002-5614-8317; Besaw, Jessica/0000-0002-7571-7132; Eger, Bryan/0000-0003-3350-9332	Department of Energy Office of Science [DE-AC02-06CH11357]; NIH [S10 OD012289]	Department of Energy Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Emil F. Pai for discussions and helpful suggestions about determination of the MastR structure. This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. The Eiger 16M detector at GM/CA-XSD was funded by NIH grant S10 OD012289. We specifically thank the staff at the GM/CA Beamlines 23-ID.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agah Sayeh, 2012, Methods Mol Biol, V914, P3, DOI 10.1007/978-1-62703-023-6_1; Beja O, 2014, P NATL ACAD SCI USA, V111, P6538, DOI 10.1073/pnas.1405093111; Brown LS, 2006, PHOTOCH PHOTOBIO SCI, V5, P538, DOI 10.1039/b514537f; BROWN LS, 1994, BIOCHEMISTRY-US, V33, P12001, DOI 10.1021/bi00206a001; DENCHER NA, 1978, FEBS LETT, V96, P322, DOI 10.1016/0014-5793(78)80427-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Engelhard C, 2018, CHEM REV, V118, P10629, DOI 10.1021/acs.chemrev.7b00715; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Gushchin I, 2018, SUBCELL BIOCHEM, V87, P19, DOI 10.1007/978-981-10-7757-9_2; Harris A, 2018, PHYS CHEM CHEM PHYS, V20, P3184, DOI 10.1039/c7cp06068h; Hasemi T, 2019, BBA-BIOENERGETICS, V1860, P136, DOI 10.1016/j.bbabio.2018.12.001; Hasemi T, 2016, J BIOL CHEM, V291, P355, DOI 10.1074/jbc.M115.688614; HAVELKA WA, 1995, J MOL BIOL, V247, P726, DOI 10.1006/jmbi.1995.0176; HENDERSON R, 1975, J MOL BIOL, V93, P123, DOI 10.1016/0022-2836(75)90123-0; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hosaka T, 2016, J BIOL CHEM, V291, P17488, DOI 10.1074/jbc.M116.728220; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Inoue K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2441; Inoue K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13415; Inoue K, 2016, J BIOL CHEM, V291, P9883, DOI 10.1074/jbc.M116.716498; Inoue K, 2015, ANGEW CHEM INT EDIT, V54, P11536, DOI 10.1002/anie.201504549; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2014, J PHYS CHEM B, V118, P11190, DOI 10.1021/jp507219q; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kandori H, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00052; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kim K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12677; Klare Johann P., 2008, V45, P73, DOI 10.1007/400_2007_041; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Kovalev K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav2671; Kurihara M, 2015, BIOPHYS PHYSICOBIOL, V12, P121, DOI 10.2142/biophysico.12.0_121; Kwon SK, 2013, GENOME BIOL EVOL, V5, P187, DOI 10.1093/gbe/evs134; Lanyi JK, 2004, BIOCHEMISTRY-US, V43, P3, DOI 10.1021/bi035843s; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Morizumi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47445-5; Mukherjee S, 2019, CURR OPIN STRUC BIOL, V57, P118, DOI 10.1016/j.sbi.2019.02.003; Muroda K, 2012, BIOCHEMISTRY-US, V51, P4677, DOI 10.1021/bi300485r; Nakajima Y, 2018, MICROBES ENVIRON, V33, P89, DOI 10.1264/jsme2.ME17197; Niho A, 2017, J AM CHEM SOC, V139, P4376, DOI 10.1021/jacs.6b12139; OTOMO J, 1995, BIOPHYS CHEM, V56, P137, DOI 10.1016/0301-4622(95)00025-S; Pinhassi J, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00003-16; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Rudiger M, 1997, EMBO J, V16, P3813, DOI 10.1093/emboj/16.13.3813; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; Schreiner M, 2015, J STRUCT BIOL, V190, P373, DOI 10.1016/j.jsb.2015.04.010; Schulz EC, 2018, NAT METHODS, V15, P901, DOI 10.1038/s41592-018-0180-2; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Shibata M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26606-y; Tittor J, 1997, J MOL BIOL, V271, P405, DOI 10.1006/jmbi.1997.1204; Varo G, 1996, BIOCHEMISTRY-US, V35, P6604, DOI 10.1021/bi9601159; Wang SL, 2013, NAT METHODS, V10, P1007, DOI [10.1038/NMETH.2635, 10.1038/nmeth.2635]; Ward ME, 2015, BIOPHYS J, V108, P1683, DOI 10.1016/j.bpj.2015.02.018; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Wierman JL, 2019, IUCRJ, V6, P305, DOI 10.1107/S2052252519001453; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshimura K, 2008, J MOL BIOL, V375, P1267, DOI 10.1016/j.jmb.2007.11.039	65	12	12	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2020	295	44					14793	14804		10.1074/jbc.RA120.014118	http://dx.doi.org/10.1074/jbc.RA120.014118			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OP9MG	32703899	Green Published, hybrid			2022-12-26	WOS:000588414100001
J	Ozono, S; Zhang, YZ; Tobiume, M; Kishigami, S; Tokunaga, K				Ozono, Seiya; Zhang, Yanzhao; Tobiume, Minoru; Kishigami, Satoshi; Tokunaga, Kenzo			Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; luminescent peptide tag; quantitation; integrase; Vif; virology; human immunodeficiency virus (HIV); viral protein; viral replication; infection	HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VIF; IDENTIFICATION; APOBEC3G; SUPPRESSION; RETROVIRUS; INFECTION; CELLS; CORE	In studies of HIV-1, virus production is normally monitored by either a reverse transcriptase assay or a p24 antigen capture ELISA. However, these assays are costly and time-consuming for routine handling of a large number of HIV-1 samples. For example, sample dilution is always required in the ELISA procedure to determine p24 protein levels because of the very narrow range of detectable concentrations in this assay. Here, we establish a novel HIV-1 production assay system to solve the aforementioned problems by using a recently developed small peptide tag called HiBiT. This peptide is a fragment of NanoLuc luciferase and generates a strong luminescent signal when complemented with the remaining subunit. To employ this technology, we constructed a novel full-length proviral HIV-1 DNA clone and a lentiviral packaging vector in which the HiBiT tag was added to the C terminus of the integrase. Tagging the integrase with the HiBiT sequence did not impede the resultant virus production, infectivity, or susceptibility to an integrase inhibitor. EM revealed normal morphology of the virus particles. Most importantly, by comparing between ELISA and the HiBiT luciferase assay, we successfully obtained an excellent linear correlation between p24 concentrations and HiBiT-based luciferase activity. Overall, we conclude that HiBiT-tagged viruses can replace the parental HIV-1 and lentiviral vectors, which enables us to perform a super-rapid, inexpensive, convenient, simple, and highly accurate quantitative assay for HIV-1/lentivirus production. This system can be widely applied to a variety of virological studies, along with screening for candidates of future antiviral drugs.	[Ozono, Seiya; Zhang, Yanzhao; Tobiume, Minoru; Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Ozono, Seiya; Kishigami, Satoshi] Univ Yamanashi, Fac Life & Environm Sci, Yamanashi, Japan	National Institute of Infectious Diseases (NIID); University of Yamanashi	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.	tokunaga@nih.go.jp	Yanzhao, Zhang/AAI-4175-2021; Tokunaga, Kenzo/Q-9914-2018	Yanzhao, Zhang/0000-0002-1937-4438; Tokunaga, Kenzo/0000-0002-2625-5322	Japan Society for the Promotion of Science KAKENHI [18K07156]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Society for the Promotion of Science KAKENHI, 18K07156 (to K. T.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Dang Y, 2009, J VIROL, V83, P8544, DOI 10.1128/JVI.00651-09; Delenda C, 2005, GENE THER, V12, pS36, DOI 10.1038/sj.gt.3302614; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; GOUDSMIT J, 1987, J INFECT DIS, V155, P558, DOI 10.1093/infdis/155.3.558; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kirui J, 2020, RETROVIROLOGY, V17, DOI 10.1186/s12977-020-00521-5; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Salamango DJ, 2019, CELL REP, V29, P1057, DOI 10.1016/j.celrep.2019.09.057; Tada T, 2015, NAT MED, V21, P1502, DOI 10.1038/nm.3956; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544, DOI 10.1128/JVI.69.7.4544-4547.1995; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003	20	15	15	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					13023	13030		10.1074/jbc.RA120.013887	http://dx.doi.org/10.1074/jbc.RA120.013887			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32719008	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000572412900013
J	Schwaba, T; Rhemtulla, M; Hopwood, CJ; Bleidorn, W				Schwaba, Ted; Rhemtulla, Mijke; Hopwood, Christopher J.; Bleidorn, Wiebke			A facet atlas: Visualizing networks that describe the blends, cores, and peripheries of personality structure	PLOS ONE			English	Article							BIG 5; 5-FACTOR MODEL; TRAITS; CIRCUMPLEX; CONSCIENTIOUSNESS; IMPULSIVITY; INHIBITION; STABILITY; PATTERNS; TAXONOMY	We created a facet atlas that maps the interrelations between facet scales from 13 hierarchical personality inventories to provide a practically useful, transtheoretical description of lower-level personality traits. We generated this atlas by estimating a series of network models that visualize the correlations among 268 facet scales administered to the Eugene-Springfield Community Sample (Ns = 571-948). As expected, most facets contained a blend of content from multiple Big Five domains and were part of multiple Big Five networks. We identified core and peripheral facets for each Big Five domain. Results from this study resolve some inconsistencies in facet placement across instruments and highlight the complexity of personality structure relative to the constraints of traditional hierarchical models that impose simple structure. This facet atlas (also available as an online point-and-click app at tedschwaba.shinyapps.io/appdata/) provides a guide for researchers who wish to measure a domain with a limited set of facets as well as information about the core and periphery of each personality domain. To illustrate the value of a facet atlas in applied and theoretical settings, we examined the network structure of scales measuring impulsivity and tested structural hypotheses from the Big Five Aspect Scales inventory.	[Schwaba, Ted; Rhemtulla, Mijke; Hopwood, Christopher J.; Bleidorn, Wiebke] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis	Schwaba, T (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	tedschwaba@gmail.com		Hopwood, Christopher/0000-0001-6645-8645; Rhemtulla, Mijke/0000-0003-2572-2424				Anusic I, 2016, J PERS SOC PSYCHOL, V110, P766, DOI 10.1037/pspp0000066; Block J, 2000, DEVELOPMENTAL SCIENCE AND THE HOLISTIC APPROACH, P155; Bringmann LF, 2018, PSYCHOL REV, V125, P606, DOI 10.1037/rev0000108; Bucher MA, 2019, J PERS ASSESS, V101, P16, DOI 10.1080/00223891.2017.1413382; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Christensen AP, 2019, J PERS ASSESS, V101, P574, DOI 10.1080/00223891.2018.1467428; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Condon David M, 2016, Eur J Pers, V30, P311; Conn S.R., 1994, 16PF 5 EDITION TECHN; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; DeYoung CG, 2015, J RES PERS, V56, P33, DOI 10.1016/j.jrp.2014.07.004; DeYoung CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00762; DeYoung CG, 2013, J PERS, V81, P465, DOI 10.1111/jopy.12020; DeYoung CG, 2012, J RES PERS, V46, P63, DOI 10.1016/j.jrp.2011.12.003; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Epskamp S, 2012, J STAT SOFTWARE, V48; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Eysenck HJ, 1947, DIMENSIONS PERSONALI; Forbes MK, 2017, J ABNORM PSYCHOL, V126, P969, DOI 10.1037/abn0000276; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Gough HG, CPI MANUAL; Grucza RA, 2007, J PERS ASSESS, V89, P167, DOI 10.1080/00223890701468568; Hall MS, 2021, PHYSIOTHER THEOR PR, V37, P1456, DOI 10.1080/09593985.2019.1692395; Hathaway S., 1951, ATLAS CLIN USE MMPI; HOFSTEE WKB, 1992, J PERS SOC PSYCHOL, V63, P146, DOI 10.1037/0022-3514.63.1.146; Hogan R., 2007, HOGAN PERSONALITY IN; Jackson D.N., 1994, JACKSON PERSONALITY; Jackson DN, 2000, 6 FACTOR PERSONALITY; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; JOHNSON JA, 1993, J PERS SOC PSYCHOL, V65, P563, DOI 10.1037/0022-3514.65.3.563; Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258; Kurtz JE, 2005, J PERS ASSESS, V85, P312, DOI 10.1207/s15327752jpa8503_07; Leary T., 1980, INTERPERSONAL DIAGNO; Lee K, 2004, MULTIVAR BEHAV RES, V39, P329, DOI 10.1207/s15327906mbr3902_8; LOEVINGER J, 1957, PSYCHOL REP, V3, P635, DOI 10.2466/PR0.3.7.635-694; Lucas RE, 2000, J PERS SOC PSYCHOL, V79, P452, DOI 10.1037//0022-3514.79.3.452; Maples J, 2014, PERSONAL DISORD, V5, P268, DOI 10.1037/per0000019; Markey P, 2010, PERS RELATIONSHIP, V17, P13, DOI 10.1111/j.1475-6811.2010.01249.x; Markon KE, 2005, J PERS SOC PSYCHOL, V88, P139, DOI 10.1037/0022-3514.88.1.139; McCrae R.R., 1992, REVISED NEO PERSONAL; MCCRAE RR, 1989, J PERS SOC PSYCHOL, V56, P586, DOI 10.1037/0022-3514.56.4.586; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Molenaar PCM, 2010, BEHAV BRAIN SCI, V33, P166, DOI 10.1017/S0140525X10000798; Mottus R, 2017, J PERS SOC PSYCHOL, V112, P474, DOI 10.1037/pspp0000100; Nigg JT, 2017, J CHILD PSYCHOL PSYC, V58, P361, DOI 10.1111/jcpp.12675; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Paunonen SV, 1998, J PERS SOC PSYCHOL, V74, P538, DOI 10.1037/0022-3514.74.2.538; Pincus A.L., 2008, CLIN PSYCHOL ASSESSM, P213; R Core Team, 2018, R LANG ENV STAT COMP; Revelle W., 2018, USE PSYCH PACKAGE FA; Revelle W, 2019, PSYCHOL ASSESSMENT, V31, P1395, DOI 10.1037/pas0000754; Roberts BW, 2005, PERS PSYCHOL, V58, P103, DOI 10.1111/j.1744-6570.2005.00301.x; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Roney E., 2017, J OPEN PSYCHOL DATA, V5, DOI [10. 5334/jopd. 32, DOI 10.5334/JOPD.32, 10.5334/jopd.32]; Sadler P, 2009, J PERS SOC PSYCHOL, V97, P1005, DOI 10.1037/a0016232; Saucier, 2016, EUGENE SPRINGFIELD C; SAUCIER G, 1992, J PERS SOC PSYCHOL, V62, P1025, DOI 10.1037/0022-3514.62.6.1025; Schwaba T, 2019, J PERS, V87, P1074, DOI 10.1111/jopy.12458; Soto CJ, 2017, J PERS SOC PSYCHOL, V113, P117, DOI 10.1037/pspp0000096; Soto CJ, 2015, CURR DIR PSYCHOL SCI, V24, P358, DOI 10.1177/0963721415589345; Soto CJ, 2009, J RES PERS, V43, P84, DOI 10.1016/j.jrp.2008.10.002; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Tellegen A, 2003, MULTIDIMENSIONAL PER; Thalmayer AG, 2014, EUR J PERSONALITY, V28, P482, DOI 10.1002/per.1969; TRACEY TJ, 1993, J COUNS PSYCHOL, V40, P396, DOI 10.1037/0022-0167.40.4.396; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; WIGGINS JS, 1979, J PERS SOC PSYCHOL, V37, P395, DOI 10.1037/0022-3514.37.3.395; Woods SA, 2016, J APPL PSYCHOL, V101, P582, DOI 10.1037/apl0000062; Wright AGC, 2012, J ABNORM PSYCHOL, V121, P951, DOI 10.1037/a0027669; Ziegler M, 2016, EUR J PSYCHOL ASSESS, V32, P105, DOI 10.1027/1015-5759/a000372	72	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236893	10.1371/journal.pone.0236893	http://dx.doi.org/10.1371/journal.pone.0236893			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730328	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000556884700056
J	Wang, WY; Carlson, CH; Smart, LB; Carlson, JE				Wang, Wanyan; Carlson, Craig H.; Smart, Lawrence B.; Carlson, John E.			Transcriptome analysis of contrasting resistance to herbivory byEmpoasca fabaein two shrub willow species and their hybrid progeny	PLOS ONE			English	Article							POTATO LEAFHOPPER HOMOPTERA; RESOURCE AVAILABILITY; READ ALIGNMENT; EMPOASCA-FABAE; ALFALFA; GENES; BIOENERGY; CLONES; CICADELLIDAE; BEHAVIOR	Short rotation woody biomass cultivars developed from fast-growing shrub species of willow (Salixspp.) have superior properties as perennial energy crops for the Northeast and Midwest US. However, the insect pest potato leafhopper (PLH)Empoasca fabae(Harris) can cause serious damage and reduce yield of susceptible genotypes. Currently, the willow cultivars in use display varying levels of susceptibility under PLH infestation. However, genes and markers for resistance to PLH are not yet available for marker-assisted selection in breeding. In this study, transcriptome differences between a resistant genotype 94006 (S.purpurea) and a susceptible cultivar 'Jorr' (S.viminalis), and their hybrid progeny were determined. Over 600 million RNA-Seq reads were generated and mapped to theSalix purpureareference transcriptome. Gene expression analyses revealed the unique defense mechanism in resistant genotype 94006 that involves PLH-induced secondary cell wall modification. In the susceptible genotypes, genes involved in programed cell death were highly expressed, explaining the necrosis symptoms after PLH feeding. Overall, the discovery of resistance genes and defense mechanisms provides new resources for shrub willow breeding and research in the future.	[Wang, Wanyan; Carlson, John E.] Penn State Univ, Ecosyst Sci & Management, University Pk, PA 16802 USA; [Carlson, Craig H.; Smart, Lawrence B.] Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Cornell AgriTech, Geneva, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University	Carlson, JE (corresponding author), Penn State Univ, Ecosyst Sci & Management, University Pk, PA 16802 USA.	jec16@psu.edu	Carlson, Craig H/O-9716-2017; Smart, Larry/AAZ-6255-2020	Carlson, Craig/0000-0003-2050-5455; Smart, Lawrence/0000-0002-7812-7736; Wang, Wanyan/0000-0003-0332-2702	USDA Agriculture and Food Research Initiative of the National Institute of Food and Agriculture [2012-68005-19703]; USDA National Institute of Food and Agriculture Federal Appropriations [PEN04532, 1000326]	USDA Agriculture and Food Research Initiative of the National Institute of Food and Agriculture; USDA National Institute of Food and Agriculture Federal Appropriations	Primary support for this research was provided to LBS and JEC as grant No. 2012-68005-19703 from the USDA Agriculture and Food Research Initiative of the National Institute of Food and Agriculture (https://nifa.usda.gov/grants).Additional support was provided to JEC from through the USDA National Institute of Food and Agriculture Federal Appropriations (https://nifa.usda.gov/nifas-discretionary-andmandatoryfunding) under Project PEN04532 and Accession number 1000326. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G.N., 2005, PLANT PATHOL, V5th; Argus G.W., 2010, FLORA N AM N MEXICO, V7, P23; BACKUS EA, 1989, ENVIRON ENTOMOL, V18, P473, DOI 10.1093/ee/18.3.473; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Belete T., 2018, TRENDS TECHNICAL SCI, V2, P30, DOI DOI 10.1080/15548627.2020.1797280; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berlin S, 2014, MOL BREEDING, V34, P1987, DOI 10.1007/s11032-014-0157-5; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carlson CH, 2017, GENOME BIOL EVOL, V9, P2377, DOI 10.1093/gbe/evx174; Chasen EM, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM13014; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Dimitriou I, 2006, BIORESOURCE TECHNOL, V97, P150, DOI 10.1016/j.biortech.2005.02.004; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; ECALE CL, 1995, ENTOMOL EXP APPL, V77, P121, DOI 10.1007/BF02383025; ECALE CL, 1995, CAN J BOT, V73, P288, DOI 10.1139/b95-031; Ecale CL, 1993, THESIS; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Etzler ME, 2009, ESSENTIALS GLYCOBIOL; Fabio ES, 2017, IND CROP PROD, V96, P57, DOI 10.1016/j.indcrop.2016.11.019; Fabio ES, 2017, GCB BIOENERGY, V9, P445, DOI 10.1111/gcbb.12344; Farmer-Hinton RL, 2013, TEACH COLL REC, V115; Fick GW, 2003, FORAGES INTRO GRASSL, P295; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Goodman R. N., 1994, HYPERSENSITIVE REACT; Gorbunova V, 1997, NUCLEIC ACIDS RES, V25, P4650, DOI 10.1093/nar/25.22.4650; Heinrich M, 2013, PLANT J, V73, P591, DOI 10.1111/tpj.12058; Heldt HW, PLANT BIOCH; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Huseth AS, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14009; Jin JP, 2015, MOL BIOL EVOL, V32, P1767, DOI 10.1093/molbev/msv058; KABRICK LR, 1990, ENTOMOL EXP APPL, V56, P287, DOI 10.1007/BF00163700; Karban R, 1997, ECOLOGY, V78, P1351; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Karp A, 2011, J INTEGR PLANT BIOL, V53, P151, DOI 10.1111/j.1744-7909.2010.01015.x; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Kopp RF, 2001, FOREST CHRON, V77, P287, DOI 10.5558/tfc77287-2; Kuzovkina YA, 2005, WATER AIR SOIL POLL, V162, P183, DOI 10.1007/s11270-005-6272-5; Labrecque M, 2005, BIOMASS BIOENERG, V29, P1, DOI 10.1016/j.biombioe.2004.12.004; LAMP WO, 1994, J KANSAS ENTOMOL SOC, V67, P354; LAMP WO, 1991, J ECON ENTOMOL, V84, P610, DOI 10.1093/jee/84.2.610; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim GH, 2017, ANNU REV PHYTOPATHOL, V55, P505, DOI 10.1146/annurev-phyto-080516-035406; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; NIELSEN GR, 1990, J ECON ENTOMOL, V83, P807, DOI 10.1093/jee/83.3.807; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ollerstam O, 2002, ENTOMOL EXP APPL, V102, P153, DOI 10.1023/A:1015810014551; Pascual MB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01030; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pucholt P, 2015, HEREDITY, V114, P575, DOI 10.1038/hdy.2014.125; Pucholt P, 2017, MOL BIOL EVOL, V34, P1991, DOI 10.1093/molbev/msx144; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Santiago R, 2013, INT J MOL SCI, V14, P6960, DOI 10.3390/ijms14046960; Serapiglia MJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-74; Smart Lawrence B., 2008, P347, DOI 10.1007/978-0-387-70805-8_13; Smart LB, 2012, HDB BIOENERGY CROP P, V22, P690; Song J., 2014, PLOS PATHOG, V10; Stoof CR, 2015, BIOENERG RES, V8, P482, DOI 10.1007/s12155-014-9515-8; Taiz L., 2010, PLANT PHYSIOL, V5, P163; TAYLOR PS, 1995, ENVIRON ENTOMOL, V24, P1115, DOI 10.1093/ee/24.5.1115; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01799; Underwood N, 2005, ECOLOGY, V86, P594, DOI 10.1890/03-0290; Volk TA, 2016, FOOD ENERGY SECUR, V5, P97, DOI 10.1002/fes3.82; Walley JW, 2013, CURR OPIN PLANT BIOL, V16, P520, DOI 10.1016/j.pbi.2013.06.011; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yazaki K, 2005, CURR OPIN PLANT BIOL, V8, P301, DOI 10.1016/j.pbi.2005.03.011; Zhou CLE, 1999, CAN J BOT, V77, P537, DOI 10.1139/cjb-77-4-537; Zhou R, 2018, MOL GENET GENOMICS, V293, P1437, DOI 10.1007/s00438-018-1473-y; Zust T, 2017, ANNU REV PLANT BIOL, V68, P513, DOI 10.1146/annurev-arplant-042916-040856	75	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236586	10.1371/journal.pone.0236586	http://dx.doi.org/10.1371/journal.pone.0236586			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726362	gold, Green Published			2022-12-26	WOS:000556908900029
J	Man, XF; Hu, N; Tan, SW; Tang, HN; Guo, Y; Tang, CY; Liu, YQ; Tang, J; Zhou, CL; Wang, F; Zhou, HD				Man, Xiao-Fei; Hu, Nan; Tan, Shu-Wen; Tang, Hao-Neng; Guo, Yue; Tang, Chen-Yi; Liu, Ya-Qing; Tang, Jun; Zhou, Ci-La; Wang, Fang; Zhou, Hou-De			Insulin receptor substrate-1 inhibits high-fat diet-induced obesity by browning of white adipose tissue through miR-503	FASEB JOURNAL			English	Article						BMPR1a; brown adipogenesis; IRS-1; miR-503; PI3K; Akt pathway	BONE MORPHOGENETIC PROTEIN; THERAPEUTIC-EFFICACY; DIFFERENTIAL ROLES; ADIPOGENESIS; MELANOMA; PREADIPOCYTE; DACARBAZINE; EXPRESSION; OSTEOBLAST	Genetic variation of insulin receptor substrate 1 (IRS-1) was found to modulate the insulin resistance of adipose tissues, but the underlying mechanism was not clear. To investigate how the IRS-1 was involved in the browning of white adipose tissue through miRNA, we identified a mutatedIrs-1(Irs-1(-/-)) mice model and found that this mice had a reduced subcutaneous WAT (sWAT) and increased brown adipose tissue (BAT) in the interscapular region. So we isolated the bone marrow stromal cells and analyzed differentially expressed miRNAs and adipogenesis-related genes with miRNA arrays and PCR arrays.Irs-1(-/-)mice showed decreased miR-503 expression, but increased expression of its target, bone morphogenetic protein receptor type 1a (BMPR1a). Overexpression of miR-503 in preadipocytes downregulated BMPR1a and impaired adipogenic activity through the phosphotidylinositol 3-kinase (PI3K/Akt) pathway, while the inhibitor had the opposite effect. In bothIrs-1(-/-)and cold-induced models, sWAT exhibited BAT features, and showed tissue-specific increased BMPR1a expression, PI3K expression, and Akt phosphorylation. Thus, our results showed that IRS-1 regulated brown preadipocyte differentiation and induced browning in sWAT through the miR-503-BMPR1a pathway, which played important roles in high-fat diet-induced obesity.	[Man, Xiao-Fei; Hu, Nan; Tan, Shu-Wen; Tang, Hao-Neng; Guo, Yue; Tang, Chen-Yi; Liu, Ya-Qing; Tang, Jun; Zhou, Ci-La; Wang, Fang; Zhou, Hou-De] Cent South Univ, Xiangya Hosp 2, Natl Clin Res Ctr Metab Dis, Hunan Prov Key Lab Metab Bone Dis,Dept Endocrinol, Changsha, Hunan, Peoples R China; [Man, Xiao-Fei] Qingdao Univ, Dept Nephrol, Affiliated Hosp, Qingdao, Peoples R China	Central South University; Qingdao University	Zhou, HD (corresponding author), Cent South Univ, Xiangya Hosp 2, Natl Clin Res Ctr Metab Dis, Hunan Prov Key Lab Metab Bone Dis,Dept Endocrinol, Changsha, Hunan, Peoples R China.	houdezhou@csu.edu.cn	Tang, Jun/GRX-1749-2022	Zhou, Hou-De/0000-0001-9131-4141; Tang, Jun/0000-0002-6908-1027	NSFC; National Natural Science Foundation of China [81770880, 81800788, 81970762]; Science and Technology Department of Hunan Province [2015JC3012, 2018SK52511]	NSFC(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province	NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 81770880, 81800788 and 81970762; Science and Technology Department of Hunan Province, Grant/Award Number: 2015JC3012 and 2018SK52511	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Castorena CM, 2014, DIABETES, V63, P2297, DOI 10.2337/db13-1686; Cervantes-Camacho C, 2015, ADIPOCYTE, V4, P248, DOI 10.1080/21623945.2015.1007823; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chen ZF, 2020, CIRC RES, V126, P330, DOI 10.1161/CIRCRESAHA.119.315246; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Fischer C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02158-z; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Guo Y, 2016, FASEB J, V30, P4214, DOI 10.1096/fj.201600445RR; Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017; Jeong MY, 2017, METABOLISM, V73, P85, DOI 10.1016/j.metabol.2017.05.009; Kubota T, 2017, CELL METAB, V25, P797, DOI 10.1016/j.cmet.2017.03.004; Kuri-Harcuch W, 2019, J CELL PHYSIOL, V234, P1111, DOI 10.1002/jcp.27060; Kwon DN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/236385; Lavin DP, 2016, DIABETOLOGIA, V59, P2280, DOI 10.1007/s00125-016-4072-7; Liu ZH, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/4143167; Malvi P, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0176-5; Malvi P, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0162-8; Malvi P, 2015, MOL ONCOL, V9, P689, DOI 10.1016/j.molonc.2014.11.006; Man XF, 2016, AM J TRANSL RES, V8, P2727; Montgomery MK, 2019, FASEB J, V33, P13267, DOI 10.1096/fj.201900909RR; Morley TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8906; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Park Anna, 2014, World J Stem Cells, V6, P33, DOI 10.4252/wjsc.v6.i1.33; Poher AL, 2015, DIABETES, V64, P3700, DOI 10.2337/db15-0210; Sarantopoulos CN, 2018, STEM CELL REV REP, V14, P27, DOI 10.1007/s12015-017-9774-9; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tang CY, 2017, MOL CELLS, V40, P123, DOI 10.14348/molcells.2017.2228; Than A, 2015, J BIOL CHEM, V290, P14679, DOI 10.1074/jbc.M115.643817; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Westrick RJ, 2010, P NATL ACAD SCI USA, V107, P16904, DOI 10.1073/pnas.1012050107; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200	42	4	4	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12308	12323		10.1096/fj.201903283RR	http://dx.doi.org/10.1096/fj.201903283RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32721050				2022-12-26	WOS:000556062700001
J	Wang, TH; Guo, YM; Wu, ZX; Xia, SQ; Hua, SJ; Tu, JX; Li, M; Chen, WJ				Wang, Tonghua; Guo, Yiming; Wu, Zengxiang; Xia, Shengqian; Hua, Shuijin; Tu, Jinxing; Li, Mei; Chen, Weijiang			Genetic characterization of a new radish introgression line carrying the restorer gene for Ogura CMS in Brassica napus	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; RAPHANUS-SATIVUS L.; FERTILITY; RFO; RAPESEED; GENOME; IDENTIFICATION; MARKERS; PROTEIN; LOCUS	Creating a homologous restorer line for Ogura cytoplasmic male sterility (Ogu-CMS) in Brassica napus is meaningful for the wider application of Ogu-CMS system in rapeseed production. Previously, an independent development of a new Ogu-CMS restorer line (CLR650) was reported locally from crossing between Raphanobrassica (AACCRR, 2n = 56) and B. napus and a new version of Ogu CMS lines CLR6430 derived from CLR650 was characterized in this study. The results showed that the fertility restoration gene in CLR6430 presented a distorted segregation in different segregating populations. However, the majority of somatic cells from roots had a regular chromosome number (2n = 38) and no radish signal covered a whole chromosome was detected using GISH. Thirty-two specific markers derived from the introgressed radish fragments were developed based on the re-sequencing results. Unique radish insertions and differences between CLR6430 and R2000 were also identified through both radish-derived markers and PCR product sequences. Further investigations on the genetic behaviors, interactions between the fertility restoration and other traits and specific molecular markers to the introgression in CLR6430 were also conducted in this study. These results should provide the evidence of nucleotide differences between CLR6430 and R2000, and the specific markers will be helpful for breeding new Ogura restore lines in future.	[Wang, Tonghua; Wu, Zengxiang; Xia, Shengqian; Tu, Jinxing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Wang, Tonghua; Guo, Yiming; Li, Mei; Chen, Weijiang] Hunan Acad Agr Sci, Crop Res Inst, Changsha, Peoples R China; [Guo, Yiming] Huazhong Agr Univ, Rapeseed Engn Res Ctr, Minist Educ, Wuhan, Peoples R China; [Hua, Shuijin] Zhejiang Acad Agr Sci, Inst Crop & Nucl Technol Utilizat, Hangzhou, Peoples R China	Huazhong Agricultural University; Hunan Academy of Agricultural Sciences; Huazhong Agricultural University; Zhejiang Academy of Agricultural Sciences	Tu, JX (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.; Li, M (corresponding author), Hunan Acad Agr Sci, Crop Res Inst, Changsha, Peoples R China.	tujx@mail.hzau.edu.cn; limei1230@126.com	Xia, Shengqian/AAA-1388-2022; Xia, Shengqian/AAW-3922-2021	Xia, Shengqian/0000-0002-9264-3649	National Natural Science Foundation for Young Scientists of China [31401467]; Key Research and Development Program of Hunan Province [2016NK2200]; Fundamental Research Funds for the Central Universities [2662020ZKPY019]	National Natural Science Foundation for Young Scientists of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Hunan Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding for operating costs of this research was provided both by the National Natural Science Foundation for Young Scientists of China (Grant No. 31401467), The Key Research and Development Program of Hunan Province (Grant No. 2016NK2200) and The Fundamental Research Funds for the Central Universities (Grant No. 2662020ZKPY019).	Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Charne DG, 2002, OILSEED BRASSICA CON; Chen WM, 2012, FORMOS J SURG, V45, P8, DOI 10.1016/j.fjs.2011.12.002; DELOURME R, 1994, THEOR APPL GENET, V88, P741, DOI 10.1007/BF01253979; Delourme R, 1999, 10 INT RAP C CANB; Desloire S, 2003, EMBO REP, V4, P588, DOI 10.1038/sj.embor.embor848; Feng JH, 2009, GENOME, V52, P401, DOI [10.1139/G09-016, 10.1139/g09-016]; Fu T. D., 1987, Cruciferae Newsletter, P46; Ge XH, 2007, CHROMOSOME RES, V15, P849, DOI 10.1007/s10577-007-1168-4; Giancola S, 2003, THEOR APPL GENET, V107, P1442, DOI 10.1007/s00122-003-1381-2; Havey MJ, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P623, DOI 10.1007/978-1-4020-3166-3_23; Heyn F.W., 1976, EUCARPIA CRUCIFERAE, V1, P15; Hu XY, 2008, MOL BREEDING, V22, P663, DOI 10.1007/s11032-008-9207-1; Kang L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00529; Kitashiba H, 2014, DNA RES, V21, P481, DOI 10.1093/dnares/dsu014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manrique-Carpintero NC, 2016, G3-GENES GENOM GENET, V6, P2617, DOI 10.1534/g3.116.030031; Mitsui Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10835; OGURA H., 1968, Memoirs of the Faculty of Agriculture, Kagoshima University, V6, P39; PELLETIER G, 1983, MOL GEN GENET, V191, P244, DOI 10.1007/BF00334821; Pelletier G, 1988, 7 INT RAP C POZN POL; Pleines SC, 2007, FERTILITY RESTORATIO; Primard-Brisset C, 2005, THEOR APPL GENET, V111, P736, DOI 10.1007/s00122-005-2059-8; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sakai T, 1996, THEOR APPL GENET, V93, P373, DOI 10.1007/BF00223179; Shiga T., 1971, JAPANESE J BREED, V21, P16; Sovero M, 1987, CYTOPLASMIC MALE STE; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Tian ET, 2014, MOL BREEDING, V34, P1361, DOI 10.1007/s11032-014-0121-4; Wang ZW, 2008, THEOR APPL GENET, V117, P313, DOI 10.1007/s00122-008-0776-5; Wang ZW, 2013, J EXP BOT, V64, P2041, DOI 10.1093/jxb/ert065; Wang ZW, 2010, MOL BREEDING, V25, P339, DOI 10.1007/s11032-009-9321-8; Yu HL, 2016, THEOR APPL GENET, V42, P1; Zhang Xiaohui, 2015, Horticultural Plant Journal, V1, P155, DOI 10.16420/j.issn.2095-9885.2016-0028; Zhang Y, 2009, BRASSICA OGURA RESTO	36	1	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236273	10.1371/journal.pone.0236273	http://dx.doi.org/10.1371/journal.pone.0236273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722687	gold, Green Published			2022-12-26	WOS:000556916000025
J	Diesinger, T; Buko, V; Lautwein, A; Dvorsky, R; Belonovskaya, E; Lukivskaya, O; Naruta, E; Kirko, S; Andreev, V; Buckert, D; Bergler, S; Renz, C; Schneider, E; Kuchenbauer, F; Kumar, M; Gunes, C; Buchele, B; Simmet, T; Muller-Enoch, D; Wirth, T; Haehner, T				Diesinger, Torsten; Buko, Vyacheslav; Lautwein, Alfred; Dvorsky, Radovan; Belonovskaya, Elena; Lukivskaya, Oksana; Naruta, Elena; Kirko, Siarhei; Andreev, Viktor; Buckert, Dominik; Bergler, Sebastian; Renz, Christian; Schneider, Edith; Kuchenbauer, Florian; Kumar, Mukesh; Guenes, Cagatay; Buechele, Berthold; Simmet, Thomas; Mueller-Enoch, Dieter; Wirth, Thomas; Haehner, Thomas			Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LIVER-DISEASE; URSODEOXYCHOLIC ACID; OXIDATIVE STRESS; P-NITROPHENOL; DOUBLE-BLIND; FATTY LIVER; LAURIC ACID; CYTOCHROME-P450; MANAGEMENT	Background and aims Alcoholic steatohepatitis (ASH)-the inflammation of fatty liver-is caused by chronic alcohol consumption and represents one of the leading chronic liver diseases in Western Countries. ASH can lead to organ dysfunction or progress to hepatocellular carcinoma (HCC). Long-term alcohol abstinence reduces this probability and is the prerequisite for liver transplantation-the only effective therapy option at present. Elevated enzymatic activity of cytochrome P450 2E1 (CYP2E1) is known to be critically responsible for the development of ASH due to excessively high levels of reactive oxygen species (ROS) during metabolization of ethanol. Up to now, no rational drug discovery process was successfully initiated to target CYP2E1 for the treatment of ASH. Methods In this study, we applied a rational drug design concept to develop drug candidates (NCE) including preclinical studies. Results A new class of drug candidates was generated successfully. Two of the most promising small compounds named 12-Imidazolyl-1-dodecanol (abbr.: I-ol) and 1-Imidazolyldodecane (abbr.: I-an) were selected at the end of this process of drug discovery and developability. These new omega-imidazolyl-alkyl derivatives act as strong chimeric CYP2E1 inhibitors at a nanomolar range. They restore redox balance, reduce inflammation process as well as the fat content in the liver and rescue the physiological liver architecture of rats consuming continuously a high amount of alcohol. Conclusions Due to its oral application and therapeutic superiority over an off-label use of the hepatoprotector ursodeoxycholic acid (UDCA), this new class of inhibitors marks the first rational, pharmaceutical concept in long-term treatment of ASH.	[Diesinger, Torsten] Donauklin Neu Ulm, Abt Innere Med, Neu Ulm, Germany; [Diesinger, Torsten; Lautwein, Alfred; Buckert, Dominik; Bergler, Sebastian; Renz, Christian; Mueller-Enoch, Dieter; Wirth, Thomas; Haehner, Thomas] Ulm Univ, Inst Physiol Chem, Ulm, Germany; [Buko, Vyacheslav; Belonovskaya, Elena; Lukivskaya, Oksana; Naruta, Elena; Kirko, Siarhei] Inst Biochem Biol Act Subst, Div Biochem Pharmacol, Grodno, BELARUS; [Buko, Vyacheslav] Univ Med Sci, Dept Biotechnol, Bialystok, Poland; [Dvorsky, Radovan] Heinrich Heine Univ Dusseldorf, Inst Biochem & Mol Biol 2, Med Fak, Dusseldorf, Germany; [Dvorsky, Radovan] Max Planck Inst Mol Physiol, Dortmund, Germany; [Andreev, Viktor] Grodno State Med Univ, Dept Med Biol & Genet, Grodno, BELARUS; [Buckert, Dominik] Univ Hosp Ulm, Dept Internal Med 2, Ulm, Germany; [Schneider, Edith; Kuchenbauer, Florian] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Kuchenbauer, Florian] Univ British Columbia, Terry Fox Lab, Vancouver, BC, Canada; [Kumar, Mukesh; Guenes, Cagatay] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Buechele, Berthold; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, Ulm, Germany; [Diesinger, Torsten] Neu Ulm Hosp, Dept Internal Med, Neu Ulm, Germany	Ulm University; National Academy of Sciences of Belarus (NASB); Institute of Biochemistry of Biologically Active Compounds of the National Academy of Sciences of Belarus; Heinrich Heine University Dusseldorf; Max Planck Society; Grodno State Medical University; Ulm University; Ulm University; University of British Columbia; Ulm University; Ulm University	Diesinger, T (corresponding author), Donauklin Neu Ulm, Abt Innere Med, Neu Ulm, Germany.; Diesinger, T (corresponding author), Ulm Univ, Inst Physiol Chem, Ulm, Germany.; Diesinger, T (corresponding author), Neu Ulm Hosp, Dept Internal Med, Neu Ulm, Germany.	tdiesinger@gmx.de	Dvorsky, Radovan/ABE-3042-2020	Kirko, Siarhei/0000-0002-6573-3139				Adas F, 1999, J LIPID RES, V40; Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; Amet Y, 1995, BIOCHEM PHARMACOL, V50, P1775, DOI 10.1016/0006-2952(95)02040-3; [Anonymous], 2014, GLOB STAT REP ALC HL; Bambal RB, 1996, BIOCHEM BIOPH RES CO, V219, P445, DOI 10.1006/bbrc.1996.0253; Bambal RB, 1996, ARCH BIOCHEM BIOPHYS, V334, P59, DOI 10.1006/abbi.1996.0429; BEERS RF, 1952, J BIOL CHEM, V195, P133; Buege J A, 1978, Methods Enzymol, V52, P302; Buko V. U., 2002, Ukrainskii Biokhimicheskii Zhurnal, V74, P88; Burra P, 2010, AM J TRANSPLANT, V10, P138, DOI 10.1111/j.1600-6143.2009.02869.x; BURSTEIN M, 1973, BIOMEDICINE, V19, P16; Buzzetti E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011646.pub2; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Crespi Charles L, 2006, Methods Mol Biol, V320, P143; Das SK, 2005, INDIAN J CLIN BIOCHE, V20, P24, DOI 10.1007/BF02867396; De Duve C, 1965, Harvey Lect, V59, P49; Eaton JE, 2011, AM J GASTROENTEROL, V106, P1638, DOI 10.1038/ajg.2011.156; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FINDLAY JBC, 1987, BIOL MEMBRANES PRACT; Germani G, 2016, REV RECENT CLIN TRIA, V11, P253, DOI 10.2174/1574887111666160815102228; Gong Yan, 2008, Cochrane Database Syst Rev, pCD000551, DOI 10.1002/14651858.CD000551.pub2; Hackett JC, 2005, BIOORGAN MED CHEM, V13, P4063, DOI 10.1016/j.bmc.2005.03.050; Hartl J, 2011, SCAND J GASTROENTERO, V46, P1257, DOI 10.3109/00365521.2011.603160; Hirano T, 2003, J LIPID RES, V44, P2193, DOI 10.1194/jlr.D300007-JLR200; Johnston JB, 2011, ARCH BIOCHEM BIOPHYS, V507, P86, DOI 10.1016/j.abb.2010.08.011; KARUZINA II, 1994, FREE RADICAL BIO MED, V16, P73, DOI 10.1016/0891-5849(94)90245-3; Kawashima A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100059; Kim MS, 2016, WORLD J GASTROENTERO, V22, P8, DOI 10.3748/wjg.v22.i1.8; Koppe SWP, 2004, J HEPATOL, V41, P592, DOI 10.1016/j.jhep.2004.06.030; Lazaridis KN, 2001, J HEPATOL, V35, P134, DOI 10.1016/S0168-8278(01)00092-7; Liberal R, 2016, WORLD J HEPATOL, V8, P1157, DOI 10.4254/wjh.v8.i28.1157; LIEBER CS, 1994, METHOD ENZYMOL, V233, P585; Liu H, 2003, KIDNEY INT, V63, P1687, DOI 10.1046/j.1523-1755.2003.00908.x; Lu P, 1997, ARCH BIOCHEM BIOPHYS, V337, P1, DOI 10.1006/abbi.1996.9768; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Lukivskaya O, 2006, Adv Med Sci, V51, P54; Mani V, 2016, MOL CELL BIOCHEM, V421, P169, DOI 10.1007/s11010-016-2798-7; Marsano LS, 2003, ALCOHOL RES HEALTH, V27, P247; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matas AJ, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/ajt.12019; Mathurin P, 2012, J HEPATOL, V56, pS39, DOI 10.1016/S0168-8278(12)60005-1; Miranda-Mendez A, 2010, INT J ENV RES PUB HE, V7, P1872, DOI 10.3390/ijerph7051872; Monostory K, 2004, CHEM-BIOL INTERACT, V147, P331, DOI 10.1016/j.cbi.2004.03.003; Mousa HS, 2016, AUTOIMMUN REV, V15, P870, DOI 10.1016/j.autrev.2016.07.003; MULLERPEDDINGHAUS R, 1987, ARZNEIMITTELFORSCH, V37-1, P589; Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206; Nguyen-Khac E, 2011, NEW ENGL J MED, V365, P1781, DOI 10.1056/NEJMoa1101214; Noroski LM, 2016, NEW ENGL J MED, V375, P2501, DOI 10.1056/NEJMc1613273; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Oliva L, 1998, ALCOHOL CLIN EXP RES, V22, P1538; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Pelletier G, 2003, HEPATOLOGY, V37, P887, DOI 10.1053/jhep.2003.50118; Phillips I. R., 2013, CYTOCHROME P450 PROT; PLEVRIS JN, 1991, EUR J GASTROEN HEPAT, V3, P653; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Rambaldi A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002148.pub2; Reardon J, 2016, J CLIN TRANSL HEPATO, V4, P192, DOI 10.14218/JCTH.2016.00023; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Saksena S, 1997, POSTGRAD MED J, V73, P75, DOI 10.1136/pgmj.73.856.75; Stickel F, 2013, J GASTROINTEST LIVER, V22, P189; Suk KT, 2014, WORLD J GASTROENTERO, V20, P12934, DOI 10.3748/wjg.v20.i36.12934; TESTA B, 1981, DRUG METAB REV, V12, P1, DOI 10.3109/03602538109011082; Vuittonet CL, 2014, AM J HEALTH-SYST PH, V71, P1265, DOI 10.2146/ajhp140028; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zerilli A, 1997, CHEM RES TOXICOL, V10, P1205, DOI 10.1021/tx970048z	67	13	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235990	10.1371/journal.pone.0235990	http://dx.doi.org/10.1371/journal.pone.0235990			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701948	Green Published, gold			2022-12-26	WOS:000575913700036
J	Maldonado, O; Jenkins, A; Belalcazar, HM; Hernandez-Cuervo, H; Hyman, KM; Ladaga, G; Padilla, L; de Erausquin, GA				Maldonado, Oscar; Jenkins, Alexandra; Belalcazar, Helen M.; Hernandez-Cuervo, Helena; Hyman, Katelynn M.; Ladaga, Giannina; Padilla, Lucia; de Erausquin, Gabriel A.			Age-dependent neuroprotective effect of an SK3 channel agonist on excitotoxity to dopaminergic neurons in organotypic culture	PLOS ONE			English	Article							SMALL-CONDUCTANCE; CELL-DEATH; MESSENGER-RNA; CAG REPEATS; GENE-EXPRESSION; KCNN3 GENE; I-H; MIDBRAIN; MESENCEPHALON; ASSOCIATION	Background Small conductance, calcium-activated (SK3) potassium channels control the intrinsic excitability of dopaminergic neurons (DN) in the midbrain and modulate their susceptibility to toxic insults during development. Methods We evaluated the age-dependency of the neuroprotective effect of an SK3 agonist, 1-Ethyl-1,3-dihydro-2H-benzimidazol-2-one (1-EBIO), on Amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) excitotoxicity to DN in ventral mesencephalon (VM) organotypic cultures. Results Most tyrosine hydroxylase (TH)+ neurons were also SK3+; SK3+/TH- cells (DN+) were common at each developmental stage but more prominently at day in vitro (DIV) 8. Young DN+ neurons were small bipolar and fusiform, whereas mature ones were large and multipolar. Exposure of organotypic cultures to AMPA (100 mu m, 16 h) had no effect on the survival of DN+ at DIV 8, but caused significant toxicity at DIV 15 (n = 15, p = 0.005) and DIV 22 (n = 15, p<0.001). These results indicate that susceptibility of DN to AMPA excitotoxicity is developmental stage-dependent in embryonic VM organotypic cultures. Immature DN+ (small, bipolar) were increased after AMPA (100 mu m, 16 h) at DIV 8, at the expense of the number of differentiated (large, multipolar) DN+ (p = 0.039). This effect was larger at DIV 15 (p<<<0.0001) and at DIV 22 (p<<<0.0001). At DIV 8, 30 mu M 1-EBIO resulted in a large increase in DN+. At DIV 15, AMPA toxicity was prevented by exposure to 30 mu M, but not 100 mu M 1-EBIO. At DIV 22, excitotoxicity was unaffected by 30 mu M 1-EBIO, and partially reduced by 100 mu M 1-EBIO. Conclusion The effects of the SK3 channel agonist 1-EBIO on the survival of SK3-expressing dopaminergic neurons were concentration-dependent and influenced by neuronal developmental stage.	[Maldonado, Oscar; Ladaga, Giannina; Padilla, Lucia; de Erausquin, Gabriel A.] Univ Texas Hlth San Antonio, Lab Brain Dev & Repair, Biggs Inst Alzheimer & Neurodegenerat Dis, San Antonio, TX 78229 USA; [Jenkins, Alexandra; Hernandez-Cuervo, Helena; Hyman, Katelynn M.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Belalcazar, Helen M.] Albert Einstein Coll Med, Dept Genet, New York, NY USA	University of Texas System; University of Texas Health San Antonio; State University System of Florida; University of South Florida; Yeshiva University	de Erausquin, GA (corresponding author), Univ Texas Hlth San Antonio, Lab Brain Dev & Repair, Biggs Inst Alzheimer & Neurodegenerat Dis, San Antonio, TX 78229 USA.	deerausquing@uthscsa.edu	Belalcazar, Helen/AAU-2279-2021; de Erausquin, Gabriel A./Z-1952-2019	de Erausquin, Gabriel A./0000-0001-6423-4461; Ladaga, Giannina Natalia/0000-0001-7937-5363	Zachry Foundation Chair; Center for Brain Health grant from the Valley Baptist Legacy Foundation; Roskamp Chair at USF Morsani College of Medicine; Fundacion FULTRA	Zachry Foundation Chair; Center for Brain Health grant from the Valley Baptist Legacy Foundation; Roskamp Chair at USF Morsani College of Medicine; Fundacion FULTRA	This work was supported in part by the Zachry Foundation Chair to Gde, and the Center for Brain Health grant from the Valley Baptist Legacy Foundation to GdE. In addition, the authors received funding from Roskamp Chair at USF Morsani College of Medicine and Fundacion FULTRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2008, MOVEMENT DISORD, V23, P319, DOI 10.1002/mds.21640; Benitez BA, 2011, NEUROPHARMACOLOGY, V60, P1176, DOI 10.1016/j.neuropharm.2010.10.024; Blank T, 2004, CNS NEUROL DISORD-DR, V3, P161, DOI 10.2174/1568007043337472; Branton RL, 1999, EXP NEUROL, V160, P88, DOI 10.1006/exnr.1999.7207; Burke RE, 2004, CELL TISSUE RES, V318, P63, DOI 10.1007/s00441-004-0908-4; CHIODO LA, 1992, SYNAPSE, V11, P294, DOI 10.1002/syn.890110405; Costantini LC, 1997, NEUROREPORT, V8, P2253, DOI 10.1097/00001756-199707070-00032; Dallerac GM, 2015, NEURODEGENER DIS, V15, P93, DOI 10.1159/000375126; de Erausquin GA, 2003, MOL PHARMACOL, V63, P784, DOI 10.1124/mol.63.4.784; DEERAUSQUIN G, 1994, MOL BRAIN RES, V21, P303, DOI 10.1016/0169-328X(94)90261-5; deErausquin G.A., 1995, NATO ASI SERIES A, V275; Deignan J, 2012, NEUROSCIENCE, V217, P67, DOI 10.1016/j.neuroscience.2012.04.053; Dolga AM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.530; Dolga AM, 2012, GLIA, V60, P2050, DOI 10.1002/glia.22419; Dorsey DA, 2006, APOPTOSIS, V11, P535, DOI 10.1007/s10495-006-5268-y; Dufour MA, 2014, J NEUROSCI RES, V92, P981, DOI 10.1002/jnr.23382; Falkenburger BH, 2006, J NEURAL TRANSM-SUPP, P261; Greco D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004977; Grube S, 2011, EMBO MOL MED, V3, P309, DOI 10.1002/emmm.201100135; Herrik KF, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00011; Hipolito L, 2015, PAIN, V156, P849, DOI 10.1097/j.pain.0000000000000124; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hopf FW, 2010, NEURON, V65, P682, DOI 10.1016/j.neuron.2010.02.015; Isaacs KR, 1996, MOL BRAIN RES, V36, P114, DOI 10.1016/0169-328X(95)00252-N; Ivkovic M, 2006, INT J NEUROSCI, V116, P157, DOI 10.1080/00207450341514; Jacobsen JPR, 2008, GENES BRAIN BEHAV, V7, P836, DOI 10.1111/j.1601-183X.2008.00416.x; JAEGER C, 1989, BRAIN RES BULL, V22, P981, DOI 10.1016/0361-9230(89)90010-5; Ji HF, 2009, EUR J NEUROSCI, V29, P1883, DOI 10.1111/j.1460-9568.2009.06735.x; Liebau S, 2007, J NEUROCHEM, V101, P1338, DOI 10.1111/j.1471-4159.2006.04437.x; Lilliu V, 2001, MOL BRAIN RES, V96, P133, DOI 10.1016/S0169-328X(01)00280-7; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Lopes FM, 2017, NEUROMOL MED, V19, P241, DOI 10.1007/s12017-017-8454-x; Marani E, 2008, ADV ANAT EMBRYOL CEL, V198, P1, DOI 10.1007/978-3-540-79460-8; Mourre C, 2017, NEUROPHARMACOLOGY, V113, P519, DOI 10.1016/j.neuropharm.2016.11.003; Mouton PR, 2017, J CHEM NEUROANAT, V80, pA1, DOI 10.1016/j.jchemneu.2016.12.002; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Noh W, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00265; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Ritsner M, 2003, PSYCHIAT GENET, V13, P143, DOI 10.1097/00041444-200309000-00002; Ritsner M, 2002, BIOL PSYCHIAT, V51, P788, DOI 10.1016/S0006-3223(01)01348-8; Sarpal D, 2004, SYNAPSE, V53, P104, DOI 10.1002/syn.20042; Schlichter LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-4; Seutin V, 2001, NEUROREPORT, V12, P255, DOI 10.1097/00001756-200102120-00015; Soden ME, 2013, NEURON, V80, P997, DOI 10.1016/j.neuron.2013.07.044; Sur M, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0119-5; Tacconi S, 2001, NEUROSCIENCE, V102, P209, DOI 10.1016/S0306-4522(00)00486-3; TESSNER TG, 1991, J BIOL CHEM, V266, P16261; Thion MS, 2018, SCIENCE, V362, P185, DOI 10.1126/science.aat0474; Tomita H, 2003, MOL PSYCHIATR, V8, P524, DOI 10.1038/sj.mp.4001271; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001	50	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0223633	10.1371/journal.pone.0223633	http://dx.doi.org/10.1371/journal.pone.0223633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701951	Green Published, gold, Green Submitted			2022-12-26	WOS:000575913700001
J	Soundharrajan, I; Kuppusamy, P; Srisesharam, S; Lee, JC; Sivanesan, R; Kim, D; Choi, KC				Soundharrajan, Ilavenil; Kuppusamy, Palaniselvam; Srisesharam, Srigopalram; Lee, Jeong Chae; Sivanesan, Ravikumar; Kim, Dahye; Choi, Ki Choon			Positive metabolic effects of selected probiotic bacteria on diet-induced obesity in mice are associated with improvement of dysbiotic gut microbiota	FASEB JOURNAL			English	Article						anti-obesity; metabolic disorders; microbiota; Lactobacillus plantarum; probiotics	HIGH-FAT DIET; CHOLESTEROL-LOWERING PROPERTIES; LACTOBACILLUS-PLANTARUM; ADIPOCYTE SIZE; INSULIN-RESISTANCE; LIPID-METABOLISM; ADIPOSE-TISSUE; WEIGHT-GAIN; INHIBITION; ADIPOGENESIS	Given the rising evidence that gut malfunction including changes in the gut microbiota composition, plays a major role in the development of obesity and associated metabolic diseases, the exploring of novel probiotic bacteria with potential health benefits has attracted great attention. RecentlyLactobacillusspp., exert potent anti-obesity effects by regulating key transcriptional and translational factors in adipose tissues. However, the molecular mechanism behind the anti-obesity effect of probiotics is not yet fully understood. Therefore, we investigated the effect ofLactobacillus plantarumA29 on the expression of adipogenic and lipogenic genes in 3T3-L1 adipocytes and high-fat diet (HFD)-fed mice. We observed that the treatment of 3T3-L1 adipocytes with the cell-free metabolites ofL plantaruminhibited their differentiation and fat depositions via downregulating the key adipogenic transcriptional factors (PPAR-gamma, C/EBP-alpha, and C/EBP-beta) and their downstream targets (FAS, aP2, ACC, and SREBP-1). Interestingly, supplementation withL plantarumreduced the fat mass and serum lipid profile concurrently with downregulation of lipogenic gene expression in the adipocytes, resulting in reductions in the bodyweight of HFD-fed obese mice.L plantarumtreatment attenuated the development of obesity in HFD-fed mice via the activation of p38MAPK, p44/42, and AMPK-alpha by increasing their phosphorylation. Further analysis revealed that A29 modulated gut-associated microbiota composition. Thus, A 29 potential probiotic strain may alleviate the obesity development and its associated metabolic disorders via inhibiting PPAR gamma through activating the p38MAPK and p44/42 signaling pathways.	[Soundharrajan, Ilavenil; Kuppusamy, Palaniselvam; Srisesharam, Srigopalram; Choi, Ki Choon] Rural Dev Adm, Natl Inst Anim Sci, Grassland & Forage Div, Cheonan 31000, South Korea; [Lee, Jeong Chae] Chonbuk Natl Univ, Res Ctr Bioact Mat, Inst Mol Biol & Genet, Jeonju, South Korea; [Sivanesan, Ravikumar] Rajah Serfoji Govt Arts Coll, Dept Zool, Thanjavur, Tamil Nadu, India; [Kim, Dahye] Jeju Natl Univ, Coll Appl Life Sci, Fac Biotechnol, Jeju, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Jeonbuk National University; Jeju National University	Choi, KC (corresponding author), Rural Dev Adm, Natl Inst Anim Sci, Grassland & Forage Div, Cheonan 31000, South Korea.; Kim, D (corresponding author), Univ Kentucky, Coll Med, Ctr Res Environm Dis, 1095 VA Dr, Lexington, KY 40536 USA.	pioioiq@nate.com; choiwh@korea.kr		Soundharrajan, Ilavenil/0000-0002-7854-5954	Cooperative Research Program for Agriculture Science and Technology Development [PJ01358902]	Cooperative Research Program for Agriculture Science and Technology Development(Rural Development Administration (RDA), Republic of Korea)	Cooperative Research Program for Agriculture Science and Technology Development, Grant/Award Number: PJ01358902	Achari A, 2017, INT J MOL SCI, V18, P1; Alard J, 2016, ENVIRON MICROBIOL, V18, P1484, DOI 10.1111/1462-2920.13181; Albano C, 2018, J DAIRY SCI, V101, P10807, DOI 10.3168/jds.2018-15096; Angin Y, 2016, EXPERIENTIA SUPPL, V107, P23, DOI 10.1007/978-3-319-43589-3_2; Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Borgeraas H, 2018, OBES REV, V19, P219, DOI 10.1111/obr.12626; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Bubnov RV, 2017, EPMA J, V8, P357, DOI 10.1007/s13167-017-0117-3; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Casarotti SN, 2015, INT DAIRY J, V41, P1, DOI 10.1016/j.idairyj.2014.08.021; Chiu CC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111220; Choi WJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57615-5; Choi WJ, 2019, J MED FOOD, V22, P560, DOI 10.1089/jmf.2018.4329; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; den Besten G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136364; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; FAO/WHO, 2002, GUID EV PROB FOODS; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Forssten SD, 2013, APPETITE, V71, P16, DOI 10.1016/j.appet.2013.06.093; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Heo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33566; Hildebrandt M, 2009, GASTROENTEROLOGY, V136; Huang WC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020353; Huang Y, 2014, APPL ENVIRON MICROB, V80, P7496, DOI 10.1128/AEM.02926-14; Hunter PM, 2017, NAT REV ENDOCRINOL, V13, P278, DOI 10.1038/nrendo.2016.210; Ilavenil S, 2016, J SCI FOOD AGR, V96, P593, DOI 10.1002/jsfa.7128; Iranmanesh M, 2014, LWT-FOOD SCI TECHNOL, V58, P355, DOI 10.1016/j.lwt.2013.10.005; Ivanovic B, 2015, AM J CARDIOVASC DRUG, V15, P403, DOI 10.1007/s40256-015-0128-1; Ji Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43092-y; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khan RA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-181; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kim S-J, 2016, MOL CELL BIOL, V36; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kumar CSVS, 2015, INT IMMUNOPHARMACOL, V25, P504, DOI 10.1016/j.intimp.2015.02.026; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Le Barz M, 2019, FASEB J, V33, P4921, DOI 10.1096/fj.201801672R; Lee CY, 2009, KAOHSIUNG J MED SCI, V25, P116, DOI 10.1016/S1607-551X(09)70050-6; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li HZ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00512; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liu YW, 2018, J MICROBIOL, V56, P601, DOI 10.1007/s12275-018-8079-2; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Mercenier A., 2008, B INT DAIRY FED, V429, P2; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Miyoshi M, 2014, EUR J NUTR, V53, P599, DOI 10.1007/s00394-013-0568-9; Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Muthusamy K, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10010417; Nakamura Futoshi, 2016, Microbial Ecology in Health and Disease, V27, P30312, DOI 10.3402/mehd.v27.30312; Nakamura F, 2016, J AGR FOOD CHEM, V64, P2549, DOI 10.1021/acs.jafc.5b05827; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Ogawa A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-36; Onishi JC, 2017, MICROBIOL-SGM, V163, P1189, DOI 10.1099/mic.0.000496; Park JE, 2014, J APPL MICROBIOL, V116, P145, DOI 10.1111/jam.12354; Park SY, 2018, KOREAN J FOOD SCI AN, V38, P99, DOI 10.5851/kosfa.2018.38.1.99; Park SY, 2015, KOREAN J FOOD SCI AN, V35, P171, DOI 10.5851/kosfa.2015.35.2.171; Park UH, 2012, J AGR FOOD CHEM, V60, P3853, DOI 10.1021/jf204514a; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Prasanna PHP, 2017, YOGURT IN HEALTH AND DISEASE PREVENTION, P171, DOI 10.1016/B978-0-12-805134-4.00009-2; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; REID G, 1988, CAN J MICROBIOL, V34, P344, DOI 10.1139/m88-063; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Salguero MV, 2019, EXP THER MED, V18, P3461, DOI 10.3892/etm.2019.7943; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Serban DE, 2014, CANCER LETT, V345, P258, DOI 10.1016/j.canlet.2013.08.013; Soundharrajan I, 2018, EVID-BASED COMPL ALT, V2018, P1; Soundharrajan I, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090318; Soundharrajan I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45793-w; Takemura N, 2010, EXP BIOL MED, V235, P849, DOI 10.1258/ebm.2010.009377; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Teng Y, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103665; Tsai YT, 2014, APPL MICROBIOL BIOT, V98, P1, DOI 10.1007/s00253-013-5346-3; Tulumoglu S, 2013, ANAEROBE, V24, P36, DOI 10.1016/j.anaerobe.2013.09.006; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Wang BH, 2017, ENGINEERING, V3, P71, DOI 10.1016/J.ENG.2017.01.008; Wang J, 2012, J DAIRY SCI, V95, P1645, DOI 10.3168/jds.2011-4768; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang YH, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9010019; World Health Organization, 2014, ANT RES GLOB REP SUR; Xie N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-53; Yu A-Q, 2016, NUTR CANC, V68, P1; Zago M, 2011, FOOD MICROBIOL, V28, P1033, DOI 10.1016/j.fm.2011.02.009; Zhang H, 2018, SYN SYST BIOTECHNO, V3, P113, DOI 10.1016/j.synbio.2018.03.001	109	14	14	4	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12289	12307		10.1096/fj.202000971R	http://dx.doi.org/10.1096/fj.202000971R		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32701200				2022-12-26	WOS:000555047900001
J	Zhao, H; Ding, F; Zheng, GH				Zhao, Hui; Ding, Feng; Zheng, Guanghong			LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer	FASEB JOURNAL			English	Article						LCN2; LncRNA TMPO-AS1; ovarian cancer; transcription factor	LONG NONCODING RNAS; LIPOCALIN 2; SURVIVAL	Ovarian cancer remains the sixth most frequently occurring cancer in women worldwide. Long noncoding RNAs (lncRNAs) are capable of regulating gene expression, and thus, participating in a wide range of biological functions and disease processes including cancer development. Our work suggests that lncRNA TMPO antisense RNA 1 (TMPO-AS1) represents an oncogenic lncRNA in ovarian cancer and presents a novel mechanism involving transcription factor E2F transcription factor 6 (E2F6) and lipocalin-2 (LCN2). We identified upregulated lncRNA TMPO-AS1 in ovarian cancer tissues and cells. siRNA-mediated silencing of lncRNA TMPO-AS1 restrained the aggressiveness of ovarian cancer cells and their pro-angiogenic ability, and reduced the expression of LCN2. LncRNA TMPO-AS1 was found to interact with E2F6, a transcriptional repressor that could bind to the promoter region of LCN2 gene. In addition, silencing of E2F6 or overexpression of LCN2 restored the aggressiveness of ovarian cancer cells and their pro-angiogenic ability following siRNA-mediated silencing of lncRNA TMPO-AS1. Taken together, we demonstrated lncRNA TMPO-AS1 could potentially promote LCN2 transcriptional activity by binding to transcription factor E2F6, and thus, stimulated the progression of ovarian cancer. These findings underscore a possible alternative therapeutic strategy for ovarian cancer treatment.	[Zhao, Hui; Zheng, Guanghong] Linyi Peoples Hosp, Dept Gynecol & Obstet, 27 Eastern Jiefang Rd, Linyi 276003, Shandong, Peoples R China; [Ding, Feng] Linyi Peoples Hosp, Dept Educ & Teaching, Linyi, Shandong, Peoples R China		Zheng, GH (corresponding author), Linyi Peoples Hosp, Dept Gynecol & Obstet, 27 Eastern Jiefang Rd, Linyi 276003, Shandong, Peoples R China.	drGuanghong@163.com						Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Chay D, 2010, INT J ONCOL, V37, P399, DOI 10.3892/ijo_00000688; Cheng FHC, 2019, CANCER SCI, V110, P1085, DOI 10.1111/cas.13920; Cho H, 2009, J HISTOCHEM CYTOCHEM, V57, P513, DOI 10.1369/jhc.2009.953257; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Guo QY, 2019, J CELL MOL MED, V23, P1840, DOI 10.1111/jcmm.14084; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Huang WH, 2018, PROSTATE, V78, P1248, DOI 10.1002/pros.23700; Johnson N, 2017, INT J GYNECOL CANCER, V27, pS14, DOI 10.1097/IGC.0000000000001115; Li YF, 2019, NETPL'19: PROCEEDINGS OF THE 2019 ACM SIGCOMM WORKSHOP ON NETWORKING AND PROGRAMMING LANGUAGES, P2, DOI 10.1145/3341561.3349591; Liu Z, 2018, DATA BRIEF, V19, P1902, DOI 10.1016/j.dib.2018.06.048; Liu Z, 2018, BBA-MOL BASIS DIS, V1864, P2785, DOI 10.1016/j.bbadis.2018.05.006; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Nikpayam Elahe, 2017, Iranian Biomedical Journal, V21, P3, DOI 10.6091/.21.1.3; Ning L, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011481; Peng FD, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0666-z; Qin ZM, 2019, BIOCHEM BIOPH RES CO, V516, P486, DOI 10.1016/j.bbrc.2019.06.088; Ren CC, 2015, INT J GYNECOL CANCER, V25, P566, DOI 10.1097/IGC.0000000000000413; Renganathan A, 2017, ADV EXP MED BIOL, V1008, P199, DOI 10.1007/978-981-10-5203-3_7; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Rojo AI, 2012, FREE RADICAL BIO MED, V52, P473, DOI 10.1016/j.freeradbiomed.2011.11.003; Sharma D, 2009, GEN COMP ENDOCR, V162, P319, DOI 10.1016/j.ygcen.2009.04.009; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Sirotkin AV, 2010, J CELL PHYSIOL, V225, P20, DOI 10.1002/jcp.22248; Sundar S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4443; Tripathi MK, 2018, DRUG DISCOV TODAY, V23, P1635, DOI 10.1016/j.drudis.2018.04.010; Yamada Y, 2016, FREE RADICAL RES, V50, P414, DOI 10.3109/10715762.2015.1134795; Yang J, 2019, J GENE MED, V21, DOI 10.1002/jgm.3125; Yang J, 2013, FASEB J, V27, P45, DOI 10.1096/fj.12-211730; Yevshin I, 2017, NUCLEIC ACIDS RES, V45, pD61, DOI 10.1093/nar/gkw951; Yu J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317709129; Zhan L, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0793-4	34	11	12	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11382	11394		10.1096/fj.201902683R	http://dx.doi.org/10.1096/fj.201902683R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32692467				2022-12-26	WOS:000554624800001
J	Macia, P; Barranco, M; Gorbena, S; Iraurgi, I				Macia, Patricia; Barranco, Mercedes; Gorbena, Susana; Iraurgi, Ioseba			Expression of resilience, coping and quality of life in people with cancer	PLOS ONE			English	Article							FORM HEALTH SURVEY; BREAST-CANCER; SOCIAL SUPPORT; EMOTIONAL DISTRESS; STRATEGIES; PREDICTORS; DEPRESSION; OLDER; ADJUSTMENT; ANXIETY	Considering the importance of coping strategies and resilience in adapting to the stress caused by cancer, the objective of this research is to explore which coping strategies are the most used, in order to know whether different groups of levels of resilience and an appropriate coping style are related to a higher quality of life and better adaptation to the disease. There were 74 participants with cancer in this study (79.7% of them were women) ranging in age from 29 to 85 years (M= 50.9). Different instruments were used to measure the resilience construct (ER-20 items Resilience Scale), coping strategies (Cognitive Emotion Regulation Questionnaire-Short) and quality of life (General Health Questionnaire). People with higher resilience showed higher scores in the use of adaptive strategies, being acceptance and positive revaluation the most frequent ones. Regarding perception of quality of life, people with lower resilience showed statistically significant differences in the dimensions of pain and general health, which were likewise the most common ones for people with lower resilience. A significant association has been demonstrated between resilience and an adaptive coping, which at the same time are positively linked to quality of life of people with cancer. This study provides information about how different groups of resilience levels are related with coping and quality of life in people with cancer. It could be useful information for psychologists in the oncological area who have to take decisions in the clinical context. A practical consequence would involve trying to modify the type of coping, as well as increasing the level of resilience in people with cancer, in order to achieve a better adjustment to the disease.	[Macia, Patricia; Gorbena, Susana; Iraurgi, Ioseba] Univ Deusto, Dept Personal Evaluat & Psychol Treatments, Bilbao, Biscay, Spain; [Barranco, Mercedes] Spanish Assoc Canc, Prov Off Biscay, Bilbao, Spain	University of Deusto	Macia, P (corresponding author), Univ Deusto, Dept Personal Evaluat & Psychol Treatments, Bilbao, Biscay, Spain.	patriciamacia@deusto.es	Iraurgi, Ioseba/B-8663-2011; Gorbeña, Susana/V-2707-2019	Iraurgi, Ioseba/0000-0002-0143-9539; Gorbena, Susana/0000-0002-5289-9850; Macia, Patricia/0000-0003-1789-1930	University of Deusto	University of Deusto	The author PM is a beneficiary of a Predoctoral research grant given by the University of Deusto. URL: https://www.deusto.es/cs/Satellite/deusto/es/universidad-deusto The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts JWF, 2015, PSYCHO-ONCOLOGY, V24, P950, DOI 10.1002/pon.3748; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; [Anonymous], 2004, EQS STRUCTURAL EQUAT; Becona E.B., 2006, REV PSICOPATOLOG A P, V11, P125, DOI [DOI 10.5944/RPPC.VOL.11.NUM.3.2006.4024, 10.5944/rppc.vol.11.num.3.2006.4024]; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cheng KKF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018101; Deimling GT, 2006, PSYCHO-ONCOL, V15, P306, DOI 10.1002/pon.955; Dura-Ferrandis E, 2017, PSYCHO-ONCOLOGY, V26, P1914, DOI 10.1002/pon.4404; Eicher M, 2015, ONCOL NURS FORUM, V42, pE3, DOI 10.1188/15.ONF.E3-E16; Falagas ME, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1744; Rodriguez CF, 2011, PSICOTHEMA, V23, P374; Fernandez-Feito A, 2015, PSICOTHEMA, V27, P128, DOI 10.7334/psicothema2014.203; Galego V., 2013, THESIS; Garnefski N, 2006, PERS INDIV DIFFER, V41, P1045, DOI 10.1016/j.paid.2006.04.010; Guil R., 2016, PSICOONCOLOGIA, V13, P127, DOI [10.5209/rev_PSIC.2016.v13.n1.52492, DOI 10.5209/REV_PSIC.2016.V13.N1.52492]; Harms CA, 2019, PSYCHO-ONCOLOGY, V28, P271, DOI 10.1002/pon.4934; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iraurgi I., 2014, DEV CONTENT VALIDITY; Iraurgi I, 2012, RESILIENCE APPROACH; Kim J, 2010, J HEALTH PSYCHOL, V15, P543, DOI 10.1177/1359105309355338; Kvillemo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112733; Lai HL, 2020, EUR J CANCER CARE, V29, DOI 10.1111/ecc.13161; Lam WWT, 2017, PSYCHO-ONCOLOGY, V26, P255, DOI 10.1002/pon.4116; Lazarus R.S., 1984, EMOTION ADAPTATION; Liu CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177055; Valero AL, 2008, DIDACT-LENG LIT, V20, P177; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Matzka M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154496; Mayordomo T, 2016, J PSYCHOL, V150, P809, DOI 10.1080/00223980.2016.1203276; Min JA, 2013, SUPPORT CARE CANCER, V21, P2469, DOI 10.1007/s00520-013-1807-6; Montiel CB, 2016, PSICOTHEMA, V28, P266, DOI 10.7334/psicothema2015.271; Nipp RD, 2016, CANCER-AM CANCER SOC, V122, P2110, DOI 10.1002/cncr.30025; Oliveros-ariza E, 2010, REV PSICOLOGIA GEPU, V1, P19; Petticrew M, 2002, BRIT MED J, V325, P1066, DOI 10.1136/bmj.325.7372.1066; Philip EJ, 2013, PSYCHO-ONCOLOGY, V22, P987, DOI 10.1002/pon.3088; Philipp R, 2019, PSYCHO-ONCOLOGY, V28, P854, DOI 10.1002/pon.5030; Pigott T. D., 2001, ED RES EVALUATION, V7, P353, DOI DOI 10.1076/EDRE.7.4.353.8937; Regier NG, 2015, AGING MENT HEALTH, V19, P1113, DOI 10.1080/13607863.2014.1003286; Ristevska-Dimitrovska Gordana, 2015, Open Access Maced J Med Sci, V3, P727, DOI 10.3889/oamjms.2015.128; Roesch SC, 2005, J BEHAV MED, V28, P281, DOI 10.1007/s10865-005-4664-z; Saita E, 2015, PSYCHO-ONCOLOGY, V24, P334, DOI [10.1080/07347332.2014.955242, DOI 10.1080/07347332.2014.955242]; Saita E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00088; Schwartz CE, 2017, QUAL LIFE RES, V26, P3075, DOI 10.1007/s11136-017-1633-2; Secinti E, 2019, CLIN PSYCHOL REV, V71, P27, DOI 10.1016/j.cpr.2019.05.001; Seib C, 2018, PSYCHO-ONCOLOGY, V27, P1787, DOI 10.1002/pon.4728; Shelby RA, 2008, J BEHAV MED, V31, P433, DOI 10.1007/s10865-008-9167-2; Silva SM, 2012, PSYCHOL HEALTH, V27, P1323, DOI 10.1080/08870446.2012.676644; Smith MM, 2016, J PSYCHOL, V150, P318, DOI 10.1080/00223980.2015.1036828; Smorti M, 2012, EUR J CANCER CARE, V21, P251, DOI 10.1111/j.1365-2354.2011.01271.x; SPSS I, 2013, SPSS STAT WIND; Stanton AL, 2002, PSYCHO-ONCOLOGY, V11, P93, DOI 10.1002/pon.574; Velasco C., 2004, B PSICOLOGIA, V82, P25; von Hippel PT, 2004, AM STAT, V58, P160, DOI 10.1198/0003130043204; Walsh DMJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00136; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wedding U, 2007, EUR J CANCER, V43, P2203, DOI 10.1016/j.ejca.2007.06.001; Wu LM, 2013, J ADV NURS, V69, P158, DOI 10.1111/j.1365-2648.2012.06003.x; Ye ZJ, 2017, PSYCHO-ONCOLOGY, V26, P829, DOI 10.1002/pon.4237	59	19	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236572	10.1371/journal.pone.0236572	http://dx.doi.org/10.1371/journal.pone.0236572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2YL	32726344	gold, Green Published			2022-12-26	WOS:000556908900010
J	Min, M; Taneepanichskul, N				Min, Myo; Taneepanichskul, Nutta			Cooking fuels use and carotid intima-media thickness during early pregnancy of women in Myanmar	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PARTICULATE MATTER; CARBON-MONOXIDE; AIR-POLLUTION; MEXICAN WOMEN; CARDIOVASCULAR-DISEASE; VASCULAR FUNCTION; BIOMASS FUEL; RISK-FACTORS; EXPOSURE	Background Fuels burned in households for cooking cause indoor air pollution, exposing those who are cooking. Despite the mounting evidence of the effects of fuels use on health, few studies focus on the effect of cooking fuels have on carotid intima-media thickness (CIMT), a surrogate atherosclerosis biomarker in the early stages of pregnancy. This study aimed to examine the association between the use of cooking fuels and CIMT during early trimester of pregnancy among cooking women in Myanmar. Methodology In this cross-sectional study, a part of an ongoing birth cohort analysis, a total of 192 cooking pregnant women over 18 years with gestational weeks less than 18 were recruited from 15 rural health centers in Nay Pyi Taw from September to November 2019. Sociodemographic data, residential data, and fuels use data were collected with semi-structured questionnaires in face-to-face interviews. Anthropometric, hemodynamic, blood lipids, and ultrasound CIMT measurements were performed under standard protocols. Multiple linear regression was modeled to explore associations. Results The study included 70 firewood fuel users, 26 charcoal fuel users, and 96 electricity fuel users. Following adjustments for potential confounding factors, firewood use was significantly associated with the increase of all CIMT analyzed. Importantly, a greater increase of mean CIMT of the right common carotid artery (RCCA; beta = 0.033 mm; 95%CI: 0.006, 0.058; P<0.05) had significant association with charcoal use compared to firewood use (beta = 0.029 mm; 95%CI: 0.010, 0.049; P<0.05). Conclusions Our findings demonstrate that the indoor use of cooking fuels that cause indoor air pollution, such as firewood and charcoal, is a considerable risk factor for human health and is associated with increased CIMT, wherein charcoal use contributes to more increase of mean CIMT of the RCCA. Measures to prevent health risks related to the use of such fuels should be instituted early on during pregnancy.	[Min, Myo; Taneepanichskul, Nutta] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand	Chulalongkorn University	Taneepanichskul, N (corresponding author), Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand.	nutta.taneepanichskul@gmail.com	Taneepanichskul, Nutta/GMW-8835-2022	Taneepanichskul, Nutta/0000-0002-7489-572X	90 TH ANNIVERSARY OF CHULALONGKORN UNIVERSITY FUND (Ratchadaphiseksomphot Endowment Fund); Grant for International Research Integration: Chula Research Scholar, Ratchadaphiseksomphot Endowment Fund	90 TH ANNIVERSARY OF CHULALONGKORN UNIVERSITY FUND (Ratchadaphiseksomphot Endowment Fund)(Chulalongkorn University); Grant for International Research Integration: Chula Research Scholar, Ratchadaphiseksomphot Endowment Fund	This study is funded by THE 90 TH ANNIVERSARY OF CHULALONGKORN UNIVERSITY FUND (Ratchadaphiseksomphot Endowment Fund) and Grant for International Research Integration: Chula Research Scholar, Ratchadaphiseksomphot Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, INDOOR AIR, V25, P341, DOI 10.1111/ina.12144; Amegah AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113920; Bartington SE, 2017, ENVIRON POLLUT, V220, P38, DOI 10.1016/j.envpol.2016.08.074; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Bruckmann A, 2016, ULTRASCHALL MED, V37; Chartier R, 2017, INDOOR AIR, V27, P147, DOI 10.1111/ina.12281; Chat V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208148; Darabian S, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0306-4; Department of Population Ministry of Immigration and Population Republic of the Union of Myanmar, 2015, 2014 MYANM POP HOUS; Enkhmaa D, 2016, J WOMENS HEALTH, V25, P284, DOI 10.1089/jwh.2015.5414; Garovic VD, 2017, MAYO CLIN P; Gill EA, 2011, PROG CARDIOVASC DIS, V53, P353, DOI 10.1016/j.pcad.2011.02.001; Kammoolkon R, 2018, ASIA-PAC J PUBLIC HE, V30, P178, DOI 10.1177/1010539517753930; Khan MN, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0272-y; Kurmi OP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-92; Lim TK, 2008, J AM SOC ECHOCARDIOG, V21, P112, DOI 10.1016/j.echo.2007.05.002; LIN H, 1988, LIFE SCI, V43, P1813, DOI 10.1016/0024-3205(88)90280-9; LIU B, 2017, SCI REPORTS, V7, DOI DOI 10.1038/SREP4150028134279; Lorenz MW, 2015, DIABETES CARE, V38, P1921, DOI 10.2337/dc14-2732; Luo X, 2011, CLIN RADIOL, V66, P393, DOI 10.1016/j.crad.2010.12.002; Ministry of Health, 2018, HOSP SAT REP 2014 16; Niemczyk NA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1841-y; Nordestgaard BG, 2017, J AM COLL CARDIOL, V70, P1637, DOI 10.1016/j.jacc.2017.08.006; Ochoa-Martinez AC, 2017, CHEMOSPHERE, V186, P770, DOI 10.1016/j.chemosphere.2017.08.055; Ochoa-Martinez AC, 2017, ENVIRON SCI POLLUT R, V24, P1862, DOI 10.1007/s11356-016-7971-8; Ofori SN, 2018, ENVIRON POLLUT, V242, P390, DOI 10.1016/j.envpol.2018.06.102; Painschab M.S., 2013, HEART; Pereira G, 2012, J EPIDEMIOL COMMUNIT; Polak JF, 2015, J AM SOC ECHOCARDIOG, V28, P1114, DOI 10.1016/j.echo.2015.04.001; Provost EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127014; Pruneda-Alvarez LG, 2016, SCI TOTAL ENVIRON, V572, P1195, DOI 10.1016/j.scitotenv.2016.08.037; Qu BG, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0041-4; Quinn AK, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0282-9; Ranzani OT, 2019, INT J EPIDEMIOLOGY; Ren LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144182; Ruiz-Vera T, 2019, ENVIRON MOL MUTAGEN, V60, P546, DOI 10.1002/em.22273; Ruiz-Vera T, 2019, DRUG CHEM TOXICOL, V42, P335, DOI 10.1080/01480545.2018.1526181; Ruiz-Vera T, 2015, ENVIRON TOXICOL PHAR, V40, P423, DOI 10.1016/j.etap.2015.07.014; Selwaness M, 2014, STROKE, V45, P3226, DOI 10.1161/STROKEAHA.114.005202; Simova I., 2015, EUR SOC CARDIOL, V13, P1; Skilton MR, 2010, STROKE, V41, P1332, DOI 10.1161/STROKEAHA.110.579219; Thein Tin Tin, 2008, PROMOTING ANTENATAL; US EPA, 2019, WOOD SMOK YOUR HLTH; Van Vliet EDS, 2019, ENVIRON INT, V124, P533, DOI 10.1016/j.envint.2019.01.046; Baroncini LAV, 2015, IJC HEART VASC, V9, P48, DOI 10.1016/j.ijcha.2015.08.003; von Bornstadt D, 2014, J CEREBR BLOOD F MET, V34, P215, DOI 10.1038/jcbfm.2013.212; WHO, HOUS AIR POLL COOK H; WHO, 2019, HOUS AIR POLL COOK H; Wolff B, 2005, STROKE, V36, P938, DOI 10.1161/01.STR.0000162712.27799.20; Wylie BJ, 2017, INDOOR AIR, V27, P136, DOI 10.1111/ina.12289	50	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236151	10.1371/journal.pone.0236151	http://dx.doi.org/10.1371/journal.pone.0236151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726349	gold, Green Published			2022-12-26	WOS:000556908900031
J	Al Slamah, T; Nicholl, BI; Alslail, FY; Harris, L; Melville, CA; Kinnear, D				Al Slamah, Thamer; Nicholl, Barbara I.; Alslail, Fatima Y.; Harris, Leanne; Melville, Craig A.; Kinnear, Deborah			Cultural adaptation of self-management of type 2 diabetes in Saudi Arabia (qualitative study)	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EDUCATION; MELLITUS; CARE; STANDARDS; OUTCOMES; PROGRAM; ADULTS	Background Saudi Arabia is continuously working on developing its health care system, however with the high prevalence of type 2 diabetes and comorbidities, such as cardiovascular diseases, self-management education programmes are essential. As part of a planned series of studies to develop a culturally sensitive type 2 diabetes self-management programme, this study explores the need versus barriers and facilitators relevant to implementing a national programme for type 2 diabetes self-management education within the community and health care system in Saudi Arabia. Methods A qualitative methodology was used to explore the views of a multidisciplinary group of diabetes health professionals and adult patients with type 2 diabetes. The views of nine health professionals working at a specialised diabetes care centre were gathered at two focus groups (four and five) that included doctors, nutritionists, health educators and nurses. Individual interviews with 12 patients with type 2 diabetes (six females and six males) attending the centre were also carried out. Recurring themes through the translated transcripts were studied and treated by the research group under pre-set protocols. Results Focus groups with health professionals revealed three main themes. 1. Resources: availability of resources and how they impacted on performance and patients' care; 2.Familiarity with self-management education programmes: educating patients and raising awareness among them; and 3. Lifestyle: patients' lifestyle and how it could affect their compliance with self-management programmes. Interviews with patients also revealed three main themes. 1. Habits: post diagnosis changes in patients' attitudes and behaviours towards diet and physical activity; 2. Health education: awareness of managing type 2 diabetes through health centre advice or self-education; and 3. Culture and society: a lack of cultural or social support created by some social practices or conventions. Conclusion The findings from this study highlight a gap in type 2 diabetes care system that can be breached through the development of a Saudi specific self-management programme for type 2 diabetes. The identified barriers and facilitators can be used for adapting a self-management programme to the Saudi context. However, initial training is needed for local health professionals to understand the mechanisms of self-management programmes. Such programmes will need to infiltrate to the society, and the patients' families, in particular to tackle the rising prevalence of type 2 diabetes in Saudi Arabia and provide a friendlier, more supportive environment for the current patients to self-manage their diabetes.	[Al Slamah, Thamer] Qassim Univ, Coll Appl Med Sci, Human Hlth Dept, Riyadh, Saudi Arabia; [Al Slamah, Thamer; Nicholl, Barbara I.] Univ Glasgow, Gen Practice & Primary Care, Inst Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Alslail, Fatima Y.] Minist Hlth, Natl Diabet Control & Prevent Program, Riyadh, Saudi Arabia; [Harris, Leanne] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland; [Melville, Craig A.; Kinnear, Deborah] Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Qassim University; University of Glasgow; Ministry of Health - Saudi Arabia; University of Glasgow; University of Glasgow	Kinnear, D (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	deborah.kinnear@glasgow.ac.uk	Nicholl, Barbara/AAY-3598-2020	Nicholl, Barbara/0000-0001-5639-0130; Alslamah, Thamer/0000-0001-8776-9514; Cairns, Deborah/0000-0002-2626-1554; Melville, Craig/0000-0001-7234-2382; Al Slail, Fatima/0000-0001-7334-2018				Al Slamah T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189160; Al-Hanawi MK, 2018, APPL HEALTH ECON HEA, V16, P55, DOI 10.1007/s40258-017-0353-7; Al-Hazzaa HM, 2007, PUBLIC HEALTH NUTR, V10, P59, DOI 10.1017/S1368980007184299; Al-Hazzaa HM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00329; Al-Rethaiaa AS, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-39; Al-Rubeaan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124446; al-Shahri Mohammad Zafir, 2002, J Transcult Nurs, V13, P133, DOI 10.1177/104365960201300206; Alqurashi KA, 2011, ANN SAUDI MED, V31, P19, DOI 10.4103/0256-4947.75773; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; [Anonymous], 2003, WORLD POP 2002; Babakus WS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-150; Banister NA, 2004, J AM DIET ASSOC, V104, P807, DOI 10.1016/j.jada.2004.02.027; Barrera M, 2006, CLIN PSYCHOL-SCI PR, V13, P311, DOI 10.1111/j.1468-2850.2006.00043.x; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Brunisholz KD, 2014, J MULTIDISCIP HEALTH, V7, P533, DOI 10.2147/JMDH.S69000; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; FAMUYIWA OO, 1992, ANN SAUDI MED, V12, P140, DOI 10.5144/0256-4947.1992.140; Fletcher Barbara, 2002, J Cardiovasc Nurs, V16, P17; FONSECA V, 1985, E AFR MED J, V62, P21; Funnell MM, 2007, DIABETES CARE, V30, P1630, DOI 10.2337/dc07-9923; Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336; Jepson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045333; Kumpfer KL, 2008, EVAL HEALTH PROF, V31, P226, DOI 10.1177/0163278708315926; Mahfouz AA, 2011, SAUDI J GASTROENTERO, V17, P318, DOI 10.4103/1319-3767.84486; Ministry of Health Saudi Arabia, 2018, STAT YB; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Osuna D, 2011, HEALTH PROMOT PRACT, V12, P341, DOI 10.1177/1524839909343279; Smith JA, 2009, QUAL RES PSYCHOL; Snape D, 2003, QUALITATIVE RES PRAC, P2; Sohal T, 2015, BARRIERS FACILITATOR, P1; Squires A, 2009, INT J NURS STUD, V46, P277, DOI 10.1016/j.ijnurstu.2008.08.006; Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213; The Ministry of Health, 2015, STAT REP; Toobert DJ, 2011, TRANSL BEHAV MED, V1, P416, DOI 10.1007/s13142-010-0011-1; Weaver RG, 2014, DIABETIC MED, V31, P1610, DOI 10.1111/dme.12513; West JD, 2002, AM J HEALTH-SYST PH, V59, P849, DOI 10.1093/ajhp/59.9.849; Yeary KHCK, 2017, PROG COMM HLTH PARTN, V11, P253, DOI 10.1353/cpr.2017.0030	37	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0232904	10.1371/journal.pone.0232904	http://dx.doi.org/10.1371/journal.pone.0232904			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722666	gold, Green Published, Green Accepted			2022-12-26	WOS:000556916000027
J	Lim, JH; Han, MH; Kim, YJ; Jeon, Y; Jung, HY; Choi, JY; Cho, JH; Kim, CD; Kim, YL; Lee, H; Kim, DK; Moon, KC; Park, SH				Lim, Jeong-Hoon; Han, Man-Hoon; Kim, Yong-Jin; Jeon, Yena; Jung, Hee-Yeon; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Lee, Hajeong; Kim, Dong Ki; Moon, Kyung Chul; Park, Sun-Hee			Novel histopathologic predictors for renal outcomes in crescentic glomerulonephritis	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED GLOMERULONEPHRITIS; ANCA-ASSOCIATED VASCULITIS; LYMPHOID STRUCTURES; T-CELLS; CLASSIFICATION; CYCLOPHOSPHAMIDE; RITUXIMAB; NEOGENESIS; DEPOSITS; PATHWAY	Introduction Crescentic glomerulonephritis (CrGN) is a histologic feature of severe glomerular injury, clinically characterized by a rapid decline of renal function when not treated in a timely fashion. Factors associated with CrGN prognosis have not been thoroughly investigated. This study investigated the prognostic predictors of renal outcomes associated with CrGN, such as the histopathologic classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis, arteriosclerosis, and tertiary lymphoid organ (TLO) formation. Methods A total of 114 patients diagnosed with CrGN between 2010 and 2018 at two university-based hospitals has been retrospectively analyzed. Relationships between potential predictors and renal outcomes were analyzed using Cox proportional hazards model and linear regression analysis. Results The mean age was 61.0 +/- 15.3 years, and 49.1% were male. Among them, 92 (80.7%) and 11 (9.6%) patients were positive for ANCA and for anti-glomerular basement membrane antibody, respectively. During the median follow-up of 458.0 days, 55 patients (48.2%) had advanced to end-stage renal disease (ESRD). Cox proportional hazards analysis revealed that patients under the mixed and sclerotic classes had worse renal survival compared to those in the focal class (mixed: hazard ratio [HR], 3.74; 95% confidence interval [CI], 1.18 to 11.82;P= 0.025; sclerotic: HR, 4.84; 95% CI, 1.44 to 16.32;P= 0.011). Severe arteriosclerosis was also associated with poor renal survival (HR, 2.44; 95% CI, 1.04 to 5.77;P= 0.042). TLOs were observed in 41 patients (36.0%). Moreover, TLO formation was also a prognostic factor for ESRD (HR, 1.82; 95% CI, 1.03 to 3.21;P= 0.040). In the multivariate linear regression analysis, age and sclerotic class were independent predictors for the change in estimated glomerular filtration rate during 1 year after biopsy. Conclusions Specific histopathologic findings, histopathologic classification, severity of arteriosclerosis, and TLO formation provide helpful information in predicting renal outcomes associated with CrGN.	[Lim, Jeong-Hoon; Jung, Hee-Yeon; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea; [Han, Man-Hoon; Kim, Yong-Jin] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Pathol, Daegu, South Korea; [Jeon, Yena] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Lee, Hajeong; Kim, Dong Ki] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Moon, Kyung Chul] Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea	Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Seoul National University (SNU); Seoul National University (SNU)	Park, SH (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea.	sh-park@knu.ac.kr	Kim, Dong Ki/J-5389-2012; Lim, Jeong-Hoon/ABE-6003-2020; Park, Sun/GSD-9620-2022; Cho, Jang-hee/ABD-3534-2020	Kim, Dong Ki/0000-0002-5195-7852; Lim, Jeong-Hoon/0000-0001-5517-9886; Cho, Jang-hee/0000-0002-7031-5214	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C0001; URL: https://www.khidi.or.kr).	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bajema IM, 1996, NEPHROL DIAL TRANSPL, V11, P1989, DOI 10.1093/oxfordjournals.ndt.a027086; Berden AE, 2012, J AM SOC NEPHROL, V23, P313, DOI 10.1681/ASN.2011040330; Berden AE, 2010, J AM SOC NEPHROL, V21, P1628, DOI 10.1681/ASN.2010050477; Brix SR, 2018, KIDNEY INT, V94, P1177, DOI 10.1016/j.kint.2018.07.020; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Van Wijngaarden RAFD, 2006, J AM SOC NEPHROL, V17, P2264, DOI 10.1681/ASN.2005080870; Djudjaj S, 2019, MOL ASPECTS MED, V65, P16, DOI 10.1016/j.mam.2018.06.002; Ellis CL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-210; Haas M, 2004, KIDNEY INT, V65, P2145, DOI 10.1111/j.1523-1755.2004.00632.x; Haas M, 2008, ARCH PATHOL LAB MED, V132, P37, DOI 10.1043/1543-2165(2008)132[37:AIKFHL]2.0.CO;2; Hedger N, 2000, NEPHROL DIAL TRANSPL, V15, P1593, DOI 10.1093/ndt/15.10.1593; Hirose O, 2017, CLIN EXP NEPHROL, V21, P643, DOI 10.1007/s10157-016-1341-1; Hogan SL, 1996, J AM SOC NEPHROL, V7, P23; Iwakiri T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-125; Jennette JC, 2003, KIDNEY INT, V63, P1164, DOI 10.1046/j.1523-1755.2003.00843.x; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Kantauskaite M, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54020017; Kim KM, 2019, KIDNEY RES CLIN PRAC, V38, P382, DOI 10.23876/j.krcp.18.0128; Koenig A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00646; Kopp JB, 2013, CURR OPIN NEPHROL HY, V22, P266, DOI 10.1097/MNH.0b013e3283600f8c; Langford CA, 1997, EUR ARCH OTO-RHINO-L, V254, P65, DOI 10.1007/BF01526181; Lee T, 2014, CLIN J AM SOC NEPHRO, V9, P905, DOI 10.2215/CJN.08290813; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mandache E, 2011, ROM J MORPHOL EMBRYO, V52, P1219; Marchal-Somme J, 2006, J IMMUNOL, V176, P5735, DOI 10.4049/jimmunol.176.10.5735; Marinkovic T, 2006, J CLIN INVEST, V116, P2622, DOI 10.1172/JCI28993; Meyrier A, 2015, NEPHROL DIAL TRANSPL, V30, P1833, DOI 10.1093/ndt/gfu366; Moroni G, 2014, AUTOIMMUN REV, V13, P723, DOI 10.1016/j.autrev.2014.02.007; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Nasr IW, 2007, AM J TRANSPLANT, V7, P1071, DOI 10.1111/j.1600-6143.2007.01756.x; Neumann I, 2003, NEPHROL DIAL TRANSPL, V18, P524, DOI 10.1093/ndt/18.3.524; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Pei G, 2014, CLIN J AM SOC NEPHRO, V9, P255, DOI 10.2215/CJN.01150113; Pepper RJ, 2013, CLIN J AM SOC NEPHRO, V8, P219, DOI 10.2215/CJN.03680412; Quintana LF, 2014, NEPHROL DIAL TRANSPL, V29, P1764, DOI 10.1093/ndt/gfu084; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Radhakrishnan J, 2012, KIDNEY INT, V82, P840, DOI 10.1038/ki.2012.280; Risdon RA, 1980, ATLAS RENAL PATHOLOG, P27; Segerer S, 2008, KIDNEY INT, V73, P533, DOI 10.1038/sj.ki.5002734; Singh SKS, 2011, CURR OPIN NEPHROL HY, V20, P258, DOI 10.1097/MNH.0b013e32834583ec; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Sund S, 1999, NEPHROL DIAL TRANSPL, V14, P2445, DOI 10.1093/ndt/14.10.2445; Tanna A, 2015, NEPHROL DIAL TRANSPL, V30, P1185, DOI 10.1093/ndt/gfu237; Thaunat O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011398; Timmer TCG, 2007, ARTHRITIS RHEUM-US, V56, P2492, DOI 10.1002/art.22748; Weyand CM, 2001, AM J PATHOL, V159, P787, DOI 10.1016/S0002-9440(10)61751-8	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236051	10.1371/journal.pone.0236051	http://dx.doi.org/10.1371/journal.pone.0236051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716952	Green Published, gold			2022-12-26	WOS:000556674500004
J	Ahenkorah, B; Nsiah, K; Baffoe, P; Ofosu, W; Gyasi, C; Owiredu, EW				Ahenkorah, Benjamin; Nsiah, Kwabena; Baffoe, Peter; Ofosu, Winfred; Gyasi, Charles; Owiredu, Eddie-Williams			Parasitic infections among pregnant women at first antenatal care visit in northern Ghana: A study of prevalence and associated factors	PLOS ONE			English	Article							MALARIA; ANEMIA	Background Parasitic infections remain widespread in developing countries and constitute a major public health problem in many parts of sub-Saharan Africa. It is prevalent among children under 5 years and pregnant women; however, studies among the later high risk group is limited in the northern part of Ghana. Here, we evaluated the prevalence and associated factors of parasitic infections among pregnant women at first antenatal care visit in northern Ghana. Methods This was a cross-sectional study conducted at the Department of Obstetrics and Gynecology, Bolgatanga Regional Hospital, Upper East Region-Ghana. A total of 334 consecutive consenting pregnant women were included. Questionnaires were administered to obtain socio-demographic data. Venous blood, stool and urine samples were collected for parasite identification using microscopy. Factors associated with parasitic infections were evaluated using regression models. Statistical analysis was performed using R. Results Parasitic infections identified were giardiasis (30.5%), P. falciparum malaria (21.6%) and schistosomiasis (0.6%). Polyparasitic infection was identified in 6.6% of the population. Increasing age [Age of 20-29 years: AOR = 0.16, 95% CI (0.06-0.38); Age of 30-39 years: AOR = 0.21, 95% CI (0.08-0.50); Age > 39 years: AOR = 0.30, 95% CI (0.11-0.83)] was associated with lower odds whiles presence of domestic animals [AOR = 1.85, 95% CI (1.01-3.39)], being in the second trimester of pregnancy [AOR = 2.21, 95% CI (1.17-4.19)], having no formal education [AOR = 3.29, 95% CI (1.47-7.35)] and basic education as the highest educational level [AOR = 6.03, 95% CI (2.46-10.81)] were independent predictors of increased odds of giardiasis. Similarly, having no formal education [AOR = 2.88, 95% CI (1.21-8.79)] was independently associated with higher odds of P. falciparum malaria. The use of insecticide treated net (ITN) [AOR = 0.43, 95% CI (0.21-0.89)] and mosquito repellent [AOR = 0.09, 95% CI (0.04-0.21)] were independent predictors of lower odds of P. falciparum malaria. Conclusion Giardiasis and P. falciparum malaria are common among pregnant women in northern Ghana. The major associated factors of giardiasis are lack of or low level of formal education, the presence of domestic animals and being in the second trimester of pregnancy. Increasing age confers protection against giardiasis. Likewise, lack of formal education is an associated factor for P. falciparum malaria among pregnant women in northern Ghana. The use of ITN and mosquito repellents reduce the risk of P. falciparum malaria. Given the possible role of parasitic infections in adverse pregnancy outcomes, our findings highlight the need for regular screening and treatment of infected women in the northern parts of Ghana. Public health education and improving socio-economic status could help reduce the risk of parasitic infections among pregnant women in the region.	[Ahenkorah, Benjamin; Owiredu, Eddie-Williams] Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Mol Med, Kumasi, Ghana; [Ahenkorah, Benjamin] Bolgatanga Reg Hosp, Biochem Unit, Bolgatanga, Upper East Regi, Ghana; [Ahenkorah, Benjamin] Bolgatanga Reg Hosp, Hematol Unit, Bolgatanga, Upper East Regi, Ghana; [Ahenkorah, Benjamin] Univ Dev Studies, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Tamale, Ghana; [Nsiah, Kwabena] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana; [Baffoe, Peter] United Nat Childrens Fund, Accra, Ghana; [Ofosu, Winfred] Ghana Hlth Serv, Accra, Ghana; [Gyasi, Charles] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Med Diagnost, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; University for Development Studies; Kwame Nkrumah University Science & Technology; Ghana Health Service; Kwame Nkrumah University Science & Technology	Owiredu, EW (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Mol Med, Kumasi, Ghana.	eddiewilliams.owiredu@gmail.com	Nsiah, Kwabena/AAP-2505-2021	Owiredu, Eddie-Williams/0000-0003-4499-0678; Gyasi, Charles/0000-0002-7549-7117				Addai-Mensah O, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/5019215; Adzitey F., 2013, J WORLDS POULT RES, V3, P1; Afoakwah C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0827-8; Akinbo F.O., 2015, NIGERIAN J EXPT CLIN, V3, P65, DOI [10.4103/2348-053X.234486, DOI 10.4103/2348-053X.234486]; Ayeh-Kumi P, 2008, GHANA J ALLIED HLTH, V2, P9; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Clerk CA, 2009, TROP MED INT HEALTH, V14, P688, DOI 10.1111/j.1365-3156.2009.02280.x; Daly ER, 2010, EPIDEMIOL INFECT, V138, P491, DOI 10.1017/S0950268809990744; Darko A., 2018, GSC BIOL PHARM SCI, V4, P7; Derso A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1859-6; Aranzales AFE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5978-4; Fuseini G., 2010, Journal of Public Health and Epidemiology, V2, P48; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; GHS, 2015, MAL PREGN; Kwenti TE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004673; Lane S, 2002, CRIT REV MICROBIOL, V28, P123, DOI 10.1080/10408410490435133; Mahande AM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1413-6; Manu G, 2017, MALARIA RES TREATMEN, V2017; Mutura A. W., 2015, East African Medical Journal, V92, P354; Ndibazza J, 2013, J INFECT DIS, V208, P2007, DOI 10.1093/infdis/jit397; Ofori Mf, 2009, Ghana Med J, V43, P13; Organization WH Control CfD, 2010, BAS MAL MICR TUT GUI; Owusu-Agyei S, 2009, MALARIA J, V8, P1; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; RCore Team, 2020, R LANG ENV STAT COMP; Ricci G, 2012, DERMATOL REP, V4, P1, DOI 10.4081/dr.2012.e1; Rodriguez-Garcia Roberto, 2002, Ginecol Obstet Mex, V70, P338; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; Solaymani-Mohammadi S, 2010, EXP PARASITOL, V126, P292, DOI 10.1016/j.exppara.2010.06.014; Spjeldnaes AO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-200; Stephens JK, 2014, PAN AFR MED J S, V17; Tay Samuel Crowther Kofi, 2017, BMC Res Notes, V10, P3, DOI 10.1186/s13104-016-2327-5; Tay SCK., 2013, OPEN J MED MICROBIOL, V3, P193, DOI 10.4236/ojmm.2013.33029; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Wekesa A W, 2014, J Parasitol Res, V2014, P823923, DOI 10.1155/2014/823923; WHO, 2017, MAL PREGN WOM WHO; Woodburn PW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000473; World Health Organization, 2020, SOIL TRANSM HELM INF; World Health Organization, 2019, WORLD MAL REP 2019 G; World Health Organization, 2003, WORLD MALARIA REPORT	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236514	10.1371/journal.pone.0236514	http://dx.doi.org/10.1371/journal.pone.0236514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706826	Green Published, gold			2022-12-26	WOS:000579931700051
J	Kim, K; Shim, H; Jung, PY; Kim, S; Choi, YU; Bae, KS; Lee, JK; Jang, JY				Kim, Kwangmin; Shim, Hongjin; Jung, Pil Young; Kim, Seongyup; Choi, Young Un; Bae, Keum Seok; Lee, Jung Kuk; Jang, Ji Young			Effectiveness of kaolin-impregnated hemostatic gauze use in preperitoneal pelvic packing for patients with pelvic fractures and hemodynamic instability: A propensity score matching analysis	PLOS ONE			English	Article							QUIKCLOT COMBAT GAUZE; LIFE-THREATENING HEMORRHAGE; INTRACORPOREAL USE; SWINE MODEL; TRAUMA; DRESSINGS; MORTALITY; INJURIES	Introduction We evaluated the effectiveness of kaolin-impregnated hemostatic gauze use in preperitoneal pelvic packing (PPP) for patients with hemodynamic instability due to severe pelvic fractures. Materials and methods Between May 2014 and October 2018, 53 of 75 patients who underwent PPP due to hemodynamic instability induced by pelvic fracture were enrolled. Their medical records were prospectively collected and retrospectively analyzed. QuikClot combat gauze (hydrophilic gauze impregnated with kaolin) and general surgical tape were used in 21 patients, while general surgical tape was used in the remaining 32 patients. Results As there were differences in the characteristics of patients between the hemostatic gauze (HG) group and control group, propensity score matching (PSM) was performed to adjust for age, sex, and lactate levels. After PSM, the clinical characteristics between the two groups became similar. There were no differences in the rates of mortality and hemorrhage-induced mortality between the two groups. However, the packed red blood cell (RBC) requirement for an additional 12 hours in the HG group was significantly lower than that in the control group (4.1 +/- 3.5 vs. 7.6 +/- 6.1 units, p = 0.035). The lengths of intensive care unit and hospital stays tended to be shorter in the HG group than in the control group (11.6 vs. 18.5 days, p = 0.1582; 30.8 vs. 47.4 days, p = 0.1861, respectively). Conclusions The use of HG during PPP did not reduce hemorrhage-induced mortality, but did reduce the need for additional packed RBC transfusions in patients with hemodynamic instability due to severe pelvic fractures.	[Kim, Kwangmin; Shim, Hongjin; Jung, Pil Young; Kim, Seongyup; Choi, Young Un; Bae, Keum Seok] Yonsei Univ, Dept Surg, Wonju Coll Med, Wonju, South Korea; [Kim, Kwangmin; Shim, Hongjin; Jung, Pil Young; Kim, Seongyup; Choi, Young Un; Bae, Keum Seok] Wonju Severance Christian Hosp, Reg Trauma Ctr, Wonju, South Korea; [Lee, Jung Kuk] Yonsei Univ, Dept Biostat, Wonju Coll Med, Wonju, South Korea; [Jang, Ji Young] Natl Hlth Insurance Serv Ilsan Hosp, Trauma Ctr, Dept Surg, Goyang, South Korea	Yonsei University; Yonsei University; National Health Insurance Service	Jang, JY (corresponding author), Natl Hlth Insurance Serv Ilsan Hosp, Trauma Ctr, Dept Surg, Goyang, South Korea.	drjangjiyoung@gmail.com; jyjang@hanmail.net		Choi, Young Un/0000-0003-2410-7788; Jang, Ji Young/0000-0001-6372-4194; JUNG, PIL YOUNG/0000-0001-6460-8072; Kim, Kwangmin/0000-0003-0496-1303				Burlew CC, 2017, J TRAUMA ACUTE CARE, V82, P233, DOI 10.1097/TA.0000000000001324; Burlew CC, 2011, J AM COLL SURGEONS, V212, P628, DOI 10.1016/j.jamcollsurg.2010.12.020; Chiara O, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0077-2; Choron RL, 2017, INJURY, V48, P158, DOI 10.1016/j.injury.2016.07.033; Eastridge BJ, 2002, J TRAUMA, V53, P446, DOI 10.1097/00005373-200209000-00009; Gegel B, 2012, MIL MED, V177, P1543, DOI 10.7205/MILMED-D-12-00165; Giannoudis PV, 2004, INJURY, V35, P671, DOI 10.1016/j.injury.2004.03.003; Granville-Chapman J, 2011, INJURY, V42, P447, DOI 10.1016/j.injury.2010.09.037; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P538, DOI 10.1097/TA.0b013e31827d5f5f; Jang JY, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0196-5; Johnson D, 2014, ANN MED SURG, V3, P21, DOI 10.1016/j.amsu.2014.03.001; Kim MJ, 2018, BMC SURG, V18, DOI 10.1186/s12893-018-0438-8; MUCHA P, 1988, SURG CLIN N AM, V68, P757; Plurad D, 2009, J TRAUMA, V66, P1482, DOI 10.1097/TA.0b013e31803420a3; Rall JM, 2013, J TRAUMA ACUTE CARE, V75, pS150, DOI 10.1097/TA.0b013e318299d909; Rhee P, 2008, J TRAUMA, V64, P1093, DOI 10.1097/TA.0b013e31812f6dbc; Sathy AK, 2009, J BONE JOINT SURG AM, V91A, P2803, DOI 10.2106/JBJS.H.00598; Sena MJ, 2013, J SURG RES, V183, P704, DOI 10.1016/j.jss.2013.02.039; Shim H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206991; Starr AJ, 2002, J ORTHOP TRAUMA, V16, P553, DOI 10.1097/00005131-200209000-00003; Wright FL, 2004, J TRAUMA, V56, P205, DOI 10.1097/01.TA.0000074349.88275.C4	21	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236645	10.1371/journal.pone.0236645	http://dx.doi.org/10.1371/journal.pone.0236645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706824	Green Published, gold			2022-12-26	WOS:000579931700059
J	Wolf, C; Drewing, K				Wolf, Christian; Drewing, Knut			The size-weight illusion comes along with improved weight discrimination	PLOS ONE			English	Article							HEAVINESS PERCEPTION; CUE COMBINATION; SURFACE TEXTURE; EXPECTANCIES; INFORMATION; MECHANISMS; DENSITY; OBJECTS; GRIP	When people judge the weight of two objects of equal mass but different size, they perceive the smaller one as being heavier. Up to date, there is no consensus about the mechanisms which give rise to this size-weight illusion. We recently suggested a model that describes heaviness perception as a weighted average of two sensory heaviness estimates with correlated noise: one estimate derived from mass, the other one derived from density. The density estimate is first derived from mass and size, but at the final perceptual level, perceived heaviness is biased by an object's density, not by its size. Here, we tested the models' prediction that weight discrimination of equal-size objects is better in lifting conditions which are prone to the size-weight illusion as compared to conditions lacking (the essentially uninformative) size information. This is predicted because in these objects density covaries with mass, and according to the model density serves as an additional sensory cue. Participants performed a two-interval forced-choice weight discrimination task. We manipulated the quality of either haptic (Experiment 1) or visual (Experiment 2) size information and measured just-noticeable differences (JNDs). Both for the haptic and the visual illusion, JNDs were lower in lifting conditions in which size information was available. Thus, when heaviness perception can be influenced by an object's density, it is more reliable. This discrimination benefit under conditions that provide the additional information that objects are of equal size is further support for the role of density and the integration of sensory estimates in the size-weight illusion.	[Wolf, Christian] Westfalische Wilhelms Univ, Allgemeine Psychol, Munster, Germany; [Drewing, Knut] Justus Liebig Univ, Allgemeine Psychol, Giessen, Germany	University of Munster; Justus Liebig University Giessen	Wolf, C (corresponding author), Westfalische Wilhelms Univ, Allgemeine Psychol, Munster, Germany.	chr.wolf@wwu.de	Wolf, Christian/K-5491-2015	Wolf, Christian/0000-0002-9969-3112	Deutsche Forschungsgemeinschaft DFG [427754309, SFB/TRR135, 222641018]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft DFG (www.dfg.de), project number 427754309 (CW) and SFB/TRR135, A05, project number 222641018 (KD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; BRODIE EE, 1984, PERCEPT PSYCHOPHYS, V36, P477, DOI 10.3758/BF03207502; Buckingham G, 2015, PSYCHOL SCI, V26, P237, DOI 10.1177/0956797614561267; Buckingham G, 2014, EXP BRAIN RES, V232, P1623, DOI 10.1007/s00221-014-3926-9; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Chouinard PA, 2009, NEUROIMAGE, V44, P200, DOI 10.1016/j.neuroimage.2008.08.023; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; CROSS DV, 1975, PERCEPT PSYCHOPHYS, V18, P79, DOI 10.3758/BF03204091; DAVIS CM, 1976, PERCEPT PSYCHOPHYS, V20, P33, DOI 10.3758/BF03198701; Dijker AJM, 2008, COGNITION, V106, P1109, DOI 10.1016/j.cognition.2007.05.009; Dijker AJM, 2014, PSYCHON B REV, V21, P1404, DOI 10.3758/s13423-014-0634-1; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; Ellis RR, 1998, PERCEPTION, V27, P193, DOI 10.1068/p270193; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; FLANAGAN JR, 1995, PERCEPT PSYCHOPHYS, V57, P282, DOI 10.3758/BF03213054; Flanagan JR, 1997, PERCEPT PSYCHOPHYS, V59, P111, DOI 10.3758/BF03206853; Flournoy, 1894, ANN PSYCHOL, V1, P198, DOI [DOI 10.3406/PSY.1894.1051, 10.3406/psy.1894.1051]; Freeman CG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222564; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Huang I, 1945, J GEN PSYCHOL, V33, P43, DOI 10.1080/00221309.1945.10544494; Kawai S, 2002, EXP BRAIN RES, V147, P23, DOI 10.1007/s00221-002-1210-x; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; MASIN SC, 1988, PERCEPT PSYCHOPHYS, V44, P309, DOI 10.3758/BF03210411; Murray DJ, 1999, PERCEPT PSYCHOPHYS, V61, P1681, DOI 10.3758/BF03213127; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Peters MAK, 2016, PEERJ, V4, DOI 10.7717/peerj.2124; Rideaux R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03400-y; ROSS HE, 1970, Q J EXP PSYCHOL, V22, P318, DOI 10.1080/00335557043000267; ROSS HE, 1966, NATURE, V212, P650, DOI 10.1038/212650a0; ROSS HE, 1969, Q J EXP PSYCHOL, V21, P346, DOI 10.1080/14640746908400230; ROSS J, 1970, PERCEPT PSYCHOPHYS, V7, P161, DOI 10.3758/BF03208648; Saccone EJ, 2019, I-PERCEPTION, V10, DOI 10.1177/2041669519850590; Saccone EJ, 2019, PSYCHON B REV, V26, P1195, DOI 10.3758/s13423-019-01604-x; Schutt HH, 2016, VISION RES, V122, P105, DOI 10.1016/j.visres.2016.02.002; Thouless RH, 1931, B J PSYCHOL-GEN SECT, V22, P1, DOI 10.1111/j.2044-8295.1931.tb00609.x; van Polanen V, 2019, NEUROPSYCHOLOGIA, V131, P306, DOI 10.1016/j.neuropsychologia.2019.05.025; Vicovaro M, 2014, ACTA PSYCHOL, V149, P52, DOI 10.1016/j.actpsy.2014.03.001; Wagenmakers E-J, 2017, PSYCHON B REV; Witt JK, 2011, J EXP PSYCHOL HUMAN, V37, P1148, DOI 10.1037/a0021933; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880; Wolf C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190624	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236440	10.1371/journal.pone.0236440	http://dx.doi.org/10.1371/journal.pone.0236440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OD5ZL	32706795	gold, Green Published			2022-12-26	WOS:000579931700043
J	Du, YR; Zhang, H; Wang, H; Wang, S; Lei, QQ; Li, C; Kong, RQ; Xu, XD				Du, Yaru; Zhang, He; Wang, Hong; Wang, Shuai; Lei, Qiqin; Li, Chao; Kong, Renqiu; Xu, Xudong			Expression from DIF1-motif promoters of hetR and patS is dependent on HetZ and modulated by PatU3 during heterocyst differentiation	PLOS ONE			English	Article							SP-STRAIN PCC-7120; PATTERN-FORMATION; CELL-DIFFERENTIATION; NITROGEN-FIXATION; VEGETATIVE CELLS; ANABAENA; GENE; PROTEIN; CYANOBACTERIA; MAINTENANCE	HetR and PatS/PatX-derived peptides are the activator and diffusible inhibitor for cell differentiation and patterning in heterocyst-forming cyanobacteria. HetR regulates target genes via HetR-recognition sites. However, some genes (such as patS/patX) upregulated at the early stage of heterocyst differentiation possess DIF1 (or DIF+) motif (TCCGGA) promoters rather than HetR-recognition sites; hetR possesses both predicted regulatory elements. How HetR controls heterocyst-specific expression from DIF1 motif promoters remains to be answered. This study presents evidence that the expression from DIF1 motif promoters of hetR, patS and patX is more directly dependent on hetZ, a gene regulated by HetR via a HetR-recognition site. The HetR-binding site upstream of hetR is not required for the autoregulation of hetR. PatU3 (3' portion of PatU) that interacts with HetZ may modulate the expression of hetR, hetZ and patS. These findings contribute to understanding of the mutual regulation of hetR, hetZ-patU and patS/patX in a large group of multicellular cyanobacteria.	[Du, Yaru; Zhang, He; Kong, Renqiu; Xu, Xudong] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China; [Du, Yaru; Wang, Hong; Li, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Hong; Wang, Shuai; Lei, Qiqin; Li, Chao; Kong, Renqiu; Xu, Xudong] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xu, XD (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China.; Xu, XD (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Hubei, Peoples R China.	xux@ihb.ac.cn		xu, xu dong/0000-0002-9987-7579	National Natural Science Foundation of China [31770044, 31270132]; State Key Laboratory of Freshwater Ecology and Biotechnology at IHB, CAS [2019FBZ09]; Knowledge Innovation Project of Hubei Province [2017CFA021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Freshwater Ecology and Biotechnology at IHB, CAS; Knowledge Innovation Project of Hubei Province	XX: National Natural Science Foundation of China (Grant numbers 31770044 and 31270132), http://www.nsfc.gov.cn; State Key Laboratory of Freshwater Ecology and Biotechnology at IHB, CAS (2019FBZ09), http://febl.ihb.cas.cn; Knowledge Innovation Project of Hubei Province (2017CFA021), http://kjt.hubei.gov.cn The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Brenes-Alvarez M, 2019, ENVIRON MICROBIOL, V21, P2544, DOI 10.1111/1462-2920.14647; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; Callahan SM, 2001, MOL MICROBIOL, V40, P941, DOI 10.1046/j.1365-2958.2001.02437.x; Castenholz R.W., 2001, BERGEYS MANUAL SYSTE, V2nd ed., P474; Christman HD, 2011, J BACTERIOL, V193, P6874, DOI 10.1128/JB.05999-11; Di Patti F, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004877; Du Y, 2012, J BACTERIOL, V194, P2297, DOI 10.1128/JB.00119-12; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Ehira S, 2006, J BACTERIOL, V188, P8520, DOI 10.1128/JB.01314-06; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Elhai J, 2018, MOL MICROBIOL, V110, P931, DOI 10.1111/mmi.14003; Flaherty BL, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0255-x; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Higa KC, 2012, MOL MICROBIOL, V83, P682, DOI 10.1111/j.1365-2958.2011.07949.x; Higa KC, 2010, MOL MICROBIOL, V77, P562, DOI 10.1111/j.1365-2958.2010.07257.x; Hou SW, 2015, SCI BULL, V60, P192, DOI 10.1007/s11434-014-0724-5; Hu HX, 2015, SCI REP-UK, V5, DOI 10.1038/srep16470; Issa AA, 2014, ADVANCES IN BIOLOGY AND ECOLOGY OF NITROGEN FIXATION, P23, DOI 10.5772/56995; Kim Y, 2013, P NATL ACAD SCI USA, V110, pE1716, DOI 10.1073/pnas.1305971110; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Latysheva N, 2012, BIOINFORMATICS, V28, P603, DOI 10.1093/bioinformatics/bts008; LEGANES F, 1994, MOL MICROBIOL, V12, P679, DOI 10.1111/j.1365-2958.1994.tb01055.x; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Munoz-Garcia J, 2016, P NATL ACAD SCI USA, V113, P6218, DOI 10.1073/pnas.1524383113; Muro-Pastor AM, 2002, MOL MICROBIOL, V44, P1377, DOI 10.1046/j.1365-2958.2002.02970.x; Pang K, 2018, CURR BIOL, V28, P616, DOI 10.1016/j.cub.2018.01.008; Park JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-759; Pratte BS, 2016, MOL MICROBIOL, V100, P1096, DOI 10.1111/mmi.13370; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rajagopalan R, 2010, J BACTERIOL, V192, P1088, DOI 10.1128/JB.01297-09; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Risser DD, 2012, P NATL ACAD SCI USA, V109, P15342, DOI 10.1073/pnas.1207530109; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Videau P, 2018, MOL MICROBIOL, V109, P91, DOI 10.1111/mmi.13974; Videau P, 2016, P NATL ACAD SCI USA, V113, pE6984, DOI 10.1073/pnas.1610533113; Videau P, 2014, J BACTERIOL, V196, P1113, DOI 10.1128/JB.01372-13; Wang Y, 2005, J BACTERIOL, V187, P8489, DOI 10.1128/JB.187.24.8489-8493.2005; Wang YL, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00076-18; Wegelius A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203898; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zhang H, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00707-17; Zhang LL, 2017, FEBS LETT, V591, P751, DOI 10.1002/1873-3468.12582; Zhang W, 2007, MOL MICROBIOL, V66, P1429, DOI 10.1111/j.1365-2958.2007.05997.x	52	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0232383	10.1371/journal.pone.0232383	http://dx.doi.org/10.1371/journal.pone.0232383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701963	Green Published, Green Submitted, gold			2022-12-26	WOS:000575913700006
J	Garcia, SM; Obukhov, AG; Herbert, LM; Walker, BR; Resta, TC; Jernigan, NL				Garcia, Selina M.; Obukhov, Alexander G.; Herbert, Lindsay M.; Walker, Benjimen R.; Resta, Thomas C.; Jernigan, Nikki L.			Coupling of store-operated calcium entry to vasoconstriction is acid-sensing ion channel 1a dependent in pulmonary but not mesenteric arteries	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CAPACITATIVE CA2+ ENTRY; NITRIC-OXIDE SYNTHASE; TRPC CHANNELS; CATION CHANNELS; STIM1; INFLUX; CELLS; ORAI1; PROLIFERATION	Although voltage-gated Ca2+ channels (VGCC) are a major Ca2+ entry pathway in vascular smooth muscle cells (VSMCs), several other Ca2+-influx mechanisms exist and play important roles in vasoreactivity. One of these is store-operated Ca2+ entry (SOCE), mediated by an interaction between STIM1 and Orai1. Although SOCE is an important mechanism of Ca2+ influx in non-excitable cells (cells that lack VGCC); there is debate regarding the contribution of SOCE to regulate VSMC contractility and the molecular components involved. Our previous data suggest acid-sensing ion channel 1a (ASIC1a) is a necessary component of SOCE and vasoconstriction in small pulmonary arteries. However, it is unclear if ASIC1a similarly contributes to SOCE and vascular reactivity in systemic arteries. Considering the established role of Orai1 in mediating SOCE in the systemic circulation, we hypothesize the involvement of ASIC1a in SOCE and resultant vasoconstriction is unique to the pulmonary circulation. To test this hypothesis, we examined the roles of Orai1 and ASIC1a in SOCE- and endothelin-1 (ET-1)-induced vasoconstriction in small pulmonary and mesenteric arteries. We found SOCE is coupled to vasoconstriction in pulmonary arteries but not mesenteric arteries. In pulmonary arteries, inhibition of ASIC1a but not Orai1 attenuated SOCE- and ET-1-induced vasoconstriction. However, neither inhibition of ASIC1a nor Orai1 altered ET-1-induced vasoconstriction in mesenteric arteries. We conclude that SOCE plays an important role in pulmonary, but not mesenteric, vascular reactivity. Furthermore, in contrast to the established role of Orai1 in SOCE in non-excitable cells, the SOCE response in pulmonary VSMCs is largely mediated by ASIC1a.	[Garcia, Selina M.; Obukhov, Alexander G.; Herbert, Lindsay M.; Walker, Benjimen R.; Resta, Thomas C.; Jernigan, Nikki L.] Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	University of New Mexico	Jernigan, NL (corresponding author), Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA.	njernigan@salud.uhm.edu		Resta, Thomas/0000-0002-7219-6159; Jernigan, Nikki/0000-0001-6269-2274	National Heart, Lung and Blood Institute [R01 HL-111084, F31 HL145836, T32 HL007736]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung and Blood Institute grants R01 HL-111084 (to N.L. Jernigan), F31 HL145836 (to S.M. Garcia) and T32 HL007736 (to T.C. Resta)	Albert AP, 2006, J PHYSIOL-LONDON, V570, P45, DOI 10.1113/jphysiol.2005.096875; Albert AP, 2003, CELL CALCIUM, V33, P345, DOI 10.1016/S0143-4160(03)00048-4; Alonso-Carbajo L, 2017, CELL CALCIUM, V66, P48, DOI 10.1016/j.ceca.2017.06.004; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Avila-Medina J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00257; Barlow CA, 2006, J PHYSIOL-LONDON, V570, P59, DOI 10.1113/jphysiol.2005.098426; Bergdahl A, 2005, AM J PHYSIOL-CELL PH, V288, pC872, DOI 10.1152/ajpcell.00334.2004; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; BOLTON TB, 1979, PHYSIOL REV, V59, P606, DOI 10.1152/physrev.1979.59.3.606; Bosc LVG, 2016, AM J PHYSIOL-LUNG C, V311, pL48, DOI 10.1152/ajplung.00040.2016; Brueggemann LI, 2006, J PHARMACOL EXP THER, V317, P488, DOI 10.1124/jpet.105.095067; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Choi S, 2014, HANDB EXP PHARMACOL, V223, P1035, DOI 10.1007/978-3-319-05161-1_13; DAVIS MJ, 1992, AM J PHYSIOL, V263, pH1292, DOI 10.1152/ajpheart.1992.263.4.H1292; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Dominguez-Rodriguez A, 2012, ARTERIOSCL THROM VAS, V32, P1325, DOI 10.1161/ATVBAHA.111.243014; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Giachini FRC, 2009, HYPERTENSION, V53, P409, DOI 10.1161/HYPERTENSIONAHA.108.124404; Gonzalez-Cobos JC, 2013, CIRC RES, V112, P1013, DOI 10.1161/CIRCRESAHA.111.300220; Guo RW, 2012, CARDIOVASC RES, V93, P360, DOI 10.1093/cvr/cvr307; Herbert LM, 2018, AM J PHYSIOL-CELL PH, V314, pC166, DOI 10.1152/ajpcell.00159.2017; Herbert LM, 2016, AM J PHYSIOL-CELL PH, V310, pC390, DOI 10.1152/ajpcell.00091.2015; Jernigan NL, 2015, EXP PHYSIOL, V100, P111, DOI 10.1113/expphysiol.2014.081612; Jernigan NL, 2012, AM J PHYSIOL-CELL PH, V302, pC931, DOI 10.1152/ajpcell.00332.2011; Jernigan NL, 2009, AM J PHYSIOL-LUNG C, V297, pL271, DOI 10.1152/ajplung.00020.2009; Jernigan NL, 2006, AM J PHYSIOL-LUNG C, V290, pL517, DOI 10.1152/ajplung.00308.2004; Jernigan NL, 2004, AM J PHYSIOL-LUNG C, V287, pL1220, DOI 10.1152/ajplung.00196.2004; Kassan M, 2016, ARTERIOSCL THROM VAS, V36, P1900, DOI 10.1161/ATVBAHA.116.307869; Kassan M, 2015, PFLUG ARCH EUR J PHY, V467, P1195, DOI 10.1007/s00424-014-1556-5; Kawanabe Y, 2003, MOL PHARMACOL, V63, P808, DOI 10.1124/mol.63.4.808; Kawanabe Y, 2002, J CARDIOVASC PHARM, V40, P438, DOI 10.1097/00005344-200209000-00013; KIRBER MT, 1988, PFLUG ARCH EUR J PHY, V412, P339, DOI 10.1007/BF01907549; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Lin LH, 2014, J CHEM NEUROANAT, V61-62, P161, DOI 10.1016/j.jchemneu.2014.10.002; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Naik JS, 2016, AM J PHYSIOL-HEART C, V311, pH1437, DOI 10.1152/ajpheart.00465.2016; Ng LC, 2012, AM J PHYSIOL-CELL PH, V303, pC1156, DOI 10.1152/ajpcell.00065.2012; Nitta CH, 2014, AM J PHYSIOL-HEART C, V306, pH41, DOI 10.1152/ajpheart.00269.2013; Ong HL, 2016, ADV EXP MED BIOL, V898, P87, DOI 10.1007/978-3-319-26974-0_5; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Park KM, 2008, AM J PHYSIOL-HEART C, V294, pH1183, DOI 10.1152/ajpheart.01148.2007; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Rodriguez-Moyano M, 2013, CARDIOVASC RES, V100, P297, DOI 10.1093/cvr/cvt196; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sadaghiani AM, 2014, CHEM BIOL, V21, P1278, DOI 10.1016/j.chembiol.2014.08.016; Snetkov VA, 2003, BRIT J PHARMACOL, V140, P97, DOI 10.1038/sj.bjp.0705408; Tosun M, 1998, J PHARMACOL EXP THER, V285, P759; Tykocki NR, 2010, CLIN SCI, V119, P361, DOI 10.1042/CS20100145; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; XU X, 1994, J BIOL CHEM, V269, P12645; Yang Y, 2015, J CARDIOVASC PHARM, V65, P571, DOI 10.1097/FJC.0000000000000225; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zhang BJ, 2018, AM J PHYSIOL-HEART C, V314, pH359, DOI 10.1152/ajpheart.00540.2017; Zhang XX, 2014, J GEN PHYSIOL, V143, P345, DOI 10.1085/jgp.201311084	67	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236288	10.1371/journal.pone.0236288	http://dx.doi.org/10.1371/journal.pone.0236288			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702049	Green Published, gold, Green Submitted			2022-12-26	WOS:000575913700070
J	Kim, JS; Kim, J; Gelegjamts, D				Kim, Jin Sun; Kim, Jinhee; Gelegjamts, Delgersuren			Knowledge, attitude and self-efficacy towards palliative care among nurses in Mongolia: A cross-sectional descriptive study	PLOS ONE			English	Article							DYING PATIENTS; BAD-NEWS; COMMUNICATION; PROVISION; CANCER; DEATH	Background Nurses have a primary role in providing palliative and end-of-life (EOL) care. Their knowledge of EOL care, attitudes toward care of the dying, and palliative care self-efficacy are important in care delivery. Little is known regarding palliative care preparedness among Mongolian nurses. This study examines palliative care knowledge, attitude towards death and dying, and self-efficacy among Mongolian nurses, and examines predictors of self-efficacy. Methods A cross-sectional descriptive study was conducted. Participants were 141 nurses employed at the National Cancer Center in Mongolia. Data was collected using a self-administered questionnaire. Results The median score for the knowledge of palliative care was 8.0/20. "Psychosocial and spiritual care" was the lowest score on the palliative care knowledge subscale. The mean score for attitude toward care of the dying was 69.1%, indicating positive attitudes. The mean score for the palliative care self-efficacy was 33.8/48. Nurses reported low self-efficacy toward communicating with dying patients and their families, and managing delirium. Palliative care knowledge and duration of experience as an oncology nurse significantly predicted self-efficacy toward palliative care, accounting for 14.0% of the variance. Conclusions Palliative education for nurses should address the knowledge gaps in EOL care and focus in increasing palliative care self-efficacy. Considering palliative care knowledge and nursing experience as an oncology nurse were significant predictors of self-efficacy toward palliative care, more effort is needed to fill the knowledge gaps in EOL care among nurses, especially for less experienced nurses.	[Kim, Jin Sun; Kim, Jinhee] Chosun Univ, Dept Nursing, Gwangju, South Korea; [Gelegjamts, Delgersuren] Chosun Univ, Grad Sch, Gwangju, South Korea; [Gelegjamts, Delgersuren] Mongolian Natl Univ, Dept Nursing, Ulaanbaatar, Mongolia	Chosun University; Chosun University; National University of Mongolia	Kim, J (corresponding author), Chosun Univ, Dept Nursing, Gwangju, South Korea.	jinheeara@chosun.ac.kr		Kim, Jinsun/0000-0001-9755-3987; Kim, Jinhee/0000-0002-8037-9174	Chosun University	Chosun University	This study was supported by research fund from Chosun University, 2017.	Anila G.D., 2015, INT J SCI RES, V4, P1790; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bjorgaas Malfrid Holmaas, 2012, Tidsskr Nor Laegeforen, V132, P546, DOI 10.4045/tidsskr.11.1031; Braun Michal, 2010, Oncol Nurs Forum, V37, pE43, DOI 10.1188/10.ONF.E43-E49; Broglio K, 2014, J HOSP PALLIAT NURS, V16, P420, DOI 10.1097/NJH.0000000000000089; Bumb M, 2017, CLIN J ONCOL NURS, V21, P573, DOI 10.1188/17.CJON.573-580; Challinor Julia M, 2016, J Glob Oncol, V2, P154, DOI 10.1200/JGO.2015.001974; Choi M, 2012, J CONTIN EDUC NURS, V43, P379, DOI 10.3928/00220124-20120615-35; Chover-Sierra E, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.1610.2847; Davaasuren O., 2017, BAOJ PALLIAT MED, V3; Davaasuren O, 2007, J PAIN SYMPTOM MANAG, V33, P568, DOI 10.1016/j.jpainsymman.2007.02.017; Davaasuren O, 2018, J PAIN SYMPTOM MANAG, V55, pS59, DOI 10.1016/j.jpainsymman.2017.02.022; Fang ML, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0282-6; Frommelt K H, 1991, Am J Hosp Palliat Care, V8, P37, DOI 10.1177/104990919100800509; Fuoto A, 2019, J HOSP PALLIAT NURS, V21, P124, DOI 10.1097/NJH.0000000000000493; Gibbs KD, 2015, J PAIN SYMPTOM MANAG, V49, P1102, DOI 10.1016/j.jpainsymman.2014.12.004; Grassi L, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0550-8; Grubb C, 2016, PALLIATIVE MED, V30, P83, DOI 10.1177/0269216315616762; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; Hannon B, 2016, J CLIN ONCOL, V34, P62, DOI 10.1200/JCO.2015.62.1615; Harden K, 2017, CLIN J ONCOL NURS, V21, pE232, DOI 10.1188/17.CJON.E232-E238; Henoch I, 2013, J PAIN SYMPTOM MANAG, V46, P785, DOI 10.1016/j.jpainsymman.2013.01.013; Hsu Hsang-Yu, 2019, Hu Li Za Zhi, V66, P32, DOI 10.6224/JN.201910_66(5).06; Iranmanesh S, 2014, PALLIAT SUPPORT CARE, V12, P203, DOI 10.1017/S1478951512001058; Jafari M, 2015, INDIAN J PALLIAT CAR, V21, P192, DOI 10.4103/0973-1075.156497; Jang Bo Jung, 2018, Journal of Hospice and Palliative Care, V21, P65, DOI 10.14475/kjhpc.2018.21.2.65; Kalogeropoulou M, 2016, WORLD J SOC SCI RES, V3, P381; Kim Boon Han, 2012, [Korean Journal of Adult Nursing, 성인간호학회지], V24, P390; Kim HS, 2011, J HOSP PALLIAT NURS, V13, P222, DOI 10.1097/NJH.0b013e318210fdec; Kurnia TA., 2019, J NERS, V13, P219, DOI [10.20473/jn.v13i2.9986, DOI 10.20473/JN.V13I2.9986]; Lange M, 2008, ONCOL NURS FORUM, V35, P955, DOI 10.1188/08.ONF.955-959; Logan Janice, 2018, Nurs Stand, V33, P63, DOI 10.7748/ns.2018.e10888; Malloy P, 2010, J HOSP PALLIAT NURS, V12, P166, DOI 10.1097/NJH.0b013e3181d99fee; Nairamdal J, 2017, 59 RES C MNUMS, P30; Nunes, 2018, NEUROPSYCHIATRY-LOND, V8, P484, DOI DOI 10.4172/NEUROPSYCHIATRY.1000370; Nyatanga Brian, 2017, Br J Community Nurs, V22, P152, DOI 10.12968/bjcn.2017.22.3.152; Oyunchimeg B, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1576-8; Phillips J, 2011, INT J NURS STUD, V48, P1096, DOI 10.1016/j.ijnurstu.2011.02.015; Qadire MA., 2014, J HOSP PALLIAT NURS, V16, P1, DOI [10.1097/NJH.0000000000000017, DOI 10.1097/NJH.0000000000000017]; Ross MM, 1996, J ADV NURS, V23, P126; Sato K, 2014, JPN J CLIN ONCOL, V44, P718, DOI 10.1093/jjco/hyu075; Shen MJ, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00160; Sleeman KE, 2019, LANCET GLOB HEALTH, V7, pE883, DOI 10.1016/S2214-109X(19)30172-X; Tait V, 2015, INT J PALLIAT CARE, DOI [10.1155/2015/, DOI 10.1155/2015/]; ten Koppel M, 2019, INT J NURS STUD, V92, P135, DOI 10.1016/j.ijnurstu.2018.09.019; Wang LP, 2018, INT J PALLIAT NURS, V24, P33, DOI 10.12968/ijpn.2018.24.1.33; Wilson Olivia, 2016, Br J Nurs, V25, P600, DOI 10.12968/bjon.2016.25.11.600; World Health Organization, 2015, WHO GUID TRANSL AD I, P4	48	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236390	10.1371/journal.pone.0236390	http://dx.doi.org/10.1371/journal.pone.0236390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32702007	Green Published, gold			2022-12-26	WOS:000575913700086
J	Peverill, RE; Cheng, K; Cameron, J; Donelan, L; Mottram, PM				Peverill, Roger E.; Cheng, Kevin; Cameron, James; Donelan, Lesley; Mottram, Philip M.			Relationships of global longitudinal strain with s ', long-axis systolic excursion, left ventricular length and heart rate	PLOS ONE			English	Article							INCREMENTAL PROGNOSTIC VALUE; MITRAL ANNULUS VELOCITY; EJECTION FRACTION; FAILURE; ECHOCARDIOGRAPHY; CARDIOTOXICITY; DYSFUNCTION; PREDICTOR; ANTHRACYCLINE; POPULATION	Background Longitudinal left ventricular (LV) contraction can be impaired in the presence of a normal LV ejection fraction (LVEF), and abnormalities have been reported in global longitudinal strain (GLS), long-axis systolic excursion (SExc), and the peak systolic velocity (s') of mitral annular motion using tissue Doppler imaging (TDI). However, the relationships of GLS with s' and SExc have not been systematically evaluated in subjects with a normal LVEF, and whether these relationships might be affected by variations in LV end-diastolic length (LVEDL) and heart rate is unknown. Methods We investigated the univariate and multivariate correlations of GLS with TDI measurements of s' and SExc (both using averages of the septal and lateral walls), LVEDL and heart rate in subjects with a normal LVEF (>50%) but a low peak early diastolic mitral annular velocity (septal e' <= 7.0 cm/s and lateral e' <= 9 cm/s), and thus an increased risk of a future cardiac event. Results 84 subjects (age 66 +/- 8 years, 29 males) with a LVEF of 62 +/- 6% and GLS of -17.5 +/- 2.3% were studied. On univariate analysis the absolute value of GLS was positively correlated with s'(r = 0.28, p<0.01) and SExc (r = 0.50, p<0.001) and inversely correlated with heart rate (r = -0.36, p = 0.001), but was not correlated with LVEDL (r = -0.15). In multivariate models, SExc explained more of the variance in GLS than s', and absolute GLS was not only positively correlated with SExc, but also inversely correlated with LVEDL. Heart rate was an independent inverse correlate of GLS in conjunction with LVEDL and either s' or SExc, but made a larger contribution in models which included s'. Interobserver correlations were close for s' and SExc (r = 0.89-0.93), but only moderate for GLS (r = 0.71). Conclusion In subjects with a normal LVEF but reduced e', the absolute value of GLS is more closely related to SExc than s', and is also independently and inversely related to LVEDL and heart rate. Measurement of SExc may provide a useful additional or alternative technique to GLS for the assessment of LV long-axis function.	[Peverill, Roger E.; Cheng, Kevin; Cameron, James; Donelan, Lesley; Mottram, Philip M.] Monash Univ, MonashHeart, Monash Cardiovasc Res Ctr, Clayton, Vic, Australia; Monash Univ, Monash Hlth, Sch Clin Sci, Dept Med, Clayton, Vic, Australia; Monash Hlth, Clayton, Vic, Australia	Monash University; Monash University	Peverill, RE (corresponding author), Monash Univ, MonashHeart, Monash Cardiovasc Res Ctr, Clayton, Vic, Australia.	roger.peverill@monash.edu	Cheng, Kevin/HDN-0268-2022; Cheng, Kevin/AAQ-6334-2020	Cheng, Kevin/0000-0003-0745-6695; Cheng, Kevin/0000-0003-0745-6695; Peverill, Roger/0000-0002-3319-5356				Biering-Sorensen T, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005521; Boyd A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175544; Carasso S, 2008, J AM SOC ECHOCARDIOG, V21, P675, DOI 10.1016/j.echo.2007.10.021; Carluccio E, 2011, EUR J HEART FAIL, V13, P292, DOI 10.1093/eurjhf/hfq203; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Dalen H, 2010, CIRC-CARDIOVASC IMAG, V3, P614, DOI 10.1161/CIRCIMAGING.109.926022; Di Salvo G, 2011, CLIN CARDIOL, V34, P500, DOI 10.1002/clc.20933; Dini FL, 2013, INT J CARDIOL, V168, P3351, DOI 10.1016/j.ijcard.2013.04.122; Florescu M, 2014, J AM SOC ECHOCARDIOG, V27, P83, DOI 10.1016/j.echo.2013.10.008; Francis DP, 1999, INT J CARDIOL, V69, P185, DOI 10.1016/S0167-5273(99)00028-5; Hedberg P, 2006, J AM SOC ECHOCARDIOG, V19, P88, DOI 10.1016/j.echo.2005.05.005; Hees PS, 2002, AM J CARDIOL, V90, P1231, DOI 10.1016/S0002-9149(02)02840-0; HOGLUND C, 1988, ACTA MED SCAND, V224, P557; Kraigher-Krainer E, 2014, J AM COLL CARDIOL, V63, P447, DOI 10.1016/j.jacc.2013.09.052; Kuznetsova T, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004661; Liu YW, 2009, J CARD FAIL, V15, P782, DOI 10.1016/j.cardfail.2009.05.006; Melendez GC, 2017, AM J CARDIOL, V119, P1637, DOI 10.1016/j.amjcard.2017.02.008; Mogelvang R, 2015, EUR HEART J-CARD IMG, V16, P1331, DOI 10.1093/ehjci/jev180; Mogelvang R, 2009, CIRCULATION, V119, P2679, DOI 10.1161/CIRCULATIONAHA.108.793471; Moreira HT, 2017, J AM SOC ECHOCARDIOG, V30, P647, DOI 10.1016/j.echo.2017.03.010; Nagy AC, 2006, NEOPLASMA, V53, P511; Negishi K, 2015, JACC-CARDIOVASC IMAG, V8, P489, DOI 10.1016/j.jcmg.2014.06.013; Pela G, 2004, J AM SOC ECHOCARDIOG, V17, P205, DOI 10.1016/j.echo.2003.12.004; Petrie MC, 2002, HEART, V87, P29, DOI 10.1136/heart.87.1.29; Peverill RE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210277; Peverill RE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173383; Peverill RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158302; Plana JC, 2014, J AM SOC ECHOCARDIOG, V27, P911, DOI [10.1016/j.echo.2014.07.012, 10.1093/ehjci/jeu192]; Poterucha JT, 2012, J AM SOC ECHOCARDIOG, V25, P733, DOI 10.1016/j.echo.2012.04.007; Rangarajan V, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0257-y; Shah AM, 2015, CIRCULATION, V132, P402, DOI 10.1161/CIRCULATIONAHA.115.015884; Stampehl MR, 2015, ECHOCARDIOGR-J CARD, V32, P71, DOI 10.1111/echo.12613; Stoylen A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000465; Stoylen A, 2018, ECHOCARDIOGR-J CARD, V35, P603, DOI 10.1111/echo.13825; Thavendiranathan P, 2014, J AM COLL CARDIOL, V63, P2751, DOI 10.1016/j.jacc.2014.01.073; Wandt B, 1997, CLIN PHYSIOL, V17, P635, DOI 10.1046/j.1365-2281.1997.00065.x; Wang M, 2005, J AM COLL CARDIOL, V45, P272, DOI 10.1016/j.jacc.2004.09.059; Wang M, 2005, J HYPERTENS, V23, P183, DOI 10.1097/00004872-200501000-00029; Wang M, 2003, J AM COLL CARDIOL, V41, P820, DOI 10.1016/S0735-1097(02)02921-2; Wenzelburger FWG, 2011, EUR J HEART FAIL, V13, P953, DOI 10.1093/eurjhf/hfr081; Yip GW, 2002, CLIN SCI, V102, P515, DOI 10.1042/CS20010196; Yu CM, 2002, CIRCULATION, V105, P1195, DOI 10.1161/hc1002.105185	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235791	10.1371/journal.pone.0235791	http://dx.doi.org/10.1371/journal.pone.0235791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702711	Green Published, gold			2022-12-26	WOS:000575913700026
J	Sass, AM; Coenye, T				Sass, Andrea M.; Coenye, Tom			Low iron-induced small RNA BrrF regulates central metabolism and oxidative stress responses in Burkholderia cenocepacia	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; IDENTIFICATION; ACTIVATION; GENES; FUR; EXPRESSION; PREDICTION; TARGETS; OPERON; CARBON	Regulatory small RNAs play an essential role in maintaining cell homeostasis in bacteria in response to environmental stresses such as iron starvation. Prokaryotes generally encode a large number of RNA regulators, yet their identification and characterisation is still in its infancy for most bacterial species. Burkholderia cenocepacia is an opportunistic pathogen with high innate antimicrobial resistance, which can cause the often fatal cepacia syndrome in individuals with cystic fibrosis. In this study we characterise a small RNA which is involved in the response to iron starvation, a condition that pathogenic bacteria are likely to encounter in the host. BrrF is a small RNA highly upregulated in Burkholderia cenocepacia under conditions of iron depletion and with a genome context consistent with Fur regulation. Its computationally predicted targets include iron-containing enzymes of the tricarboxylic acid (TCA) cycle such as aconitase and succinate dehydrogenase, as well as iron-containing enzymes responsible for the oxidative stress response, such as superoxide dismutase and catalase. Phenotypic and gene expression analysis of BrrF deletion and overexpression mutants show that the regulation of these genes is BrrF-dependent. Expression of acnA, fumA, sdhA and sdhC was downregulated during iron depletion in the wild type strain, but not in a BrrF deletion mutant. TCA cycle genes not predicted as target for BrrF were not affected in the same manner by iron depletion. Likewise, expression of sodB and katB was dowregulated during iron depletion in the wild type strain, but not in a BrrF deletion mutant. BrrF overexpression reduced aconitase and superoxide dismutase activities and increased sensitivity to hydrogen peroxide. All phenotypes and gene expression changes of the BrrF deletion mutant could be complemented by overexpressing BrrF in trans. Overall, BrrF acts as a regulator of central metabolism and oxidative stress response, possibly as an iron-sparing measure to maintain iron homeostasis under conditions of iron starvation.	[Sass, Andrea M.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium	Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium.	tom.coenye@ugent.be	Sass, Andrea Michaela/G-6537-2014; Coenye, Tom/A-6291-2014	Sass, Andrea Michaela/0000-0001-9396-7648; Coenye, Tom/0000-0002-6407-0601	Belgian Science Policy Office (Belspo) through the Interuniversity Attraction Pole Program [VII/2012-2017, P7/28]	Belgian Science Policy Office (Belspo) through the Interuniversity Attraction Pole Program	TC received funding from the Belgian Science Policy Office (Belspo) through the Interuniversity Attraction Pole Program (Phase VII/2012-2017, Project P7/28). http://www.belspo.be/belspo/iap/index_en.stm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2003, FEMS MICROBIOLOGY RE, V27, P215, DOI [10.1016/S0168-6445(03)00055-X, DOI 10.1016/S0168-6445(03)00055-X]; Aubert DF, 2014, METHODS MOL BIOL, V1197, P311, DOI 10.1007/978-1-4939-1261-2_18; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Beauchene NA, 2015, MBIO, V6, DOI 10.1128/mBio.01947-15; Bramer CO, 2002, APPL ENVIRON MICROB, V68, P271, DOI 10.1128/AEM.68.1.271-279.2002; Brickman TJ, 2012, MOL MICROBIOL, V86, P580, DOI 10.1111/mmi.12003; Bruder S, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0526-3; Butt AT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00460; Calderon PF, 2014, BIOCHEM BIOPH RES CO, V450, P641, DOI 10.1016/j.bbrc.2014.06.031; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Chao YJ, 2017, MOL CELL, V65, P39, DOI 10.1016/j.molcel.2016.11.002; Chareyre S, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008078; Chavarria M, 2013, ENVIRON MICROBIOL, V15, P1772, DOI 10.1111/1462-2920.12069; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; GRUER MJ, 1994, MICROBIOL-SGM, V140, P2531, DOI 10.1099/00221287-140-10-2531; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; Hassett DJ, 1997, J BACTERIOL, V179, P1452, DOI 10.1128/jb.179.5.1452-1459.1997; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Keith KE, 2007, INFECT IMMUN, V75, P2451, DOI 10.1128/IAI.01556-06; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kiekens S, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00579-17; Lefebre MD, 2005, MICROBIOL-SGM, V151, P1975, DOI 10.1099/mic.0.27704-0; Loprasert S, 2003, FEBS LETT, V542, P17, DOI 10.1016/S0014-5793(03)00328-4; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Nelson CE, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00754-18; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Reinhart AA, 2015, INFECT IMMUN, V83, P863; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Salvail H, 2012, WIRES RNA, V3, P26, DOI 10.1002/wrna.102; Sass A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15818-3; Sass AM, 2019, MICROBIOL-SGM, V165, P1135, DOI 10.1099/mic.0.000848; Sass AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1993-3; Sass AM, 2013, ISME J, V7, P1568, DOI 10.1038/ismej.2013.36; Sato T, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00479-17; Stubben CJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-385; Wang J, 2015, NUCLEIC ACIDS RES, V43, P10308, DOI 10.1093/nar/gkv1158; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111; Wright PR, 2013, P NATL ACAD SCI USA, V110, pE3487, DOI 10.1073/pnas.1303248110; Yuhara S, 2008, MICROBIOL-SGM, V154, P1763, DOI 10.1099/mic.0.2007/015537-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236405	10.1371/journal.pone.0236405	http://dx.doi.org/10.1371/journal.pone.0236405			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702060	gold, Green Published, Green Submitted			2022-12-26	WOS:000575913700090
J	Walsh, CA; Akrap, N; Garre, E; Magnusson, Y; Harrison, H; Andersson, D; Jonasson, E; Rafnsdottir, S; Choudhry, H; Buffa, F; Ragoussis, J; Stahlberg, A; Harris, A; Landberg, G				Walsh, Claire A.; Akrap, Nina; Garre, Elena; Magnusson, Ylva; Harrison, Hannah; Andersson, Daniel; Jonasson, Emma; Rafnsdottir, Svanheidur; Choudhry, Hani; Buffa, Francesca; Ragoussis, Jiannis; Stahlberg, Anders; Harris, Adrian; Landberg, Goran			The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer	PLOS ONE			English	Article							METABOLISM; SURVIVAL; IDENTIFICATION; HETEROGENEITY; HYPOXIA; PATHWAY	The definitive characterization of common cancer stem cell (CSCs) subpopulations in breast cancer subtypes with distinct genotypic and phenotypic features remains an ongoing challenge. In this study, we have used a non-biased genome wide screening approach to identify transcriptional networks that may be specific to the CSC subpopulations in both luminal and basal breast cancer subtypes. In depth studies of three CSC-enriched breast cancer cell lines representing various subtypes of breast cancer revealed a striking hyperactivation of the mevalonate metabolic pathway in comparison to control cells. The upregulation of metabolic networks is a key feature of tumour cells securing growth and proliferative capabilities and dysregulated mevalonate metabolism has been associated with tumour malignancy and cellular transformation in breast cancer. Furthermore, accumulating evidence suggests that Simvastatin therapy, a mevalonate pathway inhibitor, could affect breast cancer progression and reduce breast cancer recurrence. When detailing the mevalonate pathway in breast cancer using a single-cell qPCR, we identified the mevalonate precursor enzyme, HMGCS1, as a specific marker of CSC-enriched subpopulations within both luminal and basal tumour subtypes. Down-regulation of HMGCS1 also decreased the CSC fraction and function in various model systems, suggesting that HMGCS1 is essential for CSC-activities in breast cancer in general. These data was supported by strong associations between HMGCS1 expression and aggressive features, such as high tumour grade, p53 mutations as well as ER-negativity in lymph node positive breast cancer. Importantly, loss of HMGCS1 also had a much more pronounced effect on CSC-activities compared to treatment with standard doses of Simvastatin. Taken together, this study highlights HMGCS1 as a potential gatekeeper for dysregulated mevalonate metabolism important for CSC-features in both luminal and basal breast cancer subtypes. Pharmacological inhibition of HMGCS1 could therefore be a superior novel treatment approach for breast cancer patients via additional CSC blocking functions.	[Walsh, Claire A.; Akrap, Nina; Garre, Elena; Magnusson, Ylva; Andersson, Daniel; Jonasson, Emma; Stahlberg, Anders; Landberg, Goran] Sahlgrenska Canc Ctr, Dept Lab Med, Gothenburg, Sweden; [Harrison, Hannah] Christie NHS Fdn Trust, Paterson Inst Canc Res, Manchester, Lancs, England; [Rafnsdottir, Svanheidur] Sahlgrens Univ Hosp, Dept Surg, Gothenburg, Sweden; [Choudhry, Hani] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Buffa, Francesca; Harris, Adrian] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford, England; [Ragoussis, Jiannis] McGill Univ, Montreal, PQ, Canada; [Ragoussis, Jiannis] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Stahlberg, Anders] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden; [Stahlberg, Anders] Sahlgrens Univ Hosp, Dept Clin Genet & Genom, Gothenburg, Sweden	University of Gothenburg; Christie NHS Foundation Trust; Paterson Institute for Cancer Research; Sahlgrenska University Hospital; King Abdulaziz University; University of Oxford; McGill University; University of Gothenburg; Sahlgrenska University Hospital	Landberg, G (corresponding author), Sahlgrenska Canc Ctr, Dept Lab Med, Gothenburg, Sweden.	goran.landberg@gu.se	Harris, Adrian L/ABA-3343-2020; Ragoussis, Ioannis/AAD-9790-2022	Harris, Adrian L/0000-0003-1376-8409; Choudhry, Hani/0000-0003-0401-6619; Andersson, Daniel/0000-0002-4564-6652; Stahlberg, Anders/0000-0003-4243-0191; Ragoussis, Ioannis/0000-0002-8515-0934	Assar Gabrielssons Research Foundation; BioCARE National Strategic Research Program at University of Gothenburg; Johan Jansson Foundation for Cancer Research; Knut and Alice Wallenberg Foundation; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden; Swedish Cancer Foundation [PjF 20 0306, 2016-438, 2016-486]; Swedish Research Council [2017-01392, 2016-01530]; Swedish Childhood Cancer Foundation [2017-0043]; Swedish government [716321, 721091]; Swedish county councils, the ALF-agreement [716321, 721091]; Wilhelm and Martina Lundgren Foundation for Scientific Research	Assar Gabrielssons Research Foundation; BioCARE National Strategic Research Program at University of Gothenburg; Johan Jansson Foundation for Cancer Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Swedish government; Swedish county councils, the ALF-agreement; Wilhelm and Martina Lundgren Foundation for Scientific Research	This work was supported by grants from Assar Gabrielssons Research Foundation; BioCARE National Strategic Research Program at University of Gothenburg; Johan Jansson Foundation for Cancer Research; Knut and Alice Wallenberg Foundation, Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden (AS); Swedish Cancer Foundation (PjF 20 0306, 2016-438 and 2016-486, GL and AS); Swedish Research Council (2017-01392 and 2016-01530, GL and AS); Swedish Childhood Cancer Foundation (2017-0043, AS); the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (716321 and 721091, GL and AS) and Wilhelm and Martina Lundgren Foundation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Akrap N, 2016, STEM CELL REP, V6, P121, DOI 10.1016/j.stemcr.2015.12.006; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ayob AZ, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0426-4; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Clendening JW, 2010, BLOOD, V115, P4787, DOI 10.1182/blood-2009-07-230508; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Engstrom MJ, 2013, BREAST CANCER RES TR, V140, P463, DOI 10.1007/s10549-013-2647-2; Eun K, 2017, BMB REP, V50, P117, DOI 10.5483/BMBRep.2017.50.3.222; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Ginestier C, 2012, STEM CELLS, V30, P1327, DOI 10.1002/stem.1122; Gobel A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1322-x; Gruenbacher G, 2015, CANCER LETT, V356, P192, DOI 10.1016/j.canlet.2014.01.013; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Jonasson E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00500; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Koohestanimobarhan S, 2018, J CELL BIOCHEM, DOI [10.1002/jcb.27544 30191610, DOI 10.1002/JCB.2754430191610]; Lee WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148818; Mannello F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-169; Menendez JA, 2013, CELL CYCLE, V12, P1166, DOI 10.4161/cc.24479; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; Owens TW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00225; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rachner TD, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3616; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Santa-Maria CA, 2013, CURR BREAST CANCER R, V5, P161, DOI 10.1007/s12609-013-0119-7; Shaker H, 2017, ONCOTARGET, V8, P25915, DOI 10.18632/oncotarget.13928; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stahlberg A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1182; Stahlberg A, 2010, METHODS, V50, P282, DOI 10.1016/j.ymeth.2010.01.002; Thurnher M, 2013, BBA-MOL CELL BIOL L, V1831, P1009, DOI 10.1016/j.bbalip.2013.03.003; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110	45	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236187	10.1371/journal.pone.0236187	http://dx.doi.org/10.1371/journal.pone.0236187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692762	Green Published, gold			2022-12-26	WOS:000554606400024
J	Ferofontov, A; Vankova, P; Man, P; Giladi, M; Haitin, Y				Ferofontov, Alisa; Vankova, Pavla; Man, Petr; Giladi, Moshe; Haitin, Yoni			Conserved cysteine dioxidation enhances membrane interaction of human Cl(-)intracellular channel 5	FASEB JOURNAL			English	Article						CLIC; mass spectrometry; oligomerization; oxidation; X-ray crystallography	CHLORIDE-ION CHANNEL; SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; MOLECULAR-CLONING; CLIC PROTEINS; SOLUBLE FORM; MUTATION; COMPLEXES; EXCHANGE	The human chloride intracellular channel (hCLIC) family is thought to transition between globular and membrane-associated forms by exposure of a hydrophobic surface. However, the molecular identity of this surface, and the triggering events leading to its exposure, remain elusive. Here, by combining biochemical and structural approaches, together with mass spectrometry (MS) analyses, we show that hCLIC5 is inherently flexible. X-ray crystallography revealed the existence of a globular conformation, while small-angle X-ray scattering showed additional elongated forms consisting of exposure of the conserved hydrophobic inter-domain interface to the bulk phase. Tryptophan fluorescence measurements demonstrated that the transition to the membrane-associated form is enhanced by the presence of oxidative environment and lipids. Using MS, we identified a dose-dependent oxidation of a highly conserved cysteine residue, known to play a key role in the structurally related omega-class of glutathione-S-transferases. Hydrogen/deuterium exchange MS analysis revealed that oxidation of this cysteine facilitates the exposure of the conserved hydrophobic inter-domain interface. Together, our results pinpoint an oxidation of a specific cysteine residue as a triggering mechanism initializing the molecular commitment for membrane interaction in the CLIC family.	[Ferofontov, Alisa; Giladi, Moshe; Haitin, Yoni] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, Tel Aviv, Israel; [Vankova, Pavla; Man, Petr] Czech Acad Sci, Div BioCeV, Inst Microbiol, Vestec, Czech Republic; [Vankova, Pavla] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic; [Haitin, Yoni] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Tel Aviv University	Haitin, Y (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, Tel Aviv, Israel.	yhaitin@post.tau.ac.il	Man, Petr/H-2451-2014; Vaňková, Pavla/AAN-7392-2021; Haitin, Yoni/AAQ-4571-2021	Man, Petr/0000-0002-1485-2197; Vaňková, Pavla/0000-0001-8722-2586; Haitin, Yoni/0000-0002-1648-6792	Israel Science Foundation (ISF) [1721/16]; I-CORE program of the Planning and Budgeting Committee [1772/12]; Israel Science Foundation [1772/12]; Israel Cancer Research Fund (ICRF) [01214, 19202]; German-Israeli Foundation for Scientific Research and Development (GIF) [I-2425-418.13/2016]; EC [731077]; Czech Science Foundation (CSF) [19-16084S]; MEYS CZ [CZ.1.05/1.1.00/02.0109, LM2015043]	Israel Science Foundation (ISF)(Israel Science Foundation); I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund (ICRF); German-Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); EC(European CommissionEuropean Commission Joint Research Centre); Czech Science Foundation (CSF); MEYS CZ	Israel Science Foundation (ISF), Grant/Award Number: 1721/16; The I-CORE program of the Planning and Budgeting Committee and the Israel Science Foundation, Grant/Award Number: 1772/12; Israel Cancer Research Fund (ICRF), Grant/Award Number: 01214; Israel Cancer Research Fund (ICRF), Grant/Award Number: 19202; The German-Israeli Foundation for Scientific Research and Development (GIF), Grant/Award Number: I-2425-418.13/2016; EC vertical bar Horizon 2020 Framework Programme (H2020), Grant/Award Number: 731077; Czech Science Foundation (CSF), Grant/Award Number: 19-16084S; MEYS CZ funds, Grant/Award Number: CZ.1.05/1.1.00/02.0109, LM2015043	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Khamici H, 2016, MEMBRANES, V6, DOI 10.3390/membranes6040051; Argenzio E, 2016, J CELL SCI, V129, P4165, DOI 10.1242/jcs.189795; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Carlini V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041484; Carofino Brandi L, 2019, Oncotarget, V10, P7251, DOI 10.18632/oncotarget.27387; Cromer BA, 2007, J MOL BIOL, V374, P719, DOI 10.1016/j.jmb.2007.09.041; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ferofontov A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25231-z; Filandr F, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020242; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goodchild Sophia C, 2011, Biophys Rev, V3, P143, DOI 10.1007/s12551-011-0053-8; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hernandez-Fernaud JR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14206; Hofmann L, 2016, ANAL BIOCHEM, V499, P63, DOI 10.1016/j.ab.2016.01.016; Hossain KR, 2019, BBA-GEN SUBJECTS, V1863, P1243, DOI 10.1016/j.bbagen.2019.04.020; Jia NN, 2016, J CANCER RES THER, V12, P892, DOI 10.4103/0973-1482.154057; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kulma M, 2019, TOXINS, V11, DOI 10.3390/toxins11080462; LANDRY D, 1993, J BIOL CHEM, V268, P14948; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; Littler DR, 2010, PROTEINS, V78, P1594, DOI 10.1002/prot.22675; Littler DR, 2008, PROTEINS, V71, P364, DOI 10.1002/prot.21704; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Neveu B, 2016, HAEMATOLOGICA, V101, P1534, DOI 10.3324/haematol.2016.149740; Patel Sameer H, 2019, Cell Physiol Biochem, V53, P44, DOI 10.33594/000000193; Peretti M, 2015, BBA-BIOMEMBRANES, V1848, P2523, DOI 10.1016/j.bbamem.2014.12.012; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Potrzebowski W, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006641; Rao SG, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00096; Seco CZ, 2015, EUR J HUM GENET, V23, P189, DOI 10.1038/ejhg.2014.83; Singh H, 2006, BIOPHYS J, V90, P1628, DOI 10.1529/biophysj.105.072678; Singha B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32885-2; Stoychev SH, 2009, BIOCHEMISTRY-US, V48, P8413, DOI 10.1021/bi9010607; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suh KS, 2005, J INVEST DERM SYMP P, V10, P105, DOI 10.1111/j.1087-0024.2005.200402.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takano K, 2012, HUM MOL GENET, V21, P4497, DOI 10.1093/hmg/dds292; Trcka F, 2019, MOL CELL PROTEOMICS, V18, P320, DOI 10.1074/mcp.RA118.001044; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Valenzuela SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056948; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Witham S, 2011, PROTEINS, V79, P2444, DOI 10.1002/prot.23065; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	58	1	1	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9925	9940		10.1096/fj.202000399R	http://dx.doi.org/10.1096/fj.202000399R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725932	Bronze			2022-12-26	WOS:000541773000001
J	Schofield, ZV; Wu, MCL; Hansbro, PM; Cooper, MA; Woodruff, TM				Schofield, Zoe, V; Wu, Mike C. L.; Hansbro, Philip M.; Cooper, Matthew A.; Woodruff, Trent M.			Acetate protects against intestinal ischemia-reperfusion injury independent of its cognate free fatty acid 2 receptor	FASEB JOURNAL			English	Article						acetate; FFA2; ischemia-reperfusion injury; neutrophils	GUT MICROBIOTA; INFLAMMATORY RESPONSES; NEUTROPHIL RECRUITMENT; MESENTERIC ISCHEMIA; MECHANISMS; ALLOSTERISM; EXPERIENCES; INDUCTION; MEDIATORS; COMPONENT	Free fatty acid 2 receptor (FFA2) is highly expressed on neutrophils and, when activated by its cognate ligand acetate, generates potent anti-inflammatory activities. The roles of FFA2 and acetate have not been explored in ischemia-reperfusion injury (IRI). We therefore examined the function of FFA2 and the therapeutic potential of acetate to reduce tissue injury in an acute model of intestinal IRI. The superior mesenteric artery of wild-type (WT) and FFA2(-/-)mice was briefly occluded then reperfused following treatment with acetate or vehicle. The absence of FFA2 resulted in intestinal injury similar to that observed in WT mice, indicating a minimal causal role for FFA2 in this model. Acetate treatment to WT mice prior to ischemia profoundly protected the intestine from IRI-induced damage. Amelioration of IRI was also observed, although to a lesser extent, when acetate was administered to FFA2(-/-)mice demonstrating that certain protective effects of acetate were FFA2-independent. Remarkably, despite the lack of tissue damage following IRI, acetate-treated mice had markedly increased neutrophil infiltration to the reperfused intestine which was dependent on FFA2. These studies reveal a minimal causal role for FFA2 in intestinal IRI but highlight the novel therapeutic potential for acetate in the amelioration of ischemia-mediated tissue damage.	[Schofield, Zoe, V; Wu, Mike C. L.; Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Schofield, Zoe, V; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hansbro, Philip M.] Centenary Inst, Ctr Inflammat, Sydney, NSW, Australia; [Hansbro, Philip M.] Univ Technol Sydney, Fac Sci, Ultimo, NSW, Australia	University of Queensland; University of Queensland; University of Sydney; Centenary Institute; University of Technology Sydney; University of Technology Sydney	Woodruff, TM (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.; Cooper, MA (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	m.cooper@uq.edu.au; t.woodruff@uq.edu.au	Woodruff, Trent/AAS-4629-2020; Hansbro, Phil/G-7486-2013; Woodruff, Trent M/B-4861-2009	Woodruff, Trent/0000-0003-1382-911X; Hansbro, Phil/0000-0002-4741-3035; Woodruff, Trent M/0000-0003-1382-911X; Schofield, Zoe/0000-0002-9065-0095	Department of Health \ National Health and Medical Research Council (NHMRC) [APP1082271, APP1086786, APP1079187, APP1175134]	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1082271, APP1086786, and APP1079187, APP1175134, APP1175134	Aoyama M, 2010, NUTRITION, V26, P653, DOI 10.1016/j.nut.2009.07.006; Arumugam TV, 2006, CLIN CHIM ACTA, V374, P33, DOI 10.1016/j.cca.2006.06.010; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648; Bolisetty S, 2009, KIDNEY INT, V75, P674, DOI 10.1038/ki.2008.689; Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782; de Oliveira THC, 2018, LAB INVEST, V98, P51, DOI 10.1038/labinvest.2017.90; Cerqueira Nereide Freire, 2005, Acta Cir. Bras., V20, P336, DOI 10.1590/S0102-86502005000400013; Chandrasekar B, 2000, FREE RADICAL BIO MED, V28, P1579, DOI 10.1016/S0891-5849(00)00273-2; Chen LW, 2008, SHOCK, V30, P563, DOI 10.1097/SHK.0b013e31816a3458; Chen Y, 2004, GUT, V53, P1772, DOI 10.1136/gut.2003.034868; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; D'Souza WN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180190; Feuerstadt Paul, 2010, Curr Gastroenterol Rep, V12, P383, DOI 10.1007/s11894-010-0127-y; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; Hamid H., 2010, PCT Int. Appl., Patent No. 2010066682; Hermann DM, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418798607; Hosios AM, 2014, CANCER METAB, V2, DOI 10.1186/s40170-014-0027-y; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23; Karkkainen JM, 2017, BEST PRACT RES CL GA, V31, P15, DOI 10.1016/j.bpg.2016.10.018; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolaczkowska E, 2012, BLOOD, V120, P4455, DOI 10.1182/blood-2012-09-457226; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; LEDER LD, 1970, BLUT, V21, P1, DOI 10.1007/BF01633225; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li SH, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/7283703; Lu YZ, 2012, LAB INVEST, V92, P783, DOI 10.1038/labinvest.2012.11; Luther B, 2018, VISC MED, V34, P217, DOI 10.1159/000490318; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mauler M, 2019, CIRCULATION, V139, P918, DOI 10.1161/CIRCULATIONAHA.118.033942; McCracken Jenna M, 2014, J Cell Death, V7, P15, DOI 10.4137/JCD.S11038; Meng D, 2016, AM J PHYSIOL-GASTR L, V311, pG744, DOI 10.1152/ajpgi.00090.2016; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Mumy KL, 2009, CURR OPIN PHARMACOL, V9, P697, DOI 10.1016/j.coph.2009.10.004; Nastasi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16148; Pierro Agostino, 2004, Semin Pediatr Surg, V13, P11, DOI 10.1053/j.sempedsurg.2003.09.003; Rodrigues SF, 2010, CARDIOVASC RES, V87, P291, DOI 10.1093/cvr/cvq090; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Schofield ZV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36242-1; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Souza DG, 2003, J IMMUNOL, V170, P4759, DOI 10.4049/jimmunol.170.9.4759; STRIETER RM, 1992, AM J PATHOL, V141, P397; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van der Beek CM, 2017, NUTR REV, V75, P286, DOI 10.1093/nutrit/nuw067; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Vinolo MAR, 2009, CELL BIOCHEM FUNCT, V27, P48, DOI 10.1002/cbf.1533; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Watanabe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110441; Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241; Wu MCL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00614; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110	65	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10418	10430		10.1096/fj.202000960R	http://dx.doi.org/10.1096/fj.202000960R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725930	Bronze			2022-12-26	WOS:000541769800001
J	Pfanzagl, V; Beale, JH; Michlits, H; Schmidt, D; Gabler, T; Obinger, C; Djinovic-Carugo, K; Hofbauer, S				Pfanzagl, Vera; Beale, John H.; Michlits, Hanna; Schmidt, Daniel; Gabler, Thomas; Obinger, Christian; Djinovic-Carugo, Kristina; Hofbauer, Stefan			X-ray-induced photoreduction of heme metal centers rapidly induces active-site perturbations in a protein-independent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein crystallography; radiation damage; heme proteins; heme; enzyme structure; oxidation-reduction (redox); X-ray crystallography; protein crystallization	THIOSULFATE DEHYDROGENASE TSDA; CHLORITE DISMUTASE; RADIATION-DAMAGE; CRYORADIOLYTIC REDUCTION; CRYSTAL-STRUCTURE; REDOX PROPERTIES; CRYSTALLOGRAPHY; MYOGLOBIN; PEROXIDASE; MECHANISM	Since the advent of protein crystallography, atomic-level macromolecular structures have provided a basis to understand biological function. Enzymologists use detailed structural insights on ligand coordination, interatomic distances, and positioning of catalytic amino acids to rationalize the underlying electronic reaction mechanisms. Often the proteins in question catalyze redox reactions using metal cofactors that are explicitly intertwined with their function. In these cases, the exact nature of the coordination sphere and the oxidation state of the metal is of utmost importance. Unfortunately, the redox-active nature of metal cofactors makes them especially susceptible to photoreduction, meaning that information obtained by photoreducing X-ray sources about the environment of the cofactor is the least trustworthy part of the structure. In this work we directly compare the kinetics of photoreduction of six different heme protein crystal species by X-ray radiation. We show that a dose of similar to 40 kilograys already yields 50% ferrous iron in a heme protein crystal. We also demonstrate that the kinetics of photoreduction are completely independent from variables unique to the different samples tested. The photoreduction-induced structural rearrangements around the metal cofactors have to be considered when biochemical data of ferric proteins are rationalized by constraints derived from crystal structures of reduced enzymes.	[Pfanzagl, Vera; Michlits, Hanna; Schmidt, Daniel; Gabler, Thomas; Obinger, Christian; Hofbauer, Stefan] BOKU Univ Nat Resources & Life Sci, Inst Biochem, Dept Chem, Vienna, Austria; [Beale, John H.] Diamond Light Source, Didcot, Oxon, England; [Djinovic-Carugo, Kristina] Univ Vienna, Dept Struct & Computat Biol, Max Perutz Labs, Vienna, Austria; [Djinovic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Ljubljana, Slovenia	University of Natural Resources & Life Sciences, Vienna; Diamond Light Source; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Ljubljana	Pfanzagl, V; Hofbauer, S (corresponding author), BOKU Univ Nat Resources & Life Sci, Inst Biochem, Dept Chem, Vienna, Austria.	vera.pfanzagl@boku.ac.at; stefan.hofbauer@boku.ac.at	Hofbauer, Stefan/I-3889-2014; Obinger, Christian/AAV-3173-2021; Djinovic-Carugo, Kristina/AAW-1167-2021	Hofbauer, Stefan/0000-0003-3375-7715; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Beale, John/0000-0003-1171-2428; Obinger, Christian/0000-0002-7133-3430; Schmidt, Daniel/0000-0002-0655-654X; Michlits, Hanna/0000-0001-5537-5035; Pfanzagl, Vera/0000-0002-9361-8365	Austrian Science Fund, FWF (Doctoral Program BioToP Molecular Technology of Proteins [W1224, P29099]; Diamond Light Source Proposal [MX19036]; ESRF [MX1998]; iNEXT program [PID: 4482]; Austrian Science Fund (FWF) [I525, I1593, P22276, P19060, W1221]; Wellcome Trust [201543/Z/16/Z]; COST action [BM1405]; WWTF (Vienna Science and Technology Fund) Chemical Biology Project [LS17-008]; Austrian Federal Ministry of Science, Research, and Economy; National Foundation for Research, Technology, and Development through funding the Christian Doppler Laboratory for High-Content Structural Biology and Biotechnology, Austria	Austrian Science Fund, FWF (Doctoral Program BioToP Molecular Technology of Proteins(Austrian Science Fund (FWF)); Diamond Light Source Proposal; ESRF; iNEXT program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Wellcome Trust(Wellcome TrustEuropean Commission); COST action(European Cooperation in Science and Technology (COST)); WWTF (Vienna Science and Technology Fund) Chemical Biology Project; Austrian Federal Ministry of Science, Research, and Economy; National Foundation for Research, Technology, and Development through funding the Christian Doppler Laboratory for High-Content Structural Biology and Biotechnology, Austria	This project was supported by the Austrian Science Fund, FWF (Doctoral Program BioToP Molecular Technology of Proteins (W1224) and the project P29099), Diamond Light Source Proposal MX19036, ESRF Proposal MX1998, and the iNEXT program (PID: 4482). The work of K. D.-C. was supported by Austrian Science Fund (FWF) Projects I525, I1593, P22276, P19060, and W1221; Wellcome Trust Collaborative Award 201543/Z/16/Z; by COST action BM1405-Nonglobular proteins-from sequence to structure, function, and application in molecular physiopathology (NGP-NET); WWTF (Vienna Science and Technology Fund) Chemical Biology Project LS17-008; the Austrian Federal Ministry of Science, Research, and Economy; and the National Foundation for Research, Technology, and Development through funding the Christian Doppler Laboratory for High-Content Structural Biology and Biotechnology, Austria.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Battistuzzi G, 2007, J BIOL INORG CHEM, V12, P951, DOI 10.1007/s00775-007-0267-1; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Blakeley MP, 2008, CURR OPIN STRUC BIOL, V18, P593, DOI 10.1016/j.sbi.2008.06.009; Bricogne G., 2017, BUSTER; Brito JA, 2015, J BIOL CHEM, V290, P9222, DOI 10.1074/jbc.M114.623397; Brito JA, 2014, ACTA CRYSTALLOGR F, V70, P1424, DOI 10.1107/S2053230X14019384; Bury CS, 2018, PROTEIN SCI, V27, P217, DOI 10.1002/pro.3302; Carugo O, 2005, TRENDS BIOCHEM SCI, V30, P213, DOI 10.1016/j.tibs.2005.02.009; CHANCE B, 1949, ARCH BIOCHEM, V21, P416; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chreifi G, 2016, P NATL ACAD SCI USA, V113, P1226, DOI 10.1073/pnas.1521664113; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Denisov IG, 2007, RADIAT PHYS CHEM, V76, P714, DOI 10.1016/j.radphyschem.2006.03.002; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Ebrahim A, 2019, IUCRJ, V6, P543, DOI 10.1107/S2052252519003956; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fukuda Y, 2016, P NATL ACAD SCI USA, V113, P2928, DOI 10.1073/pnas.1517770113; Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Gumiero A, 2011, J BIOL CHEM, V286, P1260, DOI 10.1074/jbc.M110.183483; HAAS DJ, 1970, ACTA CRYSTALL B-STRU, VB 26, P998, DOI 10.1107/S0567740870003485; Halsted TP, 2018, IUCRJ, V5, P22, DOI 10.1107/S2052252517016128; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; Hersleth HP, 2008, CHEM BIODIVERS, V5, P2067, DOI 10.1002/cbdv.200890189; Hersleth HP, 2008, BIOCHEM J, V412, P257, DOI 10.1042/BJ20070921; Hersleth HP, 2007, J BIOL CHEM, V282, P23372, DOI 10.1074/jbc.M701948200; Hersleth HP, 2011, BBA-PROTEINS PROTEOM, V1814, P785, DOI 10.1016/j.bbapap.2010.07.019; Hofbauer S, 2016, FEBS J, V283, P4386, DOI 10.1111/febs.13930; Hofbauer S, 2016, BIOCHEMISTRY-US, V55, P5398, DOI 10.1021/acs.biochem.6b00701; Hofbauer S, 2015, ARCH BIOCHEM BIOPHYS, V574, P36, DOI 10.1016/j.abb.2015.01.010; Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P3145, DOI 10.1021/bi500401k; Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P77, DOI 10.1021/bi401042z; Hofbauer S, 2012, BIOCHEMISTRY-US, V51, P9501, DOI 10.1021/bi3013033; Holton JM, 2009, J SYNCHROTRON RADIAT, V16, P133, DOI 10.1107/S0909049509004361; HOPE H, 1988, ACTA CRYSTALLOGR B, V44, P22, DOI 10.1107/S0108768187008632; Hough MA, 2008, J MOL BIOL, V378, P353, DOI 10.1016/j.jmb.2008.01.097; Jakopitsch C, 2014, J INORG BIOCHEM, V135, P10, DOI 10.1016/j.jinorgbio.2014.02.010; Jenner LP, 2019, J BIOL CHEM, V294, P18002, DOI 10.1074/jbc.RA119.010084; Johansson LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3911; JONES GDD, 1987, NATURE, V330, P772, DOI 10.1038/330772a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kato Y, 2000, BIOCHEMISTRY-US, V39, P800, DOI 10.1021/bi991598u; Kekilli D, 2017, IUCRJ, V4, P263, DOI 10.1107/S2052252517002159; Kobayashi K, 2005, J BIOL CHEM, V280, P5486, DOI 10.1074/jbc.M410474200; Kostan J, 2010, J STRUCT BIOL, V172, P331, DOI 10.1016/j.jsb.2010.06.014; Kozlowski LP, 2017, NUCLEIC ACIDS RES, V45, pD1112, DOI 10.1093/nar/gkw978; Kurth JM, 2016, J BIOL CHEM, V291, P24804, DOI 10.1074/jbc.M116.753863; Li KC, 1999, APPL ENVIRON MICROB, V65, P2654; Macedo S, 2009, J SYNCHROTRON RADIAT, V16, P191, DOI 10.1107/S0909049509003331; Marshall NM, 2009, NATURE, V462, P113, DOI 10.1038/nature08551; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meharenna YT, 2010, BIOCHEMISTRY-US, V49, P2984, DOI 10.1021/bi100238r; PETSKO GA, 1975, J MOL BIOL, V96, P381, DOI 10.1016/0022-2836(75)90167-9; Pfanzagl V, 2019, J INORG BIOCHEM, V199, DOI 10.1016/j.jinorgbio.2019.110761; Pfanzagl V, 2018, J BIOL CHEM, V293, P14823, DOI 10.1074/jbc.RA118.004773; Sawai H, 2009, J BIOL CHEM, V284, P32089, DOI 10.1074/jbc.M109.018762; Schaffner I, 2017, ACS CATAL, V7, P7962, DOI 10.1021/acscatal.7b01749; Schaffner I, 2015, MOL MICROBIOL, V96, P1053, DOI 10.1111/mmi.12989; Shimada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603042; Sliz P, 2003, STRUCTURE, V11, P13, DOI 10.1016/S0969-2126(02)00910-3; Southworth-Davies RJ, 2007, J SYNCHROTRON RADIAT, V14, P73, DOI 10.1107/S0909049506044177; Spence JCH, 2017, STRUCT DYNAM-US, V4, DOI 10.1063/1.4984606; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tosha T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01702-1; Unno M, 2007, J AM CHEM SOC, V129, P13394, DOI 10.1021/ja076108x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zeldin OB, 2013, P NATL ACAD SCI USA, V110, P20551, DOI 10.1073/pnas.1315879110; Zeldin OB, 2013, J SYNCHROTRON RADIAT, V20, P49, DOI 10.1107/S0909049512044706	77	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13488	13501		10.1074/jbc.RA120.014087	http://dx.doi.org/10.1074/jbc.RA120.014087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32723869	Green Published, hybrid			2022-12-26	WOS:000576321100007
J	Burton, MJ; Cresser-Brown, J; Thomas, M; Portolano, N; Basran, J; Freeman, SL; Kwon, H; Bottrill, AR; Llansola-Portoles, MJ; Pascal, AA; Jukes-Jones, R; Chernova, T; Schmid, R; Davies, NW; Storey, NM; Dorlet, P; Moody, PCE; Mitcheson, JS; Raven, EL				Burton, Mark J.; Cresser-Brown, Joel; Thomas, Morgan; Portolano, Nicola; Basran, Jaswir; Freeman, Samuel L.; Kwon, Hanna; Bottrill, Andrew R.; Llansola-Portoles, Manuel J.; Pascal, Andrew A.; Jukes-Jones, Rebekah; Chernova, Tatyana; Schmid, Ralf; Davies, Noel W.; Storey, Nina M.; Dorlet, Pierre; Moody, Peter C. E.; Mitcheson, John S.; Raven, Emma L.			Discovery of a heme-binding domain in a neuronal voltage-gated potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; hERG3; ion channel; PAS domain; Cap domain; heme regulation; hERG; X-ray crystallography; protein crystallization; heme regulation	THIOL/DISULFIDE REDOX SWITCH; REGULATORY MOTIFS; CRYSTAL-STRUCTURE; CARBON-MONOXIDE; PAS DOMAINS; K+ CHANNELS; HUMAN ETHER; MECHANISM; PROTEIN; OXYGEN	The EAG (ether-a-go-go) family of voltage-gated K(+)channels are important regulators of neuronal and cardiac action potential firing (excitability) and have major roles in human diseases such as epilepsy, schizophrenia, cancer, and sudden cardiac death. A defining feature of EAG (Kv10-12) channels is a highly conserved domain on the N terminus, known as the eag domain, consisting of a Per-ARNT-Sim (PAS) domain capped by a short sequence containing an amphipathic helix (Cap domain). The PAS and Cap domains are both vital for the normal function of EAG channels. Using heme-affinity pulldown assays and proteomics of lysates from primary cortical neurons, we identified that an EAG channel, hERG3 (Kv11.3), binds to heme. In whole-cell electrophysiology experiments, we identified that heme inhibits hERG3 channel activity. In addition, we expressed the Cap and PAS domain of hERG3 inEscherichia coliand, using spectroscopy and kinetics, identified the PAS domain as the location for heme binding. The results identify heme as a regulator of hERG3 channel activity. These observations are discussed in the context of the emerging role for heme as a regulator of ion channel activity in cells.	[Burton, Mark J.; Thomas, Morgan; Portolano, Nicola] Univ Leicester, Dept Chem, Leicester, Leics, England; [Basran, Jaswir; Schmid, Ralf; Davies, Noel W.; Storey, Nina M.; Moody, Peter C. E.; Mitcheson, John S.] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England; [Burton, Mark J.; Thomas, Morgan; Portolano, Nicola; Basran, Jaswir; Schmid, Ralf; Davies, Noel W.; Storey, Nina M.] Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester, Leics, England; [Bottrill, Andrew R.] Univ Leicester, Prot Nucle Acid Chem Lab, Leicester, Leics, England; [Cresser-Brown, Joel; Freeman, Samuel L.; Kwon, Hanna; Raven, Emma L.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Llansola-Portoles, Manuel J.; Pascal, Andrew A.] Univ Paris Saclay, CNRS, Inst Integrat Biol Cell, CEA, Gif Sur Yvette, France; [Jukes-Jones, Rebekah; Chernova, Tatyana] Univ Cambridge, Med Res Council Toxicol Unit, Leicester, Leics, England; [Dorlet, Pierre] Aix Marseille Univ, Lab Bioenerget & Ingn Prot, CNRS, Marseille, France	University of Leicester; University of Leicester; University of Leicester; University of Leicester; University of Bristol; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Raven, EL (corresponding author), Univ Bristol, Sch Chem, Bristol, Avon, England.	emma.raven@bristol.ac.uk	Thomas, Morgan/GZM-2473-2022; Bottrill, Andrew/ABD-1459-2021; Llansola-Portoles, Manuel J./ABI-1060-2020; pascal, andrew a/B-6186-2014	Bottrill, Andrew/0000-0002-5182-3643; Llansola-Portoles, Manuel J./0000-0002-8065-9459; pascal, andrew a/0000-0002-1844-6065; Dorlet, Pierre/0000-0001-7394-3374; Thomas, Morgan/0000-0002-1610-3499; Kwon, Hanna/0000-0001-6941-4808	Biotechnology and Biological Sciences Research Council [BB/K000128/1, BB/M018598/1]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INBS-05]; BBSRC [BB/M018598/1, BB/K000128/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French Infrastructure for Integrated Structural Biology (FRISBI); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/K000128/1 and BB/M018598/1 (to E. L. R.). This work benefited from the Biophysics Platform of Institute for Integrative Biology of the Cell, supported by iBiSA and by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INBS-05.	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; Augustynek B, 2014, EXP NEUROL, V257, P70, DOI 10.1016/j.expneurol.2014.04.022; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burton MJ, 2016, P NATL ACAD SCI USA, V113, P3785, DOI 10.1073/pnas.1600211113; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Dawson R. M. C., 1975, DATA BIOCH RES; Freeman SL, 2019, P NATL ACAD SCI USA, V116, P19911, DOI 10.1073/pnas.1905216116; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gong WM, 2000, BIOCHEMISTRY-US, V39, P3955, DOI 10.1021/bi992346w; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; Kalsbeck WA, 1996, BIOCHEMISTRY-US, V35, P3429, DOI 10.1021/bi952662k; Kapetanaki SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03291-z; Kitanishi K, 2008, BIOCHEMISTRY-US, V47, P6157, DOI 10.1021/bi7023892; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; LEE BC, 1992, INFECT IMMUN, V60, P810, DOI 10.1128/IAI.60.3.810-816.1992; Li Z., 2011, HEME BIOL SECRET LIF; LIGHT WR, 1990, J BIOL CHEM, V265, P15623; Lorinczi E, 2016, J BIOL CHEM, V291, P17907, DOI 10.1074/jbc.M116.733576; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Otto BR, 1998, J EXP MED, V188, P1091, DOI 10.1084/jem.188.6.1091; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Reynolds MF, 1998, J AM CHEM SOC, V120, P9080, DOI 10.1021/ja981146p; Robinson SR, 2009, REDOX REP, V14, P228, DOI 10.1179/135100009X12525712409931; Sahoo N, 2013, P NATL ACAD SCI USA, V110, pE4036, DOI 10.1073/pnas.1313247110; Shimizu T, 2019, CHEM SOC REV, V48, P5624, DOI 10.1039/c9cs00268e; Shimizu T, 2015, CHEM REV, V115, P6491, DOI 10.1021/acs.chemrev.5b00018; Smith AT, 2015, CHEM REV, V115, P2532, DOI 10.1021/cr500056m; Smith AG, 2011, METALLOMICS, V3, P955, DOI 10.1039/c1mt00085c; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Wang S, 2009, P NATL ACAD SCI USA, V106, P2957, DOI 10.1073/pnas.0809100106; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Wu JY, 2011, NEW PHYTOL, V189, P1060, DOI 10.1111/j.1469-8137.2010.03564.x; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2010, J BIOL CHEM, V285, P20117, DOI 10.1074/jbc.M110.116483; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651	51	8	8	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13277	13286		10.1074/jbc.RA120.014150	http://dx.doi.org/10.1074/jbc.RA120.014150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32723862	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000574483500012
J	Aydemir, BC; Ozmen, CY; Kibar, U; Mutaf, F; Buyuk, PB; Bakir, M; Ergul, A				Aydemir, Birsen Cakir; Ozmen, Canan Yuksel; Kibar, Umut; Mutaf, Filiz; Buyuk, Pelin Burcu; Bakir, Melike; Ergul, Ali			Salt stress induces endoplasmic reticulum stress-responsive genes in a grapevine rootstock	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION-FACTOR GENES; FATTY-ACID-COMPOSITION; SALINITY TOLERANCE; GLYCINE BETAINE; PLANT-RESPONSES; QUALITY-CONTROL; ARABIDOPSIS; ETHYLENE; EXPRESSION	Grapevines, although adapted to occasional drought or salt stress, are relatively sensitive to growth- and yield-limiting salinity stress. To understand the molecular mechanisms of salt tolerance and endoplasmic reticulum (ER) stress and identify genes commonly regulated by both stresses in grapevine, we investigated transcript profiles in leaves of the salt-tolerant grapevine rootstock 1616C under salt- and ER-stress. Among 1643 differentially expressed transcripts at 6 h post-treatment in leaves, 29 were unique to ER stress, 378 were unique to salt stress, and 16 were common to both stresses. At 24 h post-treatment, 243 transcripts were unique to ER stress, 1150 were unique to salt stress, and 168 were common to both stresses. GO term analysis identified genes in categories including 'oxidative stress', 'protein folding', 'transmembrane transport', 'protein phosphorylation', 'lipid transport', 'proteolysis', 'photosynthesis', and 'regulation of transcription'. The expression of genes encoding transporters, transcription factors, and proteins involved in hormone biosynthesis increased in response to both ER and salt stresses. KEGG pathway analysis of differentially expressed genes for both ER and salt stress were divided into four main categories including; carbohydrate metabolism, amino acid metabolism, signal transduction and lipid metabolism. Differential expression of several genes was confirmed by qRT-PCR analysis, which validated our microarray results. We identified transcripts for genes that might be involved in salt tolerance and also many genes differentially expressed under both ER and salt stresses. Our results could provide new insights into the mechanisms of salt tolerance and ER stress in plants and should be useful for genetic improvement of salt tolerance in grapevine.	[Aydemir, Birsen Cakir] Ege Univ, Fac Agr, Dept Hort, Izmir, Turkey; [Ozmen, Canan Yuksel; Mutaf, Filiz; Buyuk, Pelin Burcu; Ergul, Ali] Ankara Univ, Biotechnol Inst, Ankara, Turkey; [Kibar, Umut] Minist Agr & Forestry, Agr & Rural Dev Support Inst, Ankara, Turkey; [Bakir, Melike] Erciyes Univ, Fac Agr, Dept Agr Biotechnol, Kayseri, Turkey	Ege University; Ankara University; Ministry of Food, Agriculture & Livestock - Turkey; Erciyes University	Ergul, A (corresponding author), Ankara Univ, Biotechnol Inst, Ankara, Turkey.	ergul@agri.ankara.edu.tr	Bakır, Melike/AAO-1287-2021; Bakir, Melike/HGD-5506-2022; Kibar, Umut/AAQ-7775-2020	Bakir, Melike/0000-0003-3465-1453; Kibar, Umut/0000-0003-0669-9142; Ergul, Ali/0000-0003-0070-0886	Scientific and Technological Research Council of Turkey (TUBITAK) [110 O105]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Funded by the Scientific and Technological Research Council of Turkey (TUBITAK), grant No: 110 O105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; [Anonymous], 2012, NUCLEIC ACIDS RES, V41, pD530, DOI [DOI 10.1093/nar/gks1050, 10.1093/nar/gks1050]; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; BOHRA JS, 1995, J AGRON CROP SCI, V174, P79, DOI 10.1111/j.1439-037X.1995.tb00197.x; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chen YN, 2014, PLANT J, V77, P97, DOI 10.1111/tpj.12373; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Cramer GR, 2001, AUST J PLANT PHYSIOL, V28, P101, DOI 10.1071/PP00101; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Deng Y, 2013, INT J MOL SCI, V14, P8188, DOI 10.3390/ijms14048188; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Eichmann R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00200; El-Shintinawy F, 2001, BIOL PLANTARUM, V44, P541, DOI 10.1023/A:1013738603020; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Fujita M, 2007, BIOCHEM BIOPH RES CO, V364, P250, DOI 10.1016/j.bbrc.2007.09.124; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Guan L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124019; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Huttner S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00067; Huttner S, 2012, PLANT MOL BIOL, V79, P21, DOI 10.1007/s11103-012-9891-4; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Jyothi-Prakash PA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0291-6; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Lee JH, 2004, PLANT MOL BIOL, V55, P61, DOI 10.1007/s11103-004-0417-6; Li H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-105; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Liu LJ, 2011, CELL RES, V21, P957, DOI 10.1038/cr.2010.181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma LY, 2012, J EXP BOT, V63, P305, DOI 10.1093/jxb/err280; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; McKersie B.D., 1994, STRESS STRESS COPING; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Mott KA, 2000, J EXP BOT, V51, P399, DOI 10.1093/jexbot/51.suppl_1.399; Muller M, 2015, PLANT PHYSIOL, V169, P32, DOI 10.1104/pp.15.00677; Muller J, 2005, PLANT CELL, V17, P149, DOI 10.1105/tpc.104.026625; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nawkar GM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00214; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; Peng Z, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-760; Qian DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep14255; Rahnama A, 2010, FUNCT PLANT BIOL, V37, P255, DOI 10.1071/FP09148; Reid RJ, 2000, AUST J PLANT PHYSIOL, V27, P709, DOI 10.1071/PP00030; ROUBELAKISANGELAKIS KA, 1991, HORTSCIENCE, V26, P1551, DOI 10.21273/HORTSCI.26.12.1551; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Rozema J, 2008, SCIENCE, V322, P1478, DOI 10.1126/science.1168572; Satoh-Cruz M, 2010, PLANT CELL PHYSIOL, V51, P1581, DOI 10.1093/pcp/pcq098; SAUER M R, 1968, Vitis, V7, P223; Saxena S.C., 2013, PLANT ACCLIMATION EN, P197, DOI DOI 10.1007/978-1-4614-5001-6_9; Schwechheimer Claus, 2009, V479, P147, DOI 10.1007/978-1-59745-289-2_10; Seo YJ, 2010, MOL CELLS, V30, P271, DOI 10.1007/s10059-010-0114-z; Simon R., 2012, BRB ARRAYTOOLS VERSI; Simon R, 2007, CANCER INFORM, V3, P11; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Su W, 2011, P NATL ACAD SCI USA, V108, P870, DOI 10.1073/pnas.1013251108; Sun L, 2013, PLANT J, V76, P274, DOI 10.1111/tpj.12287; Tattersall EAR, 2005, AM J ENOL VITICULT, V56, P400; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Upadhyay A, 2018, PLANT PHYSIOL BIOCH, V129, P168, DOI 10.1016/j.plaphy.2018.05.032; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; WALKER RR, 1981, AUST J PLANT PHYSIOL, V8, P359, DOI 10.1071/PP9810359; Walker RR, 2004, AUST J GRAPE WINE R, V10, P90, DOI 10.1111/j.1755-0238.2004.tb00011.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang Y, 2000, J HORTIC SCI BIOTECH, V75, P623, DOI 10.1080/14620316.2000.11511297; Weiner JJ, 2010, CURR OPIN PLANT BIOL, V13, P495, DOI 10.1016/j.pbi.2010.09.007; Xu LX, 2011, CROP SCI, V51, P273, DOI 10.2135/cropsci2010.06.0368; Yang XW, 2018, PLANT SCI, V277, P229, DOI 10.1016/j.plantsci.2018.09.013; Zhang LX, 2011, PLANT PHYSIOL, V157, P854, DOI 10.1104/pp.111.179028; Zhong DH, 2011, J AM SOC HORTIC SCI, V136, P35, DOI 10.21273/JASHS.136.1.35	88	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236424	10.1371/journal.pone.0236424	http://dx.doi.org/10.1371/journal.pone.0236424			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730292	gold, Green Published			2022-12-26	WOS:000556884700071
J	Shehzad, T; Okuno, K				Shehzad, Tariq; Okuno, Kazutoshi			Genetic analysis of QTLs controlling allelopathic characteristics in sorghum	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BICOLOR L. MOENCH; ALLELOCHEMICAL SORGOLEONE; SEEDLING GROWTH; ROOT; WEED; ASSOCIATION; GERMINATION; RESIDUES; RICE	Mature sorghum herbage is known to contain several water-soluble secondary metabolites (allelochemicals). In this study, we investigated quantitative trait loci (QTLs) associated with allelochemical characteristics in sorghum using linkage mapping and linkage disequilibrium (LD)-based association mapping. A sorghum diversity research set (SDRS) of 107 accessions was used in LD mapping whereas, F(2:3)lines derived from a cross between Japanese and African landraces were used in linkage mapping. The QTLs were further confirmed by positional (targeted) association mapping with Q+K model. The inhibitory effect of water-soluble extracts (WSE) was tested on germination and root length of lettuce seedlings in four concentrations (25%, 50%, 75% and 100%). A Significant range of variations was observed among genotypes in both types of mapping populations (P< 0.05). A total of 181 simple sequence repeats (SSRs) derived from antecedently reported map have been used for genotyping of SDRS. A genetic linkage map of 151 sorghum SSR markers was also developed on 134 F(2)individuals. The total map length was 1359.3 cM, with an average distance of 8.2 cM between adjacent markers. LD mapping identified three QTLs for inhibition effect on germination and seven QTLs for root length of lettuce seedlings. Whereas, a total of six QTLs for inhibition of germination and ten QTLs for root length were detected in linkage mapping approach. The percent phenotypic variation explained by individual QTL ranged from 6.9% to 27.3% in SDRS and 9.9% to 35.6% in F(2:3)lines. Regional association analysis identified four QTLs, three of them are common in other methods too. No QTL was identified in the region where major gene for sorgoleone (SOR1) has been cloned previously on chromosome 5.	[Shehzad, Tariq] Univ Georgia, Coll Agr & Environm Sci, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Okuno, Kazutoshi] Kayada 2069-6, Yachiyo, Chiba, Japan; [Shehzad, Tariq] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar	University System of Georgia; University of Georgia; Qatar University	Shehzad, T (corresponding author), Univ Georgia, Coll Agr & Environm Sci, Plant Genome Mapping Lab, Athens, GA 30602 USA.; Shehzad, T (corresponding author), Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar.	tshehzad@qu.edu.qa	Okuno, Kazutoshi/AAQ-9507-2021	Shehzad, Tariq/0000-0002-5408-7282	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was financially supported under Japan Society for the Promotion of Science ((https://www.jsps.go.jp/english/e-ippan/index.html) postdoctoral fellowship for overseas researchers FY2010-2011 to TS. We are also thankful to Qatar National Library (QNL) for paying all article processing charges to journal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AR, 2002, J ENVIRON BIOL, V23, P19; Alsaadawi IS, 2009, ALLELOPATHY J, V24, P255; Baerson SR, 2007, J BIOL CHEM, V6, P3231; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattramakki D, 2000, GENOME, V43, P988, DOI 10.1139/gen-43-6-988; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; CHANG M, 1986, J AM CHEM SOC, V108, P7858, DOI 10.1021/ja00284a074; Cheema ZA, 2000, PAK J AGR SCI, V37, P140; Cook D, 2010, PLANT CELL, V22, P867, DOI 10.1105/tpc.109.072397; Courtois B, 1998, ALL RIC P WORKSH ALL, P57; Crasta OR, 1999, MOL GEN GENET, V262, P579, DOI 10.1007/s004380051120; Dayan FE, 2003, J BIOL CHEM, V278, P28607, DOI 10.1074/jbc.M304185200; Dayan FE, 2006, PLANTA, V224, P339, DOI 10.1007/s00425-005-0217-5; Dayan FE, 2009, J EXP BOT, V60, P2107, DOI 10.1093/jxb/erp082; Duke SO, 2001, WEED TECHNOL, V15, P826, DOI 10.1614/0890-037X(2001)015[0826:SFUTTP]2.0.CO;2; Ebana K, 2001, AGRON J, V93, P12, DOI 10.2134/agronj2001.93112x; Ebana K, 2001, BREEDING SCI, V51, P47, DOI 10.1270/jsbbs.51.47; Fate GD, 1996, J AM CHEM SOC, V118, P11369, DOI 10.1021/ja961395i; Fateh E., 2012, ADV ENV BIO, V6, P940; Hoffman ML, 1996, WEED SCI, V44, P402, DOI 10.1017/S0043174500094078; Iqbal Z, 2003, WEED SCI, V51, P657, DOI 10.1614/0043-1745(2003)051[0657:AAOBIA]2.0.CO;2; Jensen LB, 2008, CROP SCI, V48, P1459, DOI 10.2135/cropsci2007.09.0533; Lander ES, 1987, GENOMICS, V1, P74; Molisch H., 1937, EINFLUSS PFLANZE AND; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; PANASIUK O, 1986, J CHEM ECOL, V12, P1533, DOI 10.1007/BF01012370; Pritchard JK, 2000, GENETICS, V155, P945; PUTNAM AR, 1983, CROP PROT, V2, P173, DOI 10.1016/0261-2194(83)90042-X; SAS Institute Inc, 2012, JMP STAT GRAPH GUID; Shang ZH, 2012, PHYTON-INT J EXP BOT, V81, P75; Shehzad T, 2015, EUPHYTICA, V203, P17, DOI 10.1007/s10681-014-1243-9; Shehzad T, 2009, BREEDING SCI, V59, P217, DOI 10.1270/jsbbs.59.217; Shehzad T, 2009, GENET RESOUR CROP EV, V56, P809, DOI 10.1007/s10722-008-9403-1; Weston LA, 2003, CRIT REV PLANT SCI, V22, P367, DOI 10.1080/713610861; Weston LA, 2013, J CHEM ECOL, V39, P142, DOI 10.1007/s10886-013-0245-8; Wu H, 2003, THEOR APPL GENET, V107, P1477, DOI 10.1007/s00122-003-1394-x; Yang XH, 2004, J EXP BOT, V55, P2251, DOI 10.1093/jxb/erh252; Yonemaru J, 2009, DNA RES, V16, P197; ZENG ZB, 1994, GENETICS, V136, P1457; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	41	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0235896	10.1371/journal.pone.0235896	http://dx.doi.org/10.1371/journal.pone.0235896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730265	Green Published, gold			2022-12-26	WOS:000556884700027
J	Mun, H; Kim, YX; Suh, DH; Lee, SL; Singh, D; Jung, ES; Lee, CH; Sung, J				Mun, Ha In; Kim, Yangmin X.; Suh, Dong Ho; Lee, Seulbi; Singh, Digar; Jung, Eun Sung; Lee, Choong Hwan; Sung, Jwakyung			Metabolomic response ofPerilla frutescensleaves, an edible-medicinal herb, to acclimatize magnesium oversupply	PLOS ONE			English	Article							SALINITY STRESS TOLERANCE; ABIOTIC STRESS; SALT STRESS; ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS; AMINO-ACID; MG; ARABIDOPSIS; PHYSIOLOGY; CHELATASE	High salt accumulation, resulting from the rampant use of chemical fertilizers in greenhouse cultivation, has deleterious effects on plant growth and crop yield. Herein, we delineated the effects of magnesium (Mg) oversupply onPerilla frutescensleaves, a traditional edible and medicinal herb used in East-Asian countries. Mg oversupply resulted in significantly higher chlorophyll content coupled with lower antioxidant activities and growth, suggesting a direct effect on subtle metabolomes. The relative abundance of bioactive phytochemicals, such as triterpenoids, flavonoids, and cinnamic acids, was lower in the Mg-oversupplied plants than in the control. Correlation analysis between plant phenotypes (plant height, total fresh weight of the shoot, leaf chlorophyll content, and leaf antioxidant content) and the altered metabolomes inP.frutescensleaves suggested an acclimatization mechanism to Mg oversupply. In conclusion,P.frutescenspreferentially accumulated compatible solutes,i.e., carbohydrates and amino acids, to cope with higher environmental Mg levels, instead of employing secondary and antioxidative metabolism.	[Mun, Ha In; Suh, Dong Ho; Singh, Digar; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Kim, Yangmin X.; Lee, Seulbi] Rural Dev Adm, Natl Inst Agr Sci, Wonju, South Korea; [Jung, Eun Sung; Lee, Choong Hwan] Konkuk Univ, Dept Syst Biotechnol, Seoul, South Korea; [Lee, Choong Hwan] Konkuk Univ, Res Inst Bioact Metabolome Network, Seoul, South Korea; [Sung, Jwakyung] Chungbuk Natl Univ, Dept Crop Sci, Coll Agr Life & Environm Sci, Cheongju, South Korea	Konkuk University; National Institute of Agricultural Sciences; Rural Development Administration (RDA); Konkuk University; Konkuk University; Chungbuk National University	Lee, CH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.; Lee, CH (corresponding author), Konkuk Univ, Dept Syst Biotechnol, Seoul, South Korea.; Lee, CH (corresponding author), Konkuk Univ, Res Inst Bioact Metabolome Network, Seoul, South Korea.; Sung, J (corresponding author), Chungbuk Natl Univ, Dept Crop Sci, Coll Agr Life & Environm Sci, Cheongju, South Korea.	chlee123@konkuk.ac.kr; jksung73@chungbuk.ac.kr	Kim, Yangmin X./V-8377-2019	Kim, Yangmin X./0000-0002-6246-5845	Rural Development Administration, Republic of Korea [PJ012523, PJ014977]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was funded by the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ012523, PJ014977)" and the 2020 RDA Fellowship Program of Rural Development Administration, Republic of Korea.	Arbona V, 2013, INT J MOL SCI, V14, P4885, DOI 10.3390/ijms14034885; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Banno N, 2004, BIOSCI BIOTECH BIOCH, V68, P85, DOI 10.1271/bbb.68.85; Cakmak I., 2010, Better Crops with Plant Food, V94, P23; Chen KW, 2015, J CHROMATOGR A, V1412, P90, DOI 10.1016/j.chroma.2015.08.007; dos Santos VS, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1209-8; DOWNTON WJS, 1977, AUST J PLANT PHYSIOL, V4, P183, DOI 10.1071/PP9770183; FAGERIA NK, 1983, PLANT SOIL, V70, P309, DOI 10.1007/BF02374887; Falleh H, 2012, PLANT PHYSIOL BIOCH, V52, P1, DOI 10.1016/j.plaphy.2011.11.001; Figueroa-Perez MG, 2014, J AGR FOOD CHEM, V62, P12027, DOI 10.1021/jf503628c; FOUGERE F, 1991, PLANT PHYSIOL, V96, P1228, DOI 10.1104/pp.96.4.1228; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GRANT CA, 1987, CAN J SOIL SCI, V67, P857, DOI 10.4141/cjss87-082; Guo W, 2015, PLOS ONE, V10, P1; ITO H, 1994, J BIOL CHEM, V269, P22034; Jung ES, 2013, PLANT SCI, V210, P61, DOI 10.1016/j.plantsci.2013.05.004; Kiani-Pouya A, 2017, PLANT CELL ENVIRON, V40, P1900, DOI 10.1111/pce.12995; Kim HJ, 2008, J AGR FOOD CHEM, V56, P3772, DOI 10.1021/jf0733719; Kobayashi K, 2008, PHOTOCH PHOTOBIO SCI, V7, P1188, DOI 10.1039/b802604c; Kumar M, 2016, ALGAL RES, V16, P76, DOI 10.1016/j.algal.2016.02.033; Kwon MC, 2019, METABOLITES, V9, DOI 10.3390/metabo9100231; Liu J, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-61; Livigni S, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1726-x; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Meng LH, 2009, MOLECULES, V14, P133, DOI 10.3390/molecules14010133; Mikkelsen R., 2010, Better Crops with Plant Food, V94, P26; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mrazova A, 2017, BIOLOGIA, V72, P36, DOI 10.1515/biolog-2017-0001; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Niu Y, 2018, SCI REP, V8, P1; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Ruan J, 1988, J SCI FOOD AGR, V76, P389; Sairam RK, 2004, CURR SCI INDIA, V86, P407; SCHUBERT S, 1995, J PLANT PHYSIOL, V146, P541, DOI 10.1016/S0176-1617(11)82021-3; Selvaraj Venkatesan, 2010, Research Journal of Phytochemistry, V4, P67; Son SY, 2016, PLANT CELL REP, V35, P1917, DOI 10.1007/s00299-016-2006-y; Sun HW, 2019, ENVIRON SCI POLLUT R, V26, P3882, DOI 10.1007/s11356-018-3865-2; Villadsen D, 2005, FUNCT PLANT BIOL, V32, P1033, DOI 10.1071/FP05102; Wang WS, 2016, J EXP BOT, V67, P405, DOI 10.1093/jxb/erv476; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09164; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yildirim E, 2009, PLANT SOIL ENVIRON, V55, P213, DOI 10.17221/383-PSE; Yuan GF, 2010, FOOD CHEM, V121, P1014, DOI 10.1016/j.foodchem.2010.01.040	46	3	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236813	10.1371/journal.pone.0236813	http://dx.doi.org/10.1371/journal.pone.0236813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726342	gold, Green Published			2022-12-26	WOS:000556908900003
J	Nicot, R; Chung, K; Vieira, AR; Raoul, G; Ferri, J; Sciote, JJ				Nicot, Romain; Chung, Kay; Vieira, Alexandre R.; Raoul, Gwenael; Ferri, Joel; Sciote, James J.			Condyle modeling stability, craniofacial asymmetry and ACTN3 genotypes: Contribution to TMD prevalence in a cohort of dentofacial deformities	PLOS ONE			English	Article							UNILATERAL POSTERIOR CROSSBITE; TEMPOROMANDIBULAR DISORDERS; ALPHA-ACTININ-3 DEFICIENCY; MANDIBULAR CONDYLE; GROWTH; ENPP1; IMBALANCE; BONE; QUESTIONNAIRE; MALOCCLUSION	Craniofacial asymmetry, mandibular condylar modeling and temporomandibular joint disorders are common comorbidities of skeletally disproportionate malocclusions, but etiology of occurrence together is poorly understood. We compared asymmetry, condyle modeling stability and temporomandibular health in a cohort of 128 patients having orthodontics and orthognathic surgery to correct dentofacial deformity malocclusions. We also comparedACTN3andENPP1genotypes for association to clinical conditions. Pre-surgical posterior-anterior cephalometric and panometric radiographic analyses; jaw pain and function questionnaire and clinical examination of TMD; and SNP-genotype analysis from saliva samples were compared to assess interrelationships. Almost half had asymmetries in need of surgical correction, which could be subdivided into four distinct morphological patterns. Asymmetric condyle modeling between sides was significantly greater in craniofacial asymmetry, but most commonly had an unanticipated pattern. Often, longer or larger condyles occurred on the shorter mandibular ramus side. Subjects with longer ramus but dimensionally smaller condyles were more likely to have self-reported TMD symptoms (p= 0.023) and significantly greater clinical diagnosis of TMD (p= 0 .000001), with masticatory myalgia most prominent. Genotyping found two significant genotype associations forACTN3rs1671064 (Q523R missense)p= 0.02; rs678397 (intronic SNP)p= 0.04 and one significant allele association rs1815739 (R577X nonsense)p= 0.00. Skeletal asymmetry, unusual condyle modeling and TMD are common and interrelated components of many dentofacial deformities. Imbalanced musculoskeletal functional adaptations and genetic or epigenetic influences contribute to the etiology, and require further investigation.	[Nicot, Romain; Raoul, Gwenael; Ferri, Joel] Univ Lille, Dept Oral & Maxillofacial Surg, CHU Lille, Inserm,Controlled Drug Delivery Syst & Biomat U10, Lille, France; [Chung, Kay; Sciote, James J.] Temple Univ, Dept Orthodont, Philadelphia, PA 19122 USA; [Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nicot, R (corresponding author), Univ Lille, Dept Oral & Maxillofacial Surg, CHU Lille, Inserm,Controlled Drug Delivery Syst & Biomat U10, Lille, France.	romain.nicot@gmail.com	; Nicot, Romain/N-3926-2013	Raoul, Gwenael/0000-0002-0925-4838; Nicot, Romain/0000-0001-7391-2121	National Institute of Dental & Craniofacial research [R21DE022427]	National Institute of Dental & Craniofacial research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	YES - This work is supported by the National Institute of Dental & Craniofacial research through a grant to Dr. Sciote; Musculoskeletal Heritable Influences on Malocclusion - R21DE022427.	Abrahamsson C, 2013, INT J ORAL MAX SURG, V42, P752, DOI 10.1016/j.ijom.2012.10.016; Al-Moraissi EA, 2017, J ORAL MAXIL SURG, V75, P1835, DOI 10.1016/j.joms.2017.03.029; Al-Rawi Natheer Hashim, 2017, Eur J Dent, V11, P99, DOI 10.4103/ejd.ejd_202_16; Aoyama Y, 2013, J HARD TISSUE BIOL, V22, P293, DOI 10.2485/jhtb.22.293; BJORK A, 1983, EUR J ORTHODONT, V5, P1; BJORK ARNE, 1955, ACTA ODONTOL SCAND, V13, P9, DOI 10.3109/00016355509028170; Chung K, 2017, AM J ORTHOD DENTOFAC, V152, P631, DOI 10.1016/j.ajodo.2017.03.024; CLARK G T, 1989, Journal of Craniomandibular Disorders, V3, P7; Constant M, 2017, J CRANIO MAXILL SURG, V45, P826, DOI 10.1016/j.jcms.2017.02.020; DAHLBERG G, 1995, ORAL SURG ORAL MED O, V79, P273, DOI 10.1016/S1079-2104(05)80219-7; Dibbets J, 2013, SEMIN ORTHOD, V19, P71, DOI 10.1053/j.sodo.2012.11.002; Fuentes MA, 2003, AM J ORTHOD DENTOFAC, V123, P160, DOI 10.1067/mod.2003.6; GERSTNER GE, 1994, COMMUNITY DENT ORAL, V22, P235, DOI 10.1111/j.1600-0528.1994.tb01810.x; Iodice G, 2016, EUR J ORTHODONT, V38, P638, DOI 10.1093/ejo/cjw003; Kilic N, 2008, AM J ORTHOD DENTOFAC, V133, P382, DOI 10.1016/j.ajodo.2006.04.041; Levinger I, 2017, BONE, V98, P26, DOI 10.1016/j.bone.2017.02.010; LOBB WK, 1987, ANGLE ORTHOD, V57, P219; Lund JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011131; MCCARTHY JG, 1990, CLIN PLAST SURG, V17, P161; Miyatake E, 2003, AM J ORTHOD DENTOFAC, V124, P435, DOI 10.1016/S0889-5406(03)00562-6; Miyazaki M, 2016, ARCH ORAL BIOL, V63, P22, DOI 10.1016/j.archoralbio.2015.11.020; Mizoguchi I, 2013, JPN DENT SCI REV, V49, P139, DOI 10.1016/j.jdsr.2013.07.004; MOHLIN B, 1980, EUR J ORTHODONT, V2, P229, DOI 10.1093/ejo/2.4.229; Nadler SF, 2001, AM J PHYS MED REHAB, V80, P572, DOI 10.1097/00002060-200108000-00005; Nam HK, 2011, J BIOL CHEM, V286, P39059, DOI 10.1074/jbc.M111.221689; Nicot R, 2016, J CRANIO MAXILL SURG, V44, P1226, DOI 10.1016/j.jcms.2016.07.010; Papachristou DJ, 2009, ARCH ORAL BIOL, V54, P1035, DOI 10.1016/j.archoralbio.2009.08.010; Paparini A, 2007, MED SCI SPORT EXER, V39, P810, DOI 10.1097/mss.0b013e3180317491; PROWLER JR, 1954, ORAL SURG ORAL MED O, V7, P133, DOI 10.1016/0030-4220(54)90043-2; RABEY G, 1971, P ROY SOC MED, V64, P103; Ranade K, 2001, GENOME RES, V11, P1262; Ruf S, 1999, AM J ORTHOD DENTOFAC, V115, P607, DOI 10.1016/S0889-5406(99)70285-4; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Shimazaki T, 2003, EUR J ORTHODONT, V25, P457, DOI 10.1093/ejo/25.5.457; Sidlauskas M, 2016, EUR J ORTHODONT, V38, P493, DOI 10.1093/ejo/cjv062; Stella J, 2016, HUM MUTAT, V37, P1190, DOI 10.1002/humu.23057; TADEJ G, 1989, ANGLE ORTHOD, V59, P187; Undt G, 2006, J CRANIO MAXILL SURG, V34, P226, DOI 10.1016/j.jcms.2005.12.005; VEIERSTED KB, 1993, SCAND J WORK ENV HEA, V19, P284, DOI 10.5271/sjweh.1472; WILLIAMS BH, 1983, ANGLE ORTHOD, V53, P228; Xu HG, 2011, MOL MED REP, V4, P831, DOI 10.3892/mmr.2011.508; Yang N, 2011, BONE, V49, P790, DOI 10.1016/j.bone.2011.07.009; Zebrick B, 2014, AM J ORTHOD DENTOFAC, V146, P603, DOI 10.1016/j.ajodo.2014.07.021	43	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236425	10.1371/journal.pone.0236425	http://dx.doi.org/10.1371/journal.pone.0236425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726330	gold, Green Published			2022-12-26	WOS:000556908900016
J	Song, XQ; Dai, EQ; Zhang, Y; Du, HT; Wang, L; Yang, NN				Song, Xinqiang; Dai, Erqin; Zhang, Yu; Du, Hongtao; Wang, Lei; Yang, Ningning			Potential mechanisms of action of celastrol against rheumatoid arthritis: Transcriptomic and proteomic analysis	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PROTEIN; EXPRESSION; INSIGHTS; MUTATION; BINDING; DOMAIN; CELLS	The clinical efficacy for treating of celastrol rheumatoid arthritis (RA) has been well-documented, but its mechanism of action remains unclear. Here we explored through what proteins and processes celastrol may act in activated fibroblast-like synoviocytes (FLS) from RA patients. Differential expression of genes and proteins after celastrol treatment of FLS was examined using RNA sequencing, label-free relatively quantitative proteomics and molecular docking. In this paper, expression of 26,565 genes and 3,372 proteins was analyzed. Celastrol was associated with significant changes in genes that respond to oxidative stress and oxygen levels, as well as genes that stabilize or synthesize components of the extracellular matrix. These results identify several potential mechanisms through which celastrol may inhibit inflammation in RA.	[Song, Xinqiang; Dai, Erqin; Zhang, Yu; Du, Hongtao; Wang, Lei; Yang, Ningning] Xinyang Normal Univ, Dept Biol Sci, Xinyang, Peoples R China; [Song, Xinqiang] Inst Conservat & Utilizat AgroBioresources Dabie, Xinyang, Peoples R China	Xinyang Normal University	Song, XQ; Yang, NN (corresponding author), Xinyang Normal Univ, Dept Biol Sci, Xinyang, Peoples R China.; Song, XQ (corresponding author), Inst Conservat & Utilizat AgroBioresources Dabie, Xinyang, Peoples R China.	xqsong2012@126.com; 308977703@qq.com		song, xinqiang/0000-0001-8119-8597	National Natural Science Foundation of China [U1804179]; Henan Science and Technology Innovation Team; Investigation on Plant Resources in Dabie Mountains; Henan key scientific and technological projects [202102310190]; Nanhu Scholars Program for Young Scholars of Xinyang Normal University [2018001]; Study and Utilization of Active Components of Special plants [2017083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Science and Technology Innovation Team; Investigation on Plant Resources in Dabie Mountains; Henan key scientific and technological projects; Nanhu Scholars Program for Young Scholars of Xinyang Normal University; Study and Utilization of Active Components of Special plants	This study was supported by the National Natural Science Foundation of China (grant no. U1804179), the Henan Science and Technology Innovation Team, the Investigation on Plant Resources in Dabie Mountains and the Study and Utilization of Active Components of Special plants (grant no. 2017083), Henan key scientific and technological projects (202102310190) and the Nanhu Scholars Program for Young Scholars of Xinyang Normal University (grant no. 2018001).	Ai RZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04310-9; Anand S, 2017, METHODS MOL BIOL, V1549, P31, DOI 10.1007/978-1-4939-6740-7_4; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Cascao R, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00069; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen SR, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00104; Conigliaro P, 2019, AUTOIMMUN REV, V18, P706, DOI 10.1016/j.autrev.2019.05.007; Deng W, 2016, CELL IMMUNOL, V303, P7, DOI 10.1016/j.cellimm.2016.04.001; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Egea-Jimenez AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12101; Evans CH, 2011, NAT REV RHEUMATOL, V7, P244, DOI 10.1038/nrrheum.2010.193; Fang ZY, 2017, GENES-BASEL, V8, DOI 10.3390/genes8090221; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; Firestein Gary S, 2018, Trans Am Clin Climatol Assoc, V129, P171; Firmino M, 2018, J PROTEOMICS, V187, P182, DOI 10.1016/j.jprot.2018.07.018; Freye-Minks C, 2003, BIOCHEMISTRY-US, V42, P620, DOI 10.1021/bi026742h; Galland M, 2014, MOL CELL PROTEOMICS, V13, P252, DOI 10.1074/mcp.M113.032227; Goeminne LJE, 2018, J PROTEOMICS, V171, P23, DOI 10.1016/j.jprot.2017.04.004; Guan SY, 2017, EXPERT OPIN THER TAR, V21, P715, DOI 10.1080/14728222.2017.1336539; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Jin AH, 2019, MAR DRUGS, V17, DOI 10.3390/md17030177; Jin L, 2019, INFLAMM BOWEL DIS, V25, P1906, DOI 10.1093/ibd/izz111; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Karami J, 2020, IMMUNOL CELL BIOL, V98, P171, DOI 10.1111/imcb.12311; Kean TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129961; Keewan E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010111; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lee JH, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104504; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li GQ, 2013, INT IMMUNOPHARMACOL, V17, P1028, DOI 10.1016/j.intimp.2013.10.006; Li TT, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100523; Li XJ, 2019, EUR J PHARMACOL, V842, P146, DOI 10.1016/j.ejphar.2018.10.043; Li Y, 2018, FREE RADICAL BIO MED, V126, P1, DOI 10.1016/j.freeradbiomed.2018.07.009; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Meng XY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02683-x; Mun S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184368; Ozbek S, 2002, EMBO J, V21, P5960, DOI 10.1093/emboj/cdf628; Pergande MR, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800432; Prasad TSK, 2017, GENOME RES, V27, P133, DOI 10.1101/gr.201368.115; Ranok A, 2015, J BIOL CHEM, V290, P2617, DOI 10.1074/jbc.M114.588905; Rodon J, 2019, NAT MED, V25, P751, DOI 10.1038/s41591-019-0424-4; Sallon C, 2017, J BIOL CHEM, V292, P15352, DOI 10.1074/jbc.M116.736207; Schultz C, 2019, BRIT J PHARMACOL, V176, P26, DOI 10.1111/bph.14516; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shrivastava AK, 2013, J PHYSIOL BIOCHEM, V69, P335, DOI 10.1007/s13105-012-0216-5; Song XQ, 2020, LIFE SCI, V240, DOI 10.1016/j.lfs.2019.117063; Song XQ, 2017, RHEUMATOL INT, V37, P1257, DOI 10.1007/s00296-017-3732-3; Sparks JA, 2019, ANN INTERN MED, V170, pITC1, DOI 10.7326/AITC201901010; Tang BF, 2018, ANTI-CANCER DRUG, V29, P530, DOI 10.1097/CAD.0000000000000621; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Underhaug J, 2013, BBA-PROTEINS PROTEOM, V1834, P2812, DOI 10.1016/j.bbapap.2013.10.008; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Westra J, 2009, ANN NY ACAD SCI, V1173, P706, DOI 10.1111/j.1749-6632.2009.04736.x; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu X, 2019, FRONT MED-PRC, V13, P411, DOI 10.1007/s11684-018-0659-3; Xu LN, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00002; Xu ZT, 2013, AM J CHINESE MED, V41, P615, DOI 10.1142/S0192415X13500432; Yoshitomi H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01395; Zhang Q, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120795; Zou HY, 2016, J BIOL CHEM, V291, P11348, DOI 10.1074/jbc.M116.720250	65	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0233814	10.1371/journal.pone.0233814	http://dx.doi.org/10.1371/journal.pone.0233814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726313	gold, Green Submitted, Green Published			2022-12-26	WOS:000556908900055
J	Jeong, D; Oh, EJ; Ko, JK; Nam, JO; Park, HS; Jin, YS; Lee, EJ; Kim, SR				Jeong, Deokyeol; Oh, Eun Joong; Ko, Ja Kyong; Nam, Ju-Ock; Park, Hee-Soo; Jin, Yong-Su; Lee, Eun Jung; Kim, Soo Rin			Metabolic engineering considerations for the heterologous expression of xylose-catabolic pathways inSaccharomyces cerevisiae	PLOS ONE			English	Article							RECOMBINANT SACCHAROMYCES-CEREVISIAE; PENTOSE-PHOSPHATE PATHWAY; IMPROVES ETHANOL-PRODUCTION; XYLITOL DEHYDROGENASE; FUNCTIONAL EXPRESSION; ADAPTIVE EVOLUTION; ANAEROBIC GROWTH; UP-REGULATION; ACETIC-ACID; ISOMERASE	Xylose, the second most abundant sugar in lignocellulosic biomass hydrolysates, can be fermented bySaccharomyces cerevisiaeexpressing one of two heterologous xylose pathways: a xylose oxidoreductase pathway and a xylose isomerase pathway. Depending on the type of the pathway, its optimization strategies and the fermentation efficiencies vary significantly. In the present study, we constructed two isogenic strains expressing either the oxidoreductase pathway (XYL123) or the isomerase pathway (XI-XYL3), and delved into simple and reproducible ways to improve the resulting strains. First, the strains were subjected to the deletion ofPHO13, overexpression ofTAL1, and adaptive evolution, but those individual approaches were only effective in the XYL123 strain but not in the XI-XYL3 strain. Among other optimization strategies of the XI-XYL3 strain, we found that increasing the copy number of the xylose isomerase gene (xylA) is the most promising but yet preliminary strategy for the improvement. These results suggest that the oxidoreductase pathway might provide a simpler metabolic engineering strategy than the isomerase pathway for the development of efficient xylose-fermenting strains under the conditions tested in the present study.	[Jeong, Deokyeol; Nam, Ju-Ock; Park, Hee-Soo; Kim, Soo Rin] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu, South Korea; [Oh, Eun Joong] Univ Colorado, Renewable & Sustainable Energy Inst RASEI, Boulder, CO 80309 USA; [Ko, Ja Kyong] Korea Inst Sci & Technol KIST, Clean Energy Res Ctr, Seoul, South Korea; [Jin, Yong-Su] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Jin, Yong-Su] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Lee, Eun Jung] Kyungpook Natl Univ, Sch Appl Chem Engn, Dept Chem Engn, Daegu, South Korea	Kyungpook National University; University of Colorado System; University of Colorado Boulder; Korea Institute of Science & Technology (KIST); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Kyungpook National University	Kim, SR (corresponding author), Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu, South Korea.; Lee, EJ (corresponding author), Kyungpook Natl Univ, Sch Appl Chem Engn, Dept Chem Engn, Daegu, South Korea.	eunjunglee@knu.ac.kr; soorinkim@knu.ac.kr	Jeong, Deokyeol/GLR-8021-2022; Jin, Yong-Su/L-4530-2013; Kim, Soo Rin/X-2192-2019	Kim, Soo Rin/0000-0001-5855-643X; Jin, Yong-Su/0000-0002-4464-9536; Jeong, Deokyeol/0000-0002-0727-2733	National Research Foundation (NRF) of Korea - Korea government [NRF-2018R1A2B2007426]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1F1A1062633]	National Research Foundation (NRF) of Korea - Korea government; National Research Foundation of Korea (NRF) - Korea government (MSIT)	This work was supported by grants from the National Research Foundation (NRF) of Korea funded by the Korea government (NRF-2018R1A2B2007426). This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1F1A1062633).	Apel AR, 2017, NUCLEIC ACIDS RES, V45, P496, DOI 10.1093/nar/gkw1023; Bamba T, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-015-0175-7; Banerjee S, 2019, BIOTECHNOL BIOPROC E, V24, P713, DOI 10.1007/s12257-019-0134-2; Bellissimi E, 2009, FEMS YEAST RES, V9, P358, DOI 10.1111/j.1567-1364.2009.00487.x; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; Cai Z, 2012, BIOTECHNOL J, V7, P34, DOI 10.1002/biot.201100053; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cunha JT, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1360-8; dos Santos LV, 2016, SCI REP-UK, V6, DOI 10.1038/srep38676; Feng QZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195633; Fujitomi K, 2012, BIORESOURCE TECHNOL, V111, P161, DOI 10.1016/j.biortech.2012.01.161; Hahn-Hagerdal B, 2007, ADV BIOCHEM ENG BIOT, V108, P147, DOI 10.1007/10_2007_062; Hector RE, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-84; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352, DOI 10.1093/oxfordjournals.jbchem.a123761; Hou J, 2016, METAB ENG, V38, P241, DOI 10.1016/j.ymben.2016.08.001; Jeong D, 2020, BIORESOURCE TECHNOL, V295, DOI 10.1016/j.biortech.2019.122259; Karhumaa K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-5; Kim B, 2013, APPL ENVIRON MICROB, V79, P931, DOI 10.1128/AEM.02736-12; Kim SR, 2015, APPL ENVIRON MICROB, V81, P1601, DOI 10.1128/AEM.03474-14; Kim SR, 2013, BIOTECHNOL ADV, V31, P851, DOI 10.1016/j.biotechadv.2013.03.004; Kim SR, 2013, FEMS YEAST RES, V13, P312, DOI 10.1111/1567-1364.12036; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Kim SR, 2012, METAB ENG, V14, P336, DOI 10.1016/j.ymben.2012.04.001; Kim S, 2013, ANAL CHEM, V85, P2169, DOI 10.1021/ac302881e; Ko JK, 2016, BIORESOURCE TECHNOL, V222, P422, DOI 10.1016/j.biortech.2016.09.130; Kobayashi Y, 2017, J IND MICROBIOL BIOT, V44, P879, DOI 10.1007/s10295-017-1912-5; Kwak S, 2018, BIOTECHNOLOGY ADV; Kwak S, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0694-9; Lee SM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0122-x; Lee SM, 2012, APPL ENVIRON MICROB, V78, P5708, DOI 10.1128/AEM.01419-12; Li XW, 2019, CURR OPIN BIOTECH, V57, P56, DOI 10.1016/j.copbio.2019.01.006; Li Xin, 2016, Biotechnol Rep (Amst), V9, P53, DOI 10.1016/j.btre.2016.01.003; Li YC, 2017, APPL MICROBIOL BIOT, V101, P7741, DOI 10.1007/s00253-017-8494-z; Li YC, 2016, J BIOSCI BIOENG, V121, P685, DOI 10.1016/j.jbiosc.2015.10.013; Lian JZ, 2018, BIOTECHNOL BIOENG, V115, P1630, DOI 10.1002/bit.26569; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Ni HY, 2007, APPL ENVIRON MICROB, V73, P2061, DOI 10.1128/AEM.02564-06; Parreiras LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107499; Hoang PTN, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1269-7; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Sato TK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006372; Scalcinati G, 2012, FEMS YEAST RES, V12, P582, DOI 10.1111/j.1567-1364.2012.00808.x; Seike T, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1474-z; Shen Y, 2012, APPL MICROBIOL BIOT, V96, P1079, DOI 10.1007/s00253-012-4418-0; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2892, DOI 10.1128/AEM.70.5.2892-2897.2004; Sonderegger M, 2003, APPL ENVIRON MICROB, V69, P1990, DOI 10.1128/AEM.69.4.1990-1998.2003; Toivari MH, 2004, APPL ENVIRON MICROB, V70, P3681, DOI 10.1128/aem.70.6.3681-3686.2004; Traff KL, 2001, APPL ENVIRON MICROB, V67, P5668, DOI 10.1128/AEM.67.12.5668-5674.2001; Van Vleet JH, 2008, METAB ENG, V10, P360, DOI 10.1016/j.ymben.2007.12.002; Verhoeven MD, 2017, SCI REP-UK, V7, DOI 10.1038/srep46155; Xu HQ, 2016, METAB ENG, V34, P88, DOI 10.1016/j.ymben.2015.12.007; Ye S, 2019, J IND MICROBIOL BIOT, V46, P1725, DOI 10.1007/s10295-019-02233-y; Zhang YF, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1560-2; Zhou H, 2012, METAB ENG, V14, P611, DOI 10.1016/j.ymben.2012.07.011	55	12	12	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236294	10.1371/journal.pone.0236294	http://dx.doi.org/10.1371/journal.pone.0236294			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716960	gold, Green Published			2022-12-26	WOS:000556674500001
J	Chen, YH; An, XH; Zhao, DY; Li, EM; Ma, RP; Li, Z; Cheng, CG				Chen, Yanhui; An, Xiuhong; Zhao, Deying; Li, Enmao; Ma, Renpeng; Li, Zhuang; Cheng, Cungang			Transcription profiles reveal sugar and hormone signaling pathways mediating tree branch architecture in apple (Malus domestica Borkh.) grafted on different rootstocks	PLOS ONE			English	Article							PHENYLPROPANOID PATHWAY; EXPRESSION ANALYSIS; GENE-EXPRESSION; ARABIDOPSIS; SCION; GROWTH; METABOLISM; INDUCTION; TOLERANCE; ACID	Apple trees grafted on different rootstock types, including vigorous rootstock (VR), dwarfing interstock (DIR), and dwarfing self-rootstock (DSR), are widely planted in production, but the molecular determinants of tree branch architecture growth regulation induced by rootstocks are still not well known. In this study, the branch growth phenotypes of three combinations of 'Fuji' apple trees grafted on different rootstocks (VR: Malus baccata; DIR: Malus baccata/T337; DSR: T337) were investigated. The VR trees presented the biggest branch architecture. The results showed that the sugar content, sugar metabolism-related enzyme activities, and hormone content all presented obvious differences in the tender leaves and buds of apple trees grafted on these rootstocks. Transcriptomic profiles of the tender leaves adjacent to the top buds allowed us to identify genes that were potentially involved in signaling pathways that mediate the regulatory mechanisms underlying growth differences. In total, 3610 differentially expressed genes (DEGs) were identified through pairwise comparisons. The screened data suggested that sugar metabolism-related genes and complex hormone regulatory networks involved the auxin (IAA), cytokinin (CK), abscisic acid (ABA) and gibberellic acid (GA) pathways, as well as several transcription factors, participated in the complicated growth induction process. Overall, this study provides a framework for analysis of the molecular mechanisms underlying differential tree branch growth of apple trees grafted on different rootstocks.	[Chen, Yanhui; An, Xiuhong; Zhao, Deying; Li, Enmao; Ma, Renpeng; Li, Zhuang; Cheng, Cungang] Chinese Acad Agricultrual Sci, Key Lab Fruit Germplasm Resources Utilizat, Key Lab Mineral Nutr & Efficient Fertilizat Decid, Minist Agr,Inst Pomol, Xingcheng, Liaoning, Peoples R China	Ministry of Agriculture & Rural Affairs	Cheng, CG (corresponding author), Chinese Acad Agricultrual Sci, Key Lab Fruit Germplasm Resources Utilizat, Key Lab Mineral Nutr & Efficient Fertilizat Decid, Minist Agr,Inst Pomol, Xingcheng, Liaoning, Peoples R China.	ccungang@163.com	An, Xiu-Hong/GZK-7337-2022		National Natural Science Foundation of China [31701902, 31201602]; Program of Developing the Modern Agricultural Industry Technology System (Apple) [CARS-27]; CAAS-ASTIP	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Developing the Modern Agricultural Industry Technology System (Apple); CAAS-ASTIP	This work was supported by the National Natural Science Foundation of China (No. 31701902; No.31201602) to XA, the Program of Developing the Modern Agricultural Industry Technology System (Apple) (CARS-27) to CC and the funding of CAAS-ASTIP to CC.	Amiri ME, 2014, J PLANT NUTR, V37, P16, DOI 10.1080/01904167.2013.792838; An JP, 2020, PLANT J, V101, P573, DOI 10.1111/tpj.14555; An JP, 2017, PLANT SOIL, V418, P255, DOI 10.1007/s11104-017-3297-7; An JP, 2016, PLANT PHYSIOL BIOCH, V108, P24, DOI 10.1016/j.plaphy.2016.06.032; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bahieldin A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0908-z; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bolt S, 2017, PLANT CELL ENVIRON, V40, P108, DOI 10.1111/pce.12838; Bowles D, 2010, ELS; Chen YH, 2017, PHYSIOL PLANTARUM, V159, P161, DOI 10.1111/ppl.12492; Corso M, 2015, J EXP BOT, V66, P5739, DOI 10.1093/jxb/erv274; Dobrev Petre I, 2012, Methods Mol Biol, V913, P251, DOI 10.1007/978-1-61779-986-0_17; Fanwoua J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00338; Fazio G, 2014, J AM SOC HORTIC SCI, V139, P87, DOI 10.21273/JASHS.139.2.87; Goren S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182334; Greer DH, 2018, ENVIRON EXP BOT, V155, P56, DOI 10.1016/j.envexpbot.2018.06.014; Harrison N, 2016, J EXP BOT, V67, P1871, DOI 10.1093/jxb/erw001; Hohnle MK, 2010, EUR J HORTIC SCI, V75, P128; Jensen PJ, 2010, TREE GENET GENOMES, V6, P57, DOI 10.1007/s11295-009-0228-7; Kanamaru N, 2004, PLANT SCI, V167, P55, DOI 10.1016/j.plantsci.2004.02.024; Kim JH, 2006, BIOSCI BIOTECH BIOCH, V70, P1471, DOI 10.1271/bbb.60006; Klumb EK, 2017, TREES-STRUCT FUNCT, V31, P1127, DOI 10.1007/s00468-017-1532-8; Koepke T, 2013, PLANT CELL REP, V32, P1321, DOI 10.1007/s00299-013-1471-9; Lauri PE, 2001, J AM SOC HORTIC SCI, V126, P169, DOI 10.21273/JASHS.126.2.169; Li MJ, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0064-8; Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047; Li T, 2017, PLANT CELL, V29, P1316, DOI 10.1105/tpc.17.00349; Li Y, 2019, J PLANT GROWTH REGUL, V38, P1287, DOI 10.1007/s00344-019-09933-w; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Liu XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169897; Luo XC, 2014, J GENET, V93, P785, DOI 10.1007/s12041-014-0462-0; Ma CQ, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5730-1; Mare C, 2013, J PLANT INTERACT, V8, P334, DOI 10.1080/17429145.2012.754958; Marini RP, 2002, J AM SOC HORTIC SCI, V127, P749, DOI 10.21273/JASHS.127.5.749; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Martinez GA, 2008, POSTHARVEST BIOL TEC, V49, P38, DOI 10.1016/j.postharvbio.2008.01.013; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Mudge K., 2009, Horticultural Reviews, V35, P437; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Noda K, 2000, SCI HORTIC-AMSTERDAM, V84, P245, DOI 10.1016/S0304-4238(99)00080-1; Nong Thi Hue, 2013, Agricultural Sciences, V4, P154; Ntatsi G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00911; Ou C., 2015, PLANT GENE, DOI [10.1016/j.plgene.2015.08.003, DOI 10.1016/J.PLGENE.2015.08.003]; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Qiu LL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3182-4; Rosa M, 2009, PLANT PHYSIOL BIOCH, V47, P300, DOI 10.1016/j.plaphy.2008.12.001; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Samuoliene G, 2016, SCI HORTIC-AMSTERDAM, V211, P167, DOI 10.1016/j.scienta.2016.08.027; Scofield S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.157081; Scofield S, 2013, PLANT J, V75, P53, DOI 10.1111/tpj.12198; Seleznyova AN, 2003, ANN BOT-LONDON, V91, P665, DOI 10.1093/aob/mcg072; Song CH, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2065-2; Stein O, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00095; Tong XL, 2018, J INTEGR AGR, V17, P847, DOI 10.1016/S2095-3119(17)61755-6; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tworkoski T, 2016, PLANT GROWTH REGUL, V78, P105, DOI 10.1007/s10725-015-0078-2; van Hooijdonk B, 2011, J AM SOC HORTIC SCI, V136, P93, DOI 10.21273/JASHS.136.2.93; Warschefsky EJ, 2016, TRENDS PLANT SCI, V21, P418, DOI 10.1016/j.tplants.2015.11.008; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Wu J, 2012, PLANT CELL TISS ORG, V111, P183, DOI 10.1007/s11240-012-0182-1; Xing LB, 2015, PLANT CELL PHYSIOL, V56, P2052, DOI 10.1093/pcp/pcv124; Xing LB, 2019, PLANT MOL BIOL, V99, P45, DOI 10.1007/s11103-018-0801-2; Xing LB, 2016, PLANT BIOTECHNOL J, V14, P749, DOI 10.1111/pbi.12425; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang DP, 2001, PLANT CELL ENVIRON, V24, P691, DOI 10.1046/j.0016-8025.2001.00720.x; Zhang GH, 2019, PHYSIOL PLANTARUM, V166, P833, DOI 10.1111/ppl.12858; Zhao L, 2014, ACTA AGR BOREALI SIN, V29, P234; Zhou YM, 2020, SCI HORTIC-AMSTERDAM, V261, DOI 10.1016/j.scienta.2019.108981	71	6	6	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236530	10.1371/journal.pone.0236530	http://dx.doi.org/10.1371/journal.pone.0236530			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706831	Green Published, gold			2022-12-26	WOS:000579931700052
J	Wang, J; Guo, JP; Zhang, YX; Yan, XR				Wang, Juan; Guo, Jinping; Zhang, Yunxiang; Yan, Xingrong			Integrated transcriptomic and metabolomic analyses of yellow horn (Xanthoceras sorbifolia) in response to cold stress	PLOS ONE			English	Article							ABIOTIC STRESSES; GENE-EXPRESSION; PROLINE CONTENT; DROUGHT STRESS; TOLERANCE; PROTEIN; GENOME; KINASE; SALT; TOOL	Xanthoceras sorbifolia, a medicinal and oil-rich woody plant, has great potential for biodiesel production. However, little study explores the link between gene expression level and metabolite accumulation of X. sorbifolia in response to cold stress. Herein, we performed both transcriptomic and metabolomic analyses of X. sorbifolia seedlings to investigate the regulatory mechanism of resistance to low temperature (4 degrees C) based on physiological profile analyses. Cold stress resulted in a significant increase in the malondialdehyde content, electrolyte leakage and activity of antioxidant enzymes. A total of 1,527 common differentially expressed genes (DEGs) were identified, of which 895 were upregulated and 632 were downregulated. Annotation of DEGs revealed that amino acid metabolism, glycolysis/gluconeogenesis, starch and sucrose metabolism, galactose metabolism, fructose and mannose metabolism, and the citrate cycle (TCA) were strongly affected by cold stress. In addition, DEGs within the plant mitogen-activated protein kinase (MAPK) signaling pathway and TF families of ERF, WRKY, NAC, MYB, and bHLH were transcriptionally activated. Through metabolomic analysis, we found 51 significantly changed metabolites, particularly with the analysis of primary metabolites, such as sugars, amino acids, and organic acids. Moreover, there is an overlap between transcript and metabolite profiles. Association analysis between key genes and altered metabolites indicated that amino acid metabolism and sugar metabolism were enhanced. A large number of specific cold-responsive genes and metabolites highlight a comprehensive regulatory mechanism, which will contribute to a deeper understanding of the highly complex regulatory program under cold stress in X. sorbifolia.	[Wang, Juan; Guo, Jinping; Zhang, Yunxiang; Yan, Xingrong] Shanxi Agr Univ, Coll Forestry, Taigu, Shanxi, Peoples R China; [Wang, Juan; Guo, Jinping; Zhang, Yunxiang; Yan, Xingrong] Shanxi Key Lab Funct Oil Tree Cultivat & Res, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University	Guo, JP (corresponding author), Shanxi Agr Univ, Coll Forestry, Taigu, Shanxi, Peoples R China.; Guo, JP (corresponding author), Shanxi Key Lab Funct Oil Tree Cultivat & Res, Taigu, Shanxi, Peoples R China.	jinpguo@126.com			Forestry Science and Technology Innovation Project of Shanxi Province [2018LYCX32]	Forestry Science and Technology Innovation Project of Shanxi Province	This study was supported by the Forestry Science and Technology Innovation Project of Shanxi Province (2018LYCX32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144509; Ahmad P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31917-1; Ali A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arbona V, 2013, INT J MOL SCI, V14, P4885, DOI 10.3390/ijms14034885; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey-Serres J, 2006, PLANT PHYSIOL, V141, P311, DOI 10.1104/pp.104.900191; Ballabio D, 2013, ANAL METHODS-UK, V5, P3790, DOI 10.1039/c3ay40582f; Bi QX, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz070; Byun MY, 2015, PLANT SCI, V236, P61, DOI 10.1016/j.plantsci.2015.03.020; Carpaneto A, 2007, PLANT PHYSIOL, V143, P487, DOI 10.1104/pp.106.090928; Chen SY, 2017, CONSERV GENET RESOUR, V9, P595, DOI 10.1007/s12686-017-0732-2; Chen W, 2013, MOL PLANT, V6, P1769, DOI 10.1093/mp/sst080; Choudhury FK, 2017, PLANT J, V90, P856, DOI 10.1111/tpj.13299; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; da Maia LC, 2017, FUNCT PLANT BIOL, V44, P419, DOI 10.1071/FP16239; da Silva FG, 2005, PLANT PHYSIOL, V139, P574, DOI 10.1104/pp.105.065748; de Zelicourt A, 2016, TRENDS PLANT SCI, V21, P677, DOI 10.1016/j.tplants.2016.04.004; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Deng QW, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0155-x; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Di Fenza M, 2017, PEERJ, V5, DOI 10.7717/peerj.2839; Djilianov D., 2005, BIOTECHNOL BIOTEC EQ, V19, P63, DOI DOI 10.1080/13102818.2005.10817287; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Guo HH, 2013, GENE, V527, P266, DOI 10.1016/j.gene.2013.05.076; Haider MS, 2017, PLANT PHYSIOL BIOCH, V121, P187, DOI 10.1016/j.plaphy.2017.10.026; Hershkovitz V, 2012, MOL PLANT PATHOL, V13, P338, DOI 10.1111/j.1364-3703.2011.00750.x; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Janska A, 2010, CZECH J GENET PLANT, V46, P35, DOI 10.17221/52/2009-CJGPB; Jeon J, 2013, J PLANT BIOL, V56, P69, DOI 10.1007/s12374-013-0903-y; Jiang JJ, 2017, J INTEGR PLANT BIOL, V59, P86, DOI 10.1111/jipb.12513; Jiao Y, 2017, J PLANT BIOCHEM BIOT, V26, P141, DOI 10.1007/s13562-016-0374-6; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Khan MS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00792; Klepikova AV, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1636-y; Klima M, 2012, BIOL PLANTARUM, V56, P157, DOI 10.1007/s10535-012-0034-1; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Lang YH, 2020, RSC ADV, V10, P6512, DOI 10.1039/c9ra09535g; Li K, 2017, PLANT PHYSIOL, V173, P1391, DOI 10.1104/pp.16.01386; Li PC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00290; Li YY, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5988-3; Liang Q, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz071; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074441; Lv WT, 2011, PLANT PHYSIOL, V156, P1921, DOI 10.1104/pp.111.175810; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Miao ZY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2019-x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Pagter M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4126-3; Peng T, 2016, PLANT CELL TISS ORG, V126, P373, DOI 10.1007/s11240-016-1004-7; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Perotti VE, 2015, PHYSIOL PLANTARUM, V153, P337, DOI 10.1111/ppl.12259; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Ruan CJ, 2017, ECOL ENG, V99, P504, DOI 10.1016/j.ecoleng.2016.11.073; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Shen CX, 2014, J PLANT BIOL, V57, P337, DOI 10.1007/s12374-014-0183-1; Shiryaeva L, 2012, METABOLOMICS, V8, pS123, DOI 10.1007/s11306-011-0304-5; Sivankalyani V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01579; Sobkowiak A, 2014, PLANT MOL BIOL, V85, P317, DOI 10.1007/s11103-014-0187-8; Solanke Amolkumar U., 2008, Physiology and Molecular Biology of Plants, V14, P69, DOI 10.1007/s12298-008-0006-2; Song YP, 2014, PLANT MOL BIOL, V86, P139, DOI 10.1007/s11103-014-0218-5; Sun CX, 2016, PLANT BIOLOGY, V18, P249, DOI 10.1111/plb.12378; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Theocharis A, 2012, PLANTA, V235, P1091, DOI 10.1007/s00425-012-1641-y; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Walworth AE, 2012, MOL BREEDING, V30, P1313, DOI 10.1007/s11032-012-9718-7; Wang JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1373-z; Wang L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103071; Wang Y, 2016, BIOL PLANTARUM, V60, P443, DOI 10.1007/s10535-016-0618-2; Wang YJ, 2003, THEOR APPL GENET, V107, P1402, DOI 10.1007/s00122-003-1378-x; Wu ZG, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01653; Xie YP, 2018, NEW PHYTOL, V218, P201, DOI 10.1111/nph.14952; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yao ZY, 2013, RENEW SUST ENERG REV, V24, P57, DOI 10.1016/j.rser.2013.03.047; Zhang YJ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1665-6; Zhao Q, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00381; Zhou QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140507	85	9	10	8	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236588	10.1371/journal.pone.0236588	http://dx.doi.org/10.1371/journal.pone.0236588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706804	gold, Green Published			2022-12-26	WOS:000579931700055
J	Karmakar, R; Schich, C; Kamprad, N; Scheller, V; Gutierrez, E; Groisman, A; Rappel, WJ; Tarantola, M				Karmakar, Richa; Schich, Christoph; Kamprad, Nadine; Scheller, Vanessa; Gutierrez, Edgar; Groisman, Alex; Rappel, Wouter-Jan; Tarantola, Marco			Novel micropatterning technique reveals dependence of cell-substrate adhesion and migration of social amoebas on parental strain, development, and fluorescent markers	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM; SYMMETRY-BREAKING; PATTERN-FORMATION; MYOSIN; ACTIN; TALIN; MORPHOGENESIS; LOCALIZATION; EXPRESSION; MEMBRANE	Cell-substrate adhesion of the social amoeba Dictyostelium discoideum, a model organism often used for the study of chemotaxis, is non-specific and does not involve focal adhesion complexes. Therefore, micropatterned substrates where adherent Dictyostelium cells are constrained to designated microscopic regions are difficult to make. Here we present a micropatterning technique for Dictyostelium cells that relies on coating the substrate with an similar to 1 mu m thick layer of polyethylene glycol (PEG) gel. We show that, when plated on a substrate with narrow parallel stripes of PEG-gel and glass, Dictyostelium cells nearly exclusive adhere to and migrate along the glass stripes, thus providing a model system to study one-dimensional migration of amoeboid cells. Surprisingly, we find substantial differences in the adhesion to PEG-gel and glass stripes between vegetative and developed cells and between two different axenic laboratory strains of Dictyostelium, AX2 and AX4. Even more surprisingly, we find that the distribution of Dictyostelium cells between PEG-gel and glass stripes is significantly affected by the expression of several fluorescent protein markers of the cytoskeleton. We carry out atomic force microscopy based single cell force spectroscopy measurements that confirm that the force of adhesion to PEG-gel substrate can be significantly different between vegetative and developed cells, AX2 and AX4 cells, and cells with and without fluorescent markers. Thus, the choice of parental background, the degree of development, and the expression of fluorescent protein markers can all have a profound effect on cell-substrate adhesion and should be considered when comparing migration of cells and when designing micropatterned substrates.	[Karmakar, Richa; Gutierrez, Edgar; Groisman, Alex; Rappel, Wouter-Jan] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Schich, Christoph; Kamprad, Nadine; Scheller, Vanessa; Tarantola, Marco] Inst Dynam Complex Syst, Gottingen, Germany; [Kamprad, Nadine; Tarantola, Marco] Max Planck Inst Dynam & Selforg, Gottingen, Germany	University of California System; University of California San Diego; Max Planck Society	Rappel, WJ (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.; Tarantola, M (corresponding author), Inst Dynam Complex Syst, Gottingen, Germany.; Tarantola, M (corresponding author), Max Planck Inst Dynam & Selforg, Gottingen, Germany.	marco.tarantola@ds.mpg.de	Groisman, Alexander/AAU-7843-2021	Karmakar, Richa/0000-0002-9741-6816	National Science Foundation [PHY-1707637, PHY-1411313]; DFG [SFB 937]; Max Planck Society; Volkswagen Foundation Initiative LIFE (Project Living Foam)	National Science Foundation(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Volkswagen Foundation Initiative LIFE (Project Living Foam)	This work was supported by the National Science Foundation under grants PHY-1707637 and grant PHY-1411313, and by DFG SFB 937 'Collective behaviour of soft and biological matter', subproject A8 'mechanics and dynamics of biological adhesion'. We also thank Eberhard Bodenschatz for his support as well as the Max Planck Society and the Volkswagen Foundation Initiative LIFE (Project Living Foam) for funding.	Agbulut O, 2006, NAT METHODS, V3, P331, DOI 10.1038/nmeth0506-331; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005; Camley BA, 2014, P NATL ACAD SCI USA, V111, P14770, DOI 10.1073/pnas.1414498111; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; Coumans JVF, 2014, EXP CELL RES, V320, P33, DOI 10.1016/j.yexcr.2013.07.019; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Dicty Base, 2010, GENE INFORM TALA; Dormann D, 2001, DEVELOPMENT, V128, P4535; Doxzen K, 2013, INTEGR BIOL-UK, V5, P1026, DOI 10.1039/c3ib40054a; Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Flores LR, 2019, SCI REPORTS, V9, P1; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gent A.N., 1958, RUBBER CHEM TECHNOL, V31, P896, DOI [10.5254/1.3542351, DOI 10.5254/1.3542351]; Huang S, 2005, CELL MOTIL CYTOSKEL, V61, P201, DOI 10.1002/cm.20077; JAY PY, 1995, J CELL SCI, V108, P387; Kamprad N, 2018, NANOSCALE, V10, P22504, DOI 10.1039/c8nr07107a; Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; LOOMIS WF, 1971, EXP CELL RES, V64, P484, DOI 10.1016/0014-4827(71)90107-8; Loomis WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042033; McCann CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087981; Miroshnikova YA, 2018, NAT CELL BIOL, V20, P69, DOI 10.1038/s41556-017-0005-z; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Moores SL, 1996, P NATL ACAD SCI USA, V93, P443, DOI 10.1073/pnas.93.1.443; Munjal A, 2014, DEVELOPMENT, V141, P1789, DOI 10.1242/dev.091645; Nagel O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113382; Okimura C, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.052401; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pollitt AY, 2006, EUR J CELL BIOL, V85, P1091, DOI 10.1016/j.ejcb.2006.05.014; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Raper KB, 1935, J AGRIC RES, V50, P0135; Rappel WJ, 2009, WIRES SYST BIOL MED, V1, P141, DOI 10.1002/wsbm.28; Sawai S, 2000, PHYS REV LETT, V85, P2212, DOI 10.1103/PhysRevLett.85.2212; Segerer FJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.228102; Simson R, 1998, BIOPHYS J, V74, P514, DOI 10.1016/S0006-3495(98)77808-7; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tarantola M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106574; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Tsujioka M, 2008, EUKARYOT CELL, V7, P906, DOI 10.1128/EC.00464-07; Tsujioka M, 2012, P NATL ACAD SCI USA, V109, P12992, DOI 10.1073/pnas.1208296109; Tzvetkova-Chevolleau T, 2009, MICROELECTRON ENG, V86, P1485, DOI 10.1016/j.mee.2008.11.095; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Wang CL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0684; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894	49	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236171	10.1371/journal.pone.0236171	http://dx.doi.org/10.1371/journal.pone.0236171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702047	Green Published, gold			2022-12-26	WOS:000575913700056
J	Minnery, M; Mathabela, N; Shubber, Z; Mabuza, K; Gorgens, M; Cheikh, N; Wilson, DP; Kelly, SL				Minnery, Mark; Mathabela, Nokwazi; Shubber, Zara; Mabuza, Khanya; Gorgens, Marelize; Cheikh, Nejma; Wilson, David P.; Kelly, Sherrie L.			Opportunities for improved HIV prevention and treatment through budget optimization in Eswatini	PLOS ONE			English	Article								Introduction Eswatini achieved a 44% decrease in new HIV infections from 2014 to 2019 through substantial scale-up of testing and treatment. However, it still has one of the highest rates of HIV incidence in the world, with 14 infections per 1,000 adults 15-49 years estimated for 2017. The Government of Eswatini has called for an 85% reduction in new infections by 2023 over 2017 levels. To make further progress towards this target and to achieve maximum health gains, this study aims to model optimized investments of available HIV resources. Methods The Optima HIV model was applied to estimate the impact of efficiency strategies to accelerate prevention of HIV infections and HIV-related deaths. We estimated the number of infections and deaths that could be prevented by optimizing HIV investments. We optimize across HIV programs, then across service delivery modalities for voluntary medical male circumcision (VMMC), HIV testing, and antiretroviral refill, as well as switching to a lower cost antiretroviral regimen. Findings Under an optimized budget, prioritising HIV testing for the general population followed by key preventative interventions may result in approximately 1,000 more new infections (2% more) being averted by 2023. More infections could be averted with further optimization between service delivery modalities across the HIV cascade. Scaling-up index and self-testing could lead to 100,000 more people getting tested for HIV (25% more tests) with the same budget. By prioritizing Fast-Track, community-based, and facility-based antiretroviral refill options, an estimated 30,000 more people could receive treatment, 17% more than baseline or US$5.5 million could be saved, 4% of the total budget. Finally, switching nonpregnant HIV-positive adults to a Dolutegravir-based antiretroviral therapy regimen and concentrating delivery of VMMC to existing fixed facilities over mobile clinics, US$4.5 million (7% of total budget) and US$6.6 million (10% of total budget) could be saved, respectively. Significance With a relatively short five-year timeframe, even under a substantially increased and optimized budget, Eswatini is unlikely to reach their ambitious national prevention target by 2023. However, by optimizing investment of the same budget towards highly cost-effective VMMC, testing, and treatment modalities, further reductions in HIV incidence and cost savings could be realized.	[Minnery, Mark; Wilson, David P.; Kelly, Sherrie L.] Burnet Inst, Melbourne, Vic, Australia; [Mathabela, Nokwazi; Mabuza, Khanya] Natl Emergency Response Council HIV AIDS, Mbabane, Eswatini; [Shubber, Zara; Gorgens, Marelize; Cheikh, Nejma] World Bank Grp, Washington, DC USA; [Wilson, David P.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Wilson, David P.] Univ Maryland, Baltimore, MD 21201 USA; [Wilson, David P.] Monash Univ, Melbourne, Vic, Australia	Burnet Institute; The World Bank; University of New South Wales Sydney; Kirby Institute; University System of Maryland; University of Maryland Baltimore; Monash University	Kelly, SL (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	sherrie.kelly@burnet.edu.au		Kelly, Sherrie/0000-0002-6232-5586	World Bank Group	World Bank Group	Funding for this study was provided by the World Bank Group.	[Anonymous], 2013, COSTS HIV TREATM CAR; BAUTISTAARREDONDO, 2018, PLOS ONE, V13, DOI DOI 10.1371/JOURNAL.PONE.0203121; Chiu C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4023-3; Dalal S, 2017, AIDS, V31, P1867, DOI 10.1097/QAD.0000000000001555; Dieleman JL, 2018, LANCET, V391, P1799, DOI 10.1016/S0140-6736(18)30698-6; Forsythe S, 2018, EVALUATING COST EFFE; Institute for Health Metrics and Evaluation (IHME), 2018, FIND GLOB BURD DIS S; Kates J., 2019, DONOR GOVT FUNDING H; Kelly S, 2014, HIV MATH MODELLING S; Kelly SL, 2018, LANCET HIV, V5, pE190, DOI 10.1016/S2352-3018(18)30024-9; Kerr CC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192944; Kingdom of eSwatini ministry of health, 2016, NAT POL GUID COMM CT; Kingdom of eSwatini ministry of health, 2019, SWAZ HIV INC MEAS SU; Kingdom of eSwatini ministry of health, 2018, MAXART EARL ACC ART; Kingdom of eSwatini Ministry of Health, 2016, SWAZ HIV INC MEAS SU; Kingdom of eSwatini ministry of health, 2014, SWAZ MAL CIRC STRAT; National emergency response council on HIV and AIDS, 2018, EXT NAT MULT HIV AID; National emergency response council on HIV and AIDS, 2014, EXT NAT MULT HIV AID; Phillips AN, 2019, LANCET HIV, V6, pE116, DOI 10.1016/S2352-3018(18)30317-5; The Kingdom of Swaziland ministry of health, 2015, NAT AIDS SPEND ASS N; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2018, 2018 EST; World Bank, 2014, HIV MATH MOD SUPP SW; World Bank, 2018, HUM CAP PROJ	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235664	10.1371/journal.pone.0235664	http://dx.doi.org/10.1371/journal.pone.0235664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701968	Green Published, gold			2022-12-26	WOS:000575913700020
J	Salger, SA; Reza, J; Deck, CA; Wahab, MA; Baltzegar, DA; Murr, AT; Borski, RJ				Salger, Scott A.; Reza, Jimi; Deck, Courtney A.; Wahab, Md Abdul; Baltzegar, David A.; Murr, Alexander T.; Borski, Russell J.			Enhanced biodiversity of gut flora and feed efficiency in pond cultured tilapia under reduced frequency feeding strategies	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; RNA GENE DATABASE; NILE TILAPIA; COMPENSATORY GROWTH; MESSENGER-RNA; DIVERSITY; SNAT2; MICROBIOTA; EXPRESSION; TELEOST	Feed constitutes 50-70% of total production costs of tilapia, one of the most widely cultured finfishes in the world. We evaluated reduced-feeding strategies for improving production efficiency of Nile tilapia (Oreochromis niloticus). In a 12-week pond trial, fish were fed daily, every other day, every third day, or not at all. Ponds were fertilized to enhance natural foods. In a fifth group fish were fed daily without pond fertilization. Fish fed daily with or without pond fertilization and fish fed every other day had higher specific growth rates, survivability, and net production than the other two treatments. Fish feed efficiency and benefit to cost ratio was highest for treatments fed in a pulsatile manner (i.e. fed every other day or every third day) with fish fed on alternate days providing the best net return among all groups. Fish fed on alternate days had more moderate gene expression levels of intestinal nutrient transporters which may allow for a more balanced and efficient nutrient uptake. Fecal microbe analyses identified 145 families of prokaryotic and 132 genera of eukaryotic organisms in tilapia. The highest diversity of prokaryotes was found in fish fed either every other day or daily in fertilized ponds and the highest diversity of eukaryotes was found in fish fed every other day. These studies indicate feeding Nile tilapia on alternate days along with weekly pond fertilization has no deleterious effects on growth, survivability, or production versus daily feeding regimes, but enhances feed efficiency by 76% and provides the greatest net return on investments. Our studies also suggest for the first time that combining alternate-day feeding with pond fertilization produces the greatest microbial biodiversity in the intestine that could contribute to enhanced feed efficiency and overall health of tilapia.	[Salger, Scott A.; Deck, Courtney A.; Baltzegar, David A.; Murr, Alexander T.; Borski, Russell J.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Reza, Jimi; Wahab, Md Abdul] Bangladesh Agr Univ, Dept Fisheries Management, Mymensingh, Bangladesh; [Wahab, Md Abdul] WorldFish, Dhaka, Bangladesh; [Baltzegar, David A.] North Carolina State Univ, Genom Sci Lab, Raleigh, NC USA	University of North Carolina; North Carolina State University; Bangladesh Agricultural University (BAU); CGIAR; Worldfish; University of North Carolina; North Carolina State University	Borski, RJ (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	russell_borski@ncsu.edu		Murr, Alexander/0000-0003-1102-9477	AquaFish Innovation Lab through the United States Agency for International Development/Oregon State University [USAID EPP-A-00-06-00012-00]; North Carolina State University; Bangladesh Agricultural University; NSF [IOS-1457040]	AquaFish Innovation Lab through the United States Agency for International Development/Oregon State University; North Carolina State University; Bangladesh Agricultural University; NSF(National Science Foundation (NSF))	This work was supported by the AquaFish Innovation Lab through the United States Agency for International Development/Oregon State University (USAID EPP-A-00-06-00012-00) and by participating institutions, particularly North Carolina State University and Bangladesh Agricultural University and the NSF (IOS-1457040 to RJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harbi AH, 2005, AQUACULTURE, V250, P566, DOI 10.1016/j.aquaculture.2005.01.026; Al-Harbi AH, 2004, AQUACULTURE, V229, P37, DOI 10.1016/S0044-8486(03)00388-0; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Anita Bhatnagar, 2013, International Journal of Environmental Sciences, V3, P1980; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Bolivar RB, 2006, N AM J AQUACULT, V68, P192, DOI 10.1577/A05-012.1; Borski R. J., 2011, Better science, better fish, better life. Proceedings of the Ninth International Symposium on Tilapia in Aquaculture, Shanghai, China, 22-24 April 2011, P95; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CHAO A, 1984, SCAND J STAT, V11, P265; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; Costa J, 2012, COMP BIOCHEM PHYS C, V155, P469, DOI 10.1016/j.cbpc.2011.12.004; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DIAMOND JM, 1987, P NATL ACAD SCI USA, V84, P2242, DOI 10.1073/pnas.84.8.2242; Diana James S., 1994, Journal of the World Aquaculture Society, V25, P497, DOI 10.1111/j.1749-7345.1994.tb00818.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egna HS, 1997, DYNAMICS POND AQUACU; ElSayed AFM, 2006, TILAPIA CULTURE, P1, DOI 10.1079/9780851990149.0000; Engle C, 2009, N AM J AQUACULT, V71, P138, DOI 10.1577/A07-097.1; FAO, 2020, STATE WORLD FISHERIE, DOI [10.4060/ca9229en, 10.4060/ca9229-n]; Farmanfarmaian A, 1999, GENET ANAL-BIOMOL E, V15, P107, DOI 10.1016/S1050-3862(99)00012-1; Ferraris RP, 1997, PHYSIOL REV, V77, P257, DOI 10.1152/physrev.1997.77.1.257; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; Food and Agriculture Organization of the United Nations, 2013, SPEC FACT SHEET OR N; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Franchi-Gazzola R, 2004, BBA-BIOMEMBRANES, V1667, P157, DOI 10.1016/j.bbamem.2004.09.012; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heikkinen J, 2006, AQUACULTURE, V261, P259, DOI 10.1016/j.aquaculture.2006.07.012; Jiang L, 2001, AM J PHYSIOL-GASTR L, V281, pG666, DOI 10.1152/ajpgi.2001.281.3.G666; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kashiwada K, 1966, B JPN SOC SCI FISH, V32, P961; Kheravii SK, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4592-2; Kocher TD, 2013, COMP GENOMICS CICHLI; Kundu MC, 2009, SCI TOTAL ENVIRON, V407, P2771, DOI 10.1016/j.scitotenv.2008.12.048; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mandal Shankar Chandra, 2009, World Journal of Fish and Marine Sciences, V1, P160; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nardi F, 2015, J BIOL CHEM, V290, P8173, DOI 10.1074/jbc.M114.625137; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Olsen I., 2014, PROKARYOTES FIRMICUT, P109, DOI DOI 10.1007/978-3-642-30120-9_213; PENG Y, 1973, J NUTR, V103, P608, DOI 10.1093/jn/103.4.608; Picha ME, 2006, GEN COMP ENDOCR, V147, P196, DOI 10.1016/j.ygcen.2005.12.020; Picha ME, 2014, AQUACULTURE, V428, P174, DOI 10.1016/j.aquaculture.2014.02.028; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; ROBINSON EH, 1978, J NUTR, V108, P1600, DOI 10.1093/jn/108.10.1600; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Sklan D, 2004, AQUAC RES, V35, P350, DOI 10.1111/j.1365-2109.2004.01020.x; Stackebrandt E., 2014, PROKARYOTES FIRMICUT, P67; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Tengjaroenkul B, 2000, AQUACULTURE, V182, P317, DOI 10.1016/S0044-8486(99)00270-7; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1004, DOI 10.1152/ajpregu.00112.2007; TITUS E, 1991, AM J PHYSIOL, V261, pR1568, DOI 10.1152/ajpregu.1991.261.6.R1568; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Verri T, 2003, FEBS LETT, V549, P115, DOI 10.1016/S0014-5793(03)00759-2; Verri T., 2012, FUNCTIONAL GENOMICS, V24, P219; Welker TL, 2011, AQUAC RES DEV, pS1; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; WON ET, 2013, FRONT ENDOCRINOL, V1, P4; Woting A, 2014, MBIO, V5, DOI 10.1128/mBio.01530-14; Yamada Kazuhiro, 2013, Met Ions Life Sci, V13, P295, DOI 10.1007/978-94-007-7500-8_9; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yu H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040501	75	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236100	10.1371/journal.pone.0236100	http://dx.doi.org/10.1371/journal.pone.0236100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702020	gold, Green Published			2022-12-26	WOS:000575913700050
J	Fernandez-Verdejo, R; Moya-Osorio, JL; Fuentes-Lopez, E; Galgani, JE				Fernandez-Verdejo, Rodrigo; Moya-Osorio, Jose Luis; Fuentes-Lopez, Eduardo; Galgani, Jose E.			Metabolic health and its association with lifestyle habits according to nutritional status in Chile: A cross-sectional study from the National Health Survey 2016-2017	PLOS ONE			English	Article							NORMAL-WEIGHT; PHYSICAL-ACTIVITY; OBESE; RISK; PREVALENCE; MORTALITY; OVERWEIGHT; PHENOTYPES	Background Lifestyle habits associate with metabolic health in overall populations. Whether such association is similar among subjects with a different nutritional status has been less studied. We aimed to (i) determine the prevalence of metabolic phenotypes in Chile, and (ii) determine the association between lifestyle habits and metabolic health according to the nutritional status. Methods The National Health Survey of Chile 2016-2017 was analyzed. A metabolically unhealthy phenotype was defined as manifesting >= 3 of the following risk factors: elevated blood pressure, elevated triglycerides, elevated glucose, elevated waist circumference, or reduced high-density lipoprotein cholesterol. Individuals manifesting <2 risk factors were considered as healthy. The nutritional status was defined as normal weight (18.5 to <25 kg/m(2)), overweight (25 to <30 kg/m(2)) or obesity (>= 30 kg/m(2)). Questionnaires were used to estimate smoking habits, alcohol intake, sedentary behavior, moderate-vigorous physical activity, fruits/vegetables consumption, and fish/seafood consumption. The association (odds ratio [95%CI]) between lifestyle habits and metabolic health was determined within each nutritional status, adjusting for age, sex, BMI (in kg/m(2)), and education. Results The prevalence of a metabolically unhealthy phenotype was 36% in the overall sample. Such a prevalence was 7%, 33% and 58% among subjects with normal weight, overweight and obesity, respectively. In subjects with normal weight, the highest quartile of fruits/vegetables consumption was associated with reduced odds of having a metabolically unhealthy phenotype (0.09 [0.01-0.48]). In subjects with obesity, the highest quartile of moderate-vigorous physical activity was associated with reduced odds of having a metabolically unhealthy phenotype (0.29 [0.09-0.91]). Conclusion One third of the Chilean population manifests an unhealthy phenotype. We identified associations between lifestyle habits and metabolic health that are specific to the nutritional status. Thus, emphasizing fruits/vegetables consumption in subjects with normal weight, and physical activity in subjects with obesity, may maximize the benefits of public health interventions.	[Fernandez-Verdejo, Rodrigo; Moya-Osorio, Jose Luis; Galgani, Jose E.] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Nutr & Dietet, Santiago, Chile; [Fuentes-Lopez, Eduardo] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Fonoaudiol, Santiago, Chile; [Galgani, Jose E.] Pontificia Univ Catolica Chile, Fac Med, Dept Nutr Diabet & Metab, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Fernandez-Verdejo, R (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Nutr & Dietet, Santiago, Chile.	rfernandev@uc.cl		Fernandez-Verdejo, Rodrigo/0000-0002-5948-2281	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [11180361, 1170117]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) #11180361 to RFV, and #1170117 to JEG. https://www.conicyt.cl/fondecyt/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Blundell JE, 2014, OBESITY FACTS, V7, P322, DOI 10.1159/000368783; Bradshaw PT, 2013, OBESITY, V21, P203, DOI 10.1002/oby.20248; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Celis-Morales C, 2015, REV MED CHILE, V143, P1435, DOI 10.4067/S0034-98872015001100009; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Departamento de Epidemiologia Ministerio de Salud de Chile, 2010, ENC NAC SAL 2009 201; Departamento de Epidemiologia Ministerio de Salud de Chile, 2017, ENC NAC SAL 2016 201; Ding C, 2016, CURR OPIN CLIN NUTR, V19, P408, DOI 10.1097/MCO.0000000000000317; Fernandez-Verdejo R, 2019, CURR OBES REP, V8, P88, DOI 10.1007/s13679-019-00339-z; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Hwang YC, 2015, INT J OBESITY, V39, P1365, DOI 10.1038/ijo.2015.75; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Lassale C, 2018, EUR HEART J, V39, P397, DOI 10.1093/eurheartj/ehx448; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Lind L, 2011, ARTERIOSCL THROM VAS, V31, pE27, DOI 10.1161/ATVBAHA.110.221572; Lopez-Garcia E, 2013, ATHEROSCLEROSIS, V231, P152, DOI 10.1016/j.atherosclerosis.2013.09.003; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Monteiro MG, 2008, ALCOHOL ATENCION PRI, DOI [10.4067/S0718-85602009000300014, DOI 10.4067/S0718-85602009000300014]; Munoz-Garach A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060320; OECD, 2021, OV OB POP IND, DOI [10.1787/86583552-en, DOI 10.1787/86583552-EN]; OECD, 2019, DAIL SMOK IND, DOI [10.1787/1ff488c2-en, DOI 10.1787/1FF488C2-EN]; OECD, 2016, INC IN IND, DOI [10.1787/459aa7f1-en, DOI 10.1787/459AA7F1-EN]; OECD data, 2016, HLTH SPENDING INDICA, DOI DOI 10.1787/8643DE7E-EN; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Perez-Hernandez AI, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00065; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076188; Riley L, 2016, AM J PUBLIC HEALTH, V106, P74, DOI 10.2105/AJPH.2015.302962; Roos V, 2017, METAB SYNDR RELAT D, V15, P118, DOI 10.1089/met.2016.0120; Serra-Majem L, 2019, MOL ASPECTS MED, V67, P1, DOI 10.1016/j.mam.2019.06.001; Stefan N, 2017, CELL METAB, V26, P292, DOI 10.1016/j.cmet.2017.07.008; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Villanueva B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194644; Wang B, 2015, HORM METAB RES, V47, P839, DOI 10.1055/s-0035-1559767; WANG ZJ, 2019, BMJ OPEN, V9, DOI DOI 10.1136/BMJOPEN-2018-02420630700478; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	40	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236451	10.1371/journal.pone.0236451	http://dx.doi.org/10.1371/journal.pone.0236451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697789	gold, Green Published			2022-12-26	WOS:000555392700006
J	Ozturk, C; Becher, MU; Kalkan, A; Kavsur, R; Weber, M; Nickenig, G; Tiyerili, V				Oeztuerk, Can; Becher, Marc Ulrich; Kalkan, Alev; Kavsur, Refik; Weber, Marcel; Nickenig, Georg; Tiyerili, Vedat			The modified MIDA-Score predicts mid-term outcomes after interventional therapy of functional mitral regurgitation	PLOS ONE			English	Article							REPAIR; RECOMMENDATIONS	Aims The preprocedural assessment of outcomes and patients' prognosis after interventional therapy of functional MR (FMR) is uncertain. Therefore, we aim to develop an easy-to-handle scoring system for adequate prediction of individual outcomes in patients with FMR after the interventional treatment. Materials and methods We retrospectively used medical data of patients with symptomatic FMR, who underwent transcatheter mitral valve repair (TMVR) from January 2014 to August 2016 in our heart center. All patients had the mean follow-up of 18 months. All clinical and echocardiographic data originate from the "Bonner Mitral Valve Register Database". Results We included 105 patients (76,7 +/- 8,8 years, 50,6% female) with symptomatic (NYHA functional class>II) moderate-to-severe or severe FMR at surgical high-risk. We modified the MIDA-Score for degenerative MR (DMR) according to the varying underlying pathomechanisms of FMR, called as "The modified MIDA Score". We found all-cause mortality of 7% within 18 months after the procedure. 34,1% of our cohort was rehospitalized; 90% of those were due to cardiovascular causes. The modified MIDA score was found to be a strong predictor for mortality and rehospitalization in patients with FMR (AUC: 0,89) and superior to the other conventional scoring systems in prediction of mortality (The modified MIDA-Score: AUC: 0,8, EuroSCORE II: AUC: 0,57, STS-Score: AUC: 0,51). The logistic regression analysis showed the modified MIDA score > 9 points to be the strongest predictor for mortality and rehospitalization after TMVR (OR: 3,35, p = 0,011). Conclusion The modified MIDA score was found to be a promising, easy-to-handle, elementary scoring system for adequate prediction of individual postinterventional prognosis in patients with FMR undergoing TMVR. Further evaluation and validation of this novel scoring system in prospective multicentric studies with a large number of patients is warranted.	[Oeztuerk, Can; Becher, Marc Ulrich; Kalkan, Alev; Kavsur, Refik; Weber, Marcel; Nickenig, Georg; Tiyerili, Vedat] Univ Hosp Bonn, Ctr Heart, Dept Cardiol, Bonn, Germany	University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ozturk, C (corresponding author), Univ Hosp Bonn, Ctr Heart, Dept Cardiol, Bonn, Germany.	can.oeztuerk@ukbonn.de		Weber, Marcel/0000-0003-4100-9522; Ozturk, Can/0000-0002-5419-2488				ANDERSON RP, 1994, ANN THORAC SURG, V57, P6, DOI 10.1016/0003-4975(94)90355-7; Baldus S, 2012, EUR J HEART FAIL, V14, P1050, DOI 10.1093/eurjhf/hfs079; Baumgartner H, 2018, KARDIOL POL, V76, P1, DOI 10.5603/KP.2018.0013; Chiarito M, 2018, HEART, V104, P306, DOI 10.1136/heartjnl-2017-311412; D'ascenzo F, 2015, AM J CARDIOL, V116, P325, DOI 10.1016/j.amjcard.2015.04.025; De Bonis M, 2016, EUR J CARDIO-THORAC, V49, P255, DOI 10.1093/ejcts/ezv043; De Rosa R, 2018, CIRC J, V82, P2800, DOI 10.1253/circj.CJ-18-0571; Feldman T, 2015, J AM COLL CARDIOL, V66, P2844, DOI 10.1016/j.jacc.2015.10.018; Giannini C, 2018, ESC HEART FAIL, V5, P1150, DOI 10.1002/ehf2.12339; Grigioni F, 2018, EUR HEART J, V39, P1281, DOI 10.1093/eurheartj/ehx465; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Marmagkiolis K, 2019, CATHETER CARDIO INTE, V94, P820, DOI 10.1002/ccd.28203; Miller M, 2018, ANN CARDIOTHORAC SUR, V7, P741, DOI 10.21037/acs.2018.10.10; Obadia JF, 2018, NEW ENGL J MED, V379, P2297, DOI 10.1056/NEJMoa1805374; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Stone GW, 2018, NEW ENGL J MED, V379, P2307, DOI 10.1056/NEJMoa1806640; Wada Y, 2015, CIRC J, V80, P139, DOI 10.1253/circj.CJ-15-0663; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	18	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236265	10.1371/journal.pone.0236265	http://dx.doi.org/10.1371/journal.pone.0236265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697799	gold, Green Published			2022-12-26	WOS:000555392700024
J	Ahmad, TR; Higuchi, S; Bertaggia, E; Hung, A; Shanmugarajah, N; Guilz, NC; Gamarra, JR; Haeusler, RA				Ahmad, Tiara R.; Higuchi, Sei; Bertaggia, Enrico; Hung, Allison; Shanmugarajah, Niroshan; Guilz, Nicole C.; Gamarra, Jennifer R.; Haeusler, Rebecca A.			Bile acid composition regulates the manganese transporter Slc30a10 in intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intestine; bile acids; manganese; organoid; metal transport; bile acid; gene expression; nuclear receptor	VITAMIN-D-RECEPTOR; EFFLUX TRANSPORTER; NUCLEAR RECEPTOR; TRACE-ELEMENTS; HOMEOSTASIS; MUTATIONS; DYSTONIA; PROTEIN; HYPERMANGANESEMIA; IDENTIFICATION	Bile acids (BAs) comprise heterogenous amphipathic cholesterol-derived molecules that carry out physicochemical and signaling functions. A major site of BA action is the terminal ileum, where enterocytes actively reuptake BAs and express high levels of BA-sensitive nuclear receptors. BA pool size and composition are affected by changes in metabolic health, and vice versa. One of several factors that differentiate BAs is the presence of a hydroxyl group on C12 of the steroid ring. 12 alpha-Hydroxylated BAs (12HBAs) are altered in multiple disease settings, but the consequences of 12HBA abundance are incompletely understood. We employed mouse primary ileum organoids to investigate the transcriptional effects of varying 12HBA abundance in BA pools. We identifiedSlc30a10as one of the top genes differentially induced by BA pools with varying 12HBA abundance. SLC30A10 is a manganese efflux transporter critical for whole-body manganese excretion. We found that BA pools, especially those low in 12HBAs, induce cellular manganese efflux and thatSlc30a10induction by BA pools is driven primarily by lithocholic acid signaling via the vitamin D receptor. Administration of lithocholic acid or a vitamin D receptor agonist resulted in increasedSlc30a10expression in mouse ileum epithelia. These data demonstrate a previously unknown role for BAs in intestinal control of manganese homeostasis.	[Ahmad, Tiara R.; Higuchi, Sei; Bertaggia, Enrico; Shanmugarajah, Niroshan; Haeusler, Rebecca A.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Ahmad, Tiara R.; Higuchi, Sei; Bertaggia, Enrico; Hung, Allison; Shanmugarajah, Niroshan; Guilz, Nicole C.; Gamarra, Jennifer R.; Haeusler, Rebecca A.] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA	Columbia University; Columbia University	Haeusler, RA (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Haeusler, RA (corresponding author), Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA.	rah2130@columbia.edu		Higuchi, Sei/0000-0002-5134-8619; Hung, Allison/0000-0001-6790-4037; Haeusler, Rebecca/0000-0002-6973-9845; Guilz, Nicole/0000-0002-6930-4577	National Institutes of Health [DK115825, T32DK007328]; Russell Berrie Foundation; NCI, National Institutes of Health, Cancer Center Support Grant [P30CA013696]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russell Berrie Foundation; NCI, National Institutes of Health, Cancer Center Support Grant	This work was supported by National Institutes of Health Grants DK115825 (to R. A. H.) and T32DK007328 (to T. R. A.) and the Russell Berrie Foundation. This work was also funded in part through NCI, National Institutes of Health, Cancer Center Support Grant P30CA013696. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad TR, 2019, NAT REV ENDOCRINOL, V15, P701, DOI 10.1038/s41574-019-0266-7; Alemi F, 2013, GASTROENTEROLOGY, V144, P145, DOI 10.1053/j.gastro.2012.09.055; Anagianni S, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0942-y; Andruska Kristin M, 2015, Curr Epidemiol Rep, V2, P143; Aschner JL, 2015, AM J CLIN NUTR, V102, P1482, DOI 10.3945/ajcn.115.116285; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Bertaggia E, 2017, AM J PHYSIOL-ENDOC M, V313, pE121, DOI 10.1152/ajpendo.00409.2016; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; Bonde Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147772; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Bunnett NW, 2014, J PHYSIOL-LONDON, V592, P2943, DOI 10.1113/jphysiol.2014.271155; Chavez-Talavera O, 2017, GASTROENTEROLOGY, V152, P1679, DOI 10.1053/j.gastro.2017.01.055; Chen P, 2018, FRONT BIOSCI-LANDMRK, V23, P1655, DOI 10.2741/4665; Chevre R, 2018, FASEB J, V32, P3792, DOI 10.1096/fj.201701084RR; Choucair I, 2020, J LIPID RES, V61, P159, DOI 10.1194/jlr.RA119000311; CIKRT M, 1973, ARCH TOXIKOL, V31, P51, DOI 10.1007/BF00330296; Clarysse S, 2009, J PHARM SCI-US, V98, P1177, DOI 10.1002/jps.21502; Coneyworth LJ, 2012, J BIOL CHEM, V287, P36567, DOI 10.1074/jbc.M112.397000; COTZIAS GC, 1964, NATURE, V201, P828, DOI 10.1038/201828a0; da Silva TC, 2016, J STEROID BIOCHEM, V163, P77, DOI 10.1016/j.jsbmb.2016.04.006; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; de Boer JF, 2018, CURR OPIN LIPIDOL, V29, P194, DOI 10.1097/MOL.0000000000000508; Du S, 2018, DIABETOLOGIA, V61, P1985, DOI 10.1007/s00125-018-4674-3; Go S, 2017, BIOCHEM BIOPH RES CO, V490, P1307, DOI 10.1016/j.bbrc.2017.07.018; Haeusler RA, 2016, J CLIN ENDOCR METAB, V101, P1935, DOI 10.1210/jc.2015-2583; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; HASSANEIN M, 1966, BRIT J IND MED, V23, P67; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Hsieh CT, 2007, PEDIATR NEUROL, V36, P181, DOI 10.1016/j.pediatrneurol.2006.10.005; HURLEY LS, 1981, PHILOS T ROY SOC B, V294, P145, DOI 10.1098/rstb.1981.0095; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; Ishizawa M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071975; Jattan J, 2017, J LIPID RES, V58, P853, DOI [10.1194/jlr.M071340, 10.1194/jlr.m071340]; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; Kaur B, 2014, ADV FOOD NUTR RES, V71, P55, DOI 10.1016/B978-0-12-800270-4.00002-X; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kramer W, 1999, J LIPID RES, V40, P1604; KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8; Levy M, 2019, J BIOL CHEM, V294, P5879, DOI 10.1074/jbc.RA118.006816; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li JN, 2019, BBA-MOL BASIS DIS, V1865, P895, DOI 10.1016/j.bbadis.2018.05.011; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MALLORY A, 1973, GASTROENTEROLOGY, V64, P26; Mallya SM, 2016, ENDOCR RES, V41, P290, DOI 10.3109/07435800.2016.1141937; Mancini FR, 2018, J DIABETES, V10, P665, DOI 10.1111/1753-0407.12654; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; Mercadante CJ, 2019, J CLIN INVEST, V129, P5442, DOI 10.1172/JCI129710; Mukhopadhyay S, 2018, NEUROTOXICOLOGY, V64, P278, DOI 10.1016/j.neuro.2017.07.030; Mukhtiar K, 2016, BRAIN DEV-JPN, V38, P862, DOI 10.1016/j.braindev.2016.04.005; Nehring JA, 2007, P NATL ACAD SCI USA, V104, P10006, DOI 10.1073/pnas.0703512104; Ng E, 2015, HUM MOL GENET, V24, P4739, DOI 10.1093/hmg/ddv190; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; Ogo OA, 2015, MOL CELL BIOL, V35, P977, DOI 10.1128/MCB.01298-14; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; RUBENSTEIN AH, 1962, LANCET, V2, P1348; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scheiber IF, 2019, J BIOL CHEM, V294, P9147, DOI 10.1074/jbc.RA119.008762; Shan ZL, 2016, ENVIRON HEALTH PERSP, V124, P1876, DOI 10.1289/EHP176; Slatis K, 2010, J LIPID RES, V51, P3289, DOI 10.1194/jlr.M009308; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stamelou M, 2012, MOVEMENT DISORD, V27, P1317, DOI 10.1002/mds.25138; Taylor CA, 2019, J BIOL CHEM, V294, P1860, DOI 10.1074/jbc.RA118.005628; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; TICHY M, 1972, ARCH TOXIKOL, V29, P51, DOI 10.1007/BF00316514; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Wahlstrom A, 2017, J LIPID RES, V58, P412, DOI 10.1194/jlr.M072819; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang X, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080497; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	88	7	7	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2020	295	35					12545	12558		10.1074/jbc.RA120.012792	http://dx.doi.org/10.1074/jbc.RA120.012792			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NL7DH	32690612	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000567571100019
J	Varga, P; Vida, N; Hartmann, P; Szabo, A; Mohacsi, A; Szabo, G; Boros, M; Tuboly, E				Varga, Petra; Vida, Noemi; Hartmann, Petra; Szabo, Anna; Mohacsi, Arpad; Szabo, Gabor; Boros, Mihaly; Tuboly, Eszter			Alternative methanogenesis - Methanogenic potential of organosulfur administration	PLOS ONE			English	Article							METHANE; GLUTATHIONE; CYSTEINE; TISSUE; LIVER; ACID; NRF2		[Varga, Petra; Vida, Noemi; Hartmann, Petra; Boros, Mihaly; Tuboly, Eszter] Univ Szeged, Inst Surg Res, Szeged, Hungary; [Szabo, Anna; Mohacsi, Arpad; Szabo, Gabor] Univ Szeged, MTA SZTE Res Grp Photoacoust Spect, Szeged, Hungary; [Tuboly, Eszter] Univ Coll Cork UCC, Dept Pharmacol & Therapeut, Cork, Ireland	Szeged University; Szeged University; University College Cork	Tuboly, E (corresponding author), Univ Szeged, Inst Surg Res, Szeged, Hungary.; Tuboly, E (corresponding author), Univ Coll Cork UCC, Dept Pharmacol & Therapeut, Cork, Ireland.	eszter.tuboly@ucc.ie	Hartmann, Petra/AAZ-7881-2021	Hartmann, Petra/0000-0002-4746-9792; Boros, Mihaly/0000-0003-1410-1999	National Research Development and Innovation Office [NKFI K120232]; Szeged Scientist Academy Program (EMMI) [TSZ:13725-2/2018/INTFIN]; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-4]; Higher Education Institutional Excellence Program [TUDFO/47138-1/2019-ITM]	National Research Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Szeged Scientist Academy Program (EMMI); New National Excellence Program of the Ministry of Human Capacities; Higher Education Institutional Excellence Program	The study was supported by the following National Research Development and Innovation Office grants: NKFI K120232. It was further supported by the Szeged Scientist Academy Program (EMMI, TSZ:13725-2/2018/INTFIN) and the -New National Excellence Program of the Ministry of Human Capacities UNKP-17-4 and the Higher Education Institutional Excellence Program TUDFO/47138-1/2019-ITM.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins AE, 2017, ALCOHOL CLIN EXP RES, V41, P911, DOI 10.1111/acer.13362; Aguilar F, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1943; Althoff F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5205; Boros M, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/1/014001; Boros M, 2012, CRIT CARE MED, V40, P1269, DOI 10.1097/CCM.0b013e31823dae05; Demirkol O, 2004, J AGR FOOD CHEM, V52, P8151, DOI 10.1021/jf040266f; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ernst IMA, 2011, PHARMACOL RES, V63, P233, DOI 10.1016/j.phrs.2010.11.005; Ferreira LF, 2009, J APPL PHYSIOL, V107, P211, DOI 10.1152/japplphysiol.00001.2009; Ghyczy M, 2003, FASEB J, V17, P1124, DOI 10.1096/fj.02-0918fje; Grimble RF, 1998, NUTRITION, V14, P605, DOI 10.1016/S0899-9007(98)80041-5; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; HARPER AE, 1970, PHYSIOL REV, V50, P428, DOI 10.1152/physrev.1970.50.3.428; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; HUNTER EAL, 1994, J NUTR, V124, P2319, DOI 10.1093/jn/124.12.2319; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; KINSCHERF R, 1994, FASEB J, V8, P448, DOI 10.1096/fasebj.8.6.7909525; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Narasimhan M, 2011, MOL PHARMACOL, V80, P988, DOI 10.1124/mol.111.073262; Perez-Torres I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102098; Roccarina D, 2010, AM J GASTROENTEROL, V105, P1250, DOI 10.1038/ajg.2009.744; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tuboly E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07637-3; Tuboly E, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/4/046004; Tuboly E, 2013, AM J PHYSIOL-CELL PH, V304, pC207, DOI 10.1152/ajpcell.00300.2012; Yuan HF, 2011, REDOX REP, V16, P38, DOI 10.1179/174329211X12968219310918	29	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236578	10.1371/journal.pone.0236578	http://dx.doi.org/10.1371/journal.pone.0236578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730295	Green Accepted, Green Published, gold			2022-12-26	WOS:000556884700010
J	Bott, C; Dressel, I; Bayer, P				Bott, Christoph; Dressel, Ingo; Bayer, Peter			Paraffin wax as self-sealing insulation material of seasonal sensible heat storage systems-A laboratory study	PLOS ONE			English	Article							THERMAL-ENERGY STORAGE; PARAFFIN/EXPANDED GRAPHITE COMPOSITE; PHASE-CHANGE MATERIALS; SOLAR-ENERGY; CONDUCTIVITY; TECHNOLOGIES	Seasonal heat storage is considered as one of the key elements on the path to a low-emission economy. Embedded in local district heating networks, they raise the share of renewable energies and balance out highly fluctuating supplies of e.g. solar systems or windmills. The technology of seasonal heat storage can be described as almost technically mature, with well-established concepts and some systems being in operation for a considerable time. Nevertheless, the operating experience gained to date also revealed two critical problems. On the one hand, even smallest leakages in sealing foils led to irreparable breakdowns. On the other hand, heat loss in the marginal areas was revealed as a key deficiency, preventing the technology from advancing towards global marketability. This study presents an experimental approach to address these two key issues in the field of seasonal energy storage. Two small-scale laboratory tests were carried out to test paraffin wax as a completely novel component in the marginal area of seasonal storages. This is based on two material properties: As hydrophobic and mobile medium, the warmed and molten paraffin should actively seal the fissures and holes in the event of leakage. Additionally, the latent heat storage properties of the paraffin wax should increase the systems' total storage capacity and reduce lateral heat losses via its low thermal conductivity. With retardation periods from 2.5 to 4 hours, the results show an effective phase change effect of the paraffin wax, which reduces energy losses and allows to buffer short-term, intensive loading and unloading processes. By storing up to 138 kJ/kg energy in the paraffin wax, increased capacities of application-scale pit storages by up to 40.70 MWh are to be expected. Additionally, the self-healing features could be successfully demonstrated: With only small losses of between 1.5 and 17%, the paraffin wax effectively sealed artificially incised leaks. Thereby, the mechanism was most effective for local defects. Following these positive demonstrations of feasibility, technical design questions still remain, which concern prevention of deformation of the paraffin wax. Once solved, this new component can then provide a path for further optimization of seasonal heat storage technologies.	[Bott, Christoph] Ingolstadt Univ Appl Sci, Inst New Energy Syst, Ingolstadt, Germany; [Bott, Christoph; Bayer, Peter] Martin Luther Univ Halle Wittenberg, Inst Geosci & Geog, Halle, Germany; [Dressel, Ingo] KS AG, Kassel, Germany	Martin Luther University Halle Wittenberg	Bott, C (corresponding author), Ingolstadt Univ Appl Sci, Inst New Energy Syst, Ingolstadt, Germany.; Bott, C (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Geosci & Geog, Halle, Germany.	Christoph.Bott@thi.de	Bayer, Peter/J-8245-2013	Bayer, Peter/0000-0003-4884-5873; Bott, Christoph/0000-0003-0400-6904	Volkswagen Foundation [93847]	Volkswagen Foundation(Volkswagen)	The present study is financially supported by the Volkswagen Foundation within the framework of the "Initiative Experiment!" under grant agreement number 93847. The funder provided support in the form of salaries for author ID, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ABHAT A, 1983, SOL ENERGY, V30, P313, DOI 10.1016/0038-092X(83)90186-X; Ahmed N, 2019, ENERG CONVERS MANAGE, V189, P14, DOI 10.1016/j.enconman.2019.03.040; Akgun M, 2007, ENERG CONVERS MANAGE, V48, P669, DOI 10.1016/j.enconman.2006.05.014; Bai YK, 2020, RENEW ENERG, V150, P487, DOI 10.1016/j.renene.2019.12.080; Benner M, 1998, SOLAR UNTERSTUTZTE N; Bespalko S, 2018, ACTA INNOVATIONS, V28, P82; Bodmann M, 2003, EUROSOLAR 2003; Bodmann M, 2004, SOLAR UNTERSTUTZTE N, P2004; Bott C, 2019, RENEW SUST ENERG REV, V113, DOI 10.1016/j.rser.2019.06.048; Cho K, 2000, INT J HEAT MASS TRAN, V43, P3183, DOI 10.1016/S0017-9310(99)00329-4; Dincer R.M, 2011, RENEWABLE ENERGY J, V2; Ellehauge K., 2007, SOLAR HEAT STORAGES; Ettouney H, 2006, ENERG CONVERS MANAGE, V47, P211, DOI 10.1016/j.enconman.2005.04.003; Faraj K, 2020, RENEW SUST ENERG REV, V119, DOI 10.1016/j.rser.2019.109579; Farid MM, 2004, ENERG CONVERS MANAGE, V45, P1597, DOI 10.1016/j.enconman.2003.09.015; Farulla GA, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10093142; Fleuchaus P, 2018, RENEW SUST ENERG REV, V94, P861, DOI 10.1016/j.rser.2018.06.057; Fourier J.B.J., 1878, ANAL THEORY HEAT, DOI DOI 10.1017/CBO9780511693205; Hadorn J-C, 2004, STORAGE SOLUTIONS SO, P1; Hahne E, 2000, SOL ENERGY, V69, P469, DOI 10.1016/S0038-092X(00)00115-8; Hasnain SM, 1998, ENERG CONVERS MANAGE, V39, P1127, DOI 10.1016/S0196-8904(98)00025-9; He B, 2002, ENERG CONVERS MANAGE, V43, P1709, DOI 10.1016/S0196-8904(01)00005-X; Heller A, 2000, SOL ENERGY, V69, P437, DOI 10.1016/S0038-092X(00)00118-3; Hesaraki A, 2015, RENEW SUST ENERG REV, V43, P1199, DOI 10.1016/j.rser.2014.12.002; Hoekstra N, 2020, SCI TOTAL ENVIRON, V709, DOI 10.1016/j.scitotenv.2019.136142; Jesumathy SP, 2012, J MECH SCI TECHNOL, V26, P959, DOI 10.1007/s12206-011-1017-4; Kabir M. S., 2020, FUDMA J SCI FJS, V4, P764; Kalaiselvam S, THERMAL ENERGY STORA; Kenisarin M, 2007, RENEW SUST ENERG REV, V11, P1913, DOI 10.1016/j.rser.2006.05.005; Koohi-Fayegh S, 2020, J ENERGY STORAGE, V27, DOI 10.1016/j.est.2019.101047; Lanahan M, 2017, ENERGIES, V10, DOI 10.3390/en10060743; Mahfuz MH, 2014, INT COMMUN HEAT MASS, V57, P132, DOI 10.1016/j.icheatmasstransfer.2014.07.022; Mangold D, 2006, ERFAHRUNGEN ERGEBNIS; Mangold D, 2003, SAISONALE WARMESPEIC, P1; Mattheess A, 2018, GREEN HEAT3 ENTWICKL, P389; Ochs F., 2013, STAND TECHNIK ERDVER; Ochs F., 2008, 4 EUR GEOS C, P105; Ochs F, 2007, LANGZEIT WARMESPEICH; OLIVETI G, 1995, SOL ENERGY, V54, P85, DOI 10.1016/0038-092X(94)00128-Z; Palacios A, 2019, RENEW SUST ENERG REV, V108, P32, DOI 10.1016/j.rser.2019.03.020; Rad FM, 2016, RENEW SUST ENERG REV, V60, P1550, DOI 10.1016/j.rser.2016.03.025; Royon L, 2001, ENERG CONVERS MANAGE, V42, P2155, DOI 10.1016/S0196-8904(00)00130-8; Sarbu I, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010191; Sari A, 2007, APPL THERM ENG, V27, P1271, DOI 10.1016/j.applthermaleng.2006.11.004; Schlosser M, 2007, LANGZEITMONITORING S; Schmidt T., 2006, NEW STEPS SEASONAL T; Schuppler S, 2019, GEOTHERM ENERGY, V7, DOI 10.1186/s40517-019-0127-6; Setterwall F, 1996, PHASE CHANGE MAT CHE; Shah SK, 2018, RENEW SUST ENERG REV, V97, P38, DOI 10.1016/j.rser.2018.08.025; Socaciu L.G., 2011, LEONARDO ELECT J PRA, V19, P49; Sorensen PA, 2018, 14 INT C EN STOR AD; Steinbach Schaumglas GmbH & Co. KG, 2020, TECHN PROP PROD STAT; Trp A, 2005, SOL ENERGY, V79, P648, DOI 10.1016/j.solener.2005.03.006; Urbaneck T, 2002, BERECHNUNG KIES WASS; Villasmil W, 2019, RENEW SUST ENERG REV, V103, P71, DOI 10.1016/j.rser.2018.12.040; Xu J, 2014, SOL ENERGY, V103, P610, DOI 10.1016/j.solener.2013.06.006; Yang T., 2019, INT C APPL EN 2019 V, P349; Zhang ZG, 2012, APPL ENERG, V91, P426, DOI 10.1016/j.apenergy.2011.10.014; Zhao JG, 2011, RENEW ENERG, V36, P1339, DOI 10.1016/j.renene.2010.11.028; Zhou D, 2012, APPL ENERG, V92, P593, DOI 10.1016/j.apenergy.2011.08.025; Ziskind G., 2020, 7 SWISS S THERM EN S	61	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236056	10.1371/journal.pone.0236056	http://dx.doi.org/10.1371/journal.pone.0236056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726357	Green Published, gold			2022-12-26	WOS:000556908900009
J	Siqueira, CAD; Freitas, YNL; Cancela, MD; Carvalho, M; Oliveras-Fabregas, A; de Souza, DLB				Siqueira, Camila Alves dos Santos; de Freitas, Yan Nogueira Leite; Cancela, Marianna de Camargo; Carvalho, Monica; Oliveras-Fabregas, Albert; de Souza, Dyego Leandro Bezerra			The effect of lockdown on the outcomes of COVID-19 in Spain: An ecological study	PLOS ONE			English	Article								It is paramount to expand the knowledge base and minimize the consequences of the pandemic caused by the new Coronavirus (SARS-Cov2). Spain is among the most affected countries that declared a countrywide lockdown. An ecological study is presented herein, assessing the trends for incidence, mortality, hospitalizations, Intensive Care Unit admissions, and recoveries per autonomous community in Spain. Trends were evaluated by the Joinpoint software. The timeframe employed was when the lockdown was declared on March 14, 2020. Daily percentage changes were also calculated, with CI = 95% and p<0.05. An increase was detected, followed by reduction, for the evaluated indicators in most of the communities. Approximately 18.33 days were required for the mortality rates to decrease. The highest mortality rate was verified in Madrid (118.89 per 100,000 inhabitants) and the lowest in Melilla (2.31). The highest daily percentage increase in mortality occurred in Catalonia. Decreasing trends were identified after approximately two weeks of the institution of the lockdown by the government. Immediately the lockdown was declared, an increase of up to 33.96% deaths per day was verified in Catalonia. In contrast, Ceuta and Melilla presented significantly lower rates because they were still at the early stages of the pandemic at the moment of lockdown. The findings presented herein emphasize the importance of early and assertive decision-making to contain the pandemic.	[Siqueira, Camila Alves dos Santos; de Souza, Dyego Leandro Bezerra] Univ Fed Rio Grande do Norte, Dept Collect Hlth, Grad Program Collect Hlth, Natal, RN, Brazil; [de Freitas, Yan Nogueira Leite] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Cancela, Marianna de Camargo] Brazilian Natl Canc Inst, Div Surveillance & Situat Anal, Rio De Janeiro, Brazil; [Carvalho, Monica] Univ Fed Paraiba, Dept Renewable Energy Engn, Joao Pessoa, Paraiba, Brazil; [Oliveras-Fabregas, Albert; de Souza, Dyego Leandro Bezerra] Univ Vic Cent Univ Catalonia UVic UCC, Res Grp Methodol Methods Models & Outcomes Hlth &, Fac Hlth Sci & Welf, Ctr Hlth & Social Care Res CESS, Barcelona, Spain; [de Souza, Dyego Leandro Bezerra] Carrer Sagrada Familia, Barcelona, Spain	Universidade Federal do Rio Grande do Norte; Universidade Federal de Amazonas; National Cancer Institute (Inca); Universidade Federal da Paraiba; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	de Souza, DLB (corresponding author), Univ Fed Rio Grande do Norte, Dept Collect Hlth, Grad Program Collect Hlth, Natal, RN, Brazil.; de Souza, DLB (corresponding author), Univ Vic Cent Univ Catalonia UVic UCC, Res Grp Methodol Methods Models & Outcomes Hlth &, Fac Hlth Sci & Welf, Ctr Hlth & Social Care Res CESS, Barcelona, Spain.; de Souza, DLB (corresponding author), Carrer Sagrada Familia, Barcelona, Spain.	dysouz@yahoo.com.br	de Camargo Cancela, Marianna/F-7309-2017; OLIVERAS FABREGAS, ALBERT/GMW-6300-2022; Carvalho, Monica/C-6500-2012; De Camargo Cancela, Marianna/D-4053-2015	OLIVERAS FABREGAS, ALBERT/0000-0001-8262-7672; Souza, Dyego L.B./0000-0001-8426-3120; Carvalho, Monica/0000-0002-8524-3452; De Camargo Cancela, Marianna/0000-0002-8169-8054	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - Brazil (CAPES, Coordination for the Improvement of Higher Education Personnel)) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - Brazil (CAPES, Coordination for the Improvement of Higher Education Personnel))	This work was financed by the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - Brazil (CAPES, Coordination for the Improvement of Higher Education Personnel) financing code 001. The funding is intended to pay article-processing charges.	Ainslie Kylie E C, 2020, Wellcome Open Res, V5, P81, DOI 10.12688/wellcomeopenres.15843.1; Ambikapathy B, 2020, JMIR PUBLIC HLTH SUR, V6, DOI [10.2196/19368, DOI 10.2196/19368]; Amblas-Novellas J, 2020, BMC GERIATR, P1, DOI [10.21203/rs.2.22586/v1, DOI 10.21203/RS.2.22586/V1]; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Armocida B, 2020, LANCET PUBLIC HEALTH, V5, pE253, DOI 10.1016/S2468-2667(20)30074-8; Cohen J, 2020, SCIENCE, V367, P727, DOI 10.1126/science.367.6479.727; D'Adamo H, 2020, J AM GERIATR SOC, V68, P912, DOI 10.1111/jgs.16445; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Flaxman S., 2020, REPORT 13 ESTIMATING, DOI 10.25561/77731; Grad S., 2020, SOCIAL DISTANCING ST, V2020, DOI [10.11392/jsao.49.40, DOI 10.1101/2020.03.22.20041079]; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; INE. Instituto Nacional de Estadistica, CONT REG ESP; INE. Instituto Nacional de Estadistica, MOD MUN PROD 01 01 2; Jensen OM, 1991, CANC REGISTRATION PR; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Lee VJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa039; Legido-Quigley H, 2020, LANCET PUBLIC HEALTH, V5, pE251, DOI 10.1016/S2468-2667(20)30060-8; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796; Ministerio de la Presidencia relaciones con las cortes y memoriademocratica, 2020, B ESTADO, V67, P25390; Ministerio de Sanidad. Gobierno de Espana, B OFICIAL ESTADO, P30361; Ministerio de sanidade, GOB ESP SIT ACT; Perez-Bermejo M, 2020, J EPIDEMIOL, V30, P236, DOI 10.2188/jea.JE20200123; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Reis RF, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109888; Saez M, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138761; Schwartz J, 2020, CLIN INFECT DIS, V71, P858, DOI 10.1093/cid/ciaa255; Sebastiani G, 2020, EUR J EPIDEMIOL, V35, P341, DOI 10.1007/s10654-020-00631-6; Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090; WHO, 2020, COR DIS COVID 19 PAN; World Health Organization, 2020, 168 WHO	37	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236779	10.1371/journal.pone.0236779	http://dx.doi.org/10.1371/journal.pone.0236779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726363	gold, Green Published			2022-12-26	WOS:000556908900004
J	Chen, WL; Peng, XY; Yu, JX; Chen, XX; Yuan, MG; Xiang, R; He, LM; Yu, DN; Kang, HH; Pan, YF; Xu, ZH				Chen, Wenlu; Peng, Xinyu; Yu, Jingxian; Chen, Xuanxuan; Yuan, Minggui; Xiang, Rong; He, Limei; Yu, Danni; Kang, Huahua; Pan, Yufang; Xu, Zhihong			FengLiao affects gut microbiota and the expression levels of Na plus /H plus exchangers, aquaporins and acute phase proteins in mice with castor oil-induced diarrhea	PLOS ONE			English	Article							UP-REGULATION; MEDICINE; SYSTEM	The severe side effects of chemosynthetic anti-diarrhea drugs have created an interest in low-toxic alternative plant-derived compounds. FengLiao consists ofPolygonum hydropiperLinn. andDaphniphyllum calycinumBench., and is widely used in China to treat diarrhea due to low levels of toxicity. In this study, the effects of FengLiao were analyzed in a castor oil-induced diarrhea model, using the anti-diarrhea drug, loperamide, as the positive control. The effects were evaluated using stool characteristics and the expression levels of various diarrhea-related factors in the jejunum and liver, as well as changes in the microbiota of the jejunum. The symptoms of diarrhea and stool consistency were improved through FengLiao and loperamide treatment. Furthermore, FengLiao down-regulated alpha 1-acid glycoprotein (AGP) and C-reactive protein (CRP) levels, and up-regulated transferrin (TRF) mRNA levels in the liver, and down-regulated Aquaporin 3 (AQP3) and Na+/H+ exchanger isoform 8 (NHE8) expression in the epithelial cells of the jejunum. It also increased the relative abundance ofBifidobacterium,Aerococcus,Corynebacterium_1 andPseudomonas, and lowered the Firmicutes/Bacteroidetes (F/B) ratio, which maintained the balance between immunity and intestinal health. Taken together, FengLiao alleviated castor oil-induced diarrhea by altering gut microbiota, and levels of jejunum epithelial transport proteins and acute phase proteins.	[Chen, Wenlu; Peng, Xinyu; Yuan, Minggui; Xiang, Rong; He, Limei; Yu, Danni; Kang, Huahua; Xu, Zhihong] Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Peoples R China; [Chen, Wenlu; Chen, Xuanxuan; Pan, Yufang] Guangdong Pharmaceut Univ, Guangzhou, Peoples R China; [Peng, Xinyu; Yuan, Minggui; Xiang, Rong; Yu, Danni; Kang, Huahua; Xu, Zhihong] Key Lab Live Stock Dis Prevent Guangdong Prov, Guangzhou, Peoples R China; [Peng, Xinyu; Yuan, Minggui; Xiang, Rong; Yu, Danni; Kang, Huahua; Xu, Zhihong] Minist Agr, Sci Observing & Expt Stn Vet Drugs & Diagnost Tec, Guangzhou, Peoples R China; [Peng, Xinyu; Yuan, Minggui; Xiang, Rong; Yu, Danni; Kang, Huahua; Xu, Zhihong] Chinese Tradit Med Engn Technol Res Ctr Guangdong, Guangzhou, Peoples R China; [Yu, Jingxian] South China Agr Univ, Guangzhou, Peoples R China	Guangdong Academy of Agricultural Sciences; Guangdong Pharmaceutical University; Ministry of Agriculture & Rural Affairs; South China Agricultural University	Peng, XY (corresponding author), Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Peoples R China.; Peng, XY (corresponding author), Key Lab Live Stock Dis Prevent Guangdong Prov, Guangzhou, Peoples R China.; Peng, XY (corresponding author), Minist Agr, Sci Observing & Expt Stn Vet Drugs & Diagnost Tec, Guangzhou, Peoples R China.; Peng, XY (corresponding author), Chinese Tradit Med Engn Technol Res Ctr Guangdong, Guangzhou, Peoples R China.	996202250@qq.com		Chen, Wen'lu/0000-0003-0199-015X; Peng, Xinyu/0000-0002-9395-6284	Institute of Animal Health, Guangdong Academy of Agricultural Sciences and Guangdong Pharmaceutical University; Special Fund for AgroScientific Research in the Public Interest Ministry of Agriculture of the People's Republic of China [201303040-16]; Agricultural Science and Technology Innovation and Major Projects of Guangdong Province (2018)	Institute of Animal Health, Guangdong Academy of Agricultural Sciences and Guangdong Pharmaceutical University; Special Fund for AgroScientific Research in the Public Interest Ministry of Agriculture of the People's Republic of China; Agricultural Science and Technology Innovation and Major Projects of Guangdong Province (2018)	This work was supported by the Institute of Animal Health, Guangdong Academy of Agricultural Sciences and Guangdong Pharmaceutical University. In addition, this work was supported by the Special Fund for AgroScientific Research in the Public Interest Ministry of Agriculture of the People's Republic of China (Grant No. 201303040-16) and Agricultural Science and Technology Innovation and Major Projects of Guangdong Province (2018) to XP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, THESIS; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Cheng KC, 2012, CURR PHARM DESIGN, V18, P4819, DOI 10.2174/138161212803216979; Chiadak JD, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101742; Fang D.S., 1964, ACTA CHIN SIN, V30, P270; Ikarashi N, 2011, BIOL PHARM BULL, V34, P238, DOI 10.1248/bpb.34.238; Jain S, 2011, J PHARM BIOALLIED SC, V3, P118, DOI 10.4103/0975-7406.76489; Jiang Q, 2016, J SUPERCOMPUT, V72, P3826, DOI 10.1007/s11227-015-1610-x; Jin M, 2020, ARCH GYNECOL OBSTET, V301, P243, DOI 10.1007/s00404-019-05336-0; Kaiser EA, 2017, NEUROPEPTIDES, V64, P95, DOI 10.1016/j.npep.2016.11.004; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Lei XL, 2018, KOREAN J PHYSIOL PHA, V22, P269, DOI 10.4196/kjpp.2018.22.3.269; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liang Y, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009359.pub2; Liu F, 2014, T DATA HIDING MULTIM, P1; Liu H, 2008, 2008 CHINESE CONTROL AND DECISION CONFERENCE, VOLS 1-11, P74, DOI 10.1109/CCDC.2008.4597273; Magnusdottir S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00148; Mousa WK, 2017, NAT PROD REP, V34, P1302, DOI 10.1039/c7np00021a; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Pelagalli A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081213; Poppleton DI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01215; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Qi FH, 2015, BIOSCI TRENDS, V9, P16, DOI 10.5582/bst.2015.01019; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roberts M C, 1989, Equine Vet J Suppl, P60, DOI 10.1111/j.2042-3306.1989.tb05658.x; Sakai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054788; Satta M, 2001, INT J PHOTOENERGY, V3; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Urdaci MC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01537; Verruck S, 2020, FOOD RES INT, V127, DOI 10.1016/j.foodres.2019.108690; Wang KL, 2017, MOLECULES, V22, DOI 10.3390/molecules22030465; WHO,, 2017, DIARRH DIS; Xu H, 2018, COMPR PHYSIOL, V8, P555, DOI 10.1002/cphy.c170027; Xu H, 2011, AM J PHYSIOL-GASTR L, V300, pG647, DOI 10.1152/ajpgi.00546.2010; Yu B, 2019, PAK J PHARM SCI, V32, P1333; Yu HL, 2018, BIOCHIMIE, V144, P153, DOI 10.1016/j.biochi.2017.11.006; Yu JK, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/3687486; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zhang D, 2017, MICROB PATHOGENESIS, V107, P430, DOI 10.1016/j.micpath.2017.04.031; Zhang XP, 2012, MOLECULES, V17, P9641, DOI 10.3390/molecules17089641; Zhao SS, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13364	48	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236511	10.1371/journal.pone.0236511	http://dx.doi.org/10.1371/journal.pone.0236511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722717	Green Published, gold			2022-12-26	WOS:000556916000033
J	Phelan, A; Ross, H; Setianto, NA; Fielding, K; Pradipta, L				Phelan, Anna (Anya); Ross, Helen; Setianto, Novie Andri; Fielding, Kelly; Pradipta, Lengga			Ocean plastic crisis-Mental models of plastic pollution from remote Indonesian coastal communities	PLOS ONE			English	Article							MARINE DEBRIS; WASTE; IMPACTS; MICROPLASTICS; EMISSIONS; ISLAND; FISH	The crisis facing the world's oceans from plastics is well documented, yet there is little knowledge of the perspectives, experiences and options of the coastal communities facing overwhelming quantities of plastics on their beaches and in their fishing waters. In emerging economies such as those in the Coral Triangle, the communities affected are among the poorest of their countries. To understand the consequences of ocean plastic pollution in coastal regions, through the eyes of local people, this study examines the knowledge, use, disposal and local consequences of single use plastics in remote island communities in two archipelagos of southern Sulawesi, Indonesia. Using mixed methods-a survey of plastic literacy and behaviour, household interviews about purchasing and disposal, and focus group discussions to generate shared mental models-we identify a complex set of factors contributing to extensive plastic leakage into the marine environment. The rising standard of living has allowed people in low resource, remote communities to buy more single-use plastic items than they could before. Meanwhile complex geography and minimal collection services make waste management a difficult issue, and leave the communities themselves to shoulder the impacts of the ocean plastic crisis. Although plastic literacy is low, there is little the coastal communities can do unless presented with better choice architecture both on the supply side and in disposal options. Our results suggest that for such coastal communities improved waste disposal is urgent. Responsible supply chains and non-plastic alternatives are needed. Producers and manufacturers can no longer focus only on low-cost packaged products, without taking responsibility for the outcomes. Without access to biodegradable, environmentally friendly products, and a circular plastic system, coastal communities and surrounding marine ecosystems will continue to be inundated in plastic waste.	[Phelan, Anna (Anya)] Univ Queensland, Business Sch, Fac Business Econ & Law, Brisbane, Qld, Australia; [Ross, Helen] Univ Queensland, Sch Agr & Food Sci, Fac Sci, Brisbane, Qld, Australia; [Setianto, Novie Andri] Jenderal Soedirman Univ, Fac Anim Sci, Purwokerto, Central Java, Indonesia; [Fielding, Kelly] Univ Queensland, Sch Commun & Arts, Fac Humaniteis & Social Sci, Brisbane, Qld, Australia; [Pradipta, Lengga] Indonesian Inst Sci LIPI, Div Human Ecol, Res Ctr Populat, Jakarta, West Java, Indonesia	University of Queensland; University of Queensland; Universitas Jenderal Soedirman; University of Queensland; Indonesian Institute of Sciences	Phelan, A (corresponding author), Univ Queensland, Business Sch, Fac Business Econ & Law, Brisbane, Qld, Australia.	a.phelan@business.uq.edu.au	Pradipta, Lengga/AAN-9227-2021; Setianto, Novie Andri/ABI-6085-2020	Pradipta, Lengga/0000-0002-0384-8205; Setianto, Novie Andri/0000-0002-3190-1384	UQ Small Grants Scheme Funded through the Global Change Institute, The University of Queensland; Global Change Institute, The University of Queensland, Brisbane, Australia	UQ Small Grants Scheme Funded through the Global Change Institute, The University of Queensland; Global Change Institute, The University of Queensland, Brisbane, Australia	AP There is no grant number associated with this internal university grant - UQ Small Grants Scheme Funded through the Global Change Institute, The University of Queensland https://gci.uq.edu.au/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the communities and local teams in Selayar and Wakatobi. This study was funded by the Global Change Institute, The University of Queensland, Brisbane, Australia. It was carried out in collaboration with the Indonesian Institute of Sciences. We thank Herry Yogaswara for guidance and support, Carl Smith for help with methods and design. Gede Eka Putra for assistance with logistics on Selayar. Amelia Phelan for assistance with fieldwork and data entry, and Robyn Gulliver for assistance with survey analysis. We would also like to thank Lisa Ruhanen and Mark Moran for their support.	Agamuthu P, 2014, MUNICIPAL SOLID WAST; Anderson Jamie, 2007, Journal of Business Strategy, V28, P14, DOI 10.1108/02756660710732611; Ang R., 2007, 2007 AMA EDUCATORSPR, V18, P5; [Anonymous], 2018, STAT DATA MARINE COA; [Anonymous], 2009, GUIDELINES USE MARKE; [Anonymous], 2019, WORLD POPULATION REV; Arkema K. K., 2015, P NATL ACAD SCI USA; Baum G, 2015, PLOS ONE, V10; Beaumont NJ, 2019, MAR POLLUT BULL, V142, P189, DOI 10.1016/j.marpolbul.2019.03.022; Bryman A, 2008, ADV MIXED METHODS RE, V21, P87, DOI DOI 10.4135/9780857024329; Chaerul M, 2014, J MATER CYCLES WASTE, V16, P509, DOI 10.1007/s10163-013-0201-2; Clifton J., 2014, ECOCULTURES, P27; Creswell J., 2003, HDB MIXED METHODS SO, P209; Dahuri R., 2007, P WORKSH COAST AR PL, P111; Damanhuri E., 2014, MUNICIPAL SOLID WAST, P139, DOI [10.1007/978-981-4451-73-4_8, DOI 10.1007/978-981-4451-73-4_8]; Das B, 2018, WASTE MANAGE, V79, P481, DOI 10.1016/j.wasman.2018.08.013; Defruyt S., 2019, J FIELD ACTIONS, P78; Defruyt S., 2019, FIELD ACTIONS SCI RE, P78; Demirdjian Z, 2017, ASBBS P, V24, P167; Duraiappah A.K., 2005, ECOSYSTEMS HUMAN WEL; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Estrellan CR, 2010, CHEMOSPHERE, V80, P193, DOI 10.1016/j.chemosphere.2010.03.057; Farhan AR, 2011, OCEAN COAST MANAGE, V54, P391, DOI 10.1016/j.ocecoaman.2010.12.003; Ferrol-Schulte D, 2015, MAR POLICY, V52, P163, DOI 10.1016/j.marpol.2014.09.026; Forrest A, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00627; Forum WE. Ellen MacArthur Foundation McKinsey & Company, 2016, NEW PLAST EC RETH FU; Fowler AR, 2012, J ADVERTISING, V41, P119, DOI 10.1080/00913367.2012.10672461; Gamse T., 2010, EUROPEAN J SCI RES, V40, P199; Garcia B, 2019, CHINESE J ENV LAW, V3, P11, DOI 10.1163/24686042-12340034; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Glaeser B, 2010, HUM ECOL REV, V17, P135; Green A., 2008, NATURE CONSERVANCY D, V16, P2008; Hardesty BD, 2017, FRONT ECOL ENVIRON, V15, P18, DOI 10.1002/fee.1447; Harris PG, 2019, CLIMATE CHANGE AND OCEAN GOVERNANCE: POLITICS AND POLICY FOR THREATENED SEAS, P1, DOI 10.1017/9781108502238; Hoegh-Guldberg O., 2009, CORAL TRIANGLE CLIMA; Hoegh-Guldberg O, 2015, REVIVING OCEAN EC CA; do Sul JAI, 2014, ENVIRON POLLUT, V185, P352, DOI 10.1016/j.envpol.2013.10.036; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Jones N, 2011, MENTAL MODELS INTERD; Jones NA, 2011, ECOL SOC, V16; Karami A, 2016, ENVIRON RES, V151, P58, DOI 10.1016/j.envres.2016.07.024; Karbalaei S, 2019, MAR POLLUT BULL, V148, P5, DOI 10.1016/j.marpolbul.2019.07.072; Kirstein IV, 2016, MAR ENVIRON RES, V120, P1, DOI 10.1016/j.marenvres.2016.07.004; Knodel J, 1993, SUCCESSFUL FOCUS GRO, P35, DOI DOI 10.4135/9781483349008; Lamb JB, 2018, SCIENCE, V359, P460, DOI 10.1126/science.aar3320; Leal W, 2019, J CLEAN PROD, V214, P550, DOI 10.1016/j.jclepro.2018.12.256; Lebreton LCM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15611; Leggett C., 2014, ASSESSING EC BENEFIT; Li WC, 2016, SCI TOTAL ENVIRON, V566, P333, DOI 10.1016/j.scitotenv.2016.05.084; Liboiron M, 2019, MAR POLLUT BULL, V141, P244, DOI 10.1016/j.marpolbul.2019.02.057; Liebner H., 1998, LIVING HIST CULTURE, P107; Linder M, 2017, GREEN CHEM LETT REV, V10, P428, DOI 10.1080/17518253.2017.1392618; Liquete C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067737; Liu Z, 2018, RESOUR CONSERV RECY, V136, P22, DOI 10.1016/j.resconrec.2018.04.005; Maani K., 2007, SYSTEMS THINKING SYS, V(2nd; MacArthur E., 2017, PLASTIC WASTE; Mangla SK, 2018, PROD PLAN CONTROL, V29, P551, DOI 10.1080/09537287.2018.1449265; McDonald P, 2014, B INDONES ECON STUD, V50, P29, DOI 10.1080/00074918.2014.896236; Mcleod E, 2010, SUSTAIN SCI, V5, P207, DOI 10.1007/s11625-010-0105-1; Meadows DH, 1982, COEVOLUTIONQUARTERLY; Minton E, 2012, J ADVERTISING, V41, P69, DOI 10.1080/00913367.2012.10672458; Mouat J., 2010, EC IMPACTS MARINE LI; Nulkar G., 2016, SUSTAINABILITY J REC, V9, P31; Ritchie H., 2018, URBANIZATION OUR WOR; Rochman CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14340; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; SENGE PM, 1992, EUR J OPER RES, V59, P137, DOI 10.1016/0377-2217(92)90011-W; Shah A. M., 2012, J ASIA PACIFIC BUSIN, V13, P4; Sheth J. N., 2016, BREAKOUT STRATEGIES; Shuker I.G., 2018, INDONESIA MARINE DEB; Singh R., 2009, MARKETING REV, V9, P3; Smith C, USING SESAMME APP SC; Statistics Bureau of Selayar Regency, 2018, KEP SEL REG FIG SEL; Statistics Bureau of Wakatobi Regency, 2018, KEP WAK REG FIG; Sterman J. D., 2002, SYSTEM DYNAMICS SYST; Sur C, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00035; Tullo A, 2018, CHEM ENG NEWS, V96, P29; Verma R, 2016, PROCEDIA ENVIRON SCI, V35, P701, DOI 10.1016/j.proenv.2016.07.069; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Wahab MRA, 2018, SELECTED TOPICS ARCH; Walker T.R., 2018, NATURE, V553, P405, DOI [DOI 10.1038/D41586-018-00933-6, 10.1038/d41586-018-00933-6]; Walker TR, 1997, MAR POLLUT BULL, V34, P61, DOI 10.1016/S0025-326X(96)00053-7; Wilcox C, 2016, MAR POLICY, V65, P107, DOI 10.1016/j.marpol.2015.10.014; Williams M., 2019, NO TIME WASTE TACKLI; Wolstenholme EF, 2003, SYST DYNAM REV, V19, P7, DOI 10.1002/sdr.259; World Economic Forum, 2016, NEW PLAST EC RETH FU; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2017, ANNU REV ENV RESOUR, V42, P1, DOI 10.1146/annurev-environ-102016-060700; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Yakin HSM., 2013, MEDITERR J SOC SCI, V4, P184, DOI [10.5901/mjss.2013.v4n9p184, DOI 10.5901/MJSS.2013.V4N9P184]; Zhao SY, 2016, SCI TOTAL ENVIRON, V550, P1110, DOI 10.1016/j.scitotenv.2016.01.112; Zurbrugg C., 2002, URBAN SOLID WASTE MA, P1	93	22	22	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236149	10.1371/journal.pone.0236149	http://dx.doi.org/10.1371/journal.pone.0236149			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722705	Green Published, gold			2022-12-26	WOS:000556916000020
J	Renaud, LR; Spekle, EM; van der Beek, AJ; van der Ploeg, HP; Pasman, HR; Huysmans, MA				Renaud, Lidewij R.; Spekle, Erwin M.; van der Beek, Allard J.; van der Ploeg, Hidde P.; Pasman, H. Roeline; Huysmans, Maaike A.			The user and non-user perspective: Experiences of office workers with long-term access to sit-stand workstations	PLOS ONE			English	Article							SEDENTARY BEHAVIOR INTERVENTIONS; SITTING TIME; HEALTH-RISKS; HOSPITALIZATION; PERCEPTIONS; STRATEGIES; OUTCOMES	Objective Sit-stand workstations have been shown to be effective in reducing sitting time in office workers. The aim of this study was to explore reasons for use and non-use of sit-stand workstations and strategies to decrease sitting and increase physical activity in the workplace from perspectives of users and non-users, as well as from managers and ergo-coaches. Methods Six group interviews with employees who have had access to sit-stand workstations for several years were conducted in a large semi-governmental organisation in the Netherlands. Verbatim transcripts were analysed using thematic analysis. Open coding was conducted by three researchers and codes and themes were discussed within the research team. Results Thematic analysis resulted in two major themes: 1) Reasons for use and non-use and 2) Strategies to increase standing and physical activity in the workplace. Shared and distinct reasons for use and non-use were identified between users and non-users of the sit-stand workstations. The most important reasons for use indicated by users were that they had experiencing immediate benefits, including staying alert and increasing focus; these benefits were not acknowledged by non-users. Non-users indicated that sitting was comfortable for them and that they were therefore not motivated to use the standing option. Strategies to increase the use of the standing option included an introductory phase to become familiar with working while standing and to experience the immediate benefits that come from using the standing option. Furthermore, providing reminders to use the standing option was suggested as a strategy to increase and sustain the use of sit-stand workstations. Increased use may lead to a change in the sitting culture within the organisation, as more employees would adopt active movement behaviours. Conclusion Immediate benefits of the use of the standing option-only mentioned by the users-was the most distinct reason to use sit-stand workstations. Future research should explore how to motivate potential users to adhere to an introductory phase in order to experience these immediate benefits, whether it is linked to the use of sit-stand workstations or other interventions to reduce sitting time.	[Renaud, Lidewij R.; Spekle, Erwin M.; van der Beek, Allard J.; van der Ploeg, Hidde P.; Pasman, H. Roeline; Huysmans, Maaike A.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam UMC, Amsterdam, Netherlands; [Spekle, Erwin M.] Occupat Hlth Serv, Arbo Unie, Utrecht, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam	Renaud, LR (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam UMC, Amsterdam, Netherlands.	l.renaud@amsterdamumc.nl	van der Ploeg, Hidde P/B-2599-2013; van der Ploeg, Hidde/ABD-6402-2021	van der Ploeg, Hidde P/0000-0002-3719-5249; Huysmans, Maaike A./0000-0002-6792-1934; van der Beek, Allard/0000-0002-4672-9062				[Anonymous], 2018, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD010912.PUB4; [Anonymous], 2014, AUSTR PHYS ACT SED B; Asvold BO, 2017, DIABETOLOGIA, V60, P830, DOI 10.1007/s00125-016-4193-z; Bailey DP, 2019, AM J PREV MED, V57, P408, DOI 10.1016/j.amepre.2019.04.015; Bernaards CM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3769-3; Biddle SJH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234762; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2021, QUAL RES SPORT EXERC, V13, P201, DOI 10.1080/2159676X.2019.1704846; Chambers AJ, 2019, APPL ERGON, V78, P37, DOI 10.1016/j.apergo.2019.01.015; Chau JY, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-752; Committee PAGA, 2018, 2018 PHYS ACT GUID A; De Cocker K, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0177-5; Dewitt S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7196-0; Dupont F, 2019, OCCUP ENVIRON MED, V76, P281, DOI 10.1136/oemed-2018-105397; Edwardson CL, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3870; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Gardner B, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0851-0; Gardner B, 2016, HEALTH PSYCHOL REV, V10, P89, DOI 10.1080/17437199.2015.1082146; Garrett G, 2019, APPL ERGON, V79, P17, DOI 10.1016/j.apergo.2019.04.003; Gezondheidsraad, 2017, 201708 GEZ; Gilson N, 2012, HEALTH PROMOT J AUST, V23, P208, DOI 10.1071/HE12208; Gilson ND, 2011, HEALTH PROMOT J AUST, V22, P38, DOI 10.1071/HE11038; Grunseit AC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-365; Hadgraft NT, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0718-9; Hadgraft NT, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0483-1; Hadgraft NT, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3611-y; Hadgraft Nyssa T, 2016, Prev Med Rep, V4, P184, DOI 10.1016/j.pmedr.2016.06.011; Healy GN, 2016, MED SCI SPORT EXER, V48, P1787, DOI 10.1249/MSS.0000000000000972; Henderson B, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6296-6; Kurita S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7782-1; Mansfield L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198483; McGuckin T, 2017, PERSPECT PUBLIC HEAL, V137, P316, DOI 10.1177/1757913917698003; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Nooijen CFJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040792; Officers UCM, 2019, UK CHIEF MED OFF PHY; Ojo SO, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7468-8; Ojo SO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030417; Parry S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078957; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Prince SA, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0790-9; Renaud LR, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15092019; RIVM, 2016, NED ZITT VEEL JONG M; Ryan CG, 2011, ERGONOMICS, V54, P531, DOI 10.1080/00140139.2011.570458; Ryde GC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16111906; Sharma PP, 2019, HUM FACTORS, V61, P816, DOI 10.1177/0018720818807043; Smith L, 2015, BMC PUBLIC HEALTH, V15, DOI [10.1186/s12889-014-1338-1, 10.1186/s12889-015-1459-1]; Stamatakis E, 2019, BRIT J SPORT MED, V53, P377, DOI 10.1136/bjsports-2018-099131; Stephens SK, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0731-z; Sudholz B, 2018, OCCUP MED-OXFORD, V68, P631, DOI 10.1093/occmed/kqy143; Sui WY, 2019, APPL ERGON, V75, P27, DOI 10.1016/j.apergo.2018.09.002; Taylor WC, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00263; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tuchsen F, 2005, OCCUP ENVIRON MED, V62, P847, DOI 10.1136/oem.2005.020537; Waters TR, 2015, REHABIL NURS, V40, P148, DOI 10.1002/rnj.166	56	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236582	10.1371/journal.pone.0236582	http://dx.doi.org/10.1371/journal.pone.0236582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722696	Green Published, gold			2022-12-26	WOS:000556916000019
J	Clark, CG; Landgraff, C; Robertson, J; Pollari, F; Parker, S; Nadon, C; Gannon, VPJ; Johnson, R; Nash, J				Clark, Clifford G.; Landgraff, Chrystal; Robertson, James; Pollari, Frank; Parker, Stephen; Nadon, Celine; Gannon, Victor P. J.; Johnson, Roger; Nash, John			Distribution of heavy metal resistance elements in Canadian Salmonella 4,[5],12:i:- populations and association with the monophasic genotypes and phenotype	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; R-TYPE ASSUT; CONFERRING MULTIDRUG-RESISTANCE; MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; HUMANS; SEROTYPE; REGION; EMERGENCE; VARIANT	Salmonella4,[5],12:i:- are monophasicS. Typhimurium variants incapable of producing the second-phase flagellar antigen. They have emerged since the mid-1990s to become one of the most prevalentSalmonellaserotypes causing human disease world-wide. Multiple genetic events associated with different genetic elements can result in the monophasic phenotype. Several jurisdictions have reported the emergence of aSalmonella4,[5],12:i:- clone with SGI-4 and a genetic element (MREL) encoding a mercury resistance operon and antibiotic resistance loci that disrupts the second phase antigen region near theiroBlocus in theSalmonellagenome. We have sequenced 810 human and animal CanadianSalmonella4,[5],12:i:- isolates and determined that isolates with SGI-4 and the mercury resistance element (MREL; also known as RR1&RR2) constitute several global clades containing various proportions of Canadian, US, and European isolates. Detailed analysis of the data provides a clearer picture of how these heavy metal elements interact with bacteria within theSalmonellapopulation to produce the monophasic phenotype. Insertion of the MREL neariroBis associated with several deletions and rearrangements of the adjacentflaAB hinregion, which may be useful for defining human case clusters that could represent outbreaks. Plasmids carrying genes encoding silver, copper, mercury, and antimicrobial resistance appear to be derived from IS26 mediated acquisition of these genes from genomes carrying SGI-4 and the MREL. Animal isolates with the mercury and As/Cu/Ag resistance elements are strongly associated with porcine sources in Canada as has been shown previously for other jurisdictions. The data acquired in these investigations, as well as from the extensive literature on the subject, may aid source attribution in outbreaks of the organism and interventions to decrease the prevalence of this clone and reduce its impact on human disease.	[Clark, Clifford G.; Landgraff, Chrystal; Nadon, Celine] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Robertson, James; Johnson, Roger; Nash, John] Publ Hlth Agcy Canada, Div Enter Dis, Natl Microbiol Lab, Guelph, ON, Canada; [Pollari, Frank; Parker, Stephen] Publ Hlth Agcy Canada, FoodNet Canada, Guelph, ON, Canada; [Nadon, Celine] Publ Hlth Agcy Canada, PulseNet Canada, Winnipeg, MB, Canada; [Gannon, Victor P. J.] Publ Hlth Agcy Canada, Div Enter Dis, Natl Microbiol Lab, Lethbridge, AB, Canada	Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada	Clark, CG (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	clifford.clark@canada.ca	; Nash, John/P-2384-2017	Clark, Clifford/0000-0003-0566-1468; Nash, John/0000-0003-2925-8710	Government of Canada Genomics Research and Development Initiative (GRDI) Phase VI; Government of Canada A-base program funding	Government of Canada Genomics Research and Development Initiative (GRDI) Phase VI; Government of Canada A-base program funding	Government of Canada Genomics Research and Development Initiative (GRDI) Phase VI -CGC, RJ Government of Canada A-base program funding -CGC, RJ, JN, JR, FP.	Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1826; Arai N, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00429-19; Arguello H, 2014, FOODBORNE PATHOG DIS, V11, P366, DOI 10.1089/fpd.2013.1672; Arnott A, 2018, EMERG INFECT DIS, V24, P751, DOI 10.3201/eid2404.171619; Arruda BL, 2019, EMERG INFECT DIS, V25, P1377, DOI 10.3201/eid2507.181453; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barco L, 2014, FOODBORNE PATHOG DIS, V11, P497, DOI 10.1089/fpd.2013.1714; Baumler AJ, 1998, J BACTERIOL, V180, P2220; Billman-Jacobe H, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02357-17, 10.1128/aac.02357-17]; Boland C, 2015, APPL ENVIRON MICROB, V81, P3169, DOI 10.1128/AEM.00270-15; Bonardi S, 2017, EPIDEMIOL INFECT, V145, P1513, DOI 10.1017/S095026881700036X; Branchu P, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01118; CDC, 2017, FOODB DIS ACT SUR NE; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Castro Fabíola Attié de, 2002, Braz J Infect Dis, V6, P244, DOI 10.1590/S1413-86702002000500005; Deng XL, 2012, FOODBORNE PATHOG DIS, V9, P305, DOI 10.1089/fpd.2011.1008; Echeita MA, 1999, J CLIN MICROBIOL, V37, P3425, DOI 10.1128/JCM.37.10.3425-3425.1999; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Elnekave E, 2018, CLIN INFECT DIS, V66, P877, DOI 10.1093/cid/cix909; Fang LX, 2016, SCI REP-UK, V6, DOI 10.1038/srep25312; Fernandes Sueli A., 2006, Rev. Inst. Med. trop. S. Paulo, V48, P179, DOI 10.1590/S0036-46652006000400001; Flockhart L, 2017, ZOONOSES PUBLIC HLTH, V64, P41, DOI 10.1111/zph.12281; Gallati C, 2013, FOODBORNE PATHOG DIS, V10, P549, DOI 10.1089/fpd.2012.1407; Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002; Garcia P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00680; Garcia P, 2013, J CLIN MICROBIOL, V51, P973, DOI 10.1128/JCM.02777-12; Gilmour MW, 2004, PLASMID, V52, P182, DOI 10.1016/j.plasmid.2004.06.006; Government of Canada, 1997, NAT ENT SURV PROGR A; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Hermans APHM, 2006, MICROBIOL-SGM, V152, P2137, DOI 10.1099/mic.0.28850-0; HOFFMANN M, 2017, FRONT MICROBIOL, V8, DOI DOI 10.3389/FCIMB.2017.01459; Hopkins K L, 2010, Euro Surveill, V15, P19580; Ido N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104380; Ido N, 2011, J VET MED SCI, V73, P241, DOI 10.1292/jvms.10-0140; Keegan VA, 2009, CAN J INFECT DIS MED, V20, P79, DOI 10.1155/2009/978784; Laorden L, 2010, J CLIN MICROBIOL, V48, P4563, DOI 10.1128/JCM.00337-10; Lucarelli C, 2012, J ANTIMICROB CHEMOTH, V67, P111, DOI 10.1093/jac/dkr391; Lucarelli C, 2010, J CLIN MICROBIOL, V48, P2103, DOI 10.1128/JCM.01371-09; Mastrorilli E, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00715; Matthews TC, 2018, BIORXIV381830; Mourao J, 2015, INT J ANTIMICROB AG, V45, P610, DOI 10.1016/j.ijantimicag.2015.01.013; Mulvey MR, 2013, J ANTIMICROB CHEMOTH, V68, P1982, DOI 10.1093/jac/dkt149; Myskova P, 2014, FOODBORNE PATHOG DIS, V11, P664, DOI 10.1089/fpd.2013.1703; Pang S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-718; Petkau A, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000116; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Petrovska L, 2016, EMERG INFECT DIS, V22, P617, DOI 10.3201/eid2204.150531; Rambaut A, 2010, FIGTREE V1 4 4; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schonfeld J, 2020, MICROBIAL RESOURCE A; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seixas R, 2016, FOODBORNE PATHOG DIS, V13, P633, DOI 10.1089/fpd.2016.2156; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; Staehlin BM, 2016, GENOME BIOL EVOL, V8, P811, DOI 10.1093/gbe/evw031; Sun HH, 2020, FOODBORNE PATHOG DIS, V17, P87, DOI 10.1089/fpd.2019.2676; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Tomiyama MPO, 2015, GENET MOL RES, V14, P19057, DOI 10.4238/2015.December.29.13; Walker M, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.00074-20; Yang XJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0137967, 10.1371/journal.pone.0125655]; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1	61	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236436	10.1371/journal.pone.0236436	http://dx.doi.org/10.1371/journal.pone.0236436			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716946	Green Published, gold			2022-12-26	WOS:000556674500026
J	Shi, X; Liu, TT; Yu, XN; Balakrishnan, A; Zhu, HR; Guo, HY; Zhang, GC; Bilegsaikhan, E; Sun, JL; Song, GQ; Weng, SQ; Dong, L; Ott, M; Zhu, JM; Shen, XZ				Shi, Xuan; Liu, Tao-Tao; Yu, Xiang-Nan; Balakrishnan, Asha; Zhu, Hai-Rong; Guo, Hong-Ying; Zhang, Guang-Cong; Bilegsaikhan, Enkhnaran; Sun, Jia-Lei; Song, Guang-Qi; Weng, Shu-Qiang; Dong, Ling; Ott, Michael; Zhu, Ji-Min; Shen, Xi-Zhong			microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit	ONCOGENE			English	Article							C-JUN; PATHWAY; JNK; PROLIFERATION; PATHOGENESIS; EXPRESSION; REPRESSION; APOPTOSIS; DATABASE; MAP3K2	Cumulative evidence suggests that microRNAs (miRNAs) promote gene expression in cancers. However, the pathophysiologic relevance of miRNA-mediated RNA activation in hepatocellular carcinoma (HCC) remains to be established. Our previous miRNA expression profiling in seven-paired HCC specimens revealed miR-93-5p as an HCC-related miRNA. In this study, miR-93-5p expression was assessed in HCC tissues and cell lines by quantitative real-time PCR and fluorescence in situ hybridization. The correlation of miR-93-5p expression with survival and clinicopathological features of HCC was determined by statistical analysis. The function and potential mechanism of miR-93-5p in HCC were further investigated by a series of gain- or loss-of-function experiments in vitro and in vivo. We identified that miR-93-5p, overexpressed in HCC specimens and cell lines, leads to poor outcomes in HCC cases and promotes proliferation, migration, and invasion in HCC cell lines. Mechanistically, rather than decreasing target mRNA levels as expected, miR-93-5p binds to the 3 '-untranslated region (UTR) of mitogen-activated protein kinase kinase kinase 2 (MAP3K2) to directly upregulate its expression and downstream p38 and c-Jun N-terminal kinase (JNK) pathway, thereby leading to cell cycle progression in HCC. Notably, we also demonstrated that c-Jun, a downstream effector of the JNK pathway, enhances miR-93-5p transcription by targeting its promoter region. Besides, downregulation of miR-93-5p significantly retarded tumor growth, while overexpression of miR-93-5p accelerated tumor growth in the HCC xenograft mouse model. Altogether, we revealed a miR-93-5p/MAP3K2/c-Jun positive feedback loop to promote HCC progression in vivo and in vitro, representing an RNA-activating role of miR-93-5p in HCC development.	[Shi, Xuan; Liu, Tao-Tao; Yu, Xiang-Nan; Zhu, Hai-Rong; Guo, Hong-Ying; Zhang, Guang-Cong; Bilegsaikhan, Enkhnaran; Sun, Jia-Lei; Song, Guang-Qi; Weng, Shu-Qiang; Dong, Ling; Zhu, Ji-Min; Shen, Xi-Zhong] Fudan Univ, Dept Gastroenterol & Hepatol, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Shi, Xuan; Liu, Tao-Tao; Yu, Xiang-Nan; Zhu, Hai-Rong; Guo, Hong-Ying; Zhang, Guang-Cong; Bilegsaikhan, Enkhnaran; Sun, Jia-Lei; Song, Guang-Qi; Weng, Shu-Qiang; Dong, Ling; Zhu, Ji-Min; Shen, Xi-Zhong] Fudan Univ, Shanghai Inst Liver Dis, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Balakrishnan, Asha; Ott, Michael] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Balakrishnan, Asha; Ott, Michael] TWINCORE, Ctr Expt & Clin Infect Res, Feodor Lynen Str 7, D-30625 Hannover, Germany; [Shen, Xi-Zhong] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, 130 Dongan Rd, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Fudan University	Zhu, JM; Shen, XZ (corresponding author), Fudan Univ, Dept Gastroenterol & Hepatol, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Zhu, JM; Shen, XZ (corresponding author), Fudan Univ, Shanghai Inst Liver Dis, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Shen, XZ (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, 130 Dongan Rd, Shanghai 200032, Peoples R China.	zhu.jimin@zs-hospital.sh.cn; shen.xizhong@zs-hospital.sh.cn	zhu, jimin/HDN-1451-2022; liu, taotao/GSI-7460-2022	Zhu, Ji-Min/0000-0002-2150-473X; Song, Guangqi/0000-0002-2409-0771	National Natural Science Foundation of China [81402273, 81672720, 81672334, 81700550]; National Clinical Key Special Subject of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Key Special Subject of China	This work was partly supported by the National Natural Science Foundation of China (grant numbers 81402273, 81672720, 81672334, and 81700550), and by the National Clinical Key Special Subject of China.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chaluvally-Raghavan P, 2016, CELL REP, V15, P1493, DOI 10.1016/j.celrep.2016.04.034; Chen CY, 2019, CLIN RES HEPATOL GAS, V43, P436, DOI 10.1016/j.clinre.2018.11.008; Chen X, 2015, MOL CANCER, V14, P11; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Delire B, 2015, EUR J CLIN INVEST, V45, P609, DOI 10.1111/eci.12441; Du L, 2014, ONCOGENE, V33, P4307, DOI 10.1038/onc.2013.381; Fallmann J, 2016, NUCLEIC ACIDS RES, V44, pD90, DOI 10.1093/nar/gkv1238; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gong C, 2015, ONCOGENE, V34, P84, DOI 10.1038/onc.2013.525; Guarnieri AL, 2018, ONCOGENE, V37, P3879, DOI 10.1038/s41388-018-0239-7; He Y, 2017, EXP THER MED, V13, P2003, DOI 10.3892/etm.2017.4204; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Ji CM, 2017, BIOTECHNOL LETT, V39, P1621, DOI 10.1007/s10529-017-2403-5; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Lee SY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53561-z; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li N, 2017, CELL DEATH DIS, V8; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Nahand JS, 2019, J CELL PHYSIOL, V234, P12188, DOI 10.1002/jcp.27956; Niu Y, 2018, ONCOGENE, V37, P1743, DOI 10.1038/s41388-017-0082-2; Ohta K, 2015, ONCOTARGET, V6, P3211, DOI 10.18632/oncotarget.3085; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pichon X, 2012, CURR PROTEIN PEPT SC, V13, P294, DOI 10.2174/138920312801619475; POLISENO L, 2010, SCI SIGNAL, V3, P29, DOI DOI 10.1126/SCISIGNAL.2000594; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sun Q, 2019, CELL DEATH DIS, V10; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang C., 2016, UROL ONCOL, V34, pe23; Wang CH, 2000, BIOCHEM BIOPH RES CO, V270, P303, DOI 10.1006/bbrc.2000.2422; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wu J, 2017, BIOCHEM BIOPH RES CO, V483, P10, DOI 10.1016/j.bbrc.2017.01.023; Xiao M, 2017, RNA BIOL, V14, P1326, DOI 10.1080/15476286.2015.1112487; Xue XF, 2018, BIOCHEM BIOPH RES CO, V502, P515, DOI 10.1016/j.bbrc.2018.05.208; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang Z, 2019, AUTOPHAGY, V15, P668, DOI 10.1080/15548627.2018.1539590; Yu J, 2015, AM J CANCER RES, V5, P802; Yu XN, 2020, ACS APPL MATER INTER, V12, P17193, DOI 10.1021/acsami.0c00375; Yu XN, 2020, ANN SURG ONCOL, V27, P1546, DOI 10.1245/s10434-020-08263-6; Zhu HR, 2018, TOHOKU J EXP MED, V245, P89, DOI 10.1620/tjem.245.89	46	16	17	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2020	39	35					5768	5781		10.1038/s41388-020-01401-0	http://dx.doi.org/10.1038/s41388-020-01401-0		JUL 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NF2QB	32719439				2022-12-26	WOS:000552933000001
J	Zhao, ZX; Li, XM; Zhou, XC				Zhao, Zhixue; Li, Xiamiao; Zhou, Xiancheng			Optimization of transportation routing problem for fresh food in time-varying road network: Considering both food safety reliability and temperature control	PLOS ONE			English	Article							ALGORITHM	Study on fresh food safety reliability and temperature control has being a research focus in the fresh food cold distribution optimization study field. On this basis, optimization of transportation routing problem with time windows for fresh food in time-varying road network is studied by considering both economic cost and fresh food safety loss. A calculation method for path division strategy is designed. A food safety value loss measurement function, a metric function of energy and heat conversion a measure function of carbon emission rate are employed by considering time-varying vehicle speeds, fuel consumptions, cost of temperature control, the loss of food safety reliability and carbon emissions from transportation and temperature control. The fresh food cold chain distribution vehicle routing problem model with time windows in time-varying road network is formulated based on the objective of the distribution cost and food safety value loss minimization. According to the characteristics of the model, an adaptive improved ant colony algorithm is designed. Finally, the experimental data show that the model can effectively avoid the congestion period, reasonably control the refrigeration temperature, reduce the distribution cost, and improve food safety.	[Zhao, Zhixue; Li, Xiamiao] Cent South Univ, Sch Traff & Transportat Engn, Changsha, Peoples R China; [Zhao, Zhixue; Zhou, Xiancheng] Hunan Univ Technol & Business, Key Lab Hunan Prov Mobile Business Intelligence, Changsha, Peoples R China	Central South University; Hunan University of Technology & Business	Zhao, ZX (corresponding author), Cent South Univ, Sch Traff & Transportat Engn, Changsha, Peoples R China.; Zhao, ZX (corresponding author), Hunan Univ Technol & Business, Key Lab Hunan Prov Mobile Business Intelligence, Changsha, Peoples R China.	zhaozhixue90@126.com			National Natural Science Foundation of China [71972069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Z X C, National Natural Science Foundation of China (No. 71972069) https://isisn.nsfc.gov.cn/.	Amorim P, 2014, TOP, V22, P489, DOI 10.1007/s11750-012-0266-4; Bruce G, 2008, VEHICLE ROUTING PROB; Chen F, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120669; Chen F, 2019, TRANSPORT RES C-EMER, V103, P17, DOI 10.1016/j.trc.2019.04.001; Chen HK, 2009, COMPUT OPER RES, V36, P2311, DOI 10.1016/j.cor.2008.09.010; Cordeau JF, 2002, J OPER RES SOC, V53, P512, DOI 10.1057/palgrave/jors/2601319; Devapriya P, 2017, EUR J OPER RES, V259, P906, DOI 10.1016/j.ejor.2016.09.019; Fang W T, 2019, CHINESE J MANAGEMENT, V27, P108; Hickman A.J., 1999, EUROPEAN COLD STARTS, V1, P69; Hsiao YH, 2017, TRENDS FOOD SCI TECH, V61, P80, DOI 10.1016/j.tifs.2016.11.016; Kang Kai, 2019, Computer Engineering and Applications, V55, P259, DOI 10.3778/j.issn.1002-8331.1709-0276; [兰辉 Lan Hui], 2015, [大连海事大学学报, Journal of Dalian Maritime University], V41, P67; Li Lin, 2010, Control and Decision, V25, P1379; Li N, 2015, APPL RES COMPUTER, V11, P67; [刘长石 Liu Changshi], 2020, [控制与决策, Control and Decision], V35, P1273; Liu H.O., 2019, STAT DECISION, V4, P176; Ma X L, 2017, IND ENG MANAGEMENT, V22, P46; Ma Xiangguo, 2016, Journal of System Simulation, V28, P1824; Osvald A, 2008, J FOOD ENG, V85, P285, DOI 10.1016/j.jfoodeng.2007.07.008; Shao Ju-ping, 2015, Industrial Engineering and Management, V20, P122; Soysal M, 2015, INT J PROD ECON, V164, P366, DOI 10.1016/j.ijpe.2014.11.016; Sun J, 2016, ACCIDENT ANAL PREV, V95, P503, DOI 10.1016/j.aap.2015.12.011; Tarantilis CD, 2001, J FOOD ENG, V50, P1, DOI 10.1016/S0260-8774(00)00187-4; Tiwari A, 2015, INT J PROD ECON, V164, P379, DOI 10.1016/j.ijpe.2014.11.003; [王晶 Wang Jing], 2018, [系统工程理论与实践, Systems Engineering-Theory & Practice], V38, P122; Wang SY, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9050694; [王勇 Wang Yong], 2020, [控制与决策, Control and Decision], V35, P1606; [吴瑶 Wu Yao], 2017, [系统工程理论与实践, Systems Engineering-Theory & Practice], V37, P172; Xiao YY, 2016, TRANSPORT RES E-LOG, V88, P146, DOI 10.1016/j.tre.2016.01.011; Xie R H, 2013, EMERGENCY MECH FOOD, P67; Zhang LL, 2020, J ADV TRANSPORT, V2020, DOI 10.1155/2020/2604012; Zwietering MH, 1996, INT J FOOD MICROBIOL, V30, P55, DOI 10.1016/0168-1605(96)00991-9	32	4	4	9	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0235950	10.1371/journal.pone.0235950; 10.1371/journal.pone.0235950.r001; 10.1371/journal.pone.0235950.r002; 10.1371/journal.pone.0235950.r003; 10.1371/journal.pone.0235950.r004; 10.1371/journal.pone.0235950.r005	http://dx.doi.org/10.1371/journal.pone.0235950; 10.1371/journal.pone.0235950.r001; 10.1371/journal.pone.0235950.r002; 10.1371/journal.pone.0235950.r003; 10.1371/journal.pone.0235950.r004; 10.1371/journal.pone.0235950.r005			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716964	Green Published, gold			2022-12-26	WOS:000556674500052
J	Jimenez, LV; Fakan, EP; McCormick, MI				Jimenez, Laura Velasquez; Fakan, Eric P.; McCormick, Mark, I			Vessel noise affects routine swimming and escape response of a coral reef fish	PLOS ONE			English	Article							ANTHROPOGENIC NOISE; SURVIVORSHIP; PERFORMANCE; EXPOSURE; HEARING	An increasing number of studies have shown that anthropogenic noise can negatively affect aspects of the anti-predator behaviour of reef fishes, potentially affecting fitness and survival. However, it has been suggested that effects could differ among noise sources. The present study compared two common sources of anthropogenic noise and investigated its effects on behavioural traits critical for fish survival. In a tank-based experiment we examined the effects of noise from 4-stroke motorboats and ships (bulk carriers > 50,000 tonnes) on the routine swimming and escape response of a coral reef fish, the whitetail damselfish (Pomacentrus chrysurus). Both 4-stroke boat and ship noise playbacks affected the fast-start response and routine swimming of whitetail damselfish, however the magnitude of the effects differed. Fish exposed to ship noise moved shorter distances and responded more slowly (higher response latency) to the startle stimulus compared to individuals under the 4-stroke noise treatment. Our study suggests that 4-stroke and ship noise can affect activity and escape response of individuals to a simulated predation threat, potentially compromising their anti-predator behaviour.	[Jimenez, Laura Velasquez; Fakan, Eric P.; McCormick, Mark, I] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Dept Marine Biol & Aquaculture, Townsville, Qld, Australia	James Cook University	Jimenez, LV (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Dept Marine Biol & Aquaculture, Townsville, Qld, Australia.	laura.velasquezjimenez@my.jcu.edu.au	Jimenez, Laura Velasquez/AAV-2432-2020	Jimenez, Laura Velasquez/0000-0002-0178-5562; Fakan, Eric/0000-0002-7060-0023	SeaWorld research and Rescue Foundation Research grant [SWR/1/2017]	SeaWorld research and Rescue Foundation Research grant	M. I. M. Grant number: SWR/1/2017 SeaWorld research and Rescue Foundation Research grant https://seaworld.com.au/conservation/get-involved/grants The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen G. R., 1991, DAMSELFISHES WORLD; Bobber RJ, 1970, UNDERWATER ELECTROAC, P271; Bracciali C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040582; Carroll AG, 2017, MAR POLLUT BULL, V114, P9, DOI 10.1016/j.marpolbul.2016.11.038; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; Colleye O, 2016, J EXP MAR BIOL ECOL, V483, P1, DOI 10.1016/j.jembe.2016.05.007; Cox K, 2018, GLOBAL CHANGE BIOL, V24, P3105, DOI 10.1111/gcb.14106; Domenici P, 1997, J EXP BIOL, V200, P1165; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; Ferran M, 2015, FUNCT ECOL, V2015; 29, P1553, DOI DOI 10.1111/1365-2435.12483; Ferrari MCO, 2015, FUNCT ECOL, V29, P1553, DOI 10.1111/1365-2435.12483; Fuiman LA, 2010, OECOLOGIA, V164, P99, DOI 10.1007/s00442-010-1712-3; Godin Jean-Guy J., 1997, P191; Gordon TAC, 2018, P NATL ACAD SCI USA, V115, P5193, DOI 10.1073/pnas.1719291115; Great Barrier Reef Marine Park Authority, 2019, GREAT BARR REEF OUTL; Great Barrier Reef Marine Park Authority, 2019, GREAT BARR REEF ANN; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Houde E.D., 1987, American Fisheries Society Symposium, P17; Jain-Schlaepfer S, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy014; Kenyon TN, 1996, J COMP PHYSIOL A, V179, P553; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Manassa RP, 2013, OECOLOGIA, V171, P845, DOI 10.1007/s00442-012-2458-x; McCormick MI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43099-5; McCormick MI, 2018, FUNCT ECOL, V32, P958, DOI 10.1111/1365-2435.13033; McCormick MI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22104-3; Nedelec SL, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0143; Neo YY, 2018, ENVIRON POLLUT, V239, P367, DOI 10.1016/j.envpol.2018.04.018; Nichols TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139157; Purser J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017478; Radford AN, 2016, GLOBAL CHANGE BIOL, V22, P3349, DOI 10.1111/gcb.13352; Radford AN, 2014, BEHAV ECOL, V25, P1022, DOI [10.1093/beheco/aru029, 10.1093/beheco/art102]; Rogers PH, 2016, ADV EXP MED BIOL, V875, P933, DOI 10.1007/978-1-4939-2981-8_115; Ross D., 1976, MECH UNDERWATER NOIS; Simpson SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10544; Simpson SD, 2015, GLOBAL CHANGE BIOL, V21, P586, DOI 10.1111/gcb.12685; Slabbekoorn H., 2014, EFFECTS NOISE AQUATI, P1057; Slabbekoorn H, 2016, ADV EXP MED BIOL, V875, P1057, DOI 10.1007/978-1-4939-2981-8_131; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Small C, 2003, J COASTAL RES, V19, P584; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Todd VLG, 2016, MAR POLLUT BULL, V102, P1, DOI 10.1016/j.marpolbul.2015.11.059; Voellmy IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102946; Wale MA, 2013, ANIM BEHAV, V86, P111, DOI 10.1016/j.anbehav.2013.05.001; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; WEBB PW, 1976, J EXP BIOL, V65, P157; Wright KJ, 2011, MAR ECOL PROG SER, V424, P1, DOI 10.3354/meps09004; Wysocki LE, 2006, BIOL CONSERV, V128, P501, DOI 10.1016/j.biocon.2005.10.020	47	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235742	10.1371/journal.pone.0235742	http://dx.doi.org/10.1371/journal.pone.0235742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702032	Green Published, gold, Green Accepted			2022-12-26	WOS:000575913700023
J	Koester, LR; Poole, DH; Serao, NVL; Schmitz-Esser, S				Koester, Lucas R.; Poole, Daniel H.; Serao, Nick V. L.; Schmitz-Esser, Stephan			Beef cattle that respond differently to fescue toxicosis have distinct gastrointestinal tract microbiota	PLOS ONE			English	Article							TALL FESCUE; ERGOT ALKALOIDS; GENE; POLYMORPHISM; HEREFORD	Tall fescue (Lolium arundinaceum) is a widely used forage grass which shares a symbiosis with the endophytic fungus Epichloe coenophiala. The endophyte produces an alkaloid toxin that provides herbivory, heat and drought resistance to the grass, but can cause fescue toxicosis in grazing livestock. Fescue toxicosis can lead to reduced weight gain and milk yields resulting in significant losses to the livestock industry. The objective of this study was to identify bacterial and fungal communities associated with fescue toxicosis tolerance. In this trial, 149 Angus cows across two farms were continuously exposed to toxic, endophyte-infected, fescue for a total of 13 weeks. Of those 149 cows, 40 were classified into either high (HT) or low (LT) tolerance groups according to their growth performance (weight gain). 20 HT and 20 LT cattle balanced by farm were selected for amplicon sequencing to compare the fecal microbiota of the two tolerance groups. This study reveals significantly (q<0.05) different bacterial and fungal microbiota between HT and LT cattle, and indicates that fungal phylotypes may be important for an animal's response to fescue toxicosis: We found that fungal phylotypes affiliating to the Neocallimastigaceae, which are known to be important fiber-degrading fungi, were consistently more abundant in the HT cattle. Whereas fungal phylotypes related to the genus Thelebolus were more abundant in the LT cattle. This study also found more pronounced shifts in the microbiota in animals receiving higher amounts of the toxin. We identified fungal phylotypes which were consistently more abundant either in HT or LT cattle and may thus be associated with the respective animal's response to fescue toxicosis. Our results thus suggest that some fungal phylotypes might be involved in mitigating fescue toxicosis.	[Koester, Lucas R.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Koester, Lucas R.; Schmitz-Esser, Stephan] Iowa State Univ, Interdept Microbiol Grad Program, Ames, IA 50011 USA; [Poole, Daniel H.] North Carolina State Univ, Dept Anim Sci, Raleigh, NC USA; [Serao, Nick V. L.; Schmitz-Esser, Stephan] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Iowa State University; Iowa State University; University of North Carolina; North Carolina State University; Iowa State University	Schmitz-Esser, S (corresponding author), Iowa State Univ, Interdept Microbiol Grad Program, Ames, IA 50011 USA.; Serao, NVL; Schmitz-Esser, S (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	serao@iastate.edu; sse@iastate.edu	Serão, Nick/AAE-5868-2019; Schmitz-Esser, Stephan/AAA-7287-2019	Serão, Nick/0000-0002-6758-208X; Schmitz-Esser, Stephan/0000-0002-1907-0709	North Carolina Cattlemen's association; North Carolina Agricultural foundation	North Carolina Cattlemen's association; North Carolina Agricultural foundation	This work was supported by North Carolina Cattlemen's association and North Carolina Agricultural foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn G, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skz374; Bastin BC, 2014, ANIM GENET, V45, P439, DOI 10.1111/age.12134; Berghof TVL, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00692; Bouton JH, 2002, AGRON J, V94, P567, DOI 10.2134/agronj2002.0567; Browning R, 2000, J ANIM SCI, V78, P124; Browning R, 2004, J ANIM SCI, V82, P634; Burke CR, 2010, J DAIRY SCI, V93, P5363, DOI 10.3168/jds.2010-3356; Campbell BT, 2014, ANIM BIOTECHNOL, V25, P1, DOI 10.1080/10495398.2013.796960; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cole N. A., 2001, PROF ANIM SCI, V17, P174, DOI DOI 10.15232/S1080-7446(15)31619-3; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Deshmukh SK, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00715; Di Blasio A, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2009-3; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Edwards JE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01657; Galliou JM, 2017, J ANIM SCI, V95, P55, DOI 10.2527/ssasas2017.0113; Guerre P, 2015, TOXINS, V7, P773, DOI 10.3390/toxins7030773; Harlow BE, 2017, J ANIM SCI, V95, P980, DOI 10.2527/jas.2016.1128; Ishaq SL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01943; Kallenbach RL, 2015, J ANIM SCI, V93, P5487, DOI 10.2527/jas.2015-9229; Khanal P, 2017, J ANIM SCI, V95, P18, DOI 10.2527/ssasas2017.038; Khanal P, 2018, P WORLD C GEN APPL L, P702; Klotz JL, 2015, TOXINS, V7, P2801, DOI 10.3390/toxins7082801; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Looper ML, 2010, J ANIM SCI, V88, P4133, DOI 10.2527/jas.2010-3192; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Mote RS, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00032-19; MOYER JL, 1993, CROP SCI, V33, P264, DOI 10.2135/cropsci1993.0011183X003300020009x; Mukhopadhyay SK, 2017, COLLOID SURFACE B, V155, P379, DOI 10.1016/j.colsurfb.2017.04.011; Mukhopadhyay SK, 2014, CARBOHYD POLYM, V104, P204, DOI 10.1016/j.carbpol.2014.01.034; Nilsson RH, 2019, NAT REV MICROBIOL, V17, P95, DOI 10.1038/s41579-018-0116-y; Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022; Parish JA, 2003, J ANIM SCI, V81, P1316; Poole RK, 2019, J ANIM SCI, V97, P3776, DOI 10.1093/jas/skz249; Poole RK, 2019, J ANIM SCI, V97, P4160, DOI 10.1093/jas/skz250; Poole RK, 2019, TOXINS, V11, DOI 10.3390/toxins11060364; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2019, R LANG ENV STAT COMP; Rattray RM, 2010, CURR MICROBIOL, V60, P229, DOI 10.1007/s00284-009-9530-8; Roberts C, 2004, MATH PHYS ANAL GEOM, V7, P1, DOI 10.1023/B:MPAG.0000022829.24539.ed; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROTTINGHAUS GE, 1993, J VET DIAGN INVEST, V5, P242, DOI 10.1177/104063879300500216; Sanglard LP, 2020, J ANIM BREED GENET, V137, P84, DOI 10.1111/jbg.12456; Storey J.D., 2020, QVALUE Q VALUE ESTIM; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strickland JR, 2011, J ANIM SCI, V89, P1603, DOI 10.2527/jas.2010-3478; Tega L, 2007, EMERG INFECT DIS, V13, P355, DOI 10.3201/eid1302.060858; Thamhesl M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0407-7; Wang TY, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-24; White Bruns T, 1990, AMPLIFICATION DIRECT, P315; Young CA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00095; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	54	12	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0229192	10.1371/journal.pone.0229192	http://dx.doi.org/10.1371/journal.pone.0229192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701945	Green Published, gold, Green Submitted			2022-12-26	WOS:000575913700003
J	Lindemann, J; Rakers, C; Matuskova, H; Simon, BJ; Kinfe, T; Petzold, GC				Lindemann, Jan; Rakers, Cordula; Matuskova, Hana; Simon, Bruce J.; Kinfe, Thomas; Petzold, Gabor C.			Vagus nerve stimulation reduces spreading depolarization burden and cortical infarct volume in a rat model of stroke	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; PERIINFARCT DEPOLARIZATIONS; DEPRESSION; BRAIN; ISCHEMIA; MIGRAINE; TRANSIENTS; INDUCTION; CHANNELS; SIZE	Cortical spreading depolarization (SD) waves negatively affect neuronal survival and outcome after ischemic stroke. We here aimed to investigate the effects of vagus nerve stimulation (VNS) on SDs in a rat model of focal ischemia. To this end, we delivered non-invasive VNS (nVNS) or invasive VNS (iVNS) during permanent middle cerebral artery occlusion (MCAO), and found that both interventions significantly reduced the frequency of SDs in the cortical peri-infarct area compared to sham VNS, without affecting relative blood flow changes, blood pressure, heart rate or breathing rate. In separate groups of rats subjected to transient MCAO, we found that cortical stroke volume was reduced 72 h after transient MCAO, whereas stroke volume in the basal ganglia remained unchanged. In rats treated with nVNS, motor outcome was improved 2 days after transient MCAO, but was similar to sham VNS animals 3 days after ischemia. We postulate that VNS may be a safe and efficient intervention to reduce the clinical burden of SD waves in stroke and other conditions.	[Lindemann, Jan; Rakers, Cordula; Matuskova, Hana; Petzold, Gabor C.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Simon, Bruce J.] ElectroCore Inc, Basking Ridge, NJ USA; [Kinfe, Thomas] Univ Hosp Bonn, Dept Neurosurg, Bonn, Germany; [Kinfe, Thomas] Univ Hosp Erlangen, Dept Neurosurg, Div Funct & Stereotact Neurosurg, Erlangen, Germany; [Petzold, Gabor C.] Univ Hosp Bonn, Dept Neurol, Div Vasc Neurol, Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Erlangen Nuremberg; University of Bonn	Petzold, GC (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.; Petzold, GC (corresponding author), Univ Hosp Bonn, Dept Neurol, Div Vasc Neurol, Bonn, Germany.	gabor.petzold@dzne.de	Kinfe, Thomas/AAY-7093-2020	Kinfe, Thomas/0000-0002-4888-543X	German Science Foundation DFG [FOR 2795/PE1193/6-1]; DZNE (DEMDAS Intersite grant); electroCore Inc.	German Science Foundation DFG(German Research Foundation (DFG)); DZNE (DEMDAS Intersite grant); electroCore Inc.	This work was supported by grants to GCP from the German Science Foundation DFG (FOR 2795/PE1193/6-1) and the DZNE (DEMDAS Intersite grant). The funder electroCore Inc. provided support in the form of materials (electrodes and stimulators) and salary for author BJS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ay I, 2016, BRAIN STIMUL, V9, P166, DOI 10.1016/j.brs.2015.11.008; Ay I, 2011, BRAIN RES, V1392, P110, DOI 10.1016/j.brainres.2011.03.060; Ay I, 2009, NEUROSCI LETT, V459, P147, DOI 10.1016/j.neulet.2009.05.018; BENMENACHEM E, 1995, EPILEPSY RES, V20, P221, DOI 10.1016/0920-1211(94)00083-9; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chen SP, 2016, PAIN, V157, P797, DOI 10.1097/j.pain.0000000000000437; Cunningham JT, 2008, NEUROPSYCHOPHARMACOL, V33, P1884, DOI 10.1038/sj.npp.1301570; Dreier JP, 2018, NEUROPHARMACOLOGY, V134, P189, DOI 10.1016/j.neuropharm.2017.09.027; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fornai F, 2011, EUR J NEUROSCI, V33, P2169, DOI 10.1111/j.1460-9568.2011.07707.x; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ginsberg MD, 2003, ANN NEUROL, V54, P330, DOI 10.1002/ana.10659; Golanov EV, 1999, BRAIN RES, V818, P304, DOI 10.1016/S0006-8993(98)01169-X; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hiraki T, 2012, J NEUROSCI RES, V90, P887, DOI 10.1002/jnr.22812; Lapilover EG, 2012, NEUROBIOL DIS, V48, P495, DOI 10.1016/j.nbd.2012.06.024; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; le Grand SM, 2011, HEADACHE, V51, P1152, DOI 10.1111/j.1526-4610.2011.01931.x; Lewine JD, 2019, NEUROMODULATION, V22, P564, DOI 10.1111/ner.12864; Liu AF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0858-0; Luckl J, 2009, J NEUROSCI RES, V87, P1219, DOI 10.1002/jnr.21933; Manta S, 2013, INT J NEUROPSYCHOPH, V16, P459, DOI 10.1017/S1461145712000387; Mestre H, 2020, SCIENCE, V367, P1211, DOI 10.1126/science.aax7171; Oshinsky ML, 2014, PAIN, V155, P1037, DOI 10.1016/j.pain.2014.02.009; Petzold GC, 2005, BRAIN RES, V1063, P9, DOI 10.1016/j.brainres.2005.09.048; Pusic KM, 2014, GLIA, V62, P1176, DOI 10.1002/glia.22672; Rakers C, 2019, GLIA, V67, P619, DOI 10.1002/glia.23544; Rakers C, 2017, GLIA, V65, P1550, DOI 10.1002/glia.23183; Rakers C, 2017, J CLIN INVEST, V127, P511, DOI 10.1172/JCI89354; Richter F, 2005, J CEREBR BLOOD F MET, V25, P1225, DOI 10.1038/sj.jcbfm.9600120; Sadeghian H, 2018, ANN NEUROL, V84, P409, DOI 10.1002/ana.25298; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Yang YR, 2018, BRAIN STIMUL, V11, P689, DOI 10.1016/j.brs.2018.01.034	37	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236444	10.1371/journal.pone.0236444	http://dx.doi.org/10.1371/journal.pone.0236444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702055	gold, Green Published			2022-12-26	WOS:000575913700094
J	Sargent, J; Roberts, V; D'Souza, K; Wright, A; Gaffney, J; Frias, A				Sargent, James; Roberts, Victoria; D'Souza, Karen; Wright, Adam; Gaffney, Jessica; Frias, Antonio			Micro-anatomic alterations of the placenta in a non-human primate model of gestational protein-restriction	PLOS ONE			English	Article							MALNUTRITION; NUTRITION	Objectives Maternal protein malnutrition is associated with impaired fetal growth, and lifetime consequences for the offspring. Our group has previously developed a model of protein-restriction in the non-human primate, which was associated with fetal growth restriction, stillbirth, decreased placental perfusion, and evidence of fetal hypoxia, suggesting perturbed vascular development. Our objective was to histologically characterize the micro-anatomic alterations associated with adverse pregnancy outcomes taking an approach that permits investigation of the 3D vascular structure and surrounding histology without the requirement for 3D vascular casting or relying on 2D stereology which both have methodological limitations. Methods Rhesus macaques were assigned in the pre-gestational period to a control diet that contained 26% protein, or study diet containing 13% protein (50% PR diet). Placental tissue was collected at delivery and processed using a clarification, immunohistochemistry, and confocal microscopy protocol published previously by our group. Three dimensional reconstructions and quantitative assessment of the vascular micro-anatomy was performed using analysis software (Imaris (R)) and statistical analysis accounted for maternal and fetal confounders. Results In unadjusted analysis, when comparing those pregnancies on a 50% PR diet (n = 4) with those on a control diet (n = 4), protein-restriction diet was associated with decreased maternal pre-pregnancy weight (difference of -1.975kg, 95% CI -3.267 to -0.6826). When controlling for maternal pre-pregnancy weight, fetal sex, and latency from tissue collection to imaging, a gestational protein-restriction diet was associated with decreases in total vascular length, total vascular surface area, total vascular volume, and vascular density. Conclusion In this pilot study, a gestational protein-restriction diet altered the placental micro-vasculature with decreased vascular caliber and density, which may be related to the observed adverse pregnancy outcomes and perturbed placental perfusion previously demonstrated in this model.	[Sargent, James] Univ Texas Hlth Sci Houston, Houston, TX 77030 USA; [Roberts, Victoria; D'Souza, Karen; Wright, Adam; Gaffney, Jessica; Frias, Antonio] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR USA; [Frias, Antonio] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA	University of Texas System; University of Texas Health Science Center Houston; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Sargent, J (corresponding author), Univ Texas Hlth Sci Houston, Houston, TX 77030 USA.	james.sargent@gmail.com		Wright, Adam/0000-0001-9524-2210; Sargent, James/0000-0002-9895-8561; DSouza, Karen/0000-0003-3230-5100	Bill & Melinda Gates Foundation [OPP1110865]; NIH [R01 HD086331]; Office of the Director, of the National Institutes of Health [P51OD011092]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this project was provided by The Bill & Melinda Gates Foundation (OPP1110865) and NIH R01 HD086331 (Frias). In addition, research reported in this publication was supported by the Office of the Director, of the National Institutes of Health under Award Number P51OD011092 to the Oregon National Primate Research Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BC, 2018, REPRODUCTION, V156, pR69, DOI 10.1530/REP-18-0130; Bourke CD, 2016, TRENDS IMMUNOL, V37, P386, DOI 10.1016/j.it.2016.04.003; Connor KL, 2018, BIOL REPROD, V98, P579, DOI 10.1093/biolre/ioy002; Fall CHD, 2013, NESTLE NUTR WORKS SE, V74, P11, DOI 10.1159/000348384; FAO IFAD UNICEF WFP and WHO, 2018, STAT FOOD SEC NUTR W; Furuya M, 2008, VASC HEALTH RISK MAN, V4, P1301, DOI 10.2147/VHRM.S4009; Ghosh S, 2012, BRIT J NUTR, V108, pS77, DOI 10.1017/S0007114512002577; Gonzalez PN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152227; Haeussner E, 2015, PLACENTA, V36, P1425, DOI 10.1016/j.placenta.2015.10.003; Junaid TO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04379-0; Kovo M, 2015, REPROD SCI, V22, P316, DOI 10.1177/1933719114542024; Marques AH, 2015, BRAIN RES, V1617, P28, DOI 10.1016/j.brainres.2014.10.051; Papathakis PC, 2016, MOL CELL ENDOCRINOL, V435, P40, DOI 10.1016/j.mce.2016.01.024; RAMSEY EM, 1976, AM J OBSTET GYNECOL, V124, P647, DOI 10.1016/0002-9378(76)90068-5; Ribatti D, 2015, METHODS MOL BIOL, V1214, P1, DOI 10.1007/978-1-4939-1462-3; Roberts VHJ, 2018, REPROD SCI, V25, P110, DOI 10.1177/1933719117704907; Sargent JA, 2019, BIOTECHNIQUES, V66, P79, DOI 10.2144/btn-2018-0110; Semba RD, 2016, EBIOMEDICINE, V6, P246, DOI 10.1016/j.ebiom.2016.02.030; ZENG LX, 2008, BMJ-BRIT MED J, V337, DOI DOI 10.1136/BMJ.A2001; Zhou J, 2016, J PEDIATR-US, V178, P40, DOI 10.1016/j.jpeds.2016.06.017	20	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235840	10.1371/journal.pone.0235840	http://dx.doi.org/10.1371/journal.pone.0235840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702025	Green Published, gold			2022-12-26	WOS:000575913700028
J	Zheng, CL; Berger, NA; Li, L; Xu, R				Zheng, Chunlei; Berger, Nathan A.; Li, Li; Xu, Rong			Epigenetic age acceleration and clinical outcomes in gliomas	PLOS ONE			English	Article							DNA METHYLATION AGE; SURVIVAL; BLOOD; EXPRESSION; MORTALITY; PROFILES; SUBSETS; RISK; WIDE	Epigenetic age acceleration-the difference between an individual's DNA methylation age and chronological age-is associated with many diseases including cancer. This study aims to evaluate epigenetic age acceleration as a prognostic biomarker for gliomas. DNA methylation data of gliomas patients (516 low-grade and intermediate-grade gliomas and 140 glioblastoma) were obtained from The Cancer Genome Atlas (TCGA) and patient epigenetic ages were computed using Horvath's age prediction model. We used multivariate linear regression to assess the association of epigenetic age acceleration with tumor molecular subtypes, including Codel, Classic-like, G-CIMP-high, G-CIMP-low, Mesenchymal-like and PA-like. Compared with Codel subtype, epigenetic ages in other molecular subtypes show deceleration after controlling age and race. Age deceleration for Classic-like, G-CIMP-high, G-CIMP-low, Mesenchymal-like and PA-like were 15.42 years (CI: 7.98-22.86, p = 5.38E-05), 25.00 years (CI: 20.79-29.22, p = 4.06E-28), 28.56 years (CI: 14.37-42.74, p = 8.75E-05), 45.34 years (CI: 38.80-51.88, p = 2.15E-36), and 53.58 years (CI: 44.90-62.26, p = 4.81E-30), respectively. Then, Cox proportional hazards regression was used to assess the association of epigenetic age acceleration with patient overall survival. Our results show epigenetic age acceleration is positively associated with patient overall survival (per 10-year age acceleration, HR = 0.89; 95%CI: 0.82-0.97; p = 9.04E-03) in multivariate analysis. When stratified by molecular subtypes, epigenetic age acceleration remains positively associated with patient survival after adjusting age and tumor grade. In conclusion, epigenetic age acceleration is significantly associated with molecular subtypes and patient overall survival in gliomas, indication that epigenetic age acceleration has potential as a quantitative prognostic biomarker for gliomas.	[Zheng, Chunlei; Xu, Rong] Case Western Reserve Univ, Sch Med, Ctr Artificial Intelligence Drug Discovery, Cleveland, OH 44106 USA; [Berger, Nathan A.] Case Western Reserve Univ, Sch Med, Ctr Sci Hlth & Soc, Cleveland, OH 44106 USA; [Berger, Nathan A.; Xu, Rong] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Li, Li] Univ Virginia, Sch Med, Dept Family Med, Charlottesville, VA 22908 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Virginia	Xu, R (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Artificial Intelligence Drug Discovery, Cleveland, OH 44106 USA.; Xu, R (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	rxx@case.edu		Zheng, Chunlei/0000-0002-9737-461X	NIH [DP2HD084068, R01 AG057557-01, R01 AG061388-01, R56 AG062272-01]; American Cancer Society [RSG-16-049-01-MPC]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society)	Funding for our research projects was provided by NIH (nih.gov) grants to RX, including DP2HD084068, R01 AG057557-01, R01 AG061388-01 and R56 AG062272-01, and American Cancer Society (cancer.org) grant (RSG-16-049-01-MPC to R. Xu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020; Chen R, 2017, NEUROTHERAPEUTICS, V14, P284, DOI 10.1007/s13311-017-0519-x; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Christiansen L, 2016, AGING CELL, V15, P149, DOI 10.1111/acel.12421; Dugue PA, 2018, INT J CANCER, V142, P1611, DOI 10.1002/ijc.31189; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Gusyatiner O, 2018, SEMIN CANCER BIOL, V51, P50, DOI 10.1016/j.semcancer.2017.11.010; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Horvath S, 2015, AGING-US, V7, P1130, DOI 10.18632/aging.100859; Horvath S, 2015, AGING CELL, V14, P491, DOI 10.1111/acel.12325; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Koch CM, 2011, AGING-US, V3, P1018, DOI 10.18632/aging.100395; Lambert SR, 2013, ACTA NEUROPATHOL, V126, P291, DOI 10.1007/s00401-013-1124-7; Lapointe S, 2018, LANCET, V392, P432, DOI 10.1016/S0140-6736(18)30990-5; Latorre E, 2017, AGEING RES REV, V36, P165, DOI 10.1016/j.arr.2017.04.004; Levine ME, 2015, AGING-US, V7, P1198, DOI 10.18632/aging.100864; Liao P, 2018, NEURO-ONCOLOGY, V20, P942, DOI 10.1093/neuonc/noy003; Lin Q, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005334; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; McClay JL, 2014, HUM MOL GENET, V23, P1175, DOI 10.1093/hmg/ddt511; Mur P, 2013, ACTA NEUROPATHOL, V126, P277, DOI 10.1007/s00401-013-1130-9; Murphy ES, 2018, INT J RADIAT ONCOL, V100, P965, DOI 10.1016/j.ijrobp.2017.12.258; Nevalainen T, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-016-0301-7; Olson RA, 2011, J NEURO-ONCOL, V105, P325, DOI 10.1007/s11060-011-0594-5; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perna L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0228-z; Ren JT, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4884-6; Shinojima N, 2003, CANCER RES, V63, P6962; Spratt DE, 2016, JAMA ONCOL, V2, P1070, DOI 10.1001/jamaoncol.2016.1854; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24; Zhang CB, 2013, FRONT MED-PRC, V7, P150, DOI 10.1007/s11684-013-0267-1; Zhang Y., 2018, ADV MECH ENG, V10, P1, DOI DOI 10.3390/su10103546; Zheng CL, 2019, CANCER EPIDEM BIOMAR, V28, P1720, DOI 10.1158/1055-9965.EPI-19-0208	39	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236045	10.1371/journal.pone.0236045	http://dx.doi.org/10.1371/journal.pone.0236045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692766	Green Published, gold			2022-12-26	WOS:000554606400022
J	Martinelli, L; Adamopoulos, A; Johansson, P; Wan, PT; Gunnarsson, J; Guo, HW; Boyd, H; Zelcer, N; Sixma, TK				Martinelli, Luca; Adamopoulos, Athanassios; Johansson, Patrik; Wan, Paul T.; Gunnarsson, Jenny; Guo, Hongwei; Boyd, Helen; Zelcer, Noam; Sixma, Titia K.			Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; E3 ubiquitin ligase; ubiquitylation (ubiquitination); cholesterol metabolism; IDOL; MYLIP; LDLR; FERM; lipoprotein metabolism; low-density lipoprotein (LDL); protein structure; small-angle X-ray scattering (SAXS); enzyme purification; FERM domain; LDL receptor	LOW-DENSITY-LIPOPROTEIN; SMALL-ANGLE SCATTERING; FULLY-AUTOMATIC CHARACTERIZATION; LEUCINE ZIPPER PROTEIN; INDUCIBLE DEGRADER; CRYSTAL-STRUCTURE; ERM PROTEINS; BIOLOGICAL MACROMOLECULES; CYTOPLASMIC TAIL; DATA-COLLECTION	Hepatic abundance of the low-density lipoprotein receptor (LDLR) is a critical determinant of circulating plasma LDL cholesterol levels and hence development of coronary artery disease. The sterol-responsive E3 ubiquitin ligase inducible degrader of the LDLR (IDOL) specifically promotes ubiquitination and subsequent lysosomal degradation of the LDLR and thus controls cellular LDL uptake. IDOL contains an extended N-terminal FERM (4.1 protein, ezrin, radixin, and moesin) domain, responsible for substrate recognition and plasma membrane association, and a second C-terminal RING domain, responsible for the E3 ligase activity and homodimerization. As IDOL is a putative lipid-lowering drug target, we investigated the molecular details of its substrate recognition. We produced and isolated full-length IDOL protein, which displayed high autoubiquitination activity. However,in vitroubiquitination of its substrate, the intracellular tail of the LDLR, was low. To investigate the structural basis for this, we determined crystal structures of the extended FERM domain of IDOL and multiple conformations of its F3ab subdomain. These reveal the archetypal F1-F2-F3 trilobed FERM domain structure but show that the F3c subdomain orientation obscures the target-binding site. To substantiate this finding, we analyzed the full-length FERM domain and a series of truncated FERM constructs by small-angle X-ray scattering (SAXS). The scattering data support a compact and globular core FERM domain with a more flexible and extended C-terminal region. This flexibility may explain the low activityin vitroand suggests that IDOL may require activation for recognition of the LDLR.	[Martinelli, Luca; Adamopoulos, Athanassios; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands; [Martinelli, Luca; Zelcer, Noam] Univ Amsterdam, Dept Med Biochem, Amsterdam UMC, Amsterdam Cardiovasc Sci & Gastroenterol & Metab, Amsterdam, Netherlands; [Johansson, Patrik; Wan, Paul T.; Gunnarsson, Jenny; Guo, Hongwei; Boyd, Helen] AstraZeneca, IMED Biotech Unit, Discovery Sci, Pepparedsleden 1, Molndal, Sweden; [Sixma, Titia K.] Oncode Inst, Utrecht, Netherlands; [Martinelli, Luca] Janssen Vaccines & Prevent BV, Analyt Dev Dept, Leiden, Netherlands; [Wan, Paul T.] Charles River Lab UK, Struct Biol, Saffron Walden, Essex, England; [Guo, Hongwei] CEV Technol AB, Gothenburg, Sweden; [Boyd, Helen] AstraZeneca, Clin Pharmacol & Safety Sci, R&D, Cambridge, England	Netherlands Cancer Institute; University of Amsterdam; AstraZeneca; AstraZeneca	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands.; Zelcer, N (corresponding author), Univ Amsterdam, Dept Med Biochem, Amsterdam UMC, Amsterdam Cardiovasc Sci & Gastroenterol & Metab, Amsterdam, Netherlands.; Sixma, TK (corresponding author), Oncode Inst, Utrecht, Netherlands.	n.zelcer@amc.uva.nl; t.sixma@nki.nl		Zelcer, Noam/0000-0001-6935-7532; Adamopoulos, Athanassios/0000-0002-3544-4619; Sixma, Titia K/0000-0001-6180-0632	ERC [617376]; European Research Council [862537]; Netherlands Organization for Scientific Research (NWO) [016.176.643]; AstraZeneca; NWO [714.014.002]; Dutch Heart Foundation [2013T111]	ERC(European Research Council (ERC)European Commission); European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); AstraZeneca(AstraZeneca); NWO(Netherlands Organization for Scientific Research (NWO)); Dutch Heart Foundation(Netherlands Heart Foundation)	This research was supported by ERC Consolidator Grant 617376 and Proof-of-Concept Grant 862537 (to N. Z.) from the European Research Council, Vici Grant 016.176.643 from the Netherlands Organization for Scientific Research (NWO), and by AstraZeneca. A. A. was supported by NWO Grant 714.014.002. N. Z. is an Established Investigator of the Dutch Heart Foundation (Grant 2013T111).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bowler MW, 2015, J SYNCHROTRON RADIAT, V22, P1540, DOI 10.1107/S1600577515016604; Bricogne G., 2017, BUSTER; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Busam RD, 2011, J BIOL CHEM, V286, P4511, DOI 10.1074/jbc.M110.174011; Calkin AC, 2011, P NATL ACAD SCI USA, V108, P20107, DOI 10.1073/pnas.1111589108; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chinthalapudi K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03648-4; Choi J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1904; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gao J, 2017, ELIFE, V6, DOI 10.7554/eLife.29178; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Konarev PV, 2015, IUCRJ, V2, P352, DOI 10.1107/S2052252515005163; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Mori T, 2007, ACTA CRYSTALLOGR F, V63, P844, DOI 10.1107/S1744309107041152; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Sorrentino V, 2013, J LIPID RES, V54, P2174, DOI 10.1194/jlr.M037713; Sorrentino V, 2013, EUR HEART J, V34, P1292, DOI 10.1093/eurheartj/ehs472; Sorrentino V, 2012, CURR OPIN LIPIDOL, V23, P213, DOI 10.1097/MOL.0b013e3283532947; Sorrentino V, 2011, J BIOL CHEM, V286, P30190, DOI 10.1074/jbc.M111.249557; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Stiegler AL, 2014, J BIOL CHEM, V289, P25362, DOI 10.1074/jbc.M114.584011; Svensson O, 2015, ACTA CRYSTALLOGR D, V71, P1757, DOI 10.1107/S1399004715011918; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van Loon NM, 2019, CURR OPIN LIPIDOL, V30, P192, DOI 10.1097/MOL.0000000000000593; van Loon NM, 2018, ARTERIOSCL THROM VAS, V38, P1785, DOI 10.1161/ATVBAHA.118.311168; Van Loon NM, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.63; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang L, 2011, GENE DEV, V25, P1262, DOI 10.1101/gad.2056211; ZULAUF M, 1992, J CRYST GROWTH, V122, P102, DOI 10.1016/0022-0248(92)90232-8	71	3	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13570	13583		10.1074/jbc.RA120.014349	http://dx.doi.org/10.1074/jbc.RA120.014349			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32727844	Green Published, hybrid			2022-12-26	WOS:000576321100012
J	Kelsey, RG; Westlind, DJ				Kelsey, Rick G.; Westlind, Douglas J.			Red turpentine beetle primary attraction to (-)-beta-pinene plus ethanol in US Pacific Northwest ponderosa pine forests	PLOS ONE			English	Article							DENDROCTONUS-VALENS COLEOPTERA; STAIN ROOT DISEASE; BARK BEETLE; ALPHA-PINENE; DIFFUSION-COEFFICIENTS; PRESCRIBED FIRE; TREE MORTALITY; FUEL-REDUCTION; CLIMATE-CHANGE; SIERRA-NEVADA	Red turpentine beetle,Dendroctonus valens(Coleoptera: Curculionidae: Scolytinae) is a non-aggressive pine bark beetle native to North America, and more aggressive invader in China. Dispersing pioneer beetles are attracted to potential host trees by oleoresin monoterpene kairomones, but respond more strongly to those combined with ethanol, a mixture often released from stressed, dying, or recently dead trees. (+)-3-Carene, usually the dominant or co-dominant monoterpene in ponderosa pine,Pinus ponderosa, is a stronger attractant than alpha-pinene or beta-pinene where tested over a large portion of theD.valensrange, while (+)-3-carene+ethanol was shown previously to attract twice the beetles of (+)-3-carene. A field test comparingD.valensattraction among the three monoterpenes when all are released with ethanol has never been reported, and was our objective. In three US Pacific Northwestern pine forests, (-)-beta-pinene+ethanol lures attracted 1.4 to 1.9 times more beetles than (+)-3-carene+ethanol. (+)- or (+/-)-alpha-pinene+ethanol lures were least attractive. A 1:1:1 monoterpene mixture+ethanol lure attracted more beetles than the 1:1:1 lure, but it was not statistically higher. Monoterpenes were dispensed from low density polyethylene bottles and their release rates monitored in laboratory and field tests. Under laboratory conditions (+)-3-carene was released much more rapidly than (+)-alpha-pinene or (-)-beta-pinene when dispensed separately, or in a 1:1:1 mixture. (+)-3-Carene in the 1:1:1 mixture increased the release of both pinenes over their rates when dispensed separately. (-)-beta-Pinene+ethanol is currently the strongest kairomone lure forD.valensattraction in US northwest pine forests, and has value for beetle detection, monitoring, research, and management.	[Kelsey, Rick G.; Westlind, Douglas J.] US Forest Serv, USDA, Pacific Northwest Res Stn, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service	Kelsey, RG (corresponding author), US Forest Serv, USDA, Pacific Northwest Res Stn, Corvallis, OR 97331 USA.	rick.kelsey@usda.gov						Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; Barbero R, 2015, INT J WILDLAND FIRE, V24, P892, DOI 10.1071/WF15083; Bradley T, 2001, FOREST ECOL MANAG, V142, P205, DOI 10.1016/S0378-1127(00)00351-0; Erbilgin N, 2001, J ECON ENTOMOL, V94, P1113, DOI 10.1603/0022-0493-94.5.1113; Erbilgin N, 2007, J CHEM ECOL, V33, P131, DOI 10.1007/s10886-006-9200-2; Fettig CJ, 2008, CAN J FOREST RES, V38, P924, DOI 10.1139/X07-243; Fettig CJ, 2014, FORESTS, V5, P153, DOI 10.3390/f5010153; Fettig CJ, 2010, FOREST ECOL MANAG, V260, P207, DOI 10.1016/j.foreco.2010.04.019; Fettig CJ, 2004, J ENTOMOL SCI, V39, P490, DOI 10.18474/0749-8004-39.4.490; Gandhi KJK, 2010, J ECON ENTOMOL, V103, P1187, DOI 10.1603/EC10026; Ganio LM, 2017, FOREST ECOL MANAG, V390, P47, DOI 10.1016/j.foreco.2017.01.008; Ganz DJ, 2002, US FOR SERV RMRS-P, P143; GARA RI, 1993, PHYTOCHEMISTRY, V34, P987, DOI 10.1016/S0031-9422(00)90699-X; GOHEEN DJ, 1985, CAN ENTOMOL, V117, P1535, DOI 10.4039/Ent1171535-12; HOBSON KR, 1993, J CHEM ECOL, V19, P1837, DOI 10.1007/BF00983790; Hood SM, 2010, FOREST ECOL MANAG, V260, P750, DOI 10.1016/j.foreco.2010.05.033; Joseph G, 2001, J CHEM ECOL, V27, P697, DOI 10.1023/A:1010345817756; Kelley ST, 1998, EVOLUTION, V52, P1731, DOI [10.2307/2411346, 10.1111/j.1558-5646.1998.tb02253.x]; Kelsey RG, 2003, CAN J FOREST RES, V33, P870, DOI 10.1139/X03-007; Kelsey RG, 2018, AGR FOREST ENTOMOL, V20, P272, DOI 10.1111/afe.12257; Kelsey RG, 2017, BIOSCIENCE, V67, P443, DOI 10.1093/biosci/bix037; Kelsey RG, 2017, FOREST ECOL MANAG, V396, P44, DOI 10.1016/j.foreco.2017.04.009; Kelsey RG, 2014, CAN J FOREST RES, V44, P554, DOI 10.1139/cjfr-2013-0428; Kelsey RG, 2013, J CHEM ECOL, V39, P494, DOI 10.1007/s10886-013-0271-6; KLEPZIG KD, 1991, FOREST SCI, V37, P1119; Littell JS, 2016, GLOBAL CHANGE BIOL, V22, P2353, DOI 10.1111/gcb.13275; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Liu YDL, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5083585; Liu ZD, 2013, CHEM SENSES, V38, P485, DOI 10.1093/chemse/bjt019; Liu ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022005; Lu M, 2017, RED TURPENTINE BEETL, P219; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Lu M, 2009, FUNGAL DIVERS, V38, P133; Lu Q, 2009, ANTON LEEUW INT J G, V96, P275, DOI 10.1007/s10482-009-9343-6; LYON R. L., 1958, CANADIAN ENT, V90, P582; Malpass D., 2010, INTRO IND POLYETHYLE; McHugh CW, 2003, ENVIRON ENTOMOL, V32, P510, DOI 10.1603/0046-225X-32.3.510; Miller DR, 2008, J ECON ENTOMOL, V101, P107, DOI 10.1603/0022-0493(2008)101[107:COABCI]2.0.CO;2; Negron JF, 2016, AGR FOREST ENTOMOL, V18, P313, DOI 10.1111/afe.12163; OWEN DR, 1987, PHYTOPATHOLOGY, V77, P631, DOI 10.1094/Phyto-77-631; Owen DR, 2005, CAN ENTOMOL, V137, P367; Owen DR, 2010, RED TURPENTINE BEETL, V55; Oxtoby D. W., 2015, PRINCIPLES MODERN CH; Peterson D.L., 2014, CLIMATE CHANGE US FO, V57, P232; Peterson DL, 2014, ADV GLOB CHANGE RES, V57, P3, DOI 10.1007/978-94-007-7515-2_1; Petrice Toby R., 2004, Great Lakes Entomologist, V37, P1; Peyches-Bach A, 2009, J FOOD ENG, V95, P45, DOI 10.1016/j.jfoodeng.2009.04.012; Ranger CM, 2013, AGR FOREST ENTOMOL, V15, P56, DOI 10.1111/j.1461-9563.2012.00591.x; Reynier A, 2001, J APPL POLYM SCI, V82, P2434, DOI 10.1002/app.2094; Reynier A, 2001, J APPL POLYM SCI, V82, P2422, DOI 10.1002/app.2093; Sajilata MG, 2007, COMPR REV FOOD SCI F, V6, P17, DOI 10.1111/j.1541-4337.2007.00014.x; SAS, 2014, BAS SAS 9 4 PROC GUI; SCHROEDER LM, 1989, J CHEM ECOL, V15, P807, DOI 10.1007/BF01015179; Schweigkofler W, 2005, CAN J FOREST RES, V35, P1798, DOI 10.1139/x05-077; Schwilk DW, 2006, FOREST ECOL MANAG, V232, P36, DOI 10.1016/j.foreco.2006.05.036; Six DL, 2009, FOREST ECOL MANAG, V258, P761, DOI 10.1016/j.foreco.2009.05.016; Smith R, 2000, PSWGTR177 USDA FOR S, P177; Smith RH, 1977, USDA TECHNICAL B, V1532; Sun BQ, 2019, MATERIALS, V12, DOI 10.3390/ma12213515; Sun JH, 2004, ENVIRON ENTOMOL, V33, P206, DOI 10.1603/0046-225X-33.2.206; Sun JH, 2013, ANNU REV ENTOMOL, V58, P293, DOI 10.1146/annurev-ento-120811-153624; Taerum SJ, 2016, BIOL J LINN SOC, V118, P486, DOI 10.1111/bij.12781; Taerum SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078126; van Willige RWG, 2002, FOOD ADDIT CONTAM A, V19, P303, DOI 10.1080/02652030110081146; VITE JP, 1962, CONTRIB BOYCE THOMPS, V21, P251; Westerling AL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0178; Westlind DJ, 2019, FOREST ECOL MANAG, V434, P181, DOI 10.1016/j.foreco.2018.12.021; Westlind DJ, 2017, FIRE ECOL, V13, P42, DOI 10.4996/fireecology.130304261; WHITE PR, 1993, J CHEM ECOL, V19, P2193, DOI 10.1007/BF00979657; Xu BB, 2014, ENTOMOL EXP APPL, V150, P269, DOI 10.1111/eea.12161; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9; Youngblood A, 2009, ECOL APPL, V19, P321, DOI 10.1890/07-1751.1	72	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236276	10.1371/journal.pone.0236276	http://dx.doi.org/10.1371/journal.pone.0236276			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730348	gold, Green Published			2022-12-26	WOS:000556884700040
J	Soboka, M; Tolessa, O; Tesfaye, M; Adorjan, K; Krahl, W; Tesfaye, E; Yitayih, Y; Strobl, R; Grill, E				Soboka, Matiwos; Tolessa, Omega; Tesfaye, Markos; Adorjan, Kristina; Krahl, Wolfgang; Tesfaye, Elias; Yitayih, Yimenu; Strobl, Ralf; Grill, Eva			Magnitude and predictors of khat use among patients with tuberculosis in Southwest Ethiopia: A longitudinal study	PLOS ONE			English	Article							MENTAL-DISORDERS; RISK-FACTORS; ALCOHOL-USE; PERSPECTIVES; DEPRESSION; MORTALITY; DISTRICT; ABUSE; DEATH	Introduction Tuberculosis (TB) is a leading cause of morbidity and mortality in low and middle-income countries. Substance use negatively affects TB treatment outcomes. Our recent study has found that khat use predicted poorer adherence to anti-TB medications. However, there is scarce longitudinal study on predictors of khat use among outpatients with TB, and this study aimed at addressing this research gap. Methods From October 2017 to October 2018, 268 outpatients with tuberculosis on DOTs were enrolled in a longitudinal study from 26 health institutions in Southwest Ethiopia. Structured questionnaires translated into local languages (Afaan Oromoo and Amharic) were used to assess khat use. Patients were followed for six months, and data were collected on three occasions during the follow-up. A generalized linear mixed model was used to identify the relation between khat use and predictors. Model fitness was checked using the Bayesian Information Criterion (BIC). Odds ratio (OR) and 95% CI were used to describe the strength of association between the outcome variable and predictors. Results The overall prevalence of khat use at baseline and first follow up was 39.2% while it was 37.3% at second follow up. Of this, 77.1% and 96.2% of them believed that khat use reduces the side effects of anti-TB medications and symptoms of tuberculosis respectively. In the final model, being male (aOR = 7.0, p-value = 0.001), being government employee (aOR = 0.03, p-value <= 0.001) and presence of alcohol use disorders (AUD) (aOR = 2.0, p-value <= 0.001) predicted khat use among outpatients with tuberculosis. Conclusion A considerable proportion of patients with TB used khat throughout DOTs and wrongly perceived that it had health benefits. The finding implies that all patients diagnosed with TB should be screened for khat use, and a particular emphasis should be given to males and individuals with a history of alcohol use. Moreover, further studies are needed to assess patients' beliefs regarding the benefits of khat use so that interventions can be developed.	[Soboka, Matiwos; Tesfaye, Elias; Yitayih, Yimenu] Jimma Univ, Dept Psychiat, Jimma, Ethiopia; [Soboka, Matiwos; Tesfaye, Markos; Adorjan, Kristina; Krahl, Wolfgang; Grill, Eva] Ludwig Maximilians Univ Munchen, Ctr Int Hlth, Munich, Germany; [Tolessa, Omega] Wolkite Univ, Dept Nursing, Wolkite, Ethiopia; [Tesfaye, Markos] St Pauls Hosp, Dept Psychiat, Millennium Med Coll, Addis Ababa, Ethiopia; [Adorjan, Kristina] LMU, Dept Psychiat & Psychotherapy, Munich, Germany; [Adorjan, Kristina] Ludwig Maximilians Univ Munchen, Inst Psychiat Phenom & Genom IPPG, Univ Hosp, Munich, Germany; [Krahl, Wolfgang] IsarAmper Klinikum, Dept Forens Psychiat, Munich, Germany; [Strobl, Ralf; Grill, Eva] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany	Jimma University; University of Munich; University of Munich; University of Munich; University of Munich	Soboka, M (corresponding author), Jimma Univ, Dept Psychiat, Jimma, Ethiopia.; Soboka, M (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Int Hlth, Munich, Germany.	matiwos2004@yahoo.com		Tesfaye, Markos/0000-0002-3351-701X; Soboka, Matiwos/0000-0003-2820-0947	Jimma University, Institute of Psychiatry Phenomics and Genomics	Jimma University, Institute of Psychiatry Phenomics and Genomics	The project was funded by Jimma University, Institute of Psychiatry Phenomics and Genomics, and a personal contribution from Dr. Michael Odenwald.	Abate A, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0194-2; Abdelwahab SI, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/604526; Adam F, 1994, Med Trop (Mars), V54, P141; Adane K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149453; Ageely HMA, 2008, J FAM COMMUNITY MED, V15, P3; Akalu TY, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-2434-7; Alemu YM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009058; Ali WM, 2010, MAYO CLIN PROC, V85, P974, DOI 10.4065/mcp.2010.0398; Alvi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140245; Alvi A, 2014, MED HYPOTHESES, V82, P667, DOI 10.1016/j.mehy.2014.02.026; Ambaw F, 2018, B WORLD HEALTH ORGAN, V96, P243, DOI 10.2471/BLT.17.192658; Anaam MS, 2013, J PHARM HEALTH SERV, V4, P115, DOI 10.1111/jphs.12012; Anaam MSI, 2013, JPHSR; Beusenberg M, 1994, USERS GUIDE SELF REP; Corkery JM, 2011, ANN I SUPER SANITA, V47, P445, DOI 10.4415/ANN_11_04_17; Cormier Renee A, 2004, BMC Womens Health, V4 Suppl 1, pS8, DOI 10.1186/1472-6874-4-S1-S8; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Damena T, 2011, ETHIOP J HEALTH SCI, V21, P37; DHADPHALE M, 1982, CENT AFR J MED, V28, P85; Dhaifalah Ishraq, 2004, Biomedical Papers (Olomouc), V148, P11; Duko B, 2019, TUBERC RES TREAT; Duko B, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0598-3; Duresso SW, 2016, ADDICTION, V111, P1666, DOI 10.1111/add.13421; Eckersley W, 2010, B WORLD HEALTH ORGAN, V88, P235, DOI 10.2471/BLT.09.067512; El-Setouhy M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2642506; Eshetie S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194675; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, HLTH HLTH REL INDICA; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, GUID CLIN PROGR MAN; Gebissa E, 2010, J ETHNOPHARMACOL, V132, P607, DOI 10.1016/j.jep.2010.01.063; Greenfield SF, 2010, PSYCHIAT CLIN N AM, V33, P339, DOI 10.1016/j.psc.2010.01.004; Haile D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130460; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Hassan NA, 2002, SAUDI MED J, V23, P850; Jaber Ammar Ali Saleh, 2017, J Pharm Policy Pract, V10, P36, DOI 10.1186/s40545-017-0124-8; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; LUQMAN W, 1976, ANN INTERN MED, V85, P246, DOI 10.7326/0003-4819-85-2-246; Mekonnen Habtamu Sewunet, 2018, BMC Res Notes, V11, P691, DOI 10.1186/s13104-018-3789-4; Mihretu A, 2017, SUBST ABUSE TREAT PR, V12, DOI 10.1186/s13011-017-0132-3; Millet JP, 2013, EUR SPINE J, V22, P539, DOI 10.1007/s00586-012-2334-8; Odenwald M, 2017, E MEDITERR HEALTH J, V23, P236, DOI 10.26719/2017.23.3.236; OMOLO OE, 1987, BRIT J ADDICT, V82, P97; Ranzani OT, 2020, LANCET INFECT DIS, V20, P123, DOI [10.1016/S1473-3099(19), 10.1016/S1473-3099(19)30518-3]; Sahile Z, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5404-y; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Soboka M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0446-5; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Stevenson M, 1996, DRUG ALCOHOL REV, V15, P73, DOI 10.1080/09595239600185691; Teferra S, 2011, TRANSCULT PSYCHIATRY, V48, P455, DOI 10.1177/1363461511408494; Tesfahuneygn Gebrehiwet, 2015, BMC Res Notes, V8, P503, DOI 10.1186/s13104-015-1452-x; Thomas F., 2001, ALCOHOL USE DISORDER; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Wolde D, 2017, INT J BACTERIOL; Wondemagegn AT, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7427892; Youngmann R, 2008, TRANSCULT PSYCHIATRY, V45, P566, DOI 10.1177/1363461508100783; Zegeye A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210422; Zetola NM, 2012, INT J TUBERC LUNG D, V16, P1529, DOI 10.5588/ijtld.12.0026	56	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236154	10.1371/journal.pone.0236154	http://dx.doi.org/10.1371/journal.pone.0236154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730258	Green Published, gold			2022-12-26	WOS:000556884700043
J	Vyas, N; Sammons, RL; Kuehne, SA; Johansson, C; Stenport, V; Wang, QX; Walmsley, AD				Vyas, N.; Sammons, R. L.; Kuehne, S. A.; Johansson, C.; Stenport, V; Wang, Q. X.; Walmsley, A. D.			The effect of standoff distance and surface roughness on biofilm disruption using cavitation	PLOS ONE			English	Article							DENTAL IMPLANT SURFACES; IN-VITRO; BACTERIAL BIOFILMS; TITANIUM SURFACES; INSTRUMENTS; TOPOGRAPHY; ADHESION; BEHAVIOR; CELLS	Effective biofilm removal from surfaces in the mouth is a clinical challenge. Cavitation bubbles generated around a dental ultrasonic scaler are being investigated as a method to remove biofilms effectively. It is not known how parameters such as surface roughness and instrument distance from biofilm affect the removal. We grewStrepotococcus sanguinisbiofilms on coverslips and titanium discs with varying surface roughness (between 0.02-3.15 mu m). Experimental studies were carried out for the biofilm removal using high speed imaging and image analysis to calculate the area of biofilm removed at varying ultrasonic scaler standoff distances from the biofilm. We found that surface roughness up to 2 mu m does not adversely affect biofilm removal but a surface roughness of 3 mu m caused less biofilm removal. The standoff distance also has different effects depending on the surface roughness but overall a distance of 1 mm is just as effective as a distance of 0.5 mm. The results show significant biofilm removal due to an ultrasonic scaler tip operating for only 2s versus 15-60s in previous studies. The technique developed for high speed imaging and image analysis of biofilm removal can be used to investigate physical biofilm disruption from biomaterial surfaces in other fields.	[Vyas, N.; Sammons, R. L.; Kuehne, S. A.; Walmsley, A. D.] Univ Birmingham, Coll Med & Dent Sci, Sch Dent, Birmingham, W Midlands, England; [Johansson, C.; Stenport, V] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Dept Prosthet Dent Dent Mat Sci, Gothenburg, Sweden; [Wang, Q. X.] Univ Birmingham, Coll Engn & Phys Sci, Sch Math, Birmingham, W Midlands, England	University of Birmingham; University of Gothenburg; University of Birmingham	Walmsley, AD (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Dent, Birmingham, W Midlands, England.	a.d.walmsley@bham.ac.uk	Kuehne, Sarah/AAV-3481-2021; wang, qianxi/A-8015-2015	Kuehne, Sarah/0000-0001-6790-8433; Wang, Qianxi/0000-0002-0664-5913	Engineering and Physical Sciences Research Council (EPSRC) [EP/P015743/1]; EPSRC [EP/P015743/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	NV, QXW and ADW recieved funding from the Engineering and Physical Sciences Research Council (EPSRC) (EP/P015743/1).https://gow.epsrc.ukri.org/NGBOViewGrant.aspx? GrantRef=EP/P015743/1 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001; Arabaci T, 2007, Int J Dent Hyg, V5, P2, DOI 10.1111/j.1601-5037.2007.00217.x; Atieh MA, 2013, J PERIODONTOL, V84, P1586, DOI 10.1902/jop.2012.120592; Azhdast MH, 2009, ADV INT MECH 2009 AI; Barkarmo S, 2019, CLIN EXPT DENT RES; Becker W, 1989, INT J ORAL MAXILLOF, V5, P31; Bevilacqua L, 2018, CURR MICROBIOL, V75, P766, DOI 10.1007/s00284-018-1446-8; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; Brujan EA, 2001, J FLUID MECH, V433, P283, DOI 10.1017/S0022112000003335; Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Dhir Sangeeta, 2013, J Indian Soc Periodontol, V17, P5, DOI 10.4103/0972-124X.107466; Drake DR, 1999, INT J ORAL MAX IMPL, V14, P226; Elani HW, 2018, J DENT RES, V97, P1424, DOI 10.1177/0022034518792567; Fabbri S, 2016, J MECH BEHAV BIOMED, V59, P197, DOI 10.1016/j.jmbbm.2015.12.012; Felver B, 2009, ULTRASON SONOCHEM, V16, P692, DOI 10.1016/j.ultsonch.2008.11.002; FOX SC, 1990, J PERIODONTOL, V61, P485, DOI 10.1902/jop.1990.61.8.485; Frenz M, 1996, PHYS REV LETT, V76, P3546, DOI 10.1103/PhysRevLett.76.3546; Gale GW, 1999, PARTICUL SCI TECHNOL, V17, P229, DOI 10.1080/02726359908906815; Gartenmann SJ, 2017, CLIN ORAL INVEST, V21, P1029, DOI 10.1007/s00784-016-1854-8; Gharechahi M., 2012, J BIOMATER NANOBIOTE, V03, P541, DOI DOI 10.4236/JBNB.2012.324056; Goh BHT, 2015, IFMBE PROC, V45, P533, DOI 10.1007/978-3-319-11128-5_133; Gustumhaugen E, 2014, CLIN ORAL IMPLAN RES, V25, P707, DOI 10.1111/clr.12130; Howlin RP, 2015, J DENT RES, V94, P1303, DOI 10.1177/0022034515589284; Klinge Bjorn, 2005, Dent Clin North Am, V49, P661, DOI 10.1016/j.cden.2005.03.007; Koo H, 2017, NATURE REV MICROBIOL; Lodovici M, 2003, TOXICOLOGY, V184, P141, DOI 10.1016/S0300-483X(02)00572-3; Louropoulou A, 2014, CLIN ORAL IMPLAN RES, V25, P1149, DOI 10.1111/clr.12224; Maisonhaute E, 2002, ULTRASON SONOCHEM, V9, P297, DOI 10.1016/S1350-4177(02)00089-5; Mei L, 2011, DENT MATER, V27, P770, DOI 10.1016/j.dental.2011.03.017; Ohl CD, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2337506; Park JB, 2015, J ORAL IMPLANTOL, V41, P419, DOI 10.1563/AAID-JOI-D-13-00078; Prathapachandran Jayachandran, 2012, Dent Res J (Isfahan), V9, P516; Pratten J, 1998, J ANTIMICROB CHEMOTH, V42, P453, DOI 10.1093/jac/42.4.453; Rivas DF, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4747166; Ronay V, 2017, CLIN ORAL IMPLAN RES, V28, P151, DOI 10.1111/clr.12773; Sahrmann P, 2015, CLIN ORAL IMPLAN RES, V26, P314, DOI 10.1111/clr.12322; Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmage P, 2014, INT J ORAL MAX IMPL, V29, P331, DOI 10.11607/jomi.2524; Song F, 2015, J DENT RES, V94, P1027, DOI 10.1177/0022034515587690; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Veerachamy S, 2014, P I MECH ENG H, V228, P1083, DOI 10.1177/0954411914556137; Vyas N, 2016, SCI REP-UK, V6, DOI 10.1038/srep32694; Vyas N, 2019, ULTRASOUND MED BIOL, V45, P1044, DOI 10.1016/j.ultrasmedbio.2019.01.002; Vyas N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149804; Walmsley AD, 2013, CLIN ORAL INVEST, V17, P1227, DOI 10.1007/s00784-012-0802-5; Walmsley AD, 2010, 39 INT C NOIS CONTR; Wang CX, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-016-0328-3; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Zaura-Arite E, 2001, J DENT RES, V80, P1436, DOI 10.1177/00220345010800051001	53	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236428	10.1371/journal.pone.0236428	http://dx.doi.org/10.1371/journal.pone.0236428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730291	Green Published, gold			2022-12-26	WOS:000556884700062
J	Ewertowska, P; Trzaskoma, Z; Sitarski, D; Gromul, B; Haponiuk, I; Czaprowski, D				Ewertowska, Paulina; Trzaskoma, Zbigniew; Sitarski, Dominik; Gromul, Bartlomiej; Haponiuk, Ireneusz; Czaprowski, Dariusz			Muscle strength, muscle power and body composition in college-aged young women and men with Generalized Joint Hypermobility	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; TEST-RETEST RELIABILITY; CLINICAL-ASSESSMENT; KNEE FUNCTION; CHILDREN; ADOLESCENCE; PERFORMANCE; CHILDHOOD; VALIDITY; LAXITY	The aim of this study was an evaluation of the musculoskeletal system in women and men with Generalized Joint Hypermobility (GJH). The study included 87 participants- 40 with Generalized Joint Hypermobility (aged 21.2 +/- 1.8 years) and 47 (aged 21.0 +/- 1.3 years) in the control group (CG). The study included the Beighton score, the measurements of body composition, muscle flexibility (Straight Leg Raise test, Popliteal Angle test, Modified Thomas Test), and the measurements of muscle strength and muscle power. T-test and Mann-Whitney U Test were applied to assess the differences between independent groups. The study showed that there were no significant differences (p>.05) in the assessed body composition and the muscle flexibility between both women and men with GJH and the participants in the CG. Under isokinetic conditions for the non-dominant lower extremity, men from the CG received significantly higher (p = .02) flexion peak torque at 180 degrees/s angular velocity. Women from the CG received a statistically significantly lower (p = .04) F/E ratio at 180 degrees/s velocity. Under isometric conditions for both women and men with GJH, there were no statistically significant differences (p>.05) in the maximum torques in knee extension and flexion compared to the CG. For women and men with GJH, the maximum power in the lower extremities and jumping ability were not significantly different (p>.05) compared to the CG participants. The body composition, muscle flexibility, muscle strength, and muscle power of adults with Generalized Joint Hypermobility did not differ compared to healthy participants. The fact that there are no differences does not exclude the efficacy of strength training in increasing levels of muscle strength and its impact on body posture and proprioception or coordination.	[Ewertowska, Paulina; Haponiuk, Ireneusz] Gdansk Univ Phys Educ & Sport, Dept Rehabil & Kinesiol, Gdansk, Poland; [Trzaskoma, Zbigniew] Jozef Pilsudski Univ Phys Educ, Fac Rehabil, Warsaw, Poland; [Sitarski, Dominik; Gromul, Bartlomiej; Czaprowski, Dariusz] Jozef Rusiecki Univ Coll, Dept Physiotherapy, Olsztyn, Poland; [Czaprowski, Dariusz] Poznan Univ Med Sci, Dept Rehabil, Poznan, Poland	Gdansk University of Physical Education & Sport; Jozef Pilsudski University Physical Education in Warsaw; Poznan University of Medical Sciences	Ewertowska, P (corresponding author), Gdansk Univ Phys Educ & Sport, Dept Rehabil & Kinesiol, Gdansk, Poland.	paulina.ewertowska.fiz@gmail.com		Ewertowska, Paulina/0000-0002-9825-6244; Haponiuk, Ireneusz/0000-0002-8361-2939				Adib N, 2005, RHEUMATOLOGY, V44, P744, DOI 10.1093/rheumatology/keh557; Beighton P, 2012, HYPERMOBILITY OF JOINTS, FOURTH EDITION, P65, DOI 10.1007/978-1-84882-085-2_5; Boyd BS, 2012, PHYSIOTHERAPY, V98, P174, DOI 10.1016/j.physio.2011.04.352; Clinch J, 2011, ARTHRITIS RHEUM-US, V63, P2819, DOI 10.1002/art.30435; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P131, DOI 10.1123/ijspp.3.2.131; Czaprowski D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121360; Czaprowski Dariusz, 2012, Ortop Traumatol Rehabil, V14, P407, DOI 10.5604/15093492.1016368; Czaprowski D, 2011, SCOLIOSIS SPINAL DIS, V6, DOI 10.1186/1748-7161-6-22; Alvares JBDR, 2015, PHYS THER SPORT, V16, P59, DOI 10.1016/j.ptsp.2014.04.004; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; Engelbert RHH, 2006, PEDIATRICS, V118, pE690, DOI 10.1542/peds.2005-2219; Engelbert RHH, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e248; Fatoye F, 2009, RHEUMATOLOGY, V48, P152, DOI 10.1093/rheumatology/ken435; Fayed N, 2011, DISABIL REHABIL, V33, P1941, DOI 10.3109/09638288.2011.553704; Hakim A, 2003, BEST PRACT RES CL RH, V17, P989, DOI 10.1016/j.berh.2003.08.001; Hakim A, 2010, HYPERMOBILITY FIBROM, P6; Hanewinkel-van Kleef YB, 2009, PEDIATR PHYS THER, V21, P194, DOI 10.1097/PEP.0b013e3181a3ac5f; Holden S, 2015, CLIN BIOMECH, V30, P469, DOI 10.1016/j.clinbiomech.2015.03.008; Jensen BR, 2013, MUSCLE NERVE, V48, P762, DOI 10.1002/mus.23802; Jindal P, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0037-x; Junge T, 2015, J ELECTROMYOGR KINES, V25, P501, DOI 10.1016/j.jelekin.2015.02.011; Juul-Kristensen B, 2017, AM J MED GENET C, V175, P116, DOI 10.1002/ajmg.c.31540; Juul-Kristensen B, 2012, KNEE, V19, P773, DOI 10.1016/j.knee.2012.02.002; Juul-Kristensen B, 2009, PEDIATRICS, V124, P1380, DOI 10.1542/peds.2009-0294; Kabiri LS, 2015, CHILD OBES, V11, P650, DOI 10.1089/chi.2014.0156; Kaminska E, 2015, J SPORT REHABIL, V24, P268, DOI 10.1123/jsr.2014-0157; Keer R, 2004, PHYS THER SPORT, V5, P51; Kelly SB, 2010, J STRENGTH COND RES, V24, P3140, DOI 10.1519/JSC.0b013e3181f9278f; Kerr AJ, 2000, PHYSIOTHERAPY, V86, P313, DOI DOI 10.1016/S0031-9406(05)61005-X; Kulik O, 2018, J ED HLTH SPORT, V8, P133; Liaghat B, 2018, J ELECTROMYOGR KINES, V39, P1, DOI 10.1016/j.jelekin.2018.01.003; Loturco I, 2016, J STRENGTH COND RES, V30, P109, DOI 10.1519/JSC.0000000000001075; Malfait F, 2006, RHEUMATOLOGY, V45, P502, DOI 10.1093/rheumatology/kei268; Markovic S, 2014, HUM MOVEMENT SCI, V33, P203, DOI 10.1016/j.humov.2013.11.004; Massy-Westropp Nicola, 2013, Journal of Musculoskeletal Research, V16, P1350006, DOI 10.1142/S0218957713500061; Mebes C, 2008, ARTHRIT RHEUM-ARTHR, V59, P1665, DOI 10.1002/art.24196; Murray KJ, 2006, BEST PRACT RES CL RH, V20, P329, DOI 10.1016/j.berh.2005.12.003; Prins M, 2008, EUR J CLIN NUTR, V62, P1065, DOI 10.1038/sj.ejcn.1602830; Przymuszaa A, 2018, J ED HLTH SPORT, V8, P246; Remvig L., 2011, INT MUSCULOSKELET ME, V33, P137, DOI [10.1179/1753615411Y.0000000009, DOI 10.1179/1753615411Y.0000000009]; Rombaut L, 2012, ARTHRIT CARE RES, V64, P1584, DOI 10.1002/acr.21726; Russek LN, 2016, CLIN RHEUMATOL, V35, P1029, DOI 10.1007/s10067-015-2951-9; Sahin N, 2008, RHEUMATOL INT, V28, P643, DOI 10.1007/s00296-007-0493-4; Scheper MC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/121054; Scheper M, 2014, CURR RHEUMATOL REV, V10, P117, DOI 10.2174/1573397111666150120112925; Slinde F, 2008, J STRENGTH COND RES, V22, P640, DOI 10.1519/JSC.0b013e3181660475; Smits-Engelsman B, 2011, J PEDIATR-US, V158, P130, DOI 10.1016/j.jpeds.2010.07.021; Sohrbeck-Nohr O, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0302-7; Trzaskoma Z, 2015, ACTA BIOENG BIOMECH, V17, P103, DOI 10.5277/ABB-00030-2014-02; Tsiros Margarita D, 2011, J Allied Health, V40, P115; van Meeteren J, 2002, J REHABIL MED, V34, P91, DOI 10.1080/165019702753557890; Wang YC, 2011, ISOKINET EXERC SCI, V19, P163, DOI 10.3233/IES-2011-0410; Yazgan P, 2015, ANN RHEUM DIS, V74, P1220, DOI 10.1136/annrheumdis-2015-eular.6201	53	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236266	10.1371/journal.pone.0236266	http://dx.doi.org/10.1371/journal.pone.0236266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726351	Green Published, gold			2022-12-26	WOS:000556908900021
J	Roh, JI; Lee, J; Sung, YH; Oh, J; Hyeon, D; Kim, Y; Lee, S; Devkota, S; Kim, HJ; Park, B; Nam, T; Song, Y; Kim, Y; Hwang, D; Lee, HW				Roh, Jae-il; Lee, Jaehoon; Sung, Young-Hoon; Oh, Jahyun; Hyeon, Do Young; Kim, Yujin; Lee, Seungeon; Devkota, Sushil; Kim, Hye Jeong; Park, Bomin; Nam, Taewook; Song, Yaechan; Kim, Yonghwan; Hwang, Daehee; Lee, Han-Woong			Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer	ONCOGENE			English	Article							ER STRESS; PI3K/AKT/MTOR PATHWAY; INDUCIBLE GENE; ACTIVATION; EXPRESSION; SURVIVAL; PHOSPHORYLATION; PROLIFERATION; METABOLISM; INHIBITORS	KRAS-mutant non-small cell lung cancer (NSCLC) is a major lung cancer subtype that leads to many cancer-related deaths worldwide. Although numerous studies on KRAS-mutant type NSCLC have been conducted, new oncogenic or tumor suppressive genes need to be detected because a large proportion of NSCLC patients does not respond to currently used therapeutics. Here, we show the tumor-promoting function of a cell cycle-related protein, PIERCE1, in KRAS-mutant NSCLC. Mechanistically, PIERCE1 depletion inhibits cell growth and AKT phosphorylation (pAKT) at S473, which is particularly observed in KRAS-mutant lung cancers. Analyses of AKT-related genes using microarray, immunoblotting, and real-time quantitative PCR indicated that PIERCE1 negatively regulates the gene expression of the AKT suppressor, TRIB3, through the CHOP pathway, which is a key regulatory pathway for TRIB3 expression. Similarly, in vivo analyses of PIERCE1 depletion in the KRAS mutation-related lung cancer mouse models revealed the suppressive effect of PIERCE1 knockout in urethane- and KRAS(G12D)-induced lung tumorigenesis with decreased pAKT levels observed in the tumors. Tissue microarrays of human lung cancers indicated the expression of PIERCE1 in 83% of lung cancers and its correlation with pAKT expression. Thus, we illustrate how PIERCE1 depletion may serve as a therapeutic strategy against KRAS-mutant NSCLC and propose the clinical benefit of PIERCE1.	[Roh, Jae-il; Lee, Jaehoon; Oh, Jahyun; Kim, Yujin; Lee, Seungeon; Kim, Hye Jeong; Park, Bomin; Nam, Taewook; Song, Yaechan; Lee, Han-Woong] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul, South Korea; [Sung, Young-Hoon] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Hyeon, Do Young; Hwang, Daehee] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Devkota, Sushil] Univ Calif San Diego, Dept Cell & Dev Biol, San Diego, CA 92093 USA; [Kim, Yonghwan] Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea	Yonsei University; University of Ulsan; Seoul National University (SNU); University of California System; University of California San Diego; Sookmyung Women's University	Lee, HW (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul, South Korea.	hwl@yonsei.ac.kr			National Research Foundation of the Republic of Korea [2018R1A2A1A05022746, 2017R1A4A1015328]; Brain Korea 21 (BK21) PLUS program	National Research Foundation of the Republic of Korea(National Research Foundation of Korea); Brain Korea 21 (BK21) PLUS program	This work was supported by the National Research Foundation of the Republic of Korea (grants 2018R1A2A1A05022746 and 2017R1A4A1015328) and in part by Brain Korea 21 (BK21) PLUS program.	Abeyrathna P, 2015, VASC PHARMACOL, V74, P38, DOI 10.1016/j.vph.2015.05.008; Barkauskas CE, 2017, DEVELOPMENT, V144, P986, DOI 10.1242/dev.140103; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Bittner N, 2014, PATHOL ONCOL RES, V20, P11, DOI 10.1007/s12253-013-9719-9; Carew JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.259; Chia S, 2015, CURR ONCOL, V22, P33, DOI 10.3747/co.22.2393; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Daga Aditi, 2015, Asian Pac J Cancer Prev, V16, P4147; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Erazo T, 2016, CLIN CANCER RES, V22, P2508, DOI 10.1158/1078-0432.CCR-15-1808; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim JY, 2016, MOL CANCER RES, V14, P1019, DOI 10.1158/1541-7786.MCR-15-0506; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Lawlor MA, 2001, J CELL SCI, V114, P2903; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ord D, 2016, BBA-MOL CELL RES, V1863, P2668, DOI 10.1016/j.bbamcr.2016.08.003; Ord T, 2017, CURR PROTEIN PEPT SC, V18, P819, DOI 10.2174/1389203718666170406124547; Ramadori G, 2015, CELL METAB, V21, P117, DOI 10.1016/j.cmet.2014.11.020; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Roh JI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193182; Roman M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0789-x; Salazar M, 2015, CELL DEATH DIFFER, V22, P131, DOI 10.1038/cdd.2014.133; Salazar M, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.980134; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; SPERANZA G, 2012, J CLIN ONCOL S, V30; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung YH, 2007, MOL CELLS, V24, P409; Sung YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27932; Sung YH, 2010, CANCER RES, V70, P10454, DOI 10.1158/0008-5472.CAN-10-0031; Tomasini P, 2016, ONCOLOGIST, V21, P1450, DOI 10.1634/theoncologist.2015-0084; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Walter DM, 2019, NATURE, V569, P423, DOI 10.1038/s41586-019-1172-9; Wang R, 2015, ONCOTARGET, V6, P34300, DOI 10.18632/oncotarget.5549; Wang Z, 2015, ONCOGENE, V34, P4975, DOI 10.1038/onc.2014.426; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Wu KH, 2012, INT J MOL SCI, V13, P11471, DOI 10.3390/ijms130911471; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zappa C, 2016, TRANSL LUNG CANCER R, V5, P288, DOI 10.21037/tlcr.2016.06.07; Zhang C, 2017, PLOS ONE, V12	55	5	5	0	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2020	39	36					5876	5887		10.1038/s41388-020-01399-5	http://dx.doi.org/10.1038/s41388-020-01399-5		JUL 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NJ1HO	32728173	hybrid, Green Published			2022-12-26	WOS:000553757600001
J	Choi, H; Lee, WH; Lee, HS; Kong, SG; Kim, D; Lee, S; Oh, H; Kim, YN; Ock, S; Kim, T; Park, MJ; Song, W; Rim, JH; Lee, JH; Jeong, S				Choi, Hyunji; Lee, Woonhyoung; Lee, Ho Sup; Kong, Seom Gim; Kim, Da Jung; Lee, Sangjin; Oh, Haeun; Kim, Ye Na; Ock, Soyoung; Kim, Taeyun; Park, Min-Jeong; Song, Wonkeun; Rim, John Hoon; Lee, Jong-Han; Jeong, Seri			The risk factors associated with treatment-related mortality in 16,073 kidney transplantation-A nationwide cohort study	PLOS ONE			English	Article							INVASIVE FUNGAL-INFECTIONS; RENAL-TRANSPLANTATION; SINGLE-CENTER; GRAFT LOSS; DEATH; RECIPIENTS; SURVIVAL; DIALYSIS; PROGRESS; OUTCOMES	Mortality at an early stage after kidney transplantation is a catastrophic event. Treatment-related mortality (TRM) within 1 or 3 months after kidney transplantation has been seldom reported. We designed a retrospective observational cohort study using a national population-based database, which included information about all kidney recipients between 2003 and 2016. A total of 16,073 patients who underwent kidney transplantation were included. The mortality rates 1 month (early TRM) and 3 months (TRM) after transplantation were 0.5% (n = 74) and 1.0% (n = 160), respectively. Based on a multivariate analysis, older age (hazard ratio [HR] = 1.06;P< 0.001), coronary artery disease (HR = 3.02;P= 0.002), and hemodialysis compared with pre-emptive kidney transplantation (HR = 2.53;P =0.046) were the risk factors for early TRM. Older age (HR = 1.07;P< 0.001), coronary artery disease (HR = 2.88;P< 0.001), and hemodialysis (HR = 2.35;P= 0.004) were the common independent risk factors for TRM. In contrast, cardiac arrhythmia (HR = 1.98;P= 0.027) was associated only with early TRM, and fungal infection (HR = 2.61;P< 0.001), and epoch of transplantation (HR = 0.34;P <0.001) were the factors associated with only TRM. The identified risk factors should be considered in patient counselling, selection, and management to prevent TRM.	[Choi, Hyunji; Lee, Woonhyoung; Oh, Haeun] Kosin Univ, Coll Med, Dept Lab Med, Busan, South Korea; [Lee, Ho Sup; Kim, Da Jung] Kosin Univ, Coll Med, Dept Hematol Oncol, Busan, South Korea; [Kong, Seom Gim] Kosin Univ, Coll Med, Dept Pediat, Busan, South Korea; [Lee, Sangjin] Pusan Natl Univ, Dept Stat, Grad Sch, Busan, South Korea; [Kim, Ye Na] Kosin Univ, Coll Med, Dept Nephrol, Busan, South Korea; [Ock, Soyoung; Kim, Taeyun] Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Park, Min-Jeong; Song, Wonkeun; Jeong, Seri] Hallym Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Rim, John Hoon] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Rim, John Hoon] Yonsei Univ, Grad Sch Med, Phys Scientist Program, Dept Med, Seoul, South Korea; [Lee, Jong-Han] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea	Pusan National University; Hallym University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University	Jeong, S (corresponding author), Hallym Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	hehebox@naver.com	LEE, SANGJIN/GLT-9252-2022; Kim, Taeyun/AAL-3477-2021	LEE, SANGJIN/0000-0001-5646-8276; Kim, Taeyun/0000-0001-7786-5051; Choi, Hyunji/0000-0002-6453-7099; Rim, John Hoon/0000-0001-6825-8479	National Research Foundation of Korea (NRF); Korean government (Ministry of Science and ICT) [NRF-2017R1C1B2004597]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry of Science and ICT)	This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korean government (Ministry of Science and ICT) [NRF-2017R1C1B2004597] (to SJ). URL: http://www.nrf.re.kr/index The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalten J, 2011, NEPHROL DIAL TRANSPL, V26, P3006, DOI 10.1093/ndt/gfq822; [Anonymous], 2018, AM J KIDNEY DIS, V71, pS337; Arend SM, 1997, NEPHROL DIAL TRANSPL, V12, P1672, DOI 10.1093/ndt/12.8.1672; Azevedo LS, 2015, CLINICS, V70, P515, DOI 10.6061/clinics/2015(07)09; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Brennan DC, 2006, NEW ENGL J MED, V355, P1967, DOI 10.1056/NEJMoa060068; Briggs JD, 2001, NEPHROL DIAL TRANSPL, V16, P1545, DOI 10.1093/ndt/16.8.1545; Chang JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183826; Chapman JR, 2017, AM J KIDNEY DIS, V69, P287, DOI 10.1053/j.ajkd.2016.08.024; DIETHELM AG, 1995, ANN SURG, V221, P446, DOI 10.1097/00000658-199505000-00002; Eswarappa M, 2015, CASE REPORTS TRANSPL, V2015, P4; Ethier MC, 2011, BLOOD, V118, P5080, DOI 10.1182/blood-2011-07-363333; Farrugia D, 2014, TRANSPL INT, V27, P262, DOI 10.1111/tri.12218; Finlayson E V, 2001, Eff Clin Pract, V4, P172; Fuster V., 2006, J AM COLL CARDIOL, V48, pe149, DOI DOI 10.1016/j.jacc.2006.07.018; Gill JS, 2003, TRANSPLANTATION, V75, P113, DOI 10.1097/00007890-200301150-00021; Haller MC, 2017, CLIN J AM SOC NEPHRO, V12, P122, DOI 10.2215/CJN.04120416; Harciarek M, 2011, KIDNEY INT, V79, P1353, DOI 10.1038/ki.2011.40; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Howard RJ, 2002, TRANSPLANTATION, V73, P1923, DOI 10.1097/00007890-200206270-00013; Hu YN, 2014, ANN THORAC SURG, V97, P973, DOI 10.1016/j.athoracsur.2013.12.016; Husain S, 2016, J HEART LUNG TRANSPL, V35, P261, DOI 10.1016/j.healun.2016.01.007; Jehn U, 2020, J CLIN MED, V9; Lee S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212748; Lenihan CR, 2013, AM J TRANSPLANT, V13, P1566, DOI 10.1111/ajt.12197; Morales JM, 2012, NEPHROL DIAL TRANSPL, V27, piv39, DOI 10.1093/ndt/gfs544; Matas AJ, 2001, ANN SURG, V234, P149, DOI 10.1097/00000658-200108000-00004; Mayo SC, 2011, HPB, V13, P473, DOI 10.1111/j.1477-2574.2011.00326.x; Miller R, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13553; Mise Y, 2015, ANN SURG, V262, P1071, DOI 10.1097/SLA.0000000000001048; Paizis IA, 2018, HELL J CARDIOL, DOI [10.1016/j.hjc.2018.07.00229981889, DOI 10.1016/J.HJC.2018.07.00229981889]; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Patel MH, 2017, RENAL FAILURE, V39, P294, DOI 10.1080/0886022X.2016.1268537; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Roberts PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188713; Roy-Chaudhury P, 2018, KIDNEY INT, V93, P941, DOI 10.1016/j.kint.2017.11.019; Santori G, 2005, TRANSPLANT INT, V18, P65, DOI 10.1111/j.1432-2277.2004.00024.x; Sayin B, 2013, INT J NEPHROL RENOV, V6, P95, DOI 10.2147/IJNRD.S42042; SCHWEITZER EJ, 1991, ANN SURG, V214, P679, DOI 10.1097/00000658-199112000-00007; Selvey LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2599-y; Shao MJ, 2017, ONCOTARGET, V8, P66426, DOI 10.18632/oncotarget.19815; Tahir S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014069; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Visser BC, 2009, ARCH SURG-CHICAGO, V144, P1021, DOI 10.1001/archsurg.2009.197; Wang JH, 2016, ADV CHRONIC KIDNEY D, V23, P281, DOI 10.1053/j.ackd.2016.07.001; Welch HG, 2002, J NATL CANCER I, V94, P1066; Yildirim A, 2006, TRANSPLANT P, V38, P2831, DOI 10.1016/j.transproceed.2006.08.162; 천승욱, 2015, Korean Journal of Transplantation, V29, P61	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236274	10.1371/journal.pone.0236274	http://dx.doi.org/10.1371/journal.pone.0236274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722695	Green Published, gold			2022-12-26	WOS:000556916000031
J	Miura, K; Takamori, A; Hamazaki, K; Tsuchida, A; Tanaka, T; Origasa, H; Inadera, H				Miura, Kayoko; Takamori, Ayako; Hamazaki, Kei; Tsuchida, Akiko; Tanaka, Tomomi; Origasa, Hideki; Inadera, Hidekuni		Japan Environm Children's Study	Dietary patterns during pregnancy and health-related quality of life: The Japan Environment and Children's Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; SELF-RATED HEALTH; FOLLOW-UP SURVEY; COHORT-I; WOMEN; VALIDITY; JPHC; DEPRESSION; RISK; REPRODUCIBILITY	Background Limited research exists on how dietary pattern (DP) influences pregnant women's health-related quality of life (HRQOL). This study aimed to identify DPs in a cohort of 92,448 pregnant Japanese women using fixed data from the Japan Environment and Children's Study (JECS) to investigate the associations of DP with HRQOL. Methods During the first trimester, DPs were assessed using the Food Frequency Questionnaire (FFQ), and HRQOL was assessed using the 8-Item Short-Form Health Survey (SF-8). DPs such as Western, Japanese and Unbalanced DP were identified through principal component analysis (PCA). Multivariable logistic model analysis was used to assess the associations between DP and HRQOL as good or poor. Results We found a significant association between poor mental HRQOL in the univariate analysis for the Western DP (p = 0.014). However, this association was not significant in the multivariate analysis adjusted for basic confounders (p = 0.078). Western DP was not highly associated with poor physical HRQOL (from low-medium to high levels of intake; adjusted odds ratio [OR] 0.87-0.88, all p <= 0.001, when comparing highest to lowest intake levels). A high intake of the Japanese DP was significantly associated with poor mental HRQOL and physical HRQOL (adjusted OR 1.20, p<0.0001 and adjusted OR 1.12, p = 0.005, respectively). A medium-high intake of the Unbalanced DP was not highly associated with poor physical HRQOL (adjusted OR 0.93, p = 0.048) but with poor mental HRQOL (adjusted OR 1.29, p<0.0001). Conclusion This is the first known prospective study to establish an association between DP and HRQOL in pregnant women. We hope that our findings will help in the field of nutritional science.	[Miura, Kayoko; Takamori, Ayako; Hamazaki, Kei; Tsuchida, Akiko; Tanaka, Tomomi; Inadera, Hidekuni] Univ Toyama, Toyama Reg Ctr JECS, Toyama, Japan; [Hamazaki, Kei; Tsuchida, Akiko; Inadera, Hidekuni] Univ Toyama, Dept Publ Hlth, Fac Med, Toyama, Japan; [Tanaka, Tomomi] Univ Toyama, Dept Pediat, Fac Med, Toyama, Japan; [Origasa, Hideki] Univ Toyama, Dept Biostat & Clin Epidemiol, Fac Med, Toyama, Japan; [Miura, Kayoko] Nagasaki Junshin Catholic Univ, Nagasaki, Japan; [Takamori, Ayako] Saga Univ Hosp, Clin Res Ctr, Saga, Japan	University of Toyama; University of Toyama; University of Toyama; University of Toyama; Saga University	Miura, K (corresponding author), Univ Toyama, Toyama Reg Ctr JECS, Toyama, Japan.; Miura, K (corresponding author), Nagasaki Junshin Catholic Univ, Nagasaki, Japan.	miura@n-junshin.ac.jp		Miura, Kayoko/0000-0001-6012-5583; Tsuchida, Akiko/0000-0003-1209-3104	Ministry of the Environment, Japan	Ministry of the Environment, Japan(Ministry of the Environment, Japan)	The JECS is funded by the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson AN, 2013, J HEALTH PSYCHOL, V18, P311, DOI 10.1177/1359105311435428; Baskin R, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12218; Bratman S, 1997, YOGA J, V42, P50; Chatzi L, 2011, PUBLIC HEALTH NUTR, V14, P1663, DOI 10.1017/S1368980010003629; Christian LM, 2013, ANN BEHAV MED, V46, P295, DOI 10.1007/s12160-013-9521-7; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Dunn TM, 2016, EAT BEHAV, V21, P11, DOI 10.1016/j.eatbeh.2015.12.006; Fukuhara S., 2004, MANUAL SF 8 JAPANESE; Hasson Dan, 2006, Popul Health Metr, V4, P8, DOI 10.1186/1478-7954-4-8; Sanchez PH, 2012, EUR J CLIN NUTR, V66, P360, DOI 10.1038/ejcn.2011.146; Ishihara J, 2003, J EPIDEMIOL, V13, pS134; Ishitsuka K, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0667-y; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Lucas M, 2014, BRAIN BEHAV IMMUN, V36, P46, DOI 10.1016/j.bbi.2013.09.014; Michikawa T, 2018, J EPIDEMIOL, V28, P99, DOI 10.2188/jea.JE20170018; Michikawa T, 2015, J EPIDEMIOL, V25, P452, DOI 10.2188/jea.JE20140186; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Nanri A, 2013, BRIT J PSYCHIAT, V203, P422, DOI 10.1192/bjp.bp.112.114793; Okubo H, 2011, BRIT J NUTR, V105, P1251, DOI 10.1017/S0007114510004782; Sasaki S, 2003, J EPIDEMIOL, V13, pS106; Shivappa N, 2017, ARCH IRAN MED, V20, P108, DOI 0172002/AIM.0010; Shivappa N, 2016, BRIT J NUTR, V116, P1077, DOI 10.1017/S0007114516002853; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Tanno K, 2012, J PSYCHOSOM RES, V73, P225, DOI 10.1016/j.jpsychores.2012.05.013; Tsubono Y, 2003, J EPIDEMIOL, V13, pS125; Tsugane S, 2003, J EPIDEMIOL, V13, pS51; WILLETT WC, 1994, AM J CLIN NUTR, V59, p171S, DOI 10.1093/ajcn/59.1.171S	27	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236330	10.1371/journal.pone.0236330	http://dx.doi.org/10.1371/journal.pone.0236330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32717744	gold, Green Published			2022-12-26	WOS:000556674500012
J	Wijeyakulasuriya, DA; Eisenhauer, EW; Shaby, BA; Hanks, EM				Wijeyakulasuriya, Dhanushi A.; Eisenhauer, Elizabeth W.; Shaby, Benjamin A.; Hanks, Ephraim M.			Machine learning for modeling animal movement	PLOS ONE			English	Article							RESOURCE SELECTION; NEURAL-NETWORKS; FRAMEWORK; STEP	Animal movement drives important ecological processes such as migration and the spread of infectious disease. Current approaches to modeling animal tracking data focus on parametric models used to understand environmental effects on movement behavior and to fill in missing tracking data. Machine Learning and Deep learning algorithms are powerful and flexible predictive modeling tools but have rarely been applied to animal movement data. In this study we present a general framework for predicting animal movement that is a combination of two steps: first predicting movement behavioral states and second predicting the animal's velocity. We specify this framework at the individual level as well as for collective movement. We use Random Forests, Neural and Recurrent Neural Networks to compare performance predicting one step ahead as well as long range simulations. We compare results against a custom constructed Stochastic Differential Equation (SDE) model. We apply this approach to high resolution ant movement data. We found that the individual level Machine Learning and Deep Learning methods outperformed the SDE model for one step ahead prediction. The SDE model did comparatively better at simulating long range movement behaviour. Of the Machine Learning and Deep Learning models the Long Short Term Memory (LSTM) individual level model did best at long range simulations. We also applied the Random Forest and LSTM individual level models to model gull migratory movement to demonstrate the generalizability of this framework. Machine Learning and deep learning models are easier to specify compared to traditional parametric movement models which can have restrictive assumptions. However, machine learning and deep learning models are less interpretable than parametric movement models. The type of model used should be determined by the goal of the study, if the goal is prediction, our study provides evidence that machine learning and deep learning models could be useful tools.	[Wijeyakulasuriya, Dhanushi A.; Eisenhauer, Elizabeth W.; Hanks, Ephraim M.] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Shaby, Benjamin A.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Colorado State University	Wijeyakulasuriya, DA (corresponding author), Penn State Univ, Dept Stat, University Pk, PA 16802 USA.	dzw5320@psu.edu		Shaby, Benjamin Adam/0000-0002-8663-536X	NSF [1414296]; NIH [GM116927]; National Science Foundation [NSF 1414296]; National Institutes of Health [NIH GM116927]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	EMH was supported by National Science Foundation grant number NSF 1414296 (https:// www.nsf.gov/). EMH was also supported by National Institutes of Health grant number NIH GM116927 (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge financial support from NSF 1414296 and NIH GM116927. Computations for this research were performed on the Pennsylvania State University's Institute for Computational and Data Sciences Advanced CyberInfrastructure (ICDS-ACI). This content is solely the responsibility of the authors and does not necessarily represent the views of the Institute for Computational and Data Sciences.	Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Avgar T, 2016, METHODS ECOL EVOL, V7, P619, DOI 10.1111/2041-210X.12528; Bianchi FM, 2017, ARXIV E PRINTS; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bridle John S, 1990, NEUROCOMPUTING, P227, DOI DOI 10.1007/978-3-642-76153-9_28; Browning E, 2018, METHODS ECOL EVOL, V9, P681, DOI 10.1111/2041-210X.12926; Carroll G, 2014, J EXP BIOL, V217, P4295, DOI 10.1242/jeb.113076; Chollet F., 2015, KERAS; Coleman T, 2017, STAT INFERENCE TREE; Coulibaly P, 2005, J HYDROL, V307, P164, DOI 10.1016/j.jhydrol.2004.10.008; DeepMind, 2016, DEEPMIND AI REDUCES; Eisenhauer E, 2020, ENVIRONMETRICS, V31, DOI 10.1002/env.2618; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Gal Y, 2016, PR MACH LEARN RES, V48; Gedeon TD, 1997, INT J NEURAL SYST, V8, P209, DOI 10.1142/S0129065797000227; Gers FA, 1999, IEE CONF PUBL, P850, DOI [10.1162/089976600300015015, 10.1049/cp:19991218]; Ghosh A, 2017, AAAI CONF ARTIF INTE, P1919; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A, 2013, ICASSP IEEE INT C AC, P38; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Hanks EM, 2017, BIORXIV; Hooten M. B., 2017, ANIMAL MOVEMENT STAT; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Jouppi NP, 2017, 44TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE (ISCA 2017), P1, DOI 10.1145/3079856.3080246; KUAN CM, 1995, J APPL ECONOMET, V10, P347, DOI 10.1002/jae.3950100403; Kucukelbir A, 2017, J MACH LEARN RES, V18, P1; Kuderer M, 2015, IEEE INT CONF ROBOT, P2641, DOI 10.1109/ICRA.2015.7139555; Langrock R, 2014, METHODS ECOL EVOL, V5, P190, DOI 10.1111/2041-210X.12155; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; McClintock BT, 2018, METHODS ECOL EVOL, V9, P1518, DOI 10.1111/2041-210X.12995; McClintock BT, 2012, ECOL MONOGR, V82, P335, DOI 10.1890/11-0326.1; Michelot T, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2452; Modlmeier AP, 2019, ELIFE, V8, DOI 10.7554/eLife.38473; Montana D. J., 1989, IJCAI-89 Proceedings of the Eleventh International Joint Conference on Artificial Intelligence, P762; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Parton A, 2017, J AGR BIOL ENVIR ST, V22, P373, DOI 10.1007/s13253-017-0286-5; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Poggio T., 2016, DEEP LEARNING MATH N, P9; Polson NG, 2017, BAYESIAN ANAL, V12, P1275, DOI 10.1214/17-BA1082; Preisler HK, 2008, INT J WILDLAND FIRE, V17, P305, DOI 10.1071/WF06162; Preisler HK, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00286.1; Preisler HK, 2004, ENVIRONMETRICS, V15, P643, DOI 10.1002/env.636; Quevillon LE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13393; Ranganath R, 2014, JMLR WORKSH CONF PRO, V33, P814; Ringner M, 2002, PHARMACOGENOMICS, V3, P403, DOI 10.1517/14622416.3.3.403; Russell JC, 2018, ANN APPL STAT, V12, P1312, DOI 10.1214/17-AOAS1113; Russell JC, 2017, J AGR BIOL ENVIR ST, V22, P313, DOI 10.1007/s13253-017-0296-3; Sahoolizadeh AH, 2008, NEW FACE RECOGNITION; Segal M, 2011, WIRES DATA MIN KNOWL, V1, P80, DOI 10.1002/widm.12; Shamoun-Baranes J, 2017, J AVIAN BIOL, V48, P49, DOI 10.1111/jav.01229; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; WHITLEY D, 1990, PARALLEL COMPUT, V14, P347, DOI 10.1016/0167-8191(90)90086-O; Wijeyakulasuriya DA, 2019, J AGR BIOL ENVIR ST, V24, P73, DOI 10.1007/s13253-018-00342-2; Xiao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000414; Xu Y, 2016, 2016 2ND IEEE INTERNATIONAL CONFERENCE ON COMPUTER AND COMMUNICATIONS (ICCC), P2873, DOI 10.1109/CompComm.2016.7925223; Ziebart B. D., 2008, AAAI, V8, P1433	62	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0235750	10.1371/journal.pone.0235750	http://dx.doi.org/10.1371/journal.pone.0235750			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716917	Green Published, gold			2022-12-26	WOS:000556674500058
J	Deng, AY; Menard, A				Deng, Alan Y.; Menard, Annie			Conserved mammalian modularity of quantitative trait loci revealed human functional orthologs in blood pressure control	PLOS ONE			English	Article							HYPERTENSION; GENE; ATP2B1; MICE; ERGIC-53; RAT	Genome-wide association studies (GWAS) have routinely detected human quantitative trait loci (QTLs) for complex traits. Viewing that most GWAS single nucleotide polymorphisms (SNPs) are found in non-coding regions unrelated to the physiology of a polygenic trait of interest, a vital question to answer is whether or not any of these SNPs can functionally alter the phenotype with which it is associated. The study of blood pressure (BP) is a case in point. Conserved mechanisms in controlling BP by modularity is now unifying differing mammalian orders in that understanding mechanisms in rodents is tantamount to revealing the same in humans, while overcoming experimental limitations imposed by human studies. As a proof of principle, we used BP QTLs from Dahl salt-sensitive rats (DSS) as substitutes to capture distinct human functional orthologs. 3 DSS BP QTLs are located into distinct genome regions and correspond to several human GWAS genes. Each of the QTLs independently exerted a major impact on BP in vivo. BP was functionally changed by normotensive alleles from each of these QTLs, and yet, the human GWAS SNPs do not exist in the rat. They cannot be responsible for physiological alterations in BP caused by these QTLs. These SNPs are genome emblems for QTLs nearby, rather than being QTLs per se, since they only emerged during primate evolution after BP-regulating mechanisms have been established. We then identified specific mutated coding domains that are conserved between rodents and humans and that may implicate different steps of a common pathway or separate pathways.	[Deng, Alan Y.; Menard, Annie] Univ Montreal, CRCHUM Ctr Hosp Univ Montreal, Dept Med, Res Ctr, Montreal, PQ, Canada	Universite de Montreal	Deng, AY (corresponding author), Univ Montreal, CRCHUM Ctr Hosp Univ Montreal, Dept Med, Res Ctr, Montreal, PQ, Canada.	alan.deng@umontreal.ca			Heart and Stroke Foundation of Canada [12345]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study is funded by Heart and Stroke Foundation of Canada, number 12345. AYD received this award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ariyarajah A, 2004, J HYPERTENS, V22, P1495, DOI 10.1097/01.hjh.0000133720.94075.6f; Arnold H, 2010, APPLIED TECHNOLOGY AND INNOVATION MANAGEMENT: INSIGHTS AND EXPERIENCES FROM AN INDUSTRY-LEADING INNOVATION CENTRE, P100, DOI 10.1007/978-3-540-88827-7_10; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Burggren W, 2011, COMPREHENSIVE PHYSL, P215; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Charron S, 2005, HUM MOL GENET, V14, P3877, DOI 10.1093/hmg/ddi412; Chauvet C, 2015, J HYPERTENS, V33, P1791, DOI 10.1097/HJH.0000000000000626; Chauvet C, 2013, HUM MOL GENET, V22, P4451, DOI 10.1093/hmg/ddt294; Chauvet C, 2012, J HYPERTENS, V30, P81, DOI 10.1097/HJH.0b013e32834dddb1; Cowley AW, 2018, HYPERTENSION, V72, P588, DOI 10.1161/HYPERTENSIONAHA.118.11494; Crespo K, 2015, CIRC-CARDIOVASC GENE, V8, P610, DOI 10.1161/CIRCGENETICS.114.000965; Crespo K, 2011, J HYPERTENS, V29, P460, DOI 10.1097/HJH.0b013e328341f1cc; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; Deng AY, 2007, HYPERTENSION, V49, P740, DOI 10.1161/01.HYP.0000259105.09235.56; Deng AY, 2020, J HYPERTENS, V38, P322, DOI 10.1097/HJH.0000000000002267; Deng AY, 2019, CAN J CARDIOL, V35, P661, DOI 10.1016/j.cjca.2018.12.029; Deng AY, 2018, HYPERTENSION, V72, P755, DOI 10.1161/HYPERTENSIONAHA.118.11385; Deng AY, 2015, J HYPERTENS, V33, P669, DOI 10.1097/HJH.0000000000000479; DENG AY, 1994, J CLIN INVEST, V93, P2701, DOI 10.1172/JCI117284; Duong C, 2007, HEREDITY, V98, P165, DOI 10.1038/sj.hdy.6800920; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Evangelou E, 2018, NAT GENET, V50, P1412, DOI 10.1038/s41588-018-0205-x; Fujiwara A, 2014, J HYPERTENS, V32, P1415, DOI 10.1097/HJH.0000000000000206; Garrett MR, 1998, GENOME RES, V8, P711, DOI 10.1101/gr.8.7.711; Gericke A, 2011, AM J PHYSIOL-HEART C, V300, pH1602, DOI 10.1152/ajpheart.00982.2010; Guo H, 2017, DEV BIOL, V430, P214, DOI 10.1016/j.ydbio.2017.07.018; Harashima S, 2012, J DIABETES INVEST, V3, P52, DOI 10.1111/j.2040-1124.2011.00138.x; Harrap SB, 2015, CIRC-CARDIOVASC GENE, V8, P541, DOI 10.1161/CIRCGENETICS.115.001188; Hauri HP, 2000, J CELL SCI, V113, P587; Jin XW, 2003, MOL CELL BIOL, V23, P1054, DOI 10.1128/MCB.23.3.1054-1060.2003; Kaczmarek K, 2009, CYTOGENET GENOME RES, V126, P243, DOI 10.1159/000251961; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Kobayashi Y, 2012, HYPERTENSION, V59, P854, DOI 10.1161/HYPERTENSIONAHA.110.165068; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Lee H, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/JOURNAL.PONE.0163072; Liang HCL, 1996, P NATL ACAD SCI USA, V93, P1671, DOI 10.1073/pnas.93.4.1671; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Munroe PB, 2013, CIRC RES, V112, P1365, DOI 10.1161/CIRCRESAHA.112.300387; Ojeda NB, 2008, FUTUR CARDIOL, V4, P163, DOI 10.2217/14796678.4.2.163; Palijan A, 2003, HYPERTENSION, V42, P515, DOI 10.1161/01.HYP.0000090096.88509.15; Rhoden A, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13262; Shin YB, 2013, J HYPERTENS, V31, P1575, DOI 10.1097/HJH.0b013e32836189e9; Stringer C, 2017, NATURE, V546, P212, DOI 10.1038/546212a; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; White CR, 2014, EVOLUTION, V68, P901, DOI 10.1111/evo.12298; Yerushalmi N, 2001, GENE, V265, P55, DOI 10.1016/S0378-1119(01)00347-X; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230	50	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235756	10.1371/journal.pone.0235756	http://dx.doi.org/10.1371/journal.pone.0235756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702059	Green Published, gold			2022-12-26	WOS:000575913700025
J	Martin, JM; Andriano, DW; Mota, NB; Mota-Rolim, SA; Araujo, JF; Solms, M; Ribeiro, S				Martin, Joshua M.; Andriano, Danyal Wainstein; Mota, Natalia B.; Mota-Rolim, Sergio A.; Araujo, John Fontenele; Solms, Mark; Ribeiro, Sidarta			Structural differences between REM and non-REM dream reports assessed by graph analysis	PLOS ONE			English	Article							STORY-LIKE ORGANIZATION; NREM SLEEP; MENTATION; TIME; EXPERIENCE; BRAIN	Dream reports collected after rapid eye movement sleep (REM) awakenings are, on average, longer, more vivid, bizarre, emotional and story-like compared to those collected after non-REM. However, a comparison of the word-to-word structural organization of dream reports is lacking, and traditional measures that distinguish REM and non-REM dreaming may be confounded by report length. This problem is amenable to the analysis of dream reports as non-semantic directed word graphs, which provide a structural assessment of oral reports, while controlling for individual differences in verbosity. Against this background, the present study had two main aims: Firstly, to investigate differences in graph structure between REM and non-REM dream reports, and secondly, to evaluate how non-semantic directed word graph analysis compares to the widely used measure of report length in dream analysis. To do this, we analyzed a set of 133 dream reports obtained from 20 participants in controlled laboratory awakenings from REM and N2 sleep. We found that: (1) graphs from REM sleep possess a larger connectedness compared to those from N2; (2) measures of graph structure can predict ratings of dream complexity, where increases in connectedness and decreases in randomness are observed in relation to increasing dream report complexity; and (3) measures of the Largest Connected Component of a graph can improve a model containing report length in predicting sleep stage and dream report complexity. These results indicate that dream reports sampled after REM awakening have on average a larger connectedness compared to those sampled after N2 (i.e. words recur with a longer range), a difference which appears to be related to underlying differences in dream complexity. Altogether, graph analysis represents a promising method for dream research, due to its automated nature and potential to complement report length in dream analysis.	[Martin, Joshua M.; Mota, Natalia B.; Mota-Rolim, Sergio A.; Ribeiro, Sidarta] Univ Fed Rio Grande do Norte, Brain Inst, Natal, RN, Brazil; [Andriano, Danyal Wainstein; Solms, Mark] Univ Cape Town, Cape Town, South Africa; [Araujo, John Fontenele] Univ Fed Rio Grande do Norte, Dept Physiol & Behav, Natal, RN, Brazil; [Martin, Joshua M.] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany	Universidade Federal do Rio Grande do Norte; University of Cape Town; Universidade Federal do Rio Grande do Norte; Humboldt University of Berlin	Ribeiro, S (corresponding author), Univ Fed Rio Grande do Norte, Brain Inst, Natal, RN, Brazil.	sidartaribeiro@neuro.ufrn.br	Mota, Natália/O-4089-2019; Araujo, John/A-6345-2010	Mota, Natália/0000-0003-2802-2001; Araujo, John/0000-0002-8022-2425	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos do Ministerio da Ciencia e Tecnologia (FINEP); Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN); CNPq [308775/2015-5, 408145/2016-1]; CAPES-SticAMSud; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07699-0]; University of Cape Town [457091]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos do Ministerio da Ciencia e Tecnologia (FINEP); Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN)(Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-SticAMSud; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Cape Town	Authors from Brazil received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; www.capes.gov.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; www.cnpq.br), Financiadora de Estudos e Projetos do Ministerio da Ciencia e Tecnologia (FINEP; www.finep.gov.br), and Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN; http://www.fapern.rn.gov.br/).SR was supported by CNPq grants 308775/2015-5 and 408145/2016-1, CAPES-SticAMSud, and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; www.fapesp.br) grant #2013/07699-0 Center for Neuromathematics. Authors from South Africa received funding from the University of Cape Town (www.uct.ac.za) through fund #457091 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; ANTROBUS J, 1983, PSYCHOPHYSIOLOGY, V20, P562, DOI 10.1111/j.1469-8986.1983.tb03015.x; ANTROBUS J, 1995, CONSCIOUS COGN, V4, P275, DOI 10.1006/ccog.1995.1039; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Bertola L, 2014, FRONTIERS AGING NEUR; Bleuler E., 1950, DEMENTIA PRAECOX GRO; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Casagrande M, 1996, DREAMING, V6, P43, DOI 10.1037/h0094445; Casagrande M, 1996, INT J NEUROSCI, V85, P19, DOI 10.3109/00207459608986348; Cavallero C., 2003, SLEEP RES ONLINE, V5, P89; Cicogna P, 1998, SLEEP, V21, P462, DOI 10.1093/sleep/21.5.462; Cipolli C, 1998, J SLEEP RES, V7, P13, DOI 10.1046/j.1365-2869.1998.00094.x; Cipolli C, 2015, J SLEEP RES, V24, P234, DOI 10.1111/jsr.12251; DEMENT W, 1957, J EXP PSYCHOL, V53, P339, DOI 10.1037/h0048189; Domhoff GW, 2008, CONSCIOUS COGN, V17, P1238, DOI 10.1016/j.concog.2008.06.010; Fosse R, 2004, PSYCHOPHYSIOLOGY, V41, P298, DOI 10.1111/j.1469-8986.2003.00146.x; FOULKES D, 1983, SLEEP, V6, P265, DOI 10.1093/sleep/6.3.265; FOULKES D, 1964, PERCEPT MOTOR SKILL, V19, P983, DOI 10.2466/pms.1964.19.3.983; Foulkes D, 1966, J ABNORM PSYCHOL, V70, P231; FOULKES DAVID, 1965, J ABNORM PSYCHOL, V70, P231, DOI 10.1037/h0022217; FOULKES WD, 1962, J ABNORM PSYCHOL, V65, P14, DOI 10.1037/h0040431; GOODENOUGH DR, 1965, J PERS SOC PSYCHOL, V2, P170, DOI 10.1037/h0022424; Hall C., 1966, CONTENT ANAL DREAMS, DOI DOI 10.1192/BJP.112.490.963; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P793, DOI 10.1017/S0140525X00003976; Hunt H, 1993, DREAMING, V3, P179, DOI DOI 10.1037/H0094379; Iber C., 2007, AASM MANUAL SCORING; Kraepelin E, 1906, SPRACHSTORUNGEN TRAU; Montangero J, 2015, WHAT RENDERS DREAMS, DOI [10.11588/ijodr.2015.2.19774, DOI 10.11588/IJODR.2015.2.19774]; Mota NB, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-017-0019-3; Mota NB, 2014, SCI REP-UK, V4, DOI 10.1038/srep03691; Mota NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034928; Mota NB, 2016, MIND BRAIN EDUC, V10, P184, DOI 10.1111/mbe.12122; Mota-Rolim SA, 2013, MED HYPOTHESES, V81, P751, DOI 10.1016/j.mehy.2013.04.049; Nielsen T., 2001, SLEEP HYPNOSIS, V3, P9; Nielsen TA, 2000, BEHAV BRAIN SCI, V23, P851, DOI 10.1017/S0140525X0000399X; Nielsen TA, 1983, SLEEP RES, V20, P181; Oudiette D, 2012, CONSCIOUS COGN, V21, P1129, DOI 10.1016/j.concog.2012.04.010; PIVIK T, 1968, J CONSULT CLIN PSYCH, V32, P144, DOI 10.1037/h0025489; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rosenlicht N, 2017, ARCH ITAL BIOL, V155, P75, DOI [10.12871/000398292017128, 10.12871/000398292017127]; Schredl M, 2004, PERCEPT MOTOR SKILL, V98, P1422, DOI 10.2466/pms.98.3c.1422-1426; Speth J, 2013, CONSCIOUS COGN, V22, P1013, DOI 10.1016/j.concog.2013.07.003; Stickgold R, 2001, SLEEP, V24, P171, DOI 10.1093/sleep/24.2.171; STICKGOLD R, 1994, CONSCIOUS COGN, V3, P16, DOI 10.1006/ccog.1994.1002; Wainstein D, 2013, THESIS; Wamsley EJ, 2007, BRAIN RES BULL, V71, P347, DOI 10.1016/j.brainresbull.2006.09.021; WATERMAN D, 1993, J SLEEP RES, V2, P8; Wechsler D., 2011, WASI 2 WECHSLER ABBR	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0228903	10.1371/journal.pone.0228903	http://dx.doi.org/10.1371/journal.pone.0228903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32701992	Green Submitted, gold, Green Published			2022-12-26	WOS:000575913700002
J	Szeker, S; Vathy-Fogarassy, A				Szeker, Szabolcs; Vathy-Fogarassy, Agnes			Weighted nearest neighbours-based control group selection method for observational studies	PLOS ONE			English	Article							PROPENSITY SCORE ESTIMATION; MATCHING METHODS; BIAS; VARIABLES; BALANCE; MODELS	Although in observational studies, propensity score matching is the most widely used balancing method, it has received much criticism. The main drawback of this method is that the individuals of the case and control groups are paired in the compressed one-dimensional space of propensity scores. In this paper, such a novel multivariate weighted k-nearest neighbours-based control group selection method is proposed which can eliminate this disadvantage of propensity score matching. The proposed method pairs the elements of the case and control groups in the original vector space of the covariates and the dissimilarities of the individuals are calculated as the weighted distances of the subjects. The weight factors are calculated from a logistic regression model fitted on the status of treatment assignment. The efficiency of the proposed method was evaluated by Monte Carlo simulations on different datasets. Experimental results show that the proposed Weighted Nearest Neighbours Control Group Selection with Error Minimization method is able to select a more balanced control group than the most widely applied greedy form of the propensity score matching method, especially for individuals characterized with few descriptive features.	[Szeker, Szabolcs; Vathy-Fogarassy, Agnes] Univ Pannonia, Dept Comp Sci & Syst Technol, Veszprem, Hungary; [Szeker, Szabolcs; Vathy-Fogarassy, Agnes] Univ Pannonia, Healthcare Business Analyt Res & Dev Ctr, Veszprem, Hungary	University of Pannonia; University of Pannonia	Szeker, S (corresponding author), Univ Pannonia, Dept Comp Sci & Syst Technol, Veszprem, Hungary.; Szeker, S (corresponding author), Univ Pannonia, Healthcare Business Analyt Res & Dev Ctr, Veszprem, Hungary.	vathy@dcs.uni-pann.hu	Vathy-Fogarassy, Ágnes/W-1072-2019	Vathy-Fogarassy, Ágnes/0000-0002-5524-1675	Szechenyi [EFOP-3.6.1-16-2016-00015]	Szechenyi	The publication was supported by Szechenyi 2020 under the EFOP-3.6.1-16-2016-00015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DW, 1980, SCAND J STAT, V7, P61; [Anonymous], 1908, BIOMETRIKA, V6, P1; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baser O, 2006, VALUE HEALTH, V9, P377, DOI 10.1111/j.1524-4733.2006.00130.x; Behar PRP, 2008, J HOSP INFECT, V68, P123, DOI 10.1016/j.jhin.2007.10.022; Biondi-Zoccai G, 2011, CONTEMP CLIN TRIALS, V32, P731, DOI 10.1016/j.cct.2011.05.006; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brown DW, 2020, STAT MED, V39, P2308, DOI 10.1002/sim.8540; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Cavuto S, 2006, DRUG DEVELOP RES, V67, P208, DOI 10.1002/ddr.20079; Chuang YW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222169; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; Cushman DO, 2017, J INT MONEY FINANC, V77, P143, DOI 10.1016/j.jimonfin.2017.07.018; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Elze MC, 2017, J AM COLL CARDIOL, V69, P345, DOI 10.1016/j.jacc.2016.10.060; Hansen BB, 2008, STAT SCI, V23, P219, DOI 10.1214/08-STS254; Harris AD, 2002, CLIN INFECT DIS, V34, P1558, DOI 10.1086/340533; Hwang SHJ, 2018, J RES EDUC EFF, V11, P559, DOI 10.1080/19345747.2018.1496500; King G, 2019, POLIT ANAL, V27, P435, DOI 10.1017/pan.2019.11; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; Lee MJ., 2016, MATCHING REGRESSION; Lee WS, 2013, EMPIR ECON, V44, P47, DOI 10.1007/s00181-011-0481-0; Mansournia MA, 2018, EUR J EPIDEMIOL, V33, P5, DOI 10.1007/s10654-017-0325-0; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Moser P, 2019, HDB EXPT PHARM, V257, P101; Pearl J, 2009, STAT MED, V28, P1415, DOI 10.1002/sim.3521; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Pell GS, 2008, NEUROIMAGE, V41, P1324, DOI 10.1016/j.neuroimage.2008.02.050; Ripollone JE, 2018, AM J EPIDEMIOL, V187, P1951, DOI 10.1093/aje/kwy078; Rosenbaum, 2002, OBSERVATIONAL STUDIE; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosholm M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216200; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; RUBIN DB, 1976, BIOMETRICS, V32, P109, DOI 10.2307/2529342; RUBIN DB, 1973, BIOMETRICS, V29, P159, DOI 10.2307/2529684; Rubin DB, 2006, MATCHED SAMPLING FOR CAUSAL EFFECTS, P1, DOI 10.2277/ 0521674360; Setoguchi S, 2008, PHARMACOEPIDEM DR S, V17, P546, DOI 10.1002/pds.1555; Shin SH, 2015, J AM COLL SURGEONS, V220, P177, DOI 10.1016/j.jamcollsurg.2014.10.014; Shipman JE, 2017, ACCOUNT REV, V92, P213, DOI 10.2308/accr-51449; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Szeker Szabolcs, 2019, 2019 IEEE International Work Conference on Bioinspired Intelligence (IWOBI). Proceedings, P000033, DOI 10.1109/IWOBI47054.2019.9114390; Thoemmes FJ, 2011, MULTIVAR BEHAV RES, V46, P90, DOI 10.1080/00273171.2011.540475; Tokuda M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219269; Wan F, 2019, STAT MED, V38, P289, DOI 10.1002/sim.7976; Wang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081045; Xu D, 2019, EXAMINING RELATIONSH; Zhao P, 2016, CONTEMP CLIN TRIALS, V47, P85, DOI 10.1016/j.cct.2015.12.012	57	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236531	10.1371/journal.pone.0236531	http://dx.doi.org/10.1371/journal.pone.0236531			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32701991	gold, Green Published			2022-12-26	WOS:000575913700101
J	Garman, KS; Ajayi, TA; Boutte, HJ; Chiu, ST; von Furstenberg, RJ; Lloyd, BR; Zhang, C; Onaitis, MW; Chow, SC; McCall, SJ				Garman, Katherine S.; Ajayi, Teminioluwa A.; Boutte, Harold J., Jr.; Chiu, Shih-Ting; von Furstenberg, Richard J.; Lloyd, Benjamin R.; Zhang, Cecelia; Onaitis, Mark W.; Chow, Shein-Chung; McCall, Shannon J.			Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma	PLOS ONE			English	Article							CIGARETTE-SMOKING; CANCER; MICROBIOME; INFLAMMATION; CARCINOMA; EXPOSURE; TONSIL; STATES; SERUM; ODDS	Background Esophageal cancer is a deadly cancer with 5-year survival <20%. Although multiple risk factors for esophageal adenocarcinoma (EAC) including obesity, GERD and smoking have been identified, these risk factors do not fully explain the rising incidence of EAC. In this study, we evaluated the association between prior history of tonsillectomy and EAC. Our goal was to determine whether tonsillectomies were more frequent in patients with EAC (cases) than in our thoracic surgery controls. Methods Cases included 452 esophagectomy cases, including 396 with EAC and 56 who underwent esophagectomy for Barrett's esophagus (BE) with high grade dysplasia (HGD). 1,102 thoracic surgery patients with surgical indications other than dysplastic BE or esophageal cancer represented the controls for our analysis. The association of tonsillectomy and HGD/EAC were primarily evaluated by using univariate tests and then verified by logistic regression analysis. Baseline demographics, medical history, and thoracic surgery controls were compared by using chi(2)tests or 95% CIs. Significant risk factors were considered as covariates in the multivariate models while evaluating the association between tonsillectomy and HGD/EAC. P-values or odds ratios were estimated with 95% confidence limits to identify significances which was more appropriate. Results Tonsillectomy was more common in cases than controls and was found to have a significant association with esophageal cancer (19.9% vs. 12.7%; p-value = 0.0003). This significant association persisted after controlling for other known risk factors/covariates. Conclusion A prior history of tonsillectomy was significantly associated with HGD/EAC and may represent an independent risk factor for the development of EAC. However, the underlying biology driving this association remains unclear.	[Garman, Katherine S.; von Furstenberg, Richard J.; Lloyd, Benjamin R.; Zhang, Cecelia] Duke Univ, Dept Med, Div Gastroenterol, Durham, NC 27708 USA; [Ajayi, Teminioluwa A.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Boutte, Harold J., Jr.] Northwestern Med, Div Gastroenterol, Dept Med, Chicago, IL USA; [Chiu, Shih-Ting] Providence Hlth & Serv, Portland, OR USA; [Onaitis, Mark W.] Univ Calif San Diego, Dept Surg, Div Cardiovasc & Thorac Surg, La Jolla, CA 92093 USA; [Chow, Shein-Chung] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [McCall, Shannon J.] Duke Univ, Dept Pathol, Durham, NC 27706 USA	Duke University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Diego; Duke University; Duke University	Garman, KS (corresponding author), Duke Univ, Dept Med, Div Gastroenterol, Durham, NC 27708 USA.	katherine.garman@duke.edu		Garman, Katherine/0000-0001-7763-8465; Ajayi, Teminioluwa/0000-0001-6891-7243; McCall, Shannon/0000-0003-3957-061X	NIH [K08 DK098528, R01 DK118022-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Katherine S. Garman received NIH funding, including funds that have supported the esophagectomy database, K08 DK098528 and an R01 DK118022-01. The authors declare no conflicts of interest.	Abrams JA, 2017, LANCET GASTROENTEROL, V2, P4, DOI 10.1016/S2468-1253(16)30177-7; Amir I, 2014, ENVIRON MICROBIOL, V16, P2905, DOI 10.1111/1462-2920.12285; An JY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11968-2; Andreu-Ballester JC, 2007, CLIN IMMUNOL, V123, P289, DOI 10.1016/j.clim.2007.02.004; Baghdadi J, 2014, CLIN LAB MED, V34, P721, DOI 10.1016/j.cll.2014.08.001; Basseri RJ, 2011, J CLIN GASTROENTEROL, V45, P912, DOI 10.1097/MCG.0b013e31822a289f; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; BOCK A, 1994, EUR ARCH OTO-RHINO-L, V251, P423; Boursi B, 2015, EUR J CANCER, V51, P2655, DOI 10.1016/j.ejca.2015.08.015; Cook MB, 2010, JNCI-J NATL CANCER I, V102, P1344, DOI 10.1093/jnci/djq289; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DERKAY CS, 1993, INT J PEDIATR OTORHI, V25, P1, DOI 10.1016/0165-5876(93)90004-M; Elliott DRF, 2017, LANCET GASTROENTEROL, V2, P32, DOI 10.1016/S2468-1253(16)30086-3; Fakhry C, 2015, CANCER PREV RES, V8, P583, DOI 10.1158/1940-6207.CAPR-15-0101; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FRIDAY GA, 1992, ANN ALLERGY, V69, P225; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Jankowski JAZ, 2018, LANCET, V392, P400, DOI 10.1016/S0140-6736(18)31388-6; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; KRALL EA, 1988, J CLIN EPIDEMIOL, V41, P1059, DOI 10.1016/0895-4356(88)90075-3; Liu N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-130; Lubin JH, 2012, CANCER EPIDEMIOL, V36, P306, DOI 10.1016/j.canep.2012.03.001; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Paulussen C, 2000, Acta Otorhinolaryngol Belg, V54, P403; Pei ZH, 2005, WORLD J GASTROENTERO, V11, P7277, DOI 10.3748/wjg.v11.i46.7277; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Purnell J.Q., 2000, DEFINITIONS CLASSIFI; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Sawada A, 2016, DIGEST DIS SCI, V61, P3161, DOI 10.1007/s10620-016-4263-6; Sun WL, 2016, J GASTROEN HEPATOL, V31, P1085, DOI 10.1111/jgh.13273; Thrift AP, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00011; Tian C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00257-5; Wang YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117535; Yamamura K, 2016, CLIN CANCER RES, V22, P5574, DOI 10.1158/1078-0432.CCR-16-1786; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046; Yu GQ, 2014, CANCER EPIDEM BIOMAR, V23, P735, DOI 10.1158/1055-9965.EPI-13-0855; Zaidi AH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2093-8; Zevallos JP, 2016, BRIT J CANCER, V114, P832, DOI 10.1038/bjc.2016.63; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598; Zupin L, 2018, INT J PEDIATR OTORHI, V107, P135, DOI 10.1016/j.ijporl.2018.01.041	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0235906	10.1371/journal.pone.0235906	http://dx.doi.org/10.1371/journal.pone.0235906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697782	Green Published, gold			2022-12-26	WOS:000555392700014
J	Mosso, M; Freudenberg, A; McCracken, K; McGivern, RF				Mosso, Matthew; Freudenberg, Adam; McCracken, Kristofer; McGivern, Robert F.			Sex differences in implicit processing of allocentric relationships between objects and location in a simon task	PLOS ONE			English	Article							S-R COMPATIBILITY; GENDER-DIFFERENCES; WORKING-MEMORY; ATTENTION; INTERFERENCE; INFORMATION; NETWORKS; STIMULUS; AGE; ACTIVATION	Simon tasks reveal implicit processing conflicts that arise when the abstract coding of stimulus position is incongruent with coding for location of the output response. Participants were tested with two versions of a Simon task in a counterbalanced order to examine a potential female bias for attending to object characteristics versus object location. Both tasks used a triangle pointing to the left or right. A simple version presented the triangle in an inner or outer position relative to central fixation. A more complex version included a frame surrounding the inner-outer triangle presentation area in order to introduce additional visual elements for left/right visual processing. When the No Frame version was the first presented, there were no sex differences in the Simon effect in either version, which is consistent with results from other studies that did not provide feedback regarding accuracy. When the initial test was the Frame version, we observed a reverse Simon effect for incongruent triangles presented in the left inner position, with females faster than males to identify the incongruent condition versus the congruent (-59 vs -5 msec). In the No Frame condition that followed, females showed a carryover effect from the previous Frame condition, exhibiting positive Simon effects that were two fold larger than males for identifying incongruent stimuli presented in the left and right outer positions. Similar to previous Simon studies, females showed longer overall reaction times than males (similar to 15%). The difference was not related to the Simon effect and is also found in other types of tasks involving early visual processing of objects with location. Based on sex differences in the Simon effect that emerged following initial experience of the triangle adjoining the frame, the present results support a female bias toward broader integration of objects within the context of location.	[Mosso, Matthew; Freudenberg, Adam; McCracken, Kristofer; McGivern, Robert F.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	California State University System; San Diego State University	McGivern, RF (corresponding author), San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA.	rmcgivern@sdsu.edu						Adam JJ, 1999, ERGONOMICS, V42, P327, DOI 10.1080/001401399185685; Ball K, 2009, NEUROPSYCHOLOGIA, V47, P1585, DOI 10.1016/j.neuropsychologia.2008.11.017; Bangasser DA, 2018, PHYSIOL BEHAV, V187, P42, DOI 10.1016/j.physbeh.2017.09.025; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Camarata S, 2006, INTELLIGENCE, V34, P231, DOI 10.1016/j.intell.2005.12.001; Christakou A, 2009, NEUROIMAGE, V48, P223, DOI 10.1016/j.neuroimage.2009.06.070; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; CRAFT JL, 1970, J EXP PSYCHOL, V83, P415, DOI 10.1037/h0028843; Dumais KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199049; Duncan J, 1998, PHILOS T ROY SOC B, V353, P1307, DOI 10.1098/rstb.1998.0285; EFRON R, 1987, NEUROPSYCHOLOGIA, V25, P637, DOI 10.1016/0028-3932(87)90054-6; Evans KL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01044; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Handa RJ, 2015, CURR EYE RES, V40, P110, DOI 10.3109/02713683.2014.952826; Hill AC, 2014, BIOL PSYCHOL, V102, P18, DOI 10.1016/j.biopsycho.2014.06.008; Hirnstein M, 2019, LATERALITY, V24, P204, DOI 10.1080/1357650X.2018.1497044; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P208, DOI 10.1007/BF00419608; HOMMEL B, 1994, PSYCHOL RES-PSYCH FO, V56, P179, DOI 10.1007/BF00419705; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Hyun JS, 2007, PSYCHON B REV, V14, P154, DOI 10.3758/BF03194043; Jansen BRJ, 2014, DEV PSYCHOL, V50, P237, DOI 10.1037/a0032493; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Kimura D., 1999, SEX COGNITION, DOI [10.1016/s0010-0277(98)00069-9, DOI 10.1016/S0010-0277(98)00069-9]; LANDAUER AA, 1980, BRIT J PSYCHOL, V71, P551, DOI 10.1111/j.2044-8295.1980.tb01766.x; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Liu G, 2013, CHINESE MED J-PEKING, V126, P2308, DOI 10.3760/cma.j.issn.0366-6999.20122637; McGivern RF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210272; McGivern RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032238; Merritt P, 2007, PERS INDIV DIFFER, V43, P597, DOI 10.1016/j.paid.2007.01.016; Miller DI, 2014, TRENDS COGN SCI, V18, P37, DOI 10.1016/j.tics.2013.10.011; Milner AD, 2017, EXP BRAIN RES, V235, P1297, DOI 10.1007/s00221-017-4917-4; Muller-Oehring EM, 2007, BRAIN RES, V1142, P189, DOI 10.1016/j.brainres.2007.01.062; Neuhaus AH, 2009, HUM BRAIN MAPP, V30, P2997, DOI 10.1002/hbm.20724; NICOLETTI R, 1989, J EXP PSYCHOL HUMAN, V15, P164, DOI 10.1037/0096-1523.15.1.164; NICOLETTI R, 1982, J EXP PSYCHOL HUMAN, V8, P664; Perry CJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00084; Ren ZT, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00248; Roalf D, 2006, BRAIN COGNITION, V60, P32, DOI 10.1016/j.bandc.2005.09.008; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Scheuringer A, 2016, PHYSIOL BEHAV, V165, P159, DOI 10.1016/j.physbeh.2016.07.012; Shen X, 2005, INT J NEUROSCI, V115, P1631, DOI 10.1080/00207450590958484; Sherman J. A, 1978, SEX RELATED COGNITIV; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SIMON JR, 1970, J EXP PSYCHOL, V86, P63, DOI 10.1037/h0029944; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Spets DS, 2019, NEUROIMAGE, V199, P626, DOI 10.1016/j.neuroimage.2019.06.027; Stoet G, 2017, PSYCHOL RES-PSYCH FO, V81, P571, DOI 10.1007/s00426-016-0763-4; Stoet G, 2010, Q J EXP PSYCHOL, V63, P633, DOI 10.1080/17470210903464253; UMILTA C, 1987, PSYCHOL RES-PSYCH FO, V49, P81, DOI 10.1007/BF00308672; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Vanderhasselt MA, 2018, BIOL PSYCHOL, V135, P29, DOI 10.1016/j.biopsycho.2018.02.017; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Voyer D, PSYCHON B REV, V24, P304, DOI [10.3759/s13423-016-1085-7, DOI 10.3759/S13423-016-1085-7]; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892; Wascher E, 2005, EXP BRAIN RES, V163, P430, DOI 10.1007/s00221-004-2198-1; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044; Zeki S, 2016, EUR J NEUROSCI, V44, P2515, DOI 10.1111/ejn.13270	57	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0235964	10.1371/journal.pone.0235964	http://dx.doi.org/10.1371/journal.pone.0235964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU0WZ	32697771	gold, Green Published			2022-12-26	WOS:000555392700003
J	Wuestefeld, A; Fuermaier, ABM; Bernardo, M; de Sa-Caputo, DC; Rittweger, J; Schoenau, E; Stark, C; Marin, PJ; Seixas, A; Judex, S; Taiar, R; Nyakas, C; van der Zee, EA; van Heuvelen, MJG; Tucha, O				Wuestefeld, Anika; Fuermaier, Anselm B. M.; Bernardo-Filho, Mario; de Sa-Caputo, Danubia Cunha; Rittweger, Joern; Schoenau, Eckhard; Stark, Christina; Marin, Pedro J.; Seixas, Aderito; Judex, Stefan; Taiar, Redha; Nyakas, Csaba; van der Zee, Eddy A.; van Heuvelen, Marieke J. G.; Tucha, Oliver			Towards reporting guidelines of research using whole-body vibration as training or treatment regimen in human subjects-A Delphi consensus study	PLOS ONE			English	Article							QUALITY; RECOMMENDATIONS; RELIABILITY; PERFORMANCE; STRENGTH; BALANCE	Background Whole-body vibration (WBV) is a method utilizing vibrating platforms to expose individuals to mechanical vibration. In its various applications, it has been linked to improved muscular, skeletal, metabolic, or cognitive functioning, quality of life, and physiological parameters such as blood pressure. Most evidence concerning WBV is inconclusive and meta-analytical reviews may not readily produce insights since the research has a risk of misunderstandings of vibration parameters and incomplete reporting occurs. This study aims at laying an empirical foundation for reporting guidelines for human WBV studies to improve the quality of reporting and the currently limited comparability between studies. Method The Delphi methodology is employed to exploit the integrated knowledge of WBV experts to distil the specific aspects of WBV methodology that should be included in such guidelines. Over three rounds of completing online questionnaires, the expert panel (round 1/2/3: 51/40/37 experts respectively from 17 countries with an average of 19.4 years of WBV research experience) rated candidate items. Results A 40-item list was established based on the ratings of the individual items from the expert panel with a large final consensus (94.6%). Conclusion The final consensus indicates comprehensiveness and valuableness of the list. The results are in line with previous guidelines but expand these extensively. The present results may therefore serve as a foundation for updated guidelines for reporting human WBV studies in order to improve the quality of reporting of WBV studies, improve comparability of studies and facilitate the development of WBV study designs.	[Wuestefeld, Anika; Fuermaier, Anselm B. M.; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Bernardo-Filho, Mario; de Sa-Caputo, Danubia Cunha] Univ Estado Rio de Janeiro, Lab Mech Vibrat & Integrat Practices, Rio De Janeiro, Brazil; [de Sa-Caputo, Danubia Cunha] Univ Estado Rio de Janeiro, Fac Bezerra Araujo, Physiotherapy Course, Rio De Janeirom, Brazil; [Rittweger, Joern] Univ Cologne, German Aerosp Ctr, Cologne, Germany; [Schoenau, Eckhard; Stark, Christina] Univ Cologne, Med Fac, Dept Pediat, Cologne, Germany; [Schoenau, Eckhard; Stark, Christina] Univ Cologne, Univ Hosp, Cologne, Germany; [Schoenau, Eckhard] Univ Cologne, Med Fac, Ctr Prevent & Rehabil, UniReha GmbH, Cologne, Germany; [Marin, Pedro J.] CyMO Res Inst, Valladolid, Spain; [Seixas, Aderito] Univ Fernando Pessoa, Escola Super Saude, Porto, Portugal; [Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Taiar, Redha] Univ Reims, Reims, France; [Nyakas, Csaba] Semmelweis Univ, Fac Hlth Sci, Dept Morphol & Physiol, Budapest, Hungary; [van der Zee, Eddy A.] Univ Groningen, Dept Mol Neurobiol, Groningen, Netherlands; [van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Helmholtz Association; German Aerospace Centre (DLR); University of Cologne; University of Cologne; University of Cologne; University of Cologne; Universidade Fernando Pessoa; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universite de Reims Champagne-Ardenne; Semmelweis University; University of Groningen; University of Groningen	Fuermaier, ABM (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	a.b.m.fuermaier@rug.nl	Rittweger, Jörn/A-4308-2009; van der Zee, Eddy/AAZ-2120-2020; Taiar, Redha/Q-6769-2016; Seixas, Adérito/J-5018-2013	Rittweger, Jörn/0000-0002-2223-8963; Taiar, Redha/0000-0002-0227-3884; Seixas, Adérito/0000-0002-6563-8246; Wuestefeld, Anika/0000-0003-1779-3388; Fuermaier, Anselm/0000-0002-2331-0840; Judex, Stefan/0000-0002-4511-1535				Alam MM, 2018, WORK, V59, P571, DOI 10.3233/WOR-182699; [Anonymous], 2019, EQUATOR NETWORK; Boerema AS, 2018, DOSE-RESPONSE, V16, DOI 10.1177/1559325818811756; Bogaerts A, 2007, GAIT POSTURE, V26, P309, DOI 10.1016/j.gaitpost.2006.09.078; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Brooks K., 1979, N CENTRAL ASS Q, V53, P377; Cardim AB, 2016, RESP CARE, V61, P1552, DOI 10.4187/respcare.04763; del Pozo-Cruz B, 2012, J ALTERN COMPLEM MED, V18, P29, DOI 10.1089/acm.2010.0691; Figueroa A, 2012, HYPERTENS RES, V35, P667, DOI 10.1038/hr.2012.15; Fincher S, 2009, ITICSE 2009: PROCEEDING OF THE 2009 ACM SIGSE ANNUAL CONFERENCE ON INNOVATION AND TECHNOLOGY IN COMPUTER SCIENCE EDUCATION, P4, DOI 10.1145/1595496.1562885; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Fischer M, 2019, FRONTIERS NEUROLOGY, V10; Fuermaier ABM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090747; Gevers DWM, 2014, APPETITE, V79, P51, DOI 10.1016/j.appet.2014.04.002; Green KC, 2007, FORESIGHT, V8; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Habibi A, 2014, INT J ENG SCI, V3, P8, DOI DOI 10.1016/S0169-2070(99)00018-7; Hahn EJ, 1999, TOB CONTROL, V8, P137, DOI 10.1136/tc.8.2.137; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Heesterbeek M., 2017, J NEUROLOGY TRANSLAT, V5, P1079; Hsu C.C, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [DOI 10.7275/PDZ9-TH90, 10.7275/pdz9-th90]; ISO 2631-1, 1997, MECH VIBRATION SHOCK; Kerlinger FN, 1973, FDN BEHAV RES, V2nd; Kiiski J, 2008, J BONE MINER RES, V23, P1318, DOI [10.1359/jbmr.080315, 10.1359/JBMR.080315]; KRIPPEND.K, 1970, EDUC PSYCHOL MEAS, V30, P61, DOI 10.1177/001316447003000105; Lam FMH, 2012, MATURITAS, V72, P206, DOI 10.1016/j.maturitas.2012.04.009; Leite HR, 2018, BRAZ J PHYS THER; LIN YK, 2017, BMC MED ETHICS, V18, DOI DOI 10.1186/S12910-017-0177-X; Lorenzen C, 2009, J SCI MED SPORT, V12, P676, DOI 10.1016/j.jsams.2008.06.008; Mbakwe AC, 2016, ACCIDENT ANAL PREV, V93, P135, DOI 10.1016/j.aap.2016.04.020; Milanese C, 2013, INT J MED SCI, V10, P307, DOI 10.7150/ijms.5161; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molnar FJ, 1999, CAN MED ASSOC J, V161, P393; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Needham DM, 2017, AM J RESP CRIT CARE, V196, P1122, DOI 10.1164/rccm.201702-0372OC; Nordlund MM, 2007, SCAND J MED SCI SPOR, V17, P12, DOI 10.1111/j.1600-0838.2006.00586.x; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Rauch F, 2010, J MUSCULOSKEL NEURON, V10, P193; Rayens MK., 2000, POLICY POLIT NURS PR, V1, P308, DOI DOI 10.1177/152715440000100409; Regterschot GRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100506; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Rowe G, 2001, INT SER OPER RES MAN, V30, P125, DOI 10.1007/978-0-306-47630-3_7; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sanders C, 1936, J AM MED ASS, V106; Santin-Medeiros F, 2017, RES SPORTS MED, V25, P101, DOI 10.1080/15438627.2016.1258638; Savage R, 2016, INT ARCH OCC ENV HEA, V89, P181, DOI 10.1007/s00420-015-1062-x; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Slatkovska L, 2010, OSTEOPOROSIS INT, V21, P1969, DOI 10.1007/s00198-010-1228-z; Song GE, 2011, KOREAN J FAM MED, V32, P399, DOI 10.4082/kjfm.2011.32.7.399; Sumsion T., 1998, BRIT J OCCUP THER, V61, P153, DOI [10.1177/030802269806100403, DOI 10.1177/030802269806100403]; Teglas T, 2018, BEHAV BRAIN RES, V349, P163, DOI 10.1016/j.bbr.2018.04.036; van der Zee EA, 2019, WHOLE BODY VIBRATION, P151; Van der Zee EA, 2010, FEDERATION EUROPEAN, V5, P24; Verhulst ALJ, 2015, ONCOL REV, V9, DOI 10.4081/oncol.2015.263; Walker A, 1996, BR J THER REHABIL, V3, P677, DOI 10.12968/bjtr.1996.3.12.14731; Weir CR, 2006, AM J MED QUAL, V21, P382, DOI 10.1177/1062860606293150; WHEDON GD, 1949, AM J MED, V6, P684; Zapf A, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0200-9; 2016, AM PSYCHOL, V71, P900, DOI DOI 10.1037/AMP000010228032786	63	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0235905	10.1371/journal.pone.0235905	http://dx.doi.org/10.1371/journal.pone.0235905			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU0WZ	32697809	Green Accepted, Green Published, gold			2022-12-26	WOS:000555392700016
J	Jiang, YL; Wen, T; Yan, R; Kim, S; Stowell, SR; Wang, WY; Wang, YC; An, GY; Cummings, RD; Ju, TZ				Jiang, Yuliang; Wen, Tao; Yan, Rui; Kim, Suryun; Stowell, Sean R.; Wang, Wenyi; Wang, Yingchun; An, Guangyu; Cummings, Richard D.; Ju, Tongzhong			O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization	FASEB JOURNAL			English	Article						Cosmc; O-glycosylation; STn antigen; Tn antigen; tumor cells	SIALYL-TN ANTIGEN; BREAST-CANCER CELLS; SURFACE EXPOSURE; CHAPERONE COSMC; SIALOSYL-TN; EXPRESSION; GLYCOSYLATION; PROTEIN; CARCINOMA; PROMOTES	The TNF-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in cells by signaling through the O-glycosylated death receptors (DR4 and DR5), but the sensitivity to TRAIL-induced apoptosis of cells varies, and the attributes of this phenomenon are complex. Human carcinoma cells often express truncated O-glycans, Tn (GalNAc alpha 1-Ser/Thr), and Sialyl-Tn (Sia alpha 2-6GalNAc alpha 1-Ser/Thr, STn) on their surface glycoproteins, yet molecular mechanisms in terms of advantages for tumor cells to have these truncated O-glycans remain elusive. Normal extended O-glycan biosynthesis is regulated by a specific molecular chaperone Cosmc through assisting of the correct folding of Core 1 beta 3 Galactosyltransferase (T-synthase). Here, we use tumor cell lines harboring mutations inCosmc,and therefore expressing Tn and STn antigens to study the role of O-glycans in TRAIL-induced apoptosis. Expression of Tn and STn in tumor cells attenuates their sensitivity to TRAIL treatment; when transfected with wild-typeCosmc, these tumor cells thus express normal extended O-glycans and become more sensitive to TRAIL treatment. Mechanistically, Tn/STn antigens impair homo-oligomerization and stability of DR4 and DR5. These results represent the first mechanistic insight into how O-glycan structures on cell surface modulate their sensitivity to apoptotic stimuli, suggesting expression of Tn/STn may offer tumor cell survival advantages through altering DR4 and/or DR5 activity.	[Jiang, Yuliang; Wang, Wenyi; Wang, Yingchun; Cummings, Richard D.; Ju, Tongzhong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Jiang, Yuliang; Wen, Tao; Yan, Rui; An, Guangyu] Capital Med Univ, Beijing Chao Yang Hosp, Dept Oncol, Beijing 100020, Peoples R China; [Kim, Suryun; Ju, Tongzhong] US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Stowell, Sean R.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Cummings, Richard D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, CLS 11087-3 Blackfan Circle, Boston, MA 02115 USA	Emory University; Capital Medical University; US Food & Drug Administration (FDA); Emory University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	An, GY (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Oncol, Beijing 100020, Peoples R China.; Cummings, RD (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, CLS 11087-3 Blackfan Circle, Boston, MA 02115 USA.; Ju, TZ (corresponding author), US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, OBP CDER, Bldg 52-72,Room 2120, Silver Spring, MD 20993 USA.	agybjcy@163.com; rcummin1@bidmc.harvard.edu; Tongzhong.ju@fda.hhs.gov	jiang, yu/HGU-0029-2022	Ju, Tongzhong/0000-0002-4429-1976	Georgia Research Alliance (GRA); NIH [U01CA168930]; National Natural Science Foundation of China [81572825, 81672338]; Beijing Natural Science Foundation [7172083]; U.S. Food and Drug Administration Intramural Research Funding	Georgia Research Alliance (GRA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); U.S. Food and Drug Administration Intramural Research Funding	This work was supported by Georgia Research Alliance (GRA) to TJ, NIH U01CA168930 to TJ and RDC., and by National Natural Science Foundation of China (81572825 to GA, 81672338 to TW) and Beijing Natural Science Foundation (7172083 to GA), and the U.S. Food and Drug Administration Intramural Research Funding to TJ.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brooks SA, 2000, HISTOL HISTOPATHOL, V15, P143, DOI 10.14670/HH-15.143; BROOKS SA, 1995, BRIT J CANCER, V71, P1033, DOI 10.1038/bjc.1995.199; Buskas T, 2009, CHEM COMMUN, P5335, DOI 10.1039/b908664c; Carlo-Stella C, 2007, CLIN CANCER RES, V13, P2313, DOI 10.1158/1078-0432.CCR-06-2774; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Davidson B, 2000, HUM PATHOL, V31, P1081, DOI 10.1053/hupa.2000.9776; Dias-Baruffi M, 2003, J BIOL CHEM, V278, P41282, DOI 10.1074/jbc.M306624200; Dufour F, 2017, CELL DEATH DIFFER, V24, P500, DOI 10.1038/cdd.2016.150; ENDO Y, 1976, J BIOCHEM-TOKYO, V80, P1; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hofmann BT, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0386-1; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; INOUE M, 1990, OBSTET GYNECOL, V75, P1032; ITZKOWITZ SH, 1989, CANCER RES, V49, P197; ITZKOWITZ SH, 1990, CANCER-AM CANCER SOC, V66, P1960, DOI 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2013, PROTEOM CLIN APPL, V7, P618, DOI 10.1002/prca.201300024; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kaiser A, 2009, ANGEW CHEM INT EDIT, V48, P7551, DOI 10.1002/anie.200902564; Kawaguchi T, 2006, BREAST CANCER RES TR, V98, P31, DOI 10.1007/s10549-005-9115-6; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Malhi H, 2006, ONCOGENE, V25, P7333, DOI 10.1038/sj.onc.1209765; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; NOVOGRODSKY A, 1975, J IMMUNOL, V115, P1243; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Posey AD, 2016, IMMUNITY, V45, P947, DOI 10.1016/j.immuni.2016.10.015; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Soares R, 1996, PATHOL RES PRACT, V192, P1181, DOI 10.1016/S0344-0338(96)80148-8; SPRINGER GF, 1989, MOL IMMUNOL, V26, P1, DOI 10.1016/0161-5890(89)90013-8; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Terasawa K, 1996, CANCER RES, V56, P2229; Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wu YH, 2012, J IMMUNOL, V188, P2914, DOI 10.4049/jimmunol.1102065; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yoshida T, 2007, ONCOL REP, V18, P1239; Zhivotovsky B, 2006, CARCINOGENESIS, V27, P1939, DOI 10.1093/carcin/bgl035	63	15	15	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11786	11801		10.1096/fj.201900053RR	http://dx.doi.org/10.1096/fj.201900053RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32692906				2022-12-26	WOS:000554623700001
J	Kohno, S; Linn, P; Nagatani, N; Watanabe, Y; Kumar, S; Soga, T; Takahashi, C				Kohno, Susumu; Linn, Paing; Nagatani, Naoko; Watanabe, Yoshihiro; Kumar, Sharad; Soga, Tomoyoshi; Takahashi, Chiaki			Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; MUTATIONAL LANDSCAPE; COLLATERAL LETHALITY; RB; CELLS; EXPRESSION; SUCLA2; ENCEPHALOMYOPATHY; DIFFERENTIATION; DEFICIENCY	RB1gene is often homozygously deleted or mutated in prostate adenocarcinomas following acquirement of castration resistance and/or metastatic ability. We found thatSUCLA2gene is frequently involved in the deletion of theRB1gene region in advanced prostate cancer. SUCLA2 constitutes the beta-subunit of succinate CoA ligase heterodimer that reversibly converts succinyl CoA into succinate. We sought the possibility that deletion ofSUCLA2gives rise to a metabolic vulnerability that could be targeted therapeutically. We found a significant metabolic shift inSUCLA2-deleted prostate cancer cells, including lower mitochondrial respiratory activity. By screening a number of libraries for compounds that induce cell death selectively inSUCLA2-deficient prostate cancer cells, we identified thymoquinone (2-isopropyl-5-methylbenzo-1,4-quinone) and PMA (phorbol-12-myristate-13-acetate) from a natural compound library. These findings indicate that the metabolic vulnerability inSUCLA2-deficient prostate cancer cells is pharmacologically targetable.	[Kohno, Susumu; Linn, Paing; Nagatani, Naoko; Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan; [Watanabe, Yoshihiro] Kanazawa Univ Hosp, iCREK, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan; [Kumar, Sharad] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5001, Australia; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan	Kanazawa University; Kanazawa University; Centre for Cancer Biology; University of South Australia; Keio University	Kohno, S; Takahashi, C (corresponding author), Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	skohno@staff.kanazawa-u.ac.jp; chtakaha@staff.kanazawa-u.ac.jp	Kumar, Sharad/AAX-7787-2020	Kumar, Sharad/0000-0001-7126-9814; Linn, Paing/0000-0001-9525-7041; Takahashi, Chiaki/0000-0003-3390-9563	Funding Program for Next Generation World-Leading Researchers from cabinet office of Japan [LS049]; MEXT [17H03576, 17K19586, 19K22555, 17K14992, 20K07612]; Japan Agency for Medical Research and Development (AMED) [19cm0106164h0001]; Daiichi-Sankyo Co. Ltd. [C1010568, C1010818]; National Health & Medical Research Council of Australia [GNT 1103006]	Funding Program for Next Generation World-Leading Researchers from cabinet office of Japan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Daiichi-Sankyo Co. Ltd.(Daiichi Sankyo Company Limited); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Drs. Y. Hirota and S. Tsutsumi for the substantial contribution to the initiation of work, Dr. A. Mizokami for helpful discussion, and Dr. Y. Watanabe for suggestion on research direction. This study was supported by Funding Program for Next Generation World-Leading Researchers (LS049) from cabinet office of Japan, Grant-in-Aid for Scientific Research (17H03576, 17K19586 and 19K22555 to CT, and 17K14992 and 20K07612 to SK) from MEXT, Project for Cancer Research and Therapeutic (P-CREATE) (19cm0106164h0001) from Japan Agency for Medical Research and Development (AMED), and TaNeDS (C1010568) and a collaborative research fund (C1010818) from Daiichi-Sankyo Co. Ltd. SK was supported by a Senior Principal Research Fellowship from the National Health & Medical Research Council of Australia (GNT 1103006).	Abida W, 2019, P NATL ACAD SCI USA, V116, P11428, DOI 10.1073/pnas.1902651116; Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Al-Amri A. M., 2009, Shiraz E Medical Journal, V10, P107; Aparicio A, 2011, NAT REV UROL, V8, P562, DOI 10.1038/nrurol.2011.107; Barbieri CE, 2013, EUR UROL, V64, P567, DOI 10.1016/j.eururo.2013.05.029; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; BOUTAGY NE, 2015, JOVE J VIS EXP OCT, V105, DOI DOI 10.3791/53216; Brough R, 2018, ONCOGENE, V37, P5701, DOI 10.1038/s41388-018-0368-z; Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Crumbaker M, 2017, CANCERS, V9, DOI 10.3390/cancers9040034; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; Dobolyi A, 2015, BRAIN STRUCT FUNCT, V220, P135, DOI 10.1007/s00429-013-0643-2; Donti TR, 2014, DIS MODEL MECH, V7, P271, DOI 10.1242/dmm.013466; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; Frank Sander, 2018, F1000Res, V7, DOI 10.12688/f1000research.14499.1; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Gao S, 2016, CELL REP, V17, P966, DOI 10.1016/j.celrep.2016.09.064; Gong XQ, 2019, CANCER DISCOV, V9, P248, DOI 10.1158/2159-8290.CD-18-0469; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; HECKER E, 1967, NATURWISSENSCHAFTEN, V54, P282, DOI 10.1007/BF00620887; Hirotsu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118699; Huang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088893; Huang YQ, 2018, ONCOL LETT, V15, P6063, DOI 10.3892/ol.2018.8123; Huggins C, 1943, SCIENCE, V97, P541, DOI 10.1126/science.97.2529.541; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; Jones RA, 2016, J CLIN INVEST, V126, P3739, DOI 10.1172/JCI81568; Kadota K, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-8; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Knudsen Erik S, 2018, Oncotarget, V9, P30940, DOI 10.18632/oncotarget.25797; Kundu J, 2014, FOOD CHEM TOXICOL, V65, P18, DOI 10.1016/j.fct.2013.12.015; Li FK, 2019, CANCER RES, V79, P3903, DOI 10.1158/0008-5472.CAN-18-3604; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Matilainen S, 2015, EUR J HUM GENET, V23, P325, DOI 10.1038/ejhg.2014.128; Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013; Mostofa AGM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00295; Muller FL, 2015, TRENDS CANCER, V1, P161, DOI 10.1016/j.trecan.2015.10.002; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Nicolay BN, 2015, GENE DEV, V29, P1875, DOI 10.1101/gad.264127.115; Ohmiya H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-269; Oser MG, 2019, CANCER DISCOV, V9, P230, DOI 10.1158/2159-8290.CD-18-0389; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salah M, 2016, MOL CARCINOGEN, V55, P1974, DOI 10.1002/mc.22444; SALOMI MJ, 1991, NUTR CANCER, V16, P67, DOI 10.1080/01635589109514142; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Ueda Yuji, 2019, Oncotarget, V10, P5412, DOI 10.18632/oncotarget.27124; VANDUUREN BL, 1969, PROG EXP TUMOR RES, V11, P31; Varaljai R, 2015, GENE DEV, V29, P1817, DOI 10.1101/gad.264036.115; Witkiewicz AK, 2018, CELL REP, V22, P1185, DOI 10.1016/j.celrep.2018.01.022; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124; Zacksenhaus E, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1481814; Zhang LD, 2016, ONCOL LETT, V12, P2840, DOI 10.3892/ol.2016.4971; Zhao YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05168-5; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	66	3	3	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2020	39	34					5690	5707		10.1038/s41388-020-1381-6	http://dx.doi.org/10.1038/s41388-020-1381-6		JUL 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NE9FK	32694611				2022-12-26	WOS:000551055100001
J	Hou, QH; Dong, YY; Yu, QH; Wang, B; Le, S; Guo, YM; Zhang, BK				Hou, Qihang; Dong, Yuanyang; Yu, Qinghua; Wang, Bo; Le, Shen; Guo, Yuming; Zhang, Bingkun			Regulation of the Paneth cell niche by exogenousL-arginine couples the intestinal stem cell function	FASEB JOURNAL			English	Article						5-FU; intestinal stem cell; L-arginine; organoids; Paneth cell; Wnt3a	SELF-RENEWAL; IN-VITRO; HOMEOSTASIS; METABOLISM	Although previous studies show that exogenous nutrients regulate the stem cell function, little is known about the effects ofL-arginine on intestinal stem cells (ISCs). In this study, we utilize mice, small intestinal (SI) organoids, and ISC-Paneth cell co-cultured models to clarify the role ofL-arginine in ISC function. We find that exogenousL-arginine is essential for ISCs proliferation and intestinal epithelial renewal. Our data show that Paneth cells, a critical component of the ISCs niche, augment the ISCs function in response toL-arginine. Moreover, enhanced the expression of Wnt3a in Paneth cells, which is a ligand of the Wnt/beta-catenin signaling pathway, mediates the effects ofL-arginine on ISCs function. Pre-treatment withL-arginine enhances the ISCs pool and protects the gut in response to injury provoked by murine tumor necrosis factor alpha (TNF-alpha) and 5-Fluorouracil (5-FU). Our findings establish that the regulation of Wnt3a in the Paneth cell niche by exogenousL-arginine couples ISCs function and favours a model in which the ISCs niche couples the nutrient levels to ISCs function.	[Hou, Qihang; Dong, Yuanyang; Wang, Bo; Guo, Yuming; Zhang, Bingkun] China Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Yu, Qinghua] Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Nanjing, Peoples R China; [Le, Shen] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA	China Agricultural University; Nanjing Agricultural University; University of Chicago	Zhang, BK (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	bingkunzhang@126.com			State Key Laboratory of Animal Nutrition [2004DA125184]; NSFC | National Natural Science Foundation of China [31502024]; Nation Key R&D Program of China [2018YFD0500600]	State Key Laboratory of Animal Nutrition; NSFC | National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nation Key R&D Program of China	the State Key Laboratory of Animal Nutrition, Grant/Award Number: 2004DA125184; NSFC | National Natural Science Foundation of China, Grant/Award Number: 31502024; Nation Key R&D Program of China, Grant/Award Number: 2018YFD0500600	Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bertrand J, 2013, AMINO ACIDS, V45, P443, DOI 10.1007/s00726-012-1325-8; Beyaz S, 2018, NATURE, V560, pE26, DOI 10.1038/s41586-018-0187-y; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; Cheng CW, 2019, CELL, V178, P1115, DOI 10.1016/j.cell.2019.07.048; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coburn LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033546; Dinesh OC, 2014, JPEN-PARENTER ENTER, V38, P973, DOI 10.1177/0148607113498906; Fan J, 2010, CLIN NUTR, V29, P124, DOI 10.1016/j.clnu.2009.07.005; Fotiadis C, 2007, ACTA CHIR BELG, V107, P192, DOI 10.1080/00015458.2007.11680039; Fritz JH, 2013, INFECT IMMUN, V81, P3500, DOI 10.1128/IAI.00789-13; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hooper KM, 2017, J CROHNS COLITIS, V11, P118, DOI 10.1093/ecco-jcc/jjw127; Hou QH, 2018, CELL DEATH DIFFER, V25, P1657, DOI 10.1038/s41418-018-0070-2; Hou QH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00599; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jiang HQ, 2012, CURR OPIN GENET DEV, V22, P354, DOI 10.1016/j.gde.2012.04.002; Meneses Andre M C, 2016, Vet Sci, V3, DOI 10.3390/vetsci3040031; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Ananthakrishnan Ashwin N, 2013, Gastroenterol Hepatol (N Y), V9, P367; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Passlack N, 2016, CYTOTECHNOLOGY, V68, P1949, DOI 10.1007/s10616-016-0008-9; Pentinmikko N, 2019, NATURE, V571, P398, DOI 10.1038/s41586-019-1383-0; Peregrina K, 2015, CARCINOGENESIS, V36, P25, DOI 10.1093/carcin/bgu221; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ungaro F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01331; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang B, 2018, CELL STEM CELL, V22, P206, DOI 10.1016/j.stem.2017.12.017; Wu G, 2000, Curr Opin Clin Nutr Metab Care, V3, P59, DOI 10.1097/00075197-200001000-00010; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zhan Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.136; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416	40	7	7	5	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10299	10315		10.1096/fj.201902573RR	http://dx.doi.org/10.1096/fj.201902573RR		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725957	Bronze			2022-12-26	WOS:000541773300001
J	Pagura, L; Tevere, E; Merli, ML; Cricco, JA				Pagura, Lucas; Tevere, Evelyn; Merli, Marcelo L.; Cricco, Julia A.			A new model forTrypanosoma cruziheme homeostasis depends on modulation ofTcHTE protein expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Trypanosoma cruzi; Chagas disease; heme; heme transport; heme responsive gene; transport; parasite; homeostasis	HEME; TRAFFICKING	Heme is an essential cofactor for many biological processes in aerobic organisms, which can synthesize itde novothrough a conserved pathway.Trypanosoma cruzi, the etiological agent of Chagas disease, as well as other trypanosomatids relevant to human health, are heme auxotrophs, meaning they must import it from their mammalian hosts or insect vectors. However, how these species import and regulate heme levels is not fully defined yet. It is known that the membrane proteinTcHTE is involved inT. cruziheme transport, although its specific role remains unclear. In the present work, we studied endogenousTcHTE in the different life cycle stages of the parasite to gain insight into its function in heme transport and homeostasis. We have confirmed thatTcHTE is predominantly detected in replicative stages (epimastigote and amastigote), in which heme transport activity was previously validated. We also showed that in epimastigotes,TcHTE protein and mRNA levels decrease in response to increments in heme concentration, confirming it as a member of the heme response gene family. Finally, we demonstrated thatT. cruziepimastigotes can sense intracellular heme by an unknown mechanism and regulate heme transport to adapt to changing conditions. Based on these results, we propose a model in whichT. cruzisenses intracellular heme and regulates heme transport activity by adjusting the expression ofTcHTE. The elucidation and characterization of heme transport and homeostasis will contribute to a better understanding of a critical pathway forT. cruzibiology allowing the identification of novel and essential proteins.	[Pagura, Lucas; Tevere, Evelyn; Merli, Marcelo L.; Cricco, Julia A.] Univ Nacl Rosario UNR, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Bioquim & Farmaceut, Rosario, Argentina; [Cricco, Julia A.] Univ Nacl Rosario UNR, Area Biofis, Dept Quim Biol, Fac Ciencias Bioquim & Farmaceut, Rosario, Argentina; [Pagura, Lucas] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Merli, Marcelo L.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; Harvard University; Harvard T.H. Chan School of Public Health; State University System of Florida; University of Florida	Cricco, JA (corresponding author), Univ Nacl Rosario UNR, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Bioquim & Farmaceut, Rosario, Argentina.; Cricco, JA (corresponding author), Univ Nacl Rosario UNR, Area Biofis, Dept Quim Biol, Fac Ciencias Bioquim & Farmaceut, Rosario, Argentina.	cricco@ibr-conicet.gov.ar	Merli, Marcelo/AAZ-8721-2021	Merli, Marcelo/0000-0001-7994-4140; Pagura, Lucas/0000-0003-1061-6311; Cricco, Julia Alejandra/0000-0002-8993-3880	UK Research and Innovation via the Global Challenges Research Fund under grant agreement "A Global Network for Neglected Tropical Diseases" [MR/P027989/1]; ANPCyT (National Agency of Scientific and Technological Promotion) [PICT 2015-2437]; CONICET; ANPCyT [PICT 2015-2437]; MRC [MR/P027989/1] Funding Source: UKRI	UK Research and Innovation via the Global Challenges Research Fund under grant agreement "A Global Network for Neglected Tropical Diseases"; ANPCyT (National Agency of Scientific and Technological Promotion)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported by UK Research and Innovation via the Global Challenges Research Fund under grant agreement "A Global Network for Neglected Tropical Diseases" Grant MR/P027989/1 and by ANPCyT (National Agency of Scientific and Technological Promotion) Grant PICT 2015-2437 (to J. A. C.). J. A. C. is a researcher of CONICET (National Research Council of Science and Technology), L. P. and M. L. M. had a fellowship from CONICET to conduct their Ph.D., E. T. has a fellowship of ANPCyT associated to grant no. PICT 2015-2437.	Atamna H, 2015, METALLOMICS, V7, P309, DOI 10.1039/c4mt00246f; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Buchensky C, 2010, FEMS MICROBIOL LETT, V312, P133, DOI 10.1111/j.1574-6968.2010.02109.x; Cabello-Donayre M, 2020, CELL MOL LIFE SCI, V77, P1827, DOI 10.1007/s00018-019-03258-3; Cabello-Donayre M, 2016, MOL MICROBIOL, V101, P895, DOI 10.1111/mmi.13430; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Cupello MP, 2014, BIOCHEM BIOPH RES CO, V449, P216, DOI 10.1016/j.bbrc.2014.05.004; Cupello MP, 2011, ACTA TROP, V120, P211, DOI 10.1016/j.actatropica.2011.08.011; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Horakova E, 2017, J BIOL CHEM, V292, P6998, DOI 10.1074/jbc.M116.762997; Koreny L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003088; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Merli ML, 2017, BIOCHEM J, V474, P2315, DOI 10.1042/BCJ20170084; Merli ML, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004359; Miguel DC, 2013, INFECT IMMUN, V81, P3620, DOI 10.1128/IAI.00687-13; Oliveira MF, 2007, COMP BIOCHEM PHYS C, V146, P168, DOI 10.1016/j.cbpc.2006.12.007; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Renberg RL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003804; Sambrook J., 2001, MOL CLONING LAB MANU; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Yuan XJ, 2016, P NATL ACAD SCI USA, V113, pE5144, DOI 10.1073/pnas.1609865113	25	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13202	13212		10.1074/jbc.RA120.014574	http://dx.doi.org/10.1074/jbc.RA120.014574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32709751	Green Published, hybrid			2022-12-26	WOS:000574483500006
J	Wang, YY; Ma, WW; Peng, IF				Wang, Yan-Ying; Ma, Wei-Wei; Peng, I-Feng			Screening of sleep assisting drug candidates with a Drosophila model	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; ALZHEIMERS-DISEASE; GINSENG EXTRACT; BEHAVIORS; MELATONIN; DISTURBANCES; COGNITION; PROTECT; MEMORY; BRAIN	Lately,Drosophilahas been favored as a model in sleep and circadian rhythm research due to its conserved mechanism and easily manageable operation. These studies have revealed the sophisticated parameters in whole-day sleep profiles ofDrosophila, drawing connections betweenDrosophilasleep and human sleep. In this study, we tested several sleep deprivation protocols (mechanical shakes and light interruptions) onDrosophilaand delineated their influences onDrosophilasleep. We applied a daytime light-deprivation protocol (DD) mimicking jet-lag to screen drugs that alleviate sleep deprivation. Characteristically, classical sleep-aid compounds exhibited different forms of influence: phenobarbital and pentobarbital modified total sleep time, while melatonin only shortened the latency to sleep. Such results construct the basis for further research on sleep benefits in other treatments inDrosophila. We screened seven herb extracts, and found very diverse results regarding their effect on sleep regulation. For instance,Panax notoginsengandWithania somniferaextracts displayed potent influence on total sleep time, whileMelissa officinalisincreased the number of sleep episodes. By comparing these treatments, we were able to rank drug potency in different aspects of sleep regulation. Notably, we also confirmed the presence of sleep difficulties in aDrosophilaAlzheimer's disease (AD) model with an overexpression of human Abeta, and recognized clear differences between the portfolios of drug screening effects in AD flies and in the control group. Overall, potential drug candidates and receipts for sleep problems can be identified separately for normal and ADDrosophilapopulations, outliningDrosophila'spotential in drug screening tests in other populations if combined with the use of other genetic disease tools.	[Wang, Yan-Ying; Ma, Wei-Wei; Peng, I-Feng] Suzhou Joekai Biotech LLC, Res Dept, Kunshan City, Jiangsu, Peoples R China; [Ma, Wei-Wei] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China	Tsinghua University	Peng, IF (corresponding author), Suzhou Joekai Biotech LLC, Res Dept, Kunshan City, Jiangsu, Peoples R China.	ifengpeng@joekaibiotech.com			Science and Technology Bureau of Kunshan City	Science and Technology Bureau of Kunshan City	YYW, WWMand IFP are full-time employees in Suzhou Joekai Biotechnology LLC (Joekai Biotech), Jiangsu, China. Joekai Biotech provided support in the form of salaries for authors [YYW, WWM, IFP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. IFP andWWMalso received Research Grants for International Collaborations (2017, 2018) from Science and Technology Bureau of Kunshan City.	Ahn J, 2006, BIOGERONTOLOGY, V7, P239, DOI 10.1007/s10522-006-9023-0; Awad R, 2009, PHYTOTHER RES, V23, P1075, DOI 10.1002/ptr.2712; BIANCHETTI A, 1995, DEMENTIA, V6, P108, DOI 10.1159/000106930; Blake MR, 2015, NEUROBIOL DIS, V77, P117, DOI 10.1016/j.nbd.2015.02.012; Bruneton J., 1999, PHARMACOGNOSIE PHYTO, P707; Bushey D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-56; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Cases J, 2011, MEDITERR J NUTR META, V4, P211, DOI 10.1007/s12349-010-0045-4; Chase JE, 1997, ANN PHARMACOTHER, V31, P1218, DOI 10.1177/106002809703101015; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Chen YL, 2015, J ETHNOPHARMACOL, V171, P307, DOI 10.1016/j.jep.2015.05.045; Chinese Pharmacopoeia Commission, 2015, MIN HLTH PEOPL REP C, P265; Cicero AFG, 2000, J ETHNOPHARMACOL, V73, P387, DOI 10.1016/S0378-8741(00)00277-4; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; GOLDBETER A, 1995, P ROY SOC B-BIOL SCI, V261, P319, DOI 10.1098/rspb.1995.0153; Guo F, 2016, NATURE, V536, P292, DOI 10.1038/nature19097; Han HJ, 2013, J ETHNOPHARMACOL, V149, P597, DOI 10.1016/j.jep.2013.07.005; Harper DG, 2001, ARCH GEN PSYCHIAT, V58, P353, DOI 10.1001/archpsyc.58.4.353; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Ibarra A, 2010, PHYTOMEDICINE, V17, P397, DOI 10.1016/j.phymed.2010.01.012; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; IKEDA M, 1971, TOXICOL APPL PHARM, V20, P30, DOI 10.1016/0041-008X(71)90086-X; ITOH T, 1989, PLANTA MED, P429, DOI 10.1055/s-2006-962058; Jeon SJ, 2015, EUR J PHARMACOL, V762, P443, DOI 10.1016/j.ejphar.2015.06.037; Jo K, 2018, FOOD SCI BIOTECHNOL, V27, P1833, DOI 10.1007/s10068-018-0431-0; Kaun KR, 2012, HUM GENET, V131, P959, DOI 10.1007/s00439-012-1146-6; Kaur T, 2017, MOL CELL BIOCHEM, V427, P91, DOI 10.1007/s11010-016-2900-1; Kumar S, 2005, CHRONOBIOL INT, V22, P641, DOI 10.1080/07420520500179423; Lewy AJ, 1997, J BIOL RHYTHM, V12, P588, DOI 10.1177/074873049701200614; Liu C, 2019, CURR BIOL, V29, P3635, DOI 10.1016/j.cub.2019.08.079; Liu ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105678; Ma H, 2009, PHYTOTHER RES, V23, P1340, DOI 10.1002/ptr.2773; Ma WW, 2017, CHIN J NAT MEDICINES, V15, P899, DOI 10.1016/S1875-5364(18)30005-0; Ma Y, 2008, J ETHNOPHARMACOL, V117, P318, DOI 10.1016/j.jep.2008.02.006; McCurry SM, 2000, SLEEP MED REV, V4, P603, DOI 10.1053/smrv.2000.0127; Mitolo M, 2018, DEMENT GERIATR COGN, V46, P371, DOI 10.1159/000494921; Nall AH, 2013, J NEUROSCI, V33, P8534, DOI 10.1523/JNEUROSCI.0253-13.2013; Peter-Derex L, 2015, SLEEP MED REV, V19, P29, DOI 10.1016/j.smrv.2014.03.007; PETKOV VD, 1987, AM J CHINESE MED, V15, P19, DOI 10.1142/S0192415X87000047; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013; Stopa EG, 1999, J NEUROPATH EXP NEUR, V58, P29, DOI 10.1097/00005072-199901000-00004; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; van Alphen B, 2013, J NEUROSCI, V33, P6917, DOI 10.1523/JNEUROSCI.0061-13.2013; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Wolkove N, 2007, CAN MED ASSOC J, V176, P1299, DOI 10.1503/cmaj.060792; Xu T, 2016, J GINSENG RES, V40, P211, DOI 10.1016/j.jgr.2015.07.007	54	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236318	10.1371/journal.pone.0236318	http://dx.doi.org/10.1371/journal.pone.0236318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726319	Green Published, gold			2022-12-26	WOS:000556908900036
J	Niu, B; Ii, MM; Jiao, Y; Wang, CL; Cao, MY; Wang, JH; Meinke, E				Niu, Ben; Martinelli II, Michael; Jiao, Yang; Wang, Chunlei; Cao, Mingyan; Wang, Jihong; Meinke, Eric			Nonspecific cleavages arising from reconstitution of trypsin under mildly acidic conditions	PLOS ONE			English	Article							MASS-SPECTROMETRY; SHOTGUN PROTEOMICS; TRYPTIC PEPTIDES; DIGESTION; IDENTIFICATION; PROTEINS; PSEUDOTRYPSIN; SPECIFICITY; QUALITY	Tryptic digestion of proteins followed by liquid chromatography with tandem mass spectrometry analysis is an extensively used approach in proteomics research and biopharmaceutical product characterization, owing to the high level of cleavage fidelity produced with this technique. However, nonspecific trypsin cleavages have been frequently reported and shown to be related to a number of digestion conditions and predigestion sample treatments. In this work, we reveal that, for a number of commercial trypsins, reconstitution and storage conditions can have a significant impact on the occurrence of trypsin nonspecific cleavages. We analyzed the tryptic digestion of a variety of biotherapeutics, using trypsins reconstituted under different conditions. The results indicate that, for many commercial trypsins, commonly recommended reconstitution/storage conditions (mildly acidic, e.g., 50 mM acetic acid, 1 mM HCl) can actually promote nonspecific trypsin activities, which are time dependent and can be as high as 20% in total relative abundance. In contrast, using water for reconstitution and storage can effectively limit nonspecific cleavages to 1%. Interestingly, the performances of different commercial trypsins were found to be quite distinct in their levels of nonspecific cleavages and responses to the two reconstitution conditions. Our findings demonstrate the importance of choosing the appropriate trypsin for tryptic digestion and the necessity of assessing the impact of trypsin reconstitution and storage on nonspecific cleavages. We advocate for manufacturers of commercial trypsins to reevaluate manufacturing processes and reconstitution/storage conditions to provide good cleavage specificity.	[Niu, Ben; Martinelli II, Michael; Jiao, Yang; Wang, Chunlei; Cao, Mingyan; Wang, Jihong; Meinke, Eric] AstraZeneca, Analyt Sci, BioPharmaceut Dev, R&D, Gaithersburg, MD 20878 USA; [Wang, Jihong] Viela Bio, Gaithersburg, MD USA; [Meinke, Eric] AveXis, Longmont, CO USA	AstraZeneca	Niu, B (corresponding author), AstraZeneca, Analyt Sci, BioPharmaceut Dev, R&D, Gaithersburg, MD 20878 USA.	ben.niu1@astrazeneca.com	Niu, Ben/AAK-4896-2020	Niu, Ben/0000-0002-6646-9085; Wang, Jihong/0000-0001-9271-0218; Cao, Mingyan/0000-0001-5277-4962; Jiao, Yang/0000-0003-0847-4211; Martinelli, Michael/0000-0002-6224-8197	AstraZeneca	AstraZeneca(AstraZeneca)	BN, MM, YJ, CW, MC, JW and EM were employed and funded by AstraZeneca. The funder provided support in the form of salaries for these authors and granted approval to publish, but did not have any additional role in the study design, data collection, analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alves G, 2013, J PROTEOME RES, V12, P2571, DOI 10.1021/pr301139y; Alves P, 2008, BIOINFORMATICS, V24, P102, DOI 10.1093/bioinformatics/btm545; Bern Marshall, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1320s40; Bongers J, 2000, J PHARMACEUT BIOMED, V21, P1099, DOI 10.1016/S0731-7085(99)00181-8; Burkhart JM, 2012, J PROTEOMICS, V75, P1454, DOI 10.1016/j.jprot.2011.11.016; Cao MY, 2019, J PHARM SCI-US, V108, P3540, DOI 10.1016/j.xphs.2019.07.019; Carpenter FH, 1967, METHOD ENZYMOL, V11, P237, DOI DOI 10.1016/S0076-6879(67)11028-8; Chamrad I, 2011, J PROTEOMICS, V74, P948, DOI 10.1016/j.jprot.2011.02.011; Dycka F, 2015, PROTEIN PEPTIDE LETT, V22, P1123, DOI 10.2174/0929866522666151008151617; Fang P, 2015, ANALYST, V140, P7613, DOI 10.1039/c5an01505g; Heissel S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218374; Hustoft HK, 2012, CRITICAL REV TRYPSIN; Keil B., 2012, SPECIFICITY PROTEOLY; Keil B., 1971, ENZYMES, V3, P249, DOI [10.1016/S1874-6047(08)60399-6., 10.1021/bi00843a047, DOI 10.1021/BI00843A047]; KEILDLOUHA V, 1971, FEBS LETT, V16, P291, DOI 10.1016/0014-5793(71)80373-3; Kim JS, 2013, J PROTEOME RES, V12, P910, DOI 10.1021/pr300955f; Konig S, 2001, J AM SOC MASS SPECTR, V12, P1180, DOI 10.1016/S1044-0305(01)00300-2; KOSTKA V, 1964, J BIOL CHEM, V239, P1799; Lowenthal MS, 2014, ANAL CHEM, V86, P551, DOI 10.1021/ac4027274; Loziuk PL, 2013, J PROTEOME RES, V12, P5820, DOI 10.1021/pr4008442; Mouchahoir T, 2018, ANAL BIOANAL CHEM, V410, P2111, DOI 10.1007/s00216-018-0848-6; Nigam A, 2018, CHROMATOGRAPHIA, V81, P57, DOI 10.1007/s10337-017-3424-x; Niu B, 2020, BIOCHEMISTRY-US, V59, P541, DOI 10.1021/acs.biochem.9b00822; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Perutka Z, 2018, MOLECULES, V23, DOI 10.3390/molecules23102637; Picotti P, 2007, MOL CELL PROTEOMICS, V6, P1589, DOI 10.1074/mcp.M700029-MCP200; Rogers RS, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0168-3; Rogers RS, 2015, MABS-AUSTIN, V7, P881, DOI 10.1080/19420862.2015.1069454; Schiel JE, 2018, ANAL BIOANAL CHEM, V410, P2127, DOI 10.1007/s00216-017-0800-1; Sergeant K, 2009, J PROTEOME RES, V8, P3182, DOI 10.1021/pr801093f; Shaw E., 1970, STRUCTURE FUNCTION R, P70; SMITH RL, 1969, J BIOL CHEM, V244, P4704; Strader MB, 2006, ANAL CHEM, V78, P125, DOI 10.1021/ac051348l; Switzar L, 2013, J PROTEOME RES, V12, P1067, DOI 10.1021/pr301201x; Vandermarliere E, 2013, MASS SPECTROM REV, V32, P453, DOI 10.1002/mas.21376; Zhang ZQ, 2019, ANAL CHEM, V91, P5252, DOI 10.1021/acs.analchem.9b00027	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236740	10.1371/journal.pone.0236740	http://dx.doi.org/10.1371/journal.pone.0236740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722706	Green Published, Green Submitted, gold			2022-12-26	WOS:000556916000023
J	Nydegger, LA; Claborn, KR				Nydegger, Liesl A.; Claborn, Kasey R.			Exploring patterns of substance use among highly vulnerable Black women at-risk for HIV through a syndemics framework: A qualitative study	PLOS ONE			English	Article							CHILDHOOD SEXUAL-ABUSE; AFRICAN-AMERICAN; MENTAL-HEALTH; WHITE WOMEN; DRUG; VIOLENCE; DISPARITIES; CHALLENGES; DISORDERS; CONTEXTS	Black women who use alcohol, marijuana, and other drugs are disproportionately affected by health disparities. Black women's HIV diagnosis rates are 15 times higher than White women, and is among the leading causes of death among Black women in the US. Previous studies support the association between substance use and HIV risk, yet it is essential to better understand the specific factors experienced within the context of substance misuse and recovery among vulnerable Black women at-risk for substance misuse, HIV, and adverse life experiences. We conducted qualitative interviews with 31 black women (ageM= 32.13, range 18-57) four times over six months. Eligible participants were 18+ years, identified as a Black/African-American woman, had unprotected vaginal or anal sex with a man in the past 30 days, and spoke fluent English. All transcripts were transcribed verbatim and were analyzed used thematic content analysis. Two groups of participants emerged: 1) those in recovery from their drug of choice (n = 11, 7 of whom misused alcohol or marijuana during the study), and 2) those who misused their drug of choice during the study (active use group; n = 20). Four themes emerged in the context of substance use: cultural factors, structural factors (i.e., housing and employment), past and present adverse life experiences, and individual factors (i.e., substance use to cope with stress, self-medicating with substances for mental health symptoms, intimate partner violence, and sex exchange). While participants in both groups used substances to cope with regard to these factors, the recovery group tended to use substances at lower frequencies and did not relapse with their drug of choice during the study. The active use group reported more substance use with regard to structural factors and recent adverse life events, had more difficulty regarding employment, and less instances of intimate partner violence (IPV) but were more likely to cope using substances. Substance use interventions tailored to vulnerable Black women should consider including trauma-informed interventions and support groups that address the structural, social, and individual factors to better serve their needs.	[Nydegger, Liesl A.] Univ Texas Austin, Coll Educ, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Claborn, Kasey R.] Univ Texas Austin, Dept Psychiat, Dell Med Sch, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Nydegger, LA (corresponding author), Univ Texas Austin, Coll Educ, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA.	Liesl.Nydegger@gmail.com	Nydegger, Liesl/M-6952-2019	Nydegger, Liesl/0000-0003-3035-3125	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P2CHD042849]; National Institute of Mental Health [T32 0MH19985, P30 MH52776]; National Institute on Drug Abuse [K23DA039037]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	LAN was supported by P2CHD042849 Eunice Kennedy Shriver National Institute of Child Health and Human Development www.nichd.nih.gov The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LAN was support by T32 0MH19985 National Institute of Mental Health www.nimh.nih.gov/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LAN was support by P30 MH52776 National Institute of Mental Health www.nimh.nih.gov/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KRC K23DA039037 National Institute on Drug Abuse www.drugabuse.gov The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiedu GB, 2017, J RACIAL ETHN HEALTH, V4, P19, DOI 10.1007/s40615-015-0195-7; Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Blakely JM, 2017, J INTERPERS VIOLENCE, DOI [10.1177/088626051770840329294757, DOI 10.1177/088626051770840329294757]; Boyd MR, 2003, ARCH PSYCHIAT NURS, V17, P249, DOI 10.1053/j.apnu.2003.10.003; Bradley ELP, 2019, MMWR-MORBID MORTAL W, V68, P416, DOI 10.15585/mmwr.mm6818a3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Briere J., 2002, APSAC HDB CHILD MALT, V2nd ed., P175; Cohen LR, 2009, AM J DRUG ALCOHOL AB, V35, P305, DOI 10.1080/00952990903060127; Collins CC, 2019, CHILD YOUTH SERV REV, V96, P34, DOI 10.1016/j.childyouth.2018.11.025; Cross D, 2015, CHILD ABUSE NEGLECT, V44, P26, DOI 10.1016/j.chiabu.2015.01.007; Dickson-Gomez J, 2017, AIDS BEHAV, V21, P2079, DOI 10.1007/s10461-017-1738-1; Dunkle KL, 2010, PUBLIC HEALTH REP, V125, P90, DOI 10.1177/00333549101250S413; El-Bassel N, 2000, AIDS EDUC PREV, V12, P154; El-Bassel N, 2011, SUBST USE MISUSE, V46, P295, DOI 10.3109/10826084.2011.523296; German D, 2015, SEX TRANSM DIS, V42, P317, DOI 10.1097/OLQ.0000000000000275; Henry M., 2017, 2017 ANN HOMELESS AS; Hines DD, 2016, UNDERST HIV AIDS EPI; Hunt MO, 2007, SOC PSYCHOL QUART, V70, P272, DOI 10.1177/019027250707000306; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Klein H, 2016, J ADDICT, V2016, P1, DOI [10.1155/2016/751382727752388, DOI 10.1155/2016/751382727752388]; Konstantopoulos WLM, 2014, ANN EMERG MED, V64, P516, DOI 10.1016/j.annemergmed.2014.05.012; Kuo C, 2014, WOMEN HEALTH, V54, P796, DOI 10.1080/03630242.2013.850143; Lacey KK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008415; McGuive TG, 2008, HEALTH AFFAIR, V27, P393, DOI 10.1377/hlthaff.27.2.393; Meyer JP, 2011, J WOMENS HEALTH, V20, P991, DOI 10.1089/jwh.2010.2328; Montano NP, 2019, AM J HEALTH PROMOT, V33, P566, DOI 10.1177/0890117118807716; Moore TM, 2008, CLIN PSYCHOL REV, V28, P247, DOI 10.1016/j.cpr.2007.05.003; Myers HF, 2015, PSYCHOL TRAUMA-US, V7, P243, DOI 10.1037/a0039077; National Institute on Alcohol Abuse and Alcoholism, 2015, DRINK LEV DEF; National Institute on Drug Abuse, 2013, SEEK TEST TREAT RET; Rountree MA, 2016, VIOLENCE AGAINST WOM, V22, P545, DOI 10.1177/1077801215607358; Singer M., 2009, INTRO SYNDEMICS CRIT; Straus Murray A, 2004, Violence Vict, V19, P507; Surratt H. L., 2005, J PSYCHOL HUMAN SEXU, V17, P23, DOI DOI 10.1300/J056v17n01_03; Surratt HL, 2012, AIDS CARE, V24, P553, DOI 10.1080/09540121.2011.630342; Torakeshwar N, 2005, J COMMUNITY PSYCHOL, V33, P655, DOI 10.1002/jcop.20077; Trabold N, 2018, J COMMUNITY PSYCHOL, V46, P418, DOI 10.1002/jcop.21948; Tsai AC, 2016, AIDS BEHAV, V20, P423, DOI 10.1007/s10461-015-1260-2; Williams DR, 2000, ETHNIC HEALTH, V5, P243, DOI 10.1080/713667453; Woods-Giscombe CL, 2010, QUAL HEALTH RES, V20, P668, DOI 10.1177/1049732310361892	40	4	4	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236247	10.1371/journal.pone.0236247	http://dx.doi.org/10.1371/journal.pone.0236247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722724	gold, Green Published			2022-12-26	WOS:000556916000049
J	Garrett, MC; O'Shea, TM; Wollenberg, AL; Bernstein, AM; Hung, D; Staarman, B; Soto, H; Deming, TJ; Sofroniew, MV; Kornblum, HI				Garrett, Matthew C.; O'Shea, Timothy M.; Wollenberg, Alexander L.; Bernstein, Alexander M.; Hung, Derek; Staarman, Brittany; Soto, Horacio; Deming, Timothy J.; Sofroniew, Michael, V; Kornblum, Harley, I			Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma	PLOS ONE			English	Article							MALIGNANT GLIOMA; LOCAL-DELIVERY; RESECTION; MULTIFORME; THERAPY; EXTENT; SURVIVAL; TEMOZOLOMIDE; CONCOMITANT; TISSUE	Introduction Surgical resection and systemic chemotherapy with temozolomide remain the mainstay for treatment of glioblastoma. However, many patients are not candidates for surgical resection given inaccessible tumor location or poor health status. Furthermore, despite being first line treatment, temozolomide has only limited efficacy. Methods The development of injectable hydrogel-based carrier systems allows for the delivery of a wide range of chemotherapeutics that can achieve high local concentrations, thus potentially avoiding systemic side effects and wide-spread neurotoxicity. To test this modality in a realistic environment, we developed a diblock copolypeptide hydrogel (DCH) capable of carrying and releasing paclitaxel, a compound that we found to be highly potent against primary gliomasphere cells. Results The DCH produced minimal tissue reactivity and was well tolerated in the immune-competent mouse brain. Paclitaxel-loaded hydrogel induced less tissue damage, cellular inflammation and reactive astrocytes than cremaphor-taxol (typical taxol-carrier) or hydrogel alone. In a deep subcortical xenograft model of glioblastoma in immunodeficient mice, injection of paclitaxel-loaded hydrogel led to local tumor control and improved survival. However, the tumor cells were highly migratory and were able to eventually escape the area of treatment. Conclusions These findings suggest this technology may be ultimately applicable to patients with deepseated inoperable tumors, but as currently formulated, complete tumor eradication would be highly unlikely. Future studies should focus on targeting the migratory potential of surviving cells.	[Garrett, Matthew C.; Staarman, Brittany] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [O'Shea, Timothy M.; Bernstein, Alexander M.; Sofroniew, Michael, V] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Wollenberg, Alexander L.; Hung, Derek; Deming, Timothy J.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Soto, Horacio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Kornblum, Harley, I] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Kornblum, Harley, I] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pharmacol, Los Angeles, CA 90095 USA; [Kornblum, Harley, I] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Kornblum, Harley, I] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University System of Ohio; University of Cincinnati; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Garrett, MC (corresponding author), Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA.	garretm4@ucmail.uc.edu	Sofroniew, Michael/ABE-8857-2020	Deming, Timothy/0000-0002-0594-5025; Garrett, Matthew/0000-0003-4567-7907	Dr. Miriam and Sheldon G. Adelson Medical Foundation; US National Institutes of Health [NS084030, NS053563]; California Institute for Regenerative Medicine	Dr. Miriam and Sheldon G. Adelson Medical Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	We thank the Microscopy Core Resource of the UCLA Broad Stem Cell Research CenterCIRM Laboratory. This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Foundation (M.V.S., T.J.D. and H.I.K.), the US National Institutes of Health (NS084030 to M.V.S. and NS053563 to H.I.K), and a training grant from the California Institute for Regenerative Medicine (M.C.G.).	Afra D, 2002, LANCET, V359, P1011; Chang SM, 2001, CANCER, V91, P417, DOI 10.1002/1097-0142(20010115)91:2<417::AID-CNCR1016>3.0.CO;2-9; Cui YN, 2013, BIOMATERIALS, V34, P8511, DOI 10.1016/j.biomaterials.2013.07.075; de la Puente P, 2018, J PHARM SCI-US, V107, P922, DOI 10.1016/j.xphs.2017.10.042; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; DuValla GA, 2009, ANTI-CANCER DRUG, V20, P89, DOI 10.1097/CAD.0b013e3283222c12; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; GRUBER ML, 1990, J NUCL MED, V31, P969; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hersh DS, 2016, NEUROSURGERY, V79, P643, DOI 10.1227/NEU.0000000000001399; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kim Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00053; Kitange GJ, 2009, NEURO-ONCOLOGY, V11, P281, DOI 10.1215/15228517-2008-090; Kubben PL, 2011, LANCET ONCOL, V12, P1062, DOI 10.1016/S1470-2045(11)70130-9; Kuhnt D, 2011, NEURO-ONCOLOGY, V13, P1339, DOI 10.1093/neuonc/nor133; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Laks DR, 2016, NEURO-ONCOLOGY, V18, P1367, DOI 10.1093/neuonc/now045; Lee SH, 1999, J CHROMATOGR B, V724, P357, DOI 10.1016/S0378-4347(98)00566-0; Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9; Orringer D, 2012, J NEUROSURG, V117, P851, DOI 10.3171/2012.8.JNS12234; Patel P, 2016, J NEUROSURG, V125, P853, DOI 10.3171/2015.7.JNS15244; Rowland MJ, 2018, BIOMATERIALS, V179, P199, DOI 10.1016/j.biomaterials.2018.05.054; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tyler B, 2010, J NEUROSURG, V113, P210, DOI 10.3171/2009.11.JNS08162; van der Sanden B, 2013, FUTURE ONCOL, V9, P817, DOI [10.2217/FON.13.30, 10.2217/fon.13.30]; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056; Yonezawa H, 2017, MOL CLIN ONCOL, V6, P105, DOI 10.3892/mco.2016.1086; Zhang S, 2014, BIOMATERIALS, V35, P1989, DOI 10.1016/j.biomaterials.2013.11.005; Zhao MN, 2018, INT J PHARMACEUT, V548, P522, DOI 10.1016/j.ijpharm.2018.07.033	33	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0219632	10.1371/journal.pone.0219632	http://dx.doi.org/10.1371/journal.pone.0219632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706829	gold, Green Published			2022-12-26	WOS:000579931700001
J	Zhang, TT; Zhou, JW; Yue, HD; Du, CY; Xiao, ZT; Zhao, WD; Li, N; Wang, XD; Liu, XZ; Li, YJ; Geng, XW; Zhang, YW; Li, L; Tian, J				Zhang, Tingting; Zhou, Jianwei; Yue, Haodi; Du, Chunyan; Xiao, Ziting; Zhao, Wendi; Li, Na; Wang, Xiangdong; Liu, Xiaozhuan; Li, Yanjun; Geng, Xiwen; Zhang, Yuwei; Li, Li; Tian, Jian			Glycogen synthase kinase-3 beta promotes radiation-induced lung fibrosis by regulating beta-catenin/lin28 signaling network to determine type II alveolar stem cell transdifferentiation state	FASEB JOURNAL			English	Article						cell differentiation state; GSK-3 beta/TGF-beta 1/beta-catenin; lin28/let-7 relative ratios; radiation-induced lung fibrosis; type II alveolar epithelial stem cells	INHIBITION; LIN28; MAINTENANCE; SURFACTANT; ACTIVATION; EXPRESSION; REPAIR; ROLES	The role of type II alveolar epithelial stem cells (AEC II) for alveolar repair in radiation-induced lung fibrosis (RILF) remains largely unknown, mainly because of AEC II phenotype's spontaneous change in vitro. Cell differentiation status is determined by Lin28 and let-7 miRNAs in see-saw-pattern. Lin28, a repressor of let-7 and a stem cell marker, is activated by beta-catenin. The expression of beta-catenin is regulated by GSK-3 beta/TGF-beta 1 signaling. To understand the true role of AEC II in RILF, we freshly isolated primary AEC II directly from thoracically irradiated lungs. We then explored the expressions of cell phenotype markers and differentiation regulators in these isolated AEC II to analyze the correlation between GSK-3 beta/TGF-beta 1/beta-catenin signaling pathway, lin28/let-7 balance, and AEC II phenotypes at different injury phases following irradiation. Results showed that isolated single primary cells displayed AEC II ultrastructural features and proSP-C positive. The gene expressions of prosp-c (an AEC II biomarker) and hopx (an AEC I marker) significantly increased in isolated AEC II during injury repair phase (P < .05) but decreased at end-stage of injury, while mesenchymal markers increased in both isolated AEC II and irradiated lungs. mRNA levels of gsk-3 beta, tgf-beta 1, and beta-catenin increased in all irradiated AEC II, but more pronounced in the second half of injury phase (P < .001). Similarly, the expression of lin28 was also significantly elevated in isolated AEC II at the late phase (P < .001). Four let-7 miRNAs were significantly upregulated in all irradiated AEC II groups (P < .001). The time-dependent and highly consistent uptrends for four lin28/let-7 ratios in sorted AEC II contrasted to downtrends in irradiated lungs. In conclusion, RILF occurred when GSK-3 beta/TGF-beta 1 signaling increased beta-catenin levels, which led to the augmentation of AEC II population by elevated lin28/let-7 ratio and the transcription of profibrotic cytokines and factors, thereby inducing AEC II to undergo transdifferentiation into mesenchymal cells.	[Zhang, Tingting; Yue, Haodi; Wang, Xiangdong; Liu, Xiaozhuan; Li, Yanjun; Geng, Xiwen] Henan Univ, Peoples Hosp Zhengzhou Univ, Henan Prov Peoples Hosp, Ctr Clin Single Cell Biomed,Sch Clin Med, Zhengzhou, Peoples R China; [Zhou, Jianwei; Xiao, Ziting; Zhao, Wendi; Tian, Jian] Henan Univ, Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Oncol,Sch Clin Med,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China; [Du, Chunyan] Zhengzhou Univ, Lab Anim Ctr, Sch Med Sci, Zhengzhou, Peoples R China; [Li, Na; Zhang, Yuwei] Henan Univ, Zhengzhou Univ, Henan Prov Peoples Hosp, Henan Prov Key Lab Kidney Dis & Immunol,Peoples H, Zhengzhou, Peoples R China; [Li, Li] Henan Univ, Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Sci Res & Discipline Construct,Peoples Hosp, Zhengzhou, Peoples R China	Henan University; Zhengzhou University; Henan University; Zhengzhou University; Zhengzhou University; Henan University; Zhengzhou University; Henan University; Zhengzhou University	Tian, J (corresponding author), Henan Univ, Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Oncol,Sch Clin Med,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China.	jacktian12@gmail.com			National Natural Science Foundation of China [81673097, 81801547]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81673097 and 81801547	Almeida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053628; Baarsma HA, 2013, BRIT J PHARMACOL, V169, P590, DOI 10.1111/bph.12098; Cai WY, 2013, J CELL SCI, V126, P2877, DOI 10.1242/jcs.123810; Christofidou-Solomidou M, 2017, RADIAT RES, V188, P491, DOI 10.1667/RR14686.1; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Gonzales LW, 2001, PEDIATR PATHOL MOL M, V20, P387, DOI 10.1080/15513810109168622; Guo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066330; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Jacobs KM, 2012, INT J CELL BIOL, V35, P1052; Liu H, 2013, ACTA PHARMACOL SIN, V34, P26; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; McDaniel K, 2016, AM J PHYSIOL-GASTR L, V310, pG757, DOI 10.1152/ajpgi.00080.2016; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Ota C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31214-x; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Selman M, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109482; Shi J, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3520581; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Singh SP, 2015, DIS MODEL MECH, V8, P931, DOI 10.1242/dmm.020511; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908	28	3	4	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12466	12480		10.1096/fj.202001518	http://dx.doi.org/10.1096/fj.202001518		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32706136	hybrid			2022-12-26	WOS:000556097100001
J	Chand, SS; Singh, B; Kumar, S				Chand, Shamal Shivneel; Singh, Baljeet; Kumar, Sanjesh			The economic burden of non-communicable disease mortality in the South Pacific: Evidence from Fiji	PLOS ONE			English	Article							GROWTH; COINTEGRATION; HEALTH; CHINA; PRODUCTIVITY; AFRICA; CANCER; INDIA; COST	Non-communicable diseases (NCDs) have emerged as one of the major endemics in Fiji which is responsible for more than 80 percent of deaths annually. In this study, we estimate the economic burden of non-communicable disease mortality in Fiji. The specific impact of diabetes, cardiovascular disease, chronic respiratory disease and cancer-related mortality on Fiji's output is also investigated using the autoregressive distributed lag bounds tests approach to cointegration. The data used is compiled from Fiji Ministry of Health and Medical Services and World Health Organization's Mortality database. Overall, the study finds that NCD mortality rate together with cardiovascular disease, diabetes, chronic respiratory disease and cancer have a significant negative effect on output per capita of Fiji between 1972 and 2016. A one percentage point increase in NCD-mortality rate reduced output per capita by 0.012 percent. In addition, a percentage point increase in the mortality rates of cardiovascular disease, diabetes, chronic respiratory disease and cancer decreased output per capita by 0.018, 0.01, 0.031, and 0.035 percent, respectively. The findings conclude that NCD poses significant economic burden in Fiji and recommend policy innovations in lessening the high risk of NCD among the Fijian population.	[Chand, Shamal Shivneel; Singh, Baljeet; Kumar, Sanjesh] Univ South Pacific, Fac Business & Econ, Sch Econ, Suva, Fiji	University of the South Pacific	Singh, B (corresponding author), Univ South Pacific, Fac Business & Econ, Sch Econ, Suva, Fiji.	singh_bl@usp.ac.fj	Singh, Baljeet/GXA-3197-2022	Singh, Baljeet/0000-0003-3285-0467				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adams C, 2013, UNION INT CANC CONTR; Alleyne G, 2011, J HEALTH COMMUN, V16, P82, DOI 10.1080/10810730.2011.602178; Anderson I., 2013, 2013 NHP; [Anonymous], 2016, NAV PDNA REP; [Anonymous], 2005, PREV CHRON DIS VIT I; BARRO RJ, 1991, Q J ECON, V106, P407, DOI 10.2307/2937943; Bloom D, 2018, REV PANAM SALUD PUBL, V42, P1; Bloom DE, 2014, J ECON AGEING, V4, P100, DOI 10.1016/j.jeoa.2014.08.003; Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Bloom DE, 2011, GLOBAL EC BURDEN NON; Chand S, 2009, STUD ST SOC PAC, P139; Dube W, 2015, J ECON STUD, V42, P138, DOI 10.1108/JES-08-2013-0116; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Frank L., 2014, TOO SICK PROGR EC IM; Gokal V., 2004, RELATIONSHIP INFLATI; GRANGER CWJ, 1981, J ECONOMETRICS, V16, P121, DOI 10.1016/0304-4076(81)90079-8; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Heenan RC, 2014, GLOB HEART, V1, P30; Javadi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024386; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; JOHANSEN S, 1990, OXFORD B ECON STAT, V52, P169, DOI 10.1111/j.1468-0084.1990.mp52002003.x; Kirigia J., 2017, INT ARCH MED, V10, P1, DOI [10.3823/2518, DOI 10.3823/2518]; Labonte R, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-21; Maharaj Jagdish C, 2012, ISRN Neurol, V2012, P802785, DOI 10.5402/2012/802785; Meyer J., 2018, DIABETES DEATHS FIJI; Ministry of Health and Medical Services, 2014, NCD PERS MOR MON BET; Murthy VNR, 2016, ECON MODEL, V59, P67, DOI 10.1016/j.econmod.2016.07.001; Narayan P., 2005, J ASIA PAC ECON, V10, DOI DOI 10.1080/1354786042000309099; Narayan PK, 2008, APPL ECON, V40, P2793, DOI 10.1080/00036840600972472; Narayan PK, 2005, APPL ECON, V37, P1979, DOI 10.1080/00036840500278103; Neeliah H., 2008, EC B, V17, P1; Pearce A, 2018, CANCER EPIDEMIOL, V53, P27, DOI 10.1016/j.canep.2017.12.013; Pesaran M.H., 1998, EC SOC MONOGR, V31, P371, DOI DOI 10.1017/CCOL521633230.011; Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616; Rahman MM, 2017, ENERG POLICY, V110, P600, DOI 10.1016/j.enpol.2017.09.006; Rao BB, 2009, APPL ECON, V41, P1653, DOI 10.1080/00036840601007252; Samargandi N, 2014, ECON MODEL, V43, P267, DOI 10.1016/j.econmod.2014.07.042; Stanciole A., 2006, ESTIMATION EC IMPACT; Suhrcke M, 2010, HEALTH ECON, V19, P1478, DOI 10.1002/hec.1565; Weil DN, 2014, HBK ECON, P623, DOI 10.1016/B978-0-444-53540-5.00003-3; World Health Organization, 2017, NONC DIS PROGR MON 2; World Health Organization, 2018, NONC DIS	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236068	10.1371/journal.pone.0236068	http://dx.doi.org/10.1371/journal.pone.0236068			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32702003	gold, Green Published			2022-12-26	WOS:000575913700045
J	Pyeon, SY; Han, GH; Ki, KD; Lee, KB; Lee, JM				Pyeon, Seung Yeon; Han, Gwan Hee; Ki, Kyung Do; Lee, Kwang-Beom; Lee, Jong-Min			Effect of delayed palliative chemotherapy on survival of patients with recurrent ovarian cancer	PLOS ONE			English	Article							LIFE CARE; END; SURVEILLANCE	For patients with recurrent ovarian cancer, the goals of chemotherapy include palliation of disease-related symptoms with minimum treatment-related side effects. However, there is currently a paucity of data regarding the initiation of palliative chemotherapy. This study aimed to compare the differences in survival rates and toxicities between patients with recurrent ovarian cancer who started palliative chemotherapy immediately versus those who received delayed chemotherapy. Through a retrospective chart review, patients who received more than three lines of chemotherapy were included. Based on the timing of third-line chemotherapy initiation, the patients were divided into two groups: delayed (DTG) and immediate (ITG) treatment groups. The chi-square test or Fisher's exact tests, and t-test or Mann-Whitney U test were used for comparing variables, as appropriate. The Kaplan-Meier method was used for survival analysis. P-value of <0.05 was considered significant. Although there was no statistically significant difference, the total number of regimens and cycles was lower in the DTG than in the ITG. No differences in toxicities and survival rates were observed between the two groups. Overall, survival and toxicity did not differ significantly between the two groups. In a palliative care setting, our findings suggest that delaying the treatment had no adverse effect on survival. Despite the lack of evidence of a survival benefit with aggressive treatment, patients chose to continue chemotherapy. Because recurrent ovarian cancer is a complex condition, patients require sufficient explanation and time to fully understand the costs and benefits related to aggressive chemotherapy.	[Pyeon, Seung Yeon; Han, Gwan Hee; Ki, Kyung Do; Lee, Jong-Min] Kyung Hee Univ Hosp Gangdong, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Kwang-Beom] Gachon Univ, Gil Med Ctr, Dept Obstet & Gynecol, Coll Med, Incheon, South Korea	Kyung Hee University; Kyung Hee University Hospital; Gachon University	Lee, JM (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Obstet & Gynecol, Seoul, South Korea.	kgo02@hanmail.net		Ki, Kyung-Do/0000-0002-1060-2297; Pyeon, Seung Yeon/0000-0001-8601-1701; Lee, Jong-Min/0000-0002-0562-5443				Barbera L, 2010, GYNECOL ONCOL, V118, P196, DOI 10.1016/j.ygyno.2010.04.014; Coquan Elodie, 2012, Rev Prat, V62, P17; Corrado G, 2017, EXPERT REV ANTICANC, V17, P1147, DOI 10.1080/14737140.2017.1398088; Fauci J, 2012, GYNECOL ONCOL, V127, P175, DOI 10.1016/j.ygyno.2012.06.025; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gadducci A, 2007, INT J GYNECOL CANCER, V17, P21, DOI 10.1111/j.1525-1438.2007.00826.x; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; National Comprehensive Cancer Network, OV CANC VERS 2; Pujade-Lauraine E, 2016, ANN ONCOL, V27, P63, DOI 10.1093/annonc/mdw079; Rustin GJS, 2010, LANCET, V376, P1155, DOI 10.1016/S0140-6736(10)61268-8; Schulkes KJG, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12796; Tanner EJ, 2010, GYNECOL ONCOL, V117, P336, DOI 10.1016/j.ygyno.2010.01.014; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Tsubamoto H, 2014, J OBSTET GYNAECOL RE, V40, P1399, DOI 10.1111/jog.12320; von Gruenigen V, 2008, CANCER, V112, P2221, DOI 10.1002/cncr.23391	15	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236244	10.1371/journal.pone.0236244	http://dx.doi.org/10.1371/journal.pone.0236244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701994	Green Published, gold			2022-12-26	WOS:000575913700062
J	Hagberg, L; Price, RW; Zetterberg, H; Fuchs, D; Gisslen, M				Hagberg, Lars; Price, Richard W.; Zetterberg, Henrik; Fuchs, Dietmar; Gisslen, Magnus			Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AIDS DEMENTIA COMPLEX; CEREBROSPINAL-FLUID; ANTIRETROVIRAL THERAPY; VIRAL ESCAPE; HIV-1-INFECTED PATIENTS; NEUROLOGICAL SYMPTOMS; VIRUS; PLASMA; RNA	HIV cerebrospinal fluid (CSF) escape is defined by a concentration of HIV-1 RNA in CSF above the lower limit of quantification of the employed assay and equal to or greater than the plasma HIV-1 RNA level in the presence of treatment-related plasma viral suppression, while CSF discordance is similarly defined by equal or higher CSF than plasma HIV-1 RNA in untreated individuals. During secondary CSF escape or discordance, disproportionate CSF HIV-1 RNA develops in relation to another infection in addition to HIV-1. We performed a retrospective review of people living with HIV receiving clinical care at Sahlgrenska Infectious Diseases Clinic in Gothenburg, Sweden who developed uncomplicated herpes zoster (HZ) and underwent a research lumbar puncture (LP) within the ensuing 150 days. Based on treatment status and the relationship between CSF and plasma HIV-1 RNA concentrations, they were divided into 4 groups:i)antiretroviral treated with CSF escape (N = 4), ii)treated without CSF escape (N = 5),iii)untreated with CSF discordance (N = 8), andiv)untreated without CSF discordance (N = 8). We augmented these with two additional cases of secondary CSF escape related to neuroborreliosis and HSV-2 encephalitis and analyzed these two non-HZ cases for factors contributing to CSF HIV-1 RNA concentrations. HIV-1 CSF escape and discordance were associated with higher CSF white blood cell (WBC) counts than their non-escape (P = 0.0087) and non-discordant (P = 0.0017) counterparts, and the CSF WBC counts correlated with the CSF HIV-1 RNA levels in both the treated (P = 0.0047) and untreated (P = 0.002) group pairs. Moreover, the CSF WBC counts correlated with the CSF:plasma HIV-1 RNA ratios of the entire group of 27 subjects (P = <0.0001) indicating a strong effect of the CSF WBC count on the relation of the CSF to plasma HIV-1 RNA concentrations across the entire sample set. The inflammatory response to HZ and its augmenting effect on CSF HIV-1 RNA was found up to 5 months after the HZ outbreak in the cross-sectional sample and, was present for one year after HZ in one individual followed longitudinally. We suggest that HZ provides a 'model' of secondary CSF escape and discordance. Likely, the inflammatory response to HZ pathology provoked local HIV-1 production by enhanced trafficking or activation of HIV-1-infected CD4+ T lymphocytes. Whereas treatment and other systemic factors determined the plasma HIV-1 RNA concentrations, in this setting the CSF WBC counts established the relation of the CSF HIV-1 RNA levels to this plasma set-point.	[Hagberg, Lars; Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Hagberg, Lars; Gisslen, Magnus] Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden; [Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UK Dementia Res Inst UCL, London, England; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Fuchs, Dietmar] Innsbruck Med Univ, Inst Biol Chem, Innsbruck, Austria	University of Gothenburg; Sahlgrenska University Hospital; University of California System; University of California San Francisco; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London; Medical University of Innsbruck	Hagberg, L (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.; Hagberg, L (corresponding author), Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden.	lars.hagberg@gu.se	Fuchs, Dietmar/AAL-8011-2021; Gisslen, Magnus/D-7454-2015	Fuchs, Dietmar/0000-0003-1627-9563; Zetterberg, Henrik/0000-0003-3930-4354; Gisslen, Magnus/0000-0002-2357-1020; Hagberg, Lars/0000-0002-5685-297X	Swedish government [ALFGBG-717531, ALFGBG-720931]; Swedish county councils, the ALF-agreement [ALFGBG-717531, ALFGBG-720931]; National Institutes of Health/National Institute of Neurological Diseases and Stroke [R01NS094067]; Swedish Research Council [2018-02532]; European Research Council [681712]	Swedish government; Swedish county councils, the ALF-agreement; National Institutes of Health/National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	MG grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-717531). RWP National Institutes of Health/National Institute of Neurological Diseases and Stroke grant R01NS094067. HZ grants from the Swedish Research Council (2018-02532) and the European Research Council (681712) and the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-720931).	Beguelin C, 2014, J INT AIDS SOC, V17, P156, DOI 10.7448/IAS.17.4.19745; Birlea M, 2011, J NEUROL SCI, V304, P22, DOI 10.1016/j.jns.2011.02.030; Bogoch II, 2011, J INFECTION, V63, P236, DOI 10.1016/j.jinf.2011.05.011; Brown M, 2001, INT J STD AIDS, V12, P79, DOI 10.1258/0956462011916820; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Collier DA, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8100190; Dahl V, 2013, AIDS, V27, P1145, DOI 10.1097/QAD.0b013e32835cf235; DAVIS LR, 1992, SOCIOL SPORT J, V9, P1; De Castro N, 2011, AIDS RES HUM RETROV, V27, P1089, DOI [10.1089/AID.2010.0340, 10.1089/aid.2010.0340]; de la Blanchardiere A, 2000, SCAND J INFECT DIS, V32, P263, DOI 10.1080/00365540050165893; DEVINSKY O, 1991, BRAIN, V114, P1181, DOI 10.1093/brain/114.3.1181; Dravid AN, 2018, MEDICINE, V97, DOI [10.1097/md.0000000000009969, 10.1097/MD.0000000000009969]; Eden A, 2016, J INFECT DIS, V214, P1822, DOI 10.1093/infdis/jiw454; Eden A, 2010, J INFECT DIS, V202, P1819, DOI 10.1086/657342; Falcone EL, 2013, CLIN INFECT DIS, V57, pE135, DOI 10.1093/cid/cit356; Ferretti F, 2015, CURR HIV-AIDS REP, V12, P280, DOI 10.1007/s11904-015-0267-7; Ferris AL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007869; GERSHON AA, 2010, J CLIN VIROL, V48, pS, DOI DOI 10.1016/S1386-6532(10)70002-020510263; Gershon AA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.16; Gilden D, 2011, NEUROPATH APPL NEURO, V37, P441, DOI 10.1111/j.1365-2990.2011.01167.x; Gilden D, 2014, HAND CLINIC, V123, P265, DOI 10.1016/B978-0-444-53488-0.00012-2; Gisslen M, 1999, J ACQ IMMUN DEF SYND, V21, P271, DOI 10.1097/00126334-199908010-00003; Gisslen M, 2000, SCAND J INFECT DIS, V32, P365, DOI 10.1080/003655400750044926; Gisslen M, 2001, HIV Med, V2, P97; Gisslen M, 2007, J INFECT DIS, V195, P1774, DOI 10.1086/518043; Grabar S, 2015, CLIN INFECT DIS, V60, P1269, DOI 10.1093/cid/ciu1161; Grahn A, 2013, J NEUROL, V260, P1813, DOI 10.1007/s00415-013-6883-5; GRAY F, 1992, NEUROPATH APPL NEURO, V18, P502, DOI 10.1111/j.1365-2990.1992.tb00817.x; Gray F, 2013, BRAIN PATHOL, V23, P525, DOI 10.1111/bpa.12038; Haanpaa M, 1998, NEUROLOGY, V51, P1405, DOI 10.1212/WNL.51.5.1405; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Ho EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066188; Ignacio RAB, 2017, VIRAL IMMUNOL, V30, P77, DOI 10.1089/vim.2016.0097; Imaz A, 2014, AIDS RES HUM RETROV, V30, P984, DOI [10.1089/aid.2014.0014, 10.1089/AID.2014.0014]; Joseph J, 2016, J VIRUS ERAD, V2, P243; Joseph SB, 2019, CLIN INFECT DIS, V69, P1345, DOI 10.1093/cid/ciy1066; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Khoury MN, 2013, J NEUROVIROL, V19, P402, DOI 10.1007/s13365-013-0175-9; Kugathasan R, 2017, CLIN INFECT DIS, V64, P1059, DOI 10.1093/cid/cix035; Laing KJ, 2018, J INFECT DIS, V218, pS68, DOI 10.1093/infdis/jiy403; Lee GQ, 2017, J CLIN INVEST, V127, P2689, DOI 10.1172/JCI93289; Lescure FX, 2013, CLIN INFECT DIS, V57, P101, DOI 10.1093/cid/cit175; Livelli A, 2019, LANCET HIV, V6, pE456, DOI 10.1016/S2352-3018(19)30143-2; Manesh A, 2019, INT J INFECT DIS, V84, P39, DOI 10.1016/j.ijid.2019.03.033; Mastrangelo A, 2019, AIDS, V33, pS159, DOI 10.1097/QAD.0000000000002266; McKay SL, 2019, CLIN INFECT DIS, DOI [10.1093/cid/ciz1090 31677266, DOI 10.1093/CID/CIZ1090 31677266]; Moling O, 2001, SCAND J INFECT DIS, V33, P398, DOI 10.1080/003655401750174309; NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Patel AK, 2018, J NEUROVIROL, V24, P498, DOI 10.1007/s13365-018-0642-4; Peluso MJ, 2012, AIDS, V26, P1765, DOI 10.1097/QAD.0b013e328355e6b2; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Probasco JC, 2010, AIDS, V24, P1001, DOI 10.1097/QAD.0b013e328331e15b; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Sinclair E, 2008, JAIDS-J ACQ IMM DEF, V47, P544, DOI 10.1097/QAI.0b013e318162754f; Spudich S, 2006, J INFECT DIS, V194, P1686, DOI 10.1086/508750; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Stam AJ, 2013, AIDS REV, V15, P152; Tambussi G, 2000, CLIN INFECT DIS, V30, P962, DOI 10.1086/313810; Trunfio M, 2019, AIDS, V33, P759, DOI 10.1097/QAD.0000000000002091; Ulfhammer G, 2018, AIDS, V32, P2171, DOI 10.1097/QAD.0000000000001950; Vafai A, 2001, AM J MED SCI, V321, P372, DOI 10.1097/00000441-200106000-00003; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Wendel KA, 2003, CLIN INFECT DIS, V37, P1107, DOI 10.1086/378300; Winston A, 2019, AIDS, V33, pS107, DOI 10.1097/QAD.0000000000002252; Yilmaz A, 2006, ANTIVIR THER, V11, P833; Yilmaz A, 2017, EXPERT REV MOL DIAGN, V17, P761, DOI 10.1080/14737159.2017.1341313; Yilmaz A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-62	68	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236162	10.1371/journal.pone.0236162	http://dx.doi.org/10.1371/journal.pone.0236162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697807	Green Published, gold, Green Submitted			2022-12-26	WOS:000555392700012
J	Schaub, C; Verdi, J; Lee, P; Terra, N; Limon, G; Raper, J; Thomson, R				Schaub, Charles; Verdi, Joseph; Lee, Penny; Terra, Nada; Limon, Gina; Raper, Jayne; Thomson, Russell			Cation channel conductance and pH gating of the innate immunity factor APOL1 are governed by pore-lining residues within the C-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						APOL1; pH-gated cation channel; pH-dependent membrane insertion; planar lipid bilayers; cytolysis; innate immunity; Trypanosoma brucei; human African trypanosomiasis (HAT); trypanosome lytic factor (TLF); kidney disease; focal-segmental glomerulosclerosis (FSGS); APOL1-associated nephropathy; kidney; ion channel; electrophysiology; apolipoprotein; lipid bilayer; lipoprotein; high-density lipoprotein (HDL); APOL1-associated nephropathy; glomerulosclerosis; nonselective cation channel	TRYPANOSOME LYTIC FACTOR; KIDNEY-DISEASE; APOLIPOPROTEIN L1; BILAYER MEMBRANES; DIPHTHERIA; INSERTION; PROTEIN; BRUCEI; FORMS; VARIANTS	The human innate immunity factor apolipoprotein L-I (APOL1) protects against infection by several protozoan parasites, includingTrypanosoma brucei brucei. Endocytosis and acidification of high-density lipoprotein-associated APOL1 in trypanosome endosomes leads to eventual lysis of the parasite due to increased plasma membrane cation permeability, followed by colloid-osmotic swelling. It was previously shown that recombinant APOL1 inserts into planar lipid bilayers at acidic pH to form pH-gated nonselective cation channels that are opened upon pH neutralization. This corresponds to the pH changes encountered during endocytic recycling, suggesting APOL1 forms a cytotoxic cation channel in the parasite plasma membrane. Currently, the mechanism and domains required for channel formation have yet to be elucidated, although a predicted helix-loop-helix (H-L-H) was suggested to form pores by virtue of its similarity to bacterial pore-forming colicins. Here, we compare recombinant human and baboon APOL1 orthologs, along with interspecies chimeras and individual amino acid substitutions, to identify regions required for channel formation and pH gating in planar lipid bilayers. We found that whereas neutralization of glutamates within the H-L-H may be important for pH-dependent channel formation, there was no evidence of H-L-H involvement in either pH gating or ion selectivity. In contrast, we found two residues in the C-terminal domain, tyrosine 351 and glutamate 355, that influence pH gating properties, as well as a single residue, aspartate 348, that determines both cation selectivity and pH gating. These data point to the predicted transmembrane region closest to the APOL1 C terminus as the pore-lining segment of this novel channel-forming protein.	[Schaub, Charles; Verdi, Joseph; Lee, Penny; Terra, Nada; Limon, Gina; Raper, Jayne; Thomson, Russell] CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA; [Schaub, Charles] CUNY, Grad Ctr, Program Biochem, New York, NY USA; [Verdi, Joseph] CUNY, Grad Ctr, Program Biol, New York, NY USA; [Verdi, Joseph] German Canc Res Ctr, Heidelberg, Germany; [Limon, Gina] NYU, Sch Med, New York, NY USA; [Schaub, Charles] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Helmholtz Association; German Cancer Research Center (DKFZ); New York University; Vanderbilt University	Thomson, R (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	rthomson@genectr.hunter.cuny.edu		Raper, Jayne/0000-0002-8723-9748; Schaub, Charles/0000-0002-3251-3455; Terra, Nada/0000-0003-2181-695X	National Science Foundation [IOS-1249166]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-1249166 (to J. R.).	Binder M.D., 2009, ENCY NEUROSCIENCE, P3183; Bruno J, 2017, J BIOL CHEM, V292, P18344, DOI 10.1074/jbc.M117.813444; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Cooper A, 2017, ELIFE, V6, DOI [10.7554/eLife.25461, 10.7554/elife.25461]; Cooper A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004903; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; FINKELSTEIN A, 1990, J PHYSIOLOGY PARIS, V84, P188; Friedman DJ, 2016, TRENDS ENDOCRIN MET, V27, P204, DOI 10.1016/j.tem.2016.02.002; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Giovinazzo JA, 2020, ELIFE, V9, DOI 10.7554/eLife.51185; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Huynh PD, 1997, J GEN PHYSIOL, V110, P229, DOI 10.1085/jgp.110.3.229; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KAGERUKA P, 1991, ANN SOC BELG MED TR, V71, P39; Kaul P, 1996, PROTEIN SCI, V5, P687; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Lannon H, 2019, KIDNEY INT, V96, P1303, DOI 10.1016/j.kint.2019.07.010; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; MARTINEZ MC, 1983, EMBO J, V2, P1501, DOI 10.1002/j.1460-2075.1983.tb01614.x; MINDELL JA, 1994, J MEMBRANE BIOL, V137, P45; Molina-Portela MP, 2008, J EXP MED, V205, P1721, DOI 10.1084/jem.20071463; Molina-Portela MD, 2005, MOL BIOCHEM PARASIT, V144, P218, DOI 10.1016/j.molbiopara.2005.08.018; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; PARKER MW, 1989, NATURE, V337, P93, DOI 10.1038/337093a0; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; Raper J, 1999, INFECT IMMUN, V67, P1910; RIFKIN MR, 1984, EXP PARASITOL, V58, P81, DOI 10.1016/0014-4894(84)90023-7; Robinson R. A., 1965, ELECTROLYTE SOLUTION, P223; Samanovic M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000276; SILVERMAN JA, 1994, J BIOL CHEM, V269, P22524; Sobko AA, 2004, FEBS LETT, V576, P205, DOI 10.1016/j.febslet.2004.09.016; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Thomson R, 2009, P NATL ACAD SCI USA, V106, P19509, DOI 10.1073/pnas.0905669106; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Verdi J, 2020, CELL HOST MICROBE, V28, P79, DOI 10.1016/j.chom.2020.04.012; Verdi J, 2020, METHODS MOL BIOL, V2116, P463, DOI 10.1007/978-1-0716-0294-2_28; Wang J, 2009, BIOCHEMISTRY-US, V48, P10446, DOI 10.1021/bi9014665; Wheeler RJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005353; Zakharov SD, 2002, BBA-BIOMEMBRANES, V1565, P333, DOI 10.1016/S0005-2736(02)00579-5	43	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13138	13149		10.1074/jbc.RA120.014201	http://dx.doi.org/10.1074/jbc.RA120.014201			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32727852	Green Published, hybrid			2022-12-26	WOS:000574483500001
J	Feng, XY; Guo, J; Sigmon, HC; Sloan, RP; Brickman, AM; Provenzano, FA; Small, SA				Feng, Xinyang; Guo, Jia; Sigmon, Hannah C.; Sloan, Richard P.; Brickman, Adam M.; Provenzano, Frank A.; Small, Scott A.		Alzheimers Dis Neuroimaging Init	Brain regions vulnerable and resistant to aging without Alzheimer's disease	PLOS ONE			English	Article							ENTORHINAL CORTEX; TOTAL NUMBER; MRI; NEURONS; SEGMENTATION; UNDERLIES; ATLAS; HIPPOCAMPUS; DYSFUNCTION; PREVALENCE	'Normal aging' in the brain refers to age-related changes that occur independent of disease, in particular Alzheimer's disease. A major barrier to mapping normal brain aging has been the difficulty in excluding the earliest preclinical stages of Alzheimer's disease. Here, before addressing this issue we first imaged a mouse model and learn that the best MRI measure of dendritic spine loss, a known pathophysiological driver of normal aging, is one that relies on the combined use of functional and structural MRI. In the primary study, we then deployed the combined functional-structural MRI measure to investigate over 100 cognitively-normal people from 20-72 years of age. Next, to cover the tail end of aging, in secondary analyses we investigated structural MRI acquired from cognitively-normal people, 60-84 years of age, who were Alzheimer's-free via biomarkers. Collectively, the results from the primary functional-structural study, and the secondary structural studies revealed that the dentate gyrus is a hippocampal region differentially affected by aging, and that the entorhinal cortex is a region most resistant to aging. Across the cortex, the primary functional-structural study revealed and that the inferior frontal gyrus is differentially affected by aging, however, the secondary structural studies implicated other frontal cortex regions. Together, the results clarify how normal aging may affect the brain and has possible mechanistic and therapeutic implications.	[Feng, Xinyang] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Guo, Jia; Sloan, Richard P.; Small, Scott A.] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Sigmon, Hannah C.; Brickman, Adam M.; Provenzano, Frank A.; Small, Scott A.] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Sloan, Richard P.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Brickman, Adam M.; Provenzano, Frank A.; Small, Scott A.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University	Small, SA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.; Small, SA (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10027 USA.; Small, SA (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	sas68@columbia.edu	Feng, Xinyang/U-5396-2019	Feng, Xinyang/0000-0003-0331-0488; Guo, Jia/0000-0003-4803-0279	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co. Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; Northern California Institute for Research and Education	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co. Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern California Institute for Research and Education	The authors received no specific funding for this work however data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Adamczuk K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0159-5; Adler DH, 2018, P NATL ACAD SCI; Allen Institute for Brain Science, 2015, TECHN WHIP PAP ALL M; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Blennow K, 2015, ALZHEIMERS DEMENT, V11, P58, DOI 10.1016/j.jalz.2014.02.004; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brickman AM, 2014, NAT NEUROSCI, V17, P1798, DOI 10.1038/nn.3850; Brickman AM, 2011, HIPPOCAMPUS, V21, P923, DOI 10.1002/hipo.20840; Brookmeyer R, 2018, ALZHEIMERS DEMENT, V14, P121, DOI 10.1016/j.jalz.2017.10.009; Burgmans S, 2009, NEUROPSYCHOLOGY, V23, P541, DOI 10.1037/a0016161; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Chetelat G, 2013, NEUROIMAGE, V76, P167, DOI 10.1016/j.neuroimage.2013.03.009; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Flores R, 2015, NEUROSCIENCE, V309, P29, DOI 10.1016/j.neuroscience.2015.08.033; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; de Leon MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191240; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duits FH, 2014, ALZHEIMERS DEMENTI S, V10; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Iglesias JE, 2015, NEUROIMAGE, V115, P117, DOI 10.1016/j.neuroimage.2015.04.042; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Greenberg DL, 2005, NEUROPSYCHOLOGIA, V43, P659, DOI 10.1016/j.neuropsychologia.2004.09.002; Guo J, 2018, JOINT ANN M ISMRM ES; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Kalkstein J, 2011, J NEUROSCI, V31, P15768, DOI 10.1523/JNEUROSCI.3209-11.2011; Kassem MS, 2013, MOL NEUROBIOL, V47, P645, DOI 10.1007/s12035-012-8365-7; Keifer OP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8582; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Killiany RJ, 2002, NEUROLOGY, V58, P1188, DOI 10.1212/WNL.58.8.1188; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lim YY, 2013, NEUROBIOL AGING, V34, P2457, DOI 10.1016/j.neurobiolaging.2013.05.006; MARTIN AJ, 1991, J CEREBR BLOOD F MET, V11, P684, DOI 10.1038/jcbfm.1991.121; Miller MI, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00054; Moreno H, 2007, ARCH NEUROL-CHICAGO, V64, P1467, DOI 10.1001/archneur.64.10.1467; Moreno H, 2006, NMR BIOMED, V19, P535, DOI 10.1002/nbm.1022; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Napper RMA, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00016; Pavlopoulos E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006373; Reagh ZM, 2018, NEURON, V97, P1187, DOI 10.1016/j.neuron.2018.01.039; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Shaw L. M., 2016, OVERVIEW 1 8 ADNI CS; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Tarawneh R, 2015, JAMA NEUROL, V72, P656, DOI 10.1001/jamaneurol.2015.0202; Turner GR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.005; Ullmann JFP, 2013, NEUROIMAGE, V78, P196, DOI 10.1016/j.neuroimage.2013.04.008; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Yassa MA, 2011, P NATL ACAD SCI USA, V108, P8873, DOI 10.1073/pnas.1101567108; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	62	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0234255	10.1371/journal.pone.0234255	http://dx.doi.org/10.1371/journal.pone.0234255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726311	gold, Green Published			2022-12-26	WOS:000556908900048
J	Hager, E; Odetokun, IA; Bolarinwa, O; Zainab, A; Okechukwu, O; Al-Mustapha, AI				Hager, Elnadi; Odetokun, Ismail A.; Bolarinwa, Obasanjo; Zainab, Ahmed; Okechukwu, Ochulor; Al-Mustapha, Ahmad I.			Knowledge, attitude, and perceptions towards the 2019 Coronavirus Pandemic: A bi-national survey in Africa	PLOS ONE			English	Article							COVID-19	The current Coronavirus (COVID-19) pandemic has impacted and changed lives on a global scale since its emergence and spread from China in late 2019. It has caused millions of infections, and thousands of deaths worldwide. However, the control of this pandemic still remains unachievable in many African countries including Egypt and Nigeria, despite the application of some strict preventive and control measures. Therefore, this study assessed the knowledge, attitude, and perceptions of Egyptians and Nigerians towards the COVID-19 pandemic. This study was designed as a cross-sectional community-based questionnaire survey in both countries. Participants' demography, knowledge, attitude, and perceptions towards the COVID-19 outbreak were obtained using a convenience sampling technique. Data collected were subjected to descriptive statistics and logistic regression analysis. A total of 1437 respondents were included in this preliminary report. The mean knowledge score was 14.7 +/- 2.3. The majority of the respondents (61.6%) had a satisfactory knowledge of the disease. Age (18-39 years), education (College/bachelors), and background of respondents were factors influencing knowledge levels. The attitude of most respondents (68.9%) towards instituted preventive measures was satisfactory with an average attitude score of 6.9 +/- 1.2. The majority of the respondents (96%) practiced self-isolation and social-distancing but only 36% follow all health recommendations. The perception of most respondents (62.1%) on the global efforts at controlling the virus and preventing further spread was satisfactory with an average score of 10.9 +/- 2.7. Only 22% of the respondents were satisfied with their country's handling of the pandemic. An apprehensive understanding of the current status in Africa through studies like KAP is crucial to avoid Africa being the next epicenter of the pandemic. For the populace to follow standard infection prevention and control measures adequately, governments need to gain the trust of citizens by strengthening the health systems and improving surveillance activities in detecting cases, to offer the optimum health services to their communities.	[Hager, Elnadi] INRA, Infectiol & Sante Publ, Nouzilly, France; [Odetokun, Ismail A.] Univ Ilorin, Dept Vet Publ Hlth & Prevent Med, Fac Vet Med, Ilorin, Kwara State, Nigeria; [Bolarinwa, Obasanjo] Univ KwaZulu Natal, Sch Nursing & Publ Hlth Med, Coll Hlth Sci, Durban, South Africa; [Zainab, Ahmed] Cairo Univ, Dept Vet Microbiol, Fac Vet Med, Cairo, Egypt; [Okechukwu, Ochulor] Inst Pasteur, Dept Global Hlth, Unit Funct Genet Infect Dis, Paris, France; [Al-Mustapha, Ahmad I.] Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland; [Al-Mustapha, Ahmad I.] Kwara State Minist Agr & Rural Dev, Dept Vet Serv, Ilorin, Nigeria; [Al-Mustapha, Ahmad I.] Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Fac Vet Med, Ibadan, Nigeria	INRAE; University of Ilorin; University of Kwazulu Natal; Egyptian Knowledge Bank (EKB); Cairo University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Helsinki; University of Ibadan	Al-Mustapha, AI (corresponding author), Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland.; Al-Mustapha, AI (corresponding author), Kwara State Minist Agr & Rural Dev, Dept Vet Serv, Ilorin, Nigeria.; Al-Mustapha, AI (corresponding author), Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Fac Vet Med, Ibadan, Nigeria.	ahmad.al-mustapha@helsinki.fi	Bolarinwa, Obasanjo/ABC-5499-2020; Odetokun, Ismail Ayoade/A-5431-2018	Odetokun, Ismail Ayoade/0000-0002-5171-1895; Bolarinwa, Obasanjo/0000-0002-9208-6408				Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7; Acter T, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138996; Africa CDC, COVID 19 DASHB; [Anonymous], COR UPD LIV; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Carlos WG, 2020, AM J RESP CRIT CARE, V201, pP7, DOI 10.1164/rccm.2014P7; Chan EYY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2245-9; de Bruin YB, 2020, SAFETY SCI, V128, DOI 10.1016/j.ssci.2020.104773; Di Gennaro F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082690; Erfani A, 2020, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.20.256651, DOI 10.2471/BLT.20.256651]; Finset A, 2020, PATIENT EDUC COUNS, V103, P873, DOI 10.1016/j.pec.2020.03.027; Gupta N, 2020, MED J ARMED FORCES I; Hassan S, 2020, CUREUS, V12, DOI 10.7759/cureus.8056; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692; Lin H, 2020, SSRN ELECT J; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Lucero-Prisno D, 2020, GLOBAL HLTH RES POLI, V5; Odetokun IA, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040243; Ohia C, 2020, INT J INFECT DIS, V95, P279, DOI 10.1016/j.ijid.2020.04.062; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Rugarabamu S., 2020, MEDRXIV, V216, P1, DOI [10.1101/2020.04.26.20080820, DOI 10.1101/2020.04.26.20080820]; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2020, COR DIS TECHN GUID; World Health Organization, 2020, DIR GEN OP REM MED B; World Health Organization (WHO), COVID 2019 SIT REP; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Zhang H, 2020, GUT, V69, P1010, DOI 10.1136/gutjnl-2020-320953; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	29	75	75	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236918	10.1371/journal.pone.0236918	http://dx.doi.org/10.1371/journal.pone.0236918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726340	Green Published, Green Submitted, gold			2022-12-26	WOS:000556908900051
J	Ajayi, IO; Ajumobi, O; Ogunwale, A; Adewole, A; Odeyinka, OT; Balogun, MS; Nguku, P; Bamiselu, O				Ajayi, IkeOluwapo O.; Ajumobi, Olufemi; Ogunwale, Akintayo; Adewole, Adefisoye; Odeyinka, Oluwaseun Temitope; Balogun, Muhammad Shakir; Nguku, Patrick; Bamiselu, Oluyomi		NFELTP Fellows	Is the malaria short course for program managers, a priority for malaria control effort in Nigeria? Evidence from a qualitative study	PLOS ONE			English	Article							ELIMINATION	Background A Malaria Short Course (MSC) was conceptualized to build the capacity of program managers for malaria control due to the lack of a single comprehensive broad-based programmatic training in Nigeria. Prior to its implementation, a needs assessment was conducted based on the perspectives of stakeholders to plan and develop the curriculum. Methods This was an exploratory qualitative study. Fifty-six purposively selected stakeholders at local, state and national levels were interviewed. Opinions on the need for training, its perceived impact, priority focus, likelihood of participation, sustainability of and planned support for the MSC were explored using a pretested researcher-designed interview guide. Interviews were audiotape recorded, and the transcripts were subjected to thematic content analysis. Results Participants included Directors of Primary Health Care (50%), State Malaria Program Officers (8.9%), State Directors of Public Health Services (7.1%) and Roll Back Malaria Officers (5.4%). Participants' mean number of years of experience in their current positions was 6.2 (SD 4.7) years. The dominant view was "malaria remains a problem in Nigeria, exacerbated by poor funding, knowledge deficit, lack of training opportunities for program managers and prioritized training budget". A common viewpoint was "to achieve the malaria policy goals, MSC should focus on improving program managers' knowledge of the disease, novel interventions, data audit and use of data for decision making, supportive supervision as well as leadership and management skills. The prioritized thematic areas were malaria epidemiology, case management and data management. The consensus opinion was the MSC would have a positive impact on the performance of program managers. All managerial participants were willing to release their staff for the MSC and encouraged step-down training. However, most participants opined they could not guarantee that their institutions would provide financial support to the MSC attendees. Conclusions Implementing the MSC for program managers was considered essential towards achieving malaria control. Moreover, there is need for prioritized funding and sustainability mechanisms to actualize the implementation of the course.	[Ajayi, IkeOluwapo O.; Odeyinka, Oluwaseun Temitope] Univ Ibadan, Dept Epidemiol & Med Stat, Coll Med, Ibadan, Nigeria; [Ajayi, IkeOluwapo O.; Ajumobi, Olufemi; Adewole, Adefisoye; Balogun, Muhammad Shakir; Nguku, Patrick; Bamiselu, Oluyomi] Nigeria Field Epidemiol & Lab Training Program, Abuja, Nigeria; [Ajumobi, Olufemi] Fed Minist Hlth, Natl Malaria Eliminat Program, Abuja, Nigeria; [Ajumobi, Olufemi] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Ogunwale, Akintayo] Univ Ibadan, Fac Publ Hlth, Dept Hlth Promot & Educ, Coll Med, Ibadan, Nigeria; [Ogunwale, Akintayo; Balogun, Muhammad Shakir] Oyo State Coll Agr & Technol, Dept Gen Studies, Igboora, Oyo State, Nigeria; [Adewole, Adefisoye; Nguku, Patrick] African Field Epidemiol Network Nigeria Country O, Abuja, Nigeria; [Ajumobi, Olufemi] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA	University of Ibadan; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Ibadan; Nevada System of Higher Education (NSHE); University of Nevada Reno	Ajumobi, O (corresponding author), Nigeria Field Epidemiol & Lab Training Program, Abuja, Nigeria.; Ajumobi, O (corresponding author), Fed Minist Hlth, Natl Malaria Eliminat Program, Abuja, Nigeria.; Ajumobi, O (corresponding author), Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.; Ajumobi, O (corresponding author), Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.	femiajumobi@gmail.com	Ajumobi, Olufemi/J-7389-2018; BALOGUN, MUHAMMAD/ABH-4227-2020	Ajumobi, Olufemi/0000-0002-2652-1205; BALOGUN, MUHAMMAD/0000-0002-4846-9698; ajayi, Ikeoluwapo/0000-0001-7719-8746; Ibrahim, Ismaila Nda/0000-0003-2874-8339	United States Centers for Disease Control and Prevention through African Field Epidemiology Network [U2GGH001876]	United States Centers for Disease Control and Prevention through African Field Epidemiology Network(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by Cooperative Agreement Number U2GGH001876 funded by the United States Centers for Disease Control and Prevention through African Field Epidemiology Network (Rebecca Barbriye) to Nigeria Field Epidemiology and Laboratory Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armat MR, 2018, QUAL REP, V23, P219; Babatunde A., 2017, TEXILA INT J PUBLIC, V5, P1, DOI [10.21522/TIJPH.2013.05.04.Art008, DOI 10.21522/TIJPH.2013.05.04.ART008]; Bennibor S, 2014, REPORT TRAINING NEED; Centers for Disease Control and Prevention, GLOB HLTH PROT SEC F; El-Moamly AA, 2013, J INFECT DEV COUNTR, V7, P769, DOI 10.3855/jidc.3079; Feachem RGA, 2019, LANCET, V394, P1056, DOI 10.1016/S0140-6736(19)31139-0; Fetene N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210624; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; Hlongwana KW, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1288954; National Malaria Elimination Programme Nigeria Nigeria National Population Commission, 2016, NIG MAL IND SURV 201; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Nwankwo B, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.289.15802; Public Health Foundation, 2014, COR COMP PUBL HLTH P; QSR QSR International., 2015, NVIVO; United Nations Department of Economic and Social Affairs., WORLD POP PROSP; WHO, 2016, WORLD MAL REP 2016; WHO, 2000, WORLD HLTH REP HLTH; WHO, 2018, WORLD MAL REP 2018; World Health Organization, 2018, WORLD MALARIA REPORT; World Health Organization, 2017, DEPRESSION; World Health Organization, 2019, HIGH BURD HIGH IMP T; Woyessa A, 2013, INT J TECHNOL ASSESS, V29, P212, DOI 10.1017/S0266462313000032	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236576	10.1371/journal.pone.0236576	http://dx.doi.org/10.1371/journal.pone.0236576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722693	gold, Green Published			2022-12-26	WOS:000556916000012
J	Kovach, K; Sabaraya, IV; Patel, P; Kirisits, MJ; Saleh, NB; Gordon, VD				Kovach, Kristin; Sabaraya, Indu Venu; Patel, Parth; Kirisits, Mary Jo; Saleh, Navid B.; Gordon, Vernita D.			Suspended multiwalled, acid-functionalized carbon nanotubes promote aggregation of the opportunistic pathogenPseudomonas aeruginosa	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; NANOPARTICLES; TOLERANCE; BIOFILMS; BACTERIA; REMOVAL; FILTER	The increasing prevalence of carbon nanotubes (CNTs) as components of new functional materials has the unintended consequence of causing increases in CNT concentrations in aqueous environments. Aqueous systems are reservoirs for bacteria, including human and animal pathogens, that can form biofilms. At high concentrations, CNTs have been shown to display biocidal effects; however, at low concentrations, the interaction between CNTs and bacteria is more complicated, and antimicrobial action is highly dependent upon the properties of the CNTs in suspension. Here, impact of low concentrations of multiwalled CNTs (MWCNTs) on the biofilm-forming opportunistic human pathogenPseudomonas aeruginosais studied. Using phase contrast and confocal microscopy, flow cytometry, and antibiotic tolerance assays, it is found that sub-lethal concentrations (2 mg/L) of MWCNTs promote aggregation ofP.aeruginosainto multicellular clusters. However, the antibiotic tolerance of these "young" bacterial-CNT aggregates is similar to that of CNT-free cultures. Overall, our results indicate that the co-occurrence of MWCNTs andP.aeruginosain aqueous systems, which promotes the increased number and size of bacterial aggregates, could increase the dose to which humans or animals are exposed.	[Kovach, Kristin; Patel, Parth; Gordon, Vernita D.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Kovach, Kristin; Patel, Parth; Gordon, Vernita D.] Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA; [Sabaraya, Indu Venu; Kirisits, Mary Jo; Saleh, Navid B.] Univ Texas Austin, Dept Civil Architectural & Environm Engn, Austin, TX 78712 USA; [Gordon, Vernita D.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Gordon, VD (corresponding author), Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.; Gordon, VD (corresponding author), Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA.; Gordon, VD (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	gordon@chaos.utexas.edu	Saleh, Navid/GNW-4156-2022	Gordon, Vernita/0000-0002-5989-9378	National Science Foundation [CBET 0846719, CBET 1916709, CMMI 1727544, DGE-1110007]; Cystic Fibrosis Foundation [GORDON1710]; National Institutes of Health [5 R01 AI121500]	National Science Foundation(National Science Foundation (NSF)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the National Science Foundation (CBET 0846719 to MJK; CBET 1916709 to MJK and NBS; CMMI 1727544 to VDG), the Cystic Fibrosis Foundation (GORDON1710 to VDG), and the National Institutes of Health (5 R01 AI121500 to VDG). KK was the recipient of a Graduate Research Fellowship from the National Science Foundation for part of the time this work was done (DGE-1110007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrooz ARMN, 2013, ENVIRON SCI TECHNOL, V47, P1853, DOI 10.1021/es3032709; Aggregation Kinetics and Fractal Dimensions of Nanomaterials in Environmental Systems, ENG NANOPARTICLES EN, P139; Aich N, 2016, ENVIRON SCI TECHNOL, V50, P3562, DOI 10.1021/acs.est.5b05447; Alhede M, 2014, PSEUDOMONAS AERUGINO; Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Arias LR, 2009, LANGMUIR, V25, P3003, DOI 10.1021/la802769m; Aviles F, 2009, CARBON, V47, P2970, DOI 10.1016/j.carbon.2009.06.044; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Brady-Estevez AS, 2008, SMALL, V4, P481, DOI 10.1002/smll.200700863; Brady-Estevez AS, 2010, LANGMUIR, V26, P14975, DOI 10.1021/la102783v; Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488; Das D, 2018, ENVIRON SCI TECHNOL, V52, P8233, DOI 10.1021/acs.est.7b05826; Das D, 2017, ENVIRON SCI-NANO, V4, P60, DOI 10.1039/c6en00294c; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Fexby S, 2007, INFECT IMMUN, V75, P30, DOI 10.1128/IAI.01117-06; FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67, DOI 10.1128/AEM.37.1.67-72.1979; Fullerenes Higher Fullerenes and their Hybrids, FULL HIGH FULL THEIR, P1; Gong H, 2013, APPL SURF SCI, V266, P219, DOI 10.1016/j.apsusc.2012.11.152; Goodwin DG, 2016, ENVIRON SCI-NANO, V3, P545, DOI 10.1039/c5en00277j; Goodwin DG, 2015, ENVIRON SCI TECHNOL, V49, P5484, DOI 10.1021/acs.est.5b00084; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; GREEN SK, 1974, APPL MICROBIOL, V28, P987, DOI 10.1128/AEM.28.6.987-991.1974; Hoiby N, 2019, INT J ANTIMICROB AG, V53, P564, DOI 10.1016/j.ijantimicag.2018.12.015; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Huang TS, 2004, DIAM RELAT MATER, V13, P1098, DOI 10.1016/j.diamond.2003.11.047; Jourdin L, 2014, J MATER CHEM A, V2, P13093, DOI 10.1039/c4ta03101f; Kang S, 2008, ENVIRON SCI TECHNOL, V42, P7528, DOI 10.1021/es8010173; Khan IA, 2013, CHEMOSPHERE, V93, P1997, DOI 10.1016/j.chemosphere.2013.07.019; Kragh KN, 2016, MBIO, V7, DOI 10.1128/mBio.00237-16; Liu XW, 2011, ENERG ENVIRON SCI, V4, P1422, DOI 10.1039/c0ee00447b; Merryman AE, 2019, SCI TOTAL ENVIRON, V670, P1140, DOI 10.1016/j.scitotenv.2019.03.311; Mohanty A, 2015, ENVIRON SCI TECH LET, V2, P105, DOI 10.1021/acs.estlett.5b00057; Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Petersen EJ, 2011, ENVIRON SCI TECHNOL, V45, P9837, DOI 10.1021/es201579y; PETERSEN NT, 2012, ENVIRON TOXICOL CHEM, V31, P55839, DOI DOI 10.4102/SATNT.V31I1.377; Rodrigues DF, 2010, ENVIRON SCI TECHNOL, V44, P4583, DOI 10.1021/es1005785; Romling U, 2014, J INTERN MED, V276, P98, DOI 10.1111/joim.12242; Saleh NB, 2008, ENVIRON SCI TECHNOL, V42, P7963, DOI 10.1021/es801251c; Saleh NB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00677; Saleh NB, 2010, ENVIRON SCI TECHNOL, V44, P2412, DOI 10.1021/es903059t; Srivastava A, 2004, NAT MATER, V3, P610, DOI 10.1038/nmat1192; Takahashi Y, 2018, J ANTIBIOT, V71, P4, DOI 10.1038/ja.2017.117; Verma A, 2015, OPT QUANT ELECTRON, V47, P1197, DOI 10.1007/s11082-014-9976-1; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wessel AK, 2014, MBIO, V5, DOI 10.1128/mBio.00992-14; Yang CN, 2010, LANGMUIR, V26, P16013, DOI 10.1021/la103110g; Yick S, 2015, RSC ADV, V5, P5142, DOI 10.1039/c4ra08187k; Zhou RH, 2006, ELECTROPHORESIS, V27, P1376, DOI 10.1002/elps.200500329	52	4	4	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236599	10.1371/journal.pone.0236599	http://dx.doi.org/10.1371/journal.pone.0236599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722685	Green Submitted, Green Published, gold			2022-12-26	WOS:000556916000032
J	Wang, YC; Liu, YN; Deng, WF; Fu, FX; Yan, SS; Yang, HW; Liu, RM; Geng, J; Xu, J; Wu, YH; Ma, JF; Zhou, JP; Liu, N; Jin, Y; Xia, RF; Elias, N; Lee, RJ; Feldman, AS; Blute, ML; Colvin, RB; Wu, CL; Miao, Y				Wang, Yuchen; Liu, Yanna; Deng, Wenfeng; Fu, Fangxiang; Yan, Susha; Yang, Hongwei; Liu, Rumin; Geng, Jian; Xu, Jian; Wu, Yihan; Ma, Junfeng; Zhou, Jiapeng; Liu, Na; Jin, Yu; Xia, Renfei; Elias, Nahel; Lee, Richard J.; Feldman, Adam S.; Blute, Michael L.; Colvin, Robert B.; Wu, Chin-Lee; Miao, Yun			Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing	ONCOGENE			English	Article							CANCER; VIRUS; GENOME; END	BK polyomavirus (BKPyV)-associated cancer after transplantation has gained increasing attention. However, the role of BKPyV integration on oncogenesis is still unclear. In this study, next-generation virome capture sequencing of primary and metastatic tumors were performed in three patients with BKPyV-associated urothelial carcinoma after renal transplantation. As a result, a total of 332 viral integration sites were identified in the six tumors. Integration of BKPyV in both primary and metastatic tumors followed the mechanism of microhomology-mediated end joining mostly, since microhomologies between human and BKPyV genomes were significantly enriched in flanking regions of 84% of the integration sites. Viral DNA breakpoints were nonrandom and tended to assemble in large T gene, small T gene and viral protein 2 gene. There were three, one and one consensus integration sites between the primary and metastatic tumors, which affectedLINC01924,eIF3c, andNEIL2genes in the three cases respectively. Thus, we concluded that integration of BKPyV was a continuous process occurring in both primary and metastatic tumors, generating heterogenous tumor cell populations. Through this ongoing process, certain cell populations might have gained growth advantage or metastatic potential, as a result of viral integration either affecting the cellular genes where the viral DNA integrated to or altering the expression or function of the viral genes.	[Wang, Yuchen; Liu, Yanna; Deng, Wenfeng; Fu, Fangxiang; Yan, Susha; Yang, Hongwei; Liu, Rumin; Xu, Jian; Wu, Yihan; Jin, Yu; Xia, Renfei; Miao, Yun] Southern Med Univ, Nanfang Hosp, Dept Organ Transplantat, Guangzhou, Peoples R China; [Geng, Jian] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China; [Ma, Junfeng; Zhou, Jiapeng; Liu, Na] Mygenostics Co, Beijing, Peoples R China; [Elias, Nahel] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA; [Lee, Richard J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Feldman, Adam S.; Blute, Michael L.; Wu, Chin-Lee] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA; [Colvin, Robert B.; Wu, Chin-Lee] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Southern Medical University - China; Southern Medical University - China; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Miao, Y (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Organ Transplantat, Guangzhou, Peoples R China.; Wu, CL (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA.; Wu, CL (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA.	cwu2@mgh.harvard.edu; miaoyunecho@126.com		Elias, Nahel/0000-0001-6466-7347	Natural Science Foundation of Guangdong Province [2020A1515010674]; National Natural Science Foundation of China [81500573]; Science and Technology Planning Project of Guangzhou [201803010109]; President Funding of Nanfang Hospital [2018B009, 2018C003]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangzhou; President Funding of Nanfang Hospital	The work was funded by Natural Science Foundation of Guangdong Province [grant number 2020A1515010674], National Natural Science Foundation of China [grant number 81500573], Science and Technology Planning Project of Guangzhou [grant number 201803010109] and President Funding of Nanfang Hospital [grant number 2018B009, 2018C003]. And we thanked Dr. Min-Hua Luo (Wuhan Institute of Virology, Wuhan, China) for her assisstant in the study design and critical revision of the manuscript.	Anzivino E, 2016, CANCER GENOM PROTEOM, V13, P499, DOI 10.21873/cgp.20013; Borchert S, 2014, J VIROL, V88, P3144, DOI 10.1128/JVI.02916-13; BRUGGE JS, 1975, J VIROL, V15, P619, DOI 10.1128/JVI.15.3.619-635.1975; CICALA C, 1993, AM J PATHOL, V142, P1524; Delbue Serena, 2014, Oncoscience, V1, P296; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Fu FX, 2018, CLIN SCI, V132, P1753, DOI 10.1042/CS20180443; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Houben R, 2013, J INVEST DERMATOL, V133, P2453, DOI 10.1038/jid.2013.169; Hu JX, 2019, CANCER INVEST, V37, P199, DOI 10.1080/07357907.2019.1618322; Javorka P, 2019, PLANT DIRECT, V3, DOI 10.1002/pld3.146; Jin Y, 2019, AM J TRANSPLANT, V19, P1158; Kenan DJ, 2017, AM J TRANSPLANT, V17, P1674, DOI 10.1111/ajt.14191; Kenan DJ, 2015, J PATHOL, V237, P379, DOI 10.1002/path.4584; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI J, 1993, J MED VIROL, V41, P11, DOI 10.1002/jmv.1890410104; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Merid SK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-308; Moens U, 2005, VIROLOGY, V331, P209, DOI 10.1016/j.virol.2004.10.021; Mouw KW, 2017, CANCER DISCOV, V7, P675, DOI 10.1158/2159-8290.CD-17-0226; Muller DC, 2018, J PATHOL, V244, P265, DOI 10.1002/path.5012; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Schwarz A, 2012, TRANSPLANTATION, V94, P396, DOI 10.1097/TP.0b013e31825a505d; Starrett GJ, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00727-4; Starrett GJ, 2019, CURR OPIN VIROL, V39, P8, DOI 10.1016/j.coviro.2019.06.009; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Wei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038533; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zhao LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12992	31	7	8	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2020	39	35					5734	5742		10.1038/s41388-020-01398-6	http://dx.doi.org/10.1038/s41388-020-01398-6		JUL 2020	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NF2QB	32724161				2022-12-26	WOS:000553333400003
J	Yitshak-Sade, M; Lane, KJ; Fabian, MP; Kloog, I; Hart, JE; Davis, B; Fong, KC; Schwartz, JD; Laden, F; Zanobetti, A				Yitshak-Sade, Maayan; Lane, Kevin J.; Fabian, M. Patricia; Kloog, Itai; Hart, Jaime E.; Davis, Brigette; Fong, Kelvin C.; Schwartz, Joel D.; Laden, Francine; Zanobetti, Antonella			Race or racial segregation? Modification of the PM(2.5)and cardiovascular mortality association	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; SHORT-TERM EXPOSURE; RESIDENTIAL SEGREGATION; SOCIOECONOMIC-STATUS; JIM-CROW; MATTER; US; PM2.5; NEIGHBORHOOD; DISPARITIES	Background Many studies have identified an inequitable distribution of exposure to PM2.5(particulate matter less than 2.5 microns) by race. We investigated the association of PM(2.5)and cardiovascular mortality considering both the decedents' race and neighborhood racial composition as potential modifiers. Methods We obtained geocoded cardiovascular mortality records of all black and white decedents from urban block-groups in Massachusetts between 2001 and 2011 (n = 130,863). We examined the association between PM(2.5)and cardiovascular mortality, and assessed effect modification by three types of racial modifiers: decedents' race, census block-group percent black and white, and two novel measures of racial segregation. The Racial Residential Segregation (RRS) quantifies the concentration of non-Hispanic blacks and whites in each block-group. The Index of Racial Dissimilarity measures dissimilarity in non-Hispanic black and white racial distribution between the smaller census block-group and larger tract. Results We found a 2.35%(95%CI: 0.92%;3.79%) increase in mortality for each 10 mu g/m(3)increase in two-day average exposure to PM2.5. The effect was modified by the block-group racial composition, with higher risks in block-groups with the highest percentage of black residents (interaction p-value = 0.04), and in block-groups with the lowest RRS (i.e. higher black to white resident ratio, interaction p-value = 0.072). Racial dissimilarity did not modify the associations. Conclusion Current levels of PM(2.5)are associated with increased cardiovascular deaths in Massachusetts, with different risks between areas with different racial composition and segregation. This suggests that pollution reductions in neighborhoods with the highest percentage of non-Hispanic blacks would be most beneficial in reducing cardiovascular mortality and disparities.	[Yitshak-Sade, Maayan; Hart, Jaime E.; Fong, Kelvin C.; Schwartz, Joel D.; Laden, Francine; Zanobetti, Antonella] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA USA; [Lane, Kevin J.; Fabian, M. Patricia] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Kloog, Itai] Ben Gurion Univ Negev, Fac Humanities & Social Sci, Dept Geog & Environm Dev, Beer Sheva, Israel; [Hart, Jaime E.; Schwartz, Joel D.; Laden, Francine] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Hart, Jaime E.; Schwartz, Joel D.; Laden, Francine] Harvard Med Sch, Boston, MA 02115 USA; [Davis, Brigette] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Fong, Kelvin C.] Yale Univ, Sch Forestry & Environm Sci, New Haven, CT USA; [Schwartz, Joel D.; Laden, Francine] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Ben Gurion University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Harvard University; Harvard T.H. Chan School of Public Health	Yitshak-Sade, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA USA.	myitshak@hsph.harvard.edu		Lane, Kevin/0000-0002-1038-6811; Yitshak-Sade, Maayan/0000-0003-4453-0401; Davis, Brigette A./0000-0002-3055-7630	National Institute of Minority Health and Health Disparities [P50MD010428]; National Institute of Environmental Health Sciences [P30 ES000002, R01 ES024332]; National Cancer Institute [R00 CA201542]; Environmental Protection Agency [RD83615601, RD83587201]	National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Environmental Protection Agency(United States Environmental Protection Agency)	This study was supported by the National Institute of Minority Health and Health Disparities grant P50MD010428; National Institute of Environmental Health Sciences grants P30 ES000002 and R01 ES024332; National Cancer Institute grant R00 CA201542; and Environmental Protection Agency grants RD83615601 and RD83587201. Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the USEPA. Further, USEPA does not endorse the purchase of any commercial products or services mentioned in the publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090; Bell ML, 2012, ENVIRON HEALTH PERSP, V120, P1699, DOI 10.1289/ehp.1205201; Bell ML, 2009, EPIDEMIOLOGY, V20, P682, DOI 10.1097/EDE.0b013e3181aba749; Bell ML, 2008, AM J EPIDEMIOL, V168, P1301, DOI 10.1093/aje/kwn252; Bell S, 2013, ANN ASSOC AM GEOGR, V103, P85, DOI 10.1080/00045608.2012.685050; Bravo MA, 2016, ENVIRON INT, V92-93, P247, DOI 10.1016/j.envint.2016.04.008; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Bureau U.S.C., 2012, US CENS REG; Burwell-Naney K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-96; Clark LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094431; Di Q, 2017, JAMA-J AM MED ASSOC, V318, P2446, DOI 10.1001/jama.2017.17923; DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191; Fecht D, 2015, ENVIRON POLLUT, V198, P201, DOI 10.1016/j.envpol.2014.12.014; Forastiere F, 2007, AM J IND MED, V50, P208, DOI 10.1002/ajim.20368; Hajat A, 2013, ENVIRON HEALTH PERSP, V121, P1325, DOI 10.1289/ehp.1206337; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kioumourtzoglou MA, 2016, EPIDEMIOLOGY, V27, P221, DOI 10.1097/EDE.0000000000000422; Kloog I, 2014, ATMOS ENVIRON, V95, P581, DOI 10.1016/j.atmosenv.2014.07.014; Kloog I, 2014, REMOTE SENS ENVIRON, V150, P132, DOI 10.1016/j.rse.2014.04.024; Kloog I, 2013, EPIDEMIOLOGY, V24, P555, DOI 10.1097/EDE.0b013e318294beaa; Kloog I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034664; Kramer MR, 2009, EPIDEMIOL REV, V31, P178, DOI 10.1093/epirev/mxp001; Krieger N, 2017, AM J PUBLIC HEALTH, V107, P903, DOI 10.2105/AJPH.2017.303713; Krieger N, 2017, J URBAN HEALTH, V94, P244, DOI 10.1007/s11524-016-0116-z; Krieger N, 2015, HEALTH PLACE, V34, P215, DOI 10.1016/j.healthplace.2015.05.008; Krieger N, 2014, EPIDEMIOLOGY, V25, P494, DOI 10.1097/EDE.0000000000000104; Krieger N, 2013, AM J PUBLIC HEALTH, V103, P2234, DOI 10.2105/AJPH.2013.301350; Makri A, 2008, INT J HYG ENVIR HEAL, V211, P326, DOI 10.1016/j.ijheh.2007.06.005; Maranville AR, 2009, ENVIRON JUSTICE, V2, P49, DOI 10.1089/env.2008.0547; Martenies SE, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101243; Mentias A, 2017, INT J CARDIOL, V248, P69, DOI 10.1016/j.ijcard.2017.05.011; Mikati I, 2018, AM J PUBLIC HEALTH, V108, P480, DOI [10.2105/AJPH.2017.304297, 10.2105/ajph.2017.304297]; Morello-Frosch RA, 2002, ENVIRON PLANN C, V20, P477, DOI 10.1068/c03r; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Roth GA, 2018, JAMA CARDIOL, V3, P375, DOI 10.1001/jamacardio.2018.0385; Schultz WM, 2018, CIRCULATION, V137, P2166, DOI 10.1161/CIRCULATIONAHA.117.029652; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Therneau T., 2017, PACKAGE SURVIVAL; Wang Y, 2017, EPIDEMIOLOGY, V28, P207, DOI 10.1097/EDE.0000000000000614; White K, 2011, HEALTH PLACE, V17, P438, DOI 10.1016/j.healthplace.2010.12.002; Williams AD, 2018, HEALTH PLACE, V51, P208, DOI 10.1016/j.healthplace.2018.04.005; Williams D.R., 2019, ANN REV PUBLIC HLTH; Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7	46	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236479	10.1371/journal.pone.0236479	http://dx.doi.org/10.1371/journal.pone.0236479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV9ND	32716950	Green Published, gold			2022-12-26	WOS:000556674500035
J	Lim, SC; Jansson, PJ; Assinder, SJ; Maleki, S; Richardson, D; Kovacevic, Z				Lim, Syer C.; Jansson, Patric J.; Assinder, Stephen J.; Maleki, Sanaz; Richardson, Des R.; Kovacevic, Zaklina			Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance	FASEB JOURNAL			English	Article						androgen receptor; androgen resistance; c-Jun; DpC; prostate cancer; PSA	DOWNSTREAM-REGULATED GENE-1; EPITHELIAL-MESENCHYMAL TRANSITION; METASTASIS SUPPRESSOR NDRG1; GROWTH-FACTOR RECEPTOR; IRON CHELATORS; UP-REGULATION; ANTITUMOR-ACTIVITY; TGF-BETA; IN-VITRO; INHIBITION	The androgen receptor (AR) is a major driver of prostate cancer (PCa) and a key therapeutic target for AR inhibitors (ie, Enzalutamide). However, Enzalutamide only inhibits androgen-dependent AR signaling, enabling intrinsic AR activationviaandrogen-independent pathways, leading to aggressive castration-resistant PCa (CRPC). We investigated the ability of novel anti-cancer agents, Dp44mT and DpC, to overcome androgen resistance. The effect of Dp44mT and DpC on androgen-dependent and independent AR signaling was assessed in androgen-dependent and -independent PCa cells using 2D- and 3D-tissue culture. The clinically trialed DpC was then examined in vivo and compared to Enzalutamide. These agents uniquely promote AR proteasomal degradation and inhibit AR transcription in PCa cells via the upregulation of c-Jun, potently reducing the AR target, prostate-specific antigen (PSA). These agents also inhibited the activation of key molecules in both androgen-dependent and independent AR signaling (ie, EGFR, MAPK, PI3K), which promote CRPC. The clinically trialed DpC also significantly inhibited PCa tumor growth, AR, and PSA expression in vivo, being more potent than Enzalutamide. DpC is a promising candidate for a unique, structurally distinct generation of AR inhibitors that simultaneously target both androgen-dependent and independent arms of AR signaling. No other therapies exhibit such comprehensive and potent AR suppression, which is critical for overcoming the development of androgen resistance.	[Lim, Syer C.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Canc Metastasis & Tumour Microenvironm Program, Camperdown, NSW, Australia; [Lim, Syer C.; Jansson, Patric J.; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Camperdown, NSW, Australia; [Assinder, Stephen J.] Univ Sydney, Discipline Physiol, Sch Med Sci, Camperdown, NSW, Australia; [Maleki, Sanaz] Univ Sydney, Sch Med Sci, Dept Pathol, Histopathol Lab, Camperdown, NSW, Australia; [Richardson, Des R.] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi, Japan; [Richardson, Des R.] Griffith Univ, Griffith Inst Drug Discovery, Ctr Canc Cell Biol, Brisbane, Qld 4111, Australia; [Lim, Syer C.; Jansson, Patric J.; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Canc Drug Resistance & Stem Cell Program, Camperdown, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Nagoya University; Griffith University; University of Sydney	Richardson, D (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Ctr Canc Cell Biol, Brisbane, Qld 4111, Australia.; Kovacevic, Z (corresponding author), Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.	d.richardson@griffith.edu.au; zaklina.kovacevic@sydney.edu.au	Jansson, Patric/AAC-4221-2022; Lim, Syer Choon/AAN-7043-2021; Kovacevic, Zaklina/ABD-9581-2021	Jansson, Patric/0000-0002-9322-653X; Lim, Syer Choon/0000-0002-5648-9453; Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0002-5506-3274	Cure Cancer Australia Foundation (CCAF) [1086449]; Department of Health \ National Health and Medical Research Council (NHMRC) [1140447, APP1159596, APP1062607, APP1144456]; Cancer Institute NSW (Cancer Institute New South Wales) [CDF171126]; University of Sydney	Cure Cancer Australia Foundation (CCAF); Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW (Cancer Institute New South Wales); University of Sydney(University of Sydney)	Cure Cancer Australia Foundation (CCAF), Grant/Award Number: 1086449; Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: 1140447, APP1159596, APP1062607 and APP1144456; Cancer Institute NSW (Cancer Institute New South Wales), Grant/Award Number: CDF171126; University of Sydney	Alimirah F, 2007, NEOPLASIA, V9, P1152, DOI 10.1593/neo.07769; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Evans MJ, 2011, PNAS, V108, P9678; Fang Z, 2012, J BIOL CHEM, V287, P2090, DOI 10.1074/jbc.M111.323303; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x; Ha S, 2013, ONCOGENE, V32, P3992, DOI 10.1038/onc.2012.412; Han YY, 2017, THERANOSTICS, V7, P1914, DOI 10.7150/thno.17852; Hsu CC, 2013, MOL CELL ENDOCRINOL, V372, P12, DOI 10.1016/j.mce.2013.03.004; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Leung JK, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00002; Li YL, 2015, INT J ONCOL, V47, P1001, DOI 10.3892/ijo.2015.3086; Liao RS, 2013, TRANSL ANDROL UROL, V2, P187, DOI 10.3978/j.issn.2223-4683.2013.09.07; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lui GYL, 2015, MOL PHARMACOL, V87, P543, DOI 10.1124/mol.114.096529; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Menezes SV, 2019, J BIOL CHEM, V294, P4045, DOI 10.1074/jbc.RA118.006279; Menezes SV, 2017, J BIOL CHEM, V292, P12772, DOI 10.1074/jbc.R117.776393; Mukherjee R, 2011, BRIT J CANCER, V104, P1920, DOI 10.1038/bjc.2011.163; Park KC, 2020, J BIOL CHEM, V295, P481, DOI 10.1074/jbc.RA119.011341; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; Rodriguez-Berriguete Gonzalo, 2012, J Signal Transduct, V2012, P169170, DOI 10.1155/2012/169170; Sanford M, 2013, DRUGS, V73, P1723, DOI 10.1007/s40265-013-0129-9; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; Saxena P, 2012, PROSTATE, V72, P769, DOI 10.1002/pros.21482; SCHER HI, 2009, J CLIN ONCOL, V27, P5011; Sharma A, 2017, MOL ONCOL, V11, P655, DOI 10.1002/1878-0261.12059; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Tu LC, 2007, MOL CELL PROTEOMICS, V6, P575, DOI 10.1074/mcp.M600249-MCP200; Vander Griend DJ, 2014, INT J BIOL SCI, V10, P627, DOI 10.7150/ijbs.8756; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Wangpu XZ, 2016, MOL PHARMACOL, V89, P521, DOI 10.1124/mol.115.103044; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xi RX, 2017, MOL PHARMACOL, V91, P499, DOI 10.1124/mol.116.107870; Xu YX, 2018, ONCOL LETT, V15, P7999, DOI 10.3892/ol.2018.8279; Yuan HQ, 2010, MOL CELL BIOCHEM, V339, P253, DOI 10.1007/s11010-010-0388-7; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhou ZD, 2010, FREE RADICAL BIO MED, V49, P1856, DOI 10.1016/j.freeradbiomed.2010.09.010	56	14	14	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11511	11528		10.1096/fj.201903167R	http://dx.doi.org/10.1096/fj.201903167R		JUL 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32713076				2022-12-26	WOS:000555979500001
J	Wang, CD; Qi, XF; Zhou, X; Sun, JM; Cai, DQ; Lu, G; Chen, XF; Jiang, ZH; Yao, YG; Chan, WY; Zhao, H				Wang, Chengdong; Qi, Xufeng; Zhou, Xiang; Sun, Jianmin; Cai, Dongqing; Lu, Gang; Chen, Xiongfong; Jiang, Zhihua; Yao, Yong-Gang; Chan, Wai Yee; Zhao, Hui			RNA-Seq analysis on ets1 mutant embryos of Xenopus tropicalis identifies microseminoprotein beta gene 3 as an essential regulator of neural crest migration	FASEB JOURNAL			English	Article						cell migration; Ets1; Msmb3; neural crest	PROSTATE SECRETORY PROTEIN; TRANSCRIPTION FACTOR ETS1; 94 AMINO-ACIDS; BETA-MICROSEMINOPROTEIN; EXPRESSION; GENE; MUTATION; DISEASE; PROTOONCOGENE; ACTIVATION	The proto-oncogeneets1is highly expressed in the pre-migratory and migratory neural crest (NC), and has been implicated in the delamination and migration of the NC cells. To identify the downstream target genes of Ets1 in this process, we did RNA sequencing (RNA-Seq) on wild-type andets1mutantX. tropicalisembryos. A list of genes with significantly differential expression was obtained by analyzing the RNA-Seq data. We validated the RNA-Seq data by quantitative PCR, and examined the expression pattern of the genes identified from this assay with whole mount in situ hybridization. A majority of the identified genes showed expression in migrating NC. Among them, the expression ofmicroseminoprotein beta gene 3(msmb3) was positively regulated by Ets1 in bothX. laevisandX. tropicalis. Knockdown ofmsmb3with antisense morpholino oligonucleotides or disruption ofmsmb3by CRISPR/Cas9 both impaired the migratory streams of NC. Our study identifiedmsmb3as an Ets1 target gene and uncovered its function in maintaining neural crest migration pattern.	[Wang, Chengdong; Lu, Gang; Chan, Wai Yee; Zhao, Hui] Chinese Univ Hong Kong, Fac Med, Minist Educ, Key Lab Regenerat Med,Sch Biomed Sci, Room 620A,LKS Integrated Biomed Sci Bldg, Hong Kong, Peoples R China; [Qi, Xufeng; Cai, Dongqing] Jinan Univ, Dept Dev & Regenerat Biol, Key Lab Regenerat Med, Minist Educ, Guangzhou, Peoples R China; [Zhou, Xiang] Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Sun, Jianmin] Ningxia Med Univ, Sch Basic Med Sci, Dept Pathogen Biol & Immunol, Yinchuan, Ningxia, Peoples R China; [Chen, Xiongfong] NCI, Adv Biomed Comp Ctr, NIH, Frederick, MD 21701 USA; [Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Jiang, Zhihua] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Yao, Yong-Gang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Yao, Yong-Gang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Yao, Yong-Gang; Chan, Wai Yee; Zhao, Hui] Kunming Inst Zool Chinese Univ Hong Kong KIZ CUHK, Hong Kong, Peoples R China; [Chan, Wai Yee; Zhao, Hui] Chinese Univ Hong Kong, Hong Kong Branch, CAS Ctr Excellence Anim Evolut & Genet, Hong Kong, Peoples R China	Chinese University of Hong Kong; Jinan University; Huazhong Agricultural University; Ningxia Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington State University; Washington State University; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong	Zhao, H (corresponding author), Chinese Univ Hong Kong, Fac Med, Minist Educ, Key Lab Regenerat Med,Sch Biomed Sci, Room 620A,LKS Integrated Biomed Sci Bldg, Hong Kong, Peoples R China.	zhaohui@cuhk.edu.hk	Sun, Jianmin/AAX-5094-2021; Yao, Yong-Gang/AAH-2303-2021; Jiang, Zhihua/A-3378-2008; Chan, Wai Yee/R-7442-2018; Chan, Wai-Yee/ABE-3738-2020; Zhao, Hui/B-8429-2016	Sun, Jianmin/0000-0003-2327-4285; Yao, Yong-Gang/0000-0002-2955-0693; Jiang, Zhihua/0000-0003-1986-088X; Chan, Wai Yee/0000-0002-9714-0936; Zhao, Hui/0000-0001-8160-6415; Wang, Chengdong/0000-0001-9891-8765	Ministry of Science and Technology of China [2016YFE0204700]; Research Grants Council, University Grants Committee (RGC, UGC) [14167017, 14112618]; Bureau of International Cooperation, Chinese Academy of Sciences [152453KYSB20170031]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Research Grants Council, University Grants Committee (RGC, UGC); Bureau of International Cooperation, Chinese Academy of Sciences(Chinese Academy of Sciences)	Ministry of Science and Technology of China, Grant/Award Number: 2016YFE0204700; Research Grants Council, University Grants Committee (RGC, UGC), Grant/Award Number: 14167017 and 14112618; Bureau of International Cooperation, Chinese Academy of Sciences, Grant/Award Number: 152453KYSB20170031	Akkers Robert C, 2012, Methods Mol Biol, V917, P279, DOI 10.1007/978-1-61779-992-1_17; Alipov G, 2005, HISTOPATHOLOGY, V46, P202, DOI 10.1111/j.1365-2559.2005.02059.x; Aoki H, 2005, DEV DYNAM, V233, P407, DOI 10.1002/dvdy.20340; Betancur P, 2011, DEVELOPMENT, V138, P3689, DOI 10.1242/dev.057836; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; BLOOM ML, 1994, P NATL ACAD SCI USA, V91, P10099, DOI 10.1073/pnas.91.21.10099; Calmont A, 2009, DEVELOPMENT, V136, P3173, DOI 10.1242/dev.028902; Dai W, 2014, CELL DEATH DIFFER, V21, P568, DOI 10.1038/cdd.2013.177; Dittmer J, 2015, SEMIN CANCER BIOL, V35, P20, DOI 10.1016/j.semcancer.2015.09.010; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Gao ZG, 2010, DEVELOPMENT, V137, P1543, DOI 10.1242/dev.047696; Garde SV, 1999, PROSTATE, V38, P118, DOI 10.1002/(SICI)1097-0045(19990201)38:2<118::AID-PROS5>3.0.CO;2-G; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Girvan AR, 2005, UROLOGY, V65, P719, DOI 10.1016/j.urology.2004.10.058; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hou L, 2004, DEVELOPMENT, V131, P3239, DOI 10.1242/dev.01193; HYAKUTAKE H, 1993, PROSTATE, V22, P347, DOI 10.1002/pros.2990220409; Lee CG, 2012, J IMMUNOL, V188, P2244, DOI 10.4049/jimmunol.1101614; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liao EC, 2000, DEVELOPMENT, V127, P5123; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; LIU AY, 1993, CANCER LETT, V74, P91, DOI 10.1016/0304-3835(93)90049-F; Ma JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.374; Marziali G, 2002, BLOOD CELL MOL DIS, V29, P553, DOI 10.1006/bcmd.2002.0595; Marziali G, 2002, ONCOGENE, V21, P7933, DOI 10.1038/sj.onc.1205925; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; Nam RK, 2006, J UROLOGY, V175, P1291, DOI 10.1016/S0022-5347(05)00695-6; Nie SY, 2015, CARDIOVASC RES, V106, P67, DOI 10.1093/cvr/cvv043; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Osborne NJ, 2005, DEV DYNAM, V232, P939, DOI 10.1002/dvdy.20258; Plouhinec JL, 2014, DEV BIOL, V386, P461, DOI 10.1016/j.ydbio.2013.12.010; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; Saldana-Caboverde A, 2015, DEV BIOL, V407, P300, DOI 10.1016/j.ydbio.2015.04.012; Schachterle W, 2012, DEV BIOL, V361, P439, DOI 10.1016/j.ydbio.2011.10.023; SETH A, 1993, ONCOGENE, V8, P1783; Shaikhibrahim Z, 2011, ONCOL REP, V25, P1125, DOI 10.3892/or.2011.1156; Shi WL, 2015, J BIOL CHEM, V290, P577, DOI 10.1074/jbc.M114.591628; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; Theveneau E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001142; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Wang CD, 2019, ZOOL RES, V40, P102, DOI 10.24272/j.issn.2095-8137.2018.064; Wang CD, 2015, J BIOL CHEM, V290, P21925, DOI 10.1074/jbc.M115.644864; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079975; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841	52	3	3	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12726	12738		10.1096/fj.202000603R	http://dx.doi.org/10.1096/fj.202000603R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32713114	hybrid			2022-12-26	WOS:000556409300001
J	Craig, LS; Hotchkiss, DR; Theall, KP; Cunningham-Myrie, C; Hernandez, JH; Gustat, J				Craig, Leslie S.; Hotchkiss, David R.; Theall, Katherine P.; Cunningham-Myrie, Colette; Hernandez, Julie H.; Gustat, Jeanette			Prevalence and patterns of multimorbidity in the Jamaican population: A comparative analysis of latent variable models	PLOS ONE			English	Article							RISK-FACTORS; NONCOMMUNICABLE DISEASES; OBESITY; HEALTH; BURDEN; BARBADOS	Background Evidence suggests that the single-disease paradigm does not accurately reflect the individual experience, with increasing prevalence of chronic disease multimorbidity, and subtle yet important differences in types of co-occurring diseases. Knowledge of multimorbidity patterns can aid clarification of individual-level burden and needs, to inform prevention and treatment strategies. This study aimed to estimate the prevalence of multimorbidity in Jamaica, identify population subgroups with similar and distinct disease profiles, and examine consistency in patterns identified across statistical techniques. Methods Latent class analysis (LCA) was used to examine multimorbidity patterns in a sample of 2,551 respondents aged 15-74 years, based on data from the nationally representative Jamaica Health and Lifestyle Survey 2007/2008 and self-reported presence/absence of 11 chronic conditions. Secondary analyses compared results with patterns identified using exploratory factor analysis (EFA). Results Nearly one-quarter of the sample (24.1%) were multimorbid (i.e. had >= 2 diseases), with significantly higher burden in females compared to males (31.6% vs. 16.1%; p<0.001). LCA revealed four distinct classes, including a predominant Relatively Healthy class, comprising 52.7% of the sample, with little to no morbidity. The remaining three classes were characterized by varying degrees and patterns of multimorbidity and labelled Metabolic (30.9%), Vascular-Inflammatory (12.2%), and Respiratory (4.2%). Four diseases determined using physical assessments (obesity, hypertension, diabetes, hypercholesterolemia) were primary contributors to multimorbidity patterns overall. EFA identified three patterns described as "Vascular" (hypertension, obesity, hypercholesterolemia, diabetes, stroke); "Respiratory" (asthma, COPD); and "Cardio-Mental-Articular" (cardiovascular disease, arthritis, mental disorders). Conclusion This first study of multimorbidity in the Caribbean has revealed a high burden of co-existing conditions in the Jamaican population, that is predominantly borne by females. Consistency across methods supports the validity of patterns identified. Future research into the causes and consequences of multimorbidity patterns can guide development of clinical and public health strategies that allow for targeted prevention and intervention.	[Craig, Leslie S.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Hotchkiss, David R.; Theall, Katherine P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA; [Cunningham-Myrie, Colette] Univ West Indies, Dept Community Hlth & Psychiat, Mona, Jamaica; [Hernandez, Julie H.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Hlth Policy & Management, New Orleans, LA USA; [Gustat, Jeanette] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA	Tulane University; Tulane University; University West Indies Mona Jamaica; Tulane University; Tulane University	Cunningham-Myrie, C (corresponding author), Univ West Indies, Dept Community Hlth & Psychiat, Mona, Jamaica.	colette.cunninghammyrie@uwimona.edu.jm		Craig, Leslie/0000-0002-2380-7240				Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; [Anonymous], 2015, LCA STAT PLUG VERS 1; [Anonymous], 2016, LCA BOOTSTR STAT FUN; Barile JP, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150179; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Cunningham-Myrie C, 2013, TROP MED INT HEALTH, V18, P1365, DOI 10.1111/tmi.12190; Cunningham-Myrie CA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7247-6; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; Dziak JJ, 2020, BRIEF BIOINFORM, V21, P553, DOI 10.1093/bib/bbz016; Ferguson TS, 2011, W INDIAN MED J, V60, P422; Ferguson TS, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-20; Fernandez MA, 2015, PUBLIC HEALTH NUTR, V18, P3070, DOI 10.1017/S1368980015002190; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Foster Nicole, 2018, Rev Panam Salud Publica, V42, pe191, DOI 10.26633/RPSP.2018.191; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Gellert P, 2019, J AGING HEALTH, V31, P580, DOI 10.1177/0898264317737894; Habib SH, 2010, DIABETES METAB SYND, V4, P41, DOI 10.1016/j.dsx.2008.04.005; Harris A, 2020, ETHNIC RACIAL STUD, V43, P816, DOI 10.1080/01419870.2019.1580379; Hassan S, 2018, OBES SCI PRACT, V4, P367, DOI 10.1002/osp4.280; Haughton D, 2009, AM STAT, V63, P81, DOI 10.1198/tast.2009.0016; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Hospedales CJ, 2011, REV PANAM SALUD PUBL, V30, P393; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Jiwani SS, 2019, LANCET GLOB HEALTH, V7, pE1644, DOI 10.1016/S2214-109X(19)30421-8; Jovic D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148646; Kanguru L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188677; Kuwornu JP, 2014, CHRON DIS INJ CAN, V34, P218; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Lanza ST, 2013, PREV SCI, V14, P157, DOI 10.1007/s11121-011-0201-1; Larsen FB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169426; Mitchell-Fearon K, 2014, W INDIAN MED J, V63, P416, DOI 10.7727/wimj.2014.065; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Olaya B, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0586-1; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Roso-Llorach A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018986; Sobers N, 2019, LANCET CHILD ADOLESC, V3, P445, DOI 10.1016/S2352-4642(19)30149-X; Uebersax J S, 1994, NIDA Res Monogr, V142, P64; Unwin N, 2017, INT J HEALTH POLICY, V6, P71, DOI 10.15171/ijhpm.2016.74; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Whitson HE, 2016, J AM GERIATR SOC, V64, P1668, DOI 10.1111/jgs.14201; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilks R, 2008, TECHNICAL REPORT; Williams B., 2012, AUST J MED SCI, V8, P223; World Health Organization, 2016, MULT TECHN SER SAF P; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127	51	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236034	10.1371/journal.pone.0236034	http://dx.doi.org/10.1371/journal.pone.0236034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32702046	gold, Green Published			2022-12-26	WOS:000575913700041
J	Vajdi, M; Nikniaz, L; Asl, AMP; Farhangi, MA				Vajdi, Mahdi; Nikniaz, Leila; Asl, Asghar Mohammad Pour; Farhangi, Mahdieh Abbasalizad			Lifestyle patterns and their nutritional, socio-demographic and psychological determinants in a community-based study: A mixed approach of latent class and factor analyses	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; HEALTH-RISK-BEHAVIORS; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; UNIVERSITY-STUDENTS; INSULIN-RESISTANCE; NATIONAL-HEALTH; CONSUMPTION; PREVALENCE; SMOKING	Background Lifestyle risk factors, such as unhealthy diet, physical inactivity or tobacco smoking can have detrimental effects on health and well-being. Therefore, it is important to examine multiple lifestyle risk factors instead of single ones. Cluster analysis allows the combination of single health behaviors in order to recognize distinguished behavior patterns. This study aimed to evaluate lifestyle patterns of general adult population in northwest of Iran with particular focus on dietary patterns, physical activity, and smoking status. Methods The current cross-sectional study consists of 525 adults aged 18-64 years from East-Azarbaijan Iran. Latent class analysis (LCA) was applied to recognize patterns of lifestyle behaviors with ingredients of diet, physical activity, and smoking status. Dietary intake was assessed using a validated food frequency questionnaire and dietary patterns were derived using factor analysis. Biochemical parameters including fasting blood sugar (FBS), serum lipids, liver enzyme and serum 25(OH)-D3 were measured with commercial ELIZA kits. Results Mean ages of participants were 42.90 +/- 11.89 years. Using principal component analysis (PCA) three major dietary patterns were extracted including traditional dietary pattern (e.g. nuts and dry fruits), unhealthy dietary pattern (e.g. fast foods, refined grains) and the healthy dietary patterns (e.g. fruits, vegetables). Using LCA, three classes of lifestyles pattern were identified: 1st class was characterized by a healthy dietary pattern, moderate physical activity, and low probability of smoking. 2nd class was characterized by a traditional dietary pattern, low level of physical activity and low probability of smoking and 3rd class was characterized by a unhealthy dietary pattern, low level of physical activity and low probability of smoking and further analysis found that there were significant differences in body mass index (BMI), Waist-to-hip ratio (WHR), FBS, Hemoglobin (Hb), education levels and anxiety status between classes (P<0.05). Conclusion This study attempts to classify Iranian adults by their own health behavior. Healthcare professionals should be aware of associations between different lifestyle risk factors and health promotion strategies should further focus on multiple behaviors at the same time. In our country, more studies about the adult population are needed to support the observed findings of our study and therefore allow for a certain generalization of the observations.	[Vajdi, Mahdi] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran; [Nikniaz, Leila] Tabriz Univ Med Sci, Tabriz Hlth Serv Management Res Ctr, Hlth Management & Safety Promot Res Inst, Tabriz, Iran; [Asl, Asghar Mohammad Pour] Tabriz Univ Med Sci, Fac Hlth, Hlth & Environm Res Ctr, Dept Epidemiol & Biostat, Tabriz, Iran; [Farhangi, Mahdieh Abbasalizad] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Farhangi, MA (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.	abbasalizad_m@yahoo.com	Nikniaz, Leila/M-5747-2017	Nikniaz, Leila/0000-0003-2951-936X; Abbasalizad Farhangi, Mahdieh/0000-0002-7036-6900; Vajdi, Mahdi/0000-0002-2828-1161	Research Undersecretary of Tabriz University of Medical Sciences	Research Undersecretary of Tabriz University of Medical Sciences	The work has been granted by Research Undersecretary of Tabriz University of Medical Sciences (Registration number: IR.TBZMED. REC.1398.07) and is obtained from the M.S thesis of Mahdi Vajdi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarpour S, 2018, CASP J INTERN MED, V9, P268, DOI 10.22088/cjim.9.3.268; Alikhani S, 2009, PUBLIC HEALTH, V123, P358, DOI 10.1016/j.puhe.2009.02.011; Amini M, 2010, NUTRITION, V26, P986, DOI 10.1016/j.nut.2010.03.006; Badedi M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2109542; Beigrezaei S, 2019, INT J PREVENTIVE MED, V10, DOI 10.4103/ijpvm.IJPVM_206_17; BRESLOW L, 1980, PREV MED, V9, P469, DOI 10.1016/0091-7435(80)90042-0; Charreire H, 2011, BRIT J NUTR, V105, P902, DOI 10.1017/S000711451000440X; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018; Collins L.M., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Collins L.M., 2009, LATENT CLASS LATENT, DOI [10.1002/9780470567333, DOI 10.1002/9780470567333]; Denova-Gutierrez E, 2010, PUBLIC HEALTH NUTR, V13, P835, DOI 10.1017/S1368980009991145; Gutierrez-Pliego LE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3527-6; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; EVERITT B, 1980, QUAL QUANT, V14, P75, DOI 10.1007/BF00154794; Farhangi MA, 2016, OBES RES CLIN PRACT, V10, pS64, DOI 10.1016/j.orcp.2015.05.011; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghanbari J, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0607-6; Gillman MW, 2001, PREV MED, V32, P295, DOI 10.1006/pmed.2000.0812; Global Tobacco Surveillance Syst Collaborating Grp, 2005, J SCHOOL HEALTH, V75, P15; Hagenaars Jacques A, 2002, APPL LATENT CLASS AN, DOI [10.1017/CBO9780511499531, DOI 10.1017/CBO9780511499531]; Heroux M, 2012, PREV SCI, V13, P183, DOI 10.1007/s11121-011-0255-0; Huang XJ, 2006, SENSORS-BASEL, V6, P756, DOI 10.3390/s6070756; IPAQ, 2005, GUIDELINES DATA PROC; JIANG YW, 2011, PREV CHRONIC DIS, V8; KESSLER G, 1970, CLIN CHEM, V16, P530; Kim J, 1978, FACTOR ANAL STAT MET; Kwan MY, 2016, HEALTH PROMOT CHRON, V36, P163, DOI 10.24095/hpcdp.36.8.03; Laska MN, 2009, PREV SCI, V10, P376, DOI 10.1007/s11121-009-0140-2; Lawder R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-330; Liao WC, 2011, J AM GERIATR SOC, V59, P200, DOI 10.1111/j.1532-5415.2010.03272.x; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Manz K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051060; Mattei J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5359-z; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; Mohammadpoorasl A, 2013, AM J MENS HEALTH, V7, P475, DOI 10.1177/1557988313483540; Moreno-Gomez C, 2012, PUBLIC HEALTH NUTR, V15, P2131, DOI 10.1017/S1368980012000080; Muff C, 2010, INT J PUBLIC HEALTH, V55, P339, DOI 10.1007/s00038-010-0152-5; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365; Nikniaz L, 2017, SPORT SCI HLTH, V13, P599, DOI [10.1007/s11332-017-0390-5, DOI 10.1007/S11332-017-0390-5]; Nikniaz L, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0455-3; Nikniaz L, 2017, BRIT FOOD J, V119, P1337, DOI 10.1108/BFJ-09-2016-0415; Noble NE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2015-8; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ogasawara H, 2016, J MULTIVARIATE ANAL, V149, P144, DOI 10.1016/j.jmva.2016.04.003; Ogihara T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173540; Ovrum A, 2011, HEALTH ECON, V20, P971, DOI 10.1002/hec.1662; PRATTALA R, 1994, SOC SCI MED, V39, P115, DOI 10.1016/0277-9536(94)90171-6; Proescholdt MG, 2012, FORTSCHR NEUROL PSYC, V80, P441, DOI 10.1055/s-0031-1282018; Rosato NS, 2012, SOC WORK RES, V36, P61, DOI 10.1093/swr/svs006; Sanchez A, 2007, AM J PREV MED, V32, P124, DOI 10.1016/j.amepre.2006.10.012; Schnuerer I, 2015, INT J PUBLIC HEALTH, V60, P111, DOI 10.1007/s00038-014-0623-1; Schulze MB, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2396; Shridhar K, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0327-0; Slattery ML, 2002, MED SCI SPORT EXER, V34, P913, DOI 10.1097/00005768-200206000-00002; Sliwinska-Mosson M, 2017, DIABETES VASC DIS RE, V14, P265, DOI 10.1177/1479164117701876; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stewart J, 2017, JRSM CARDIOVASC DIS, V6, DOI 10.1177/2048004016687211; Suh SY, 2013, J KOREAN MED SCI, V28, P869, DOI 10.3346/jkms.2013.28.6.869; Tabrizi JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165264; Vasheghani-Farahani Ali, 2011, Asian J Sports Med, V2, P106; Walsh EI, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00315; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	68	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236242	10.1371/journal.pone.0236242	http://dx.doi.org/10.1371/journal.pone.0236242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32701986	Green Published, gold			2022-12-26	WOS:000575913700061
J	Kennard, HR; Huebner, GM; Shipworth, D; Oreszczyn, T				Kennard, Harry R.; Huebner, Gesche M.; Shipworth, David; Oreszczyn, Tadj			The associations between thermal variety and health: Implications for space heating energy use	PLOS ONE			English	Article							TEMPERATURE; MORTALITY; ENVIRONMENTS; RHYTHMS; WINTER	Fossil fuels dominate domestic heating in temperate climates. In the EU, domestic space heating accounts for around 20% of final energy demand. Reducing domestic demand temperatures would reduce energy demand. However, cold exposure has been shown to be associated with adverse health conditions. Using an observational dataset of 77,762 UK Biobank participants, we examine the standard deviation of experienced temperature (named herethermal variety) measured by a wrist worn activity and temperature monitor. After controlling for covariates such as age, activity level and obesity, we show that thermal variety is 0.15 degrees C 95% CI [0.07-0.23] higher for participants whose health satisfaction was 'extremely happy' compared to 'extremely unhappy'. Higher thermal variety is also associated with a lower risk of having morbidities related to excess winter deaths. We argue that significant CO(2)savings would be made by increasing thermal variety and reducing domestic demand temperatures in the healthiest homes. However, great care is needed to avoid secondary health impacts due to mould and damp. Vulnerable households should receive increased attention.	[Kennard, Harry R.; Huebner, Gesche M.; Shipworth, David; Oreszczyn, Tadj] UCL, Energy Inst, London, England	University of London; University College London	Kennard, HR (corresponding author), UCL, Energy Inst, London, England.	h.kennard@ucl.ac.uk		Kennard, Harry/0000-0002-4542-0768; Huebner, Gesche/0000-0002-1304-4366	Engineering and Physical Sciences Research Council Centre for Doctoral Training in Energy Demand (LoLo) [EP/L01517X/1, EP/H009612/1]; UK Research and Innovation through the Centre for Research into Energy Demand Solutions [EP/R 035288/1]; Research Councils UK Centre for Energy Epidemiology [EP/K011839]; EPSRC [EP/R035288/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council Centre for Doctoral Training in Energy Demand (LoLo); UK Research and Innovation through the Centre for Research into Energy Demand Solutions; Research Councils UK Centre for Energy Epidemiology; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	HRK: Engineering and Physical Sciences Research Council Centre for Doctoral Training in Energy Demand (LoLo), grant numbers EP/L01517X/1 and EP/H009612/1. http://www.lolo.ac.uk/GMH and HRK: UK Research and Innovation through the Centre for Research into Energy Demand Solutions, grant reference number EP/R 035288/1 https://www.creds.ac.uk/GMH and HRK: Research Councils UK Centre for Energy Epidemiology EP/K011839 https://gow.epsrc.ukri.org/NGBOViewGrant.aspx?GrantRef=EP/K011839/1 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, AX3 DAT SHEET; Brager G, 2015, BUILD RES INF, V43, P274, DOI 10.1080/09613218.2015.993536; Cambridge Architectural Research, 2012, MUCH EN COULD BE SAV; Corbalan-Tutau MD, 2011, CHRONOBIOL INT, V28, P425, DOI 10.3109/07420528.2011.574766; Deller D, 2018, ENERG POLICY, V119, P168, DOI 10.1016/j.enpol.2018.03.033; Doherty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169649; European Commission, 2016, SWD, V24, P1; Global Modeling and Assimilation Office (GMAO), 2016, 9 GMAO; Global Modeling and Assimilation Office (GMAO), 2015, INST1 2D ASM NX MERR, DOI [10.5067/3Z173KIE2TPD, DOI 10.5067/3Z173KIE2TPD]; Hatfield CF, 2004, BRAIN, V127, P1061, DOI 10.1093/brain/awh129; Hellwig RT, 2015, BUILD RES INF, V43, P302, DOI 10.1080/09613218.2015.1004150; Huebner GM, 2015, BUILD RES INF, V43, P185, DOI 10.1080/09613218.2014.922339; Jang T, 2017, ISSCC DIG TECH PAP I, P148, DOI 10.1109/ISSCC.2017.7870304; Jevons R, 2016, PUBLIC HEALTH, V136, P4, DOI 10.1016/j.puhe.2016.02.007; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; Kennard HR, 2019, J PUBLIC HEALTH-UK, V41, P870, DOI 10.1093/pubmed/fdz073; Kennard H.R, 2018, PREANALYSIS PLAN EXP; Lee J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43167-w; Lesna IK, 2015, J THERM BIOL, V52, P192, DOI 10.1016/j.jtherbio.2015.07.007; Lichtenbelta WV, 2017, BUILD RES INF, V45, P819, DOI 10.1080/09613218.2017.1307647; Office of National Statistics, 2018, EXC WINT MORT ENGL W; Parkinson T, 2015, BUILD RES INF, V43, P288, DOI 10.1080/09613218.2015.989662; Powells G, 2019, ENERGY RES SOC SCI, V54, P56, DOI 10.1016/j.erss.2019.03.015; Saltykova M.M., 2018, NEUROSCI BEHAV PHYSI, V48, P543, DOI [10.1007/s11055-018-0597-1, DOI 10.1007/S11055-018-0597-1]; Shahzad S, 2020, J SUSTAIN DEV ENERGY, V8, P373, DOI 10.13044/j.sdewes.d7.0298; Song XP, 2017, SCI TOTAL ENVIRON, V586, P241, DOI 10.1016/j.scitotenv.2017.01.212; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; US Energy Information, 2012, ANN EN REV 2011 TABL; Zhang H, 2015, BUILD ENVIRON, V91, P15, DOI 10.1016/j.buildenv.2015.03.013	30	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236116	10.1371/journal.pone.0236116	http://dx.doi.org/10.1371/journal.pone.0236116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697777	Green Published, gold			2022-12-26	WOS:000555392700008
J	Pereira, FM; Almeida, MDCD; Santos, FLN; Carreiro, RP; Galvao-Castro, B; Grassi, MFR				Pereira, Felicidade Mota; Almeida, Maria da Conceicao Chagas de; Santos, Fred Luciano Neves; Carreiro, Roberto Perez; Galvao-Castro, Bernardo; Grassi, Maria Fernanda Rios			Distribution of Human T-Lymphotropic Virus (HTLV) and Hepatitis C Co-infection in Bahia, Brazil	PLOS ONE			English	Article							TYPE-1 COINFECTION; INFECTED PATIENTS; BLOOD-DONORS; HCV; PREVALENCE; HIV; TRANSMISSION; RISK; HBV; POPULATION	Both Human T-lymphotropic virus type 1 (HTLV-1) and hepatitis C virus (HCV) are endemic in Brazil. In Salvador, the capital of the state of Bahia, 2% and 1.5% of the general population is infected with HTLV-1 or HCV. This study aimed to estimate the prevalence and the distribution of HTLV/HCV coinfection in Bahia. This cross-sectional study was conducted at the Central Laboratory of Public Health for the state of Bahia (LACEN-BA). All samples in the LACEN database submitted to serological testing for anti-HCV (chemiluminescence) and anti-HTLV-1/2 (chemiluminescence/ELISA and Western blot) from 2004 to 2013 were included. Infection rate was expressed as the number of infected individuals per 100,000 inhabitants in a given municipality; municipalities were grouped by microregion for further analysis. A total of 120,192 samples originating from 358 of the 417 municipalities in Bahia (85.8%) were evaluated. The overall HCV coinfection rate in HTLV-positive was 14.31% [2.8 (ranging from 0.4 to 8.0) per 100,000 inhabitants.] Twenty-one (5%) of the municipalities reported at least one case of HTLV/HCV coinfection. Most cases (87%) were concentrated in three microregions (Salvador: 79%, Ilheus/Itabuna: 5%, Porto Seguro: 3%). Coinfection occurred more frequently in males (51%) with a mean age of 59 [(IQR): 46-59] years. HTLV/HCV coinfection in the state of Bahia was more frequently found among males living in the microregions of Salvador, Ilheus/Itabuna and Porto Seguro, all of which are known to be endemic for HTLV infection.	[Pereira, Felicidade Mota; Santos, Fred Luciano Neves; Galvao-Castro, Bernardo; Grassi, Maria Fernanda Rios] FIOCRUZ BA, Goncalo Moniz Inst, Adv Publ Hlth Lab, Salvador, BA, Brazil; [Pereira, Felicidade Mota] LACEN, Goncalo Moniz Publ Hlth Cent Lab, Salvador, BA, Brazil; [Almeida, Maria da Conceicao Chagas de] FIOCRUZ BA, Goncalo Moniz Inst, Mol Epidemiol & Biostat Lab, Salvador, BA, Brazil; [Carreiro, Roberto Perez] FIOCRUZ BA, Goncalo Moniz Inst, CIDACS, Ctr Integrat Data & Hlth Knowledge, Salvador, BA, Brazil; [Galvao-Castro, Bernardo; Grassi, Maria Fernanda Rios] EBMSP, Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Grassi, MFR (corresponding author), FIOCRUZ BA, Goncalo Moniz Inst, Adv Publ Hlth Lab, Salvador, BA, Brazil.; Grassi, MFR (corresponding author), EBMSP, Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil.	fernanda.grassi@fiocruz.br	SANTOS, Fred/S-2954-2019; Grassi, Fernanda/X-7360-2019; Carreiro, Roberto/E-6303-2012	SANTOS, Fred/0000-0002-3944-0818; Grassi, Fernanda/0000-0002-7356-5569; Carreiro, Roberto/0000-0002-0356-0076	Coordination of Superior Level Staff Improvement-Brazil (CAPES) [001]; National Foundation for the Development of Private Higher Education (FUNADESP) [9600140, 9600141]	Coordination of Superior Level Staff Improvement-Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Foundation for the Development of Private Higher Education (FUNADESP)	This work was supported by the Coordination of Superior Level Staff Improvement-Brazil (CAPES) -Finance Code 001 and National Foundation for the Development of Private Higher Education (FUNADESP), grants 9600140 and 9600141. Maria Fernanda R. Grassi and Bernardo Galvao-Castro are research fellows of CNPq (process no. 304811/2017-3 and 311054/2014-5, respectively).	Abad-Fernandez M, 2015, AIDS, V29, P401, DOI 10.1097/QAD.0000000000000555; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Bahia F, 2011, JAIDS-J ACQ IMM DEF, V57, pS202, DOI 10.1097/QAI.0b013e31821e9a1e; Bittencourt AL, 2001, J ACQ IMMUN DEF SYND, V26, P490, DOI 10.1097/00126334-200104150-00016; Boschi-Pinto C, 2000, J INFECT DIS, V181, P35, DOI 10.1086/315177; Brito VD, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00961-18; Cardoso DF, 2009, REV INST MED TROP SP, V51, P325, DOI 10.1590/S0036-46652009000600003; Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027; Caterino-De-Araujo A, 2018, MEM I OSWALDO CRUZ, V113, P130, DOI 10.1590/0074-02760170307; Caterino-de-Araujo A, 2015, AIDS RES HUM RETROV, V31, P543, DOI [10.1089/aid.2014.0287, 10.1089/AID.2014.0287]; de la Fuente L, 2006, J CLIN VIROL, V35, P244, DOI 10.1016/j.jcv.2005.06.006; Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013; Espindola OM, 2017, INT J INFECT DIS, V57, P116, DOI 10.1016/j.ijid.2017.01.037; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Hayashi J., 1994, J EPIDEMIOL, V4, P17, DOI [10.2188/jea.4.17, DOI 10.2188/JEA.4.17]; Hisada M, 2003, J INFECT DIS, V188, P891, DOI 10.1086/377585; ISHAK R, 1995, AIDS RES HUM RETROV, V11, P813, DOI 10.1089/aid.1995.11.813; KAMIHIRA S, 1991, JPN J MED, V30, P492; Kishihara Y, 2001, J INFECT DIS, V184, P1114, DOI 10.1086/323890; Kucharska M, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.35658; Le Marchand C, 2015, BRAZ J INFECT DIS, V19, P486, DOI 10.1016/j.bjid.2015.06.007; Li HC, 2004, J INFECT DIS, V190, P1275, DOI 10.1086/423941; Maciel AM, 2015, ARCH CLIN MICROBIOL, V6, P1; MANNS A, 1992, INT J CANCER, V51, P886, DOI 10.1002/ijc.2910510609; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Ministerio da Saude do Brasil, 2018, B EP HEP VIR; Moreira M, 2013, BRAZ J INFECT DIS, V17, P661, DOI 10.1016/j.bjid.2013.04.009; Naz A, 2018, PAK J MED SCI, V34, P1204, DOI 10.12669/pjms.345.15707; Nunes D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171303; Oliveira AB, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-38; Milagres FAP, 2009, REV SOC BRAS MED TRO, V42, P363, DOI 10.1590/S0037-86822009000400001; Pereira FM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01002; Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60; Petruzziello A, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0099-0; Pinto MT, 2012, REV INST MED TROP SP, V54, P123, DOI 10.1590/S0036-46652012000300002; Prasetyo AA, 2013, J INFECT DEV COUNTR, V7, P453, DOI 10.3855/jidc.2965; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; Ramos JM, 2012, J CLIN VIROL, V53, P268, DOI 10.1016/j.jcv.2011.12.004; Silva MC, 2016, J MED VIROL, V88, P1967, DOI 10.1002/jmv.24538; SULLIVAN MT, 1991, ARCH INTERN MED, V151, P2043, DOI 10.1001/archinte.151.10.2043; Terrault NA, 2002, HEPATOLOGY, V36, pS99, DOI 10.1053/jhep.2002.36797; Tokunaga M, 2014, J GASTROENTEROL, V49, P1567, DOI 10.1007/s00535-013-0928-5; Vallejo A, 2015, J CLIN VIROL, V64, P72, DOI 10.1016/j.jcv.2015.01.010; Zarife MAS, 2006, T ROY SOC TROP MED H, V100, P663, DOI 10.1016/j.trstmh.2005.09.009; Ziaee M, 2015, PAK J MED SCI, V31, P1246, DOI 10.12669/pjms.315.7888	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0223087	10.1371/journal.pone.0223087	http://dx.doi.org/10.1371/journal.pone.0223087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692782	Green Published, Green Submitted, gold			2022-12-26	WOS:000554606400014
J	Son, KY; Kim, SH; Sunwoo, S; Lee, JY; Lim, S; Kim, YS				Son, Ki Young; Kim, Seung Hee; Sunwoo, Sung; Lee, Ji-Yun; Lim, Seongmi; Kim, Young Sik			Association between disability and cardiovascular event and mortality: A nationwide representative longitudinal study in Korea	PLOS ONE			English	Article							BODY-MASS INDEX; HANDGRIP STRENGTH; PHYSICAL PERFORMANCE; HEALTH DISPARITIES; WOMEN; BEHAVIORS; ADULTS; PATTERNS; RISK; MEN	This study aimed to examine the association between disability and cardiovascular (CV) disease incidence and mortality in Korea longitudinally, using a national representative sample. We used the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) database, which includes information on the disability of the National Screening Program participants such as severity and type of disability, which were obtained from the Korean National Disability Registry. Cox proportional hazard models were used to evaluate the association between disability and CV disease incidence and mortality. We constructed four models with different levels of adjustment, in which Model 3 was a fully adjusted model. This study included 514,679 participants, and 7,317 CV deaths were reported within a mean follow up of 10.8 +/- 3.9 years (maximum, 13.9 years). For 5,572,130 person-year (PY) follow-up, the CV mortality rate was 1.313 per 1,000 PY. In Models 1 and 2, CV disease incidence was significantly higher in participants with disability than in those without disability. In Model 3, the incidence was higher only among participants aged 50-64 years and severe disabled participants aged <50 years. CV mortality was significantly higher in participants with disability than in those without disability in all Models, and the mortality increased in both sexes in Models 1 and 2 but only increased in men in Model 3. Similar results were observed in the subgroup analysis of health behavior and chronic diseases. People with disability showed higher CV disease incidence and mortality than those without disability, regardless of the type of disability or risk factors for CV disease.	[Son, Ki Young; Kim, Seung Hee; Sunwoo, Sung; Lee, Ji-Yun; Kim, Young Sik] Univ Ulsan, Asan Med Ctr, Dept Family Med, Coll Med, Seoul, South Korea; [Lim, Seongmi] Chung Ang Univ, Coll Nursing, Seoul, South Korea	University of Ulsan; Asan Medical Center; Chung Ang University	Kim, YS (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Family Med, Coll Med, Seoul, South Korea.	youngkim@amc.seoul.kr		Lim, Seongmi/0000-0001-5481-434X; Kim, Young Sik/0000-0002-1786-4273; Son, Ki Young/0000-0003-1262-100X	Rehabilitation Research & Development Support Program [NRC RSP-2019002]; National Rehabilitation Center, Ministry of Health and Welfare, Korea	Rehabilitation Research & Development Support Program; National Rehabilitation Center, Ministry of Health and Welfare, Korea	This study was supported by the Rehabilitation Research & Development Support Program (#NRC RSP-2019002), National Rehabilitation Center, Ministry of Health and Welfare, Korea. YSK received the grant. URL of funder is following: http://www.nrc.go.kr/eng/main.do The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; Becker H, 2008, PUBLIC HEALTH NURS, V25, P526, DOI 10.1111/j.1525-1446.2008.00739.x; Bertoli S, 2006, NUTR METAB CARDIOVAS, V16, P100, DOI 10.1016/j.numecd.2005.05.007; Blaum CS, 2005, DIABETIC MED, V22, P543, DOI 10.1111/j.1464-5491.2005.01457.x; Brawarsky P, 2002, TOB CONTROL, V11, pII29; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P853; Chainani V, 2016, INT J CARDIOL, V215, P487, DOI 10.1016/j.ijcard.2016.04.068; Cooper R, 2008, MENOPAUSE, V15, P1079, DOI 10.1097/gme.0b013e31816f63a3; Diab ME, 2004, ARCH PHYS MED REHAB, V85, P749, DOI 10.1016/j.apmr.2003.06.028; Drum C., 2005, CALIFORNIAN J HLTH P, V3, P29, DOI 10.32398/cjhp.v3i3.647; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Havercamp SM, 2004, PUBLIC HEALTH REP, V119, P418, DOI 10.1016/j.phr.2004.05.006; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; Jones GC, 2004, FAM COMMUNITY HEALTH, V27, P22, DOI 10.1097/00003727-200401000-00004; Jones GC, 2008, DISABIL REHABIL, V30, P901, DOI 10.1080/09638280701800392; Kattainen A, 2004, J CLIN EPIDEMIOL, V57, P513, DOI 10.1016/j.jclinepi.2003.10.004; Ko KD, 2011, ARCH PHYS MED REHAB, V92, P1230, DOI 10.1016/j.apmr.2011.03.004; Landi F, 2010, J CLIN EPIDEMIOL, V63, P752, DOI 10.1016/j.jclinepi.2009.09.007; Lawthers AG, 2003, INT J QUAL HEALTH C, V15, P287, DOI 10.1093/intqhc/mzg048; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Mansson NO, 1996, INT J EPIDEMIOL, V25, P80, DOI 10.1093/ije/25.1.80; National Institute on Alcohol Abuse Alcoholism, 2007, HELP PAT WHO DRINK T; National Rehabilitation Center, 2018, 2016 STAT DIS HLTH; Nosek MA, 1997, ARCH PHYS MED REHAB, V78, pS39, DOI 10.1016/S0003-9993(97)90220-3; Orwoll E, 2006, ARCH INTERN MED, V166, P2124, DOI 10.1001/archinte.166.19.2124; Ramirez A, 2005, AM J PUBLIC HEALTH, V95, P2057, DOI 10.2105/AJPH.2005.066118; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rimmer JH, 1999, MED SCI SPORT EXER, V31, P613, DOI 10.1097/00005768-199904000-00020; Ruige JB, 2011, HEART, V97, P870, DOI 10.1136/hrt.2010.210757; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Shin DW, 2016, JAMA INTERN MED, V176, P138, DOI 10.1001/jamainternmed.2015.7110; Smith EM, 2009, ARCH PHYS MED REHAB, V90, P1127, DOI 10.1016/j.apmr.2008.09.578; WHO, 2001, INT CLASS FUNCT DIS	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236665	10.1371/journal.pone.0236665	http://dx.doi.org/10.1371/journal.pone.0236665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730313	Green Published, gold			2022-12-26	WOS:000556884700072
J	Salama, II; Sami, SM; Abdellatif, GA; Mohsen, A; Rasmy, H; Kamel, SA; Ibrahim, MH; Mostafa, M; Fouad, WA; Raslan, HM				Salama, Iman I.; Sami, Samia M.; Abdellatif, Ghada A.; Mohsen, Amira; Rasmy, Hanaa; Kamel, Solaf Ahmed; Ibrahim, Mona Hamed; Mostafa, Mona; Fouad, Walaa A.; Raslan, Hala M.			Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; RISK-FACTORS; EXPRESSION; MEMORY; BRAIN; ASSOCIATION; PATHWAY; OBESITY	Objectives To assess the potential value of some miRNAs as diagnostic biomarkers for mild cognitive impairment (MCI) among patients with type2 diabetes mellitus (T2DM) and to identify other risk factors for MCI among them. Methods This study enrolled 163 adults with T2DM using face to face interview. Cognitive function with its domains was assessed using Adenbrooke's Cognitive Examination III (ACE III). Lipid profile, glycated hemoglobin, and miR-128, miR-132, miR- 874, miR-134, miR-323, and miR-382 expressions, using quantitative real-time PCR, were assessed. Results MCI was detected among 59/163 (36.2%) patients with T2DM. Plasma expression of miR-132 was significantly higher in T2DM patients with MCI compared to those without MCI and to normal cognitive healthy individuals (median = 2, 1.1 and 1.2 respectively, P < 0.05. Logistic regression analysis showed that higher miR-132 expression with adjusted odds ratio (AOR): 1.2 (95% CI 1.0-1.3), female gender (AOR:2.1; 95%CI 1.0-4.3), education below postgraduate (secondary and university education with AOR: 9.5 & 19.4 respectively) were the significant predicting factors for MCI among T2DM patients. Using ROC curve, miR-132 was the only assayed miRNA that significantly differentiates T2DM patients with MCI from those with normal cognition with 72.3% sensitivity, 56.2% specificity, and 63.8% accuracy (P < 0.05). Other studied miRNAs showed lower sensitivity and specificity for detecting MCI among studied T2DM participants. Conclusion MCI affects nearly one-third of adult patients with T2DM. A significantly over expression of miR-132 was detected among T2DM with MCI compared to those with normal cognition.	[Salama, Iman I.; Abdellatif, Ghada A.; Mohsen, Amira; Fouad, Walaa A.] Natl Res Ctr, Dept Community Med, Cairo, Egypt; [Sami, Samia M.] Natl Res Ctr, Dept Child Hlth, Cairo, Egypt; [Rasmy, Hanaa; Kamel, Solaf Ahmed; Ibrahim, Mona Hamed] Natl Res Ctr, Ctr Excellence, Clin & Chem Pathol Dept, Cairo, Egypt; [Mostafa, Mona; Raslan, Hala M.] Natl Res Ctr, Dept Internal Med, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Salama, II (corresponding author), Natl Res Ctr, Dept Community Med, Cairo, Egypt.	salamaiman@yahoo.com	Salama, Iman/S-2199-2019; Attia, Hanaa/GRO-5659-2022; Raslan, Hala/ABH-7956-2020; Elshaarawy, Ghada Abdrabo/AFM-0565-2022; Elshaarawy, Ghada Abdrabo/AAH-2968-2022	Salama, Iman/0000-0001-8901-4625; Attia, Hanaa/0000-0001-6401-8849; Elshaarawy, Ghada Abdrabo/0000-0001-7165-0594; Elshaarawy, Ghada Abdrabo/0000-0001-7165-0594; Sami, Samia/0000-0003-1832-2932; Kamel, Solaf Ahmed/0000-0002-9342-3672	Science and Technology Development Fund (STDF), Egypt [15026]; STDF [4880]	Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF)); STDF(Science and Technology Development Fund (STDF))	This project is supported financially by the Science and Technology Development Fund (STDF), Egypt, Grant No: 15026, PI: Iman I Salama. STDF Grant No 4880 for capacity building for laboratory Equipment, PI: Hanaa Rasmy. Website: http://stdf.eg/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif G. A., 2020, Open Access Macedonian Journal of Medical Sciences, V8, P105, DOI 10.3889/oamjms.2020.4245; Albai O, 2019, NEUROPSYCH DIS TREAT, V15, P167, DOI 10.2147/NDT.S189905; Angelucci F, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00665; Baby N, 2020, AGING CELL, V19, DOI 10.1111/acel.13046; Bekris LM, 2013, BIOMARKERS, V18, P455, DOI 10.3109/1354750X.2013.814073; Belongie KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182932; Biessels GJ, 2018, NAT REV ENDOCRINOL, V14, P591, DOI 10.1038/s41574-018-0048-7; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Butte NF, 2015, AM J CLIN NUTR, V102, P256, DOI 10.3945/ajcn.115.111872; Caracciolo L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04445-9; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Curb JD, 1999, NEUROLOGY, V52, P971, DOI 10.1212/WNL.52.5.971; Ebady SA, 2008, DIABETES RES CLIN PR, V82, P305, DOI 10.1016/j.diabres.2008.08.020; El Fatimy R, 2018, ACTA NEUROPATHOL, V136, P537, DOI 10.1007/s00401-018-1880-5; Feinkohl I, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0130-5; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gao YX, 2015, DIABETES RES CLIN PR, V109, P299, DOI 10.1016/j.diabres.2015.05.019; Geng LJ, 2018, YONSEI MED J, V59, P1096, DOI 10.3349/ymj.2018.59.9.1096; Hansen KF, 2016, LEARN MEMORY, V23, P61, DOI 10.1101/lm.039578.115; Hansen KF, 2013, BRAIN STRUCT FUNCT, V218, P817, DOI 10.1007/s00429-012-0431-4; Iacomino G, 2019, GENES NUTR, V14, DOI 10.1186/s12263-018-0622-6; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Li JQ, 2016, J NEUROL NEUROSUR PS, V87, P476, DOI 10.1136/jnnp-2014-310095; Moradifard S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20959-0; Mukhin VN., 2017, NEUROSCI BEHAV PHYS, V47, P508, DOI [10.1007/s11055-017-0427-x, DOI 10.1007/S11055-017-0427-X]; Muller M, 2014, NEUROBIOL AGING, V35, P152, DOI 10.1016/j.neurobiolaging.2013.07.005; Noone P, 2015, OCCUP MED-OXFORD, V65, P418, DOI 10.1093/occmed/kqv041; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Ojo O, 2015, INT J ENV RES PUB HE, V12, P8281, DOI 10.3390/ijerph120708281; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Pichler S, 2017, NEUROBIOL AGING, V50, DOI 10.1016/j.neurobiolaging.2016.09.019; Piscopo P, 2019, AGEING RES REV, V50, P131, DOI 10.1016/j.arr.2018.11.005; Piscopo P, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00017; Qian Y, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00770; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Rani A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00323; Roberts RO, 2014, J NUCL MED, V55, P759, DOI 10.2967/jnumed.113.132647; Saab BJ, 2014, NEUROPHARMACOLOGY, V80, P61, DOI 10.1016/j.neuropharm.2014.01.026; Salama Iman I, 2019, Open Access Maced J Med Sci, V7, P3253, DOI 10.3889/oamjms.2019.834; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sheinerman KS, 2013, AGING-US, V5, P925, DOI 10.18632/aging.100624; Sheinerman KS, 2012, AGING-US, V4, P590, DOI 10.18632/aging.100486; Son SM, 2016, AUTOPHAGY, V12, P784, DOI 10.1080/15548627.2016.1159375; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Williamson JD, 2014, JAMA INTERN MED, V174, P324, DOI 10.1001/jamainternmed.2013.13656; Wu HZY, 2016, J ALZHEIMERS DIS, V49, P755, DOI 10.3233/JAD-150619; Xie B, 2015, J ALZHEIMERS DIS, V45, P721, DOI 10.3233/JAD-142847; Xu T, 2014, EXPERT OPIN THER TAR, V18, P153, DOI 10.1517/14728222.2014.855201; Yuan XY, 2017, REV NEUROSCIENCE, V28, P715, DOI 10.1515/revneuro-2017-0016; Zhang Q, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/862473; Zhou M, 2018, MOL NEUROBIOL, V55, P917, DOI 10.1007/s12035-016-0365-6	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236453	10.1371/journal.pone.0236453	http://dx.doi.org/10.1371/journal.pone.0236453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726329	Green Published, gold			2022-12-26	WOS:000556908900007
J	Shkarin, R; Shkarina, S; Weinhardt, V; Surmenev, RA; Surmeneva, MA; Shkarin, A; Baumbach, T; Mikut, R				Shkarin, Roman; Shkarina, Svetlana; Weinhardt, Venera; Surmenev, Roman A.; Surmeneva, Maria A.; Shkarin, Andrei; Baumbach, Tilo; Mikut, Ralf			GPU-accelerated ray-casting for 3D fiber orientation analysis	PLOS ONE			English	Article							AUTOMATED MEASUREMENT; FOURIER-ANALYSIS; ALIGNMENT; COMPOSITES; QUANTIFICATION; ORGANIZATION; TOMOGRAPHY; MORPHOLOGY; ALGORITHM; MODELS	Orientation analysis of fibers is widely applied in the fields of medical, material and life sciences. The orientation information allows predicting properties and behavior of materials to validate and guide a fabrication process of materials with controlled fiber orientation. Meanwhile, development of detector systems for high-resolution non-invasive 3D imaging techniques led to a significant increase in the amount of generated data per a sample up to dozens of gigabytes. Though plenty of 3D orientation estimation algorithms were developed in recent years, neither of them can process large datasets in a reasonable amount of time. This fact complicates the further analysis and makes impossible fast feedback to adjust fabrication parameters. In this work, we present a new method for quantifying the 3D orientation of fibers. The GPU implementation of the proposed method surpasses another popular method for 3D orientation analysis regarding accuracy and speed. The validation of both methods was performed on a synthetic dataset with varying parameters of fibers. Moreover, the proposed method was applied to perform orientation analysis of scaffolds with different fibrous micro-architecture studied with the synchrotron mu CT imaging setup. Each acquired dataset of size 600x600x450 voxels was analyzed in less 2 minutes using standard PC equipped with a single GPU.	[Shkarin, Roman; Weinhardt, Venera; Shkarin, Andrei; Baumbach, Tilo] Karlsruhe Inst Technol, Lab Applicat Synchrotron Radiat, Karlsruhe, Germany; [Shkarin, Roman; Mikut, Ralf] Karlsruhe Inst Technol, Inst Automat & Appl Comp Sci, Karlsruhe, Germany; [Shkarina, Svetlana; Surmenev, Roman A.; Surmeneva, Maria A.] Natl Res Tomsk Polytech Univ, Res Sch Chem & Appl Biomed Sci, Phys Mat Sci & Composite Mat Ctr, Tomsk, Russia; [Shkarina, Svetlana; Weinhardt, Venera; Baumbach, Tilo] Karlsruhe Inst Technol, Inst Photon Sci & Synchrotron Radiat, Eggenstein Leopoldshafen, Germany; [Weinhardt, Venera] Heidelberg Univ, Ctr Organismal Studies, COS, Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Tomsk Polytechnic University; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg	Shkarin, R (corresponding author), Karlsruhe Inst Technol, Lab Applicat Synchrotron Radiat, Karlsruhe, Germany.; Shkarin, R (corresponding author), Karlsruhe Inst Technol, Inst Automat & Appl Comp Sci, Karlsruhe, Germany.	roman.v.shkarin@gmail.com	Mikut, Ralf/A-5949-2013; Surmenev, Roman/A-2492-2014; Weinhardt, Venera/T-3932-2017	Mikut, Ralf/0000-0001-9100-5496; Surmenev, Roman/0000-0002-8061-3047; Weinhardt, Venera/0000-0002-9774-3833	German States by Karlsruhe House of Young Scientists (KHYS); German Research foundation [WE6221/1-1]; German Ministry of Education and Research BMBF [05K16VH1, 05K12VH1]; Heidelberg Karlsruhe Research Partnership initiative (HEiKA)	German States by Karlsruhe House of Young Scientists (KHYS); German Research foundation(German Research Foundation (DFG)); German Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); Heidelberg Karlsruhe Research Partnership initiative (HEiKA)	The author R.S. was financed by Graduate Funding from the German States provided by Karlsruhe House of Young Scientists (KHYS), V.W. was funded by German Research foundation WE6221/1-1, S.S. was partially supported by German Ministry of Education and Research BMBF 05K16VH1. The work was funded by the German Ministry of Education and Research BMBF 05K12VH1, and the Heidelberg Karlsruhe Research Partnership initiative (HEiKA).	Abadi Martin, 2016, ABS160508695 CORR, V16, P265, DOI DOI 10.5555/3026877.3026899; Abdin Y, 2014, COMPOS PART A-APPL S, V67, P171, DOI 10.1016/j.compositesa.2014.08.025; Abu Anas EM, 2010, PHYS MED BIOL, V55, P6911, DOI 10.1088/0031-9155/55/22/020; Altendorf H, 2012, J MICROSC-OXFORD, V247, P161, DOI 10.1111/j.1365-2818.2012.03629.x; Altendorf H., 2009, IMAGE ANAL STEREOL, V28, P143, DOI DOI 10.5566/IAS.V28.P143-153; Ayres CE, 2008, J BIOMAT SCI-POLYM E, V19, P603, DOI 10.1163/156856208784089643; Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626; Blanc R, 2006, COMPOS PART A-APPL S, V37, P197, DOI 10.1016/j.compositesa.2005.04.021; CABRAL B, 1994, P 1994 S VOL VIS, P91, DOI DOI 10.1145/197938.197972; Choong LT, 2015, J MATER SCI, V50, P3014, DOI 10.1007/s10853-015-8834-2; D'Amore A, 2010, BIOMATERIALS, V31, P5345, DOI 10.1016/j.biomaterials.2010.03.052; Eberhardt C, 2001, COMPOS SCI TECHNOL, V61, P1389, DOI 10.1016/S0266-3538(01)00038-0; Eckert CE, 2011, ANN BIOMED ENG, V39, P205, DOI 10.1007/s10439-010-0162-8; Emerson MJ, 2017, COMPOS PART A-APPL S, V97, P83, DOI 10.1016/j.compositesa.2016.12.028; Fung DT, 2010, ANN BIOMED ENG, V38, P1741, DOI 10.1007/s10439-010-9976-7; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P9684, DOI 10.1167/iovs.11-7894; Gorodzha SN, 2015, IOP CONF SER-MAT SCI, V98, DOI 10.1088/1757-899X/98/1/012024; Johnson WS, 1996, J COMPOS TECH RES, V18, P1, DOI 10.1520/CTR10459J; Kak AC., 2001, PRINCIPLES COMPUTERI, P275, DOI DOI 10.1137/1.9780898719277.CH7; Karlon WJ, 1998, ANAT RECORD, V252, P612, DOI 10.1002/(SICI)1097-0185(199812)252:4<612::AID-AR12>3.0.CO;2-1; Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226; Kastner J, 2015, ADV COMPUT VIS PATT, P227, DOI 10.1007/978-1-4471-6741-9_8; Lam S.K., 2015, P 2 WORKSHOP LLVM CO, P1, DOI [10.1145/2833157.2833162, DOI 10.1145/2833157.2833162]; Lau TY, 2012, OPT EXPRESS, V20, P21821, DOI 10.1364/OE.20.021821; Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lee YH, 2002, MATER RES INNOV, V6, P65, DOI 10.1007/s10019-002-0180-8; Lins LC, 2017, J BIOMED MATER RES B, V105, P2376, DOI 10.1002/jbm.b.33778; Liu ZY, 2017, BIOMATERIALS, V116, P34, DOI 10.1016/j.biomaterials.2016.11.041; Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003; Miettinen A, 2015, COMPOS PART A-APPL S, V77, P188, DOI 10.1016/j.compositesa.2015.07.005; Munch B, 2009, EMPA ACTIVITIES, V17, P34, DOI DOI 10.1364/0E.17.008567; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Orlova Y, 2011, BIOMATERIALS, V32, P5615, DOI 10.1016/j.biomaterials.2011.04.042; Palagyi K, 1998, PATTERN RECOGN LETT, V19, P613, DOI 10.1016/S0167-8655(98)00031-2; Paten JA, 2013, BIOMATERIALS, V34, P2577, DOI 10.1016/j.biomaterials.2012.12.028; Persson NE, 2017, CHEM MATER, V29, P3, DOI 10.1021/acs.chemmater.6b01825; Pourdeyhimi B, 1997, TEXT RES J, V67, P143, DOI 10.1177/004051759706700211; Pudney C, 1998, COMPUT VIS IMAGE UND, V72, P404, DOI 10.1006/cviu.1998.0680; Putti M, 2015, POLYMER, V63, P189, DOI 10.1016/j.polymer.2015.03.006; Quinn KP, 2015, EXP DERMATOL, V24, P78, DOI 10.1111/exd.12553; Quinn KP, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046003; Redon C, 1998, J MICROSC-OXFORD, V191, P258; Regnier G, 2008, POLYM ENG SCI, V48, P2159, DOI 10.1002/pen.21161; Rolo TD, 2014, P NATL ACAD SCI USA, V111, P3921, DOI 10.1073/pnas.1308650111; Schaub NJ, 2013, BIONANOSCIENCE, V3, P329, DOI 10.1007/s12668-013-0100-y; Shi HL, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-50; Shkarin R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215137; Shkarina S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27097-7; Soltani P., 2015, WORLD J TEXTILE ENG, V1, P41; Soltani P, 2014, POWDER TECHNOL, V254, P44, DOI 10.1016/j.powtec.2014.01.001; Te mann M, 2010, EURASIP J ADV SIG PR, V2010; Tseng HC, 2013, J RHEOL, V57, P1597, DOI 10.1122/1.4821038; Tunak M, 2014, TEXT RES J, V84, P989, DOI 10.1177/0040517513509852; van Zuijlen PPM, 2002, J PATHOL, V198, P284, DOI 10.1002/path.1219; Velez-Garcia GM, 2012, COMPOS PART A-APPL S, V43, P104, DOI 10.1016/j.compositesa.2011.09.024; Wirjadi O, 2009, ECS10: THE10TH EUROPEAN CONGRESS OF STEREOLOGY AND IMAGE ANALYSIS, P107; Zandt BJ, 2017, J NEUROSCI METH, V279, P101, DOI 10.1016/j.jneumeth.2017.01.008; ZELENY J, 1917, PHYS REV, V10, P1; Zhang LJ, 2017, TEXT RES J, V87, P2263, DOI 10.1177/0040517516669070; Zhu NB, 2009, PROCEEDINGS OF THE 2009 CHINESE CONFERENCE ON PATTERN RECOGNITION AND THE FIRST CJK JOINT WORKSHOP ON PATTERN RECOGNITION, VOLS 1 AND 2, P319; Zhu YT, 1997, J COMPOS MATER, V31, P1287, DOI 10.1177/002199839703101302	62	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236420	10.1371/journal.pone.0236420	http://dx.doi.org/10.1371/journal.pone.0236420			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726324	Green Published, gold			2022-12-26	WOS:000556908900022
J	Kim, H; Lim, YK; Goh, Y; Jeong, C; Hwang, UJ; Choi, SH; Cho, B; Kwak, J				Kim, Hojin; Lim, Young Kyung; Goh, Youngmoon; Jeong, Chiyoung; Hwang, Ui-Jung; Choi, Sang Hyoun; Cho, Byungchul; Kwak, Jungwon			Plan optimization with L0-norm and group sparsity constraints for a new rotational, intensity-modulated brachytherapy for cervical cancer	PLOS ONE			English	Article							BEAM ORIENTATION OPTIMIZATION; RADIATION-THERAPY; INTERSTITIAL BRACHYTHERAPY; CLINICAL IMPACT; RECOMMENDATIONS; DOSIMETRY; PRINCIPLES; PARAMETERS; ALGORITHM; TERMS	The aim of this work is to build a framework that comprehends inverse planning procedure and plan optimization algorithm tailored to a novel directional beam intensity-modulated brachytherapy (IMBT) of cervical cancer using a rotatable, single-channel radiation shield. Inverse planning is required for finding optimal beam emitting direction, source dwell position and dwell time, which begin with creating a kernel matrix for each structure based on Monte-Carlo simulated dose distribution in the rotatable shield. For efficient beam delivery and less transit dose, the number of source dwell positions and angles needs to be minimized. It can be solved by L0-norm regularization for fewest possible dwell points, and by group sparsity constraint in L2,p-norm (0 <= p<1) besides L0-norm for fewest active applicator rotating angles. The dose distributions from our proposed algorithms were compared to those of conventional tandem-based intracavitary brachytherapy (ICR) plans for six cervical cancer patients. The algorithmic performance was evaluated in delivery efficiency and plan quality relative to the unconstrained algorithm. The proposed framework yielded substantially enhanced plan quality over the conventional ICR plans. The L0-norm and (group sparsity+L0-norm) constrained algorithms reduced the number of source dwell points by 60 and 70% and saved 5 and 8 rotational angles on average (7 and 11 angles for highly modulated cases), relative to the unconstrained algorithm, respectively. Though both algorithms reduced the optimal source dwell positions and angles, the group sparsity constrained optimization with L0-norm was more effective than the L0-norm constraint only, mainly because of considering physical constraints of the new IMBT applicator. With much fewer dwell points compared to the unconstrained, the proposed algorithms led to statistically similar plan quality in dose volume histograms and iso-dose lines. It also demonstrated that the plan optimized by rotating the applicator resulted in much better plan quality than that of conventional applicator-based plans.	[Kim, Hojin; Goh, Youngmoon; Jeong, Chiyoung] Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Lim, Young Kyung] Natl Canc Ctr, Proton Therapy Ctr, Goyang, South Korea; [Hwang, Ui-Jung] Chungnam Natl Univ Hosp, Dept Radiat Oncol, Daejeon, South Korea; [Choi, Sang Hyoun] Korea Canc Ctr Hosp, Dept Radiat Oncol, Seoul, South Korea; [Cho, Byungchul; Kwak, Jungwon] Univ Ulsan, Dept Radiat Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Kim, Hojin] Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; National Cancer Center - Korea (NCC); Chungnam National University; Chungnam National University Hospital; National Cancer Center - Korea (NCC); University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System	Lim, YK (corresponding author), Natl Canc Ctr, Proton Therapy Ctr, Goyang, South Korea.	jwkwak0301@gmail.com; yklim@ncc.re.kr	Kim, Hojin/AAS-2315-2021; Goh, Youngmoon/ACK-0291-2022	Kim, Hojin/0000-0002-4652-8682; Goh, Youngmoon/0000-0003-4934-1730	National Research Foundation of Korea (NRF) [NRF-2017R1D1A1B04033367, NRF-2016 M2A2A7A03913304]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) through grant number NRF-2017R1D1A1B04033367 and NRF-2016 M2A2A7A03913304.	[Anonymous], 1999, PIRS629R NAT RES COU; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Berek J. S., 2012, BEREK NOVAKS GYNECOL; Bortfeld T, 2006, PHYS MED BIOL, V51, pR363, DOI 10.1088/0031-9155/51/13/R21; Boyd S, 2011, TRENDS MACH LEARN, V3, P1, DOI DOI 10.1561/2200000016; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Chambolle A, 2011, J MATH IMAGING VIS, V40, P120, DOI 10.1007/s10851-010-0251-1; Dimopoulos JCA, 2012, RADIOTHER ONCOL, V103, P113, DOI 10.1016/j.radonc.2011.12.024; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Ebert M. A., 2006, Australasian Physical & Engineering Sciences in Medicine, V29, P165, DOI 10.1007/BF03178889; Ebert MA, 2002, PHYS MED BIOL, V47, P2495, DOI 10.1088/0031-9155/47/14/309; Gerbaulet A, 2002, GEC ESTRO HDB BRACHY; Goh Y, 2018, INT J RADIAT ONCOL, V102, pS151, DOI 10.1016/j.ijrobp.2018.06.366; Goldstein T., 2009, SIAM J IMAGING SCI; Gu WB, 2018, MED PHYS, V45, P1338, DOI 10.1002/mp.12788; Haie-Meder C, 2005, RADIOTHER ONCOL, V74, P235, DOI 10.1016/j.radonc.2004.12.015; Han DY, 2014, INT J RADIAT ONCOL, V89, P666, DOI 10.1016/j.ijrobp.2014.02.039; Jia X, 2011, PHYS MED BIOL, V56, P6205, DOI 10.1088/0031-9155/56/19/004; Kang HC, 2010, RADIOTHER ONCOL, V97, P507, DOI 10.1016/j.radonc.2010.10.002; Kirisits C, 2006, INT J RADIAT ONCOL, V65, P624, DOI 10.1016/j.ijrobp.2006.01.036; Lang S, 2006, RADIOTHER ONCOL, V78, P185, DOI 10.1016/j.radonc.2006.01.001; Leibel SA, 2002, CANCER J, V8, P164, DOI 10.1097/00130404-200203000-00010; Lin LY, 2008, MED PHYS, V35, P240, DOI 10.1118/1.2815623; Mollenhoff T, 2015, INT WORKSH EN MIN ME; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; O'Connor D, 2017, FAST NONCOPLANAR BEA; Potter R, 2006, RADIOTHER ONCOL, V78, P67, DOI 10.1016/j.radonc.2005.11.014; Potter R, 2007, RADIOTHER ONCOL, V83, P148, DOI 10.1016/j.radonc.2007.04.012; Pugachev AB, 2000, MED PHYS, V27, P1238, DOI 10.1118/1.599001; Rivard MJ, 2004, MED PHYS, V31, P633, DOI 10.1118/1.1646040; Sadozye AH, 2012, CURR ONCOL REP, V14, P519, DOI 10.1007/s11912-012-0275-3; Shi CY, 2010, MED PHYS, V37, P3725, DOI 10.1118/1.3456598; Tanderup K, 2010, RADIOTHER ONCOL, V94, P173, DOI 10.1016/j.radonc.2010.01.001; Webster MJ, 2013, MED PHYS, V40, DOI 10.1118/1.4769416	35	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236585	10.1371/journal.pone.0236585	http://dx.doi.org/10.1371/journal.pone.0236585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722692	Green Published, gold			2022-12-26	WOS:000556916000017
J	Schilling, R; Colledge, F; Puhse, U; Gerber, M				Schilling, Rene; Colledge, Flora; Puehse, Uwe; Gerber, Markus			Stress-buffering effects of physical activity and cardiorespiratory fitness on metabolic syndrome: A prospective study in police officers	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTOR; OF-THE-ART; PERCEIVED STRESS; HAIR CORTISOL; WORK; HEALTH; PREVALENCE; FREQUENCY	Metabolic syndrome (MetS) is a worldwide health concern related to cardiovascular disease. Stress at work increases the risk for MetS, whereas physical activity and cardiorespiratory fitness (CF) have been shown to be potential buffers against stress. The aim of this study was to test the stress-buffering effects of physical activity and CF on the relationship between work stress and MetS. In a prospective study, we followed 97 police officers (mean age = 39.7 years; mean body mass index = 25.74 kg/m(2)) over one year and assessed MetS, as defined by the National Cholesterol Education Program Adult Treatment Panel III. Stress at work was measured with the Job Content Questionnaire, as well as the Effort-Reward Imbalance Questionnaire. Physical activity was assessed objectively via 7-day accelerometry. CF was assessed with the angstrom strand bicycle ergometer test. Hierarchical linear regression models were carried out to predict MetS at follow-up (mean overall MetS score = 1.22), after controlling for baseline levels and sociodemographic background (mean overall MetS score = 1.19). Higher CF levels were significantly associated with lower MetS risk at follow-up (beta = -.38). By contrast, no main effects were found for physical activity and work stress. However, high effort and demand were significantly correlated with increased blood pressure (effort:r= .23 for systolic blood pressure;r= .21 for diastolic blood pressure) and waist circumference (effort:r= .26; demand:r= .23). Moreover, no significant interaction effects occurred between work stress and CF/physical activity. The results emphasize the importance of high levels of CF in the prevention of MetS in police officers. Accordingly, provision of regular training opportunities and repeated CF testing should be considered as a strategy in overall corporate health promotion.	[Schilling, Rene; Colledge, Flora; Puehse, Uwe; Gerber, Markus] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland	University of Basel	Schilling, R (corresponding author), Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland.	rene.schilling@unibas.ch	Gerber, Markus/H-8654-2014; vandoni, matteo/AAS-7299-2021	Gerber, Markus/0000-0001-6140-8948; vandoni, matteo/0000-0002-3405-9364				Aiken LS, 1991, MULTIPLE REGRESSION, pxi; American Psychological Association, 2017, STRESS AM STAT OUR N; Carayon P, 1999, WORK STRESS, V13, P32, DOI 10.1080/026783799296174; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Charles LE, 2008, OBESITY, V16, P2489, DOI 10.1038/oby.2008.395; Clarke J, 2013, APPL PHYSIOL NUTR ME, V38, P773, DOI 10.1139/apnm-2013-0049; Davila EP, 2010, DIABETES CARE, V33, P2390, DOI 10.2337/dc10-0681; Dragano N, 2017, EPIDEMIOLOGY, V28, P619, DOI 10.1097/EDE.0000000000000666; Eriksson AK, 2013, DIABETOLOGE, V9, P438, DOI 10.2337/dc12-1738; Ferguson B, 2014, J CAN CHIROPR ASS, V58, P328; Folsom AR, 1997, MED SCI SPORT EXER, V29, P901, DOI 10.1097/00005768-199707000-00009; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Foss MLK, 1998, SJ FOXS PHYSL BASIS; Franke WD, 2010, J OCCUP ENVIRON MED, V52, P561, DOI 10.1097/JOM.0b013e3181dd086b; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; Garbarino S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144318; Gaziano T, 2012, BRUNWALDS HEART DIS; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Gerber, 2018, HDB STRESSREGULATION, P93, DOI [10.1007/978-3-662-49322-9_5, DOI 10.1007/978-3-662-49322-9_5]; Gerber M, 2018, HDB STRESSREGULATION, P3, DOI [10.1007/978-3-662-49322-9_26, DOI 10.1007/978-3-662-49322-9_26]; Gerber M., 2020, SPORTPSYCHOLOGIE, P581, DOI [10.1007/978-3-662-56802-6_25, DOI 10.1007/978-3-662-56802-6_25]; Gerber M, 2017, MED SCI SPORT EXER, V49, P581, DOI 10.1249/MSS.0000000000001123; Gerber M, 2016, MED SCI SPORT EXER, V48, P2075, DOI 10.1249/MSS.0000000000001005; Gerber M, 2013, J OCCUP HEALTH, V55, P376, DOI 10.1539/joh.13-0030-OA; Gerber M, 2013, NEUROPSYCHOBIOLOGY, V68, P100, DOI 10.1159/000351735; Gerber M, 2012, J SPORT SCI MED, V11, P571; Gerber M, 2010, J CRIM JUST, V38, P1167, DOI 10.1016/j.jcrimjus.2010.09.005; Gerber M, 2010, PSYCHOL SPORT EXERC, V11, P286, DOI 10.1016/j.psychsport.2010.02.004; Gerber M, 2009, SCAND J PUBLIC HEALT, V37, P801, DOI 10.1177/1403494809350522; Gharbi A, 2008, 2008 5TH INTERNATIONAL SUMMER SCHOOL AND SYMPOSIUM ON MEDICAL DEVICES AND BIOSENSORS, P136, DOI 10.1109/ISSMDBS.2008.4575024; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/s2214-109x(18)30357-7, 10.1016/S2214-109X(18)30357-7]; Habersaat SA, 2015, SOC SCI MED, V143, P213, DOI 10.1016/j.socscimed.2015.08.043; Hartel S, 2011, EUR REV AGING PHYS A, V8, P109, DOI 10.1007/s11556-010-0074-5; Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P243; Hjemdahl P, 2002, CIRCULATION, V106, P2634, DOI 10.1161/01.CIR.0000041502.43564.79; Holmes M., 2017, HDB STRESSREGULATION, P311; Humbarger CD, 2004, MED SCI SPORT EXER, V36, pS161, DOI 10.1097/00005768-200405001-00767; Jain A, 2017, ANN CLIN BIOCHEM, V54, P331, DOI 10.1177/0004563216661737; Joo G-y, 2017, KJFP, V7, P726, DOI [10.21215/kjfp.2017.7.5.726, DOI 10.21215/KJFP.2017.7.5.726]; Kaltsas GA, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P303; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kasten N., 2018, HDB STRESSREGULATION, P1; Kivimaki M, 2018, NAT REV CARDIOL, V15, P215, DOI 10.1038/nrcardio.2017.189; Klaperski S., 2018, HDB STRESSREGULATION, P227, DOI [DOI 10.1007/978-3-662-49322-9_8, 10.1007/978-3-662-49322-9_8]; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Landsbergis P, 2018, OCCUPATIONAL ENV HLT, V7, P325; Lee RS, 2014, NEUROENDOCRINOLOGY, V100, P278, DOI 10.1159/000369585; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Loerbroks A, 2015, INT J CARDIOL, V182, P390, DOI 10.1016/j.ijcard.2015.01.030; Magnavita N, 2018, INT ARCH OCC ENV HEA, V91, P377, DOI 10.1007/s00420-018-1290-y; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Myers J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071652; Nordgren B, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-305; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; Russ TC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4933; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Sara JD, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008073; Shane JM, 2010, J CRIM JUST, V38, P807, DOI 10.1016/j.jcrimjus.2010.05.008; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 2005, PSYCHONEUROENDOCRINO, V30, P1033, DOI 10.1016/j.psyneuen.2005.03.017; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Silverman MN, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0040; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; strand P-O, 2003, TXB WORK PHYSL PHYSL, P1; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Van der Doef M, 1999, WORK STRESS, V13, P87, DOI 10.1080/026783799296084; Violanti JM, 2017, POLICING, V40, P642, DOI 10.1108/PIJPSM-06-2016-0097; Violanti JM, 2017, PSYCHONEUROENDOCRINO, V75, P124, DOI 10.1016/j.psyneuen.2016.10.017; Violanti JM, 2009, ARCH ENVIRON OCCUP H, V64, P194, DOI 10.1080/19338240903241259; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization (WHO), 2010, WHO GUID DRAWING BLO; Yoo HL, 2009, J OCCUP ENVIRON MED, V51, P46, DOI 10.1097/JOM.0b013e31817f9e43; YOUNG DR, 1994, J PSYCHOSOM RES, V38, P451, DOI 10.1016/0022-3999(94)90106-6	82	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236526	10.1371/journal.pone.0236526	http://dx.doi.org/10.1371/journal.pone.0236526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722703	gold, Green Published, Green Accepted			2022-12-26	WOS:000556916000042
J	Gyawali, N; Moreira, LA; Murphy, AK; Hugo, LE; Devine, GJ				Gyawali, Narayan; Moreira, Luciano Andrade; Murphy, Amanda K.; Hugo, Leon E.; Devine, Gregor J.			A micro-PRNT for the detection of Ross River virus antibodies in mosquito blood meals: A useful tool for inferring transmission pathways	PLOS ONE			English	Article							REDUCTION NEUTRALIZATION TEST; HOST IMMUNOGLOBULIN-G; AEDES-ALBOPICTUS; DIPTERA; INFECTIONS; HEMOLYMPH; ACCURACY; ASSAY	Introduction Many arboviruses of public health significance are maintained in zoonotic cycles with complex transmission pathways. The presence of serum antibody against arboviruses in vertebrates provides evidence of their historical exposure but reveals nothing about the vectorreservoir relationship. Moreover, collecting blood or tissue samples from vertebrate hosts is ethically and logistically challenging. We developed a novel approach for screening the immune status of vertebrates against Ross River virus that allows us to implicate the vectors that form the transmission pathways for this commonly notified Australian arboviral disease. Methods A micro-plaque reduction neutralisation test (micro-PRNT) was developed and validated on koala (Phascolarctos cinereus) sera against a standard PRNT. The ability of the microPRNT to detect RRV antibodies in mosquito blood meals was then tested using two mosquito models. Laboratory-reared Aedes aegypti were fed, via a membrane, on sheep blood supplemented with RRV seropositive and seronegative human sera. Aedes notoscriptus were fed on RRV seropositive and seronegative human volunteers. Blood-fed mosquitoes were harvested at various time points after feeding and their blood meals analysed for the presence of RRV neutralising antibodies using the micro-PRNT. Results There was significant agreement of the plaque neutralisation resulting from the micro-PRNT and standard PRNT techniques (R-2 = 0.65; P < 0.0001) when applied to RRV antibody detection in koala sera. Sensitivity and specificity of the micro-PRNT assay were 88.2% and 96%, respectively, in comparison with the standard PRNT. Blood meals from mosquitoes fed on sheep blood supplemented with RRV antibodies, and on blood from RRV seropositive humans neutralised the virus by >= 50% until 48 hr post feeding. The vertebrate origin of the blood meal was also ascertained for the same samples, in parallel, using established molecular techniques. Conclusions The small volumes of blood present in mosquito abdomens can be used to identify RRV antibodies and therefore host exposure to arbovirus infection. In tandem with the accurate identification of the mosquito, and diagnostics for the host origin of the blood meal, this technique has tremendous potential for exploring RRV transmission pathways. It can be adapted for similar studies on other mosquito borne zoonoses.	[Gyawali, Narayan; Moreira, Luciano Andrade; Murphy, Amanda K.; Hugo, Leon E.; Devine, Gregor J.] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute	Gyawali, N (corresponding author), QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.	narayan.gyawali@qimrberghofer.edu.au	Devine, Gregor J/H-1141-2014; Hugo, Leon/O-3013-2018	Devine, Gregor J/0000-0001-6312-0390; Hugo, Leon/0000-0002-6767-9850; Gyawali, Narayan/0000-0003-1738-8315	Australian Post Graduate Award; Mosquito Control Laboratory, QIMR Berghofer; Mosquito and Arbovirus Research Committee (MARC)	Australian Post Graduate Award(Australian Government); Mosquito Control Laboratory, QIMR Berghofer; Mosquito and Arbovirus Research Committee (MARC)	This work was supported by an Australian Post Graduate Award to A Murphy, by funds from the Mosquito Control Laboratory, QIMR Berghofer and by the Mosquito and Arbovirus Research Committee (MARC) which is an independent Australian organization funded by local government, government agencies, industry and scientific institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Government, 2015, OUR N OUR FUT WHIT P; Barbazan P, 2009, VECTOR-BORNE ZOONOT, V9, P103, DOI 10.1089/vbz.2007.0242; Baylis M, 2017, ENVIRON HEALTH-GLOB, V16, P45, DOI 10.1186/s12940-017-0326-1; BENYAKIR D, 1987, J PARASITOL, V73, P669, DOI 10.2307/3282157; Borges MBJ, 2008, BIOLOGICALS, V36, P105, DOI 10.1016/j.biologicals.2007.07.001; Centers for Disease Control and Prevention (CDC), CDC ARB CAT; Claflin SB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005070; De Moraes CM, 2014, P NATL ACAD SCI USA, V111, P11079, DOI 10.1073/pnas.1405617111; DOHERTY RL, 1963, AUST J EXP BIOL MED, V41, P17, DOI 10.1038/icb.1963.2; FRASER JRE, 1986, CLIN RHEUM DIS, V12, P369; FRENCH E. L., 1952, MED JOUR AUSTRALIA, V1, P100; Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001; Gyawali N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02818; Gyawali N, 2020, VECTOR-BORNE ZOONOT, V20, P33, DOI 10.1089/vbz.2019.2467; Gyawali N, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3455-2; Gyawali N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02150; Gyawali N, 2017, MICROBES INFECT, V19, P388, DOI 10.1016/j.micinf.2017.05.002; HATFIELD PR, 1988, MED VET ENTOMOL, V2, P339, DOI 10.1111/j.1365-2915.1988.tb00206.x; Hugo LE, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007281; Hugo LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058656; IRBY WS, 1989, J MED ENTOMOL, V26, P284, DOI 10.1093/jmedent/26.4.284; JEFFERY GEOFFREY M., 1956, EXPTL PARASITOL, V5, P371, DOI 10.1016/0014-4894(56)90021-2; Komar N, 2015, J AM MOSQUITO CONTR, V31, P1, DOI 10.2987/14-6468R.1; KONISHI E, 1989, J MED ENTOMOL, V26, P535, DOI 10.1093/jmedent/26.6.535; Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8; LACKIE AM, 1989, MED VET ENTOMOL, V3, P225, DOI 10.1111/j.1365-2915.1989.tb00220.x; Lau C, 2017, INT J INFECT DIS, V57, P73, DOI 10.1016/j.ijid.2017.01.041; Lee SS, 2017, VACCINE, V35, P5481, DOI 10.1016/j.vaccine.2017.03.019; Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50; Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020; MINOURA H, 1985, EXP PARASITOL, V60, P355, DOI 10.1016/0014-4894(85)90042-6; MULLER D, 1986, MED J AUSTRALIA, V144, P41, DOI 10.5694/j.1326-5377.1986.tb113633.x; PHILLIPS DA, 1990, MED J AUSTRALIA, V152, P463, DOI 10.5694/j.1326-5377.1990.tb125304.x; Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004; SERVICE MW, 1986, B ENTOMOL RES, V76, P321, DOI 10.1017/S0007485300014796; Simoes M, 2012, BIOLOGICALS, V40, P399, DOI 10.1016/j.biologicals.2012.09.005; Stephenson EB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2733-8; TESH RB, 1988, AM J TROP MED HYG, V39, P127, DOI 10.4269/ajtmh.1988.39.127; VAUGHAN JA, 1988, J MED ENTOMOL, V25, P472, DOI 10.1093/jmedent/25.6.472; Vorou RM, 2007, EPIDEMIOL INFECT, V135, P1231, DOI 10.1017/S0950268807008527	40	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0229314	10.1371/journal.pone.0229314	http://dx.doi.org/10.1371/journal.pone.0229314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706777	gold, Green Submitted, Green Published			2022-12-26	WOS:000579931700003
J	Tan, CY; Opaskornkul, K; Thanawongnuwech, R; Arshad, SS; Hassan, L; Ooi, PT				Tan, Chew Yee; Opaskornkul, Keerati; Thanawongnuwech, Roongroje; Arshad, Siti Suri; Hassan, Latiffah; Ooi, Peck Toung			First molecular detection and complete sequence analysis of porcine circovirus type 3 (PCV3) in Peninsular Malaysia	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; VIRUS; PIGS; DISEASE; INFECTIONS; OUTBREAK; REVEALS; STRAIN	Porcine circovirus type 3 (PCV3) is a newly emerging virus in the swine industry, first reported recently in 2016. PCV3 assembles into a 2000 bp circular genome; slightly larger than PCV1 (1758-1760 bp), PCV2 (1766-1769 bp) and PCV4 (1770 bp). Apart from being associated with porcine dermatitis and nephropathy syndrome (PDNS), PCV3 has been isolated from pigs with clinical signs of reproductive failures, myocarditis, porcine respiratory disease complex (PRDC) and neurologic disease. Given that PCV3 is increasingly reported in countries including Thailand and U.S. with whom Malaysia shares trade and geographical relationship; and that PCV3 is associated with several clinical presentations that affect productivity, there is a need to study the presence and molecular characteristics of PCV3 in Malaysian swine farms. Twenty-four commercial swine farms, three abattoirs and retail shops in Peninsular Malaysia were sampled using convenience sampling method. A total of 281 samples from 141 pigs, including 49 lung archive samples were tested for PCV3 by conventional PCR. Twenty-eight lung samples from wild boar population in Peninsular Malaysia were also included. Nucleotide sequences were analyzed for maximum likelihood phylogeny relationship and pairwise distances. Results revealed that PCV3 is present in Peninsular Malaysia at a molecular prevalence of 17.02%, with inguinal lymph nodes and lungs showing the highest molecular detection rates of 81.82% and 71.43% respectively. Despite wide reports of PCV3 in healthy animals and wild boars, no positive samples were detected in clinically healthy finishers and wild boar population of this study. PCV3 strain A1 and A2 were present in Malaysia, and Malaysian PCV3 strains were found to be phylogenetically related to Spanish, U.S. and Mexico strains.	[Tan, Chew Yee; Opaskornkul, Keerati; Ooi, Peck Toung] Univ Putra Malaysia, Fac Vet Med, Dept Vet Clin Studies, Serdang, Selangor, Malaysia; [Thanawongnuwech, Roongroje] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Pathol, Bangkok, Thailand; [Arshad, Siti Suri] Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang, Selangor, Malaysia; [Hassan, Latiffah] Univ Putra Malaysia, Fac Vet Med, Dept Vet Lab Diagnost, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Chulalongkorn University; Universiti Putra Malaysia; Universiti Putra Malaysia	Ooi, PT (corresponding author), Univ Putra Malaysia, Fac Vet Med, Dept Vet Clin Studies, Serdang, Selangor, Malaysia.	ooi@upm.edu.my	Ooi, Peck Toung/E-7365-2017	Ooi, Peck Toung/0000-0002-1174-0288; Tan, Chew Yee/0000-0002-2674-3959				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chen GH, 2017, TRANSBOUND EMERG DIS, V64, P1650, DOI 10.1111/tbed.12702; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Cortey M, 2011, VET J, V187, P363, DOI 10.1016/j.tvjl.2009.12.023; Department of Veterinary Services Malaysia (DVS Malaysia), LIVESTOCK STAT; Fan SX, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00100-17, 10.1128/genomea.00100-17]; Fenaux M, 2000, J CLIN MICROBIOL, V38, P2494, DOI 10.1128/JCM.38.7.2494-2503.2000; Firth C, 2009, J VIROL, V83, P12813, DOI 10.1128/JVI.01719-09; Franzo G, 2018, TRANSBOUND EMERG DIS, V65, P602, DOI 10.1111/tbed.12836; Franzo G, 2019, TRANSBOUND EMERG DIS, V66, P1548, DOI 10.1111/tbed.13180; Franzo G, 2018, TRANSBOUND EMERG DIS, V65, P957, DOI 10.1111/tbed.12905; Fu X, 2018, TRANSBOUND EMERG DIS, V65, pe296, DOI 10.1111/tbed.12752; FU YX, 1993, GENETICS, V133, P693; Fux R, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0929-3; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harding J. C. S., 2007, Banff Pork Seminar Proceedings 2007. This Global Business of Pork, 16-19 January 2007, Banff, Alberta, Canada, P27; Harms PA, 2001, VET PATHOL, V38, P528, DOI 10.1354/vp.38-5-528; Hayashi S, 2018, J VET MED SCI, P18; IBM, 2016, ANN REPORT; International Committee on Taxonomy of Viruses (ICTV), ONL 10 REP INT COMM; Jiang HJ, 2019, J VIROL, V93, DOI 10.1128/JVI.02045-18; Kedkovid R, 2018, VET MICROBIOL, V215, P71, DOI 10.1016/j.vetmic.2018.01.004; Kekarainen T, 2014, J GEN VIROL, V95, P1734, DOI 10.1099/vir.0.065318-0; Kim J, 2003, VET J, V166, P251, DOI 10.1016/S1090-0233(02)00257-5; Klaumann F, 2018, TRANSBOUND EMERG DIS, V65, P1290, DOI 10.1111/tbed.12876; Klaumann F, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00315; Klaumann F, 2019, TRANSBOUND EMERG DIS, V66, P91, DOI 10.1111/tbed.12988; Ku X, 2017, TRANSBOUND EMERG DIS, V64, P703, DOI 10.1111/tbed.12638; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwon T, 2017, VET MICROBIOL, V207, P178, DOI 10.1016/j.vetmic.2017.06.013; Lam SK, 2002, CLIN INFECT DIS, V34, pS48, DOI 10.1086/338818; Lara G, 2019, MEXICO LIVESTOCK PRO; Li D.Y., 2019, J ENV EC, V4, P10; Li GR, 2018, VIRULENCE, V9, P1301, DOI 10.1080/21505594.2018.1492863; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Li XD, 2018, VIROL SIN, V33, P373, DOI 10.1007/s12250-018-0041-2; Linz GM, MANAGING VERTEBRATE; Litwin S, 1992, THEORETICAL EXPT INS, V66, P279, DOI [10.1007/978-3-642-76977-1_17, DOI 10.1007/978-3-642-76977-1_17]; Mankertz A, 2004, VET MICROBIOL, V98, P81, DOI 10.1016/j.vetmic.2003.10.014; Meehan BM, 1997, J GEN VIROL, V78, P221, DOI 10.1099/0022-1317-78-1-221; Meehan BM, 1998, J GEN VIROL, V79, P2171, DOI 10.1099/0022-1317-79-9-2171; Morozov I, 1998, J CLIN MICROBIOL, V36, P2535, DOI 10.1128/JCM.36.9.2535-2541.1998; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Olvera A, 2007, VIROLOGY, V357, P175, DOI 10.1016/j.virol.2006.07.047; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Opriessnig T, 2013, VET MICROBIOL, V163, P177, DOI 10.1016/j.vetmic.2012.12.019; Palinski R, 2017, J VIROL, V91, DOI [10.1128/JVI.01879-16, 10.1128/jvi.01879-16]; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Prinz C, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1133-9; Qi SS, 2019, TRANSBOUND EMERG DIS, V66, P1004, DOI 10.1111/tbed.13125; Rollins LA, 2009, MOL ECOL, V18, P1560, DOI 10.1111/j.1365-294X.2009.04132.x; Rosario K, 2017, ARCH VIROL, V162, P1447, DOI 10.1007/s00705-017-3247-y; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Saraiva GL, 2018, VIRUS GENES, V54, P376, DOI 10.1007/s11262-018-1545-4; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stadejek T, 2017, TRANSBOUND EMERG DIS, V64, P1350, DOI 10.1111/tbed.12672; Sukmak M, 2019, TRANSBOUND EMERG DIS, V66, P611, DOI 10.1111/tbed.13057; TAJIMA F, 1989, GENETICS, V123, P585; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Phan TG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0642-z; Wang W, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1793-0; Weaver S, 2018, MOL BIOL EVOL, V35, P773, DOI 10.1093/molbev/msx335; Xiao CT, 2015, J GEN VIROL, V96, P1830, DOI 10.1099/vir.0.000100; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhai SL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0892-4; Zhang D, 2015, ARCH VIROL, V160, P3149, DOI 10.1007/s00705-015-2615-8; Zhang JX, 2018, VIRUS GENES, V54, P140, DOI 10.1007/s11262-017-1509-0; Zou YW, 2018, ARCH VIROL, V163, P2841, DOI 10.1007/s00705-018-3914-7	72	13	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0235832	10.1371/journal.pone.0235832	http://dx.doi.org/10.1371/journal.pone.0235832			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706778	Green Published, gold			2022-12-26	WOS:000579931700009
J	Jones, S; Subramaniam, G; Plucinski, MM; Patel, D; Padilla, J; Aidoo, M; Talundzic, E				Jones, Sophie; Subramaniam, Gireesh; Plucinski, Mateusz M.; Patel, Dhruviben; Padilla, Jasmine; Aidoo, Michael; Talundzic, Eldin			One-step PCR: A novel protocol for determination of pfhrp2 deletion status in Plasmodium falciparum	PLOS ONE			English	Article							HISTIDINE-RICH PROTEIN-2; RAPID DIAGNOSTIC-TESTS; GENETIC DIVERSITY; MALARIA; REGION; HRP3	Histidine-rich protein 2 (HRP2) detecting rapid diagnostic tests (RDTs) have played an important role in enabling prompt malaria diagnosis in remote locations. However, emergence of pfhrp2 deleted parasites is threatening the efficacy of RDTs, and the World Health Organization (WHO) has highlighted surveillance of these deletions as a priority. Nested PCR is used to confirm pfhrp2 deletion but is costly and laborious. Due to spurious amplification of paralogue pfhrp3, the identity of nested exon 1 PCR product must be confirmed by sequencing. Here we describe a new one-step PCR method for detection of pfhrp2. To determine sensitivity and specificity, all PCRs were performed in triplicate. Using photoinduced electron transfer (PET) PCR detecting 18srRNA as true positive, one-step had comparable sensitivity of 95.0% (88.7-98.4%) to nested exon 1, 99.0% (94.6-99.9%) and nested exon 2, 98.0% (93.0-99.8%), and comparable specificity 93.8% (69.8-99.8%) to nested exon 1 100.0% (79.4-100.0%) and nested exon 2, 100.0% (74.4-100.0%). Sequencing revealed that one step PCR does not amplify pfhrp3. Logistic regression models applied to measure the 95% level of detection of the one-step PCR in clinical isolates provided estimates of 133p/mu L (95% confidence interval (CI): 3-793p/mu L) for whole blood (WB) samples and 385p/mu L (95% CI: 31-2133 p/mu L) for dried blood spots (DBSs). When considering protocol attributes, the one-step PCR is less expensive, faster and more suitable for high throughput. In summary, we have developed a more accurate PCR method that may be ideal for the application of the WHO protocol for investigating pfhrp2 deletions in symptomatic individuals presenting to health care facilities.	[Jones, Sophie; Subramaniam, Gireesh; Plucinski, Mateusz M.; Patel, Dhruviben; Aidoo, Michael; Talundzic, Eldin] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30329 USA; [Jones, Sophie; Patel, Dhruviben] Williams Consulting, Baltimore, MD 21228 USA; [Subramaniam, Gireesh; Padilla, Jasmine] Oak Ridge Inst Sci & Educ, Atlanta, GA USA; [Plucinski, Mateusz M.] Presidents Malaria Initiat, Atlanta, GA USA; [Padilla, Jasmine] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Div Sci Resources, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Centers for Disease Control & Prevention - USA	Jones, S (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30329 USA.; Jones, S (corresponding author), Williams Consulting, Baltimore, MD 21228 USA.	hte6@cdc.gov		Plucinski, Mateusz/0000-0002-7322-4625	Advanced Molecular Detection (AMD) initiative at the CDC; Williams Consulting LLC	Advanced Molecular Detection (AMD) initiative at the CDC; Williams Consulting LLC	This work was made possible through support from the Advanced Molecular Detection (AMD) initiative at the CDC. Authors Sophie Jones and Dhruviben Patel are employed by Williams Consulting LLC. Williams Consulting LLC provided support in the form of salary for authors SJ and DP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Amoah LE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1159-z; Atroosh WM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1008-x; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Berhane A, 2018, EMERG INFECT DIS, V24, P462, DOI 10.3201/eid2403.171723; Berzosa P, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03178-9; Beshir KB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15031-2; Bharti PK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01506-9; Bharti PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157949; Candrinho B, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2796-9; Davlantes E, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2290-9; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Fall B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-107; Fontecha G, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2668-3; Funwei R, 2019, ACTA TROP, V196, P121, DOI 10.1016/j.actatropica.2019.05.016; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gupta H, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2061-z; Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26; Jones S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-266; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kozycki CT, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1768-1; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Laban NM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0544-3; Li PP, 2015, ACTA TROP, V152, P26, DOI 10.1016/j.actatropica.2015.08.003; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Mariette N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-219; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Solano CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131576; Nderu D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38175-1; Nguyen-Dumont T, 2015, ANAL BIOCHEM, V470, P48, DOI 10.1016/j.ab.2014.10.010; Nima MK, 2017, AM J TROP MED HYG, V97, P1155, DOI 10.4269/ajtmh.16-0884; Nsobya SL NE, 2016, AM SOC TROP MED HYG; Okoth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126805; Parr JB, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2287-4; Parr JB, 2017, J INFECT DIS, V216, P36, DOI 10.1093/infdis/jiw538; Plucinski M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2101-8; Plucinski MM, 2019, J INFECT DIS, V219, P437, DOI 10.1093/infdis/jiy525; Plucinski MM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006278; Viana GMR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171150; SCHERF A, 1992, NUCLEIC ACIDS RES, V20, P1491, DOI 10.1093/nar/20.7.1491; Sepulveda N, 2018, INFECT GENET EVOL, V62, P211, DOI 10.1016/j.meegid.2018.04.039; Shyu, 1992, STAT MODELS; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; WHO, 2019, WORLD MALARIA REPORT; WHO, 2018, WORLD MAL REP 2018; WHO, 2018, PROT EST PREV PFHRP2; Woodrow CJ, 2017, J INFECT DIS, V216, P504, DOI 10.1093/infdis/jix345; World Health Organization, 2017, MAL RAP DIAGN TEST P; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	54	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236369	10.1371/journal.pone.0236369	http://dx.doi.org/10.1371/journal.pone.0236369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702040	Green Published, gold			2022-12-26	WOS:000575913700082
J	Liu, Y; Brown, PN; Ragone, D; Gibson, DL; Murch, SJ				Liu, Ying; Brown, Paula N.; Ragone, Diane; Gibson, Deanna L.; Murch, Susan J.			Breadfruit flour is a healthy option for modern foods and food security	PLOS ONE			English	Article							ARTOCARPUS-ALTILIS; MORACEAE; BIOACCESSIBILITY; CONSERVATION; TECHNOLOGIES; QUALITY; PROTEIN; CROP	Breadfruit is a traditional staple crop from Pacific islands with the potential to improve worldwide food security and mitigate diabetes. Flour produced from breadfruit is a gluten-free, low glycemic index, nutrient dense and complete protein option for modern foods but basic scientific knowledge of health impacts of a breadfruit-based diet in animals and humans was lacking. We designed a series of studies to provide basic and fundamental data on impacts of a breadfruit-based diet through an in vitro and in vivo model. Cooked breadfruit flour was digested through a multi-stage enzyme digestion model to estimate protein digestibility in comparison to wheat flour. Breadfruit protein was found to be easier to digest than wheat protein in the enzyme digestion model. The flour digestions were applied to Caco-2 cells to test the cytotoxicity and to measure the immunogenicity through cytokine expression. No significant differences were observed for immune factors and cytokines (IL-4, IL-10, IL-8, TNF-alpha, IFN-gamma) on Caco-2 cells between the breadfruit and wheat groups. A breadfruit-based rodent chow was formulated by substitution of all of the wheat in the standard formulation with breadfruit. The diets were isocaloric, nutrient equivalent and used to feed male and female C57BL/6 mice for 21 days. No sign of malnutrition, discomfort, illness or death was observed among the mice because of the diet. The histology and the cytokine expression of the mice ileum from both groups were analyzed and showed similar results. The expression of major bacteria was measured in the colon and showed similar results. Mice fed the breadfruit diet had a significantly higher growth rate and body weight than standard diet fed mice. No negative health outcomes were observed in studies with in vitro or in vivo models and breadfruit flour is a healthy alternative to other starches for modern foods.	[Liu, Ying; Murch, Susan J.] Univ British Columbia, Chem, Kelowna, BC, Canada; [Liu, Ying; Brown, Paula N.] British Columbia Inst Technol, Nat Hlth & Food Prod Res Grp, Burnaby, BC, Canada; [Ragone, Diane] Natl Trop Bot Garden, Breadfruit Inst, Kauai, HI USA; [Gibson, Deanna L.] Univ British Columbia, Biol, Kelowna, BC, Canada	University of British Columbia; British Columbia Institute of Technology; University of British Columbia	Murch, SJ (corresponding author), Univ British Columbia, Chem, Kelowna, BC, Canada.	susan.murch@ubc.ca	Murch, Susan/AAA-6703-2021; Gibson, Deanna L/CAF-4166-2022; Liu, Ying/AAE-2594-2020	Murch, Susan/0000-0001-5803-9483; Gibson, Deanna L/0000-0003-0052-7550; Liu, Ying/0000-0002-1403-7803	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; Canadian Institutes of Health Research; University of British Columbia; Breadfruit Institute at the National Tropical Botanical Garden	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia; Breadfruit Institute at the National Tropical Botanical Garden	The authors are grateful to the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs program, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the Canadian Institutes of Health Research, the University of British Columbia internal grants program and the Breadfruit Institute at the National Tropical Botanical Garden for funding for this program.	Adepeju BA, 2014, FOOD SCI QUALITY MAN, V28, P78; Aka L. O., 2009, Nigerian Veterinary Journal, V30, P26; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Amesn D, 2009, METHOD MOL BIOL, V511, P107, DOI [10.1007/978-1-59745-447-6_, DOI 10.1007/978-1-59745-447-6_5]; Andrade IHP, 2020, COLLOID SURFACE A, V586, DOI 10.1016/j.colsurfa.2019.124277; Bahado-Singh PS, 2016, BR J NUTR, V96, P476; Baker J, 2012, AM J PHYSIOL-GASTR L, V303, pG825, DOI 10.1152/ajpgi.00327.2011; Brown K, 2012, NUTRIENTS, V4, P1552, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan YK, 2013, ANN NUTR METAB, V63, P28, DOI 10.1159/000354902; Generoso SD, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0052-z; GRANT G, 1995, J AGR SCI, V124, P437, DOI 10.1017/S0021859600073391; Hoffman RA, 1997, AM J PHYSIOL-GASTR L, V272, pG383, DOI 10.1152/ajpgi.1997.272.2.G383; Huang SQ, 2019, FOODS, V8, DOI 10.3390/foods8110586; Jones AMP, 2011, J FOOD COMPOS ANAL, V24, P1091, DOI 10.1016/j.jfca.2011.04.002; Kiers JL, 2000, J SCI FOOD AGR, V80, P1325, DOI 10.1002/1097-0010(200007)80:9&lt;1325::AID-JSFA648&gt;3.0.CO;2-K; Lincoln NK, 2019, HORTICULTURAL REV, P380; Liu Y, 2015, AMINO ACIDS, V47, P847, DOI 10.1007/s00726-015-1914-4; Liu Y, 2014, FRUITS, V69, P345, DOI 10.1051/fruits/2014023; Mondal S, 2013, NEUROLOGY, V80; Motion Analysis, 2020, RAPT 12HS; Murch SJ, 2008, NATURWISSENSCHAFTEN, V95, P99, DOI 10.1007/s00114-007-0295-2; do Nascimento TP, 2020, J SCI FOOD AGR, V100, P1962, DOI 10.1002/jsfa.10209; Ragone D., 1997, ARTOCARPUS ALTILIS P; Ragone D, 2006, ECON BOT, V60, P335, DOI 10.1663/0013-0001(2006)60[335:SEOFQA]2.0.CO;2; Raiola A, 2012, FOOD CHEM TOXICOL, V50, P280, DOI 10.1016/j.fct.2011.09.031; Ramdath DD, 2004, BRIT J NUTR, V91, P971, DOI 10.1079/BJN20041125; Shi WL, 2007, ACTA HORTIC, P169, DOI 10.17660/ActaHortic.2007.757.23; Strober W., 2015, CURR PROTOC IMMUNOL, DOI 10.1002/0471142735.ima03bs111; Tenore GC, 2013, FOOD CHEM, V141, P3519, DOI 10.1016/j.foodchem.2013.06.051; Turi CE, 2015, TRENDS FOOD SCI TECH, V45, P264, DOI 10.1016/j.tifs.2015.07.014; Turi CE, 2013, PLANTA MED, V79, P1370, DOI 10.1055/s-0033-1350618; USDA, 2015, DAT FOOD PATT EQ DAT; van der Waaij LA, 2005, INFLAMM BOWEL DIS, V11, P865, DOI 10.1097/01.mib.0000179212.80778.d3; Widanagamage RD, 2009, INT J FOOD SCI NUTR, V60, P215, DOI 10.1080/09637480902849195	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236300	10.1371/journal.pone.0236300	http://dx.doi.org/10.1371/journal.pone.0236300			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702056	Green Published, gold			2022-12-26	WOS:000575913700073
J	Xuan, Y; Xu, LY; Liu, GH; Zhou, J				Xuan, Yan; Xu, Linyun; Liu, Guanhua; Zhou, Jie			The vibrational response of simulated Ginkgo biloba fruit based on their frequency spectrum characteristics	PLOS ONE			English	Article							SWEET CHERRY; STEM SYSTEM; SHAKER; DAMAGE	The most effective method for harvesting forest fruit is the mechanical vibration harvesting method. During the forced vibration process, the fruit will be shed from the tree when the inertia of the fruit is greater than the fruit's pedicel retention force. In order to study the movement response characteristics of the Ginkgo biloba fruit in depth, for a small Ginkgo biloba fruit tree, the frequency curve of the fruit tree had been obtained in this paper, based on the pulse hammer excitation method, and four resonant frequencies and four trough point frequencies, in the frequency range of 10 Hz similar to 25 Hz, were determined as the test excitation frequency. Through a comparison test between the simulated fruit and the Ginkgo biloba fruit, both the simulated fruit and the real Ginkgo biloba fruit demonstrated good response consistency, and the results had shown that the simulated fruit could be used to replace the Ginkgo biloba fruit. The acceleration response of the resonant frequency and the trough point frequency for two test points of the two primary branches had also been analyzed. It was found that the resonant frequency caused an obvious harmonic response. For the same frequency, the fruit at some points produced a very strong vibrational response, while at other points the fruit was almost stationary. Therefore, it was difficult for a fruit tree to completely shed all its fruit through excitation at a single frequency. It was more difficult to induce a strong vibrational response of fruit on branches of higher stiffness. On the contrary, it was easier to induce a strong vibrational response on more flexible branches regardless of the resonant frequency or the trough point frequency excitation.	[Xuan, Yan; Xu, Linyun; Liu, Guanhua; Zhou, Jie] Nanjing Forestry Univ, Coll Mech & Elect Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Xu, LY (corresponding author), Nanjing Forestry Univ, Coll Mech & Elect Engn, Nanjing, Jiangsu, Peoples R China.	lyxu@njfu.com.cn			National Key Research and Development Plan of China [2016YFD0701501]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX17_0862]	National Key Research and Development Plan of China; Postgraduate Research & Practice Innovation Program of Jiangsu Province	This study was supported by the National Key Research and Development Plan of China (Grant No. 2016YFD0701501), the Postgraduate Research & Practice Innovation Program of Jiangsu Province (Grant No. KYCX17_0862).	Cai Fei, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P208; Castro-Garcia S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081760; Chen Du, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P195; Chen Yuanbin, 2011, J HENAN FORESTRY SCI, V31, P46; Ciro HJ, 2001, APPL ENG AGRIC, V17, P475; Diener R, 1965, VIBRATION CHARACTERI, P398; [杜小强 Du Xiaoqiang], 2016, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V47, P59; Du XQ, 2012, BIOSYST ENG, V111, P305, DOI 10.1016/j.biosystemseng.2011.12.009; Erdogan D, 2003, BIOSYST ENG, V85, P19, DOI 10.1016/S1537-5110(03)00024-2; Fu Wei, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P65; [国靖 Guo Jing], 2017, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V37, P118; He L, 2013, BIOSYST ENG, V116, P309, DOI 10.1016/j.biosystemseng.2013.08.013; He Miao, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P47, DOI 10.11975/j.issn.1002-6819.2017.11.006; jinbao Liu, 2013, AGR ENG, V3, P68; Li ChengSong, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P39; Lin Huan, 2016, Journal of Forestry Engineering, V1, P100; Lin XW, 2017, AEBMR ADV ECON, V33, P58; Parchomchuk P, 1972, THEOR COMPUT SCI, V40, P131; Qu Wei, 2014, Journal of Northwest A & F University - Natural Science Edition, V42, P223; Tian F, 2019, INT J BIOL MACROMOL, V126, P917, DOI 10.1016/j.ijbiomac.2018.12.177; Torregrosa A, 2014, BIOSYST ENG, V119, P1, DOI 10.1016/j.biosystemseng.2013.12.010; Torregrosa A, 2009, BIOSYST ENG, V104, P18, DOI 10.1016/j.biosystemseng.2009.06.005; TSATSARELIS CA, 1987, J AGR ENG RES, V38, P77, DOI 10.1016/0021-8634(87)90120-X; UPADHYAYA SK, 1981, T ASAE, V24, P846, DOI 10.13031/2013.34351; Wang ChangQin, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P10; Zhou JF, 2016, BIOSYST ENG, V144, P105, DOI 10.1016/j.biosystemseng.2016.02.007; Zhou JF, 2016, COMPUT ELECTRON AGR, V121, P282, DOI 10.1016/j.compag.2016.01.004; Zhou JF, 2014, BIOSYST ENG, V125, P36, DOI 10.1016/j.biosystemseng.2014.06.016	28	4	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235494	10.1371/journal.pone.0235494	http://dx.doi.org/10.1371/journal.pone.0235494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701957	Green Published, gold			2022-12-26	WOS:000575913700016
J	Wang, LD; Liang, WS; Wang, SS; Wang, ZX; Bai, H; Jiang, Y; Bi, YL; Chen, GH; Chang, GB				Wang, Laidi; Liang, Wenshuang; Wang, Shasha; Wang, Zhixiu; Bai, Hao; Jiang, Yong; Bi, Yulin; Chen, Guohong; Chang, Guobin			Circular RNA expression profiling reveals that circ-PLXNA1 functions in duck adipocyte differentiation	PLOS ONE			English	Article							MIR-214; INHIBITION; GROWTH; GENE	Adipocytes are derived from pluripotent mesenchymal stem cells through adipogenesis. Pre-adipocyte differentiation in poultry greatly influences fat deposition and meat quality. Circular RNAs (circRNAs) have an important function in cancer and some differentiation processes. Herein, high-throughput transcriptome sequencing was used to detect circRNAs present in cherry valley duck pre-adipocyte and adipocyte differentiation over 3 days. We identified 9,311 circRNAs and 141 differentially expressed circRNAs. Sequencing results were verified through qRT-PCR using seven randomly selected circRNAs, and competing endogenous RNA (ceRNA) networks were exhibited by ten important circRNAs in duck adipocyte differentiation. circRNA plexin A1 (circ-PLXNA1) was detected in duck adipocytes and mainly expressed in adipose, leg muscle and liver. Inhibition of circ-PLXNA1 limited the differentiation of duck adipocyte. There were four corresponding miRNAs for circ-PLXNA1 and 313 target genes for those miRNAs. CeRNA"circ-PLXNA1/miR-214/CTNNB1 axis" was focused and verified by a dual-luciferase reporter experiment. After co-transfection of cells with si-circ-PLXNA1 and miR-214 mimics, the expression level of CTNNB1 was down-regulated, triglyceride content and the adipogenic capacity of preadipocytes decreased. While there were no significant change after si-CTNNB1 transfection. All these results provide further insight into the circRNAs, especially for circ-PLXNA1 in duck adipocyte differentiation.	[Wang, Laidi; Liang, Wenshuang; Wang, Shasha; Wang, Zhixiu; Jiang, Yong; Bi, Yulin; Chen, Guohong; Chang, Guobin] Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Jiangsu, Peoples R China; [Bai, Hao] Yangzhou Univ, Inst Agr Sci & Technol Dev, Minist Educ China, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Ministry of Education, China; Yangzhou University	Chang, GB (corresponding author), Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Jiangsu, Peoples R China.	gbchang@yzu.edu.cn		Wang, Laidi/0000-0003-0267-3025	National Science AMP; Technology Pillar Program of China [2015BAD03B03]; National Natural Science Youth Fund [31802057]; Jiangsu province 333 Talent Project [20180418]	National Science AMP; Technology Pillar Program of China; National Natural Science Youth Fund; Jiangsu province 333 Talent Project	This study was supported by the National Science & Technology Pillar Program of China [grant no 2015BAD03B03] (Guobin Chang), the National Natural Science Youth Fund [grant no 31802057] (Yulin Bi), and the Jiangsu province 333 Talent Project [grant no 20180418].	Cai HC, 2018, AGING-US, V10, P2511, DOI 10.18632/aging.101565; Cao FD, 2017, MOL MED REP, V16, P9301, DOI 10.3892/mmr.2017.7821; Chandrasekaran KS, 2017, CELL BIOCHEM FUNCT, V35, P464, DOI 10.1002/cbf.3304; Chen B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020177; Chen L, 2015, CURR GENOMICS, V16, P312, DOI 10.2174/1389202916666150707161554; Chen YH, 2017, GENE, V629, P35, DOI 10.1016/j.gene.2017.07.078; Cheng FX, 2020, DIAGN PATHOL, V15, DOI 10.1186/s13000-019-0914-1; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Ding F, 2015, CYTOTECHNOLOGY, V67, P773, DOI 10.1007/s10616-014-9715-2; Ding F, 2012, COMP BIOCHEM PHYS B, V163, P154, DOI 10.1016/j.cbpb.2012.05.014; Fu LY, 2018, CANCER MED-US, V7, P3101, DOI 10.1002/cam4.1574; Han D, 2017, HEPATOLOGY, V66, P1151, DOI 10.1002/hep.29270; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15184; Hermier D, 1997, J NUTR, V127, pS805, DOI 10.1093/jn/127.5.805S; Heumuller AW, 2019, CIRC RES, V124, P456, DOI 10.1161/CIRCRESAHA.118.314521; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Inestrosa NC, 2015, CELL TISSUE RES, V359, P215, DOI 10.1007/s00441-014-1996-4; Kong YX, 2016, NEURON, V91, P548, DOI 10.1016/j.neuron.2016.06.018; Kotan LD, 2019, CLIN GENET, V95, P320, DOI 10.1111/cge.13482; Kramer MC, 2015, GENE DEV, V29, P2168, DOI 10.1101/gad.270421.115; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li MY, 2018, THERANOSTICS, V8, P5855, DOI 10.7150/thno.27285; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Munoz-Descalzo S, 2015, SEMIN CELL DEV BIOL, V47-48, P101, DOI 10.1016/j.semcdb.2015.08.011; Ouyang HJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00172; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Roberto VP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21735-w; Sheng ZY, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00431; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Wang JZ, 2019, MOL THER, V27, P1718, DOI 10.1016/j.ymthe.2019.09.001; Wang Q, 2017, ALCOHOL, V58, P13, DOI 10.1016/j.alcohol.2016.11.006; Wang SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196371; Wang SS, 2018, GENE, V661, P126, DOI 10.1016/j.gene.2018.03.085; Wu Y, 2011, MOL BIOL REP, V38, P2479, DOI 10.1007/s11033-010-0384-8; Xi FX, 2019, INT J MOL SCI, V12, P8; Xu JY, 2019, FASEB J, V33, P2659, DOI 10.1096/fj.201800243RRR; Yang YB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx166; Yu H, 2018, BIOCHEM BIOPH RES CO, V506, P455, DOI 10.1016/j.bbrc.2018.10.087; Zhang XH, 2017, ONCOTARGET, V8, P34961, DOI 10.18632/oncotarget.16442; Zhang ZC, 2014, MOL CELL BIOL, V34, P2330, DOI 10.1128/MCB.00070-14; Zhao YF, 2017, EUR J PHARMACOL, V816, P138, DOI 10.1016/j.ejphar.2017.08.009; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	47	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236069	10.1371/journal.pone.0236069	http://dx.doi.org/10.1371/journal.pone.0236069			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692763	Green Published, gold			2022-12-26	WOS:000554606400031
J	Byrne, PO; Hristova, K; Leahy, DJ				Byrne, Patrick O.; Hristova, Kalina; Leahy, Daniel J.			EGFR forms ligand-independent oligomers that are distinct from the active state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor receptor; receptor tyrosine kinase; signal transduction; membrane protein; oligomerization; fluorescence resonance energy transfer; FRET; EGFR	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; PLASMA-MEMBRANE; EXTRACELLULAR REGION; PROTEIN INTERACTIONS; CATALYTIC-ACTIVITY; ENERGY-TRANSFER; KINASE DOMAIN; ACTIVATION; DIMERIZATION	The human epidermal growth factor receptor (EGFR/ERBB1) is a receptor tyrosine kinase (RTK) that forms activated oligomers in response to ligand. Much evidence indicates that EGFR/ERBB1 also forms oligomers in the absence of ligand, but the structure and physiological role of these ligand-independent oligomers remain unclear. To examine these features, we use fluorescence microscopy to measure the oligomer stability and FRET efficiency for homo- and hetero-oligomers of fluorescent protein-labeled forms of EGFR and its paralog, human epidermal growth factor receptor 2 (HER2/ERBB2) in vesicles derived from mammalian cell membranes. We observe that both receptors form ligand-independent oligomers at physiological plasma membrane concentrations. Mutations introduced in the kinase region at the active state asymmetric kinase dimer interface do not affect the stability of ligand-independent EGFR oligomers. These results indicate that ligand-independent EGFR oligomers form using interactions that are distinct from the EGFR active state.	[Byrne, Patrick O.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Byrne, Patrick O.; Leahy, Daniel J.] Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA; [Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Whiting Sch Engn, Baltimore, MD 21218 USA	Johns Hopkins University; University of Texas System; University of Texas Austin; Johns Hopkins University	Leahy, DJ (corresponding author), Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA.	dleahy@austin.utexas.edu		Leahy, Daniel/0000-0001-7074-2358	National Institutes of Health [5R01GM099321-17]; Cancer Prevention Research Institute of Texas (CPRIT) Grant [RR160023]; National Science Foundation (NSF) [MCB-1712740]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT) Grant; National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Institutes of Health Grant 5R01GM099321-17 and Cancer Prevention Research Institute of Texas (CPRIT) Grant RR160023 (to P.O.B. and D.J.L.) and by National Science Foundation (NSF) Grant MCB-1712740 (to K. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carpenter G, 1978, Symp Soc Dev Biol, P13; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; COWLEY GP, 1986, BRIT J CANCER, V53, P223, DOI 10.1038/bjc.1986.39; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; Del Piccolo N, 2012, ANAL CHEM, V84, P8650, DOI [10.1021/ac301776j, 10.1021/ac301776J]; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; Diwanji D, 2019, IUBMB LIFE, V71, P706, DOI 10.1002/iub.2060; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; GREEN MR, 1983, DEV BIOL, V100, P506, DOI 10.1016/0012-1606(83)90243-9; HOLLEY RW, 1977, P NATL ACAD SCI USA, V74, P5046, DOI 10.1073/pnas.74.11.5046; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Kim DH, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006660; King C, 2017, J BIOL CHEM, V292, P5291, DOI 10.1074/jbc.M116.764282; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; Kovacs E, 2015, MOL CELL BIOL, V35, P3083, DOI 10.1128/MCB.00248-15; Kozer N, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066002; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2008, ANAL CHEM, V80, P5976, DOI 10.1021/ac800616u; Liang SI, 2018, CELL REP, V22, P2593, DOI 10.1016/j.celrep.2018.02.031; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; OPRESKO LK, 1990, J CELL BIOL, V111, P1661, DOI 10.1083/jcb.111.4.1661; Padfield E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00005; Pahuja KB, 2018, CANCER CELL, V34, P792, DOI 10.1016/j.ccell.2018.09.010; Penuel E, 2002, J BIOL CHEM, V277, P28468, DOI 10.1074/jbc.M202510200; Pines G, 2010, ONCOGENE, V29, P5850, DOI 10.1038/onc.2010.313; Purba ER, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020013; Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n; Reddy CC, 1996, J CELL PHYSIOL, V166, P512, DOI 10.1002/(SICI)1097-4652(199603)166:3<512::AID-JCP6>3.0.CO;2-S; REES AR, 1979, NATURE, V281, P309, DOI 10.1038/281309a0; Sacco AG, 2016, ONCOTARGETS THER, V9, P1927, DOI 10.2147/OTT.S93720; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Sarabipour S, 2015, BBA-BIOMEMBRANES, V1848, P1591, DOI 10.1016/j.bbamem.2015.04.002; Singh DR, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.07.003; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stoneman MR, 2019, NAT METHODS, V16, P493, DOI 10.1038/s41592-019-0408-9; TODARO GJ, 1976, NATURE, V264, P26, DOI 10.1038/264026a0; Valley CC, 2015, MOL BIOL CELL, V26, P4087, DOI 10.1091/mbc.E15-05-0269; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1; Yang RYC, 2010, CHEM BIOL DRUG DES, V76, P1, DOI 10.1111/j.1747-0285.2010.00986.x; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yoshida T, 2008, INT J CANCER, V122, P1530, DOI 10.1002/ijc.23253; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zanetti-Domingues LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06632-0; Zhang FN, 2015, ANAL CHEM, V87, P9960, DOI 10.1021/acs.analchem.5b02572; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	70	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13353	13362		10.1074/jbc.RA120.012852	http://dx.doi.org/10.1074/jbc.RA120.012852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32727847	Green Published, hybrid			2022-12-26	WOS:000574483500018
J	Eaton, WD; McGee, KM; Alderfer, K; Jimenez, AR; Hajibabaei, M				Eaton, William D.; McGee, Katie M.; Alderfer, Kiley; Jimenez, Angie Ramirez; Hajibabaei, Mehrdad			Increase in abundance and decrease in richness of soil microbes following Hurricane Otto in three primary forest types in the Northern Zone of Costa Rica	PLOS ONE			English	Article							CARBON-USE EFFICIENCY; TROPICAL DRY FOREST; COMMUNITY STRUCTURE; FUNGAL COMMUNITIES; LIGNIN DEGRADATION; DEBRIS DEPOSITION; SUBTROPICAL WET; RAIN-FOREST; PUERTO-RICO; NITROGEN	Little is known of how hurricane-induced deposition of canopy material onto tropical forest floors influences the soil microbial communities involved in decomposition of these materials. In this study, to identify how soil bacterial and fungal communities might change after a hurricane, and their possible roles in the C and N cycles, soils were collected from five 2000 m(2)permanent plots in Lowland, Upland and Riparian primary forests in Costa Rica 3 months before and 7 months after Hurricane Otto damaged the forests. The soil Water, inorganic N and Biomass C increased and total organic C decreased Post-Hurricane, all of which best predicted the changes in the Post-Hurricane soil microbial communities. Post-Hurricane soils from all forest types showed significant changes in community composition of total bacteria, total fungi, and five functional groups of microbes (i.e., degrading/lignin degrading, NH4+-producing, and ammonium oxidizing bacteria, and the complex C degrading/wood rot/lignin degrading and ectomycorrhizal fungi), along with a decrease in richness in genera of all groups. As well, the mean proportion of DNA sequences (MPS) of all five functional groups increased. There were also significant changes in the MPS values of 7 different fungal and 7 different bacterial genera that were part of these functional groups. This is the first evidence that hurricane-induced deposition of canopy material is stimulating changes in the soil microbial communities after the hurricane, involving changes in specific taxonomic and functional group genera, and reduction in the community richness while selecting for dominant genera possibly better suited to process the canopy material. These changes may represent examples of taxonomic switching of functionally redundant microbial genera in response to dramatic changes in resource input. It is possible that differences in these microbial communities and genera may serve as indicators of disturbed and recovering regional soil ecosystems, and should be evaluated in the future.	[Eaton, William D.; Alderfer, Kiley; Jimenez, Angie Ramirez] Pace Univ, Biol Dept, New York, NY 10038 USA; [McGee, Katie M.; Hajibabaei, Mehrdad] Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON, Canada	Pace University; University of Guelph	Eaton, WD (corresponding author), Pace Univ, Biol Dept, New York, NY 10038 USA.	weaton@pace.edu	McGee, Katie/ABD-8317-2020	Eaton, William/0000-0002-6596-0331; Alderfer, Kiley/0000-0002-1073-6471				Alef K., 1995, METHODS APPL SOIL MI, P350; Anderson J. M., 1993, TROPICAL SOIL BIOL F; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; Anderson TH, 2003, AGR ECOSYST ENVIRON, V98, P285, DOI 10.1016/S0167-8809(03)00088-4; Anderson TH, 2010, SOIL BIOL BIOCHEM, V42, P2039, DOI 10.1016/j.soilbio.2010.06.026; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Baskaran P, 2017, NEW PHYTOL, V213, P1452, DOI 10.1111/nph.14213; Bossio DA, 2005, MICROB ECOL, V49, P50, DOI 10.1007/s00248-003-0209-6; Bradford MA, 2013, NEW PHYTOL, V199, P7, DOI 10.1111/nph.12334; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Cantrell SA, 2014, FOREST ECOL MANAG, V332, P22, DOI 10.1016/j.foreco.2014.07.010; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Mestre MC, 2011, FEMS MICROBIOL ECOL, V78, P531, DOI 10.1111/j.1574-6941.2011.01183.x; Chassot O, 2005, COSTA RICA, P1; Chen J, 2017, BIOGEOSCIENCES, V14, P2513, DOI 10.5194/bg-14-2513-2017; Cregger MA, 2014, FUNCT ECOL, V28, P1534, DOI 10.1111/1365-2435.12282; del Arroyo OG, 2018, GLOBAL CHANGE BIOL, V24, P1673, DOI 10.1111/gcb.14027; Deng Q, 2018, SOIL BIOL BIOCHEM, V121, P8, DOI 10.1016/j.soilbio.2018.02.023; Eaton WD, 2019, RESTOR ECOL, V27, P1263, DOI 10.1111/rec.12978; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Ewing SA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002838; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gavito ME, 2018, FOREST ECOL MANAG, V426, P81, DOI 10.1016/j.foreco.2017.08.041; Gonzalez G, 2014, FOREST ECOL MANAG, V332, P32, DOI 10.1016/j.foreco.2014.06.024; Hagenbo A, 2018, J ECOL, V106, P490, DOI 10.1111/1365-2745.12917; Hartshorn G.S., 1994, SELVA ECOLOGY NATURA; Herbert DA, 1999, ECOLOGY, V80, P908, DOI 10.1890/0012-9658(1999)080[0908:HDTAHF]2.0.CO;2; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; Huang XF, 2013, BIOTECHNOL BIOENG, V110, P1616, DOI 10.1002/bit.24833; Huang XQ, 2015, MICROBIOL RES, V181, P33, DOI 10.1016/j.micres.2015.08.004; Isobe K, 2011, J FOREST RES-JPN, V16, P351, DOI 10.1007/s10310-011-0266-5; Janusz G, 2017, FEMS MICROBIOL REV, V41, P941, DOI 10.1093/femsre/fux049; Jaramillo VJ, 2018, FOREST ECOL MANAG, V426, P72, DOI 10.1016/j.foreco.2017.12.031; JONES RD, 1980, MICROB ECOL, V6, P339, DOI 10.1007/BF02010496; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kaisermann A, 2015, APPL SOIL ECOL, V86, P158, DOI 10.1016/j.apsoil.2014.10.009; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; KIELAK AM, 2016, FRONT MICROBIOL, V7, P57220, DOI DOI 10.3389/FMICB.2016.0167427840624; Kivlin SN, 2016, ENVIRON MICROBIOL, V18, P4662, DOI 10.1111/1462-2920.13342; Krashevska V, 2012, OECOLOGIA, V170, P1067, DOI 10.1007/s00442-012-2360-6; Kyaschenko J, 2017, ISME J, V11, P863, DOI 10.1038/ismej.2016.184; Laverman AM, 2001, MICROB ECOL, V42, P35, DOI 10.1007/s002480000038; Lennon JT, 2012, ECOLOGY, V93, P1867, DOI 10.1890/11-1745.1; Liao XL, 2016, SCI TOTAL ENVIRON, V556, P136, DOI 10.1016/j.scitotenv.2016.02.203; Lin WR, 2011, SYDOWIA; Lindahl BD, 2015, NEW PHYTOL, V205, P1443, DOI 10.1111/nph.13201; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Liu XB, 2018, FORESTS, V9, DOI 10.3390/f9070420; Liu XB, 2018, FORESTS, V9, DOI 10.3390/f9060367; Lodge DJ, 2016, FORESTS, V7, DOI 10.3390/f7110264; Lodge DJ, 2014, FOREST ECOL MANAG, V332, P11, DOI 10.1016/j.foreco.2014.03.002; LODGE DJ, 1991, BIOTROPICA, V23, P336, DOI 10.2307/2388249; Long X, 2012, SOIL BIOL BIOCHEM, V46, P163, DOI 10.1016/j.soilbio.2011.12.013; Looby CI, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-12; LOVELL RD, 1995, SOIL BIOL BIOCHEM, V27, P969, DOI 10.1016/0038-0717(94)00241-R; Lugo AE, 2008, AUSTRAL ECOL, V33, P368, DOI 10.1111/j.1442-9993.2008.01894.x; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; McDowell WH, 1996, BIOTROPICA, V28, P577, DOI 10.2307/2389098; McGee KM, 2014, J INSECT BEHAV, V27, P206, DOI 10.1007/s10905-013-9413-5; McGee KM, 2019, MICROB ECOL, V77, P148, DOI 10.1007/s00248-018-1206-0; McGee KM, 2019, APPL SOIL ECOL, V137, P139, DOI 10.1016/j.apsoil.2019.02.007; Mcgee KM, 2015, APPL SOIL ECOL, V87, P99, DOI 10.1016/j.apsoil.2014.11.009; Mendes LW, 2015, MICROB ECOL, V70, P255, DOI 10.1007/s00248-014-0559-2; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Middelhoven WJ, 2006, ANTON LEEUW INT J G, V90, P57, DOI 10.1007/s10482-006-9060-3; MOORE JC, 1991, AGR ECOSYST ENVIRON, V34, P371, DOI 10.1016/0167-8809(91)90122-E; Navarrete A. A., 2010, Diversity, V2, P787; Navarrete AA, 2015, MOL ECOL, V24, P2433, DOI 10.1111/mec.13172; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Osburn ED, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02872; Ostertag R, 2003, ECOSYSTEMS, V6, P261, DOI 10.1007/PL00021512; Pajares S., 2016, FRONTIERS MICROBIOLO, V7, P921, DOI DOI 10.3389/FMICB.2016.00921; Paul Eldor Alvin, 2015, SOIL MICROBIOLOGY EC, Vfourth; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Powers JS, 2009, J ECOL, V97, P801, DOI 10.1111/j.1365-2745.2009.01515.x; Princic A, 1998, APPL ENVIRON MICROB, V64, P3584; Ranjan K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00779; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Rineau F, 2013, ISME J, V7, P2010, DOI 10.1038/ismej.2013.91; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; SANFORD RL, 1991, BIOTROPICA, V23, P364, DOI 10.2307/2388253; Silver WL, 2014, FOREST ECOL MANAG, V332, P47, DOI 10.1016/j.foreco.2014.05.018; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Sulman BN, 2017, ECOL LETT, V20, P1043, DOI 10.1111/ele.12802; Talbot JM, 2008, FUNCT ECOL, V22, P955, DOI 10.1111/j.1365-2435.2008.01402.x; TANNER EVJ, 1991, BIOTROPICA, V23, P513, DOI 10.2307/2388274; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; WHIGHAM DF, 1991, BIOTROPICA, V23, P434, DOI 10.2307/2388263; Yu SQ, 2019, ECOL EVOL, V9, P11344, DOI 10.1002/ece3.5635; Zak DR, 2019, NEW PHYTOL, V223, P33, DOI 10.1111/nph.15679; Zhou ZH, 2018, GLOBAL ECOL BIOGEOGR, V27, P110, DOI 10.1111/geb.12663	99	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0231187	10.1371/journal.pone.0231187	http://dx.doi.org/10.1371/journal.pone.0231187			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730267	Green Published, gold			2022-12-26	WOS:000556884700088
J	Llewelyn, VK; Berger, L; Glass, BD				Llewelyn, Victoria K.; Berger, Lee; Glass, Beverley D.			Can models of percutaneous absorption based on in vitro data in frogs predict in vivo absorption?	PLOS ONE			English	Article							WATER-BALANCE; SKIN; PERMEABILITY	The primary aim of in vitro testing of chemicals delivered via the percutaneous route is to predict the absorption that would ensue if exposure occurred in live animals. While there is mounting evidence that in vitro diffusion studies in mammalian skin can provide valid information regarding likely in vivo absorption, little is known whether such a correlation exists between in vitro diffusion testing and in vivo blood levels in amphibians. The current study used previously-reported in vitro absorption data for caffeine, benzoic acid, and ibuprofen across isolated skin from the cane toad (Rhinella marina) to produce a series of linear mixed-effect models of the absorption parameters flux and permeability coefficient (K-p). Models investigated the relative impacts of animal weight, physicochemical characteristics of the applied chemical (logP or molecular weight), and site of application. The top models were then used to predict the flux, K(p)and serum concentrations of the same three model chemicals. Finally, the absorption of these chemicals was determined in live cane toads, and results compared to the model predictions. LogP and site of application were included in all top models. In vivo absorption rates were lower than predicted for all chemicals, however, the models provided reasonable predictions of serum concentration, with factors of difference (FOD) ranging from 2.5-10.5. Ibuprofen, the chemical with the highest relative lipophilicity, had the poorest predictive performance, consistently having the highest FOD for all predictions. This report presents the first models of percutaneous absorption in an amphibian. These models provide a basic method to establish the approximate in vivo absorption of hydrophilic and moderately-lipophilic chemicals through frog skin, and could therefore be used to predict absorption when formulating such chemicals for treatment of disease in frogs, or for risk-assessments regarding chemical pollutants in frog habitats.	[Llewelyn, Victoria K.; Glass, Beverley D.] James Cook Univ, Coll Med & Dent, Pharm, Townsville, Qld, Australia; [Berger, Lee] Univ Melbourne, Melbourne Vet Sch, Hlth Res Grp 1, Werribee, Vic, Australia; [Llewelyn, Victoria K.] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia	James Cook University; University of Melbourne; Flinders University South Australia	Llewelyn, VK (corresponding author), James Cook Univ, Coll Med & Dent, Pharm, Townsville, Qld, Australia.; Llewelyn, VK (corresponding author), Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia.	victoria.llewelyn@my.jcu.edu.au	; Llewelyn, Victoria/J-8954-2016	Berger, Lee/0000-0001-9227-5439; Llewelyn, Victoria/0000-0002-2755-5343				Akomeah FK, 2007, J PHARM SCI-US, V96, P824, DOI 10.1002/jps.20773; [Anonymous], 2021, LANG ENV STAT COMP; Ardente AJ, 2008, ENVIRON TOXICOL PHAR, V25, P373, DOI 10.1016/j.etap.2007.12.001; Benech-Kieffer F, 2003, SKIN PHARMACOL APPL, V16, P343, DOI 10.1159/000072929; BENTLEY PJ, 1976, J PHYSIOL-LONDON, V261, P603, DOI 10.1113/jphysiol.1976.sp011576; Downes H., 2002, Journal of Herpetological Medicine and Surgery, V12, P4; Ertl RP, 1998, COMP BIOCHEM PHYS C, V121, P85, DOI 10.1016/S0742-8413(98)10032-4; European Medicines Agency Committee for Human Medicinal Products, 2018, CHMPQWP7082822018 EU; FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356; Godin B, 2007, ADV DRUG DELIVER REV, V59, P1152, DOI 10.1016/j.addr.2007.07.004; Jakasa I, 2008, HUM EXP TOXICOL, V27, P281, DOI 10.1177/0960327107085826; Kaufmann K, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-016-0080-y; KEARNS GL, 1981, J CHROMATOGR, V226, P183, DOI 10.1016/S0378-4347(00)84219-X; Kielhorn J, 2006, 235 WHO; Lehman PA, 2011, SKIN PHARMACOL PHYS, V24, P224, DOI 10.1159/000324884; LETCHER J, 1992, ZOO BIOL, V11, P243, DOI 10.1002/zoo.1430110404; Llewelyn VK, 2016, J VET PHARMACOL THER, V39, P109, DOI 10.1111/jvp.12264; Llewelyn VK, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02127; Llewelyn VK, 2019, ENVIRON TOXICOL CHEM, V38, P361, DOI 10.1002/etc.4302; Llewelyn VK, 2018, ENVIRON TOXICOL PHAR, V60, P5, DOI 10.1016/j.etap.2018.03.019; Moss GP, 2012, CURR OPIN COLLOID IN, V17, P166, DOI 10.1016/j.cocis.2012.01.002; Ockleford C, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5125; Organisation for Economic Co-operation and Development, 2004, SKIN ABS IN VIV METH; Organisation for Economic Co-operation and Development, 2011, GUID NOT DERM ABS; Pinheiro J., 2017, NLME LINEAR NONLINEA, P31; Quaranta A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007699; RIVIERE J E, 1979, Journal of Veterinary Pharmacology and Therapeutics, V2, P235, DOI 10.1111/j.1365-2885.1979.tb00381.x; Roberts AA, 2019, MED MYCOL, V57, P204, DOI 10.1093/mmy/myy010; SHOEMAKE.VH, 1965, COMP BIOCHEM PHYSIOL, V15, P81, DOI 10.1016/0010-406X(65)90336-1; TOLEDO RC, 1993, COMP BIOCHEM PHYS A, V105, P593, DOI 10.1016/0300-9629(93)90259-7; TRACY CR, 1976, ECOL MONOGR, V46, P293, DOI 10.2307/1942256; Willens S, 2006, ENVIRON TOXICOL PHAR, V22, P255, DOI 10.1016/j.etap.2006.04.010; Wright Kevin M., 2001, P15; Wright Kevin M., 2001, P309	34	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235737	10.1371/journal.pone.0235737	http://dx.doi.org/10.1371/journal.pone.0235737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726322	Green Published, Green Accepted, gold			2022-12-26	WOS:000556908900018
J	Veelenturf, CA; Sinclair, EM; Paladino, FV; Honarvar, S				Veelenturf, Callie A.; Sinclair, Elizabeth M.; Paladino, Frank V.; Honarvar, Shaya			Predicting the impacts of sea level rise in sea turtle nesting habitat on Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							CARETTA-CARETTA; DERMOCHELYS-CORIACEA; LEATHERBACK; CONSERVATION; SUCCESS; PRECIPITATION; VULNERABILITY; MORTALITY; SELECTION; AFRICA	Sea level is expected to rise 44 to 74 cm by the year 2100, which may have critical, previously un-investigated implications for sea turtle nesting habitat on Bioko Island, Equatorial Guinea. This study investigates how nesting habitat will likely be lost and altered with various increases in sea level, using global sea level rise (SLR) predictions from the Intergovernmental Panel on Climate Change. Beach profiling datasets from Bioko's five southern nesting beaches were used in GIS to create models to estimate habitat loss with predicted increases in sea level by years 2046-2065 and 2081-2100. The models indicate that an average of 62% of Bioko's current nesting habitat could be lost by 2046-2065 and 87% by the years 2081-2100. Our results show that different study beaches showed different levels of vulnerability to increases in SLR. In addition, on two beaches erosion and tall vegetation berms have been documented, causing green turtles to nest uncharacteristically in front of the vegetation line. We also report that development plans are currently underway on the beach least susceptible to future increases in sea level, highlighting how anthropogenic encroachment combined with SLR can be particularly detrimental to nesting turtle populations. Identified habitat sensitivities to SLR will be used to inform the government of Equatorial Guinea to consider the vulnerability of their resident turtle populations and projected climate change implications when planning for future development. To our knowledge this is the first study to predict the impacts of SLR on a sea turtle nesting habitat in Africa.	[Veelenturf, Callie A.; Sinclair, Elizabeth M.; Paladino, Frank V.; Honarvar, Shaya] Purdue Univ Ft Wayne, Dept Biol, Ft Wayne, IN 46805 USA; [Veelenturf, Callie A.; Sinclair, Elizabeth M.; Paladino, Frank V.; Honarvar, Shaya] Bioko Marine Turtle Program, Malabo, Equat Guinea; [Honarvar, Shaya] Univ Hawaii Manoa, Sch Life Sci, Honolulu, HI 96822 USA	Purdue University System; Purdue University; University of Hawaii System; University of Hawaii Manoa	Veelenturf, CA (corresponding author), Purdue Univ Ft Wayne, Dept Biol, Ft Wayne, IN 46805 USA.; Veelenturf, CA (corresponding author), Bioko Marine Turtle Program, Malabo, Equat Guinea.	info@leatherbackproject.org		Veelenturf, Callie/0000-0003-0435-0182; Paladino, Frank V./0000-0002-6452-0086	HESS Equatorial Guinea, Inc. [208369]; Purdue University Fort Wayne Schrey professorship	HESS Equatorial Guinea, Inc.; Purdue University Fort Wayne Schrey professorship	HESS Equatorial Guinea, Inc. (SH, #208369, https://www.hess.com/operations) and Purdue University Fort Wayne Schrey professorship (FP) provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J.D., 2006, ENDANGER SPECIES RES, V2, P21, DOI DOI 10.3354/ESR002021; Biasutti M, 2013, J GEOPHYS RES-ATMOS, V118, P9534, DOI 10.1002/jgrd.50694; BLANCK CE, 1981, J EXP MAR BIOL ECOL, V49, P163, DOI 10.1016/0022-0981(81)90068-X; BUSTARD HR, 1969, SCIENCE, V163, P939, DOI 10.1126/science.163.3870.939; Butynski Thomas M., 1996, Oryx, V30, P143; CASTROVIEJO J, 1994, BIODIVERS CONSERV, V3, P828, DOI 10.1007/BF00129661; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Cook KH, 2013, J CLIMATE, V26, P5931, DOI 10.1175/JCLI-D-12-00455.1; Cooper JAG, 2004, GLOBAL PLANET CHANGE, V43, P157, DOI 10.1016/j.gloplacha.2004.07.001; ECKERT KL, 1990, BIOL CONSERV, V53, P37, DOI 10.1016/0006-3207(90)90061-S; Fish MR, 2008, OCEAN COAST MANAGE, V51, P330, DOI 10.1016/j.ocecoaman.2007.09.002; Fish MR, 2005, CONSERV BIOL, V19, P482, DOI 10.1111/j.1523-1739.2005.00146.x; FLETCHER CH, 1992, EARTH-SCI REV, V33, P73, DOI 10.1016/0012-8252(92)90021-K; Fretey J, 2007, CHELONIAN CONSERV BI, V6, P126, DOI 10.2744/1071-8443(2007)6[126:LDCNAT]2.0.CO;2; Fuentes MMPB, 2010, AQUAT CONSERV, V20, P132, DOI 10.1002/aqc.1088; Garcia A, 2003, BIOL CONSERV, V111, P253, DOI 10.1016/S0006-3207(02)00300-2; Garcia-Grajales J, 2019, ANIM BIODIV CONSERV, V42, P143, DOI 10.32800/abc.2019.42.0143; Girondot M, 2002, ANIM CONSERV, V5, P75, DOI 10.1017/S1367943002001099; GORNITZ V, 1991, GLOBAL PLANET CHANGE, V89, P379, DOI 10.1016/0921-8181(91)90118-G; Gutierrez BT, 2011, J GEOPHYS RES-EARTH, V116, DOI [10.1029/20101F001891, 10.1029/2010JF001891]; Haensler A, 2013, CLIMATIC CHANGE, V121, P349, DOI 10.1007/s10584-013-0863-8; Hamann M, 2007, CLIMATE CHANGE GREAT, P667; Hays GC, 2001, INT J REMOTE SENS, V22, P1403, DOI 10.1080/01431160118422; Honarvar S, 2008, OECOLOGIA, V157, P221, DOI 10.1007/s00442-008-1065-3; Honarvar S, 2016, CHELONIAN CONSERV BI, V15, P79, DOI 10.2744/CCB-1194.1; HORROCKS JA, 1991, MAR ECOL PROG SER, V69, P1, DOI 10.3354/meps069001; Hughes GR, 1970, LAMMERGEYER, V12, P7; Kikukawa A, 1999, J ZOOL, V249, P447, DOI 10.1017/S0952836999009826; Kornaraki E, 2006, BIOL CONSERV, V130, P324, DOI 10.1016/j.biocon.2005.12.027; Limpus CJ, 2006, IMPACTS CLIMATE CHAN, P34; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Mimura N, 1999, CLIM RES, V12, P137, DOI 10.3354/cr012137; Mortimer Jeanne A., 1995, P45; Nicholls RJ, 2006, PHILOS T R SOC A, V364, P1073, DOI 10.1098/rsta.2006.1754; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Pariyar S., 2019, INT J ECOLOGY ENV SC, V1, P12; Poloczanska ES, 2009, ADV MAR BIOL, V56, P151, DOI 10.1016/S0065-2881(09)56002-6; PRITCHARD PCH, 1980, AM ZOOL, V20, P609; Salmon M, 1995, J HERPETOL, V29, P560, DOI 10.2307/1564739; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sylla MB, 2013, INT J CLIMATOL, V33, P1805, DOI 10.1002/joc.3551; Tomas J, 2010, BIODIVERS CONSERV, V19, P2699, DOI 10.1007/s10531-010-9868-z; Veelenturf CA, 2017, THESIS; Watterson I, 2007, REGIONAL CLIMATE CHA; WHITMORE CP, 1985, BIOL CONSERV, V34, P251, DOI 10.1016/0006-3207(85)90095-3; Woodroffe CD, 1999, MAR GEOL, V160, P85, DOI 10.1016/S0025-3227(99)00009-2; Wyneken J., 2013, BIOL SEA TURTLES, VIII, P353; Zavaleta-Lizarraga L, 2013, REV MEX BIODIVERS, V84, P927, DOI 10.7550/rmb.31913	50	4	4	9	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0222251	10.1371/journal.pone.0222251	http://dx.doi.org/10.1371/journal.pone.0222251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726310	gold, Green Submitted, Green Published			2022-12-26	WOS:000556908900050
J	Yi, KS; Choi, JA; Kim, P; Ryu, DK; Yang, EJ; Son, D; Shin, J; Park, H; Lee, S; Lee, HJ; Im, BH; Chae, JS; Lee, EB; Lee, SY; Song, MK				Yi, Kye Sook; Choi, Jung-ah; Kim, Pankyeom; Ryu, Dong-Kyun; Yang, Eunji; Son, Dain; Shin, JiYoung; Park, Hayan; Lee, Sena; Lee, HyunJoo; Im, Bok-Hyeon; Chae, Ji-Sang; Lee, Eun Beom; Lee, Soo-Young; Song, Manki			Broader neutralization of CT-P27 against influenza A subtypes by combining two human monoclonal antibodies	PLOS ONE			English	Article							EPITOPE	There are several broadly neutralizing monoclonal antibodies that neutralize influenza viruses with different mechanisms from traditional polyclonal antibodies induced by vaccination. CT149, which is one of the broadly neutralizing antibodies, was also previously reported to neutralize group 2 and some of group 1 influenza viruses (13 out of 13 tested group 2 viruses and 5 out of 11 group 1 viruses). In this study, we developed another antibody with the aim of compensating partial coverage of CT149 against group 1 influenza viruses. CT120 was screened among different antibody candidates and mixed with CT149. Importantly, although the binding sites of CT120 and CT149 are close to each other, the two antibodies do not interfere. The mixture of CT120 and CT149, which we named as CT-P27, showed broad efficacy by neutralizing 37 viruses from 11 different subtypes, of both group 1 and 2 influenza A viruses. Moreover, CT-P27 showedin vivotherapeutic efficacy, long prophylactic potency, and synergistic effect with oseltamivir in influenza virus-challenged mouse models. Our findings provide a novel therapeutic opportunity for more efficient treatment of influenza.	[Yi, Kye Sook; Kim, Pankyeom; Ryu, Dong-Kyun; Son, Dain; Shin, JiYoung; Lee, HyunJoo; Im, Bok-Hyeon; Chae, Ji-Sang; Lee, Eun Beom; Lee, Soo-Young] Celltrion Inc, Biotechnol Res Inst, Incheon, South Korea; [Choi, Jung-ah; Yang, Eunji; Park, Hayan; Lee, Sena; Song, Manki] Int Vaccine Inst, Sci Unit, Seoul, South Korea	Celltrion; International Vaccine Institute	Lee, SY (corresponding author), Celltrion Inc, Biotechnol Res Inst, Incheon, South Korea.; Song, MK (corresponding author), Int Vaccine Inst, Sci Unit, Seoul, South Korea.	mksong@IVI.INT; sooyoung.lee@celltrion.com		Ryu, Dong-Kyun/0000-0003-4237-4740	Korea Healthcare technology R&D Project - Grant [A103001]; Ministry of Health &Welfare, Republic of Korea [HI15C2971]	Korea Healthcare technology R&D Project - Grant; Ministry of Health &Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	1. Korea Healthcare technology R&D Project - Grant No.: A103001. 2. Ministry of Health &Welfare, Republic of Korea -- Grant No.: HI15C2971. The funder 'Biotechnology Research Institute, Celltrion Inc' provided support in the form of salaries for authors [Kye Sook Yi, Pankyeom Kim, Dong-kyun Ryu, Dain Son, JiYoung Shin, HyunJoo Lee, Bok-Hyeon Im, Ji-Sang Chae, Eun Beom Lee, Soo-Young Lee], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; Chosewood LC, 2009, BIOSAFETY MICROBIOLO; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Hayden FG, 2018, NEW ENGL J MED, V379, P913, DOI 10.1056/NEJMoa1716197; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kallewaard NL, 2016, CELL, V166, P596, DOI 10.1016/j.cell.2016.05.073; Lee HJ, 2013, BIOTECHNOL PROGR, V29, P432, DOI 10.1002/btpr.1685; Lee JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159823; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Omoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27890-4; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; Smith Steven M, 2010, Paediatr Drugs, V12, P285, DOI 10.2165/11532530-000000000-00000; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2014, J VIROL, V88, P13580, DOI 10.1128/JVI.02289-14; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Tharakaraman K, 2015, P NATL ACAD SCI USA, V112, P10890, DOI 10.1073/pnas.1502374112; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708	24	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236172	10.1371/journal.pone.0236172	http://dx.doi.org/10.1371/journal.pone.0236172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726321	Green Published, gold			2022-12-26	WOS:000556908900002
J	Kelly, S; Doyle, B; de Eyto, E; Dillane, M; McGinnity, P; Poole, R; White, M; Jennings, E				Kelly, Sean; Doyle, Brian; de Eyto, Elvira; Dillane, Mary; McGinnity, Phil; Poole, Russell; White, Martin; Jennings, Eleanor			Impacts of a record-breaking storm on physical and biogeochemical regimes along a catchment-to-coast continuum	PLOS ONE			English	Article							ECOSYSTEM METABOLISM; LAKE; WATER; DRIVEN; ESTUARINE; DYNAMICS; CLIMATE; EVENTS; FLOODS; WINTER	The impacts of changes in climate are often most readily observed through the effects of extremes in local weather, effects that often propagate through multiple ecosystem levels. Precise effects of any extreme weather event depend not only on the type of event and its timing, but also on the ecosystem affected. Here the cascade of effects following the arrival of an atmospheric river (directed by record-breaking Storm Desmond) across terrestrial, freshwater and coastal zones is quantified, using the Burrishoole system on the Atlantic coast of Ireland as a natural observatory. We used a network of high-frequencyin-situsensors to capture in detail the effects of an unprecedented period of rainfall, high wind speeds and above-average winter air temperatures on catchment and estuarine dynamics. In the main freshwater lake, water clarity decreased and acidity increased during Storm Desmond. Surface heat input, due to a warm and moist above-lake air mass, was rapidly distributed throughout the water column. River discharge into the downstream coastal basin was estimated to be the highest on record (since 1976), increasing the buoyancy flux by an order of magnitude and doubling the water column stratification stability. Entrainment of salt into the outflowing freshwater plume exported resident salt from the inner estuarine basin, resulting in net salt loss. Here, the increased stratification markedly reinforced isolation of the bottom waters, promoting deoxygenation. Measurements of current between the inner estuarine basin and the adjacent coastal waters indicated a 20-fold increase in the volume of seaward flowing low-salinity water, as a result of storm rainfall over the watershed. Storm impacts spanned the full catchment-to-coast continuum and these results provide a glimpse into a potential future for hydrological systems where these severe hydroclimatic events are expected to occur more frequently.	[Kelly, Sean; Doyle, Brian; Jennings, Eleanor] Dundalk Inst Technol, Ctr Freshwater & Environm Studies, Louth, Ireland; [Kelly, Sean; Doyle, Brian; de Eyto, Elvira; Dillane, Mary; McGinnity, Phil; Poole, Russell] Marine Inst, Newport, Mayo, Ireland; [McGinnity, Phil] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [White, Martin] Natl Univ Ireland Galway, Earth & Ocean Sci, Galway, Ireland	Dundalk Institute of Technology; Marine Institute Ireland; University College Cork; Ollscoil na Gaillimhe-University of Galway	Kelly, S (corresponding author), Dundalk Inst Technol, Ctr Freshwater & Environm Studies, Louth, Ireland.; Kelly, S (corresponding author), Marine Inst, Newport, Mayo, Ireland.	sean.kelly@dkit.ie		white, martin/0000-0003-3271-1221	Irish Government [CF/15/03, BEYOND 2020 PBA/FS/16/02]; Marine Institute under the Marine Research Programme [RESPI/FS/16/01]	Irish Government; Marine Institute under the Marine Research Programme	SK was funded under the Marine Research programme by the Irish Government (Cullen Fellowship CF/15/03 and BEYOND 2020 PBA/FS/16/02). PMcG was also supported by the Marine Institute under the Marine Research Programme (RESPI/FS/16/01). https://www.marine.ie/Home/home.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Allen GL, 1998, ESTUAR COAST SHELF S, V47, P487, DOI 10.1006/ecss.1998.0367; [Anonymous], 2011, ARCGIS DESKT REL 10; Barker L, 2016, WEATHER, V71, P324, DOI 10.1002/wea.2822; Bouffard D, 2016, BIOGEOSCIENCES, V13, P3573, DOI 10.5194/bg-13-3573-2016; Bowen MM, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001231; Breitburg D, 2018, SCIENCE, V359, P46, DOI 10.1126/science.aam7240; Chikita K, 2000, HYDROL PROCESS, V14, P557, DOI 10.1002/(SICI)1099-1085(20000228)14:3<557::AID-HYP954>3.0.CO;2-M; Cooney EM, 2018, J GEOPHYS RES-BIOGEO, V123, P1719, DOI 10.1029/2017JG004216; Cossu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057444; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; de Eyto E, 2019, ESTUAR COAST SHELF S, V218, P278, DOI 10.1016/j.ecss.2018.12.010; de Eyto E, 2016, INLAND WATERS, V6, P483, DOI 10.5268/IW-6.4.875; de Eyto E, 2016, CAN J FISH AQUAT SCI, V73, P1759, DOI 10.1139/cjfas-2015-0450; Deryugina T, 2013, CLIMATIC CHANGE, V118, P397, DOI 10.1007/s10584-012-0615-1; Doyle BC, 2019, BIOGEOSCIENCES, V16, P1053, DOI 10.5194/bg-16-1053-2019; Dyer K.R., 1997, ESTUARIES PHYS INTRO, Vsecond; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emery W.J., 2001, DATA ANAL METHODS PH, P159, DOI DOI 10.1016/C2010-0-66362-0; FARMER DM, 1983, PROG OCEANOGR, V12, P147, DOI 10.1016/0079-6611(83)90004-6; Fofonoff N. P., 1983, UNESCO TECHNICAL PAP; Giling DP, 2017, GLOBAL CHANGE BIOL, V23, P1448, DOI 10.1111/gcb.13512; Gill A., 1982, ATMOSPHERE OCEAN DYN; GILLIBRAND PA, 1995, J PHYS OCEANOGR, V25, P1488, DOI 10.1175/1520-0485(1995)025<1488:DWRITU>2.0.CO;2; HAAPALA H, 1975, OIKOS, V26, P26, DOI 10.2307/3543272; Haarsma RJ, 2013, GEOPHYS RES LETT, V40, P1783, DOI 10.1002/grl.50360; Havens KE, 2011, J PLANKTON RES, V33, P1081, DOI 10.1093/plankt/fbr002; Horn DA, 2001, J FLUID MECH, V434, P181, DOI 10.1017/S0022112001003536; Imada Y, 2018, B AM METEOROL SOC, V99, pS97, DOI 10.1175/BAMS-D-17-0109.1; IMBODEN DM, 1988, PROC INT ASSOC THE 1, V23, P67; Jennings E, 2012, FRESHWATER BIOL, V57, P589, DOI 10.1111/j.1365-2427.2011.02729.x; Kasprzak P, 2017, ECOSYSTEMS, V20, P1407, DOI 10.1007/s10021-017-0121-4; Kelly S, 2018, MAR ECOL PROG SER, V603, P265, DOI 10.3354/meps12727; Kelly S, 2018, MAR FRESHWATER RES, V69, P432, DOI 10.1071/MF17199; Kelly S. A., 2019, THESIS; KULLENBERG GEB, 1976, TELLUS, V28, P159, DOI 10.1111/j.2153-3490.1976.tb00663.x; Kunkel KE, 2013, B AM METEOROL SOC, V94, P499, DOI 10.1175/BAMS-D-11-00262.1; Laval BE, 2008, J GREAT LAKES RES, V34, P189, DOI 10.3394/0380-1330(2008)34[189:WSUIAF]2.0.CO;2; Lavers DA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034010; Lee SB, 2012, ESTUAR COAST SHELF S, V111, P1, DOI 10.1016/j.ecss.2012.05.034; Lorke A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034607; MacCready P, 1999, J PHYS OCEANOGR, V29, P708, DOI 10.1175/1520-0485(1999)029<0708:EATCIR>2.0.CO;2; Marine Institute, 2016, NEWP RES FAC ANN REP; Marine Institute, 2019, NEWP RES FAC ANN REP; Matthews T, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa98c8; McCarthy M, 2016, WEATHER, V71, P305, DOI 10.1002/wea.2823; Monismith SG, 2002, J PHYS OCEANOGR, V32, P3003, DOI 10.1175/1520-0485(2002)032<3003:SAFIVO>2.0.CO;2; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Nino Y, 2003, J HYDRAUL RES, V41, P609, DOI 10.1080/00221680309506893; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Otto FEL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050422; Otto FEL, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9663; Pakhomova S, 2014, GEOCHEM T, V15, DOI 10.1186/1467-4866-15-5; Perga ME, 2018, GLOBAL CHANGE BIOL, V24, P5004, DOI 10.1111/gcb.14384; Poole WR, 2018, ICES J MAR SCI, V75, P1627, DOI 10.1093/icesjms/fsy053; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Robins PE, 2016, ESTUAR COAST SHELF S, V169, P119, DOI 10.1016/j.ecss.2015.12.016; Robins PE, 2014, ESTUAR COAST SHELF S, V151, P88, DOI 10.1016/j.ecss.2014.09.019; Sadro S, 2012, ARCT ANTARCT ALP RES, V44, P222, DOI 10.1657/1938-4246-44.2.222; Schaller N, 2016, NAT CLIM CHANGE, V6, P627, DOI [10.1038/nclimate2927, 10.1038/NCLIMATE2927]; Schinke H, 1998, CONT SHELF RES, V18, P67, DOI 10.1016/S0278-4343(97)00071-X; Schmidt W., 1928, GEOGR ANN, V10, P145, DOI [10.1080/20014422.1928.11880475, DOI 10.2307/519789]; Shintani T, 2010, LIMNOL OCEANOGR, V55, P1377, DOI 10.4319/lo.2010.55.3.1377; Sieck LC, 2007, WATER RESOUR RES, V43, DOI [10.1029/2005wr004773, DOI 10.1029/2005WR004773]; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Thomson RE, 2017, J GEOPHYS RES-OCEANS, V122, P2976, DOI 10.1002/2016JC012512; Thorpe SA, 1998, LIMNOL OCEANOGR, V43, P936, DOI 10.4319/lo.1998.43.5.0936; Trenberth KE, 2012, CLIMATIC CHANGE, V115, P283, DOI 10.1007/s10584-012-0441-5; ValleLevinson A, 1996, CONT SHELF RES, V16, P1819, DOI 10.1016/0278-4343(96)00016-7; Vaz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047349; Voynova YG, 2017, BIOGEOSCIENCES, V14, P541, DOI 10.5194/bg-14-541-2017; Watts LJ, 1998, ESTUAR COAST SHELF S, V46, P39, DOI 10.1006/ecss.1997.0250; Wetz MS, 2013, MAR POLLUT BULL, V69, P7, DOI 10.1016/j.marpolbul.2013.01.020; Woolway RI, 2018, CLIMATIC CHANGE, V151, P333, DOI 10.1007/s10584-018-2302-3; Woolway RI, 2015, ENVIRON MODELL SOFTW, V70, P191, DOI 10.1016/j.envsoft.2015.04.013; Yang ZQ, 2015, ESTUAR COAST SHELF S, V156, P19, DOI 10.1016/j.ecss.2014.08.015; Zeng XB, 1998, J CLIMATE, V11, P2628, DOI 10.1175/1520-0442(1998)011<2628:IOBAAF>2.0.CO;2	77	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0235963	10.1371/journal.pone.0235963	http://dx.doi.org/10.1371/journal.pone.0235963			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722700	Green Published, gold			2022-12-26	WOS:000556916000009
J	Johnson, SC; Chakraborty, S; Drosou, A; Cunnea, P; Tzovaras, D; Nixon, K; Zawieja, DC; Muthuchamy, M; Fotopoulou, C; Moore, JE				Johnson, Sarah C.; Chakraborty, Sanjukta; Drosou, Anastasios; Cunnea, Paula; Tzovaras, Dimitrios; Nixon, Katherine; Zawieja, David C.; Muthuchamy, Mariappan; Fotopoulou, Christina; Moore, James E., Jr.			Inflammatory state of lymphatic vessels and miRNA profiles associated with relapse in ovarian cancer patients	PLOS ONE			English	Article							CELLS; LYMPHANGIOGENESIS; GROWTH; ANGIOGENESIS; MYELOPEROXIDASE; EXPRESSION; SURVIVAL; TUMORIGENESIS; METASTASIS; MICRORNAS	Lymphogenic spread is associated with poor prognosis in epithelial ovarian cancer (EOC), yet little is known regarding roles of non-peri-tumoural lymphatic vessels (LVs) outside the tumour microenvironment that may impact relapse. The aim of this feasibility study was to assess whether inflammatory status of the LVs and/or changes in the miRNA profile of the LVs have potential prognostic and predictive value for overall outcome and risk of relapse. Samples of macroscopically normal human lymph LVs (n = 10) were isolated from the external iliac vessels draining the pelvic region of patients undergoing debulking surgery. This was followed by quantification of the inflammatory state (low, medium and high) and presence of cancer-infiltration of each LV using immunohistochemistry. LV miRNA expression profiling was also performed, and analysed in the context of high versus low inflammation, and cancer-infiltrated versus non-cancer-infiltrated. Results were correlated with clinical outcome data including relapse with an average follow-up time of 13.3 months. The presence of a high degree of inflammation correlated significantly with patient relapse (p = 0.033). Cancer-infiltrated LVs showed a moderate but non-significant association with relapse (p = 0.07). Differential miRNA profiles were identified in cancer-infiltrated LVs and those with high versus low inflammation. In particular, several members of the let-7 family were consistently down-regulated in highly inflamed LVs (>1.8-fold, p<0.05) compared to the less inflamed ones. Down-regulation of the let-7 family appears to be associated with inflammation, but whether inflammation contributes to or is an effect of cancer-infiltration requires further investigation.	[Johnson, Sarah C.; Moore, James E., Jr.] Imperial Coll London, Dept Bioengn, London, England; [Chakraborty, Sanjukta; Zawieja, David C.; Muthuchamy, Mariappan] Texas A&M Univ, Coll Med, College Stn, TX 77843 USA; [Drosou, Anastasios; Tzovaras, Dimitrios] Ctr Res & Technol Hellas, Informat Technol Inst, Thessaloniki, Greece; [Cunnea, Paula; Nixon, Katherine; Fotopoulou, Christina] Imperial Coll London, Dept Surg & Canc, London, England	Imperial College London; Texas A&M University System; Texas A&M University College Station; Centre for Research & Technology Hellas; Imperial College London	Moore, JE (corresponding author), Imperial Coll London, Dept Bioengn, London, England.	james.moore.jr@imperial.ac.uk	Chakraborty, Sanjukta/AFO-9240-2022; Tzovaras, Dimitrios/ABB-9576-2021; Moore, James/D-1326-2013	Chakraborty, Sanjukta/0000-0002-4869-3198; Tzovaras, Dimitrios/0000-0001-6915-6722; Johnson, Sarah/0000-0002-0174-6483; Moore, James/0000-0003-1604-158X	Myrovlytis Trust; Rosetrees Trust; Imperial Health Charity; Imperial Private Healthcare; NIH [U01-HL123420]	Myrovlytis Trust; Rosetrees Trust(Rosetrees Trust); Imperial Health Charity; Imperial Private Healthcare; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CF and PC are funded by the Myrovlytis Trust (https://www.myrovlytistrust.org), Rosetrees Trust (https://rosetreestrust.co.uk/) and Imperial Health Charity (https://www.imperialcharity.org.uk/), KN is funded by Imperial Private Healthcare (https://imperialprivatehealthcare.co.uk/) and Imperial Health Charity. DZ and JM acknowledge funding from NIH grant U01-HL123420. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the `author contributions' section.	Aldrich MB, 2013, CYTOKINE, V64, P362, DOI 10.1016/j.cyto.2013.05.015; Bachmann C, 2016, J CANCER, V7, P2241, DOI 10.7150/jca.15644; Bachmann C, 2016, MOL CLIN ONCOL, V5, P483, DOI 10.3892/mco.2016.982; Bao Mh, 2014, PLOS ONE, V9, P1; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Boyerinas B, 2012, MICRORNA, V1, P34, DOI [10.2174/2211536611201010034, DOI 10.2174/2211536611201010034]; Bridenbaugh EA, 2013, LYMPHAT RES BIOL, V11, P155, DOI 10.1089/lrb.2013.0023; Cai J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.39; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Castillo-Tong DC, 2014, TUMOR BIOL, V35, P141, DOI 10.1007/s13277-013-1017-3; Chakraborty S, 2015, AM J PHYSIOL-HEART C, V309, pH2042, DOI 10.1152/ajpheart.00467.2015; Chakraborty S, 2015, AM J PHYSIOL-CELL PH, V309, pC680, DOI 10.1152/ajpcell.00122.2015; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Chen X, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0304-6; Choudhury Saibyasachi N, 2012, Microrna, V1, P65; Cromer WE, 2014, ANGIOGENESIS, V17, P395, DOI 10.1007/s10456-013-9393-2; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Deb B, 2018, J CELL PHYSIOL, V233, P3846, DOI 10.1002/jcp.26095; Dieterich LC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00066; Ding ZF, 2013, INT J CARDIOL, V168, P1378, DOI 10.1016/j.ijcard.2012.12.045; Dowdle A, 2013, PALGRAVE PIVOT, P16; Dubrot J, 2014, J EXP MED, V211, P1153, DOI 10.1084/jem.20132000; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabbri E, 2016, ONCOL REP, V35, P2866, DOI 10.3892/or.2016.4676; Fu X, 2012, FEBS LETT, V586, P1279, DOI 10.1016/j.febslet.2012.03.006; Gerard C, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00848; Giacca M, 2012, GENE THER, V19, P622, DOI 10.1038/gt.2012.17; Guan H, 2013, EUROPEAN J IMMUNOLOG, V01, P43; Han SC, 2018, MED SCI MONIT BASIC, V24, P40, DOI 10.12659/MSMBR.907333; Harter P, 2019, NEW ENGL J MED, V380, P822, DOI 10.1056/NEJMoa1808424; Honglei Y, INT J CLIN EXP PATHO, V9, P3357; Hu J, 2014, EUR J CANCER, V50, P2336, DOI 10.1016/j.ejca.2014.06.005; Hunter MC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00613; Ji XM, 2019, MOL CELL BIOCHEM, V462, P75, DOI 10.1007/s11010-019-03611-x; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones D, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00036; Jones D, 2012, ARTERIOSCL THROM VAS, V32, P633, DOI 10.1161/ATVBAHA.111.243576; Kagawa T, 2016, ENDOCR J, V63, P375, DOI 10.1507/endocrj.EJ15-0577; Khan Amjad A, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6020033; Klinke A, 2011, BLOOD, V117, P1350, DOI 10.1182/blood-2010-05-284513; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Leu AJ, 2000, CANCER RES, V60, P4324; Li J, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.62; Liang L, 2017, ONCOTARGET, V8, P107033, DOI 10.18632/oncotarget.22300; Liao S, 2011, P NATL ACAD SCI USA, V108, P18784, DOI 10.1073/pnas.1116152108; Liao YC, 2014, J AM COLL CARDIOL, V63, P1685, DOI 10.1016/j.jacc.2013.09.069; Lin ZW, 2017, SCI REP-UK, V7, DOI 10.1038/srep42498; Liu NH, 2012, CANCER INVEST, V30, P577, DOI 10.3109/07357907.2012.707265; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Petrillo M, 2016, ANN ONCOL, V27, P625, DOI 10.1093/annonc/mdw007; Qin B, 2012, BMB REP, V45, P464, DOI 10.5483/BMBRep.2012.45.8.033; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Stachura J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1182278; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Sun CY, 2012, CARCINOGENESIS, P34; Swaminathan S, 2012, J IMMUNOL, V188, P6238, DOI 10.4049/jimmunol.1101196; Tiruppathi C, 2004, P NATL ACAD SCI USA, V101, P7699, DOI 10.1073/pnas.0401712101; Tzeng HE, 2016, ONCOTARGET, V7, P38566, DOI 10.18632/oncotarget.9570; Vierra A, 2005, RES SERIES, V37; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang S, 2019, J CELL MOL MED, V23, P556, DOI 10.1111/jcmm.13960; Wimberger P, 2007, GYNECOL ONCOL, V106, P69, DOI 10.1016/j.ygyno.2007.02.026; Wu XD, 2017, ONCOTARGET, V8, P58072, DOI 10.18632/oncotarget.19489; Xu JB, 2012, INT J CANCER, V130, P787, DOI 10.1002/ijc.26035; Yang G, 2016, ONCOTARGET, V7, P55900, DOI 10.18632/oncotarget.10152; Yee D, 2017, J BIOL CHEM, V292, P20683, DOI 10.1074/jbc.M117.809053; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zolla V, 2015, AGING CELL, V14, P582, DOI 10.1111/acel.12330	75	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0230092	10.1371/journal.pone.0230092	http://dx.doi.org/10.1371/journal.pone.0230092			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716937	Green Submitted, Green Published, gold			2022-12-26	WOS:000556674500032
J	Koc, OM; Kremer, C; Hens, N; Bielen, R; Busschots, D; Van Damme, P; Robaeys, G				Koc, Ozgur M.; Kremer, Cecile; Hens, Niel; Bielen, Rob; Busschots, Dana; Van Damme, Pierre; Robaeys, Geert			Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium	PLOS ONE			English	Article							VIRUS INFECTION; HORIZONTAL TRANSMISSION; LIVER-CANCER; PREVALENCE; MODEL; VACCINATION; POPULATION; COVERAGE; CHILDREN; FLANDERS	Background Turkey is an intermediate hepatitis B virus (HBV) endemic country. However, prevalence among Turkish migrants in Belgium is unknown, especially in those born in Belgium with a foreign-born parent, i.e. second-generation migrants (SGM). Aims To evaluate the prevalence of HBV infection and associated risk factors in Turkish first-generation migrants (FGM), i.e. foreign-born, and SGM. Methods Between September 2017 and May 2019, free outreach testing for hepatitis B surface antigen (HBsAg), hepatitis B core antibodies (anti-HBc), and antibodies against HBsAg was offered to Turkish migrants in Middle-Limburg, Belgium. Face-to-face questionnaire assessed HBV risk factors. HBsAg positive patients were referred and followed up. Turkish SGM were stratified into birth cohort born before and after 1987, since those born after 1987 should be covered by the universal infant vaccination program. Results A total of 1,081/1,113 (97.1%) Turkish did go for HBV testing. Twenty-six (2.4%) were HBsAg positive; 11/26 were unaware of their status and 10/11 were successfully referred. HBsAg prevalence was 3.0% in FGM and 1.5% in SGM,p= .070. Only one out of seven HBsAg positive SGM was born after 1987. In the multiple generalized estimating equations model, the most important risk factors for anti-HBc positivity were male gender (p= .021), older age (p< .001), FGM (p< .001), low educational level of the mother (p= .003), HBV infected mother (p= .008), HBV infected siblings (p= .002), HBV infected other family member (p= .004), gynaecological examination in Turkey or unsafe male circumcision (p= .032) and dental treatment in Turkey (p= .049). Conclusion Outreach testing was well-accepted and referral to specialist care was generally successful. National HBV screening should be implemented in the Turkish FGM population and might be considered in SGM not covered by primary prevention strategies.	[Koc, Ozgur M.; Bielen, Rob; Busschots, Dana; Robaeys, Geert] Ziekenhuis Oost Limburg, Dept Gastroenterol & Hepatol, Genk, Belgium; [Koc, Ozgur M.; Bielen, Rob; Busschots, Dana; Robaeys, Geert] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium; [Koc, Ozgur M.] Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands; [Kremer, Cecile; Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I Biost, Data Sci Inst, Hasselt, Belgium; [Hens, Niel] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modelling Infect Dis, Antwerp, Belgium; [Van Damme, Pierre] Antwerp Univ, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Antwerp, Belgium; [Robaeys, Geert] KULeuven, Dept Gastroenterol & Hepatol, Univ Hosp, Leuven, Belgium	East Limburg Hospital; Hasselt University; Maastricht University; Hasselt University; University of Antwerp; University of Antwerp; KU Leuven	Koc, OM (corresponding author), Ziekenhuis Oost Limburg, Dept Gastroenterol & Hepatol, Genk, Belgium.; Koc, OM (corresponding author), Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.; Koc, OM (corresponding author), Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands.	ozgur.koc@uhasselt.be	Kremer, Cécile/ABG-8062-2021; Hens, Niel/M-4445-2017	van damme, pierre/0000-0002-8642-1249; Hens, Niel/0000-0003-1881-0637	Gilead Sciences	Gilead Sciences(Gilead Sciences)	This study was sponsored by Gilead Sciences. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad AA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2921-8; Bailey MB, 2011, J COMMUN HEALTH, V36, P538, DOI 10.1007/s10900-010-9339-1; Beutels M, 1997, EUR J EPIDEMIOL, V13, P275, DOI 10.1023/A:1007393405966; Burgazli KM, 2014, EUR REV MED PHARMACO, V18, P869; Chang ET, 2009, AM J HEALTH PROMOT, V23, P176, DOI 10.4278/ajhp.071025115; Cohen C, 2011, J VIRAL HEPATITIS, V18, P377, DOI 10.1111/j.1365-2893.2010.01401.x; Degertekin H, 2008, PUBLIC HEALTH, V122, P1315, DOI 10.1016/j.puhe.2008.04.010; Doganci T, 2005, WORLD J GASTROENTERO, V11, P418, DOI 10.3748/wjg.v11.i3.418; Erol S, 2003, EUR J GASTROEN HEPAT, V15, P345, DOI 10.1097/00042737-200304000-00002; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Harris AM, 2018, MMWR-MORBID MORTAL W, V67, P541, DOI 10.15585/mmwr.mm6719a2; Juon HS, 2008, J COMMUN HEALTH, V33, P199, DOI 10.1007/s10900-008-9091-y; Koc O, 2019, EURO SURVEILL, V24; Koc OM, 2018, ACTA GASTRO-ENT BELG, V81, P503; Koc OM, 2019, J MED VIROL; Koc OM, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015412; Lernout T, 2014, CLIN MICROBIOL INFEC, V20, P19, DOI 10.1111/1469-0691.12535; Molenberghs G., 2005, MODELS DISCRETE LONG; Myran DT, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091898; Ortiz E, 2019, J COMMUNITY HLTH; Papatheodoridis G, 2015, J VIRAL HEPATITIS, V22, P409, DOI 10.1111/jvh.12314; Papatheodoridis GV, 2012, J HEPATOL, V57, P196, DOI 10.1016/j.jhep.2011.11.030; Pollack H, 2011, HEALTH AFFAIR, V30, P1974, DOI 10.1377/hlthaff.2011.0700; Quoilin S, 2007, EUR J EPIDEMIOL, V22, P195, DOI 10.1007/s10654-007-9105-6; Richter C, 2012, EPIDEMIOL INFECT, V140, P724, DOI 10.1017/S0950268811001270; Suijkerbuijk AWM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207037; Terrault NA, 2018, HEPATOLOGY, V67, P1560, DOI 10.1002/hep.29800; Theeten H, 2014, EPIDEMIOL INFECT, V142, P251, DOI 10.1017/S0950268813001064; Theeten H, 2009, ACTA PAEDIATR, V98, P1307, DOI 10.1111/j.1651-2227.2009.01331.x; Toy M, 2013, BEST PRACT RES CL GA, V27, P973, DOI 10.1016/j.bpg.2013.08.020; Toy M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-337; Tozun N, 2015, CLIN MICROBIOL INFEC, V21, P1020, DOI 10.1016/j.cmi.2015.06.028; Ucmak H, 2007, EPIDEMIOL INFECT, V135, P1338, DOI 10.1017/S0950268807008011; Vandermeulen C, 2008, PEDIATRICS, V121, pE428, DOI 10.1542/peds.2007-1415; Veldhuijzen IK, 2012, J HEPATOL, V57, P1171, DOI 10.1016/j.jhep.2012.07.036; Ward JW, 2019, GASTROENTEROLOGY, V156, P297, DOI 10.1053/j.gastro.2018.10.048; Whelan J, 2012, VACCINE, V30, P5651, DOI 10.1016/j.vaccine.2012.06.080; World Health Organization, 2018, HEP B	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0234740	10.1371/journal.pone.0234740; 10.1371/journal.pone.0234740.r001; 10.1371/journal.pone.0234740.r002; 10.1371/journal.pone.0234740.r003; 10.1371/journal.pone.0234740.r004	http://dx.doi.org/10.1371/journal.pone.0234740; 10.1371/journal.pone.0234740.r001; 10.1371/journal.pone.0234740.r002; 10.1371/journal.pone.0234740.r003; 10.1371/journal.pone.0234740.r004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV9ND	32716949	Green Published, gold			2022-12-26	WOS:000556674500051
J	Zhang, Y; Liu, Y; Gong, HH; Wu, L				Zhang, Yue; Liu, Ying; Gong, Honghan; Wu, Lin			Quantitative lung lesion features and temporal changes on chest CT in patients with common and severe SARS-CoV-2 pneumonia	PLOS ONE			English	Article							CORONAVIRUS; OUTBREAK	The purpose of this study was to describe the temporal evolution of quantitative lung lesion features on chest computed tomography (CT) in patients with common and severe types of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Records of patients diagnosed with SARS-CoV-2 pneumonia were reviewed retrospectively from 24 January 2020 to 15 March 2020. Patients were classified into common and severe groups according to the diagnostic criteria of severe pneumonia. The quantitative CT features of lung lesions were automatically calculated using artificial intelligence algorithms, and the percentages of ground-glass opacity volume (PGV), consolidation volume (PCV) and total lesion volume (PTV) were determined in both lungs. PGV, PCV and PTV were analyzed based on the time from the onset of initial symptoms in the common and severe groups. In the common group, PTV increased slowly and peaked at approximately 12 days from the onset of the initial symptoms. In the severe group, PTV peaked at approximately 17 days. The severe pneumonia group exhibited increased PGV, PCV and PTV compared with the common group. These features started to appear in Stage 2 (4-7 days from onset of initial symptoms) and were observed in all subsequent stages (p<0.05). In severe SARS-CoV-2 pneumonia patients, PGV, PCV and PTV began to significantly increase in Stage 2 and decrease in Stage 5 (22-30 days). Compared with common SARS-CoV-2 pneumonia patients, the patients in the severe group exhibited increased PGV, PCV and PTV as well as a later peak time of lesion and recovery time.	[Zhang, Yue] Nanchang Univ, Affiliated Hosp 1, Hlth Management Ctr, Nanchang, Jiangxi, Peoples R China; [Liu, Ying] Nanchang Univ, Affiliated Hosp 1, Dept Emergency Med, Nanchang, Jiangxi, Peoples R China; [Gong, Honghan; Wu, Lin] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Wu, L (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.	linwuncu@163.com			Natural Science Foundation of Jiangxi, China [2017BAB215048]; Science and Technology Project of Jiangxi Health Committee [20181020]; Science and Technology Research Project of Jiangxi Provincial Department of Education [700993003]	Natural Science Foundation of Jiangxi, China(Natural Science Foundation of Jiangxi Province); Science and Technology Project of Jiangxi Health Committee; Science and Technology Research Project of Jiangxi Provincial Department of Education	This study was supported by the Natural Science Foundation of Jiangxi, China (Grant no. 2017BAB215048), the Science and Technology Project of Jiangxi Health Committee (Grant no. 20181020), and the Science and Technology Research Project of Jiangxi Provincial Department of Education (Grant no. 700993003).	Abdi M, 2020, INFECT CONT HOSP EP, V41, P754, DOI 10.1017/ice.2020.86; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Al-Mandhari A, 2020, E MEDITERR HEALTH J, V26, P136, DOI 10.26719/2020.26.2.136; Ali SA, 2020, J INFECT PUBLIC HEAL, V13, P644, DOI [10.1016/j.jiph.2020.02.033, 10.1016/j.jiph.2019.02.033]; [Anonymous], 2020, NEW CORONAVIRUS PNEU; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1148/radiol.2020200230, 10.1007/s00330-019-06574-1]; Depeursinge A, 2015, INVEST RADIOL, V50, P261, DOI 10.1097/RLI.0000000000000127; Duan YN, 2020, RADIOLOGY, V295, P21, DOI 10.1148/radiol.2020200323; Fang Y, 2020, RADIOLOGY, DOI [10.1148/radiol.2020200432:200432, DOI 10.1148/RADIOL.2020200432:200432]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kanne JP, 2020, RADIOLOGY, V295, P16, DOI 10.1148/radiol.2020200241; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Li L., 2020, RADIOLOGY, V296, pe65, DOI 10.1148/radiol.2020200905; Liu KC, 2020, EUR J RADIOL, V126, DOI 10.1016/j.ejrad.2020.108941; Pan F, 2020, RADIOLOGY, DOI 10.1148/radiol.2020200370; Patrucco F, 2020, PANMINERVA MED, V62, P73, DOI 10.23736/S0031-0808.20.03897-5; Reeves JJ, 2020, J AM MED INFORM ASSN, V27, P853, DOI 10.1093/jamia/ocaa037; Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang Y, 2020, RADIOLOGY, DOI [10.1148/radiol.2020200843:200843, DOI 10.1148/RADIOL.2020200843]; Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490	22	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236858	10.1371/journal.pone.0236858	http://dx.doi.org/10.1371/journal.pone.0236858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706819	Green Published, gold			2022-12-26	WOS:000579931700063
J	Babazadeh, S; Anglewicz, P; Wisniewski, JM; Kayembe, PK; Hernandez, J; Bertrand, JT				Babazadeh, Saleh; Anglewicz, Philip; Wisniewski, Janna M.; Kayembe, Patrick K.; Hernandez, Julie; Bertrand, Jane T.			The influence of health facility-level access measures on modern contraceptive use in Kinshasa, DRC	PLOS ONE			English	Article							FAMILY-PLANNING-SERVICES; CONTEXTUAL INFLUENCES; FERTILITY TRANSITION; WOMEN; CARE; DETERMINANTS; QUALITY; IMPACT; COMMUNICATION; COUNTRIES	Expanding access to family planning (FP) is a principal objective of global family planning efforts and has been a driving force of national family planning programs in recent years. Many country programs are working alongside with the international family planning community to expand access to modern contraceptives. However, there is a challenging need for measuring all aspects of access. Measuring access usually requires linking information from multiple sources (e.g., individual women and facilities). To assess the influence of access to family planning services on modern contraceptive use among women, we link four rounds of individual women and service delivery points survey data from PMA2020 in Kinshasa. Multilevel logistics regression on pooled data is performed to test the influence of facility-level access factors on individual-level contraceptive use. We add variables tailored from a conceptual framework to cover elements of access to family planning: administrative access, geographic or physical access, economic access or affordability, cognitive access, service quality, and psychological access. We find that the effect of community and facility-level access factors varies extensively but having fewer stocked-out facilities and more facilities with long-acting permanent methods (LAPM) increases the odds of using modern contraceptives among women in Kinshasa. Our study shows that reliable supply chain with a broad array of method mix will increase the odds of modern contraceptive use at community level among women in Kinshasa. Using to community-oriented practices and service delivery along with empowering women to make health-related decisions should become a priority of family planning programs and international stakeholders in the country.	[Babazadeh, Saleh; Wisniewski, Janna M.; Hernandez, Julie; Bertrand, Jane T.] Tulane Sch Publ Hlth & Trop Med, Dept Hlth Policy & Management, New Orleans, LA 70112 USA; [Anglewicz, Philip] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Kayembe, Patrick K.] Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO	Tulane University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universite de Kinshasa	Babazadeh, S (corresponding author), Tulane Sch Publ Hlth & Trop Med, Dept Hlth Policy & Management, New Orleans, LA 70112 USA.	sbabazad@tulane.edu		Babazadeh, Saleh/0000-0002-2178-310X	BMGF	BMGF	BMGF is the grant awarded to Tulane University to implement PMA2020 surveys in the DRC. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L. B., 1998, Contributions to Nepalese Studies, V25, P95; Adebayo SB, 2013, J BIOSOC SCI, V45, P57, DOI 10.1017/S0021932012000326; Akilimali P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022295; Akin JS, 1999, HEALTH POLICY PLANN, V14, P135, DOI 10.1093/heapol/14.2.135; [Anonymous], 2018, PMA2020 PERF MONT AC; [Anonymous], 2019, AFRICAN PRIME NEWS; Bawah AA, 2002, STUD FAMILY PLANN, V33, P185, DOI 10.1111/j.1728-4465.2002.00185.x; BERTRAND JT, 1995, INT FAM PLAN PERSPEC, V21, P64, DOI 10.2307/2133525; Blackstone SR, 2017, INT Q COMMUNITY HEAL, V37, P79, DOI 10.1177/0272684X16685254; Bogale B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-342; BONGAARTS J, 1984, POPUL DEV REV, V10, P511, DOI 10.2307/1973518; Burgert CR, 2014, LINKING DHS HOUSEHOL; CALDWELL JC, 1992, POPUL DEV REV, V18, P211, DOI 10.2307/1973678; Chamla Dick D, 2007, Confl Health, V1, P12, DOI 10.1186/1752-1505-1-12; CHAYOVAN N, 1984, STUD FAMILY PLANN, V15, P201, DOI 10.2307/1965734; Choi Y, 2016, STUD FAMILY PLANN, V47, P145, DOI 10.1111/j.1728-4465.2016.00059.x; CLELAND J, 1987, POP STUD-J DEMOG, V41, P5, DOI 10.1080/0032472031000142516; Clements Steve, 2004, Afr J Reprod Health, V8, P124, DOI 10.2307/3583186; Colleran H, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0398; CORNELIUS RM, 1983, STUD FAMILY PLANN, V14, P302, DOI 10.2307/1965616; Curtis SL, 1996, CONTRACEPTIVE KNOWLE; Demographia, 2019, DEMOGRAPHIA, V1904; Donabedian A, 1973, ASPECTS MEDICALCARE; Dynes M, 2012, HEALTH PLACE, V18, P766, DOI 10.1016/j.healthplace.2012.04.006; Ejembi C.L., 2015, CONTEXTUAL FACTORS I; Elfstrom KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040670; Engstrom R, 2013, J MAPS, V9, P36, DOI 10.1080/17445647.2013.765366; Entwisle B, 1997, DEMOGRAPHY, V34, P171, DOI 10.2307/2061697; GAGE AJ, 1995, STUD FAMILY PLANN, V26, P264, DOI 10.2307/2138012; Gauthier B, 2011, SOC SCI MED, V73, P540, DOI 10.1016/j.socscimed.2011.06.008; Guilkey DK, 1997, POP STUD-J DEMOG, V51, P173, DOI 10.1080/0032472031000149896; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Hermalin AI, 1983, FERTILITY REGULATION; Hutchinson PL, 2011, BMC HEALTH SERV RES, V11, P1; Ibisomi L, 2014, INT PERSPECT SEX R H, V40, DOI 10.1363/4003914; Jato MN, 1999, INT FAM PLAN PERSPEC, V25, P60, DOI 10.2307/2991943; Kabeer N., 2009, MICROFINANCE, P128; Kaggwa EB, 2008, INT FAM PLAN PERSPEC, V34, P79, DOI 10.1363/ifpp.34.079.08; Kane TT, 1998, STUD FAMILY PLANN, V29, P309, DOI 10.2307/172277; Kante AM, 2016, TROP MED INT HEALTH, V21, P504, DOI 10.1111/tmi.12672; Ketende C, 2003, INT FAM PLAN PERSPEC, V29, P130, DOI 10.2307/3181079; Kradval O., 2002, DEMOGRAPHY, V39, P233, DOI [10.1353/dem.2002.0017, DOI 10.1353/DEM.2002.0017]; Kritz MM, 2000, ROLE GENDER CONTEXT; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Kwete D, 2018, GLOB HEALTH-SCI PRAC, V6, P40, DOI 10.9745/GHSP-D-17-00346; Mensch B, 1996, STUD FAMILY PLANN, V27, P59, DOI 10.2307/2138134; Ministere du Plan et Suivi de la Mise en oeuvre de la Revolution de la Modernite (MPSMRM) MdlSPM et ICF International, 2014, ICF INT ENQ MOGR SAN; Ministry of Public Health Democratic Republic of the Congo, 2014, FAM PLANN NAT MULT S; PARK CB, 1977, STUD FAMILY PLANN, V8, P67, DOI 10.2307/1965529; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Population Reference Bureau, 2018, WORLD POP DAT SHEET; Prata N, 2017, AFR J REPROD HEALTH, V21, P35, DOI 10.29063/ajrh2017/v21i2.5; RamaRao S, 2015, STUD FAMILY PLANN, V46, P97, DOI 10.1111/j.1728-4465.2015.00017.x; Shah NM, 1998, INT FAM PLAN PERSPEC, V24, P133, DOI 10.2307/3038210; Skiles MP, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-14; Speizer IS, 2014, GLOB HEALTH-SCI PRAC, V2, P410, DOI 10.9745/GHSP-D-14-00109; StataCorp, 2017, STATA STAT SOFTWARE; Stephenson R, 2003, AM J PUBLIC HEALTH, V93, P1820, DOI 10.2105/AJPH.93.11.1820; Stephenson R, 2008, HEALTH PLACE, V14, P841, DOI 10.1016/j.healthplace.2008.01.005; Stephenson R, 2008, INT FAM PLAN PERSPEC, V34, P62, DOI 10.1363/ifpp.34.062.08; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Storey D, 1999, J HEALTH COMMUN, V4, P271, DOI 10.1080/108107399126823; TSUI AO, 1981, DEMOGRAPHY, V18, P615, DOI 10.2307/2060950; TUOANE M, 2003, AFRICAN POPULATION S, V18, P105; Wang W., 2012, FAMILY PLANNING SUPP; World Bank Group, 2019, WORLD BANK POP EST P; Yao J, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3834-y; Yao J, 2013, SOC SCI MED, V96, P60, DOI [10.1016/j.socscimed.2013.07.025, 10.1016/j.socscimed.2012.11.005]; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	69	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236018	10.1371/journal.pone.0236018	http://dx.doi.org/10.1371/journal.pone.0236018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32701979	Green Published, gold			2022-12-26	WOS:000575913700039
J	Tran, HTL; Morikawa, K; Anggakusuma; Zibi, R; Thi, VLD; Penin, F; Heim, MH; Quadroni, M; Pietschmann, T; Gouttenoire, J; Moradpour, D				Tran, Huong T. L.; Morikawa, Kenichi; Anggakusuma; Zibi, Rose; Viet Loan Dao Thi; Penin, Francois; Heim, Markus H.; Quadroni, Manfredo; Pietschmann, Thomas; Gouttenoire, Jerome; Moradpour, Darius			OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; CELLULAR SUBSTRATE; ADAPTER PROTEIN; NS3/4A PROTEASE; CLEAVAGE; REPLICATION; SEQUENCE; PATHWAY; LINES; GENE	The hepatitis C virus (HCV) nonstructural protein 3-4A (NS3-4A) protease is a key component of the viral replication complex and the target of protease inhibitors used in current clinical practice. By cleaving and thereby inactivating selected host factors it also plays a role in the persistence and pathogenesis of hepatitis C. Here, we describe ovarian cancer immunoreactive antigen domain containing protein 1 (OCIAD1) as a novel cellular substrate of the HCV NS3-4A protease. OCIAD1 was identified by quantitative proteomics involving stable isotopic labeling using amino acids in cell culture coupled with mass spectrometry. It is a poorly characterized membrane protein believed to be involved in cancer development. OCIAD1 is cleaved by the NS3-4A protease at Cys 38, close to a predicted transmembrane segment. Cleavage was observed in heterologous expression systems, the replicon and cell culture-derived HCV systems, as well as in liver biopsies from patients with chronic hepatitis C. NS3-4A proteases from diverse hepacivirus species efficiently cleaved OCIAD1. The subcellular localization of OCIAD1 on mitochondria was not altered by NS3-4A-mediated cleavage. Interestingly, OCIAD2, a homolog of OCIAD1 with a cysteine residue in a similar position and identical subcellular localization, was not cleaved by NS3-4A. Domain swapping experiments revealed that the sequence surrounding the cleavage site as well as the predicted transmembrane segment contribute to substrate selectivity. Overexpression as well as knock down and rescue experiments did not affect the HCV life cyclein vitro, raising the possibility that OCIAD1 may be involved in the pathogenesis of hepatitis Cin vivo.	[Tran, Huong T. L.; Morikawa, Kenichi; Zibi, Rose; Viet Loan Dao Thi; Gouttenoire, Jerome; Moradpour, Darius] Lausanne Univ Hosp, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Tran, Huong T. L.; Morikawa, Kenichi; Zibi, Rose; Viet Loan Dao Thi; Gouttenoire, Jerome; Moradpour, Darius] Univ Lausanne, Lausanne, Switzerland; [Anggakusuma; Pietschmann, Thomas] TWINCORE Ctr Expt & Clin Infect Res, Inst Expt Virol, Hannover, Germany; [Penin, Francois] Univ Lyon, Inst Biol & Chim Prot Bases Mol & Struct Syst Inf, UMR 5086, CNRS,Labex Ecofect, Lyon, France; [Heim, Markus H.] Univ Hosp Basel, Div Gastroenterol & Hepatol, Basel, Switzerland; [Quadroni, Manfredo] Univ Lausanne, Prot Anal Facil, Lausanne, Switzerland; [Morikawa, Kenichi] Hokkaido Univ, Div Gastroenterol & Hepatol, Fac Med, Sapporo, Hokkaido, Japan; [Morikawa, Kenichi] Grad Sch Med, Sapporo, Hokkaido, Japan; [Anggakusuma] UniQure NV, Amsterdam, Netherlands; [Viet Loan Dao Thi] Heidelberg Univ Hosp, Cluster Excellence Cell Networks, Dept Infect Dis & Virol, Schaller Res Grp, Heidelberg, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Helmholtz Association; Helmholtz-Center for Infection Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Basel; University of Lausanne; Hokkaido University; Ruprecht Karls University Heidelberg	Moradpour, D (corresponding author), Lausanne Univ Hosp, Div Gastroenterol & Hepatol, Lausanne, Switzerland.; Moradpour, D (corresponding author), Univ Lausanne, Lausanne, Switzerland.	Darius.Moradpour@chuv.ch	Gouttenoire, Jérôme/AAQ-8353-2020; Heim, Markus/A-7526-2008	Gouttenoire, Jérôme/0000-0002-7715-1494; Heim, Markus/0000-0002-7523-4894; Kusuma, Angga/0000-0002-5060-5310	Swiss National Science Foundation [31003A-156030, 31003A_179424]; Novartis Foundation [18C140]; European Research Council [ERC-2011-StG_281473-VIRAFRONT]; Helmholtz Association [SO-024]; Faculty of Biology and Medicine of the University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); European Research Council(European Research Council (ERC)European Commission); Helmholtz Association(Helmholtz Association); Faculty of Biology and Medicine of the University of Lausanne	This work was supported by the Swiss National Science Foundation (31003A-156030 and 31003A_179424 to DM) as well as the Novartis Foundation (18C140 to DM). TP was supported by the European Research Council (ERC-2011-StG_281473-VIRAFRONT) and the Helmholtz Association (SO-024). HTLT is the recipient of a PhD in Life Sciences stipend from the Faculty of Biology and Medicine of the University of Lausanne.	Anggakusuma, 2016, J VIROL, V90, P10670, DOI 10.1128/JVI.01634-16; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartenschlager R, 2018, VIRUS RES, V248, P53, DOI 10.1016/j.virusres.2018.02.016; Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426; Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; Bender S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005264; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Brenndorfer ED, 2009, HEPATOLOGY, V49, P1810, DOI 10.1002/hep.22857; Chen TI, 2019, J VIROL, V93, DOI 10.1128/JVI.01273-19; Gagne B, 2017, TRAFFIC, V18, P362, DOI 10.1111/tra.12480; Han J, 2014, CELL MOL LIFE SCI, V71, P2561, DOI 10.1007/s00018-013-1515-x; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Kang X, 2013, VIROLOGY, V435, P385, DOI 10.1016/j.virol.2012.10.025; Kohlway A, 2014, J VIROL, V88, P628, DOI 10.1128/JVI.02052-13; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Luo LY, 2001, BIOCHEM BIOPH RES CO, V280, P401, DOI 10.1006/bbrc.2000.4126; Maillard PV, 2007, PLOS PATHOG, V3, P2052, DOI 10.1371/journal.ppat.0030200; Mawatari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082094; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moradpour D, 2016, J HEPATOL, V65, pS143, DOI 10.1016/j.jhep.2016.07.026; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Morikawa K, 2014, HEPATOLOGY, V59, P423, DOI 10.1002/hep.26671; Oshiumi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003533; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Sengupta S, 2008, GYNECOL ONCOL, V109, P226, DOI 10.1016/j.ygyno.2007.12.024; Sinha A, 2013, CELL REP, V4, P649, DOI 10.1016/j.celrep.2013.07.029; Sinha S, 2019, BLOOD, V133, P2385, DOI 10.1182/blood.2019000530; Sinha S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25667-3; Thomas DL, 2019, NEW ENGL J MED, V380, P2041, DOI 10.1056/NEJMra1810477; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236447	10.1371/journal.pone.0236447	http://dx.doi.org/10.1371/journal.pone.0236447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697788	Green Published, gold			2022-12-26	WOS:000555392700018
J	Zhou, HY; Zhu, M; Ma, L; Zhou, JM; Dong, B; Zhang, GN; Cen, S; Wang, YC; Wang, JX				Zhou, Huiyu; Zhu, Mei; Ma, Ling; Zhou, Jinming; Dong, Biao; Zhang, Guoning; Cen, Shan; Wang, Yucheng; Wang, Juxian			Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study	PLOS ONE			English	Article							OPTIMIZATION; AMINE	A series of potent HIV-1 protease inhibitors, containing diverse piperidine analogues as the P2-ligands, 4-substituted phenylsulfonamides as the P2'-ligands and a hydrophobic cyclopropyl group as the P1'-ligand, were designed, synthesized and evaluated in this work. Among these twenty-four target compounds, many of them exhibited excellent activity against HIV-1 protease with half maximal inhibitory concentration (IC50) values below 20 nM. Particularly, compound 22a containing a (R)-piperidine-3-carboxamide as the P2-ligand and a 4-methoxylphenylsulfonamide as the P2'-ligand exhibited the most effective inhibitory activity with an IC50 value of 3.61 nM. More importantly, 22a exhibited activity with inhibition of 42% and 26% against wild-type and Darunavir (DRV)-resistant HIV-1 variants, respectively. Additionally, the molecular docking of 22a with HIV-1 protease provided insight into the ligand-binding properties, which was of great value for further study.	[Zhou, Huiyu; Zhu, Mei; Ma, Ling; Dong, Biao; Zhang, Guoning; Cen, Shan; Wang, Yucheng; Wang, Juxian] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing, Peoples R China; [Zhou, Jinming] Zhejiang Normal Univ, Key Lab, Minist Educ Adv Catalysis Mat, Dept Chem, Jinhua, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhejiang Normal University	Wang, YC; Wang, JX (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing, Peoples R China.	wyc9999@126.com; imbjxwang@163.com	Wang, Yu/GZL-9655-2022; Zhang, Guoning/J-9185-2012	Zhang, Guoning/0000-0003-1736-6749	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2019ZX09201001-003]; CAMS Innovation Fund for Medical Sciences [CIFMS 2016-I2M-1011]	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China; CAMS Innovation Fund for Medical Sciences	This work is supported by National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China (2019ZX09201001-003) and CAMS Innovation Fund for Medical Sciences (CIFMS 2016-I2M-1011) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin SA, 2018, SAR QSAR ENVIRON RES, V29, P385, DOI 10.1080/1062936X.2018.1447511; Aoki M, 2018, MBIO, V9, DOI 10.1128/mBio.02425-17; Aoki M, 2017, ELIFE, V6, DOI 10.7554/eLife.28020; Bai XG, 2017, EUR J MED CHEM, V137, P30, DOI 10.1016/j.ejmech.2017.05.024; Bell JL, 2013, BIOORG MED CHEM LETT, V23, P3826, DOI 10.1016/j.bmcl.2013.04.080; Biofocus PLC, 2004, [No title captured], Patent No. [WO2004/58259 2004 A1, 200458259]; Bungard CJ, 2017, ACS MED CHEM LETT, V8, P1292, DOI 10.1021/acsmedchemlett.7b00386; Centers for Disease Control, 1981, MMWR-MORBID MORTAL W, V30, P250; Delino NS, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.02060-17, 10.1128/AAC.02060-17]; Dou Y, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127019; Ganguly AK, 2014, TETRAHEDRON, V70, P2894, DOI 10.1016/j.tet.2014.03.038; Gao BL, 2011, BIOORG MED CHEM LETT, V21, P3730, DOI 10.1016/j.bmcl.2011.04.070; Garcia JM, 2009, ANTIVIR RES, V81, P239, DOI 10.1016/j.antiviral.2008.12.004; Ghosh AK, 2006, J MED CHEM, V49, P5252, DOI 10.1021/jm060561m; Ghosh AK, 2019, BIOORG MED CHEM LETT, V29, P2565, DOI 10.1016/j.bmcl.2019.08.006; Ghosh AK, 2018, J MED CHEM, V61, P9722, DOI 10.1021/acs.jmedchem.8b01227; Ghosh AK, 2018, CHEMMEDCHEM, V13, P803, DOI 10.1002/cmdc.201700824; Ghosh AK, 2016, J MED CHEM, V59, P5172, DOI 10.1021/acs.jmedchem.5b01697; Ghosh AK, 2015, J MED CHEM, V58, P5334, DOI 10.1021/acs.jmedchem.5b00676; Ghosh AK, 2013, INTRODUCTION TO BIOLOGICAL AND SMALL MOLECULE DRUG RESEARCH AND DEVELOPMENT: THEORY AND CASE STUDIES, P355, DOI 10.1016/B978-0-12-397176-0.00013-3; Ghosh AK, 2009, J MED CHEM, V52, P3902, DOI 10.1021/jm900303m; Gregson SJ, 2001, J MED CHEM, V44, P737, DOI 10.1021/jm001064n; He MZ, 2010, CHEM BIOL DRUG DES, V76, P174, DOI 10.1111/j.1747-0285.2010.00995.x; Kovalevsky AY, 2006, J MOL BIOL, V363, P161, DOI 10.1016/j.jmb.2006.08.007; MATAYOSHI ED, 1990, SCIENCE, V247, P954, DOI 10.1126/science.2106161; Mehellou Y, 2010, J MED CHEM, V53, P521, DOI 10.1021/jm900492g; Midde NM, 2016, EXPERT OPIN INV DRUG, V25, P1189, DOI 10.1080/13543784.2016.1212837; Parai MK, 2012, J MED CHEM, V55, P6328, DOI 10.1021/jm300238h; Rusere LN, 2019, J MED CHEM, V62, P8062, DOI 10.1021/acs.jmedchem.9b00838; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; UNAIDS, 2020, GLOB HIV AIDS STAT 2, V3, P15; Yang ZH, 2015, BIOORG MED CHEM LETT, V25, P1880, DOI 10.1016/j.bmcl.2015.03.047; Zhu M, 2020, EUR J MED CHEM, V186, DOI 10.1016/j.ejmech.2019.111900; Zhu M, 2020, EUR J MED CHEM, V185, DOI 10.1016/j.ejmech.2019.111866; Zhu M, 2019, BIOORG MED CHEM LETT, V29, P1541, DOI 10.1016/j.bmcl.2019.03.049	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0235483	10.1371/journal.pone.0235483	http://dx.doi.org/10.1371/journal.pone.0235483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7SC	32697773	Green Published, gold			2022-12-26	WOS:000575905100003
J	Hong, HG; Li, Y				Hong, Hyokyoung G.; Li, Yi			Estimation of time-varying reproduction numbers underlying epidemiological processes: A new statistical tool for the COVID-19 pandemic	PLOS ONE			English	Article							MODELS; CORONAVIRUSES; TRANSMISSION; BIAS	The coronavirus pandemic has rapidly evolved into an unprecedented crisis. The susceptible-infectious-removed (SIR) model and its variants have been used for modeling the pandemic. However, time-independent parameters in the classical models may not capture the dynamic transmission and removal processes, governed by virus containment strategies taken at various phases of the epidemic. Moreover, few models account for possible inaccuracies of the reported cases. We propose a Poisson model with time-dependent transmission and removal rates to account for possible random errors in reporting and estimate a time-dependent disease reproduction number, which may reflect the effectiveness of virus control strategies. We apply our method to study the pandemic in several severely impacted countries, and analyze and forecast the evolving spread of the coronavirus. We have developed an interactive web application to facilitate readers' use of our method.	[Hong, Hyokyoung G.] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [Li, Yi] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	Michigan State University; University of Michigan System; University of Michigan	Li, Y (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	yili@umich.edu	Hong, Hyokyoung Grace/ABG-6009-2020	Hong, Hyokyoung Grace/0000-0002-4280-6243	NSF [DMS-1915099]; NIH [R01AG056764]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was partially supported by the grants from NSF (DMS-1915099, Hong) and NIH (R01AG056764, Li).	Akgul A, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/158134; Alvarez I, 2009, ALPHA-REV ARTES LET, P9, DOI 10.4067/S0718-22012009000100002; Alvarez MA, 2013, IEEE T PATTERN ANAL, V35, P2693, DOI 10.1109/TPAMI.2013.86; [Anonymous], 2015, METHODS MOL BIOL, DOI DOI 10.1007/978-1-4939-2438-7_1; [Anonymous], 2020, CORONAVIRUS ASIAN NA; [Anonymous], 2020, CHINAS VIRUS CASES R; Blackwood JC., 2018, LETT BIOMATH, V5, P195, DOI [10.30707/LiB5.1Blackwood, DOI 10.30707/LIB5.1BLACKWOOD]; Boatto S, 2018, SIR MODEL TIME DEPEN; Chang S. L., 2020, ARXIV200310218; Chen Y., 2020, ARXIV200200418; Chen Y.-C., 2020, ARXIV200300122QBIOPE; Chen Y-C, 2020, ARXIV200300122; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Cox Jr LA, 2012, RISK ANAL FDN MODELS; de Boor C., 2001, APPL MATH SCI, V27; Diekmann O., 2000, MATH COMPUT BIOL, V5; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Eichner M, 2003, AM J EPIDEMIOL, V158, P110, DOI 10.1093/aje/kwg103; Giraldo JO, 2008, EPIDEMIOL INFECT, V136, P679, DOI 10.1017/S0950268807009260; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hilbe JM, 2014, MODELING COUNT DATA, P1; Hossain M.M., 2020, F1000RESEARCH; Huang XD, 2016, ENVIRON RES, V146, P308, DOI 10.1016/j.envres.2016.01.013; Jones H., 2007, NOTES R0; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kirkeby C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26491-5; Laguzet L, 2015, B MATH BIOL, V77, P1955, DOI 10.1007/s11538-015-0111-7; Lawrence N. D., 2007, ADV NEURAL INFORM PR, P785; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Liu QH, 2018, P NATL ACAD SCI USA, V115, P12680, DOI 10.1073/pnas.1811115115; Maier BF, 2020, ARXIV200207572; Mkhatshwa T, 2010, ARXIV10070908, P146; Nesteruk I, 2020, STAT BASED PREDICTIO; O'Dea EB, 2014, EPIDEMICS-NETH, V6, P18, DOI 10.1016/j.epidem.2013.12.002; PARR WC, 1983, BIOMETRIKA, V70, P719, DOI 10.2307/2336511; Paterlini M, 2020, CLOSING BORDERS IS R; Pellis L., 2020, ARXIV200400117; Peng L., 2020, ARXIV200206563; Perperoglou A, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0666-3; Picchiotti N, 2020, COVID 19 ITALIAN EUR; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay JO, 2007, J ROY STAT SOC B, V69, P741, DOI 10.1111/j.1467-9868.2007.00610.x; Ruppert D, 1997, J AM STAT ASSOC, V92, P1049, DOI 10.2307/2965570; Sansonetti PJ, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012463; Sarkodie SA, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03747; Schwartz EJ, 2015, MATH BIOSCI, V270, P198, DOI 10.1016/j.mbs.2015.03.007; ScienceMag.org, 2020, SCI MAGAZINE; Song PX, 2020, EPIDEMIOLOGICAL FORE; Tanne JH, 2020, BMJ, V368; Tognotti E, 2013, EMERG INFECT DIS, V19, P254, DOI 10.3201/eid1902.120312; Trombetta H, 2016, PATHOG GLOB HEALTH, V110, P113, DOI 10.1080/20477724.2016.1181294; Wang C., 2020, EVOLVING EPIDEMIOLOG; Wheeler MW, 2014, J AM STAT ASSOC, V109, P894, DOI 10.1080/01621459.2014.899234; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Yoon D, 2020, WHY A SOUTH KOREAN C; Zhang Y, 2020, THE IMPACT OF SOCIAL; Zhou T, 2020, J EVID-BASED MED, V13, P3, DOI 10.1111/jebm.12376; Zhuang LL, 2013, THEOR ECOL-NETH, V6, P457, DOI 10.1007/s12080-013-0180-x	59	42	42	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236464	10.1371/journal.pone.0236464	http://dx.doi.org/10.1371/journal.pone.0236464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692753	gold, Green Published, Green Submitted			2022-12-26	WOS:000554606400021
J	Kim, Y; Tanaka, K; Matsuoka, S				Kim, Yoomi; Tanaka, Katsuya; Matsuoka, Shunji			Environmental and economic effectiveness of the Kyoto Protocol	PLOS ONE			English	Article							OIL PRICE SHOCKS; STOCK MARKETS; EMISSIONS; UNCERTAINTY; POLLUTION; IMPACTS; WORLD; TERM; TOO; US	This study investigates the environmental and economic impacts of the Kyoto Protocol on Annex I parties through an impact assessment by combining the propensity score matching and the difference-in-difference methods. We establish a country-level panel data set including CO(2)emissions, gross domestic product (GDP), and other socioeconomic data for 1997-2008 and 2005-2008. Based on the impact evaluation, we conduct the simulation predicting the impacts of the Protocol to capture the differences of marginal damage cost of carbon emissions between the actual and counterfactual situations. The results suggest that participating as an Annex I party has a significant positive impact on CO(2)emission reductions, but a negative impact on the GDP of the participants in the long run. The predicted marginal benefit of the Protocol based on the marginal damage cost of carbon emissions shows that the marginal benefit of emission reductions mitigates a limited portion of the GDP loss. Future global climate change frameworks should focus on balancing the impact on economic and environmental performance in order to ensure sustainable development, especially for developing countries that have low capacity to mitigate emissions.	[Kim, Yoomi] Ewha Womans Univ, Dept Publ Adm, Seoul, South Korea; [Tanaka, Katsuya] Shiga Univ, Res Ctr Sustainabil & Environm, Shiga, Japan; [Matsuoka, Shunji] Waseda Univ, Grad Sch Asia Pacific Studies GSAPS, Tokyo, Japan	Ewha Womans University; Shiga University; Waseda University	Kim, Y (corresponding author), Ewha Womans Univ, Dept Publ Adm, Seoul, South Korea.	kimym@ewha.ac.kr		Kim, Yoomi/0000-0003-1521-6069; Tanaka, Katsuya/0000-0003-0455-0133	Ewha Womans University Research Grant of 2018	Ewha Womans University Research Grant of 2018	This work was funded by the Ewha Womans University Research Grant of 2018 to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakvik A, 2011, EUR J POLIT ECON, V27, P343, DOI 10.1016/j.ejpoleco.2010.12.001; Akhtar R, 2018, SPRINGER CLIMATE, P41, DOI 10.1007/978-3-319-61346-8_4; Almer C, 2017, J ENVIRON ECON MANAG, V82, P125, DOI 10.1016/j.jeem.2016.11.003; Babiker M, 2000, ENERG POLICY, V28, P525, DOI 10.1016/S0301-4215(00)00033-1; Bang G, 2016, POLITICS GOV, V4, P209, DOI 10.17645/pag.v4i3.640; Barrett S, 2008, OXFORD REV ECON POL, V24, P239, DOI 10.1093/oxrep/grn015; Bashir MF, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138835; Bohmelt T, 2010, AUST J POLIT SCI, V45, P245, DOI 10.1080/10361141003736158; Bohringer C, 2003, OXFORD REV ECON POL, V19, P451, DOI 10.1093/oxrep/19.3.451; Bohringer C, 2001, INTERNATIONALIZATION OF THE ECONOMY AND ENVIRONMENTAL POLICY OPTIONS, P161; Cadot O, 2012, 6295 WORLD BANK; Caldwell L. K., 1990, INT ENV POLICY EMERG; Carnell S, 2012, INT REV PSYCHIATR, V24, P189, DOI 10.3109/09540261.2012.676988; de Bruyn SM, 1998, ECOL ECON, V25, P161, DOI 10.1016/S0921-8009(97)00178-X; de Chazournes LB, 1998, KYOTO PROTOCOL UN FR; Dirnitrov R, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.583; EIA (U.S. Energy Information Administration), SPOT PRIC; Golub A, 2006, CONTEMP ECON POLICY, V24, P520, DOI 10.1093/cep/byl012; Grubb M, 2004, INT REV ENV STRATEGI, V5, P15; Grunewald N., 2011, CARBON DIOXIDE EMISS, P1; Grunewald N, 2016, ENVIRON DEV ECON, V21, P1, DOI 10.1017/S1355770X15000091; Hafner-Burton EM, 2005, AM J SOCIOL, V110, P1373, DOI 10.1086/428442; Helm C, 2000, J CONFLICT RESOLUT, V44, P630, DOI 10.1177/0022002700044005004; Hermwille L, 2017, CLIM POLICY, V17, P150, DOI 10.1080/14693062.2015.1115231; Hintermann B, 2019, ENVIRON RESOUR ECON, V74, P761, DOI 10.1007/s10640-019-00346-7; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Kim Y, 2014, CRR DISCUSSION PAP A, V10; Kim Y, 2017, GLOBAL ENVIRON POLIT, V17, P77, DOI 10.1162/GLEP_a_00391; Kucik J, 2008, INT ORGAN, V62, P477, DOI 10.1017/S0020818308080168; Kumazawa R., 2012, J EC FINANCE, V36, P201, DOI DOI 10.1007/s12197-010-9164-5; Kuriyama A, 2018, APPL ENERG, V220, P286, DOI 10.1016/j.apenergy.2018.03.025; Lantz V, 2006, ECOL ECON, V57, P229, DOI 10.1016/j.ecolecon.2005.04.006; Le Quere C, 2020, NATURE CLIMATE CHANG, P1; Maamoun N, 2019, J ENVIRON ECON MANAG, V95, P227, DOI 10.1016/j.jeem.2019.04.001; Manne A, 1998, EFFICIENCY EQUITY CL, P43; Michalek J, 2012, 25419 EUR EN IPTS; Mitchell RB, 2003, ANNU REV ENV RESOUR, V28, P429, DOI 10.1146/annurev.energy.28.050302.105603; Mu R, 2007, WPS4340 WORLD BANK; Murdoch JC, 1997, ECONOMICA, V64, P281, DOI 10.1111/1468-0335.00078; Nordhaus W. D., 1999, ROLL DICE AGAIN EC G; Ono S, 2011, EUR J COMP ECON, V8, P29; Park J, 2008, ENERG ECON, V30, P2587, DOI 10.1016/j.eneco.2008.04.003; Pickering J, 2018, CLIM POLICY, V18, P818, DOI 10.1080/14693062.2017.1412934; Rhodes CJ, 2016, SCI PROGRESS-UK, V99, P97, DOI 10.3184/003685016X14528569315192; Serre C., 2015, EMISSIONS TRADING WO; Sprinz DF, 2018, CLIM POLICY, V18, P828, DOI 10.1080/14693062.2017.1410090; Talukdar D, 2001, WORLD DEV, V29, P827, DOI 10.1016/S0305-750X(01)00008-0; Tang WQ, 2010, ENERG ECON, V32, pS3, DOI 10.1016/j.eneco.2010.01.002; Taskinsoy J., 2020, NO BRAINER TACKLE CL, DOI [10.2139/ssrn.3532709, DOI 10.2139/SSRN.3532709]; Tol RSJ, 2003, CLIMATIC CHANGE, V56, P265, DOI 10.1023/A:1021753906949; Tol RSJ, 2005, ENERG POLICY, V33, P2064, DOI 10.1016/j.enpol.2004.04.002; UNFCCC, 2018, 2018 UN FRAM CONV CL; UNFCCC, 2012, FCCCSBI201231; Urpelainen J, 2018, CLIM POLICY, V18, P839, DOI 10.1080/14693062.2017.1406843; Villoria-Saez P, 2016, J CLEAN PROD, V127, P49, DOI 10.1016/j.jclepro.2016.03.148; Vollenweider J, 2013, INT ENVIRON AGREEM-P, V13, P343, DOI 10.1007/s10784-012-9193-y; WEISS EB, 1993, GEORGETOWN LAW J, V81, P675; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; World Bank, WORLD DEV IND WDI; Yohe GW, 2003, CLIMATIC CHANGE, V56, P235, DOI 10.1023/A:1021723530541; Zhang HB, 2017, ADV CLIM CHANG RES, V8, P220, DOI 10.1016/j.accre.2017.09.002	62	12	12	10	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236299	10.1371/journal.pone.0236299	http://dx.doi.org/10.1371/journal.pone.0236299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MS9QL	32692765	gold, Green Published			2022-12-26	WOS:000554606400006
J	Natali, EN; Principato, S; Ferlicca, F; Bianchi, F; Fontana, LE; Faleri, A; Pansegrau, W; Lo Surdo, P; Bartohai, E; Santini, L; Brune, B; Giusti, F; Veggi, D; Ferlenghi, I; Norais, N; Scarselli, M				Natali, Eriberto Noel; Principato, Silvia; Ferlicca, Francesca; Bianchi, Federica; Fontana, Lucia Eleonora; Faleri, Agnese; Pansegrau, Werner; Lo Surdo, Paola; Bartohai, Erika; Santini, Laura; Brune, Brunelia; Giusti, Fabiola; Veggi, Daniele; Ferlenghi, Ilaria; Norais, Nathalie; Scarselli, Maria			Synergic complement-mediated bactericidal activity of monoclonal antibodies with distinct specificity	FASEB JOURNAL			English	Article						bactericidal activity; monoclonal antibodies; Neisseria meningitidis; synergy	H-BINDING-PROTEIN; MENINGOCOCCAL SEROGROUP-B; MULTICOMPONENT VACCINE; PROTECTIVE ANTIGEN; MASS-SPECTROMETRY; EPITOPE DENSITY; TERMINAL DOMAIN; 4CMENB; NEUTRALIZATION; COMBINATIONS	The classical complement pathway is triggered when antigen-bound immunoglobulins bind to C1q through their Fc region. While C1q binds to a single Fc with low affinity, a higher avidity stable binding of two or more of C1q globular heads initiates the downstream reactions of the complement cascade ultimately resulting in bacteriolysis. Synergistic bactericidal activity has been demonstrated when monoclonal antibodies recognize nonoverlapping epitopes of the same antigen. The aim of the present work was to investigate the synergistic effect between antibodies directed toward different antigens. To this purpose, we investigated the bactericidal activity induced by combinations of monoclonal antibodies (mAbs) raised against factor H-binding protein (fHbp) and Neisserial Heparin-Binding Antigen (NHBA), two major antigens included in Bexsero, the vaccine against Meningococcus B, for prevention from this devastating disease in infants and adolescents. Collectively, our results show that mAbs recognizing different antigens can synergistically activate complement even when each single Mab is not bactericidal, reinforcing the evidence that cooperative immunity induced by antigen combinations can represent a remarkable added value of multicomponent vaccines. Our study also shows that the synergistic effect of antibodies is modulated by the nature of the respective epitopes, as well as by the antigen density on the bacterial cell surface.	[Natali, Eriberto Noel; Principato, Silvia; Ferlicca, Francesca; Bianchi, Federica; Fontana, Lucia Eleonora; Faleri, Agnese; Pansegrau, Werner; Lo Surdo, Paola; Bartohai, Erika; Santini, Laura; Brune, Brunelia; Giusti, Fabiola; Veggi, Daniele; Ferlenghi, Ilaria; Norais, Nathalie; Scarselli, Maria] GSK, Siena, Italy; [Natali, Eriberto Noel] Univ Florence, CERM, Dept Chem, Florence, Italy; [Principato, Silvia] Univ Siena, Dept Biol Sci, Siena, Italy; [Bianchi, Federica] GSK, Rockville, MD USA	GlaxoSmithKline; University of Florence; University of Siena; GlaxoSmithKline	Scarselli, M (corresponding author), GSK, Siena, Italy.	maria.x.scarselli@gsk.com			GlaxoSmithKline (GSK)	GlaxoSmithKline (GSK)(GlaxoSmithKline)	GlaxoSmithKline (GSK)	Arlaud GJ, 2001, IMMUNOL REV, V180, P136, DOI 10.1034/j.1600-065X.2001.1800112.x; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Beernink PT, 2015, MBIO, V6, DOI 10.1128/mBio.00842-15; Beernink PT, 2009, MOL IMMUNOL, V46, P1647, DOI 10.1016/j.molimm.2009.02.021; Biagini M, 2016, P NATL ACAD SCI USA, V113, P2714, DOI 10.1073/pnas.1521142113; Brier S, 2012, BIOCHEMISTRY-US, V51, P6738, DOI 10.1021/bi300656w; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Carr K, 2009, BIOMED CHROMATOGR, V23, P1108, DOI 10.1002/bmc.1231; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; Chen ZC, 2009, INFECT IMMUN, V77, P3902, DOI 10.1128/IAI.00200-09; COOPER LJN, 1993, J IMMUNOL, V150, P2231; Degn SE, 2013, SCAND J IMMUNOL, V78, P181, DOI 10.1111/sji.12070; Diamant E, 2015, TOXINS, V7, P1854, DOI 10.3390/toxins7061854; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Esposito V, 2011, J BIOL CHEM, V286, P41767, DOI 10.1074/jbc.M111.289314; Faleri A, 2014, FASEB J, V28, P1644, DOI 10.1096/fj.13-239012; Giuliani M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22057-7; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2010, VACCINE, V28, P5023, DOI 10.1016/j.vaccine.2010.05.014; Giuntini S, 2012, INFECT IMMUN, V80, P187, DOI 10.1128/IAI.05956-11; LACHMANN PJ, 1984, SPRINGER SEMIN IMMUN, V7, P143, DOI 10.1007/BF01893018; Lopez-Sagaseta J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02827-7; Malito E, 2016, BIOCHEM J, V473, P4699, DOI 10.1042/BCJ20160806; Maritan M, 2017, ACTA CRYSTALLOGR F, V73, P305, DOI 10.1107/S2053230X17006021; McIntosh EDG, 2015, VACCINE, V33, P4414, DOI 10.1016/j.vaccine.2015.07.019; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Miglietta R, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0346-3; Muzzi A, 2013, MBIO, V4, DOI 10.1128/mBio.00163-13; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Ngundi MM, 2012, CLIN VACCINE IMMUNOL, V19, P731, DOI 10.1128/CVI.05714-11; O'Ryan M, 2014, DRUGS, V74, P15, DOI 10.1007/s40265-013-0155-7; Oostindie SC, 2019, HAEMATOLOGICA, V104, P1841, DOI 10.3324/haematol.2018.207266; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Partridge E, 2017, VACCINE, V35, P4236, DOI 10.1016/j.vaccine.2017.06.020; Plested JS, 2009, CLIN VACCINE IMMUNOL, V16, P785, DOI 10.1128/CVI.00007-09; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Rossi R, 2016, INFECT IMMUN, V84, P1735, DOI 10.1128/IAI.01491-15; Seib KL, 2015, EXPERT REV VACCINES, V14, P841, DOI 10.1586/14760584.2015.1016915; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Thielens NM, 2017, MOL IMMUNOL, V89, P73, DOI 10.1016/j.molimm.2017.05.025; Ueha S, 2015, CANCER IMMUNOL RES, V3, P631, DOI 10.1158/2326-6066.CIR-14-0190; Valdez KPR, 2015, VIROLOGY, V475, P187, DOI 10.1016/j.virol.2014.11.011; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Vu DM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00341; Vu DM, 2011, VACCINE, V29, P1968, DOI 10.1016/j.vaccine.2010.12.075; Wei H, 2014, DRUG DISCOV TODAY, V19, P95, DOI 10.1016/j.drudis.2013.07.019; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620	53	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10329	10341		10.1096/fj.201902795R	http://dx.doi.org/10.1096/fj.201902795R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725956	hybrid, Green Submitted			2022-12-26	WOS:000541771500001
J	Wang, JY; Kaplan, N; Wysocki, J; Yang, WD; Lu, K; Peng, H; Batlle, D; Lavker, RM				Wang, Junyi; Kaplan, Nihal; Wysocki, Jan; Yang, Wending; Lu, Kurt; Peng, Han; Batlle, Daniel; Lavker, Robert M.			The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation	FASEB JOURNAL			English	Article						cornea; corneal epithelial cells; COVID-19; macrophages; SARS-CoV-2	ANGIOTENSIN-CONVERTING ENZYME-2; SARS CORONAVIRUS; ACE2; RECEPTOR; DYSFUNCTION; DELETION; STRESS; INJURY; MICE	Angiotensin converting enzyme 2 (ACE2) plays an important role in inflammation, which is attributable at least, in part, to the conversion of the pro-inflammatory angiotensin (Ang) II peptide into angiotensin 1-7 (Ang 1-7), a peptide which opposes the actions of AngII. ACE2 and AngII are present in many tissues but information on the cornea is lacking. We observed that mice deficient in theAce2gene (Ace2(-/-)), developed a cloudy cornea phenotype as they aged. Haze occupied the central cornea, accompanied by corneal edema and neovascularization. In severe cases with marked chronic inflammation, a cell-fate switch from a transparent corneal epithelium to a keratinized, stratified squamous, psoriasiform-like epidermis was observed. The stroma contained a large number of CD11c, CD68, and CD3 positive cells. Corneal epithelial debridement experiments in young ACE2-deficient mice showed normal appearing corneas, devoid of haze. We hypothesized, however, that these mice are "primed" for a corneal inflammatory response, which once initiated, would persist. In vitro studies reveal that interleukins (IL-1a, IL-1b), chemokines (CCL2, CXCL8), and TNF-alpha, are all significantly elevated, resulting in a cytokine storm-like phenotype. This phenotype could be partially rescued by treatment with the AngII type 1 receptor (AT1R) antagonist, losartan, suggesting that the observed effect was mediated by AngII acting on its main receptor. Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes human ACE2 as the receptor for entry with subsequent downregulation of ACE2, corneal inflammation in Ace2(-/-)mice may have a similar mechanism with that in COVID-19 patients. Thus the Ace2(-/-)cornea, because of easy accessibility, may provide an attractive model to explore the molecular mechanisms, immunological changes, and treatment modalities in patients with COVID-19.	[Wang, Junyi] Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Ctr 1, Beijing, Peoples R China; [Wang, Junyi; Kaplan, Nihal; Yang, Wending; Lu, Kurt; Peng, Han; Lavker, Robert M.] Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-124, Chicago, IL 60611 USA; [Wysocki, Jan; Batlle, Daniel] Northwestern Univ, Feinberg Sch Med, Dept Med Nephrol & Hypertens, Chicago, IL 60611 USA	Chinese People's Liberation Army General Hospital; Northwestern University; Northwestern University; Feinberg School of Medicine	Peng, H; Lavker, RM (corresponding author), Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-124, Chicago, IL 60611 USA.; Batlle, D (corresponding author), Northwestern Univ, Dept Med Nephrol & Hypertens, 320 E Super St,Searle 10-511, Chicago, IL 60611 USA.	han-peng@northwestern.edu; d-batlle@northwestern.edu; r-lavker@northwestern.edu	wang, junyi/GYA-3213-2022		National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR075049]; National Institutes of Health [EY06769, EY017539, EY019463]; Dermatology Foundation; Eversight [AR064144, AR071168]; NIDDK [R01DK104785]; International Postdoctoral Exchange Fellowship Program [20180087]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Eversight; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); International Postdoctoral Exchange Fellowship Program	National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: AR075049; National Institutes of Health, Grant/Award Number: EY06769, EY017539 and EY019463; Dermatology Foundation research grant and Career Development; Eversight, Grant/Award Number: AR064144 and AR071168; NIDDK, Grant/Award Number: R01DK104785; International Postdoctoral Exchange Fellowship Program, Grant/Award Number: 20180087	AIELLO F, 2020, EYE 0518, DOI DOI 10.1038/S41433-020-0926-9; Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163; Behrens EM, 2017, ARTHRITIS RHEUMATOL, V69, P1135, DOI 10.1002/art.40071; Bian F, 2015, INVEST OPHTH VIS SCI, V56, P4908, DOI 10.1167/iovs.15-16631; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Chen CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06152-x; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Desautels JD, 2020, OPHTHALMOL THER, V9, P371, DOI 10.1007/s40123-020-00254-w; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; FERRARA JLM, 1993, TRANSPLANT P, V25, P1216; Gralinski LE, 2015, J PATHOL, V235, P185, DOI 10.1002/path.4454; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta N, 2011, BRIT J OPHTHALMOL, V95, P194, DOI 10.1136/bjo.2009.173724; Gurley SB, 2008, EXP PHYSIOL, V93, P538, DOI 10.1113/expphysiol.2007.040014; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Guy JL, 2003, BIOCHEMISTRY-US, V42, P13185, DOI 10.1021/bi035268s; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hanff TC, 2020, CLIN INFECT DIS, V71, P870, DOI 10.1093/cid/ciaa329; Hui KPY, 2020, LANCET RESP MED, V8, P687, DOI 10.1016/S2213-2600(20)30193-4; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Israili ZH, 2000, J HUM HYPERTENS, V14, pS73, DOI 10.1038/sj.jhh.1000991; Jin HY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0616-8; Kaplan N, 2020, FASEB J, V34, P525, DOI 10.1096/fj.201901512R; Kazama K, 2004, CIRC RES, V95, P1019, DOI 10.1161/01.RES.0000148637.85595.c5; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kusnadi A, 2019, IMMUNITY, V51, P241, DOI 10.1016/j.immuni.2019.06.005; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Lgic R, 2018, EXP EYE RES, V166, P74; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Lin CI, 2018, INT J BIOL SCI, V14, P253, DOI 10.7150/ijbs.23489; Nakamura T, 2014, J CLIN INVEST, V124, P385, DOI 10.1172/JCI71488; Napoli PE, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051269; Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734; Oudit GY, 2003, TRENDS CARDIOVAS MED, V13, P93, DOI 10.1016/S1050-1738(02)00233-5; Park JK, 2016, J CELL BIOL, V215, P667, DOI 10.1083/jcb.201604032; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Prestes TRR, 2017, CURR DRUG TARGETS, V18, P1301, DOI 10.2174/1389450117666160727142401; Serfozo P, 2020, HYPERTENSION, V75, P173, DOI 10.1161/HYPERTENSIONAHA.119.14071; Stepp MA, 2014, EXP EYE RES, V121, P178, DOI 10.1016/j.exer.2014.02.007; Suzuki Y, 2000, J NEPHROL, V13, pS101; Thomas MC, 2010, CIRC RES, V107, P888, DOI 10.1161/CIRCRESAHA.110.219279; Tikellis C, 2004, CURR EYE RES, V29, P419, DOI 10.1080/02713680490517944; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tyburski JG, 2001, SURGERY, V130, P748, DOI 10.1067/msy.2001.118094; Vallabh NA, 2017, MITOCHONDRION, V36, P103, DOI 10.1016/j.mito.2017.05.009; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wysocki J, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120886; Wysocki J, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.264; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Xie L X, 2020, Zhonghua Yan Ke Za Zhi, V56, P250, DOI 10.3760/cma.j.cn112142-20200220-00091; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Zhang B N, 2020, Zhonghua Yan Ke Za Zhi, V56, P438, DOI 10.3760/cma.j.cn112142-20200310-00170; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zou KJ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695962	57	24	24	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10505	10515		10.1096/fj.202001020R	http://dx.doi.org/10.1096/fj.202001020R		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725927	Green Published, Bronze			2022-12-26	WOS:000541770400001
J	Kelly, FD; Tran, KD; Hatfield, J; Schmidt, K; Sanchez, MA; Landfear, SM				Kelly, Felice D.; Tran, Khoa D.; Hatfield, Jess; Schmidt, Kat; Sanchez, Marco A.; Landfear, Scott M.			A cytoskeletal protein complex is essential for division of intracellular amastigotes ofLeishmania mexicana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Leishmania; cytoskeleton; cytokinesis; protein complex; protein targeting; infectious disease; flagellum	MICROTUBULE-ASSOCIATED PROTEIN; TRYPANOSOMA-BRUCEI; GLUCOSE-TRANSPORTER; BLOOD-STREAM; GENE; CYTOKINESIS; TRAFFICKING; MEMBRANE; SEQUENCE; TAG	Previous studies inLeishmania mexicanahave identified the cytoskeletal protein KHARON as being important for both flagellar trafficking of the glucose transporter GT1 and for successful cytokinesis and survival of infectious amastigote forms inside mammalian macrophages. KHARON is located in three distinct regions of the cytoskeleton: the base of the flagellum, the subpellicular microtubules, and the mitotic spindle. To deconvolve the different functions for KHARON, we have identified two partner proteins, KHAP1 and KHAP2, which associate with KHARON. KHAP1 is located only in the subpellicular microtubules, whereas KHAP2 is located at the subpellicular microtubules and the base of the flagellum. BothKHAP1andKHAP2null mutants are unable to execute cytokinesis but are able to traffic GT1 to the flagellum. These results confirm that KHARON assembles into distinct functional complexes and that the subpellicular complex is essential for cytokinesis and viability of disease-causing amastigotes but not for flagellar membrane trafficking.	[Kelly, Felice D.; Tran, Khoa D.; Hatfield, Jess; Schmidt, Kat; Sanchez, Marco A.; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Tran, Khoa D.] Lions VisionGift, Portland, OR USA	Oregon Health & Science University	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	landfear@ohsu.edu		Hatfield, Jess/0000-0003-3892-7138; Kelly, Felice/0000-0002-9596-2944	National Institutes of Health [R01AI121160, R21AI107144, 1F32AI096854]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01AI121160 to F. D. K., J. H., K. S., M. A. S., and S. M. L. and R21AI107144 (to F. D. K. and S. M. L.) and 1F32AI096854 (to K. D. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AFFOLTER M, 1994, J STRUCT BIOL, V112, P241, DOI 10.1006/jsbi.1994.1024; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Beneke T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007828; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Dang HQ, 2017, MBIO, V8, DOI [10.1128/mBio.02120-16, 10.1128/mbio.02120-16]; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; HEMPHILL A, 1992, J CELL BIOL, V117, P95, DOI 10.1083/jcb.117.1.95; Heras SR, 2006, CELL MOL LIFE SCI, V63, P1449, DOI 10.1007/s00018-006-6038-2; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelly FD, 2020, MICROBIOL MOL BIOL R, V84, DOI 10.1128/MMBR.00079-19; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Li ZK, 1999, GENE, V237, P235, DOI 10.1016/S0378-1119(99)00234-6; Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Park SH, 2008, J IMMUNOL METHODS, V331, P27, DOI 10.1016/j.jim.2007.10.012; Potter SC, 2018, NUCLEIC ACIDS RES, V46, pW200, DOI 10.1093/nar/gky448; RINDISBACHER L, 1993, MOL BIOCHEM PARASIT, V58, P83, DOI 10.1016/0166-6851(93)90093-D; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rodriguez-Contreras D, 2015, FASEB J, V29, P11, DOI 10.1096/fj.14-251991; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sanchez MA, 2016, J BIOL CHEM, V291, P19760, DOI 10.1074/jbc.M116.739235; SASSE R, 1988, J CELL SCI, V90, P577; SCHNEIDER A, 1988, SCIENCE, V241, P459, DOI 10.1126/science.3393912; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Sinclair-Davis AN, 2017, J CELL SCI, V130, P3918, DOI 10.1242/jcs.207209; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Sunter J, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170165; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tran AN, 2003, ACTA TROP, V87, P269, DOI 10.1016/S0001-706X(03)00067-6; Tran KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134432; Tran KD, 2013, J BIOL CHEM, V288, P22721, DOI 10.1074/jbc.M113.483461; Tran KD, 2012, J CELL SCI, V125, P3293, DOI 10.1242/jcs.103028; Wheeler RJ, 2016, J CELL SCI, V129, P854, DOI 10.1242/jcs.183152; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wheeler RJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005353; Zhou Q, 2018, J BIOL CHEM, V293, P16177, DOI 10.1074/jbc.RA118.004888; Zhou Q, 2018, NUCLEIC ACIDS RES, V46, P8216, DOI 10.1093/nar/gky557	49	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					13106	13122		10.1074/jbc.RA120.014065	http://dx.doi.org/10.1074/jbc.RA120.014065			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32719012	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000572412900019
J	Jungers, CF; Elliff, JM; Masson-Meyers, DS; Phiel, CJ; Origanti, S				Jungers, Courtney F.; Elliff, Jonah M.; Masson-Meyers, Daniela S.; Phiel, Christopher J.; Origanti, Sofia			Regulation of eukaryotic translation initiation factor 6 dynamics through multisite phosphorylation by GSK3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eIF6; phosphorylation; serum starvation; translation; translation initiation; ribosome; glycogen synthase kinase 3 (GSK3); serine; threonine protein kinase	GLYCOGEN-SYNTHASE KINASE-3; 60S RIBOSOMAL-SUBUNIT; BETA-CATENIN; ORNITHINE-DECARBOXYLASE; SUBSTRATE-SPECIFICITY; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; MESSENGER-RNA; EIF6 RELEASE; ACTIVATION	Eukaryotic translation initiation factor 6 (eIF6) is essential for the synthesis of 60S ribosomal subunits and for regulating the association of 60S and 40S subunits. A mechanistic understanding of how eIF6 modulates translation in response to stress, specifically starvation-induced stress, is lacking. We here show a novel mode of eIF6 regulation by glycogen synthase kinase 3 (GSK3) that is predominantly active in response to serum starvation. Both GSK3 alpha and GSK3 beta phosphorylate human eIF6. Multiple residues in the C terminus of eIF6 are phosphorylated by GSK3 in a sequential manner. In response to serum starvation, eIF6 accumulates in the cytoplasm, and this altered localization depends on phosphorylation by GSK3. Disruption of eIF6 phosphorylation exacerbates the translation inhibitory response to serum starvation and stalls cell growth. These results suggest that eIF6 regulation by GSK3 contributes to the attenuation of global protein synthesis that is critical for adaptation to starvation-induced stress.	[Jungers, Courtney F.; Elliff, Jonah M.; Masson-Meyers, Daniela S.; Origanti, Sofia] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Phiel, Christopher J.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Origanti, Sofia] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Marquette University; University of Colorado System; University of Colorado Denver; Saint Louis University	Origanti, S (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.; Origanti, S (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	sofia.origanti@slu.edu	Masson-Meyers, Daniela/GYU-3472-2022	Phiel, Christopher/0000-0002-9265-2676; Origanti, Sofia/0000-0002-6953-0160	National Institutes of Health [R15GM126477, R15GM119103]; Wisconsin Women's Health Foundation through a Markos Breast Cancer Woman Faculty Scholar grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Women's Health Foundation through a Markos Breast Cancer Woman Faculty Scholar grant	This work was supported by the National Institutes of Health Grants R15GM126477 (to S. O.) and R15GM119103 (to C. J. P.). This work was also supported by the Wisconsin Women's Health Foundation through a Markos Breast Cancer Woman Faculty Scholar grant (to S. O.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achilli Cesare, 2018, Journal of Biological Methods, V5, pe104, DOI 10.14440/jbm.2018.275; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Biswas A, 2011, J BIOL CHEM, V286, P3129, DOI 10.1074/jbc.M110.188565; Brina D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9261; Brina D, 2015, BBA-GENE REGUL MECH, V1849, P830, DOI 10.1016/j.bbagrm.2014.09.010; Brina D, 2011, CELL CYCLE, V10, P3441, DOI 10.4161/cc.10.20.17796; Burwick N, 2012, BLOOD, V120, P5143, DOI 10.1182/blood-2012-04-420166; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Clarke K, 2017, CELL REP, V21, P1507, DOI 10.1016/j.celrep.2017.10.040; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Iadevaia V, 2014, SEMIN CELL DEV BIOL, V36, P113, DOI 10.1016/j.semcdb.2014.08.004; Imami K, 2012, MOL CELL PROTEOMICS, V11, P1741, DOI 10.1074/mcp.M112.019919; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Kater L, 2017, CELL, V171, P1599, DOI 10.1016/j.cell.2017.11.039; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Klammer M, 2012, MOL CELL PROTEOMICS, V11, P651, DOI 10.1074/mcp.M111.016410; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Knutsen JHJ, 2015, J CELL SCI, V128, P4420, DOI 10.1242/jcs.176545; Kramer Thomas, 2012, Int J Alzheimers Dis, V2012, P381029, DOI 10.1155/2012/381029; Krokowski D, 2011, CELL CYCLE, V10, P2691, DOI 10.4161/cc.10.16.16844; Liu BT, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2015.1138018; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Ma CY, 2017, NAT STRUCT MOL BIOL, V24, P214, DOI 10.1038/nsmb.3364; Malyutin AG, 2017, EMBO J, V36, P854, DOI 10.15252/embj.201696012; Manning BD, 2013, CANCER CELL, V23, P713, DOI 10.1016/j.ccr.2013.05.012; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Miluzio A, 2016, BIOCHEM SOC T, V44, P1667, DOI 10.1042/BST20160179; Miluzio A, 2015, ONCOTARGET, V6, P37480, DOI 10.18632/oncotarget.5462; Miluzio A, 2011, CANCER CELL, V19, P765, DOI 10.1016/j.ccr.2011.04.018; Miluzio A, 2009, EMBO REP, V10, P459, DOI 10.1038/embor.2009.70; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; NIELSEN PJ, 1981, EUR J BIOCHEM, V120, P523, DOI 10.1111/j.1432-1033.1981.tb05731.x; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Origanti S, 2007, CANCER RES, V67, P4834, DOI 10.1158/0008-5472.CAN-06-4627; Origanti S, 2012, BIOCHEM J, V442, P199, DOI 10.1042/BJ20111464; Patchett S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006894; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pesce E, 2015, SCI REP-UK, V5, DOI 10.1038/srep15401; Proud C G, 2001, Prog Mol Subcell Biol, V26, P95; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Solari FA, 2015, MOL BIOSYST, V11, P1487, DOI 10.1039/c5mb00024f; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; TZAMARIAS D, 1989, CELL, V57, P947, DOI 10.1016/0092-8674(89)90333-4; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; Wang XM, 2002, BIOCHEM J, V367, P475, DOI 10.1042/BJ20020677; Weis F, 2015, NAT STRUCT MOL BIOL, V22, P914, DOI 10.1038/nsmb.3112; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938; Yoshikawa H, 2018, ELIFE, V7, DOI 10.7554/eLife.36530; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeidner Leigh C, 2011, Int J Biochem Mol Biol, V2, P318	76	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2020	295	36					12796	12813		10.1074/jbc.RA120.013324	http://dx.doi.org/10.1074/jbc.RA120.013324			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NQ9DL	32703900	hybrid, Green Published			2022-12-26	WOS:000571166700019
J	Kwon, O; Choi, MB				Kwon, Ohseok; Choi, Moon Bo			Interspecific hierarchies from aggressiveness and body size among the invasive alien hornet, Vespa velutina nigrithorax, and five native hornets in South Korea	PLOS ONE			English	Article							HYMENOPTERA VESPIDAE; COLONY SIZE; 1ST RECORD; COMPETITION; LEPELETIER; SPREAD; DISPLACEMENT; DISCOVERY; EVOLUTION; HONEYBEES	The range of the invasive alien hornet,Vespa velutina nigrithorax, has been expanding since its introduction to Korea in 2003. Here, we compare the aggressive behaviors and body size ofV.velutina nigrithoraxwith five native hornet species to identify the interspecific hierarchies that influence the rate of spread of this species. Aggressive behaviors were classified into 11 categories, and each interaction was scored as a win, loss, or tie. We found thatV.velutinawas superior toV.simillimain fights thatV.velutinawon and showed a high incidence of threatening behavior.V.mandariniaoutperformedV.velutinain fights thatV.mandariniawon and grappling behavior was common.V.analiswas superior toV.velutinain fights thatV.analiswon and showed a high degree of threatening behavior.V.crabrowas superior toV.velutinain fights thatV.crabrowon and showed a high rate of threatening behavior.V.dybowskiiwas superior toV.velutinain fights thatV.dybowskiiwon and showed a high incidence of threatening and grappling behaviors. The body size ofV.velutinawas greater thanV.simillima(although not statistically significant) and smaller than all otherVespaspecies. Therefore, according to this study, the low interspecific hierarchies ofV.velutinaseem to be a major cause of the slower spread in Korea than in Europe. However, over time, its density has gradually increased within the forest, where it seems to be overcoming its disadvantages and expanding its range, possibly because the large colonies and good flying abilities of this species help it secure food.	[Kwon, Ohseok; Choi, Moon Bo] Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea; [Choi, Moon Bo] Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu, South Korea	Kyungpook National University; Kyungpook National University	Choi, MB (corresponding author), Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea.; Choi, MB (corresponding author), Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu, South Korea.	kosinchoi@hanmail.net						Arca M, 2015, BIOL INVASIONS, V17, P2357, DOI 10.1007/s10530-015-0880-9; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Boulay R, 2014, J EVOLUTION BIOL, V27, P2856, DOI 10.1111/jeb.12515; Bradshaw CJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12986; Briffa M, 2008, ANIM BEHAV, V75, P1053, DOI 10.1016/j.anbehav.2007.08.016; Budge GE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185172; Carpintero S, 2008, BIOL INVASIONS, V10, P25, DOI 10.1007/s10530-007-9103-3; Carrasco LR, 2010, J R SOC INTERFACE, V7, P529, DOI 10.1098/rsif.2009.0266; Sanches FHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029746; Cheng YN, 2017, J EXP BIOL, V220, P645, DOI 10.1242/jeb.148783; Choi Duck-Soo, 2012, Korean Journal of Applied Entomology, V51, P141, DOI 10.5656/KSAE.2012.04.0.21; Choi MB, 2019, ENTOMOL RES, V49, P141, DOI 10.1111/1748-5967.12350; Choi MB, 2019, J MED ENTOMOL, V56, P254, DOI 10.1093/jme/tjy144; Choi Moon Bo, 2015, Journal of Ecology and Environment, V38, P367, DOI 10.5141/ecoenv.2015.038; Choi Moon Bo, 2013, Korean Journal of Applied Entomology, V52, P85, DOI 10.5656/KSAE.2013.02.1.072; Choi MB, 2012, J ASIA-PAC ENTOMOL, V15, P473, DOI 10.1016/j.aspen.2011.11.004; Choi Moon-Bo, 2012, Journal of Korean Nature, V5, P305; Choi MB, 2012, ENTOMOL RES, V42, P308, DOI 10.1111/j.1748-5967.2012.00472.x; Cini A, 2018, ECOL ENTOMOL, V43, P351, DOI 10.1111/een.12507; Crowder DW, 2010, BIOL INVASIONS, V12, P2857, DOI 10.1007/s10530-010-9733-8; de Haro L, 2010, TOXICON, V55, P650, DOI 10.1016/j.toxicon.2009.08.005; Do Y, 2019, ENTOMOL RES, V49, P456, DOI 10.1111/1748-5967.12390; Drake, 1986, ECOLOGY BIOL INVASIO; Goyens J, 2015, J INSECT BEHAV, V28, P227, DOI 10.1007/s10905-015-9495-3; Han Jung Min, 2008, Entomological Research, V38, P281, DOI 10.1111/j.1748-5967.2008.00188.x; Haxaire Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P194; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jang Y, 2008, BEHAV ECOL SOCIOBIOL, V62, P1397, DOI 10.1007/s00265-008-0568-6; Jung C., 2007, KOREAN J, V22, P53; Jung C., 2012, KOREAN J APICULTURE, V27, P7; Kareiva P, 1996, ECOLOGY, V77, P1651, DOI 10.2307/2265766; Kim Jeong-Kyu, 2011, Korean Journal of Systematic Zoology, V27, P105, DOI 10.5635/KJSZ.2011.27.1.105; Kim Jeong-Kyu, 2006, Entomological Research, V36, P112, DOI 10.1111/j.1748-5967.2006.00018.x; Kim Y, 2011, J ASIA-PAC ENTOMOL, V14, P473, DOI 10.1016/j.aspen.2011.06.002; Korea Forest Service, 2015, FOR BAS STAT; Lee H, 2020, ENTOMOL RES, V50, P14, DOI 10.1111/1748-5967.12402; Lee Heung Sik, 2020, Korean Journal of Applied Entomology, V59, P71, DOI 10.5656/KSAE.2020.02.0.012; Lioy S, 2019, NEOBIOTA, P51, DOI 10.3897/neobiota.46.33099; Matsuura M., 1984, B FAC AGR MEIJI U, V69, P1; Matsuura M., 1990, BIOL VESPINE WASPS; Minoshima Yusuke N., 2015, Japanese Journal of Systematic Entomology, V21, P259; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Monceau K, 2015, B ENTOMOL RES, V105, P462, DOI 10.1017/S0007485315000280; Monceau K, 2017, INSECT SCI, V24, P663, DOI 10.1111/1744-7917.12331; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Park J. J., 2016, J APICUL, V31, P293, DOI DOI 10.17519/APICULTURE.2016.11.31.4.293; PARKER GA, 1976, AM NAT, V110, P1055, DOI 10.1086/283126; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Perrard A, 2013, J HYMENOPT RES, V32, P1, DOI 10.3897/JHR.32.4685; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Poidatz J, 2018, ECOL EVOL, V8, P7588, DOI 10.1002/ece3.4182; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Robinet C, 2017, J APPL ECOL, V54, P205, DOI 10.1111/1365-2664.12724; Rome Q, 2015, J APPL ENTOMOL, V139, P771, DOI 10.1111/jen.12210; Ronconi RA, 2011, CAN J ZOOL, V89, P356, DOI 10.1139/Z11-006; Ruiz G. M, 2003, INVASIVE SPECIES VEC; Sakai Yoshiaki, 2014, Japanese Journal of Entomology (New Series), V17, P32; Sauvard D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198597; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Songvorawit N, 2018, J INSECT BEHAV, V31, P347, DOI 10.1007/s10905-018-9683-z; Sung S, 2018, ENTOMOL RES, V48, P505, DOI 10.1111/1748-5967.12325; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Thiery D, 2018, ENTOMOL GEN, V38, P145, DOI 10.1127/entomologia/2018/0719; Toepfer S, 2004, BIOCONTROL, V49, P385, DOI 10.1023/B:BICO.0000034604.30847.44; UENO T, 2014, INT J CHEM ENV BIOL, V2, P220; Villemant C, 2015, PEERJ, V3, DOI 10.7717/peerj.947; Walters AC, 2005, AUSTRAL ECOL, V30, P395, DOI 10.1111/j.1442-9993.2005.01481.x; Wittman SE, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2403; Yamasaki K, 2019, SCI NAT-HEIDELBERG, V106, DOI 10.1007/s00114-019-1609-x; Yoshimoto J, 2005, ECOL RES, V20, P405, DOI 10.1007/s11284-005-0054-9; Yoshimoto J, 2009, ANN ENTOMOL SOC AM, V102, P201, DOI 10.1603/008.102.0203; Yoshimoto J, 2009, EUR J ENTOMOL, V106, P529, DOI 10.14411/eje.2009.066; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	76	9	9	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0226934	10.1371/journal.pone.0226934	http://dx.doi.org/10.1371/journal.pone.0226934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722670	Green Published, Green Submitted, gold			2022-12-26	WOS:000556916000038
J	Zhu, J; Shen, BY; Abbasi, A; Hoshmand-Kochi, M; Li, HF; Duong, TQ				Zhu, Jocelyn; Shen, Beiyi; Abbasi, Almas; Hoshmand-Kochi, Mahsa; Li, Haifang; Duong, Tim Q.			Deep transfer learning artificial intelligence accurately stages COVID-19 lung disease severity on portable chest radiographs	PLOS ONE			English	Article							PNEUMONIA; WUHAN	This study employed deep-learning convolutional neural networks to stage lung disease severity of Coronavirus Disease 2019 (COVID-19) infection on portable chest x-ray (CXR) with radiologist score of disease severity as ground truth. This study consisted of 131 portable CXR from 84 COVID-19 patients (51M 55.1 +/- 14.9yo; 29F 60.1 +/- 14.3yo; 4 missing information). Three expert chest radiologists scored the left and right lung separately based on the degree of opacity (0-3) and geographic extent (0-4). Deep-learning convolutional neural network (CNN) was used to predict lung disease severity scores. Data were split into 80% training and 20% testing datasets. Correlation analysis between AI-predicted versus radiologist scores were analyzed. Comparison was made with traditional and transfer learning. The average opacity score was 2.52 (range: 0-6) with a standard deviation of 0.25 (9.9%) across three readers. The average geographic extent score was 3.42 (range: 0-8) with a standard deviation of 0.57 (16.7%) across three readers. The inter-rater agreement yielded a Fleiss' Kappa of 0.45 for opacity score and 0.71 for extent score. AI-predicted scores strongly correlated with radiologist scores, with the top model yielding a correlation coefficient (R-2) of 0.90 (range: 0.73-0.90 for traditional learning and 0.83-0.90 for transfer learning) and a mean absolute error of 8.5% (ranges: 17.2-21.0% and 8.5%-15.5, respectively). Transfer learning generally performed better. In conclusion, deep-learning CNN accurately stages disease severity on portable chest x-ray of COVID-19 lung infection. This approach may prove useful to stage lung disease severity, prognosticate, and predict treatment response and survival, thereby informing risk management and resource allocation.	[Zhu, Jocelyn; Shen, Beiyi; Abbasi, Almas; Hoshmand-Kochi, Mahsa; Li, Haifang; Duong, Tim Q.] SUNY Stony Brook, Dept Radiol, Renaissance Sch Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Duong, TQ (corresponding author), SUNY Stony Brook, Dept Radiol, Renaissance Sch Med, Stony Brook, NY 11794 USA.	tim.duong@stonybrook.edu	Duong, Tim/AAL-8357-2021	Duong, Tim/0000-0001-6403-2827				Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4; Arel I, 2010, IEEE COMPUT INTELL M, V5, P13, DOI 10.1109/MCI.2010.938364; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bejnordi BE, 2018, MODERN PATHOL, V31, P1502, DOI 10.1038/s41379-018-0073-z; Byra M, 2018, INT J COMPUT ASS RAD, V13, P1895, DOI 10.1007/s11548-018-1843-2; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1148/radiol.2020200230, 10.1007/s00330-019-06574-1]; Cohen J. P., 2020, ARXIV PREPRINT ARXIV; Dadario AMV, 2020, RADIOLOGY, V296, pE192, DOI 10.1148/radiol.2020201178; Hall LO, ARXIV200402060; Harris M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221339; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li K, 2020, INVEST RADIOL, DOI [10.1097/RLI.0000000000000672 32118615, DOI 10.1097/RLI.0000000000000672 32118615]; Li L., 2020, RADIOLOGY, V296, pe65, DOI 10.1148/radiol.2020200905; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Narin A., 2020, ARXIV200310849; Rahimzadeh Mohammad, 2020, Inform Med Unlocked, V19, P100360, DOI 10.1016/j.imu.2020.100360; Salehi S, 2020, AM J ROENTGENOL, V215, P87, DOI 10.2214/AJR.20.23034; Samala RK, 2017, PHYS MED BIOL, V62, P8894, DOI 10.1088/1361-6560/aa93d4; Singh D, 2020, EUR J CLIN MICROBIOL, V39, P1379, DOI 10.1007/s10096-020-03901-z; Taylor E, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0103-y; Wang L, 2020, ARXIV200309871V1; Wang YZ, 2020, NEURORADIOLOGY, V62, P1141, DOI 10.1007/s00234-020-02455-3; Warren MA, 2018, THORAX, V73, P840, DOI 10.1136/thoraxjnl-2017-211280; Wong HYF., 2019, RADIOLOGY, DOI [10.1148/radiol.2020201160, DOI 10.1148/RADIOL.2020201160]	28	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236621	10.1371/journal.pone.0236621	http://dx.doi.org/10.1371/journal.pone.0236621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722697	Green Published, gold			2022-12-26	WOS:000556916000021
J	Zhang, JJ; Ye, ZY; Li, KF				Zhang, JunJie; Ye, ZiYang; Li, KaiFeng			Multi-sensor information fusion detection system for fire robot through back propagation neural network	PLOS ONE			English	Article							TIME	Objective To reduce the danger for firefighters and ensure the safety of firefighters as much as possible, based on the back propagation neural network (BPNN) the fire sensor multi-sensor information fusion detection system is investigated. Method According to previous studies, the information sources and information processing methods for the design of this study are first explained. Then, the basic structure and flowchart of the research object in this study are designed. Based on the structure diagram and flowchart, the BPNN is selected to fuse the feature layers in this study, and the fuzzy control is selected to fuse the decision layers in this study. The multi-sensor information fusion detection system collects information for the sensors first, processes the collected information, and sends it to the processor of the robot. The processor analyzes and processes the received signal, and transmits the obtained information to the control terminal through the wireless communication system. Results Through the tests in this study, it is found that when the number of hidden layer nodes of the BPNN is 7, the optimal training result is obtained. On this basis, the test of BPNN in this study is performed. The test results show that after 127 iterations, the error of the BPNN reaches the lowest target value, indicating that the BPNN achieves an excellent level of accuracy. The trained BPNN has a running time of 0.0276 s and a mean square error of 0.0013. The smaller the mean square error value is, the higher the accuracy of the BPNN is, which shows that the BPNN meets the high precision requirements of this study. Conclusion The research on the multi-sensor information fusion detection system of fire robots in this study can provide theoretical support for the research on forest fire detection in China. Since the proposed BPNN-based robot is applied to the inspection and processing of forest remaining fire, the results are applicable to the forests of various countries, with a wide range of applications.	[Zhang, JunJie; Ye, ZiYang; Li, KaiFeng] Univ Leeds, Sch Elect & Elect Engn, Leeds, W Yorkshire, England	University of Leeds	Li, KF (corresponding author), Univ Leeds, Sch Elect & Elect Engn, Leeds, W Yorkshire, England.	duangegao@gmail.com	Li, Kai/HCI-8860-2022					Bu ML, 2014, FRONT ECON GLOBAL, V14, P73, DOI 10.1108/S1574-871520140000014004; Feng J., 2018, J BIOMED OPT, V24; Harish B, 2017, INDIAN J PUBLIC HLTH, V8, P1196; Hou AD, 2019, STEEL RES INT, V90, DOI 10.1002/srin.201900116; Jiang D., 2017, J COMPUTER APPL, V12, P47; Jiang Y, 2019, PHYSICA A, V527, DOI 10.1016/j.physa.2019.121177; Jiao CM, 2018, FIRE MATER, V42, P454, DOI 10.1002/fam.2507; Li SX, 2020, J APPL POLYM SCI, V137, DOI 10.1002/app.48307; McArdle D., 2019, PREHOSP DISASTER MED, V34; Mizuno N, 2019, ADV ROBOTICS, V33, P687, DOI 10.1080/01691864.2019.1632221; Mostafa SA, 2018, INT J MED INFORM, V112, P173, DOI 10.1016/j.ijmedinf.2018.02.001; Naderpour M, 2018, PROCESS SAF ENVIRON, V116, P354, DOI 10.1016/j.psep.2018.03.008; Rao DC, 2019, J BIONIC ENG, V16, P235, DOI 10.1007/s42235-019-0020-9; Shojaiemehr B, 2016, INFORM SYSTEMS FRONT, V20, P161; Sowah RA, 2017, IEEE T IND APPL, V53, P559, DOI 10.1109/TIA.2016.2613075; Tao ChangSen, 2018, Journal of Beijing Forestry University, V40, P55; Vernon MJ, 2018, FOREST ECOL MANAG, V422, P190, DOI 10.1016/j.foreco.2018.03.043; Wang BB, 2018, J HAZARD MATER, V352, P92, DOI 10.1016/j.jhazmat.2018.03.033; Wang JW, 2018, IEEE T FUZZY SYST, V26, P2967, DOI 10.1109/TFUZZ.2018.2809686; Wang ZN, 2018, NAT HAZARDS, V92, P1889, DOI 10.1007/s11069-018-3264-5; Zhang DW, 2018, INFORM SCIENCES, V457, P182, DOI 10.1016/j.ins.2018.02.026	21	4	5	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236482	10.1371/journal.pone.0236482	http://dx.doi.org/10.1371/journal.pone.0236482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706794	gold, Green Published			2022-12-26	WOS:000579931700046
J	Kuddus, MA; Meehan, MT; White, LJ; McBryde, ES; Adekunle, AI				Kuddus, Md Abdul; Meehan, Michael T.; White, Lisa J.; McBryde, Emma S.; Adekunle, Adeshina, I			Modeling drug-resistant tuberculosis amplification rates and intervention strategies in Bangladesh	PLOS ONE			English	Article							MATHEMATICAL-MODEL; TRANSMISSION; COST; ASIA	Tuberculosis (TB) is the seventh leading cause of morbidity and mortality in Bangladesh. Although the National TB control program (NTP) of Bangladesh is implementing its nationwide TB control strategies, more specific and effective single or combination interventions are needed to control drug-susceptible (DS) and multi-drug resistant (MDR) TB. In this study, we developed a two strain TB mathematical model with amplification and fit it to the Bangladesh TB data to understand the transmission dynamics of DS and MDR TB. Sensitivity analysis was used to identify important parameters. We evaluated the cost-effectiveness of varying combinations of four basic control strategies including distancing, latent case finding, case holding and active case finding, all within the optimal control framework. From our fitting, the model with different transmission rates between DS and MDR TB best captured the Bangladesh TB reported case counts. The estimated basic reproduction number for DS TB was 1.14 and for MDR TB was 0.54, with an amplification rate of 0.011 per year. The sensitivity analysis also indicated that the transmission rates for both DS and MDR TB had the largest influence on prevalence. To reduce the burden of TB (both DS and MDR), our finding suggested that a quadruple control strategy that combines distancing control, latent case finding, case holding and active case finding is the most cost-effective. Alternative strategies can be adopted to curb TB depending on availability of resources and policy makers' decisions.	[Kuddus, Md Abdul; Meehan, Michael T.; McBryde, Emma S.; Adekunle, Adeshina, I] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia; [Kuddus, Md Abdul; McBryde, Emma S.] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Kuddus, Md Abdul] Univ Rajshahi, Dept Math, Rajshahi, Bangladesh; [White, Lisa J.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Nuffield Dept Med, Oxford, England; [Adekunle, Adeshina, I] Victoria Univ, Decis Sci Program, Melbourne, Vic, Australia	James Cook University; James Cook University; University of Rajshahi; University of Oxford; Victoria University	Adekunle, AI (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia.; Adekunle, AI (corresponding author), Victoria Univ, Decis Sci Program, Melbourne, Vic, Australia.	kunle102@yahoo.com		Adekunle, Adeshina/0000-0002-1811-1310; White, Lisa/0000-0002-6523-185X	College of Medicine and Dentistry at the James Cook University, Australia [JCU-QLD-835481]	College of Medicine and Dentistry at the James Cook University, Australia	This work was conducted as a part of a PhD programme of the first authors and funded by the College of Medicine and Dentistry at the James Cook University, Australia (JCU-QLD-835481).	Agusto FB, 2014, BIOSYSTEMS, V119, P20, DOI 10.1016/j.biosystems.2014.03.006; Ahmed N, 2011, TUBERCULOSIS, V91, P407, DOI 10.1016/j.tube.2011.03.006; Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42; Koch R, 1982, Zentralbl Bakteriol Mikrobiol Hyg A, V251, P287; [Anonymous], 2017, MATLAB V 9 2 0 R2017; ATN Bangla, 2018, TEL FEE PACK PROGR T; Banks HT, 2017, APPL MATH LETT, V74, P33, DOI 10.1016/j.aml.2017.05.005; Banu S, 2017, INT J TUBERC LUNG D, V21, P12, DOI 10.5588/ijtld.16.0384; Bhunu CP, 2008, J THEOR BIOL, V254, P633, DOI 10.1016/j.jtbi.2008.06.023; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brooks-Pollock E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008479; Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Directorate General of Health Services (DGHS) National Tuberculosis Control Program (NTP), NAT GUID OP MAN PROG; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gao DP, 2018, APPL MATH MODEL, V58, P47, DOI 10.1016/j.apm.2017.12.027; Golden MP, 2005, AM FAMILY PHYS, V72; Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843; Inc. GraphPad Software, 2007, PRISM; Islam MA, 2002, B WORLD HEALTH ORGAN, V80, P445; Kim Sara, 2014, Osong Public Health Res Perspect, V5, P40, DOI 10.1016/j.phrp.2014.01.002; Kim S, 2018, J THEOR BIOL, V443, P100, DOI 10.1016/j.jtbi.2018.01.026; Lenhart S., 2007, OPTIMAL CONTROL APPL; Lobato MN, 2003, AM J PREV MED, V24, P249, DOI 10.1016/S0749-3797(02)00583-4; Maude RJ, 2010, INT HEALTH, V2, P239, DOI 10.1016/j.inhe.2010.09.005; Ministry of health and family welfare, 2011, HUMAN RESOURCES DEV; Mishra B., 2014, J EGYPT MATH SOC, V22, P311, DOI DOI 10.1016/J.JOEMS.2013.07.006; National Tuberculosis Control Program (NTP), 2002, ANN REPORT; NTP, 2017, ANN REPORT; Okuonghae D, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01530; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Pontryagin L.S., 2018, MATH THEORY OPTIMAL; Shayla I, 2015, POST 2015 DEV AGENDA; The World Bank, 2011, BANGL HOSP BEDS PER; Trauer JM, 2014, J THEOR BIOL, V358, P74, DOI 10.1016/j.jtbi.2014.05.023; Ullah S, 2019, MATH COMPUTERS SIMUL; Whang S, 2011, J THEOR BIOL, V279, P120, DOI 10.1016/j.jtbi.2011.03.009; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; *WHO, 2005, EST UN COSTS PAT SER; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2010, WHOHTMTB20107; World Health Organization, 2017, WHOHTMTB201723; World Health Organization, 2013, WHOHTMTB201311; Yang Y, 2016, COMPUTATIONAL MATH M, V2016; Yang YL, 2010, CHAOS SOLITON FRACT, V43, P79, DOI 10.1016/j.chaos.2010.09.002; Zaman K., 2007, 11 ASCON ICDDR B SCI, V86, P4	47	8	8	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236112	10.1371/journal.pone.0236112	http://dx.doi.org/10.1371/journal.pone.0236112			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702052	Green Published, Green Accepted, gold			2022-12-26	WOS:000575913700051
J	Akefe, IO; Ayo, JO; Sinkalu, VO				Akefe, Isaac Oluwatobi; Ayo, Joseph Olusegun; Sinkalu, Victor Olusegun			Kaempferol and zinc gluconate mitigate neurobehavioral deficits and oxidative stress induced by noise exposure in Wistar rats	PLOS ONE			English	Article							DNA-BINDING; ANTIOXIDANT; PERFORMANCE; IMPACT; MEMORY; FLAVONOLS; DISCOVERY; BEHAVIOR; HORMONES; SYSTEM	This study investigated the effects of kaempferol and zinc gluconate on neurobehavioural and oxidative stress changes in Wistar rats exposed to noise. Thirty (30) rats were randomly divided into five groups: Groups I and II were administered with deionized water (DW); Group III, kaempferol (K); Group IV, zinc gluconate (Zn); Group V, kaempferol + zinc gluconate. Groups II, III, IV, and V were subjected to noise stress (N) induced by exposing rats to 100 dB (4 h/day) for 15 days, from day 33 to day 48 after starting the drug treatments. Neuromuscular coordination, motor coordination, motor strength, sensorimotor reflex, and learning and memory, were evaluated using standard laboratory methods. Levels of nitric oxide (NO), malondialdehyde (MDA) and activities of glutathione peroxidase (GPx), catalase and superoxide dismutase (SOD) were evaluated in the hippocampus. Exposure of rats to noise, induced significant neurobehavioural deficits and oxidative stress while the combined administration of kaempferol and zinc gluconate significantly (P < 0.05) improved open-field performance, motor coordination, motor strength, sensorimotor reflex, and learning and memory. Co-administration of kaempferol and zinc gluconate ameliorated noise-induced oxidative stress as demonstrated by the significantly increased activities of GPx, catalase, and SOD, and decreased levels of NO and MDA (P < 0.05 and P < 0.01 respectively), compared to the DW + N group. Our results suggest that oxidative stress, evidenced by increased NO and MDA concentration and decreased activities of GPx, catalase and SOD, were involved in the molecular mechanism underlying neurobehavioural impairment in Wistar rats, exposed to noise stress. Single treatment of kaempferol exerted a more potent mitigative effect than zinc gluconate, while their combination produced an improved outcome.	[Akefe, Isaac Oluwatobi] Univ Jos, Fac Vet Med, Dept Physiol Biochem & Pharmacol, Jos, Nigeria; [Akefe, Isaac Oluwatobi; Ayo, Joseph Olusegun; Sinkalu, Victor Olusegun] Ahmadu Bello Univ, Fac Vet Med, Dept Physiol, Zaria, Nigeria	University of Jos; Ahmadu Bello University	Akefe, IO (corresponding author), Univ Jos, Fac Vet Med, Dept Physiol Biochem & Pharmacol, Jos, Nigeria.; Akefe, IO (corresponding author), Ahmadu Bello Univ, Fac Vet Med, Dept Physiol, Zaria, Nigeria.	i.akefe@uq.edu.au	Akefe, Isaac Oluwatobi/ABE-2760-2021	Akefe, Isaac Oluwatobi/0000-0003-4738-0701				Abou-Donia MB, 2001, TOXICOL SCI, V60, P305, DOI 10.1093/toxsci/60.2.305; Alawieh A, 2015, EXPERT REV PROTEOMIC, V12, P185, DOI 10.1586/14789450.2015.1024228; ALGERS BO, 1978, Acta Veterinaria Scandinavica Supplementum, P1; Aluwong T, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13314; Ambali Suleiman F, 2012, Toxicol Int, V19, P144, DOI 10.4103/0971-6580.97211; Anand Gupta D., 2014, ISSUES BIOL SCI PHAR, V2, P8; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Baliatsas C, 2016, SCI TOTAL ENVIRON, V557, P163, DOI 10.1016/j.scitotenv.2016.03.065; Bernatova I, 2007, PHYSIOL RES, V56, P667, DOI 10.33549/physiolres.931386; Bigoniya P., 2013, INT J PHARM BIOL SCI, V3, P139; Brown GR, 2008, BEHAV PROCESS, V78, P442, DOI 10.1016/j.beproc.2008.02.019; Cheng L, 2011, PHYSIOL BEHAV, V104, P981, DOI 10.1016/j.physbeh.2011.06.018; Di GQ, 2018, NOISE HEALTH, V20, P9, DOI 10.4103/nah.NAH_27_17; Doronicheva N, 2007, BIOL PHARM BULL, V30, P213, DOI 10.1248/bpb.30.213; Fregoneze JB, 1999, BRAZ J MED BIOL RES, V32, P1217, DOI 10.1590/S0100-879X1999001000007; Haberman RP, 2017, NEUROBIOL AGING, V54, P144, DOI 10.1016/j.neurobiolaging.2016.12.021; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Hou LF, 2004, ORG BIOMOL CHEM, V2, P1419, DOI 10.1039/b401550a; Huet-Bello O, 2017, NOISE HEALTH, V19, P239, DOI 10.4103/nah.NAH_97_16; Isaac AO, 2017, INSIGHTS BIOMEDICINE, V2, P15, DOI [10.21767/2572-5610.100031, DOI 10.21767/2572-5610.100031]; Ismaila SO, 2014, J BASIC APPL SCI, V3, P116, DOI DOI 10.1016/J.BJBAS.2014.05.004; Jafari Z, 2019, NEUROBIOL AGING, V77, P66, DOI 10.1016/j.neurobiolaging.2019.01.019; Khalaf AA, 2017, INT J PHARMACOL, V13, P22, DOI 10.3923/ijp.2017.22.32; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Lopez-Sanchez C, 2007, BRAIN RES, V1182, P123, DOI 10.1016/j.brainres.2007.08.087; Marreiro DD, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020024; Michaud DS, 2016, J ACOUST SOC AM, V139, P1455, DOI 10.1121/1.4942390; Nunes R, 2017, PHARM BIOL, V55, P114, DOI 10.1080/13880209.2016.1230636; Nyarubeli IP, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081367; Parat MO, 1997, BIOL TRACE ELEM RES, V60, P187, DOI 10.1007/BF02784439; Pinar T, 2011, UHOD-ULUSLAR HEMATOL, V21, P10, DOI 10.4999/uhod.10094; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P357, DOI 10.1016/j.jtemb.2014.09.002; Prasad AS, 2013, ADV NUTR, V4, P176, DOI 10.3945/an.112.003210; Ren J, 2019, EXP THER MED, V18, P2759, DOI 10.3892/etm.2019.7886; Romanazzi G, 2017, CRIT REV FOOD SCI, V57, P579, DOI 10.1080/10408398.2014.900474; Sadhana Shrivastava, 2017, Free Radicals and Antioxidants, V7, P36; Sahin K, 2003, J NUTR, V133, P2808, DOI 10.1093/jn/133.9.2808; Said MA, 2016, GEN PHYSIOL BIOPHYS, V35, P371, DOI 10.4149/gpb_2016003; Saki G, 2016, INT J PHARM RES ALLI, V5, P67; Samardzic J, 2013, VOJNOSANIT PREGL, V70, P391, DOI 10.2298/VSP111129036S; Sandstead HH, 1998, AM J CLIN NUTR, V68, p470S, DOI 10.1093/ajcn/68.2.470S; Shen KK, 2011, BIOSCI TRENDS, V5, P30, DOI 10.5582/bst.2011.v5.1.30; Tao Shan, 2015, J Otol, V10, P21, DOI 10.1016/j.joto.2015.07.001; Tu YC, 2007, J AGR FOOD CHEM, V55, P9969, DOI 10.1021/jf0717788; Tuerdi A, 2017, NEUROSCI LETT, V642, P123, DOI 10.1016/j.neulet.2017.02.003; vanAcker SABE, 1996, FREE RADICAL BIO MED, V20, P331, DOI 10.1016/0891-5849(95)02047-0; Vauzour D, 2014, J SCI FOOD AGR, V94, P1042, DOI 10.1002/jsfa.6473; Vaziri ND, 1999, KIDNEY INT, V56, P1492, DOI 10.1046/j.1523-1755.1999.00670.x; Verhaegh GW, 1998, MOL CARCINOGEN, V21, P205, DOI 10.1002/(SICI)1098-2744(199803)21:3<205::AID-MC8>3.0.CO;2-K; Vissiennon C, 2012, J NUTR BIOCHEM, V23, P733, DOI 10.1016/j.jnutbio.2011.03.017; Wang LS, 2006, J AGR FOOD CHEM, V54, P9798, DOI 10.1021/jf0620719; Wankhar D., 2014, BIOMED PREV NUTR, V4, P219; World Health Organization (WHO), 2019, DEAFN HEAR LOSS GLOB; Yeh CW, 2019, BIOMED J, V42, P46, DOI 10.1016/j.bj.2018.10.009; Yoshikawa, 2000, Pathophysiology, V7, P131, DOI 10.1016/S0928-4680(00)00040-7; Zhang L, 2015, J NEUROGASTROENTEROL, V21, P189, DOI 10.5056/jnm14119; Zheng KC, 2007, J OCCUP HEALTH, V49, P32, DOI 10.1539/joh.49.32; Zhu H, 2001, J BIOMED SCI, V8, P467, DOI 10.1007/BF02256609	59	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236251	10.1371/journal.pone.0236251	http://dx.doi.org/10.1371/journal.pone.0236251			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692754	gold, Green Published			2022-12-26	WOS:000554606400002
J	Legault, MA; Sandoval, J; Provost, S; Barhdadi, A; Perreault, LPL; Shah, SI; Lumbers, RT; de Denus, S; Tyl, B; Tardif, JC; Dube, MP				Legault, Marc-Andre; Sandoval, Johanna; Provost, Sylvie; Barhdadi, Amina; Lemieux Perreault, Louis-Philippe; Shah, Sonia; Lumbers, R. Thomas; de Denus, Simon; Tyl, Benoit; Tardif, Jean-Claude; Dube, Marie-Pierre			A genetic model of ivabradine recapitulates results from randomized clinical trials	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ATRIAL-FIBRILLATION; MENDELIAN RANDOMIZATION; HEART-FAILURE; RISK; LOCI; METAANALYSIS; BRADYCARDIA	Background Naturally occurring human genetic variants provide a valuable tool to identify drug targets and guide drug prioritization and clinical trial design. Ivabradine is a heart rate lowering drug with protective effects on heart failure despite increasing the risk of atrial fibrillation. In patients with coronary artery disease without heart failure, the drug does not protect against major cardiovascular adverse events prompting questions about the ability of genetics to have predicted those effects. This study evaluates the effect of a variant inHCN4, ivabradine's drug target, on safety and efficacy endpoints. Methods We used genetic association testing and Mendelian randomization to predict the effect of ivabradine and heart rate lowering on cardiovascular outcomes. Results Using data from the UK Biobank and large GWAS consortia, we evaluated the effect of a heart rate-reducing genetic variant at theHCN4locus encoding ivabradine's drug target. These genetic association analyses showed increases in risk for atrial fibrillation (OR 1.09, 95% CI: 1.06-1.13, P = 9.3 x10(-9)) in the UK Biobank. In a cause-specific competing risk model to account for the increased risk of atrial fibrillation, theHCN4variant reduced incident heart failure in participants that did not develop atrial fibrillation (HR 0.90, 95% CI: 0.83-0.98, P = 0.013). In contrast, the same heart rate reducingHCN4variant did not prevent a composite endpoint of myocardial infarction or cardiovascular death (OR 0.99, 95% CI: 0.93-1.04, P = 0.61). Conclusion Genetic modelling of ivabradine recapitulates its benefits in heart failure, promotion of atrial fibrillation, and neutral effect on myocardial infarction.	[Legault, Marc-Andre; Sandoval, Johanna; Provost, Sylvie; Barhdadi, Amina; Lemieux Perreault, Louis-Philippe; de Denus, Simon; Tardif, Jean-Claude; Dube, Marie-Pierre] Montreal Heart Inst, Montreal, PQ, Canada; [Legault, Marc-Andre] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada; [Legault, Marc-Andre; Sandoval, Johanna; Provost, Sylvie; Barhdadi, Amina; Lemieux Perreault, Louis-Philippe; Dube, Marie-Pierre] Univ Montreal, Beaulieu Saucier Pharmacogen Ctr, Montreal, PQ, Canada; [Shah, Sonia] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Shah, Sonia] UCL, Inst Cardiovasc Sci, London, England; [Lumbers, R. Thomas] UCL, Inst Hlth Informat, London, England; [Lumbers, R. Thomas] UCL, Hlth Data Res UK London, London, England; [Lumbers, R. Thomas] St Bartholomews Hosp, Bart's Heart Ctr, London, England; [de Denus, Simon] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Tyl, Benoit] Inst Rech Int Servier, Cardiovasc Ctr Therapeut Innovat, Suresnes, France; [Tardif, Jean-Claude; Dube, Marie-Pierre] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Queensland; University of London; University College London; University of London; University College London; University of London; University College London; University of London; Queen Mary University London; Universite de Montreal; Servier; Institut de Recherches Internationales Servier; Universite de Montreal	Tardif, JC; Dube, MP (corresponding author), Montreal Heart Inst, Montreal, PQ, Canada.; Dube, MP (corresponding author), Univ Montreal, Beaulieu Saucier Pharmacogen Ctr, Montreal, PQ, Canada.; Tardif, JC; Dube, MP (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.	marie-pierre.dube@umontreal.ca; jean-claude.tardif@icm-mhi.org	Legault, Marc-André/HHD-1804-2022; Legault, Marc-André/GNH-5935-2022; Dube, Marie-Pierre/B-9364-2008; Shah, Sonia/N-7547-2013	Lemieux Perreault, Louis-Philippe/0000-0001-7423-0958; Sandoval, Johanna/0000-0002-7543-2188; Dube, Marie-Pierre/0000-0001-8442-4393; Shah, Sonia/0000-0001-5860-4526; Legault, Marc-Andre/0000-0001-6927-1210; Tyl, Benoit/0000-0001-5297-8412	Health Collaboration Acceleration Fund from the Ministere de l'Economie et de l'Innovation du Gouvernement du Quebec; Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from the Canadian Institutes of Health Research (CIHR); Canada Research Chair in personalized medicine; Universite de Montreal Pfizerendowed research chair in atherosclerosis; Canada Research Chair in precision medicine data analysis; Universite de Montreal Beaulieu-saucier Chair in Pharmacogenomics; National Health and Medical Research Council (NHMRC) fellowship; NHMRC [1113400]; UK Research and Innovation Rutherford Fellowship	Health Collaboration Acceleration Fund from the Ministere de l'Economie et de l'Innovation du Gouvernement du Quebec; Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in personalized medicine; Universite de Montreal Pfizerendowed research chair in atherosclerosis; Canada Research Chair in precision medicine data analysis; Universite de Montreal Beaulieu-saucier Chair in Pharmacogenomics; National Health and Medical Research Council (NHMRC) fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UK Research and Innovation Rutherford Fellowship	This work was supported by the Health Collaboration Acceleration Fund from the Ministere de l'Economie et de l'Innovation du Gouvernement du Quebec. M.-A.L. is supported by a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from the Canadian Institutes of Health Research (CIHR). J.-C.T. holds the Canada Research Chair in personalized medicine and the Universite de Montreal Pfizerendowed research chair in atherosclerosis. M.-P.D. holds the Canada Research Chair in precision medicine data analysis. S.d.D. holds the Universite de Montreal Beaulieu-saucier Chair in Pharmacogenomics. SS is partly supported by a National Health and Medical Research Council (NHMRC) fellowship and NHMRC Program Grant 1113400. R.T.L. is supported by a UK Research and Innovation Rutherford Fellowship. Laboratoire Servier provided support in the form of salaries for author B. Tyl but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burgess S, 2017, STAT METHODS MED RES, V26, P2333, DOI 10.1177/0962280215597579; Burgess S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14156-4; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; DAVIES NM, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K601; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708; Ference BA, 2015, J AM COLL CARDIOL, V65, P1552, DOI 10.1016/j.jacc.2015.02.020; Fox K, 2015, EUR HEART J, V36, P3291, DOI 10.1093/eurheartj/ehv451; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Grundvold I, 2013, CIRC-ARRHYTHMIA ELEC, V6, P726, DOI 10.1161/CIRCEP.113.000267; Hemani G, 2018, HUM MOL GENET, V27, pR195, DOI 10.1093/hmg/ddy163; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Larsson SC, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.119.002459; Malik R, 2018, NAT GENET, V50, P524, DOI 10.1038/s41588-018-0058-3; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Milano A, 2014, J AM COLL CARDIOL, V64, P745, DOI 10.1016/j.jacc.2014.05.045; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Pitcairn Emily, 2017, Commun Integr Biol, V10, pe1309488, DOI 10.1080/19420889.2017.1309488; Roselli C, 2018, NAT GENET, V50, P1225, DOI 10.1038/s41588-018-0133-9; Shah S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13690-5; Swedberg K, 2010, REV PORT CARDIOL, V29, P1273, DOI 10.1016/S0140-6736(10)61198-1; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2	33	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236193	10.1371/journal.pone.0236193	http://dx.doi.org/10.1371/journal.pone.0236193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692755	Green Published, Green Submitted, gold			2022-12-26	WOS:000554606400003
J	Sun, SS				Sun, SongSong			A new stress field intensity model and its application in component high cycle fatigue research	PLOS ONE			English	Article							STRENGTH; CRACK; BEHAVIOR; TIP	Fatigue limit load is one of the most important and concerned factors in designing and manufacturing critical mechanical parts such as the crankshafts. Usually, this governing parameter is obtained by experiment, which is expensive, time-consuming and only feasible in analyzing the case of simple structure. Still, there's a big obstacle to clear to get the fatigue limit load of a sophisticated structure effectively and efficiently. This paper applied the stress field intensity theory to make quick component fatigue limit load predictions. First, the field diameter of a given crankshaft was determined based on its limit stress state and a stress distribution fitting approach. Then, this parameter was used to predict the high-cycle bending fatigue limit load of a new crankshaft composed of the same material. Finally, a corresponding experimental verification was conducted to evaluate the accuracy of the predictions. The results indicated that the original stress field intensity model may not be suitable due to the errors in the predictions, which can be attributed to the structural features. The new model proposed in this paper can provide higher accuracy in quick fatigue load prediction, making it superior to the traditional model in engineering application.	[Sun, SongSong] Nanjing Forestry Univ, Coll Automobile & Traff Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Sun, SS (corresponding author), Nanjing Forestry Univ, Coll Automobile & Traff Engn, Nanjing, Jiangsu, Peoples R China.	sunsong1987@126.com		songsong, sun/0000-0003-1593-1847	National Natural Science Foundation of The Jiangsu Higher Education Institutions of China [18KJB460019]	National Natural Science Foundation of The Jiangsu Higher Education Institutions of China	This study is finally supported by The National Natural Science Foundation of The Jiangsu Higher Education Institutions of China under the Grant Number of No. 18KJB460019.	Adib-Ramezani H, 2007, COMP MATER SCI, V39, P649, DOI 10.1016/j.commatsci.2006.08.017; Chang CC, 2019, J ENERG ENG, V145, DOI 10.1061/(ASCE)EY.1943-7897.0000617; Chen XP, 2014, ENG FAIL ANAL, V42, P210, DOI 10.1016/j.engfailanal.2014.04.015; Chen Xiaoping, 2010, Proceedings of the 2010 International Conference on Measuring Technology and Mechatronics Automation (ICMTMA 2010), P548, DOI 10.1109/ICMTMA.2010.290; Hammouda MMI, 2004, INT J FATIGUE, V26, P183, DOI 10.1016/S0142-1123(03)00093-8; Hammouda MMI, 2004, INT J FATIGUE, V26, P173, DOI 10.1016/S0142-1123(03)00094-X; Hammouda MMI, 1999, FATIGUE FRACT ENG M, V22, P145; Hu Z, 2019, INT J FATIGUE, V123, P105, DOI 10.1016/j.ijfatigue.2019.02.009; Leitner M, 2017, INT J FATIGUE, V100, P159, DOI 10.1016/j.ijfatigue.2017.03.023; Li Yuchun, 2002, Journal of Mechanical Strength, V24, P258; Linul E, 2017, FATIGUE FRACT ENG M, V40, P597, DOI 10.1111/ffe.12535; Liu G, 2014, J SHIP MECH, V18; Liviu Marsavinaa, 2019, INT J FATIGUE, V127, P10; Morita T, 2016, MAT SCI ENG A-STRUCT, V661, P105, DOI 10.1016/j.msea.2016.03.015; Sadowski T, 2014, KEY ENG MATER, V601, P25, DOI 10.4028/www.scientific.net/KEM.601.25; Sha D, 2012, J VIBRATION MEASUR S, V32; Spaggiari A, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.459; Sun SS, 2016, ENG FAIL ANAL, V70, P31, DOI 10.1016/j.engfailanal.2016.07.005; Sun SS, 2016, ENG FAIL ANAL, V60, P199, DOI 10.1016/j.engfailanal.2015.11.053; Sun SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167722; Taylor D, 2007, THEORY CRITICAL DIST; Tian J, 2018, J COASTAL RES, P531, DOI 10.2112/SI83-089.1; Tian J, 2018, ENERGIES, V11, DOI 10.3390/en11112892; Tian J, 2019, INT J NEUROSCI, V129, P896, DOI 10.1080/00207454.2019.1586687; Wang AC, 2019, MATH PROBL ENG, V2019, DOI 10.1155/2019/3091071; Wang B, 2015, MATER DESIGN, V85, P91, DOI 10.1016/j.matdes.2015.07.013; Xu XL, 2018, ENG FAIL ANAL, V92, P84, DOI 10.1016/j.engfailanal.2018.05.007; Yang Tai, 2016, PLOS ONE, V1; YAO WX, 1993, INT J FATIGUE, V15, P243, DOI 10.1016/0142-1123(93)90182-P; YAO WX, 1995, INT J FATIGUE, V17, P245, DOI 10.1016/0142-1123(95)93538-D; Zhang Y, 2020, MATH PROBL ENG, V2020, DOI 10.1155/2020/2153235; Zhao D, 2017, ENG FAIL ANAL, V81, P1, DOI 10.1016/j.engfailanal.2017.07.019; Zhou M, 2011, J SW JIAOTONG U, V46	33	6	6	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0235323	10.1371/journal.pone.0235323	http://dx.doi.org/10.1371/journal.pone.0235323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692776	gold, Green Published			2022-12-26	WOS:000554606400009
J	Ko, KP; Jeong, SI; Lim, JS; Lee, KW; Lee, MG; Chi, SG				Ko, Kyung-Phil; Jeong, Seong-In; Lim, Ji-Sun; Lee, Kyung-Woo; Lee, Min-Goo; Chi, Sung-Gil			NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX	ONCOGENE			English	Article							TUMOR-NECROSIS-FACTOR; E3 UBIQUITIN LIGASE; NF-KAPPA-B; SUPPRESSOR GENE; CONFORMATIONAL-CHANGE; RAS; ALPHA; EFFECTOR; RASSF1A; DEATH	NORE1A (RASSF5) is a tumor suppressor of the Ras-association domain family (RASSF) that is commonly inactivated in multiple human cancers. However, the molecular mechanism underlying its growth inhibition function remains largely undefined. Here we report that NORE1A antagonizes tumor necrosis factor receptor I (TNFRI) through the assembly of ITCH-mediated destruction complex to suppress TNF-NF-kappa B signaling and tumorigenesis. Moreover, NORE1A is identified as a transcription target of NF-kappa B, which directs an apoptotic switch of TNF effect by blocking ITCH interaction with and ubiquitination of BAX. Mechanistically, NORE1A binds directly to TNFRI and ITCH via the C1 and PPXY domains, respectively to facilitate the formation of ITCH-mediated destruction complex followed by ubiquitination-mediated lysosomal degradation of TNFRI. Through this function, NORE1A suppresses TNF-induced NF-kappa B-mediated transcription of pro-inflammatory and tumor-promoting genes, epithelial-to-mesenchymal transition, invasion and migration of tumor cells, and also debilitates tumor cell activation of macrophage and fibroblast. While NORE1A suppresses TNF receptor-mediated apoptosis, it activates TNF-induced apoptosis through BAX activation by protecting BAX from ITCH binding and ubiquitination. Cytotoxic response to TNF is substantially attenuated in NORE1A-depleted cells and tumors, and NORE1A-induced tumor regression is highly impeded in BAX-depleted tumors. An inverse correlation is shown between NORE1A and TNFRI expression in both cancer cell lines and primary tumors, and NORE1A effect on survival of cancer patients is strongly associated with expression status of ITCH. Collectively, this study uncovers that NORE1A directs a substrate switch of ITCH favoring TNFRI over BAX to terminate TNF signaling and accelerate apoptosis, illuminating the mechanistic consequence of NORE1A inactivation in tumorigenesis.	[Ko, Kyung-Phil; Jeong, Seong-In; Lim, Ji-Sun; Lee, Kyung-Woo; Lee, Min-Goo; Chi, Sung-Gil] Korea Univ, Dept Life Sci, Seoul 02841, South Korea	Korea University	Chi, SG (corresponding author), Korea Univ, Dept Life Sci, Seoul 02841, South Korea.	chi6302@korea.ac.kr		Chi, Sung-Gil/0000-0003-4643-9003	National Research Foundation of Korea, Republic of Korea [NRF-2018R1A2A1A05020236]; Korea University Grant, Republic of Korea [K1705811]	National Research Foundation of Korea, Republic of Korea(National Research Foundation of Korea); Korea University Grant, Republic of Korea	This work was supported in part by National Research Foundation of Korea (Grant numbers NRF-2018R1A2A1A05020236, SGC) and Korea University Grant (K1705811, SGC), Republic of Korea.	Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x; Baillat G, 2005, BBA-MOL CELL RES, V1745, P101, DOI 10.1016/j.bbamcr.2004.12.005; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Calvisi DF, 2009, CANCER RES, V69, P4629, DOI 10.1158/0008-5472.CAN-08-3672; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Choi YB, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00422-16; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; Donninger H, 2015, J CELL BIOL, V208, P777, DOI 10.1083/jcb.201408087; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14; Guan JJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt539; Hesson L, 2003, ONCOGENE, V22, P947, DOI 10.1038/sj.onc.1206191; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hong IS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.64; Irimia M, 2004, ONCOGENE, V23, P8695, DOI 10.1038/sj.onc.1207914; Johnson BN, 2012, P NATL ACAD SCI USA, V109, P6283, DOI 10.1073/pnas.1113248109; Jones SJ, 1999, J IMMUNOL, V162, P1042; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kim H, 2015, CELL REP, V11, P1151, DOI 10.1016/j.celrep.2015.04.048; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Lee CK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-577; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Martinez-Reza I, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0398-9; Matthews CP, 2007, CURR CANCER DRUG TAR, V7, P317, DOI 10.2174/156800907780809723; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Park J, 2010, J BIOL CHEM, V285, P35029, DOI 10.1074/jbc.M110.165506; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Prando ED, 2011, EPIGENETICS-US, V6, P1413, DOI 10.4161/epi.6.12.18271; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2013, INT J MOL SCI, V14, P14475, DOI 10.3390/ijms140714475; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Suryaraja R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.91; TALMADGE JE, 1988, CANCER RES, V48, P544; Tchikov V, 2011, EUR J CELL BIOL, V90, P467, DOI 10.1016/j.ejcb.2010.11.002; Tomita Y, 2004, INT J CANCER, V112, P927, DOI 10.1002/ijc.20493; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zheng WW, 2016, INT J CLIN EXP MED, V9, P2027	53	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2020	39	34					5675	5689		10.1038/s41388-020-01392-y	http://dx.doi.org/10.1038/s41388-020-01392-y		JUL 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NE9FK	32690868				2022-12-26	WOS:000550641000001
J	Reidenbach, AG; Mesleh, MF; Casalena, D; Vallabh, SM; Dahlin, JL; Leed, AJ; Chan, AI; Usanov, DL; Yehl, JB; Lemke, CT; Campbell, AJ; Shah, RN; Shrestha, OK; Sacher, JR; Rangel, VL; Moroco, JA; Sathappa, M; Nonato, MC; Nguyen, KT; Wright, SK; Liu, DR; Wagner, FF; Kaushik, VK; Auld, DS; Schreiber, SL; Minikel, EV				Reidenbach, Andrew G.; Mesleh, Michael F.; Casalena, Dominick; Vallabh, Sonia M.; Dahlin, Jayme L.; Leed, Alison J.; Chan, Alix I.; Usanov, Dmitry L.; Yehl, Jenna B.; Lemke, Christopher T.; Campbell, Arthur J.; Shah, Rishi N.; Shrestha, Om K.; Sacher, Joshua R.; Rangel, Victor L.; Moroco, Jamie A.; Sathappa, Murugappan; Nonato, Maria Cristina; Nguyen, Kong T.; Wright, S. Kirk; Liu, David R.; Wagner, Florence F.; Kaushik, Virendar K.; Auld, Douglas S.; Schreiber, Stuart L.; Minikel, Eric Vallabh			Multimodal small-molecule screening for human prion protein binders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PrP; prion; fragment screening; 19F NMR; STD NMR; TROSY NMR; DNA-encoded library; DSF; in silicoscreening; binders; prion disease; drug screening; high-throughput screening (HTS); drug discovery; small molecule; nuclear magnetic resonance (NMR); neurodegenerative disease; differential scanning fluorimetry	TIME BIOLOGICAL ANNOTATION; DRUG DISCOVERY; STRUCTURAL BASIS; NMR; INHIBITION; DISEASE; LIGAND; MECHANISM; BINDING; POTENT	Prion disease is a rapidly progressive neurodegenerative disorder caused by misfolding and aggregation of the prion protein (PrP), and there are currently no therapeutic options. PrP ligands could theoretically antagonize prion formation by protecting the native protein from misfolding or by targeting it for degradation, but no validated small-molecule binders have been discovered to date. We deployed a variety of screening methods in an effort to discover binders of PrP, including(19)F-observed and saturation transfer difference (STD) NMR spectroscopy, differential scanning fluorimetry (DSF), DNA-encoded library selection, andin silicoscreening. A single benzimidazole compound was confirmed in concentration-response, but affinity was very weak (K-d> 1 mm), and it could not be advanced further. The exceptionally low hit rate observed here suggests that PrP is a difficult target for small-molecule binders. Whereas orthogonal binder discovery methods could yield high-affinity compounds, non-small-molecule modalities may offer independent paths forward against prion disease.	[Reidenbach, Andrew G.; Vallabh, Sonia M.; Chan, Alix I.; Usanov, Dmitry L.; Liu, David R.; Schreiber, Stuart L.; Minikel, Eric Vallabh] Broad Inst MIT & Harvard, Chem Biol & Therapeut Sci Program, Cambridge, MA 02142 USA; [Mesleh, Michael F.; Leed, Alison J.; Usanov, Dmitry L.; Yehl, Jenna B.; Lemke, Christopher T.; Campbell, Arthur J.; Sacher, Joshua R.; Moroco, Jamie A.; Sathappa, Murugappan; Wagner, Florence F.; Kaushik, Virendar K.] Broad Inst MIT & Harvard, Ctr Dev Therapeut, Cambridge, MA 02142 USA; [Casalena, Dominick; Shrestha, Om K.; Wright, S. Kirk; Auld, Douglas S.] Novartis Inst Biomed Res NIBR, Facilitated Access Screening Technol FAST Lab, Cambridge, MA USA; [Vallabh, Sonia M.; Wagner, Florence F.; Minikel, Eric Vallabh] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Vallabh, Sonia M.; Minikel, Eric Vallabh] Prion Alliance, Cambridge, MA 02140 USA; [Vallabh, Sonia M.; Dahlin, Jayme L.; Minikel, Eric Vallabh] Harvard Med Sch, Boston, MA 02115 USA; [Dahlin, Jayme L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Shah, Rishi N.] MIT, Undergrad Res Opportun Program UROP, Cambridge, MA 02139 USA; [Rangel, Victor L.; Nonato, Maria Cristina] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Nguyen, Kong T.] Atomwise, Artificial Intelligence Mol Screen AIMS Awards Pr, San Francisco, CA USA; [Liu, David R.] Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA; [Liu, David R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Liu, David R.; Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Universidade de Sao Paulo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University	Minikel, EV (corresponding author), Broad Inst MIT & Harvard, Chem Biol & Therapeut Sci Program, Cambridge, MA 02142 USA.; Minikel, EV (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Minikel, EV (corresponding author), Prion Alliance, Cambridge, MA 02140 USA.; Minikel, EV (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	eminikel@broadinstitute.org	Dahlin, Jayme/AAM-2306-2021; Liu, David R./HCH-3132-2022; Nonato, Maria Cristina C/C-5659-2012; Sacher, Joshua/M-7463-2016	Nonato, Maria Cristina C/0000-0002-4916-1505; Dahlin, Jayme/0000-0003-4151-9944; Sacher, Joshua/0000-0003-4381-3979; Chan, Alix/0000-0002-2698-4031; Lopes Rangel, Victor/0000-0002-7580-3452	National Institutes of Health [F31 AI122592, R35 GM118062, T32 HL007627]; Prion Alliance; BroadIgnite; Artificial Intelligence Molecular Screen (AIMS) Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prion Alliance; BroadIgnite; Artificial Intelligence Molecular Screen (AIMS) Award	This work was supported by the National Institutes of Health (F31 AI122592 to E. V. M., R35 GM118062 to D. R. L., supporting A. I. C. and D. L. U., and T32 HL007627 to J. L. D.), Prion Alliance, BroadIgnite, and an anonymous organization. Atomwise provided effort and reagents in kind as part of an Artificial Intelligence Molecular Screen (AIMS) Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2018, ANNU REV PHARMACOL, V58, P331, DOI 10.1146/annurev-pharmtox-010617-052745; Ahn S, 2018, MOL PHARMACOL, V94, P850, DOI 10.1124/mol.118.111948; Baell JB, 2018, ACS CHEM BIOL, V13, P36, DOI 10.1021/acschembio.7b00903; Banik SM, 2020, NATURE, V584, P291, DOI 10.1038/s41586-020-2545-9; Baral PK, 2014, STRUCTURE, V22, P291, DOI 10.1016/j.str.2013.11.009; Barreca ML, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010027; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; Blochberger TC, 1997, PROTEIN ENG, V10, P1465, DOI 10.1093/protein/10.12.1465; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bruns RF, 2012, J MED CHEM, V55, P9763, DOI 10.1021/jm301008n; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Chamberlain PP, 2019, NAT CHEM BIOL, V15, P937, DOI 10.1038/s41589-019-0362-y; Chessari G, 2015, J MED CHEM, V58, P6574, DOI 10.1021/acs.jmedchem.5b00706; Chilton M, 2017, J MED CHEM, V60, P4923, DOI 10.1021/acs.jmedchem.7b00208; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Denisov IG, 2017, CHEM REV, V117, P4669, DOI 10.1021/acs.chemrev.6b00690; Doak BC, 2014, CHEM BIOL, V21, P1115, DOI 10.1016/j.chembiol.2014.08.013; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Dyer C, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4608; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Evans EGB, 2016, STRUCTURE, V24, P1057, DOI 10.1016/j.str.2016.04.017; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Ferreira NC, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01441-17; Friberg KN, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.6; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Gerry CJ, 2016, J AM CHEM SOC, V138, P8920, DOI 10.1021/jacs.6b04614; Ghaemmaghami S, 2010, J VIROL, V84, P3408, DOI 10.1128/JVI.02145-09; Giles K, 2016, J PHARMACOL EXP THER, V358, P537, DOI 10.1124/jpet.116.235556; Giles K, 2015, J PHARMACOL EXP THER, V355, P2, DOI 10.1124/jpet.115.224659; Gossert AD, 2016, PROG NUCL MAG RES SP, V97, P82, DOI 10.1016/j.pnmrs.2016.09.001; Guha R, 2007, J STAT SOFTW, V18; Gunther EC, 2019, CELL REP, V26, P145, DOI 10.1016/j.celrep.2018.12.021; Hafner-Bratkovic I, 2008, J NEUROCHEM, V104, P1553, DOI 10.1111/j.1471-4159.2007.05105.x; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Haftchenary S, 2016, ACS COMB SCI, V18, P569, DOI 10.1021/acscombsci.6b00050; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hanan EJ, 2020, J MED CHEM, V63, P11330, DOI 10.1021/acs.jmedchem.0c00093; Harner MJ, 2013, J BIOMOL NMR, V56, P65, DOI 10.1007/s10858-013-9740-z; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Hsieh CH, 2019, CELL METAB, V30, P1131, DOI 10.1016/j.cmet.2019.08.023; Kawasaki Y, 2007, J VIROL, V81, P12889, DOI 10.1128/JVI.01563-07; Kawatake S, 2006, BIOL PHARM BULL, V29, P927, DOI 10.1248/bpb.29.927; Kingma D. P., 2017, METHOD STOCHASTIC OP; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P759, DOI 10.1128/AAC.50.2.759-761.2006; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Lai AC, 2017, NAT REV DRUG DISCOV, V16, P101, DOI 10.1038/nrd.2016.211; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lu D, 2013, J PHARMACOL EXP THER, V347, P325, DOI 10.1124/jpet.113.205799; Macedo B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051023; Massignan T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23180; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McDonald AJ, 2019, STRUCTURE, V27, P907, DOI 10.1016/j.str.2019.03.008; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Minikel EV, 2019, MOL CELL PROTEOMICS, V18, P2388, DOI 10.1074/mcp.RA119.001702; Minikel EV, 2020, NUCLEIC ACIDS RES, V48, P10615, DOI 10.1093/nar/gkaa616; Nelson SD, 2016, ORG LETT, V18, P6280, DOI 10.1021/acs.orglett.6b03118; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Orru CD, 2017, METHODS MOL BIOL, V1658, P185, DOI 10.1007/978-1-4939-7244-9_14; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Parker CG, 2017, CELL, V168, P527, DOI 10.1016/j.cell.2016.12.029; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Poncet-Montange G, 2011, J BIOL CHEM, V286, P27718, DOI 10.1074/jbc.M111.234393; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raymond GJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131175; Reidenbach AG, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010001; Scott JD, 2016, J MED CHEM, V59, P10435, DOI 10.1021/acs.jmedchem.6b00307; Spagnolli G., 2020, BIORXIV, DOI [10.1101/2020.03.31.018069, DOI 10.1101/2020.03.31.018069]; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Stincardini C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182589; Usanov DL, 2018, NAT CHEM, V10, P704, DOI 10.1038/s41557-018-0033-8; Usher KC, 1998, BIOCHEMISTRY-US, V37, P16082, DOI 10.1021/bi981210f; Vallabh SM, 2020, LANCET NEUROL, V19, P361, DOI 10.1016/S1474-4422(19)30403-X; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Villar EA, 2014, NAT CHEM BIOL, V10, P723, DOI [10.1038/nchembio.1584, 10.1038/NCHEMBIO.1584]; Vogtherr M, 2003, J MED CHEM, V46, P3563, DOI 10.1021/jm034093h; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wallach I., 2015, ARXIV151002855; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	90	7	7	3	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13516	13531		10.1074/jbc.RA120.014905	http://dx.doi.org/10.1074/jbc.RA120.014905			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32723867	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000576321100009
J	Cao, YB; Kumar, S; Namkung, Y; Gagnon, L; Cho, A; Laporte, SA				Cao, Yubo; Kumar, Sahil; Namkung, Yoon; Gagnon, Laurence; Cho, Aaron; Laporte, Stephane A.			Angiotensin II type 1 receptor variants alter endosomal receptor-beta-arrestin complex stability and MAPK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II type 1 receptor (AT1R); arrestin; bioluminescence resonance energy transfer (BRET); endocytosis; ERK1; 2; G protein-coupled receptor (GPCR); MAPK; naturally occurring variants; trafficking; angiotensin II; extracellular-signal-regulated kinase (ERK); mitogen-activated protein kinase	SIGNAL-REGULATED KINASES; CLATHRIN ADAPTER; BETA-ARRESTIN2; ENDOCYTOSIS; ROLES	The angiotensin II (AngII) type 1 receptor (AT1R), a member of the G protein-coupled receptor (GPCR) family, signals through G proteins and beta-arrestins, which act as adaptors to regulate AT1R internalization and mitogen-activated protein kinase (MAPK) ERK1/2 activation. beta-arrestin-dependent ERK1/2 regulation is the subject of important studies because its spatiotemporal control remains poorly understood for many GPCRs, including AT1R. To study the link between beta-arrestin-dependent trafficking and ERK1/2 signaling, we investigated three naturally occurring AT1R variants that show distinct receptor-beta-arrestin interactions: A163T, T282M, and C289W. Using bioluminescence resonance energy transfer (BRET)-based and conformational fluorescein arsenical hairpin-BRET sensors coupled with high-resolution fluorescence microscopy, we show that all AT1R variants form complexes with beta-arrestin2 at the plasma membrane and efficiently internalize into endosomes upon AngII stimulation. However, mutant receptors imposed distinct conformations in beta-arrestin2 and differentially impacted endosomal trafficking and MAPK signaling. Notably, T282M accumulated in endosomes, but its ability to form stable complexes following internalization was reduced, markedly impairing its ability to co-traffic with beta-arrestin2. We also found that despite beta-arrestin2 overexpression, T282M's and C289W's residency with beta-arrestin2 in endosomes was greatly reduced, leading to decreased beta-arrestin-dependent ERK1/2 activation, faster recycling of receptors to the plasma membrane, and impaired AngII-mediated proliferation. Our findings reveal that naturally occurring AT1R variants alter the patterns of receptor/beta-arrestin2 trafficking and suggest conformationally dependent beta-arrestin-mediated MAPK activation as well as endosomal receptor-beta-arrestin complex stabilization in the mitogenic response of AT1R.	[Cao, Yubo; Laporte, Stephane A.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Kumar, Sahil; Namkung, Yoon; Gagnon, Laurence; Cho, Aaron; Laporte, Stephane A.] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada	McGill University; McGill University	Laporte, SA (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.; Laporte, SA (corresponding author), McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada.	stephane.laporte@mcgill.ca	Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; 	Canadian Institutes of Health Research (CIHR) [MOP-74603]; Fonds de recherche sante Quebec (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche sante Quebec (FRQS)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-74603 to (S.A.L.) and Fonds de recherche sante Quebec (FRQS) doctoral training scholarship (to Y. C.) and master's training scholarship (to L. G.).	Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Arsenault J, 2010, PHARMACOGENET GENOM, V20, P377, DOI 10.1097/FPC.0b013e32833a6d4a; Beautrait A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15054; Cao YB, 2019, METHODS MOL BIOL, V1957, P59, DOI 10.1007/978-1-4939-9158-7_3; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Eichel K, 2018, NATURE, V557, P381, DOI 10.1038/s41586-018-0079-1; Gagnon L, 2019, J BIOL CHEM, V294, P17409, DOI 10.1074/jbc.RA119.010324; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gribouval O, 2005, NAT GENET, V37, P964, DOI 10.1038/ng1623; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Gurevich VV, 2019, MOL CELL ENDOCRINOL, V484, P34, DOI 10.1016/j.mce.2019.01.019; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Laporte SA, 2019, METHODS MOL BIOL, V1957, P9, DOI 10.1007/978-1-4939-9158-7_2; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Namkung Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat1631; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; O'Hayre M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3395; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Srivastava A, 2015, TRENDS ENDOCRIN MET, V26, P628, DOI 10.1016/j.tem.2015.09.001; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yoshida T, 2009, CLIN J AM SOC NEPHRO, V4, P883, DOI 10.2215/CJN.04350808; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	35	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13169	13180		10.1074/jbc.RA120.014330	http://dx.doi.org/10.1074/jbc.RA120.014330			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32703898	Green Published, hybrid			2022-12-26	WOS:000574483500003
J	Miura, S; Yoshihisa, A; Misaka, T; Yamaki, T; Kojima, T; Toyokawa, M; Ogawa, K; Shimura, H; Yamamoto, N; Kasahara, K; Takeishi, Y; Kitazume, S				Miura, Saori; Yoshihisa, Akiomi; Misaka, Tomofumi; Yamaki, Takayoshi; Kojima, Takao; Toyokawa, Masahiro; Ogawa, Kazuei; Shimura, Hiroki; Yamamoto, Naomasa; Kasahara, Kohji; Takeishi, Yasuchika; Kitazume, Shinobu			Amyloid precursor protein 770 is specifically expressed and released from platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein; CD40L; platelet; DAPT; angina pectoris; biomarker; cardiovascular disease; heart failure; ischemia; plasma; shedding	TRAP CD40 LIGAND; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; ALZHEIMERS-DISEASE; BETA; INHIBITION; MARKER; RISK; MICE	Platelets not only play an essential role in hemostasis after vascular injury but are also involved in the development of coronary artery disease (CAD) and cerebrovascular lesions. Patients with CAD and cerebral ischemia are recommended to undergo antiplatelet therapy, but they have an increased incidence of major bleeding complications. Both assessment of the platelet activation status and response to antiplatelet therapy in each patient are highly desired. beta-Amyloid precursor protein (APP) 770 is expressed in vascular endothelial cells, and its extracellular region, a soluble form of APP770 (sAPP770, also called nexin-2), is proteolytically cleaved for shedding. Abundant sAPP770 is also released from activated platelets. In this study, we used peripheral blood samples from patients with CAD and control subjects and evaluated sAPP770 as a specific biomarker for platelet activation. First, the plasma levels of sAPP770 correlated well with those of the soluble form CD40 ligand (CD40L), an established biomarker for platelet activation. Additionally, flow cytometry analysis using peripheral blood cells showed that CD40L expression is up-regulated in activated T cells, whereas APP770 expression is negligible in all blood cell types except platelets. Following stimulation with collagen or ADP, aggregating platelets immediately released sAPP770. Finally, patients with dual antiplatelet therapy showed significantly lower levels of plasma sAPP770 than those with no therapy. Taken together, our data show that plasma sAPP770 could be a promising biomarker for platelet activation.	[Miura, Saori; Toyokawa, Masahiro; Ogawa, Kazuei; Kitazume, Shinobu] Fukushima Med Univ, Preparing Sect, New Fac Med Sci, Fukushima, Japan; [Yoshihisa, Akiomi; Misaka, Tomofumi; Yamaki, Takayoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan; [Kojima, Takao] Fukushima Med Univ, Dept Neurosurg, Fukushima, Japan; [Shimura, Hiroki] Fukushima Med Univ, Dept Lab Med, Fukushima, Japan; [Yamamoto, Naomasa] Ohu Univ, Dept Biochem, Sch Pharmaceut Sci, Fukushima, Japan; [Kasahara, Kohji] Tokyo Metropolitan Inst Med Sci, Lab Biomembrane, Tokyo, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Tokyo Metropolitan Institute of Medical Science	Kitazume, S (corresponding author), Fukushima Med Univ, Preparing Sect, New Fac Med Sci, Fukushima, Japan.	shinobuk@fmu.ac.jp			AMED Grant [JP18am0101036]; KAKENHI [16K08601, MO18K0747]	AMED Grant; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by AMED Grant JP18am0101036 (to S. K.) and KAKENHI Grants 16K08601 (to S. K.) and MO18K0747 (to S. M.).	ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; BUSH AI, 1990, J BIOL CHEM, V265, P15977; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Kim YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114053; Kitazume S, 2012, J BIOL CHEM, V287, P40817, DOI 10.1074/jbc.M112.398578; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Lee PY, 2005, AM J MED, V118, P723, DOI 10.1016/j.amjmed.2005.03.041; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Ludewig B, 1996, EUR J IMMUNOL, V26, P3137, DOI 10.1002/eji.1830261246; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Malinin A, 2007, THROMB RES, V119, P277, DOI 10.1016/j.thromres.2006.01.019; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Patrono C, 2004, CHEST, V126, p234S, DOI 10.1378/chest.126.3_suppl.234S; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; SCHMAIER AH, 1993, J CLIN INVEST, V92, P2540, DOI 10.1172/JCI116863; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Tang K, 2006, J NEUROL SCI, V240, P53, DOI 10.1016/j.jns.2005.09.002; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; van Werkum JW, 2008, PLATELETS, V19, P479, DOI 10.1080/09537100802317918; VANNOSTRAND WE, 1995, THROMB RES, V78, P43, DOI 10.1016/0049-3848(95)00033-X; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Wang JC, 2003, AM J CARDIOL, V92, P1492, DOI 10.1016/j.amjcard.2003.08.072; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Xu F, 2007, STROKE, V38, P2598, DOI 10.1161/STROKEAHA.106.480103	39	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13194	13201		10.1074/jbc.RA120.012904	http://dx.doi.org/10.1074/jbc.RA120.012904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32709752	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000574483500005
J	Tang, VW; Nadkarni, AV; Brieher, WM				Tang, Vivian W.; Nadkarni, Ambika V.; Brieher, William M.			Catastrophic actin filament bursting by cofilin, Aip1, and coronin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cofilin; cytoskeleton; electron microscopy (EM); cell motility; depolymerization; Aip1; coronin; bursting; bursting; coronin	ACANTHAMOEBA ACTOPHORIN ADF/COFILIN; D-BINDING-PROTEIN; F-ACTIN; INTERACTING PROTEIN-1; DEPOLYMERIZING FACTOR; NUCLEOTIDE STATE; LINKED CHANGES; COMET TAILS; DYNAMICS; TURNOVER	Cofilin is an actin filament severing protein necessary for fast actin turnover dynamics. Coronin and Aip1 promote cofilin-mediated actin filament disassembly, but the mechanism is somewhat controversial. An early model proposed that the combination of cofilin, coronin, and Aip1 disassembled filaments in bursts. A subsequent study only reported severing. Here, we used EM to show that actin filaments convert directly into globular material. A monomer trap assay also shows that the combination of all three factors produces actin monomers faster than any two factors alone. We show that coronin accelerates the release of Pi from actin filaments and promotes highly cooperative cofilin binding to actin to create long stretches of polymer with a hypertwisted morphology. Aip1 attacks these hypertwisted regions along their sides, disintegrating them into monomers or short oligomers. The results are consistent with a catastrophic mode of disassembly, not enhanced severing alone.	[Tang, Vivian W.; Nadkarni, Ambika V.; Brieher, William M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Nadkarni, Ambika V.] Univ Calif Berkeley, Dept Mol Cell Biol, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Berkeley	Brieher, WM (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.	wbrieher@illinois.edu		Nadkarni, Ambika/0000-0002-5890-3259	National Institutes of Health [R01-DK098398, R01-GM106106]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is funded by the National Institutes of Health (R01-DK098398 to V.W. Tang and R01-GM106106 to W.M. Brieher). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Brieher W, 2013, MOL BIOL CELL, V24, P2299, DOI 10.1091/mbc.E12-09-0694; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Clark MG, 2006, MOL BIOL CELL, V17, P1971, DOI 10.1091/mbc.E05-10-0956; Clark MG, 2007, GENETICS, V176, P1527, DOI 10.1534/genetics.107.072066; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; De la Cruz EM, 2015, BIOPHYS J, V108, P2270, DOI 10.1016/j.bpj.2015.03.058; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Echauri-Espinosa RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038237; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Fritzsche M, 2013, MOL BIOL CELL, V24, P757, DOI 10.1091/mbc.E12-06-0485; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Howard J., 2001, MECH MOTOR PROTEINS; Huehn A, 2018, J BIOL CHEM, V293, P5377, DOI 10.1074/jbc.AC118.001843; Huehn AR, 2020, P NATL ACAD SCI USA, V117, P1478, DOI 10.1073/pnas.1915987117; Jansen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8202; Kotila T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13213-2; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kueh HY, 2010, BIOPHYS J, V99, P2153, DOI 10.1016/j.bpj.2010.07.038; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lechuga S, 2015, AM J PHYSIOL-GASTR L, V308, pG745, DOI 10.1152/ajpgi.00446.2014; LEES A, 1984, BIOCHEMISTRY-US, V23, P3038, DOI 10.1021/bi00308a030; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mikati MA, 2015, J MOL BIOL, V427, P3137, DOI 10.1016/j.jmb.2015.08.011; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; Nadkarni AV, 2014, CURR BIOL, V24, P2749, DOI 10.1016/j.cub.2014.09.048; Narita A, 2020, J MUSCLE RES CELL M, V41, P141, DOI 10.1007/s10974-019-09546-6; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Niedermayer T, 2012, P NATL ACAD SCI USA, V109, P10769, DOI 10.1073/pnas.1121381109; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Shekhar S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13268-1; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Tanaka K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04290-w; Tsuji T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004921; VANBAELEN H, 1980, J BIOL CHEM, V255, P2270; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wioland H, 2019, P NATL ACAD SCI USA, V116, P2595, DOI 10.1073/pnas.1812053116; Wioland H, 2017, CURR BIOL, V27, P1956, DOI 10.1016/j.cub.2017.05.048; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Zhang HT, 2013, J BIOL CHEM, V288, P20966, DOI 10.1074/jbc.M113.484535	61	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13299	13313		10.1074/jbc.RA120.015018	http://dx.doi.org/10.1074/jbc.RA120.015018			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32723865	hybrid, Green Published			2022-12-26	WOS:000574483500014
J	Solomon-Degefa, H; Gebauer, JM; Jeffries, CM; Freiburg, CD; Meckelburg, P; Bird, LE; Baumann, U; Svergun, DI; Owens, RJ; Werner, JM; Behrmann, E; Paulsson, M; Wagener, R				Solomon-Degefa, Herimela; Gebauer, Jan M.; Jeffries, Cy M.; Freiburg, Carolin D.; Meckelburg, Patrick; Bird, Louise E.; Baumann, Ulrich; Svergun, Dmitri I.; Owens, Raymond J.; Werner, Jorn M.; Behrmann, Elmar; Paulsson, Mats; Wagener, Raimund			Structure of a collagen VI alpha 3 chain VWA domain array: adaptability and functional implications of myopathy causing mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen VI; VWA domain; extracellular matrix; myopathy; crystallography; single-particle EM; collagen; extracellular matrix protein; muscular dystrophy; small-angle X-ray scattering (SAXS); single-particle analysis; electron microscopy (EM)	VON-WILLEBRAND-FACTOR; SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; CONGENITAL MUSCULAR-DYSTROPHY; BETHLEM MYOPATHY; A-DOMAIN; ORGANIZATION; EVOLUTION; BEAMLINE; COL6A3	Collagen VI is a ubiquitous heterotrimeric protein of the extracellular matrix (ECM) that plays an essential role in the proper maintenance of skeletal muscle. Mutations in collagen VI lead to a spectrum of congenital myopathies, from the mild Bethlem myopathy to the severe Ullrich congenital muscular dystrophy. Collagen VI contains only a short triple helix and consists primarily of von Willebrand factor type A (VWA) domains, protein-protein interaction modules found in a range of ECM proteins. Disease-causing mutations occur commonly in the VWA domains, and the second VWA domain of the alpha 3 chain, the N2 domain, harbors several such mutations. Here, we investigate structure-function relationships of the N2 mutations to shed light on their possible myopathy mechanisms. We determined the X-ray crystal structure of N2, combined with monitoring secretion efficiency in cell culture of selected N2 single-domain mutants, finding that mutations located within the central core of the domain severely affect secretion efficiency. In longer alpha 3 chain constructs, spanning N6-N3, small-angle X-ray scattering demonstrates that the tandem VWA array has a modular architecture and samples multiple conformations in solution. Single-particle EM confirmed the presence of multiple conformations. Structural adaptability appears intrinsic to the VWA domain region of collagen VI alpha 3 and has implications for binding interactions and modulating stiffness within the ECM.	[Solomon-Degefa, Herimela; Freiburg, Carolin D.; Wagener, Raimund] Univ Cologne, Fac Med, Ctr Biochem, Cologne, Germany; [Gebauer, Jan M.; Meckelburg, Patrick; Baumann, Ulrich; Behrmann, Elmar] Univ Cologne, Inst Biochem, Cologne, Germany; [Jeffries, Cy M.; Svergun, Dmitri I.] European Mol Biol Lab, Hamburg Unit, Hamburg, Germany; [Bird, Louise E.; Owens, Raymond J.] Rutherford Appleton Lab Harwell, Res Complex Harwell, Oxford, England; [Bird, Louise E.; Owens, Raymond J.] Univ Oxford, Struct Biol Div, Wellcome Human Genet Ctr, Oxford, England; [Werner, Jorn M.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Behrmann, Elmar] Ctr Adv European Studies & Res caesar, Max Planck Res Grp Struct Dynam Prot, Bonn, Germany; [Paulsson, Mats; Wagener, Raimund] Ctr Mol Med CMMC, Cologne, Germany; [Paulsson, Mats; Wagener, Raimund] Cologne Ctr Musculoskeletal Biomech CCMB, Cologne, Germany	University of Cologne; University of Cologne; European Molecular Biology Laboratory (EMBL); University of Oxford; Wellcome Centre for Human Genetics; University of Southampton; Center of Advanced European Studies & Research (CAESAR); University of Cologne	Wagener, R (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, Cologne, Germany.; Wagener, R (corresponding author), Ctr Mol Med CMMC, Cologne, Germany.; Wagener, R (corresponding author), Cologne Ctr Musculoskeletal Biomech CCMB, Cologne, Germany.	raimund.wagener@uni-koeln.de	Baumann, Ulrich/B-1220-2013; Behrmann, Elmar/I-5808-2015; Gebauer, Jan/C-3085-2009	Behrmann, Elmar/0000-0001-6794-3669; /0000-0002-8718-7343; Freiburg, Patrick/0000-0001-7451-9698; Gebauer, Jan/0000-0002-3989-4748	German Research Foundation [SFB 829-B2, FOR 2722-B1, SFB 829-B11]; UK Medical Research Council [MR/K018779/1]; iNEXT [653706]; Horizon 2020 program of the European Union [PID: 2861, INST 216/682-1 FUGG]; FUGG from the German Research Foundation [INST 216/682-1]; MRC [MR/K018779/1] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); iNEXT; Horizon 2020 program of the European Union; FUGG from the German Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the German Research Foundation Grants SFB 829-B2 and FOR 2722-B1 (to M. P. and R. W.) and Grant SFB 829-B11 (to U. B.), and by a UK Medical Research Council Grant MR/K018779/1 (to L. E. B. and R. J. O). Portions of this work was also supported by iNEXT Grant 653706 (to C. M. J. and D. I. S.), funded by the Horizon 2020 program of the European Union (PID: 2861) using the Structural Audit program and an iNEXT proposal ID 5602 (to H. S. D. and R. W.). Crystals were grown in the Cologne Crystallization Facility (C2f.uni-koeln.de; grant no. INST 216/682-1 FUGG from the German Research Foundation).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Baldauf C, 2009, J THROMB HAEMOST, V7, P2096, DOI 10.1111/j.1538-7836.2009.03640.x; Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0; Becker AKA, 2015, PROTEIN EXPRES PURIF, V107, P20, DOI 10.1016/j.pep.2014.11.005; Becker AKA, 2014, STRUCTURE, V22, P199, DOI 10.1016/j.str.2013.06.028; Beecher N, 2011, J BIOL CHEM, V286, P40266, DOI 10.1074/jbc.M111.265595; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brown PH, 2008, COMPUT PHYS COMMUN, V178, P105, DOI 10.1016/j.cpc.2007.08.012; Butterfield RJ, 2013, HUM MUTAT, V34, P1558, DOI 10.1002/humu.22429; Cescon M, 2015, J CELL SCI, V128, P3525, DOI 10.1242/jcs.169748; Chen JM, 2009, HUM MUTAT, V30, P1435, DOI 10.1002/humu.21088; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fitzgerald J, 2001, J BIOL CHEM, V276, P187, DOI 10.1074/jbc.M008173200; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Foley AR, 2011, ANN NEUROL, V69, P206, DOI 10.1002/ana.22283; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Godwin ARF, 2017, ACTA BIOMATER, V52, P21, DOI 10.1016/j.actbio.2016.12.023; Graewert MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10734; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Hajizadeh NR, 2018, J SYNCHROTRON RADIAT, V25, P906, DOI 10.1107/S1600577518005398; Heumuller SE, 2019, J BIOL CHEM, V294, P13769, DOI 10.1074/jbc.RA119.008641; Higuchi I, 2001, ANN NEUROL, V50, P261, DOI 10.1002/ana.1120; JANDER R, 1983, EUR J BIOCHEM, V133, P39, DOI 10.1111/j.1432-1033.1983.tb07427.x; Jeffries CM, 2016, NAT PROTOC, V11, P2122, DOI 10.1038/nprot.2016.113; Jeffries CM, 2015, J SYNCHROTRON RADIAT, V22, P273, DOI 10.1107/S1600577515000375; Jobsis GJ, 1996, NEUROLOGY, V46, P779, DOI 10.1212/WNL.46.3.779; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Knupp C, 2001, EMBO J, V20, P372, DOI 10.1093/emboj/20.3.372; Konarev PV, 2015, IUCRJ, V2, P352, DOI 10.1107/S2052252515005163; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Lamande SR, 2018, MATRIX BIOL, V71-72, P348, DOI 10.1016/j.matbio.2017.12.008; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lampe AK, 2005, J MED GENET, V42, P108, DOI 10.1136/jmg.2004.023754; Maass T, 2016, J BIOL CHEM, V291, P5247, DOI 10.1074/jbc.M115.705160; Marakhonov AV, 2018, GENE, V672, P165, DOI 10.1016/j.gene.2018.06.026; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mazzucato M, 1999, J BIOL CHEM, V274, P3033, DOI 10.1074/jbc.274.5.3033; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriya T, 2017, JOVE-J VIS EXP, DOI 10.3791/55448; ODERMATT E, 1983, BIOCHEM J, V211, P295, DOI 10.1042/bj2110295; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sasaki T, 2000, FASEB J, V14, P761, DOI 10.1096/fasebj.14.5.761; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; Suhre MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4392; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Tuckwell D, 1999, BIOCHEM SOC T, V27, P835, DOI 10.1042/bst0270835; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang RZ, 2010, J BIOL CHEM, V285, P10005, DOI 10.1074/jbc.M109.093666	74	1	1	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2020	295	36					12755	12771		10.1074/jbc.RA120.014865	http://dx.doi.org/10.1074/jbc.RA120.014865			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NQ9DL	32719005	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-26	WOS:000571166700016
J	Cabrera-Aguilera, I; Falcones, B; Calvo-Fernandez, A; Benito, B; Barreiro, E; Gea, J; Farre, R; Almendros, I; Farre, N				Cabrera-Aguilera, Ignacio; Falcones, Bryan; Calvo-Fernandez, Alicia; Benito, Begona; Barreiro, Esther; Gea, Joaquim; Farre, Ramon; Almendros, Isaac; Farre, Nuria			The conventional isoproterenol-induced heart failure model does not consistently mimic the diaphragmatic dysfunction observed in patients	PLOS ONE			English	Article							RESPIRATORY MUSCLE STRENGTH; CONTRACTILE DYSFUNCTION; VENTILATORY DRIVE; GENE-EXPRESSION; WEAKNESS; CLENBUTEROL; EXERCISE; DYSPNEA; LUNG; MICE	Heart failure (HF) impairs diaphragm function. Animal models realistically mimicking HF should feature both the cardiac alterations and the diaphragmatic dysfunction characterizing this disease. The isoproterenol-induced HF model is widely used, but whether it presents diaphragmatic dysfunction is unknown. However, indirect data from research in other fields suggest that isoproterenol could increase diaphragm function. The aim of this study was to test the hypothesis that the widespread rodent model of isoproterenol-induced HF results in increased diaphragmatic contractility. Forty C57BL/6J male mice were randomized into 2 groups: HF and healthy controls. After 30 days of isoproterenol infusion to establish HF,in vivodiaphragmatic excursion andex vivoisolated diaphragm contractibility were measured. As compared with healthy controls, mice with isoproterenol-induced HF showed the expected changes in structural and functional echocardiographic parameters and lung edema. isoproterenol-induced HF increased in vivo diaphragm excursion (by approximate to 30%, p<0.01) and increased by approximate to 50% bothex vivopeak specific force (p<0.05) and tetanic force (p<0.05) at almost all 10-100 Hz frequencies (p<0.05), with reduced fatigue resistance (p<0.01) when compared with healthy controls. Expression of myosin genes encoding the main muscle fiber types revealed thatMyh4was higher in isoproterenol-induced HF than in healthy controls (p<0.05), suggesting greater distribution of type IIb fibers. These results show that the conventional isoproterenol-induced HF model increases diaphragm contraction, a finding contrary to what is observed in patients with HF. Therefore, this specific model seems limited for translational an integrative HF research, especially when cardio-respiratory interactions are investigated.	[Cabrera-Aguilera, Ignacio; Falcones, Bryan; Farre, Ramon; Almendros, Isaac] Univ Barcelona, Fac Med & Ciencies Salut, Unitat Biofis & Bioengn, Barcelona, Spain; [Cabrera-Aguilera, Ignacio; Farre, Nuria] IMIM Hosp Mar Med Res Inst, Heart Dis Biomed Res Grp, Barcelona, Spain; [Cabrera-Aguilera, Ignacio] Univ Talca, Fac Hlth Sci, Sch Kinesiol, Dept Human Movement Sci, Talca, Chile; [Calvo-Fernandez, Alicia; Benito, Begona; Farre, Nuria] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Calvo-Fernandez, Alicia; Farre, Nuria] Hosp del Mar, Dept Cardiol, Heart Failure Unit, Barcelona, Spain; [Benito, Begona] Hosp Univ Vall dHebron, Vall dHebron Res Inst VHIR, Cardiol Dept, Barcelona, Spain; [Benito, Begona] CIBER Enfermedades Cardiovasc, Madrid, Spain; [Barreiro, Esther; Gea, Joaquim] Hosp del Mar, Resp Dept, Barcelona, Spain; [Barreiro, Esther; Gea, Joaquim] Hosp del Mar, Med Res Inst IMIM, Barcelona, Spain; [Barreiro, Esther; Gea, Joaquim] Univ Pompeu Fabra, Hlth & Expt Sci Dept CEXS, Barcelona, Spain; [Barreiro, Esther; Gea, Joaquim; Farre, Ramon; Almendros, Isaac] CIBER Enfermedades Resp, Madrid, Spain; [Farre, Ramon; Almendros, Isaac] Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain	University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universidad de Talca; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Farre, N (corresponding author), IMIM Hosp Mar Med Res Inst, Heart Dis Biomed Res Grp, Barcelona, Spain.; Farre, N (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.; Farre, N (corresponding author), Hosp del Mar, Dept Cardiol, Heart Failure Unit, Barcelona, Spain.	NFarreLopez@parcdesalutmar.cat	Farre, Nuria/I-2668-2019; Almendros, Isaac/A-8251-2016; Falcones, Bryan/R-9300-2018; Farre, Ramon/L-2664-2017	Farre, Nuria/0000-0003-3110-6572; Almendros, Isaac/0000-0002-1998-9379; Falcones, Bryan/0000-0002-3781-269X; Farre, Ramon/0000-0002-9084-7824	ANID-PFCHA - Chilean Doctorate Fellowship 2017 [72180089]	ANID-PFCHA - Chilean Doctorate Fellowship 2017	ICA is supported by ANID-PFCHA - Chilean Doctorate Fellowship 2017; Grant No. 72180089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2019, J CACHEXIA SARCOPENI, V10, P1102, DOI 10.1002/jcsm.12448; Agrawal S, 2003, JPN J PHYSIOL, V53, P229, DOI 10.2170/jjphysiol.53.229; Ahn B, 2015, AM J PHYSIOL-LUNG C, V309, pL497, DOI 10.1152/ajplung.00176.2015; Almendros I, 2008, RESP PHYSIOL NEUROBI, V162, P100, DOI 10.1016/j.resp.2008.04.009; AMBROSINO N, 1994, EUR RESPIR J, V7, P17, DOI 10.1183/09031936.94.07010017; Benes J, 2011, CLIN SCI, V121, P29, DOI 10.1042/CS20100527; Blackwood SJ, 2019, PFLUG ARCH EUR J PHY, V471, P1305, DOI 10.1007/s00424-019-02304-0; Bowen TS, 2015, J APPL PHYSIOL, V118, P11, DOI 10.1152/japplphysiol.00756.2014; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cabrera-Aguilera I, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01364; Carmo M M., 2001, Pathophysiology, V8, P55, DOI 10.1016/S0928-4680(01)00065-7; Chang SC, 2018, METHODS MOL BIOL, V1816, P207, DOI 10.1007/978-1-4939-8597-5_16; CLARKE H H, 1955, Arch Phys Med Rehabil, V36, P376; Coblentz PD, 2019, AM J PHYSIOL-LUNG C, V316, pL679, DOI 10.1152/ajplung.00516.2018; Coirault C, 2001, CHEST, V119, P1755, DOI 10.1378/chest.119.6.1755; Coirault Catherine, 2007, Am J Physiol Heart Circ Physiol, V292, pH1009; Cross TJ, 2020, J APPL PHYSIOL, V128, P214, DOI 10.1152/japplphysiol.00113.2019; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; Dawson NJ, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13030; De Sousa E, 2001, J MOL CELL CARDIOL, V33, P699, DOI 10.1006/jmcc.2000.1336; Dube BP, 2016, EUR RESPIR REV, V25, P317, DOI 10.1183/16000617.0048-2016; EVANS SA, 1995, THORAX, V50, P625, DOI 10.1136/thx.50.6.625; Farre N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172745; Figueroa MS, 2006, RESPIR CARE, V51, P403; Filusch A, 2011, INT J CARDIOL, V150, P182, DOI 10.1016/j.ijcard.2010.04.006; Foster AJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1303; Fujimura N, 2000, AM J RESP CRIT CARE, V161, P440, DOI 10.1164/ajrccm.161.2.9904044; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Gillis TE, 2016, AM J PHYSIOL-HEART C, V310, pH572, DOI 10.1152/ajpheart.00773.2015; HAMMOND MD, 1990, CHEST, V98, P1091, DOI 10.1378/chest.98.5.1091; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; HOWELL S, 1984, AM REV RESPIR DIS, V129, P118; Hughes PD, 1999, AM J RESP CRIT CARE, V160, P529, DOI 10.1164/ajrccm.160.2.9810081; Jaenisch RB, 2018, CAN J PHYSIOL PHARM, V96, DOI 10.1139/cjpp-2017-0069; Jaenisch RB, 2017, CAN J CARDIOL, V33, P508, DOI 10.1016/j.cjca.2016.11.004; Kelley RC, 2017, HEART FAIL REV, V22, P191, DOI 10.1007/s10741-016-9549-4; Kurapati R, 2012, HUM MOL GENET, V21, P1706, DOI 10.1093/hmg/ddr605; Li X, 2000, CIRCULATION, V102, P1690, DOI 10.1161/01.CIR.102.14.1690; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes FDS, 2008, INT J EXP PATHOL, V89, P216, DOI 10.1111/j.1365-2613.2008.00587.x; Lynch GS, 1999, CLIN EXP PHARMACOL P, V26, P117, DOI 10.1046/j.1440-1681.1999.03001.x; MACLENNAN PA, 1989, BIOCHEM J, V264, P573, DOI 10.1042/bj2640573; Mangner N, 2016, MED SCI SPORT EXER, V48, P2118, DOI 10.1249/MSS.0000000000001016; Manning J, 2017, MUSCLE NERVE, V56, pE134, DOI 10.1002/mus.25644; MCPARLAND C, 1992, AM REV RESPIR DIS, V146, P467, DOI 10.1164/ajrccm/146.2.467; Meyer FJ, 2001, CIRCULATION, V103, P2153; Miwa Y, EXPRESSION MYOSIN HE, V86, P105; Moorwood C, 2013, JOVE-J VIS EXP, DOI 10.3791/50036; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Reading SA, 2003, CAN J PHYSIOL PHARM, V81, P986, DOI 10.1139/Y03-104; Ribeiro Jorge P, 2009, Curr Heart Fail Rep, V6, P95; Lima ARR, 2014, CELL PHYSIOL BIOCHEM, V34, P333, DOI 10.1159/000363003; Stassijns G, 1999, EUR RESPIR J, V13, P391, DOI 10.1183/09031936.99.13239199; Taylor BJ, 2018, J CARD FAIL, V24, P217, DOI 10.1016/j.cardfail.2018.02.007; Tikunov B, 1997, CIRCULATION, V95, P910; Tikunova S, 2018, J PHYSIOL-LONDON, V596, P4651, DOI 10.1113/JP276296; Van der Heijden HFM, 1998, J APPL PHYSIOL, V85, P215, DOI 10.1152/jappl.1998.85.1.215; van Hees HWH, 2011, BRIT J PHARMACOL, V162, P566, DOI 10.1111/j.1476-5381.2010.01048.x; van Hees HWH, 2010, INT J CARDIOL, V141, P275, DOI 10.1016/j.ijcard.2008.12.042; Watchko JF, 1998, COMP BIOCHEM PHYS B, V119, P459, DOI 10.1016/S0305-0491(98)00006-6; Whitehead NP, 2016, J PHYSIOL-LONDON, V594, P7215, DOI 10.1113/JP272707; Witt C, 1997, EUR HEART J, V18, P1322; Yamada K, 2016, J CARD FAIL, V22, P38, DOI 10.1016/j.cardfail.2015.10.010; Zuo L, 2014, JOVE-J VIS EXP, DOI 10.3791/51290	64	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236923	10.1371/journal.pone.0236923	http://dx.doi.org/10.1371/journal.pone.0236923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730329	gold, Green Published			2022-12-26	WOS:000556884700091
J	Forsman, A; De Moor, T; van Weeren, R; Bravo, G; Ghorbani, A; Dehkordi, MAE; Farjam, M				Forsman, Anders; De Moor, Tine; van Weeren, Rene; Bravo, Giangiacomo; Ghorbani, Amineh; Dehkordi, Molood Ale Ebrahim; Farjam, Mike			Eco-evolutionary perspectives on emergence, dispersion and dissolution of historical Dutch commons	PLOS ONE			English	Article							ADAPTIVE GOVERNANCE; COLLECTIVE ACTION; MASS EXTINCTION; DIVERSIFICATION; SURVIVAL; TRAGEDY; INSTITUTIONS; CONSERVATION; ECOLOGY; SCALE	Historical commons represent self-governed governance regimes that regulate the use and management of natural and man-made shared resources. Despite growing scientific interests, analyses of commons evolution and temporal dynamics are rare and drivers of change (birth, adaptation, dissolution) remain obscure. We apply an interdisciplinary approach and address these issues from an eco-evolutionary perspective. Analyses of > 400 Dutch commons over more than a millennium (between the 9(th)and the 20(th)century) uncovered that most commons originated between 1200 and 1700, and that there was a particularly high rate of evolution during 1300-1550, a pattern intermediate to gradualism and punctuated equilibrium in biological evolution. Dissolutions of commons were rare prior to 1800 and peaked around 1850, comparable to a mass extinction in biology. Temporal trends in number, spatial distribution, density, and dispersion of historical commons were distinctive and resembled developments seen at the levels of species and individuals in the growth of biological communities and populations, in that they showed signs of saturation determined by the abundance and distribution of resources. The spatiotemporal dynamics of commons also pointed to important roles of social, economic and political factors, such as new reclamations of resources and pressure on resources due to population growth. Despite internal and external pressures, the self-governing commons studied here were very successful, in the sense that they persisted for on average >350 years. There was a weak positive relationship between the use of multiple resources and the lifespan of commons, resembling associations between diversity and persistence seen in biological systems. It is argued that eco-evolutionary perspectives can further the understanding of the long-term dynamics of commons as institutions for collective action, vitalize future research, improve management of shared goods, and advise about sustainable utilization of finite resources.	[Forsman, Anders] Linnaeus Univ, Dept Biol & Environm Sci, Kalmar, Sweden; [De Moor, Tine; van Weeren, Rene] Univ Utrecht, Dept Hist & Art Hist, Utrecht, Netherlands; [Bravo, Giangiacomo; Farjam, Mike] Linnaeus Univ, Dept Social Studies, Vaxjo, Sweden; [Bravo, Giangiacomo; Farjam, Mike] Linnaeus Univ, Ctr Data Intens Sci & Applicat, Vaxjo, Sweden; [Ghorbani, Amineh; Dehkordi, Molood Ale Ebrahim] Delft Univ Technol, Fac Technol Policy & Management, Delft, Netherlands	Linnaeus University; Utrecht University; Linnaeus University; Linnaeus University; Delft University of Technology	Forsman, A (corresponding author), Linnaeus Univ, Dept Biol & Environm Sci, Kalmar, Sweden.	anders.forsman@lnu.se	Farjam, Mike/Z-1342-2019; Forsman, Anders/G-8778-2012	Farjam, Mike/0000-0002-0882-4851; Ale Ebrahim Dehkordi, Molood/0000-0002-2848-9202; Bravo, Giangiacomo/0000-0003-2837-0137; De Moor, Tine/0000-0002-9462-6404; Forsman, Anders/0000-0001-9598-7618	Riksbankens Jubileumsfond; Linnaeus University	Riksbankens Jubileumsfond; Linnaeus University	Financial support was provided by the Riksbankens Jubileumsfond, project MIDI: Modelling institutional dynamics in historical commons (https://lnu.se/en/research/searchresearch/forskningsprojekt/projectmodelling-institutional-dynamics-in-historical-commons/) and by Linnaeus University (to A.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACvdGavN Beekman, 1915, TEKSTEN S GRAVENHAGE; [Anonymous], 1934, I EC; Baumgartner F.R., 2009, AGENDAS INSTABILITY, V2nd; Baumgartner FR, 2006, J EUR PUBLIC POLICY, V13, P959, DOI 10.1080/13501760600923805; Baumgartner FR, 2009, AM J POLIT SCI, V53, P603, DOI 10.1111/j.1540-5907.2009.00389.x; Bercovitz J, 2007, STRATEGIC MANAGE J, V28, P61, DOI 10.1002/smj.568; Berkes F., 1998, LINKING SOCIAL ECOLO, V1st, DOI DOI 10.1017/CBO9780511541957; Brakensiek, 2000, JB WIRTSCHAFTSGESCHI, V41, P9, DOI [DOI 10.1524/JBWG.2000.41.2.9, 10.1524/jbwg.2000.41.2.9]; Brakensiek S., 2000, JB WIRTSCHAFTSGESCHI, V2; Bravo G., 2008, INT J COMMONS, V2, P155, DOI [10.18352/ijc.98, DOI 10.18352/IJC.98]; BRUDERL J, 1992, AM SOCIOL REV, V57, P227, DOI 10.2307/2096207; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Casari M, 2018, P NATL ACAD SCI USA, V115, P2728, DOI 10.1073/pnas.1713496115; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Clark G, 1998, J ECON HIST, V58, P73, DOI 10.1017/S0022050700019896; Darwin C, 1859, ORIGIN SPECIES MEANS; De Monte Verloren JP, 1939, GRONDBEZIT STANDEN O; de Moor M., 2002, MANAGEMENT COMMON LA, DOI DOI 10.1484/M.CORN-EB.4.00172; De Moor T., 2015, RURAL HIST YB, V12, P175; De Moor T., OXFORD HDB TRANSNATI; de Moor T, 2016, INT J COMMONS, V10, P529, DOI 10.18352/ijc.760; De Moor T, 2008, INT REV SOC HIST, V53, P179, DOI 10.1017/S0020859008003660; De Moor T, 2009, ECON HIST REV, V62, P1, DOI 10.1111/j.1468-0289.2008.00426.x; De Moor Tine., 2015, DILEMMA COMMONERS UN, DOI 10.1017/CBO9781139135450; De Vrankrijker ACJ., 1962, ERFGOOIERS; Demelas M.D., 2003, PROPRIETES COLLECTIV; DeMoor T., 2013, HOMO COOPERANS I COL; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Farjam M, 2020, INT J COMMONS, V14, P78, DOI 10.5334/ijc.959; Filatotchev I, 2003, J MANAGE STUD, V40, P895, DOI 10.1111/1467-6486.00364; Folke C, 2007, ECOL RES, V22, P14, DOI 10.1007/s11284-006-0074-0; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; Forsman A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36265; Forsman A, 2014, P NATL ACAD SCI USA, V111, P302, DOI 10.1073/pnas.1317745111; Foster KR, 2004, J EVOLUTION BIOL, V17, P1058, DOI 10.1111/j.1420-9101.2004.00747.x; Fretwell S.D., 1970, ACTA BIOTHEOR, V19, P16, DOI DOI 10.1007/BF01601953; Gerding MAW, 1995, THESIS; HANNAN MT, 1977, AM J SOCIOL, V82, P929, DOI 10.1086/226424; HANNAN MT, 1984, AM SOCIOL REV, V49, P149, DOI 10.2307/2095567; Hannink G., 1992, MARKEBOEK MARKE RAAL; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Hoppenbrouwers P., 2002, MANAGEMENT COMMON LA, P87, DOI [10.1484/M.CORN-EB.4.00175, DOI 10.1484/M.CORN-EB.4.00175]; Huang L, 2004, SAS C P MIDWEST SAS; Hui C, 2017, P NATL ACAD SCI USA, V114, P12507, DOI 10.1073/pnas.1704213114; JABLONSKI D, 1989, PHILOS T ROY SOC B, V325, P357, DOI 10.1098/rstb.1989.0093; Jones JA, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00071; Killingback T, 2006, P ROY SOC B-BIOL SCI, V273, P1477, DOI 10.1098/rspb.2006.3476; Knudsen HK, 2005, J BEHAV HEALTH SER R, V32, P241, DOI 10.1007/BF02291825; Lack D, 1933, J ANIM ECOL, V2, P239, DOI 10.2307/961; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Malthus TR, 1798, ESSAY PRINCIPLE POPU, V1; Mangani A, 2017, ONLINE INFORM REV, V41, P19, DOI 10.1108/OIR-09-2015-0310; Mayr E., 1982, GROWTH BIOL THOUGHT; Meert H, 2005, J RURAL STUD, V21, P81, DOI 10.1016/j.jrurstud.2004.08.007; Nagendra H, 2014, ECOL SOC, V19, DOI 10.5751/ES-06582-190267; O'Driscoll A, 2013, J BIOMED INFORM, V46, P774, DOI 10.1016/j.jbi.2013.07.001; Ostrom Elinor, 2014, Journal of Bioeconomics, V16, P3, DOI 10.1007/s10818-013-9154-8; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Ostrom E., 1990, EVOLUTION I COLLECTI; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Quental TB, 2013, SCIENCE, V341, P290, DOI 10.1126/science.1239431; R Core Team, 2018, R LANG ENV STAT COMP; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Schindler DE, 2015, FRONT ECOL ENVIRON, V13, P257, DOI 10.1890/140275; Schultz L, 2015, P NATL ACAD SCI USA, V112, P7369, DOI 10.1073/pnas.1406493112; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; SIMBERLOFF DS, 1970, ECOLOGY, V51, P934, DOI 10.2307/1933995; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Slicher van Bath B. H., 1970, GESCHIEDENIS OVERIJS, P93; Slicher van Bath BH, 1944, BIJDRAGE GESCHIEDENI; SMITH JM, 1979, PROC R SOC SER B-BIO, V205, P475, DOI 10.1098/rspb.1979.0080; Spek T, 2010, BEWONINGS LANDSCHAPS; StatisticsNetherlands(CBS), 2007, DUTCH CENS 1795 1971; Stern I, 2004, STRATEGIC MANAGE J, V25, P487, DOI 10.1002/smj.400; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; van Weeren R, 2014, AGR HIST REV, V62, P256; VANBATH BS, 1960, AGRARISCHE GESCHIEDE; Vandermeer J, 2010, SCI ED KNOWL, V3, P15; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wible B, 2018, SCIENCE, V362, P1236, DOI 10.1126/science.aaw0911; Wilson E.O., 1975, P1; Wilson E. O., 1998, CONSILIENCE UNITY KN; WILSON EO, 1987, J ANIM ECOL, V56, P1, DOI 10.2307/4795	84	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236471	10.1371/journal.pone.0236471	http://dx.doi.org/10.1371/journal.pone.0236471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730285	Green Published, gold			2022-12-26	WOS:000556884700076
J	Breitbart, EW; Choudhury, K; Andersen, AD; Bunde, H; Breitbart, M; Sideri, AM; Fengler, S; Zibert, JR				Breitbart, Eckhard W.; Choudhury, Kohelia; Andersen, Anders Daniel; Bunde, Henriette; Breitbart, Marianne; Sideri, Antonia Maria; Fengler, Susanne; Zibert, John Robert			Improved patient satisfaction and diagnostic accuracy in skin diseases with a Visual Clinical Decision Support System-A feasibility study with general practitioners	PLOS ONE			English	Article								Patient satisfaction is an important indicator of health care quality, and it remains an important goal for optimal treatment outcomes to reduce the level of misdiagnoses and inappropriate or absent therapeutic actions. Digital support tools for differential diagnosis to assist clinicians in reaching the correct diagnosis may be helpful, but how the use of these affect patients is not clear. The primary objective of this feasibility study was to investigate patient experience and satisfaction in a primary care setting where general practitioners (GPs) used a visual clinical decision support system (CDSS) compared with standard consultations. Secondary objectives were diagnostic accuracy and length of consultation. Thirty-one patients with a dermatologist-confirmed skin diagnosis were allocated to consult GPs that had been randomized to conduct either standard consultations (SDR, n = 21) or CDSS (n = 16) on two separate study days one week apart. All patients were diagnosed independently by multiple GPs (n = 3-8) in both the SDR and CDSS study arms. Using the CDSS, more patients felt involved in the decision making (P = 0.05). In addition, more patients were exposed to images during the consultations (P = 6.8e-27), and 83% of those that were shown images replied they felt better supported in the consultation. The use of CDSS significantly improved the diagnostic accuracy (34%, P = 0.007), and did not increase the duration of the consultation (median 10 minutes in both arms). This study shows for the first time that compared with standard GP consultations, CDSS assist the GP on skin related diagnoses and improve patient satisfaction and diagnostic accuracy without impacting the duration of the consultations. This is likely to increase correct treatment choices, patient adherence, and overall result in better healthcare outcomes.	[Breitbart, Eckhard W.; Choudhury, Kohelia; Bunde, Henriette; Breitbart, Marianne; Fengler, Susanne] Assoc Dermatol Prevent ADP, Hamburg, Germany; [Andersen, Anders Daniel; Sideri, Antonia Maria; Zibert, John Robert] LEO Innovat Lab, Copenhagen, Denmark		Zibert, JR (corresponding author), LEO Innovat Lab, Copenhagen, Denmark.	johnzibert@gmail.com	Zibert, John Robert/GRY-3584-2022; Andersen, Anders Daniel/AAV-5053-2021	Zibert, John Robert/0000-0002-3220-8303	LEO Innovation Lab	LEO Innovation Lab	The Study was funded by LEO Innovation Lab (sponsor) and provided salaries to the authors AMS, ADA and JRZ, and financial support to ADP to conduct the study. Sponsor was responsible for the study according to the law and regulations, and also had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Cimas M, 2016, INT J QUAL HEALTH C, V28, P275, DOI 10.1093/intqhc/mzw024; Clayman ML, 2016, MED DECIS MAKING, V36, P427, DOI 10.1177/0272989X15613530; David Consuelo V, 2011, Dermatol Online J, V17, P1; Elmore N, 2016, BRIT J GEN PRACT, V66, pE896, DOI 10.3399/bjgp16X687733; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Kirch W, 2004, J PUBLIC HLTH, V12, P154; Makoul G, 2007, PATIENT EDUC COUNS, V67, P333, DOI 10.1016/j.pec.2007.05.005; Papier A, 2001, J AM MED INFORM ASSN, P987; Suh Won S, 2010, J Prev Med Public Health, V43, P26, DOI 10.3961/jpmph.2010.43.1.26; Tleyjeh IM, 2006, CLIN INFECT DIS, V43, P1177, DOI 10.1086/508283	13	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235410	10.1371/journal.pone.0235410	http://dx.doi.org/10.1371/journal.pone.0235410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2YL	32726308	Green Published, gold			2022-12-26	WOS:000556908900027
J	le Roex, N; Ferreira, SM				le Roex, Nikki; Ferreira, Sam M.			Age structure changes indicate direct and indirect population impacts in illegally harvested black rhino	PLOS ONE			English	Article							DICEROS-BICORNIS; LION PREDATION; GAME RESERVE; DYNAMICS; RECRUITMENT; HUNTERS	Overharvesting affects the size and growth of wildlife populations and can impact population trajectories. Overharvesting can also severely alter population structure and may result in changes in spatial organisation, social dynamics and recruitment. Understanding the relationship between overharvesting and population growth is therefore crucial for the recovery of exploited species. The black rhinoceros (Diceros bicornis; black rhino) is a long-lived megaherbivore native to sub-Saharan Africa, listed as Critically Endangered on the IUCN Red List of Threatened Species. Since 2009, the targeted illegal killing of rhino for their horns has escalated dramatically in South Africa. Given their slow life trajectories, spatial structure and social dynamics, black rhino may be susceptible to both direct and indirect impacts of overharvesting. Our study compared black rhino demography before and during extensive poaching to understand the impact of illegal killing. The population exhibited significant changes in age structure after four years of heavy poaching; these changes were primarily explained by a decrease in the proportion of calves over time. Population projections incorporating both direct poaching removals and decreased fecundity/recruitment were most similar to the observed demographic profile in 2018, suggesting that indirect impacts are also contributing to the observed population trajectory. These indirect impacts are likely a result of decreased density, through processes such as reduced mate-finding, population disturbance and/or increased calf predation. This study illustrates the combined effect of direct and indirect impacts on an endangered species, providing a more comprehensive approach by which to evaluate exploited populations.	[le Roex, Nikki; Ferreira, Sam M.] South African Natl Pk, Sci Serv, Skukuza, South Africa; [le Roex, Nikki] Univ Cape Town, Dept Biol Sci, Inst Communities & Wildlife Africa iCWild, Cape Town, South Africa	University of Cape Town	le Roex, N (corresponding author), South African Natl Pk, Sci Serv, Skukuza, South Africa.; le Roex, N (corresponding author), Univ Cape Town, Dept Biol Sci, Inst Communities & Wildlife Africa iCWild, Cape Town, South Africa.	nleroex@panthera.org			WWF South Africa	WWF South Africa	NLR was supported by a grant from WWF South Africa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock K., 1994, P S RHIN GAM RANC AN; Ahmad AH, 2013, J INDONESIAN NATURAL, V1, P12; Allee W.C, 1931, ANIMAL AGGREGATION S; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; [Anonymous], 2019, R LANG ENV STAT COMP; Ausband DE, 2015, ANIM CONSERV, V18, P415, DOI 10.1111/acv.12187; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Brain C, 1999, AFR J ECOL, V37, P107, DOI 10.1046/j.1365-2028.1999.00137.x; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Emslie R.H., 2016, AFRICAN ASIAN RHINOC; Emslie RH, 1995, FINE TUNING RHINO MA, P1; Fattebert J, 2016, J ZOOL, V299, P153, DOI 10.1111/jzo.12344; Ferreira SM, 2011, S AFR J WILDL RES, V41, P192, DOI 10.3957/056.041.0206; Frank SC, 2017, URSUS, V28, P150, DOI 10.2192/URSU-D-16-00028.1; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Garnier JN, 2001, MOL ECOL, V10, P2031, DOI 10.1046/j.0962-1083.2001.01338.x; Gascoigne J, 2009, POPUL ECOL, V51, P355, DOI 10.1007/s10144-009-0146-4; Gertenbach W.P.D., 1984, Koedoe, V26, P9; Goddard J., 1967, East African Wildlife Journal, V5, P133; Gosselin J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1840; Greaver C, 2014, AUSTRAL ECOL, V39, P437, DOI 10.1111/aec.12101; Hall-Martin A., 1979, Oryx, V15, P27; Hall-Martin A, 1994, P S RHIN GAM RANCH A; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; HITCHINS PM, 1983, S AFR J WILDL RES, V13, P78; Hitchins PM, 1971, P S BIOT CSIR PRET S, P79; Hrabar H, 2005, ANIM CONSERV, V8, P259, DOI 10.1017/S1367943005002234; Hubschle AM, 2017, CURR SOCIOL, V65, P427, DOI 10.1177/0011392116673210; Jones T, 2018, ECOL INDIC, V88, P115, DOI 10.1016/j.ecolind.2018.01.030; Leclerc M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45222; Lent PC, 2003, S AFR J WILDL RES, V33, P109; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Linklater WL, 2010, S AFR J WILDL RES, V40, P58, DOI 10.3957/056.040.0107; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Mating Goddard J., 1966, AFR J ECOL, V4, P69, DOI [10.1111/j.1365-2028.1966.tb00883.x, DOI 10.1111/J.1365-2028.1966.TB00883.X]; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Okes N., 2017, PENDANTS POWDER PATH; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Plotz RD, 2009, AFR ZOOL, V44, P283, DOI 10.3377/004.044.0216; Rogan MS, 2017, BIOL CONSERV, V210, P233, DOI 10.1016/j.biocon.2017.04.020; Rushton SP, 2006, J WILDLIFE MANAGE, V70, P1102, DOI 10.2193/0022-541X(2006)70[1102:EOCFPA]2.0.CO;2; Schenkel R., 1969, ECOLOGY BEHAV BLACK; Shannon G, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-62; Treves A, 2005, PEOPLE WILDLIFE CONF, DOI [10.1016/j.jtbi.2005.03.003, DOI 10.1016/J.JTBI.2005.03.003]; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; Wells H, 1998, BIOL CONSERV, V86, P317, DOI 10.1016/S0006-3207(98)00032-9; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	49	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236790	10.1371/journal.pone.0236790	http://dx.doi.org/10.1371/journal.pone.0236790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726369	gold, Green Published			2022-12-26	WOS:000556908900030
J	van de Vijver, B; Robert, K; Majewska, R; Frankovich, TA; Panagopoulou, A; Bosak, S				van de Vijver, Bart; Robert, Kathe; Majewska, Roksana; Frankovich, Thomas A.; Panagopoulou, Aliki; Bosak, Suncica			Geographical variation in the diatom communities associated with loggerhead sea turtles (Caretta caretta)	PLOS ONE			English	Article							SP. NOV.; MARINE DIATOM; BENTHIC DIATOMS; EPIZOIC DIATOM; BACILLARIOPHYTA; MORPHOLOGY; COCCONEIS; GENERA; SKIN	Epizoic diatoms form an important part of micro-epibiota of marine vertebrates such as whales and sea turtles. The present study explores and compares the diversity and biogeography of diatom communities growing on the skin and shell of loggerhead sea turtles (Caretta caretta) from four different localities: Adriatic Sea (Croatia), Ionian Sea (Greece), South Africa and Florida Bay (USA) using both light and scanning electron microscopy. We observed almost 400 diatom taxa belonging to more than 100 genera. Diatom communities from Greece and Croatia showed the highest similarity and were statistically different from those recorded from South Africa and Florida. Part of this variation could be attributed to differences in sampling techniques; however, we believe that geography had an important role. In general, contrary to several previous observations from sea turtles, the presumably exclusively epizoic diatoms contributed less than common benthic taxa to the total diatom flora, which might have been related to the loggerhead feeding behavior. Moreover, skin samples differed from carapace samples in having a distinct diatom composition with a higher proportion of the putative true epizoonts. Our results indicate that epizoic diatom communities differ according to loggerhead geographical location and substrate (skin vs. carapace). The relative abundances of common benthic diatoms and putative exclusive epizoic taxa may inform about sea turtle habitat use or behavior though detailed comparisons among different host species have yet to be performed.	[van de Vijver, Bart; Robert, Kathe] Meise Bot Garden, Res Dept, Meise, Belgium; [van de Vijver, Bart; Robert, Kathe] Univ Antwerp, ECOBE, Dept Biol, Antwerp, Belgium; [Majewska, Roksana] North West Univ, Sch Biol Sci, Unit Environm Sci & Management, Potchefstroom, South Africa; [Majewska, Roksana] South African Inst Aquat Biodivers SAIAB, Grahamstown, South Africa; [Frankovich, Thomas A.] Florida Int Univ, Inst Environm, Miami, FL 33199 USA; [Panagopoulou, Aliki] Sea Turtle Protect Soc Greece, ARCHELON, Athens, Greece; [Bosak, Suncica] Univ Zagreb, Dept Biol, Fac Sci, Zagreb, Croatia	University of Antwerp; North West University - South Africa; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; State University System of Florida; Florida International University; University of Zagreb	Bosak, S (corresponding author), Univ Zagreb, Dept Biol, Fac Sci, Zagreb, Croatia.	suncica.bosak@biol.pmf.hr	Majewska, Roksana/P-1280-2015; Bosak, Suncica/L-7149-2015	Majewska, Roksana/0000-0003-2681-4304; Bosak, Suncica/0000-0002-4604-2324	Croatian Science Fund (HRZZ) [UIP-2017-05-5635]; Systematics Association (UK) through the Systematics Research Fund Award	Croatian Science Fund (HRZZ); Systematics Association (UK) through the Systematics Research Fund Award	SB was funded by Croatian Science Fund (HRZZ) UIP-2017-05-5635, RM was funded by the Systematics Association (UK) through the Systematics Research Fund Award (R. Majewska/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Blanco Irene, 2014, V60, P5; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1956, SCI REPORTS WHALES R; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Battelli C, 2016, ACTA ADRIAT, V57, P173; Bennett AG, 1920, P R SOC LOND B-CONTA, V91, P352, DOI 10.1098/rspb.1920.0021; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Car A, 2012, EUR J PHYCOL, V47, P433, DOI 10.1080/09670262.2012.735255; Casale P, 2018, ENDANGER SPECIES RES, V36, P229, DOI 10.3354/esr00901; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Denys Luc, 1997, Diatom Research, V12, P1; Belando MD, 2018, EUR J PHYCOL, V53, P208, DOI 10.1080/09670262.2018.1426787; Ehrhart Llewellyn M., 1999, P61; Foged N., 1975, BIBLIOTHECA PHYCOLOG, V16, P1; Frankovich TA., 2015, MICROBIOLOGY EVERGLA, P239; Frankovich TA, 2016, PHYTOTAXA, V272, P101, DOI 10.11646/phytotaxa.272.2.1; Fuller WJ, 2010, J NAT HIST, V44, P1743, DOI 10.1080/00222931003624820; Hasle G.R., 1997, TOMAS CR IDENTIFYING; Haywood JC, 2020, MAR BIOL, V167, DOI 10.1007/s00227-020-3647-5; Hein MK., 2008, ICONOGR DIATOMOL, P1; Holmes Robert W., 1993, Bulletin of the National Science Museum Series B (Botany), V19, P1; HOLMES RW, 1985, BRIT PHYCOL J, V20, P43, DOI 10.1080/00071618500650061; Jiang HY, 2015, PHYTOTAXA, V195, P53, DOI 10.11646/phytotaxa.195.1.3; Kaleli A, 2018, FOTTEA, V18, P212, DOI 10.5507/fot.2018.007; Kovach Computing Services, 1993, MULT STAT PACK VERS; Majewska R, 2020, BOT LETT, V167, P7, DOI 10.1080/23818107.2019.1691648; Majewska R, 2019, EUR J PHYCOL, V54, P609, DOI 10.1080/09670262.2019.1628307; Majewska R, 2017, NOVA HEDWIG BEIH, V146, P23, DOI 10.1127/1438-9134/2017/023; Majewska R, 2018, DIATOM RES, V33, P229, DOI 10.1080/0269249X.2018.1491426; Majewska R, 2017, MICROB ECOL, V74, P969, DOI 10.1007/s00248-017-0987-x; Majewska R, 2017, BOT MAR, V60, P303, DOI 10.1515/bot-2016-0114; Majewska R, 2015, PHYTOTAXA, V233, P236, DOI 10.11646/phytotaxa.233.3.2; Majewska R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130351; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Park Jinsoon, 2012, Ocean Science Journal, V47, P101, DOI 10.1007/s12601-012-0011-9; Pinou T., 2019, Marine Turtle Newsletter, P22; Preen AR, 1996, J HERPETOL, V30, P94, DOI 10.2307/1564718; Rees AF, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3055-z; Rees AF, 2013, MAR BIOL, V160, P519, DOI 10.1007/s00227-012-2107-2; Riaux-Gobin C, 2017, DIATOM RES, V32, P109, DOI 10.1080/0269249X.2017.1299042; Rivera SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195770; Robert K, 2019, PHYTOTAXA, V414, P113, DOI 10.11646/phytotaxa.414.2.3; Robinson N.J., 2013, SEA TURTLES, P457, DOI [10.1016/B978-0-12-409548-9.04352-9, DOI 10.1016/B978-0-12-409548-9.04352-9]; Robinson NJ, 2017, J MAR BIOL ASSOC UK, V97, P1233, DOI 10.1017/S0025315416000734; Robinson NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157011; Round F. E., 1990, DIATOMS BIOL MORPHOL; Schofield G., 2006, ENDANGER SPECIES RES, V2, P71, DOI [DOI 10.3354/ESR002071, 110.3354/esr002071]; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Trobajo R, 2004, NOVA HEDWIGIA, V79, P433, DOI 10.1127/0029-5035/2004/0079-0433; Trobajo R, 2013, DIATOM RES, V28, P37, DOI 10.1080/0269249X.2012.734531; Van de Vijver B, 2019, PHYTOTAXA, V425, P105, DOI 10.11646/phytotaxa.425.2.5; Van der Werff A., 1953, P INT ASS THEORETICA, V12, P276, DOI [10.1080/03680770.1950.11895297, DOI 10.1080/03680770.1950.11895297]; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wetzel CE, 2010, VIE MILIEU, V60, P177; Wetzel CE, 2012, DIATOM RES, V27, P1, DOI 10.1080/0269249X.2011.642498; Witkowski A., 2000, ICONOGRAPHIA DIATOMO, V7, P1	57	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236513	10.1371/journal.pone.0236513	http://dx.doi.org/10.1371/journal.pone.0236513			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726804	Green Published, gold			2022-12-26	WOS:000556908900038
J	Ahrens, P; Andersen, LO; Lilje, B; Johannesen, TB; Dahl, EG; Baig, S; Jensen, JS; Falk, L				Ahrens, Peter; Andersen, Lee O'Brien; Lilje, Berit; Johannesen, Thor Bech; Dahl, Ebba Gomez; Baig, Sharmin; Jensen, Jorgen Skov; Falk, Lars			Changes in the vaginal microbiota following antibiotic treatment forMycoplasma genitalium,Chlamydia trachomatisand bacterial vaginosis	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; DISEASE; WOMEN; DNA	The human vagina harbor a rich microbiota. The optimal state is dominated by lactobacilli that help to maintain health and prevent various diseases. However, the microbiota may rapidly change to a polymicrobial state that has been linked to a number of diseases. In the present study, the temporal changes of the vaginal microbiota in patients treated for sexually transmitted diseases or bacterial vaginosis (BV) and in untreated controls were studied for 26 days. The patients included 52 women treated with azithromycin, tetracyclines or moxifloxacin for present or suspected infection withChlamydia trachomatisorMycoplasma genitalium. Women with concurrent BV were also treated with metronidazole. The controls were 10 healthy women of matching age. The microbiota was analyzed by 16S rRNA gene deep sequencing, specific qPCRs and microscopy. There was generally good correlation between Nugent score and community state type (CST) and qPCR confirmed the sequencing results. By sequencing, more than 600 different taxa were found, but only 33 constituted more than 1 parts per thousand of the sequences. In both patients and controls the microbiota could be divided into three different community state types, CST-I, CST-III and CST-IV. Without metronidazole, the microbiota remained relatively stable regarding CST although changes were seen during menstrual periods. Administration of metronidazole changed the microbiota from CST-IV to CST-III in approximately 50% of the treated patients. In contrast, the CST was generally unaffected by azithromycin or tetracyclines. In 30% of the BV patients,Gardnerella vaginaliswas not eradicated by metronidazole. The majority of women colonized withUreaplasma parvumremained positive after azithromycin whileU.urealyticumwas eradicated.	[Ahrens, Peter; Andersen, Lee O'Brien; Lilje, Berit; Johannesen, Thor Bech; Dahl, Ebba Gomez; Baig, Sharmin; Jensen, Jorgen Skov] Statens Serum Inst, Dept Bacteriol Parasitol & Mycol, Copenhagen, Denmark; [Dahl, Ebba Gomez; Falk, Lars] Linkoping Univ Hosp, Dept Dermatovenereol, Linkoping, Sweden; [Dahl, Ebba Gomez; Falk, Lars] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Dahl, Ebba Gomez] Hlth Ctr Gullviksborg, Malmo, Sweden	Statens Serum Institut; Linkoping University; Linkoping University	Ahrens, P; Jensen, JS (corresponding author), Statens Serum Inst, Dept Bacteriol Parasitol & Mycol, Copenhagen, Denmark.; Falk, L (corresponding author), Linkoping Univ Hosp, Dept Dermatovenereol, Linkoping, Sweden.; Falk, L (corresponding author), Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden.	pae@ssi.dk; jsj@ssi.dk; lars.falk@regionostergotland.se	Falk, Lars/AAG-8348-2020	Jensen, Jorgen Skov/0000-0002-7464-7435; Ahrens, Peter/0000-0003-3776-7929				AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Beeton ML, 2016, ANTIMICROB AGENTS CH, V60, P52, DOI 10.1128/AAC.00889-15; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Brookheart RT, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2019.01.229; CHOW AW, 1986, AM J OBSTET GYNECOL, V154, P120, DOI 10.1016/0002-9378(86)90406-0; Datcu R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-480; Edwards VL, 2019, MBIO, V10, DOI 10.1128/mBio.01548-19; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; Falk L, 2015, J ANTIMICROB CHEMOTH, V70, P3134, DOI 10.1093/jac/dkv246; Ferris MJ, 2007, J CLIN MICROBIOL, V45, P1016, DOI 10.1128/JCM.02085-06; Filardo S, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00094-19; Frolund M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214425; Frolund M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102743; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Ghartey JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096659; Haahr T, 2016, HUM REPROD, V31, P795, DOI 10.1093/humrep/dew026; Horner PJ, 2016, INT J STD AIDS, V27, P928, DOI 10.1177/0956462416648585; Jakobsson T, 2007, J CLIN MICROBIOL, V45, P3145, DOI 10.1128/JCM.00558-07; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Joag V, 2019, CLIN INFECT DIS, V68, P1675, DOI 10.1093/cid/ciy762; Kalyoussef S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049506; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Koedooder R, 2019, HUM REPROD, V34, P1042, DOI 10.1093/humrep/dez065; Krogsgaard LR, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0027-2; Lokken EM, 2017, AM J EPIDEMIOL, V186, P194, DOI 10.1093/aje/kwx043; Mayer BT, 2015, J INFECT DIS, V212, P793, DOI 10.1093/infdis/jiv079; McDonald JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157046; Mortensen C, 2013, LIVER INT, V33, P1309, DOI 10.1111/liv.12205; Noyes N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191625; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Petrina MAB, 2019, ANAEROBE, V56, P61, DOI 10.1016/j.anaerobe.2019.02.005; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ring HC, 2017, JAMA DERMATOL, V153, P897, DOI 10.1001/jamadermatol.2017.0904; Sherrard J, 2018, INT J STD AIDS, V29, P1258, DOI 10.1177/0956462418785451; Singh AE, 2019, CLIN INFECT DIS, VXx, P1; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Valentine-King MA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01104-17; Verwijs MC, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.08.008; Virtanen S, 2019, SCI REP, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Westh H, 2008, SEX TRANSM INFECT, V84, P546, DOI 10.1136/sti.2008.031906; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Witkin SS, 2013, MBIO, V4, DOI 10.1128/mBio.00460-13; Zhang R, 2019, FRONT MICROBIOL, V10, P1	47	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236036	10.1371/journal.pone.0236036	http://dx.doi.org/10.1371/journal.pone.0236036			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722712	Green Published, gold			2022-12-26	WOS:000556916000036
J	Paulin, S; Alm, RA; Beyer, P				Paulin, Sarah; Alm, Richard A.; Beyer, Peter			A novel pre-clinical antibacterial pipeline database	PLOS ONE			English	Review								The clinical pipeline continues to be insufficient to contain antimicrobial resistance, and further investment and research is needed to ensure that a robust pipeline is built to treat the WHO priority pathogens list of antibiotic-resistant bacteria. To shed light further upstream on the preclinical pipeline the WHO has undertaken a review of the antibacterial preclinical pipeline and published the data of all identified projects in a publicly accessible database. The database captures 252 unique antibacterial agents in preclinical development being developed by 145 individual institutions, of which the majority are smaller biotech companies and academic institutions. There is a higher degree of innovation in the preclinical pipeline with a significant number of non-traditional approaches being pursued. For even a fraction of these projects to reach clinical development or the market, there is a need to shift the market dynamics for new antibacterials through the identification of new solutions beyond push and pull incentives.	[Paulin, Sarah; Beyer, Peter] WHO, Antimicrobial Resistance Div, Dept Global Coordinat & Partnership, Geneva, Switzerland; [Alm, Richard A.] CARB X, Boston, MA USA	World Health Organization	Paulin, S (corresponding author), WHO, Antimicrobial Resistance Div, Dept Global Coordinat & Partnership, Geneva, Switzerland.	paulins@who.int		Beyer, Peter/0000-0003-4168-8668; Paulin, Sarah/0000-0002-9341-1196	ASPR/BARDA [IDSEP160030]; Wellcome Trust; Global AMR Innovation Fund (GAMRIF) - UK Government Department of Health and Social Care (DHSC); German Federal Ministry of Education and Research (BMBF); Bill & Melinda Gates Foundation; government of the United States (BARDA); government of the United States (NIAID); United Kingdom (DHSC); United Kingdom (GAMRIF); Germany (BMBF)	ASPR/BARDA; Wellcome Trust(Wellcome TrustEuropean Commission); Global AMR Innovation Fund (GAMRIF) - UK Government Department of Health and Social Care (DHSC); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); government of the United States (BARDA); government of the United States (NIAID); United Kingdom (DHSC); United Kingdom (GAMRIF); Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	The Government of Austria and the Global Antibiotic Research and Development Partnership (GARDP) provided support in the form of salaries for authors SP, and PB. In addition RAA was supported by the Cooperative Agreement Number IDSEP160030 from ASPR/BARDA and by awards from Wellcome Trust, the Global AMR Innovation Fund (GAMRIF) funded by the UK Government Department of Health and Social Care (DHSC), the German Federal Ministry of Education and Research (BMBF) and the Bill & Melinda Gates Foundation, as administrated by CARB-X. CARB-X provided support in the form of salaries for RAA. The contents do not necessarily represent the views of the CARB-X project nor any CARB-X project funder including the governments of the United States (BARDA, NIAID), the United Kingdom (DHSC, GAMRIF), or Germany (BMBF), the Wellcome Trust, or the Bill & Melinda Gates Foundation. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2019, GLOB OBS HLTH R D WH; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; MULLARD A, 2019, NAT REV DRUG DISCOV, V18, P411; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Roland D., 2019, WALL STREET J; Theuretzbacher U, 2019, NAT REV MICROBIOL; US Centers for Disease Control and Prevention, 2019, ANTIBIOTIC RESISTANC; WHO, 2019, ANT AG PRECL DEV OP; World Health Organization, 2017, PRIOR PATH GUID DISC; World Health Organization, 2019, 2019 ANT AG CLIN DEV	10	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236604	10.1371/journal.pone.0236604	http://dx.doi.org/10.1371/journal.pone.0236604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722726	gold, Green Published			2022-12-26	WOS:000556916000041
J	Brambilla, PG; Polli, M; Pradelli, D; Papa, M; Rizzi, R; Bagardi, M; Bussadori, C				Brambilla, Paola Giuseppina; Polli, Michele; Pradelli, Danitza; Papa, Melissa; Rizzi, Rita; Bagardi, Mara; Bussadori, Claudio			Epidemiological study of congenital heart diseases in dogs: Prevalence, popularity, and volatility throughout twenty years of clinical practice	PLOS ONE			English	Article							PULMONIC STENOSIS; SUBAORTIC STENOSIS; MIXED-BREED; ECHOCARDIOGRAPHY; DEFECTS; VALVE; RISK	The epidemiology of Congenital Heart Diseases (CHDs) has changed over the past twenty years. This study aimed to evaluate the prevalence of CHD(s)in the population of dogs recruited in a single referral center (RC); compare the epidemiological features of CHD(s)in screened breeds (Boxers) versus non-screened (French and English Bulldogs, German Shepherds);investigate the association of breeds with the prevalence of CHDs; determine the popularity and volatility of breeds over a 20-year period; analysed the trends of the most popular breeds in the overall population of new-born dogs registered in the Italian Kennel Club (IKC) from 1st January 1997 to 31st December 2017. The RC's cardiological database was analysed, and 1,779 clinical records were included in a retrospective observation study. Descriptive statistics and frequencies regarding the most representative breeds and CHD(s)were generated. A logistic regression model was used to analyse the trends of the most common CHD(s)found in single and in cluster of breeds. The relationship between breed popularity and presence of CHD(s)was studied. The most common CHD(s)were Pulmonic Stenosis, Patent Ductus Arteriosus, Subaortic Stenosis, Ventricular Septal Defect, Aortic Stenosis, Tricuspid Dysplasia, Atrial Septal Defect, Double Chamber Right Ventricle, Mitral Dysplasia, and others less frequent. The most represented pure breeds were Boxer, German Shepherd, French Bulldog, English Bulldog, Maltese, Newfoundland, Rottweiler, Golden Retriever, Chihuahua, and others in lower percentage. Chihuahuas, American Staffordshire Terriers, Border Collies, French Bulldogs, and Cavalier King Charles Spaniel were the most appreciated all of which showed a high value of volatility. This study found evidence for the value of the screening program implemented in Boxers; fashions and trends influence dog owners' choices more than the worries of health problems in a breed. Effective breeding programs are needed in order to control the diffusion of CHD(s)without impoverishing the genetic pool.	[Brambilla, Paola Giuseppina; Polli, Michele; Rizzi, Rita; Bagardi, Mara] Univ Milan, Dept Vet Med, Lodi, Italy; [Pradelli, Danitza; Papa, Melissa; Bussadori, Claudio] Clin Vet Gran Sasso, Dept Cardiol, Milan, Italy	University of Milan	Brambilla, PG (corresponding author), Univ Milan, Dept Vet Med, Lodi, Italy.	paola.brambilla@unimi.it	BRAMBILLA, PAOLA GIUSEPPINA/AAZ-2032-2020; Bagardi, Mara/AAR-1770-2021	BRAMBILLA, PAOLA GIUSEPPINA/0000-0003-4255-555X; Bagardi, Mara/0000-0002-5247-3796; Pradelli, Danitza/0000-0002-5471-7547				Archer J, 2011, ETHOLOGY, V117, P217, DOI 10.1111/j.1439-0310.2010.01863.x; Baumgartner C, 2003, SCHWEIZ ARCH TIERH, V145, P527, DOI 10.1024/0036-7281.145.11.527; Garcia-Rodriguez MB, 2009, CAN VET J, V50, P933; Bellumori TP, 2013, JAVMA-J AM VET MED A, V242, P1549, DOI 10.2460/javma.242.11.1549; Buchanan J, 1992, CURRENT VET THERAPY, P647; Buchanan J. W., 1999, TXB CANINE FELINE CA, P458; Bussadori C, 2000, J Vet Cardiol, V2, P15, DOI 10.1016/S1760-2734(06)70007-8; Bussadori C, 2001, J Vet Cardiol, V3, P7, DOI 10.1016/S1760-2734(06)70014-5; Bussadori C, 2001, J VET INTERN MED, V15, P553, DOI 10.1892/0891-6640(2001)015&lt;0553:BVIDWP&gt;2.3.CO;2; Bussadori C, 2009, VET J, V181, P187, DOI 10.1016/j.tvjl.2008.02.008; Caivano D, 2018, J SMALL ANIM PRACT, V59, P161, DOI 10.1111/jsap.12760; DETWEILER D. K., 1965, ANN NY ACAD SCI, V127, P481, DOI 10.1111/j.1749-6632.1965.tb49421.x; Detweiler DK, 1961, AJPH, V51, P229; Garncarz M, 2017, MED WETER, V73, P651, DOI 10.21521/mw.5784; Ghirlanda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106565; Ghirlanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074770; Henderson RA, 1998, CURRENT TECHNIQUES S, P652; Herzog H, 2006, SOC ANIM, V14, P383, DOI 10.1163/156853006778882448; HUNT GB, 1990, AUST VET PRACT, V20, P70; Locatelli C, 2013, J SMALL ANIM PRACT, V54, P445, DOI 10.1111/jsap.12113; Locatelli C, 2011, J SMALL ANIM PRACT, V52, P246, DOI 10.1111/j.1748-5827.2011.01055.x; MacDonald KA, 2006, VET CLIN N AM-SMALL, V36, P503, DOI 10.1016/j.cvsm.2005.12.006; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Menegazzo L, 2012, J ANIM SCI, V90, P419, DOI 10.2527/jas.2011-4018; Navalon I, 2015, J VET CARDIOL, V17, P262, DOI 10.1016/j.jvc.2015.08.007; O'Neill DG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217928; O'Neill DG, 2015, CANINE GENET EPIDEMI, P2, DOI [10.1186/s40575-015-0013-x, DOI 10.1186/S40575-015-0013-X]; Ohad DG, 2013, VET J, V197, P351, DOI 10.1016/j.tvjl.2013.01.012; Oliveira P, 2011, J VET INTERN MED, V25, P477, DOI 10.1111/j.1939-1676.2011.0711.x; Orton EC, 1995, CONGENITAL HEART DEF, P203; Packer RMA, 2017, ANIM WELFARE, V5, P1; Packer RMA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219918; PATTERSON DF, 1971, CIRC RES, V29, P1, DOI 10.1161/01.RES.29.1.1; PATTERSON DF, 1981, AM J CARDIOL, V47, P631, DOI 10.1016/0002-9149(81)90548-8; PYLE RL, 1976, AM HEART J, V92, P324, DOI 10.1016/S0002-8703(76)80113-5; Quintavalla C, 2010, VET J, V185, P332, DOI 10.1016/j.tvjl.2009.06.027; SandOe P, 2017, PLOS ONE, V24, P1; Saunders AB, 2014, J VET INTERN MED, V28, P401, DOI 10.1111/jvim.12267; Scansen B., 2017, VET SCI, V4, P1; Schrope DP, 2015, J VET CARDIOL, V17, P192, DOI 10.1016/j.jvc.2015.06.001; Spalla I, 2016, J VET INTERN MED, V30, P706, DOI 10.1111/jvim.13938; THOMAS WP, 1993, J VET INTERN MED, V7, P247, DOI 10.1111/j.1939-1676.1993.tb01015.x; Tidholm A, 1997, J SMALL ANIM PRACT, V38, P94, DOI 10.1111/j.1748-5827.1997.tb03326.x; 1998, SMALL ANIMAL CARDIOV, P218	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0230160	10.1371/journal.pone.0230160	http://dx.doi.org/10.1371/journal.pone.0230160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716943	Green Submitted, Green Published, gold			2022-12-26	WOS:000556674500020
J	Deichsel, EL; John-Stewart, GC; Walson, JL; Mbori-Ngacha, D; Richardson, BA; Guthrie, BL; Farquhar, C; Bosire, R; Pavlinac, PB				Deichsel, Emily L.; John-Stewart, Grace C.; Walson, Judd L.; Mbori-Ngacha, Dorothy; Richardson, Barbra A.; Guthrie, Brandon L.; Farquhar, Carey; Bosire, Rose; Pavlinac, Patricia B.			Examining the relationship between diarrhea and linear growth in Kenyan HIV-exposed, uninfected infants	PLOS ONE			English	Article							GLOBAL ENTERIC MULTICENTER; CHILD UNDERNUTRITION; DEVELOPING-COUNTRIES; LOW-INCOME; MORTALITY; ASSOCIATION; MORBIDITY; RISK; MALNUTRITION; WEIGHT	Background Diarrhea in infancy can compromise linear growth and this relationship is likely influenced by diarrhea severity, number of episodes, and the timing of those episodes. HIV exposed, uninfected infants (HEU) have higher risk of growth faltering, infectious morbidity and mortality than HIV-unexposed infants and may be representative of children particularly vulnerable to diarrhea-associated linear growth faltering. Methodology/Principal findings We utilized data from a cohort of Kenyan HEU infants followed from birth to 12 months of age. Infant length and morbidity were ascertained at monthly study visits and sick visits. Longitudinal models estimated the association between diarrhea severity and length-for-age Z-score (LAZ) in the following month, at 12 months of age, and in 6-month intervals. The 372 enrolled infants experienced an average of 2.15 episodes (range: 0-8) of diarrhea and 0.54 episodes (0-4) of moderate-to-severe diarrhea (MSD) between birth and 12 months. Surviving infants had a mean LAZ of -0.97 (standard deviation: 1.2) at 12 months. MSD was significantly associated with an average loss of 0.14 (95% Confidence Interval [CI]: -0.24, -0.05, p = 0.003) in LAZ one month after the episode. Linear growth outcomes were not predicted by cumulative episodes of diarrhea, or timing of diarrhea during infancy. Conclusions/Significance Diarrhea severity influenced the relationship between diarrhea and subsequent linear growth. HEU infants with MSD may benefit from nutritional interventions following severe diarrhea to protect against linear growth faltering.	[Deichsel, Emily L.; John-Stewart, Grace C.; Walson, Judd L.; Guthrie, Brandon L.; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [John-Stewart, Grace C.; Walson, Judd L.; Richardson, Barbra A.; Guthrie, Brandon L.; Farquhar, Carey; Pavlinac, Patricia B.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [John-Stewart, Grace C.; Walson, Judd L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [John-Stewart, Grace C.; Walson, Judd L.; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA USA; [Walson, Judd L.] Child Acute Illness & Nutr CHAIN Network, Nairobi, Kenya; [Mbori-Ngacha, Dorothy] United Nations Childrens Fund UNICEF, New York, NY USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bosire, Rose] Kenya Med Res Inst KEMRI, Ctr Publ Hlth Res, Nairobi, Kenya; [Deichsel, Emily L.] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; UNICEF; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University System of Maryland; University of Maryland Baltimore	Deichsel, EL (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Deichsel, EL (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA.	edeichsel@som.umaryland.edu		Deichsel, Emily/0000-0002-6172-9458	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [R01 HD-23412, 1F31 HD-089507]	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [grant numbers R01 HD-23412 to GJS, 1F31 HD-089507 to ELD]. The funder had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. https://www.nih.gov/about-nih/whatwe-do/nih-almanac/eunice-kennedy-shriver-national-institute-child-health-humandevelopment-nichd.; We would like to thank the mothers and children who participated in the study, as well as the research personnel, clinic staff, and data management teams in Nairobi Kenya and Seattle, who made this study possible. We thank the University of Nairobi and Kenyatta National Hospital for support in conducting the parent study and providing administrative and physical infrastructure.	ASHWORTH A, 1969, BRIT J NUTR, V23, P835, DOI 10.1079/BJN19690094; BAIRAGI R, 1987, INT J EPIDEMIOL, V16, P477, DOI 10.1093/ije/16.3.477; BLACK RE, 1984, PEDIATRICS, V73, P799; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BRIEND A, 1989, LANCET, V2, P319; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Checkley W, 2003, AM J EPIDEMIOL, V157, P166, DOI 10.1093/aje/kwf179; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Cheung YB, 2010, ACTA PAEDIATR, V99, P1719, DOI 10.1111/j.1651-2227.2009.01593.x; Deichsel EL, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12861; Evans C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00190; Gichuhi C, 2005, East Afr Med J, V82, P447; Gough EK, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2267; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Joint United Nations Programme on HIV/AIDS(UNAIDS), 2016, UNAIDS FACT SHEET, P18; Jones AD, 2015, AM J TROP MED HYG, V92, P463, DOI 10.4269/ajtmh.14-0448; Khavari N, 2014, INT HEALTH, V6, P298, DOI 10.1093/inthealth/ihu061; KNOPPERS BM, 2017, BMJ GLOB HEALTH, V2, DOI DOI 10.1038/S41536-017-0007-2; Kotloff KL, 2019, LANCET GLOB HEALTH, V7, pE568, DOI 10.1016/S2214-109X(19)30076-2; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Lamberti LM, 2015, AM J TROP MED HYG, V93, P250, DOI 10.4269/ajtmh.14-0727; Marquez C, 2014, J TROP PEDIATRICS, V60, P434, DOI 10.1093/tropej/fmu045; Moore SR, 2010, GASTROENTEROLOGY, V139, P1156, DOI 10.1053/j.gastro.2010.05.076; Morris SS, 1996, AM J EPIDEMIOL, V144, P582, DOI 10.1093/oxfordjournals.aje.a008968; Obimbo EM, 2009, JAIDS-J ACQ IMM DEF, V51, P209, DOI 10.1097/QAI.0b013e31819c16d8; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Prendergast AJ, 2016, CURR OPIN INFECT DIS, V29, P229, DOI 10.1097/QCO.0000000000000261; Richard SA, 2014, J NUTR, V144, P965, DOI 10.3945/jn.113.187161; Richard SA, 2013, AM J EPIDEMIOL, V178, P1129, DOI 10.1093/aje/kwt094; Rogawski ET, 2018, LANCET GLOB HLTH; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; SLOGROVE AL, 2016, FRONT IMMUNOL, V7, DOI DOI 10.3389/FIMMU.2016.00001; Slogrove A, 2012, J TROP PEDIATRICS, V58, P505, DOI 10.1093/tropej/fms019; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Sztam KA, 2016, J PEDIATR-US, V175, P54, DOI 10.1016/j.jpeds.2016.04.088; TAHA TE, 1995, INT J EPIDEMIOL, V24, P1022, DOI 10.1093/ije/24.5.1022; Van Der Kam S, 2016, RANDOMISED CONTROLLE, P1; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; WHO, 2006, WHO CHILD GROWTH STA	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0235704	10.1371/journal.pone.0235704; 10.1371/journal.pone.0235704.r001; 10.1371/journal.pone.0235704.r002; 10.1371/journal.pone.0235704.r003; 10.1371/journal.pone.0235704.r004	http://dx.doi.org/10.1371/journal.pone.0235704; 10.1371/journal.pone.0235704.r001; 10.1371/journal.pone.0235704.r002; 10.1371/journal.pone.0235704.r003; 10.1371/journal.pone.0235704.r004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716913	gold, Green Published			2022-12-26	WOS:000556674500030
J	Lee, WJ; Jung, KH; Ryu, YJ; Lee, ST; Park, KI; Chu, K; Kim, M; Lee, SK; Roh, JK				Lee, Woo-Jin; Jung, Keun-Hwa; Ryu, Young Jin; Lee, Soon-Tae; Park, Kyung-Il; Chu, Kon; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Echocardiographic index E/e' in association with cerebral white matter hyperintensity progression	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; SMALL VESSEL DISEASE; ARTERIAL STIFFNESS; HEART-FAILURE; RECOMMENDATIONS; PULSATILITY; IMPAIRMENT; STATEMENT; DEMENTIA; SOCIETY	Cerebral white-matter hyperintensities (WMHs) on MRI is associated with reduced compliance of the cerebral arterioles. We hypothesized that an echocardiography index for left ventricular (LV) diastolic function, E/e', might reflect the cerebral arteriolar compliance and evaluated the association between E/e' and long-term progression rate of the cerebral WMH volume. This retrospective study included individuals who were >= 50 years of age, with a preserved LV ejection fraction (>= 50%) and neurological function status (modified Rankin scale score <= 1), and underwent initial and follow-up MRI evaluations within intervals of 34-45 months. Baseline clinical, laboratory, and echocardiography markers such as ejection fraction, LV mass index, and E/e' were obtained. WMH volume progression rate between the baseline and follow-up MRIs was designated as the outcome factor. 392 individuals (57.1% men; mean age: 66.7 +/- 8.4 years) were followed-up for 38.2 +/- 3.4 months. The mean WMH volume progression rate was 1.35 +/- 2.65 mL/year. The log-transformed value of WMH volume progression rate was linearly associated with the log-transformed E/e' (B coefficient = 0.365; 95% confidence interval [CI] 0.180-0.551;P= 0.001), along with the log-transformed values of baseline WMH volume (B = 0.142; 95% CI 0.106-0.179;P<0.001) and glomerular filtration rate (B = -0.182; 95% CI -0.321-0.044;P= 0.010). Additionally, a subgroup with an E/e' >= 15 exhibited a significantly higher WMH progression rate compared to the subgroups with lower E/e' values (P<0.001), especially in the lower quartiles (quartiles 1 and 2) of the baseline WMH volume. We concluded that echocardiographic marker E/e' is associated with the long-term progression rate of cerebral WMHs in population with preserved LV systolic function.	[Lee, Woo-Jin; Jung, Keun-Hwa; Lee, Soon-Tae; Park, Kyung-Il; Chu, Kon; Kim, Manho; Lee, Sang Kun] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Ryu, Young Jin] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam Si, Gyeonggi Do, South Korea; [Park, Kyung-Il] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Neurol, Seoul, South Korea; [Roh, Jae-Kyu] Armed Forces Capital Hosp, Dept Neurol, Seongnam Si, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Jung, KH (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.	jungkh@gmail.com		Jung, Keun-Hwa/0000-0003-1433-8005; Park, Kyung-Il/0000-0001-8064-6749; Chu, Kon/0000-0001-5863-0302	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2018M3C7A1056889]; Ildong Pharm Co., Ltd [0620151320]	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Ildong Pharm Co., Ltd	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (english.msip. go.kr)(2018M3C7A1056889). Jung KH was supported by research grant from Ildong Pharm Co., Ltd (https://www.ildong.com)(0620151320).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arques Stephane, 2007, Cardiovasc Ultrasound, V5, P16, DOI 10.1186/1476-7120-5-16; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Borlaug BA, 2014, NAT REV CARDIOL, V11, P507, DOI 10.1038/nrcardio.2014.83; Calvet D, 2010, CIRCULATION, V121, P1623, DOI 10.1161/CIRCULATIONAHA.109.906958; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; IBM Corp, REL 2015 IBM SPSS ST; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85; Jefferson AL, 2015, CIRCULATION, V131, P1333, DOI 10.1161/CIRCULATIONAHA.114.012438; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Kang S, 2010, EUR HEART J, V31, P2799, DOI 10.1093/eurheartj/ehq296; Khatri M, 2007, STROKE, V38, P3121, DOI 10.1161/STROKEAHA.107.493593; Kou S, 2014, EUR HEART J-CARD IMG, V15, P680, DOI 10.1093/ehjci/jet284; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lee WJ, 2018, JAMA NEUROL, V75, P80, DOI 10.1001/jamaneurol.2017.2853; Lee WJ, 2017, RADIOLOGY, V284, P824, DOI 10.1148/radiol.2017162064; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Moore EE, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009041; Nagueh SF, 2020, JACC-CARDIOVASC IMAG, V13, P228, DOI 10.1016/j.jcmg.2018.10.038; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Reed AL, 2011, AM J PHYSIOL-HEART C, V301, pH824, DOI 10.1152/ajpheart.00407.2010; Richards JE, 2016, NEUROIMAGE, V124, P1254, DOI 10.1016/j.neuroimage.2015.04.055; Rosenberg GA, 2001, STROKE, V32, P1162, DOI 10.1161/01.STR.32.5.1162; Schmidt P, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101849; Sciarretta S, 2009, CLIN SCI, V116, P467, DOI 10.1042/CS20080390; Sharp AS, 2009, EUROPEAN HEART J; Thirion JP, 1999, IEEE T MED IMAGING, V18, P429, DOI 10.1109/42.774170; Thomas L, 2019, J AM COLL CARDIOL, V73, P1961, DOI 10.1016/j.jacc.2019.01.059; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wardlaw JM, 2013, STROKE, V44, P525, DOI 10.1161/STROKEAHA.112.669994; Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236473	10.1371/journal.pone.0236473	http://dx.doi.org/10.1371/journal.pone.0236473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716979	Green Published, gold			2022-12-26	WOS:000556674500033
J	Vendramini, THA; Pedrinelli, V; Macedo, HT; Zafalon, RVA; Risolia, LW; Rentas, MF; Macegoza, MV; Gameiro, AH; Brunetto, MA				Annibale Vendramini, Thiago Henrique; Pedrinelli, Vivian; Macedo, Henrique Tobaro; Amorim Zafalon, Rafael Vessecchi; Risolia, Larissa Wunsche; Rentas, Mariana Fragoso; Macegoza, Matheus Vinicius; Gameiro, Augusto Hauber; Brunetto, Marcio Antonio			Homemade versus extruded and wet commercial diets for dogs: Cost comparison	PLOS ONE			English	Article							NUTRITIONAL COMPOSITION; GLUCOSE; OWNERS	The present study aimed to verify and compare the costs of homemade diets with extruded and wet commercial diets for dogs in maintenance and consuming therapeutic diets (obesity, congestive heart failure, diabetes, hepatic encephalopathy, chronic kidney disease, and food hypersensitivity), which is important information that impacts in the choice of food by the owners. The maintenance energy requirements (MER) were estimated for adult dogs of different sizes (3 kg, 15 kg, 30 kg, and 50 kg) and the daily amounts of food intake were estimated for each type of food. The costs were calculated per day, per 1000 kcal of metabolizable energy of product and per kg of metabolic weight of the animal. Fourteen complete and balanced homemade diets were formulated, and in each proposed group, two diets with different protein sources were used. Under the conditions of the present study, it was possible to conclude that homemade diets were more expensive than dry maintenance diets and dry therapeutic diets, while commercial wet diets were more expensive in all of the scenarios.	[Annibale Vendramini, Thiago Henrique; Macedo, Henrique Tobaro; Amorim Zafalon, Rafael Vessecchi; Rentas, Mariana Fragoso; Macegoza, Matheus Vinicius; Brunetto, Marcio Antonio] Univ Sao Paulo, Pet Nutrol Res Ctr, Sch Vet Med & Anim Sci, Nutr & Prod Dept, Pirassununga, Brazil; [Pedrinelli, Vivian; Risolia, Larissa Wunsche; Brunetto, Marcio Antonio] Univ Sao Paulo, Vet Teaching Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, Brazil; [Gameiro, Augusto Hauber] Univ Sao Paulo, Sch Vet Med & Anim Sci, Nutr & Prod Dept, Lab Socioecon Anal & Anim Sci, Pirassununga, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Brunetto, MA (corresponding author), Univ Sao Paulo, Pet Nutrol Res Ctr, Sch Vet Med & Anim Sci, Nutr & Prod Dept, Pirassununga, Brazil.; Brunetto, MA (corresponding author), Univ Sao Paulo, Vet Teaching Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, Brazil.	mabrunetto@usp.br	Pedrinelli, Vivian/AAH-4103-2019; Pedrinelli, Vivian/AFG-3190-2022; Brunetto, Marcio/AAQ-9767-2021; Pedrinelli, Vivian/AAF-1350-2022	Pedrinelli, Vivian/0000-0001-5954-4086; Pedrinelli, Vivian/0000-0001-5954-4086; Brunetto, Marcio/0000-0003-3240-0343; Fragoso Rentas, Mariana/0000-0001-9423-9976; Vendramini, Thiago/0000-0003-4457-8392				Brunetto MA, 2007, ACTA SCI VET S2, V35, P233; Brunetto MA, 2011, BRIT J NUTR, V106, pS194, DOI 10.1017/S0007114511000870; Carciofi AC, 2006, ARQ BRAS MED VET ZOO, V58, P421, DOI 10.1590/S0102-09352006000300021; Carciofi AC, 2003, S NUTR AN EST 3 2003, P71; Casna BR, 2017, 17 ANN AAVN CLIN NUT; Dodd SAS., 2018, ESVCN P 2018, P227; Fascetti AJ, 2012, APPLIED VETERINARY CLINICAL NUTRITION, P289; FEDIAF, 2019, NUTR GUID COMPL COMP; Freeman LM, 2003, J AM VET MED ASSOC, V223, P1301, DOI 10.2460/javma.2003.223.1301; Halfen DP, 2017, PESQUI VET BRASIL, V37, P1453, DOI [10.1590/S0100-736X2017001200015, 10.1590/s0100-736x2017001200015]; Laflamme DP, 2008, JAVMA-J AM VET MED A, V232, P687, DOI 10.2460/javma.232.5.687; Marquez BP, 2018, 18 ANN AAVN CLIN NUT; Meyer H., 2010, SMALL ANIMAL CLIN NU, P1155; Michel KE, 2006, VET CLIN N AM-SMALL, V36, P1269, DOI 10.1016/j.cvsm.2006.08.003; Nucleo de Estudos e Pesquisas em Alimentacao Universidade Estadual de Campinas, 2011, TAB BRAS COMP AL; ORNELLAS L. H., 2007, DIETARY TECHNIQUE SE; Pedrinelli V, 2019, SCI REP, V9, P1; Porsani MYH., 2019, ACVIM P ACVIM; Prelaud P, 2006, ENCY CANINE CLIN NUT, P61; Singh S, 2007, INT J FOOD SCI TECH, V42, P916, DOI 10.1111/j.1365-2621.2006.01309.x; Teixeira F. A., 2017, Brazilian Journal of Veterinary Research and Animal Science, V54, P330, DOI 10.11606/issn.1678-4456.bjvras.2017.133289; Urrego M. I. G., 2017, Brazilian Journal of Veterinary Research and Animal Science, V54, P398, DOI 10.11606/issn.1678-4456.bjvras.2017.133279; Verlinden A, 2006, CRIT REV FOOD SCI, V46, P259, DOI 10.1080/10408390591001117	23	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236672	10.1371/journal.pone.0236672	http://dx.doi.org/10.1371/journal.pone.0236672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706820	Green Published, gold			2022-12-26	WOS:000579931700060
J	Kiddle, SJ; Whittaker, HR; Seaman, SR; Quint, JK				Kiddle, Steven J.; Whittaker, Hannah R.; Seaman, Shaun R.; Quint, Jennifer K.			Prediction of five-year mortality after COPD diagnosis using primary care records	PLOS ONE			English	Article							RISK	Accurate prognosis information after a diagnosis of chronic obstructive pulmonary disease (COPD) would facilitate earlier and better informed decisions about the use of prevention strategies and advanced care plans. We therefore aimed to develop and validate an accurate prognosis model for incident COPD cases using only information present in general practitioner (GP) records at the point of diagnosis. Incident COPD patients between 2004-2012 over the age of 35 were studied using records from 396 general practices in England. We developed a model to predict all-cause five-year mortality at the point of COPD diagnosis, using 47,964 English patients. Our model uses age, gender, smoking status, body mass index, forced expiratory volume in 1-second (FEV1) % predicted and 16 co-morbidities (the same number as the Charlson Co-morbidity Index). The performance of our chosen model was validated in all countries of the UK (N = 48,304). Our model performed well, and performed consistently in validation data. The validation area under the curves in each country varied between 0.783-0.809 and the calibration slopes between 0.911-1.04. Our model performed better in this context than models based on the Charlson Co-morbidity Index or Cambridge Multimorbidity Score. We have developed and validated a model that outperforms general multimorbidity scores at predicting five-year mortality after COPD diagnosis. Our model includes only data routinely collected before COPD diagnosis, allowing it to be readily translated into clinical practice, and has been made available through an online risk calculator (https://skiddle.shinyapps.io/incidentcopdsurvival/).	[Kiddle, Steven J.; Seaman, Shaun R.] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Kiddle, Steven J.; Whittaker, Hannah R.; Quint, Jennifer K.] Imperial Coll London, Natl Heart & Lung Inst, London, England	MRC Biostatistics Unit; University of Cambridge; Imperial College London	Kiddle, SJ (corresponding author), Univ Cambridge, MRC Biostat Unit, Cambridge, England.; Kiddle, SJ; Quint, JK (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	steven.kiddle@mrc-bsu.cam.ac.uk; j.quint@imperial.ac.uk	quint, jennifer/ABE-3384-2020	Quint, Jennifer/0000-0003-0149-4869	MRC Career Development Award [MR/P021573/1]; MRC Programme Grant [MC_UU_00002/10]; MRC [MC_UU_00002/10, MR/P021573/1] Funding Source: UKRI	MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SJK is supported by a MRC Career Development Award (MR/P021573/1). SRS is supported by MRC Programme Grant (MC_UU_00002/10). The funders had no role in the decision to publish. We acknowledge CPRD @ University of Cambridge for developing and sharing disease definitions, and Silvia Mendonica and Duncan Edwards (University of Cambridge) in particular for advice on implementing these and the Cambridge multimorbidity score. We would like to thank peer reviewers whose comments improved our manuscript. This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency. The data is provided by patients and collected by the NHS as part of their care and support. ONS is the provider of ONS mortality data used in this study. ONS and HES data copyright (c) (2018), re-used with the permission of The Health & Social Care Information Centre. All rights reserved. The interpretation and conclusions contained in this study are those of the author/s alone.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Berry CE, 2010, COPD, V7, P375, DOI 10.3109/15412555.2010.510160; Bloom CI, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1310-0; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Torres JP, 2014, THORAX, V69, P799, DOI 10.1136/thoraxjnl-2014-205770; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Gallagher AM, 2019, PHARMACOEPIDEM DR S, V28, P563, DOI 10.1002/pds.4747; Rodriguez LAG, 2010, RESP MED, V104, P1691, DOI 10.1016/j.rmed.2010.04.018; Gayle AV, 2019, THORAX, V74, P483, DOI 10.1136/thoraxjnl-2018-212514; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2019, POCK GUID COPD DIAGN; Guerra B, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1013-y; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Lawson CA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5489; Maters GA, 2014, COPD, V11, P468, DOI 10.3109/15412555.2014.898026; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Quint JK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005540; Reeves D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004952; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stolz D, 2014, EUR RESPIR J, V44, pP644	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236011	10.1371/journal.pone.0236011	http://dx.doi.org/10.1371/journal.pone.0236011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692772	Green Published, gold, Green Submitted			2022-12-26	WOS:000554606400008
J	Attanasio, S; Ferriero, R; Gernoux, G; De Cegli, R; Carissimo, A; Nusco, E; Campione, S; Teckman, J; Mueller, C; Piccolo, P; Brunetti-Pierri, N				Attanasio, Sergio; Ferriero, Rosa; Gernoux, Gwladys; De Cegli, Rossella; Carissimo, Annamaria; Nusco, Edoardo; Campione, Severo; Teckman, Jeffrey; Mueller, Christian; Piccolo, Pasquale; Brunetti-Pierri, Nicola			CHOP and c-JUN up-regulate the mutant Z alpha(1)-antitrypsin, exacerbating its aggregation and liver proteotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha1-antitrypsin deficiency; CHOP; SERPINA1; c-JUN; liver; liver injury; c-Jun transcription factor; serpin; transcription regulation; alpha1-antitrypsin	ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; PROTEIN-SYNTHESIS; CELL-DEATH; DISEASE; DEFICIENCY; EXPRESSION; INJURY; TRANSCRIPTION; PATHWAY	alpha(1)-Antitrypsin (AAT) encoded by theSERPINA1gene is an acute-phase protein synthesized in the liver and secreted into the circulation. Its primary role is to protect lung tissue by inhibiting neutrophil elastase. The Z allele ofSERPINA1encodes a mutant AAT, named ATZ, that changes the protein structure and leads to its misfolding and polymerization, which cause endoplasmic reticulum (ER) stress and liver disease through a gain-of-function toxic mechanism. Hepatic retention of ATZ results in deficiency of one of the most important circulating proteinase inhibitors and predisposes to early-onset emphysema through a loss-of-function mechanism. The pathogenetic mechanisms underlying the liver disease are not completely understood. C/EBP-homologous protein (CHOP), a transcription factor induced by ER stress, was found among the most up-regulated genes in livers of PiZ mice that express ATZ and in human livers of patients homozygous for the Z allele. Compared with controls, juvenile PiZ/Chop(-/-)mice showed reduced hepatic ATZ and a transcriptional response indicative of decreased ER stress by RNA-Seq analysis. Livers of PiZ/Chop(-/-)mice also showed reducedSERPINA1mRNA levels. By chromatin immunoprecipitations and luciferase reporter-based transfection assays, CHOP was found to up-regulateSERPINA1cooperating with c-JUN, which was previously shown to up-regulateSERPINA1, thus aggravating hepatic accumulation of ATZ. IncreasedCHOPlevels were detected in diseased livers of children homozygous for the Z allele. In summary, CHOP and c-JUN up-regulateSERPINA1transcription and play an important role in hepatic disease by increasing the burden of proteotoxic ATZ, particularly in the pediatric population.	[Attanasio, Sergio; Ferriero, Rosa; De Cegli, Rossella; Nusco, Edoardo; Piccolo, Pasquale; Brunetti-Pierri, Nicola] Telethon Inst Genet & Med, Pozzuoli, Italy; [Gernoux, Gwladys; Mueller, Christian] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Mueller, Christian] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA USA; [Carissimo, Annamaria] CNR, Inst Appl Math Mauro Picone, Naples, Italy; [Campione, Severo] Cardarelli Hosp, Pathol Unit, Naples, Italy; [Teckman, Jeffrey] St Louis Univ, Sch Med, St Louis, MO USA; [Piccolo, Pasquale; Brunetti-Pierri, Nicola] Univ Naples Federico II, Dept Translat Med, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Antonio Cardarelli Hospital; Saint Louis University; University of Naples Federico II	Piccolo, P; Brunetti-Pierri, N (corresponding author), Telethon Inst Genet & Med, Pozzuoli, Italy.; Piccolo, P; Brunetti-Pierri, N (corresponding author), Univ Naples Federico II, Dept Translat Med, Naples, Italy.	piccolo@tigem.it; brunetti@tigem.it	GERNOUX, Gwladys/D-3267-2019; Brunetti-Pierri, Nicola/K-8465-2016	GERNOUX, Gwladys/0000-0002-1268-7001; Brunetti-Pierri, Nicola/0000-0002-6895-8819; Mueller, Christian/0000-0003-3589-8749; Attanasio, Sergio/0000-0003-2576-0834	Fondazione Telethon Italy; Alpha-1 Foundation; Gordon L. Snider Award 2016; "Federico II" University of Naples (STAR Program); Alpha-1-Anti-trypsin Laurell's Training Award (ALTA)	Fondazione Telethon Italy(Fondazione Telethon); Alpha-1 Foundation; Gordon L. Snider Award 2016; "Federico II" University of Naples (STAR Program); Alpha-1-Anti-trypsin Laurell's Training Award (ALTA)	This work was supported by grants from Fondazione Telethon Italy (to N. B.-P.), the Alpha-1 Foundation (research grant (to N. B.-P.) and Gordon L. Snider Award 2016 (to P. P.), and the "Federico II" University of Naples (STAR Program) (to P. P.). S. A. is supported by an Alpha-1-Anti-trypsin Laurell's Training Award (ALTA).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Chu AS, 2016, LIVER TRANSPLANT, V22, P886, DOI 10.1002/lt.24434; Clark VC, 2018, J HEPATOL, V69, P1357, DOI 10.1016/j.jhep.2018.08.005; DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donato LJ, 2012, AM J CLIN PATHOL, V138, P398, DOI 10.1309/AJCPMEEJK32ACYFP; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hubner RH, 2009, AM J RESP CELL MOL, V40, P239, DOI 10.1165/rcmb.2008-0029OC; Kalsheker N, 2002, BIOCHEM SOC T, V30, P93, DOI 10.1042/bst0300093; Lindblad D, 2007, HEPATOLOGY, V46, P1228, DOI 10.1002/hep.21822; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mueller C, 2012, MOL THER, V20, P590, DOI 10.1038/mt.2011.292; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pastore N, 2017, HEPATOLOGY, V65, P1865, DOI 10.1002/hep.29035; Pastore N, 2013, EMBO MOL MED, V5, P397, DOI 10.1002/emmm.201202046; Perlmutter DH, 2006, PEDIATR RES, V60, P233, DOI 10.1203/01.pdr.0000228350.61496.90; Perlmutter DH, 2002, J CLIN INVEST, V110, P1579, DOI 10.1172/JCI200216787; Piccolo P, 2017, HEPATOLOGY, V66, P124, DOI 10.1002/hep.29160; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudnick DA, 2006, HEPATOLOGY, V44, P976, DOI 10.1002/hep.21326; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1988, ACTA PAEDIATR SCAND, V77, P847, DOI 10.1111/j.1651-2227.1988.tb10767.x; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Yang Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01612; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	45	8	8	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13213	13223		10.1074/jbc.RA120.014307	http://dx.doi.org/10.1074/jbc.RA120.014307			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32723872	hybrid, Green Published			2022-12-26	WOS:000574483500007
J	Dall, E; Zauner, FB; Soh, WT; Demir, F; Dahms, SO; Cabrele, C; Huesgen, PF; Brandstetter, H				Dall, Elfriede; Zauner, Florian B.; Soh, Wai Tuck; Demir, Fatih; Dahms, Sven O.; Cabrele, Chiara; Huesgen, Pitter F.; Brandstetter, Hans			Structural and functional studies ofArabidopsis thalianalegumain beta reveal isoform specific mechanisms of activation and substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine protease; crystal structure; pH regulation; transpeptidation; structural biology; plant biochemistry; protein stability	VACUOLAR PROCESSING ENZYME; ASPARAGINYL ENDOPEPTIDASE; PEPTIDE MACROCYCLIZATION; CIRCULAR PROTEINS; LEGUMAIN; SEED; ELECTROSTATICS; PURIFICATION; CYCLOTIDES; LIBRARIES	The vacuolar cysteine protease legumain plays important functions in seed maturation and plant programmed cell death. Because of their dual protease and ligase activity, plant legumains have become of particular biotechnological interest,e.g.for the synthesis of cyclic peptides for drug design or for protein engineering. However, the molecular mechanisms behind their dual protease and ligase activities are still poorly understood, limiting their applications. Here, we present the crystal structure ofArabidopsis thalianalegumain isoform beta (AtLEG beta) in its zymogen state. Combining structural and biochemical experiments, we show for the first time that plant legumains encode distinct, isoform-specific activation mechanisms. Whereas the autocatalytic activation of isoform gamma (AtLEG gamma) is controlled by the latency-conferring dimer state, the activation of the monomeric AtLEG beta is concentration independent. Additionally, in AtLEG beta the plant-characteristic two-chain intermediate state is stabilized by hydrophobic rather than ionic interactions, as in AtLEG gamma, resulting in significantly different pH stability profiles. The crystal structure of AtLEG beta revealed unrestricted nonprime substrate binding pockets, consistent with the broad substrate specificity, as determined by degradomic assays. Further to its protease activity, we show that AtLEG beta exhibits a true peptide ligase activity. Whereas cleavage-dependent transpeptidase activity has been reported for other plant legumains, AtLEG beta is the first example of a plant legumain capable of linking free termini. The discovery of these isoform-specific differences will allow us to identify and rationally design efficient ligases with application in biotechnology and drug development.	[Dall, Elfriede; Zauner, Florian B.; Soh, Wai Tuck; Dahms, Sven O.; Cabrele, Chiara; Brandstetter, Hans] Salzburg Univ, Dept Biosci, Salzburg, Austria; [Demir, Fatih; Huesgen, Pitter F.] Forschungszentrum Julich, Cent Inst Engn Elect & Analyt, ZEA 3, Julich, Germany; [Huesgen, Pitter F.] Univ Cologne, Fac Med, CECAD, Cologne, Germany; [Huesgen, Pitter F.] Univ Cologne, Univ Hosp, Cologne, Germany; [Huesgen, Pitter F.] Univ Cologne, Fac Math & Nat Sci, Inst Biochem, Cologne, Germany	Salzburg University; Helmholtz Association; Research Center Julich; University of Cologne; University of Cologne; University of Cologne	Dall, E; Brandstetter, H (corresponding author), Salzburg Univ, Dept Biosci, Salzburg, Austria.	elfriede.dall@sbg.ac.at; hans.brandstetter@sbg.ac.at	Soh, Wai Tuck/AAN-7188-2020; Huesgen, Pitter/E-9246-2019; Dall, Elfriede/F-1711-2017; Cabrele, Chiara/B-8790-2015; Brandstetter, Hans/E-6754-2011	Soh, Wai Tuck/0000-0003-0082-7983; Huesgen, Pitter/0000-0002-0335-2242; Dall, Elfriede/0000-0002-0823-8983; Cabrele, Chiara/0000-0002-7550-6896; Dahms, Sven/0000-0002-0915-7579; Brandstetter, Hans/0000-0002-6089-3045; Demir, Fatih/0000-0002-5744-0205	Austrian Science Fund (FWF) [W_01213, P31867]; European Research Council; European Union [639905]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission)	This work was primarily supported by the Austrian Science Fund (FWF, project numbers W_01213 and P31867) with additional support by a starting grant of the European Research Council with funding from the European Union's Horizon 2020 program (grant 639905 to P. F. H.).	ABE Y, 1993, J BIOL CHEM, V268, P3525; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BECKER C, 1995, EUR J BIOCHEM, V228, P456, DOI 10.1111/j.1432-1033.1995.tb20284.x; Bernath-Levin K, 2015, CHEM BIOL, V22, P571, DOI 10.1016/j.chembiol.2015.04.010; Biniossek ML, 2016, MOL CELL PROTEOMICS, V15, P2515, DOI 10.1074/mcp.O115.056671; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 2013, CURR OPIN CHEM BIOL, V17, P546, DOI 10.1016/j.cbpa.2013.05.033; Craik DJ, 2012, TOXINS, V4, P139, DOI 10.3390/toxins4020139; Dahms SO, 2019, J THROMB HAEMOST, V17, P470, DOI 10.1111/jth.14384; Dall E, 2018, J BIOL CHEM, V293, P13151, DOI 10.1074/jbc.RA118.002154; Dall E, 2015, ANGEW CHEM INT EDIT, V54, P2917, DOI 10.1002/anie.201409135; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Dall E, 2012, ACTA CRYSTALLOGR F, V68, P24, DOI 10.1107/S1744309111048020; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; Harris KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10199; Hatsugai N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00234; Hemu XY, 2019, P NATL ACAD SCI USA, V116, P11737, DOI 10.1073/pnas.1818568116; Hiraiwa N, 1999, FEBS LETT, V447, P213, DOI 10.1016/S0014-5793(99)00286-0; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04669-9; James AM, 2019, PLANT J, V98, P988, DOI 10.1111/tpj.14293; Julian I, 2013, J EXP BOT, V64, P2929, DOI 10.1093/jxb/ert132; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Lesner A, 2011, CURR PHARM DESIGN, V17, P4308, DOI 10.2174/138161211798999393; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muntz K, 2002, TRENDS PLANT SCI, V7, P340, DOI 10.1016/S1360-1385(02)02298-7; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nakaune S, 2005, PLANT CELL, V17, P876, DOI 10.1105/tpc.104.026872; Nguyen GKT, 2014, NAT CHEM BIOL, V10, P732, DOI [10.1038/NCHEMBIO.1586, 10.1038/nchembio.1586]; Niesen F., 2010, EXCEL SCRIPT ANAL PR; Poncet V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00618; Rinschen MM, 2017, J AM SOC NEPHROL, V28, P2867, DOI 10.1681/ASN.2016101119; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; SHIMADA T, 1994, PLANT CELL PHYSIOL, V35, P713, DOI 10.1093/oxfordjournals.pcp.a078648; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Tiedemann J, 2001, PLANTA, V212, P728, DOI 10.1007/s004250000435; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Vidmar R, 2017, EMBO J, V36, P2455, DOI 10.15252/embj.201796750; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang J, 2001, BIOTECHNIQUES, V31, P722, DOI 10.2144/01314bm01; Weng SSH, 2019, MOL CELL PROTEOMICS, V18, P2335, DOI 10.1074/mcp.TIR119.001560; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada K, 2020, NEW PHYTOL, V226, P21, DOI 10.1111/nph.16306; Zauner FB, 2018, PLANT CELL, V30, P686, DOI 10.1105/tpc.17.00963; Zauner FB, 2018, J BIOL CHEM, V293, P8934, DOI 10.1074/jbc.M117.817031	59	11	11	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					13047	13064		10.1074/jbc.RA120.014478	http://dx.doi.org/10.1074/jbc.RA120.014478			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32719006	Green Published, hybrid			2022-12-26	WOS:000572412900015
J	She, L; Alanazi, HH; Yan, LP; Brooks, EG; Dube, PH; Xiang, Y; Zhang, FS; Sun, YL; Liu, Y; Zhang, X; Li, XD				She, Li; Alanazi, Hamad H.; Yan, Liping; Brooks, Edward G.; Dube, Peter H.; Xiang, Yan; Zhang, Fushun; Sun, Yilun; Liu, Yong; Zhang, Xin; Li, Xiao-Dong			Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; IFN-GAMMA; IMMUNITY; INTERLEUKIN-33; ASTHMA; RECOGNITION; INTERFERON; CYTOKINE; VIRUSES; IL-33	Repeated exposures to environmental allergens in susceptible individuals drive the development of type 2 inflammatory conditions such as asthma, which have been traditionally considered to be mainly mediated by Th2 cells. However, emerging evidence suggest that a new innate cell type, group 2 innate lymphoid cells (ILC2), plays a central role in initiating and amplifying a type 2 response, even in the absence of adaptive immunity. At present, the regulatory mechanisms for controlling ILC2 activation remain poorly understood. Here we report that respiratory delivery of immunogenic extracellular RNA (exRNAs) derived from RNA- and DNA-virus infected cells, was able to activate a protective response against acute type 2 lung immunopathology and airway hyperresponsiveness (AHR) induced by IL-33 and a fungal allergen,A.flavus, in mice. Mechanistically, we found that the innate immune responses triggered by exRNAs had a potent suppressive effectin vivoon the proliferation and function of ILC2 without the involvement of adaptive immunity. We further provided the loss-of-function genetic evidence that the TLR3- and MAVS-mediated signaling axis is essential for the inhibitory effects of exRNAs in mouse lungs. Thus, our results indicate that the host detection of extracellular immunostimulatory RNAs generated during respiratory viral infections have an important function in the regulation of ILC2-driven acute lung inflammation.	[She, Li; Alanazi, Hamad H.; Yan, Liping; Dube, Peter H.; Xiang, Yan; Zhang, Fushun; Sun, Yilun; Li, Xiao-Dong] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA; [She, Li; Liu, Yong; Zhang, Xin] Cent South Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Brooks, Edward G.] Univ Texas Hlth San Antonio, Long Sch Med, Div Immunol & Infect Dis, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Central South University; University of Texas System; University of Texas Health San Antonio	Li, XD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA.	lix8@uthscsa.edu		She, Li/0000-0002-5512-8349; Li, Xiao-Dong/0000-0002-4349-6996; Brooks, Edward/0000-0002-1962-3334; Alanazi, Hamad/0000-0002-5248-1489	China Scholarship Council; Hunan Provincial Innovation Foundation for Postgraduate [CX201713068]; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia; UT Health San Antonio School of Medicine Startup Fund; Max and Minnei Voelcker Fund	China Scholarship Council(China Scholarship Council); Hunan Provincial Innovation Foundation for Postgraduate; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia; UT Health San Antonio School of Medicine Startup Fund; Max and Minnei Voelcker Fund	LS is supported by the China Scholarship Council and Hunan Provincial Innovation Foundation for Postgraduate (CX201713068). HHA is supported by the Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia. X.D.L. is supported by the UT Health San Antonio School of Medicine Startup Fund and the Max and Minnei Voelcker Fund.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Barlow JL, 2019, ANNU REV PHYSIOL, V81, P429, DOI 10.1146/annurev-physiol-020518-114630; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kubo M, 2017, IMMUNOL REV, V278, P162, DOI 10.1111/imr.12557; Kumar A, 2008, GENES IMMUN, V9, P294, DOI 10.1038/gene.2008.17; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Liu L, 2019, NAT IMMUNOL, V20, P1681, DOI 10.1038/s41590-019-0513-z; Lynch JP, 2016, SEMIN RESP CRIT CARE, V37, P586, DOI 10.1055/s-0036-1584923; Maazi H, 2018, J ALLERGY CLIN IMMUN, V141, P893, DOI 10.1016/j.jaci.2017.04.043; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Mahmutovic-Persson I, 2014, ALLERGY, V69, P348, DOI 10.1111/all.12329; Medina JL, 2012, AM J RESP CELL MOL, V46, P815, DOI 10.1165/rcmb.2011-0135OC; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2015, NAT PROTOC, V10, P792, DOI 10.1038/nprot.2015.047; Nakao F, 2001, J ALLERGY CLIN IMMUN, V107, P499, DOI 10.1067/mai.2001.113051; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Pinto LA, 2007, ALLERGY, V62, P1456, DOI 10.1111/j.1398-9995.2007.01479.x; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Stehle C, 2016, NAT IMMUNOL, V17, P43, DOI 10.1038/ni.3353; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Thio CLP, 2019, J ALLERGY CLIN IMMUN, V144, P682, DOI 10.1016/j.jaci.2019.03.008; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Watson A, 2020, AM J RESP CRIT CARE, V201, P83, DOI 10.1164/rccm.201901-0214OC; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009; Zhao Y, 2019, J VIROL, V93, DOI 10.1128/JVI.01085-19; Zhao Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07314-7; Zhu J, 2019, J ALLERGY CLIN IMMUN, V143, P114, DOI 10.1016/j.jaci.2018.04.003	57	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236744	10.1371/journal.pone.0236744	http://dx.doi.org/10.1371/journal.pone.0236744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730309	gold, Green Published			2022-12-26	WOS:000556884700020
J	Gill, S; Sumrell, RM; Sima, A; Cifu, DX; Gorgey, AS				Gill, Satinder; Sumrell, Ryan M.; Sima, Adam; Cifu, David X.; Gorgey, Ashraf S.			Waist circumference cutoff identifying risks of obesity, metabolic syndrome, and cardiovascular disease in men with spinal cord injury	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-COMPOSITION; INDIVIDUALS; ASSOCIATIONS; MANAGEMENT; ADIPOSITY; PROFILE; INDEX	Objectives To apply spinal cord injury (SCI) specific waist circumference (WC) cutoff point to identify risks of 1) obesity, 2) metabolic syndrome (MetS), 3) cardiovascular disease (CVD). Methods Thirty-six men with chronic SCI underwent anthropometric measurements, dual-energy x-ray absorptiometry (DXA), and magnetic resonance imaging (MRI) to measure total and regional adiposity. An SCI specific WC cutoff point of 86.5 cm was applied to the existing general population criteria. Pearson chi-square (chi(2)) analyses tested the difference in the number of participants classified as obese using the SCI specific cutoff point compared to the general population criteria. Sensitivity and specificity analyses relative to percentage body fat mass and visceral adipose tissue was used to assess classification performance of this cutoff point. The interrater reliability for three definitions of MetS was assessed using Cohen's Kappa (kappa) values. Linear regression analyses were utilized to propose SCI specific Framingham Coronary Heart Disease Risk Score (FRS) cutoff value. Results Using SCI specific WC cutoff point of 86.5 cm, 36% of participants were classified as obese compared to only 3% when using WC of 102 cm(P< 0.001). Relative to percentage body fat mass, the general population WC cutoff point of 102 cm had a sensitivity of 6.3% and specificity of 100% both which changed to 68.8% and 90%, respectively, with a SCI specific cutoff point of 86.5 cm. Similar results were obtained when using visceral adipose tissue as a reference. The Kappa (kappa) values improved substantially after using SCI specific criteria (0.95 +/- 0.05) compared to the general population criteria (0.47 +/- 0.28) for three definitions of MetS. The SCI specific FRS cutoff value of 6 was predicted after applying a WC cutoff of 86.5 cm. Conclusions Using the existing general population criteria underestimated persons with SCI who are at risk of developing obesity, MetS, and CVD. The recommended SCI specific criteria are likely to distinguish those at risks of developing comorbidities and allow healthcare providers to intervene in a timely manner.	[Gill, Satinder; Sumrell, Ryan M.; Gorgey, Ashraf S.] Hunter Holmes McGuire VA Med Ctr, Spinal Cord Injury & Disorders, Richmond, VA 23249 USA; [Sima, Adam] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Cifu, David X.; Gorgey, Ashraf S.] Virginia Commonwealth Univ, Phys Med & Rehabil, Richmond, VA 23284 USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Gorgey, AS (corresponding author), Hunter Holmes McGuire VA Med Ctr, Spinal Cord Injury & Disorders, Richmond, VA 23249 USA.; Gorgey, AS (corresponding author), Virginia Commonwealth Univ, Phys Med & Rehabil, Richmond, VA 23284 USA.	ashraf.gorgey@va.gov	Gorgey, Ashraf S/I-5455-2019	Gorgey, Ashraf S/0000-0002-9157-6034	Department of Veteran Affairs, Veteran Health Administration, Rehabilitation Research and Development Service [B7867-W]; DoD-CDRMP [W81XWH-14-SCIRP-CTA]	Department of Veteran Affairs, Veteran Health Administration, Rehabilitation Research and Development Service(US Department of Veterans Affairs); DoD-CDRMP	The study is supported by the Department of Veteran Affairs, Veteran Health Administration, Rehabilitation Research and Development Service (B7867-W (ASG)), and DoD-CDRMP (W81XWH-14-SCIRP-CTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abilmona SM, 2019, SPINAL CORD, V57, P229, DOI 10.1038/s41393-018-0207-7; Alberti KGMM, 2006, DIABETIC MED, V23; Bauman WA, 2008, SPINAL CORD, V46, P466, DOI 10.1038/sj.sc.3102161; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dionyssiotis Y, 2019, J MUSCULOSKEL NEURON, V19, P21; Edwards LA, 2008, AM J CLIN NUTR, V87, P600, DOI 10.1093/ajcn/87.3.600; Farkas GJ, 2019, J SPINAL CORD MED, V42, P430, DOI 10.1080/10790268.2018.1436125; Finnie AK, 2008, SPINAL CORD, V46, P608, DOI 10.1038/sc.2008.21; Gater DR, 2019, J SPINAL CORD MED, V42, P86, DOI 10.1080/10790268.2017.1423266; Gorgey AS, 2018, SPINAL CORD, V56, P987, DOI 10.1038/s41393-018-0079-x; Gorgey AS, 2014, J SPINAL CORD MED, V37, P693, DOI 10.1179/2045772314Y.0000000245; Gorgey AS, 2012, MED SCI SPORT EXER, V44, P165, DOI 10.1249/MSS.0b013e31822672aa; Gorgey AS, 2011, METABOLISM, V60, P843, DOI 10.1016/j.metabol.2010.08.002; Gorgey Ashraf S, 2007, Top Spinal Cord Inj Rehabil, V12, P1, DOI 10.1310/sci1204-1; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Inayama T, 2014, SPINAL CORD, V52, P836, DOI 10.1038/sc.2014.162; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Kocina P, 1997, SPORTS MED, V23, P48, DOI 10.2165/00007256-199723010-00005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laughton GE, 2009, SPINAL CORD, V47, P757, DOI 10.1038/sc.2009.33; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; McCauley LS, 2018, PM&R, V10, P817, DOI 10.1016/j.pmrj.2018.02.007; McCauley LS, 2018, J CLIN DENSITOM; Nash Mark S, 2018, Curr Phys Med Rehabil Rep, V6, P264, DOI 10.1007/s40141-018-0203-z; NHIBI, HIGH BLOOD CHOL EV T; Ravensbergen HJC, 2014, J NEUROTRAUM, V31, P292, DOI 10.1089/neu.2013.3042; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Spungen AM, 2003, J APPL PHYSIOL, V95, P2398, DOI 10.1152/japplphysiol.00729.2002; Sumrell RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203049; Yahiro AM, 2019, J SPINAL CORD MED	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236752	10.1371/journal.pone.0236752	http://dx.doi.org/10.1371/journal.pone.0236752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726371	gold, Green Published			2022-12-26	WOS:000556908900046
J	Zhao, DY; Zhong, GY; Song, GQ				Zhao, Dongyan; Zhong, Gan-yuan; Song, Guo-qing			Transfer of endogenous small RNAs between branches of scions and rootstocks in grafted sweet cherry trees	PLOS ONE			English	Article							LONG-DISTANCE; FT PROTEIN; FLORAL INDUCTION; COMPANION CELLS; MESSENGER-RNA; MOVEMENT; ARABIDOPSIS; SUFFICIENT; CYTOSCAPE; FLORIGEN	Grafting is a well-established agricultural practice in cherry production for clonal propagation, altered plant vigor and architecture, increased tolerance to biotic and abiotic stresses, precocity, and higher yield. Mobile molecules, such as water, hormones, nutrients, DNAs, RNAs, and proteins play essential roles in rootstock-scion interactions. Small RNAs (sRNAs) are 19 to 30-nucleotides (nt) RNA molecules that are a group of mobile signals in plants. Rootstock-to-scion transfer of transgene-derived small interfering RNAs enabled virus resistance in nontransgenic sweet cherry scion. To determine whether there was long-distance scion-to-rootstock transfer of endogenous sRNAs, we compared sRNAs profiles in bud tissues of an ungrafted 'Gisela 6' rootstock, two sweet cherry 'Emperor Francis' scions as well as their 'Gisela 6' rootstocks. Over two million sRNAs were detected in each sweet cherry scion, where 21-nt sRNA (56.1% and 55.8%) being the most abundant, followed by 24-nt sRNAs (13.1% and 12.5%). Furthermore, we identified over three thousand sRNAs that were potentially transferred from the sweet cherry scions to their corresponding rootstocks. In contrast to the sRNAs in scions, among the transferred sRNAs in rootstocks, the most abundant were 24-nt sRNAs (46.3% and 34.8%) followed by 21-nt sRNAs (14.6% and 19.3%). In other words, 21-nt sRNAs had the least transferred proportion out of the total sRNAs in sources (scions) while 24-nt had the largest proportion. The transferred sRNAs were from 574 cherry transcripts, of which 350 had a match from theArabidopsis thalianastandard protein set. The finding that "DNA or RNA binding activity" was enriched in the transcripts producing transferred sRNAs indicated that they may affect the biological processes of the rootstocks at different regulatory levels. Overall, the profiles of the transported sRNAs and their annotations revealed in this study facilitate a better understanding of the role of the long-distance transported sRNAs in sweet cherry rootstock-scion interactions as well as in branch-to-branch interactions in a tree.	[Zhao, Dongyan; Song, Guo-qing] Michigan State Univ, Dept Hort, Plant Biotechnol Resource & Outreach Ctr, E Lansing, MI 48824 USA; [Zhao, Dongyan] Cornell Univ, Biotechnol Ctr, Ithaca, NY USA; [Zhong, Gan-yuan] ARS, Grape Genet Res Unit, USDA, Geneva, NY USA	Michigan State University; Cornell University; United States Department of Agriculture (USDA)	Song, GQ (corresponding author), Michigan State Univ, Dept Hort, Plant Biotechnol Resource & Outreach Ctr, E Lansing, MI 48824 USA.	songg@msu.edu			AgBioResearch of Michigan State University	AgBioResearch of Michigan State University	This research was supported by AgBioResearch of Michigan State University. There was no additional external funding received for this study.	Aguero CB, 2005, MOL PLANT PATHOL, V6, P43, DOI 10.1111/j.1364-3703.2004.00262.x; Alagna F, 2016, J BIOL CHEM, V291, P5542, DOI 10.1074/jbc.M115.701276; Allevato E, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9120828; Andrews S., 2010, FASTQC QUALITY CONTR; Bhogale S, 2014, PLANT PHYSIOL, V164, P1011, DOI 10.1104/pp.113.230714; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Chen QG, 2018, P NATL ACAD SCI USA, V115, P2830, DOI 10.1073/pnas.1719455115; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Dandekar AM, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00084; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Gautier AT, 2019, J EXP BOT, V70, P747, DOI 10.1093/jxb/ery422; Goldschmidt EE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00727; Golecki B, 1998, PLANTA, V206, P630, DOI 10.1007/s004250050441; Gutzwiler J, 2001, ACTA HORTIC, P321, DOI 10.17660/ActaHortic.2001.557.42; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harada T, 2010, SCI HORTIC-AMSTERDAM, V125, P545, DOI 10.1016/j.scienta.2010.05.013; Haroldsen VM, 2012, J FRONTIERS PLANT SC, V3, P1, DOI DOI 10.3389/FPLS.2012.00001; Huang NC, 2018, PLANT PHYSIOL, V178, P783, DOI 10.1104/pp.18.00725; Hudson WH, 2014, NAT REV MOL CELL BIO, V15, P749, DOI 10.1038/nrm3884; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kalantidis K, 2008, BIOL CELL, V100, P13, DOI 10.1042/BC20070079; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li JX, 2013, J EXP BOT, V64, P4851, DOI 10.1093/jxb/ert266; Lu KJ, 2012, RNA BIOL, V9, P653, DOI 10.4161/rna.19965; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Melnyk CW, 2011, EMBO J, V30, P3553, DOI 10.1038/emboj.2011.274; Molnar A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2010-11-12-219; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mudge K., 2009, Horticultural Reviews, V35, P437; Notaguchi M, 2008, PLANT CELL PHYSIOL, V49, P1645, DOI 10.1093/pcp/pcn154; Omid A, 2007, J EXP BOT, V58, P3645, DOI 10.1093/jxb/erm214; Prodhomme D, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2055-9; Putterill J, 2016, CURR OPIN PLANT BIOL, V33, P77, DOI 10.1016/j.pbi.2016.06.008; Sarkies P, 2014, NAT REV MOL CELL BIO, V15, P525, DOI 10.1038/nrm3840; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song GQ, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0188-5; Song GQ, 2015, J AM SOC HORTIC SCI, V140, P203, DOI 10.21273/JASHS.140.3.203; Spiegelman Z, 2013, PLANT SCI, V213, P1, DOI 10.1016/j.plantsci.2013.08.011; Taller J, 1998, THEOR APPL GENET, V97, P705, DOI 10.1007/s001220050946; Tamaki S, 2015, P NATL ACAD SCI USA, V112, pE901, DOI 10.1073/pnas.1417623112; Tiedemann R., 1994, J PLANT PHYSL, DOI [10.1016/s0176-1617(11)80663-2, DOI 10.1016/S0176-1617(11)80663-2]; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Yoo SJ, 2013, PLANT CELL PHYSIOL, V54, P119, DOI 10.1093/pcp/pcs158; Zamboni A, 2008, IFOREST, V1, P122, DOI 10.3832/ifor0465-0010122; Zhao DY, 2014, PLANT BIOTECHNOL J, V12, P1319, DOI 10.1111/pbi.12243; Zhu Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.75, 10.1038/nplants.2016.75]	51	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236376	10.1371/journal.pone.0236376	http://dx.doi.org/10.1371/journal.pone.0236376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722723	Green Published, gold			2022-12-26	WOS:000556916000010
J	Jung, H; Seo, SB				Jung, Hyeonsoo; Seo, Sang-Beom			Histone lysine demethylase 3B (KDM3B) regulates the propagation of autophagy via transcriptional activation of autophagy-related genes	PLOS ONE			English	Article							TRANS-RETINOIC ACID; EPIGENETIC REGULATION; METHYLTRANSFERASE; INHIBITION; VCP/P97; CANCER; MTOR; MECHANISM; DISEASE; PROTEIN	Autophagy, a self-degradative physiological process, is critical for homeostasis maintenance and energy source balancing in response to various stresses, including nutrient deprivation. It is a highly conserved catabolic process in eukaryotes and is indispensable for cell survival as it involves degradation of unessential or excessive components and their subsequent recycling as building blocks for the synthesis of necessary molecules. Although the dysregulation of autophagy has been reported to broadly contribute to various diseases, including cancers and neurodegenerative diseases, the molecular mechanisms underlying the epigenetic regulation of autophagy are poorly elucidated. Here, we report that the level of lysine demethylase 3B (KDM3B) increases in nutrient-deprived HCT116 cells, a colorectal carcinoma cell line, resulting in transcriptional activation of the autophagy-inducing genes. KDM3B was found to enhance the transcription by demethylating H3K9me2 on the promoter of these genes. Furthermore, we observed that the depletion of KDM3B inhibited the autophagic flux in HCT116 cells. Collectively, these data suggested the critical role of KDM3B in the regulation of autophagy-related genes via H3K9me2 demethylation and induction of autophagy in nutrient-starved HCT116 cells.	[Jung, Hyeonsoo; Seo, Sang-Beom] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea	Chung Ang University	Seo, SB (corresponding author), Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea.	sangbs@cau.ac.kr		Seo, Sang Beom/0000-0003-4709-6022	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2019R1A4A2001609, NRF-2017R1A2B4004407]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2019R1A4A2001609 and NRF-2017R1A2B4004407) to Sang Beom Seo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MJ, 2019, BIOCHEM BIOPH RES CO, V508, P576, DOI 10.1016/j.bbrc.2018.11.179; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Baek SH, 2017, MOL CELL, V65, P781, DOI 10.1016/j.molcel.2016.12.027; Chen S, 2017, NUCLEIC ACIDS RES, V45, P1144, DOI 10.1093/nar/gkw1025; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Ichimura Y, 2010, SEMINARS IMMUNOPATHO; Jung H, 2017, SCI REP-UK, V7, DOI 10.1038/srep46182; Kang JY, 2018, FASEB J, V32, P5737, DOI 10.1096/fj.201800242R; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Levy JMM, 2014, CANCER DISCOV, V4, P773, DOI 10.1158/2159-8290.CD-14-0049; LI J, 2017, NATURE COMMUNICATION, V8, DOI DOI 10.1038/NCOMMS1514628440295; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Maycotte P, 2014, CANCER RES, V74, P2579, DOI 10.1158/0008-5472.CAN-13-3470; Meyer H., 2014, VCP P97 SYSTEM GLANC; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pyo JO, 2012, EXP MOL MED, V44, P73, DOI 10.3858/emm.2012.44.2.029; Savickiene J, 2012, CELL MOL BIOL LETT, V17, P501, DOI 10.2478/s11658-012-0024-5; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Shin HJR, 2016, NATURE, V534, P553, DOI 10.1038/nature18014; Tam RCY, 2017, EXP CELL RES, V352, P304, DOI 10.1016/j.yexcr.2017.02.017; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Verma M., 2018, EPIGENETICS AGING LO, P439, DOI DOI 10.1016/B978-0-12-811060-7.00021-8; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wei FZ, 2015, AUTOPHAGY, V11, P2309, DOI 10.1080/15548627.2015.1117734; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Wu FQ, 2016, J HEPATOL, V65, P314, DOI 10.1016/j.jhep.2016.04.019; Yin PQ, 2017, VIROL SIN, V32, P245, DOI 10.1007/s12250-016-3914-2; Zhang H, 2018, AUTOPHAGY	44	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236403	10.1371/journal.pone.0236403	http://dx.doi.org/10.1371/journal.pone.0236403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716961	gold, Green Published			2022-12-26	WOS:000556674500048
J	Strong, MD; Hart, MD; Tang, TZ; Ojo, BA; Wu, L; Nacke, MR; Agidew, WT; Hwang, HJ; Hoyt, PR; Bettaieb, A; Clarke, SL; Smith, BJ; Stoecker, BJ; Lucas, EA; Lin, DB; Chowanadisai, W				Strong, Morgan D.; Hart, Matthew D.; Tang, Tony Z.; Ojo, Babajide A.; Wu, Lei; Nacke, Mariah R.; Agidew, Workneh T.; Hwang, Hong J.; Hoyt, Peter R.; Bettaieb, Ahmed; Clarke, Stephen L.; Smith, Brenda J.; Stoecker, Barbara J.; Lucas, Edralin A.; Lin, Dingbo; Chowanadisai, Winyoo			Role of zinc transporter ZIP12 in susceptibility-weighted brain magnetic resonance imaging (MRI) phenotypes and mitochondrial function	FASEB JOURNAL			English	Article						metal homeostasis; mitochondria; neurite outgrowth; neurodegeneration; nutrigenomics	ALPHA-SYNUCLEIN OVEREXPRESSION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; IRON ACCUMULATION; MISSENSE VARIANT; TRANSGENIC MICE; GENE VARIANTS; COMPLEX-I; NEURODEGENERATION; DYSFUNCTION	Brain zinc dysregulation is linked to many neurological disorders. However, the mechanisms regulating brain zinc homeostasis are poorly understood. We performed secondary analyses of brain MRI GWAS and exome sequencing data from adults in the UK Biobank. Coding ZIP12 polymorphisms in zinc transporter ZIP12 (SLC39A12)were associated with altered brain susceptibility weighted MRI (swMRI). Conditional and joint association analyses revealed independent GWAS signals in linkage disequilibrium with 2 missense ZIP12 polymorphisms, rs10764176 and rs72778328, with reduced zinc transport activity. ZIP12 rare coding variants predicted to be deleterious were associated with similar impacts on brain swMRI. In Neuro-2a cells, ZIP12 deficiency by short hairpin RNA (shRNA) depletion or CRISPR/Cas9 genome editing resulted in impaired mitochondrial function, increased superoxide presence, and detectable protein carbonylation. Inhibition of Complexes I and IV of the electron transport chain reduced neurite outgrowth in ZIP12 deficient cells. Transcriptional coactivator PGC-1 alpha, mitochondrial superoxide dismutase (SOD2), and chemical antioxidants alpha-tocopherol, MitoTEMPO, and MitoQ restored neurite extension impaired by ZIP12 deficiency. Mutant forms of alpha-synuclein and tau linked to familial Parkinson's disease and frontotemporal dementia, respectively, reduced neurite outgrowth in cells deficient in ZIP12. Zinc and ZIP12 may confer resilience against neurological diseases or premature aging of the brain.	[Strong, Morgan D.; Hart, Matthew D.; Tang, Tony Z.; Ojo, Babajide A.; Wu, Lei; Nacke, Mariah R.; Agidew, Workneh T.; Clarke, Stephen L.; Smith, Brenda J.; Stoecker, Barbara J.; Lucas, Edralin A.; Lin, Dingbo; Chowanadisai, Winyoo] Oklahoma State Univ, Dept Nutr Sci, 301 Human Sci, Stillwater, OK 74078 USA; [Hwang, Hong J.; Hoyt, Peter R.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Bettaieb, Ahmed] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Tennessee System; University of Tennessee Knoxville	Chowanadisai, W (corresponding author), Oklahoma State Univ, Dept Nutr Sci, 301 Human Sci, Stillwater, OK 74078 USA.	winyoo.chowanadisai@okstate.edu	Wu, Lei/GLV-1137-2022	Wu, Lei/0000-0002-6070-1998; Smith, Brenda/0000-0002-7296-8534; Lin, Dingbo/0000-0002-7441-8210; , Stephen/0000-0001-8313-9638; Hoyt, Peter/0000-0002-2767-0923	Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR16-060]; Office of the Vice President of Research at Oklahoma State University; Oklahoma Agricultural Experiment Station (OAES) [OKL03053]; National Science Foundation (NSF) [DBI 1626257, OCI 1531128, OCI 1039829]; Niblack Foundation; Oak Ridge National Laboratory	Oklahoma Center for the Advancement of Science and Technology (OCAST); Office of the Vice President of Research at Oklahoma State University; Oklahoma Agricultural Experiment Station (OAES); National Science Foundation (NSF)(National Science Foundation (NSF)); Niblack Foundation; Oak Ridge National Laboratory(United States Department of Energy (DOE))	Oklahoma Center for the Advancement of Science and Technology (OCAST), Grant/Award Number: HR16-060; Office of the Vice President of Research at Oklahoma State University; Oklahoma Agricultural Experiment Station (OAES), Grant/Award Number: OKL03053; National Science Foundation (NSF), Grant/Award Number: DBI 1626257, OCI 1531128 and OCI 1039829; Niblack Foundation; Oak Ridge National Laboratory	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALI SF, 1994, SYNAPSE, V18, P27, DOI 10.1002/syn.890180105; Alizadeh BZ, 2009, NEUROBIOL AGING, V30, P330, DOI 10.1016/j.neurobiolaging.2007.05.026; Anazi S, 2017, MOL PSYCHIATR, V22, P615, DOI 10.1038/mp.2016.113; Aoun M, 2015, INT J BIOCHEM CELL B, V63, P25, DOI 10.1016/j.biocel.2015.01.018; Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793; Baldauf L, 2019, NEUROSCI LETT, V713, DOI 10.1016/j.neulet.2019.134521; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BarKalifa R, 2009, EUR J PHARMACOL, V618, P15, DOI 10.1016/j.ejphar.2009.07.019; BARTZOKIS G, 1994, BIOL PSYCHIAT, V35, P480, DOI 10.1016/0006-3223(94)90047-7; Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6; Bartzokis G, 2010, J ALZHEIMERS DIS, V20, P333, DOI 10.3233/JAD-2010-1368; Belaidi AA, 2016, J NEUROCHEM, V139, P179, DOI 10.1111/jnc.13425; Benyamin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5926; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blankenhaus B, 2019, MOL METAB, V24, P64, DOI 10.1016/j.molmet.2019.03.008; Bly M, 2006, SCHIZOPHR RES, V81, P321, DOI 10.1016/j.schres.2005.07.039; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonanni L, 2006, J NEUROSCI, V26, P6851, DOI 10.1523/JNEUROSCI.5444-05.2006; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Carrera N, 2012, BIOL PSYCHIAT, V71, P169, DOI 10.1016/j.biopsych.2011.09.032; Chen LA, 2015, J NEUROSCI, V35, P890, DOI 10.1523/JNEUROSCI.0089-14.2015; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Chowanadisai W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111535; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Cirulli ET, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14288-y; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Cummins N, 2019, EMBO J, V38, DOI 10.15252/embj.201899360; Dallabona C, 2016, BRAIN, V139, P782, DOI 10.1093/brain/awv392; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7; Fadista J, 2016, EUR J HUM GENET, V24, P1202, DOI 10.1038/ejhg.2015.269; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finkelstein DI, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0456-2; Frohnert BI, 2013, ADV NUTR, V4, P157, DOI 10.3945/an.112.003319; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; GEYER CA, 1988, J COMPUT ASSIST TOMO, V12, P40, DOI 10.1097/00004728-198801000-00006; Gholap DS, 2010, ANAL CHIM ACTA, V664, P19, DOI 10.1016/j.aca.2010.01.052; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Hagemeier J, 2018, NEUROIMAGE-CLIN, V17, P530, DOI 10.1016/j.nicl.2017.11.003; Haller G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06705-0; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hayflick S.J., 2018, HDB CLIN NEUROLOGY, V147, P293, DOI [10.1016/b978-0-444-63233-3.00019-1, DOI 10.1016/B978-0-444-63233-3.00019-1]; Hayflick SJ, 2006, AM J NEURORADIOL, V27, P1230; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hingwala DR, 2013, CLIN RADIOL, V68, pE338, DOI 10.1016/j.crad.2012.12.003; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Invernizzi F, 2013, HUM MUTAT, V34, P1619, DOI 10.1002/humu.22441; Jurgens Caroline K, 2010, PLoS Curr, V2, DOI 10.1371/currents.RRN1173; Kamens J, 2015, NUCLEIC ACIDS RES, V43, pD1152, DOI 10.1093/nar/gku893; Kanda T, 2016, JPN J RADIOL, V34, P258, DOI 10.1007/s11604-016-0532-8; Kartikasalwah Al, 2010, Biomed Imaging Interv J, V6, pe6, DOI 10.2349/biij.6.1.e6; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim Y, 2019, ANTIOXID REDOX SIGN, V31, P275, DOI 10.1089/ars.2018.7606; Kmita K, 2015, P NATL ACAD SCI USA, V112, P5685, DOI 10.1073/pnas.1424353112; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Langley J, 2017, MOVEMENT DISORD, V32, P441, DOI 10.1002/mds.26883; Lee JH, 2011, J MOV DISORD, V4, P60, DOI 10.14802/jmd.11012; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li DL, 2016, GASTROENTEROLOGY, V151, P724, DOI 10.1053/j.gastro.2016.06.051; Li HL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.169797; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Q., 2016, ER GOLGI APPARATUS, V8, P35; Luo S, 2018, NEUROL SCI, V39, P1049, DOI 10.1007/s10072-018-3324-3; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mattson MP, 1999, J NEUROSCI RES, V56, P8, DOI 10.1002/(SICI)1097-4547(19990401)56:1<8::AID-JNR2>3.3.CO;2-7; Mehemed TM, 2013, AM J NEURORADIOL, V34, pE72, DOI 10.3174/ajnr.A3571; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miranda JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049371; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; MUTISYA EM, 1994, J NEUROCHEM, V63, P2179; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ning Z, 2017, AM J HUM GENET, V101, P903, DOI 10.1016/j.ajhg.2017.09.027; Ojo B, 2016, J NUTR, V146, P1483, DOI 10.3945/jn.115.226688; Perfeito R, 2014, MOL CELL NEUROSCI, V62, P51, DOI 10.1016/j.mcn.2014.08.002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riley LG, 2017, J INHERIT METAB DIS, V40, P261, DOI 10.1007/s10545-016-0010-6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roelofs BA, 2015, FREE RADICAL BIO MED, V86, P250, DOI 10.1016/j.freeradbiomed.2015.05.032; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Sampietro M, 2001, NEUROBIOL AGING, V22, P563, DOI 10.1016/S0197-4580(01)00219-6; Scarr E, 2016, NPJ SCHIZOPHR, V2, DOI 10.1038/npjschz.2016.2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott I, 2014, J BIOL CHEM, V289, P2864, DOI 10.1074/jbc.M113.521641; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902; Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Szabados T, 2004, BEHAV BRAIN RES, V154, P31, DOI 10.1016/j.bbr.2004.01.016; Tsushima Y, 2006, CURR PROBL DIAGN RAD, V35, P140, DOI 10.1067/j.cpradiol.2006.04.002; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Wang DF, 2018, SCIENCE, V362, P333, DOI 10.1126/science.aao1797; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wolansky LJ, 1999, AM J NEURORADIOL, V20, P1653; Wu L, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600576; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14868-x; Zarb Y, 2019, BRAIN, V142, P885, DOI 10.1093/brain/awz032; Zhang G, 2018, J MOL CELL CARDIOL, V118, P169, DOI 10.1016/j.yjmcc.2018.03.019; Zhao L, 2015, NATURE, V524, P356, DOI 10.1038/nature14620; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	139	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12702	12725		10.1096/fj.202000772R	http://dx.doi.org/10.1096/fj.202000772R		JUL 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716562	Bronze			2022-12-26	WOS:000556423800001
J	Modzelewska, D; Sole-Navais, P; Zhang, G; Muglia, LJ; Nilsson, S; Jacobsson, B				Modzelewska, Dominika; Sole-Navais, Pol; Zhang, Ge; Muglia, Louis J.; Nilsson, Staffan; Jacobsson, Bo			Importance of the environment for gestational duration variability and correlation between relatives - results from the Medical Swedish Birth Registry, 1973-2012	PLOS ONE			English	Article							PRETERM BIRTH; AGE BIRTH; DELIVERY; WEIGHT; COHORT; HERITABILITY; SUBGROUPS; PATTERNS; MOTHER; SWEDEN	It has been suggested that the intergenerational associations in gestational age at delivery are considerably affected by temporal changes in the environmental conditions. We explored whether changing environment affects familial resemblance of gestational age at delivery. Understanding how correlation changes in different settings allows to design better studies aimed to detect genes and environmental factors involved in the parturition process. The Swedish Medical Birth Register was used to retrieve births during 1973-2012. In total, 454,433 parent-child, 2,247,062 full sibling, 405,116 maternal half-sibling and 469,995 paternal half-sibling pairs were identified. A decreasing trend in correlation, associated with increasing age gaps, was observed among all siblings, with the largest drop for full siblings, from rho = 0.32 (95% confidence interval (CI): 0.31, 0.33) for full siblings with one-year gap to rho = 0.16 (95% CI: 0.10, 0.22) for full siblings with age gap above 20 years. A variation in association between full siblings born up to two years apart was observed; estimate rho = 0.28 (95% CI: 0.26, 0.3) in 1973, and rho = 0.36 (95% CI: 0.33, 0.38) in 2012. Observed variability in the association in gestational age at delivery between the relatives with respect to their birth year or age gap suggests the existence of temporally changing environmental factors.	[Modzelewska, Dominika; Sole-Navais, Pol; Jacobsson, Bo] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Zhang, Ge; Muglia, Louis J.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet,Coll Med, Cincinnati, OH USA; [Zhang, Ge; Muglia, Louis J.] Cincinnati Childrens Hosp Med Ctr, Ctr Prevent Preterm Birth, Cincinnati, OH USA; [Muglia, Louis J.] Burroughs Wellcome Fund, Off President, Res Triangle Pk, NC USA; [Nilsson, Staffan] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Norwegian Inst Publ Hlth, Dept Genet & Bioinformat, Div Hlth Data & Digitalizat, Oslo, Norway	University of Gothenburg; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Burroughs Wellcome Fund; Chalmers University of Technology; Sahlgrenska University Hospital; Norwegian Institute of Public Health (NIPH)	Modzelewska, D (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden.	dominika.modzelewska@gu.se	Jacobsson, Bo/ABF-3231-2020; Jacobsson, Bo/O-8007-2014	Jacobsson, Bo/0000-0001-5079-2374; Jacobsson, Bo/0000-0001-5079-2374; Sole-Navais, Pol/0000-0002-3326-266X; Nilsson, Staffan/0000-0003-4748-0446	Swedish government [ALFGBG-717501, ALFGBG-507701, ALFGBG426411]; Swedish Research Council [2015-02559]; March of Dimes Foundation [21-FY16-121]; Burroughs Wellcome Fund Preterm Birth Research Grant [10172896]; March of Dimes Prematurity Research Center Ohio Collaborative	Swedish government; Swedish Research Council(Swedish Research CouncilEuropean Commission); March of Dimes Foundation(March of Dimes); Burroughs Wellcome Fund Preterm Birth Research Grant; March of Dimes Prematurity Research Center Ohio Collaborative(March of Dimes)	BJ: 1. Swedish government grants to researchers in the public health sector, grants no.: ALFGBG-717501, ALFGBG-507701, ALFGBG426411, URL: https://www.vr.se 2. The Swedish Research Council, grants no. 2015-02559, URL: https://www.vr.se, 3. The March of Dimes Foundation, grant no.: 21-FY16-121, URL: https://www.marchofdimes.org 4. The Burroughs Wellcome Fund Preterm Birth Research Grant, grants no.: 10172896, URL: https://www.bwfund.org LM: 1. The March of Dimes Prematurity Research Center Ohio Collaborative, URL: https://www.marchofdimes.org	Althabe F., 2012, BORN TOO SOON GLOBAL; Bergsjo P, 1990, ACTA OBSTET GYN SCAN, V69, P197, DOI 10.3109/00016349009028681; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Bladh M, 2015, TWIN RES HUM GENET, V18, P581, DOI 10.1017/thg.2015.60; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; Castrillio SM, 2014, MATERN CHILD HLTH J, V18, P2456, DOI 10.1007/s10995-014-1484-1; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; De Stavola BL, 2011, AM J EPIDEMIOL, V174, P52, DOI 10.1093/aje/kwr032; Hennessy E, 1998, PAEDIATR PERINAT EP, V12, P61, DOI 10.1046/j.1365-3016.1998.0120s1061.x; Kallen B., 2003, SWEDISH MED BIRTH RE; Klebanoff MA, 1997, AM J OBSTET GYNECOL, V176, P521, DOI 10.1016/S0002-9378(97)70540-4; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; MAGNUS P, 1993, ANN HUM BIOL, V20, P231, DOI 10.1080/03014469300002662; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Morken NH, 2005, ACTA OBSTET GYN SCAN, V84, P558, DOI 10.1111/j.0001-6349.2005.00765.x; Morken NH, 2008, ACTA OBSTET GYN SCAN, V87, P1374, DOI 10.1080/00016340802491508; Morken Nils-Halvdan, 2008, BMC Womens Health, V8, P16, DOI 10.1186/1472-6874-8-16; Murray SR, 2019, ACTA OBSTET GYN SCAN, V98, P106, DOI 10.1111/aogs.13455; Nguyen TH, 1999, ULTRASOUND OBST GYN, V14, P23, DOI 10.1046/j.1469-0705.1999.14010023.x; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009; Selling KE, 2006, BJOG-INT J OBSTET GY, V113, P430, DOI 10.1111/j.1471-0528.2006.00872.x; Smid MC, 2017, AM J OBSTET GYNECOL, V217; Stephansson O, 2015, ANN REPORT; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Wu W, 2015, HUM GENET, V134, P803, DOI 10.1007/s00439-015-1558-1; York TP, 2015, HUM GENET, V134, P809, DOI 10.1007/s00439-015-1574-1; York TP, 2013, AM J EPIDEMIOL, V178, P543, DOI 10.1093/aje/kwt005; Zhang G, 2017, NEW ENGL J MED, V377, P1156, DOI 10.1056/NEJMoa1612665	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236494	10.1371/journal.pone.0236494	http://dx.doi.org/10.1371/journal.pone.0236494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706811	Green Published, gold			2022-12-26	WOS:000579931700047
J	Melendez-Rosa, J; Bi, K; Lacey, EA				Melendez-Rosa, Jesyka; Bi, Ke; Lacey, Eileen A.			Mating system is correlated with immunogenetic diversity in sympatric species of Peromyscine mice	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MHC-DQA LOCUS; GENETIC DRIFT; PHYLOGENETIC ANALYSIS; BALANCING SELECTION; ALLELIC DIVERSITY; MATE CHOICE; R-PACKAGE; POPULATIONS; EVOLUTION	The number of reproductive partners per individual varies markedly across animal mating systems. This variation may be an important determinant of patterns of immunogenetic diversity, particularly at Major Histocompatibility Complex (MHC) Class I and II loci. To compare immunogenetic variation in taxa with markedly different mating systems, we used RNAseq-generated data to quantify genotypic diversity in three species of Peromyscine rodents: the monogamous California mouse (Peromyscus californicus) and the polygynandrous deer mouse (P. maniculatus) and brush mouse (P. boylii). By sampling populations of these species from multiple localities in California, we were able to conduct replicated analyses of the relationship between mating system and immunogenetic variation. Across the four localities sampled, diversity at MHC Class I and II genes was consistently higher in the two polygynandrous species. We found no evidence that sampling location (i.e., variation in habitat conditions) contributed to observed differences in MHC variation among populations or species. Collectively, our data indicate that immunogenetic variation in Peromyscine mice is associated with reproductive behavior, rather than geographic locality or habitat type. The consistently greater variability detected in the polygynandrous species examined suggests that balancing selection imposed by behaviorally-mediated pathogen exposure is important in maintaining variation at MHC genes in these animals.	[Melendez-Rosa, Jesyka; Lacey, Eileen A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Melendez-Rosa, Jesyka; Bi, Ke; Lacey, Eileen A.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Bi, Ke] Univ Calif Berkeley, Computat Genom Resource Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Melendez-Rosa, J (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	jesykamelendez@gmail.com			National Science Foundation Doctoral Dissertation Improvement Grant [NSF-DDIG: IOS - 1502063]; National Science Foundation Postdoctoral Research Fellowship in Biology [NSF-PRFB: DBI - 1811008]; Museum of Vertebrate Zoology at UC Berkeley; American Society of Mammologists; University of California Natural Reserve System; NIH [S10 OD018174]	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); National Science Foundation Postdoctoral Research Fellowship in Biology; Museum of Vertebrate Zoology at UC Berkeley; American Society of Mammologists; University of California Natural Reserve System; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Science Foundation Doctoral Dissertation Improvement Grant (NSF-DDIG: IOS -1502063) (https://www.nsf.gov) and a National Science Foundation Postdoctoral Research Fellowship in Biology (NSF-PRFB: DBI -1811008) (https://www.nsf.gov) to JMR. The work was further supported by small grants from the Museum of Vertebrate Zoology at UC Berkeley (http://mvz.berkeley.edu/), the American Society of Mammologists (http://www.mammalsociety.org/), and the University of California Natural Reserve System (https://ucnrs.org/) made to JMR. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Amills M, 2008, GENES IMMUN, V9, P651, DOI 10.1038/gene.2008.62; [Anonymous], 2014, J APPL ECOL, DOI [DOI 10.1111/1365-2664.12306, DOI 10.1016/S0167-8809(99)00024-9]; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; BIRDSALL DA, 1973, EVOLUTION, V27, P106, DOI 10.1111/j.1558-5646.1973.tb05922.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradley RD, 2007, J MAMMAL, V88, P1146, DOI 10.1644/06-MAMM-A-342R.1; Capittini C, MHC VARIATION MATE C, P12; Chessel D., 2004, R NEWS, V4, P5; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; de Bellocq JG, 2005, GLOBAL ECOL BIOGEOGR, V14, P115, DOI 10.1111/j.1466-822X.2005.00143.x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Excoffier L, 1992, ANAL MOL VARIANCE IN, V13; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; FOLTZ DW, 1981, AM NAT, V117, P665, DOI 10.1086/283751; Galavemi M, 2016, J HERED, V107, P134, DOI 10.1093/jhered/esv090; Garrigan D, 2003, EVOLUTION, V57, P1707; Grinnell J, 1913, U CALIFORNIA PUBLICA, V10, P197; GRINNELL JOSEPH, 1934, JOUR MAMMAL, V15, P210, DOI 10.2307/1373853; Hedrick PW., 1999, GENETICA, V104, P104; Jameson E. W., 2004, MAMMALS CALIFORNIA; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kalcounis-Rueppell Matina C., 2009, Mammalian Species, P1, DOI 10.1644/838.1; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Karvonen Anssi, 2012, International Journal of Ecology, P1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; King J.A., 1968, SPECIAL PUBLICATION, V2; Klein J, 1993, ANNU REV IMMUNOL, V27; Klein J., 1998, ENCY IMMUNOLOGY, P1700; Knafler GJ, 2012, J HERED, V103, P759, DOI 10.1093/jhered/ess054; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; MacManes MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037562; MacManes MD, 2011, NATURWISSENSCHAFTEN, V98, P951, DOI 10.1007/s00114-011-0848-2; Melendez-Rosa J, 2019, ECOL EVOL, V9, P5975, DOI 10.1002/ece3.5181; Melendez-Rosa J, 2018, BEHAV ECOL, V29, P1167, DOI 10.1093/beheco/ary096; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pfau RS, 1999, IMMUNOGENETICS, V49, P886, DOI 10.1007/s002510050569; Ramsey E, 2011, INT J ENTREP BEHAV R, V17, DOI 10.1108/ijebr.2011.16017baa.001; RIBBLE DO, 1990, BEHAV ECOL SOCIOBIOL, V26, P9; RIBBLE DO, 1991, BEHAV ECOL SOCIOBIOL, V29, P161, DOI 10.1007/BF00166397; Richman AD, 2003, GENET RES, V82, P89, DOI 10.1017/S0016672303006347; Richman AD, 2003, GENETICS, V164, P289, DOI 10.1016/S0065-2660(03)50015-3; Richman AD, 2001, MOL ECOL, V10, P2765, DOI 10.1046/j.0962-1083.2001.01402.x; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Singhal S, 2013, MOL ECOL RESOUR, V13, P403, DOI 10.1111/1755-0998.12077; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; Sommer S, 2005, BEHAV ECOL SOCIOBIOL, V58, P181, DOI 10.1007/s00265-005-0909-7; Sommer S, 2002, BEHAV ECOL SOCIOBIOL, V51, P214, DOI 10.1007/S00265-001-0432-4; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Star B, 2013, GENETICS, V194, P235, DOI 10.1534/genetics.113.149781; Strand TM, 2012, ECOL EVOL, V2, P341, DOI 10.1002/ece3.86; Tajima F., 1989, STAT METHODFOR TESTI, V11; Tobler M, 2014, J EVOLUTION BIOL, V27, P960, DOI 10.1111/jeb.12370; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	77	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236084	10.1371/journal.pone.0236084	http://dx.doi.org/10.1371/journal.pone.0236084			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701975	Green Published, gold			2022-12-26	WOS:000575913700047
J	Onimaru, K; Nishimura, O; Kuraku, S				Onimaru, Koh; Nishimura, Osamu; Kuraku, Shigehiro			Predicting gene regulatory regions with a convolutional neural network for processing double-strand genome sequence information	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DNA ELEMENTS; DEEP; ENCYCLOPEDIA; BINDING; CTCF	With advances in sequencing technology, a vast amount of genomic sequence information has become available. However, annotating biological functions particularly of non-protein-coding regions in genome sequences without experiments is still a challenging task. Recently deep learning-based methods were shown to have the ability to predict gene regulatory regions from genome sequences, promising to aid the interpretation of genomic sequence data. Here, we report an improvement of the prediction accuracy for gene regulatory regions by using the design of convolution layers that efficiently process genomic sequence information, and developed a software, DeepGMAP, to train and compare different deep learning-based models (https://github.com/koonimaru/DeepGMAP). First, we demonstrate that our convolution layers, termed forward- and reverse-sequence scan (FRSS) layers, integrate both forward and reverse strand information, and enhance the power to predict gene regulatory regions. Second, we assessed previous studies and identified problems associated with data structures that caused overfitting. Finally, we introduce visualization methods to examine what the program learned. Together, our FRSS layers improve the prediction accuracy for gene regulatory regions.	[Onimaru, Koh; Nishimura, Osamu; Kuraku, Shigehiro] RIKEN, Ctr Biosyst Dynam Res BDR, Lab Phyloinformat, Chuo Ku, Kobe, Hyogo, Japan	RIKEN	Onimaru, K (corresponding author), RIKEN, Ctr Biosyst Dynam Res BDR, Lab Phyloinformat, Chuo Ku, Kobe, Hyogo, Japan.	koh.onimaru@riken.jp	Kuraku, Shigehiro/B-2801-2009; Onimaru, Koh/AAB-4923-2019; Onimaru, Koh/K-5289-2014	Kuraku, Shigehiro/0000-0003-1464-8388; Nishimura, Osamu/0000-0003-1969-2580; Onimaru, Koh/0000-0002-2428-9510	JSPS KAKENHI [17K15132]; Special Postdoctoral Researcher Program of RIKEN; MEXT	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Special Postdoctoral Researcher Program of RIKEN; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by JSPS KAKENHI grant number 17K15132 to KO, a Special Postdoctoral Researcher Program of RIKEN to KO, and a research grant from MEXT to the RIKEN Center for Life Science Technologies and RIKEN Center for Biosystems Dynamics Research.	Alain G, 2016, UNDERSTANDING INTERM; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Davis JE, 2006, DEAF WAY II READER: PERSPECTIVES FROM THE SECOND INTERNATIONAL CONFERENCE ON DEAF CULTURE, P233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erhan D, 2009, U MONTR, V1341, P1, DOI DOI 10.2464/JILM.23.425; Ghandi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003711; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hinton GE, 2012, COURSERA NEURAL NETW, P26; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Kingma DP., 2014, ADAM METHOD STOCHAST; Kratochwil CF, 2015, BIOESSAYS, V37, P213, DOI 10.1002/bies.201400142; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Meadows JRS, 2017, NAT REV GENET, V18, P624, DOI 10.1038/nrg.2017.51; Min X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1878-3; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Singh S, 2016, PREDICTING ENHANCER; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yosinski J., 2015, ICML DEEP LEARN WORK; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	36	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235748	10.1371/journal.pone.0235748	http://dx.doi.org/10.1371/journal.pone.0235748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701977	Green Published, gold			2022-12-26	WOS:000575913700024
J	Shirazian, S; Nakhjiri, AT; Heydarinasab, A; Ghadiri, M				Shirazian, Saeed; Nakhjiri, Ali Taghvaie; Heydarinasab, Amir; Ghadiri, Mandi			Theoretical investigations on the effect of absorbent type on carbon dioxide capture in hollow-fiber membrane contactors	PLOS ONE			English	Article							AQUEOUS ALKANOLAMINE SOLVENTS; CO2 ABSORPTION; CHEMICAL ABSORPTION; REACTION-KINETICS; MASS-TRANSFER; LIQUID ABSORBENTS; AMINE SOLUTIONS; GAS-MIXTURES; MONOETHANOLAMINE; SIMULATION	Chemical absorption of carbon dioxide from flue or natural gas in hollow-fiber membrane contactors (HFMCs) has been one of the most beneficial techniques to alleviate its emission into the environment. A theoretical research study was done to investigate the change in membrane specifications and operating conditions on CO2 absorption using different alkanolamine solvents. The mathematical model was developed for a parallel counter-current fluid flow through a HFMC. The developed model's equations were solved based on finite element method. The simulations revealed that the increase in membrane porosity, length and the number of fibers has a positive impact on CO2 removal, while the gas flow rate and tortuosity enhancement resulted in the reduction of CO2 absorption. Furthermore, it was found that 4-diethylamino-2-butanol (DEAB) with approximately 100% CO2 absorption is suggested as the best solvent in this system, but ethyl-ethanolamine (EEA) with only 46% CO2 absorption had the lowest capacity for CO2 absorption (DEAB>MEA>EDA>MDEA> EA>EEA). It is worth pointing out that the CO2 absorption can be improved using EEA solvent via change in membrane specifications such as increase in membrane porosity, length and the number of fibres.	[Shirazian, Saeed] Duy Tan Univ, Inst Res & Dev, Da Nang, Vietnam; [Shirazian, Saeed] Duy Tan Univ, Fac Environm & Chem Engn, Da Nang, Vietnam; [Nakhjiri, Ali Taghvaie; Heydarinasab, Amir] Islamic Azad Univ, Dept Petr & Chem Engn, Sci & Res Branch, Tehran, Iran; [Ghadiri, Mandi] Ton Duc Thang Univ, Informetr Res Grp, Ho Chi Minh City, Vietnam; [Ghadiri, Mandi] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam	Duy Tan University; Duy Tan University; Islamic Azad University; Ton Duc Thang University; Ton Duc Thang University	Ghadiri, M (corresponding author), Ton Duc Thang Univ, Informetr Res Grp, Ho Chi Minh City, Vietnam.; Ghadiri, M (corresponding author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.	mahdi.ghadiri@tdtu.edu.vn	Taghvaie Nakhjiri, Ali/ABG-2176-2021; Heydarinasab, Amir/AAI-5750-2020	Taghvaie Nakhjiri, Ali/0000-0001-6244-3446; Heydarinasab, Amir/0000-0002-0417-4863; , Mahdi/0000-0001-5335-7546				Al-Marzouqi M, 2008, SEP PURIF TECHNOL, V62, P499, DOI 10.1016/j.seppur.2008.02.009; BARTH D, 1986, INT J CHEM KINET, V18, P445, DOI 10.1002/kin.550180404; Bird RB, 1960, TRANSPORT PHENOMENA, V16; Brunetti A, 2010, J MEMBRANE SCI, V359, P115, DOI 10.1016/j.memsci.2009.11.040; Cao F, 2019, INT J GREENH GAS CON, V82, P210, DOI 10.1016/j.ijggc.2018.12.011; Cheng MD, 2010, J CHEM THERMODYN, V42, P342, DOI 10.1016/j.jct.2009.09.005; Devries NP, CO2 ABSORPTION CONCE; Eslami S, 2011, ADV ENG SOFTW, V42, P612, DOI 10.1016/j.advengsoft.2011.05.002; Fadaei F, 2011, DESALINATION, V275, P126, DOI 10.1016/j.desal.2011.02.039; Faiz R, 2011, SEP PURIF TECHNOL, V76, P351, DOI 10.1016/j.seppur.2010.11.005; Faiz R, 2009, J MEMBRANE SCI, V342, P269, DOI 10.1016/j.memsci.2009.06.050; Gabelman A, 1999, J MEMBRANE SCI, V159, P61, DOI 10.1016/S0376-7388(99)00040-X; Ghadiri M, 2017, ENVIRON SCI POLLUT R, V24, P14508, DOI 10.1007/s11356-017-9048-8; Ghadiri M, 2013, INT J GREENH GAS CON, V13, P1, DOI 10.1016/j.ijggc.2012.11.030; Haghshenas H, 2016, CHEM ENG PROCESS, V102, P194, DOI 10.1016/j.cep.2016.01.015; HAPPEL J, 1959, AICHE J, V5, P174, DOI 10.1002/aic.690050211; HIKITA H, 1977, CHEM ENG J BIOCH ENG, V13, P7, DOI 10.1016/0300-9467(77)80002-6; Li JL, 2005, SEP PURIF TECHNOL, V41, P109, DOI 10.1016/j.seppur.2004.09.008; Li JL, 2007, IND ENG CHEM RES, V46, P4426, DOI 10.1021/ie0614982; Lu JG, 2005, IND ENG CHEM RES, V44, P9230, DOI 10.1021/ie058023f; Masoumi S, 2013, ENERG FUEL, V27, P5423, DOI 10.1021/ef401228z; Mehrpooya M, 2017, J CLEAN PROD, V142, P1749, DOI 10.1016/j.jclepro.2016.11.112; Melnikov SM, 2018, J PHYS CHEM B, V122, P2769, DOI 10.1021/acs.jpcb.7b10322; Nakhjiri AT, 2020, J ENVIRON CHEM ENG, V8, DOI 10.1016/j.jece.2020.104130; Nakhjiri AT, 2020, PERIOD POLYTECH-CHEM, V64, P135, DOI 10.3311/PPch.13172; Nakhjiri AT, 2019, J IND ENG CHEM, V78, P106, DOI 10.1016/j.jiec.2019.06.031; Nakhjiri AT, 2018, CHINESE J CHEM ENG, V26, P1845, DOI 10.1016/j.cjche.2017.12.012; Nakhjiri AT, 2018, J MEMBRANE SCI, V565, P1, DOI 10.1016/j.memsci.2018.07.095; Nakhjiri AT, 2018, SUSTAIN ENVIRON RES, V28, P186, DOI 10.1016/j.serj.2018.02.003; Nakhjiri AT, 2018, J ENVIRON CHEM ENG, V6, P1500, DOI 10.1016/j.jece.2018.01.068; Nakhjiri AT, 2019, J MOL LIQ; Niknam M, 2020, INT J GREENH GAS CON, V93, DOI 10.1016/j.ijggc.2019.102877; Park SW, 2006, KOREAN J CHEM ENG, V23, P138, DOI 10.1007/BF02705705; Paul S, 2008, CHEM ENG J, V144, P352, DOI 10.1016/j.cej.2008.01.036; Paul S, 2007, IND ENG CHEM RES, V46, P2576, DOI 10.1021/ie061476f; Pishnamazi M, 2020, J MOL LIQ, V314, DOI 10.1016/j.molliq.2020.113635; Pishnamazi M, 2020, J MOL LIQ, V313, DOI 10.1016/j.molliq.2020.113584; Pishnamazi M, 2020, J MOL LIQ, V313, DOI 10.1016/j.molliq.2020.113531; Portugal AF, 2008, CHEM ENG SCI, V63, P3493, DOI 10.1016/j.ces.2008.04.017; Rao AB, 2002, ENVIRON SCI TECHNOL, V36, P4467, DOI 10.1021/es0158861; Razavi SMR, 2016, ARAB J CHEM, V9, P62, DOI 10.1016/j.arabjc.2015.06.006; Rouzitalab Z, 2018, J ENVIRON CHEM ENG, V6, P6653, DOI 10.1016/j.jece.2018.10.035; Salvi AP, 2014, CAN J CHEM ENG, V92, P2021, DOI 10.1002/cjce.22064; Sekar RC., 2005, CARBON DIOXIDE CAPTU; Sema T, 2012, CHEM ENG SCI, V81, P251, DOI 10.1016/j.ces.2012.06.028; Sema T, 2012, IND ENG CHEM RES, V51, P925, DOI 10.1021/ie200832c; Sema T, 2011, IND ENG CHEM RES, V50, P14008, DOI 10.1021/ie2008345; Shirazian, 2020, SCI REP, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4, 10.1038/s41598-020-58472-y]; Srisurichan S, 2006, J MEMBRANE SCI, V277, P186, DOI 10.1016/j.memsci.2005.10.028; VERSTEEG GF, 1988, J CHEM ENG DATA, V33, P29, DOI 10.1021/je00051a011; Wang R, 2004, CHEM ENG PROCESS, V43, P849, DOI 10.1016/S0255-2701(03)00105-3; Yuan Y, 2019, INT J GREENH GAS CON, V85, P182, DOI 10.1016/j.ijggc.2019.03.007; Zaidiza DA, 2017, SEP PURIF TECHNOL, V188, P38, DOI 10.1016/j.seppur.2017.06.074; Zhang L, 2015, RSC ADV, V5, P424, DOI 10.1039/c4ra08376h; Zhang WD, 2014, J MEMBRANE SCI, V470, P399, DOI 10.1016/j.memsci.2014.06.059; Zhang Z, 2015, ASME 2015 POW C COLL; Zhou S, 2010, CHEMSUSCHEM, V3, P913, DOI 10.1002/cssc.200900293	57	16	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236367	10.1371/journal.pone.0236367	http://dx.doi.org/10.1371/journal.pone.0236367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701989	Green Published, gold			2022-12-26	WOS:000575913700081
J	Sparrenberg, LT; Greiner, B; Mathis, HP				Sparrenberg, Lorenz Tim; Greiner, Benjamin; Mathis, Harald Peter			Bleaching correction for DNA measurements in highly diluted solutions using confocal microscopy	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; DIFFUSION; EXTRACTION; MOLECULES	Determining the concentration of nucleic acids in biological samples precisely and reliably still is a challenge. In particular when only very small sample quantities are available for analysis, the established fluorescence-based methods give insufficient results. Photobleaching is seen as the main reason for this. In this paper we present a method to correct for the photobleaching effect. Using confocal microscopy with single molecule sensitivity, we derived calibration curves from DNA solutions with defined fragment length. We analyzed dilution series over a wide range of concentrations (1 pg/mu l-1000 pg/mu l) and measured their specific diffusion coefficients employing fluorescence correlation spectroscopy. Using this information, we corrected the measured fluorescence intensity of the calibration solutions for photobleaching effects. We evaluated our method by analyzing a series of DNA mixtures of varying composition. For fragments smaller than 1000 bp, our method allows to determine sample concentrations with high precision in very small sample quantities (< 2 mu l with concentrations < 20 pg/mu l). Once the technical parameters are determined and remain stable in an established process, our improved calibration method will make measuring molecular biological samples of unknown sequence composition more efficient, accurate and sample-saving than previous methods.	[Sparrenberg, Lorenz Tim] Rhein Westfal TH Aachen, Inst Biotechnol, Aachen, Germany; [Sparrenberg, Lorenz Tim; Greiner, Benjamin; Mathis, Harald Peter] Fraunhofer Inst Appl Informat Technol FIT, St Augustin, Germany	RWTH Aachen University; Fraunhofer Gesellschaft	Sparrenberg, LT (corresponding author), Rhein Westfal TH Aachen, Inst Biotechnol, Aachen, Germany.; Sparrenberg, LT (corresponding author), Fraunhofer Inst Appl Informat Technol FIT, St Augustin, Germany.	lorenz.sparrenberg@fit.fraunhofer.de		Sparrenberg, Lorenz/0000-0001-9450-7387				ARAGON SR, 1975, BIOPOLYMERS, V14, P119, DOI 10.1002/bip.1975.360140110; Doi M., 1986, INT SERIES MONOGRAPH; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Dragan AI, 2012, J FLUORESC, V22, P1189, DOI 10.1007/s10895-012-1059-8; Dragan AI, 2010, BIOPHYS J, V99, P3010, DOI 10.1016/j.bpj.2010.09.012; Enderlein J., 1997, Bioimaging, V5, P88, DOI 10.1002/1361-6374(199709)5:3<88::AID-BIO2>3.3.CO;2-U; Epstein JR, 2002, ANAL CHIM ACTA, V469, P3, DOI 10.1016/S0003-2670(02)00030-2; Hoseini SS, 2015, J BIOL ENG, V9, DOI 10.1186/1754-1611-9-2; Ishii K, 2015, OPT EXPRESS, V23, P32387, DOI 10.1364/OE.23.032387; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Nkodo AE, 2001, ELECTROPHORESIS, V22, P2424, DOI 10.1002/1522-2683(200107)22:12<2424::AID-ELPS2424>3.0.CO;2-1; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Petrov EP, 2008, SPRINGER SER FLUORES, V06, P145, DOI 10.1007/4243_2008_032; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Robertson RM, 2006, P NATL ACAD SCI USA, V103, P7310, DOI 10.1073/pnas.0601903103; Robin JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24067; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweyer Paul, 1909; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; SONG LL, 1995, BIOPHYS J, V68, P2588, DOI 10.1016/S0006-3495(95)80442-X; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Zander C, 2002, SINGLE MOL DETECTION, DOI [10.1002/3527600809, DOI 10.1002/3527600809]	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0231918	10.1371/journal.pone.0231918	http://dx.doi.org/10.1371/journal.pone.0231918			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702012	gold, Green Submitted, Green Published			2022-12-26	WOS:000575913700005
J	Kwon, BS; Kim, Y; Lee, SH; Lim, SY; Lee, YJ; Park, JS; Cho, YJ; Yoon, HI; Lee, CT; Lee, JH				Kwon, Byoung Soo; Kim, Youlim; Lee, Sang Hoon; Lim, Sung Yoon; Lee, Yeon Joo; Park, Jong Sun; Cho, Young-Jae; Yoon, Ho Il; Lee, Choon-Taek; Lee, Jae Ho			The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis	PLOS ONE			English	Article							1ST-LINE ANTITUBERCULOSIS DRUGS; RISK-FACTORS; 5-YEAR EXPERIENCE; HEPATOTOXICITY; PREVALENCE	Background Pyrazinamide (PZA) is a common drug that causes serious adverse events (SAEs). The aim of this study was to determine the incidence of and risk factors for SAEs due to PZA during first-line anti-tuberculosis treatment. Methods The medical records of patients with tuberculosis (TB) treated with PZA-containing regimens including first-line drugs-ethambutol, rifampicin, and isoniazid-from January 2003 to June 2016 were reviewed. SAEs were defined as side effects that led to drug discontinuation. The causative drug was determined based on the disappearance of the SAEs upon drug withdrawal and/or the recurrence of the same SAEs with re-challenge. Results Of 2,478 patients with TB, 16.4% experienced SAEs. The incidence of SAEs increased significantly as age increased, except with rifampin. PZA accounted for most SAEs (55.8%). Hepatotoxicity was the most common SAE due to PZA (44.5%), followed by gastrointestinal (GI) intolerance (23.8%). The risk of SAEs due to PZA increased significantly as age increased, when sex and comorbidities were adjusted (odds ratio, 1.013; 95% confidence interval, 1.004-1.023;P= 0.007). In the subgroup analysis, older age was an independent risk factor for GI intolerance but not for hepatotoxicity. Conclusion PZA was the most common drug associated with SAEs among the first-line anti-TB drugs, and old age was an independent factor for SAE occurrence. This study suggests that the early recognition of whether the causative agent is PZA may improve effective treatment compliance, particularly in elderly patients.	[Kwon, Byoung Soo; Kim, Youlim; Lee, Sang Hoon; Lim, Sung Yoon; Lee, Yeon Joo; Park, Jong Sun; Cho, Young-Jae; Yoon, Ho Il; Lee, Choon-Taek; Lee, Jae Ho] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seongnam Si, Gyeonggi Do, South Korea; [Kim, Youlim] Chuncheon Sacred Heart Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Chuncheon Si, Gangwon Do, South Korea; [Lee, Sang Hoon] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Pulmonol,Inst Chest Dis,Coll Med, Seoul, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System	Lee, JH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seongnam Si, Gyeonggi Do, South Korea.	jhlee7@snubh.org	Cho, Young-Jae/D-5528-2012	Cho, Young-Jae/0000-0001-6943-4462; Lee, Sang Hoon/0000-0002-7706-5318				Alipanah N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002595; ANahid P, 2016, CLIN INFECT DIS OFFI, V63, pe147; Chang KC, 2008, AM J RESP CRIT CARE, V177, P1391, DOI 10.1164/rccm.200802-355OC; Chung-Delgado K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027610; El Bouazzi O, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.167.10060; Fulton Maryann M, 2005, J Am Acad Nurse Pract, V17, P123, DOI 10.1111/j.1041-2972.2005.0020.x; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hagiwara E, 2019, J INFECT CHEMOTHER, V25, P1026, DOI 10.1016/j.jiac.2019.05.030; Jeong I, 2015, J KOREAN MED SCI, V30, P167, DOI 10.3346/jkms.2015.30.2.167; Kim TO, 2019, KOREAN J INTERN MED; Kwon YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-121; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Lv XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065037; Mallet L, 2007, LANCET, V370, P185, DOI 10.1016/S0140-6736(07)61092-7; Marra F, 2007, INT J TUBERC LUNG D, V11, P868; Mhimbira F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005342; Miyazawa Naoki, 2013, Kekkaku, V88, P297; Nahid P, 2016, CLIN INFECT DIS, V63, P853, DOI 10.1093/cid/ciw566; Pettit AC, 2013, INT J TUBERC LUNG D, V17, P486, DOI 10.5588/ijtld.12.0133; Piccirillo JF, 2008, CRIT REV ONCOL HEMAT, V67, P124, DOI 10.1016/j.critrevonc.2008.01.013; Rajagopalan S, 2016, CLIN GERIATR MED, V32, P479, DOI 10.1016/j.cger.2016.02.006; Ramappa V, 2013, J CLIN EXP HEPATOL, V3, P37, DOI 10.1016/j.jceh.2012.12.001; Raviglione M, 2016, INFECT DIS REP, V8, P33, DOI 10.4081/idr.2016.6570; Saha A, 2016, J PRIM CARE COMMUNIT, V7, P171, DOI 10.1177/2150131916642431; Schaberg T, 1996, EUR RESPIR J, V9, P2026, DOI 10.1183/09031936.96.09102026; Shih TY, 2013, ANTIMICROB AGENTS CH, V57, P1685, DOI 10.1128/AAC.01866-12; Shu CC, 2013, INT J TUBERC LUNG D, V17, P934, DOI 10.5588/ijtld.12.0782; Singh A, 2015, CLIN EPIDEMIOL GLOB, V3, pS80, DOI 10.1016/j.cegh.2015.10.005; Singh Sarman, 2015, J Lab Physicians, V7, P1, DOI 10.4103/0974-2727.154778; Smith C, 2014, THORAX, V69, P956, DOI 10.1136/thoraxjnl-2013-204503; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Tost JR, 2005, INT J TUBERC LUNG D, V9, P534; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; 2012, GLOB TUB REP, P1	34	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236109	10.1371/journal.pone.0236109	http://dx.doi.org/10.1371/journal.pone.0236109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692774	Green Published, gold			2022-12-26	WOS:000554606400017
J	Yadikar, H; Torres, I; Aiello, G; Kurup, M; Yang, ZH; Lin, F; Kobeissy, F; Yost, R; Wang, KK				Yadikar, Hamad; Torres, Isabel; Aiello, Gabrielle; Kurup, Milin; Yang, Zhihui; Lin, Fan; Kobeissy, Firas; Yost, Richard; Wang, Kevin K.			Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GLYCOGEN-SYNTHASE KINASE-3; PAIRED HELICAL FILAMENTS; OKADAIC ACID; IN-VITRO; ALZHEIMERS-DISEASE; PHOSPHORYLATION SITES; SELECTIVE INHIBITOR; ABNORMAL-BEHAVIOR; CALPAIN INHIBITOR	Tauopathies are a class of neurodegenerative disorders characterized by abnormal deposition of post-translationally modified tau protein in the human brain. Tauopathies are associated with Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE), and other diseases. Hyperphosphorylation increases tau tendency to aggregate and form neurofibrillary tangles (NFT), a pathological hallmark of AD. In this study, okadaic acid (OA, 100 nM), a protein phosphatase 1/2A inhibitor, was treated for 24h in mouse neuroblastoma (N2a) and differentiated rat primary neuronal cortical cell cultures (CTX) to induce tau-hyperphosphorylation and oligomerization as a cell-based tauopathy model. Following the treatments, the effectiveness of different kinase inhibitors was assessed using the tauopathy-relevant tau antibodies through tau-immunoblotting, including the sites: pSer202/pThr205 (AT8), pThr181 (AT270), pSer202 (CP13), pSer396/pSer404 (PHF-1), and pThr231 (RZ3). OA-treated samples induced tau phosphorylation and oligomerization at all tested epitopes, forming a monomeric band (46-67 kDa) and oligomeric bands (170 kDa and 240 kDa). We found that TBB (a casein kinase II inhibitor), AR and LiCl (GSK-3 inhibitors), cyclosporin A (calcineurin inhibitor), and Saracatinib (Fyn kinase inhibitor) caused robust inhibition of OA-induced monomeric and oligomeric p-tau in both N2a and CTX culture. Additionally, a cyclin-dependent kinase 5 inhibitor (Roscovitine) and a calcium chelator (EGTA) showed contrasting results between the two neuronal cultures. This study provides a comprehensive view of potential drug candidates (TBB, CsA, AR, and Saracatinib), and their efficacy against tau hyperphosphorylation and oligomerization processes. These findings warrant further experimentation, possibly including animal models of tauopathies, which may provide a putative Neurotherapy for AD, CTE, and other forms of tauopathy-induced neurodegenerative diseases.	[Yadikar, Hamad; Torres, Isabel; Aiello, Gabrielle; Kurup, Milin; Yang, Zhihui; Lin, Fan; Kobeissy, Firas; Wang, Kevin K.] Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med, Gainesville, FL 32611 USA; [Yadikar, Hamad; Torres, Isabel; Aiello, Gabrielle; Kurup, Milin; Yang, Zhihui; Lin, Fan; Kobeissy, Firas; Wang, Kevin K.] Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA; [Yadikar, Hamad; Torres, Isabel; Aiello, Gabrielle; Kurup, Milin; Yang, Zhihui; Lin, Fan; Kobeissy, Firas; Wang, Kevin K.] Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Neurosci & Chem, Gainesville, FL 32611 USA; [Yadikar, Hamad] Kuwait Univ, Fac Sci, Dept Biol Sci, Safat, Kuwait; [Yadikar, Hamad; Yost, Richard] Univ Florida, Dept Chem, Chem Lab Bldg, Gainesville, FL 32611 USA; [Kobeissy, Firas] Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon; [Wang, Kevin K.] Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Kuwait University; State University System of Florida; University of Florida; American University of Beirut	Yadikar, H (corresponding author), Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med, Gainesville, FL 32611 USA.; Yadikar, H (corresponding author), Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA.; Yadikar, H (corresponding author), Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Neurosci & Chem, Gainesville, FL 32611 USA.; Yadikar, H (corresponding author), Kuwait Univ, Fac Sci, Dept Biol Sci, Safat, Kuwait.; Yadikar, H (corresponding author), Univ Florida, Dept Chem, Chem Lab Bldg, Gainesville, FL 32611 USA.	hamad.yadikar@ku.edu.kw	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Yadikar, Hamad/0000-0001-5112-9005	University of Florida Departments of Emergency Medicine and Psychiatry	University of Florida Departments of Emergency Medicine and Psychiatry	This work was supported by funding from the University of Florida Departments of Emergency Medicine and Psychiatry.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Aldag M, 2017, J NEUROTRAUM, V34, pS26, DOI 10.1089/neu.2017.5218; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Amundsen R, 2012, DRUG METAB DISPOS, V40, P655, DOI 10.1124/dmd.111.043018; Ando K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005917; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; AVILA J, 1994, CELL MOL BIOL RES, V40, P573; Avila J, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00262; Baker S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0300-0; Bennett PC, 2001, NEUROBIOL LEARN MEM, V75, P91, DOI 10.1006/nlme.1999.3959; Besser LM, 2019, J NEUROPATH EXP NEUR, V78, P219, DOI 10.1093/jnen/nly132; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bhat RV, 2018, J ALZHEIMERS DIS, V64, pS547, DOI 10.3233/JAD-179934; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Boban M, 2019, J NEUROSCI METH, V319, P60, DOI 10.1016/j.jneumeth.2018.09.030; Bretteville A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00480; Broetto N, 2016, BRAIN RES BULL, V124, P136, DOI 10.1016/j.brainresbull.2016.04.014; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011886; Chen Y, 2012, PLANTA MED, V78, P1337, DOI 10.1055/s-0032-1314965; Chopra P, 2009, CYTOTECHNOLOGY, V60, P77, DOI 10.1007/s10616-009-9217-9; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; d'Abramo C, 2016, NEUROBIOL AGING, V37, P58, DOI 10.1016/j.neurobiolaging.2015.09.017; DAVIS DR, 1995, BIOCHEM J, V309, P941, DOI 10.1042/bj3090941; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Drognitz O, 2004, AM J TRANSPLANT, V4, P1042, DOI 10.1111/j.1600-6143.2004.00457.x; Ercan E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0229-1; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fu ZQ, 2010, J ALZHEIMERS DIS, V21, P1107, DOI 10.3233/JAD-2010-100687; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Georgievska B, 2013, J NEUROCHEM, V125, P446, DOI 10.1111/jnc.12203; Gerson JE, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0245-9; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; GREENWOOD JA, 1994, J BIOL CHEM, V269, P4373; Guan PP, 2019, CELL MOL IMMUNOL, V16, P892, DOI 10.1038/s41423-019-0294-1; Henkins KM, 2012, BRAIN PATHOL, V22, P826, DOI 10.1111/j.1750-3639.2012.00598.x; Henzing AJ, 2006, J MED CHEM, V49, P7636, DOI 10.1021/jm060385h; Ho YS, 2012, J ALZHEIMERS DIS, V28, P839, DOI 10.3233/JAD-2011-111037; Hubinger G, 2008, J ALZHEIMERS DIS, V13, P281; Huseby CJ, 2019, J ALZHEIMERS DIS, V71, P979, DOI 10.3233/JAD-190604; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; Jones NC, 2012, NEUROBIOL DIS, V45, P897, DOI 10.1016/j.nbd.2011.12.005; Kamat PK, 2013, NEUROSCIENCE, V238, P97, DOI 10.1016/j.neuroscience.2013.01.075; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Khelifa T, 1999, BIOCHEM PHARMACOL, V58, P1247, DOI 10.1016/S0006-2952(99)00213-0; Kimura T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00044; Knaryan VH, 2014, J NEUROCHEM, V130, P280, DOI 10.1111/jnc.12629; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Kovacs GG, 2018, HAND CLINIC, V145, P355, DOI 10.1016/B978-0-12-802395-2.00025-0; Kramer Thomas, 2012, Int J Alzheimers Dis, V2012, P381029, DOI 10.1155/2012/381029; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Lee S, 2013, BRAIN RES, V1495, P30, DOI 10.1016/j.brainres.2012.10.023; Li CZ, 2017, EMBO J, V36, P3120, DOI 10.15252/embj.201797724; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu JH, 2017, CELL PHYSIOL BIOCHEM, V44, P423, DOI 10.1159/000485008; Liu W, 2016, BIOCHEM BIOPH RES CO, V478, P852, DOI 10.1016/j.bbrc.2016.08.037; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Lovestone S, 2015, J ALZHEIMERS DIS, V45, P75, DOI 10.3233/JAD-141959; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Mathuram TL, 2018, DRUG RES, V68, P436, DOI 10.1055/s-0044-100186; Medina M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041160; Medina M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00024; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Ni RQ, 2018, J NUCL MED, V59, P960, DOI 10.2967/jnumed.117.201632; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nygaard HB, 2018, BIOL PSYCHIAT, V83, P369, DOI 10.1016/j.biopsych.2017.06.004; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Pacifici M, 2012, JOVE-J VIS EXP, DOI 10.3791/3965; Panza F, 2019, EXPERT REV NEUROTHER, V19, P397, DOI 10.1080/14737175.2019.1606715; Panza F, 2016, IMMUNOTHERAPY-UK, V8, P1119, DOI 10.2217/imt-2016-0019; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Perrine K, 2017, WORLD NEUROSURG, V102, P533, DOI 10.1016/j.wneu.2017.02.084; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Pir GJ, 2017, FASEB J, V31, P5137, DOI 10.1096/fj.201701007; Polanco JC, 2018, NAT REV NEUROL, V14, P22, DOI 10.1038/nrneurol.2017.162; Prabhakaran J, 2017, ACS CHEM NEUROSCI, V8, P1697, DOI 10.1021/acschemneuro.6b00376; Qin M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0663-0; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rabano A, 2016, METHODS MOL BIOL, V1303, P143, DOI 10.1007/978-1-4939-2627-5_7; Rosenberger AFN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0470-x; Rubenstein R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00124; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sahara N, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00663; Sarno S, 2011, CURR TOP MED CHEM, V11, P1340, DOI 10.2174/156802611795589638; Schlachetzki JCM, 2013, REV BRAS PSIQUIATR, V35, pS92, DOI 10.1590/1516-4446-2013-1159; Segura-Egea JJ, 2003, J ENDODONT, V29, P211, DOI 10.1097/00004770-200303000-00012; Serkova N, 1996, BBA-MOL CELL RES, V1314, P93, DOI 10.1016/S0167-4889(96)00081-X; Shen XY, 2018, INT J MOL MED, V41, P1138, DOI 10.3892/ijmm.2017.3281; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Sparks P, 2020, CLIN J SPORT MED, V30, pS1, DOI 10.1097/JSM.0000000000000541; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Strang KH, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0458-0; Swingle Mark, 2007, V365, P23; Tan CC, 2018, J ALZHEIMERS DIS, V61, P487, DOI 10.3233/JAD-170187; TAPLEY P, 1992, ONCOGENE, V7, P371; Tell V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00189; Theendakara V, 2017, MOL CELL NEUROSCI, V83, P83, DOI 10.1016/j.mcn.2017.07.002; Thuret G, 2003, BRIT J OPHTHALMOL, V87, P346, DOI 10.1136/bjo.87.3.346; Toledo FD, 2014, ARCH TOXICOL, V88, P1695, DOI 10.1007/s00204-014-1219-5; Tolosa E, 2014, MOVEMENT DISORD, V29, P470, DOI 10.1002/mds.25824; Valdiglesias V, 2013, MAR DRUGS, V11, P4328, DOI 10.3390/md11114328; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Voss K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-18; Wang JZ, 2001, FEBS LETT, V507, P81, DOI 10.1016/S0014-5793(01)02944-1; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; Wang QB, 2002, CHINESE MED J-PEKING, V115, P884; Yu DY, 2006, BIOL CHEM, V387, P977, DOI 10.1515/BC.2006.121; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhang Q, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00146; Zhang Z, 2010, BRAIN RES, V1359, P233, DOI 10.1016/j.brainres.2010.08.077; Zhao L, 2016, EXP BIOL MED, V241, P1825, DOI 10.1177/1535370216650759; Zhao ZB, 2019, GENE DEV, V33, P61, DOI 10.1101/gad.319830.118; ZIMMERMANN A, 1992, BRIT J CANCER, V66, P1077, DOI 10.1038/bjc.1992.413	137	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0224952	10.1371/journal.pone.0224952	http://dx.doi.org/10.1371/journal.pone.0224952			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692785	Green Published, Green Submitted, gold			2022-12-26	WOS:000554606400013
J	Hosseini, Z; Veenstra, G; Khan, NA; Conklin, AI				Hosseini, Zeinab; Veenstra, Gerry; Khan, Nadia A.; Conklin, Annalijn, I			Associations between social connections, their interactions, and obesity differ by gender: A population-based, cross-sectional analysis of the Canadian Longitudinal Study on Aging	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; UNITED-STATES; OLDER-ADULTS; HEALTH; MORTALITY; MEN; LONELINESS; WOMEN; DETERMINANTS; INEQUALITIES	Objectives To quantify the link between four different types of social ties and objective measures of abdominal and general obesity, and to explore their inter-relationships in association with obesity using a gender-sensitive analysis. Methods A cross-sectional analysis of 28,238 adults (45-85 years) from the baseline Canadian Longitudinal Study on Aging Comprehensive cohort (2012-15). Social ties (marital status, living arrangement, social network size, and social participation) and measured anthropometry (body mass index, waist circumference) were analyzed using linear and logistic regression models with interaction terms conditioned on known confounders. Results We found that being single, widowed or divorced/separated was associated with worse anthropometric outcomes in women, including higher odds of both abdominal and general obesity, and that associations were enhanced when combined with limited social participation, lone-living and greater social network size. Few clear associations were observed in men. Limited social participation (no social activities at least once/month) among women was associated with larger waist circumference (+4.19 cm [95% CI: 1.86, 6.52]) and higher odds of both abdominal and general obesity. By contrast, associations appeared to be reversed in men: lone-living and smaller social networks were associated with lower odds of obesity, compared to co-living and larger social networks. We also found that more regular social participation can potentially mitigate the adverse associations between non-partnership (single, divorced) and obesity in women. Overall, the combined influence of two types of social tie deficits on excess weight measures was more pronounced in women than men. Conclusions Results highlight the importance of considering how the role of social ties for obesity prevention may differ for women and men. Frequent social participation and number of social contacts may matter for assessing whether divorced, single or lone-living older women are at risk of obesity while living arrangement and social contacts may matter for obesity in men.	[Hosseini, Zeinab; Conklin, Annalijn, I] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada; [Veenstra, Gerry] Univ British Columbia, Dept Sociol, Vancouver, BC, Canada; [Khan, Nadia A.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Khan, Nadia A.; Conklin, Annalijn, I] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	Hosseini, Z (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada.	seh653@usask.ca		Conklin, Annalijn/0000-0002-6532-8790	Canadian Institutes of Health Research [162987]; Government of Canada through the Canadian Institutes of Health Research (CIHR) [LSA 94473]; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Canada through the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was funded by the Canadian Institutes of Health Research (PI: AC, grant #162987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge this research was made possible using the data/biospecimens collected by the Canadian Longitudinal Study on Aging (CLSA), led by Drs. Parminder Raina, Christina Wolfson and Susan Kirkland. Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 94473 and the Canada Foundation for Innovation. This research has been conducted using the CLSA Baseline Comprehensive Dataset version 4.0, under Application Number 19CA003.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Ball K, 2003, INT J OBESITY, V27, P394, DOI 10.1038/sj.ijo.0802237; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bird CE, 2008, GENDER AND HEALTH: THE EFFECTS OF CONSTRAINED CHOICES AND SOCIAL POLICIES, P1, DOI 10.1017/CBO9780511807305; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; BRINES J, 1994, AM J SOCIOL, V100, P652, DOI 10.1086/230577; Calasanti TM, 2001, ROWMAN ALTAMIRA; COMMISSION OF THE EUROPEAN COMMUNITIES, 2007, WHITE PAP, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Conklin AI, 2016, PLOS ONE, P11; Conklin AI, 2014, OLD AD; Conklin AI, 2014, SOC SCI MED, V100, P167, DOI 10.1016/j.socscimed.2013.08.018; Crenshaw K., 1991, STANFORD LAW REV, P1241, DOI [DOI 10.2307/1229039, 10.2307/1229039]; Davidson K, 2001, AGEING SOC, V21, P297, DOI 10.1017/S0144686X01008169; EVERS S, 1987, NUTR RES, V7, P3, DOI 10.1016/S0271-5317(87)80186-0; Ferrie JE, 2005, INT J EPIDEMIOL, V34, P640, DOI 10.1093/ije/dyi063; Fuhrer R, 1999, SOC SCI MED, V48, P77, DOI 10.1016/S0277-9536(98)00290-1; Grundy E, 2003, SOC SCI MED, V56, P935, DOI 10.1016/S0277-9536(02)00093-X; Hankivsky O., 2008, Critical Public Health, V18, P271, DOI 10.1080/09581590802294296; HANSON BS, 1989, AM J EPIDEMIOL, V130, P100, DOI 10.1093/oxfordjournals.aje.a115301; HESSLER RM, 1995, ARCH GERONTOL GERIAT, V21, P291, DOI 10.1016/0167-4943(95)00669-C; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Janghorbani M, 2008, ASS BODY MASS INDEX; Kamiya Y, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-81; KAPLAN GA, 1988, AM J EPIDEMIOL, V128, P370, DOI 10.1093/oxfordjournals.aje.a114977; Kaplan MS, 2003, J GERONTOL A-BIOL, V58, P1018; Khlat M, 2009, SOC SCI MED, V68, P1692, DOI 10.1016/j.socscimed.2009.02.024; Kobayashi LC, 2018, ANN BEHAV MED, V52, P582, DOI 10.1093/abm/kax033; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Lee Won Joon, 2013, J Prev Med Public Health, V46, P336, DOI 10.3961/jpmph.2013.46.6.336; LILLARD LA, 1995, AM J SOCIOL, V100, P1131, DOI 10.1086/230634; Lipowicz A, 2002, AM J HUM BIOL, V14, P468, DOI 10.1002/ajhb.10062; LIU K, 1988, AM J EPIDEMIOL, V127, P864, DOI 10.1093/oxfordjournals.aje.a114870; Marmot M, 2008, HLTH EQUITY ACTION S, V246, DOI [10.1080/17441692.2010.514617, DOI 10.1080/17441692.2010.514617]; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Meerwijk EL, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303578; Menec VH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211143; NOPPA H, 1980, J EPIDEMIOL COMMUN H, V34, P139, DOI 10.1136/jech.34.2.139; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; Raina PS, 2008, PROTOCOL VERSION 3; Rijken AJ, 2014, EUR SOCIOL REV, V30, P470, DOI 10.1093/esr/jcu051; Rutledge T, 2003, PSYCHOSOM MED, V65, P688, DOI 10.1097/01.PSY.0000041470.25130.6C; Sawyer RL, 1986, 6 USE CTR EPIDEMIOLO; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; SHYE D, 1995, SOC SCI MED, V41, P935, DOI 10.1016/0277-9536(94)00404-H; Sobal J., 2003, GEND ISSUES, V21, P75, DOI [DOI 10.1007/S12147-003-0007-Y, 10.1007/s12147-003-0007-y]; Son H, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060919; Statistics Canada, 2019, OB CAN AD 2016 2017; Statistics Canada, 2019, 82625X STAT CAN; Statistics Canada, 2019, FAM MATT BEING SEP D; Statistics Canada, 2016, CENS POP; Statistics Canada, 2016, DISTR LIV ARR POP AG; Twells Laurie K, 2014, CMAJ Open, V2, pE18, DOI 10.9778/cmajo.20130016; Verloo M, 2006, EUR J WOMENS STUD, V13, P211, DOI 10.1177/1350506806065753; Vozikaki M, 2018, ARCH HELL MED, V35, P506; Wister A, 2019, CAN J AGING, V38, P180, DOI 10.1017/S0714980818000612; Yang YC, 2016, P NATL ACAD SCI USA, V113, P578, DOI 10.1073/pnas.1511085112	60	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0235977	10.1371/journal.pone.0235977	http://dx.doi.org/10.1371/journal.pone.0235977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730260	Green Published, gold			2022-12-26	WOS:000556884700063
J	Rueda, AM; de los Santos, YL; Vincent, AT; Letourneau, M; Hernandez, I; Sanchez, CI; Molina, VD; Ospina, SA; Veyrier, FJ; Doucet, N				Rueda, Andres M.; Lopez de los Santos, Yossef; Vincent, Antony T.; Letourneau, Myriam; Hernandez, Ines; Sanchez, Clara, I; Molina, Daniel, V; Ospina, Sonia A.; Veyrier, Frederic J.; Doucet, Nicolas			Genome sequencing and functional characterization of a Dictyopanus pusillus fungal enzymatic extract offers a promising alternative for lignocellulose pretreatment of oil palm residues	PLOS ONE			English	Article							EMPTY FRUIT BUNCH; WOOD DECAY FUNGI; LACCASE ACTIVITY; ENZYMES; PRODUCTS; REVEALS; OVERPRODUCTION; IDENTIFICATION; FERMENTATION; DEGRADATION	The pretreatment of biomass remains a critical requirement for bio-renewable fuel production from lignocellulose. Although current processes primarily involve chemical and physical approaches, the biological breakdown of lignin using enzymes and microorganisms is quickly becoming an interesting eco-friendly alternative to classical processes. As a result, bioprospection of wild fungi from naturally occurring lignin-rich sources remains a suitable method to uncover and isolate new species exhibiting ligninolytic activity. In this study, wild species of white rot fungi were collected from Colombian forests based on their natural wood decay ability and high capacity to secrete oxidoreductases with high affinity for phenolic polymers such as lignin. Based on high activity obtained from solid-state fermentation using a lignocellulose source from oil palm as matrix, we describe the isolation and whole-genome sequencing ofDictyopanus pusillus, a wild basidiomycete fungus exhibiting ABTS oxidation as an indication of laccase activity. Functional characterization of a crude enzymatic extract identified laccase activity as the main enzymatic contributor to fungal extracts, an observation supported by the identification of 13 putative genes encoding for homologous laccases in the genome. To the best of our knowledge, this represents the first report of an enzymatic extract exhibiting laccase activity in theDictyopanusgenera, offering means to exploit this species and its enzymes for the delignification process of lignocellulosic by-products from oil palm.	[Rueda, Andres M.; Lopez de los Santos, Yossef; Vincent, Antony T.; Letourneau, Myriam; Veyrier, Frederic J.; Doucet, Nicolas] Univ Quebec, Ctr Armand Frappier Sante Biotechnol, Inst Natl Rech Sci INRS, Laval, PQ, Canada; [Rueda, Andres M.; Ospina, Sonia A.] Univ Nacl Colombia, Inst Biotecnol, Bogota, Colombia; [Rueda, Andres M.; Hernandez, Ines; Sanchez, Clara, I] Univ Ind Santander, Ctr Estudios & Invest Ambientales, Bucaramanga, Colombia; [Sanchez, Clara, I] Univ Ind Santander, Escuela Microbiol, Bucaramanga, Colombia; [Molina, Daniel, V] Univ Ind Santander, Escuela Quim, Bucaramanga, Colombia; [Doucet, Nicolas] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Universidad Nacional de Colombia; Universidad Industrial de Santander; Universidad Industrial de Santander; Universidad Industrial de Santander	Doucet, N (corresponding author), Univ Quebec, Ctr Armand Frappier Sante Biotechnol, Inst Natl Rech Sci INRS, Laval, PQ, Canada.	nocolas.doucet@inrs.ca	V., Daniel R. Molina/AAF-9916-2021; Vincent, Antony T./AAY-2428-2020	Vincent, Antony T./0000-0002-1338-5785; Doucet, Nicolas/0000-0002-1952-9380; Sanchez, Clara/0000-0002-0142-8848; Rueda, Andres/0000-0003-0775-8490	Universidad Industrial de Santander, Vicerrectoria de Investigacion y Extension [5199]; Industrias Acuna INAL LTDA [8712]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05557]; NSERC; Colombian Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias) [567]; Emerging Leaders in the Americas Program (ELAP) from the Government of Canada; Fonds de Recherche Quebec-Sante (FRQS) [35038, 281993]	Universidad Industrial de Santander, Vicerrectoria de Investigacion y Extension; Industrias Acuna INAL LTDA; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Colombian Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Emerging Leaders in the Americas Program (ELAP) from the Government of Canada; Fonds de Recherche Quebec-Sante (FRQS)	This work was partially supported by a grant from Universidad Industrial de Santander, Vicerrectoria de Investigacion y Extension (Grant number 5199) (to C.I.S. and D.M.V.), Industrias Acuna INAL LTDA (Grant number 8712) (to C.I.S.), and a Natural Sciences and Engineering Research Council of Canada (NSERC), via Discovery Grant RGPIN-2016-05557 (to N.D.). A.T.V. received a Postdoctoral Fellowship from NSERC. A.M.R. was supported by a doctoral scholarship from the Colombian Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias) (PhD scholarship 567, 2012), and was the recipient of a scholarship from the Emerging Leaders in the Americas Program (ELAP) from the Government of Canada. F.V. and N.D. hold Fonds de Recherche Quebec-Sante (FRQS) Research Scholar Junior 1 and Senior Career Awards, respectively (numbers 35038 and 281993). There was no additional external funding received for this study.; This work was partially supported by a grant from Universidad Industrial de Santander, Vicerrectoria de Investigacion y Extension (Grant number 5199) (to C.I.S. and D.M.V.), Industrias Acuna INAL LTDA (Grant number 8712) (to C.I.S.), and a Natural Sciences and Engineering Research Council of Canada (NSERC), via Discovery Grant RGPIN-2016-05557 (to N.D.). A.T.V. received a Postdoctoral Fellowship from NSERC. A.M.R. was supported by a doctoral scholarship from the Colombian Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias) (PhD scholarship 567, 2012), and was the recipient of a scholarship from the Emerging Leaders in the Americas Program (ELAP) from the Government of Canada. F.V. and N.D. hold Fonds de Recherche Quebec-Sante (FRQS) Research Scholar Junior 1 and Senior Career Awards, respectively (numbers 35038 and 281993). There was no additional external funding received for this study.	Abbas A, 2005, CURR GENET, V47, P49, DOI 10.1007/s00294-004-0550-4; Alcalde M, 2015, TRENDS BIOTECHNOL, V33, P155, DOI 10.1016/j.tibtech.2014.12.007; Arce-Sarria A, 2018, CATALYSTS, V8, DOI 10.3390/catal8060222; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2002, FEMS MICROBIOL LETT, V206, P69, DOI 10.1111/j.1574-6968.2002.tb10988.x; Bechara EJH, 2015, CURR BIOL, V25, pR283, DOI 10.1016/j.cub.2015.01.004; Colavolpe MB, 2014, BRAZ J MICROBIOL, V45, P1263, DOI 10.1590/S1517-83822014000400017; Bhutto AW, 2017, ENERGY, V122, P724, DOI 10.1016/j.energy.2017.01.005; Bilal M, 2017, INT J BIOL MACROMOL, V98, P447, DOI 10.1016/j.ijbiomac.2017.01.133; BLANCHETTE RA, 1984, APPL ENVIRON MICROB, V48, P647, DOI 10.1128/AEM.48.3.647-653.1984; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Chang SH, 2014, BIOMASS BIOENERG, V62, P174, DOI 10.1016/j.biombioe.2014.01.002; Chen HZ, 2016, RENEW SUST ENERG REV, V57, P468, DOI 10.1016/j.rser.2015.12.069; Choi Yuen-Wah, 1999, Fungal Diversity, V3, P29; Couto SR, 2005, BIOCHEM ENG J, V22, P211, DOI 10.1016/j.bej.2004.09.013; Davidi L, 2016, P NATL ACAD SCI USA, V113, P10854, DOI 10.1073/pnas.1608012113; Division S., 2020, FAOSTAT STAT DAT; Eastwood DC, 2014, ACS SYM SER, V1158, P93; Fernandez-Fueyo E, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0462-9; Floudas D, 2015, FUNGAL GENET BIOL, V76, P78, DOI 10.1016/j.fgb.2015.02.002; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gasser CA, 2012, APPL MICROBIOL BIOT, V95, P1115, DOI 10.1007/s00253-012-4178-x; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gupta VK, 2016, TRENDS BIOCHEM SCI, V41, P633, DOI 10.1016/j.tibs.2016.04.006; HARRIS JL, 1986, J CLIN MICROBIOL, V24, P460, DOI 10.1128/JCM.24.3.460-461.1986; Henske JK, 2018, BIOCHEM ENG J, V130, P83, DOI 10.1016/j.bej.2017.11.015; Hilden K, 2013, APPL MICROBIOL BIOT, V97, P1589, DOI 10.1007/s00253-012-4011-6; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Hyde KD, 2019, FUNGAL DIVERS, V97, P1, DOI 10.1007/s13225-019-00430-9; Jarvinen J, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-62; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kachlishvili E, 2006, WORLD J MICROB BIOT, V22, P391, DOI 10.1007/s11274-005-9046-8; Kajita S, 2004, APPL MICROBIOL BIOT, V66, P194, DOI 10.1007/s00253-004-1663-x; Kamcharoen A, 2014, INT J ENERGY ENVIR E, V5, P303, DOI 10.1007/s40095-014-0136-y; Khindaria A, 1995, BIOCHEMISTRY-US, V34, P16860, DOI 10.1021/bi00051a037; Kim NK, 2016, MYCOBIOLOGY, V44, P146, DOI 10.5941/MYCO.2016.44.3.146; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Krah FS, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1229-7; Kumar AK, 2017, BIORESOUR BIOPROCESS, V4, DOI 10.1186/s40643-017-0137-9; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Li HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28303-2; Li P, 2011, ENZYME MICROB TECH, V48, P1, DOI 10.1016/j.enzmictec.2010.07.005; Lim SH, 2013, MYCOBIOLOGY, V41, P214, DOI 10.5941/MYCO.2013.41.4.214; Machado KMG, 2005, BRAZ J MICROBIOL, V36, P246, DOI 10.1590/S1517-83822005000300008; Madhavan A, 2017, APPL BIOCHEM BIOTECH, V183, P636, DOI 10.1007/s12010-017-2568-3; Mali T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185171; Maqbool Z, 2016, ENVIRON SCI POLLUT R, V23, P16904, DOI 10.1007/s11356-016-7003-8; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreno LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171291; Mukhopadhyay M, 2011, BIOMASS BIOENERG, V35, P3584, DOI 10.1016/j.biombioe.2011.05.013; Munk L, 2015, BIOTECHNOL ADV, V33, P13, DOI 10.1016/j.biotechadv.2014.12.008; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; PELAEZ F, 1995, MYCOL RES, V99, P37, DOI 10.1016/S0953-7562(09)80313-4; Peng M, 2018, FUNGAL GENET BIOL, V112, P40, DOI 10.1016/j.fgb.2017.08.001; Pineros-Castro Y, 2014, INT BIODETER BIODEGR, V91, P24, DOI 10.1016/j.ibiod.2014.03.009; Plaza GA, 2004, POL J ENVIRON STUD, V13, P315; Presley GN, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02987-16, 10.1128/aem.02987-16]; Pryszcz LP, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw294; Raja HA, 2017, J NAT PROD, V80, P756, DOI 10.1021/acs.jnatprod.6b01085; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Savinova OS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00152; Schubert M, 2008, BIOL CONTROL, V45, P111, DOI 10.1016/j.biocontrol.2008.01.001; Singh P, 2013, INT BIODETER BIODEGR, V82, P96, DOI 10.1016/j.ibiod.2012.12.016; Sirim Demet, 2011, Database (Oxford), V2011, pbar006, DOI 10.1093/database/bar006; Suhara H, 2012, INT BIODETER BIODEGR, V75, P176, DOI 10.1016/j.ibiod.2012.05.042; Sulaiman F, 2011, BIOMASS BIOENERG, V35, P3775, DOI 10.1016/j.biombioe.2011.06.018; Upadhyay P, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0316-3; Vikineswary S, 2006, BIORESOURCE TECHNOL, V97, P171, DOI 10.1016/j.biortech.2005.02.015; Wang HL, 2015, BIOPROC BIOSYST ENG, V38, P957, DOI 10.1007/s00449-014-1341-z; Wong DWS, 2009, APPL BIOCHEM BIOTECH, V157, P174, DOI 10.1007/s12010-008-8279-z; Worrall JJ, 1997, MYCOLOGIA, V89, P199, DOI 10.2307/3761073; Xu XQ, 2018, BIORESOURCE TECHNOL, V247, P88, DOI 10.1016/j.biortech.2017.08.192; Zanirun Z, 2015, INT BIODETER BIODEGR, V105, P13, DOI 10.1016/j.ibiod.2015.08.010; Zhang JW, 2016, P NATL ACAD SCI USA, V113, P10968, DOI 10.1073/pnas.1608454113	81	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0227529	10.1371/journal.pone.0227529	http://dx.doi.org/10.1371/journal.pone.0227529			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730337	Green Submitted, Green Published, gold			2022-12-26	WOS:000556884700061
J	Boethius, A; Kjallquist, M; Magnell, O; Apel, J				Boethius, Adam; Kjallquist, Mathilda; Magnell, Ola; Apel, Jan			Human encroachment, climate change and the loss of our archaeological organic cultural heritage: Accelerated bone deterioration at Agerod, a revisited Scandinavian Mesolithic key-site in despair	PLOS ONE			English	Article							PRESERVATION; WETLANDS	Ancient organic remains are essential for the reconstruction of past human lifeways and environments but are only preserved under particular conditions. Recent findings indicate that such conditions are becoming rarer and that archaeological sites with previously good preservation, are deteriorating. To investigate this, we returned to the well-known Swedish Mesolithic site Agerod I. Here we present the result of the re-excavation and the osteological analyses of the bone remains from the 1940s, 1970s and 2019 excavation campaigns of the site, to document and quantify changes in bone preservation and relate them to variations in soil conditions and on-site topography. The results indicate that the bone material has suffered from accelerated deterioration during the last 75 years. This has led to heavily degraded remains in some areas and complete destruction in others. We conclude that while Agerod can still be considered an important site, it has lost much of the properties that made it unique. If no actions are taken to secure its future preservation, the site will soon lose the organic remains that before modern encroachment and climate change had been preserved for 9000 years. Finally, because Agerod has not been subjected to more or heavier encroachment than most other archaeological sites, our results also raise questions of the state of organic preservation in other areas and call for a broad examination of our most vulnerable hidden archaeological remains.	[Boethius, Adam] Lund Univ, Dept Archaeol & Ancient Hist, Lund, Sweden; [Kjallquist, Mathilda; Magnell, Ola] Natl Hist Museums, Lund, Sweden; [Apel, Jan] Stockholm Univ, Dept Archaeol & Class Studies, Stockholm, Sweden	Lund University; Stockholm University	Boethius, A (corresponding author), Lund Univ, Dept Archaeol & Ancient Hist, Lund, Sweden.	adam.boethius@ark.lu.se	Boethius, Adam/AAZ-7049-2020	Boethius, Adam/0000-0002-8923-6233	Crafoord foundation [20180631]; Lennart J. Hagglunds foundation; Swedish National Heritage Board [RAA-2018-3237]	Crafoord foundation; Lennart J. Hagglunds foundation; Swedish National Heritage Board	We are grateful for the financial support from: JA, Crafoord foundation, nr. 20180631 https://www.crafoord.se/AB, Lennart J. Hagglunds foundation for archaeological research and education http://hagglundsstiftelse.se/AB, the Swedish National Heritage Board, RAA-2018-3237, https://www.raa.se/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althin C.-A., 1954, ACTA ARCHAEOLOGICA L, V1; Apel J., 2018, ECOLOGY EARLY SETTLE, P277; ARMENTANO TV, 1986, J ECOL, V74, P755, DOI 10.2307/2260396; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Boethius A., 2018, ACTA ARCHAEOLOGICA L, V4; Boethius A., QUANTIFYING ARCHAEO; Boethius A., 2018, ECOLOGY EARLY SETTLE, P99; Boethius A, 2020, HOLOCENE, V30, P632, DOI 10.1177/0959683619895585; Boethius A, 2018, J ARCHAEOL SCI, V93, P196, DOI 10.1016/j.jas.2018.02.018; Boethius A, 2017, J ARCHAEOL SCI-REP, V13, P625, DOI 10.1016/j.jasrep.2017.05.014; Boethius A, 2016, J ARCHAEOL SCI, V66, P169, DOI 10.1016/j.jas.2016.01.008; Boreham S, 2011, J ARCHAEOL SCI, V38, P2833, DOI 10.1016/j.jas.2011.01.016; Bruun-Pedersen JR, 2014, 2014 2ND WORKSHOP ON VIRTUAL AND AUGMENTED ASSISTIVE TECHNOLOGY (VAAT), P23, DOI 10.1109/VAAT.2014.6799464; Clark J. G. D., 1936, MESOLITHIC SETTLEMEN; Forssander J., 1930, MEDDELANDEN FRAN LUN, VIV, P25; Forssander J., 1938, ALDSTA SKANE SKANES, P1; Grillakis MG, 2019, SCI TOTAL ENVIRON, V660, P1245, DOI 10.1016/j.scitotenv.2019.01.001; Gross D, 2019, HOLOCENE, V29, P197, DOI 10.1177/0959683618810390; Hambrecht G, 2017, AM ANTIQUITY, V82, P627, DOI 10.1017/aaq.2017.30; Hammarstrand Dehman C., 2009, MESOLITISKA LAMNINGA, V32, P18; High K., 2016, P NATL ACAD SCI USA; Hogberg A, 2017, WORLD ARCHAEOL, V49, P639, DOI 10.1080/00438243.2017.1406398; Hollesen J, 2017, ARCHAEOMETRY, V59, P1175, DOI 10.1111/arcm.12319; Hollesen J, 2015, ARCHAEOMETRY, V57, P362, DOI 10.1111/arcm.12094; Hollesen J, 2018, ANTIQUITY, V92, P573, DOI 10.15184/aqy.2018.8; Hollund HI, 2012, INT J OSTEOARCHAEOL, V22, P537, DOI 10.1002/oa.1273; Huisman D.J., 2009, DEGRADATION ARCHAEOL; Hultgreen T., 1985, VIKING, V48, P83; Jans MME, 2002, ARCHAEOMETRY, V44, P343, DOI 10.1111/1475-4754.t01-1-00067; Kars E, 2002, DEGRADATION BONE IND, P1; Koivisto S, 2017, ARCHAEOLOGY FINNISH; Larsson L., 1978, ACTA ARCHAEOLOGICA L, V4, P12; Larsson L., 1978, MEDDELANDE FRAN LUND, P28; Larsson L., 1983, AGEROD ATLANTIC BOG; Lepiksaar J., 1978, AGEROD IB AGEROD ID, P234; Lindborg U., 1990, LUFTFORORENINGAR KUL, P1; Martens V.V., 2017, ARCHAEOLOGICAL REV C, V32, P123; Martens VV, 2016, CONSERV MANAGE ARCHA, V18, P8, DOI 10.1080/13505033.2016.1181930; Mathiessen H., 2004, KULTURARV SJ LLANDS, P43; McGovern TH, 2018, CONSERV MANAGE ARCHA, V20, P165, DOI 10.1080/13505033.2018.1521205; Meiklejohn C., 1981, FORNVANNEN, V76, P161; Milner N, 2011, J ARCHAEOL SCI, V38, P2818, DOI 10.1016/j.jas.2011.02.015; National Academies of Sciences E. & Medicine, 2016, ATTR EXTR WEATH EV C; Nilsson T., 1964, ENTWICKLUNGSGESCHICH, V59; Nilsson T., 1967, POLLENANALYTISCHE DA, V16; Nilsson T., 1964, STANDARDPOLLENDIAGRA, V59; Nord A.G., 2002, PAVERKAN ARKEOLOGISK; Nord AG, 2007, BARA NATURLIG FORSUR; Nord AG, 2005, J NORDIC ARCHAEOLOGI, V15, P77; Nord AG, 1991, STONE WEATHERING AIR; Reventlow C. D., 1886, FYNDEN FRAN RINGSJON, P140; Reventlow C. D., 1889, KONGL VITTERHERHETS, P77; Ritchie K.C., 2013, DANISH J ARCHAEOLOGY, V2, P45, DOI [10.1080/21662282.2013.821792, DOI 10.1080/21662282.2013.821792]; Robson HK, 2018, J ARCHAEOL SCI-REP, V17, P895, DOI 10.1016/j.jasrep.2016.02.009; Rydbeck O., 1930, ACTA ARCHAEOL, V1, P55; Segerberg A., 1999, BALINGE MOSSAR KUSTB; Sjostrom A., 2004, RONNEHOLM 6 10 12 14, V32, P18; Sjostrom A., 1995, GRAVNINGSRAPPORT RON, V32, P18; Sjostrom A., 2013, MESOLITISKA LAMNINGA, V32, P18; Sjostrom A., 1997, LUND ARCHAEOLOGICAL, V3, P5; Sorensen M., 2012, EMERGENCE PRESSURE B, P237, DOI [DOI 10.1007/978-1-4614-2003-3, 10.1007/978-1-4614-2003-3_9, DOI 10.1007/978-1-4614-2003-3_9]; Thomas S. E., 1954, ACTA ARCHAEOLOGICA L, V1; Tjellden AKE, 2016, CONSERV MANAGE ARCHA, V18, P126, DOI 10.1080/13505033.2016.1182768; Turner-Walker G., 1999, B GEOL SOC NORFOLK, V48, P3; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2	65	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236105	10.1371/journal.pone.0236105	http://dx.doi.org/10.1371/journal.pone.0236105			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2YL	32726345	Green Published, gold			2022-12-26	WOS:000556908900025
J	Zhou, QQ; Shi, YT; Qi, H; Liu, HJ; Wei, NN; Jiang, Y; Wang, KW				Zhou, Qiqi; Shi, Yuntao; Qi, Hang; Liu, Huijie; Wei, Ningning; Jiang, Yong; Wang, KeWei			Identification of two natural coumarin enantiomers for selective inhibition of TRPV2 channels	FASEB JOURNAL			English	Article						brown adipocytes; differentiation; murraxocin; TRPV2 channel	BROWN ADIPOSE-TISSUE; ACTIVATION; DIFFERENTIATION; THERMOGENESIS; EXPRESSION; LIGAND; MICE	Thermosensitive transient receptor potential vanilloid 2 (thermoTRPV2) is a nonselective Ca2+-permeable cation channel broadly expressed, and is implicated in the pathology of diseases such as diabetes and pancreatitis. However, the physiological and pharmacological functions of TRPV2 channels have not been extensively investigated because of the absence of specific modulators. In this study, we report a pair of natural coumarin derivative enantiomers (-)-murraxocin (B304-1) and (+)-murraxocin (B304-2) fromMurraya exoticafor their selective inhibition of TRPV2 channels expressed in HEK293 cells and native TRPV2 currents in differentiated brown adipocytes. Whole-cell patch clamp recordings confirmed the enantiomers B304-1 and B304-2 could selectively inhibit the agonist mediated activation of TRPV2 current with IC(50)values of 22.2 +/- 7.8 mu M and 3.7 +/- 0.7 mu M, respectively. Molecular docking and site-directed mutagenesis revealed a key residue I600 of TRPV2 critical for the binding of the enantiomers. Furthermore, B304-1 and B304-2 significantly reversed TRPV2 agonist-induced inhibition of mouse brown adipocyte differentiation. Taken together, our identification of two natural coumarin enantiomers provides valuable tools and chemical leads for further elucidation of TRPV2 channel function, and pharmacological modulation of thermoTRPV2 in brown adipocytes may represent a new therapeutic strategy for treatment of energy imbalance or metabolic disorders.	[Zhou, Qiqi; Qi, Hang; Liu, Huijie; Wei, Ningning; Wang, KeWei] Qingdao Univ, Dept Pharmacol, Sch Pharm, Qingdao 266021, Peoples R China; [Shi, Yuntao; Jiang, Yong] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China	Qingdao University; Peking University	Wei, NN; Wang, KW (corresponding author), Qingdao Univ, Dept Pharmacol, Sch Pharm, Qingdao 266021, Peoples R China.; Jiang, Y (corresponding author), Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.	weiningning@qdu.edu.cn; yongjiang@bjmu.edu.cn; wangkw@qdu.edu.cn	Jiang, Yong/C-4026-2016	Jiang, Yong/0000-0002-8450-7786	National Natural Science Foundation of China (NSFC) [81573410]; Ministry of Science and technology China [2018ZX09711001-004-006]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81573410; Ministry of Science and technology China, Grant/Award Number: 2018ZX09711001-004-006	Arechaga I, 2001, IUBMB LIFE, V52, P165, DOI 10.1080/15216540152845966; Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; BARIK BR, 1987, PHYTOCHEMISTRY, V26, P3319, DOI 10.1016/S0031-9422(00)82496-6; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bishnoi M, 2018, OBES REV, V19, P1269, DOI 10.1111/obr.12703; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao X, 2012, J BIOL CHEM, V287, P25905, DOI 10.1074/jbc.M112.364869; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chai H, 2019, J MED CHEM, V62, P1373, DOI 10.1021/acs.jmedchem.8b01496; Che H, 2014, PFLUG ARCH EUR J PHY, V466, P947, DOI 10.1007/s00424-013-1355-4; Cromer BA, 2008, TOXICON, V51, P163, DOI 10.1016/j.toxicon.2007.10.012; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Darakhshan S, 2015, PHARMACOL RES, V91, P15, DOI 10.1016/j.phrs.2014.10.009; Flockerzi V., 2007, V179, P1; Fricke TC, 2019, P NATL ACAD SCI USA, V116, P24359, DOI 10.1073/pnas.1904332116; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gao W, 2017, METHODS MOL BIOL, V1566, P3, DOI 10.1007/978-1-4939-6820-6_1; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gudermann T, 2005, N-S ARCH PHARMACOL, V371, P241, DOI 10.1007/s00210-005-1029-7; Heler R, 2013, CHANNELS, V7, P74, DOI 10.4161/chan.23453; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Klement G, 2013, BIOPHYS J, V104, P798, DOI 10.1016/j.bpj.2013.01.008; Kojima I, 2014, HANDB EXP PHARMACOL, V222, P247, DOI 10.1007/978-3-642-54215-2_10; Lei L, 2013, J BIOL CHEM, V288, P10427, DOI 10.1074/jbc.M113.457291; Li WQ, 2010, MOLECULES, V15, P5831, DOI 10.3390/molecules15085831; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Munakata Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19765-5; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nagasawa M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12296; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Qin N, 2008, J NEUROSCI, V28, P6231, DOI 10.1523/JNEUROSCI.0504-08.2008; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reddy Narendra L, 2014, BMC Obes, V1, P13, DOI 10.1186/s40608-014-0013-5; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Rychkov G., 2007, V179, P23; Sharma R, 2006, PHYTOTHER RES, V20, P607, DOI 10.1002/ptr.1909; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Stokes AJ, 2005, J CELL BIOCHEM, V94, P669, DOI 10.1002/jcb.20331; Stokes AJ, 2004, J EXP MED, V200, P137, DOI 10.1084/jem.20032082; Sugio S, 2017, FASEB J, V31, P1368, DOI 10.1096/fj.201600686RR; Sun WP, 2017, CELL BIOL INT, V41, P908, DOI 10.1002/cbin.10783; Sun WP, 2017, CHANNELS, V11, P94, DOI 10.1080/19336950.2016.1228401; Sun WP, 2016, PFLUG ARCH EUR J PHY, V468, P1527, DOI 10.1007/s00424-016-1846-1; Sun WP, 2016, EMBO REP, V17, P383, DOI 10.15252/embr.201540819; Tang Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0041-2; Tian You-Qing, 2008, Zhongguo Zhong Yao Za Zhi, V33, P339; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Warwick CA, 2019, PAIN, V160, P702, DOI 10.1097/j.pain.0000000000001449; Wei NN, 2016, J BIOL CHEM, V291, P640, DOI 10.1074/jbc.M115.654392; Yang J S, 1983, Yao Xue Xue Bao, V18, P760; Zhang XL, 2018, NAT STRUCT MOL BIOL, V25, P1009, DOI 10.1038/s41594-018-0148-z; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	58	8	9	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12338	12353		10.1096/fj.201901541RRR	http://dx.doi.org/10.1096/fj.201901541RRR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729134	hybrid			2022-12-26	WOS:000556784300001
J	Taubert, F; Hetzer, J; Schmid, JS; Huth, A				Taubert, Franziska; Hetzer, Jessica; Schmid, Julia Sabine; Huth, Andreas			Confronting an individual-based simulation model with empirical community patterns of grasslands	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; VEGETATION DYNAMICS; MANAGED GRASSLANDS; CARBON DYNAMICS; PRODUCTIVITY; BIODIVERSITY; ECOSYSTEM; SCALE; COMPETITION; DIVERSITY	Grasslands contribute to global biogeochemical cycles and can host a high number of plant species. Both-species dynamics and biogeochemical fluxes-are influenced by abiotic and biotic environmental factors, management and natural disturbances. In order to understand and project grassland dynamics under global change, vegetation models which explicitly capture all relevant processes and drivers are required. However, the parameterization of such models is often challenging. Here, we report on testing an individual- and process-based model for simulating the dynamics and structure of a grassland experiment in temperate Europe. We parameterized the model for three species and confront simulated grassland dynamics with empirical observations of their monocultures and one two-species mixture. The model reproduces general trends of vegetation patterns (vegetation cover and height, aboveground biomass and leaf area index) for the monocultures and two-species community. For example, the model simulates well an average annual grassland cover of 70% in the species mixture (observed cover of 77%), but also shows mismatches with specific observation values (e.g. for aboveground biomass). By a sensitivity analysis of the applied inverse model parameterization method, we demonstrate that multiple vegetation attributes are important for a successful parameterization while leaf area index revealed to be of highest relevance. Results of our study pinpoint to the need of improved grassland measurements (esp. of temporally higher resolution) in close combination with advanced modelling approaches.	[Taubert, Franziska; Hetzer, Jessica; Schmid, Julia Sabine; Huth, Andreas] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Huth, Andreas] Univ Osnabruck, Inst Environm Syst Res, Osnabruck, Lower Saxony, Germany; [Huth, Andreas] German Ctr Integrat Biodivers Res iDiv, Leipzig, Saxony, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University Osnabruck	Taubert, F (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany.	franziska.taubert@ufz.de		Taubert, Franziska/0000-0001-7594-8152; Hetzer, Jessica/0000-0002-2384-0024; Schmid, Julia/0000-0003-2378-8980	Federal Ministry of Food and Agriculture (BMEL)	Federal Ministry of Food and Agriculture (BMEL)	The project is supported (was supported) by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support programme.	Abaye AO, 2019, COMMON GRASSES, LEGUMES AND FORBS OF THE EASTERN UNITED STATES: IDENTIFICATION AND ADAPTATION, P1, DOI 10.1016/C2016-0-05364-0; Adler PB, 2011, SCIENCE, V334, P905; AMTHOR JS, 1984, PLANT CELL ENVIRON, V7, P561, DOI 10.1111/1365-3040.ep11591833; [Anonymous], 2010, P 23 GEN M EUR GRASS; Batello Ceds., 2005, GRASSLANDS WORLD, V34; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Berger U, 2000, ECOL MODEL, V132, P287, DOI 10.1016/S0304-3800(00)00298-2; Bohn FJ, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160521; Bohn K, 2011, BIOGEOSCIENCES, V8, P1107, DOI 10.5194/bg-8-1107-2011; Botkin D.B., 1993, FOREST DYNAMICS ECOL; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Butler EE, 2017, P NATL ACAD SCI USA, V114, pE10937, DOI 10.1073/pnas.1708984114; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Cipriotti PA, 2016, METHODS ECOL EVOL, V7, P313, DOI 10.1111/2041-210X.12464; Confalonieri R, 2014, ECOL MODEL, V286, P1, DOI 10.1016/j.ecolmodel.2014.04.019; Crawford M, 2019, OIKOS, V128, P441, DOI 10.1111/oik.05567; Csillery K, 2012, METHODS ECOL EVOL, V3, P475, DOI 10.1111/j.2041-210X.2011.00179.x; de Myttenaere A, 2016, NEUROCOMPUTING, V192, P38, DOI 10.1016/j.neucom.2015.12.114; Edelfeldt S, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11100187; Fauvel M, 2020, REMOTE SENS ENVIRON, V237, DOI 10.1016/j.rse.2019.111536; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fischer R, 2019, SURVEYS GEOPHYS; Fischer R, 2016, ECOL MODEL, V326, P124, DOI 10.1016/j.ecolmodel.2015.11.018; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Griffiths P, 2020, REMOTE SENS ENVIRON, V238, DOI 10.1016/j.rse.2019.03.017; Griffiths P, 2019, REMOTE SENS ENVIRON, V220, P135, DOI 10.1016/j.rse.2018.10.031; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; Haddad NM, 2002, ECOL LETT, V5, P110, DOI 10.1046/j.1461-0248.2002.00293.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hartig F, 2011, ECOL LETT, V14, P816, DOI 10.1111/j.1461-0248.2011.01640.x; Haughey E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33262-9; Heisse K, 2007, OECOLOGIA, V152, P435, DOI 10.1007/s00442-007-0666-6; Isselstein J., 2005, Agronomy Research, V3, P139; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kinzig A. P., 2002, FUNCTIONAL CONSEQUEN; Kipling RP, 2016, SCI TOTAL ENVIRON, V566, P851, DOI 10.1016/j.scitotenv.2016.05.144; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Knapp N, 2018, REMOTE SENS ENVIRON, V205, P199, DOI 10.1016/j.rse.2017.11.018; Knyazikhin Y., 1999, MODIS ATBD; Kohler P, 2004, MECH PROMOTING TROPI, V105, P177; Kraft NJB, 2015, P NATL ACAD SCI USA, V112, P797, DOI 10.1073/pnas.1413650112; Lehmann S, 2015, ECOL MODEL, V301, P98, DOI 10.1016/j.ecolmodel.2015.01.013; Lenth R., 2019, Journal of Statistical Software, V60, P1; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Maire V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077372; Maire V, 2013, ECOL MODEL, V254, P80, DOI 10.1016/j.ecolmodel.2012.03.039; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; May F, 2009, OIKOS, V118, P1830, DOI 10.1111/j.1600-0706.2009.17724.x; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Moulin T, 2018, ECOL MODEL, V374, P22, DOI 10.1016/j.ecolmodel.2018.02.013; Movedi E, 2019, ECOL MODEL, V401, P111, DOI 10.1016/j.ecolmodel.2019.03.001; PACALA SW, 1990, ECOL MONOGR, V60, P113, DOI 10.2307/1943028; PACALA SW, 1985, AM NAT, V125, P385, DOI 10.1086/284349; PARTON WJ, 1988, BIOGEOCHEMISTRY, V5, P109, DOI 10.1007/BF02180320; Polley HW, 2013, OIKOS, V122, P1275, DOI 10.1111/j.1600-0706.2013.00338.x; POORTER H, 1992, NEW PHYTOL, V120, P159, DOI 10.1111/j.1469-8137.1992.tb01069.x; Preidl S, 2020, REMOTE SENS ENVIRON, V240, DOI 10.1016/j.rse.2020.111673; Proulx R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013382; Pulina A, 2017, GRASS FORAGE SCI, DOI [10.1111/gfs.12310.hal-01637737, DOI 10.1111/GFS.12310.HAL-01637737]; Rammer W, 2019, METHODS ECOL EVOL, V10, P879, DOI 10.1111/2041-210X.13171; Rodig E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13063-y; Rodig E, 2017, GLOBAL ECOL BIOGEOGR, V26, P1292, DOI 10.1111/geb.12639; Rolinski S, 2018, GEOSCI MODEL DEV, V11, P429, DOI 10.5194/gmd-11-429-2018; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Sakschewski B, 2016, NAT CLIM CHANGE, V6, P1032, DOI [10.1038/nclimate3109, 10.1038/NCLIMATE3109]; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Schmidtlein S, 2010, J VEG SCI, V21, P1162, DOI 10.1111/j.1654-1103.2010.01221.x; Shugart H.H., 1998, TERRESTRIAL ECOSYSTE; Shugart HH, 2015, FRONT ECOL ENVIRON, V13, P503, DOI 10.1890/140327; Siehoff S, 2011, ECOL MODEL, V222, P3854, DOI 10.1016/j.ecolmodel.2011.10.003; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Soussana JF, 2012, ECOL MODEL, V231, P134, DOI 10.1016/j.ecolmodel.2012.02.002; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Taubert F, 2012, ECOL MODEL, V245, P84, DOI 10.1016/j.ecolmodel.2012.04.007; Thornley J. H. M., 2007, Mathematical models in agriculture: quantitative methods for the plant, animal and ecological sciences, DOI 10.1079/9780851990101.0000; Thornley J.H.M., 1998, GRASSLAND DYNAMICS E, DOI 10.1079/9780851992273.0000; Thornley JHM, 1998, GRASSLAND DYNAMICS; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1988; van Oijen M, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8020014; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; Weiner J, 2001, AM NAT, V158, P438, DOI 10.1086/321988; Weiss L, 2015, ECOL MODEL, V303, P1, DOI 10.1016/j.ecolmodel.2015.02.002; Weisser WW, 2017, BASIC APPL ECOL, V23, P1, DOI 10.1016/j.baae.2017.06.002; Weryszko-Chmielewska E, 2012, ACTA AGROBOTANICA, V65; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; WYSZOMIRSKI T, 1986, EKOL POL-POL J ECOL, V34, P615; Xu XM, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9030254; Zelnik YR, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00224	95	7	7	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236546	10.1371/journal.pone.0236546	http://dx.doi.org/10.1371/journal.pone.0236546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722690	Green Published, gold			2022-12-26	WOS:000556916000016
J	Leem, J; Kim, HY				Leem, JoonBum; Kim, Ha Young			Action-specialized expert ensemble trading system with extended discrete action space using deep reinforcement learning	PLOS ONE			English	Article							PREDICTING STOCK; MACHINE; LIQUIDITY; FRAMEWORK; RETURNS	Despite active research on trading systems based on reinforcement learning, the development and performance of research methods require improvements. This study proposes a new action-specialized expert ensemble method consisting of action-specialized expert models designed specifically for each reinforcement learning action: buy, hold, and sell. Models are constructed by examining and defining different reward values that correlate with each action under specific conditions, and investment behavior is reflected with each expert model. To verify the performance of this technique, profits of the proposed system are compared to those of single trading and common ensemble systems. To verify robustness and account for the extension of discrete action space, we compared and analyzed changes in profits of the three actions to our model's results. Furthermore, we checked for sensitivity with three different reward functions: profit, Sharpe ratio, and Sortino ratio. All experiments were conducted with S&P500, Hang Seng Index, and Eurostoxx50 data. The model was 39.1% and 21.6% more efficient than single and common ensemble models, respectively. Considering the extended discrete action space, the 3-action space was extended to 11- and 21-action spaces, and the cumulative returns increased by 427.2% and 856.7%, respectively. Results on reward functions indicated that our models are well trained; results of the Sharpe and Sortino ratios were better than the implementation of profit only, as in the single-model cases. The Sortino ratio was slightly better than the Sharpe ratio.	[Leem, JoonBum] Ajou Univ, Dept Financial Engn, Suwon, South Korea; [Kim, Ha Young] Yonsei Univ, Grad Sch Informat, Seoul, South Korea	Ajou University; Yonsei University	Kim, HY (corresponding author), Yonsei Univ, Grad Sch Informat, Seoul, South Korea.	haimkgetup@gmail.com	Chanelian, Serena/ABE-4873-2021; Kim, Hayoung/GQP-0924-2022	Chanelian, Serena/0000-0001-5727-6137; Kim, Ha Young/0000-0001-5115-9984	Technology Advancement Research Program (TARP) - Ministry of Land, Infrastructure and Transport of the Korean government [19CTAP-C152020-01]	Technology Advancement Research Program (TARP) - Ministry of Land, Infrastructure and Transport of the Korean government(Ministry of Land, Infrastructure & Transport (MOLIT), Republic of Korea)	This research was supported by a grant (19CTAP-C152020-01) from the Technology Advancement Research Program (TARP) funded by the Ministry of Land, Infrastructure and Transport of the Korean government. The funder played no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The author JB was involved in the study prior to belonging to Daishin Asset Management company, and no funds have been contributed by the company. The specific roles of these authors are articulated in the `author contributions' section.	Almahdi S, 2017, EXPERT SYST APPL, V87, P267, DOI 10.1016/j.eswa.2017.06.023; Andrychowicz M, 2020, INT J ROBOT RES, V39, P3, DOI 10.1177/0278364919887447; Angluin D., 1988, Machine Learning, V2, P319, DOI 10.1023/A:1022821128753; Baek Y, 2018, EXPERT SYST APPL, V113, P457, DOI 10.1016/j.eswa.2018.07.019; Bao W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180944; Beattie C., 2016, ARXIV161203801; BELLMAN R, 1957, J MATH MECH, V6, P679, DOI 10.1512/iumj.1957.6.56038; Booth A, 2014, EXPERT SYST APPL, V41, P3651, DOI 10.1016/j.eswa.2013.12.009; Brockman Greg, 2016, ARXIV160601540; Chatzis SP, 2018, EXPERT SYST APPL, V112, P353, DOI 10.1016/j.eswa.2018.06.032; Chong E, 2017, EXPERT SYST APPL, V83, P187, DOI 10.1016/j.eswa.2017.04.030; Deng Y, 2017, IEEE T NEUR NET LEAR, V28, P653, DOI 10.1109/TNNLS.2016.2522401; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Duan Y, 2016, PR MACH LEARN RES, V48; Dulac-Arnold, 2015, ARXIV151207679; Giacomel F, 2015, 2015 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY (WI-IAT), VOL 2, P230, DOI 10.1109/WI-IAT.2015.43; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hausknecht M.J., 2015, AAAI FALL S; Haykin S, 2010, NEURAL NETWORKS LEAR, V3; Heaton J.B., 2016, DEEP PORTFOLIO THEOR; Henderson P, 2018, AAAI CONF ARTIF INTE, P3207; Huang C. Y., 2018, ARXIV180702787; Huang HH, 2015, J FINANC RES, V38, P59, DOI 10.1111/jfir.12052; Huang W, 2005, COMPUT OPER RES, V32, P2513, DOI 10.1016/j.cor.2004.03.016; JEGADEESH N, 1993, J FINANC, V48, P65, DOI 10.1111/j.1540-6261.1993.tb04702.x; Jeong G, 2019, EXPERT SYST APPL, V117, P125, DOI 10.1016/j.eswa.2018.09.036; Jin C, 2018, ADV NEUR IN, V31; Ju C, 2018, J APPL STAT, V45, P2800, DOI 10.1080/02664763.2018.1441383; Kretchmar RM, 2002, 6TH WORLD MULTICONFERENCE ON SYSTEMICS, CYBERNETICS AND INFORMATICS, VOL VI, PROCEEDINGS, P114; Lauer Martin, 2000, P 17 INT C MACHINE L; Lillicrap TP, 2015, CONTINUOUS CONTROL D, DOI [DOI 10.1561/2200000006, 10.48550/arXiv.1509.02971]; Liu T, 2018, IEEE-CAA J AUTOMATIC, V5, P827, DOI 10.1109/JAS.2018.7511144; Mnih V., 2013, ARXIV13125602, DOI DOI 10.1038/NATURE14236; Mnih V, 2016, PR MACH LEARN RES, V48; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Moody J, 2001, IEEE T NEURAL NETWOR, V12, P875, DOI 10.1109/72.935097; Nair Arun, 2015, ARXIV150704296; Patel J, 2015, EXPERT SYST APPL, V42, P2162, DOI 10.1016/j.eswa.2014.10.031; Patel J, 2015, EXPERT SYST APPL, V42, P259, DOI 10.1016/j.eswa.2014.07.040; Pendharkar PC, 2018, EXPERT SYST APPL, V103, P1, DOI 10.1016/j.eswa.2018.02.032; Roll R, 2010, J BANK FINANC, V34, P2562, DOI 10.1016/j.jbankfin.2010.04.012; Saad David, 1998, ONLINE LEARN, V5, P6; SHARPE WF, 1994, J PORTFOLIO MANAGE, V21, P49, DOI 10.3905/jpm.1994.409501; TRAFALIS TB, 2000, IEEE IJCNN, P348, DOI DOI 10.1109/IJCNN.2000.859420; Tsai CF, 2009, LECT NOTES ENG COMP, P755; Tsai CF, 2011, APPL SOFT COMPUT, V11, P2452, DOI 10.1016/j.asoc.2010.10.001; Umino K, 2018, LECT NOTES ARTIF INT, V10838, P140, DOI 10.1007/978-3-319-93794-6_10; van Hasselt H, 2009, IEEE IJCNN, P1144; Wang JN, 2019, INT J FINANC ECON, V24, P890, DOI 10.1002/ijfe.1697; Wang Y., 2017, DEEP Q TRADING; Wang Z, 2015, ARXIV151106581; Weng B., 2018, EXPERT SYST APPL, DOI [10.1016/j.eswa.2017.12.02132288338, DOI 10.1016/J.ESWA.2017.12.02132288338]; Yang B, 2017, CHIN CONTR CONF, P3882, DOI 10.23919/ChiCC.2017.8027964; YANG C., 2019, DESTECH T EC BUSINES, DOI [10.12783/dtem/ssemr2019/30873, DOI 10.12783/DTEM/SSEMR2019/30873]; Zhou Z.H., 2012, ENSEMBLE METHODS FDN, DOI DOI 10.1201/B12207	57	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236178	10.1371/journal.pone.0236178; 10.1371/journal.pone.0236178.r001; 10.1371/journal.pone.0236178.r002; 10.1371/journal.pone.0236178.r003; 10.1371/journal.pone.0236178.r004	http://dx.doi.org/10.1371/journal.pone.0236178; 10.1371/journal.pone.0236178.r001; 10.1371/journal.pone.0236178.r002; 10.1371/journal.pone.0236178.r003; 10.1371/journal.pone.0236178.r004			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV9ND	32716945	Green Published, gold			2022-12-26	WOS:000556674500011
J	Sato, Y; Fujimoto, S; Iseki, K; Konta, T; Moriyama, T; Yamagata, K; Tsuruya, K; Narita, I; Kondo, M; Kasahara, M; Shibagaki, Y; Asahi, K; Watanabe, T				Sato, Yuji; Fujimoto, Shouichi; Iseki, Kunitoshi; Konta, Tsuneo; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Narita, Ichiei; Kondo, Masahide; Kasahara, Masato; Shibagaki, Yugo; Asahi, Koichi; Watanabe, Tsuyoshi			Higher baseline uric acid concentration is associated with non-attainment of optimal blood pressure	PLOS ONE			English	Article							ARTERIAL STIFFNESS; HYPERTENSION; HYPERURICEMIA; ADOLESCENTS	A significant relationship exists between elevated uric acid concentration and both prevalent and incident hypertension; however, data regarding the influence of higher uric acid concentration at baseline on blood pressure control by antihypertensive drugs is scarce. Thus, a prospective cohort study was performed. The study outcome was the non-attainment of optimal blood pressure (NOBP). NOBP level was defined according to the Japanese hypertension guideline. This study enrolled a Japanese community-based cohort (N = 8,664; age 65.5 +/- 6.4 years; women, 55.0%) who were not using antihypertensive drugs on the first visit for a health check-up program but started using antihypertensive drug(s) on the next-year visit. The participants were classified into quartiles based basic uric acid concentration. Odds ratios (ORs) were calculated for NOBP as the primary outcome measure. Multivariable logistic analysis showed that quartile 4 was significantly associated with NOBP when quartile 1 was set as the reference (OR (95% confidence interval), 1.36 (1.16-1.59), p<0.01), adjusted for potential confounders, such as age, sex, body mass index, presence of diabetes/dyslipidemia/chronic kidney disease (CKD), history of cardiovascular disease, daily drinking, and current smoking. In the subgroup analysis of female participants and participants with diabetes and CKD, a significant association was observed between +1 mg/dL of uric acid and NOBP. Higher uric acid concentration at baseline was significantly associated with NOBP on the first use of antihypertensive drug(s).	[Sato, Yuji] Natl Hlth Insurance Takachiho Town Hosp, Dept Internal Med, Div Nephrol, Miyazaki, Japan; [Fujimoto, Shouichi] Univ Miyazaki, Dept Hemovasc Med & Artificial Organs, Fac Med, Miyazaki, Japan; [Fujimoto, Shouichi; Iseki, Kunitoshi; Konta, Tsuneo; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Narita, Ichiei; Kondo, Masahide; Kasahara, Masato; Shibagaki, Yugo; Asahi, Koichi; Watanabe, Tsuyoshi] Steering Comm Res Design Comprehens Hlth Care Sys, Fukushima, Japan	University of Miyazaki	Sato, Y (corresponding author), Natl Hlth Insurance Takachiho Town Hosp, Dept Internal Med, Div Nephrol, Miyazaki, Japan.	ysato@med.miyazaki-u.ac.jp	Narita, Ichiei/G-5204-2017; Konta, Tsuneo/AAO-9286-2021	Narita, Ichiei/0000-0001-7692-3096; 	Ministry of Health, Labour and Welfare (JP) [H20-Junkankitou (Seishu).Ippan-008, H24Nanchitou (Jin).Ippan-006]; Japan Agency for Medical Research and Development [JP17ek0310005, JP18ek0310010, JP19ek0310010, JP18lk1010033]	Ministry of Health, Labour and Welfare (JP); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Ministry of Health, Labour and Welfare (JP) grants H20-Junkankitou (Seishu).Ippan-008 and H24Nanchitou (Jin).Ippan-006 to TW and the Japan Agency for Medical Research and Development grants JP17ek0310005, JP18ek0310010, JP19ek0310010 and JP18lk1010033 to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45680-4; [Anonymous], 2006, HYPERTENS RES, V29, pS1; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Canepa M, 2017, HYPERTENSION, V69, P228, DOI 10.1161/HYPERTENSIONAHA.116.08114; Chen Q, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009765; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Hirai H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39049-w; Janghorbani Mohsen, 2018, Rev Diabet Stud, V14, P354, DOI 10.1900/RDS.2017.14.354; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kinoshita M, 2018, J ATHEROSCLER THROMB, V25, P846, DOI 10.5551/jat.GL2017; Kohagura K, 2013, HYPERTENS RES, V36, P43, DOI 10.1038/hr.2012.135; Kudo A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44477-9; Kuwabara M, 2014, HYPERTENS RES, V37, P785, DOI 10.1038/hr.2014.75; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Nagahama K, 2015, HYPERTENS RES, V38, P213, DOI 10.1038/hr.2014.161; Nagano S, 2017, HYPERTENS RES, V40, P620, DOI 10.1038/hr.2017.10; Ohta Y, 2017, HYPERTENS RES, V40, P259, DOI 10.1038/hr.2016.139; Perlstein TS, 2004, KIDNEY INT, V66, P1465, DOI 10.1111/j.1523-1755.2004.00909.x; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Radenkovic S, 2015, J HYPERTENS, V33, pE117, DOI 10.1097/01.hjh.0000467665.99650.0f; */* S  62, 2011, DIABETES CARE S1, V34, pS6, DOI DOI 10.2337/DC11-S062; Shankar A, 2006, J HUM HYPERTENS, V20, P937, DOI 10.1038/sj.jhh.1002095; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Tanaka A, 2018, INT J CARDIOL, V272, P308, DOI 10.1016/j.ijcard.2018.06.017; Uedono H, 2015, KIDNEY BLOOD PRESS R, V40, P315, DOI 10.1159/000368507; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105125, 10.1371/journal.pone.0114259]; Wang Y, 2017, MED SCI MONITOR, V23, P790, DOI 10.12659/MSM.899563; Yokokawa H, 2016, J CLIN HYPERTENS, V18, P53, DOI 10.1111/jch.12627	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236602	10.1371/journal.pone.0236602	http://dx.doi.org/10.1371/journal.pone.0236602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716977	Green Published, gold			2022-12-26	WOS:000556674500046
J	Don, SSL; Robertson, KL; Lin, HH; Labriola, C; Harrington, ME; Taylor, SR; Farkas, ME				Don, Sujeewa S. Lellupitiyage; Robertson, Kelly L.; Lin, Hui-Hsien; Labriola, Caroline; Harrington, Mary E.; Taylor, Stephanie R.; Farkas, Michelle E.			Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner	PLOS ONE			English	Article							GENE-EXPRESSION; FLAVONOID NOBILETIN; CANCER CELLS; CLOCK; IDENTIFICATION; BIOACTIVATION; METABOLISM; INHIBITION; MODULATORS; TARGETS	The natural product nobiletin is a small molecule, widely studied with regard to its therapeutic effects, including in cancer cell lines and tumors. Recently, nobiletin has also been shown to affect circadian rhythms via their enhancement, resulting in protection against metabolic syndrome. We hypothesized that nobiletin's anti-oncogenic effects, such as prevention of cell migration and formation of anchorage independent colonies, are correspondingly accompanied by modulation of circadian rhythms. Concurrently, we wished to determine whether the circadian and anti-oncogenic effects of nobiletin differed across cancer cell lines. In this study, we assessed nobiletin's circadian and therapeutic characteristics to ascertain whether these effects depend on cell line, which here also varied in terms of baseline circadian rhythmicity. Three cell culture models where nobiletin's effects on cell proliferation and migration have been studied previously were evaluated: U2OS (bone osteosarcoma), which possesses robust circadian rhythms; MCF7 (breast adenocarcinoma), which has weak circadian rhythms; and MDA-MB-231 (breast adenocarcinoma), which is arrhythmic. We found that circadian, migration, and proliferative effects following nobiletin treatment were subtle in the U2OS and MCF7 cells. On the other hand, changes were clear in MDA-MB-231s, where nobiletin rescued rhythmicity and substantially reduced oncogenic features, specifically two-dimensional cell motility and anchorage-independent growth. Based on these results and those previously described, we posit that the effects of nobiletin are indeed cell-type dependent, and that a positive correlation may exist between nobiletin's circadian and therapeutic effects.	[Don, Sujeewa S. Lellupitiyage; Lin, Hui-Hsien; Farkas, Michelle E.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Robertson, Kelly L.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Labriola, Caroline; Harrington, Mary E.] Smith Coll, Dept Psychol, Northampton, MA 01063 USA; [Taylor, Stephanie R.] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Smith College; Colby College	Farkas, ME (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	farkas@chem.umass.edu		Lellupitiyage Don, Sujeewa Sampath/0000-0001-7576-0379; Taylor, Stephanie/0000-0003-3562-6479; Harrington, Mary/0000-0003-2266-6455	University of Massachusetts Amherst Chemistry-Biology Interface Training Program Fellowship - University of Massachusetts Amherst Commonwealth Honors College Honors Research Grant; Office of the Provost at Colby College - National Institutes of Health [R15 GM126545]	University of Massachusetts Amherst Chemistry-Biology Interface Training Program Fellowship - University of Massachusetts Amherst Commonwealth Honors College Honors Research Grant; Office of the Provost at Colby College - National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHL was funded by a University of Massachusetts Amherst Chemistry-Biology Interface Training Program Fellowship; https://www.umass.edu/cbi/traineeships.html KLR was funded by a University of Massachusetts Amherst Commonwealth Honors College Honors Research Grant; https://www.umass.edu/honors/admissions/scholarships/research SRT was funded by the Office of the Provost at Colby College; www.colby.edu/provost MEH was funded by the National Institutes of Health (R15 GM126545); www.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Caviglia C, 2015, ANALYST, V140, P3623, DOI 10.1039/c5an00097a; Chacolla-Huaringa R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071499; Chen C, 2014, ANTICANCER RES, V34, P1785; Chen JR, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-15; Chen JC, 2015, INT J ONCOL, V46, P2629, DOI 10.3892/ijo.2015.2946; Chen Z, 2012, P NATL ACAD SCI USA, V109, P101, DOI 10.1073/pnas.1118034108; Cheng HL, 2016, ONCOTARGET, V7, P35208, DOI 10.18632/oncotarget.9106; Da CL, 2016, ONCOL REP, V35, P2767, DOI 10.3892/or.2016.4661; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Don SSL, 2019, CELL CYCLE, V18, P2447, DOI 10.1080/15384101.2019.1648957; Feillet C, 2014, P NATL ACAD SCI USA, V111, P9828, DOI 10.1073/pnas.1320474111; Foteinou PT, 2018, P NATL ACAD SCI USA, V115, P11643, DOI 10.1073/pnas.1803410115; Fujioka A, 2006, BIOCHEM BIOPH RES CO, V346, P169, DOI 10.1016/j.bbrc.2006.05.094; Gutierrez-Monreal MA, 2016, CHRONOBIOL INT, V33, P392, DOI 10.3109/07420528.2016.1152976; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; He BK, 2016, CURR DRUG METAB, V17, P503, DOI 10.2174/1389200217666160111124439; Hirayama J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37879-8; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Horibata S, 2015, JOVE-J VIS EXP, DOI 10.3791/52727; Hsiao PC, 2014, TUMOR BIOL, V35, P11903, DOI 10.1007/s13277-014-2457-0; Iurisci I, 2006, CANCER RES, V66, P10720, DOI 10.1158/0008-5472.CAN-06-2086; Izumo M, 2006, PLOS COMPUT BIOL, V2, P1248, DOI 10.1371/journal.pcbi.0020136; Jonkman JEN, 2014, CELL ADHES MIGR, V8, P440, DOI 10.4161/cam.36224; Kiessling S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0349-7; Lee YC, 2011, MOL CELL BIOCHEM, V347, P103, DOI 10.1007/s11010-010-0618-z; Lee YS, 2013, J NUTR BIOCHEM, V24, P156, DOI 10.1016/j.jnutbio.2012.03.014; Leise TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033334; LEVINE JD, 2002, BMC NEUROSCI, V3; Li SM, 2006, BIOMED CHROMATOGR, V20, P133, DOI 10.1002/bmc.540; Li XM, 2010, CANCER RES, V70, P3351, DOI 10.1158/0008-5472.CAN-09-4235; Lien LM, 2016, PHYTOTHER RES, V30, P214, DOI 10.1002/ptr.5517; Lin HH, 2020, INTEGR CANCER THER, V19, DOI 10.1177/1534735420924094; Lin HH, 2020, METHOD ENZYMOL, V639, P115, DOI 10.1016/bs.mie.2020.04.011; Lin HH, 2019, INTEGR CANCER THER, V18, DOI 10.1177/1534735419836494; Liu B, 2016, BIOMED PHARMACOTHER, V81, P104, DOI 10.1016/j.biopha.2016.03.051; Liu JL, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Muelas MW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21050-4; Nakajima A, 2013, BEHAV BRAIN RES, V250, P351, DOI 10.1016/j.bbr.2013.05.025; Nohara K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174281; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Rahman Sabhi, 2017, Journal of Circadian Rhythms, V15, P3, DOI 10.5334/jcr.147; Relogio A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004338; Rodriguez M, 2013, MOL CANCER RES, V11, P780, DOI 10.1158/1541-7786.MCR-12-0675; Rossetti S, 2012, CELL CYCLE, V11, P350, DOI 10.4161/cc.11.2.18792; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Shinozaki A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170904; Song MY, 2016, J AGR FOOD CHEM, V64, P4943, DOI 10.1021/acs.jafc.6b01367; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Sp N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060772; Sp N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050935; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Surichan S, 2018, FOOD CHEM TOXICOL, V113, P228, DOI 10.1016/j.fct.2018.01.047; Surichan S, 2012, FOOD CHEM TOXICOL, V50, P3320, DOI 10.1016/j.fct.2012.06.030; Tamai TK, 2018, EMBO MOL MED, P1, DOI [10.15252/emmm.201708365, DOI 10.15252/EMMM.201708365]; Tominari T, 2012, J PHARMACOL SCI, V119, P390, DOI 10.1254/jphs.11188SC; Wei D, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00690; Welsh DK, 2005, METHOD ENZYMOL, V393, P269, DOI 10.1016/S0076-6879(05)93011-5; Xiong YJ, 2015, MOL NUTR FOOD RES, V59, P829, DOI 10.1002/mnfr.201400614; Yabuki Y, 2014, NEUROSCIENCE, V259, P126, DOI 10.1016/j.neuroscience.2013.11.051; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Yasuda N, 2014, BRAIN RES, V1559, P46, DOI 10.1016/j.brainres.2014.02.007; Yeom M, 2018, MOLECULES, V23, DOI 10.3390/molecules23040745; Yi LT, 2011, PHYSIOL BEHAV, V102, P1, DOI 10.1016/j.physbeh.2010.10.008; Yuk T, 2018, EVID-BASED COMPL ALT, V2018, P1, DOI DOI 10.1155/2018/; Zhang N, 2016, MOL CELL BIOCHEM, V417, P87, DOI 10.1007/s11010-016-2716-z; Zielinski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096462	72	10	10	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236315	10.1371/journal.pone.0236315	http://dx.doi.org/10.1371/journal.pone.0236315			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706791	gold, Green Submitted, Green Published			2022-12-26	WOS:000579931700024
J	Axelsson, J; Scott, K; Dillner, J; Lindh, CH; Zhang, H; Rylander, L; Rignell-Hydbom, A				Axelsson, Jonatan; Scott, Kristin; Dillner, Joakim; Lindh, Christian H.; Zhang, He; Rylander, Lars; Rignell-Hydbom, Anna			Exposure to polychlorinated compounds and cryptorchidism; A nested case-control study	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; CONGENITAL CRYPTORCHIDISM; ORGANOCHLORINE PESTICIDES; TESTICULAR DYSGENESIS; SERUM CONCENTRATIONS; BREAST-MILK; HYPOSPADIAS; PREVALENCE; BIPHENYLS; HEALTH	Background Maldescended testes or cryptorchidism is a genital birth defect that affects 2-9% of all male new-borns. Over the last 40 years there have been reports of increased prevalence in countries like the US, the UK and the Scandinavian countries. This possible increase has in some studies been linked to a foetal exposure to chemical pollutants. In this matched case-control study, we analysed maternal serum samples in early pregnancy for three different organochlorine compounds, to investigate whether the levels were associated with the risk of cryptorchidism. Method Maternal serum samples taken during the first trimester of pregnancy from 165 cases (boys born with cryptorchidism) and 165 controls, matched for birth year and maternal age, parity and smoking habits during the pregnancy, were retrieved from the Southern Sweden Maternity Biobank. The samples were analysed for 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153), dichlorodiphenyltrichloroethane (p,p'-DDE) and hexachlorobenzene (HCB), using gas chromatography mass spectrometry. Associations between exposure and cryptorchidism were evaluated by conditional logistic regression. Results We found no statistically significantly associations between exposure to these compounds and cryptorchidism, either when the exposure variables were used as a continuous variable, or when the exposure levels were divided in quartiles. Conclusion We found no evidence of an association between maternal levels of PCB-153, p,p'-DDE or HCB during the pregnancy and the risk of having cryptorchidism in the sons.	[Axelsson, Jonatan] Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden; [Axelsson, Jonatan; Scott, Kristin; Lindh, Christian H.; Rylander, Lars; Rignell-Hydbom, Anna] Lund Univ, Dept Lab Med, Div Occupat & Environm Med, Lund, Sweden; [Axelsson, Jonatan; Zhang, He] Lund Univ, Dept Translat Med, Reprod Med, Malmo, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Karolinska Institutet	Axelsson, J (corresponding author), Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden.; Axelsson, J (corresponding author), Lund Univ, Dept Lab Med, Div Occupat & Environm Med, Lund, Sweden.; Axelsson, J (corresponding author), Lund Univ, Dept Translat Med, Reprod Med, Malmo, Sweden.	jonatan.axelsson@med.lu.se		Lindh, Christian/0000-0001-7435-9890; Zhang, He/0000-0002-4572-8420; Rylander, Lars/0000-0001-8288-8207	Swedish Research Council [ARH: 2008-32038-63634-60]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	ARH: 2008-32038-63634-60, The Swedish Research Council, https://www.vr.se/english.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abballe A, 2008, ANN I SUPER SANITA, V44, P281; Acerini CL, 2009, ARCH DIS CHILD, V94, P868, DOI 10.1136/adc.2008.150219; Atuma SS, 1998, FOOD ADDIT CONTAM, V15, P142, DOI 10.1080/02652039809374623; Bergbrant S, 2018, J PEDIATR-US, V194, P197, DOI 10.1016/j.jpeds.2017.09.062; Bhatia R, 2005, ENVIRON HEALTH PERSP, V113, P220, DOI 10.1289/ehp.7382; Boisen KA, 2004, LANCET, V363, P1264, DOI 10.1016/S0140-6736(04)15998-9; Bonde JP, 2017, HUM REPROD UPDATE, V23, P104, DOI 10.1093/humupd/dmw036; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Cano-Sancho G, 2020, MOL CELL ENDOCRINOL, V499, DOI 10.1016/j.mce.2019.110606; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Damgaard IN, 2006, ENVIRON HEALTH PERSP, V114, P1133, DOI 10.1289/ehp.8741; Fisher M, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0143-y; Glynn AW, 2000, SCI TOTAL ENVIRON, V263, P197, DOI 10.1016/S0048-9697(00)00703-8; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Grimvall E, 1997, ARCH ENVIRON CON TOX, V32, P329, DOI 10.1007/s002449900193; Gurney JK, 2017, NAT REV UROL, V14, P534, DOI 10.1038/nrurol.2017.90; Hauser R, 2003, ENVIRON HEALTH PERSP, V111, P1505, DOI 10.1289/ehp.6175; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Jorgensen A, 2015, SEMIN CELL DEV BIOL, V45, P124, DOI 10.1016/j.semcdb.2015.09.013; Koskenniemi JJ, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0065-0; Krysiak-Baltyn K, 2012, INT J ANDROL, V35, P294, DOI 10.1111/j.1365-2605.2012.01268.x; Lymperi S, 2018, METABOLISM, V86, P79, DOI 10.1016/j.metabol.2018.03.022; McGlynn KA, 2009, ENVIRON HEALTH PERSP, V117, P1472, DOI 10.1289/ehp.0800389; Nieschlag E, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P193, DOI 10.1007/978-3-540-78355-8_13; Paulozzi LJ, 1999, ENVIRON HEALTH PERSP, V107, P297, DOI 10.2307/3434597; Pierik FH, 2007, ENVIRON RES, V105, P364, DOI 10.1016/j.envres.2007.04.005; Porpora MG, 2013, INT J ENV RES PUB HE, V10, P699, DOI 10.3390/ijerph10020699; Rignell-Hydbom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044767; Rylander L, 2012, CHEMOSPHERE, V88, P828, DOI 10.1016/j.chemosphere.2012.03.089; Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Tabachnick BG, 2013, LOGISTIC REGRESSION, P439; Toppari J, 2001, HUM REPROD UPDATE, V7, P282, DOI 10.1093/humupd/7.3.282; Torres-Sanchez L, 2013, ENVIRON HEALTH PERSP, V121, P263, DOI 10.1289/ehp.1205034; Virtanen HE, 2007, ACTA PAEDIATR, V96, P611, DOI 10.1111/j.1651-2227.2007.00241.x; Vizcaino E, 2014, ENVIRON INT, V65, P107, DOI 10.1016/j.envint.2014.01.004; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241	37	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236394	10.1371/journal.pone.0236394	http://dx.doi.org/10.1371/journal.pone.0236394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702712	gold, Green Published			2022-12-26	WOS:000575913700087
J	Jose, B; Manhica, I; Jones, J; Mutaquiha, C; Zindoga, P; Eduardo, I; Creswell, J; Qin, ZZ; Ramis, O; Ramiro, I; Chidacua, M; Cowan, J				Jose, B.; Manhica, I; Jones, J.; Mutaquiha, C.; Zindoga, P.; Eduardo, I; Creswell, J.; Qin, Z. Z.; Ramis, O.; Ramiro, I; Chidacua, M.; Cowan, J.			Using community health workers for facility and community based TB case finding: An evaluation in central Mozambique	PLOS ONE			English	Article							TUBERCULOSIS	Background Mozambique has one of the highest incidence rates of both TB and HIV in the world and an estimated tuberculosis (TB) treatment coverage of only 57% in 2018. Numerous approaches are being tested to reduce existing gaps in coverage and the estimated number of missing cases. Methods Thirty Community Healthcare Workers (CHWs) were tasked with increasing TB notifications by performing verbal facility-based TB screening of all people presenting for care and TB contact tracing in the community. Using routine National TB Program data, we analyzed trends in TB notifications in five intervention districts and seven control districts in Manica province the year before this project and during a one-year intervention period. Results In the four quarters before the study, the intervention districts notified 5,219 individuals with all forms of TB, and the control districts notified 2,248 TB cases. During the study 5,982 all forms of people with TB were notified in the intervention area, an increase of 763 (14.6%) over the baseline, whereas the control districts notified 1,877 persons with TB, a decrease of -371 (-16.5%). The CHW screening activities yielded 1,502 notified and treated individuals with TB. Conclusions Employing CHWs to promote facility-based TB screening and household contact tracing may lead to an overall increase in TB notification.	[Jose, B.; Manhica, I; Jones, J.; Mutaquiha, C.; Zindoga, P.] Mozambique Minist Hlth, Natl TB Program, Maputo, Mozambique; [Eduardo, I] Mozambique Minist Hlth, Prov TB Program, Manica, Mozambique; [Creswell, J.; Qin, Z. Z.; Ramis, O.] Stop TB Partnership, TB REACH, Geneva, Switzerland; [Ramiro, I; Chidacua, M.; Cowan, J.] Hlth Alliance Int, Beira, Mozambique; [Cowan, J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Cowan, J (corresponding author), Hlth Alliance Int, Beira, Mozambique.; Cowan, J (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	jcowan22@gmail.com		Zindoga, Pereira/0000-0002-0348-574X; Qin, Zhi Zhen/0000-0002-3956-5223	Global Affairs Canada; Bill and Melinda Gates Foundation; USAID through Stop TB Partnership's TB REACH initiative; 2015 developmental grant from the University of Washington Center for AIDS Research (CFAR); NIH [AI027757]; NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NIA); NIH (NIGMS); NIH (NIDDK)	Global Affairs Canada(CGIAR); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); USAID through Stop TB Partnership's TB REACH initiative; 2015 developmental grant from the University of Washington Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Global Affairs Canada, The Bill and Melinda Gates Foundation and USAID through Stop TB Partnership's TB REACH initiative. JCreswell and ZZQ received salary from Global Affairs Canada. This study was also supported in part by a 2015 developmental grant from the University of Washington Center for AIDS Research (CFAR), an NIH funded program under award number AI027757 which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK). This funder provided salary support for JCowan. Funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the `author contributions' section. There was no additional external funding received for this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, Global Affairs Canada, USAID, The Bill and Melinda Gases Foundation, USAID or the Stop TB Partnership.	Agins BD, 2019, LANCET INFECT DIS; [Anonymous], 2022, FLEMING FUND; [Anonymous], 2013, EXPLORING INDIVIDUAL; [Anonymous], 2019, MOZ NAT TB PROGR ANN; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Beste J, 2018, INT J TUBERC LUNG D, V22, P1358, DOI DOI 10.5588/IJTLD.17.0901; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Creswell J, 2015, INT J TUBERC LUNG D, V19, P545, DOI 10.5588/ijtld.14.0775; Datiko DG, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000390; De Schacht C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219470; Garcia-Basteiro AL, 2019, EUR RESP J; Gurung SC, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0603-z; Inguane CA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20846; John S, 2015, INT J TUBERC LUNG D, V19, P463, DOI 10.5588/ijtld.14.0679; Joint initiative FIND, JOINT IN FIND TREAT; Kim J, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010423; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150405; NOSTER J, 2019, J CLIN TUBERC OTHER, V15, DOI DOI 10.1371/JOURNAL.PPAT.1007741; Reid MJA, 2019, LANCET, V393, P1331, DOI 10.1016/S0140-6736(19)30024-8; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Sanaie A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163813; Ssemmondo E, 2016, JAIDS-J ACQ IMM DEF, V73, pE46, DOI 10.1097/QAI.0000000000001142; Stop TB Partnership, 2019, TB REACHS MON EV M E; Stop TB Partnership, 2019, STOP TB PARTN TB REA; Subbaraman R, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002754; The World Bank, 2018, WORLD BANK COUNTR PR; UNAIDS, 2019, UNAIDS COUNTR SIT MO; Vyas A, 2019, INT J TUBERC LUNG D, V23, P750, DOI 10.5588/ijtld.18.0741; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2013, TUB DIAGN XPERT MTB; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2019, MOZ HIV TUB HEP NAT	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236262	10.1371/journal.pone.0236262	http://dx.doi.org/10.1371/journal.pone.0236262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702073	gold, Green Published			2022-12-26	WOS:000575913700065
J	Lin, YH; Hung, SJ; Chen, YL; Lin, CH; Kung, TF; Yeh, YC; Tseng, JT; Liu, T				Lin, Yu-Hung; Hung, Sheng-Jou; Chen, Yi-Lin; Lin, Cheng-Han; Kung, Te-Fang; Yeh, Yi-Chun; Tseng, Joseph T.; Liu, Tsunglin			Dissecting efficiency of a 5 ' rapid amplification of cDNA ends (5 '-RACE) approach for profiling T-cell receptor beta repertoire	PLOS ONE			English	Article							IMMUNOGLOBULIN; DESIGN	Deep sequencing of T-cell receptor (TCR) genes is powerful at profiling immune repertoire. To prepare a TCR sequencing library, multiplex polymerase chain reaction (mPCR) is widely applied and is highly efficient. That is, most mPCR products contain the region critical for antigen recognition, which also indicates regular V(D)J recombination. Multiplex PCR, however, may suffer from primer bias. A promising alternative is 5'-RACE, which avoids primer bias by applying only one primer pair. In 5'-RACE data, however, non-regular V(D)J recombination (e.g., TCR sequences without a V gene segment) has been observed and the frequency varies (30-80%) between studies. This suggests that the cause of or how to reduce non-regular TCR sequences is not yet well known by the science community. Although it is possible to speculate the cause by comparing the 5 '-RACE protocols, careful experimental confirmation is needed and such a systematic study is still not available. Here, we examined the 5'-RACE protocol of a commercial kit and demonstrated how a modification increased the fraction of regular TCR-beta sequences to >85%. We also found a strong linear correlation between the fraction of short DNA fragments and the percentage of non-regular TCR-beta sequences, indicating that the presence of short DNA fragments in the library was the main cause of non-regular TCR-beta sequences. Therefore, thorough removal of short DNA fragments from a 5'-RACE library is the key to high data efficiency. We highly recommend conducting a fragment length analysis before sequencing, and the fraction of short DNA fragments can be used to estimate the percentage of non-regular TCR sequences. As deep sequencing of TCR genes is still relatively expensive, good quality control should be valuable.	[Lin, Yu-Hung; Hung, Sheng-Jou; Lin, Cheng-Han; Kung, Te-Fang; Yeh, Yi-Chun; Tseng, Joseph T.; Liu, Tsunglin] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan; [Chen, Yi-Lin] Natl Cheng Kung Univ Hosp, Dept Pathol, Mol Diagnost Lab, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Tseng, JT; Liu, T (corresponding author), Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan.	tctseng@mail.nck.edu.tw; tsunglin@mail.nck.edu.tw	Tseng, Joseph Ta-Chien/I-2850-2018	Tseng, Joseph Ta-Chien/0000-0002-3304-6086	Ministry of Science and Technology of Taiwan [MOST 107-2221-E-006-198-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by grant from Ministry of Science and Technology of Taiwan (MOST 107-2221-E-006-198-MY2) to TL. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alachkar H, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0395-3; [Anonymous], 2005, Nat Methods, V2, P629; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Calis JJA, 2014, TRENDS IMMUNOL, V35, P581, DOI 10.1016/j.it.2014.09.004; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Choudhury NJ, 2016, EUR UROL FOCUS, V2, P445, DOI 10.1016/j.euf.2015.09.007; Fang H, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.968467; Gonzalez D, 2003, LEUKEMIA, V17, P1051, DOI 10.1038/sj.leu.2402937; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Hung SJ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1304-2; Inoue H, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1204507; Joshi K, 2019, NAT MED, V25, P1549, DOI 10.1038/s41591-019-0592-2; Kiyotani K, 2018, J HUM GENET, V63, P239, DOI 10.1038/s10038-017-0364-0; Liu Xiao, 2016, PLoS One, V11, pe0152464, DOI 10.1371/journal.pone.0152464; Mamedov IZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00456; Rosati E, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0379-9; Ruggiero E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9081; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Six A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00413; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236366	10.1371/journal.pone.0236366	http://dx.doi.org/10.1371/journal.pone.0236366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702062	gold, Green Published			2022-12-26	WOS:000575913700080
J	Yan, PP; Liu, J; Zhou, R; Lin, C; Wu, KH; Yang, SB; Yang, S; Zhou, JY; Xu, LJ; Wang, H; Zhao, L				Yan, Pingping; Liu, Jian; Zhou, Rui; Lin, Chuang; Wu, Kunhe; Yang, Shibin; Yang, Shuai; Zhou, Jueyu; Xu, Lijun; Wang, Hui; Zhao, Liang			LASP1 interacts with N-WASP to activate the Arp2/3 complex and facilitate colorectal cancer metastasis by increasing tumour budding and worsening the pattern of invasion	ONCOGENE			English	Article							LIM; PROTEINS; PROLIFERATION; MIGRATION; CELLS	LIM and SH3 protein 1 (LASP1) is a metastasis-related protein reported to enhance tumour progression in colorectal cancer (CRC). However, the underlying mechanism is still elusive. As the major biological and pathological functions of LASP1 are accomplished by its LIM and SH3 domains via protein-protein interactions, a yeast two-hybrid system was employed to screen novel LASP1-interacting proteins. N-WASP, a member of the Wiskott-Aldrich syndrome protein (WASP) family, was screened and identified as a LASP1-interacting protein overexpressed in CRC tissues. N-WASP could stimulate the migration and invasion of CRC cells in vitro and increase the formation of subcutaneous tumours, mesenteric implanted tumours and hepatic metastatic tumours. N-WASP could interact with and activate the Arp2/3 complex to stimulate actin polymerization, thus changing the migratory and invasive capabilities of CRC cells. The interaction of LASP1 with N-WASP did not influence the expression of N-WASP but recovered the reduced actin polymerization induced by N-WASP silencing. High N-WASP expression was detected in most clinical colorectal samples, and it was positively correlated with the expression of LASP1 and ARP3, as well as the tumour budding and pattern of invasion, but negatively correlated with host lymphocytic response. Our study suggests a new mechanism for LASP1-mediated CRC metastasis determined by exploring LASP1-interacting proteins and identifies N-WASP as a potential therapeutic target for CRC.	[Yan, Pingping; Liu, Jian; Zhou, Rui; Lin, Chuang; Xu, Lijun; Zhao, Liang] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China; [Yan, Pingping; Liu, Jian; Zhou, Rui; Xu, Lijun; Zhao, Liang] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Peoples R China; [Yan, Pingping; Liu, Jian; Zhou, Rui; Xu, Lijun; Zhao, Liang] Southern Med Univ, Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou, Peoples R China; [Wu, Kunhe] Guangdong Women & Children Hosp, Dept Pathol, Guangzhou 511442, Guangdong, Peoples R China; [Yang, Shibin] Sun Yat Sen Univ, Gastrointestinal Surg Ctr, Affiliated Hosp 1, Guangzhou 510080, Peoples R China; [Yang, Shuai] Sun Yat Sen Univ, Dept Neurosurg, Affiliated Hosp 1, Guangzhou 510080, Peoples R China; [Zhou, Jueyu] Southern Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Guangzhou 510515, Peoples R China; [Wang, Hui] Guangzhou Med Univ, Dept Med Oncol, Affiliated Tumor Hosp, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China; Guangzhou Medical University	Zhao, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China.; Zhao, L (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Peoples R China.; Zhao, L (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou, Peoples R China.	liangsmu@foxmail.com	xu, li/GNH-3667-2022		National Natural Science Foundation of China [81773082, 81702903, 81872423, 81972813]; Guangdong Natural Science Foundation [2018B030311036, 2019A1515010974]; Fork Ying Tung Education Foundation [161035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fork Ying Tung Education Foundation	This work was supported by the National Natural Science Foundation of China (Nos. 81773082, 81702903, 81872423, 81972813), Guangdong Natural Science Foundation (2018B030311036, 2019A1515010974) and Fork Ying Tung Education Foundation (161035).	Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Caie PD, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-156; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Chatterjee D, 2019, ENT-EAR NOSE THROAT, V98, pE112, DOI 10.1177/0145561319848669; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Cronin KA, 2018, CANCER-AM CANCER SOC, V124, P2785, DOI [10.1002/cncr.31551, 10.1002/cncr.32802]; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Duvall-Noelle N, 2016, ONCOGENE, V35, P1122, DOI 10.1038/onc.2015.166; Gao QZ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0443-y; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Heerema MGJ, 2016, HISTOPATHOLOGY, V68, P388, DOI 10.1111/his.12754; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lane J, 2014, CANCER GENOM PROTEOM, V11, P155; Li H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05280-6; Li YF, 2013, HEAD NECK PATHOL, V7, P211, DOI 10.1007/s12105-012-0412-1; Lugli A, 2017, MODERN PATHOL, V30, P1299, DOI 10.1038/modpathol.2017.46; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Nakagawa H, 2006, FEBS LETT, V580, P3223, DOI 10.1016/j.febslet.2006.04.082; Niu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26112; Orth MF, 2015, ONCOTARGET, V6, P26, DOI 10.18632/oncotarget.3083; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Prall F, 1994, HISTOPATHOLOGY, V78, P635; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Salvi A, 2015, INT J ONCOL, V46, P1901, DOI 10.3892/ijo.2015.2923; Shao ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25631; Sun WD, 2017, ONCOL REP, V37, P341, DOI 10.3892/or.2016.5223; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; van Wyk HC, 2019, ANN SURG ONCOL, V26, P4397, DOI 10.1245/s10434-019-07931-6; Wang H, 2014, CLIN CANCER RES, V20, P5835, DOI 10.1158/1078-0432.CCR-14-0485; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zhao TS, 2015, CANCER RES, V75, P111, DOI 10.1158/0008-5472.CAN-14-2040; Zhou R, 2018, INT J CANCER, V142, P1853, DOI 10.1002/ijc.31206	38	10	11	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2020	39	35					5743	5755		10.1038/s41388-020-01397-7	http://dx.doi.org/10.1038/s41388-020-01397-7		JUL 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NF2QB	32704133				2022-12-26	WOS:000551792300001
J	Ng, HP; Kim, GD; Chan, ER; Dunwoodie, SL; Mahabeleshwar, GH				Hang Pong Ng; Kim, Gun-Dong; Chan, E. Ricky; Dunwoodie, Sally L.; Mahabeleshwar, Ganapati H.			CITED2 limits pathogenic inflammatory gene programs in myeloid cells	FASEB JOURNAL			English	Article						CITED2; inflammation; innate immunity; macrophage	CREB-BINDING-PROTEIN; KAPPA-B; HEART; IDENTIFICATION; RECOGNITION; RESOLUTION; RECEPTORS	Monocyte-derived macrophages are the major innate immune cells that provide the first line of cellular defense against infections or injuries. These recruited macrophages at the site of inflammation are exposed to a broad range of cytokines that categorically incite a robust pro-inflammatory response. However, macrophage pro-inflammatory activation must be under exquisite control to avert unbridled inflammation. Thus, endogenous mechanisms must exist that rigorously preserve macrophage quiescence and yet, allow nimble pro-inflammatory macrophage response with precise spatiotemporal control. Herein, we identify the CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich carboxyl-terminal domain 2 (CITED2) as a critical intrinsic negative regulator of inflammation, which broadly attenuates pro-inflammatory gene programs in macrophages. Our in vivo studies revealed that myeloid-CITED2 deficiency significantly heightened macrophages and neutrophils recruitment to the site of inflammation. Our integrated transcriptomics and gene set enrichment analysis (GSEA) studies uncovered that CITED2 deficiency broadly enhances NF kappa B targets, IFN gamma/IFN alpha responses, and inflammatory response gene expression in macrophages. Using complementary gain- and loss-of-function studies, we observed that CITED2 overexpression attenuate and CITED2 deficiency elevate LPS-induced NF kappa B transcriptional activity and NF kappa B-p65 recruitment to target gene promoter in macrophages. More importantly, blockade of NF kappa B signaling completely reversed elevated pro-inflammatory gene expression in macrophages. Collectively, our findings show that CITED2 restrains NF kappa B activation and curtails broad pro-inflammatory gene programs in myeloid cells.	[Hang Pong Ng; Kim, Gun-Dong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA; [Chan, E. Ricky] Case Western Reserve Univ, Sch Med, Cleveland Inst Computat Biol, Cleveland, OH 44106 USA; [Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Dunwoodie, Sally L.] UNSW Sydney, Sydney, NSW, Australia; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Cardiovasc Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Case Western Reserve University	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA.	ghm4@case.edu			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL126626, HL141423]; Crohn's and Colitis Foundation of America (CCFA) [421904]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Crohn's and Colitis Foundation of America (CCFA)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL126626 and HL141423; Crohn's and Colitis Foundation of America (CCFA), Grant/Award Number: 421904	Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Chu WT, 2020, P NATL ACAD SCI USA, V117, P5595, DOI 10.1073/pnas.1915333117; Das A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00022; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Kim GD, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00452-17; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Li YP, 1999, ANTIOXID REDOX SIGN, V1, P97, DOI 10.1089/ars.1999.1.1-97; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mukherjee SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001647; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Platanitis E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02542; Preis JI, 2006, GENESIS, V44, P579, DOI 10.1002/dvg.20251; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Varma TK, 2002, CLIN DIAGN LAB IMMUN, V9, P530, DOI 10.1128/CDLI.9.3.530-543.2002; Volcik KA, 2004, AM J MED GENET A, V126A, P324, DOI 10.1002/ajmg.a.20578; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Withington SL, 2006, DEV BIOL, V294, P67, DOI 10.1016/j.ydbio.2006.02.025; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	36	5	5	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12100	12113		10.1096/fj.202000864R	http://dx.doi.org/10.1096/fj.202000864R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32697413	Green Published, hybrid			2022-12-26	WOS:000554917800001
J	Xu, XL; Wang, SH; Dong, JH; Shen, ZC; Xu, SW				Xu, Xinliang; Wang, Shihao; Dong, Jinhui; Shen, Zhicheng; Xu, Shuwan			An analysis of the domestic resumption of social production and life under the COVID-19 epidemic	PLOS ONE			English	Article								Population migration and urban traffic are two important aspects of the socioeconomic system. We analyze the trends of social production and resumption of life after the coronavirus disease 2019 (COVID-19)-influenced Spring Festival in 2020 with statistics on reported cases of COVID-19 from China's National Health Commission and big data from Baidu Migration (a platform collecting population migration data). We find that (1) the distribution of COVID-19 cases throughout mainland China has a specific spatial pattern. Provinces in eastern China have more reported cases than those in western China, and provinces adjacent to Hubei have more confirmed COVID-19 cases than nonadjacent provinces. Densely populated regions with well-developed economies and transportation are more likely to have cluster infection incidents. (2) The COVID-19 epidemic severely impacts the return of the migrant population in the Spring Festival travel rush, as demonstrated by the significant reduction in the return scale, along with the extended timespan and uncertainty regarding the end of the travel rush. Among 33 provinces, special administrative regions, autonomous regions and municipalities, 23 of them (approximately 70%) have a return rate below 60%. Hubei, Hong Kong, Xinjiang, and Inner Mongolia have the lowest return rates (below 5%), whereas the return rates in Hainan and Shandong, 272.72% and 97.35%, respectively, indicate the best trend of resumption. Due to government regulations, the population return in densely populated and well-developed regions shows a positive trend. (3) The resumption of urban traffic is slow and varies greatly in different regions. The urban traffic conditions in 22 provinces and municipalities have a more than 60% level of resumption. Guizhou and Yunnan have the highest level of resumption of urban traffic, whereas Xinjiang, Hubei, and Heilongjiang have the lowest (29.37%, 35.76%, and 37.90%, respectively). However, provinces and municipalities with well-developed intercity traffic have a lower level of resumption, mainly because of regulatory methods such as lockdowns and traffic restrictions. The increased public awareness of epidemic prevention and the decreased frequency of outdoor activities are also two positive factors slowing the spread of the epidemic. (4) Time will be necessary to fully resume social production and life throughout China. Xining and Jinan have the highest levels of resumption, 82.14% and 71.51%, respectively. Urumqi and Wuhan are the cities with the lowest levels of resumption, only 0.11% and 0.61%, respectively. Currently, 12 of 33 provinces and municipalities have levels of resumption of more than 80%; among them, Guizhou, Yunnan, and Gansu have with the highest levels of resumption and have nearly resumed the 2019 levels of work and life, whereas Xinjiang and Hubei have the lowest resumption rates, only 0.09% and 7.57%, respectively. Thus, relevant government departments should focus more on densely populated and well-developed provinces and cities when applying epidemic prevention and work resumption methods. We reveal the general conditions of the epidemic and the population return scale across China, along with urban traffic conditions and the resumption of social production and life under COVID-19, providing a scientific basis for local governments to make further decisions on work resumption.	[Xu, Xinliang; Wang, Shihao; Dong, Jinhui; Shen, Zhicheng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Wang, Shihao; Shen, Zhicheng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Shuwan] Renmin Univ China, High Sch, Tongzhou Campus, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Renmin University of China	Xu, XL (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	xuxl@lreis.ac.cn		Wang, Shihao/0000-0001-8091-4926	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA20010302]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by the Strategic Priority Research Program of the Chinese Academy of Sciences(No. XDA20010302).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahas R, 2005, FUTURES, V37, P547, DOI 10.1016/j.futures.2004.10.012; Chen B, 2013, URBAN PROBLEMS, P1; Chen R., 2014, CHINA POPULATION RES, V10, P104; de Haas H, 2010, INT MIGR REV, V44, P227, DOI 10.1111/j.1747-7379.2009.00804.x; [冯章献 Feng Zhangxian], 2019, [经济地理, Economic Geography], V39, P101; Hu Y, STAT DECISION; Jiang X., 2017, POPUL, V23, P13; Jiang X.R., 2017, CHIN J POPUL SCI, V2, P35; LAN T, 2017, EC VISION, P88, DOI DOI 10.1109/ICVISP.2017.9; Shen G.B., 2020, J SHANGHAI U INT BUS, V27, P16, DOI DOI 10.16060/J.CNKI.2095-8072.2020.02.002; Sun F., 2006, ECON GEOGR, V26, P974; [孙桂平 Sun Guiping], 2019, [地域研究与开发, Areal Research and Development], V38, P166; Tan Y, 2018, J HEBEI NORMAL U SCI, V32, P74; Xu X, 2002, J U ELECT SCI TECHNO; [赵梓渝 Zhao Ziyu], 2017, [地理科学进展, Progress in Geography], V36, P952	15	20	21	9	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236387	10.1371/journal.pone.0236387	http://dx.doi.org/10.1371/journal.pone.0236387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU0WZ	32697812	Green Published, gold			2022-12-26	WOS:000555392700023
J	Ji, YC; Zhang, JJ; Lu, YY; Yi, QZ; Chen, MQ; Xie, SP; Mao, XT; Xiao, Y; Meng, FL; Zhang, ML; Yang, RL; Guan, MX				Ji, Yanchun; Zhang, Juanjuan; Lu, Yuanyuan; Yi, Qiuzi; Chen, Mengquan; Xie, Shipeng; Mao, Xiaoting; Xiao, Yun; Meng, Feilong; Zhang, Minglian; Yang, Rulai; Guan, Min-Xin			Complex I mutations synergize to worsen the phenotypic expression of Leber's hereditary optic neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Leber's hereditary optic neuropathy; mitochondrial DNA; mutation; ubiquinone oxidoreductase; pathophysiology; mitochondrial disease; mitochondrial respiratory chain complex; mitophagy; vision; pathogenesis; organelle; oxygen radicals; human genetics; apoptosis; molecular modeling; modifier; NADH; ubiquinone oxidoreductase; penetrance	HAN CHINESE SUBJECTS; 12S RIBOSOMAL-RNA; OXIDATIVE STRESS; MTDNA; METABOLISM; AUTOPHAGY; CELLS; MANIFESTATION; MITOCHONDRIA; PENETRANCE	Leber's hereditary optic neuropathy (LHON) is a maternal inheritance of eye disease because of the mitochondrial DNA (mtDNA) mutations. We previously discovered a 3866T>C mutation within the gene for the ND1 subunit of complex I as possibly amplifying disease progression for patients bearing the disease-causing 11778G>A mutation within the gene for the ND4 subunit of complex I. However, whether and how the ND1 mutation exacerbates the ND4 mutation were unknown. In this report, we showed that four Chinese families bearing both m.3866T>C and m.11778G>A mutations exhibited higher penetrances of LHON than 6 Chinese pedigrees carrying only the m.3866T>C mutation or families harboring only the m.11778G>A mutation. The protein structure analysis revealed that the m.3866T>C (I187T) and m.11778G>A (R340H) mutations destabilized the specific interactions with other residues of ND1 and ND4, thereby altering the structure and function of complex I. Cellular data obtained using cybrids, constructed by transferring mitochondria from the Chinese families into mtDNA-less (rho degrees) cells, demonstrated that the mutations perturbed the stability, assembly, and activity of complex I, leading to changes in mitochondrial ATP levels and membrane potential and increasing the production of reactive oxygen species. These mitochondrial dysfunctions promoted the apoptotic sensitivity of cells and decreased mitophagy. Cybrids bearing only the m.3866T>C mutation displayed mild mitochondrial dysfunctions, whereas those harboring both m.3866T>C and m.11778G>A mutations exhibited greater mitochondrial dysfunctions. These suggested that the m.3866T>C mutation acted in synergy with the m.11778G>A mutation, aggravating mitochondrial dysfunctions and contributing to higher penetrance of LHON in these families carrying both mtDNA mutations.	[Ji, Yanchun; Meng, Feilong; Yang, Rulai] Zhejiang Univ, Sch Med, Dept Genet & Metab Dis, Hangzhou, Zhejiang, Peoples R China; [Ji, Yanchun; Meng, Feilong; Guan, Min-Xin] Zhejiang Univ, Sch Med, Div Med Genet & Genom, Childrens Hosp,Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China; [Ji, Yanchun; Lu, Yuanyuan; Yi, Qiuzi; Mao, Xiaoting; Xiao, Yun; Meng, Feilong; Guan, Min-Xin] Zhejiang Univ, Sch Med, Inst Genet, Hangzhou, Zhejiang, Peoples R China; [Zhang, Juanjuan; Lu, Yuanyuan] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Chen, Mengquan] Wenzhou Hosp Tradit Chinese Med, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Xie, Shipeng; Zhang, Minglian] Hebei Prov Eye Hosp, Dept Ophthalmol, Xingtai, Hebei, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Key Lab Reprod Genet, Minist Educ PRC, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Joint Inst Genet & Genom Med Zhejiang Univ & Univ, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Wenzhou Medical University; Zhejiang University	Yang, RL (corresponding author), Zhejiang Univ, Sch Med, Dept Genet & Metab Dis, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Div Med Genet & Genom, Childrens Hosp,Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Key Lab Reprod Genet, Minist Educ PRC, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Joint Inst Genet & Genom Med Zhejiang Univ & Univ, Hangzhou, Zhejiang, Peoples R China.	chsczx@zju.edu.cn; gminxin88@zju.edu.cn	Zhang, Juan/GRX-2638-2022; Zhang, Yonghui/AGY-9072-2022	Guan, Min-Xin/0000-0001-5067-6736	National Key R&D Program of China [2018YFC1002700, 2018YFC1004802]; Ministry of Science and Technology of China [31970557, 31471191, 81400434]; Natural Science Foundation of China	National Key R&D Program of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by and the National Key R&D Program of China, grant 2018YFC1002700 and 2018YFC1004802, from the Ministry of Science and Technology of China, and grants 31970557, 31471191, and 81400434 from the Natural Science Foundation of China.	Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arduino DM, 2012, HUM MOL GENET, V21, P4680, DOI 10.1093/hmg/dds309; Bahr T, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165743; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Caporali L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007210; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; Country MW, 2017, BRAIN RES, V1672, P50, DOI 10.1016/j.brainres.2017.07.025; Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Fan WL, 2019, J BIOL CHEM, V294, P19292, DOI 10.1074/jbc.RA119.010598; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Houstek J, 1999, HUM MOL GENET, V8, P1967; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Ji YC, 2019, HUM MOL GENET, V28, P1515, DOI 10.1093/hmg/ddy450; Ji YC, 2016, INVEST OPHTH VIS SCI, V57, P2377, DOI 10.1167/iovs.16-19243; Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241; Jiang PP, 2016, HUM MOL GENET, V25, P3613, DOI 10.1093/hmg/ddw199; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158; Kabakov AE, 2018, METHODS MOL BIOL, V1709, P107, DOI 10.1007/978-1-4939-7477-1_9; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1993, J BIOL CHEM, V268, P10228; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Liang M, 2014, INVEST OPHTH VIS SCI, V55, P1321, DOI 10.1167/iovs.13-13011; Liu XL, 2011, OPHTHALMOLOGY, V118, P978, DOI 10.1016/j.ophtha.2010.09.003; Mackey DA, 1996, AM J HUM GENET, V59, P481; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Maresca A, 2014, CURR MOL MED, V14, P985, DOI 10.2174/1566524014666141010132627; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Qian YP, 2011, MITOCHONDRION, V11, P871, DOI 10.1016/j.mito.2011.06.006; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Qu J, 2010, BBA-GEN SUBJECTS, V1800, P305, DOI 10.1016/j.bbagen.2009.08.010; Qu J, 2009, OPHTHALMOLOGY, V116, P558, DOI 10.1016/j.ophtha.2008.10.022; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Ronghua L, 2006, GENE, V376, P79, DOI 10.1016/j.gene.2006.02.014; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sadun AA, 2011, CURR TREAT OPTION NE, V13, P109, DOI 10.1007/s11940-010-0100-y; Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sharma LK, 2019, HUM MOL GENET, V28, P422, DOI 10.1093/hmg/ddy354; Song LY, 2017, BRAIN RES, V1657, P232, DOI 10.1016/j.brainres.2016.12.019; Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Torroni A, 1997, AM J HUM GENET, V60, P1107; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2017, HANDB EXP PHARMACOL, V240, P339, DOI 10.1007/164_2017_2; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107; Zhang JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05571-y; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317; Zhou XT, 2012, INVEST OPHTH VIS SCI, V53, P4586, DOI 10.1167/iovs.11-9109; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	81	14	15	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13224	13238		10.1074/jbc.RA120.014603	http://dx.doi.org/10.1074/jbc.RA120.014603			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32723871	Green Published, hybrid			2022-12-26	WOS:000574483500008
J	Miyasaka, M; Mioka, T; Kishimoto, T; Itoh, E; Tanaka, K				Miyasaka, Mamoru; Mioka, Tetsuo; Kishimoto, Takuma; Itoh, Eriko; Tanaka, Kazuma			A complex genetic interaction implicates that phospholipid asymmetry and phosphate homeostasis regulate Golgi functions	PLOS ONE			English	Article							P-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSLOCASE; MEMBRANE-PROTEINS; ER PROTEINS; YEAST; TRANSPORT; FLIPPASE; PHOSPHATIDYLSERINE; RETRIEVAL	In eukaryotic cells, phospholipid flippases translocate phospholipids from the exoplasmic to the cytoplasmic leaflet of the lipid bilayer. Budding yeast contains five flippases, of which Cdc50p-Drs2p and Neo1p are primarily involved in membrane trafficking in endosomes and Golgi membranes. TheANY1/CFS1gene was identified as a suppressor of growth defects in theneo1 Delta andcdc50 Delta mutants. Cfs1p is a membrane protein of the PQ-loop family and is localized to endosomal/Golgi membranes, but its relationship to phospholipid asymmetry remains unknown. Theneo1 Delta cfs1 Delta mutant appears to function normally in membrane trafficking but may function abnormally in the regulation of phospholipid asymmetry. To identify a gene that is functionally relevant toNEO1andCFS1, we isolated a mutation that is synthetically lethal withneo1 Delta cfs1 Delta and identifiedERD1. Erd1p is a Golgi membrane protein that is involved in the transport of phosphate (Pi) from the Golgi lumen to the cytoplasm. The Neo1p-depletedcfs1 Delta erd1 Delta mutant accumulated plasma membrane proteins in the Golgi, perhaps due to a lack of phosphatidylinositol 4-phosphate. The Neo1p-depletedcfs1 Delta erd1 Delta mutant also exhibited abnormal structure of the endoplasmic reticulum (ER) and induced an unfolded protein response, likely due to defects in the retrieval pathway from thecis-Golgi region to the ER. Genetic analyses suggest that accumulation of Pi in the Golgi lumen is responsible for defects in Golgi functions in the Neo1p-depletedcfs1 Delta erd1 Delta mutant. Thus, the luminal ionic environment is functionally relevant to phospholipid asymmetry. Our results suggest that flippase-mediated phospholipid redistribution and luminal Pi concentration coordinately regulate Golgi membrane functions.	[Miyasaka, Mamoru; Mioka, Tetsuo; Kishimoto, Takuma; Itoh, Eriko; Tanaka, Kazuma] Hokkaido Univ, Inst Genet Med, Div Mol Interact, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Miyasaka, Mamoru] Hokkaido Univ, Dept Gastroenterol Surg 2, Fac Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Tanaka, K (corresponding author), Hokkaido Univ, Inst Genet Med, Div Mol Interact, Grad Sch Life Sci, Sapporo, Hokkaido, Japan.	k-tanaka@igm.hokudai.ac.jp	Tanaka, Kazuma/A-4240-2012; Kishimoto, Takuma/AAP-1813-2021	Mioka, Tetsuo/0000-0002-4653-1718; Tanaka, Kazuma/0000-0003-1936-2856	JSPS KAKENHI [JP18K14645, JP18K06104, JP19K06536]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant numbers JP18K14645 (TM), JP18K06104 (TK), and JP19K06536 (KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Auesukaree C, 2003, BIOCHEM BIOPH RES CO, V306, P843, DOI 10.1016/S0006-291X(03)01068-4; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; BASSON ME, 1986, P NATL ACAD SCI USA, V83, P5563, DOI 10.1073/pnas.83.15.5563; Bi EF, 1996, MOL CELL BIOL, V16, P5264; BISSON LF, 1982, GENETICS, V102, P341; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brachmann CB, 1998, YEAST, V14, P115; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; De Matteis MA, 2013, BIOESSAYS, V35, P612, DOI 10.1002/bies.201200180; EGNER R, 1995, MOL CELL BIOL, V15, P5879; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; FISCHHOFF DA, 1984, GENE, V27, P239, DOI 10.1016/0378-1119(84)90069-6; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gloor Y, 2010, EUR J CELL BIOL, V89, P575, DOI 10.1016/j.ejcb.2010.02.004; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Guthrie C., 2002, GUIDE YEAST GENETICS; HARDWICK KG, 1990, EMBO J, V9, P623, DOI 10.1002/j.1460-2075.1990.tb08154.x; HARDWICK KG, 1990, NUCLEIC ACIDS RES, V18, P2177, DOI 10.1093/nar/18.8.2177; Haucke V, 2003, TRENDS CELL BIOL, V13, P59, DOI 10.1016/S0962-8924(02)00011-9; Heidtman M, 2003, J CELL BIOL, V163, P57, DOI 10.1083/jcb.200306118; Hermesh O, 2014, J CELL SCI, V127, P3373, DOI 10.1242/jcs.149799; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Huang YN, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158581; Hurlimann HC, 2009, EMBO REP, V10, P1003, DOI 10.1038/embor.2009.105; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; Kishimoto T, 2005, MOL BIOL CELL, V16, P5592, DOI 10.1091/mbc.E05-05-0452; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mioka T, 2014, MICROBIOLOGYOPEN, V3, P803, DOI 10.1002/mbo3.211; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Panatala R, 2015, J CELL SCI, V128, P2021, DOI 10.1242/jcs.102715; PELHAM HRB, 1988, EMBO J, V7, P1757, DOI 10.1002/j.1460-2075.1988.tb03005.x; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rose MD., 1990, METHODS YEAST GENETI; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; Sakane H, 2006, CELL STRUCT FUNCT, V31, P87, DOI 10.1247/csf.06021; Sambrook J, 2001, MOL CLONING LAB MANN; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Snyder NA, 2017, G3-GENES GENOM GENET, V7, P3913, DOI 10.1534/g3.117.300339; Suda Y, 2018, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00122; Takar M, 2019, J LIPID RES, V60, P1032, DOI 10.1194/jlr.M093526; Takar M, 2016, J BIOL CHEM, V291, P15727, DOI 10.1074/jbc.M115.686253; Takeda M, 2014, EUKARYOT CELL, V13, P363, DOI 10.1128/EC.00279-13; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; van Leeuwen J, 2016, SCIENCE, V354, DOI 10.1126/science.aag0839; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; Yamagami K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120108; Yamamoto T, 2017, G3-GENES GENOM GENET, V7, P179, DOI 10.1534/g3.116.035238; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	81	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236520	10.1371/journal.pone.0236520	http://dx.doi.org/10.1371/journal.pone.0236520			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730286	gold, Green Published			2022-12-26	WOS:000556884700104
J	Theis, T; Kumar, S; Wei, ELN; Nguyen, J; Glynos, V; Paranjape, N; Askarifirouzjaei, H; Khajouienejad, L; Berthiaume, F; Young, W; Schachner, M				Theis, Thomas; Kumar, Suneel; Wei, Elena; Nguyen, Jennifer; Glynos, Vicci; Paranjape, Nikita; Askarifirouzjaei, Hadi; Khajouienejad, Leila; Berthiaume, Francois; Young, Wise; Schachner, Melitta			Myristoylated alanine-rich C-kinase substrate effector domain peptide improves sex-specific recovery and axonal regrowth after spinal cord injury	FASEB JOURNAL			English	Article						myristoylated alanine-rich C-kinase substrate; polysialic acid; regeneration; sex difference; spinal cord injury	ADHESION MOLECULE NCAM; POLYSIALIC ACID; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; CALMODULIN-BINDING; MARCKS DEFICIENCY; PROTEIN; RECEPTOR; EXPRESSION; MEMBRANE	Myristoylated alanine-rich C-kinase substrate (MARCKS) is an intracellular receptor for polysialic acid. MARCKS supports development, synaptic plasticity, and regeneration after injury. MARCKS binds with its functionally essential effector domain (ED) to polysialic acid. A 25-mer peptide comprising the ED of MARCKS stimulates neuritogenesis of primary hippocampal neurons after addition to the culture. This motivated us to investigate whether ED peptide has similar effects in spinal cord injury. ED peptide supported recovery and regrowth of monoaminergic axons in female, but not in male mice. Sex-specific differences in response to ED peptide application also occurred in cultured neurons. In female but not male neurons, the ED peptide enhanced neurite outgrowth that could be suppressed by inhibitors of the estrogen receptors alpha and beta, fibroblast growth factor receptor-1, protein kinase C, and matrix metalloproteinase 2. In addition, we observed female-specific elevation of phosphorylated MARCKS levels after ED peptide treatment. In male neurons, the ED peptide enhanced neuritogenesis in the presence of an androgen receptor inhibitor to the extent seen in ED peptide-treated female neurons. However, inhibition of androgen receptor did not lead to increased phosphorylation of MARCKS. These results provide insights into the functions of a novel compound contributing to gender-dependent regeneration.	[Theis, Thomas; Wei, Elena; Nguyen, Jennifer; Glynos, Vicci; Paranjape, Nikita; Askarifirouzjaei, Hadi; Khajouienejad, Leila; Young, Wise; Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, 604 Allis Rd, Piscataway, NJ 08554 USA; [Theis, Thomas; Wei, Elena; Nguyen, Jennifer; Glynos, Vicci; Paranjape, Nikita; Askarifirouzjaei, Hadi; Khajouienejad, Leila; Young, Wise; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allis Rd, Piscataway, NJ 08554 USA; [Kumar, Suneel; Berthiaume, Francois] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08554 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Rutgers State Univ, Keck Ctr Collaborat Neurosci, 604 Allis Rd, Piscataway, NJ 08554 USA.; Schachner, M (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allis Rd, Piscataway, NJ 08554 USA.	schachner@dls.rutgers.edu	Berthiaume, Francois/ABD-2139-2020; Nguyen, Jennifer/GVS-4347-2022; Theis, Thomas/I-4247-2019; Kumar, Suneel/I-4404-2019	Theis, Thomas/0000-0001-5555-8501; Kumar, Suneel/0000-0003-4829-8654; Wei, Elena/0000-0003-2885-0659; Khajoueinejad, Leila/0000-0002-4269-3082	New Jersey Commission on Spinal Cord Research (NJSCR) [CSCR18ERG015]	New Jersey Commission on Spinal Cord Research (NJSCR)	New Jersey Commission on Spinal Cord Research (NJSCR), Grant/Award Number: CSCR18ERG015	Al-Shboul OA, 2018, BIOMED REP, V8, P283, DOI 10.3892/br.2018.1053; ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; ALLEN LAH, 1995, EMBO J, V14, P1109, DOI 10.1002/j.1460-2075.1995.tb07094.x; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bielecki B, 2016, P NATL ACAD SCI USA, V113, P14829, DOI 10.1073/pnas.1614826113; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; Chan WM, 2013, TRANSL STROKE RES, V4, P447, DOI 10.1007/s12975-012-0249-7; Chen X, 2019, P NATL ACAD SCI USA, V116, P5765, DOI 10.1073/pnas.1814909116; Chen Yuying, 2013, Top Spinal Cord Inj Rehabil, V19, P1, DOI 10.1310/sci1901-1; CRUTCHER KA, 1978, AM J ANAT, V153, P159, DOI 10.1002/aja.1001530110; David S, 2012, INT REV NEUROBIOL, V106, P127, DOI 10.1016/B978-0-12-407178-0.00006-5; Decuypere Jean-Paul, 2011, J Aging Res, V2011, P920178, DOI 10.4061/2011/920178; El Amri M, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0445-1; Elkabes S, 2014, EXP NEUROL, V259, P28, DOI 10.1016/j.expneurol.2014.01.008; Fargo KN, 2008, HORM BEHAV, V53, P716, DOI 10.1016/j.yhbeh.2008.01.014; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; Heller M, 2003, J NEUROCHEM, V84, P557, DOI 10.1046/j.1471-4159.2003.01537.x; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Janas T, 2001, ACTA BIOCHIM POL, V48, P163; Janas T, 2000, EUR BIOPHYS J BIOPHY, V29, P507, DOI 10.1007/s002490000097; Kataria H, 2016, MOL NEUROBIOL, V53, P4461, DOI 10.1007/s12035-015-9352-6; Kawashima T, 2018, NEUROSCI RES, V129, P32, DOI 10.1016/j.neures.2017.07.005; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kleene R, 2019, RESTOR NEUROL NEUROS, V37, P291, DOI 10.3233/RNN-190903; Kleene R, 2010, J BIOL CHEM, V285, P28968, DOI 10.1074/jbc.M110.114876; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Lin HY, 1998, MOL CELL BIOL, V18, P3762, DOI 10.1128/MCB.18.7.3762; LOBAUGH LA, 1990, J BIOL CHEM, V265, P18393; Loers G, 2017, J NEUROCHEM, V142, P392, DOI 10.1111/jnc.14076; Matsumoto A, 1997, BRAIN RES BULL, V44, P539, DOI 10.1016/S0361-9230(97)00240-2; McNamara RK, 1998, J COMP NEUROL, V397, P337; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Namekata K, 2012, GENES CELLS, V17, P688, DOI 10.1111/j.1365-2443.2012.01616.x; Pan HC, 2014, NEUROSCIENCE, V277, P356, DOI 10.1016/j.neuroscience.2014.06.069; Pooley AE, 2015, BRAIN RES, V1624, P19, DOI 10.1016/j.brainres.2015.07.015; Qin ZH, 1996, BIOCHEMISTRY-US, V35, P2917, DOI 10.1021/bi9521452; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sainath R, 2015, CELL TISSUE RES, V359, P267, DOI 10.1007/s00441-014-1955-0; Saini V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26927; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; Swierczynski SL, 1996, DEV BIOL, V179, P135, DOI 10.1006/dbio.1996.0246; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Tajik A, 2020, ANAL BIOCHEM, V600, DOI 10.1016/j.ab.2020.113743; Theis T, 2018, MOL NEUROBIOL, V55, P8203, DOI 10.1007/s12035-018-0953-8; Theis T, 2017, MOL NEUROBIOL, V54, P4659, DOI 10.1007/s12035-016-0007-z; Theis T, 2013, J BIOL CHEM, V288, P6726, DOI 10.1074/jbc.M112.444034; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; VanderHorst VGJM, 2006, J CHEM NEUROANAT, V31, P2, DOI 10.1016/j.jchemneu.2005.08.003; Victor K, 1999, BIOCHEMISTRY-US, V38, P12527, DOI 10.1021/bi990847b; Westphal N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09468-8; Westphal N, 2016, MOL CELL NEUROSCI, V74, P114, DOI 10.1016/j.mcn.2016.05.003; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Xiao ZF, 2016, SCI CHINA LIFE SCI, V59, P647, DOI 10.1007/s11427-016-5080-z; Yin Y, 2015, WORLD J GASTROENTERO, V21, P4536, DOI 10.3748/wjg.v21.i15.4536; ZANGAR RC, 1995, CARCINOGENESIS, V16, P2593, DOI 10.1093/carcin/16.10.2593; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhu H, 2016, CELL TRANSPLANT, V25, P1925, DOI 10.3727/096368916X691411	72	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12677	12690		10.1096/fj.202000026RR	http://dx.doi.org/10.1096/fj.202000026RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729988				2022-12-26	WOS:000556803600001
J	Zhang, E; Nguyen, T; Zhao, M; Dang, SH; Chen, JY; Bian, WH; Walcott, GP				Zhang, Eric; Nguyen, Thanh; Zhao, Meng; Dang, Son Hai; Chen, Jake Y.; Bian, Weihua; Walcott, Gregory P.			Identifying the key regulators that promote cell-cycle activity in the hearts of early neonatal pigs after myocardial injury	PLOS ONE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE PROLIFERATION; SIGNALING PATHWAYS; EXPRESSION; GROWTH; ROLES; DIFFERENTIATION; ACTIVATION	Mammalian cardiomyocytes exit the cell cycle shortly after birth. As a result, an occurrence of coronary occlusion-induced myocardial infarction often results in heart failure, postinfarction LV dilatation, or death, and represents one of the most significant public health morbidities worldwide. Interestingly however, the hearts of neonatal pigs have been shown to regenerate following an acute myocardial infarction (MI) occuring on postnatal day 1 (P1); a recovery period which is accompanied by an increased expression of markers for cell-cycle activity, and suggests that early postnatal myocardial regeneration may be driven in part by the MI-induced proliferation of pre-existing cardiomyocytes. In this study, we identified signaling pathways known to regulate the cell cycle, and determined of these, the pathways persistently upregulated in response to MI injury. We identified five pathways (mitogen associated protein kinase [MAPK], Hippo, cyclic [cAMP], Janus kinase/signal transducers and activators of transcription [JAK-STAT], and Ras) which were comprehensively upregulated in cardiac tissues collected on day 7 (P7) and/or P28 of the P1 injury hearts. Several of the initiating master regulators (e.g., CSF1/CSF1R, TGFB, and NPPA) and terminal effector molecules (e.g., ATF4, FOS, RELA/B, ITGB2, CCND1/2/3, PIM1, RAF1, MTOR, NKF1B) in these pathways were persistently upregulated at day 7 through day 28, suggesting there exists at least some degree of regenerative activity up to 4 weeks following MI at P1. Our observations provide a list of key regulators to be examined in future studies targeting cell-cycle activity as an avenue for myocardial regeneration.	[Zhang, Eric; Zhao, Meng; Bian, Weihua; Walcott, Gregory P.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Nguyen, Thanh; Chen, Jake Y.] Univ Alabama Birmingham, Informat Inst, Birmingham, AL USA; [Dang, Son Hai] Univ Alabama Birmingham, Dept Comp Sci, Birmingham, AL USA; [Walcott, Gregory P.] Univ Alabama Birmingham, Dept Med Cardiovasc Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Walcott, GP (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.; Walcott, GP (corresponding author), Univ Alabama Birmingham, Dept Med Cardiovasc Dis, Birmingham, AL 35294 USA.	gregorywalcott@uabmc.edu		zhao, meng/0000-0003-4303-2726; Chen, Jake/0000-0001-8829-7504; Nguyen, Thanh/0000-0002-8440-1594	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	At the time of working on this study and the manuscript, all of the authors (EZ, TN, MZ, SDHD, JC, WB and GPW) were employed by GoodAI Research s.r.o. The funder provided support in the form of salaries for all authors, provided the hardware for performing experiments and approved the final decision to publish. The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. This study was funded in part by the NIH. No additional external funding was received for this study. The specific roles of the authors are articulated in the `Author Contributions' section.	Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnolds DE, 2012, J CLIN INVEST, V122, P2509, DOI 10.1172/JCI62617; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brown K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189818; Bruntz RC, 2014, PHARMACOL REV, V66, P1033, DOI 10.1124/pr.114.009217; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Castellan RFP, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00007; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Francis SH, 2010, CIRC RES, V107, P1164, DOI 10.1161/CIRCRESAHA.110.233239; Fuller SJ, 2015, CARDIOVASC RES, V108, P87, DOI 10.1093/cvr/cvv210; Garcia-Campos MA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00383; Gorbe A, 2010, BASIC RES CARDIOL, V105, P643, DOI 10.1007/s00395-010-0097-0; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Guimaraes-Camboa N, 2015, DEV CELL, V33, P507, DOI 10.1016/j.devcel.2015.04.021; Haubner BJ, 2016, CIRC RES, V118, P216, DOI 10.1161/CIRCRESAHA.115.307017; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jahangiri L, 2016, DEVELOPMENT, V143, P113, DOI 10.1242/dev.126136; Jia YF, 2015, ARCH TOXICOL, V89, P179, DOI 10.1007/s00204-014-1433-1; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karra R, 2015, P NATL ACAD SCI USA, V112, P13255, DOI 10.1073/pnas.1511209112; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lalowski MM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00365; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Leach JP, 2017, NATURE, V550, P260, DOI 10.1038/nature24045; Leblond AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137515; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu RJ, 2016, J MOL CELL CARDIOL, V101, P44, DOI 10.1016/j.yjmcc.2016.08.018; Liu S, 2019, WIRES DEV BIOL, V8, DOI 10.1002/wdev.335; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maier HJ, 2012, P NATL ACAD SCI USA, V109, P11794, DOI 10.1073/pnas.1116584109; Man J, 2018, CELL MOL LIFE SCI, V75, P1435, DOI 10.1007/s00018-017-2737-0; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Metrich M, 2010, PFLUG ARCH EUR J PHY, V459, P535, DOI 10.1007/s00424-009-0747-y; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Minamino T, 2002, P NATL ACAD SCI USA, V99, P3866, DOI 10.1073/pnas.062453699; Mohamed TMA, 2018, CELL, V173, P104, DOI 10.1016/j.cell.2018.02.014; Mohammadi MM, 2017, EMBO MOL MED, V9, P265, DOI 10.15252/emmm.201606602; Nagata Y, 2006, J CELL BIOL, V174, P245, DOI 10.1083/jcb.200605028; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Okazaki T, 2007, AM J PATHOL, V171, P1093, DOI 10.2353/ajpath.2007.061191; Omar B, 2009, CELL SIGNAL, V21, P760, DOI 10.1016/j.cellsig.2009.01.015; Palmen M, 2004, J AM COLL CARDIOL, V44, P1113, DOI 10.1016/j.jacc.2004.05.067; Pawlak M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060289; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Proud CG, 2004, CARDIOVASC RES, V63, P403, DOI 10.1016/j.cardiores.2004.02.003; Rhee JW, 2018, CIRC RES, V122, P14, DOI 10.1161/CIRCRESAHA.117.312287; Rodriguez P, 2006, J BIOL CHEM, V281, P38599, DOI 10.1074/jbc.M604139200; Singh BN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06617-z; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; del Campo CV, 2016, SCI REP-UK, V6, DOI 10.1038/srep35366; Wu F, 2019, MOL MED REP, V19, P3871, DOI 10.3892/mmr.2019.10001; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Xu JW, 2009, CIRC RES, V105, P304, DOI 10.1161/CIRCRESAHA.109.201509; Ye L, 2018, CIRCULATION, V138, P2798, DOI 10.1161/CIRCULATIONAHA.117.031542; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhang YL, 2017, CANCER BIOL MED, V14, P90, DOI 10.20892/j.issn.2095-3941.2016.0086; Zhao J, 2015, INT J CLIN EXP PATHO, V8, P15947; Zhou HY, 2015, P NATL ACAD SCI USA, V112, P11864, DOI 10.1073/pnas.1516237112; Zhu WQ, 2018, CIRCULATION, V138, P2809, DOI 10.1161/CIRCULATIONAHA.118.034886	77	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0232963	10.1371/journal.pone.0232963	http://dx.doi.org/10.1371/journal.pone.0232963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730272	Green Published, gold			2022-12-26	WOS:000556884700094
J	Yuan, XY; Zhang, H; Huang, LR; Zhang, F; Sheng, XW; Cui, A				Yuan, Xue-Yan; Zhang, Hui; Huang, Li-Ru; Zhang, Fan; Sheng, Xiao-Wen; Cui, Ai			Evaluation of health-related quality of life and the related factors in a group of Chinese patients with interstitial lung diseases	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; REFERENCE VALUES; FUNCTION TESTS; SURVEY SF-36; STANDARDIZATION; RELIABILITY; MORTALITY; CAPACITY; DYSPNEA	Introduction Interstitial lung diseases (ILDs) include a wide variety of chronic progressive pulmonary diseases characterized by lung inflammation, fibrosis and hypoxemia and can progress to respiratory failure and even death. ILDs are associated with varying degrees of quality of life impairments in affected people. Studies on the quality of life in patients with ILDs are still limited, and there are few studies with long-term follow-up periods in these patients. Methods Data from patients who were clinically diagnosed with ILDs in the Respiratory Department, Beijing Chaoyang Hospital, Capital Medical University from January 2017 to February 2018 were collected. Clinical status and HRQoL were assessed at baseline and subsequently at 6- and 12-month intervals with the LCQ, mMRC, HADS, SF-36, and SGRQ. Multivariate linear regression was used to evaluate the determinants of the decline in HRQoL. Results A total of 139 patients with idiopathic interstitial pneumonia (IIP) and 30 with connective tissue disease-associated ILD (CTD-ILD) were enrolled, 140 of whom completed the follow-up. The mean age was 63.7 years, and 92 patients were men. At baseline, the decline in HRQoL assessed by the SF-36 and SGRQ was significantly associated with the mMRC, LCQ and HADS depression score. In the follow-up, changes in FVC%, DLco%, mMRC and LCQ were significantly associated with changes in HRQoL. Conclusions HRQoL in both IIP and CTD-ILD patients deteriorates to varying degrees, and the trend suggests that poor HRQoL in these patients is associated with many determinants, primarily dyspnea, cough and depression. Improving HRQoL is the main aim when treating patients living with ILDs.	[Yuan, Xue-Yan; Zhang, Hui; Huang, Li-Ru; Zhang, Fan; Sheng, Xiao-Wen; Cui, Ai] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China; [Cui, Ai] Beijing Inst Resp Med, Beijing, Peoples R China	Capital Medical University	Cui, A (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China.; Cui, A (corresponding author), Beijing Inst Resp Med, Beijing, Peoples R China.	cuiai@ccmu.edu.cn		xueyan, Yuan/0000-0002-3373-0347	Scientific Research Cultivation Project of Beijing Municipal Hospital, Beijing Municipal Administration of Hospitals [PX201741]	Scientific Research Cultivation Project of Beijing Municipal Hospital, Beijing Municipal Administration of Hospitals	This study was supported from Scientific Research Cultivation Project of Beijing Municipal Hospital, Beijing Municipal Administration of Hospitals (No. PX201741) and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou KM, 2014, EUR RESPIR REV, V23, P40, DOI 10.1183/09059180.00009113; Azadeh N, 2017, CHEST, V152, P842, DOI 10.1016/j.chest.2017.03.033; Bahmer T, 2016, RESPIRATION, V91, P497, DOI 10.1159/000446607; Belkin A, 2013, CURR OPIN PULM MED, V19, P474, DOI 10.1097/MCP.0b013e328363f479; Berry CE, 2012, CHEST, V142, P704, DOI 10.1378/chest.11-1332; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Coelho AC, 2010, J BRAS PNEUMOL, V36, P562, DOI 10.1590/S1806-37132010000500007; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; de Boer S, 2014, RESPIROLOGY, V19, P1019, DOI 10.1111/resp.12359; Demoruelle MK, 2016, BEST PRACT RES CL RH, V30, P39, DOI 10.1016/j.berh.2016.04.006; Furukawa T, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0503-3; Glaspole IN, 2017, RESPIROLOGY, V22, P950, DOI 10.1111/resp.12989; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kocheril SV, 2005, ARTHRIT RHEUM-ARTHR, V53, P549, DOI 10.1002/art.21322; Kotecha J, 2016, SARCOIDOSIS VASC DIF, V33, P341; Kreuter M, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1298-1; Kreuter M, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1020-3; Kreuter M, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0621-y; Lubin M, 2014, CHEST, V145, P1333, DOI 10.1378/chest.13-1984; Ma Wei, 2009, Cough, V5, P7, DOI 10.1186/1745-9974-5-7; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Margaritopoulos GA, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0027-2016; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Michielsen HJ, 2007, RESPIRATION, V74, P401, DOI 10.1159/000092670; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Natalini JG, 2017, RESP MED, V127, P1, DOI 10.1016/j.rmed.2017.04.002; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P729, DOI 10.1590/S0100-879X1999000600008; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Nishiyama O, 2005, RESP MED, V99, P408, DOI 10.1016/j.rmed.2004.09.005; Oga T, 2003, AM J RESP CRIT CARE, V167, P544, DOI 10.1164/rccm.200206-583OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rajala K, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0738-x; Ryerson CJ, 2014, CHEST, V145, P723, DOI 10.1378/chest.13-1474; Spagnolo P, 2018, LANCET RESP MED, V6, P389, DOI 10.1016/S2213-2600(18)30064-X; Suzuki A, 2018, RESPIROLOGY, V23, P851, DOI 10.1111/resp.13293; Swigris JJ, 2018, BMJ OPEN RESPIR RES, V5, DOI 10.1136/bmjresp-2018-000278; Swigris JJ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0124-1; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; van Manen MJG, 2017, THER ADV RESPIR DIS, V11, P157, DOI 10.1177/1753465816686743; van Manen MJG, 2016, EUR RESPIR REV, V25, P278, DOI 10.1183/16000617.0090-2015; Wallace B, 2015, RHEUMATOLOGY, V54, P1369, DOI 10.1093/rheumatology/keu456; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Witt S, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1010-5; Yildirim F, 2019, KAOHSIUNG J MED SCI, V35, P365, DOI 10.1002/kjm2.12066; Yount SE, 2016, LUNG, V194, P227, DOI 10.1007/s00408-016-9850-y; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	6	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236346	10.1371/journal.pone.0236346	http://dx.doi.org/10.1371/journal.pone.0236346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726327	Green Published, gold			2022-12-26	WOS:000556908900026
J	Afiaz, A; Biswas, RK; Shamma, R; Ananna, N				Afiaz, Awan; Biswas, Raaj Kishore; Shamma, Raisa; Ananna, Nurjahan			Intimate partner violence (IPV) with miscarriages, stillbirths and abortions: Identifying vulnerable households for women in Bangladesh	PLOS ONE			English	Article							MATERNAL AGE; DOMESTIC VIOLENCE; PREGNANCY; PREVALENCE; RISK; EXPERIENCES; MARRIAGE; PATTERNS; IMPACT; CARE	Intimate partner violence (IPV) is a social problem in Bangladesh with adverse effects on maternal healthcare. This study analyzed the sociodemographic factors responsible for intimate partner violence and its overall association with reproductive healthcare-specifically miscarriages, stillbirths and induced abortions (MSA)-using Bangladesh Demographic Health Survey 2007, which contains the latest available intimate partner violence data till date, with the hypothesis that intimate partner violence is associated with miscarriages, stillbirths and induced abortions. The generalized linear regression model was fitted to 3,920 women adjusting survey weights and cluster/strata variations. The study concluded that 1 out of every 4 women who reported experiencing intimate partner violence also reported having one or more of miscarriages, stillbirths and induced abortions. The results revealed that intimate partner violence and miscarriages, stillbirths and induced abortions were significantly associated with the age of the women, residence, age of the women at their first birth, sex of household head and the household's financial condition. Furthermore, the odds of having one or more miscarriages, stillbirths and abortions was increased by 35% for women who were victims to intimate partner violence, establishing a significant association between miscarriages, stillbirths and abortions and intimate partner violence. There appeared to be a need to address the issue in both paradigms, particularly for the poor rural women in Bangladeshi patriarchal society. These findings demand a combined intervention effort in the vulnerable cohorts, especially if Bangladesh intends to attain the goals 3.1 and 5.2 of the Sustainable Development Goals (SDG) by 2030.	[Afiaz, Awan; Shamma, Raisa] Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh; [Biswas, Raaj Kishore] Univ New South Wales, Sch Aviat, Transport & Rd Safety TARS Res Ctr, Sydney, NSW, Australia; [Ananna, Nurjahan] Ibrahim Med Coll, Dhaka, Bangladesh	University of Dhaka; University of New South Wales Sydney	Afiaz, A (corresponding author), Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh.	aafiaz@isrt.ac.bd	Biswas, Raaj Kishore/K-4256-2018	Biswas, Raaj Kishore/0000-0003-4294-6323; Shamma, Raisa/0000-0001-5431-1267; Afiaz, Awan/0000-0001-5801-9087				Abir T, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1410048; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Aklimunnessa K., 2007, J MENS HLTH GENDER, V4, P52, DOI [DOI 10.1016/J.JMHG.2006.10, DOI 10.1016/J.JMHG.2006.10.016]; Alhusen JL, 2015, J WOMENS HEALTH, V24, P100, DOI 10.1089/jwh.2014.4872; Allen C, 1979, RESOURCES POWER HUSB; Bailey BA, 2010, INT J WOMENS HEALTH, V2, P183, DOI 10.2147/ijwh.s8632; Bangladesh Demographic and Health Survey, 2007, BANGL DEM HLTH SURV; Bates LM, 2004, INT FAM PLAN PERSPEC, V30, P190, DOI 10.1363/3019004; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bhowmik J, 2019, PUBLIC HEALTH, V170, P113, DOI 10.1016/j.puhe.2019.02.027; Biswas RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187884; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Coker AL, 2004, PAEDIATR PERINAT EP, V18, P260, DOI 10.1111/j.1365-3016.2004.00569.x; de Bocanegra HT, 2010, VIOLENCE AGAINST WOM, V16, P601, DOI 10.1177/1077801210366965; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; DHS, 2013, 6 DHS; Dobash R., 1979, VIOLENCE WIVES CASE; Dutton DG, 2006, RETHINKING DOMESTIC VIOLENCE, P1; Ferdos J, 2018, AGGRESSIVE BEHAV, V44, P294, DOI 10.1002/ab.21752; GELLES RJ, 1985, ANNU REV SOCIOL, V11, P347, DOI 10.1146/annurev.so.11.080185.002023; Giles-Sims J., 1983, WIFE BATTERING SYSTE; Goldman BM, 2013, WOMEN HLTH, P725; Hasan MT, 2014, J INTERPERS VIOLENCE, V29, P3105, DOI 10.1177/0886260514534525; Huang L, 2008, CAN MED ASSOC J, V178, P165, DOI 10.1503/cmaj.070150; Kabeer N, 2011, DEV CHANGE, V42, P499, DOI 10.1111/j.1467-7660.2011.01703.x; Kamal SMM, 2015, J BIOSOC SCI, V47, P120, DOI 10.1017/S0021932013000746; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Lawson J, 2012, J HUM BEHAV SOC ENVI, V22, P572, DOI 10.1080/10911359.2011.598748; Lipsky S, 2003, OBSTET GYNECOL, V102, P557, DOI 10.1016/S0029-7844(03)00573-8; Magnus MC, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l869; Martin-de-las-Heras S, 2019, BJOG-INT J OBSTET GY, V126, P778, DOI 10.1111/1471-0528.15592; Mashreky SR, 2016, INT J, V1, P1; McCullagh P, 1989, GEN LINEAR MODELS; Nasir K, 2003, EUR J PUBLIC HEALTH, V13, P105, DOI 10.1093/eurpub/13.2.105; Naved RT., 2017, UNDERSTANDING INTIMA; Rahman M, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0095-7; Rahman M, 2011, J FAM VIOLENCE, V26, P411, DOI 10.1007/s10896-011-9375-3; Reddy UM, 2006, AM J OBSTET GYNECOL, V195, P764, DOI 10.1016/j.ajog.2006.06.019; Rutstein S.O., 2004, DHS COMP REPORTS; Sambisa W, 2011, J INTERPERS VIOLENCE, V26, P2592, DOI 10.1177/0886260510388282; Samuels F, 2019, J FAM VIOLENCE, V34, P107, DOI 10.1007/s10896-018-0003-3; Schuler SR, 2008, STUD FAMILY PLANN, V39, P49, DOI 10.1111/j.1728-4465.2008.00150.x; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Silverman JG, 2006, AM J OBSTET GYNECOL, V195, P140, DOI 10.1016/j.ajog.2005.12.052; Singh S, 2017, INT PERSPECT SEX R H, V43, P1, DOI 10.1363/43e2417; Stockl Heidi, 2014, BMC Public Health, V14, P751, DOI 10.1186/1471-2458-14-751; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; Strand SJM, 2019, VIOLENCE AGAINST WOM, V25, P188, DOI 10.1177/1077801218766611; WHO Department of Reproductive Health and Research London School of Hygiene and Tropical Medicine South African Medical Research Council, 2013, GLOBAL REGIONAL ESTI, DOI DOI 10.1007/S13398-014-0173-7.2; Wolfgang M. E., 1967, SUBCULTURE VIOLENCE; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization [WHO], 2012, INT PARTN VIOL UND A; Wu EW, 2003, AIDS BEHAV, V7, P291, DOI 10.1023/A:1025447820399	55	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236670	10.1371/journal.pone.0236670	http://dx.doi.org/10.1371/journal.pone.0236670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722708	gold, Green Published			2022-12-26	WOS:000556916000030
J	Newby, JM; O'Moore, K; Tang, S; Christensen, H; Faasse, K				Newby, Jill M.; O'Moore, Kathleen; Tang, Samantha; Christensen, Helen; Faasse, Kate			Acute mental health responses during the COVID-19 pandemic in Australia	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; AUDIT-C; ALCOHOL MISUSE; ANXIETY; PREVALENCE; DEPRESSION; SYMPTOMS; IMPACT; OUTBREAK; STRESS	The acute and long-term mental health impacts of the COVID-19 pandemic are unknown. The current study examined the acute mental health responses to the COVID-19 pandemic in 5070 adult participants in Australia, using an online survey administered during the peak of the outbreak in Australia (27(th)March to 7(th)April 2020). Self-report questionnaires examined COVID-19 fears and behavioural responses to COVID-19, as well as the severity of psychological distress (depression, anxiety and stress), health anxiety, contamination fears, alcohol use, and physical activity. 78% of respondents reported that their mental health had worsened since the outbreak, one quarter (25.9%) were very or extremely worried about contracting COVID-19, and half (52.7%) were worried about family and friends contracting COVID-19. Uncertainty, loneliness and financial worries (50%) were common. Rates of elevated psychological distress were higher than expected, with 62%, 50%, and 64% of respondents reporting elevated depression, anxiety and stress levels respectively, and one in four reporting elevated health anxiety in the past week. Participants with self-reported history of a mental health diagnosis had significantly higher distress, health anxiety, and COVID-19 fears than those without a prior mental health diagnosis. Demographic (e.g., non-binary or different gender identity; Aboriginal and Torres Strait Islander status), occupational (e.g., being a carer or stay at home parent), and psychological (e.g., perceived risk of contracting COVID-19) factors were associated with distress. Results revealed that precautionary behaviours (e.g., washing hands, using hand sanitiser, avoiding social events) were common, although in contrast to previous research, higher engagement in hygiene behaviours was associated with higher stress and anxiety levels. These results highlight the serious acute impact of COVID-19 on the mental health of respondents, and the need for proactive, accessible digital mental health services to address these mental health needs, particularly for those most vulnerable, including people with prior history of mental health problems. Longitudinal research is needed to explore long-term predictors of poor mental health from the COVID-19 pandemic.	[Newby, Jill M.; Faasse, Kate] UNSW Sydney, Sch Psychol, Sydney, NSW, Australia; [Newby, Jill M.; O'Moore, Kathleen; Tang, Samantha; Christensen, Helen] UNSW Sydney, Black Dog Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Black Dog Institute; University of New South Wales Sydney	Newby, JM (corresponding author), UNSW Sydney, Sch Psychol, Sydney, NSW, Australia.; Newby, JM (corresponding author), UNSW Sydney, Black Dog Inst, Sydney, NSW, Australia.	j.newby@unsw.edu.au	Christensen, Helen/F-5053-2012	Christensen, Helen/0000-0003-0435-2065; Faasse, Kate/0000-0003-3073-3718	MRFF Career Development Fellowship	MRFF Career Development Fellowship(Medical Research Future Fund (MRFF))	This study was funded by a MRFF Career Development Fellowship to JMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Andrews G, 2018, J ANXIETY DISORD, V55, P70, DOI 10.1016/j.janxdis.2018.01.001; Asmundson GJG, 2008, J COGN PSYCHOTHER, V22, P87, DOI 10.1891/0889-8391.22.2.87; Asmundson GJG, 2020, J ANXIETY DISORD, V70, DOI 10.1016/j.janxdis.2020.102196; Australian Bureau of Statistics, 2014, NAT HLTH SURV 1 RES; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Beutel ME, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1262-x; Blakey SM, 2017, J CLIN PSYCHOL MED S, V24, P270, DOI 10.1007/s10880-017-9514-y; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Bults M, 2015, DISASTER MED PUBLIC, V9, P207, DOI 10.1017/dmp.2014.160; Burns GL, 1996, BEHAV RES THER, V34, P163, DOI 10.1016/0005-7967(95)00035-6; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cerami C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00556; Chua SE, 2004, CAN J PSYCHIAT, V49, P391, DOI 10.1177/070674370404900609; Chua SE, 2004, CAN J PSYCHIAT, V49, P385, DOI 10.1177/070674370404900607; Cortes-Alvarez NY, 2020, DISASTER MED PUBLIC, V14, P413, DOI 10.1017/dmp.2020.215; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Delaney KE, 2014, ADDICT SCI CLIN PRAC, V9, DOI 10.1186/1940-0640-9-2; Faasse K, 2020, PUBLIC PERCEPTIONS C, DOI [10.1101/2020.04.25.20079996, DOI 10.1101/2020.04.25.20079996]; Glonti K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123117; Gomez-Salgado J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113947; Greenwood JLJ, 2010, J PHYS ACT HEALTH, V7, P571, DOI 10.1123/jpah.7.5.571; Harvey SB, EXPECTED IMPACT COVI; Hedman E, 2016, BRIT J PSYCHIAT, V209, P409, DOI 10.1192/bjp.bp.116.181396; Hobden B, 2017, AUST J PRIM HEALTH, V23, P263, DOI [10.1071/py16076, 10.1071/PY16076]; Holmes EA, LANCET PSYCHIAT; Huang Y, 2020, GEN ANXIETY DISORDER, V2020; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Kochhar AS, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102213; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Liu CH, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113172; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Moldofsky H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-37; Newby JM, 2018, INTERNET BASED COGNI, P89; Ozamiz-Etxebarria N, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00054020, 10.1590/0102-311x00054020]; Phua DH, 2005, ACAD EMERG MED, V12, P322, DOI 10.1197/j.aem.2004.11.015; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rodriguez-Rey R, 2020, PSYCHOL TRAUMA THEOR; Shahidinejad A, 2021, CLUSTER COMPUT, V24, P319, DOI [10.1007/s10586-020-03107-0, 10.1145/3334480.3381661]; Smith L, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2019.112564; Sunderland M, 2013, BRIT J PSYCHIAT, V202, P56, DOI 10.1192/bjp.bp.111.103960; Tyrer P, 2011, J PSYCHOSOM RES, V71, P392, DOI 10.1016/j.jpsychores.2011.07.004; Varshney M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233874; Verma S, 2020, INT J SOC PSYCHIATR, V66, P756, DOI 10.1177/0020764020934508; Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028; Wheaton MG, 2012, COGNITIVE THER RES, V36, P210, DOI 10.1007/s10608-011-9353-3; WHO, 2020, COR DIS COVID 19 PAN; Wind TR, 2020, INTERNET INTERV, V20, DOI 10.1016/j.invent.2020.100317; Wu Z, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI [10.1001/jama.2020.2648, DOI 10.1001/JAMA.2020.2648]; Xu ZG, 2020, INT J COMP METH-SING, V17, DOI 10.1142/S0219876219500051; Zhang Y, 2020, INT J COMP METH-SING, V17, DOI 10.1142/S0219876219500312	56	209	212	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236562	10.1371/journal.pone.0236562	http://dx.doi.org/10.1371/journal.pone.0236562			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722711	gold, Green Submitted, Green Published			2022-12-26	WOS:000556916000047
J	Yang, H; Geng, YH; Wang, P; Yang, H; Zhou, YT; Zhang, HQ; He, HY; Fang, WG; Tian, XX				Yang, Hui; Geng, Yue-Hang; Wang, Peng; Yang, Han; Zhou, Yan-Ting; Zhang, Hong-Quan; He, Hui-Ying; Fang, Wei-Gang; Tian, Xin-Xia			Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; PURINERGIC RECEPTORS; CELL INVASION; LEADING ROLE; METASTASIS; ACTIVATION; INFLAMMATION; EPITHELIUM; IMMUNITY; FAMILY	Our previous research demonstrated that extracellular adenosine 5 '-triphosphate (ATP) could promote breast cancer cell invasion. However, the impact of extracellular ATP on chemoresistance and the mechanisms behind ATP pro-invasion and pro-chemoresistance remain unclear. Here we aimed to determine the molecules or signaling pathways involved. cDNA microarray was performed to identify the differentially expressed genes before and after ATP treatment. As a result, Sex-determining region Y-box 9 (SOX9) was up-regulated after ATP treatment in breast cancer cells. In vitro invasion and migration assays demonstrated that knocking down SOX9 attenuated ATP-driven invasive capability. Mass spectrometry and co-IP revealed that SOX9 interacted with Janus kinase 1 (JAK1). Afterward, IL-6-JAK1-STAT3 signaling was demonstrated to promote SOX9 expression and invasion following ATP treatment. Notably, ATP-IL-6-SOX9 signaling was shown to stimulate chemoresistance in breast cancer cells. ChIP assays identified some potential SOX9 target genes, among which carcinoembryonic antigen-related cell adhesion molecule 5/6 (CEACAM5/6) was demonstrated to mediate ATP pro-invasive function, while ATP-binding cassette subfamily B member 1 (ABCB1) and ATP-binding cassette subfamily G member 2 (ABCG2) mediated ATP-driven chemoresistance. In addition, SOX9-knockdown and apyrase (an ATP hydrolase)-treated MDA-MB-231 cells illustrated decreased tumor growth and enhanced drug sensitivity in nude mice. In vitro spheroid formation assays also proved the significance of ATP-SOX9 in mediating chemoresistance. Moreover, molecules involved in ATP-SOX9 signaling were up-regulated in human breast carcinoma specimens and were associated with poor prognosis. Altogether, SOX9 signaling is vital in ATP-driven invasion and chemoresistance, which may serve as a potential target for breast cancer therapies.	[Yang, Hui; Geng, Yue-Hang; Yang, Han; Zhou, Yan-Ting; He, Hui-Ying; Fang, Wei-Gang; Tian, Xin-Xia] Peking Univ, Dept Pathol, Key Lab Carcinogenesis & Translat Res, Minist Educ,Sch Basic Med Sci,Hosp 3,Hlth Sci Ctr, Beijing 100191, Peoples R China; [Wang, Peng; Zhang, Hong-Quan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Beijing 100191, Peoples R China	Peking University; Peking University	Fang, WG; Tian, XX (corresponding author), Peking Univ, Dept Pathol, Key Lab Carcinogenesis & Translat Res, Minist Educ,Sch Basic Med Sci,Hosp 3,Hlth Sci Ctr, Beijing 100191, Peoples R China.	wgfang@bjmu.edu.cn; tianxinxia@bjmu.edu.cn		Wang, Peng/0000-0002-2558-292X; Tian, Xin-Xia/0000-0002-1593-4987; Yang, Hui/0000-0002-9138-1325	National Natural Science Foundation of China [81872382, 81621063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants to XXT and WGF from the National Natural Science Foundation of China (No 81872382 and 81621063).	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Chen H, 2017, CLIN CANCER RES, V23, P5176, DOI 10.1158/1078-0432.CCR-17-0177; Chen L, 2004, CANCER LETT, V215, P239, DOI 10.1016/j.canlet.2004.05.023; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Di Virgilio F, 2017, ONCOGENE, V36, P293, DOI 10.1038/onc.2016.206; Di Virgilio F, 2016, CURR OPIN PHARMACOL, V29, P17, DOI 10.1016/j.coph.2016.05.001; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Eguchi Y, 1997, CANCER RES, V57, P1835; FANG WG, 1992, J CLIN INVEST, V89, P191, DOI 10.1172/JCI115562; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Galluzzi L, 2015, CELL REP, V11, P1501, DOI 10.1016/j.celrep.2015.05.041; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gilbert SM, 2019, ONCOGENE, V38, P194, DOI 10.1038/s41388-018-0426-6; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Kumar S, 2015, CELL REP, V12, P1325, DOI 10.1016/j.celrep.2015.07.034; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Leung CON, 2016, ONCOTARGET, V7, P29371, DOI 10.18632/oncotarget.8835; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Li WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133165; Liu Y, 2018, CANCER LETT, V430, P1, DOI 10.1016/j.canlet.2018.04.043; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Patel A, 2017, SCIENCE, V356, P753, DOI 10.1126/science.aaf6846; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; Prevostel C, 2017, EUR J CANCER, V86, P150, DOI 10.1016/j.ejca.2017.08.037; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Qiu ML, 2020, EXP CELL RES, V392, DOI 10.1016/j.yexcr.2020.112002; Qiu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.011437, DOI 10.1371/JOURNAL.PONE.011437]; Qiu Y, 2018, ONCOL REP, V39, P138, DOI 10.3892/or.2017.6081; Roger S, 2011, EXPERT OPIN INV DRUG, V20, P875, DOI 10.1517/13543784.2011.583918; Santos JC, 2016, CANCER RES, V76, P6735, DOI 10.1158/0008-5472.CAN-16-1120; Shan L, 2016, CANCER CELL, V30, P708, DOI 10.1016/j.ccell.2016.09.010; Solini A, 1999, J CELL SCI, V112, P297; Verhalen B, 2017, NATURE, V543, P738, DOI 10.1038/nature21414; Wang H, 2015, CANCER CELL, V27, P193, DOI 10.1016/j.ccell.2014.11.017; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang X, 2017, ONCOTARGET, V8, P87860, DOI 10.18632/oncotarget.21231; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Xia MS, 2015, J MOL NEUROSCI, V55, P131, DOI 10.1007/s12031-014-0393-5; Yang H, 2019, CANCER SCI, V110, P2456, DOI 10.1111/cas.14086; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zalzali H, 2008, ONCOGENE, V27, P7131, DOI 10.1038/onc.2008.331; Zeng HL, 2016, CANCER CELL, V30, P459, DOI 10.1016/j.ccell.2016.08.001; Zhang JL, 2017, CANCER SCI, V108, P1318, DOI 10.1111/cas.13273; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	50	23	23	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2020	39	35					5795	5810		10.1038/s41388-020-01402-z	http://dx.doi.org/10.1038/s41388-020-01402-z		JUL 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NF2QB	32724162				2022-12-26	WOS:000553333400001
J	Baraibar, B; Murrell, EG; Bradley, BA; Barbercheck, ME; Mortensen, DA; Kaye, JP; White, CM				Baraibar, Barbara; Murrell, Ebony G.; Bradley, Brosi A.; Barbercheck, Mary E.; Mortensen, David A.; Kaye, Jason P.; White, Charles M.			Cover crop mixture expression is influenced by nitrogen availability and growing degree days	PLOS ONE			English	Article							PLANTING DATE; PERFORMANCE; FIXATION; BENEFITS; SYSTEM	Cover crop mixtures can provide multiple ecosystem services but provisioning of these services is contingent upon the expression of component species in the mixture. From the same seed mixture, cover crop mixture expression varied greatly across farms and we hypothesized that this variation was correlated with soil inorganic nitrogen (N) concentrations and growing degree days. We measured fall and spring biomass of a standard five-species mixture of canola (Brassica napusL.), Austrian winter pea (Pisum sativumL), triticale (x TriticosecaleWittm.), red clover (Trifolium pratenseL.) and crimson clover (Trifolium incarnatumL.) seeded at a research station and on 8 farms across Pennsylvania and New York in two consecutive years. At the research station, soil inorganic N (soil iN) availablity and cumulative fall growing degree days (GDD) were experimentally manipulated through fertilizer additions and planting date. Farmers seeded the standard mixture and a "farm-tuned" mixture of the same five species with component seeding rates adjusted to achieve farmer-desired services. We used Structural Equation Modeling to parse out the effects of soil iN and GDD on cover crop mixture expression. When soil iN and fall GDD were high, canola dominated the mixture, especially in the fall. Low soil iN favored legume species while a shorter growing season favored triticale. Changes in seeding rates influenced mixture composition in fall and spring but interacted with GDD to determine the final expression of the mixture. Our results show that when soil iN availability is high at the time of cover crop planting, highly competitive species can dominate mixtures which could potentially decrease services provided by other species, especially legumes. Early planting dates can exacerbate the dominance of aggressive species. Managers should choose cover crop species and seeding rates according to their soil iN and GDD to ensure the provision of desired services.	[Baraibar, Barbara; Mortensen, David A.; White, Charles M.] Penn State Univ, Dept Plant Sci, State Coll, PA 16801 USA; [Murrell, Ebony G.; Bradley, Brosi A.; Kaye, Jason P.] Penn State Univ, Dept Ecosyst Sci & Management, State Coll, PA USA; [Barbercheck, Mary E.] Penn State Univ, Dept Entomol, State Coll, PA USA; [Murrell, Ebony G.] Land Inst, Crop Protect Ecol, Salina, KS USA; [Mortensen, David A.] Univ New Hampshire, Dept Agr Nutr & Foods Syst, Durham, NH 03824 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University System Of New Hampshire; University of New Hampshire	Baraibar, B (corresponding author), Penn State Univ, Dept Plant Sci, State Coll, PA 16801 USA.	bbaraibar@hotmail.com	Baraibar, Bàrbara/U-3119-2019	Baraibar, Bàrbara/0000-0003-1601-7731	USDA National Institute of Food and Agriculture Organic Research and Extension Initiative [PENW-2015-07433, 2015-5130024156, 1007156]	USDA National Institute of Food and Agriculture Organic Research and Extension Initiative	This work was supported by the USDA National Institute of Food and Agriculture Organic Research and Extension Initiative (https://nifa.usda.gov/funding-opportunity/organic-agriculture-research-and-extension-initiative) under Project PENW-2015-07433, Grant No. 2015-5130024156, Accession No. 1007156 to JPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraibar B, 2018, WEED SCI, V66, P121, DOI 10.1017/wsc.2017.59; Blesh J, 2018, J APPL ECOL, V55, P38, DOI 10.1111/1365-2664.13011; Brainard DC, 2011, WEED TECHNOL, V25, P473, DOI 10.1614/WT-D-10-00134.1; Brennan EB, 2011, AGRON J, V103, P1563, DOI 10.2134/agronj2010.0152er; Clark AJ, 2007, AGRON J, V99, P43, DOI 10.2134/agronj2005.0362; CLARK AJ, 1994, AGRON J, V86, P1065, DOI 10.2134/agronj1994.00021962008600060025x; Coombs C, 2017, FIELD CROP RES, V201, P75, DOI 10.1016/j.fcr.2016.11.001; Finney DM, 2017, AGR ENV LETT, V2, DOI 10.2134/ael2017.09.0033; Finney DM, 2017, J APPL ECOL, V54, P509, DOI 10.1111/1365-2664.12765; Finney DM, 2016, AGRON J, V108, P39, DOI 10.2134/agronj15.0182; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Hayden ZD, 2015, AGRON J, V107, P33, DOI 10.2134/agronj14.0237; Kaye J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215448; Lawson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129597; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Moller K, 2008, NUTR CYCL AGROECOSYS, V82, P233, DOI 10.1007/s10705-008-9182-2; Murrell EG, 2017, AGRON J, V109, P259, DOI 10.2134/agronj2016.03.0174; Poffenbarger HJ, 2015, AGRON J, V107, P2083, DOI 10.2134/agronj15.0065; SARE Sustainable Agriculture Research and Education, 2016, 2015 2016 ANN REP CO; Schipanski ME, 2014, AGR SYST, V125, P12, DOI 10.1016/j.agsy.2013.11.004; Schipanski ME, 2012, PLANT SOIL, V357, P147, DOI 10.1007/s11104-012-1137-3; Snapp SS, 2005, AGRON J, V97, P322; Soil Survey Staff, 1999, AGR HDB, V2nd, P436; Stamm M, FACTORS HELP DETERMI; Wendling M, 2017, AGR ECOSYST ENVIRON, V241, P88, DOI 10.1016/j.agee.2017.03.003; White C., 2015, MAKING MOST MIXTURES; White CM, 2017, AGR ECOSYST ENVIRON, V237, P121, DOI 10.1016/j.agee.2016.12.016; Wortman SE, 2012, AGRON J, V104, P699, DOI 10.2134/agronj2011.0422; Wortman SE, 2012, AGRON J, V104, P1425, DOI 10.2134/agronj2012.0185	29	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0235868	10.1371/journal.pone.0235868; 10.1371/journal.pone.0235868.r001; 10.1371/journal.pone.0235868.r002; 10.1371/journal.pone.0235868.r003; 10.1371/journal.pone.0235868.r004	http://dx.doi.org/10.1371/journal.pone.0235868; 10.1371/journal.pone.0235868.r001; 10.1371/journal.pone.0235868.r002; 10.1371/journal.pone.0235868.r003; 10.1371/journal.pone.0235868.r004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716963	gold, Green Published			2022-12-26	WOS:000556674500031
J	Tenzin, C; Chansatitporn, N; Dendup, T; Dorji, T; Lhazeen, K; Tshering, D; Pelzang, T				Tenzin, Chador; Chansatitporn, Natkamol; Dendup, Tashi; Dorji, Tandin; Lhazeen, Karma; Tshering, Dorji; Pelzang, Thinley			Factors associated with multidrug-resistant tuberculosis (MDR-TB) in Bhutan: A nationwide case-control study	PLOS ONE			English	Article							RISK-FACTORS	Background Multidrug-resistant tuberculosis (MDR-TB) is a growing public health concern globally. In Bhutan, the rates of MDR-TB are high. Data on the risk factors of MDR-TB that can help inform policies are limited in Bhutan. This study aimed to determine the risk factors associated with MDR-TB. Methods A nationwide unmatched case-control study was conducted that included 79 MDR-TB cases and 118 controls. Data was collected by trained health workers through interviews using a structured questionnaire. Logistic regression analysis was performed to identify the risk factors associated with MDR-TB. Results The mean age of the participants was 32.4 and 33.7 years among the cases and the controls, respectively. In the multivariate analysis, the odds of having MDR-TB was higher among those who slept for less than 9 hours a day (AOR: 2.77, 95%CI: 1.11-6.92), frequently travelled in public transport (AOR: 2.96, 95% CI: 1.36-6.48), and had previous TB treatment (AOR: 5.90, 95%CI: 2.55-13.64). A greater number of rooms was also marginally associated with odds of having MDR-TB. Conclusions The findings suggest previous TB treatment, inadequate sleep duration, and travelling by public transport to be the risk factors associated with having MDR-TB in Bhutan. Intensification of early case detection, strengthening directly observed treatment strategy, improving treatment adherence, and increasing awareness can help control the rising MDR-TB epidemic.	[Tenzin, Chador] Bumthang Gen Hosp, Royal Govt Bhutan, Minist Hlth, Bumthang, Bhutan; [Tenzin, Chador; Chansatitporn, Natkamol] Mahidol Univ, Fac Publ Hlth, Dept Biostat, Bangkok, Thailand; [Dendup, Tashi] Univ Wollongong, Sch Hlth & Soc, Fac Social Sci, Wollongong, NSW, Australia; [Dorji, Tandin] Royal Govt Bhutan, Dept Med Serv, Minist Hlth, Kawangjangsa, Thimphu, Bhutan; [Lhazeen, Karma] Royal Govt Bhutan, Dept Publ Hlth, Minist Hlth, Kawangjangsa, Thimphu, Bhutan; [Tshering, Dorji] Cent Reg Referral Hosp, Royal Govt Bhutan, Minist Hlth, Gelephu, Bhutan; [Pelzang, Thinley] Phuentsholing Gen Hosp, Minist Hlth, Royal Govt Bhutan, Phuentsholing, Bhutan	Mahidol University; University of Wollongong	Tenzin, C (corresponding author), Bumthang Gen Hosp, Royal Govt Bhutan, Minist Hlth, Bumthang, Bhutan.; Tenzin, C (corresponding author), Mahidol Univ, Fac Publ Hlth, Dept Biostat, Bangkok, Thailand.	chador8tenzin@gmail.com			Ministry of Health of Bhutan	Ministry of Health of Bhutan	The conduct of this study was supported with financial assistance from the Ministry of Health of Bhutan and the Swiss Association for Bhutan Healthcare System Support.	Alene KA, 2018, J INFECTION, V77, P357, DOI 10.1016/j.jinf.2018.07.007; [Anonymous], 2015, EPIDEMIOLOGY OPEN AC, DOI DOI 10.1142/S2010135X15500058; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Bixler E, 2009, SLEEP MED, V10, pS3, DOI 10.1016/j.sleep.2009.07.005; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Chuchottaworn C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139986; Darnal JB, 2013, OUTBREAK SURVEILLANC, V6, P6; Horna-Campos OJ, 2010, INT J TUBERC LUNG D, V14, P714; Kibret KT, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0214-x; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Li WB, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0045-1; Li XX, 2015, AM J TROP MED HYG, V92, P280, DOI 10.4269/ajtmh.13-0717; Lila Maya Adhikar TD, 2015, PROSPECTIVE DRUG RES; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; Ministry of Health, 2017, NAT GUID MAN DRUG RE; Ministry of Health, 2017, MIN HLTH ANN HLTH B; Ministry of Health, 2016, NAT GUID MAN TUB, VSixth; National Statistics Bureau, 2018, STAT YB BHUT 2018; Regional Office for South-East Asia WHO, 2017, BEND CURV END TB ANN; Rifat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105214; Shariff NM, 2016, INT J MYCOBACT, V5, P51, DOI 10.1016/j.ijmyco.2015.11.001; Stosic M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6021-5; Suwankeeree W, 2014, INT J EVID-BASED HEA, V12, P3, DOI 10.1097/01.XEB.0000444614.17658.46; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Wang K, 2014, MICROB DRUG RESIST, V20, P294, DOI 10.1089/mdr.2013.0145; Workicho A, 2017, INFECT DRUG RESIST, V10, P91, DOI 10.2147/IDR.S126274; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization. Regional Office for South-East Asia, 2016, TUBERCULOSIS CONTROL; Zamudio C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115230; Zhang CR, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2067-x	32	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236250	10.1371/journal.pone.0236250	http://dx.doi.org/10.1371/journal.pone.0236250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716965	Green Published, gold			2022-12-26	WOS:000556674500003
J	Muller, SJ; Mirzahossein, E; Iftekhar, EN; Bacher, C; Schrufer, S; Schubert, DW; Fabry, B; Gekle, S				Mueller, Sebastian J.; Mirzahossein, Elham; Iftekhar, Emil N.; Baecher, Christian; Schruefer, Stefan; Schubert, Dirk W.; Fabry, Ben; Gekle, Stephan			Flow and hydrodynamic shear stress inside a printing needle during biofabrication	PLOS ONE			English	Article							HYDROGELS; ALGINATE	We present a simple but accurate algorithm to calculate the flow and shear rate profile of shear thinning fluids, as typically used in biofabrication applications, with an arbitrary viscosity-shear rate relationship in a cylindrical nozzle. By interpolating the viscosity with a set of power-law functions, we obtain a mathematically exact piecewise solution to the incompressible Navier-Stokes equation. The algorithm is validated with known solutions for a simplified Carreau-Yasuda fluid, full numerical simulations for a realistic chitosan hydrogel as well as experimental velocity profiles of alginate and chitosan solutions in a microfluidic channel. We implement the algorithm in an easy-to-use Python tool, included as Supplementary Material, to calculate the velocity and shear rate profile during the printing process, depending on the shear thinning behavior of the bioink and printing parameters such as pressure and nozzle size. We confirm that the shear stress varies in an exactly linear fashion, starting from zero at the nozzle center to the maximum shear stress at the wall, independent of the shear thinning properties of the bioink. Finally, we demonstrate how our method can be inverted to obtain rheological bioink parameters in-situ directly before or even during printing from experimentally measured flow rate versus pressure data.	[Mueller, Sebastian J.; Baecher, Christian; Gekle, Stephan] Univ Bayreuth, Biofluid Simulat & Modeling, Bayreuth, Germany; [Mirzahossein, Elham; Iftekhar, Emil N.; Fabry, Ben] Friedrich Alexander Univ Erlangen Nurnberg, Dept Phyiscs, Erlangen, Germany; [Schruefer, Stefan; Schubert, Dirk W.] Friedrich Alexander Univ Erlangen Nurnberg, Inst Polymer Mat, Erlangen, Germany; [Schruefer, Stefan; Schubert, Dirk W.] Bavarian Polymer Inst, KeyLab Adv Fiber Technol, Furth, Germany	University of Bayreuth; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Gekle, S (corresponding author), Univ Bayreuth, Biofluid Simulat & Modeling, Bayreuth, Germany.	stephan.gekle@uni-bayreuth.de	Fabry, Ben/C-5496-2013; Gekle, Stephan/I-9695-2014; Müller, Sebastian/AAS-1763-2021	Fabry, Ben/0000-0003-1737-0465; Gekle, Stephan/0000-0001-5597-1160; Müller, Sebastian/0000-0002-6020-4991; Iftekhar, Emil Nafis/0000-0003-0188-500X	Deutsche Forschungsgemeinschaft [SFB-TRR 225, 326998133]; National Institutes of Health [HL120839]; Studienstiftung des deutschen Volkes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Studienstiftung des deutschen Volkes	This work was funded by the Deutsche Forschungsgemeinschaft (SFB-TRR 225, project number 326998133, subprojects A01, A07 and B07) (to SJM, EM, SS, DWS, BF and SG). This work was partly funded by the National Institutes of Health grant HL120839 (to BF). Christian Bacher thanks the Studienstiftung des deutschen Volkes for financial support. Stephan Gekle thanks the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Blaeser A, 2016, ADV HEALTHC MATER, V5, P326, DOI 10.1002/adhm.201500677; Blair GWS, 1939, J PHYS CHEM-US, V43, P853, DOI 10.1021/j150394a004; CARREAU PJ, 1972, T SOC RHEOL, V16, P99, DOI 10.1122/1.549276; Cruz DA, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4006288; Emmermacher J, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab7553; Escudier MP, 2001, J NON-NEWTON FLUID, V97, P99, DOI 10.1016/S0377-0257(00)00178-6; Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234; Holzl K, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/3/032002; Jose RR, 2016, ACS BIOMATER SCI ENG, V2, P1662, DOI 10.1021/acsbiomaterials.6b00088; Jungst T, 2016, CHEM REV, V116, P1496, DOI 10.1021/acs.chemrev.5b00303; Larsen BE, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0147-7; Leppiniemi J, 2017, ACS APPL MATER INTER, V9, P21959, DOI 10.1021/acsami.7b02756; Limbach HJ, 2006, COMPUT PHYS COMMUN, V174, P704, DOI 10.1016/j.cpc.2005.10.005; Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042; Manojlovic V, 2006, J CHEM TECHNOL BIOT, V81, P505, DOI 10.1002/jctb.1465; Markstedt K, 2015, BIOMACROMOLECULES, V16, P1489, DOI 10.1021/acs.biomac.5b00188; Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004; Ning LQ, 2018, ACS BIOMATER SCI ENG, V4, P3906, DOI 10.1021/acsbiomaterials.8b00714; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Ostwald W, 1929, KOLLOID Z, V47, P176, DOI 10.1007/BF01496959; Ouyang LL, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/3/035020; Paxton N, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa8dd8; Phillips TN, 2011, IMA J APPL MATH, V76, P790, DOI 10.1093/imamat/hxr003; Roehm D, 2012, EUR PHYS J-SPEC TOP, V210, P89, DOI 10.1140/epjst/e2012-01639-6; Sarker B, 2015, INT J BIOL MACROMOL, V78, P72, DOI 10.1016/j.ijbiomac.2015.03.061; Sarker M, 2017, J MANUF SCI E-T ASME, V139, DOI 10.1115/1.4036226; Shi J, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aac946; Snyder J, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/044106; Sochi T, 2015, RHEOL ACTA, V54, P745, DOI 10.1007/s00397-015-0863-x; Thakur A, 2016, NANOSCALE, V8, P12362, DOI 10.1039/c6nr02299e; Tian XY, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/4/045005; Wu QH, 2018, ACS BIOMATER SCI ENG, V4, P2643, DOI 10.1021/acsbiomaterials.8b00415; Zhao Y, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/045002; Zuidema JM, 2014, J BIOMED MATER RES B, V102, P1063, DOI 10.1002/jbm.b.33088	35	17	18	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236371	10.1371/journal.pone.0236371	http://dx.doi.org/10.1371/journal.pone.0236371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706802	Green Published, gold			2022-12-26	WOS:000579931700035
J	Just, JM; Scherbaum, N; Specka, M; Puth, MT; Weckbecker, K				Just, Johannes M.; Scherbaum, Norbert; Specka, Michael; Puth, Marie-Therese; Weckbecker, Klaus			Rate of opioid use disorder in adults who received prescription opioid pain therapy-A secondary data analysis	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; DEPENDENCE; DEPRESSION; PREVALENCE; CRITERIA; MISUSE; RISKS; ABUSE	Background and aims Data on rates of prescription opioid use disorder (pOUD) in European countries is limited. The aim of this investigation was to analyze a representative population sample regarding the 1-year prevalence of opioid use disorder in patients who received prescription opioid pain therapy and to identify related risk factors. Design Cross-sectional secondary data analysis Setting Secondary data analysis based on data from the 2015 Epidemiological Survey of Substance Abuse (ESA 2015) in Germany Participants German-speaking individuals living in private households aged 18 to 64 years were investigated. A total of 9204 individuals participated in the survey, resulting in a response rate of 52.2%. Primary and secondary outcome measures Primary outcome measure was the weighted prevalence of pOUD in the subgroup of study participants who had received prescription opioids. Secondary outcome measure was an analysis of risk factors connected with pOUD in the same subgroup. Findings A total of n = 9204 participants were included in the study of which n = 275 had received an opioid prescription in the last 12 months of which n = 54 were diagnosed with pOUD. The weighted 1-year prevalence of pOUD was 21.2% (mild: 14.7% vertical bar moderate: 3.5% vertical bar severe: 2.9%). Participants who had received opioid pain therapy had significantly higher odds of pOUD if they reported signs of depression (OR: 2.69; CI 95%: 1.13-6.38), inexplicable physical complaints (OR: 2.68; CI 95%: 1.14-6.31) or a psychiatric diagnosis (OR: 4.12; CI 95%: 1.36-12.43), and significantly lower odds of pOUD if they reported the use of non-opioid painkillers (OR: 0.27; CI 95%: 0.09-0.81). Conclusions pOUD is a common phenomenon in working-age patients who receive prescription opioid pain therapy in Germany and may be related to the co-existence of psychosomatic and psychiatric disorders such as depression.	[Just, Johannes M.; Weckbecker, Klaus] Univ Witten Herdecke, Fac Hlth, Inst Gen Practice & Interprofess Care, Dept Med, Witten, Germany; [Scherbaum, Norbert; Specka, Michael] Univ Duisburg Essen, LVR Hosp Essen, Med Fac, Dept Addict Behav & Addict Med, Essen, Germany; [Puth, Marie-Therese] Univ Hosp Bonn, Dept Med Biometry Informat & Epidemiol IMBIE, Bonn, Germany	Witten Herdecke University; University of Duisburg Essen; University of Bonn	Just, JM (corresponding author), Univ Witten Herdecke, Fac Hlth, Inst Gen Practice & Interprofess Care, Dept Med, Witten, Germany.	johannes.just@uni-wh.de	Weckbecker, Klaus/AGP-8017-2022	Schmitz, Marie-Therese/0000-0003-1351-9381; Specka, Michael/0000-0001-5194-7876				American Psychiatric Association, DIAGNOSTIC STAT MANU, DOI [10.1111/j.1360-0443.2010.03144.x, DOI 10.1111/J.1360-0443.2010.03144.X]; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Boscarino JA, 2015, SUBST ABUSE REHABIL, V6, P83, DOI 10.2147/SAR.S85667; Dasgupta N., 2008, AM J PUBLIC HEALTH, V108, P182; Degenhardt L, 2015, LANCET PSYCHIAT, V2, P314, DOI 10.1016/S2215-0366(15)00005-X; Edlund MJ, 2010, DRUG ALCOHOL DEPEN, V112, P90, DOI 10.1016/j.drugalcdep.2010.05.017; European Monitoring Centre for Drugs and Drug Addiction, 2019, EMCDDA STAT B; Frieden TR, 2016, NEW ENGL J MED, V374, P1501, DOI 10.1056/NEJMp1515917; Hauser W, 2020, SCHMERZ, V34, pS8, DOI 10.1007/s00482-018-0331-5; Hauser W, 2020, SCHMERZ, V34, P204, DOI 10.1007/s00482-020-00472-y; Hauser W, 2018, PAIN, V159, P85, DOI 10.1097/j.pain.0000000000001067; Hauser W, 2016, PAIN MANAG, V6, P249, DOI 10.2217/pmt.16.5; Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782; Just JM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026871; Just JM, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0775-9; Marschall U, 2016, EUR J PAIN, V20, P767, DOI 10.1002/ejp.802; Novak SP, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0909-3; O'Brien C, 2011, ADDICTION, V106, P866, DOI 10.1111/j.1360-0443.2010.03144.x; OECD, 2019, Addressing problematic opioid use in OECD countries, DOI 10.1787/a18286f0-en; Piontek D., 2016, SUCHT, V62, P259, DOI [10.1024/0939-5911/a000444, DOI 10.1024/0939-5911/A000444, DOI 10.1024/0939-5911/a000444]; Radbruch L, 2013, SUBST ABUS, V34, P313, DOI 10.1080/08897077.2012.735216; Reinecke H, 2015, BRIT J PHARMACOL, V172, P324, DOI 10.1111/bph.12634; Scherrer JF, 2015, PAIN, V156, P348, DOI 10.1097/01.j.pain.0000460316.58110.a0; Turk DC, 2008, CLIN J PAIN, V24, P497, DOI 10.1097/AJP.0b013e31816b1070; Von Korff M, 2017, INT J DRUG POLICY, V46, P90, DOI 10.1016/j.drugpo.2017.05.053; WEBER MM, 1988, INT CLIN PSYCHOPHARM, V3, P255, DOI 10.1097/00004850-198807000-00007; Weckbecker K, 2019, BUNDESGESUNDHEITSBLA, V62, P1446, DOI 10.1007/s00103-019-03044-3	27	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236268	10.1371/journal.pone.0236268	http://dx.doi.org/10.1371/journal.pone.0236268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32702036	gold, Green Published			2022-12-26	WOS:000575913700067
J	Prates, L; Politis, GG; Perez, SI				Prates, Luciano; Politis, Gustavo G.; Ivan Perez, S.			Rapid radiation of humans in South America after the last glacial maximum: A radiocarbon-based study	PLOS ONE			English	Article							INFERRING EXTINCTION; CONFIDENCE-INTERVALS; POPULATION; COLONIZATION; DEMOGRAPHY; SITE; TIME; DISTRIBUTIONS; DISPERSAL	The early peopling of the Americas has been one of the most hotly contested topics in American anthropology and a research issue that draws archaeologists into a multidisciplinary debate. In South America, although the background data on this issue has increased exponentially in recent decades, the core questions related to the temporal and spatial patterns of the colonization process remain open. In this paper we tackle these questions in the light of the quantitative analysis of a screened radiocarbon database of more than 1600 early dates. We explore the frequency of radiocarbon dates as proxies for assessing population growth; and define a reliable and statistically well supported lower chronological bound (not to the exact date) for the earliest human arrival. Our results suggest that the earliest chronological threshold for the peopling of South America should be between 16,600 and 15,100, with a mean estimated date similar to 15,500 cal BP (post Last Glacial Maximum). Population would have grown until the end of Antarctic Cold Reversal stadia) similar to 12,500 cal BP at the time of the main extinctions of megafauna-, when the increase rate slows, probably as a result of the changes that occurred in the trophic niche of humans.	[Prates, Luciano; Politis, Gustavo G.; Ivan Perez, S.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Prates, Luciano] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Arqueol, La Plata, Argentina; [Politis, Gustavo G.] Univ Nacl Ctr Prov Buenos Aires, Inst Invest Arqueol & Paleontol Cuaternario Pampe, Olavarria, Argentina; [Ivan Perez, S.] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Antropol, La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Comision Nacional de Energia Atomica (CNEA); National University of La Plata; Museo La Plata	Prates, L (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Prates, L (corresponding author), Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Arqueol, La Plata, Argentina.	lprates@fcnym.unlp.edu.ar			Center for the Evolution of Cultural Diversity; Institute of Archaeology, University College London (UK) [A008]; PUE-CONICET 2017-2021 "Ajuste cronologico de los procesos de continuidad y cambio en las sociedades indigenas del centroeste de Argentina"	Center for the Evolution of Cultural Diversity; Institute of Archaeology, University College London (UK); PUE-CONICET 2017-2021 "Ajuste cronologico de los procesos de continuidad y cambio en las sociedades indigenas del centroeste de Argentina"	Funding for the building of the database of this paper was provided by the Center for the Evolution of Cultural Diversity. Institute of Archaeology, University College London (UK); Project "Early population history of the Americas (#A008)." In addition, the research for this article received funds from PUE-CONICET 2017-2021 "Ajuste cronologico de los procesos de continuidad y cambio en las sociedades indigenas del centroeste de Argentina."The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DG, 2000, AM ANTIQUITY, V65, P43, DOI 10.2307/2694807; [Anonymous], 2019, R LANG ENV STAT COMP; Barrientos G., 2002, PERSPECTIVAS INTEGRA, P221; Bevan A, 2018, RCARBON METHODS CALI; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Boeda E, 2014, ANTIQUITY, V88, P927, DOI 10.1017/S0003598X00050845; Borrero LA, 1999, J WORLD PREHIST, V13, P321, DOI 10.1023/A:1022341730119; Borrero LuisAlberto., 2016, PALEOAMERICA, DOI [10.1080/20555563.2015.1136498, DOI 10.1080/20555563.2015.1136498]; Bradshaw CJA, 2012, QUATERNARY SCI REV, V33, P14, DOI 10.1016/j.quascirev.2011.11.021; BRYAN A L, 1973, Quaternary Research (Orlando), V3, P237, DOI 10.1016/0033-5894(73)90043-4; Bueno, 2014, ANTIQUITY, V88, P943, DOI DOI 10.1017/S0003598X00050845; Bueno L, 2013, QUATERN INT, V301, P1, DOI 10.1016/j.quaint.2013.04.008; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Crema ER, 2017, J ARCHAEOL SCI, V87, P1, DOI 10.1016/j.jas.2017.09.007; Crema ER, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154809; Dillehay T. D., 1997, ARCHAEOLOGICAL CONTE, VII; Dillehay TD, 2008, ENCICLOPEDIA ARCHAEO, P1683; Dillehay TD, 2019, QUATERNARY RES, V92, P70, DOI 10.1017/qua.2018.145; Dillehay TD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602778; Dillehay TD, 2012, QUATERNARY RES, V77, P418, DOI 10.1016/j.yqres.2012.02.003; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Dincauze D.F., 1984, ADV WORLD ARCHAEOL, V3, P275; Farina RA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2211; Fiedel SJ, 2017, QUATERN INT, V444, P4, DOI 10.1016/j.quaint.2017.06.022; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Goldberg A, 2016, NATURE, V532, P232, DOI 10.1038/nature17176; Gomez-Carballa A, 2018, GENOME RES, V28, P767, DOI 10.1101/gr.234674.118; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Holen SR, 2017, NATURE, V544, P479, DOI 10.1038/nature22065; Perez SI, 2016, QUATERN INT, V425, P214, DOI 10.1016/j.quaint.2016.05.004; Jackson D., 2015, PALEOAMERICA, V1, P213; Lanata JL, 2008, WORLD ARCHAEOL, V40, P520, DOI 10.1080/00438240802452890; Llamas B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501385; LYNCH TF, 1974, QUATERNARY RES, V4, P356, DOI 10.1016/0033-5894(74)90022-2; Maggard GJ, 2010, CURRENT RESEARCH IN, V27, P17; Marshall CR, 1997, PALEOBIOLOGY, V23, P165, DOI 10.1017/S0094837300016766; McCarthy MA, 1998, BIOL CONSERV, V83, P9, DOI 10.1016/S0006-3207(97)00048-7; McInerny GJ, 2006, CONSERV BIOL, V20, P562, DOI 10.1111/j.1523-1739.2006.00377.x; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Metcalf JL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501682; Moreno-Mayar JV, 2018, NATURE, V553, P203, DOI 10.1038/nature25173; Pedro JB, 2016, NAT GEOSCI, V9, P51, DOI [10.1038/ngeo2580, 10.1038/NGEO2580]; Pinotti T, 2019, CURR BIOL, V29, P149, DOI 10.1016/j.cub.2018.11.029; Politis G, 2015, MOBILITY ANCIENT SOC, P89; Politis GG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162870; Posth C, 2018, CELL, V175, P1185, DOI 10.1016/j.cell.2018.10.027; Potter B, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5473; Prasciunas M.M., 2015, CLOVIS EDGE NEW UNDE, P21; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; Rothhammer F, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.23029; Saltre F, 2015, QUATERNARY SCI REV, V112, P128, DOI 10.1016/j.quascirev.2015.01.022; Scheib CL, 2018, SCIENCE, V360, P1024, DOI 10.1126/science.aar6851; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Solow AR, 2006, P NATL ACAD SCI USA, V103, P7351, DOI 10.1073/pnas.0509480103; South A, 2011, R J, V3, P35; Steele J, 1998, WORLD ARCHAEOL, V30, P286, DOI 10.1080/00438243.1998.9980411; STRAUSS D, 1989, MATH GEOL, V21, P411, DOI 10.1007/BF00897326; Stuiver M., 2019, CALIB 7 0; Suarez R, 2018, QUATERN INT, V473, P242, DOI 10.1016/j.quaint.2017.08.024; Surovell TA, 2003, CURR ANTHROPOL, V44, P580, DOI 10.1086/377651; Sutter RC, J ARCHAEOLOGICAL RES, P1; Timpson A, 2014, J ARCHAEOL SCI, V52, P549, DOI 10.1016/j.jas.2014.08.011; Waters M. R., 2013, PALEOAMERICAN ODYSSE, P541; Williams AN, 2012, J ARCHAEOL SCI, V39, P578, DOI 10.1016/j.jas.2011.07.014	66	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236023	10.1371/journal.pone.0236023	http://dx.doi.org/10.1371/journal.pone.0236023			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU0WZ	32697794	gold, Green Published			2022-12-26	WOS:000555392700025
J	Yam, EA; Kahabuka, C; Mbita, G; Winani, K; Apicella, L; Casalini, C; Mbuguni, Z				Yam, Eileen A.; Kahabuka, Catherine; Mbita, Gaspar; Winani, Koheleth; Apicella, Louis; Casalini, Caterina; Mbuguni, Zuhura			Safer conception for female sex workers living with HIV in Dar es Salaam, Tanzania: Cross-sectional analysis of needs and opportunities in integrated family planning/HIV services	PLOS ONE			English	Article							FERTILITY INTENTIONS; AFFECTED COUPLES; REPRODUCTIVE HEALTH; CARE PROVIDERS; PREGNANCY; WOMEN; COMMUNICATION; PERSPECTIVES; KNOWLEDGE; CHILDREN	Background With the advent of effective treatment, women living with HIV can plan for pregnancy while minimizing risk of transmission to infants and seronegative partners. Family planning (FP) services tend to focus solely on addressing contraceptive need, but HIV-positive women-including female sex workers-often plan to have children someday. Various "safer conception" strategies are now available to support women living with HIV achieve fertility intentions, and integrated HIV/FP services may be a promising platform to offer these services. Methods At integrated community-based HIV/FP service delivery sites operated by Jhpiego's Sauti project in Dar es Salaam, we conducted exit interviews with 300 HIV-positive female sex workers. Descriptive analyses were conducted to describe their desire for children, use of condoms and other modern contraceptive methods, self-reported viral suppression, and knowledge of and interest in safer conception strategies. We conducted bivariate and multivariate logistic regression analysis to examine correlates of fertility desire among respondents. Results Median age of participants was 32. Nearly one-third wished to have a child within two years. Seventy-two percent had heard of having the HIV-positive partner taking ART to reduce sexual transmission during pregnancy attempts. Thirty-one percent felt the amount of FP content covered in the consultation was "too little." Factors significantly associated with desire for children were having a nonpaying partner (adjusted odds ratio [AOR] 2.18, 95% confidence interval [CI]1.13-4.20) and having fewer children (AOR 0.65, 95% CI 0.48-0.87). Viral suppression was not associated with fertility desire. Conclusions Sex workers living with HIV attending integrated HIV/FP services have need for both contraception as well as safer conception counseling. This integrated service delivery modality is a promising platform for providing safer conception services. FP counseling for HIV-positive women should be broadened to broach the topic of safer pregnancy, as well as explicit counseling on strategies to minimize risk of sexual transmission to partners.	[Yam, Eileen A.] Populat Council, Washington, DC USA; [Kahabuka, Catherine] CSK Res Solut Ltd, Dar Es Salaam, Tanzania; [Mbita, Gaspar; Casalini, Caterina] Jhpiego, Sauti Program, Dar Es Salaam, Tanzania; [Winani, Koheleth; Mbuguni, Zuhura] Minist Hlth Community Dev Gender Elderly & Childr, Reprod & Child Hlth Sect, Dar Es Salaam, Tanzania; [Apicella, Louis] Populat Council, Dar Es Salaam, Tanzania	Population Council; Jhpiego	Yam, EA (corresponding author), Populat Council, Washington, DC USA.	eyam@popcouncil.org			President's Emergency Plan for AIDS Relief (PEPFAR); US Agency for International Development (USAID)	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Agency for International Development (USAID)(United States Agency for International Development (USAID))	The funder [the President's Emergency Plan for AIDS Relief (PEPFAR) and the US Agency for International Development (USAID)] had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors EY and LA are employees of the Population Council, which was the recipient of the funder's support. The Population Council issued a subaward to the Tanzanian commercial research firm, CSK Research Solutions, to implement data collection activities (i.e., survey administration, data management, fieldwork management). Author CK is the owner of CSK Research Solutions. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2017, LANCET HIV, V4, pE475, DOI 10.1016/S2352-3018(17)30183-2; Argento E, 2015, DRUG ALCOHOL DEPEN, V157, P166, DOI 10.1016/j.drugalcdep.2015.10.022; Beckham SW, 2015, STUD FAMILY PLANN, V46, P55, DOI 10.1111/j.1728-4465.2015.00015.x; Beckham SW, 2015, CULT HEALTH SEX, V17, P165, DOI 10.1080/13691058.2014.961034; Bekker L-G, 2011, S AFR J HIV MED, V12; Beyeza-Kashesya J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192902; Black V, 2016, BJOG-INT J OBSTET GY, V123, P1585, DOI 10.1111/1471-0528.14156; Brown J, 2016, AIDS EDUC PREV, V28, P524, DOI 10.1521/aeap.2016.28.6.524; Cernigliaro D, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0613-1; Chadwick Rachelle J, 2011, Top Antivir Med, V19, P148; Coll AS, 2016, AIDS CARE, V28, P513, DOI 10.1080/09540121.2015.1112349; Crankshaw TL, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18832; Davies NECG, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21271; Deering KN, 2015, AIDS CARE, V27, P1241, DOI 10.1080/09540121.2015.1050981; Drainoni Mari-Lynn, 2018, J Health Dispar Res Pract, V11, P19; Duff P, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-61; Fakoya A, 2008, HIV MED, V9, P681, DOI 10.1111/j.1468-1293.2008.00634.x; Feldblum PJ, 2007, CONTRACEPTION, V76, P105, DOI 10.1016/j.contraception.2007.04.009; Goggin K, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0793-y; Haberlen SA, 2017, STUD FAMILY PLANN, V48, P153, DOI 10.1111/sifp.12018; Heffron R, 2018, AIDS BEHAV, V22, P1758, DOI 10.1007/s10461-017-1902-7; ICF, 2012, SA OV 2012; Ippoliti NB, 2017, STUD FAMILY PLANN, V48, P121, DOI 10.1111/sifp.12020; Davey D, 2018, AIDS BEHAV, V22, P2916, DOI 10.1007/s10461-018-2170-x; Kahabuka C, 2018, INT C FAM PLANN NOV; Kawale P, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0004-0; Kawale P, 2014, AIDS CARE, V26, P769, DOI 10.1080/09540121.2013.855294; Khidir H, 2018, AIDS BEHAV, V22, P1725, DOI 10.1007/s10461-017-1719-4; Krashin JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198798; Long JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218291; Loutfy MR, 2012, J OBSTET GYNAECOL CA, V34, P575, DOI 10.1016/S1701-2163(16)35274-4; Madeiro AP, 2015, CIENC SAUDE COLETIVA, V20, P587, DOI 10.1590/1413-81232015202.11202014; Mason J, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21312; Matthews LT, 2018, AIDS BEHAV, V22, P1713, DOI 10.1007/s10461-017-1777-7; Melaku YA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0137-2; Miller R, 1997, AFRICA OPERATIONS RE; Mindry DL, 2015, AIDS CARE, V27, P25, DOI 10.1080/09540121.2014.951311; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC), 2017, 2016 2017 INT BIOL D; Mmeje O, 2015, AIDS CARE, V27, P10, DOI 10.1080/09540121.2014.946385; Mpondo BCT, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/7089150; Narasimhan M, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21829; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; O'Reilly KR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-935; Peltzer K, 2018, HIV AIDS-RES PALLIAT, V10, P9, DOI [10.2147/HIV.S153212, 10.2147/RIVS.153212]; Rao A, 2016, OBSTET GYNECOL, V128, P15, DOI 10.1097/AOG.0000000000001471; Rivero ER S, 2008, ASSESSING INTEGRATIO; Salamander Trust, 2014, BUILD SAF HOUS FIRM; Saleem HT, 2016, INT PERSPECT SEX R H, V42, P179, DOI 10.1363/42e2916; Schwartz S, 2015, JAIDS-J ACQ IMM DEF, V68, pS91, DOI 10.1097/QAI.0000000000000448; Schwartz SR, 2014, AIDS, V28, pS277, DOI 10.1097/QAD.0000000000000330; Serour GI., 2019, GLOBAL REPROD HLTH, V4, pe27; Wagner GJ, 2013, ISRN INFECT DIS, DOI [10.5402/2013/478192 25379322, DOI 10.5402/2013/478192]; Wagner GJ, 2017, AIDS BEHAV, V21, P2479, DOI 10.1007/s10461-017-1732-7; Weldegebreal R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1366-5; West N, 2016, AIDS CARE, V28, P390, DOI 10.1080/09540121.2015.1093596; Wilcher R, 2013, AIDS, V27, pS65, DOI 10.1097/QAD.0000000000000051; World Health Organization, 2017, CONS GUID SEX REPR H; Yam EA, 2018, INT C FAM PLANN KIG; Yam EA, 2019, HEALTH CARE WOMEN IN, V40, P981, DOI 10.1080/07399332.2019.1623801; Yam EA, 2017, LANCET HIV, V4, pE10, DOI 10.1016/S2352-3018(16)30221-1; Yam EA, 2014, J FAM PLAN REPROD H, V40, P102, DOI 10.1136/jfprhc-2012-100527	61	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0235739	10.1371/journal.pone.0235739	http://dx.doi.org/10.1371/journal.pone.0235739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MS9QL	32692777	Green Published, gold			2022-12-26	WOS:000554606400018
J	Gimenez-Gomez, JM; Peris, JE; Subiza, B				Gimenez-Gomez, Jose-Manuel; Peris, Josep E.; Subiza, Begona			An egalitarian approach for sharing the cost of a spanning tree	PLOS ONE			English	Article								Aminimum cost spanning treeproblem analyzes the way to efficiently connect individuals to a source. Hence the question is how to fairly allocate the total cost among these agents. Our approach, reinterpreting the spanning tree cost allocation as a claims problem defines a simple way to allocate the optimal cost with two main criteria: (1) each individual only pays attention to a few connection costs (the total cost of the optimal network and the cost of connecting himself to the source); and (2) an egalitarian criteria is used to share costs. Then, using claims rules, we define an egalitarian solution so that the total cost is allocated asequallyas possible. We show that this solutions could propose allocations outside the core, a counter-intuitive fact whenever cooperation is necessary. Then we propose a modification to get a core selection, obtaining in this case an alternative interpretation of theFolksolution.	[Gimenez-Gomez, Jose-Manuel] Univ Rovira & Virgili, Dept Econ, Reus, Spain; [Gimenez-Gomez, Jose-Manuel] Univ Rovira & Virgili, ECO SOS, Reus, Spain; [Peris, Josep E.; Subiza, Begona] Univ Alacant, Metodes Quantitatius & Teoria Econ, Alacant, Spain; [Peris, Josep E.; Subiza, Begona] Univ Alacant, IUDESP, Alacant, Spain	Universitat Rovira i Virgili; Universitat Rovira i Virgili; Universitat d'Alacant; Universitat d'Alacant	Peris, JE (corresponding author), Univ Alacant, Metodes Quantitatius & Teoria Econ, Alacant, Spain.; Peris, JE (corresponding author), Univ Alacant, IUDESP, Alacant, Spain.	peris@ua.es	Giménez-Gómez, José Manuel/F-3095-2011	Gimenez-Gomez, Jose-Manuel/0000-0003-0202-4623; Peris, Josep E./0000-0002-2239-2215	Spanish Ministry of Economy and Competitiveness [ECO2016-75410-P, ECO2016-77200-P]; Universitat Rovira i Virgili; Generalitat de Catalunya [2018PRF-URV-B2-53, 2017SGR770]; Generalitat Valenciana [BEST/2019]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Universitat Rovira i Virgili; Generalitat de Catalunya(Generalitat de Catalunya); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	Financial support from the Spanish Ministry of Economy and Competitiveness under projects ECO2016-75410-P (AEI/FEDER UE) and ECO2016-77200-P (AEI/FEDER UE), and from Universitat Rovira i Virgili and Generalitat de Catalunya under projects 2018PRF-URV-B2-53 and 2017SGR770, is gratefully acknowledged. Financial support from the Generalitat Valenciana (BEST/2019 grants) to visit the UNSW is gratefully acknowledged.	[Anonymous], 2019, DIVIDE THERE ISNT EN; Bergantinos G, 2004, MATH METHOD OPER RES, V59, P393, DOI 10.1007/s001860400352; Bergantinos G., 2008, CZECH EC REV, V2, P251; Bergantinos G, 2007, J ECON THEORY, V137, P326, DOI 10.1016/j.jet.2006.11.001; BIRD CG, 1976, NETWORKS, V6, P335, DOI 10.1002/net.3230060404; Bogomolnaia A, 2010, GAME ECON BEHAV, V69, P238, DOI 10.1016/j.geb.2009.11.001; Casajus A, 2013, J MATH ECON, V49, P58, DOI 10.1016/j.jmateco.2012.09.008; Dutta B, 2004, GAME ECON BEHAV, V48, P223, DOI 10.1016/j.geb.2003.09.008; Estevez-Fernandez A, 2014, EUR J OPER RES, V237, P606, DOI 10.1016/j.ejor.2014.01.056; Feltkamp V., 1994, 1994106 TILB U CTR E; Hernandez P, 2016, J MATH ECON, V66, P72, DOI 10.1016/j.jmateco.2016.06.006; Kar A, 2002, GAME ECON BEHAV, V38, P265, DOI 10.1006/game.2001.0883; MOULIN H, 1987, INT J GAME THEORY, V16, P161, DOI 10.1007/BF01756289; Pop PC, 2018, EUR J OPER RES, V265, P478, DOI 10.1016/j.ejor.2017.08.015; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Subiza B, 2016, OPER RES LETT, V44, P598, DOI 10.1016/j.orl.2016.06.008; Trudeau C, 2020, MATH SOC SCI, V103, P8, DOI 10.1016/j.mathsocsci.2019.10.002; Trudeau C, 2017, J ECON THEORY, V169, P425, DOI 10.1016/j.jet.2017.03.001; Trudeau C, 2012, GAME ECON BEHAV, V75, P402, DOI 10.1016/j.geb.2011.09.002; Vicente-Perez Jose, 2019, COMPROMISING C UNPUB	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236058	10.1371/journal.pone.0236058	http://dx.doi.org/10.1371/journal.pone.0236058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730259	Green Published, Green Submitted, gold			2022-12-26	WOS:000556884700013
J	Andrews, ESV; Rzoska-Smith, E; Arcus, VL				Andrews, Emma S. V.; Rzoska-Smith, Elizabeth; Arcus, Vickery L.			Post-transcriptional modulation of the SigF regulon inMycobacterium smegmatisby the PhoH2 toxin-antitoxin	PLOS ONE			English	Article							MYCOBACTERIUM-SMEGMATIS; STATIONARY-PHASE; GENE; EXPRESSION; PROTEINS; HELICASE; ROLES; HEAT	PhoH2 proteins are highly conserved across bacteria and archaea yet their biological function is poorly characterised. We examined the growth profiles ofMycobacterium smegmatisstrainsmc(2)155andmc(2)155 Delta phoH2and observed the same growth profile and growth rate in a variety of conditions. In light of the comparable growth, we used RNAseq to provide a snapshot of the differences between the transcriptomes ofM.smegmatis mc(2)155andM.smegmatis mc(2)155 Delta phoH2during normal growth. At 48 hours, elevated expression of thesigFregulon was observed in Delta phoH2relative to wild type. In biochemical assays, PhoH2 showed activity towardsigFmRNA insinuating a role of PhoH2 in modulating the pool ofsigFmRNA in the cell during normal growth, adding further complexity to the repertoire of reported mechanisms of post-translational regulation. Multiple copies of the preferred target site of PhoH2 were identified in loops of thesigFmRNA structure, leading us to propose a mechanism for the activity of PhoH2 that is initiated after assembly on specific single-stranded loops of RNA. We hypothesise that PhoH2 is a toxin-antitoxin that contributes to the regulation of SigF at a post-transcriptional level through targeted activity onsigFmRNA. This work presents the first evidence for post-transcriptional regulation of SigF along with the biological function of PhoH2 fromM.smegmatis. This has implications for the highly conserved PhoH2 toxin-antitoxin module across the mycobacteria including the important human pathogenM.tuberculosis.	[Andrews, Emma S. V.; Rzoska-Smith, Elizabeth; Arcus, Vickery L.] Univ Waikato, Div Hlth Engn Comp & Sci, Sch Sci, Hamilton, New Zealand	University of Waikato	Andrews, ESV (corresponding author), Univ Waikato, Div Hlth Engn Comp & Sci, Sch Sci, Hamilton, New Zealand.	eandrews@waikato.ac.nz	Andrews, Emma/P-9877-2016	Andrews, Emma/0000-0003-2153-4346	ESVA Waikato Medical Research Foundation [239]; University of Waikato SIF medium research grant (2017); Waikato Medical Research Foundation; University of Waikato Strategic Initiative Fund	ESVA Waikato Medical Research Foundation; University of Waikato SIF medium research grant (2017); Waikato Medical Research Foundation; University of Waikato Strategic Initiative Fund	ESVA Waikato Medical Research Foundation grant #239 (2015) https://wmrf.org.nz/ESVA University of Waikato SIF medium research grant (2017) https://www.waikato.ac.nz/researchenterprise/funding The funders had no role in the study design, data collection, decision to publish or preparation of the manuscript.; The Waikato Medical Research Foundation and University of Waikato Strategic Initiative Fund for consumables funding. A/Prof W Patrick for laboratory space to complete final experiments.	Andrews E.S.V., 2013, BIOL BIOCH PHOH2 PRO; Andrews ESV, 2020, PROTEIN SCI, V29, P883, DOI 10.1002/pro.3814; Andrews ESV, 2015, TUBERCULOSIS, V95, P385, DOI 10.1016/j.tube.2015.03.013; Beaucher J, 2002, MOL MICROBIOL, V45, P1527, DOI 10.1046/j.1365-2958.2002.03135.x; DeMaio J, 1996, P NATL ACAD SCI USA, V93, P2790, DOI 10.1073/pnas.93.7.2790; Fedida A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060136; Gebhard S, 2008, MICROBIOL-SGM, V154, P2786, DOI 10.1099/mic.0.2008/018044-0; Gomez M, 1998, MOL MICROBIOL, V29, P617, DOI 10.1046/j.1365-2958.1998.00960.x; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Humpel A, 2010, J BACTERIOL, V192, P2491, DOI 10.1128/JB.00035-10; Ishige T, 2003, J BACTERIOL, V185, P4519, DOI 10.1128/JB.185.15.4519-4529.2003; Larisch C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-4; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michele TM, 1999, ANTIMICROB AGENTS CH, V43, P218, DOI 10.1128/AAC.43.2.218; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Pyle AM, 2009, CELL, V139, P458, DOI 10.1016/j.cell.2009.10.016; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Singh AK, 2008, CURR MICROBIOL, V56, P574, DOI 10.1007/s00284-008-9126-8; Singh AK, 2015, MICROBIOLOGYOPEN, V4, P896, DOI 10.1002/mbo3.288; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Williams EP, 2007, J BACTERIOL, V189, P4234, DOI 10.1128/JB.00201-07	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236551	10.1371/journal.pone.0236551	http://dx.doi.org/10.1371/journal.pone.0236551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726339	Green Published, Green Submitted, gold			2022-12-26	WOS:000556908900042
J	Paradkar, M; Padmapriyadarsini, C; Jain, D; Shivakumar, SVBY; Thiruvengadam, K; Gupte, AN; Thomas, B; Kinikar, A; Sekar, K; Bharadwaj, R; Dolla, CK; Gaikwad, S; Elilarasi, S; Lokhande, R; Reddy, D; Murali, L; Kulkarni, V; Pradhan, N; Hanna, LE; Pattabiraman, S; Kohli, R; Rani, S; Suryavanshi, N; Shrinivasa, BM; Cox, SR; Selvaraju, S; Gupte, N; Mave, V; Gupta, A; Bollinger, RC				Paradkar, Mandar; Padmapriyadarsini, Chandrasekaran; Jain, Divyashri; Shivakumar, Shri Vijay Bala Yogendra; Thiruvengadam, Kannan; Gupte, Akshay N.; Thomas, Beena; Kinikar, Aarti; Sekar, Krithika; Bharadwaj, Renu; Dolla, Chandra Kumar; Gaikwad, Sanjay; Elilarasi, S.; Lokhande, Rahul; Reddy, Devarajulu; Murali, Lakshmi; Kulkarni, Vandana; Pradhan, Neeta; Hanna, Luke Elizabeth; Pattabiraman, Sathyamurthi; Kohli, Rewa; Rani, S.; Suryavanshi, Nishi; Shrinivasa, B. M.; Cox, Samyra R.; Selvaraju, Sriram; Gupte, Nikhil; Mave, Vidya; Gupta, Amita; Bollinger, Robert C.		CTRIUMPH-RePORT India Study Team	Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India	PLOS ONE			English	Article							RISK-FACTORS; ALCOHOL-USE; INFECTION; EXPOSURE; THERAPY; TESTS; BCG	The World Health Organization (WHO) recently changed its guidance for tuberculosis (TB) preventive treatment (TPT) recommending TPT for all pulmonary TB (PTB) exposed household contacts (HHC) to prevent incident TB disease (iTBD), regardless of TB infection (TBI) status. However, this recommendation was conditional as the strength of evidence was not strong. We assessed risk factors for iTBD in recently-exposed adult and pediatric Indian HHC, to determine which HHC subgroups might benefit most from TPT. We prospectively enrolled consenting HHC of adult PTB patients in Pune and Chennai, India. They underwent clinical, microbiologic and radiologic screening for TB disease (TBD) and TBI, at enrollment, 4-6, 12 and 24 months. TBI testing was performed by tuberculin skin test (TST) and Quantiferon (R)- Gold-in-Tube (QGIT) assay. HHC without baseline TBD were followed for development of iTBI and iTBD. Using mixed-effect Poisson regression, we assessed baseline characteristics including TBI status, and incident TBI (iTBI) using several TST and/or QGIT cut-offs, as potential risk factors for iTBD. Of 1051 HHC enrolled, 42 (4%) with baseline TBD and 12 (1%) with no baseline TBI test available, were excluded. Of the remaining 997 HHC, 707 (71%) had baseline TBI (TST #x2265; 5 mm or QGIT #x2265; 0.35 IU/ml). Overall, 20 HHC (2%) developed iTBD (12 cases/1000 person-years, 95%CI: 8-19). HIV infection (aIRR = 29.08, 95% CI: 2.38-355.77, p = 0.01) and undernutrition (aIRR = 6.16, 95% CI: 1.89-20.03, p = 0.003) were independently associated with iTBD. iTBD was not associated with age, diabetes mellitus, smoking, alcohol, and baseline TBI, or iTBI, regardless of TST (#x2265; 5 mm, #x2265; 10 mm, #x2265; 6 mm increase) or QGIT (#x2265; 0.35 IU/ml, #x2265; 0.7 IU/ml) cut-offs. Given the high overall risk of iTBD among recently exposed HHCs, and the lack of association between TBI status and iTBD, our findings support the new WHO recommendation to offer TPT to all HHC of PTB patients residing in a high TB burden country such as India, and do not suggest any benefit of TBI testing at baseline or during follow-up to risk stratify recently-exposed HHC for TPT.	[Paradkar, Mandar; Jain, Divyashri; Kulkarni, Vandana; Pradhan, Neeta; Kohli, Rewa; Suryavanshi, Nishi; Gupte, Nikhil; Mave, Vidya] Johns Hopkins Univ, Clin Res Site, Byramjee Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India; [Paradkar, Mandar; Shivakumar, Shri Vijay Bala Yogendra; Kulkarni, Vandana; Pradhan, Neeta; Kohli, Rewa; Suryavanshi, Nishi; Gupte, Nikhil; Mave, Vidya] Johns Hopkins Univ, Ctr Clin Global Hlth Educ, Pune, Maharashtra, India; [Padmapriyadarsini, Chandrasekaran; Thiruvengadam, Kannan; Thomas, Beena; Sekar, Krithika; Dolla, Chandra Kumar; Reddy, Devarajulu; Murali, Lakshmi; Hanna, Luke Elizabeth; Pattabiraman, Sathyamurthi; Rani, S.; Shrinivasa, B. M.; Selvaraju, Sriram] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Gupte, Akshay N.; Cox, Samyra R.; Gupte, Nikhil; Mave, Vidya; Gupta, Amita; Bollinger, Robert C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Kinikar, Aarti; Bharadwaj, Renu; Gaikwad, Sanjay; Lokhande, Rahul] Byramjee Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India; [Kinikar, Aarti; Bharadwaj, Renu; Gaikwad, Sanjay; Lokhande, Rahul] Sassoon Gen Hosp, Pune, Maharashtra, India; [Elilarasi, S.] Inst Child Hlth, Chennai, Tamil Nadu, India; [Elilarasi, S.] Hosp Children, Chennai, Tamil Nadu, India	B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University; Johns Hopkins University; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Johns Hopkins University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune	Paradkar, M (corresponding author), Johns Hopkins Univ, Clin Res Site, Byramjee Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India.; Paradkar, M (corresponding author), Johns Hopkins Univ, Ctr Clin Global Hlth Educ, Pune, Maharashtra, India.	drman23@gmail.com	Pradhan, Neeta/ABE-5539-2021; Cox, Samyra R/GMW-6349-2022; Thiruvengadam, Kannan/AAQ-8532-2021; Paradkar, Mandar/ABF-6776-2020; Kohli, Rewa/AAD-6052-2021	Cox, Samyra R/0000-0001-9953-1693; Thiruvengadam, Kannan/0000-0002-3758-1094; Paradkar, Mandar/0000-0001-9843-4656; Shivakumar, Shri Vijay Bala Yogendra/0000-0003-0935-8423; Bollinger, Robert/0000-0002-6798-6834; , Rewa/0000-0001-7208-1282; Bharadwaj, Renu/0000-0002-4286-7337; Gupta, Amita/0000-0001-7036-2718	Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR); USA National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research (OAR); National Institutes of Health [NIH 1R01A1I097494-01A1]; NIH [UM1AI069465]; BJGMC JHU HIV TB Program - Fogarty International Center, NIH [D43TW009574]	Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); USA National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research (OAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BJGMC JHU HIV TB Program - Fogarty International Center, NIH	Data in this manuscript were collected as part of the Regional Prospective Observational Research for Tuberculosis (RePORT) India Consortium. CTRIUMPH is part of the RePORT consortium funded with Federal funds from the Government of India's (GOI) Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), the USA National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID), the Office of AIDS Research (OAR), and distributed in part by CRDF Global (USB1-31147-XX-13 to AG). This work was also supported by the National Institutes of Health (NIH 1R01A1I097494-01A1 to JG), the NIH funded Johns Hopkins Baltimore-Washington-India Clinical Trials Unit for NIAID Networks (UM1AI069465 to AG, VM, NG). Aarti Kinikar, Rajesh Kulkarni and Rahul Lokhande are supported by the BJGMC JHU HIV TB Program funded by the Fogarty International Center, NIH (D43TW009574 to RCB). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the DBT, the ICMR, the NIH, or CRDF Global. Any mention of trade names, commercial projects or organizations does not imply endorsement by any of the sponsoring organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASS JB, 1981, AM REV RESPIR DIS, V123, P394; Behr MA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2738; CDC, 2020, BODY MASS INDEX; CDC, 2012, TB EL TUB SKIN TEST; CDC, 2016, TUB SKIN TEST FACT S; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Chandrasekaran P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199360; Dolla CK, 2019, T R SOC TROP MED HYG; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Fox GJ, 2017, INT J INFECT DIS, V56, P68, DOI 10.1016/j.ijid.2016.11.006; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; Hensel RL, 2016, INT J TUBERC LUNG D, V20, P71, DOI 10.5588/ijtld.15.0457; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Jonsson J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187313; Kigozi NG, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7194-2; Landry J, 2008, INT J TUBERC LUNG D, V12, P1352; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; MADDALI MV, 2016, BMJ OPEN, V6, DOI DOI 10.1136/BMJOPEN-2015-01054226916698; Marais BJ, 2018, LANCET GLOB HEALTH, V6, pE1260, DOI 10.1016/S2214-109X(18)30449-2; Mave V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218034; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Moonan PK, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001135; Nair D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162090; Narasimhan P, 2017, T ROY SOC TROP MED H, V111, P55, DOI 10.1093/trstmh/trx016; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Pai M, 2015, LUNG INDIA, V32, P205, DOI 10.4103/0970-2113.156210; Pathmanathan I, 2018, INT J TUBERC LUNG D, V22, P596, DOI 10.5588/ijtld.17.0758; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; QIAGEN, 2016, QGIT PACK INS; Sachdeva Kuldeep S, 2019, Indian J Tuberc, V66, P165, DOI 10.1016/j.ijtb.2019.02.005; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Saunders MJ, 2017, LANCET INFECT DIS, V17, P1190, DOI 10.1016/S1473-3099(17)30447-4; Schablon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115322; Sharma SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169539; Shivakumar SVBY, 2018, INT J TUBERC LUNG D, V22, P686, DOI 10.5588/ijtld.17.0598; Silva DR, 2018, J BRAS PNEUMOL, V44, P145, DOI [10.1590/s1806-37562017000000443, 10.1590/S1806-37562017000000443]; Simpson T, 2012, HEART LUNG, V41, P553, DOI 10.1016/j.hrtlng.2012.06.005; Singh J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069730; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Tagmouti Saloua, 2014, Ann Am Thorac Soc, V11, P1267, DOI 10.1513/AnnalsATS.201405-188OC; Tieu HV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105003; van Schalkwyk C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095372; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2014, STAND TB CAR IND; World Health Organization, 2020, OP HDB TUB MOD 1 PRE; World Health Organization, 2020, WHO CHILD GROWTH STA; World Health Organization, 2018, LAT TUB INF UPD CONS	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236743	10.1371/journal.pone.0236743	http://dx.doi.org/10.1371/journal.pone.0236743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726367	gold, Green Accepted, Green Published			2022-12-26	WOS:000556908900024
J	Quosay, AA; Knez, D; Ziaja, J				Quosay, Awad Ahmed; Knez, Dariusz; Ziaja, Jan			Hydraulic fracturing: New uncertainty based modeling approach for process design using Monte Carlo simulation technique	PLOS ONE			English	Article								Hydraulic fracturing is a key method used in completion of shale gas wells as well as in well stimulation. There are a lot of factors affecting the hydraulic fracturing treatment; i.e. formation in-situ stresses, fracturing fluid properties, proppant, pumping rate, reservoir fluid and rock properties horizontal ellipsis etc. For predictive modeling, these factors are associated with a lot of uncertainties, since most of them are laboratory measured, calculated or subjectively estimated. Moreover, the precise contribution of each factor on the final fracturing result is unknown for each individual case. Therefore, for better treatment performance and in order to find the best range of designing parameters, a hydraulic fracturing predictive model that involves these uncertainties is required specially for newly exploited shale gas reservoir. In this paper a new uncertainty-based approach is described for hydraulic fracturing processes. It is based on assigning probability distribution for some variables and parameters used in the designing process. These probability distributions are used as input data for analytical equations that describe the fracturing processes. Monte Carlo Simulation technique is used to apply uncertainty-based values on the designing analytical formulas. A hypothetical hydraulic fracturing example is used to simulate the effect of different variables and designing parameters on the entire fracturing process. The simulation results are illustrated into probability distribution curves and variance-based sensitivity analysis is performed to assess the contribution and the correlation between different variables and outcomes. Fracture geometry is almost controlled by the injection fluid's viscosity, in case of constant injection rate; while rock properties have insignificant effect on the fracture width compares to fracturing fluid's effect. Therefore more emphases shall be directed to rheological modeling of the fracturing fluid. It is found also that fracture height, which is difficult to be estimated, is the most crucial parameter in the calculation of treatment size or the injected fluid's volume. Proppant porosity, injected fluid viscosity and formation strength are slightly affecting propped fracture width, while proppant final concentration plays the main role of determining the calculated propped fracture width. It is observed from the simulation results that the initial formation permeability will extremely affect the post fracturing skin factor while other formation rock properties have almost no effect on the skin factor. Throughout the implementation of the uncertainty-based modeling approach for hydraulic fracturing process design, it is found that uncertainties in the value of many variables and parameters are slightly affecting the process outcomes. However, injected fluid viscosity, shale formation permeability and proppant final concentration are found to be the most influencing factors in the entire process. Therefore, it is highly recommended to perform in-depth study for these factors prior conducting any designing process of hydraulic fracturing.	[Quosay, Awad Ahmed] Univ Khartoum, Dept Petr Engn, Khartoum, Sudan; [Knez, Dariusz; Ziaja, Jan] AGH Univ Sci & Technol, Fac Drilling Oil & Gas, Krakow, Poland	University of Khartoum; AGH University of Science & Technology	Knez, D (corresponding author), AGH Univ Sci & Technol, Fac Drilling Oil & Gas, Krakow, Poland.	knez@agh.edu.pl	Knez, Dariusz/T-6955-2017; Ziaja, Jan Dariusz/S-1939-2018	Knez, Dariusz/0000-0003-1028-2497; Ziaja, Jan Dariusz/0000-0002-4915-5121	AGH [16.16.190.779]	AGH	The project was supported by the AGH subsidy 16.16.190.779.	AGARWAL RG, 1979, J PETROL TECHNOL, V31, P362, DOI 10.2118/6838-PA; Carbo Ceramics, PHYS PROP PROPJP TOP; Chen YF, 2020, J ENERG RESOUR-ASME, V142, DOI 10.1115/1.4046791; CINCOLEY H, 1981, J PETROL TECHNOL, V33, P1749, DOI 10.2118/7490-PA; Crain ER, 2000, CRAINS PETRO PHYS HD; Devictor N., 2007, ADV METHODS UNCERTAI; Economides M. J., 2000, RESERVOIR STIMULATIO, V3rd; Fan Y, 2019, J PETROL SCI ENG, V176, P1053, DOI 10.1016/j.petrol.2019.02.028; GEERTSMA J, 1969, J PETROL TECHNOL, V21, P1571, DOI 10.2118/2458-PA; Guo B, 2007, PETROLEUM PRODUCTION ENGINEERING: A COMPUTER-ASSISTED APPROACH, P1, DOI 10.1016/B978-075068270-1/50004-9; Han G., 2019, SPE AAPG SEG UNC RES, DOI [10.15530/urtec-2019-34, DOI 10.15530/URTEC-2019-34]; Jonkman R. M., 2000, SPE EUR PETRC PAR FR, DOI [10.2118/65144-MS, DOI 10.2118/65144-MS]; Kurison C, 2019, J NAT GAS SCI ENG, V71, DOI 10.1016/j.jngse.2019.102948; Loeve M., 1978, PROBABILITY THEORY G; Mcnamee P., 2008, DECISION ANAL PROFES; Mohaghegh S, 1996, SPE RESERVOIR ENG, V11, P268, DOI 10.2118/31159-PA; Mohaghegh SD, 2002, SPE, DOI [10.2118/77597-MS, DOI 10.2118/77597-MS]; Nagel N., 2015, 49 US ROCK MECH GEOM; Nagel N.B., 2012, SPE HYDR FRACT TECHN, P19, DOI [10.2118/152192-MS, DOI 10.2118/152192-MS]; Podhoretz S. B., 2014, OFFSH TECHN C, DOI [10.4043/25179-MS, DOI 10.4043/25179-MS]; Quosay AA, 2016, OIL GAS-EUR MAG, V42, P140; SNEDDON IN, 1946, Q APPL MATH, V4, P262, DOI 10.1090/qam/17161; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6	23	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236726	10.1371/journal.pone.0236726	http://dx.doi.org/10.1371/journal.pone.0236726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726370	gold, Green Published			2022-12-26	WOS:000556908900057
J	Maeda, T; Kitamura, S; Nishihara, H; Yanagi, T				Maeda, Takuya; Kitamura, Shinya; Nishihara, Hiroshi; Yanagi, Teruki			Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies	ONCOGENE			English	Article							COMBINATION CHEMOTHERAPY; ANTITUMOR-ACTIVITY; BREAST-CANCER; DOCETAXEL; EFFICACY; ERIBULIN; OUTCOMES; PROTEIN; GROWTH; TUMOR	Although the prognosis of advanced extramammary Paget's disease (EMPD) is poor, there have been no preclinical research models for the development of novel therapeutics. This study aims to establish a preclinical research model for EMPD. We transplanted EMPD tissue into immunodeficient NOD/Scid mice. Histopathological and genetic analyses using a comprehensive cancer panel were performed. For in vivo preclinical treatments, trastuzumab, lapatinib, docetaxel, or eribulin were administered to patient-derived xenograft (PDX) models. Tissue transplanted from the EMPD patient was enlarged in NOD/Scid mice and was transplanted into further generations. Both the transplantation of PDX intonu/numice and the reanimation of the cryopreserved xenografted tumors in NOD/Scid mice were successful. We also established an EMPD-PDX-derived primary cell culture. Histopathologically, the xenografted tumors were positive for CK7, which was consistent with the patient's tumors. Genetically, the pathogenic mutationERBB2S310F was detected in the patient's tumors (primary intraepidermal lesion, metastatic lymph node) and was observed in the xenografted tumors even after continued passages. The xenografted tumors responded well to trastuzumab and lapatinib therapy. Also, cytotoxic agents (docetaxel and eribulin) were effective against the xenografted tumors. This PDX model (EMPD-PDX-H1) could be a powerful tool for the research and development of EMPD treatments.	[Maeda, Takuya; Kitamura, Shinya; Yanagi, Teruki] Hokkaido Univ, Fac Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Maeda, Takuya; Kitamura, Shinya; Yanagi, Teruki] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Nishihara, Hiroshi] Keio Univ, Sch Med, Keio Canc Ctr, Genom Unit, Tokyo, Japan	Hokkaido University; Hokkaido University; Keio University	Yanagi, T (corresponding author), Hokkaido Univ, Fac Med, Dept Dermatol, Sapporo, Hokkaido, Japan.; Yanagi, T (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.	yanagi@med.hokudai.ac.jp	Yanagi, Teruki/D-4222-2017	Yanagi, Teruki/0000-0003-2196-7600	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology in Japan [18K08259]	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Ms. Yuko Tateda for her technical assistance. This work was supported in part by KAKENHI grant #18K08259 to TY from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Hatta N, 2008, BRIT J DERMATOL, V158, P313, DOI 10.1111/j.1365-2133.2007.08314.x; Hendrikx JJMA, 2016, INT J CANCER, V138, P758, DOI 10.1002/ijc.29812; Herrel LA, 2015, ANN SURG ONCOL, V22, P1625, DOI 10.1245/s10434-014-4139-y; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hirai I, 2019, ONCOLOGIST, V24, pE394, DOI 10.1634/theoncologist.2018-0856; Hirakawa S, 2009, AM J PATHOL, V175, P2235, DOI 10.2353/ajpath.2009.090420; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; Ivanics T, 2018, LAB INVEST, V98, P947, DOI 10.1038/s41374-018-0042-7; Kanitakis J, 2007, J EUR ACAD DERMATOL, V21, P1450, DOI 10.1111/j.1468-3083.2007.02438.x; Karam A, 2012, GYNECOL ONCOL, V125, P346, DOI 10.1016/j.ygyno.2012.01.032; Karam A, 2008, GYNECOL ONCOL, V111, P568, DOI 10.1016/j.ygyno.2007.12.014; Kato M, 2019, BRIT J DERMATOL, V181, P831, DOI 10.1111/bjd.17922; Kavuri SM, 2015, CANCER DISCOV, V5, P832, DOI 10.1158/2159-8290.CD-14-1211; Kiniwa Y, 2019, J DERMATOL SCI, V94, P229, DOI 10.1016/j.jdermsci.2019.03.006; Koga Y, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050418; Ma CX, 2017, CLIN CANCER RES, V23, P5687, DOI 10.1158/1078-0432.CCR-17-0900; NISHI M, 1992, J NATL CANCER I, V84, P519, DOI 10.1093/jnci/84.7.519; Nonagase Y, 2016, ONCOTARGET, V7, P84860, DOI 10.18632/oncotarget.12743; Oashi K, 2014, BRIT J DERMATOL, V170, P1354, DOI 10.1111/bjd.12788; Ohara K, 2016, J DERMATOL SCI, V83, P234, DOI 10.1016/j.jdermsci.2016.06.004; Paget J., 1874, ST BARTHOLOMEWS HOSP, V10, P87; Richter CE, 2010, J CLIN PATHOL, V63, P544, DOI 10.1136/jcp.2010.077446; Takahagi S, 2009, J DERMATOL, V36, P457, DOI 10.1111/j.1346-8138.2009.00676.x; Takeichi T, 2020, CANCERS, V12, DOI 10.3390/cancers12040820; Tanaka R, 2013, BRIT J DERMATOL, V168, P1259, DOI 10.1111/bjd.12249; Tanaka R, 2016, CLIN EXP METASTAS, V33, P687, DOI 10.1007/s10585-016-9804-z; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tokuda Y, 2015, INT J CLIN ONCOL, V20, P194, DOI 10.1007/s10147-014-0686-2; Towle MJ, 2012, ANTICANCER RES, V32, P1611; Twelves C, 2014, BREAST CANCER RES TR, V148, P553, DOI 10.1007/s10549-014-3144-y; Vornicova O, 2014, ONCOLOGIST, V19, P1006, DOI 10.1634/theoncologist.2014-0054; Wainberg ZA, 2010, CLIN CANCER RES, V16, P1509, DOI 10.1158/1078-0432.CCR-09-1112; Wolff AC, 2018, J CLIN ONCOL, V36, P2105, DOI 10.1200/JCO.2018.77.8738; Yanagi T, 2018, CANCER RES, V78, P6795, DOI 10.1158/0008-5472.CAN-18-1495; Yanagi T, 2014, CANCER RES, V74, P5795, DOI 10.1158/0008-5472.CAN-14-0872; Yoshino K, 2016, J DERMATOL, V43, P633, DOI 10.1111/1346-8138.13200; Zhang GH, 2019, J INVEST DERMATOL, V139, P789, DOI 10.1016/j.jid.2018.08.030	39	9	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2020	39	36					5867	5875		10.1038/s41388-020-01404-x	http://dx.doi.org/10.1038/s41388-020-01404-x		JUL 2020	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NJ1HO	32724160	Green Submitted			2022-12-26	WOS:000553333400002
J	Nam, TS; Park, DR; Rah, SY; Woo, TG; Chung, HT; Brenner, C; Kim, UH				Nam, Tae-Sik; Park, Dae-Ryoung; Rah, So-Young; Woo, Tae-Gyu; Chung, Hun Taeg; Brenner, Charles; Kim, Uh-Hyun			Interleukin-8 drives CD38 to form NAADP from NADP(+)and NAAD in the endolysosomes to mobilize Ca(2+)and effect cell migration	FASEB JOURNAL			English	Article						calcium; cell migration; nicotinamide adenine dinucleotide; signal transduction	ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; NICOTINIC-ACID; NAD(+); CA2+; CAMP	Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most potent Ca(2+)mobilizing second messenger whose formation has remained elusive. In vitro, CD38-mediated NAADP synthesis requires an acidic pH and a nonphysiological concentration of nicotinic acid (NA). We discovered that CD38 catalyzes synthesis of NAADP by exchanging the nicotinamide moiety of nicotinamide adenine dinucleotide phosphate (NADP(+)) for the NA group of nicotinic acid adenine dinucleotide (NAAD) inside endolysosomes of interleukin 8 (IL8)-treated lymphokine-activated killer (LAK) cells. Upon IL8 stimulation, cytosolic NADP(+)is transported to acidified endolysosomes via connexin 43 (Cx43) and gated by cAMP-EPAC-RAP1-PP2A signaling. CD38 then performs a base-exchange reaction with the donor NA group deriving from NAAD, produced by newly described endolysosomal activities of NA phosphoribosyltransferase (NAPRT) and NMN adenyltransferase (NMNAT) 3. Thus, the membrane organization of endolysosomal CD38, a signal-mediated transport system for NADP(+)and luminal NAD(+)biosynthetic enzymes integrate signals from a chemokine and cAMP to specify the spatiotemporal mobilization of Ca(2+)to drive cell migration.	[Nam, Tae-Sik; Park, Dae-Ryoung; Rah, So-Young; Woo, Tae-Gyu; Kim, Uh-Hyun] Chonbuk Natl Univ, Med Sch, Dept Biochem, Jeonju 561182, South Korea; [Nam, Tae-Sik; Park, Dae-Ryoung; Rah, So-Young; Woo, Tae-Gyu; Kim, Uh-Hyun] Chonbuk Natl Univ, Med Sch, Natl Creat Res Lab Signaling Ca2, Jeonju, South Korea; [Chung, Hun Taeg] Univ Ulsan, Dept Biol Sci, Ulsan, South Korea; [Brenner, Charles] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Jeonbuk National University; Jeonbuk National University; University of Ulsan; University of Iowa	Kim, UH (corresponding author), Chonbuk Natl Univ, Med Sch, Dept Biochem, Jeonju 561182, South Korea.; Brenner, C (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu; uhkim@chonbuk.ac.kr	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Rah, So-Young/0000-0002-0255-1960	National Research Foundation of Korea (NRF) [2012R1A3A2026453, 2014R1A6A1030318]; Roy J. Carver Trust	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Roy J. Carver Trust	National Research Foundation of Korea (NRF), Grant/Award Number: 2012R1A3A2026453, 2014R1A6A1030318 and 2012R1A3A2026453; Roy J. Carver Trust	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bruzzone S, 2001, FASEB J, V15, P10; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Fujita T, 2005, CELL SIGNAL, V17, P167, DOI 10.1016/j.cellsig.2004.06.008; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hong K, 2008, J BIOL CHEM, V283, P23129, DOI 10.1074/jbc.M800478200; Kato Y, 2015, ARTERIOSCL THROM VAS, V35, P2617, DOI 10.1161/ATVBAHA.115.306534; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; LEE HC, 1995, J BIOL CHEM, V270, P9060, DOI 10.1074/jbc.270.16.9060; Lorraine C, 2015, BIOCHEM SOC T, V43, P482, DOI 10.1042/BST20150034; Park DR, 2019, FASEB J, V33, P3404, DOI 10.1096/fj.201800235R; Park KH, 2013, J BIOL CHEM, V288, P35548, DOI 10.1074/jbc.M113.489278; Rah SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10741; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Ring S, 2015, J IMMUNOL, V194, P3735, DOI 10.4049/jimmunol.1401434; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012; Vasudevan SR, 2008, BIOCHEM J, V411, P63, DOI 10.1042/BJ20071616; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Wilson HL, 1998, BIOCHEM J, V331, P837, DOI 10.1042/bj3310837; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; Yamamoto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147037; Yen MC, 2009, CLIN CANCER RES, V15, P641, DOI 10.1158/1078-0432.CCR-08-1988; Yoshino J, 2013, METHODS MOL BIOL, V1077, P203, DOI 10.1007/978-1-62703-637-5_14; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700	38	13	13	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12565	12576		10.1096/fj.202001249R	http://dx.doi.org/10.1096/fj.202001249R		JUL 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32717131				2022-12-26	WOS:000556425100001
J	Li, XS; Li, YF; Wu, TQ; Qu, CY; Ning, P; Shi, JL; Tian, XH				Li, Xiushuang; Li, Yafei; Wu, Tianqi; Qu, Chunyan; Ning, Peng; Shi, Jianglan; Tian, Xiaohong			Potassium fertilization combined with crop straw incorporation alters soil potassium fractions and availability in northwest China: An incubation study	PLOS ONE			English	Article							ORGANIC-MATTER; USE EFFICIENCY; PHYSICAL PROTECTION; SPATIAL VARIABILITY; AGRICULTURAL SOILS; RESIDUE MANAGEMENT; NUTRIENT BALANCES; CARBON; NITROGEN; DYNAMICS	Potassium (K) input is essential for the improvement of soil fertility in agricultural systems. However, organic amendment may differ from mineral K fertilization with respect to modifying the soil K transformation among different fractions, affecting soil K availability. We conducted a 60-day lab incubation experiment to evaluate the response of soil K dynamics and availability in various fractions with a view to simulating crop residue return and chemical K fertilization in an Anthrosol of northwest China. The tested soil was divided into two main groups, no K fertilization (K0) and K fertilization (K1), each of which was subjected to four straw addition regimes: no straw addition (Control), wheat straw addition (WS), maize straw addition (MS), and both wheat straw and maize straw addition (WS+MS). Soil K levels in the available (AK) and non-exchangeable (NEK) fractions were both significantly increased after K addition, following the order of K>WS> MS. Fertilizer K was the most efficient K source, demonstrating a 72.9% efficiency in increasing soil AK, while wheat and maize straw exhibited efficiencies of 47.1% and 39.3%, respectively. Furthermore, K fertilization and wheat and maize straw addition increased the soil AK in a cumulative manner when used in combination. The mobility factor (M-F) and reduced partition index (I-R) of soil K were used to quantitate the comprehensive soil K mobility and stability, respectively. Positive relationships were observed between the M-F and all relatively available fractions of soil K, whereas the I-R value of soil K correlated negatively with both M-F and all available fractions of soil K. In conclusion, straw amendment could be inferior to mineral K fertilization in improving soil K availability when they were almost equal in the net K input. Crop straw return coupled with K fertilization can be a promising strategy for improving both soil K availability and cycling in soil-plant systems.	[Li, Xiushuang; Li, Yafei; Wu, Tianqi; Qu, Chunyan; Ning, Peng; Shi, Jianglan; Tian, Xiaohong] Northwest A&F Univ, Coll Nat Resources & Environm, Minist Agr & Rural Affairs, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Shaanxi, Peoples R China; [Ning, Peng; Shi, Jianglan; Tian, Xiaohong] Minist Agr & Rural Affairs, Sci Lab Heyang Agr Environm & Farmland Cultivat, Heyang, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Shi, JL (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Minist Agr & Rural Affairs, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Shaanxi, Peoples R China.; Shi, JL (corresponding author), Minist Agr & Rural Affairs, Sci Lab Heyang Agr Environm & Farmland Cultivat, Heyang, Shaanxi, Peoples R China.	shijl81@nwsuaf.edu.cn		Li, Xiushuang/0000-0003-0920-5566	Natural Sciences Fundamental Research Program of Shaanxi [2017JM4029]; Key R&D Program of Shaanxi [2019ZDLNY01-05-01]; National Key R&D Program, China [2016YFD0200308]	Natural Sciences Fundamental Research Program of Shaanxi; Key R&D Program of Shaanxi; National Key R&D Program, China	This work was financed by the Natural Sciences Fundamental Research Program of Shaanxi (2017JM4029), the Key R&D Program of Shaanxi (2019ZDLNY01-05-01), and the National Key R&D Program (2016YFD0200308), China. Their recipients were Prof. Shi Jianglan and Tian Xiaohong, who gave us some important suggestion about the conception, design, and perforation of the experiment, and the writing of the manuscript.	[Anonymous], 1996, METHODS SOIL ANAL 3; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Barre P, 2008, PLANT SOIL, V302, P213, DOI 10.1007/s11104-007-9471-6; Blanchet G, 2017, GEODERMA, V290, P107, DOI 10.1016/j.geoderma.2016.12.002; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chatterjee A, 2013, AGRON J, V105, P685, DOI 10.2134/agronj2012.0350; Chen BQ, 2014, AGRON SUSTAIN DEV, V34, P429, DOI 10.1007/s13593-014-0207-8; CHEN JS, 1992, COMMUN SOIL SCI PLAN, V23, P1145, DOI 10.1080/00103629209368657; Chen RR, 2014, GLOBAL CHANGE BIOL, V20, P2356, DOI 10.1111/gcb.12475; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; DELAHAY P, 1968, J ELECTROANAL CHEM, V18, P194, DOI 10.1016/0368-1874(68)87023-6; Dikgwatlhe SB, 2014, SOIL TILL RES, V144, P110, DOI 10.1016/j.still.2014.07.014; Drake JE, 2013, BIOGEOSCIENCES, V10, P821, DOI 10.5194/bg-10-821-2013; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; Gao C, 2006, PEDOSPHERE, V16, P253, DOI 10.1016/S1002-0160(06)60051-9; Ge WeiJian, 2012, Plant Nutrition and Fertilizer Science, V18, P629; Gusiatin ZM, 2015, ENVIRON EARTH SCI, V74, P6233, DOI 10.1007/s12665-015-4649-3; Han FX, 2003, ADV ENVIRON RES, V8, P113, DOI 10.1016/s1093-0191(02)00142-9; Hassink J, 1997, SOIL SCI SOC AM J, V61, P131, DOI 10.2136/sssaj1997.03615995006100010020x; Holland J, 2014, SOIL RES, V52, P129, DOI 10.1071/SR13171; Huang SW, 2009, COMMUN SOIL SCI PLAN, V40, P2833, DOI 10.1080/00103620903173848; Huang X, 2012, ATMOS ENVIRON, V50, P9, DOI 10.1016/j.atmosenv.2012.01.017; Kimetu JM, 2010, AUST J SOIL RES, V48, P577, DOI 10.1071/SR10036; Li N, 2018, IOP C SER EARTH ENV, V108, DOI 10.1088/1755-1315/108/3/032036; Li S, 2016, SOIL TILL RES, V157, P43, DOI 10.1016/j.still.2015.11.002; Liao YL, 2013, J INTEGR AGR, V12, P694, DOI 10.1016/S2095-3119(13)60288-9; Liu C, 2014, GLOBAL CHANGE BIOL, V20, P1366, DOI 10.1111/gcb.12517; Liu XM, 2009, GEODERMA, V152, P23, DOI 10.1016/j.geoderma.2009.05.022; Malo DD, 2005, SOIL TILL RES, V81, P277, DOI 10.1016/j.still.2004.09.015; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; Mazzilli SR, 2014, SOIL BIOL BIOCHEM, V75, P273, DOI 10.1016/j.soilbio.2014.04.005; Miretzky P, 2011, J SOIL SEDIMENT, V11, P619, DOI 10.1007/s11368-011-0343-6; Moody PW, 2006, AUST J SOIL RES, V44, P265, DOI 10.1071/SR05154; Mulumba LN, 2008, SOIL TILL RES, V98, P106, DOI 10.1016/j.still.2007.10.011; Niu JF, 2013, FIELD CROP RES, V140, P69, DOI 10.1016/j.fcr.2012.10.008; Ogaard AF, 2005, J PLANT NUTR SOIL SC, V168, P80, DOI [10.1002/jpin.200421454, 10.1002/jpln.200421454]; OLK DC, 1995, SOIL SCI SOC AM J, V59, P1250, DOI 10.2136/sssaj1995.03615995005900050007x; Raheb A, 2012, J SOIL SCI PLANT NUT, V12, P747, DOI 10.4067/S0718-95162013005000021; Rodriguez L, 2009, J ENVIRON MANAGE, V90, P1106, DOI 10.1016/j.jenvman.2008.04.007; Rosolem CA, 2005, COMMUN SOIL SCI PLAN, V36, P1063, DOI 10.1081/CSS-200050497; Rousk K, 2016, GLOBAL CHANGE BIOL, V22, P4150, DOI 10.1111/gcb.13296; Sarkar GK, 2014, COMMUN SOIL SCI PLAN, V45, P61, DOI 10.1080/00103624.2013.848880; Sarkar GK, 2013, GEODERMA, V207, P8, DOI 10.1016/j.geoderma.2013.04.029; Schneider A., 2010, EUROPEAN J SOIL SCI, V48, P263; Shakeri S, 2018, J ARID LAND, V10, P217, DOI 10.1007/s40333-018-0052-8; Sheldrick WF, 2003, AGR ECOSYST ENVIRON, V94, P341, DOI 10.1016/S0167-8809(02)00038-5; Smith SR, 2009, ENVIRON INT, V35, P142, DOI 10.1016/j.envint.2008.06.009; Sui N, 2015, FIELD CROP RES, V172, P132, DOI 10.1016/j.fcr.2014.11.011; Tan DH, 2017, NUTR CYCL AGROECOSYS, V108, P121, DOI 10.1007/s10705-017-9843-0; Tan DS, 2012, AGR ECOSYST ENVIRON, V148, P65, DOI 10.1016/j.agee.2011.11.016; Wang HJ, 2008, NUTR CYCL AGROECOSYS, V81, P203, DOI 10.1007/s10705-007-9157-8; Xu MG, 2011, BIOL FERT SOILS, V47, P745, DOI 10.1007/s00374-011-0579-8; Yu CJ, 2010, CAN J CHEM ENG, V88, P874, DOI 10.1002/cjce.20321; Zhang HM, 2010, NUTR CYCL AGROECOSYS, V88, P341, DOI 10.1007/s10705-010-9359-3; Zhang HM, 2009, CHINESE SCI BULL, V54, P1773, DOI 10.1007/s11434-009-0164-9; Zhang XF, 2017, CATENA, V156, P176, DOI 10.1016/j.catena.2017.04.012; Zhao BZ, 2016, ENVIRON SCI POLLUT R, V23, P17581, DOI 10.1007/s11356-016-6927-3; Zhao YC, 2009, ENVIRON GEOL, V57, P1089, DOI 10.1007/s00254-008-1399-5; Zhen L, 2006, J ENVIRON MANAGE, V79, P409, DOI 10.1016/j.jenvman.2005.08.009; Zhu LQ, 2015, CATENA, V135, P283, DOI 10.1016/j.catena.2015.08.008	61	6	6	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236634	10.1371/journal.pone.0236634	http://dx.doi.org/10.1371/journal.pone.0236634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706842	gold, Green Published			2022-12-26	WOS:000579931700058
J	Rad, SMAH; Poudel, A; Tan, GMY; McLellan, AD				Rad, Ali Hosseini S. M.; Poudel, Aarati; Tan, Grace Min Yi; McLellan, Alexander D.			Promoter choice: Who should drive the CAR in T cells?	PLOS ONE			English	Article							LENTIVIRAL VECTORS; GENE-EXPRESSION; TRANSDUCTION; DIFFERENTIATION; TRANSCRIPTION; LYMPHOCYTES; ACTIVATION; RECEPTORS; SURVIVAL	Chimeric antigen receptor (CAR) T cell therapy is an effective treatment for B cell malignancies, with emerging potential for the treatment of other hematologic cancers and solid tumors. The strength of the promoter within the CAR cassette will alter CAR-polypeptide levels on the cell surface of the T cell-impacting on the kinetics of activation, survival and memory cell formation in T cells. In addition to the CAR, promoters can be used to drive other genes of interest to enhance CAR T cell function. Expressing multiple genes from a single RNA transcript can be effectively achieved by linking the genes via a ribosomal skip site. However, promoters may differ in their ability to transcribe longer RNAs, or could interfere with lentiviral production, or transduction frequencies. In this study we compared the ability of the strong well-characterized promoters CMV, EF-1, hPGK and RPBSA to drive functional expression of a single RNA encoding three products: GFP, CAR, plus an additional cell-survival gene, Mcl-1. Although the four promoters produced similarly high lentiviral titres, EF-1 gave the best transduction efficacy of primary T cells. Major differences were found in the ability of the promoters to drive expression of long RNA encoding GFP, CAR and Mcl-1, highlighting promoter choice as an important consideration for gene therapy applications requiring the expression of long and complex mRNA.	[Rad, Ali Hosseini S. M.; Poudel, Aarati; Tan, Grace Min Yi; McLellan, Alexander D.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand	University of Otago	Rad, SMAH; McLellan, AD (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	a.hosseini.rad@postgrad.otago.ac.nz; alex.mclellan@otago.ac.nz	Hosseini Rad, Ali/ABD-3953-2021	Hosseini Rad S.M, Ali/0000-0002-7107-3528; McLellan, Alexander/0000-0003-0761-0947	Cancer Society New Zealand [19.11]; University of Otago Research Grant Committee; Royal Society Marsden fund [18-UOO-188]	Cancer Society New Zealand; University of Otago Research Grant Committee; Royal Society Marsden fund(Royal Society of New ZealandMarsden Fund (NZ))	This study was funded by The Cancer Society New Zealand (19.11) and The University of Otago Research Grant Committee (2019). ADM and AR received salary support from the Royal Society Marsden fund 18-UOO-188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Andersen JL, 2012, NAT CELL BIOL, V14, P563, DOI 10.1038/ncb2511; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Burns WR, 2009, BLOOD, V114, P2888, DOI 10.1182/blood-2009-01-199216; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chang ZNL, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0519-8; Chmielewski M, 2004, J IMMUNOL, V173, P7647, DOI 10.4049/jimmunol.173.12.7647; Curtin JA, 2008, GENE THER, V15, P384, DOI 10.1038/sj.gt.3303105; Drent E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197349; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunkle A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.95; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Frigault MJ, 2015, CANCER IMMUNOL RES, V3, P356, DOI 10.1158/2326-6066.CIR-14-0186; Fu X, 2010, PLOS ONE, V5; Gallegos AM, 2016, NAT IMMUNOL, V17, P379, DOI 10.1038/ni.3386; Gilham DE, 2010, J GENE MED, V12, P129, DOI 10.1002/jgm.1421; Han C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02912-x; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Hosokawa H, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028621; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Jones S, 2009, HUM GENE THER, V20, P630, DOI 10.1089/hum.2008.048; Kim EH, 2016, VIROLOGY, V490, P75, DOI 10.1016/j.virol.2016.01.008; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; McLellan AD, 2019, IMMUNOLOGY CELL BIOL; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morciano G, 2016, BIOL CELL, V108, P279, DOI 10.1111/boc.201600019; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; Naldini L, 2016, SCIENCE, V353, P1101, DOI 10.1126/science.aah6192; Philip B, 2014, BLOOD, V124, P1277, DOI 10.1182/blood-2014-01-545020; Rothenberg EV, 2014, TRENDS IMMUNOL, V35, P195, DOI 10.1016/j.it.2014.03.001; Sakemura R, 2016, CANCER IMMUNOL RES, V4, P658, DOI 10.1158/2326-6066.CIR-16-0043; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Stoiber S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050472; Urso K, 2011, BLOOD, V118, P795, DOI 10.1182/blood-2010-12-322701; Wang DW, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-019-02206-w; Wang XY, 2017, J CELL MOL MED, V21, P3044, DOI 10.1111/jcmm.13216; Watts TH, 2010, J IMMUNOL, V185, P3785, DOI 10.4049/jimmunol.1090085; YEE JK, 1987, P NATL ACAD SCI USA, V84, P5197, DOI 10.1073/pnas.84.15.5197	41	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0232915	10.1371/journal.pone.0232915	http://dx.doi.org/10.1371/journal.pone.0232915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706785	Green Published, Green Submitted, gold			2022-12-26	WOS:000579931700004
J	Wahla, AS; Mallat, J; Zoumot, Z; Shafiq, I; De Oliveira, B; Uzbeck, M; Souilamas, R				Wahla, Ali Saeed; Mallat, Jihad; Zoumot, Zaid; Shafiq, Irfan; De Oliveira, Bruno; Uzbeck, Mateen; Souilamas, Redha			Complications of surgical and percutaneous tracheostomies, and factors leading to decannulation success in a unique Middle Eastern population	PLOS ONE			English	Article							MECHANICAL VENTILATION; TRACHEOTOMY; PLACEMENT; OUTCOMES	Introduction Surgical and percutaneous tracheostomy remains a commonly performed procedure in the intensive care unit (ICU). Given the unique patient population in the Middle East we decided to perform a review of the procedures performed in our hospital over a two-year period. Methods Single centre, retrospective observational study. All tracheostomies performed between January 2016 and January 2018 were included in the study. The primary outcome was the rate of tracheostomy complications. Multivariate logistic regression analysis was used to identify the independent factors associated with complications and decannulations. Results One hundred sixty-four patients were included in the study. Percutaneous tracheostomy was performed in 99 patients (60.4%). Complications occurred in thirty-eight patients (23%). Higher Left ventricular ejection fraction (OR = 0.94, 95%CI: [0.898-0.985]) and percutaneous tracheostomy (OR = 0.107, 95%CI: [0.029-0.401]) were associated with lower complications. Good Eastern Cooperative Oncology Group (ECOG) performance status (OR = 4.1, 95%CI: [1.3-13.3]) and downsized tracheostomy tube (OR = 6.5, 95%CI: [2.0-21.0]) were associated with successful decannulations. Successful decannulation was associated with lower hospital mortality when compated to those who could not be decannulated (3.2% vs 33.3% p < 0.0001). Conclusion In our older population with high comorbidities, percutaneous tracheostomies were associated with less complications than surgical tracheostomies. Patients with poor premorbid functional status and those who could not have their tracheostomy tube sucessfuly downsized were less likely to be decannulated, and had a higher mortality. This data enables physicians to inform the families of the added risks involved with tracheostomy in this patient group.	[Wahla, Ali Saeed; Zoumot, Zaid; Shafiq, Irfan; Uzbeck, Mateen] Cleveland Clin Abu Dhabi, Resp Inst, Abu Dhabi, U Arab Emirates; [Wahla, Ali Saeed; Mallat, Jihad; De Oliveira, Bruno] Cleveland Clin Abu Dhabi, Crit Care Inst, Abu Dhabi, U Arab Emirates; [Souilamas, Redha] Cleveland Clin Abu Dhabi, Heart & Vasc Inst, Abu Dhabi, U Arab Emirates	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Wahla, AS (corresponding author), Cleveland Clin Abu Dhabi, Resp Inst, Abu Dhabi, U Arab Emirates.; Wahla, AS (corresponding author), Cleveland Clin Abu Dhabi, Crit Care Inst, Abu Dhabi, U Arab Emirates.	WahlaA@ClevelandClinicAbuDhabi.ae		Wahla, Ali/0000-0002-4783-8324				Byhahn C, 2005, ANAESTHESIA, V60, P12, DOI 10.1111/j.1365-2044.2004.03707.x; Delaney A, 2006, CRIT CARE, V10, DOI 10.1186/cc4887; Fernandez-Bussy S, 2015, J BRONCHOL INTERN PU, V22, P357, DOI 10.1097/LBR.0000000000000177; Frengley JD, 2014, J AM GERIATR SOC, V62, P1, DOI 10.1111/jgs.12597; Gysin C, 1999, ANN SURG, V230, P708, DOI 10.1097/00000658-199911000-00014; Putensen C, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0544-7; Shah RK, 2012, LARYNGOSCOPE, V122, P25, DOI 10.1002/lary.21907; Trouillet JL, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0381-y; Trouillet JL, 2011, ANN INTERN MED, V154, P373, DOI 10.7326/0003-4819-154-6-201103150-00002; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	10	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236093	10.1371/journal.pone.0236093	http://dx.doi.org/10.1371/journal.pone.0236093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706784	gold, Green Published			2022-12-26	WOS:000579931700016
J	Yamazaki, M; Honda, S; Tamaki, K; Irie, M; Mihara, T				Yamazaki, Mayako; Honda, Sokichi; Tamaki, Keisuke; Irie, Megumi; Mihara, Takuma			Effects of (+)-bicuculline, a GABAa receptor antagonist, on auditory steady state response in free-moving rats	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; COGNITIVE DYSFUNCTION; PREFRONTAL CORTEX; GENE-EXPRESSION; NMDA ANTAGONIST; SCHIZOPHRENIA; MODEL; BICUCULLINE; KETAMINE; NEURONS	Auditory steady-state responses (ASSRs) are states in which the electrical activity of the brain reacts steadily to repeated auditory stimuli. They are known to be useful for testing the functional integrity of neural circuits in the cortex, as well as for their capacity to generate synchronous activity in both human and animal models. Furthermore, abnormal gamma oscillations on ASSR are typically observed in patients with schizophrenia (SZ). Changes in neural synchrony may reflect aberrations in cortical gamma-aminobutyric acid (GABA) neurotransmission. However, GABA's impact and effects related to ASSR are still unclear. Here, we examined the effect of a GABAa receptor antagonist, (+)-bicuculline, on ASSR in free-moving rats. (+)-Bicuculline (1, 2 and 4 mg/kg, sc) markedly and dose-dependently reduced ASSR signals, consistent with current hypotheses. In particular, (+)-bicuculline significantly reduced event-related spectral perturbations (ERSPs) at 2 and 4 mg/kg between 10 and 30 minutes post-dose. Further, bicuculline (2 and 4 mg/kg) significantly and dose-dependently increased baseline gamma power. Furthermore, the occurrence of convulsions was consistent with the drug's pharmacokinetics. For example, high doses of (+)-bicuculline such as those greater than 880 ng/g in the brain induced convulsion. Additionally, time-dependent changes in ERSP with (+)-bicuculline were observed in accordance with drug concentration. This study partially unraveled the contribution of GABAa receptor signals to the generation of ASSR.	[Yamazaki, Mayako; Honda, Sokichi; Tamaki, Keisuke; Mihara, Takuma] Astellas Pharma Inc, Dept Neurosci, Drug Discovery Res, Tsukuba, Ibaraki, Japan; [Irie, Megumi] Astellas Pharma Inc, Drug Discovery Res, Anal & Pharmacokinet Res Labs, Tsukuba, Ibaraki, Japan	Astellas Pharmaceuticals; Astellas Pharmaceuticals	Yamazaki, M (corresponding author), Astellas Pharma Inc, Dept Neurosci, Drug Discovery Res, Tsukuba, Ibaraki, Japan.	mayako.yamazaki@astellas.com		Yamazaki, Mayako/0000-0002-1654-1851				Adell A, 2012, SCHIZOPHRENIA BULL, V38, P9, DOI 10.1093/schbul/sbr133; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Brenner CA, 2003, AM J PSYCHIAT, V160, P2238, DOI 10.1176/appi.ajp.160.12.2238; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chiu PW, 2018, SCHIZOPHR RES, V193, P295, DOI 10.1016/j.schres.2017.07.021; Eder HG, 1997, EPILEPSIA, V38, P516, DOI 10.1111/j.1528-1157.1997.tb01134.x; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Frohlich J, 2014, J PSYCHOPHARMACOL, V28, P287, DOI 10.1177/0269881113512909; Goetz T, 2007, PROG BRAIN RES, V160, P21, DOI 10.1016/S0079-6123(06)60003-4; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Gunduz-Bruce H, 2009, BRAIN RES REV, V60, P279, DOI 10.1016/j.brainresrev.2008.07.006; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hong LE, 2004, SCHIZOPHR RES, V70, P293, DOI 10.1016/j.schres.2003.12.011; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; JOHNSTON GA, 1972, NATURE-NEW BIOL, V240, P219, DOI 10.1038/newbio240219a0; Johnston GAR, 2013, BRIT J PHARMACOL, V169, P328, DOI 10.1111/bph.12127; Kaar SJ, 2019, J NEURAL TRANSM, V126, P1637, DOI 10.1007/s00702-019-02080-2; Kozono N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44936-3; Krishnan GP, 2009, NEUROIMAGE, V47, P1711, DOI 10.1016/j.neuroimage.2009.03.085; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; LEVIN VA, 1980, J MED CHEM, V23, P682, DOI 10.1021/jm00180a022; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2008, NEUROPSYCHOPHARMACOL, V33, P141, DOI 10.1038/sj.npp.1301563; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; LINS OG, 1995, EVOKED POTENTIAL, V96, P420, DOI 10.1016/0168-5597(95)00048-W; Liu XR, 2004, DRUG METAB DISPOS, V32, P132, DOI 10.1124/dmd.32.1.132; LUBY ED, 1962, AM J PSYCHIAT, V119, P61, DOI 10.1176/ajp.119.1.61; Magiorkinis E, 2014, EPILEPSY RES TREAT, V2014, P24; Nakazawa K, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-016-0003-3; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; PONG SF, 1972, BRAIN RES, V42, P486, DOI 10.1016/0006-8993(72)90547-1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Regan D., 1989, HUMAN BRAIN ELECTROP; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Rowland LM, 2016, MOL PSYCHIATR, V21, P198, DOI 10.1038/mp.2015.34; Saunders JA, 2012, BEHAV BRAIN RES, V234, P233, DOI 10.1016/j.bbr.2012.06.032; Sivarao DV, 2013, NEUROPHARMACOLOGY, V73, P1, DOI 10.1016/j.neuropharm.2013.05.006; Sohal VS, 2012, BIOL PSYCHIAT, V71, P1039, DOI 10.1016/j.biopsych.2012.01.024; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SOUKUPOVA S, 1993, EPILEPSY RES, V15, P27, DOI 10.1016/0920-1211(93)90006-S; Spencer KM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.033.2009; Sullivan EM, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu118; Summerfield SG, 2007, J PHARMACOL EXP THER, V322, P205, DOI 10.1124/jpet.107.121525; Tada M, 2016, CEREB CORTEX, V26, P1027, DOI 10.1093/cercor/bhu278; Teale P, 2008, NEUROIMAGE, V42, P1481, DOI 10.1016/j.neuroimage.2008.06.020; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Vohs JL, 2012, INT J PSYCHOPHYSIOL, V86, P136, DOI 10.1016/j.ijpsycho.2012.04.002; Vohs JL, 2010, INT J NEUROPSYCHOPH, V13, P487, DOI 10.1017/S1461145709990307; Wang DS, 2017, ANESTHESIOLOGY, V126, P666, DOI 10.1097/ALN.0000000000001483; Wang M, 2015, NEUROSCI BULL, V31, P191, DOI 10.1007/s12264-014-1504-6; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5	58	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236363	10.1371/journal.pone.0236363	http://dx.doi.org/10.1371/journal.pone.0236363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706815	Green Published, gold			2022-12-26	WOS:000579931700032
J	Bobillo-Perez, S; Girona-Alarcon, M; Corniero, P; Sole-Ribalta, A; Balaguer, M; Esteban, E; Valls, A; Jordan, I; Cambra, FJ				Bobillo-Perez, Sara; Girona-Alarcon, Monica; Corniero, Patricia; Sole-Ribalta, Anna; Balaguer, Monica; Esteban, Elisabeth; Valls, Anna; Jordan, Iolanda; Cambra, Francisco Jose			Pro-atrial natriuretic peptide and proadrenomedullin before cardiac surgery in children. Can we predict the future?	PLOS ONE			English	Article							REGIONAL PRO-ADRENOMEDULLIN; PROGNOSTIC VALUE; HEART-DISEASE; PLASMA-LEVELS; RISK; BIOMARKERS; DIAGNOSIS; MARKERS; BNP; FAILURE	Introduction and objective Pro-atrial natriuretic peptide (proANP) and pro-adrenomedullin (proADM) levels increase in acute heart failure and sepsis. After cardiac surgery, children may require increased support in the intensive care unit and may develop complications. The aim of this study was to evaluate the utility of proANP and proADM values, determined prior to cardiac surgery, for predicting the need for increased respiratory or inotropic support during the post-operative period. Methods This was a prospective study in children. Biomarkers were analyzed before surgery using a single blood test. The primary endpoints were the need for greater respiratory and/or inotropic support during the post-operative period. Secondary endpoints were the relationship between these biomarkers and complications after surgery. Results One hundred thirteen patients were included. ProANP and proADM were higher in children who required greater respiratory and inotropic support, especially proANP; for increased respiratory support, 578.9 vs. 106.6 pmol/L (p = 0.004), and for increased inotropic support, 1938 vs. 110.4 pmol/L (p = 0.002). ProANP had a greater AUC than proADM for predicting increased respiratory support after surgery: 0.791 vs. 0.724. A possible cut-off point for proANP could be. 325 pmol/L (sensitivity = 66.7% and specificity = 88.8%). In the multivariate analysis, the logarithmic transformation of proANP was independently associated with the need for increased respiratory support (OR = 3.575). Patients who presented a poor outcome after cardiac surgery also had higher biomarker values (proADM, p = 0.013; proANP, p = 0.001). Conclusions Elevated proANP before cardiac surgery may identify which children will need more respiratory and inotropic support during the post-operative period.	[Bobillo-Perez, Sara; Girona-Alarcon, Monica; Corniero, Patricia; Sole-Ribalta, Anna; Balaguer, Monica; Esteban, Elisabeth; Jordan, Iolanda; Cambra, Francisco Jose] Univ Barcelona, Pediat Intens Care Unit, Hosp St Joan de Deu, Barcelona, Spain; [Bobillo-Perez, Sara; Girona-Alarcon, Monica; Sole-Ribalta, Anna; Balaguer, Monica; Esteban, Elisabeth; Cambra, Francisco Jose] Univ Barcelona, Disorders Immun & Respirat Pediat Crit Patient Re, Inst Recerca Hosp St Joan de Deu, Barcelona, Spain; [Valls, Anna] Univ Barcelona, Biochem Lab, Hosp St Joan de Deu, Barcelona, Spain; [Jordan, Iolanda] CIBERESP, Pediat Infect Dis Res Grp, Inst Recerca Hosp St Joan de Deu, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Jordan, I (corresponding author), Univ Barcelona, Pediat Intens Care Unit, Hosp St Joan de Deu, Barcelona, Spain.; Jordan, I (corresponding author), CIBERESP, Pediat Infect Dis Res Grp, Inst Recerca Hosp St Joan de Deu, Barcelona, Spain.	ijordan@sjdhospitalbarcelona.org	Pérez, Sara Bobillo/E-8224-2018; lasosa, Francisco José Cambra/ABH-4656-2020; BOBILLO-PEREZ, SARA/W-8374-2019; Girona-Alarcon, Monica/ABH-4405-2020; Jordan, Iolanda/U-5791-2017	Pérez, Sara Bobillo/0000-0001-8889-2995; BOBILLO-PEREZ, SARA/0000-0001-8889-2995; Girona-Alarcon, Monica/0000-0002-2752-7481; Jordan, Iolanda/0000-0002-2041-4425				Abella R, 2012, J MATERN-FETAL NEO M, V25, P2756, DOI 10.3109/14767058.2012.718393; Amirnovin R, 2013, J THORAC CARDIOV SUR, V145, P1279, DOI 10.1016/j.jtcvs.2012.07.067; Andaluz-Ojeda D, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0238-9; BALLERMANN BJ, 1986, CIRC RES, V58, P619, DOI 10.1161/01.RES.58.5.619; Bobillo-Perez S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215690; Cannesson M, 2007, ANESTH ANALG, V104, P1059, DOI 10.1213/01.ane.0000263644.98314.e2; Cantinotti M, 2017, J THORAC CARDIOV SUR, V154, P641, DOI 10.1016/j.jtcvs.2017.03.022; Cantinotti M, 2015, CLIN CHEM LAB MED, V53, P1839, DOI 10.1515/cclm-2014-1084; Cantinotti M, 2015, CARDIOL YOUNG, V25, P424, DOI 10.1017/S1047951114002133; Cantinotti M, 2014, HEART FAIL REV, V19, P727, DOI 10.1007/s10741-014-9422-2; Cantinotti M, 2011, CLIN CHEM LAB MED, V49, P567, DOI 10.1515/CCLM.2011.106; Cantinotti M, 2013, J THORAC CARDIOV SUR, V145, P1415, DOI 10.1016/j.jtcvs.2012.12.086; Cantinotti M, 2013, CIRC J, V77, P188, DOI 10.1253/circj.CJ-12-0834; Cantinotti M, 2012, CLIN CHEM LAB MED, V50, P2009, DOI 10.1515/cclm-2012-0125; Cao Y, 2012, ACTA PAEDIATR, V101, P242, DOI 10.1111/j.1651-2227.2011.02511.x; Christ-Crain M, 2005, CRIT CARE, V9, pR816, DOI 10.1186/cc3885; Davidson J, 2012, INTENS CARE MED, V38, P1184, DOI 10.1007/s00134-012-2544-x; Gaies MG, 2014, PEDIATR CRIT CARE ME, V15, P529, DOI 10.1097/PCC.0000000000000153; Gessler P, 2006, J PEDIATR-US, V148, P372, DOI 10.1016/j.jpeds.2005.10.039; Grass B, 2014, EARLY HUM DEV, V90, P293, DOI 10.1016/j.earlhumdev.2014.03.002; Hauser JA, 2016, HEART, V102, P1633, DOI 10.1136/heartjnl-2016-309460; Hirata Y, 1996, J CLIN ENDOCR METAB, V81, P1449, DOI 10.1210/jc.81.4.1449; Idzikowska K, 2018, J INT MED RES, V46, P3017, DOI 10.1177/0300060518786907; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; Koch A, 2007, INT J CARDIOL, V114, P339, DOI 10.1016/j.ijcard.2006.01.022; Lipinska-Gediga M, 2012, INFECTION, V40, P303, DOI 10.1007/s15010-011-0235-0; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Meune C, 2012, AM J CARDIOL, V109, P1117, DOI 10.1016/j.amjcard.2011.11.047; Mir TS, 2003, PEDIATRICS, V112, P896, DOI 10.1542/peds.112.4.896; Morgenthaler NG, 2005, CRIT CARE, V9, pR37, DOI 10.1186/cc3015; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Niedner MF, 2010, CONGENIT HEART DIS, V5, P243, DOI 10.1111/j.1747-0803.2010.00396.x; O'Brien SM, 2009, J THORAC CARDIOV SUR, V138, P1139, DOI 10.1016/j.jtcvs.2009.03.071; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Qu JB, 2017, J THORAC CARDIOV SUR, V154, P631, DOI 10.1016/j.jtcvs.2016.12.056; Seligman R, 2008, INTENS CARE MED, V34, P2084, DOI 10.1007/s00134-008-1173-x; Sole-Ribalta A, 2020, EUR J PEDIATR, V179, P1089, DOI 10.1007/s00431-020-03587-7; Szekely A, 2006, PEDIATR ANESTH, V16, P1166, DOI 10.1111/j.1460-9592.2006.01957.x; Tabib A, 2016, RES CARDIOVASC MED, V5, P3, DOI [10.4103/2251-9572.218740, DOI 10.4103/2251-9572.218740]; Travaglino F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-184; Ueda S, 1999, AM J RESP CRIT CARE, V160, P132, DOI 10.1164/ajrccm.160.1.9810006; Westerlind A, 2008, CLIN PHYSIOL FUNCT I, V28, P277, DOI 10.1111/j.1475-097X.2008.00805.x; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Yoshibayashi M, 1996, EUR J ENDOCRINOL, V135, P265, DOI 10.1530/eje.0.1350265	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236377	10.1371/journal.pone.0236377	http://dx.doi.org/10.1371/journal.pone.0236377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702064	Green Published, gold			2022-12-26	WOS:000575913700085
J	Engels, JL; Watson, S; Dulai, H; Burnett, KM; Wada, CA; Aga, A; DeMaagd, N; McHugh, J; Sumida, B; Bremer, LL				Engels, Jennifer L.; Watson, Sheree; Dulai, Henrietta; Burnett, Kimberly M.; Wada, Christopher A.; Aga, Anoilani; DeMaagd, Nathan; McHugh, John; Sumida, Barbara; Bremer, Leah L.			Collaborative research to support urban agriculture in the face of change: The case of the Sumida watercress farm on O'ahu	PLOS ONE			English	Article							ECOSYSTEM SERVICES; GARDENS; AVAILABILITY; RESILIENCE	As urban areas expand around the world, there are growing efforts to restore and protect natural and agricultural systems for the multitude of ecosystem services they provide to urban communities. This study presents a researcher-farmer collaboration in a highly urbanized area of O'ahu focused on understanding the historical and current challenges and opportunities faced by a culturally and socially valued spring-dependent urban farm, Sumida Farm, which produces the majority of the state of Hawai. i's watercress. We conducted a long-term trend analysis (25 years) of factors identified by the farmers to be important historical drivers of crop yield, including groundwater pumping, pest outbreaks, temperature, Oceanic Nino Index, and precipitation. We combined this analysis with a year of intensive spring water sampling on the farm to evaluate nutrient and contaminant composition and flow to understand water-related stressors, as well as evaluate the potential of the farm to provide nutrient retention services. We found negative correlations between historical crop yields and increases in the Oceanic Nino Index, temperature thresholds, and pest outbreaks. Despite the surrounding urbanization, we found on-farm water quality to be very high, and microbial analyses revealed an abundance of denitrifiers (nirS gene) suggesting that the farm provides a nutrient retention service to downstream systems. Finally, we found that socio-cultural values including heritage value, aesthetic value, and educational value are increasingly important for the Sumida family and surrounding community. These socio-cultural benefits alongside highly valued local food production and nutrient retention services are essential for continued community and political support. Collectively, our study demonstrates that challenges facing urban agricultural systems shift through time, and that recognition of the beyond crop-yield benefits of these systems to urban communities is essential to their long-term survival.	[Engels, Jennifer L.] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Watson, Sheree] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Dulai, Henrietta] Univ Hawaii Manoa, Dept Earth Sci, Honolulu, HI 96822 USA; [Dulai, Henrietta; Bremer, Leah L.] Univ Hawaii Manoa, Water Resource Res Ctr, Honolulu, HI 96822 USA; [Burnett, Kimberly M.; Wada, Christopher A.; DeMaagd, Nathan; Bremer, Leah L.] Univ Hawaii Manoa, Univ Hawaii Econ Res Org, Honolulu, HI 96822 USA; [Aga, Anoilani] Univ Hawaii Manoa, Inst Hawaiian Language Res & Translat, Honolulu, HI 96822 USA; [DeMaagd, Nathan] Univ Hawaii Manoa, Dept Econ, Honolulu, HI 96822 USA; [McHugh, John] Hawaii Dept Agr, Pesticides Branch, Honolulu, HI USA; [Sumida, Barbara] Sumida Farm, Aiea, HI USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Engels, JL (corresponding author), Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	engels@hawaii.edu	Dulai, Henrietta/AAY-9632-2020; Burnett, Kimberly/CAF-0517-2022; Wada, Christopher/I-8105-2016	Dulai, Henrietta/0000-0001-5970-1483; Engels, Jennifer/0000-0003-3953-1768; Watson, Sheree/0000-0002-3412-9596; Wada, Christopher/0000-0002-4916-9769	U.S.A. National Science Foundation Integrative and Collaborative Education and Research Division [1645515]; Hawai'i EPSCoR Program; U.S.A. National Science Foundation's Research Infrastructure Improvement (RII) Track-1: 'Ike Wai: Securing Hawai'i's Water Future Award [OIA-1557349]	U.S.A. National Science Foundation Integrative and Collaborative Education and Research Division; Hawai'i EPSCoR Program; U.S.A. National Science Foundation's Research Infrastructure Improvement (RII) Track-1: 'Ike Wai: Securing Hawai'i's Water Future Award	Jennifer Engels received funds to conduct this work from the U.S.A. National Science Foundation Integrative and Collaborative Education and Research Division; Award #: 1645515; Award Name: Collaborative Research: Active Societal Participation in Research and Education. These funders required that the research team be a Mobile Working Group that included community partners. Additional support came from the Hawai'i EPSCoR Program; U.S.A. National Science Foundation's Research Infrastructure Improvement (RII) Track-1: 'Ike Wai: Securing Hawai'i's Water Future Award #OIA-1557349. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2016, POTENTIAL ECOSYSTEM; Alberti Marina, 2004, Urban Ecosystems, V7, P241, DOI 10.1023/B:UECO.0000044038.90173.c6; [Anonymous], 2013, FEATURED FARM SUMIDA; [Anonymous], 2013, HAWAII FOOD MAP SUMI; [Anonymous], 1919, KA NUPEPA KUOKOA, VLVII; [Anonymous], 2010, AIEAS GREEN PATCH HE; Barbieri C, 2012, TOURISM MANAGE, V33, P509, DOI 10.1016/j.tourman.2011.05.009; Bremer LL, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124502; Businger S, 2018, B AM METEOROLOGICAL, V100; Camps-Calvet M, 2016, ENVIRON SCI POLICY, V62, P14, DOI 10.1016/j.envsci.2016.01.007; Connolly JJ, 2013, LANDSCAPE URBAN PLAN, V109, P76, DOI 10.1016/j.landurbplan.2012.07.001; COSTAPIERCE BA, 1987, BIOSCIENCE, V37, P320, DOI 10.2307/1310688; CUMBUS IP, 1980, AQUAT BOT, V9, P343, DOI 10.1016/0304-3770(80)90035-2; Dorres DE., 2018, STABLE ISOTOPE GEOCH; Elmqvist T, 2015, CURR OPIN ENV SUST, V14, P101, DOI 10.1016/j.cosust.2015.05.001; Forsyth B., 2013, HAWAII INDEPENDENT; Fujii J, 1993, SAVING FAMILY FARM S; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Kamakau S., 1865, KA NUPEPA KUOKOA, VIV; Kanahele GS, 1996, WAIKIKI 100 BC 1900; Keeler BL, 2019, NAT SUSTAIN, V2, P29, DOI 10.1038/s41893-018-0202-1; Kelly JL, 2012, IDENTIFICATION QUANT; Kurashima N, 2019, NAT SUSTAIN, V2, P191, DOI 10.1038/s41893-019-0226-1; Ling G., 1996, ASSESSMENT NITRATE L; Lovell ST, 2013, LANDSCAPE ECOL, V28, P1447, DOI 10.1007/s10980-013-9912-y; Malo D, 1898, HAWAII ANTIQUITIES; McHugh J, 1987, RES EXTENSION SERIES; MCHUGH JJ, 1980, HORTSCIENCE, V15, P801; McMillen H, 2017, REG ENVIRON CHANGE, V17, P579, DOI 10.1007/s10113-016-1032-1; McPhearson T, 2015, ECOSYST SERV, V12, P152, DOI 10.1016/j.ecoser.2014.07.012; McPhearson T, 2014, AMBIO, V43, P502, DOI 10.1007/s13280-014-0509-8; Middle I, 2014, URBAN FOR URBAN GREE, V13, P638, DOI 10.1016/j.ufug.2014.09.001; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Mostafanezhad M, 2018, GEOFORUM, V91, P227, DOI 10.1016/j.geoforum.2018.03.011; National Centers for Environmental Information National Oceanic and Atmospheric Administration, GLOB SUMM MONTH HON; Natuhara Y, 2013, ECOL ENG, V56, P97, DOI 10.1016/j.ecoleng.2012.04.026; Nickerson N. P., 2001, Journal of Travel Research, V40, P19, DOI 10.1177/004728750104000104; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Oki DS, 2005, 20055253 SCI INV; Orsini F, 2014, FOOD SECUR, V6, P781, DOI 10.1007/s12571-014-0389-6; Ott S, 2017, HUFFPOST; Peterson CH, 2008, ADV MAR BIOL, V54, P221, DOI 10.1016/S0065-2881(08)00004-7; Pulou J, 2012, ECOL ENG, V49, P212, DOI 10.1016/j.ecoleng.2012.08.002; Ray DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6989; REJMANKOVA E, 1992, AQUAT BOT, V43, P283, DOI 10.1016/0304-3770(92)90073-R; Richardson CM, 2017, J HYDROL-REG STUD, V11, P178, DOI 10.1016/j.ejrh.2015.11.006; Rotzoll K, 2012, 20125009 US GEOL SUR; Schack N., 2018, SUMIDA FARM HEART AI; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schuyler JD, 1889, REPORT WATER SUPPLY; Spirandelli D, 2018, ASSESSING VULNERABIL; Uaua WH, 1870, KE AU OKOA, VIV; United States Geological Survey, 2012, WDRUS2012 US GEOL SU; University of Hawai`i Foundation, 2017, I HAW LANG RES TRANS; Van Rees CB, 2014, WETLANDS, V34, P335, DOI 10.1007/s13157-013-0501-2; Visher FN, 1964, 1778 US GEOL SURV; Yamane S., 2011, ROOTS WATER	58	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235661	10.1371/journal.pone.0235661	http://dx.doi.org/10.1371/journal.pone.0235661			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32702038	gold, Green Published			2022-12-26	WOS:000575913700019
J	Hilsden, RJ; Maxwell, CM; Forbes, N; Bridges, RJ; Rostom, A; Dube, C; Boyne, D; Brenner, D; Heitman, SJ				Hilsden, Robert J.; Maxwell, Courtney M.; Forbes, Nauzer; Bridges, Ronald J.; Rostom, Alaa; Dube, Catherine; Boyne, Devon; Brenner, Darren; Heitman, Steven J.			Development of a definition and rules for causal attribution of post-colonoscopy bleeding	PLOS ONE			English	Article							ENDOSCOPIC MUCOSAL RESECTION; RISK-FACTORS; POLYPECTOMY HEMORRHAGE; AGREEMENT; RATERS; COLD	Background Post-colonoscopy bleeding (PCB) is an important colonoscopy quality indicator that is recommended to be routinely collected by colorectal cancer screening programs and endoscopy quality improvement programs. We created a standardized and reliable definition of PCB and set of rules for attributing the relatedness of PCB to a colonoscopy. Methods PCB events were identified from colonoscopies performed at the Forzani & MacPhail Colon Cancer Screening Centre. Existing definitions and relatedness rules for PCB were reviewed by the authors and a draft definition and set of rules was created. The definition and rules were revised after initial testing was performed using a set of 15 bleeding events. Information available for each event included the original endoscopy report and data abstracted from the emergency or inpatient record by a trained research assistant. A validation set of 32 bleeding events were then reviewed to assess their interrater reliability by having three endoscopists and one research assistant complete independent reviews and three endoscopists complete a consensus review. The Kappa statistic was used to measure interrater reliability. Results The panel classified 28 of 32 events as meeting the definition of PCB and rated 7, 8 and 6 events as definitely, probably and possibly related to the colonoscopy, respectively. The Kappa for the definition of PCB for the three independent reviews was 0.82 (substantial agreement). The Kappa for the attribution of the PCB to the colonoscopy by the three endosocopists was 0.74 (substantial agreement). The research assistant had a high agreement with the panel for both the definition (100% agreement) and application of the causal criteria (kappa 0.95). Conclusions A standardized definition of PCB and attribution rules achieved high interrater reliability by endoscopists and a non-endoscopist and provides a template of required data for event adjudication by screening and quality improvement programs.	[Hilsden, Robert J.; Forbes, Nauzer; Bridges, Ronald J.; Heitman, Steven J.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Hilsden, Robert J.; Forbes, Nauzer; Boyne, Devon; Brenner, Darren; Heitman, Steven J.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Maxwell, Courtney M.] Alberta Hlth Serv, Forzani & MacPhail Colon Canc Screening Ctr, Calgary, AB, Canada; [Rostom, Alaa; Dube, Catherine] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Brenner, Darren] Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Ottawa; University of Calgary	Hilsden, RJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada.; Hilsden, RJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.	rhilsden@ucalgary.ca		Maxwell, Courtney/0000-0001-5213-6493; Hilsden, Robert/0000-0003-1545-1093				[Anonymous], 2013, NCI GUIDELINES INVES; Bahin FF, 2016, AM J GASTROENTEROL, V111, P1115, DOI 10.1038/ajg.2016.235; Buddingh KT, 2011, AM J GASTROENTEROL, V106, P1119, DOI 10.1038/ajg.2010.507; Burgess NG, 2014, CLIN GASTROENTEROL H, V12, P651, DOI 10.1016/j.cgh.2013.09.049; Chang LC, 2019, ENDOSC INT OPEN, V7, pE232, DOI 10.1055/a-0810-0439; Gimeno-Garcia AZ, 2012, EUR J GASTROEN HEPAT, V24, P520, DOI 10.1097/MEG.0b013e328350fcdc; Kim JH, 2013, J GASTROEN HEPATOL, V28, P645, DOI 10.1111/jgh.12132; Kothari ST, 2019, GASTROINTEST ENDOSC, V90, P863, DOI 10.1016/j.gie.2019.07.033; Lieberman D, 2007, GASTROINTEST ENDOSC, V65, P757, DOI 10.1016/j.gie.2006.12.055; Metz AJ, 2011, ENDOSCOPY, V43, P506, DOI 10.1055/s-0030-1256346; Mitani AA, 2017, ANN EPIDEMIOL, V27, P677, DOI 10.1016/j.annepidem.2017.09.001; Nelson KP, 2015, STAT MED, V34, P3116, DOI 10.1002/sim.6546; Nelson KR, 2008, CAN J STAT, V36, P411, DOI 10.1002/cjs.5550360306; Papastergiou V, 2018, ENDOSCOPY, V50, P403, DOI 10.1055/s-0043-118594; Qumseya BJ, 2013, J DIGEST DIS, V14, P140, DOI 10.1111/1751-2980.12002; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Sawhney MS, 2008, ENDOSCOPY, V40, P115, DOI 10.1055/s-2007-966959; Sharma RS, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/9423142; Watabe H, 2006, GASTROINTEST ENDOSC, V64, P73, DOI 10.1016/j.gie.2006.02.054; Wu XR, 2013, INT J COLORECTAL DIS, V28, P1127, DOI 10.1007/s00384-013-1661-5; Yamashina T, 2017, ENDOSC INT OPEN, V5, pE587, DOI 10.1055/s-0043-105578; Zhang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108290	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235902	10.1371/journal.pone.0235902	http://dx.doi.org/10.1371/journal.pone.0235902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701949	Green Published, gold			2022-12-26	WOS:000575913700031
J	Malik, R; Corrales, C; Linsenmeier, M; Alalami, H; Sepanj, N; Bitan, G				Malik, Ravinder; Corrales, Christian; Linsenmeier, Miriam; Alalami, Huda; Sepanj, Niki; Bitan, Gal			Examination of SOD1 aggregation modulators and their effect on SOD1 enzymatic activity as a proxy for potential toxicity	FASEB JOURNAL			English	Article						Proteinopathies; amyloid; enzyme activity; Thioflavin T; therapeutic index	ZINC SUPEROXIDE-DISMUTASE; AMYLOIDOGENIC PROTEINS; COPPER; INHIBITORS; MICE; MECHANISM	Small-molecule inhibitors of abnormal protein self-assembly are promising candidates for developing therapy against proteinopathies. Such compounds have been examined primarily as inhibitors of amyloid beta-protein (A beta), whereas testing of inhibitors of other amyloidogenic proteins has lagged behind. An important issue with screening compound libraries is that although an inhibitor suitable for therapy must be both effective and nontoxic, typical screening focuses on efficacy, whereas safety typically is tested at a later stage using cells and/or animals. In addition, typical thioflavin T (ThT)-fluorescence-based screens use the final fluorescence value as a readout, potentially missing important kinetic information. Here, we examined potential inhibitors of superoxide dismutase 1 (SOD1) using ThT-fluorescence including the different phases of fluorescence change and added a parallel screen of SOD1 activity as a potential proxy for compound toxicity. Some compounds previously reported to inhibit other amyloidogenic proteins also inhibited SOD1 aggregation at low micromolar concentrations, whereas others were ineffective. Analysis of the lag phase and exponential slope added important information that could help exclude false-positive or false-negative results. SOD1 was highly resistant to inhibition of its activity, and therefore, did not have the necessary sensitivity to serve as a proxy for examining potential toxicity.	[Malik, Ravinder; Corrales, Christian; Linsenmeier, Miriam; Alalami, Huda; Sepanj, Niki; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Bitan, Gal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Linsenmeier, Miriam] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bitan, G (corresponding author), Gordon Neurosci Res Bldg 451, Los Angeles, CA 90095 USA.	gbitan@mednet.ucla.edu	Bitan, Gal/U-2204-2019	Bitan, Gal/0000-0001-7046-3754	HHS \ NIH \ National Institute on Aging (NIA) [R01AG050721]; RGK Foundation [20143057]	HHS \ NIH \ National Institute on Aging (NIA); RGK Foundation	HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: R01AG050721; RGK Foundation, Grant/Award Number: 20143057	Abdolvahabi A, 2017, ACS CHEM NEUROSCI, V8, P1378, DOI 10.1021/acschemneuro.7b00029; Abdolvahabi A, 2016, ACS CHEM NEUROSCI, V7, P799, DOI 10.1021/acschemneuro.6b00048; Andrich K, 2015, ADV EXP MED BIOL, V863, P139, DOI 10.1007/978-3-319-18365-7_7; Anzai I, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00040; Atlasi RS, 2018, ACS CHEM BIOL, V13, P2794, DOI 10.1021/acschembio.8b00729; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bitan G, 2019, PROG MOL BIOL TRANSL, V168, P277, DOI 10.1016/bs.pmbts.2019.07.010; Brennan RE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0430-8; Bunton-Stasyshyn RKA, 2015, NEUROSCIENTIST, V21, P519, DOI 10.1177/1073858414561795; Cantu-Medellin N, 2013, REDOX BIOL, V1, P353, DOI 10.1016/j.redox.2013.05.002; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Core Team R, 2013, R LANG ENV STAT COMP; Dong XW, 2016, CHEM SCI, V7, P6251, DOI 10.1039/c6sc01272h; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lang L, 2015, P NATL ACAD SCI USA, V112, P9878, DOI 10.1073/pnas.1503328112; Liu TY, 2012, CHEMMEDCHEM, V7, P359, DOI 10.1002/cmdc.201100585; Malik R, 2019, J BIOL CHEM, V294, P3501, DOI 10.1074/jbc.RA118.005940; Metrick MA, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0887-z; Metrick MA, 2019, P NATL ACAD SCI USA, V116, P23029, DOI 10.1073/pnas.1909322116; MISRA HP, 1979, J BIOL CHEM, V254, P1623; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Rahimi F, 2016, DEVELOPING THERAPEUTICS FOR ALZHEIMER'S DISEASE: PROGRESS AND CHALLENGES, P97, DOI 10.1016/B978-0-12-802173-6.00006-X; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Sakellariou GK, 2018, ANTIOXID REDOX SIGN, V28, P275, DOI 10.1089/ars.2017.7249; Sangwan S, 2017, P NATL ACAD SCI USA, V114, P8770, DOI 10.1073/pnas.1705091114; Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222; Schrader T, 2016, CHEM COMMUN, V52, P11318, DOI 10.1039/c6cc04640a; Sehati S, 2011, FREE RADICAL BIO MED, V50, P1591, DOI 10.1016/j.freeradbiomed.2011.03.004; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; Somwar R, 2011, P NATL ACAD SCI USA, V108, P16375, DOI 10.1073/pnas.1113554108; Sutherland MW, 1997, FREE RADICAL RES, V27, P283, DOI 10.3109/10715769709065766; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Talbiersky P, 2008, J AM CHEM SOC, V130, P9824, DOI 10.1021/ja801441j; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Tokuda E, 2018, BBA-MOL BASIS DIS, V1864, P2119, DOI 10.1016/j.bbadis.2018.03.015; Weissmann N, 2000, AM J PHYSIOL-LUNG C, V279, pL683, DOI 10.1152/ajplung.2000.279.4.L683; ZOLNIEROWICZ S, 1988, BIOCHEM INT, V17, P303	44	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11957	11969		10.1096/fj.202000948R	http://dx.doi.org/10.1096/fj.202000948R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32701214	Green Published, Green Accepted			2022-12-26	WOS:000555048200001
J	Diccianni, MB; Kempinska, K; Gangoti, JA; Yu, AL; Sorkin, LS				Diccianni, Mitchell B.; Kempinska, Katarzyna; Gangoti, Jon A.; Yu, Alice L.; Sorkin, Linda S.			Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO	PLOS ONE			English	Article							DIFLUOROMETHYLORNITHINE DFMO; POLYAMINES; PAIN; GANGLIOSIDE; ANTIBODY; NEUROBLASTOMA; NOCICEPTION; MODULATION; EXPRESSION; PREVENTION	Background Anti-GD2 therapy with dinutuximab is effective in improving the survival of high-risk neuroblastoma patients in remission and after relapse. However, allodynia is the major dose-limiting side effect, hindering its use for neuroblastoma patients at higher doses and for other GD2-expressing malignancies. As polyamines can enhance neuronal sensitization, including development of allodynia and other forms of pathological pain, we hypothesized that polyamine depletion might prove an effective strategy for relief of anti-GD2 induced allodynia. Method Sprague-Dawley rats were allowed to drink water containing various concentrations of difluoromethylornithine (DFMO) for several days prior to behavioral testing. Anti-GD2 (14G2a) was injected into the tail vein of lightly sedated animals and basal mechanical hindpaw withdrawal threshold assessed by von Frey filaments. Endpoint serum DFMO and polyamines, assessed 24h after 14G2a injection, were measured by HPLC and mass spectrometry. Results An i.v. injection of 14G2a causes increased paw sensitivity to light touch in this model, a response that closely mimics patient allodynia. Animals allowed to drink water containing 1% DFMO exhibited a significant reduction of 14G2a-induced pain sensitivity (allodynia). Increasing the dosage of the immunotherapeutic increased the magnitude (intensity and duration) of the pain behavior. Administration of DFMO attenuated the enhanced sensitivity. Consistent with the known actions of DFMO on ornithine decarboxylase (ODC), serum putrescene and spermidine levels were significantly reduced by DFMO, though the decrease in endpoint polyamine levels did not directly correlate with the behavioral changes. Conclusions Our results demonstrate that DFMO is an effective agent for reducing anti-GD2 -induced allodynia. Using DFMO in conjunction with dinutuximab may allow for dose escalation in neuroblastoma patients. The reduction in pain may be sufficient to allow new patient populations to utilize this therapy given the more acceptable side effect profile. Thus, DFMO may be an important adjunct to anti-GD2 immunotherapy in addition to a role as a potential anti-cancer therapeutic.	[Diccianni, Mitchell B.; Kempinska, Katarzyna; Gangoti, Jon A.; Yu, Alice L.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Yu, Alice L.] Chang Gung Mem Hosp Linkou, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Yu, Alice L.] Chang Gung Univ, Taoyuan, Taiwan; [Sorkin, Linda S.] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA	University of California System; University of California San Diego; Chang Gung Memorial Hospital; Chang Gung University; University of California System; University of California San Diego	Diccianni, MB (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.	mdiccianni@ucsd.edu		yu, alice/0000-0003-2444-0505; Diccianni, Mitchell/0000-0002-5017-9585	United Therapeutics Corporation	United Therapeutics Corporation	This study was funded by United Therapeutics Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/742407; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025220; Bassiri H, 2015, TRANSL PEDIATR, V4, P226, DOI 10.3978/j.issn.2224-4336.2015.04.06; Boeshore KL, 2004, J NEUROBIOL, V59, P216, DOI 10.1002/neu.10308; Byun JA, 2008, BIOMED CHROMATOGR, V22, P73, DOI 10.1002/bmc.898; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHEUNG NKV, 1985, CANCER RES, V45, P2642; Cipolla BG, 2010, BIOMED PHARMACOTHER, V64, P363, DOI 10.1016/j.biopha.2009.09.022; Evageliou NF, 2016, CLIN CANC RES OFFICI; Ferrier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077828; Fuccio C, 2009, EUR J PHARMACOL, V603, P42, DOI 10.1016/j.ejphar.2008.11.060; Gewehr C, 2011, PHARMACOL BIOCHEM BE, V99, P775, DOI 10.1016/j.pbb.2011.07.002; Gillin S, 1998, ANESTH ANALG, V86, P111, DOI 10.1097/00000539-199801000-00022; KOLHEKAR R, 1994, NEUROSCIENCE, V63, P925, DOI 10.1016/0306-4522(94)90560-6; Lin Y, 2016, CELL PHYSIOL BIOCHEM, V38, P1553, DOI 10.1159/000443096; Magnes C, 2014, J CHROMATOGR A, V1331, P44, DOI 10.1016/j.chroma.2013.12.061; Mantyselka P, 2017, PAIN MED, V18, P1145, DOI 10.1093/pm/pnw285; Mecha M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.71; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Mody R, 2017, LANCET ONCOL, V18, P946, DOI 10.1016/S1470-2045(17)30355-8; Noordzij M, 2011, NEPHRON CLIN PRACT, V118, pC319, DOI 10.1159/000322830; Ohmi Y, 2012, NEUROCHEM RES, V37, P1185, DOI 10.1007/s11064-012-0764-7; Ozkaynak MF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01355; Raj KP, 2013, BRIT J CANCER, V108, P512, DOI 10.1038/bjc.2013.15; Rivat C, 2008, PAIN, V137, P125, DOI 10.1016/j.pain.2007.08.021; SCHULZ G, 1984, CANCER RES, V44, P5914; Sholler GLS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32659-w; Sholler GLS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127246; Silva MA, 2011, BIOCHEM PHARMACOL, V82, P269, DOI 10.1016/j.bcp.2011.04.015; Simon T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-21; Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658; Slart R, 1997, PAIN, V69, P119, DOI 10.1016/S0304-3959(96)03247-2; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; Sorkin LS, 2002, BRAIN RES, V930, P67, DOI 10.1016/S0006-8993(01)03408-4; Sundstrom E, 2001, PHARMACOL TOXICOL, V88, P342; Suzuki M, 2015, EXPERT OPIN THER TAR, V19, P349, DOI 10.1517/14728222.2014.986459; Tan-No K, 2004, BRAIN RES, V1008, P49, DOI 10.1016/j.brainres.2004.02.027; UTTENREUTHERFISCHER MM, 1995, CANCER IMMUNOL IMMUN, V41, P29, DOI 10.1007/BF01788957; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Wallace MS, 1997, ANESTH ANALG, V85, P794, DOI 10.1097/00000539-199710000-00014; WELLS MR, 1987, EXP NEUROL, V95, P313, DOI 10.1016/0014-4886(87)90141-5; Wiberg R, 2018, NEUROREPORT, V29, P779, DOI 10.1097/WNR.0000000000001031; Xiao WH, 1997, PAIN, V69, P145, DOI 10.1016/S0304-3959(96)03280-0; Yu AL, 2014, ADV NEUROBLASTOMA RE; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	45	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236115	10.1371/journal.pone.0236115	http://dx.doi.org/10.1371/journal.pone.0236115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697811	Green Published, gold			2022-12-26	WOS:000555392700009
J	Astner, AF; Hayes, DG; Pingali, SV; O'Neill, HM; Littrell, KC; Evans, BR; Urban, VS				Astner, Anton F.; Hayes, Douglas G.; Pingali, Sai Venkatesh; O'Neill, Hugh M.; Littrell, Kenneth C.; Evans, Barbara R.; Urban, Volker S.			Effects of soil particles and convective transport on dispersion and aggregation of nanoplastics via small-angle neutron scattering (SANS) and ultra SANS (USANS)	PLOS ONE			English	Article							MULCH FILMS; FRESH-WATER; MICROPLASTICS; NANOPARTICLES; MECHANISMS; TOXICITY; IMPACT	Terrestrial nanoplastics (NPs) pose a serious threat to agricultural food production systems due to the potential harm of soil-born micro- and macroorganisms that promote soil fertility and ability of NPs to adsorb onto and penetrate into vegetables and other crops. Very little is known about the dispersion, fate and transport of NPs in soils. This is because of the challenges of analyzing terrestrial NPs by conventional microscopic techniques due to the low concentrations of NPs and absence of optical transparency in these systems. Herein, we investigate the potential utility of small-angle neutron scattering (SANS) and Ultra SANS (USANS) to probe the agglomeration behavior of NPs prepared from polybutyrate adipate terephthalate, a prominent biodegradable plastic used in agricultural mulching, in the presence of vermiculite, an artificial soil. SANS with the contrast matching technique was used to study the aggregation of NPs co-dispersed with vermiculite in aqueous media. We determined the contrast match point for vermiculite was 66% D2O / 33% H2O. At this condition, the signal for vermiculite was similar to 50-100%-fold lower that obtained using neat H2O or D2O as solvent. According to SANS and USANS, smaller-sized NPs (50 nm) remained dispersed in water and did not undergo size reduction or self-agglomeration, nor formed agglomerates with vermiculite. Larger-sized NPs (300-1000 nm) formed self-agglomerates and agglomerates with vermiculite, demonstrating their significant adhesion with soil. However, employment of convective transport (simulated byex situstirring of the slurries prior to SANS and USANS analyses) reduced the self-agglomeration, demonstrating weak NP-NP interactions. Convective transport also led to size reduction of the larger-sized NPs. Therefore, this study demonstrates the potential utility of SANS and USANS with contrast matching technique for investigating behavior of terrestrial NPs in complex soil systems.	[Astner, Anton F.; Hayes, Douglas G.] Univ Tennessee, Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA; [Pingali, Sai Venkatesh; O'Neill, Hugh M.; Littrell, Kenneth C.; Evans, Barbara R.; Urban, Volker S.] Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Energy (DOE); Oak Ridge National Laboratory	Hayes, DG (corresponding author), Univ Tennessee, Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA.; Pingali, SV (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA.	dhayes1@utk.edu; pingalis@ornl.gov	Littrell, Kenneth C/D-2106-2013; Urban, Volker S/N-5361-2015	Littrell, Kenneth C/0000-0003-2308-8618; Urban, Volker S/0000-0002-7962-3408; Astner, Anton/0000-0003-1162-7426; O'Neill, Hugh/0000-0003-2966-5527; Hayes, Douglas/0000-0003-0303-1411; Pingali, Sai Venkatesh/0000-0001-7961-4176	University of Tennessee Institute for a Secure and Sustainable Environment; University of Tennessee Institute of Agriculture; Mobius, Inc (Lenoir City, TN)	University of Tennessee Institute for a Secure and Sustainable Environment; University of Tennessee Institute of Agriculture; Mobius, Inc (Lenoir City, TN)	DGH, HON and BRE received seed funding from the University of Tennessee Institute for a Secure and Sustainable Environment. AFA and DGH received seed funding from the University of Tennessee Institute of Agriculture and Mobius, Inc (Lenoir City, TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agamalian M, 2018, J PHYS CONF SER, V1021, DOI 10.1088/1742-6596/1021/1/012033; Alimi OS, 2018, ENVIRON SCI TECHNOL, V52, P1704, DOI 10.1021/acs.est.7b05559; Barboza LGA, 2018, MAR POLLUT BULL, V133, P336, DOI 10.1016/j.marpolbul.2018.05.047; Astner AF, 2019, SCI TOTAL ENVIRON, V685, P1097, DOI 10.1016/j.scitotenv.2019.06.241; Besseling E, 2014, ENVIRON SCI TECHNOL, V48, P12336, DOI 10.1021/es503001d; Blake G.R., 2008, ENCY SOIL SCI, DOI [10.1007/978-1-4020-3995-9_406, DOI 10.1007/978-1-4020-3995-9_406]; Bouwmeester H, 2015, ENVIRON SCI TECHNOL, V49, P8932, DOI 10.1021/acs.est.5b01090; Chen QQ, 2017, SCI TOTAL ENVIRON, V584, P1022, DOI 10.1016/j.scitotenv.2017.01.156; Doerr SH, 2000, EARTH-SCI REV, V51, P33, DOI 10.1016/S0012-8252(00)00011-8; Eckert EM, 2018, ENVIRON POLLUT, V234, P495, DOI 10.1016/j.envpol.2017.11.070; English M., 2019, THESIS; European Standard ECfS, 2018, 170332018 ECFS EN; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Gigault J, 2018, ENVIRON POLLUT, V235, P1030, DOI 10.1016/j.envpol.2018.01.024; Goldberger JR, 2015, RENEW AGR FOOD SYST, V30, P143, DOI 10.1017/S1742170513000276; Gourmelon G., 2015, GLOBAL PLASTIC PRODU; Gutierrez T. J., 2019, POLYM AGRI FOOD APPL, P183, DOI DOI 10.1007/978-3-030-19416-1_11; Hartmann NB, 2019, ENVIRON SCI TECHNOL, V53, P1039, DOI 10.1021/acs.est.8b05297; Hayes DG, 2017, POLYM TEST, V62, P454, DOI 10.1016/j.polymertesting.2017.07.027; Heller WT, 2018, J APPL CRYSTALLOGR, V51, P242, DOI 10.1107/S1600576718001231; Heller WT, 2014, J APPL CRYSTALLOGR, V47, P1238, DOI 10.1107/S1600576714011285; Horton AA, 2017, SCI TOTAL ENVIRON, V586, P127, DOI 10.1016/j.scitotenv.2017.01.190; Huffer T, 2016, ENVIRON POLLUT, V214, P194, DOI 10.1016/j.envpol.2016.04.018; Jayaram DT, 2017, NANOSCALE, V9, P7595, DOI 10.1039/c6nr09500c; Kasirajan S, 2012, AGRON SUSTAIN DEV, V32, P501, DOI 10.1007/s13593-011-0068-3; Kijchavengkul T, 2008, CHEMOSPHERE, V71, P942, DOI 10.1016/j.chemosphere.2007.10.074; Kline SR, 2006, J APPL CRYSTALLOGR, V39, P895, DOI 10.1107/S0021889806035059; Koelmans AA, 2013, ENVIRON SCI TECHNOL, V47, P7812, DOI 10.1021/es401169n; KOTLARCHYK M, 1983, J CHEM PHYS, V79, P2461, DOI 10.1063/1.446055; Li CH, 2014, AGROECOL SUST FOOD, V38, P861, DOI 10.1080/21683565.2014.884515; Lu L, 2018, SCI TOTAL ENVIRON, V631-632, P449, DOI 10.1016/j.scitotenv.2018.03.051; Lucas N, 2008, CHEMOSPHERE, V73, P429, DOI 10.1016/j.chemosphere.2008.06.064; Mattsson K, 2015, ENVIRON SCI-PROC IMP, V17, P1712, DOI 10.1039/c5em00227c; Motokawa R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06585; Nolte TM, 2017, AQUAT TOXICOL, V183, P11, DOI 10.1016/j.aquatox.2016.12.005; Oberbeckmann S, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02709; Pedersen JS, 1997, ADV COLLOID INTERFAC, V70, P171, DOI 10.1016/S0001-8686(97)00312-6; Pitt JA, 2018, AQUAT TOXICOL, V194, P185, DOI 10.1016/j.aquatox.2017.11.017; SCHMIDT PW, 1991, J APPL CRYSTALLOGR, V24, P414, DOI 10.1107/S0021889891003400; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steinmetz Z, 2016, SCI TOTAL ENVIRON, V550, P690, DOI 10.1016/j.scitotenv.2016.01.153; USDA Textural Soil Classification, 1987, SOIL MECH LEV 1 MOD	42	8	9	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0235893	10.1371/journal.pone.0235893	http://dx.doi.org/10.1371/journal.pone.0235893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692771	gold, Green Published, Green Submitted			2022-12-26	WOS:000554606400032
J	Dargent, A; Chatelain, E; Kreitmann, L; Quenot, JP; Cour, M; Argaud, L				Dargent, Auguste; Chatelain, Emeric; Kreitmann, Louis; Quenot, Jean-Pierre; Cour, Martin; Argaud, Laurent		COVID-LUS Study Grp	Lung ultrasound score to monitor COVID-19 pneumonia progression in patients with ARDS	PLOS ONE			English	Article								COVID-19 pneumonia typically begins with subpleural ground glass opacities with progressive extension on computerized tomography studies. Lung ultrasound is well suited to this interstitial, subpleural involvement, and it is now broadly used in intensive care units (ICUs). The extension and severity of lung infiltrates can be described numerically with a reproducible and validated lung ultrasound score (LUSS). We hypothesized that LUSS might be useful as a tool to non-invasively monitor the evolution of COVID-19 pneumonia at the bedside. LUSS monitoring was rapidly implemented in the management of our COVID-19 patients with RT-PCR-documented COVID-19. The LUSS was evaluated repeatedly at the bedside. We present a graphic description of the course of LUSS during COVID-19 in 10 consecutive patients admitted in our intensive care unit with moderate to severe ARDS between March 15 and 30(th). LUSS appeared to be closely related to the disease progression. In successfully extubated patients, LUSS decreased and was lower than at the time of intubation. LUSS increased inexorably in a patient who died from refractory hypoxemia. LUSS helped with the diagnosis of ventilator-associated pneumonia (VAP), showing an increased score and the presence of new lung consolidations in all 5 patients with VAPs. There was also a good agreement between CT-scans and LUSS as for the presence of lung consolidations. In conclusion, our early experience suggests that LUSS monitoring accurately reflect disease progression and indicates potential usefulness for the management of COVID-19 patients with ARDS. It might help with early VAP diagnosis, mechanical ventilation weaning management, and potentially reduce the need for X-ray and CT exams. LUSS evaluation is easy to use and readily available in ICUs throughout the world, and might be a safe, cheap and simple tool to optimize critically ill COVID-19 patients care during the pandemic.	[Dargent, Auguste; Chatelain, Emeric; Kreitmann, Louis; Cour, Martin; Argaud, Laurent] Hop Edouard Herriot, Hosp Civils Lyon, Serv Med Intens Reanimat Med, Lyon, France; [Kreitmann, Louis; Cour, Martin; Argaud, Laurent] Univ Claude Bernard Lyon 1, Univ Lyon, Fac Med Lyon Est, Lyon, France; [Quenot, Jean-Pierre] CHU Dijon, Med Intens Reanimat, Dijon, France; [Quenot, Jean-Pierre] Univ Bourgogne Franche Comte, LNC, Dijon, France; [Quenot, Jean-Pierre] INSERM, UMR1231, LNC, Dijon, France; [Quenot, Jean-Pierre] FCS Bourgogne Franche Comte, LipST LabEx, Dijon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Dargent, A (corresponding author), Hop Edouard Herriot, Hosp Civils Lyon, Serv Med Intens Reanimat Med, Lyon, France.	auguste.dargent@chu-lyon.fr	Cour, M/T-2525-2019; Kreitmann, Louis/AAZ-2613-2021; Dargent, Auguste/ABB-5690-2021; Carmen, Team3/Y-7384-2019	Kreitmann, Louis/0000-0002-7580-9870; Dargent, Auguste/0000-0003-1784-1212; Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; QUENOT, Jean-Pierre/0000-0003-2351-682X				[Anonymous], 2020, ACAD RADIOL; Mongodi S, 2016, CHEST, V149, P969, DOI 10.1016/j.chest.2015.12.012; Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6; Pesenti A, 2016, INTENS CARE MED, V42, P686, DOI 10.1007/s00134-016-4328-1; Pisani L, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0241-6; Soummer A, 2012, CRIT CARE MED, V40, P2064, DOI 10.1097/CCM.0b013e31824e68ae	6	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236312	10.1371/journal.pone.0236312	http://dx.doi.org/10.1371/journal.pone.0236312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692769	Green Published, gold			2022-12-26	WOS:000554606400010
J	Zhang, PH; Yang, YT; Qian, K; Li, LL; Zhang, CP; Fu, XY; Zhang, XM; Chen, H; Liu, QQ; Cao, SN; Cui, JJ				Zhang, Panhong; Yang, Yutao; Qian, Kai; Li, Lianlian; Zhang, Cuiping; Fu, Xiaoyi; Zhang, Xiumei; Chen, Huan; Liu, Qiongqing; Cao, Shengnan; Cui, Jiajun			A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressingHER2expression in breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; miR-23b-3p; ZBTB1; HER2; tamoxifen resistance; drug resistance; glycolysis; microRNA (miRNA); transcription coregulator; tamoxifen resistance	ESTROGEN-RECEPTOR INTERACTION; ENDOCRINE RESISTANCE; CROSS-TALK; MECHANISMS; TRANSCRIPTION; COACTIVATOR; EXPRESSION; PATHWAY; MED1	Transcriptional repressor zinc finger and BTB domain containing 1 (ZBTB1) is required for DNA repair. Because DNA repair defects often underlie genome instability and tumorigenesis, we determined to study the role of ZBTB1 in cancer. In this study, we found that ZBTB1 is down-regulated in breast cancer and this down-regulation is associated with poor outcome of breast cancer patients. ZBTB1 suppresses breast cancer cell proliferation and tumor growth. The majority of breast cancers are estrogen receptor (ER) positive and selective estrogen receptor modulators such as tamoxifen have been widely used in the treatment of these patients. Unfortunately, many patients develop resistance to endocrine therapy. Tamoxifen-resistant cancer cells often exhibit higher HER2 expression and an increase of glycolysis. Our data revealed that ZBTB1 plays a critical role in tamoxifen resistancein vitroandin vivo. To see if ZBTB1 regulates HER2 expression, we tested the recruitments of ZBTB1 onHER2regulatory sequences. We observed that over-expressed ZBTB1 occupies the estrogen receptor alpha (ER alpha)-binding site of theHER2intron in tamoxifen-resistant cells, suppressing tamoxifen-induced transcription. In an effort to identify potential microRNAs (miRNAs) regulating ZBTB1, we found that miR-23b-3p directly targets ZBTB1. MiR-23b-3p regulates HER2 expression and tamoxifen resistance via targeting ZBTB1. Finally, we found that miR-23b-3p/ZBTB1 regulates aerobic glycolysis in tamoxifen-resistant cells. Together, our data demonstrate that ZBTB1 is a tumor suppressor in breast cancer cells and that targeting the miR-23b-3p/ZBTB1 may serve as a potential therapeutic approach for the treatment of tamoxifen resistant breast cancer.	[Zhang, Panhong; Qian, Kai; Li, Lianlian; Fu, Xiaoyi; Zhang, Xiumei; Liu, Qiongqing; Cao, Shengnan; Cui, Jiajun] Yichun Univ, Ctr Translat Med, Yichun, Jiangxi, Peoples R China; [Yang, Yutao] Capital Med Univ, Dept Neurobiol, Beijing, Peoples R China; [Zhang, Cuiping] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY USA; [Fu, Xiaoyi] Yichun Univ, Affiliated Hosp 2, Dept Pathol, Yichun, Jiangxi, Peoples R China; [Chen, Huan] Yichun Univ, Affiliated Hosp 1, Dept Pathol, Yichun, Jiangxi, Peoples R China	Yichun University; Capital Medical University; University of Kentucky; Yichun University; Yichun University	Cui, JJ (corresponding author), Yichun Univ, Ctr Translat Med, Yichun, Jiangxi, Peoples R China.	cui_jj@hotmail.com			National Natural Science Foundation of China [31660325]; University Science & Technology landing project of Jiangxi province [93KJLD12093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Science & Technology landing project of Jiangxi province	This work was supported by National Natural Science Foundation of China 31660325 (to J. C.) and University Science & Technology landing project of Jiangxi province Grant 93KJLD12093 (to J. C.).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Bacci M, 2019, CELL REP, V28, P104, DOI 10.1016/j.celrep.2019.06.010; Burrows K, 2017, MUCOSAL IMMUNOL, V10, P1518, DOI 10.1038/mi.2017.17; Cao X, 2018, J CELL MOL MED, V22, P4012, DOI 10.1111/jcmm.13663; Cao X, 2016, J IMMUNOL, V197, P1199, DOI 10.4049/jimmunol.1600013; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cuesta R, 2019, J BIOL CHEM, V294, P2267, DOI 10.1074/jbc.RA118.004383; Cui J, 2015, ONCOGENE, V34, P3895, DOI 10.1038/onc.2014.430; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Cui JJ, 2011, CELL MOL LIFE SCI, V68, P1091, DOI 10.1007/s00018-010-0511-7; Gebert LFR, 2019, NAT REV MOL CELL BIO, V20, P21, DOI 10.1038/s41580-018-0045-7; Germain D, 2011, ENDOCRIN METAB CLIN, V40, P473, DOI 10.1016/j.ecl.2011.05.009; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Gu J, 2018, CANCER LETT, V434, P1, DOI 10.1016/j.canlet.2018.06.039; He MJ, 2019, ONCOGENE, V38, P5551, DOI 10.1038/s41388-019-0817-3; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kim H, 2014, MOL CELL, V54, P107, DOI 10.1016/j.molcel.2014.02.017; Kirkegaard T, 2007, CLIN CANCER RES, V13, P1405, DOI 10.1158/1078-0432.CCR-06-1933; Klinge CM, 1998, MOL CELL ENDOCRINOL, V143, P79, DOI 10.1016/S0303-7207(98)00130-0; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Manavathi B, 2013, ENDOCR REV, V34, P1, DOI 10.1210/er.2011-1057; Mansouri S, 2017, EUR J PHARMACOL, V804, P78, DOI 10.1016/j.ejphar.2017.03.026; Mills JN, 2018, CURR OPIN PHARMACOL, V41, P59, DOI 10.1016/j.coph.2018.04.009; Ni ZH, 2018, AUTOPHAGY, V14, P685, DOI 10.1080/15548627.2017.1407887; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Ohashi T, 2017, CANCER SCI, V108, P1128, DOI 10.1111/cas.13244; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Ruprecht B, 2017, CANCER RES, V77, P1842, DOI 10.1158/0008-5472.CAN-16-2976; Santiago-Gomez A, 2019, CANCER LETT, V458, P66, DOI 10.1016/j.canlet.2019.05.014; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Siggs OM, 2012, J EXP MED, V209, P19, DOI 10.1084/jem.20112084; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Wang JJ, 2016, CANCER LETT, V378, P69, DOI 10.1016/j.canlet.2016.05.004; Wang MN, 2018, CANCER LETT, V439, P113, DOI 10.1016/j.canlet.2018.07.014; Xu L, 2017, P NATL ACAD SCI USA, V114, P3981, DOI 10.1073/pnas.1609758114; Yang LQ, 2018, CANCER LETT, V414, P44, DOI 10.1016/j.canlet.2017.11.007; Zdralevic M, 2018, J BIOL CHEM, V293, P15947, DOI 10.1074/jbc.RA118.004180; Zheng DS, 2018, CANCER LETT, V438, P24, DOI 10.1016/j.canlet.2018.09.001	50	10	10	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2020	295	41					14140	14152		10.1074/jbc.RA119.010759	http://dx.doi.org/10.1074/jbc.RA119.010759			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OG1HE	32690611	hybrid, Green Published			2022-12-26	WOS:000581643400015
J	Stachler, AE; Wortz, J; Alkhnbashi, OS; Turgeman-Grott, I; Smith, R; Allers, T; Backofen, R; Gophna, U; Marchfelder, A				Stachler, Aris-Edda; Woertz, Julia; Alkhnbashi, Omer S.; Turgeman-Grott, Israela; Smith, Rachel; Allers, Thorsten; Backofen, Rolf; Gophna, Uri; Marchfelder, Anita			Adaptation induced by self-targeting in a type I-B CRISPR-Cas system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR-Cas; type I-B; archaea; Haloferax volcanii; adaptation; self-targeting; crRNA; homologous recombination; naive adaptation	PROTOSPACER ADJACENT MOTIFS; SPACER ACQUISITION; FOREIGN DNA; INTERFERENCE; RNAS; DEGRADATION; ACTIVATION; RESISTANCE; PROTEINS; DEFENSE	Haloferax volcaniiis, to our knowledge, the only prokaryote known to tolerate CRISPR-Cas-mediated damage to its genome in the WT background; the resulting cleavage of the genome is repaired by homologous recombination restoring the WT version. In mutantHaloferaxstrains with enhanced self-targeting, cell fitness decreases and microhomology-mediated end joining becomes active, generating deletions in the targeted gene. Here we use self-targeting to investigate adaptation inH. volcaniiCRISPR-Cas type I-B. We show that self-targeting and genome breakage events that are induced by self-targeting, such as those catalyzed by active transposases, can generate DNA fragments that are used by the CRISPR-Cas adaptation machinery for integration into the CRISPR loci. Low cellular concentrations of self-targeting crRNAs resulted in acquisition of large numbers of spacers originating from the entire genomic DNA. In contrast, high concentrations of self-targeting crRNAs resulted in lower acquisition that was mostly centered on the targeting site. Furthermore, we observed naive spacer acquisition at a low level in WTHaloferaxcells and with higher efficiency upon overexpression of the Cas proteins Cas1, Cas2, and Cas4. Taken together, these findings indicate that naive adaptation is a regulated process inH. volcaniithat operates at low basal levels and is induced by DNA breaks.	[Stachler, Aris-Edda; Woertz, Julia; Marchfelder, Anita] Ulm Univ, Biol 2, Ulm, Germany; [Alkhnbashi, Omer S.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, Freiburg, Germany; [Turgeman-Grott, Israela; Smith, Rachel; Gophna, Uri] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Tel Aviv, Israel; [Allers, Thorsten] Univ Nottingham, Sch Life Sci, Nottingham, England; [Backofen, Rolf] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Backofen, Rolf; Marchfelder, Anita] Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany	Ulm University; University of Freiburg; Tel Aviv University; University of Nottingham; University of Freiburg; University of Freiburg	Marchfelder, A (corresponding author), Ulm Univ, Biol 2, Ulm, Germany.	anita.marchfelder@uni-ulm.de	Backofen, Rolf/AAC-1569-2021	Smith, Rachel/0000-0003-1614-9793; Allers, Thorsten/0000-0002-7308-3332; Turgeman Grott, Israela/0000-0003-3937-9460; Gophna, Uri/0000-0001-5129-5652; Alkhnbashi, Omer S./0000-0001-8088-590X; Marchfelder, Anita/0000-0002-1382-1794; Wortz, Julia/0000-0003-0701-1397	Deutsche Forschungsgemeinschaft (DFG) [Ma1538/27-1]; BBSRC [BB/R007543/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant Ma1538/27-1 (to A. M.).	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Andrews S., 2010, FASTQC QUALITY CONTR; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Behler J, 2018, NAT MICROBIOL, V3, P367, DOI 10.1038/s41564-017-0103-5; Brendel J, 2014, J BIOL CHEM, V289, P7164, DOI 10.1074/jbc.M113.508184; Briner AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133661; Brodt A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-65; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dyall-Smith M., 2008, HALOHANDBOOK PROTOCO; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Garrett S, 2020, NUCLEIC ACIDS RES, V48, P6120, DOI 10.1093/nar/gkaa381; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jevtic Z, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800491; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Liu T, 2017, NUCLEIC ACIDS RES, V45, P8978, DOI 10.1093/nar/gkx612; Liu T, 2015, NUCLEIC ACIDS RES, V43, P1044, DOI 10.1093/nar/gku1383; Maier L-K, 2017, RNA METABOLISM GENE, V32, DOI DOI 10.1007/978-3-319-65795-0_11; Maier LK, 2019, RNA BIOL, V16, P469, DOI 10.1080/15476286.2018.1460994; Maier LK, 2015, J BIOL CHEM, V290, P4192, DOI 10.1074/jbc.M114.617506; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; McGinn J, 2019, NAT REV MICROBIOL, V17, P7, DOI 10.1038/s41579-018-0071-7; Naor A, 2016, P NATL ACAD SCI USA, V113, pE4654, DOI 10.1073/pnas.1606416113; Naor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015833; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Ramachandran A, 2020, J BIOL CHEM, V295, P3403, DOI 10.1074/jbc.RA119.012196; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Shiimori M, 2017, NUCLEIC ACIDS RES, V45, P11281, DOI 10.1093/nar/gkx839; Shiriaeva AA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12417-w; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Stachler AE, 2020, METHODS, V172, P76, DOI 10.1016/j.ymeth.2019.05.023; Stachler AE, 2017, NUCLEIC ACIDS RES, V45, P5208, DOI 10.1093/nar/gkx150; Stachler AE, 2016, J BIOL CHEM, V291, P15226, DOI 10.1074/jbc.M116.724062; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Turgeman-Grott I, 2019, NAT MICROBIOL, V4, P177, DOI 10.1038/s41564-018-0302-8; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Wimmer F, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.03078; Xiao YB, 2017, NATURE, V550, P137, DOI 10.1038/nature24020	61	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13502	13515		10.1074/jbc.RA120.014030	http://dx.doi.org/10.1074/jbc.RA120.014030			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32723866	hybrid, Green Published			2022-12-26	WOS:000576321100008
J	Massmig, M; Reijerse, E; Krausze, J; Laurich, C; Lubitz, W; Jahn, D; Moser, J				Massmig, Marco; Reijerse, Edward; Krausze, Joern; Laurich, Christoph; Lubitz, Wolfgang; Jahn, Dieter; Moser, Juergen			Carnitine metabolism in the human gut: characterization of the two-component carnitine monooxygenase CntAB fromAcinetobacter baumannii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carnitine monooxygenase; CntAB; trimethylamine; gut microbiota; Rieske-type oxygenase; l-carnitine; electron paramagnetic resonance; site-directed mutagenesis; metalloenzyme; iron-sulfur protein; enzyme mechanism; electron paramagnetic resonance (EPR)	TRIMETHYLAMINE-N-OXIDE; SMALL-ANGLE SCATTERING; RIESKE-TYPE OXYGENASE; NAPHTHALENE DIOXYGENASE; MICROBIOTA; CLUSTER; DIHYDROXYLATION; MACROMOLECULES; DIVERSITY; REDUCTASE	Bacterial formation of trimethylamine (TMA) from carnitine in the gut microbiome has been linked to cardiovascular disease. During this process, the two-component carnitine monooxygenase (CntAB) catalyzes the oxygen-dependent cleavage of carnitine to TMA and malic semialdehyde. Individual redox states of the reductase CntB and the catalytic component CntA were investigated based on mutagenesis and electron paramagnetic resonance (EPR) spectroscopic approaches. Protein ligands of the flavin mononucleotide (FMN) and the plant-type [2Fe-2S] cluster of CntB and also of the Rieske-type [2Fe-2S] cluster and the mononuclear [Fe] center of CntA were identified. EPR spectroscopy of variant CntA proteins suggested a hierarchical metallocenter maturation, Rieske [2Fe-2S] followed by the mononuclear [Fe] center. NADH-dependent electron transferviathe redox components of CntB and within the trimeric CntA complex for the activation of molecular oxygen was investigated. EPR experiments indicated that the two electrons from NADH were allocated to the plant-type [2Fe-2S] cluster and to FMN in the form of a flavin semiquinone radical. Single-turnover experiments of this reduced CntB species indicated the translocation of the first electron onto the [Fe] center and the second electron onto the Rieske-type [2Fe-2S] cluster of CntA to finally allow for oxygen activation as a basis for carnitine cleavage. EPR spectroscopic investigation of CntA variants indicated an unusual intermolecular electron transfer between the subunits of the CntA trimerviathe "bridging" residue Glu-205. On the basis of these data, a redox catalytic cycle for carnitine monooxygenase was proposed.	[Massmig, Marco; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Braunschweig, Germany; [Reijerse, Edward; Laurich, Christoph; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, Mulheim, Germany; [Krausze, Joern] Tech Univ Carolo Wilhelmina Braunschweig, Inst Plant Biol, Braunschweig, Germany; [Jahn, Dieter] Braunschweig Ctr Integrated Syst Biol, Braunschweig, Germany	Braunschweig University of Technology; Max Planck Society; Braunschweig University of Technology	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Braunschweig, Germany.	j.moser@tu-bs.de		Moser, Jurgen/0000-0001-9373-4967	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	E.R. and W.L. thank the Max Planck Society for its continuous financial support.	Abu-Omar MM, 2005, CHEM REV, V105, P2227, DOI 10.1021/cr040653o; Baratto MC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143402; Barry SM, 2013, ACS CATAL, V3, P2362, DOI 10.1021/cs400087p; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Birrell JA, 2016, BIOCHEMISTRY-US, V55, P4344, DOI 10.1021/acs.biochem.6b00341; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Capyk JK, 2012, J BIOL INORG CHEM, V17, P425, DOI 10.1007/s00775-011-0865-9; Chistiakov DA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00671; CORRELL CC, 1992, SCIENCE, V258, P1604, DOI 10.1126/science.1280857; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Daughtry KD, 2012, J AM CHEM SOC, V134, P2823, DOI 10.1021/ja2111898; Ertekin E, 2017, ENVIRON SCI TECHNOL, V51, P175, DOI 10.1021/acs.est.6b03705; Falony G, 2015, ANNU REV MICROBIOL, V69, P305, DOI 10.1146/annurev-micro-091014-104422; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gally C, 2015, ANGEW CHEM INT EDIT, V54, P12952, DOI 10.1002/anie.201506527; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; Hudlicky T, 1999, ALDRICHIM ACTA, V32, P35; Karlsson A, 2000, J INORG BIOCHEM, V78, P83, DOI 10.1016/S0162-0134(99)00213-5; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KLEBER HP, 1977, ARCH MICROBIOL, V112, P201, DOI 10.1007/BF00429336; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Lee JK, 2005, J BIOL CHEM, V280, P36719, DOI 10.1074/jbc.M505334200; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Manthey M., 1988, Informationen fur die Fischwirtschaft, V35, P131; MARQUIS NR, 1964, J LIPID RES, V5, P184; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Nam JW, 2001, BIOSCI BIOTECH BIOCH, V65, P254, DOI 10.1271/bbb.65.254; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; Peng RH, 2010, REV ENVIRON CONTAM T, V206, P65, DOI 10.1007/978-1-4419-6260-7_4; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Reijerse E, 2012, J MAGN RESON, V214, P237, DOI 10.1016/j.jmr.2011.11.011; Resnick SM, 1996, J IND MICROBIOL BIOT, V17, P438, DOI 10.1007/BF01574775; Rostas A, 2018, J AM CHEM SOC, V140, P16521, DOI 10.1021/jacs.8b07544; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Senthong V, 2016, J AM COLL CARDIOL, V67, P2620, DOI 10.1016/j.jacc.2016.03.546; Shao YH, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00377-18; STOCKEMER J, 1985, ARCH LEBENSMITTELHYG, V36, P116; Summers RM, 2011, MICROBIOL-SGM, V157, P583, DOI 10.1099/mic.0.043612-0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331; Tarasev M, 2006, BIOCHEMISTRY-US, V45, P10208, DOI 10.1021/bi060219b; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Voss I, 2011, J BIOL CHEM, V286, P50, DOI 10.1074/jbc.M110.161562; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; YEH WK, 1977, BIOCHEM BIOPH RES CO, V78, P401, DOI 10.1016/0006-291X(77)91268-2; Zhu YJ, 2014, P NATL ACAD SCI USA, V111, P4268, DOI 10.1073/pnas.1316569111	58	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					13065	13078		10.1074/jbc.RA120.014266	http://dx.doi.org/10.1074/jbc.RA120.014266			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32694223	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000572412900016
J	Khorasani, N; Sadeghi, M; Nowzari-Dalini, A				Khorasani, Najme; Sadeghi, Mehdi; Nowzari-Dalini, Abbas			A computational model of stem cell molecular mechanism to maintain tissue homeostasis	PLOS ONE			English	Article							GENE-EXPRESSION; LINEAGE SPECIFICATION; SELF-RENEWAL; NOISE; FATE; DIVISION; DIFFERENTIATION; CONSEQUENCES; DYNAMICS; LAMBDA	Stem cells, with their capacity to self-renew and to differentiate to more specialized cell types, play a key role to maintain homeostasis in adult tissues. To investigate how, in the dynamic stochastic environment of a tissue, non-genetic diversity and the precise balance between proliferation and differentiation are achieved, it is necessary to understand the molecular mechanisms of the stem cells in decision making process. By focusing on the impact of stochasticity, we proposed a computational model describing the regulatory circuitry as a tri-stable dynamical system to reveal the mechanism which orchestrate this balance. Our model explains how the distribution of noise in genes, linked to the cell regulatory networks, affects cell decision-making to maintain homeostatic state. The noise effect on tissue homeostasis is achieved by regulating the probability of differentiation and self-renewal through symmetric and/or asymmetric cell divisions. Our model reveals, when mutations due to the replication of DNA in stem cell division, are inevitable, how mutations contribute to either aging gradually or the development of cancer in a short period of time. Furthermore, our model sheds some light on the impact of more complex regulatory networks on the system robustness against perturbations.	[Khorasani, Najme; Nowzari-Dalini, Abbas] Univ Tehran, Coll Sci, Sch Math Stat & Comp Sci, Tehran, Iran; [Sadeghi, Mehdi] Natl Inst Genet Engn & Biotechnol NIGEB, Tehran, Iran; [Sadeghi, Mehdi] Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran	University of Tehran	Nowzari-Dalini, A (corresponding author), Univ Tehran, Coll Sci, Sch Math Stat & Comp Sci, Tehran, Iran.	nowzari@ut.ac.ir		Nowzari-Dalini, Abbas/0000-0003-4598-2645				Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1; Andrecut M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019358; Arkin A, 1998, GENETICS, V149, P1633; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bergsmedh A, 2011, GENES-BASEL, V2, P420, DOI 10.3390/genes2030420; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bhattacharya S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-85; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Bradshaw N, 2015, ELIFE, V4, DOI 10.7554/eLife.08145; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Ceafalan LC, 2018, EUR J CELL BIOL, V97, P442, DOI 10.1016/j.ejcb.2018.07.001; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen LY, 2010, CELL RES, V20, P982, DOI 10.1038/cr.2010.106; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; De Mot L, 2016, BIOPHYS J, V110, P710, DOI 10.1016/j.bpj.2015.12.020; DELBRUCK M, 1945, J BACTERIOL, V50, P131; Delbruck M., 1940, J CHEM PHYS, V8, P120, DOI [10.1063/1.1750549, DOI 10.1063/1.1750549]; Doss CGP, 2012, APPL TRANSL GENOM, V1, P37, DOI 10.1016/j.atg.2012.06.002; Dubnau D, 2002, BACILLUS SUBTILIS IT, P453; Duff C, 2012, J MATH BIOL, V64, P449, DOI 10.1007/s00285-011-0419-3; El Samad H, 2005, INT J ROBUST NONLIN, V15, P691, DOI 10.1002/rnc.1018; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Erban R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046001; Folguera-Blasco N, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006592; Frede J, 2016, NAT CELL BIOL, V18, P967, DOI 10.1038/ncb3400; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gonze D, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00034; Greulich P, 2016, P NATL ACAD SCI USA, V113, P7509, DOI 10.1073/pnas.1602779113; Guisoni N, 2017, DEVELOPMENT, V144, P1177, DOI 10.1242/dev.137950; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kirk DL, 2005, BIOESSAYS, V27, P299, DOI 10.1002/bies.20197; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Krieger T, 2015, DEVELOPMENT, V142, P1396, DOI 10.1242/dev.101063; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lu T, 2004, SYSTEMS BIOL, V1, P121, DOI 10.1049/sb:20045016; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Monahan LG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00019; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Perez-Carrasco R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005154; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Pickett-Heaps JD, 1999, AM J BOT, V86, P153, DOI 10.2307/2656933; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; PTASHNE M, 1967, NATURE, V214, P232, DOI 10.1038/214232a0; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Rulands S, 2018, NAT PHYS, V14, P469, DOI 10.1038/s41567-018-0055-6; Rulands S, 2016, CURR OPIN CELL BIOL, V43, P38, DOI 10.1016/j.ceb.2016.07.001; Safdari H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232060; Schultz MB, 2016, DEVELOPMENT, V143, P3, DOI 10.1242/dev.130633; Sharifi-Zarchi A, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0169-8; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Simons BD, 2017, CURR OPIN SYST BIOL, V5, P57, DOI DOI 10.1016/J.COISB.2017.08.001; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Sonnenschein C, 2014, J BIOSCIENCES, V39, P281, DOI 10.1007/s12038-013-9403-y; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; Waddington C., 1957, STRATEGY GENES; WADDINGTON C. H., 1939, An Introduction to Modern Genetics.; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]; Wolk CP, 1996, ANNU REV GENET, V30, P59, DOI 10.1146/annurev.genet.30.1.59; Wu GM, 2010, DEVELOPMENT, V137, P4159, DOI 10.1242/dev.056630; Wu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050715; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564	101	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236519	10.1371/journal.pone.0236519	http://dx.doi.org/10.1371/journal.pone.0236519			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730297	Green Submitted, gold, Green Published			2022-12-26	WOS:000556884700084
J	Lee, JY; Fan, CC; Chou, NL; Lin, HW; Chang, MS				Lee, Jin-Yu; Fan, Chih-Chen; Chou, Nai-Lin; Lin, Hung-Wei; Chang, Mau-Sun			PHRF1 promotes migration and invasion by modulating ZEB1 expression	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; POLYMERASE-II CTD; TUMOR-SUPPRESSOR; E-CADHERIN; TRANSCRIPTION ELONGATION; METASTASIS; GROWTH; DOMAIN	PHRF1 (PHD and RING finger domain-containing protein 1) suppresses acute promyelocytic leukemia (APL) by promoting TGIF (TG-interacting factor) ubiquitination, while the PML-RAR alpha protein interferes with PHRF1-mediated TGIF breakdown to facilitate APL. Beyond its role in APL tumorigenesis, PHRF1 contributes to non-homologous end-joining by linking H3K36 methylation and Nbs1 upon DNA damage insults. However, little is known regarding its function in tumor invasion. Here we highlight the unreported details of PHRF1 in the invasion of lung cancer cells by modulating the transcriptional level ofZEB1, a prominent regulator involved in epithelial-mesenchymal transition. PHRF1 associated with the phosphorylated C-terminal repeat domain of Rpb1, the large subunit of RNA polymerase II, through its C-terminal Set2 Rpb1 Interacting (SRI) domain. Chromatin immunoprecipitation revealed that PHRF1 bound to the proximal region adjacent to the transcription start site ofZEB1. SRI-deleted PHRF1 neither associated with Rpb1 nor increasedZEB1's expression. Collectively, PHRF1 might take the stage at migration and invasion by modulating the expression of ZEB1.	[Lee, Jin-Yu; Chou, Nai-Lin; Lin, Hung-Wei; Chang, Mau-Sun] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Fan, Chih-Chen] Mackay Mem Hosp, Dept Superintendent Off, Taipei, Taiwan; [Fan, Chih-Chen] Yuanpei Univ, Dept Med Lab Sci & Biotechnol, Hsinchu, Taiwan; [Chang, Mau-Sun] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	National Taiwan University; Mackay Memorial Hospital; Academia Sinica - Taiwan	Chang, MS (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.; Chang, MS (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	mschang@ntu.edu.tw		CHANG, MAU-SUN/0000-0002-3703-2386	Ministry of Science and Technology [MOST 106-2311-B-002-004]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Ministry of Science and Technology (MOST 106-2311-B-002-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors did not receive a salary from our funders.	Adachi Y, 2009, FEBS LETT, V583, P430, DOI 10.1016/j.febslet.2008.12.042; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Chang CF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.81; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Daulny A, 2008, P NATL ACAD SCI USA, V105, P19649, DOI 10.1073/pnas.0809372105; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Ettahar A, 2015, CELL REP, V10, P883, DOI [10.1016/j.celrep.2015.01.024, DOI 10.1016/J.CELREP.2015.01.024]; Ettahar A, 2013, CELL REP, V4, P530, DOI 10.1016/j.celrep.2013.07.009; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Jeronimo C, 2016, J MOL BIOL, V428, P2607, DOI 10.1016/j.jmb.2016.02.006; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Larsen JE, 2016, J CLIN INVEST, V126, P3219, DOI 10.1172/JCI76725; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Rebehmed J, 2014, FEBS LETT, V588, P4431, DOI 10.1016/j.febslet.2014.10.014; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Singh M, 2008, MODERN PATHOL, V21, P912, DOI 10.1038/modpathol.2008.82; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Takeyama Y, 2010, CANCER LETT, V296, P216, DOI 10.1016/j.canlet.2010.04.008; Wang YD, 2016, ONCOTARGET, V7, P64360, DOI 10.18632/oncotarget.11842; Wei SC, 2016, TRENDS CELL BIOL, V26, P111, DOI 10.1016/j.tcb.2015.09.009; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Zhang JX, 2013, MOL BIOL REP, V40, P949, DOI 10.1007/s11033-012-2136-4	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236876	10.1371/journal.pone.0236876	http://dx.doi.org/10.1371/journal.pone.0236876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730336	gold, Green Published			2022-12-26	WOS:000556884700083
J	Opheim, GL; Holme, AM; Holm, MB; Michelsen, TM; Zahid, SM; Roland, MCP; Henriksen, T; Haugen, G				Opheim, Gun Lisbet; Holme, Ane Moe; Holm, Maia Blomhoff; Michelsen, Trond Melbye; Zahid, Saba Muneer; Roland, Marie Cecilie Paasche; Henriksen, Tore; Haugen, Guttorm			The impact of umbilical vein blood flow and glucose concentration on blood flow distribution to the fetal liver and systemic organs in healthy pregnancies	FASEB JOURNAL			English	Article						fetal glucose supply; fetal liver blood flow; fetal-maternal glucose gradient; maternal nutritional status	DUCTUS-VENOSUS; PULSATILITY INDEX; REFERENCE RANGES; GROWTH; METABOLISM; CIRCULATION; 2ND-HALF; FETUSES	Glucose is a major energy substrate for the fetus, including liver, heart, and brain metabolism. The umbilical vein (UV) blood flow supplies the fetal liver directly from the placenta, whereas a fraction is shunted via ductus venosus (DV) to the fetal systemic circulation bypassing the fetal liver. We hypothesized UV glucose concentration to be a major regulator of the distribution of glucose supply between the fetal liver and DV, and explored the influence of maternal metabolic status on this distribution. We included 124 healthy women with normal singleton pregnancies, scheduled for elective cesarean section. UV and DV blood flow measurements were performed by Doppler ultrasound immediately before, and blood samples were obtained during surgery. UV blood flow was significantly correlated with DV blood flow, liver blood flow, and the DV shunting fraction, while UV glucose concentration was not. For normal-weight mothers, the maternal-fetal glucose gradient was positively correlated with DV shunting fraction, and negatively with liver blood flow. For the fetuses of the overweight mothers no such correlation was found. This indicates that within the normal physiological range the human fetus makes adaptations of blood flow to ensure individual needs related to the offered maternal energy supply.	[Opheim, Gun Lisbet; Zahid, Saba Muneer; Haugen, Guttorm] Oslo Univ Hosp, Dept Fetal Med, Rikshosp, Sognsvannsveien 20,POB 4950 Nydalen, N-0424 Oslo, Norway; [Opheim, Gun Lisbet; Michelsen, Trond Melbye; Roland, Marie Cecilie Paasche] Oslo Univ Hosp, Norwegian Advisory Unit Womens Hlth, Rikshosp, Oslo, Norway; [Opheim, Gun Lisbet; Michelsen, Trond Melbye; Zahid, Saba Muneer; Henriksen, Tore; Haugen, Guttorm] Univ Oslo, Inst Clin Med, Oslo, Norway; [Holme, Ane Moe; Holm, Maia Blomhoff; Michelsen, Trond Melbye; Roland, Marie Cecilie Paasche; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Rikshosp, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway	Opheim, GL (corresponding author), Oslo Univ Hosp, Dept Fetal Med, Rikshosp, Sognsvannsveien 20,POB 4950 Nydalen, N-0424 Oslo, Norway.	glopheim@gmail.com			Norwegian National Advisory Unit on Women's Health; South-Eastern Norway Regional Health Authority	Norwegian National Advisory Unit on Women's Health; South-Eastern Norway Regional Health Authority	The Norwegian National Advisory Unit on Women's Health (to GLO, TMM, and MPR) and the South-Eastern Norway Regional Health Authority (to AMH, MBH, and TMM) provided financial support to conduct the research. The funders had no involvement in the study design, data collection, analyses, or interpretation. Furthermore, they were not involved in the writing or the decision to publish this paper	Acharya G, 2005, AM J OBSTET GYNECOL, V192, P937, DOI 10.1016/j.ajog.2004.09.019; BATTAGLIA FC, 1978, PHYSIOL REV, V58, P499, DOI 10.1152/physrev.1978.58.2.499; Bellotti M, 2004, AM J OBSTET GYNECOL, V190, P1347, DOI 10.1016/j.ajog.2003.11.018; Brown JM, 2019, J CLIN INVEST, V129, P3035, DOI 10.1172/JCI130904; Catalano PM, 2017, BMJ-BRIT MED J, V356, DOI [10.1136/bmj.j1, 10.1136/bmj.j1631]; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; CHIBA Y, 1992, No To Hattatsu, V24, P136; du Plessis AJ, 2009, CLIN PERINATOL, V36, P531, DOI 10.1016/j.clp.2009.07.002; Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088; Ebbing C, 2011, ULTRASOUND OBST GYN, V38, P303, DOI 10.1002/uog.9046; EDELSTONE DI, 1978, CIRC RES, V42, P426, DOI 10.1161/01.RES.42.3.426; Godfrey KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041759; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; Haugen G, 2004, ULTRASOUND OBST GYN, V24, P599, DOI 10.1002/uog.1744; Haugen G, 2014, ACTA OBSTET GYN SCAN, V93, P778, DOI 10.1111/aogs.12419; HAY WW, 1991, P NUTR SOC, V50, P321, DOI 10.1079/PNS19910042; Holme AM, 2017, JOVE-J VIS EXP, DOI 10.3791/55847; Holme AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117084; Houin SS, 2015, AM J PHYSIOL-ENDOC M, V308, pE306, DOI 10.1152/ajpendo.00396.2014; Ikenoue S, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.04.022; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Kalhan S, 2000, SEMIN PERINATOL, V24, P94, DOI 10.1053/sp.2000.6360; Kessler J, 2007, ULTRASOUND OBST GYN, V30, P52, DOI 10.1002/uog.4054; Kessler J, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.038; Kessler J, 2009, PEDIATR RES, V66, P113, DOI 10.1203/PDR.0b013e3181a29077; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P143, DOI 10.1002/uog.2784; Kiserud T, 2000, AM J OBSTET GYNECOL, V182, P147, DOI 10.1016/S0002-9378(00)70504-7; Kiserud T, 1998, ULTRASOUND MED BIOL, V24, P1301, DOI 10.1016/S0301-5629(98)00131-8; Kiserud T, 1998, ULTRASOUND OBST GYN, V11, P419, DOI 10.1046/j.1469-0705.1998.11060419.x; KISERUD T, 1994, ULTRASOUND MED BIOL, V20, P225, DOI 10.1016/0301-5629(94)90062-0; Lund A, 2019, MATERNAL DIABETES ME; MARI G, 1989, AM J OBSTET GYNECOL, V160, P698, DOI 10.1016/S0002-9378(89)80063-8; Michelsen TM, 2019, J CLIN ENDOCR METAB, V104, P873, DOI 10.1210/jc.2018-01154; Mizuno K, 2017, HEPATOL RES, V47, P160, DOI 10.1111/hepr.12760; Nyberg MK, 2010, ULTRASOUND OBST GYN, V36, P718, DOI 10.1002/uog.7701; Opheim GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216176; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Sewell MF, 2007, J REPROD MED, V52, P907; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Skjaerven R, 2000, AM J OBSTET GYNECOL, V183, P689, DOI 10.1067/mob.2000.106590; Tchirikov M, 2006, ULTRASOUND OBST GYN, V27, P452, DOI 10.1002/uog.2747; Tchirikov M, 2002, PLACENTA, V23, pS153, DOI 10.1053/plac.2002.0810; WLADIMIROFF JW, 1987, OBSTET GYNECOL, V69, P705; WLADIMIROFF JW, 1986, BRIT J OBSTET GYNAEC, V93, P471, DOI 10.1111/j.1471-0528.1986.tb08656.x	47	7	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12481	12491		10.1096/fj.202000766R	http://dx.doi.org/10.1096/fj.202000766R		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729124	Green Published			2022-12-26	WOS:000556799000001
J	Sun, BF; Ma, MY; Li, Y; Zheng, LL				Sun, Baofeng; Ma, Mingyang; Li, Yan; Zheng, Lili			Analysis on the stability and evolutionary trend of the symbiosis system in the supply chain of fresh agricultural products	PLOS ONE			English	Article								In order to increase the stability of fresh agricultural product supply chain, farmers and enterprises need to evolve into a symbiotic system of supply chain. At the present stage, symbiotic relations and evolutionary trends in a symbiotic system for fresh agricultural product supply chains lack quantitative methods for determining symbiotic criteria. In the sense of quantification -oriented criteria, symbiotic systems for fresh agricultural product supply chains are defined, and an improved stationary state analysis method is proposed. Three key steps in this method are quantifying a symbiotic energy model with an evaluation model of ecological carrying capacity, setting up a system evolution model based on the logistic growth function, and verifying the symbiotic system's singularity and phase transition boundary by Lyapunov indirect method. MATLAB numerical simulation shows that types of singularity and the phase transition boundary of symbiotic system are divided effectively. And in both conditions, infinite exponential growth and convergence to steady state, the mutualism mode is the optimal choice for the symbiotic system we defined, symbiotic relations between farmers and cooperative companies are stable and long-term at this time. Those conclusions provide a reference approach to enhance the overall prospective benefits to the fresh agricultural products supply chain.	[Sun, Baofeng; Ma, Mingyang; Li, Yan; Zheng, Lili] Jilin Univ, Transportat Coll, Changchun, Peoples R China	Jilin University	Zheng, LL (corresponding author), Jilin Univ, Transportat Coll, Changchun, Peoples R China.	lilizheng@jlu.edu.cn			National Natural Science Foundation of China [51775238, 51308249]; Transportation Science and Technology Project of Jilin Province of China [20160112]; Ministry of Education in China [16JDGC006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Transportation Science and Technology Project of Jilin Province of China; Ministry of Education in China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/english/site_1/) under Grant 51775238&51308249 to B.F.S; Transportation Science and Technology Project of Jilin Province of China under Grant 20160112 to B.F.S and Humanities and Social Science Research Program of the Ministry of Education in China under Grant 16JDGC006 to B.F.S.	CAO J, 2015, J NATURAL RESOURCES, V16, P1, DOI DOI 10.1515/IJEEPS-2014-0121; Costanza R, 1995, ECOL ECON, V15, P89, DOI 10.1016/0921-8009(95)00074-7; Ding Y, 2009, ECOLOGY, V38, P136; Hamza A, 2018, TURK J MATH, V42, P841, DOI 10.3906/mat-1703-65; Hao Zhang, 2000, J TONGJI U NATURAL S, V28, P65; He Yafen, 2019, EXPLORING SPATIOTEMP; JIANG Peiwen, 2018, GUIZHOU AGR U, V46, P164; Kalman R. E., 1960, J BASIC ENG-T ASME, V82, P371; Li Ji-cai, 2018, DISCRETE DYN NAT SOC, P1026; Li Tongshan, 2017, ZHONGZHOU ACAD J, V4, P43; LIU Chunmei, 2010, APPL LYAPUNOV METHOD; Liu Xiaodong, 2005, LOGISTICS TECHNOLOGY, V6, P66; Ma Shihua, 1998, COMPUTER INTEGRATED, V4, P19; Ntabe EN, 2015, INT J PROD ECON, V169, P310, DOI 10.1016/j.ijpe.2015.08.008; Odum E P., 1953, FUNDAMENTALS ECOLOGY, V29, P43; REES WE, 1994, INVESTING IN NATURAL CAPITAL, P362; REN Zhang, 2012, MODERN BUSINESS, V17, P18; Shelby B., 1984, Leisure Sciences, V6, P433, DOI 10.1080/01490408409513047; Sun Ying, 2014, LOGISTICS TECHNOLOGY, V33, P277; Tao YY, 2016, AER ADV ENG RES, V79, P554; XIAO Hong, 2012, PRICE THEORY PRACTIC, V2, P36; Xie G, 2011, EUR J OPER RES, V214, P403, DOI 10.1016/j.ejor.2011.04.036; Xu Qiang, 2015, Industrial Engineering Journal, V18, P59, DOI 10.3969/j.issn.1007-7375.2015.02.009; Yukalov VI, 2003, PHYSICA A, V328, P409, DOI 10.1016/S0378-4371(03)00549-1	24	4	4	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236334	10.1371/journal.pone.0236334	http://dx.doi.org/10.1371/journal.pone.0236334			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730346	Green Published, gold			2022-12-26	WOS:000556884700012
J	Nersisyan, S; Shkurnikov, M; Turchinovich, A; Knyazev, E; Tonevitsky, A				Nersisyan, Stepan; Shkurnikov, Maxim; Turchinovich, Andrey; Knyazev, Evgeny; Tonevitsky, Alexander			Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2	PLOS ONE			English	Article							GENE-REGULATION; MICRORNA; CELLS	Development of novel approaches for regulating the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) is becoming increasingly important within the context of the ongoing COVID-19 pandemic since these enzymes play a crucial role in cell infection. In this work we searched for putative ACE2 and TMPRSS2 expression regulation networks mediated by various miRNA isoforms (isomiR) across different human organs using publicly available paired miRNA/mRNA-sequencing data from The Cancer Genome Atlas (TCGA) project. As a result, we identified several miRNA families targeting ACE2 and TMPRSS2 genes in multiple tissues. In particular, we found that lysine-specific demethylase 5B (JARID1B), encoded by the KDM5B gene, can indirectly affect ACE2 / TMPRSS2 expression by repressing transcription of hsa-let-7e / hsa-mir-125a and hsa-mir-141 / hsa-miR-200 miRNA families which are targeting these genes.	[Nersisyan, Stepan; Knyazev, Evgeny; Tonevitsky, Alexander] Higher Sch Econ, Fac Biol & Biotechnol, Moscow, Russia; [Nersisyan, Stepan] Lomonosov Moscow State Univ, Fac Mech & Math, Moscow, Russia; [Shkurnikov, Maxim] Minist Hlth Russian Federat, Branch Natl Med Res Radiol Ctr, PA Hertsen Moscow Oncol Res Ctr, Moscow, Russia; [Turchinovich, Andrey] SciBerg E Kfm, Mannheim, Germany; [Knyazev, Evgeny; Tonevitsky, Alexander] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	HSE University (National Research University Higher School of Economics); Lomonosov Moscow State University; Ministry of Health of the Russian Federation; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Nersisyan, S (corresponding author), Higher Sch Econ, Fac Biol & Biotechnol, Moscow, Russia.; Nersisyan, S (corresponding author), Lomonosov Moscow State Univ, Fac Mech & Math, Moscow, Russia.	s.a.nersisyan@gmail.com	Tonevitsky, Alexander/R-5596-2019; Knyazev, Evgeny/E-2977-2014; Nersisyan, Stepan/AAG-6242-2019; Shkurnikov, Maxim Yu/C-7587-2014	Knyazev, Evgeny/0000-0002-9414-2573; Nersisyan, Stepan/0000-0002-8830-4679; Turchinovich, Andrey/0000-0003-4153-0895	Russian Academic Excellence Project '5-100'	Russian Academic Excellence Project '5-100'(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	The article was prepared within the framework of the Basic Research Program at HSE University and funded by the Russian Academic Excellence Project '5-100'. The funder provided support in the form of salaries for authors A Tu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122; Bruscella P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00824; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Galatenko VV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20215-5; Ganai SA, 2015, J BIOMOL STRUCT DYN, V33, P1185, DOI 10.1080/07391102.2014.938247; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang YF, 2016, EUR REV MED PHARMACO, V20, P4055; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lai FW, 2014, J VIROL, V88, P54, DOI 10.1128/JVI.02678-13; Liu Q, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.21; Lukassen S, 2020, EMBO J, V39, DOI 10.15252/embj.20105114; Magee RG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22488-2; Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837; Maltseva Diana V, 2014, BMC Res Notes, V7, P871, DOI 10.1186/1756-0500-7-871; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Mercey O, 2017, FEBS LETT, V591, P693, DOI 10.1002/1873-3468.12595; Mitra D, 2011, J BIOL CHEM, V286, P40531, DOI 10.1074/jbc.M111.304865; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Sheinerman KS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00150; Pan L, 2020, AM J GASTROENTEROL, V115, P766, DOI 10.14309/ajg.0000000000000620; Peng Xinxia, 2011, mBio, V2, DOI 10.1128/mBio.00198-11; Pinto Bruna G G, 2020, medRxiv, DOI 10.1101/2020.03.21.20040261; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reddy KB, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0185-1; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Telonis AG, 2017, NUCLEIC ACIDS RES, V45, P2973, DOI 10.1093/nar/gkx082; Telonis AG, 2015, NUCLEIC ACIDS RES, V43, P9158, DOI 10.1093/nar/gkv922; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tong Z, 2019, NUCLEIC ACIDS RES, V47, pD253, DOI 10.1093/nar/gky1023; Turchinovich A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00011; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Veksler-Lublinsky I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-249; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zhang X, 2020, EMERG MICROBES INFEC, V9, P733, DOI 10.1080/22221751.2020.1738277; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	52	44	46	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235987	10.1371/journal.pone.0235987	http://dx.doi.org/10.1371/journal.pone.0235987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726325	gold, Green Published			2022-12-26	WOS:000556908900037
J	Suarez-Arnedo, A; Figueroa, FT; Clavijo, C; Arbelaez, P; Cruz, JC; Munoz-Camargo, C				Suarez-Arnedo, Alejandra; Torres Figueroa, Felipe; Clavijo, Camila; Arbelaez, Pablo; Cruz, Juan C.; Munoz-Camargo, Carolina			An image J plugin for the high throughput image analysis ofin vitroscratch wound healing assays	PLOS ONE			English	Article							IN-VITRO; CELL-MIGRATION; PROLIFERATION; STERILIZATION; FIBROBLASTS; INVASION; ENHANCE; MODELS	In vitroscratch wound healing assay, a simple and low-cost technique that works along with other image analysis tools, is one of the most widely used 2D methods to determine the cellular migration and proliferation in processes such as regeneration and disease. There are open-source programs such as imageJ to analyze images ofin vitroscratch wound healing assays, but these tools require manual tuning of various parameters, which is time-consuming and limits image throughput. For that reason, we developed an optimized plugin for imageJ to automatically recognize the wound healing size, correct the average wound width by considering its inclination, and quantify other important parameters such as: area, wound area fraction, average wound width, and width deviation of the wound images obtained from a scratch/ wound healing assay. Our plugin is easy to install and can be used with different operating systems. It can be adapted to analyze both individual images and stacks. Additionally, it allows the analysis of images obtained from bright field, phase contrast, and fluorescence microscopes. In conclusion, this new imageJ plugin is a robust tool to automatically standardize and facilitate quantification of differentin vitrowound parameters with high accuracy compared with other tools and manual identification.	[Suarez-Arnedo, Alejandra; Torres Figueroa, Felipe; Clavijo, Camila; Arbelaez, Pablo; Cruz, Juan C.; Munoz-Camargo, Carolina] Univ Los Andes, Dept Biomed Engn, Bogota, Colombia	Universidad de los Andes (Colombia)	Cruz, JC; Munoz-Camargo, C (corresponding author), Univ Los Andes, Dept Biomed Engn, Bogota, Colombia.	jc.cruz@uniandes.edu.co; c.munoz2016@uniandes.edu.co	Torres Figueroa, Felipe/HGC-9549-2022	Torres Figueroa, Felipe/0000-0001-6747-548X; , Carolina/0000-0001-6238-9021	Department of Biomedical Engineering at Universidad de los Andes; Vice-provost of Research at Universidad de los Andes	Department of Biomedical Engineering at Universidad de los Andes; Vice-provost of Research at Universidad de los Andes	This work was financially supported by the Department of Biomedical Engineering at Universidad de los Andes, by the start-up funding to Assistant Professors FAPA (Fondo de Apoyo a Profesores Asistentes of Carolina Munoz), and by an internal call for termination of publications (CI001-Publica tus nuevos conocimientos o expone tus nuevas creaciones) from Vice-provost of Research at Universidad de los Andes.	Belvedere R, 2016, SCI REP, P6; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cui Y, 2017, SENSOR ACTUAT B-CHEM, V250, P461, DOI 10.1016/j.snb.2017.04.183; Doyle W, 2012, FOOD CHEM TOXICOL, V50, P3759, DOI 10.1016/j.fct.2012.07.008; Erdogan B, 2017, J CELL BIOL, V216, P3799, DOI 10.1083/jcb.201704053; Faramarzi N, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201701347; Fenu M, 2019, SCI REP, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Glass M, 2012, PATTERN RECOGN, V45, P3154, DOI 10.1016/j.patcog.2012.03.001; Goetsch KP, 2013, J MUSCLE RES CELL M, V34, P333, DOI 10.1007/s10974-013-9364-7; Grada A, 2017, J INVEST DERMATOL, V137, pE11, DOI 10.1016/j.jid.2016.11.020; Jonkman JEN, 2014, CELL ADHES MIGR, V8, P440, DOI 10.4161/cam.36224; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Lingen MW, 2003, METH MOLEC MED, V78, P337; Maharlooei MK, 2011, DIABETES RES CLIN PR, V93, P228, DOI 10.1016/j.diabres.2011.04.018; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Munker TJAG, 2018, J MECH BEHAV BIOMED, V81, P168, DOI 10.1016/j.jmbbm.2018.01.033; Naves LB, 2016, ESSAYS BIOCHEM, V60, P357, DOI 10.1042/EBC20160043; Nyegaard Steffen, 2016, Metab Eng Commun, V3, P76, DOI 10.1016/j.meteno.2016.03.002; Pan BL, 2018, CELL PHYSIOL BIOCHEM, V45, P1410, DOI 10.1159/000487567; Park SR, 2018, MOL THER, V26, P606, DOI 10.1016/j.ymthe.2017.09.023; Qazi TH, 2017, BIOMATERIALS, V140, P103, DOI 10.1016/j.biomaterials.2017.06.019; Rodriguez Luis G., 2004, V294, P23; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Snyder S, 2017, ANN BIOMED ENG, V45, P2049, DOI 10.1007/s10439-017-1849-x; van der Meer AD, 2010, AM J PHYSIOL-HEART C, V298, pH719, DOI 10.1152/ajpheart.00933.2009; Vang Mouritzen M, 2018, J VIS EXP; Venter C, 2019, BIOTECHNIQUES, V66, P99, DOI 10.2144/btn-2018-0132; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Xu JB, 2019, BIOMED PHARMACOTHER, V111, P1066, DOI 10.1016/j.biopha.2019.01.002; Yavuz C, 2016, J SUPERCRIT FLUID, V107, P114, DOI 10.1016/j.supflu.2015.08.019; YOU CM, 2017, SCI REP, V7, P55839, DOI DOI 10.1038/S41598-016-0028-X	35	86	86	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0232565	10.1371/journal.pone.0232565	http://dx.doi.org/10.1371/journal.pone.0232565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722676	Green Published, Green Submitted, gold			2022-12-26	WOS:000556916000040
J	Fazel, MF; Abu, IF; Mohamad, MHN; Agarwal, R; Iezhitsa, I; Bakar, NS; Juliana, N; Mellor, IR; Franzyk, H				Fazel, Muhammad Fattah; Abu, Izuddin Fahmy; Mohamad, Mohamad Haiqal Nizar; Agarwal, Renu; Iezhitsa, Igor; Bakar, Nor Salmah; Juliana, Norsham; Mellor, Ian R.; Franzyk, Henrik			Philanthotoxin-343 attenuates retinal and optic nerve injury, and protects visual function in rats with N-methyl-D-aspartate-induced excitotoxicity	PLOS ONE			English	Article							MAGNESIUM ACETYLTAURATE; NMDA RECEPTORS; GLAUCOMA; MODULATION; BLOCK; BLINDNESS; BEHAVIOR; ANALOGS; VENOM; WASP	Retinal ganglion cell (RGC) loss and optic neuropathy, both hallmarks of glaucoma, have been shown to involve N-methyl-D-aspartate receptor (NMDAR)-mediated excitotoxicity. This study investigated the neuroprotective effects of Philanthotoxin (PhTX)-343 in NMDA-induced retinal injury to alleviate ensuing visual impairments. Sprague-Dawley rats were divided into three; Group I was intravitreally injected with phosphate buffer saline as the control, Group II was injected with NMDA (160 nM) to induce retinal excitotoxic injury, while Group III was injected with PhTX-343 (160 nM) 24 h prior to excitotoxicity induction with NMDA. Rats were subjected to visual behaviour tests seven days post-treatment and subsequently euthanized. Rat retinas and optic nerves were subjected to H&E and toluidine blue staining, respectively. Histological assessments showed that NMDA exposure resulted in significant loss of retinal cell nuclei and thinning of ganglion cell layer (GCL). PhTX-343 pre-treatment prevented NMDA-induced changes where the RGC layer morphology is similar to the control. The numbers of nuclei in the NMDA group were markedly lower compared to the control (p<0.05). PhTX-343 group had significantly higher numbers of nuclei within 100 mu m length and 100 mu m(2) area of GCL (2.9- and 1.7-fold, respectively) compared to NMDA group (p<0.05). PhTX-343 group also displayed lesser optic nerve fibres degeneration compared to NMDA group which showed vacuolation in all sections. In the visual behaviour test, the NMDA group recorded higher total distance travelled, and lower total immobile time and episodes compared to the control and PhTX-343 groups (p<0.05). Object recognition tests showed that the rats in PhTX-343 group could recognize objects better, whereas the same objects were identified as novel by NMDA rats despite multiple exposures (p<0.05). Visual performances in the PhTX-343 group were all comparable with the control (p>0.05). These findings suggested that PhTX-343 inhibit retinal cell loss, optic nerve damage, and visual impairments in NMDA-induced rats.	[Fazel, Muhammad Fattah; Abu, Izuddin Fahmy; Mohamad, Mohamad Haiqal Nizar] Univ Kuala Lumpur, Inst Med Sci Technol, Kuala Lumpur, Malaysia; [Agarwal, Renu; Iezhitsa, Igor] Int Med Univ, Sch Med, Kuala Lumpur, Malaysia; [Bakar, Nor Salmah] Univ Teknol MARA, Fac Med, Sungai Buloh, Selangor, Malaysia; [Juliana, Norsham] Univ Sains Islam Malaysia, Fac Med & Hlth Sci, Kuala Lumpur, Malaysia; [Mellor, Ian R.] Univ Nottingham, Fac Med & Hlth Sci, Sch Life Sci, Nottingham, England; [Franzyk, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Kuala Lumpur; International Medical University Malaysia; Universiti Teknologi MARA; Universiti Sains Islam Malaysia; University of Nottingham; University of Copenhagen	Abu, IF (corresponding author), Univ Kuala Lumpur, Inst Med Sci Technol, Kuala Lumpur, Malaysia.	izuddin@unikl.edu.my	Juliana, Norsham/V-2181-2019; Mohamad, Mohamad Haiqal Nizar/ABF-7155-2021; Abu, Izuddin Fahmy/D-1610-2017; Agarwal, Renu/ABA-7780-2020; Iezhitsa, Igor/B-5687-2012	Abu, Izuddin Fahmy/0000-0001-6205-001X; Iezhitsa, Igor/0000-0002-2852-8486; Fazel, Muhammad Fattah/0000-0003-0479-9289; Nor Salmah, Bakar/0000-0002-0381-6887; Mohamad, Mohamad Haiqal Nizar/0000-0002-2422-2180; Franzyk, Henrik/0000-0002-2822-1927	Ministry of Higher Education, Malaysia [FRGS/1/2017/SKK10/UNIKL/02/1]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	IFA received the Fundamental Research Grant Scheme (FRGS) from the Ministry of Higher Education, Malaysia (FRGS/1/2017/SKK10/UNIKL/02/1). http://www.mohe.gov.my/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu IF, 2015, NEURODEGENERATIVE S1, V15, P817; Agarwal R, 2009, INDIAN J OPHTHALMOL, V57, P257, DOI 10.4103/0301-4738.53049; Arfuzir NNN, 2016, NEUROSCIENCE, V325, P153, DOI 10.1016/j.neuroscience.2016.03.041; Banerjee A., 2019, NATL J PHYSL PHARM P, V9, P1, DOI [10.5455/njppp.2019.9.0307323032019, DOI 10.5455/NJPPP.2019.9.0307323032019]; Bourne RRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162229; BRACKLEY PTH, 1993, J PHARMACOL EXP THER, V266, P1573; Brubaker RF, 1996, AM J OPHTHALMOL, V121, P473, DOI 10.1016/S0002-9394(14)75421-2; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Doozandeh Azadeh, 2016, J Ophthalmic Vis Res, V11, P209, DOI 10.4103/2008-322X.183923; Frolund S, 2010, J MED CHEM, V53, P7441, DOI 10.1021/jm100886h; GLICKMAN SE, 1958, CAN J PSYCHOLOGY, V12, P45, DOI 10.1037/h0083721; Green AC, 1996, BRAIN RES, V717, P135, DOI 10.1016/0006-8993(96)00042-X; HARTVEIT E, 1994, J COMP NEUROL, V348, P570, DOI 10.1002/cne.903480407; Iezhitsa IN, 2011, NUTR NEUROSCI, V14, P10, DOI 10.1179/174313211X12966635733277; Jafri AJA, 2020, MOL VIS, V26, P392; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P1380; Kachel HS, 2019, J MED CHEM, V62, P6214, DOI 10.1021/acs.jmedchem.9b00519; KALIVRETENOS AG, 1993, J ORG CHEM, V58, P6596, DOI 10.1021/jo00076a017; Kim YW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57066-7; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Lambuk L, 2017, NEUROTOX RES, V31, P31, DOI 10.1007/s12640-016-9658-9; Maharajah KR, 2008, CLIN EXP OPHTHALMOL, V36, P222, DOI 10.1111/j.1442-9071.2008.01719.x; Mellor IR, 2003, NEUROPHARMACOLOGY, V44, P70, DOI 10.1016/S0028-3908(02)00336-2; Lazaldin MAM, 2020, EUR J NEUROSCI, V51, P2394, DOI 10.1111/ejn.14662; NAKANISHI K, 1990, PURE APPL CHEM, V62, P1223, DOI 10.1351/pac199062071223; Niwa M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010110; PIEK T, 1980, J INSECT PHYSIOL, V26, P345, DOI 10.1016/0022-1910(80)90003-7; PIEK T, 1975, TOXICON, V13, P199, DOI 10.1016/0041-0101(75)90146-4; PIEK T, 1971, Comparative and General Pharmacology, V2, P317, DOI 10.1016/0010-4035(71)90057-7; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rosini M, 2019, EUR J MED CHEM, V180, P111, DOI 10.1016/j.ejmech.2019.07.011; Russo R, 2008, J NEUROCHEM, V107, P1347, DOI 10.1111/j.1471-4159.2008.05694.x; Salt T, 2006, EYE, V20, P730, DOI 10.1038/sj.eye.6701967; Seo SJ, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1690256; Spasov AA, 2008, ZH VYSSH NERV DEYAT+, V58, P476; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tanito M, 2018, GRAEF ARCH CLIN EXP, V256, P2013, DOI 10.1007/s00417-018-4058-x; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Weinreb RN, 2018, OPHTHALMOLOGY, V125, P1874, DOI 10.1016/j.ophtha.2018.06.017; Wellendorph P, 2003, EUR J MED CHEM, V38, P117, DOI 10.1016/S0223-5234(02)00003-X; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Zoccolan D, 2015, BEHAV BRAIN RES, V285, P10, DOI 10.1016/j.bbr.2014.12.053	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236450	10.1371/journal.pone.0236450	http://dx.doi.org/10.1371/journal.pone.0236450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706792	Green Published, gold			2022-12-26	WOS:000579931700045
J	Gunerka, P; Gala, K; Banach, M; Dominowski, J; Hucz-Kalitowska, J; Mulewski, K; Hajnal, A; Mikus, EG; Smuga, D; Zagozda, M; Dubiel, K; Pieczykolan, J; Zygmunt, BM; Wieczorek, M				Gunerka, Pawel; Gala, Kamila; Banach, Martyna; Dominowski, Jakub; Hucz-Kalitowska, Joanna; Mulewski, Krzysztof; Hajnal, Agnes; Mikus, Endre G.; Smuga, Damian; Zagozda, Marcin; Dubiel, Krzysztof; Pieczykolan, Jerzy; Zygmunt, Beata M.; Wieczorek, Maciej			Preclinical characterization of CPL302-253, a selective inhibitor of PI3K delta, as the candidate for the inhalatory treatment and prevention of Asthma	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; ANIMAL-MODELS; PI3K; EXACERBATIONS; MECHANISMS; STABILITY; DISCOVERY; SAFETY; POTENT; DELTA	Asthma is a common chronic inflammatory disease. Although effective asthma therapies are available, part of asthmatic population do not respond to these treatment options. In this work we present the result of development of CPL302-253 molecule, a selective PI3K delta inhibitor. This molecule is intended to be a preclinical candidate for dry powder inhalation in asthma treatment. Studies we performed showed that this molecule is safe and effective PI3K delta inhibitor that can impact many immune functions. We developed a short, 15-day HDM induced asthma mouse model, in which we showed that CPL302-253 is able to block inflammatory processes leading to asthma development in vivo.	[Gunerka, Pawel; Gala, Kamila; Banach, Martyna; Dominowski, Jakub; Hucz-Kalitowska, Joanna; Mulewski, Krzysztof; Smuga, Damian; Zagozda, Marcin; Dubiel, Krzysztof; Pieczykolan, Jerzy; Zygmunt, Beata M.; Wieczorek, Maciej] Celon Pharma SA, CelonPharma Innovat Drugs Res & Dev Dept, Lomianki, Poland; [Hajnal, Agnes; Mikus, Endre G.] LabMagister Training & Sci Ltd, Budapest, Hungary		Zygmunt, BM (corresponding author), Celon Pharma SA, CelonPharma Innovat Drugs Res & Dev Dept, Lomianki, Poland.	Beata.Zygmunt@celonpharma.com			Celon Pharma; LabMagister Training and Science Ltd.; Narodowe Centrum Badan i Rozwoju [POIR.01.01.01-001341/15]	Celon Pharma; LabMagister Training and Science Ltd.; Narodowe Centrum Badan i Rozwoju(National Centre for Research & Development, Poland)	The work presented in this manuscript was funded by commercial companies: Celon Pharma and LabMagister Training and Science Ltd. The work was supported by Narodowe Centrum Badan i Rozwoju (grant nr POIR.01.01.01-001341/15). PG, KG, MB, JD, JHK, KM, DS, KD, JP, BMZ andMW are employees of Celon Pharma. AH and EGH are employees of LabMagister Training and Science Ltd. The funders provided support in the form of salaries for authors PG, KG, MB, JD, JHK, KM, DS, KD, JP, BMZ, MW, AH and EGH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Allen RA, 2017, J PHARMACOL EXP THER, V361, P429, DOI 10.1124/jpet.116.237347; Aun MV, 2017, J ASTHMA ALLERGY, V10, P293, DOI 10.2147/JAA.S121092; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003; Blair HA, 2018, DRUGS, V78, P1847, DOI 10.1007/s40265-018-1013-4; Bowes J, 2012, NAT REV DRUG DISCOV, V11, P909, DOI 10.1038/nrd3845; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Chapman DG, 2014, J CELL BIOCHEM, V115, P2055, DOI 10.1002/jcb.24881; Cohen Y, 2011, ORAL ONCOL, V47, P946, DOI 10.1016/j.oraloncology.2011.07.013; Denlinger LC, 2017, AM J RESP CRIT CARE, V195, P302, DOI 10.1164/rccm.201602-0419OC; Down K, 2015, J MED CHEM, V58, P7381, DOI 10.1021/acs.jmedchem.5b00767; Drewry DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181585; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Greenwell IB, 2017, ONCOLOGY-NY, V31, P821; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hoegenauer K, 2017, ACS MED CHEM LETT, V8, P975, DOI 10.1021/acsmedchemlett.7b00293; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jeong JS, 2019, INT J MOL SCI, V20; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lampson BL, 2017, EXPERT OPIN INV DRUG, V26, P1267, DOI 10.1080/13543784.2017.1384815; Masimirembwa CM, 2003, CLIN PHARMACOKINET, V42, P515, DOI 10.2165/00003088-200342060-00002; Morita H, 2016, J ALLERGY CLIN IMMUN, V138, P1253, DOI 10.1016/j.jaci.2016.09.011; Nelson RP, 1996, J ALLERGY CLIN IMMUN, V98, P258, DOI 10.1016/S0091-6749(96)70148-3; Obach RS, 1999, DRUG METAB DISPOS, V27, P1350; Okabe S, 2019, ANN HEMATOL, V98, P723, DOI 10.1007/s00277-018-3547-7; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Price DB, 2015, LANCET RESP MED, V3, P849, DOI 10.1016/S2213-2600(15)00367-7; Rao VK, 2017, BLOOD, V130, P2307, DOI 10.1182/blood-2017-08-801191; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Williamson B, 2017, J PHARMACOL TOX MET, V84, P31, DOI 10.1016/j.vascn.2016.10.006; Wilson R, 2018, CLIN THER, V40, P1410, DOI 10.1016/j.clinthera.2018.06.011; Woo LN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24574-x; Yoo EJ, 2017, AM J RESP CELL MOL, V56, P700, DOI 10.1165/rcmb.2016-0308TR; Zirlik Katja, 2018, Recent Results Cancer Res, V212, P243, DOI 10.1007/978-3-319-91439-8_12	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236159	10.1371/journal.pone.0236159	http://dx.doi.org/10.1371/journal.pone.0236159			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702053	Green Published, gold			2022-12-26	WOS:000575913700052
J	Wu, YT; Chiang, PH				Wu, Yen-Ting; Chiang, Po Hui			Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: Medium-term results from a single centre	PLOS ONE			English	Article							OUTCOMES	We report medium-term results in men receiving primary whole-gland HIFU (WG-HIFU) and following salvage treatment. One hundred and twenty-eight patients in a single hospital were enrolled. The enrolled patients were treated with WG-HIFU for primary localized prostate cancer. Salvage treatment include androgen deprivation therapy, secondary HIFU and salvage radiation therapy. Our primary outcomes were biochemical recurrence-free survival, salvage treatment-free survival, and metastasis-free survival. Secondary outcomes included urinary incontinence, de novo erectile dysfunction, acute epididymitis, bladder neck contracture, and urethral stricture. The 5-year biochemical recurrence-free survival rates were 85.7%, 82.7%, and 45.2% for D'Amico low-, intermediate-, and high-risk groups, respectively. Multivariate analysis revealed high risk group is the only predictor of significant shorter biochemical recurrence free survival, salvage treatment free survival, and metastasis free survival. Of 38 patients receiving salvage treatment after biochemical recurrence, 29 (76.3%) became free from biochemical recurrence. Rates of the adverse events of urinary incontinence, acute epididymitis, bladder neck contracture or urethral stricture, and de novo erectile dysfunction were 2.3%, 10.9%, 20.3%, 65.6%, respectively. In conclusion, WG-HIFU is an effective treatment option for localised prostate cancer, especially in D'Amico low- and intermediate-risk cases. The success rate of salvage treatment with radiation therapy and secondary HIFU for biochemical recurrence was acceptable. Fewer adverse events were caused by HIFU, especially incontinence and erectile dysfunction, than by radical prostatectomy and radiotherapy.	[Wu, Yen-Ting; Chiang, Po Hui] Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan; [Wu, Yen-Ting; Chiang, Po Hui] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chiang, Po Hui] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University	Chiang, PH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan.; Chiang, PH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chiang, PH (corresponding author), Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan.	cphtem@yahoo.com.tw						Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Blana A, 2004, UROLOGY, V63, P297, DOI 10.1016/j.urology.2003.09.020; Chen PY, 2018, INT J UROL, V25, P615, DOI 10.1111/iju.13581; Chiang PH, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3584-4; Crouzet S, 2014, EUR UROL, V65, P907, DOI 10.1016/j.eururo.2013.04.039; Dickinson L, 2016, EUR UROL, V70, P668, DOI 10.1016/j.eururo.2016.02.054; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Duran-Rivera A, 2018, ACTAS UROL ESP, V42, P450, DOI 10.1016/j.acuro.2017.11.007; Ficarra V, 2009, EUR UROL, V55, P1037, DOI 10.1016/j.eururo.2009.01.036; Health Promotion Administration, 2018, CANC REG ANN REP 201; Liu YY, 2016, ANN SURG ONCOL, V23, P328, DOI 10.1245/s10434-015-4686-x; Madersbacher S, 2003, J ENDOUROL, V17, P667, DOI 10.1089/089277903322518680; Matzinger O, 2009, EUR J CANCER, V45, P2825, DOI 10.1016/j.ejca.2009.07.009; Ramsay CR, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19490; Rebillard X, 2008, BJU INT, V101, P1205, DOI 10.1111/j.1464-410X.2008.07504.x; Sung HH, 2012, PROSTATE, V72, P1399, DOI 10.1002/pros.22491; Tsakiris P, 2008, J ENDOUROL, V22, P221, DOI 10.1089/end.2007.9849; Uchida T, 2006, BJU INT, V97, P56, DOI 10.1111/j.1464-410X.2006.05864.x	18	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236026	10.1371/journal.pone.0236026	http://dx.doi.org/10.1371/journal.pone.0236026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701978	gold, Green Published			2022-12-26	WOS:000575913700040
J	Fry, CV; Cai, XJ; Zhang, Y; Wagner, CS				Fry, Caroline V.; Cai, Xiaojing; Zhang, Yi; Wagner, Caroline S.			Consolidation in a crisis: Patterns of international collaboration in early COVID-19 research	PLOS ONE			English	Article								This paper seeks to understand whether a catastrophic and urgent event, such as the first months of the COVID-19 pandemic, accelerates or reverses trends in international collaboration, especially in and between China and the United States. A review of research articles produced in the first months of the COVID-19 pandemic shows that COVID-19 research had smaller teams and involved fewer nations than pre-COVID-19 coronavirus research. The United States and China were, and continue to be in the pandemic era, at the center of the global network in coronavirus related research, while developing countries are relatively absent from early research activities in the COVID-19 period. Not only are China and the United States at the center of the global network of coronavirus research, but they strengthen their bilateral research relationship during COVID-19, producing more than 4.9% of all global articles together, in contrast to 3.6% before the pandemic. In addition, in the COVID-19 period, joined by the United Kingdom, China and the United States continued their roles as the largest contributors to, and home to the main funders of, coronavirus related research. These findings suggest that the global COVID-19 pandemic shifted the geographic loci of coronavirus research, as well as the structure of scientific teams, narrowing team membership and favoring elite structures. These findings raise further questions over the decisions that scientists face in the formation of teams to maximize a speed, skill trade-off. Policy implications are discussed.	[Fry, Caroline V.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cai, Xiaojing; Wagner, Caroline S.] Ohio State Univ, John Glenn Coll Publ Affairs, Columbus, OH 43210 USA; [Cai, Xiaojing] Zhejiang Univ, Sch Publ Affairs, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yi] Univ Technol Sydney, Ctr Artificial Intelligence, Ultimo, Australia; [Fry, Caroline V.] Univ Hawaii Manoa, Shidler Coll Business, Dept Management & Ind Relat, Honolulu, HI 96822 USA	Massachusetts Institute of Technology (MIT); University System of Ohio; Ohio State University; Zhejiang University; University of Technology Sydney; University of Hawaii System; University of Hawaii Manoa	Wagner, CS (corresponding author), Ohio State Univ, John Glenn Coll Publ Affairs, Columbus, OH 43210 USA.	wagner.911@osu.edu	Zhang, Yi/AAT-6945-2021; Cai, Xiaojing/AAN-5077-2021	Zhang, Yi/0000-0002-7731-0301; Cai, Xiaojing/0000-0001-7346-6029; Wagner, Caroline/0000-0002-1724-8489	Fulbright Association; Natural Science Foundation of China [71843012]	Fulbright Association; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fulbright Association and the Natural Science Foundation of China (71843012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, J INFORMETR, V6, P403, DOI 10.1016/j.joi.2012.01.002; Agrawal A, 2016, AM ECON J-APPL ECON, V8, P100, DOI 10.1257/app.20140135; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Bhatia G, 2020, TRACKING SPREAD NOVE; Bikard M, 2015, MANAGE SCI, V61, P1473, DOI 10.1287/mnsc.2014.2052; Catalini C, 2018, MANAGE SCI, V64, P4348, DOI 10.1287/mnsc.2017.2798; Kirchgaessner Stephanie, 2020, GUARDIAN; Leydesdorff L, 2008, J INFORMETR; Patel VM, 2011, J ROY SOC MED, V104, P251, DOI 10.1258/jrsm.2011.110005; Wagner CS, 2015, MINERVA, V53, P199, DOI 10.1007/s11024-015-9273-6; Wagner CS, 2005, RES POLICY, V34, P1608, DOI 10.1016/j.respol.2005.08.002; Wagner CS, 2015, PLOS ONE, V10; Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Zaki M.J., 2014, DATA MINING ANAL FUN; Zhang Y, 2014, TECHNOL FORECAST SOC, V85, P26, DOI 10.1016/j.techfore.2013.12.019	18	68	70	12	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236307	10.1371/journal.pone.0236307	http://dx.doi.org/10.1371/journal.pone.0236307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MS9QL	32692757	Green Published, gold			2022-12-26	WOS:000554606400016
J	Luu, AR; Wong, C; Agrawal, V; Wise, N; Handyside, B; Lo, MJ; Pacheco, G; Felix, JB; Giaramita, A; d'Azzo, A; Vincelette, J; Bullens, S; Bunting, S; Christianson, TM; Hague, CM; LeBowitz, JH; Yogalingam, G				Luu, Amanda R.; Wong, Cara; Agrawal, Vishal; Wise, Nathan; Handyside, Britta; Lo, Melanie J.; Pacheco, Glenn; Felix, Jessica B.; Giaramita, Alexander; d'Azzo, Alessandra; Vincelette, Jon; Bullens, Sherry; Bunting, Stuart; Christianson, Terri M.; Hague, Charles M.; LeBowitz, Jonathan H.; Yogalingam, Gouri			Intermittent enzyme replacement therapy prevents Neu1 deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene therapy; genetic disease; complex; neuraminidase; sialidase; beta-galactosidase; enzyme replacement therapy; GM1 gangliosidosis; PPCA	GANGLIOSIDOSIS	Mutations in thegalactosidase beta 1(GLB1) gene cause lysosomal beta-galactosidase (beta-Gal) deficiency and clinical onset of the neurodegenerative lysosomal storage disease, GM1 gangliosidosis. beta-Gal and neuraminidase 1 (NEU1) form a multienzyme complex in lysosomes along with the molecular chaperone, protective protein cathepsin A (PPCA). NEU1 is deficient in the neurodegenerative lysosomal storage disease sialidosis, and its targeting to and stability in lysosomes strictly depend on PPCA. In contrast, beta-Gal only partially depends on PPCA, prompting us to investigate the role that beta-Gal plays in the multienzyme complex. Here, we demonstrate that beta-Gal negatively regulates NEU1 levels in lysosomes by competitively displacing this labile sialidase from PPCA. Chronic cellular uptake of purified recombinant human beta-Gal (rh beta-Gal) or chronic lentiviral-mediated GLB1 overexpression in GM1 gangliosidosis patient fibroblasts coincides with profound secondary NEU1 deficiency. A regimen of intermittent enzyme replacement therapy dosing with rh beta-Gal, followed by enzyme withdrawal, is sufficient to augment beta-Gal activity levels in GM1 gangliosidosis patient fibroblasts without promoting NEU1 deficiency. In the absence of beta-Gal, NEU1 levels are elevated in the GM1 gangliosidosis mouse brain, which are restored to normal levels following weekly intracerebroventricular dosing with rh beta-Gal. Collectively, our results highlight the need to carefully titrate the dose and dosing frequency of beta-Gal augmentation therapy for GM1 gangliosidosis. They further suggest that intermittent intracerebroventricular enzyme replacement therapy dosing with rh beta-Gal is a tunable approach that can safely augment beta-Gal levels while maintaining NEU1 at physiological levels in the GM1 gangliosidosis brain.	[Luu, Amanda R.; Wong, Cara; Agrawal, Vishal; Wise, Nathan; Handyside, Britta; Lo, Melanie J.; Pacheco, Glenn; Felix, Jessica B.; Giaramita, Alexander; Vincelette, Jon; Bullens, Sherry; Bunting, Stuart; Christianson, Terri M.; Hague, Charles M.; LeBowitz, Jonathan H.; Yogalingam, Gouri] BioMarin Pharmaceut Inc, Res Dept, Novato, CA 94949 USA; [d'Azzo, Alessandra] St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA	BioMarin Pharmaceutical Inc.; St Jude Children's Research Hospital	Yogalingam, G (corresponding author), BioMarin Pharmaceut Inc, Res Dept, Novato, CA 94949 USA.	gyogalingam@bmrn.com		Felix, Jessica/0000-0003-2586-6591	Allievex Corp.	Allievex Corp.	This work was supported by Allievex Corp.	Annunziata I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3734; Baek RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013468; Bonten EJ, 2014, CELL MOL LIFE SCI, V71, P2017, DOI 10.1007/s00018-013-1538-3; Bonten EJ, 2009, J BIOL CHEM, V284, P28430, DOI 10.1074/jbc.M109.031419; Brunetti-Pierri N, 2008, MOL GENET METAB, V94, P391, DOI 10.1016/j.ymgme.2008.04.012; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Champigny MJ, 2005, EXP CELL RES, V311, P157, DOI 10.1016/j.yexcr.2005.08.023; Chen JC, 2020, J BIOL CHEM, V295, P13532, DOI 10.1074/jbc.RA119.009811; Kannebley JS, 2015, JIMD REP, V24, P115, DOI 10.1007/8904_2015_451; Lawrence R, 2019, MOL GENET METAB REP, V21, DOI 10.1016/j.ymgmr.2019.100524; Martin DR, 2008, MOL GENET METAB, V94, P212, DOI 10.1016/j.ymgme.2008.02.004; McCurdy VJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007733; Takaura N, 2003, GENE THER, V10, P1487, DOI 10.1038/sj.gt.3302033; Utz JRJ, 2017, MOL GENET METAB, V121, P170, DOI 10.1016/j.ymgme.2017.04.011; van der Spoel A, 2000, J BIOL CHEM, V275, P10035, DOI 10.1074/jbc.275.14.10035; White EJ, 2018, J BIOL CHEM, V293, P14689, DOI 10.1074/jbc.RA118.004589; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; Yogalingam G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207836; ZHOU XY, 1995, GENE DEV, V9, P2623, DOI 10.1101/gad.9.21.2623	19	7	7	4	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13556	13569		10.1074/jbc.RA119.010794	http://dx.doi.org/10.1074/jbc.RA119.010794			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32727849	Green Published, hybrid			2022-12-26	WOS:000576321100011
J	Krycer, JR; Quek, LE; Francis, D; Zadoorian, A; Weiss, FC; Cooke, KC; Nelson, ME; Diaz-Vegas, A; Humphrey, SJ; Scalzo, R; Hirayama, A; Ikeda, S; Shoji, F; Suzuki, K; Huynh, K; Giles, C; Varney, B; Nagarajan, SR; Hoy, AJ; Soga, T; Meikle, PJ; Cooney, GJ; Fazakerley, DJ; James, DE				Krycer, James R.; Quek, Lake-Ee; Francis, Deanne; Zadoorian, Armella; Weiss, Fiona C.; Cooke, Kristen C.; Nelson, Marin E.; Diaz-Vegas, Alexis; Humphrey, Sean J.; Scalzo, Richard; Hirayama, Akiyoshi; Ikeda, Satsuki; Shoji, Futaba; Suzuki, Kumi; Huynh, Kevin; Giles, Corey; Varney, Bianca; Nagarajan, Shilpa R.; Hoy, Andrew J.; Soga, Tomoyoshi; Meikle, Peter J.; Cooney, Gregory J.; Fazakerley, Daniel J.; James, David E.			Insulin signaling requires glucose to promote lipid anabolism in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; glucose; insulin; fatty acid; lipid; Drosophila; cell metabolism; fat tissue; metabolic regulation; kinase signaling	FATTY-ACID SYNTHESIS; ADIPOSE-TISSUE; METABOLISM; RESISTANCE; DROSOPHILA; RESPIRATION; REVEALS; STARVATION; REGULATOR; HORMONES	Adipose tissue is essential for metabolic homeostasis, balancing lipid storage and mobilization based on nutritional status. This is coordinated by insulin, which triggers kinase signaling cascades to modulate numerous metabolic proteins, leading to increased glucose uptake and anabolic processes like lipogenesis. Given recent evidence that glucose is dispensable for adipocyte respiration, we sought to test whether glucose is necessary for insulin-stimulated anabolism. Examining lipogenesis in cultured adipocytes, glucose was essential for insulin to stimulate the synthesis of fatty acids and glyceride-glycerol. Importantly, glucose was dispensable for lipogenesis in the absence of insulin, suggesting that distinct carbon sources are used with or without insulin. Metabolic tracing studies revealed that glucose was required for insulin to stimulate pathways providing carbon substrate, NADPH, and glycerol 3-phosphate for lipid synthesis and storage. Glucose also displaced leucine as a lipogenic substrate and was necessary to suppress fatty acid oxidation. Together, glucose provided substrates and metabolic control for insulin to promote lipogenesis in adipocytes. This contrasted with the suppression of lipolysis by insulin signaling, which occurred independently of glucose. Given previous observations that signal transduction acts primarily before glucose uptake in adipocytes, these data are consistent with a model whereby insulin initially utilizes protein phosphorylation to stimulate lipid anabolism, which is sustained by subsequent glucose metabolism. Consequently, lipid abundance was sensitive to glucose availability, both during adipogenesis and inDrosophilafliesin vivo. Together, these data highlight the importance of glucose metabolism to support insulin action, providing a complementary regulatory mechanism to signal transduction to stimulate adipose anabolism.	[Krycer, James R.; Francis, Deanne; Zadoorian, Armella; Weiss, Fiona C.; Cooke, Kristen C.; Nelson, Marin E.; Diaz-Vegas, Alexis; Humphrey, Sean J.; Fazakerley, Daniel J.; James, David E.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Krycer, James R.; Quek, Lake-Ee; Francis, Deanne; Zadoorian, Armella; Weiss, Fiona C.; Cooke, Kristen C.; Nelson, Marin E.; Diaz-Vegas, Alexis; Humphrey, Sean J.; Varney, Bianca; Nagarajan, Shilpa R.; Hoy, Andrew J.; Cooney, Gregory J.; Fazakerley, Daniel J.; James, David E.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Quek, Lake-Ee] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Scalzo, Richard] Univ Sydney, Fac Engn & Informat Technol, Sydney, NSW, Australia; [Varney, Bianca; Nagarajan, Shilpa R.; Hoy, Andrew J.; Cooney, Gregory J.; James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Hirayama, Akiyoshi; Ikeda, Satsuki; Shoji, Futaba; Suzuki, Kumi; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Hirayama, Akiyoshi; Soga, Tomoyoshi] Japan Agcy Med Res & Dev AMED, AMED CREST, Chiyoda Ku, Otemachi, Tokyo, Japan; [Huynh, Kevin; Giles, Corey; Meikle, Peter J.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Fazakerley, Daniel J.] Univ Cambridge, Metab Res Labs, Wellcome Trust Med Res Council Inst Metab Sci, Cambridge, England	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Keio University; Baker Heart and Diabetes Institute; University of Cambridge	James, DE (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.; James, DE (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.; James, DE (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	david.james@sydney.edu.au	Nelson, Marin/AAG-6653-2021; Giles, Corey/AAM-9003-2020; Francis, Deanne/AAF-5766-2020; Diaz Vegas, Alexis/I-1941-2013; Hoy, Andrew/J-2289-2017	Giles, Corey/0000-0002-6050-1259; Francis, Deanne/0000-0002-4158-1521; Cooke, Kristen/0000-0002-3534-1660; James, David/0000-0001-5946-5257; Varney, Bianca/0000-0002-0611-6018; Diaz Vegas, Alexis/0000-0001-5227-4482; Hoy, Andrew/0000-0003-3922-1137; Meikle, Peter/0000-0002-2593-4665; Krycer, James/0000-0003-1536-7270; Nelson, Marin/0000-0001-7001-406X	National Health and Medical Research Council [GNT1086850, APP1019680, GNT1061122, GNT1086851]; Professorial Research Fellowship from the University of Sydney Medical School; National Health and Medical Research Council Early Career Fellowship [APP1072440]; Australian Diabetes Society Skip Martin Early-Career Fellowship; Diabetes Australia Research Program grant; Charles Perkins Centre EarlyCareer Seed Funding Grant; Research on Development of New Drugs (GAPFREE) from the Japan Agency for Medical Research and Development (AMED); AMED-CREST from AMED; Yamagata prefectural government; City of Tsuruoka	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Professorial Research Fellowship from the University of Sydney Medical School; National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Diabetes Society Skip Martin Early-Career Fellowship; Diabetes Australia Research Program grant; Charles Perkins Centre EarlyCareer Seed Funding Grant; Research on Development of New Drugs (GAPFREE) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED-CREST from AMED; Yamagata prefectural government; City of Tsuruoka	D. E. J. was supported by Senior Principal Research Fellowship APP1019680 and Project Grants GNT1061122 and GNT1086851 from the National Health and Medical Research Council. G. J. C. was supported by a Professorial Research Fellowship from the University of Sydney Medical School. D. E. J. and G. J. C. were also supported by National Health and Medical Research Council Project Grant GNT1086850. J. R. K. was supported by National Health and Medical Research Council Early Career Fellowship APP1072440, an Australian Diabetes Society Skip Martin Early-Career Fellowship, a Diabetes Australia Research Program grant, and a Charles Perkins Centre EarlyCareer Seed Funding Grant. D. F. was funded by a Diabetes Australia Research Program Grant and Charles Perkins Centre EarlyCareer Seed Funding Grant. A. H. was funded by the Research on Development of New Drugs (GAPFREE) from the Japan Agency for Medical Research and Development (AMED). T. S. was funded by the AMED-CREST from AMED. A. H. and T. S. were supported by funds from the Yamagata prefectural government and the City of Tsuruoka.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alfa RW, 2016, DIS MODEL MECH, V9, P365, DOI 10.1242/dmm.023887; BALLY PR, 1960, J BIOL CHEM, V235, P333; Chitraju C, 2017, CELL METAB, V26, P407, DOI 10.1016/j.cmet.2017.07.012; DENTON RM, 1967, BIOCHEM J, V104, P423, DOI 10.1042/bj1040423; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Fazakerley DJ, 2019, J LIPID RES, V60, P1720, DOI 10.1194/jlr.R087510; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; FELLER D. D., 1962, BIOCHIM ET BIOPHYS ACTA, V62, P40, DOI 10.1016/0006-3002(62)90490-0; FELLER DD, 1959, J LIPID RES, V1, P90; Feoktistova Maria, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087379; Francis D, 2019, BIOTECHNIQUES, V67, P122, DOI 10.2144/btn-2019-0062; GARVEY WT, 1988, DIABETES METAB REV, V4, P543, DOI 10.1002/dmr.5610040602; Graham P, 2017, CURR TOP DEV BIOL, V121, P397, DOI 10.1016/bs.ctdb.2016.07.011; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Jackson RM, 2017, J BIOL CHEM, V292, P18556, DOI 10.1074/jbc.M117.791970; JUNGAS RL, 1968, BIOCHEMISTRY-US, V7, P3708, DOI 10.1021/bi00850a050; Kearney AL, 2019, J BIOL CHEM, V294, P16729, DOI 10.1074/jbc.RA119.010036; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Krycer JR, 2020, J BIOL CHEM, V295, P99, DOI 10.1074/jbc.RA119.011695; Krycer JR, 2020, J BIOL CHEM, V295, P83, DOI 10.1074/jbc.RA119.011178; Krycer JR, 2018, BIOTECHNIQUES, V64, P27, DOI 10.2144/000114629; Krycer JR, 2017, CELL REP, V21, P3536, DOI 10.1016/j.celrep.2017.11.085; Krycer JR, 2017, BIOCHEM BIOPH RES CO, V489, P399, DOI 10.1016/j.bbrc.2017.05.151; Krycer JR, 2017, FEBS LETT, V591, P322, DOI 10.1002/1873-3468.12549; Lee KP, 2014, FUNCT ECOL, V28, P1144, DOI 10.1111/1365-2435.12247; Liu L, 2016, NAT CHEM BIOL, V12, P345, DOI [10.1038/NCHEMBIO.2047, 10.1038/nchembio.2047]; Liu XJ, 2018, CELL, V175, P502, DOI 10.1016/j.cell.2018.08.040; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Ma DKG, 2015, CELL, V161, DOI 10.1016/j.cell.2015.04.041; MARSHALL S, 1989, J BIOL CHEM, V264, P2029; MCGARRY JD, 1978, J BIOL CHEM, V253, P8294; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Prabhu AV, 2013, FEBS LETT, V587, P983, DOI 10.1016/j.febslet.2013.02.040; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; RODBELL M, 1964, J BIOL CHEM, V239, P375; RODBELL M, 1966, J BIOL CHEM, V241, P140; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; ROSENTHA.J, 1974, AM J PHYSIOL, V226, P411, DOI 10.1152/ajplegacy.1974.226.2.411; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; STANSBIE D, 1976, BIOCHEM J, V154, P225, DOI 10.1042/bj1540225; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Temple KA, 2007, FEBS LETT, V581, P469, DOI 10.1016/j.febslet.2007.01.007; Thurmond J, 2019, NUCLEIC ACIDS RES, V47, pD759, DOI 10.1093/nar/gky1003; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; VEGA FV, 1978, BIOCHIM BIOPHYS ACTA, V512, P221, DOI 10.1016/0005-2736(78)90232-8; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WINDMUELLER HG, 1966, J BIOL CHEM, V241, P2891; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255	55	19	19	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13250	13266		10.1074/jbc.RA120.014907	http://dx.doi.org/10.1074/jbc.RA120.014907			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32723868	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-26	WOS:000574483500010
J	Christensen, LFB; Nowak, JS; Sonderby, TV; Frank, SA; Otzen, DE				Christensen, Line Friis Bakmann; Nowak, Jan Stanislaw; Sonderby, Thorbjorn Vincent; Frank, Signe Andrea; Otzen, Daniel Erik			Quantitating denaturation by formic acid: imperfect repeats are essential to the stability of the functional amyloid protein FapC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						functional amyloid; protein stability; fibril; formic acid; protein denaturation; thermodynamics; FapC; Pseudomonas; m-values; heat capacity	ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ACCESSIBLE SURFACE; KINETIC-ANALYSIS; CURLI FIBERS; M-VALUES; UBIQUITIN; LYSOZYME; THERMODYNAMICS; BINDING	Bacterial functional amyloids are evolutionarily optimized to aggregate, so much so that the extreme robustness of functional amyloid makes it very difficult to examine their structure-function relationships in a detailed manner. Previous work has shown that functional amyloids are resistant to conventional chemical denaturants, but they dissolve in formic acid (FA) at high concentrations. However, systematic investigation requires a quantitative analysis of FA's ability to denature proteins. Amyloid formed byPseudomonassp. protein FapC provides an excellent model to investigate FA denaturation. It contains three imperfect repeats, and stepwise removal of these repeats slows fibrillation and increases fragmentation during aggregation. However, the link to stability is unclear. We first calibrated FA denaturation using three small, globular, and acid-resistant proteins. This revealed a linear relationship between the concentration of FA and the free energy of unfolding with a slope ofm(FA+pH)(the combined contribution of FA and FA-induced lowering of pH), as well as a robust correlation between protein size andm(FA+pH). We then measured the solubilization of fibrils formed from different FapC variants with varying numbers of repeats as a function of the concentration of FA. This revealed a decline in the number of residues driving amyloid formation upon deleting at least two repeats. The midpoint of denaturation declined with the removal of repeats. Complete removal of all repeats led to fibrils that were solubilized at FA concentrations 2-3 orders of magnitude lower than the repeat-containing variants, showing that at least one repeat is required for the stability of functional amyloid.	[Christensen, Line Friis Bakmann; Nowak, Jan Stanislaw; Sonderby, Thorbjorn Vincent; Frank, Signe Andrea; Otzen, Daniel Erik] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark	Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark.	dao@inano.au.dk		Otzen, Daniel/0000-0002-2918-8989	Innovation Foundation Denmark through the Joint Programme on Neurodegenerative Diseases (aSynProtec) [5188-00003B]; Independent Research Council Denmark, Technology and Production [9041-00123B]; Lundbeck Foundation [R276-2018671]; Independent Research Council Denmark; Natural Sciences [8021-00208B]	Innovation Foundation Denmark through the Joint Programme on Neurodegenerative Diseases (aSynProtec); Independent Research Council Denmark, Technology and Production; Lundbeck Foundation(Lundbeckfonden); Independent Research Council Denmark; Natural Sciences	D. E. O. and L. F. B. C. are funded by Innovation Foundation Denmark (Grant 5188-00003B) through the Joint Programme on Neurodegenerative Diseases (aSynProtec). D. E. O. and J. S. N. are funded by the Independent Research Council Denmark, Technology and Production (Grant 9041-00123B) and the Lundbeck Foundation (Grant R276-2018671). D. E. O. and T. S. are funded by the Independent Research Council Denmark, Natural Sciences (Grant 8021-00208B).	AHMAD F, 1982, J BIOL CHEM, V257, P2935; Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002; Andersen KK, 2012, BIOCHEMISTRY-US, V51, P8371, DOI 10.1021/bi300974y; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bleem A, 2018, J MOL BIOL, V430, P3751, DOI 10.1016/j.jmb.2018.06.043; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cheng X, 2017, J AM CHEM SOC, V139, P9885, DOI 10.1021/jacs.7b03261; Choi TS, 2014, BIOPHYS J, V107, P1939, DOI 10.1016/j.bpj.2014.09.008; Christensen LFB, 2019, ACS OMEGA, V4, P4029, DOI 10.1021/acsomega.8b03590; Chyan CL, 2004, BIOPHYS J, V87, P3995, DOI 10.1529/biophysj.104.042754; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Courchesne NMD, 2017, ACS BIOMATER SCI ENG, V3, P733, DOI 10.1021/acsbiomaterials.6b00437; Danielsen HN, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030058; DEVRIES OMH, 1993, ARCH MICROBIOL, V159, P330, DOI 10.1007/BF00290915; Dueholm M., 2012, AMYLOID FIBRILS PREF, P411; Dueholm MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076630; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; EYRE DR, 1974, CALC TISS RES, V15, P125, DOI 10.1007/BF02059050; Gasior P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-55; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hawthorne W, 2016, BIOCHEM SOC T, V44, P1643, DOI 10.1042/BST20160245; HERSKOVITS TT, 1977, BIOCHIM BIOPHYS ACTA, V490, P192, DOI 10.1016/0005-2795(77)90119-2; Houen G, 1996, ACTA CHEM SCAND, V50, P68, DOI 10.3891/acta.chem.scand.50-0068; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jourdan M, 2001, BIOCHEMISTRY-US, V40, P10317, DOI 10.1021/bi010767j; Khabiri M, 2013, J MOL MODEL, V19, P4701, DOI 10.1007/s00894-012-1507-z; KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Kim MH, 1996, J CHEM SOC FARADAY T, V92, P4951, DOI 10.1039/ft9969204951; Lazar I., 2010, GEL ANAL 2010A FREEW; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lins L, 2003, PROTEIN SCI, V12, P1406, DOI 10.1110/ps.0304803; Milardi D, 2007, ANGEW CHEM INT EDIT, V46, P7993, DOI 10.1002/anie.200701987; Moran SD, 2014, J PHYS CHEM LETT, V5, P1984, DOI 10.1021/jz500794d; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Najarzadeh Z, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110659; Najarzadeh Z, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2019.140263; NOZAKI Y, 1970, J BIOL CHEM, V245, P1648; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Otzen DE, 2008, BBA-PROTEINS PROTEOM, V1784, P400, DOI 10.1016/j.bbapap.2007.11.010; Otzen DE, 2004, PROTEIN SCI, V13, P3253, DOI 10.1110/ps.04991004; Otzen DE, 2002, J MOL BIOL, V315, P1231, DOI 10.1006/jmbi.2001.5300; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Pedersen JS, 2004, J MOL BIOL, V341, P575, DOI 10.1016/j.jmb.2004.06.020; PFEIL W, 1976, BIOPHYS CHEM, V4, P23, DOI 10.1016/0301-4622(76)80003-8; Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/bse0560207, 10.1042/BSE0560207]; Rasmussen CB, 2019, PROTEIN SCI, V28, P633, DOI 10.1002/pro.3566; Rasmussen HO, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.129434; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Rouse SL, 2018, J MOL BIOL, V430, P3685, DOI 10.1016/j.jmb.2018.05.004; Rouse SL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00361-6; Surana P, 2016, PROTEIN SCI, V25, P1438, DOI 10.1002/pro.2940; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tian PF, 2015, J AM CHEM SOC, V137, P22, DOI 10.1021/ja5093634; Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e; Timasheff SN, 2003, BIOPHYS CHEM, V105, P421, DOI 10.1016/S0301-4622(03)00106-6; Uhlich GA, 2002, INFECT IMMUN, V70, P395, DOI 10.1128/IAI.70.1.395-399.2002; Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004; Venkataramani Sathyadevi, 2013, J Pharm Bioallied Sci, V5, P148, DOI 10.4103/0975-7406.111821; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wiehlmann L, 2007, INT J MED MICROBIOL, V297, P615, DOI 10.1016/j.ijmm.2007.03.014; Wijaya EC, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5010055; Wijaya EC, 2016, PHYS CHEM CHEM PHYS, V18, P25926, DOI 10.1039/c6cp03334b; WINTRODE PL, 1994, PROTEINS, V18, P246, DOI 10.1002/prot.340180305; Zeng GH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01099; Zheng S, 2016, PROTEOMICS, V16, P1059, DOI 10.1002/pmic.201500366	76	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					13031	13046		10.1074/jbc.RA120.013396	http://dx.doi.org/10.1074/jbc.RA120.013396			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32719003	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000572412900014
J	Fredericks, LR; Lee, MD; Roslund, CR; Crabtree, AM; Allen, PB; Rowley, PA				Fredericks, Lance R.; Lee, Mark D.; Roslund, Cooper R.; Crabtree, Angela M.; Allen, Peter B.; Rowley, Paul A.			The design and implementation of restraint devices for the injection of pathogenic microorganisms into Galleria mellonella	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; IMMUNE-RESPONSE; VIRULENCE; LARVAE; MODEL; INFECTION; HOST; BACTERIAL; MUTANTS; STRAINS	The injection of laboratory animals with pathogenic microorganisms poses a significant safety risk because of the potential for injury by accidental needlestick. This is especially true for researchers using invertebrate models of disease due to the required precision and accuracy of the injection. The restraint of the greater wax moth larvae (Galleria mellonella) is often achieved by grasping a larva firmly between finger and thumb. Needle resistant gloves or forceps can be used to reduce the risk of a needlestick but can result in animal injury, a loss of throughput, and inconsistencies in experimental data. Restraint devices are commonly used for the manipulation of small mammals, and in this manuscript, we describe the construction of two devices that can be used to entrap and restrainG.mellonellalarvae prior to injection with pathogenic microbes. These devices reduce the manual handling of larvae and provide an engineering control to protect against accidental needlestick injury while maintaining a high rate of injection.	[Fredericks, Lance R.; Lee, Mark D.; Roslund, Cooper R.; Crabtree, Angela M.; Rowley, Paul A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Allen, Peter B.] Univ Idaho, Dept Chem, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Rowley, PA (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	prowley@uidaho.edu		Lee, Mark/0000-0002-9083-2323; Rowley, Paul/0000-0002-3590-5139; Roslund, Cooper/0000-0003-3615-7125	Institute for Modeling Collaboration and Innovation at the University of Idaho (NIH) [P20 GM104420]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103408]; National Science Foundation Science and Technology Center [DBI-0939454]; National Science Foundation [1818368]; Office of Undergraduate Research at the University of Idaho; University of Idaho -Open Access Publishing Fund	Institute for Modeling Collaboration and Innovation at the University of Idaho (NIH); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; National Science Foundation Science and Technology Center(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Office of Undergraduate Research at the University of Idaho; University of Idaho -Open Access Publishing Fund	The research was supported by funds provided to PAR by the Institute for Modeling Collaboration and Innovation at the University of Idaho (NIH grant P20 GM104420), the Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant #P20GM103408, the National Science Foundation Science and Technology Center on evolution in action, DBI-0939454 and the National Science Foundation grant number 1818368.Funding was also provided by the Office of Undergraduate Research at the University of Idaho awarded to LRF and CRR. Publication of this article was funded by the University of Idaho -Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and any opinions, findings, and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the funders.	Allegra E, 2018, CHEMOSPHERE, V198, P469, DOI 10.1016/j.chemosphere.2018.01.175; Ames L, 2017, VIRULENCE, V8, P1909, DOI 10.1080/21505594.2017.1347744; Andrea A, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030085; BIRD FT, 1961, CAN J MICROBIOL, V7, P827, DOI 10.1139/m61-098; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Browne N, 2015, VIRULENCE, V6, P458, DOI 10.1080/21505594.2015.1021540; Champion OL, 2018, J FUNGI, V4, DOI 10.3390/jof4030108; Chertkova EA, 2018, J INVERTEBR PATHOL, V153, P203, DOI 10.1016/j.jip.2018.02.020; Chosewood CL, 2009, HHS PUBLICATION CDC; Coates CJ, 2019, CELL BIOL TOXICOL, V35, P219, DOI 10.1007/s10565-018-09448-2; Cook SM, 2013, VIRULENCE, V4, P350, DOI 10.4161/viru.25240; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Dalton JP, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00099; DUDZIAK B, 1969, ACTA MICROBIOL POL, V1, P137; Dunn MJ, 2018, JOVE-J VIS EXP, DOI 10.3791/58914; Fedhila S, 2010, J INVERTEBR PATHOL, V103, P24, DOI 10.1016/j.jip.2009.09.005; Gago S, 2014, VIRULENCE, V5, P278, DOI 10.4161/viru.26973; Harding CR, 2013, JOVE-J VIS EXP, DOI 10.3791/50964; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Kavanagh Kevin, 2010, Fungal Biology Reviews, V24, P79, DOI 10.1016/j.fbr.2010.04.001; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KROPINSKI AMB, 1975, CAN J MICROBIOL, V21, P2084, DOI 10.1139/m75-297; KURSTAK E, 1968, CAN J MICROBIOL, V14, P233, DOI 10.1139/m68-039; Machholz E, 2012, JOVE-J VIS EXP, DOI 10.3791/2771; Maurer E, 2019, MED MYCOL, V57, P351, DOI 10.1093/mmy/myy042; MORELLINI M, 1957, Ann Ist Carlo Forlanini, V17, P149; Mowlds P, 2008, MICROBES INFECT, V10, P628, DOI 10.1016/j.micinf.2008.02.011; OMODEI-ZORINI A, 1947, Ann Ist Carlo Forlanini, V10, P157; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Sheehan G, 2018, VIRULENCE, V9, P1625, DOI 10.1080/21505594.2018.1526531; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; VAIDYA VG, 1971, EXPERIENTIA, V27, P148, DOI 10.1007/BF02145861; YOELI MEIR, 1958, EXPTL PARASITOL, V7, P531, DOI 10.1016/0014-4894(58)90044-4; ZIMMERMANN G, 1986, J APPL ENTOMOL, V102, P213, DOI 10.1111/j.1439-0418.1986.tb00912.x	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0230767	10.1371/journal.pone.0230767	http://dx.doi.org/10.1371/journal.pone.0230767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730254	Green Submitted, Green Published, gold			2022-12-26	WOS:000556884700025
J	von Essen, M; Leung, WTM; Bosch, J; Pooley, S; Ayres, C; Price, SJ				von Essen, Marius; Leung, William T. M.; Bosch, Jaime; Pooley, Simon; Ayres, Cesar; Price, Stephen J.			High pathogen prevalence in an amphibian and reptile assemblage at a site with risk factors for dispersal in Galicia, Spain	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; RANAVIRUS INFECTION; CHYTRIDIOMYCOSIS; TRANSMISSION; IRIDOVIRUS; IMPACT; FROGS	Ranaviruses are agents of disease, mortality and population declines in ectothermic vertebrates and emergences have been repeatedly linked to human activities. Ranaviruses in the common midwife toad ranavirus lineage are emerging in Europe. They are known to be severe multi-host pathogens of amphibians and can also cause disease in reptiles. Recurrent outbreaks of ranavirus disease and mortality affecting three species have occurred at a small reservoir in north-west Spain but no data were available on occurrence of the pathogen in the other amphibian and reptile species present or at adjacent sites. We sampled nine species of amphibians and reptiles at the reservoir and nearby sites and screened for ranavirus presence using molecular methods. Our results show infection with ranavirus in all nine species, including first reports forHyla molleri,Pelophylax perezi,Rana iberica, andPodarcis bocagei. We detected ranavirus in all four local sites and confirmed mass mortality incidents involvingLissotriton boscaiandTriturus marmoratuswere ongoing. The reservoir regularly hosts water sports tournaments and the risks of ranavirus dispersal through the translocation of contaminated equipment are discussed.	[von Essen, Marius; Leung, William T. M.; Price, Stephen J.] Zool Soc London, Inst Zool, Regents Pk, London, England; [von Essen, Marius; Pooley, Simon] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England; [Bosch, Jaime] CSIC, Museo Nacl Ciencias Nat, Madrid, Spain; [Bosch, Jaime] Univ Oviedo, Res Unit Biodivers CSIC UO PA, Edificio Invest, Mieres, Spain; [Ayres, Cesar] Assoc Herpetol Espanola, Madrid, Spain; [Price, Stephen J.] UCL Genet Inst, London, England; [von Essen, Marius] Stanford Univ, Earth Syst Sci Dept, Via Ortega, Stanford, CA 94305 USA	Zoological Society of London; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; University of London; University College London; Stanford University	Bosch, J (corresponding author), CSIC, Museo Nacl Ciencias Nat, Madrid, Spain.; Bosch, J (corresponding author), Univ Oviedo, Res Unit Biodivers CSIC UO PA, Edificio Invest, Mieres, Spain.	bosch@mncn.csic.es	Bosch, Jaime/H-3042-2011; von Essen, Marius/GXM-4544-2022	Bosch, Jaime/0000-0002-0099-7934; Leung, William/0000-0003-1616-175X; Pooley, Simon/0000-0002-0260-6159	Imperial College London M.Sc. Conservation Science Project Bursary 2016; ENEDAS e.V. through the Johann Christian Wiegleb Stipendium fur Feldforschung; NERC [NE/M000338/1, NE/M000591/1, NE/M00080X/1]; Spanish Ministry of Economy and Competitiveness [CGL2015-70070-R]	Imperial College London M.Sc. Conservation Science Project Bursary 2016; ENEDAS e.V. through the Johann Christian Wiegleb Stipendium fur Feldforschung; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by Imperial College London M.Sc. Conservation Science Project Bursary 2016, ENEDAS e.V. through the Johann Christian Wiegleb Stipendium fur Feldforschung, and NERC grants NE/M000338/1, NE/M000591/1, and NE/M00080X/1. JB was supported by Spanish Ministry of Economy and Competitiveness grant CGL2015-70070-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).	[Anonymous], 2016, SERV INF ANF REPT BA; Ariel E, 2010, ARCH VIROL, V155, P1261, DOI 10.1007/s00705-010-0715-z; Ayres C, 2015, FROGLOG, V23, P46; Ayres C, 2012, ACTA HERPETOL, V7, P171; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brunner J.L., 2015, RANAVIRUSES LETHAL P, P71, DOI [10.1007/978-3-319-13755-1_4, DOI 10.1007/978-3-319-13755-1_4]; Bryan LK, 2009, DIS AQUAT ORGAN, V84, P89, DOI 10.3354/dao02036; Casais R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39674-5; Duffus ALJ, 2008, J WILDLIFE DIS, V44, P109, DOI 10.7589/0090-3558-44.1.109; Duffus A. L. J., 2015, RANAVIRUSES LETHAL P, P9, DOI DOI 10.1007/978-3-319-13755-1; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Gieseke T., 2017, SHARED GOVERNANCE SU, DOI [10.1201/9781315371078, DOI 10.1201/9781315371078]; Gray MJ, 2007, DIS AQUAT ORGAN, V77, P97, DOI 10.3354/dao01837; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Gray MJ, 2015, RANAVIRUS LETHAL PAT, P12; Gray MJ, 2015, RANAVIRUSES, P209; Greer AL, 2008, J ANIM ECOL, V77, P364, DOI 10.1111/j.1365-2656.2007.01330.x; Greer AL, 2007, J WILDLIFE DIS, V43, P525, DOI 10.7589/0090-3558-43.3.525; Greer AL, 2009, DIS AQUAT ORGAN, V85, P1, DOI 10.3354/dao02061; Harp EM, 2006, J WILDLIFE DIS, V42, P307, DOI 10.7589/0090-3558-42.2.307; Hoverman JT, 2012, ECOHEALTH, V9, P36, DOI 10.1007/s10393-011-0731-9; Hyatt AD, 2000, ARCH VIROL, V145, P301, DOI 10.1007/s007050050025; La Fauce K, 2012, AQUACULTURE, V354, P64, DOI 10.1016/j.aquaculture.2012.04.006; Lesbarreres D, 2012, BIOL LETTERS, V8, P481, DOI 10.1098/rsbl.2011.0951; Leung WTM, 2017, J VIROL METHODS, V249, P147, DOI 10.1016/j.jviromet.2017.08.016; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Meng Y, 2013, J VIROL METHODS, V194, P211, DOI 10.1016/j.jviromet.2013.08.024; Miller DL, 2015, RANAVIRUS LETHAL PAT, P1171; Miller HC, 2006, CONSERV GENET, V7, P1001, DOI 10.1007/s10592-006-9120-2; Nazir J, 2012, DIS AQUAT ORGAN, V98, P177, DOI 10.3354/dao02443; NEPARC, 2014, DIS FIELD EQ MIN RIS; OIE, 2016, AQ AN HLTH COD; Picco AM, 2008, CONSERV BIOL, V22, P1582, DOI 10.1111/j.1523-1739.2008.01025.x; Pokrant F, 2016, BIOL J LINN SOC, V118, P873, DOI 10.1111/bij.12782; Poll CR, 2009, J EXOT PET MED, V18, P20, DOI 10.1053/j.jepm.2008.10.005; Price SJ, 2017, VIROLOGY, V511, P272, DOI 10.1016/j.virol.2017.08.001; Price SJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0952; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; Rosa GM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43260; Schloegel LM, 2010, DIS AQUAT ORGAN, V92, P101, DOI 10.3354/dao02140; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Stohr AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118633; Strain GF, 2009, ENVIRON MONIT ASSESS, V156, P1, DOI 10.1007/s10661-008-0459-3; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Whittington RJ, 2010, J FISH DIS, V33, P95, DOI 10.1111/j.1365-2761.2009.01110.x; Whittington RJ, 1996, AUST VET J, V73, P112, DOI 10.1111/j.1751-0813.1996.tb09992.x	47	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236803	10.1371/journal.pone.0236803	http://dx.doi.org/10.1371/journal.pone.0236803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730306	Green Accepted, Green Published, gold			2022-12-26	WOS:000556884700098
J	Kang, MJ; Park, JH; Park, S; Kim, NG; Kim, EY; Yu, YM; Kim, D; Lee, JY; Shin, WG; Choi, SA				Kang, Min Jung; Park, Ji Hyun; Park, Sunny; Kim, Nam Gyu; Kim, Eun Young; Yu, Yun Mi; Kim, Do Young; Lee, Ju-Yeun; Shin, Wan Gyoon; Choi, Soo An			Community pharmacists' knowledge, perceptions, and practices about topical corticosteroid counseling: A real-world cross-sectional survey and focus group discussions in Korea	PLOS ONE			English	Article							CUSHINGS-SYNDROME; ATOPIC-DERMATITIS; PHOBIA; MANAGEMENT; STEROIDS; CHILDREN; THERAPY; ECZEMA; MISUSE	Topical corticosteroids (TCs) are widely used to treat dermatological conditions such as eczema and psoriasis. It can be a safe and effective treatment when used appropriately. However, misguided information and corticosteroid phobia appear to contribute to inadequate adherence to therapy, leading to unsatisfactory treatment outcomes. Therefore, community pharmacists (CPs) are in a prime position to inform patients about the appropriate use of medicine. The aim of this study was to examine how the knowledge and perceptions of CPs, as well as other factors, associate CPs' patient counseling practice around the use of TCs. A structured, validated questionnaire was distributed to CPs in the Republic of Korea, and additional focus group discussions were implemented to obtain a deeper understanding of the survey findings. We analyzed the survey results by applying a modified knowledge-perception-practice model. In addition, we used path analysis to validate the model and assessed how knowledge level and perceptions of barriers affect CPs' counseling behavior. We ran a multiple regression to identify factors that associate CPs' practice levels. A total of 1018 surveys were analyzed. In general, respondents had sufficient knowledge to provide appropriate patient counseling on TC use. An increase in knowledge level positively associated the quality of practice, and more knowledge increased the perception of barriers that negatively associated patient counseling. Location in rural areas and pharmacists' perception of counseling barriers negatively associated the quality of practice. A higher level of knowledge, training in ADEs, higher proportion of OTC TC sales, and increased time for counseling positively associated the quality of practice. Therefore, minimizing barriers such as negative perceptions is very important in facilitating CPs' counseling practice around TC use.	[Kang, Min Jung] Seoul Natl Univ Hosp, Dept Pharm, Seoul, South Korea; [Kang, Min Jung] Seoul Natl Univ Hosp, Biomed Res Inst, Clin Trials Ctr, Seoul, South Korea; [Park, Ji Hyun; Choi, Soo An] Korea Univ, Coll Pharm, Sejong, South Korea; [Park, Sunny; Choi, Soo An] Korea Univ, Coll Pharm, Sejong, South Korea; [Park, Sunny; Choi, Soo An] Korea Univ, Pharmaceut Sci Res Inst, Sejong, South Korea; [Kim, Nam Gyu] Wellmarker Bio Co, Clin Dev Team, Seoul, South Korea; [Kim, Eun Young] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Yu, Yun Mi] Yonsei Univ, Coll Pharm, Dept Pharm, Seoul, South Korea; [Yu, Yun Mi] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Seoul, South Korea; [Kim, Do Young] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Do Young] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea; [Lee, Ju-Yeun; Shin, Wan Gyoon] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Ju-Yeun; Shin, Wan Gyoon] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Choi, Soo An] Korea Univ, Korea Univ Guro Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University; Korea University; Chung Ang University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Choi, SA (corresponding author), Korea Univ, Coll Pharm, Sejong, South Korea.; Choi, SA (corresponding author), Korea Univ, Coll Pharm, Sejong, South Korea.; Choi, SA (corresponding author), Korea Univ, Pharmaceut Sci Res Inst, Sejong, South Korea.; Choi, SA (corresponding author), Korea Univ, Korea Univ Guro Hosp, Dept Internal Med, Seoul, South Korea.	sachoi@korea.ac.kr		Park, Ji Hyun/0000-0002-6705-2193; Kim, Do Young/0000-0002-0194-9854; Yu, Yun Mi/0000-0002-8267-9453; Kang, Min Jung/0000-0002-8066-8267	Ministry of Food and Drug Safety [14172MFDS159]; National Research Foundation of Korea (NRF) - Ministry of Education [2019R1A6A1A03031807]; MFDS; Ministry of Education	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); MFDS(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Ministry of Education	This research was supported by a grant (14172MFDS159) from Ministry of Food and Drug Safety and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2019R1A6A1A03031807). The funders (including MFDS and Ministry of Education) provided support in the expenses related to research progress, but the funding organizations did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of our authors are articulated in the 'author contributions' section. The author Nam Gyu Kim's current affiliation is Wellmarker Bio Co, but they were not affiliated with that company during their involvement in this study, and Wellmarker Bio Co had no part in the research presented here.	Ahmad DS, 2014, TROP J PHARM RES, V13, P445, DOI 10.4314/tjpr.v13i3.20; Al Khaja KAJ, 2007, PHARM WORLD SCI, V29, P395, DOI 10.1007/s11096-007-9087-1; Aubert-Wastiaux H, 2011, BRIT J DERMATOL, V165, P808, DOI 10.1111/j.1365-2133.2011.10449.x; Bos B, 2019, PEDIATR DERMATOL, V36, P100, DOI 10.1111/pde.13698; Brown KK, 2006, J AM ACAD DERMATOL, V55, P607, DOI 10.1016/j.jaad.2005.12.021; Charman C, 2003, CLIN DERMATOL, V21, P193, DOI 10.1016/S0738-081X(02)00368-1; Charman CR, 2000, BRIT J DERMATOL, V142, P931, DOI 10.1046/j.1365-2133.2000.03473.x; Cork MJ, 2003, BRIT J DERMATOL, V149, P582, DOI 10.1046/j.1365-2133.2003.05595.x; Coureau B, 2008, ANN PHARMACOTHER, V42, P1903, DOI 10.1345/aph.1L067; Devaraj N K, 2019, Med J Malaysia, V74, P187; Ermis B, 2003, CLIN ENDOCRINOL, V58, P795, DOI 10.1046/j.1365-2265.2003.18021.x; Ference JD, 2009, AM FAM PHYSICIAN, V79, P135; Furue M, 2003, BRIT J DERMATOL, V148, P128, DOI 10.1046/j.1365-2133.2003.04934.x; Glass BD, 2009, CURR DRUG SAF, V4, P74, DOI 10.2174/157488609787354459; Guven A, 2007, J PEDIATR ENDOCR MET, V20, P1173; GUIN JD, 1981, J AM ACAD DERMATOL, V4, P417, DOI 10.1016/S0190-9622(81)70040-9; Guven A, 2005, HORM RES, V64, P35, DOI 10.1159/000087288; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; Kojima R, 2013, PEDIATR DERMATOL, V30, P29, DOI 10.1111/j.1525-1470.2012.01808.x; Koster ES, 2019, INT J CLIN PHARM-NET, V41, P711, DOI 10.1007/s11096-019-00827-1; Kumar MA, 2011, INT J PHARM SCI REV, V9, P132; Lau WM, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5030041; Millard AN, 2019, JAMA DERMATOL, V155, P838, DOI 10.1001/jamadermatol.2018.5353; Mollerup A, 2014, CONTACT DERMATITIS, V71, P202, DOI 10.1111/cod.12243; Muleme J, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00318; Raffin D, 2016, ACTA DERM-VENEREOL, V96, P177, DOI 10.2340/00015555-2157; Rapaport MJ, 2003, CLIN DERMATOL, V21, P201, DOI 10.1016/S0738-081X(02)00365-6; Sadek MM, 2016, SAUDI PHARM J, V24, P563, DOI 10.1016/j.jsps.2015.03.023; Santer M, 2006, CLIN EXP DERMATOL, V31, P671, DOI 10.1111/j.1365-2230.2006.02210.x; Service KSI, 2014, 3 1 DISTR MED CAR I; Service KSI, 2014, NUMB CLIN PER SPEC A; Smith SD, 2010, AUSTRALAS J DERMATOL, V51, P168, DOI 10.1111/j.1440-0960.2010.00636.x; Smith SD, 2015, AUSTRALAS J DERMATOL; SNEDDON I, 1969, BRIT MED J, V1, P671; Song SY, 2019, J DERMATOL TREAT, V30, P245, DOI 10.1080/09546634.2018.1508817; Thompson AM, 2019, CLIN J AM SOC NEPHRO, V14, P1531, DOI 10.2215/CJN.02790319; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tucker Rod, 2012, Int J Pharm Pract, V20, P344, DOI 10.1111/j.2042-7174.2012.00212.x; World Health Organization, ADVOCACY COMMUNICATI	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236797	10.1371/journal.pone.0236797	http://dx.doi.org/10.1371/journal.pone.0236797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726366	Green Published, gold			2022-12-26	WOS:000556908900045
J	Rethorn, ZD; Pettitt, RW; Dykstra, E; Pettitt, CD				Rethorn, Zachary D.; Pettitt, Robert W.; Dykstra, Emily; Pettitt, Cherie D.			Health and wellness coaching positively impacts individuals with chronic pain and pain-related interference	PLOS ONE			English	Article							PSYCHOSOCIAL FACTORS; MAINTENANCE; MANAGEMENT; COMMUNITY; OUTCOMES; ADULTS; TRIAL; CARE	Objectives Health and wellness coaching (HWC) interventions have been reported to improve health outcomes for individuals with chronic diseases such as diabetes, cardiovascular disease, or cancer. However, HWC also holds potential as an effective intervention within a biopsychosocial chronic pain management framework. The aim of the present study was to evaluate the effects of HWC on individuals with chronic pain. Methods Participants were referred by their primary care provider or insurance company to a comprehensive telephonic 12-month pain management HWC program. Relationships between pain outcomes and physical and psychological factors were retrospectively analyzed. Mixed linear-effects modeling explored whether physical and psychological variables were associated with pain outcomes over time. Results Four hundred nineteen participants (female, 58.9%; mean age, 54.8) enrolled in the program and 181 completed the intervention. After 12 months in the program, statistically and clinically significant reductions were observed for pain intensity (Hedges' g = 1.00) and pain-related interference (Hedges' g = 1.13). Linear mixed-effects modeling indicated that improvements in physical functioning and psychological factors were associated with improvements in pain intensity. Discussion Our results provide a novel analysis on the effects of HWC on chronic pain and pain-related interference. HWC appears to be a promising intervention to improve pain-related outcomes in a population with chronic pain. Further investigation of HWC as an intervention for chronic pain is warranted.	[Rethorn, Zachary D.] Duke Univ, Phys Therapy Div, Durham, NC 27708 USA; [Rethorn, Zachary D.; Pettitt, Robert W.; Dykstra, Emily; Pettitt, Cherie D.] Rocky Mt Univ Hlth Profess, Provo, UT 84606 USA; [Pettitt, Cherie D.] Western Governors Univ, WGU Acad, Salt Lake City, UT USA	Duke University; Rocky Mountain University Health Professions	Rethorn, ZD (corresponding author), Duke Univ, Phys Therapy Div, Durham, NC 27708 USA.; Rethorn, ZD (corresponding author), Rocky Mt Univ Hlth Profess, Provo, UT 84606 USA.	Zachary.Rethorn@gmail.com		Rethorn, Zachary/0000-0001-6412-0894				Alencar MK, 2019, J TELEMED TELECARE, V25, P151, DOI 10.1177/1357633X17745471; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boonstra AM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01466; Clark DO, 2019, OBES SCI PRACT, V5, P111, DOI 10.1002/osp4.318; Clark ME, 2003, J REHABIL RES DEV, V40, P381, DOI 10.1682/JRRD.2003.09.0381; Curtis R, 2016, J APPL BIOBEHAV RES, V22, P1; Davis RM, 2010, DIABETES CARE, V33, P1712, DOI 10.2337/dc09-1919; Dejonghe LAL, 2017, PATIENT EDUC COUNS, V100, P1643, DOI 10.1016/j.pec.2017.04.012; Doran G., 1981, MANAG REV, V70, P35, DOI DOI 10.1177/004057368303900411; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Edwards RR, 2016, J PAIN, V17, pT70, DOI 10.1016/j.jpain.2016.01.001; Elliott AM, 2002, PAIN, V99, P299, DOI 10.1016/S0304-3959(02)00138-0; Fine PG, 2011, PAIN MED, V12, P996, DOI 10.1111/j.1526-4637.2011.01187.x; Gatchel RJ, 2014, AM PSYCHOL, V69, P119, DOI 10.1037/a0035514; Geneen LJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011279.pub3; Geurts JW, 2017, HEALTH EXPECT, V20, P1201, DOI 10.1111/hex.12527; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Haugen HA, 2007, OBESITY, V15, P3067, DOI 10.1038/oby.2007.365; Hurkmans E, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.7713; Hylands-White N, 2017, RHEUMATOL INT, V37, P29, DOI 10.1007/s00296-016-3481-8; Inst Med, 2011, RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH, P1; Interagency Pain Research Coordinating Committee, 2016, NAT PAIN STRAT COMPR; Jacobsen L, 2001, BONICAS MANAGEMENT P; Jensen MP, 2011, ARCH PHYS MED REHAB, V92, P146, DOI 10.1016/j.apmr.2010.09.021; Kivela K, 2014, PATIENT EDUC COUNS, V97, P147, DOI 10.1016/j.pec.2014.07.026; Kristensen M, 2004, ADV PHYSIOL EDUC, V28, P2, DOI 10.1152/advan.00042.2003; Marsh I, 2012, DEMOCRATIC DECLINE AND DEMOCRATIC RENEWAL: POLITICAL CHANGE IN BRITAIN, AUSTRALIA AND NEW ZEALAND, P3; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Moyers TB, 2016, J SUBST ABUSE TREAT, V65, P36, DOI 10.1016/j.jsat.2016.01.001; Mundal I, 2014, PAIN, V155, P1555, DOI 10.1016/j.pain.2014.04.033; National Board for Health & Wellness Coaching, 2019, WHAT IS HLTH WELLN C; Nicholas MK, 2008, PAIN, V134, P158, DOI 10.1016/j.pain.2007.04.007; Nicholas MK, 2019, PAIN, V160, P1156, DOI 10.1097/j.pain.0000000000001496; Olsen Jeanette M, 2010, Am J Health Promot, V25, pe1, DOI 10.4278/ajhp.090313-LIT-101; Peters SAE, 2012, J CLIN EPIDEMIOL, V65, P686, DOI 10.1016/j.jclinepi.2011.11.012; Pizzo PA, 2012, NEW ENGL J MED, V366, P197, DOI 10.1056/NEJMp1109084; Rethorn ZD, 2019, PHYS THER, V99, P1354, DOI 10.1093/ptj/pzz098; Schaller A, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1788-6; Seal K, 2017, J GEN INTERN MED, V32, P931, DOI 10.1007/s11606-017-4047-5; Sforzo GA, 2018, AM J LIFESTYLE MED, V12, P436, DOI 10.1177/1559827617708562; Smith J, 2019, PAIN MED, V20, P2385, DOI 10.1093/pm/pnz208; Spring B, 2013, JAMA INTERN MED, V173, P105, DOI 10.1001/jamainternmed.2013.1221; Thomas ML, 2012, ONCOL NURS FORUM, V39, P39, DOI 10.1188/12.ONF.39-49; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Vale MJ, 2003, ARCH INTERN MED, V163, P2775, DOI 10.1001/archinte.163.22.2775; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Whibley D, 2019, CLIN J PAIN, V35, P544, DOI 10.1097/AJP.0000000000000697	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236734	10.1371/journal.pone.0236734	http://dx.doi.org/10.1371/journal.pone.0236734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV9ND	32716976	Green Published, gold			2022-12-26	WOS:000556674500008
J	Xue, YF; Zhang, LM; Qiao, LS; Shen, DG				Xue, Yanfang; Zhang, Limei; Qiao, Lishan; Shen, Dinggang			Estimating sparse functional brain networks with spatial constraints for MCI identification	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CONNECTIVITY; REGIONS; CORTEX	Functional brain network (FBN), estimated with functional magnetic resonance imaging (fMRI), has become a potentially useful way of diagnosing neurological disorders in their early stages by comparing the connectivity patterns between different brain regions across subjects. However, this depends, to a great extent, on the quality of the estimated FBNs, indicating that FBN estimation is a key step for the subsequent task of disorder identification. In the past decades, researchers have developed many methods to estimate FBNs, including Pearson's correlation and (regularized) partial correlation, etc. Despite their widespread applications in current studies, most of the existing methods estimate FBNs only based on the dependency between the measured blood oxygen level dependent (BOLD) signals, which ignores spatial relationship of signals associated with different brain regions. Due to the space and material parsimony principle of our brain, we believe that the spatial distance between brain regions has an important influence on FBN topology. Therefore, in this paper, we assume that spatially neighboring brain regions tend to have stronger connections and/or share similar connections with others; based on this assumption, we propose two novel methods to estimate FBNs by incorporating the information of brain region distance into the estimation model. To validate the effectiveness of the proposed methods, we use the estimated FBNs to identify subjects with mild cognitive impairment (MCI) from normal controls (NCs). Experimental results show that the proposed methods are better than the baseline methods in the sense of MCI identification accuracy.	[Xue, Yanfang; Zhang, Limei; Qiao, Lishan] Liaocheng Univ, Sch Math, Liaocheng, Shandong, Peoples R China; [Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC 27515 USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Shen, Dinggang] Shanghai United Imaging Intelligence Co Ltd, Dept Res & Dev, Shanghai, Peoples R China	Liaocheng University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Korea University	Qiao, LS (corresponding author), Liaocheng Univ, Sch Math, Liaocheng, Shandong, Peoples R China.	qlishan@163.com	Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698	National Natural Science Foundation of China [61976110, 11931008]; Natural Science Foundation of Shandong Province [ZR2018MF020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work is supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/)(61976110, 11931008) and Natural Science Foundation of Shandong Province(http://cloud.sdstc.gov.cn/) (ZR2018MF020). There was no additional external funding received for this study.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Bijsterbosch J., 2017, INTRO RESTING STATE; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brown C.J., 2016, ARXIV161108699; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen XB, 2016, HUM BRAIN MAPP, V37, P3282, DOI 10.1002/hbm.23240; Choi H, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006978; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; Dadi K, 2019, NEUROIMAGE, V192, P115, DOI 10.1016/j.neuroimage.2019.02.062; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drzezga A, 2005, J NUCL MED, V46, P1625; Forman MS, 2007, NEUROLOGY, V68, P757, DOI 10.1212/01.wnl.0000256373.39415.b1; Fornito A, 2016, FUNDAMENTALS BRAIN N; Gao Y, MED IMAGE RETRIEVAL; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Huang SA, 2010, NEUROIMAGE, V50, P935, DOI 10.1016/j.neuroimage.2009.12.120; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Korhonen O, 2017, NETW NEUROSCI, V1, P254, DOI [10.1162/NETN_a_00013, 10.1162/netn_a_00013]; Lee H, 2011, IEEE T MED IMAGING, V30, P1154, DOI 10.1109/TMI.2011.2140380; Li WK, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00055; Liu J., 2011, SPARSE LEARNING EFFI; Luo SQ, 2019, INT CON DISTR COMP S, P1019, DOI 10.1109/ICDCS.2019.00105; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Martinez B, 2019, NEURAL REGEN RES, V14, P242, DOI 10.4103/1673-5374.244784; Poldrack RA, 2015, NATURE, V526, P371, DOI 10.1038/nature15692; Preti MG, 2015, INT S BIOM IM; Qiao LS, 2016, NEUROIMAGE, V141, P399, DOI 10.1016/j.neuroimage.2016.07.058; Rubinov M, 2015, P NATL ACAD SCI USA, V112, P10032, DOI 10.1073/pnas.1420315112; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang HFE, 2018, NEUROIMAGE, V166, P167, DOI 10.1016/j.neuroimage.2017.10.036; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang H, 2016, J ALZHEIMERS DIS, V54, P1095, DOI 10.3233/JAD-160092	40	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0235039	10.1371/journal.pone.0235039	http://dx.doi.org/10.1371/journal.pone.0235039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32707574	gold, Green Published			2022-12-26	WOS:000579931700007
J	Bailey-Steinitz, LJ; Shih, YH; Radeke, MJ; Coffey, PJ				Bailey-Steinitz, Lindsay J.; Shih, Ying-Hsuan; Radeke, Monte J.; Coffey, Pete J.			An in vitro model of chronic wounding and its implication for age-related macular degeneration	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; ENDOTHELIAL GROWTH-FACTOR; GEOGRAPHIC ATROPHY; OXIDATIVE STRESS; CELLS; EXPRESSION; SECRETION; CULTURE; DRUSEN; INFLAMMATION	Degeneration of the retinal pigment epithelium (RPE) plays a central role in age-related macular degeneration (AMD). Throughout life, RPE cells are challenged by a variety of cytotoxic stressors, some of which are cumulative with age and may ultimately contribute to drusen and lipofuscin accumulation. Stressors such as these continually damage RPE cells resulting in a state of chronic wounding. Current cell-based platforms that model a state of chronic RPE cell wounding are limited, and the RPE cellular response is not entirely understood. Here, we used the electric cell-substrate impedance sensing (ECIS) system to induce a state of acute or chronic wounding on differentiated human fetal RPE cells to analyze changes in the wound repair response. RPE cells surrounding the lesioned area employ both cell migration and proliferation to repair wounds but fail to reestablish their original cell morphology or density after repetitive wounding. Chronically wounded RPE cells develop phenotypic AMD characteristics such as loss of cuboidal morphology, enlarged size, and multinucleation. Transcriptomic analysis suggests a systemic misregulation of RPE cell functions in bystander cells, which are not directly adjacent to the wound. Genes associated with the major RPE cell functions (LRAT, MITF, RDH11) significantly downregulate after wounding, in addition to differential expression of genes associated with the cell cycle (CDK1, CDC6, CDC20), inflammation (IL-18, CCL2), and apoptosis (FAS). Interestingly, repetitive wounding resulted in prolonged misregulation of genes, including FAS, LRAT, and PEDF. The use of ECIS to induce wounding resulted in an over-representation of AMD-associated genes among those dysregulated genes, particularly genes associated with advanced AMD. This simple system provides a new model for further investigation of RPE cell wound response in AMD pathogenesis.	[Bailey-Steinitz, Lindsay J.; Shih, Ying-Hsuan; Radeke, Monte J.; Coffey, Pete J.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Bailey-Steinitz, Lindsay J.; Shih, Ying-Hsuan] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Coffey, Pete J.] Univ Calif Santa Barbara, Neurosci Res Inst, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA; [Coffey, Pete J.] Univ Coll London UCL, Inst Ophthalmol, London Project Cure Blindness, ORBIT, London, England; [Coffey, Pete J.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, UCL Inst Ophthalmol, London, England	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Bailey-Steinitz, LJ (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.; Bailey-Steinitz, LJ (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	ljbailey@ucsb.edu		Coffey, Peter/0000-0002-5427-2939; Bailey-Steinitz, Lindsay/0000-0003-3696-3047	William K. Bowes Jr. Foundation; Garland Initiative for Vision; California Institute for Regenerative Medicine [LA1-02086]	William K. Bowes Jr. Foundation; Garland Initiative for Vision; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was funded by the William K. Bowes Jr. Foundation, Garland Initiative for Vision (www.wkbowesjrfoundation.org), and the California Institute for Regenerative Medicine (LA1-02086, PC, www.cirm.ca.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hussaini H, 2009, EXP EYE RES, V88, P610, DOI 10.1016/j.exer.2008.09.021; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; ASHBURN FS, 1980, INVEST OPHTH VIS SCI, V19, P1427; Bhatia SK, 2016, MOL VIS, V22, P898; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Bonilha VL, 2008, CLIN OPHTHALMOL, V2, P413; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Cassidy L, 1998, BRIT J OPHTHALMOL, V82, P181, DOI 10.1136/bjo.82.2.181; Chen Y, 2007, J BIOL CHEM, V282, P34420, DOI 10.1074/jbc.M611289200; Chua HL, 2004, HUM IMMUNOL, V65, P317, DOI 10.1016/j.humimm.2004.01.004; Cramerotti A, 2013, PHOTOCINEMA: THE CREATIVE EDGES OF PHOTOGRAPHY AND FILM, P70; Daniel E, 2014, OPHTHALMOLOGY, V121, P656, DOI 10.1016/j.ophtha.2013.10.019; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Farazdaghi MK, 2019, J OPHTHAL VIS RES, V14, P78, DOI 10.4103/jovr.jovr_125_18; Fisher Cody R., 2018, INVEST OPHTH VIS SCI, V59, P41, DOI DOI 10.1167/I0VS.18-24289; Fleckenstein M, 2018, OPHTHALMOLOGY, V125, P369, DOI 10.1016/j.ophtha.2017.08.038; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; FRIEDMAN AH, 1977, SURV OPHTHALMOL, V21, P375, DOI 10.1016/0039-6257(77)90041-8; Garcia-Layana A, 2017, CLIN INTERV AGING, V12, P1579, DOI 10.2147/CIA.S142685; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Greene WA, 2016, INVEST OPHTH VIS SCI, V57, P4428, DOI 10.1167/iovs.16-19192; Grunwald JE, 2017, OPHTHALMOLOGY, V124, P97, DOI 10.1016/j.ophtha.2016.09.012; Hahne M, 1996, EUR J IMMUNOL, V26, P721, DOI 10.1002/eji.1830260332; Hanus J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.478; Hanus J, 2015, AGEING RES REV, V24, P286, DOI 10.1016/j.arr.2015.09.002; Hirano Y, 2014, NAT MED, V20, P1372, DOI 10.1038/nm.3671; Hu J, 2001, MOL VIS, V7, P14; Hu J, 2010, METHODS MOL BIOL, V652, P55, DOI 10.1007/978-1-60327-325-1_2; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Jin ML, 2000, INVEST OPHTH VIS SCI, V41, P4324; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Jonas JB, 2010, ARCH OPHTHALMOL-CHIC, V128, P1281, DOI 10.1001/archophthalmol.2010.227; Kamei M, 1996, CURR EYE RES, V15, P714; Kaplan HJ, 1999, NAT MED, V5, P292, DOI 10.1038/6509; Kaszubski P, 2016, OPHTHALMIC RES, V55, P185, DOI 10.1159/000443209; Kay P, 2013, J CELL MOL MED, V17, P833, DOI 10.1111/jcmm.12070; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Keese CR, 2003, ELECT WOUND HEALING; Khandhadia S, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000164X; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kutty RK, 2016, MOL VIS, V22, P1156; Lambert NG, 2016, PROG RETIN EYE RES, V54, P64, DOI 10.1016/j.preteyeres.2016.04.003; LESCHEY KH, 1990, INVEST OPHTH VIS SCI, V31, P839; Levy O, 2015, EMBO MOL MED, V7, P211, DOI 10.15252/emmm.201404524; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Matsumoto H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.334; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734; Nivison-Smith L, 2014, OPTOMETRY VISION SCI, V91, P832, DOI 10.1097/OPX.0000000000000281; Peitzman ER, 2015, AM J PHYSIOL-CELL PH, V309, pC847, DOI 10.1152/ajpcell.00159.2015; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Plafker SM, 2012, INT REV CEL MOL BIO, V298, P135, DOI 10.1016/B978-0-12-394309-5.00004-3; Qiu FF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01119-2; Radeke MJ, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0183-x; Ramasamy S, 2014, INT J NANOMED, V9, P5789, DOI 10.2147/IJN.S71128; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rudnicka AR, 2015, AM J OPHTHALMOL, V160, P85, DOI 10.1016/j.ajo.2015.04.003; Seddon JM, 2016, JAMA OPHTHALMOL, V134, P1272, DOI 10.1001/jamaophthalmol.2016.3519; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Volland S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125631; Wang CH, 2012, BIOCHEM BIOPH RES CO, V425, P33, DOI 10.1016/j.bbrc.2012.07.044; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P6026, DOI 10.1167/iovs.10-7023; Yang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30933	81	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236298	10.1371/journal.pone.0236298	http://dx.doi.org/10.1371/journal.pone.0236298			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701996	Green Published, gold			2022-12-26	WOS:000575913700072
J	Farci, R; Carta, A; Cocco, E; Frau, J; Fossarello, M; Diaz, G				Farci, Roberta; Carta, Arturo; Cocco, Eleonora; Frau, Jessica; Fossarello, Maurizio; Diaz, Giacom			Optical coherence tomography angiography in multiple sclerosis: A cross-sectional study	PLOS ONE			English	Article							AMPLITUDE-DECORRELATION ANGIOGRAPHY; VISUAL DYSFUNCTION; PATHOGENESIS; PATHOLOGY; PLAQUES; DAMAGE	Objectives To evaluate retinal axonal density and retinal capillary flow density (CFD) variations in patients affected by multiple sclerosis (MS) as documented by Optical Coherence Tomography Angiography (OCT-A). Material and methods A cross-sectional study was performed in a tertiary university eye hospital on 94 eyes from 48 MS patients compared to 37 eyes from 23 matched controls. MS patients were divided in two groups: those with previous episodes of optic neuritis (MS ON+, 71.4%) and those without any previous visual complaint (no optic neuritis group, MS ON, 28.6%). Patients underwent macular and optic nerve head OCT-A with Optovue XR Avanti (Optovue, Freemont, California) after that preliminary evaluation of the ganglion cell complex (GCC) and of the retinal nerve fiber layer (RNFL) was achieved for each single eye by SD-OCT. CFD was evaluated in three different retinal layers of MS patients and controls: superficial capillary plexus (SCP), deep capillary plexus (DCP) and the choriocapillaris layer (CL). Each layer was analyzed in 18 preset subregions automatically detected by the system. CFD values were then correlated to the RNFL thickness and GCC thickness in the groups: p values were computed by t-tests between each group of MS patients and controls. A p-value of < 0.05 was considered significant. Results A significant difference in the overall CFD values was found between ON+ and ON- patients when compared to controls in 18 subregions of SCP. Furthermore, a significant difference was found between MS patients and controls in 16 subregions analyzed corresponding to the CL layer without difference between the two MS subgroups (ON+ and ON-) Conclusions OCT-A when performed at the optic nerve head level and at the macular region is characterized by a reduction of retinal perfusion in a significant portion of MS patients independently if they had a previous history of optic nerve inflammation or not.	[Farci, Roberta; Fossarello, Maurizio] Univ Cagliari, Eye Clin, Cagliari, Italy; [Carta, Arturo] Univ Parma, Dept Med & Surg, Ophthalmol Unit, Parma, Italy; [Cocco, Eleonora; Frau, Jessica] Univ Cagliari, Multiple Sclerosis Ctr, Dept Med Sci & Publ Hlth, Binaghi Hosp, Cagliari, Italy; [Diaz, Giacom] Univ Cagliari, Biomed Sci Dept, Cagliari, Italy	University of Cagliari; University of Parma; University of Cagliari; University of Cagliari	Farci, R (corresponding author), Univ Cagliari, Eye Clin, Cagliari, Italy.	roberta_farci@yahoo.com	carta, arturo/AAA-4260-2021; Fossarello, Maurizio/AAD-8235-2021; Cocco, Eleonora/G-5064-2012; Fossarello, Maurizio/G-2032-2015	Cocco, Eleonora/0000-0002-3878-8820; Fossarello, Maurizio/0000-0003-1520-7760; Carta, Arturo/0000-0002-6284-0588; Farci, Roberta/0000-0002-0323-3032				ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Allen NB, 2008, NEUROEPIDEMIOLOGY, V30, P234, DOI 10.1159/000128103; Audoin B, 2006, BRAIN, V129, P1031, DOI 10.1093/brain/awl039; Balcer LJ, 2006, NEW ENGL J MED, V354, P1273, DOI 10.1056/NEJMcp053247; Caprio M G, 2016, J VASC MED SURG, V4, P259; Cennamo G, 2016, EYE, V30, P456, DOI 10.1038/eye.2015.256; Costello F:, 2006, INT J MULT SCLER CAR, V8, P1; D'haeseleer M, 2013, P NATL ACAD SCI USA, V110, P5654, DOI 10.1073/pnas.1222560110; Dake MD, 2012, TECH VASC INTERV RAD, V15, P94, DOI 10.1053/j.tvir.2012.02.002; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; Esen E, 2016, OPHTHALMOLOGICA, V235, P65, DOI 10.1159/000441152; Feucht N, 2019, MULT SCLER J, V25, P224, DOI 10.1177/1352458517750009; FOG T, 1965, ACTA NEUROL SCAND, VS 41, P3; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Gao SS, 2015, OPT LETT, V40, P2305, DOI 10.1364/OL.40.002305; Garcia-Martin E, 2019, ACTA OPHTHALMOL, V97, pE77, DOI 10.1111/aos.13807; Gonzalez-Lopez JJ, 2014, BIOMED RES INT; HOLLANDER H, 1984, EXP BRAIN RES, V55, P483; Huang D, 2016, DEV OPHTHALMOL, V56, P6, DOI 10.1159/000442770; IKUTA F, 1976, NEUROLOGY, V26, P26, DOI 10.1212/WNL.26.6_Part_2.26; Jankowska-Lech I, 2015, MED SCI MONITOR, V21, P1066, DOI 10.12659/MSM.890899; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Jm C., 1868, GAZ HOPITAUX, P554; Kaufhold F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071145; Kessel L, 2018, CLIN EXP OPHTHALMOL, V46, P1075, DOI 10.1111/ceo.13327; Kutzelnigg A, 2014, HAND CLINIC, V122, P15, DOI 10.1016/B978-0-444-52001-2.00002-9; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Pfueller CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018019; Plumb J, 2002, BRAIN PATHOL, V12, P154; POSER CM, 1986, ACTA NEUROPATHOL, V71, P1, DOI 10.1007/BF00687954; Pul R, 2016, EXP THER MED, V12, P190, DOI 10.3892/etm.2016.3300; Putnam TJ, 1933, NEW ENGL J MED, V209, P786, DOI 10.1056/NEJM193310192091604; Rindfleisch E., 1863, ARCH PATHOL ANAT PH, V26, P474, DOI [10.1007/BF01878008, DOI 10.1007/BF01878008]; Sepulcre J, 2009, NEUROIMAGE, V47, P773, DOI 10.1016/j.neuroimage.2009.04.054; Sinnecker T, 2015, EUR RADIOL, V25, P122, DOI 10.1007/s00330-014-3358-8; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; TOUSSAINT D, 1983, J CLIN NEURO-OPHTHAL, V3, P211; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Wang XG, 2014, BRIT J OPHTHALMOL, V98, P1368, DOI 10.1136/bjophthalmol-2013-304547; Waxman SG, 2007, NEUROLOGY; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yousefipour Gholamali, 2016, Acta Med Iran, V54, P382	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236090	10.1371/journal.pone.0236090	http://dx.doi.org/10.1371/journal.pone.0236090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702050	Green Published, gold			2022-12-26	WOS:000575913700048
J	Gavriil, A; Thanasoulia, A; Skandamis, PN				Gavriil, Alkmini; Thanasoulia, Athina; Skandamis, Panagiotis N.			Sublethal concentrations of undissociated acetic acid may not always stimulate acid resistance in Salmonella enterica sub. enterica serovar Enteritidis Phage Type 4: Implications of challenge substrate associated factors	PLOS ONE			English	Article							MEMBRANE-LIPID COMPOSITION; ESCHERICHIA-COLI O157-H7; TOLERANCE RESPONSE; GENE-EXPRESSION; LACTIC-ACID; LISTERIA-MONOCYTOGENES; VEROTOXIN SECRETION; STRESS-RESPONSE; ORGANIC-ACIDS; FATTY-ACIDS	Acid adaptation enhances survival of foodborne pathogens under lethal acid conditions that prevail in several food-related ecosystems. In the present study, the role of undissociated acetic acid in inducing acid resistance of Salmonella Enteritidis Phage Type 4 both in laboratory media and in an acid food matrix was investigated. Several combinations of acetic acid (0, 15, 25, 35 and 45 mM) and pH values (4.0, 4.5, 5.0, 5.5, 6.0) were screened for their ability to activate acid resistance mechanisms of pathogen exposed to pH 2.5 (screening assay). Increased survival was observed when increasing undissociated acetic acid within a range of sublethal concentrations (1.9-5.4 mM), but only at pH 5.5 and 6.0. No effect was observed at lower pH values, regardless of the undissociated acetic acid levels. Three combinations (15mM/pH5.0, 35mM/pH5.5, 45mM/pH6.0) were selected and further used for adaptation prior to inoculation in commercial tarama (fish roe) salad, i.e., an acid spread (pH 4.35 +/- 0.02), stored at 5 degrees C. Surprisingly and contrary to the results of the screening assay, none of the acid adaptation treatments enhanced survival of Salmonella Enteritidis in the food matrix, as compared to non-adapted cells (control). Further examination of the food pH value, acidulant and storage (challenge) temperature on the responses of the pathogen adapted to 15mM/pH5.0, 35mM/pH5.5 and 45mM/pH6.0 was performed in culture media. Cells adapted to 35mM/pH5.5 were unable to induce acid resistance when exposed to pH 4.35 (tarama salad pH value) at 37 degrees C and 5 degrees C, whereas incubation under refrigeration (5 degrees C) at pH 4.35 sensitized 45mM/pH6.0 adapted cells against the subsequent acid and cold stress. In conclusion, pre-exposure to undissociated acetic acid affected the adaptive responses of Salmonella Enteritidis Phage Type 4 in a concentration- and pH-dependent manner, with regard to conditions prevailing during acid challenge.	[Gavriil, Alkmini; Thanasoulia, Athina; Skandamis, Panagiotis N.] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Qual Control & Hyg, Athens, Greece	Agricultural University of Athens	Skandamis, PN (corresponding author), Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Qual Control & Hyg, Athens, Greece.	pskan@aua.gr		Gavriil, Alkmini/0000-0003-3331-0825				Abdelwaheb C, 2009, PATHOL BIOL, V57, P358, DOI 10.1016/j.patbio.2008.02.020; Albert I, 2005, INT J FOOD MICROBIOL, V100, P197, DOI 10.1016/j.ijfoodmicro.2004.10.016; Alvarez-Ordonez A, 2009, MEAT SCI, V81, P65, DOI 10.1016/j.meatsci.2008.06.019; Alvarez-Ordonez A, 2015, INT J FOOD MICROBIOL, V213, P99, DOI 10.1016/j.ijfoodmicro.2015.06.004; Alvarez-Ordonez A, 2012, FOOD RES INT, V45, P482, DOI 10.1016/j.foodres.2011.04.002; Alvarez-Ordonez A, 2010, FOOD MICROBIOL, V27, P44, DOI 10.1016/j.fm.2009.07.015; Alvarez-Ordonez A, 2010, INT J FOOD MICROBIOL, V136, P278, DOI 10.1016/j.ijfoodmicro.2009.09.024; Alvarez-Ordonez A, 2009, FOODBORNE PATHOG DIS, V6, P1147, DOI 10.1089/fpd.2009.0313; Alvarez-Ordonez A, 2009, FOOD MICROBIOL, V26, P347, DOI 10.1016/j.fm.2008.11.002; Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Begley M, 2015, ANNU REV FOOD SCI T, V6, P191, DOI 10.1146/annurev-food-030713-092350; Berk PA, 2005, J APPL MICROBIOL, V99, P859, DOI 10.1111/j.1365-2672.2005.02658.x; Boziaris IS, 1998, INT J FOOD MICROBIOL, V43, P7, DOI 10.1016/S0168-1605(98)00083-X; Chapman B, 2009, APPL ENVIRON MICROB, V75, P3605, DOI 10.1128/AEM.02462-08; Chen Z., 2017, J FOOD MICROBIOLOGY, V2, pe103; European Food Safety Authority, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5500; Fang FC, 2016, CELL HOST MICROBE, V20, P133, DOI 10.1016/j.chom.2016.07.009; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Greenacre EJ, 2006, INT J FOOD MICROBIOL, V112, P62, DOI 10.1016/j.ijfoodmicro.2006.05.012; Greenacre EJ, 2006, APPL ENVIRON MICROB, V72, P5623, DOI 10.1128/AEM.00538-06; Greenacre EJ, 2003, APPL ENVIRON MICROB, V69, P3945, DOI 10.1128/AEM.69.7.3945-3951.2003; HUMPHREY TJ, 1993, LETT APPL MICROBIOL, V16, P228, DOI 10.1111/j.1472-765X.1993.tb01404.x; Kim GH, 2015, J FOOD SCI, V80, pM2257, DOI 10.1111/1750-3841.12996; Kim GS, 2016, J SENSORS, V2016, DOI 10.1155/2016/1865614; Koutsoumanis KP, 2004, LETT APPL MICROBIOL, V38, P321, DOI 10.1111/j.1472-765X.2004.01491.x; Kwon YM, 2000, J FOOD SCI, V65, P1037, DOI 10.1111/j.1365-2621.2000.tb09413.x; Lachica M, 2019, ANIM PROD SCI, V59, P1470, DOI [10.1071/AN18149, 10.1071/an18149]; Lago M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02362-3; LEE IS, 1995, MOL MICROBIOL, V17, P155; LEE IS, 1994, J BACTERIOL, V176, P1422, DOI 10.1128/jb.176.5.1422-1426.1994; Lee SY, 2016, FOOD MICROBIOL, V55, P95, DOI 10.1016/j.fm.2015.10.021; Lianou A, 2012, WOODHEAD PUBL FOOD S, P592; Lianou A, 2017, FOOD MICROBIOL, V62, P99, DOI 10.1016/j.fm.2016.10.011; Liu JM, 2017, FOOD RES INT, V92, P33, DOI 10.1016/j.foodres.2016.12.006; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; MCDONALD LC, 1983, APPL ENVIRON MICROB, V45, P360, DOI 10.1128/AEM.45.2.360-365.1983; Presser KA, 1997, APPL ENVIRON MICROB, V63, P2355, DOI 10.1128/AEM.63.6.2355-2360.1997; Ricke SC, 2003, POULTRY SCI, V82, P632, DOI 10.1093/ps/82.4.632; Shen H, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01305; Shen HW, 2007, INT J FOOD MICROBIOL, V114, P380, DOI 10.1016/j.ijfoodmicro.2006.09.033; Smittle RB, 2000, J FOOD PROTECT, V63, P1144, DOI 10.4315/0362-028X-63.8.1144; Spector MP, 2012, FOOD RES INT, V45, P455, DOI 10.1016/j.foodres.2011.06.056; Tiwari RP, 2004, J BASIC MICROB, V44, P137, DOI 10.1002/jobm.200310333; Usaga J, 2014, J FOOD PROTECT, V77, P1656, DOI 10.4315/0362-028X.JFP-14-126; Viala JPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022397; Vivijs B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01672; Waterman SR, 1998, APPL ENVIRON MICROB, V64, P3882; Wesche AM, 2009, J FOOD PROTECT, V72, P1121, DOI 10.4315/0362-028X-72.5.1121; Yang YS, 2014, INT J FOOD MICROBIOL, V191, P24, DOI 10.1016/j.ijfoodmicro.2014.08.034; Yang YS, 2014, INT J FOOD MICROBIOL, V172, P102, DOI 10.1016/j.ijfoodmicro.2013.12.006; Ye BN, 2019, J FOOD SCI, V84, P599, DOI 10.1111/1750-3841.14465; Yoon JH, 2014, J APPL MICROBIOL, V117, P1700, DOI 10.1111/jam.12637; Yuk HG, 2006, FOOD MICROBIOL, V23, P694, DOI 10.1016/j.fm.2005.12.003; Yuk HG, 2005, J FOOD PROTECT, V68, P673, DOI 10.4315/0362-028X-68.4.673; Yuk HG, 2004, APPL ENVIRON MICROB, V70, P3500, DOI 10.1128/AEM.70.6.3500-3505.2004	56	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0234999	10.1371/journal.pone.0234999	http://dx.doi.org/10.1371/journal.pone.0234999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702039	Green Published, gold			2022-12-26	WOS:000575913700011
J	Ng, MSY; Ullah, S; Wilson, G; McDonald, S; Sypek, M; Mallett, AJ				Ng, Monica S. Y.; Ullah, Shahid; Wilson, Gregory; McDonald, Stephen; Sypek, Matthew; Mallett, Andrew J.			ABO blood group relationships to kidney transplant recipient and graft outcomes	PLOS ONE			English	Article							SURVIVAL; DISEASE; CANCER; IMPACT; POPULATION	Introduction Certain ABO blood types have been linked to cardiovascular disease, infection and cancers. The effect of recipient ABO blood group on patient and graft survival has not been studied in ABO-matched kidney transplantation. This study aims to determine the association between kidney transplant recipient ABO blood groups with patient and graft survival in Australian and New Zealand. Methods All Australian and New Zealand transplant recipients who received ABO-compatible primary kidney transplants between 1995-2016 were analysed using a de-identified dataset from the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry. Primary analysis was undertaken of recipient ABO blood group O versus non-O blood groups. The primary outcome was patient survival post kidney transplantation and the secondary outcome was death censored graft survival. Recipient age at first transplant, gender, ethnicity, body mass index, smoking status, vascular disease, presence of diabetes mellitus, chronic lung disease, primary kidney disease, donor source, donor age and gender, and era of transplants were included in the multivariate model as confounders. Results and conclusions On analysis of 15,523 kidney transplant recipients, blood group O was not associated with patient survival (hazard ratio (HR) 0.96, 95% confidence interval (CI) 0.89-1.04) nor death censored graft survival (HR 0.97, 95% CI 0.89-1.05) compared to non-blood group O recipients. Competing risks analyses showed an increased risk of cancer-related mortality in blood group O recipients on univariate analyses (HR 1.18, 95% CI 1.01-1.37) however, this became insignificant on multivariate analyses. On secondary analyses, recipient blood group AB (4.11% participants) was associated with inferior death censored graft survival compared to those with blood group O (HR 1.24, 95% CI 1.02-1.50). Although recipient ABO blood groups were not associated with patient nor graft survival, differences in cause-specific mortality between individual blood groups cannot be excluded based on current analyses.	[Ng, Monica S. Y.; Mallett, Andrew J.] Royal Brisbane & Womens Hosp, Kidney Hlth Serv, Brisbane, Qld, Australia; [Ng, Monica S. Y.; Wilson, Gregory; Mallett, Andrew J.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Ullah, Shahid; McDonald, Stephen; Sypek, Matthew] South Australian Hlth & Med Res Inst, Australia & New Zealand Dialysis & Transplant Reg, Adelaide, SA, Australia; [Ullah, Shahid] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Ullah, Shahid; McDonald, Stephen] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Wilson, Gregory] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia; [Sypek, Matthew] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Sypek, Matthew] Royal Melbourne Hosp, Dept Nephrol, Melbourne, Vic, Australia; [Mallett, Andrew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Royal Brisbane & Women's Hospital; University of Queensland; South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia; University of Adelaide; University of Melbourne; Royal Melbourne Hospital; University of Queensland	Ng, MSY; Mallett, AJ (corresponding author), Royal Brisbane & Womens Hosp, Kidney Hlth Serv, Brisbane, Qld, Australia.; Ng, MSY; Mallett, AJ (corresponding author), Univ Queensland, Fac Med, Brisbane, Qld, Australia.; Mallett, AJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	Monica.Ng@health.qld.gov.au; Andrew.mallett@health.qld.gov.au	Ng, Monica Suet Ying/AGO-9524-2022; Ng, Monica/HGA-8450-2022	Ng, Monica Suet Ying/0000-0002-0431-9110; Ullah, Shahid/0000-0003-0010-2640; Sypek, Matthew/0000-0002-9952-0852	Robert and Janelle Bird Postdoctoral Research Fellowship	Robert and Janelle Bird Postdoctoral Research Fellowship	We acknowledge the Australian and New Zealand nephrology community (physicians, surgeons, database managers, nurses, renal operators, and patients) for providing information and maintaining the ANZDATA Registry database. MSYN acknowledges the Robert and Janelle Bird Postdoctoral Research Fellowship.	Ahmadi SF, 2014, AM J NEPHROL, V40, P315, DOI 10.1159/000367812; Arend SM, 1997, NEPHROL DIAL TRANSPL, V12, P1672, DOI 10.1093/ndt/12.8.1672; Au EH, 2019, J AM SOC NEPHROL, V30, P471, DOI 10.1681/ASN.2018090906; Barone M, 2008, TRANSPLANTATION, V85, P844, DOI 10.1097/TP.0b013e318166cc38; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Ewald DR, 2016, WIRES SYST BIOL MED, V8, P517, DOI 10.1002/wsbm.1355; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Franchini M, 2013, CLIN CHEM LAB MED, V51, P1545, DOI 10.1515/cclm-2013-0168; Franchini M, 2012, CRIT REV CL LAB SCI, V49, P137, DOI 10.3109/10408363.2012.708647; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Garratty G, 2000, TRANSFUS MED REV, V14, P291, DOI 10.1053/tmrv.2000.16228; Goto T, 2017, AM J TRANSPLANT S3, V17, P766; KARAKOUSIS CP, 1986, J SURG ONCOL, V33, P24, DOI 10.1002/jso.2930330107; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Keith DS, 2004, J AM SOC NEPHROL, V15, P1086, DOI 10.1097/01.ASN.0000119572.02053.F2; Klatte T, 2014, J UROLOGY, V191, P1238, DOI 10.1016/j.juro.2013.11.106; Lim WH, 2017, LANCET DIABETES ENDO, V5, P26, DOI 10.1016/S2213-8587(16)30317-5; Lin MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122856; Liumbruno GM, 2014, J THROMB THROMBOLYS, V38, P160, DOI 10.1007/s11239-013-1027-4; Liumbruno GM, 2013, BLOOD TRANSFUS-ITALY, V11, P491, DOI 10.2450/2013.0152-13; LOWE JB, 1993, BAILLIERE CLIN HAEM, V6, P465, DOI 10.1016/S0950-3536(05)80155-6; McDonald Stephen, 2004, Nephrology (Carlton), V9 Suppl 4, pS138, DOI 10.1111/j.1440-1797.2004.00350.x; Meier-Kriesche HU, 2000, KIDNEY INT, V58, P1311, DOI 10.1046/j.1523-1755.2000.00287.x; Nourbala MH, 2011, IRAN J KIDNEY DIS, V5, P141; ORIHUELA E, 1987, J UROLOGY, V138, P758, DOI 10.1016/S0022-5347(17)43363-5; Rogers NM, 2006, TRANSPLANTATION, V82, P882, DOI 10.1097/01.tp.0000232439.88527.49; Snyder JJ, 2006, J AM SOC NEPHROL, V17, P2056, DOI 10.1681/ASN.2006030201; Storry J R, 2009, Immunohematology, V25, P48; Taborelli M, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1283-4; Tsuang W, 2017, AM J TRANSPLANT, V17, P598; Vadivelu MK, 2004, ANN HEMATOL, V83, P584, DOI 10.1007/s00277-004-0888-1; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Wright J, 2016, ANAL KIDNEY ALLOCATI; Wu C, 2005, J AM SOC NEPHROL, V16, P3437, DOI 10.1681/ASN.2005040439; Xie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011972; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002	36	1	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236396	10.1371/journal.pone.0236396	http://dx.doi.org/10.1371/journal.pone.0236396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702043	gold, Green Published, Green Accepted			2022-12-26	WOS:000575913700088
J	Tozzi, AE; Gesualdo, F; Rizzo, C; Carloni, E; Russo, L; Campagna, I; Villani, A; Reale, A; Concato, C; Linardos, G; Pandolfi, E				Tozzi, Alberto Eugenio; Gesualdo, Francesco; Rizzo, Caterina; Carloni, Emanuela; Russo, Luisa; Campagna, Ilaria; Villani, Alberto; Reale, Antonino; Concato, Carlo; Linardos, Giulia; Pandolfi, Elisabetta			A data driven clinical algorithm for differential diagnosis of pertussis and other respiratory infections in infants	PLOS ONE			English	Article							PERSISTENT COUGH; CHILDREN; ADULTS; DEFINITIONS; BURDEN	Background Clinical criteria for pertussis diagnosis and clinical case definitions for surveillance are based on a cough lasting two or more weeks. As several pertussis cases seek care earlier, a clinical tool independent of cough duration may support earlier recognition. We developed a data-driven algorithm aimed at predicting a laboratory confirmed pertussis. Methods We enrolled children < 12 months of age presenting with apnoea, paroxistic cough, whooping, or post-tussive vomiting, irrespective of the duration of cough. Patients underwent a RT-PCR test for pertussis and other viruses. Through a logistic regression model, we identified symptoms associated with laboratory confirmed pertussis. We then developed a predictive decision tree through Quinlan's C4.5 algorithm to predict laboratory confirmed pertussis. Results We enrolled 543 children, of which 160 had a positive RT-PCR for pertussis. A suspicion of pertussis by a physician (aOR 5.44) or a blood count showing leukocytosis and lymphocytosis (aOR 4.48) were highly predictive of lab confirmed pertussis. An algorithm including a suspicion of pertussis by a physician, whooping, cyanosis and absence of fever was accurate (79.9%) and specific (94.0%) and had high positive and negative predictive values (PPV 76.3% NPV 80.7%). Conclusions An algorithm based on clinical symptoms, not including the duration of cough, is accurate and has high predictive values for lab confirmed pertussis. Such a tool may be useful in low resource settings where lab confirmation is unavailable, to guide differential diagnosis and clinical decisions. Algorithms may also be useful to improve surveillance for pertussis and anticipating classification of cases.	[Tozzi, Alberto Eugenio; Gesualdo, Francesco; Rizzo, Caterina; Carloni, Emanuela; Russo, Luisa; Campagna, Ilaria; Pandolfi, Elisabetta] Bambino Gesu Pediat Hosp, Predict & Prevent Med Res Unit, Multifactorial & Syst Dis Res Area, Rome, Italy; [Villani, Alberto] Bambino Gesu Pediat Hosp, Dept Pediat, Gen Pediat & Infect Dis Unit, Rome, Italy; [Reale, Antonino] Bambino Gesu Pediat Hosp, Pediat Emergency Dept, Rome, Italy; [Concato, Carlo; Linardos, Giulia] Bambino Gesu Pediat Hosp, Lab Dept, Virol Unit, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Gesualdo, F (corresponding author), Bambino Gesu Pediat Hosp, Predict & Prevent Med Res Unit, Multifactorial & Syst Dis Res Area, Rome, Italy.	francesco.gesualdo@opbg.net	Tozzi, Alberto Eugenio/F-9494-2012; Villani, Alberto/K-9844-2018; Rizzo, Caterina/H-4092-2012; Gesualdo, Francesco/H-9221-2012	Tozzi, Alberto Eugenio/0000-0002-6884-984X; Rizzo, Caterina/0000-0002-5583-7508; Gesualdo, Francesco/0000-0002-9087-4398	ECDC (European Center for Disease Control) [ECDC/2015/017]; Bambino Gesu Children's Hospital	ECDC (European Center for Disease Control); Bambino Gesu Children's Hospital	This work was partially supported by the ECDC (European Center for Disease Control) within the Pertinent project (Pertussis in Infants European Network), a European hospital-based network dedicated to measuring pertussis burden in infants and to studying pertussis vaccine effectiveness (framework contract number ECDC/2015/017). The study received additional funding from internal research funds of the Bambino Gesu Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], REC SURV STAND PERT; [Anonymous], 2020 CAS DEF; Beyer WEP, 2006, VACCINE, V24, P6602, DOI 10.1016/j.vaccine.2006.05.038; Cherry JD, 2012, CLIN INFECT DIS, V54, P1756, DOI 10.1093/cid/cis302; Crowcroft NS, 2003, ARCH DIS CHILD, V88, P802, DOI 10.1136/adc.88.9.802; Dominguez A, 2017, J INFECTION, V75, P426, DOI 10.1016/j.jinf.2017.08.008; Ebell MH, 2017, J AM BOARD FAM MED, V30, P308, DOI 10.3122/jabfm.2017.03.160330; Frumkin K, 2013, J EMERG MED, V44, P889, DOI 10.1016/j.jemermed.2012.09.037; Ghanaie RM, 2010, INT J INFECT DIS, V14, pE1072, DOI 10.1016/j.ijid.2010.07.005; Guiso Nicole, 2011, Vaccine, V29, P1115, DOI 10.1016/j.vaccine.2010.12.010; Jogi P, 2018, INFECTION, V46, P83, DOI 10.1007/s15010-017-1095-z; Kimberlin DW, 2020, RED BOOK; Knapp JK, 2019, PREV MED REP, V16, DOI 10.1016/j.pmedr.2019.100973; Koh MT, 2016, EPIDEMIOL INFECT, V144, P1192, DOI 10.1017/S0950268815002393; Krishnan SG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219534; Lee AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195979; Maqbool A., 2011, NELSON TXB PEDIAT; Masseria C, 2017, PEDIATR INFECT DIS J, V36, pE54, DOI 10.1097/INF.0000000000001440; Moore A, 2017, CHEST, V152, P353, DOI 10.1016/j.chest.2017.04.186; Muloiwa R, 2018, VACCINE, V36, P2385, DOI 10.1016/j.vaccine.2018.03.025; Nanji KC, 2018, J AM MED INFORM ASSN, V25, P476, DOI 10.1093/jamia/ocx115; Plint AC, 2004, ACAD EMERG MED, V11, P353, DOI 10.1197/j.aem.2003.12.003; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ristic M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204103; Shakib JH, 2009, J PUBLIC HEALTH MAN, V15, P479, DOI 10.1097/PHH.0b013e3181af0ac3; Stefanelli P, 2017, HUM VACC IMMUNOTHER, V13, P1073, DOI 10.1080/21645515.2016.1276139; Tan TN, 2015, PEDIATR INFECT DIS J, V34, pE222, DOI 10.1097/INF.0000000000000795; von Konig CHW, 2014, EXPERT REV VACCINES, V13, P1167, DOI 10.1586/14760584.2014.950237; Wu DX, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1615-3; Yeung KHT, 2017, LANCET INFECT DIS, V17, P974, DOI 10.1016/S1473-3099(17)30390-0	30	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236041	10.1371/journal.pone.0236041	http://dx.doi.org/10.1371/journal.pone.0236041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702054	Green Published, gold			2022-12-26	WOS:000575913700044
J	Wendelmuth, M; Wiliam, M; Todorov, H; Radyushkin, K; Gerber, S; Schweiger, S				Wendelmuth, M.; Wiliam, M.; Todorov, H.; Radyushkin, K.; Gerber, S.; Schweiger, S.			Dynamic longitudinal behavior in animals exposed to chronic social defeat stress	PLOS ONE			English	Article							BRAIN; DEPRESSION	Chronic social defeat (CSD) can lead to impairments in social interaction and other behaviors that are supposed to model features of major depressive disorder (MDD). Not all animals subjected to CSD, however, develop these impairments, and maintained social interaction in some animals is widely used as a model for resilience to stress-induced mental dysfunctions. So far, animals have mainly been studied shortly (24 hours and 7 days) after CSD exposure and longitudinal development of behavioral phenotypes in individual animals has been mostly neglected. We have analyzed social interaction and novel object recognition behavior of stressed mice at different time points after CSD and have found very dynamic courses of behavior of individual animals. Instead of the two groups, resilient or susceptible, that are found at early time points our data suggest four groups with (i, ii) animals behaving resilient or susceptible at early and late time points, respectively (iii) animals that start susceptible and recover with time or (iv) animals that are resilient at early time points but develop vulnerability later on.	[Wendelmuth, M.; Todorov, H.; Gerber, S.; Schweiger, S.] Univ Med Ctr, Inst Human Genet, Mainz, Germany; [Wiliam, M.; Radyushkin, K.; Schweiger, S.] Leibniz Inst Resilience Res, Mainz, Germany; [Gerber, S.] Johannes Gutenberg Univ Mainz, Fac Biol, Inst Dev Biol & Neurobiol IDN, Computat Syst Genet, Mainz, Germany; [Gerber, S.] Johannes Gutenberg Univ Mainz, Ctr Computat Sci Mainz, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Wiliam, M (corresponding author), Leibniz Inst Resilience Res, Mainz, Germany.	miwilliam@uni-mainz.de	Gerber, Susanne/I-6352-2018	Gerber, Susanne/0000-0001-9513-0729; Wendelmuth, Marlon/0000-0002-3983-9570; Willam, Michael/0000-0003-2730-6379	DFG (Deutsche Forschungsgemeinschaft) [CRC 1193]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The work was funded by the DFG (Deutsche Forschungsgemeinschaft), CRC 1193. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Ayash S, 2020, J PSYCHIATR RES, V120, P64, DOI 10.1016/j.jpsychires.2019.10.001; Bagot RC, 2016, NEURON, V90, P969, DOI 10.1016/j.neuron.2016.04.015; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005; Cabal AT, 2017, BEHAV BRAIN RES, V317, P424, DOI 10.1016/j.bbr.2016.09.055; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hui CW, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00013; Hultman R, 2018, CELL, V173, P166, DOI 10.1016/j.cell.2018.02.012; Hultman R, 2016, NEURON, V91, P439, DOI 10.1016/j.neuron.2016.05.038; Kalisch R, 2019, PERSPECT PSYCHOL SCI, V14, P765, DOI 10.1177/1745691619855637; Kalisch R, 2017, NAT HUM BEHAV, V1, P784, DOI 10.1038/s41562-017-0200-8; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Meerlo, 1996, Stress, V1, P21; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Von Frijtag JC, 2000, BEHAV BRAIN RES, V117, P137, DOI 10.1016/S0166-4328(00)00300-4; Watkins LE, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00258	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235268	10.1371/journal.pone.0235268	http://dx.doi.org/10.1371/journal.pone.0235268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701959	gold, Green Submitted, Green Published			2022-12-26	WOS:000575913700014
J	Blazquez, E; Pujols, J; Segales, J; Rodriguez, F; Crenshaw, J; Rodriguez, C; Rodenas, J; Polo, J				Blazquez, Elena; Pujols, Joan; Segales, Joaquim; Rodriguez, Fernando; Crenshaw, Joe; Rodriguez, Carmen; Rodenas, Jesus; Polo, Javier			Commercial feed containing porcine plasma spiked with African swine fever virus is not infective in pigs when administered for 14 consecutive days	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; DRIED ANIMAL PLASMA; TRANSMISSION; PATHOGENESIS; DIARRHEA	The objective of this study was to determine if commercially collected liquid porcine plasma contaminated with African swine fever virus (ASFV) and fed for 14 consecutive days would infect pigs. Commercially collected liquid porcine plasma was mixed with the serum from an ASFV experimentally infected pig. To simulate the potential of pigs slaughtered being ASFV viremic but asymptomatic and passing antemortem inspection, the ratio of liquid plasma from healthy animals to serum from an ASFV infected pig used in this study represented 0.4% or 2.0% of the pigs slaughtered being viremic (Studies 1 or 2, respectively). The contaminated liquid plasma was mixed on commercial feed and pigs were fed for 14 consecutive days providing to each pig 10(4.3) or 10(5.0) TCID50 ASFV daily (Studies 1 or 2, respectively). Pigs were observed for an additional 5 or 9 days (Studies 1 or 2, respectively). In both experiments, the pigs did not become infected with ASFV during the 14d feeding period or during the subsequent observation period. In these experiments, unprocessed liquid plasma contaminated with ASFV mixed on commercial feed and fed for 14 consecutive days did not infect pigs. From our results we can conclude that the infectious dose of ASFV on feed is much higher than that previously reported, at least with ASFV-spiked raw plasma.	[Blazquez, Elena; Pujols, Joan; Rodriguez, Fernando] Ctr Recerca Sanitat Anim CReSA IRTA, IRTA, Barcelona, Spain; [Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Polo, Javier] APC EUROPE SLU, Barcelona, Spain; [Blazquez, Elena; Pujols, Joan; Segales, Joaquim; Rodriguez, Fernando] OIE Collaborating Ctr Res & Control Emerging & Re, Barcelona, Spain; [Segales, Joaquim] Univ Autonoma Barcelona UAB, Dept Sanitat & Anat Anim, Barcelona, Spain; [Segales, Joaquim] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA UAB, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Crenshaw, Joe; Polo, Javier] APC LLC, Ankeny, IA USA	IRTA; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; IRTA	Blazquez, E (corresponding author), Ctr Recerca Sanitat Anim CReSA IRTA, IRTA, Barcelona, Spain.; Blazquez, E (corresponding author), APC EUROPE SLU, Barcelona, Spain.; Blazquez, E (corresponding author), OIE Collaborating Ctr Res & Control Emerging & Re, Barcelona, Spain.	elenablazquezsalvador@gmail.com	Rodriguez, Fernando/GLN-3947-2022; Segalés, Joaquim/A-4933-2011; Pujols, Joan/K-9693-2015	Rodriguez, Fernando/0000-0001-7361-8408; Segalés, Joaquim/0000-0002-1539-7261; Blazquez Salvador, Elena/0000-0001-8115-3225; Crenshaw, Joe/0000-0002-6704-9373; Pujols, Joan/0000-0002-6940-1529	APC Europe, S.L.U., Granollers, Spain	APC Europe, S.L.U., Granollers, Spain	Funding for this study was provided by APC Europe, S.L.U., Granollers, Spain. This company manufactures animal blood products for animal consumption. The funder provided support in the form of salaries for authors EB, JC, CR, JR and J. Polo retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso C, 2018, J GEN VIROL, V99, P613, DOI 10.1099/jgv.0.001049; Bla zquez E, 2018, 7 CHIN LEM SWIN C ZH, P451; Chapman DAG, 2011, EMERG INFECT DIS, V17, P599, DOI 10.3201/eid1704.101283; Christopher-Hennings J, 2012, DIS SWINE, P77; Cowan L, 2015, VET MICROBIOL, V176, P1, DOI 10.1016/j.vetmic.2014.12.003; De Oliveira RP, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030300; Dee SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194509; Diaz I, 2010, P IPVS C VANC CAN, P560; Duffy MA, 2018, TRANSL ANIM SCI, V2, P349, DOI 10.1093/tas/txy088; Fernandez-Pinero J, 2013, TRANSBOUND EMERG DIS, V60, P48, DOI 10.1111/j.1865-1682.2012.01317.x; Galindo-Cardiel I, 2013, VIRUS RES, V173, P180, DOI 10.1016/j.virusres.2012.12.018; Gallardo C, 2015, J CLIN MICROBIOL, V53, P2555, DOI 10.1128/JCM.00857-15; GREIG A, 1972, J COMP PATHOL, V82, P73, DOI 10.1016/0021-9975(72)90028-X; Guinat C, 2016, VET REC, V178, DOI 10.1136/vr.103593; HEUSCHELE WP, 1967, ARCH GES VIRUSFORSCH, V21, P349, DOI 10.1007/BF01241735; Kasorndorkbua C, 2002, J VIROL METHODS, V101, P71, DOI 10.1016/S0166-0934(01)00420-7; Moreto M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59756-z; Niederwerder MC, 2019, EMERG INFECT DIS, V25, P891, DOI 10.3201/eid2505.181495; Nofrarias M, 2006, J ANIM SCI, V84, P2735, DOI 10.2527/jas.2005-414; Peace RM, 2011, J NUTR, V141, P1312, DOI 10.3945/jn.110.136796; Perez-Bosque A, 2004, J NUTR, V134, P2667, DOI 10.1093/jn/134.10.2667; Perez-Bosque A, 2006, J NUTR, V136, P2838, DOI 10.1093/jn/136.11.2838; Perez-Bosque A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100657; Perez-Bosque A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154823; PLOWRIGH.W, 1969, VET REC, V85, P668; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0235895	10.1371/journal.pone.0235895	http://dx.doi.org/10.1371/journal.pone.0235895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7SC	32697784	gold, Green Published			2022-12-26	WOS:000575905100009
J	Liu, AL; Ildefonso, CJ; Bond, WS; Hurwitz, MY; Hurwitz, RL				Liu, Alice; Ildefonso, Cristhian J.; Bond, Wesley S.; Hurwitz, Mary Y.; Hurwitz, Richard L.			Inhibitors of metalloprotease, gamma-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; CD44 INTRACELLULAR DOMAIN; VISION LOSS; PKC BETA; PHASE-I; RUBOXISTAURIN; HYALURONAN; CIDOFOVIR; EFFICACY; SAFETY	Adenoviruses cause upper respiratory infections, conjunctivitis, keratitis, and gastrointestinal illness. These can be fatal in immunocompromised individuals. Adenoviruses have also been engineered into viral vectors to deliver therapeutic genes or induce immunity as vaccine carriers. The success of ocular gene therapy is driven partly by the immunologic and biochemical influences of the intraocular environment. We have shown that versican and hyaluronan modulate adenoviral vector transgene expression through CD44 signaling. Herein we explored the role of these pathways on virus replication and viral protein expression of wild type adenovirus. We report that the addition of vitreous humor (which contains both versican and hyaluronan) increases viral hexon protein levels. Vitreous humor also increased wild type adenovirus DNA replicationin vitro. Metalloproteinase and gamma-secretase inhibitors, which inhibit CD44 proteolytic activation, blocked adenoviral replicationin vitro. Similarly, protein kinase C and RhoA kinase inhibitors, both proteins associated with CD44 mediated pathways, also inhibited wild type adenoviral replicationin vitro. Application of metalloproteinase and gamma-secretase inhibitors to human conjunctival explants sharply decreased adenoviral vector gene expression. Our results demonstrate that pharmacologic delivery of these inhibitors is easily achievable. The inhibition of these enzymes should be explored as potential therapies of wild type adenoviral infections.	[Liu, Alice; Ildefonso, Cristhian J.; Bond, Wesley S.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Liu, Alice; Hurwitz, Richard L.] Baylor Coll Med, Summer Undergrad Res Training Program, Houston, TX 77030 USA; [Ildefonso, Cristhian J.; Bond, Wesley S.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Liu, Alice] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Ildefonso, Cristhian J.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Bond, Wesley S.] Sparks Therapeut, Philadelphia, PA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Duke University; State University System of Florida; University of Florida	Hurwitz, MY (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	mhurwitz@bcm.edu	Ildefonso, Cristhian/AAC-3576-2021	Liu, Alice/0000-0003-3988-212X	National Institutes of Health [GM085793]; Retina Research Foundation; Golfers Against Cancer	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina Research Foundation; Golfers Against Cancer	This study was funded in part by awards from the National Institutes of Health GM085793 (CJI), the Retina Research Foundation (https://retinaresearchfnd.org/, RLH) and the Golfers Against Cancer (https://golfersagainstcancer.org/, RLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadieh H, 2019, BRIT J OPHTHALMOL, V103, P922, DOI 10.1136/bjophthalmol-2018-312244; Aiello LP, 2011, RETINA-J RET VIT DIS, V31, P2084, DOI 10.1097/IAE.0b013e3182111669; Aiello LP, 2006, INVEST OPHTH VIS SCI, V47, P86, DOI 10.1167/iovs.05-0757; Akinfenwa PY, 2017, J BIOL CHEM, V292, P14381, DOI 10.1074/jbc.M116.773549; Augelli-Szafran CE, 2010, CURR ALZHEIMER RES, V7, P207, DOI 10.2174/156720510791050920; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Chaudhuri SR, 2007, MOL THER, V15, P566, DOI 10.1038/sj.mt.6300044; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Doan ML, 2007, J HEART LUNG TRANSPL, V26, P883, DOI 10.1016/j.healun.2007.06.009; Geyeregger R, 2014, J IMMUNOTHER, V37, P245, DOI 10.1097/CJI.0000000000000034; Ghebremedhin B, 2014, EUR J MICROBIOL IMMU, V4, P26, DOI 10.1556/EuJMI.4.2014.1.2; Grimley MS, 2017, BIOL BLOOD MARROW TR, V23, P512, DOI 10.1016/j.bbmt.2016.12.621; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; Ildefonso CJ, 2012, J BIOL CHEM, V287, P32697, DOI 10.1074/jbc.M112.347369; Ildefonso CJ, 2010, MOL THER, V18, P1885, DOI 10.1038/mt.2010.139; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kimberlin DW, 2018, DIS ACOI RED BOOK, V31st; Leen AM, 2006, NAT MED, V12, P1160, DOI 10.1038/nm1475; Ljungman P, 2003, BONE MARROW TRANSPL, V31, P481, DOI 10.1038/sj.bmt.1703798; Meyer K, 1934, J BIOL CHEM, V107, P629; Miletti-Gonzalez KE, 2012, J BIOL CHEM; Molina JR, 2005, ANTI-CANCER DRUG, V16, P997, DOI 10.1097/01.cad.0000176504.86551.5c; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Neofytos D, 2007, BIOL BLOOD MARROW TR, V13, P74, DOI 10.1016/j.bbmt.2006.08.040; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Rizvi NA, 2004, CLIN CANCER RES, V10, P1963, DOI 10.1158/1078-0432.CCR-1183-02; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sebag, 1992, DUANES CLIN OPHTHALM, V5, P1; Sheetz MJ, 2013, INVEST OPHTH VIS SCI, V54, P1750, DOI 10.1167/iovs.12-11055; Sonoda KH, 2005, IMMUNOLOGY, V116, P390, DOI 10.1111/j.1365-2567.2005.02239.x; Stein-Streilein Joan, 2002, Int Rev Immunol, V21, P123, DOI 10.1080/08830180212066; Takahashi K, 1999, INT J CANCER, V80, P387, DOI 10.1002/(SICI)1097-0215(19990129)80:3<387::AID-IJC9>3.3.CO;2-K; Wold WSM, 2013, CURR GENE THER, V13, P421	36	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236175	10.1371/journal.pone.0236175	http://dx.doi.org/10.1371/journal.pone.0236175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697798	Green Published, gold			2022-12-26	WOS:000555392700007
J	Lu, YJ; Qin, S; Zhao, L; Yue, L; Wu, TZ; Qin, B; Xu, Z				Lu, Yijie; Qin, Shan; Zhao, Lei; Yue, Lan; Wu, Tianzhun; Qin, Bo; Xu, Zhen			Optimization of stimulation parameters for epi-retinal implant based on biosafety consideration	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; PULSE	Background Optimizing stimulation protocol is essential for clinical application of retinal prosthesis. Elongating stimulation pulse width (similar to 25ms /phase) has been proposed as an effective method to improve spatial resolution of epi-retinal implants. However, it is unknown whether longer stimulus pulse width will increase the risk of damaging the retina. In addition, with the advent of next generation retinal prosthesis featuring high-density microelectrode array, it is tempting to optimizing a single set of parameters for all electrodes instead of optimizing parameters of each electrode, but this approach raised biosafety concern. We sought to study the effect of stimulus pulse width on the response of retinal ganglion cells to electrical stimulation, and evaluate if the single parameter set approach was valid based on biosafety measures. Methods We stimulated mouse retina using biphasic pulse waveform generated by chosen electrodes (single or a 3x3 assembly) from multiple microelectrode arrays, recorded their action potentials and performed spike sorting. We tested various stimulus intensity with two fixed pulse width: a short one for 1 millisecond per phase, and a long one for 25 milliseconds per phase. All these assays were performed on two mouse models: the wildtype C57BL/6J mice and the photoreceptor degenerated rd10 mice. The action-potential-frequency vs stimulus amplitude profiles were plotted, and three parameters were extracted: the threshold (the lowest stimulus amplitude activating RGC units), safety-limit (stimulus amplitude that attenuated the firing rate to half of the maximum response), and the stimulation amplitude range (the difference between threshold and safety limit parameters). Results In single-electrode stimulation experiment, we found that on average 85% of the recorded units showed attenuated response to extreme stimulation; among those units, an average of 51% stopped responding during stimulation ramping and failed to recover after one-hour post-stimulation, indicating extreme stimulation can damage RGC units. Twenty-five-millisecond pulse stimulation significantly reduced safety-limit and stimulation-amplitude-range parameters of recorded RGC units compared to 1ms pulse stimulation. During stimulus amplitude ramping, the maximum proportion of responsive healthy RGC units was 51% on average in 25ms pulse condition, and 76% on average in 1ms pulse condition, indicating long pulse may inflict more strain on RGCs, and a significant amount of inappropriately stimulated RGCs always exist. The contrast of these proportions could be explained by the tight correlation between the threshold and safety-limit parameter in 25ms pulse condition. These results were corroborated by those from 3x3 array stimulation experiments. Conclusion Base on a biosafety measure (RGCs' evoked firing rate in response to electrical stimulation), we proposed that longer stimulation pulse width could lead to reduced retinal response and thus highlighted the importance of carefully setting the stimulation amplitude in this case. Our results also suggested that optimizing a single set of parameters for all electrodes without individual tweaking always generated a significant amount of inappropriately stimulated RGCs, especially in the long pulse stimulation condition.	[Lu, Yijie; Qin, Shan; Zhao, Lei; Wu, Tianzhun; Xu, Zhen] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Lu, Yijie; Qin, Bo] Shenzhen Aier Eye Hosp, Shenzhen, Peoples R China; [Qin, Shan] Cent South Univ, Shenzhen Hosp, Xiangya Hosp 2, Shenzhen Shekou Peoples Hosp, Shenzhen, Peoples R China; [Yue, Lan] Univ Southern Calif, Roski Eye Inst, Los Angeles, CA 90007 USA	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Southern California	Xu, Z (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.; Qin, B (corresponding author), Shenzhen Aier Eye Hosp, Shenzhen, Peoples R China.	qqinbozf@163.com; zhen.xu@siat.ac.cn	xu, zhen/ABG-7393-2020	xu, zhen/0000-0002-5674-9067	National Key R&D Program of China [2017YFC0111202]; National Natural Science Foundation of China [31800871, 31700893]; Shenzhen Science and Technology Research Program [JCYJ20170818163342873, JCYJ20180507182033219, JCYJ20170818163320865, JCYJ20170818161734072]; Guangdong Science and Technology Research Program [2019A050503007]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Research Program; Guangdong Science and Technology Research Program	This work was supported by National Key R&D Program of China (2017YFC0111202, Z.X.), National Natural Science Foundation of China (31800871, Z. X.; 31700893, L. Y.), Shenzhen Science and Technology Research Program (JCYJ20170818163342873, Z. X.; JCYJ20180507182033219, Z. X.; JCYJ20170818163320865, Z. X.; JCYJ20170818161734072, L. Z.), Guangdong Science and Technology Research Program (2019A050503007, T. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KN, 2015, KOREAN J PHYSIOL PHA, V19, P167, DOI 10.4196/kjpp.2015.19.2.167; [Anonymous], 2019, R LANG ENV STAT COMP; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Boinagrov D, 2010, J NEUROPHYSIOL, V104, P2236, DOI 10.1152/jn.00343.2010; Cohen E, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056017; Duong T., 2019, KS KERNEL SMOOTHING; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Medeiros NE, 2001, INVEST OPHTH VIS SCI, V42, P795; O'Hearn TM, 2006, VISION RES, V46, P3198, DOI 10.1016/j.visres.2006.03.031; Stett A, 2000, VISION RES, V40, P1785, DOI 10.1016/S0042-6989(00)00005-5; Weitz AC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4877; Weitz AC, 2013, J NEUROPHYSIOL, V109, P1979, DOI 10.1152/jn.00852.2012	12	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236176	10.1371/journal.pone.0236176	http://dx.doi.org/10.1371/journal.pone.0236176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697792	gold, Green Published			2022-12-26	WOS:000555392700005
J	Milivojevic, M; Che, XY; Bateman, L; Cheng, A; Garcia, BA; Hornig, M; Huber, M; Klimas, NG; Lee, BH; Lee, HJ; Levine, S; Montoya, JG; Peterson, DL; Komaroff, AL; Lipkin, WI				Milivojevic, Milica; Che, Xiaoyu; Bateman, Lucinda; Cheng, Aaron; Garcia, Benjamin A.; Hornig, Mady; Huber, Manuel; Klimas, Nancy G.; Lee, Bohyun; Lee, Hyoungjoo; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Komaroff, Anthony L.; Lipkin, W. Ian			Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; CATHELICIDIN LL-37; MUTATIONAL STATUS; GENE; EXPRESSION; ANTIBODIES; PEPTIDE; SERUM; INFLAMMATION; INSTRUMENT	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is an unexplained chronic, debilitating illness characterized by fatigue, sleep disturbances, cognitive dysfunction, orthostatic intolerance and gastrointestinal problems. Using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), we analyzed the plasma proteomes of 39 ME/CFS patients and 41 healthy controls. Logistic regression models, with both linear and quadratic terms of the protein levels as independent variables, revealed a significant association between ME/CFS and the immunoglobulin heavy variable (IGHV) region 3-23/30. Stratifying the ME/CFS group based on self-reported irritable bowel syndrome (sr-IBS) status revealed a significant quadratic effect of immunoglobulin lambda constant region 7 on its association with ME/CFS with sr-IBS whilst IGHV3-23/30 and immunoglobulin kappa variable region 3-11 were significantly associated with ME/CFS without sr-IBS. In addition, we were able to predict ME/CFS status with a high degree of accuracy (AUC = 0.774-0.838) using a panel of proteins selected by 3 different machine learning algorithms: Lasso, Random Forests, and XGBoost. These algorithms also identified proteomic profiles that predicted the status of ME/CFS patients with sr-IBS (AUC = 0.806-0.846) and ME/CFS without sr-IBS (AUC = 0.754-0.780). Our findings are consistent with a significant association of ME/CFS with immune dysregulation and highlight the potential use of the plasma proteome as a source of biomarkers for disease.	[Milivojevic, Milica; Che, Xiaoyu; Cheng, Aaron; Lee, Bohyun; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA; [Che, Xiaoyu] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Bateman, Lucinda] Bateman Horne Ctr, Salt Lake City, UT USA; [Garcia, Benjamin A.; Lee, Hyoungjoo] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hornig, Mady] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Huber, Manuel] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, German Res Ctr Environm Hlth, Neuherberg, Germany; [Klimas, Nancy G.] Nova Southeastern Univ, Coll Osteopath Med, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA; [Klimas, Nancy G.] Miami VA Med Ctr, Miami, FL USA; [Levine, Susan] Levine Clin, New York, NY USA; [Montoya, Jose G.] Palo Alto Med Fdn, Jack S Remington Lab Specialty Diagnost Toxoplasm, Palo Alto, CA USA; [Peterson, Daniel L.] Sierra Internal Med Incline Village, Incline Village, NV USA; [Komaroff, Anthony L.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Nova Southeastern University; Palo Alto Medical Foundation Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lipkin, WI (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.	wil2001@cumc.columbia.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Montoya, Jose G/0000-0002-3378-8071; Hornig, Mady/0000-0001-7572-3092; Cheng, Aaron/0000-0001-7924-075X	National Institutes of Allergy and Infectious Diseases [U54AI138370]	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WIL U54AI138370 National Institutes of Allergy and Infectious Diseases niaid.nih.gov WIL Gift -no award number available Solve ME/CFS Initiative solvecfs.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson PJ, 2017, VACCINE, V35, P5576, DOI 10.1016/j.vaccine.2017.08.053; Allain JS, 2018, HAEMATOLOGICA, V103, pE207, DOI 10.3324/haematol.2017.177444; Allain TJ, 1997, BIOL PSYCHIAT, V41, P567, DOI 10.1016/S0006-3223(96)00074-1; Alter HJ, 2012, MBIO, V3, DOI 10.1128/mBio.00266-12; Arcaini L, 2009, BLOOD CELL MOL DIS, V42, P286, DOI 10.1016/j.bcmd.2009.01.004; Baraniuk JN, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-22; Berget E, 2015, LEUKEMIA RES, V39, P702, DOI 10.1016/j.leukres.2015.03.003; Bikos V, 2012, LEUKEMIA, V26, P1638, DOI 10.1038/leu.2012.3; Bomben R, 2010, CLIN CANCER RES, V16, P620, DOI 10.1158/1078-0432.CCR-09-1638; Bradley AS, 2013, CLIN EXP IMMUNOL, V172, P73, DOI 10.1111/cei.12043; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brenu EW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-1; Brenu EW, 2014, INT IMMUNOL, V26, P233, DOI 10.1093/intimm/dxt068; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; Bryson S, 2016, J IMMUNOL, V196, P4723, DOI 10.4049/jimmunol.1402890; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Chang CM, 2012, CANCER-AM CANCER SOC, V118, P5929, DOI 10.1002/cncr.27612; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Ciregia F, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.184; Ciregia F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-243; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Druhan LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170261; Fluge O, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89376; Frost R A, 1998, Curr Opin Clin Nutr Metab Care, V1, P195, DOI 10.1097/00075197-199803000-00010; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gachard N, 2013, LEUKEMIA, V27, P183, DOI 10.1038/leu.2012.257; Garcia-Alvarez M, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0213-9; Germain A, 2018, METABOLITES, V8, DOI 10.3390/metabo8040090; Germain A, 2017, MOL BIOSYST, V13, P371, DOI 10.1039/c6mb00600k; Giloteaux L, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0171-4; Marin IGGY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/257517; Grunenberg A, 2017, DTSCH ARZTEBL INT, V114, P745, DOI 10.3238/arztebl.2017.0745; Guenther S, 2015, HUM IMMUNOL, V76, P729, DOI 10.1016/j.humimm.2015.09.028; Hadzidimitriou A, 2011, BLOOD, V118, P3088, DOI 10.1182/blood-2011-03-343434; Haney E, 2015, ANN INTERN MED, V162, P834, DOI 10.7326/M15-0443; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Institute of Medicine, 2015, MYALG ENC CHRON FAT, DOI [10.17226/19012 25695122, DOI 10.17226/190122]; ITO H, 1992, GASTROENTEROLOGY, V102, P1686, DOI 10.1016/0016-5085(92)91731-I; Janda A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00022; Jason L, 2010, AM J BIOCH BIOTECHNO, V6, P120, DOI [DOI 10.3844/AJBBSP.2010.120, DOI 10.3844/AJBBSP.2010.120.135]; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; Kennedy G, 2005, FREE RADICAL BIO MED, V39, P584, DOI 10.1016/j.freeradbiomed.2005.04.020; Kennedy G, 2004, J CLIN PATHOL, V57, P891, DOI 10.1136/jcp.2003.015511; Klimas NG, 2015, FATIGUE, V3, P75, DOI 10.1080/21641846.2015.1023652; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Kochi Y, 2009, J IMMUNOL, V183, P5502, DOI 10.4049/jimmunol.0901982; Kusaka S, 2018, CLIN EXP IMMUNOL, V191, P96, DOI 10.1111/cei.13047; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Li FJ, 2013, EUR J IMMUNOL, V43, P2980, DOI 10.1002/eji.201243068; LICASTRO F, 1995, ALZ DIS ASSOC DIS, V9, P112, DOI 10.1097/00002093-199509020-00009; Maes M, 2005, NEUROENDOCRINOL LETT, V26, P487; Maggio M, 2013, NUTRIENTS, V5, P4184, DOI 10.3390/nu5104184; Majewski K, 2018, CENT EUR J IMMUNOL, V43, P453, DOI 10.5114/ceji.2018.81355; Mansbach JM, 2017, CLIN INFECT DIS, V65, P967, DOI 10.1093/cid/cix483; McLean GR, 2006, MOL IMMUNOL, V43, P2012, DOI 10.1016/j.molimm.2005.11.016; McLean GR, 2005, J IMMUNOL, V174, P4768, DOI 10.4049/jimmunol.174.8.4768; Memon RA, 2000, ARTERIOSCL THROM VAS, V20, P1536, DOI 10.1161/01.ATV.20.6.1536; Miyajima M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074453; Nagy-Szakal D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28477-9; Nagy-Szakal D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0261-y; Naviaux RK, 2016, P NATL ACAD SCI USA, V113, pE5472, DOI 10.1073/pnas.1607571113; Niemann CU, 2013, SEMIN CANCER BIOL, V23, P410, DOI 10.1016/j.semcancer.2013.09.001; Noy A, 2017, BLOOD, V129, P2224, DOI 10.1182/blood-2016-10-747345; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Osborn TM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2520; Piktel E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092516; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Ramirez-Tejero JA, 2018, J PROTEOMICS, V186, P47, DOI 10.1016/j.jprot.2018.07.009; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Schauber J, 2006, EUR J GASTROEN HEPAT, V18, P615, DOI 10.1097/00042737-200606000-00007; Scheibenbogen C, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1263-z; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Stanganelli C, 2013, CL LYMPH MYELOM LEUK, V13, P447, DOI 10.1016/j.clml.2013.02.019; Steck E, 2007, MATRIX BIOL, V26, P30, DOI 10.1016/j.matbio.2006.09.006; The Gerard K H, 2007, PLoS Clin Trials, V2, pe19, DOI 10.1371/journal.pctr.0020019; Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179; Thomson CA, 2011, J IMMUNOL, V186, P2291, DOI 10.4049/jimmunol.0904092; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tomic S, 2012, ARCH MED SCI, V8, P886, DOI 10.5114/aoms.2012.31620; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wahlen K, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02400; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Xhindoli D, 2016, BBA-BIOMEMBRANES, V1858, P546, DOI 10.1016/j.bbamem.2015.11.003; Yamano E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34990	92	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236148	10.1371/journal.pone.0236148	http://dx.doi.org/10.1371/journal.pone.0236148			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692761	gold, Green Published			2022-12-26	WOS:000554606400029
J	Li, KD; Liu, T; Chen, J; Ni, HY; Li, WH				Li, Kangdi; Liu, Ting; Chen, Jie; Ni, Huying; Li, Wenhua			Survivin in breast cancer-derived exosomes activates fibroblasts by up-regulating SOD1, whose feedback promotes cancer proliferation and metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; myofibroblasts; exosome; survivin; SOD1; breast cancer; tumor microenvironment; exosome (vesicle)	EXTRACELLULAR VESICLES; TUMOR MICROENVIRONMENT; TARGETING SURVIVIN; CELLS; MECHANISMS; EXPRESSION	Cancer-associated fibroblasts (CAFs) play a critical role in the coevolution of breast tumor cells and their microenvironment by modifying cellular compartments and regulating cancer cell functions via stromal-epithelial dialogue. However, the relationship and interaction between stromal and epithelial cells is still poorly understood. Herein, we revealed that breast cancer cells have a stronger ability to activate fibroblasts and transform them into myofibroblasts (CAF-like) than normal breast epithelial cells, and this stronger ability occurs through paracrine signaling. In turn, myofibroblasts promote the proliferation, epithelial-to-mesenchymal transition (EMT), and stemness of breast cancer cells. Detailed regulatory mechanisms showed that, compared with normal cells, Survivin is overexpressed in breast cancer cells and secreted extracellularly in the form of exosomes, which are then internalized by fibroblasts. Breast cancer cell-derived survivin up-regulates SOD1 expression in fibroblasts and then converts them into myofibroblasts, conversely inducing breast cancer progressionin vitroandin vivo. Thus, our results indicate that survivin acts as an activator of the tumor microenvironment and that SOD1 up-regulation in fibroblasts can promote breast cancer progression. These results suggest that targeting survivin and SOD1 may be a potential therapeutic strategy for breast cancer.	[Li, Kangdi; Liu, Ting; Chen, Jie; Ni, Huying; Li, Wenhua] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China	Wuhan University	Li, WH (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China.	whli@whu.edu.cn			National Natural Science Foundation of China [81472684]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Foundation of China Grant 81472684 (to W. L.).	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Arcucci A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4502846; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Challagundla KB, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv135; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; Chen Y, 2017, ONCOGENE, V36, P4692, DOI 10.1038/onc.2017.100; Chu JR, 2010, CANCER LETT, V297, P207, DOI 10.1016/j.canlet.2010.05.013; Costa A, 2014, SEMIN CANCER BIOL, V25, P23, DOI 10.1016/j.semcancer.2013.12.007; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Fernandez JG, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-209; Fujiwara T, 2019, EXP DERMATOL, V28, P485, DOI 10.1111/exd.13404; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Harding CV, 2013, J CELL BIOL, V200, P367, DOI 10.1083/jcb.201212113; Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006; Kanwar JR, 2011, DRUG DISCOV TODAY, V16, P485, DOI 10.1016/j.drudis.2011.04.001; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Lladser A, 2011, ADV CANCER RES, V111, P1, DOI 10.1016/B978-0-12-385524-4.00001-5; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; Maia J, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00018; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Martinez-Outschoorn U, 2014, SEMIN ONCOL, V41, P195, DOI 10.1053/j.seminoncol.2014.03.002; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Patel GK, 2017, BRIT J CANCER, V116, P609, DOI 10.1038/bjc.2017.18; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; Shimoda M, 2014, NAT CELL BIOL, V16, P889, DOI 10.1038/ncb3021; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Valencia T, 2014, CANCER CELL, V26, P121, DOI 10.1016/j.ccr.2014.05.004	47	25	25	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13737	13752		10.1074/jbc.RA120.013805	http://dx.doi.org/10.1074/jbc.RA120.013805			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32709750	Green Published, hybrid			2022-12-26	WOS:000578444100004
J	Campbell, AC; Stiers, KM; Del Campo, JSM; Mehra-Chaudhary, R; Sobrado, P; Tanner, JJ				Campbell, Ashley C.; Stiers, Kyle M.; Martin Del Campo, Julia S.; Mehra-Chaudhary, Ritcha; Sobrado, Pablo; Tanner, John J.			Trapping conformational states of a flavin-dependentN-monooxygenasein crystalloreveals protein and flavin dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; enzyme structure; flavoprotein; enzyme kinetics; site-directed mutagenesis; siderophore; flavin-dependent monooxygenases; ornithine hydroxylase	BINDING HOT-SPOTS; INVASIVE ASPERGILLOSIS; ORNITHINE-HYDROXYLASE; SIDEROPHORE; SIDA; OPTIMIZATION; SELECTIVITY; VALIDATION; MECHANISM; CATALYSIS	The siderophore biosynthetic enzyme A (SidA) ornithine hydroxylase fromAspergillus fumigatusis a fungal disease drug target involved in the production of hydroxamate-containing siderophores, which are used by the pathogen to sequester iron. SidA is anN-monooxygenase that catalyzes the NADPH-dependent hydroxylation ofl-ornithine through a multistep oxidative mechanism, utilizing a C4a-hydroperoxyflavin intermediate. Here we present four new crystal structures of SidA in various redox and ligation states, including the first structure of oxidized SidA without NADP(H) orl-ornithine bound (resting state). The resting state structure reveals a newoutactive site conformation characterized by large rotations of the FAD isoalloxazine around the C1-' C2 ' and N10-C1 ' bonds, coupled to a 10-angstrom movement of the Tyr-loop. Additional structures show that either flavin reduction or the binding of NADP(H) is sufficient to drive the FAD to theinconformation. The structures also reveal protein conformational changes associated with the binding of NADP(H) andl-ornithine. Some of these residues were probed using site-directed mutagenesis. Docking was used to explore the active site of theoutconformation. These calculations identified two potential ligand-binding sites. Altogether, our results provide new information about conformational dynamics in flavin-dependent monooxygenases. Understanding the different active site conformations that appear during the catalytic cycle may allow fine-tuning of inhibitor discovery efforts.	[Campbell, Ashley C.; Stiers, Kyle M.; Mehra-Chaudhary, Ritcha; Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Martin Del Campo, Julia S.; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; Virginia Polytechnic Institute & State University; University of Missouri System; University of Missouri Columbia	Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.; Sobrado, P (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.; Tanner, JJ (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	psobrado@vt.edu; tannerjj@missouri.edu		Tanner, John/0000-0001-8314-113X; S. Martin del Campo, Julia/0000-0001-8914-2504; Campbell, Ashley/0000-0002-0178-4017	National Science Foundation [CHE-2003658, CHE-2003986]; Fulbright Science & Innovation Graduate Award	National Science Foundation(National Science Foundation (NSF)); Fulbright Science & Innovation Graduate Award	Research reported in this publication was supported by the National Science Foundation Grants CHE-2003658 (to P. S) and CHE-2003986 (to J. J. T). A. C. C. was funded in part by a Fulbright Science & Innovation Graduate Award.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Badieyan S, 2015, J ORG CHEM, V80, P2139, DOI 10.1021/jo502651v; Becker DF, 2011, ANTIOXID REDOX SIGN, V14, P1079, DOI 10.1089/ars.2010.3417; Carver PL, 2018, CURR MED CHEM, V25, P85, DOI 10.2174/0929867324666170720110049; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Davies M, 2015, NUCLEIC ACIDS RES, V43, pW612, DOI 10.1093/nar/gkv352; del Campo JSM, 2016, ACS CHEM BIOL, V11, P3035, DOI 10.1021/acschembio.6b00666; Desoubeaux G, 2018, COMPARATIVE MED, V68, P109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Gore S, 2017, STRUCTURE, V25, P1916, DOI 10.1016/j.str.2017.10.009; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Haas H, 2014, NAT PROD REP, V31, P1266, DOI 10.1039/c4np00071d; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Landon MR, 2009, J COMPUT AID MOL DES, V23, P491, DOI 10.1007/s10822-009-9283-2; Maschmeyer G, 2007, DRUGS, V67, P1567, DOI 10.2165/00003495-200767110-00004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006; Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Robinson R, 2015, ARCH BIOCHEM BIOPHYS, V585, P25, DOI 10.1016/j.abb.2015.09.008; Robinson R, 2014, BBA-PROTEINS PROTEOM, V1844, P778, DOI 10.1016/j.bbapap.2014.02.005; Robinson RM, 2019, PROTEIN SCI, V28, P90, DOI 10.1002/pro.3487; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Setser JW, 2014, BIOCHEMISTRY-US, V53, P6063, DOI 10.1021/bi500655q; Seyedmousavi S, 2015, MED MYCOL, V53, P765, DOI 10.1093/mmy/myv067; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	41	8	8	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13239	13249		10.1074/jbc.RA120.014750	http://dx.doi.org/10.1074/jbc.RA120.014750			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32723870	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000574483500009
J	Kurita, D; Abo, T; Himeno, H				Kurita, Daisuke; Abo, Tatsuhiko; Himeno, Hyouta			Molecular determinants of release factor 2 for ArfA-mediated ribosome rescue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome; translation; ribosome rescue; ArfA; RF2; peptidyl-tRNA hydrolysis; stalled ribosome; protein synthesis; stop codon-independent termination; translation release factor; translation control	PEPTIDYL-TRANSFER-RNA; ESCHERICHIA-COLI; TRANSLATION TERMINATION; STALLED RIBOSOMES; STRUCTURAL BASIS; MESSENGER-RNA; STOP-CODON; RF2; INSIGHTS; PROTEIN	Translation termination in bacteria requires that the stop codon be recognized by release factor RF1 or RF2, leading to hydrolysis of the ester bond between the peptide and tRNA on the ribosome. As a consequence, normal termination cannot proceed if the translated mRNA lacks a stop codon. InEscherichia coli, the ribosome rescue factor ArfA releases the nascent polypeptide from the stalled ribosome with the help of RF2 in a stop codon-independent manner. Interestingly, the reaction does not proceed if RF1 is instead provided, even though the structures of RF1 and RF2 are very similar. Here, we identified the regions of RF2 required for the ArfA-dependent ribosome rescue system. Introduction of hydrophobic residues from RF2 found at the interface between RF2 and ArfA into RF1 allowed RF1 to associate with the ArfA-ribosome complex to a certain extent but failed to promote peptidyl-tRNA hydrolysis, whereas WT RF1 did not associate with the complex. We also identified the key residues required for the process after ribosome binding. Our findings provide a basis for understanding how the ArfA-ribosome complex is specifically recognized by RF2 and how RF2 undergoes a conformational change upon binding to the ArfA-ribosome complex.	[Kurita, Daisuke; Himeno, Hyouta] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan; [Abo, Tatsuhiko] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan	Hirosaki University; Okayama University	Kurita, D; Himeno, H (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan.	dkurita@hirosaki-u.ac.jp; himeno@hirosaki-u.ac.jp	Kurita, Daisuke/E-9135-2013	Himeno, Hyouta/0000-0003-1281-4629; Kurita, Daisuke/0000-0003-3426-3864	Japan Society for the Promotion of Science [16K18684, 18K06350, 18H02163]; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation)	This research was supported by Japan Society for the Promotion of Science Grants 16K18684 (to D. K.), 18K06350 (to T. A.), and 18H02163 (to H. H.) and a grant from the Uehara Memorial Foundation (to D. K.).	ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; Adio S, 2018, ELIFE, V7, DOI 10.7554/eLife.34252; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Demo G, 2017, ELIFE, V6, DOI 10.7554/eLife.23687; Dunkle JA, 2010, ANNU REV BIOPHYS, V39, P227, DOI 10.1146/annurev.biophys.37.032807.125954; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Fu ZA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10608-z; Giudice E, 2013, TRENDS BIOCHEM SCI, V38, P403, DOI 10.1016/j.tibs.2013.06.002; Goralski TDP, 2018, MBIO, V9, DOI 10.1128/mBio.02436-18; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Himeno H, 2015, BIOCHIMIE, V114, P102, DOI 10.1016/j.biochi.2014.11.014; Huter P, 2017, NATURE, V541, P546, DOI 10.1038/nature20821; Indrisiunaite G, 2015, J MOL BIOL, V427, P1848, DOI 10.1016/j.jmb.2015.01.007; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; James NR, 2016, SCIENCE, V354, P1437, DOI 10.1126/science.aai9127; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Korkmaz G, 2017, J BIOL CHEM, V292, P15134, DOI 10.1074/jbc.M117.785238; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Korostelev AA, 2011, RNA, V17, P1409, DOI 10.1261/rna.2733411; Koutmou KS, 2014, RNA, V20, P609, DOI 10.1261/rna.042523.113; Kurita D, 2014, NUCLEIC ACIDS RES, V42, P13339, DOI 10.1093/nar/gku1069; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Ma BY, 2004, J BIOL CHEM, V279, P53875, DOI 10.1074/jbc.M407412200; Ma CY, 2017, NATURE, V541, P550, DOI 10.1038/nature20822; Nakamura Y, 2011, WIRES RNA, V2, P647, DOI 10.1002/wrna.81; Rawat U, 2006, J MOL BIOL, V357, P1144, DOI 10.1016/j.jmb.2006.01.038; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Shimokawa-Chiba N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13408-7; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Sund J, 2010, NATURE, V465, P947, DOI 10.1038/nature09082; Svidritskiy E, 2019, ELIFE, V8, DOI 10.7554/eLife.46850; Svidritskiy E, 2018, STRUCTURE, V26, P821, DOI 10.1016/j.str.2018.04.001; Trappl K, 2016, J MOL BIOL, V428, P1333, DOI 10.1016/j.jmb.2016.01.021; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zeng FX, 2017, NATURE, V541, P554, DOI 10.1038/nature21053	46	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13326	13337		10.1074/jbc.RA120.014664	http://dx.doi.org/10.1074/jbc.RA120.014664			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32727848	Green Published, hybrid			2022-12-26	WOS:000574483500016
J	Katsikoudi, A; Ficulle, E; Cavallini, A; Sharman, G; Guyot, A; Zagnoni, M; Eastwood, BJ; Hutton, M; Bose, S				Katsikoudi, Antigoni; Ficulle, Elena; Cavallini, Annalisa; Sharman, Gary; Guyot, Amelie; Zagnoni, Michele; Eastwood, Brian J.; Hutton, Michael; Bose, Suchira			Quantitative propagation of assembled human Tau from Alzheimer's disease brain in microfluidic neuronal cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human; microtubule; neurodegeneration; protein aggregation; Tau protein (Tau); tauopathy; drug screening; Alzheimer disease; neurodegenerative disease; neuron; microfluidics; propagation	PATHOLOGICAL TAU; MOUSE MODEL; MICROGLIA; ANLE138B; SPREAD; PRION	Tau aggregation and hyperphosphorylation is a key neuropathological hallmark of Alzheimer's disease (AD), and the temporospatial spread of Tau observed during clinical manifestation suggests that Tau pathology may spread along the axonal network and propagate between synaptically connected neurons. Here, we have developed a cellular model that allows the study of human AD-derived Tau propagation from neuron to neuron using microfluidic devices. We show by using high-content imaging techniques and an in-house developed interactive computer program that human AD-derived Tau seeds rodent Tau that propagates trans-neuronally in a quantifiable manner in a microfluidic culture model. Moreover, we were able to convert this model to a medium-throughput format allowing the user to handle 16 two-chamber devices simultaneously in the footprint of a standard 96-well plate. Furthermore, we show that a small molecule inhibitor of aggregation can block the trans-neuronal transfer of Tau aggregates, suggesting that the system can be used to evaluate mechanisms of Tau transfer and find therapeutic interventions.	[Katsikoudi, Antigoni; Ficulle, Elena; Cavallini, Annalisa; Sharman, Gary; Guyot, Amelie; Eastwood, Brian J.; Hutton, Michael; Bose, Suchira] Eli Lilly & Co Ltd, Dept Neurosci, Windlesham, Surrey, England; [Zagnoni, Michele] Univ Strathclyde, Ctr Microsyst & Photon, Dept Elect & Elect Engn, Glasgow, Lanark, Scotland; [Katsikoudi, Antigoni] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	Eli Lilly; University of Strathclyde; University of Oxford	Bose, S (corresponding author), Eli Lilly & Co Ltd, Dept Neurosci, Windlesham, Surrey, England.	bose_suchira@lilly.com		Katsikoudi, Antigoni/0000-0002-5079-7527; Zagnoni, Michele/0000-0003-3198-9491	King's College London Brain Banks	King's College London Brain Banks	We thank James Hutt (PerkinElmer) for assistance with Harmony software; the patients who donated their brains to the Manchester and King's College London Brain Banks; and Michel Goedert and Benjamin Falcon (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK) for critical review of the manuscript.	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; AVILA J, 1994, INT J DEV BIOL, V38, P13; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2011, ACTA NEUROPATHOL, V121, P589, DOI 10.1007/s00401-011-0825-z; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Clavaguera F, 2014, ACTA NEUROPATHOL, V127, P299, DOI 10.1007/s00401-013-1231-5; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; DeVos SL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00267; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; GOTTMANN K, 1994, DEV BRAIN RES, V81, P77, DOI 10.1016/0165-3806(94)90070-1; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Gribaudo S, 2019, STEM CELL REP, V12, P230, DOI 10.1016/j.stemcr.2018.12.007; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Hallinan G. I., 2018, EFFICIENT PROPAGATIO, DOI [10.1101/372029, DOI 10.1101/372029]; Holloway PM, 2019, LAB CHIP, V19, P1484, DOI 10.1039/c9lc00078j; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Katsinelos T, 2018, CELL REP, V23, P2039, DOI 10.1016/j.celrep.2018.04.056; Kaufman SK, 2018, ACTA NEUROPATHOL, V136, P57, DOI 10.1007/s00401-018-1855-6; Leyns CEG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0192-x; MacKerron C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15950-0; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Park JW, 2013, LAB CHIP, V13, P509, DOI 10.1039/c2lc41081h; Park J, 2009, BIOMED MICRODEVICES, V11, P1145, DOI 10.1007/s10544-009-9331-7; Robertson G, 2014, INTEGR BIOL-UK, V6, P636, DOI 10.1039/c3ib40221e; Takeda S, 2016, ANN NEUROL, V80, P355, DOI 10.1002/ana.24716; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; Vasconcelos B, 2016, ACTA NEUROPATHOL, V131, P549, DOI 10.1007/s00401-015-1525-x; Wagner J, 2015, ACTA NEUROPATHOL, V130, P619, DOI 10.1007/s00401-015-1483-3; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI 10.1038/nrn.2016.13; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y; Wegrzynowici M, 2019, ACTA NEUROPATHOL, V138, P575, DOI 10.1007/s00401-019-02023-x; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Zilberzwige-Tal S, 2018, CHEM-ASIAN J, V13, P3437, DOI 10.1002/asia.201801007	44	10	10	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					13079	13093		10.1074/jbc.RA120.013325	http://dx.doi.org/10.1074/jbc.RA120.013325			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32699110	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000572412900017
J	Gingerich, AD; Doja, F; Thomason, R; Toth, E; Bradshaw, JL; Douglass, MV; McDaniel, LS; Rada, B				Gingerich, Aaron D.; Doja, Fayhaa; Thomason, Rachel; Toth, Eszter; Bradshaw, Jessica L.; Douglass, Martin, V; McDaniel, Larry S.; Rada, Balazs			Oxidative killing of encapsulated and nonencapsulated Streptococcus pneumoniae by lactoperoxidase-generated hypothiocyanite	PLOS ONE			English	Article							VIRULENCE FACTORS; DUAL OXIDASES; HOST-DEFENSE; COLONIZATION; PEROXIDE; THIOCYANATE; CHILDREN; SYSTEM; RESISTANCE; CAPSULES	Streptococcus pneumoniae(Pneumococcus) infections affect millions of people worldwide, cause serious mortality and represent a major economic burden. Despite recent successes due to pneumococcal vaccination and antibiotic use, Pneumococcus remains a significant medical problem. Airway epithelial cells, the primary responders to pneumococcal infection, orchestrate an extracellular antimicrobial system consisting of lactoperoxidase (LPO), thiocyanate anion and hydrogen peroxide (H2O2). LPO oxidizes thiocyanate using H(2)O(2)into the final product hypothiocyanite that has antimicrobial effects against a wide range of microorganisms. However, hypothiocyanite's effect on Pneumococcus has never been studied. Our aim was to determine whether hypothiocyanite can killS.pneumoniae. Bactericidal activity was measured in a cell-freein vitrosystem by determining the number of surviving pneumococci via colony forming units on agar plates, while bacteriostatic activity was assessed by measuring optical density of bacteria in liquid cultures. Our results indicate that hypothiocyanite generated by LPO exerted robust killing of both encapsulated and nonencapsulated pneumococcal strains. Killing ofS.pneumoniaeby a commercially available hypothiocyanite-generating product was even more pronounced than that achieved with laboratory reagents. Catalase, an H(2)O(2)scavenger, inhibited killing of pneumococcal by hypothiocyanite under all circumstances. Furthermore, the presence of the bacterial capsule or lytA-dependent autolysis had no effect on hypothiocyanite-mediated killing of pneumococci. On the contrary, a pneumococcal mutant deficient in pyruvate oxidase (main bacterial H(2)O(2)source) had enhanced susceptibility to hypothiocyanite compared to its wild-type strain. Overall, results shown here indicate that numerous pneumococcal strains are susceptible to LPO-generated hypothiocyanite.	[Gingerich, Aaron D.; Doja, Fayhaa; Thomason, Rachel; Toth, Eszter; Douglass, Martin, V; Rada, Balazs] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Bradshaw, Jessica L.; McDaniel, Larry S.] Univ Mississippi, Med Ctr, Dept Microbiol & Immunol, Jackson, MS 39216 USA	University System of Georgia; University of Georgia; University of Mississippi; University of Mississippi Medical Center	Rada, B (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	radab@uga.edu		Gingerich, Aaron/0000-0002-8139-611X; douglass, martin/0000-0001-7057-557X	National Institutes of Health, National Institute of Allergy and Infectious Diseases [R21AI124189-01A1, 1 R21 AI147097-01A1]; University of Georgia Office of Vice President for Research	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Georgia Office of Vice President for Research	This study was supported by the following: 1. BR. R21AI124189-01A1 National Institutes of Health, National Institute of Allergy and Infectious Diseases R21AI124189-01A1 URL: https://www.niaid.nih.gov 2. BR, startup funds provided by the University of Georgia Office of Vice President for Research URL: https://research.uga.edu; 3. BR. 1 R21 AI147097-01A1 National Institutes of Health, National Institute of Allergy and Infectious Diseases URL: https://www.niaid.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; Andisi VF, 2012, INFECT IMMUN, V80, P1037, DOI 10.1128/IAI.05563-11; Ashby MT, 2008, J DENT RES, V87, P900, DOI 10.1177/154405910808701003; AUNE TM, 1978, BIOCHEMISTRY-US, V17, P1005, DOI 10.1021/bi00599a010; Bafort F, 2014, ENZYME RES, V2014, DOI DOI 10.1155/2014/517164; Bafort F, 2014, ENZYME RES, V2014, DOI [10.1155/2014/51716425309750, DOI 10.1155/2014/51716425309750]; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bryant JC, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0881-6; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068277; Cegolon L, 2014, INT J HYG ENVIR HEAL, V217, P17, DOI 10.1016/j.ijheh.2013.03.001; Chandler JD, 2012, BIOCHEM PHARMACOL, V84, P1381, DOI 10.1016/j.bcp.2012.07.029; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; DENNY FW, 1986, AM J TROP MED HYG, V35, P1; Dixit C, 2016, IDCases, V4, P56, DOI 10.1016/j.idcr.2016.04.001; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; Echlin H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005951; Gau J, 2018, ARCH ORAL BIOL, V85, P70, DOI 10.1016/j.archoralbio.2017.09.037; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Gingerich A, 2016, INFLAMM RES, V65, P71, DOI 10.1007/s00011-015-0892-z; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Keller LE, 2016, MBIO, V7, DOI 10.1128/mBio.01792-15; Keller LE, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00055; Keller LE, 2013, GENOME ANNOUNC, V1; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lisher JP, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00291-16; Liu J, 2018, ANGEW CHEM INT EDIT, V57, P12702, DOI 10.1002/anie.201806197; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Moreau-Marquis S, 2015, J ANTIMICROB CHEMOTH, V70, P160, DOI 10.1093/jac/dku357; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nagai K, 2018, J INFECT CHEMOTHERAP; Patel U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199167; Paton J.C., 2019, MICROBIOL SPECTR, V7; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; POURTOIS M, 1990, J BIOL BUCCALE, V18, P251; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rada B, 2014, AM J RESP CELL MOL, V50, P125, DOI 10.1165/rcmb.2013-0254OC; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Rai P, 2015, P NATL ACAD SCI USA, V112, pE3421, DOI 10.1073/pnas.1424144112; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Riddles PW, 1979, ANAL BIOCHEM, V94, DOI [10.1016/0003-2697(79)90792-937780, DOI 10.1016/0003-2697(79)90792-937780]; RONDA C, 1987, EUR J BIOCHEM, V164, P621, DOI 10.1111/j.1432-1033.1987.tb11172.x; Sarr D, 2018, J MICROBIOL, V56, P373, DOI 10.1007/s12275-018-7545-1; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THOMAS EL, 1978, INFECT IMMUN, V20, P456, DOI 10.1128/IAI.20.2.456-463.1978; VANALPHEN L, 1995, AM J RESP CRIT CARE, V151, P2094, DOI 10.1164/ajrccm.151.6.7767563; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Yesilkaya H, 2013, TRENDS MICROBIOL, V21, P187, DOI 10.1016/j.tim.2013.01.004; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Zahlten J, 2015, J INFECT DIS, V211, P1822, DOI 10.1093/infdis/jiu806	53	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236389	10.1371/journal.pone.0236389	http://dx.doi.org/10.1371/journal.pone.0236389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730276	Green Published, gold			2022-12-26	WOS:000556884700073
J	Lam-Cassettari, C; Kohlhoff, J				Lam-Cassettari, Christa; Kohlhoff, Jane			Effect of maternal depression on infant-directed speech to prelinguistic infants: Implications for language development	PLOS ONE			English	Article							PERINATAL MENTAL-DISORDERS; MOTHERS SPEECH; POSTNATAL DEPRESSION; SOCIAL FEEDBACK; RESPONSIVENESS; PREVALENCE; INCOME; PITCH; VOICE; MOOD	The nature and timing of caregivers' speech provides an important foundation for infant attention and language development in the first year of life. Infant-directed speech is a key component of responsive parent-infant communication that is typically characterised by exaggerated intonation and positive affect. This study examines the effect of postnatal depression on the expression of positive vocal affect and pitch, the quantity of mothers' infant-directed speech input and the timing of vocal responses between mother and infant. Postnatal mothers currently experiencing symptoms of depression (n= 13) were matched to postnatal mothers who were not experiencing symptoms of depression (n= 13), and audio-recorded while playing with their 6-month-old infants. Compared with depressed mothers, non-depressed mothers used a higher mean pitch and pitch range, spoke more, gave faster verbal responses and were rated as expressing more positive valence in their voice. These preliminary findings indicate that mothers experiencing low mood use less infant-directed speech and less exaggerated pitch with prelinguistic infants. Postnatal depression is a major health issue that adversely impacts the parent and child. Early interventions for PND may benefit from identifying ways to support the timing of conversations and mothers' use of appropriate vocal pitch and infant-directed speech modifications. Further research is needed to confirm whether these strategies support early conversations.	[Lam-Cassettari, Christa] Western Sydney Univ, Sydney, NSW, Australia; [Lam-Cassettari, Christa] MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia; [Kohlhoff, Jane] Karitane, Carramar, NSW, Australia; [Kohlhoff, Jane] Univ New South Wales, Kensington, NSW, Australia	Western Sydney University; University of New South Wales Sydney	Lam-Cassettari, C (corresponding author), Western Sydney Univ, Sydney, NSW, Australia.; Lam-Cassettari, C (corresponding author), MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia.	c.lam-cassettari@westernsydney.edu.au		Lam-Cassettari, Christa/0000-0001-6167-551X	South West Sydney Research Small Grant 2016-2017; Marcus and Amalia Wallenberg Foundation (SE) [2013.0056]	South West Sydney Research Small Grant 2016-2017; Marcus and Amalia Wallenberg Foundation (SE)	CLC and JK were awarded a South West Sydney Research Small Grant 2016-2017. CLC was also supported by the Marcus and Amalia Wallenberg Foundation (SE) (2013.0056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEBE B, 1988, J PSYCHOLINGUIST RES, V17, P245, DOI 10.1007/BF01686358; BETTES BA, 1988, CHILD DEV, V59, P1089, DOI 10.1111/j.1467-8624.1988.tb03261.x; Bird K. D., 2004, ANAL VARIANCE VIA CO, DOI [10.4135/9781849208598, DOI 10.4135/9781849208598]; Biringen Z., 2009, UNIVERSAL LANGUAGE L; Boersma P., 2018, PRAAT DOING PHONETIC; BOYCE P, 1993, AUST NZ J PSYCHIAT, V27, P472, DOI 10.3109/00048679309075805; Braten S., 1998, INTERSUBJECTIVE COMM, P15; BREZNITZ Z, 1987, CHILD DEV, V58, P395, DOI 10.2307/1130516; Burnham D, 2002, SCIENCE, V296, P1435, DOI 10.1126/science.1069587; COHN JF, 1988, DEV PSYCHOL, V24, P386, DOI 10.1037/0012-1649.24.3.386; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; FERNALD A, 1993, CHILD DEV, V64, P657, DOI 10.2307/1131209; FERNALD A, 1984, DEV PSYCHOL, V20, P104, DOI 10.1037/0012-1649.20.1.104; FIELD T, 1989, INFANT BEHAV DEV, V12, P357, DOI 10.1016/0163-6383(89)90044-1; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Goldstein MH, 2008, PSYCHOL SCI, V19, P515, DOI 10.1111/j.1467-9280.2008.02117.x; Golinkoff RM, 2015, CURR DIR PSYCHOL SCI, V24, P339, DOI 10.1177/0963721415595345; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Herrera E, 2004, J AFFECT DISORDERS, V81, P29, DOI 10.1016/j.jad.2003.07.001; Hilbrink EE, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01492; Jaffe J, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00137; Kaplan PS, 2011, INFANT BEHAV DEV, V34, P35, DOI 10.1016/j.infbeh.2010.07.014; Kaplan PS, 2001, INFANCY, V2, P537, DOI 10.1207/S15327078IN0204_08; Kaplan PS, 1999, CHILD DEV, V70, P560, DOI 10.1111/1467-8624.00041; Kitamura C, 2003, INFANCY, V4, P85, DOI 10.1207/S15327078IN0401_5; Kitamura C, 2009, INFANCY, V14, P77, DOI 10.1080/15250000802569777; Kondaurova MV, 2015, J SPEECH LANG HEAR R, V58, P590, DOI 10.1044/2015_JSLHR-S-14-0095; Lam C, 2012, DEVELOPMENTAL SCI, V15, P212, DOI 10.1111/j.1467-7687.2011.01118.x; Leclere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113571; Murray Lynne, 2014, Community Pract, V87, P34; Ogbo FA, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1598-x; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Oller D. K., 1980, CHILD PHONOLOGY, V1, P93, DOI [10.1016/B978-0-12-770601-6.50011-5, DOI 10.1016/B978-0-12-770601-6.50011-5]; OLLER DK, 1988, CHILD DEV, V59, P441, DOI 10.1111/j.1467-8624.1988.tb01479.x; Porritt LL, 2014, LANG LEARN DEV, V10, P51, DOI 10.1080/15475441.2013.802962; Ramirez NF, 2020, P NATL ACAD SCI USA, V117, P3484, DOI 10.1073/pnas.1921653117; Ramirez-Esparza N, 2017, CHILD DEV, V88, P1216, DOI 10.1111/cdev.12648; Ramirez-Esparza N, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01008; Reissland N, 2003, J CHILD PSYCHOL PSYC, V44, P255, DOI 10.1111/1469-7610.00118; RUTTER DR, 1987, DEV PSYCHOL, V23, P54, DOI 10.1037/0012-1649.23.1.54; Saint-Georges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078103; SCHLANSKER JT, 1980, J PSYCHOL, V105, P157, DOI 10.1080/00223980.1980.9915146; Spinelli M, 2017, DEV REV, V44, P1, DOI 10.1016/j.dr.2016.12.001; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Stern D. N., 2004, 1 RELATIONSHIP INFAN; Van Egeren LA, 2001, DEV PSYCHOL, V37, P684, DOI 10.1037/0012-1649.37.5.684; Warlaumont AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145096; Warlaumont AS, 2014, PSYCHOL SCI, V25, P1314, DOI 10.1177/0956797614531023; WERKER JF, 1989, CAN J PSYCHOL, V43, P230, DOI 10.1037/h0084224	53	11	11	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236787	10.1371/journal.pone.0236787	http://dx.doi.org/10.1371/journal.pone.0236787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730322	Green Published, gold			2022-12-26	WOS:000556884700070
J	Li, YL; Chen, XL; Wang, JQ; Zou, GP; Wang, L; Li, XS				Li, Yali; Chen, Xiuli; Wang, Jiaqi; Zou, Guangping; Wang, Lu; Li, Xueshuang			Two responses to MeJA induction of R2R3-MYB transcription factors regulate flavonoid accumulation in Glycyrrhiza uralensis Fisch	PLOS ONE			English	Article							METHYL JASMONATE; SUSPENSION-CULTURES; OXIDATIVE STRESS; CELL-SUSPENSION; SALICYLIC-ACID; MYB; ARABIDOPSIS; EXPRESSION; BIOSYNTHESIS; ROOT	Flavonoids are key components of licorice plant that directly affect its medicinal quality. Importantly, the MYB family of transcription factors serves to regulate the synthesis of flavonoids in plants. The MYB transcription factors represent one of the largest families of transcription factors in plants and play important roles in the process of plant growth and development. MYB gene expression is induced by a number of plant hormones, including the lipid-based hormone jasmonate (JA). Methyl jasmonate (MeJA) is an endogenous plant growth regulator that can induce the JA signaling pathway, which functions to regulate the synthesis of secondary metabolites, including flavonoids. In this study, MeJA was added to licorice cell suspensions, and RNA-seq analysis was performed to identify the differentially expressed genes. As a result, the MYB transcription factorsGlMYB4 and GlMYB88were demonstrated to respond significantly to MeJA induction. Subsequently, theGlMYB4andGlMYB88protein were shown to localize to the cell nucleus, and it was verified thatGlMYB4andGlMYB88could positively regulate the synthesis of flavonoids in licorice cells. Overall, this research helps illustrate the molecular regulation of licorice flavonoid biosynthesis induced by MeJA.	[Li, Yali; Wang, Jiaqi; Zou, Guangping; Wang, Lu; Li, Xueshuang] Inner Mongolia Univ Sci & Technol, Sch Life Sci & Technol, Baotou, Peoples R China; [Chen, Xiuli] Biol Sci & Technol Inst, Baotou Teachers Coll, Baotou, Inner Mongolia, Peoples R China	Inner Mongolia University of Science & Technology; Baotou Teachers College	Li, YL (corresponding author), Inner Mongolia Univ Sci & Technol, Sch Life Sci & Technol, Baotou, Peoples R China.	btliyali@126.com			National Natural Science Foundation of China [81960688]; Inner Mongolia Autonomous Region (IMAR) Natural Science Foundation [2017MS (LH) 0304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Autonomous Region (IMAR) Natural Science Foundation	the National Natural Science Foundation of China (81960688). the Inner Mongolia Autonomous Region (IMAR) Natural Science Foundation [2017MS (LH) 0304]	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Ampomah-Dwamena C, 2019, NEW PHYTOL, V221, P309, DOI 10.1111/nph.15362; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Bovy A, 2002, PLANT CELL, V14, P2509, DOI 10.1105/tpc.004218; Chen HJ, 2011, FOOD CHEM, V126, P1741, DOI 10.1016/j.foodchem.2010.12.074; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chin YW, 2007, J AGR FOOD CHEM, V55, P4691, DOI 10.1021/jf0703553; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Coskun O, 2005, PHARMACOL RES, V51, P117, DOI 10.1016/j.phrs.2004.06.002; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Delgado LD, 2018, MOLECULES, V23, DOI 10.3390/molecules23061433; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Duhoux A, 2015, PLANT MOL BIOL, V87, P473, DOI 10.1007/s11103-015-0292-3; Farag MA, 2015, J ADV RES, V6, P99, DOI 10.1016/j.jare.2014.05.001; Fukuchi K, 2016, IN VIVO, V30, P777, DOI 10.21873/invivo.10994; Graf T, 1992, CURR OPIN GENET DEV, V2, P249, DOI 10.1016/S0959-437X(05)80281-3; Huang H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01525; ITO M, 1988, ANTIVIR RES, V10, P289, DOI 10.1016/0166-3542(88)90047-2; ITO M, 1987, ANTIVIR RES, V7, P127, DOI 10.1016/0166-3542(87)90001-5; Kang SM, 2004, PLANT SCI, V166, P745, DOI 10.1016/j.plantsci.2003.11.022; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Li G, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1931-7; Li ST, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-295; Li YL, 2012, BIOTECHNOL BIOTEC EQ, V26, P3231; Li YL, 2007, J ETHNOPHARMACOL, V113, P115, DOI 10.1016/j.jep.2007.05.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MB, 2001, PLANT CELL REP, V20, P674; Ma DW, 2018, PLANT J, V96, P949, DOI 10.1111/tpj.14081; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; MIRJALILI N, 1995, BIOTECHNOL BIOENG, V48, P123, DOI 10.1002/bit.260480206; Moyano E, 1996, PLANT CELL, V8, P1519, DOI 10.1105/tpc.8.9.1519; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Ohno H, 2014, IN VIVO, V28, P785; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Pavlova SI, 2003, PHARM CHEM J, V37, P314, DOI DOI 10.1023/A:1026005931751; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Shabani L, 2009, RUSS J PLANT PHYSL+, V56, P621, DOI 10.1134/S1021443709050069; Shelton D, 2012, PLANT PHYSIOL, V159, P531, DOI 10.1104/pp.112.194753; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tong T, 2020, SMALL, V16, DOI 10.1002/smll.201906206; Traboulsi H, 2015, ANTIMICROB AGENTS CH, V59, P6317, DOI 10.1128/AAC.01098-15; Tugizimana F, 2015, PLANT BIOTECHNOL REP, V9, P125, DOI 10.1007/s11816-015-0350-y; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Wang FB, 2019, PLANT BIOTECHNOL REP, V13, P219, DOI 10.1007/s11816-019-00530-7; Wang HH, 2019, PLANT CELL REP, V38, P927, DOI 10.1007/s00299-019-02413-1; Wang YD, 2004, BIOCHEM ENG J, V19, P259, DOI 10.1016/j.bej.2004.02.006; Wang YC, 2019, PLANT PHYSIOL BIOCH, V139, P273, DOI 10.1016/j.plaphy.2019.03.031; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu JJ, 2013, PLANT MOL BIOL, V83, P77, DOI 10.1007/s11103-013-0025-4; Yang L, 2018, ECOTOX ENVIRON SAFE, V158, P18, DOI 10.1016/j.ecoenv.2018.04.015; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Yang Y, 2007, Z NATURFORSCH C, V62, P410; Yuan F, 2016, PLANT MOL BIOL, V91, P241, DOI 10.1007/s11103-016-0460-0; Zhang J, 2018, PLANT MOL BIOL, V98, P205, DOI 10.1007/s11103-018-0770-5; Zhang QY, 2009, J CHROMATOGR A, V1216, P1954, DOI 10.1016/j.chroma.2008.07.072; Zhao MZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179990	60	13	16	10	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236565	10.1371/journal.pone.0236565	http://dx.doi.org/10.1371/journal.pone.0236565			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730299	gold, Green Published			2022-12-26	WOS:000556884700053
J	Takahashi, A; Naruse, H; Kitade, I; Shimada, S; Tsubokawa, M; Kokubo, Y; Matsumine, A				Takahashi, Ai; Naruse, Hiroaki; Kitade, Ippei; Shimada, Seiichiro; Tsubokawa, Misao; Kokubo, Yasuo; Matsumine, Akihiko			Functional outcomes after the treatment of hip fracture	PLOS ONE			English	Article							MORTALITY; PROGRAM	Osteoporotic hip fracture is a major public health issue. Estimation of the outcome and maximization of functional recovery after fracture is very important in the treatment of older patients. The purposes of this study were to clarify the functional outcomes after the treatment of hip fracture and to identify the factors that influence functional recovery. In the present study, 228 patients admitted to an acute-care hospital from January 2016 to June 2018 were evaluated. The patients were categorized into a trochanteric fracture group (n = 128) and a neck fracture group (n = 100). We retrospectively reviewed their ambulation ability 6 months after fracture using the Functional Ambulation Category (FAC) score. The other survey items were the presurgical duration, length of hospital stay, time until beginning to walk using parallel bars, complications affecting treatment, and mortality rate. The 6-month follow-up rate was 54.4% (n = 124). The results showed that the patients with trochanteric fracture were significantly older than those with neck fracture (86 vs. 82 years, respectively; p = 0.03). In total, 85.0% of patients with trochanteric fracture and 92.2% of patients with neck fracture were independent ambulators before injury (FAC score of 4 or 5). The FAC score 6 months after fracture was positively correlated with the FAC score before fracture and at discharge (all p<0.001) and negatively correlated with patient age (p<0.001) and presurgical duration for patients with neck fracture (p = 0.04). There was no statistically significant correlation with the length of hospital stay or the time until beginning to walk using parallel bars. In conclusion, patients with trochanteric fractures were older than those with neck fractures. In both fracture types, walking recovery 6 months after hip fracture was related to the FAC score before injury and at discharge from an acute-care hospital but not to the time until beginning to walk using parallel bars.	[Takahashi, Ai; Tsubokawa, Misao; Kokubo, Yasuo; Matsumine, Akihiko] Univ Fukui, Dept Orthopaed & Rehabil Med, Fukui, Fukui, Japan; [Takahashi, Ai; Naruse, Hiroaki; Kitade, Ippei; Shimada, Seiichiro; Tsubokawa, Misao; Kokubo, Yasuo; Matsumine, Akihiko] Univ Fukui Hosp, Div Rehabil Med, Fukui, Fukui, Japan	University of Fukui; University of Fukui	Takahashi, A (corresponding author), Univ Fukui, Dept Orthopaed & Rehabil Med, Fukui, Fukui, Japan.; Takahashi, A (corresponding author), Univ Fukui Hosp, Div Rehabil Med, Fukui, Fukui, Japan.	aitun@u-fukui.ac.jp		Takahashi, Ai/0000-0001-5750-1971				[Anonymous], 2018, AO OTA FRACTURE DISL; Beaupre LA, 2013, BEST PRACT RES CL RH, V27, P771, DOI 10.1016/j.berh.2014.01.001; Brach JS, 2013, CURR GERIATR REP, V2, P230, DOI 10.1007/s13670-013-0059-0; Cabinet Office Japan, 2018, ANN REP AG SOC; Cenzer IS, 2016, J AM GERIATR SOC, V64, P1863, DOI 10.1111/jgs.14237; Chang WL, 2018, INT J SURG, V52, P320, DOI 10.1016/j.ijsu.2018.02.061; Eastwood EA, 2002, J AM GERIATR SOC, V50, P1240, DOI 10.1046/j.1532-5415.2002.50311.x; Hagino H, 2004, J ORTHOP SCI, V9, P1, DOI 10.1007/s00776-003-0741-8; Hagino H, 2009, OSTEOPOROSIS INT, V20, P543, DOI 10.1007/s00198-008-0685-0; Hagino H, 2012, YONAGO ACTA MED, V55, P21; Handoll HHG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001704.pub4; Japanese Orthopaedic Surgical Society Guideline Committee, 2011, FEM NECK TROCH FRACT; Latham NK, 2014, JAMA-J AM MED ASSOC, V311, P700, DOI 10.1001/jama.2014.469; Liu Y, 2018, AGING CLIN EXP RES, V30, P323, DOI 10.1007/s40520-017-0789-5; Mehrholz J, 2007, ARCH PHYS MED REHAB, V88, P1314, DOI 10.1016/j.apmr.2007.06.764; National Institute of Clinical Excellence (NICE), 2017, HIP FRACT MAN CLIN G; Norring-Agerskov D, 2013, DAN MED J, V60; Orimo H, 2016, OSTEOPOROSIS INT, V27, P1777, DOI 10.1007/s00198-015-3464-8; PARKER MJ, 1993, J BONE JOINT SURG BR, V75, P797, DOI 10.1302/0301-620X.75B5.8376443; Sakamoto K, 2006, J ORTHOP SCI, V11, P127, DOI 10.1007/s00776-005-0998-1; Sasabuchi Y, 2018, INJURY, V49, P1848, DOI 10.1016/j.injury.2018.07.026; Schnell S, 2010, GERIATR ORTHOP SURG, V1, P6, DOI 10.1177/2151458510378105; Shyu YIL, 2012, INT J GERIATR PSYCH, V27, P529, DOI 10.1002/gps.2750; Sylliaas H, 2012, AGE AGEING, V41, P206, DOI 10.1093/ageing/afr164; Tanner DA, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-12; Thingstad P, 2016, OSTEOPOROSIS INT, V27, P933, DOI 10.1007/s00198-015-3313-9	26	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236652	10.1371/journal.pone.0236652	http://dx.doi.org/10.1371/journal.pone.0236652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730298	gold, Green Published			2022-12-26	WOS:000556884700060
J	Bouchnita, A; Terekhov, K; Nony, P; Vassilevski, Y; Volpert, V				Bouchnita, Anass; Terekhov, Kirill; Nony, Patrice; Vassilevski, Yuri; Volpert, Vitaly			A mathematical model to quantify the effects of platelet count, shear rate, and injury size on the initiation of blood coagulation under venous flow conditions	PLOS ONE			English	Article							ADVECTION-DIFFUSION EQUATIONS; FINITE-VOLUME METHOD; THRESHOLD RESPONSE; CLOT FORMATION; TISSUE FACTOR; THROMBOSIS; HEMOSTASIS; FIBRIN; ANTITHROMBIN; DYNAMICS	Platelets upregulate the generation of thrombin and reinforce the fibrin clot which increases the incidence risk of venous thromboembolism (VTE). However, the role of platelets in the pathogenesis of venous cardiovascular diseases remains hard to quantify. An experimentally validated model of thrombin generation dynamics is formulated. The model predicts that a high platelet count increases the peak value of generated thrombin as well as the endogenous thrombin potential (ETP) as reported in experimental data. To investigate the effects of platelets density, shear rate, and wound size on the initiation of blood coagulation, we calibrate a previously developed model of venous thrombus formation and implement it in 3D using a novel cell-centered finite-volume solver. We conduct numerical simulations to reproducein vitroexperiments of blood coagulation in microfluidic capillaries. Then, we derive a reduced one-equation model of thrombin distribution from the previous model under simplifying hypotheses and we use it to determine the conditions of clotting initiation on the platelet count, the shear rate, and the plasma composition. The initiation of clotting also exhibits a threshold response to the size of the wounded region in good agreement with the reported experimental findings.	[Bouchnita, Anass] Ecole Cent Casablanca, Casablanca, Morocco; [Terekhov, Kirill; Vassilevski, Yuri; Volpert, Vitaly] Russian Acad Sci, Marchuk Inst Numer Math, Moscow, Russia; [Nony, Patrice] Hosp Civils Lyon, Serv Pharmacol Clin, Lyon, France; [Vassilevski, Yuri] Sechenov Univ, Moscow, Russia; [Vassilevski, Yuri] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Volpert, Vitaly] Univ Lyon 1, Inst Camille Jordan, Villeurbanne, France; [Volpert, Vitaly] INRIA Lyon La Doua, INRIA Team Dracula, Villeurbanne, France; [Volpert, Vitaly] Peoples Friendship Univ Russia, RUDN Univ, Moscow, Russia	Russian Academy of Sciences; CHU Lyon; Sechenov First Moscow State Medical University; Moscow Institute of Physics & Technology; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Peoples Friendship University of Russia	Bouchnita, A (corresponding author), Ecole Cent Casablanca, Casablanca, Morocco.	anass.bouchnita@centrale-casablanca.ma	Vassilevski, Yuri/A-6068-2016; Volpert, Vitaly/E-2969-2019; Terekhov, Kirill/AAE-6817-2021; Bouchnita, Anass/AAW-2021-2021	Vassilevski, Yuri/0000-0002-4718-1377; Terekhov, Kirill/0000-0001-6548-0496; Bouchnita, Anass/0000-0002-2729-6484	RFBR [18-31-20048]; world-class research center "Moscow Center for Fundamental and Applied Mathematics"; Ministry of Education and Science of the Russian Federation [075-15-2019-1624]; RUDN University Program 5-100; Russian Science Foundation [14-31-00024]	RFBR(Russian Foundation for Basic Research (RFBR)); world-class research center "Moscow Center for Fundamental and Applied Mathematics"; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); RUDN University Program 5-100; Russian Science Foundation(Russian Science Foundation (RSF))	K. Terekhov was supported by RFBR grant 18-31-20048. Yu. Vassilevski was supported by the world-class research center "Moscow Center for Fundamental and Applied Mathematics" (agreement with the Ministry of Education and Science of the Russian Federation No. 075-15-2019-1624). V. Volpert was supported by the "RUDN University Program 5-100." The development of the 3D numerical model of thrombus growth under venous flow conditions was supported by Russian Science Foundation grant 14-31-00024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M, 2008, J THEOR BIOL, V253, P725, DOI 10.1016/j.jtbi.2008.04.015; Belyaev AV, 2018, PHYS LIFE REV, V26-27, P57, DOI 10.1016/j.plrev.2018.02.005; Belyaev AV, 2019, RUSS J NUMER ANAL M, V34, P241, DOI 10.1515/rnam-2019-0020; Belyaev AV, 2018, MATH MODEL NAT PHENO, V13, DOI 10.1051/mmnp/2018043; Belyaev AV, 2015, BIOPHYS J, V109, P450, DOI 10.1016/j.bpj.2015.06.019; Bouchnita A, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2850; Bouchnita A, 2016, MATH MODEL NAT PHENO, V11, P28, DOI 10.1051/mmnp/201611603; Bouchnita A, 2019, COMPUTERS FLUIDS; Bouchnita A, 2017, CR BIOL, V340, P456, DOI 10.1016/j.crvi.2017.10.002; Bouchnita A, 2016, APPL MATH LETT, V51, P74, DOI 10.1016/j.aml.2015.07.010; Brotman DJ, 2004, SOUTH MED J, V97, P213, DOI 10.1097/01.SMJ.0000105663.01648.25; BUSS DH, 1985, AM J HEMATOL, V20, P365, DOI 10.1002/ajh.2830200408; Dargaud Y, 2010, THROMB RES, V126, P436, DOI 10.1016/j.thromres.2010.08.007; Elizondo P, 2016, BIOPHYS J, V111, P2722, DOI 10.1016/j.bpj.2016.10.030; ETHIER CR, 1994, INT J NUMER METH FL, V19, P369, DOI 10.1002/fld.1650190502; Fasano A., 2017, HEMOMATH MATH BLOOD, V18; Fogelson AL, 2012, BIOPHYS J, V102, P10, DOI 10.1016/j.bpj.2011.10.048; Galochkina T, 2017, MATH MODEL NAT PHENO, V12, P196, DOI 10.1051/mmnp/201712512; Galochkina T, 2017, MATH BIOSCI, V288, P130, DOI 10.1016/j.mbs.2017.03.008; Gerotziafas GT, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-16; Govindarajan V, 2016, BIOPHYS J, V110, P1869, DOI 10.1016/j.bpj.2016.03.010; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Hosseinzadegan H, 2017, BIOTECHNOL BIOENG, V114, P2154, DOI 10.1002/bit.26343; Kapyrin I, 2019, PARALLEL FINITE VOLU; Kastrup CJ, 2007, BIOPHYS J, V93, P2969, DOI 10.1529/biophysj.107.109009; Krasotkina YV, 2000, BBA-GEN SUBJECTS, V1474, P337, DOI 10.1016/S0304-4165(00)00019-2; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Leiderman K, 2011, MATH MED BIOL, V28, P47, DOI 10.1093/imammb/dqq005; Lipnikov K, 2010, J COMPUT PHYS, V229, P4017, DOI 10.1016/j.jcp.2010.01.035; Litvinov Rustem I, 2017, ISBT Sci Ser, V12, P176, DOI 10.1111/voxs.12331; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Nikitin K, 2010, RUSS J NUMER ANAL M, V25, P335, DOI 10.1515/RJNAMM.2010.022; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Rasche H, 2001, EUR HEART J SUPPL, V3, pQ3, DOI 10.1016/S1520-765X(01)90034-3; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Sequeira A, 2014, MATH MODEL NAT PHENO, V9, P34, DOI 10.1051/mmnp/20149604; Shen F, 2008, ARTERIOSCL THROM VAS, V28, P2035, DOI 10.1161/ATVBAHA.108.173930; Shibeko AM, 2009, BIOCHEM MOSC SUPPL S, V3, P388, DOI 10.1134/S1990747809040047; Susree AM, 2016, MATH MODEL NAT PHENO, V11, P71, DOI 10.1051/mmnp/201611605; Tosenberger A, 2016, J MATH BIOL, V72, P649, DOI 10.1007/s00285-015-0891-2; Tosenberger A, 2011, MATH MODEL NAT PHENO, V6, P320, DOI 10.1051/mmnp/20116512; Tsakiris DA, 1999, THROMB HAEMOSTASIS, V81, P177, DOI 10.1055/s-0037-1614439; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; van der Bom JG, 2009, J THROMB HAEMOST, V7, P399, DOI 10.1111/j.1538-7836.2008.03267.x; Vassilevski Y.V., 2013, INMOST PROGRAMMING P, P144; Wiebe EM, 2003, J BIOL CHEM, V278, P35767, DOI 10.1074/jbc.M304803200; Wu WT, 2017, SCI REP-UK, V7, DOI 10.1038/srep42720; Wufsus AR, 2013, BIOPHYS J, V104, P1812, DOI 10.1016/j.bpj.2013.02.055; Zakai NA, 2004, J THROMB HAEMOST, V2, P2156, DOI 10.1111/j.1538-7836.2004.00991.x	49	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235392	10.1371/journal.pone.0235392	http://dx.doi.org/10.1371/journal.pone.0235392			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726315	gold, Green Published			2022-12-26	WOS:000556908900049
J	Subki, A; Ho, CL; Ismail, NFN; Abidin, AAZ; Yusof, ZNB				Subki, Atiqah; Ho, Chai Ling; Ismail, Nur Farhah Nabihan; Zainal Abidin, Aisamuddin Ardi; Balia Yusof, Zetty Norhana			Identification and characterisation of thiamine pyrophosphate (TPP) riboswitch inElaeis guineensis	PLOS ONE			English	Article							GENE-EXPRESSION; RNA STRUCTURE; WEB-SERVER; BIOSYNTHESIS; TARGETS; PLANTS	The oil palm (Elaeis guineensis) is an important crop in Malaysia but its productivity is hampered by various biotic and abiotic stresses. Recent studies suggest the importance of signalling molecules in plants in coping against stresses, which includes thiamine (vitamin B-1). Thiamine is an essential microelement that is synthesizedde novoby plants and microorganisms. The active form of thiamine, thiamine pyrophosphate (TPP), plays a prominent role in metabolic activities particularly as an enzymatic cofactor. Recently, thiamine biosynthesis pathways in oil palm have been characterised but the search of novel regulatory element known as riboswitch is yet to be done. Previous studies showed that thiamine biosynthesis pathway is regulated by an RNA element known as riboswitch. Riboswitch binds a small molecule, resulting in a change in production of the proteins encoded by the mRNA. TPP binds specifically to TPP riboswitch to regulate thiamine biosynthesis through a variety of mechanisms found in archaea, bacteria and eukaryotes. This study was carried out to hunt for TPP riboswitch in oil palm thiamine biosynthesis gene. Riboswitch detection software like RiboSW, RibEx, Riboswitch Scanner and Denison Riboswitch Detector were utilised in order to locate putative TPP riboswitch in oil palmThiCgene sequence that encodes for the first enzyme in the pyrimidine branch of the pathway. The analysis revealed a 192 bp putative TPP riboswitch located at the 3' untranslated region (UTR) of the mRNA. Further comparative gene analysis showed that the 92-nucleotide aptamer region, where the metabolite binds was conserved inter-species. The secondary structure analysis was also carried out using Mfold Web server and it showed a stem-loop structure manifested with stems (P1-P5) with minimum free energy of -12.26 kcal/mol. Besides that, the interaction of riboswitch and its ligand was determined using isothermal titration calorimetry (ITC) and it yielded an exothermic reaction with 1:1 stoichiometry interaction with binding affinities of 0.178 nM, at 30 degrees C. To further evaluate the ability of riboswitch to control the pathway, exogenous thiamine was applied to four months old of oil palm seedlings and sampling of spear leaves tissue was carried out at days 0, 1, 2 and 3 post-treatment for expression analysis ofThiCgene fragment via quantitative polymerase chain reaction (qPCR). Results showed an approximately 5-fold decrease inThiCgene expression upon application of exogenous thiamine. Quantification of thiamine and its derivatives was carried out via HPLC and the results showed that it was correlated to the down regulation ofThiCgene expression. The application of exogenous thiamine to oil palm affectedThiCgene expression, which supported the prediction of the presence of TPP riboswitch in the gene. Overall, this study provides the first evidence on the presence, binding and the functionality of TPP riboswitch in oil palm. This study is hoped to pave a way for better understanding on the regulation of thiamine biosynthesis pathway in oil palm, which can later be exploited for various purposes especially in manipulation of thiamine biosynthesis pathways in combating stresses in oil palm.	[Subki, Atiqah; Zainal Abidin, Aisamuddin Ardi; Balia Yusof, Zetty Norhana] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor, Malaysia; [Ho, Chai Ling] Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia; [Ismail, Nur Farhah Nabihan; Zainal Abidin, Aisamuddin Ardi; Balia Yusof, Zetty Norhana] Univ Putra Malaysia, Lab Marine Biotechnol, Inst Biosci, Serdang, Selangor, Malaysia; [Balia Yusof, Zetty Norhana] Univ Putra Malaysia, Bioproc & Biomfg Res Ctr, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Yusof, ZNB (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor, Malaysia.; Yusof, ZNB (corresponding author), Univ Putra Malaysia, Lab Marine Biotechnol, Inst Biosci, Serdang, Selangor, Malaysia.; Yusof, ZNB (corresponding author), Univ Putra Malaysia, Bioproc & Biomfg Res Ctr, Serdang, Selangor, Malaysia.	zettynorhana@upm.edu.my	Balia Yusof, Zetty Norhana/R-4136-2017	Balia Yusof, Zetty Norhana/0000-0002-7414-5689	Skim Geran Penyelidikan Fundamental (FRGS), Kementerian Pendidikan Tinggi Malaysia [5524589]; Geran Putra IPS Universiti Putra Malaysia [9511100, 9515900]; Science Fund Grant Ministry of Science, Technology and Innovation (MOSTI), Malaysian Government [5450799]	Skim Geran Penyelidikan Fundamental (FRGS), Kementerian Pendidikan Tinggi Malaysia; Geran Putra IPS Universiti Putra Malaysia; Science Fund Grant Ministry of Science, Technology and Innovation (MOSTI), Malaysian Government	The research funds were awarded to Z.N. B. Yusof by: 1. Skim Geran Penyelidikan Fundamental (FRGS), Kementerian Pendidikan Tinggi Malaysia (5524589) http://www.mohe.gov.my/en/initiatives-2/187-program-utama/penyelidikan/548-research-grants-information 2. Geran Putra IPS Universiti Putra Malaysia (9511100 & 9515900). https://rmc.upm.edu.my/documentfile 3. Science Fund Grant Ministry of Science, Technology and Innovation (MOSTI), Malaysian Government (5450799). https://ernd.mestecc.gov.my/site/login The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; Aghdam EM, 2016, GENE, V592, P244, DOI 10.1016/j.gene.2016.07.035; Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Bastet L, 2011, MOL MICROBIOL, V80, P1148, DOI 10.1111/j.1365-2958.2011.07654.x; Bocobza S, 2007, GENE DEV, V21, P2874, DOI 10.1101/gad.443907; Bocobza SE, 2008, TRENDS PLANT SCI, V13, P526, DOI 10.1016/j.tplants.2008.07.004; Bocobza SE, 2014, PLANT J, V79, P693, DOI 10.1111/tpj.12540; Chang TH, 2009, RNA, V15, P1426, DOI 10.1261/rna.1623809; Chen LH, 2010, ACS CHEM BIOL, V5, P355, DOI 10.1021/cb9003139; Croft MT, 2007, P NATL ACAD SCI USA, V104, P20770, DOI 10.1073/pnas.0705786105; Goyer A, 2010, PHYTOCHEMISTRY, V71, P1615, DOI 10.1016/j.phytochem.2010.06.022; Guan Jiahn-Chou, 2014, Front Plant Sci, V5, P370, DOI 10.3389/fpls.2014.00370; Haller A, 2013, P NATL ACAD SCI USA, V110, P4188, DOI 10.1073/pnas.1218062110; Havill JT, 2014, BIOINFORMATICS, V30, P3012, DOI 10.1093/bioinformatics/btu479; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; Kamarudin AN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01799; Kong DY, 2008, CELL RES, V18, P566, DOI 10.1038/cr.2008.35; Kulshina N, 2010, RNA, V16, P186, DOI 10.1261/rna.1847310; Li SS, 2013, NUCLEIC ACIDS RES, V41, P3022, DOI 10.1093/nar/gkt057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz R, 2016, METHODS, V103, P86, DOI 10.1016/j.ymeth.2016.04.004; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Ludin NA, 2014, J CLEAN PROD, V65, P9, DOI 10.1016/j.jclepro.2013.11.063; Mangel N, 2017, J EXP BOT, V68, P3351, DOI 10.1093/jxb/erx196; McRose D, 2014, ISME J, V8, P2517, DOI 10.1038/ismej.2014.146; Mizoue LS, 2004, ANAL BIOCHEM, V326, P125, DOI 10.1016/j.ab.2003.10.048; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; MOZAFAR A, 1993, J PLANT PHYSIOL, V142, P438, DOI 10.1016/S0176-1617(11)81249-6; Mukherjee S, 2016, BIOINFORMATICS, V32, P776, DOI 10.1093/bioinformatics/btv640; Pourcel L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00160; Proshkin S, 2014, BBA-GENE REGUL MECH, V1839, P974, DOI 10.1016/j.bbagrm.2014.04.002; Rapala-Kozik M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-2; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Salim NN, 2009, METHODS, V47, P198, DOI 10.1016/j.ymeth.2008.09.003; Saponaro A, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2957; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Subki A, 2018, J OIL PALM RES, V30, P236, DOI 10.21894/jopr.2018.0028; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wu X, 2017, NUCLEIC ACIDS RES, V45, P12140, DOI 10.1093/nar/gkx999; Yadav S., 2014, J COMPUTATIONAL BIOL, V21, P1, DOI [10.1089/cmb.2013.0004, DOI 10.1089/CMB.2013.0004]; Yusof ZNB, 2015, J OIL PALM RES, V27, P12	46	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235431	10.1371/journal.pone.0235431	http://dx.doi.org/10.1371/journal.pone.0235431			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726320	gold, Green Published, Green Accepted			2022-12-26	WOS:000556908900065
J	Kim, HY; Kwon, WY; Park, JB; Lee, MH; Oh, YJ; Suh, S; Baek, YH; Jeong, JS; Yoo, YH				Kim, Hye Young; Kwon, Woo Young; Park, Joon Beom; Lee, Mi Hwa; Oh, Yoo Jin; Suh, SungHwan; Baek, Yang Hyun; Jeong, Jin Sook; Yoo, Young Hyun			Hepatic STAMP2 mediates recombinant FGF21-induced improvement of hepatic iron overload in nonalcoholic fatty liver disease	FASEB JOURNAL			English	Article						hepatic steatosis; insulin resistance; iron exporter; iron homeostasis	HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; SEX-DIFFERENCES; STEAP PROTEINS; CELLULAR IRON; STEATOHEPATITIS; FERROPORTIN; HOMEOSTASIS; STEATOSIS; HYPERFERRITINEMIA	Although previous studies have shown that the administration of fibroblast growth factor 21 (FGF21) reverses hepatic steatosis, the mechanism by which FGF21 exerts a therapeutic effect on nonalcoholic fatty liver disease (NAFLD) is not yet entirely understood. We previously demonstrated that hepatic six transmembrane protein of prostate 2 (STAMP2) may represent a suitable target for NAFLD. We investigated the mechanism underlying the therapeutic effect of recombinant FGF21 on NAFLD, focusing on the involvement of hepatic STAMP2. In this study, we used human nonalcoholic steatosis patient pathology samples, C57BL/6 mice for a high-fat diet (HFD)-induced in vivo NAFLD model, and used human primary hepatocytes and HepG2 cells for oleic acid (OA)-induced in vitro NAFLD model. We observed that recombinant FGF21 treatment ameliorated hepatic steatosis and insulin resistance through the upregulation of STAMP2 expression. We further observed hepatic iron overload (HIO) and reduced iron exporter, ferroportin expression in the liver samples obtained from human NAFLD patients, and HFD-induced NAFLD mice and in OA-treated HepG2 cells. Importantly, recombinant FGF21 improved HIO through the hepatic STAMP2-mediated upregulation of ferroportin expression. Our data suggest that hepatic STAMP2 may represent a suitable therapeutic intervention target for FGF21-induced improvement of NAFLD accompanying HIO.	[Kim, Hye Young; Kwon, Woo Young; Park, Joon Beom; Lee, Mi Hwa; Oh, Yoo Jin; Yoo, Young Hyun] Dong A Univ, Dept Anat & Cell Biol, Coll Med, Busan 49201, South Korea; [Suh, SungHwan] Dong A Univ, Dept Endocrinol, Coll Med, Busan, South Korea; [Baek, Yang Hyun] Dong A Univ, Dept Gastroenterol, Coll Med, Busan, South Korea; [Jeong, Jin Sook] Dong A Univ, Coll Med, Dept Pathol, Busan, South Korea	Dong A University; Dong A University; Dong A University; Dong A University	Yoo, YH (corresponding author), Dong A Univ, Dept Anat & Cell Biol, Coll Med, Busan 49201, South Korea.	yhyoo@dau.ac.kr			National Research Foundation of Korea - Korea government [NRF-2019R1A2C2002266, NRF-2019R1C1C1002274, NRF-2016R1A5A2007009]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (No. NRF-2019R1A2C2002266, NRF-2019R1C1C1002274, NRF-2016R1A5A2007009).	Abedini A, 2007, IMMUNOL CELL BIOL, V85, P399, DOI 10.1038/sj.icb.7100107; Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Anderson ER, 2013, COMPR PHYSIOL, V3, P315, DOI 10.1002/cphy.c120016; BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122; Boga S, 2015, J GASTROINTEST LIVER, V24, P293, DOI 10.15403/jgld.2014.1121.243.hak; Britton LJ, 2016, WORLD J GASTROENTERO, V22, P8112, DOI 10.3748/wjg.v22.i36.8112; Chen XL, 2014, ENDOCRINE, V47, P372, DOI 10.1007/s12020-014-0230-1; Chitturi S, 2002, HEPATOLOGY, V36, P142, DOI 10.1053/jhep.2002.33892; Chukijrungroat N, 2017, AM J PHYSIOL-ENDOC M, V313, pE203, DOI 10.1152/ajpendo.00076.2017; Datz C, 2017, MINERVA ENDOCRINOL, V42, P173, DOI 10.23736/S0391-1977.16.02565-7; Datz C, 2013, EUR J CLIN INVEST, V43, P215, DOI 10.1111/eci.12032; Deguti MM, 2003, BRAZ J MED BIOL RES, V36, P739, DOI 10.1590/S0100-879X2003000600009; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Duseja A, 2005, WORLD J GASTROENTERO, V11, P393, DOI 10.3748/wjg.v11.i3.393; Ebe H, 2019, MOD RHEUMATOL, V29, P714, DOI 10.1080/14397595.2018.1484415; Fargion S, 2001, AM J GASTROENTEROL, V96, P2448, DOI 10.1111/j.1572-0241.2001.04052.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; Harrison-Findik DD, 2010, WORLD J HEPATOL, V2, P302, DOI 10.4254/wjh.v2.i8.302; Iwasa M, 2010, HEPATOL RES, V40, P1188, DOI 10.1111/j.1872-034X.2010.00724.x; Kim HY, 2015, J HEPATOL, V63, P477, DOI 10.1016/j.jhep.2015.01.025; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Kong WN, 2014, BIOL TRACE ELEM RES, V160, P258, DOI 10.1007/s12011-014-0051-3; Murali AR, 2018, HEPATOL RES, V48, pE30, DOI 10.1111/hepr.12921; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Oh YJ, 2018, MOL PHARMACOL, V94, P1401, DOI 10.1124/mol.118.113217; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Olynyk JK, 2005, AM J GASTROENTEROL, V100, P837, DOI 10.1111/j.1572-0241.2005.41287.x; Olynyk JK, 2009, CLIN GASTROENTEROL H, V7, P359, DOI 10.1016/j.cgh.2008.11.010; Pietrangelo Antonello, 2016, J Hepatol, V65, P226, DOI 10.1016/j.jhep.2016.01.037; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Scarl RT, 2017, J ENDOCRINOL, V234, pR123, DOI 10.1530/JOE-16-0594; Sikkeland J, 2016, MOL CELL ENDOCRINOL, V425, P26, DOI 10.1016/j.mce.2016.02.013; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Sumida Y, 2003, J HEPATOL, V38, P32, DOI 10.1016/S0168-8278(02)00331-8; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Waki H, 2007, CELL, V129, P451, DOI 10.1016/j.cell.2007.04.022; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Younossi ZM, 1999, HEPATOLOGY, V30, P847, DOI 10.1002/hep.510300407; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Zhu SL, 2016, MOL CELL BIOCHEM, V420, P107, DOI 10.1007/s11010-016-2774-2; Zhu SL, 2014, ACTA BIOCH BIOPH SIN, V46, P1041, DOI 10.1093/abbs/gmu097	48	9	10	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12354	12366		10.1096/fj.202000790R	http://dx.doi.org/10.1096/fj.202000790R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32721044				2022-12-26	WOS:000556062000001
J	Topalidou, A; Markarian, G; Downe, S				Topalidou, Anastasia; Markarian, Garik; Downe, Soo			Thermal imaging of the fetus: An empirical feasibility study	PLOS ONE			English	Article							THERMOGRAPHY; RELIABILITY; RANGE	Digital Infrared Thermal Imaging (DITI) has much potential in the field of maternal-fetal health and wellbeing research. The fact that it is totally non-invasive is particularly important in this context. The purpose of this study was, for the first time, to assess DITI's ability to record fetal presentation and position, and other pregnancy-related physiological factors, via their superficial thermal prints. Ten healthy pregnant women (approximately 34-37 weeks of gestation) were recorded with two thermal imaging cameras (Flir C3 and i3 TE-Q1) from five different viewpoints. Participants' views about the use of DITI in research and clinical practice were also assessed by a completion of a survey. Free hand polygon region of interests (ROIs) were drawn in order to include the entire anatomical area for investigation. The use of free hand polygon ROIs showed high reliability. Thermal images analysis revealed that fetuses presenting cephalically can be identified by the use of DITI, under specific conditions. Fetal movements influenced the thermal patterns that were produced. Future studies need to verify the heat patterns on the skin related to the placenta location, in order to understand the produced thermal recordings. Pregnant women rated the idea of using DITI in research and clinical practice very highly. This work represents a first contribution towards the use of DITI for the recording of fetal presentation and position. As it does not require direct contact and since it is completely non-invasive, it could be used to record maternal-fetal dynamic dyadic interaction in pregnancy. However, although the preliminary results are promising, further trans-disciplinary studies with a well-established protocol, more sophisticated thermal cameras, and bigger cohorts are needed.	[Topalidou, Anastasia; Downe, Soo] Univ Cent Lancashire, Sch Community Hlth & Midwifery, Fac Hlth & Wellbeing, Res Childbirth & Hlth Unit, Preston, Lancs, England; [Markarian, Garik] Univ Lancaster, Sch Comp & Commun, Lancaster, Lancs, England; [Markarian, Garik] Rinicare Ltd, Lancaster, England	University of Central Lancashire; Lancaster University	Topalidou, A (corresponding author), Univ Cent Lancashire, Sch Community Hlth & Midwifery, Fac Hlth & Wellbeing, Res Childbirth & Hlth Unit, Preston, Lancs, England.	atopalidou@uclan.ac.uk	Topalidou, Anastasia/AFS-0887-2022	Topalidou, Anastasia/0000-0003-0280-6801	University of Central Lancashire, Idea Investment Voucher; COST Action [IS1405]; EU COST (European Cooperation in Science and Technology)	University of Central Lancashire, Idea Investment Voucher; COST Action(European Cooperation in Science and Technology (COST)); EU COST (European Cooperation in Science and Technology)	The authors (AT, GM and SD) received funding from the University of Central Lancashire, Idea Investment Voucher. The funder provided support in the form of salary (part-time) for AT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section. This article is based upon work funded by the COST Action IS1405 BIRTH: "Building Intrapartum Research Through Health An interdisciplinary whole system approach to understanding and contextualising physiological labour and birth" (http://www.cost.eu/COST_ Actions/isch/IS1405), supported by EU COST (European Cooperation in Science and Technology).; This article is based upon work from COST Action IS1405 BIRTH: "Building Intrapartum Research Through Health-An interdisciplinary whole system approach to understanding and contextualising physiological labour and birth" (http://www.cost.eu/COST_Actions/isch/IS1405), supported by EU COST (European Cooperation in Science and Technology).	ABITBOL MM, 1993, AM J PHYS ANTHROPOL, V91, P367, DOI 10.1002/ajpa.1330910309; Arora N, 2008, AM J SURG, V196, P523, DOI 10.1016/j.amjsurg.2008.06.015; Asakura Hirobumi, 2004, Journal of Nippon Medical School, V71, P360, DOI 10.1272/jnms.71.360; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; BIRNBAUM SJ, 1964, ANN NY ACAD SCI, V121, P209, DOI 10.1111/j.1749-6632.1964.tb13697.x; Bowers S, 2009, THERIOGENOLOGY, V72, P372, DOI 10.1016/j.theriogenology.2009.03.005; Bradford B, 2018, WOMEN BIRTH, V31, pE287, DOI 10.1016/j.wombi.2017.12.007; Chetani M, 2017, INT J REPROD CONTRAC, V6, P3280; Cho YJ, 2017, BIOMED OPT EXPRESS, V8, P4480, DOI 10.1364/BOE.8.004480; Church CC, 2012, SAFE USE ULTRASOUND, V3rd, P46; Coady AM, 2015, TWININGS TXB FETAL A, V3rd, P81, DOI [10.1016/C2010-0-67979-X, DOI 10.1016/C2010-0-67979-X]; Currier D, 1990, ELEMENTS RES PHYS TH; DAVID H, 1975, BRIT MED J, V2, P62, DOI 10.1136/bmj.2.5962.62; Deng FG, 2015, MED PHYS, V42, P2242, DOI 10.1118/1.4907969; DiEdwardo CA, 2010, PLASTIC SURG SECRETS, V2nd, P532; DiPietro JA, 2006, BEHAV NEUROSCI, V120, P687, DOI 10.1037/0735-7044.120.3.687; DiPietro JA, 2010, MATERNAL INFLUENCES ON FETAL NEURODEVELOPMENT: CLINICAL AND RESEARCH ASPECTS, P19, DOI 10.1007/978-1-60327-921-5_3; Duarte A, 2014, PROC TECH, V16, P1560, DOI 10.1016/j.protcy.2014.10.178; Duck FA., 2012, SAFE USE ULTRASOUND, P4; Ebisch SJ, 2012, BIOL PSYCHOL, V89, P123, DOI 10.1016/j.biopsycho.2011.09.018; Evans JD., 1996, STRAIGHTFORWARD STAT; Falzon Owen, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P5664, DOI 10.1109/EMBC.2018.8513497; Garbey M, 2007, IEEE T BIO-MED ENG, V54, P1418, DOI 10.1109/TBME.2007.891930; GAUTHERIE M, 1980, CANCER, V45, P51, DOI 10.1002/1097-0142(19800101)45:1<51::AID-CNCR2820450110>3.0.CO;2-L; GILBERT RD, 1985, J APPL PHYSIOL, V59, P634, DOI 10.1152/jappl.1985.59.2.634; Hahn AC, 2012, BIOL LETTERS, V8, P864, DOI 10.1098/rsbl.2012.0338; Incropera F.P., 1990, INTRO HEAT TRANSFER, V2; Jones BF, 1998, IEEE T MED IMAGING, V17, P1019, DOI 10.1109/42.746635; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lam TCM., 2002, FIELD METHOD, V14, P418, DOI [10.1177/152582202237730, DOI 10.1177/152582202237730]; MEBAN C, 1983, J ANAT, V137, P271; Merla A., 2004, BIOMED TECH, V48, P284; MILLAR KG, 1966, BRIT MED J, V1, P1571, DOI 10.1136/bmj.1.5503.1571; Murthy R, 2004, P ANN INT IEEE EMBS, V26, P1196; Naik S, 2017, 2017 INTERNATIONAL CONFERENCE ON EMERGING TRENDS & INNOVATION IN ICT (ICEI), P15, DOI 10.1109/ETIICT.2017.7977003; Pereira T, 2016, INFRARED PHYS TECHN, V78, P84, DOI 10.1016/j.infrared.2016.07.019; Piscicelli C, 2015, STROKE, V46, P1979, DOI 10.1161/STROKEAHA.115.009610; POMERANCE JJ, 1977, PEDIATRICS, V59, P345; POWER GG, 1984, J APPL PHYSIOL, V57, P917, DOI 10.1152/jappl.1984.57.3.917; Puri C., 2005, CHI 05 EXTENDED ABST, P1725, DOI DOI 10.1145/1056808.1057007; REDISCH W, 1952, CIRCULATION, V6, P862, DOI 10.1161/01.CIR.6.6.862; Savastano DM, 2009, AM J CLIN NUTR, V90, P1124, DOI 10.3945/ajcn.2009.27567; Sillero-Quintana M., 2012, THERMOLOGY INT, V22, P143; Simoes R, 2012, COMPUTATIONAL VISION AND MEDICAL IMAGE PROCESSING: VIPIMAGE 2011, P285; Simoes R, 2012, J THERM BIOL, V37, P608, DOI 10.1016/j.jtherbio.2012.07.006; ter Haar G., 2012, SAFE USE ULTRASOUND, V3rd, P1; Topalidou A, 2016, INFRARED PHYS TECHN, V75, P59, DOI 10.1016/j.infrared.2015.12.016; Topalidou A, 2014, ACTA BIOENG BIOMECH, V16, P117, DOI 10.5277/abb140114; Usamentiaga R, 2014, SENSORS-BASEL, V14, P12305, DOI 10.3390/s140712305; WALKER D, 1969, Journal of Obstetrics and Gynaecology of the British Commonwealth, V76, P503; Webb SS, 2011, ACTA OBSTET GYN SCAN, V90, P1259, DOI 10.1111/j.1600-0412.2011.01226.x	52	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0226755	10.1371/journal.pone.0226755	http://dx.doi.org/10.1371/journal.pone.0226755			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722675	gold, Green Published, Green Accepted			2022-12-26	WOS:000556916000015
J	Beltran, JF; Wahba, BM; Hose, N; Shasha, D; Kline, RP				Beltran, Juan Felipe; Wahba, Brandon Malik; Hose, Nicole; Shasha, Dennis; Kline, Richard P.		Alzheimer's Dis Neuroimaging Init	Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database	PLOS ONE			English	Article							HYPOTHETICAL MODEL; COGNITIVE DECLINE; COMPOSITE SCORE; ATROPHY RATE; CONVERSION; DIAGNOSIS; TOXICITY; MARKER; MEMORY; MCI	The Alzheimer's Disease Neuroimaging (ADNI) database is an expansive undertaking by government, academia, and industry to pool resources and data on subjects at various stage of symptomatic severity due to Alzheimer's disease. As expected, magnetic resonance imaging is a major component of the project. Full brain images are obtained at every 6-month visit. A range of cognitive tests studying executive function and memory are employed less frequently. Two blood draws (baseline, 6 months) provide samples to measure concentrations of approximately 145 plasma biomarkers. In addition, other diagnostic measurements are performed including PET imaging, cerebral spinal fluid measurements of amyloid-beta and tau peptides, as well as genetic tests, demographics, and vital signs. ADNI data is available upon review of an application. There have been numerous reports of how various processes evolve during AD progression, including alterations in metabolic and neuroendocrine activity, cell survival, and cognitive behavior. Lacking an analytic model at the onset, we leveraged recent advances in machine learning, which allow us to deal with large, non-linear systems with many variables. Of particular note was examining how well binary predictions of future disease states could be learned from simple, non-invasive measurements like those dependent on blood samples. Such measurements make relatively little demands on the time and effort of medical staff or patient. We report findings with recall/precision/area under the receiver operator curve after application of CART, Random Forest, Gradient Boosting, and Support Vector Machines, Our results show (i) Random Forests and Gradient Boosting work very well with such data, (ii) Prediction quality when applied to relatively easily obtained measurements (Cognitive scores, Genetic Risk and plasma biomarkers) achieve results that are competitive with magnetic resonance techniques. This is by no means an exhaustive study, but instead an exploration of the plausibility of defining a series of relatively inexpensive, broad population based tests.	[Beltran, Juan Felipe; Wahba, Brandon Malik; Shasha, Dennis] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA; [Hose, Nicole] Fordham Univ, Lincoln Ctr Campus, New York, NY 10023 USA; [Kline, Richard P.] NYU, Dept Anesthesiol, Langone Med Ctr, Ctr Cognit Neurol, New York, NY 10016 USA; [Beltran, Juan Felipe] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Beltran, Juan Felipe] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA; [Wahba, Brandon Malik] Washington Univ, Med Sch, St Louis, MO 63110 USA	New York University; Fordham University; New York University; NYU Langone Medical Center; Cornell University; Cornell University; Washington University (WUSTL)	Kline, RP (corresponding author), NYU, Dept Anesthesiol, Langone Med Ctr, Ctr Cognit Neurol, New York, NY 10016 USA.	rpk1@columbia.edu		Wahba, Brandon Malik/0000-0002-8767-5195	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; BristolMyers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; National Institute of Biomedical Imaging and Bioengineering	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); BristolMyers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; BristolMyers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Avidan MS, 2009, ANESTHESIOLOGY, V111, P964, DOI 10.1097/ALN.0b013e3181bc9719; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Crane PK, 2012, BRAIN IMAGING BEHAV, V6, P502, DOI 10.1007/s11682-012-9186-z; Criscuolo C, 2014, NEUROBIOL AGING; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; DELEON MJ, 1989, LANCET, V2, P672; Deroo S., 2014, ACS CHEM BIOL; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Dimitriadis SI, 2018, J NEUROSCI METH, V302, P14, DOI 10.1016/j.jneumeth.2017.12.010; Doan L, 2017, SCAND J PAIN; Friedman JH, 1997, DATA MIN KNOWL DISC, V1, P55, DOI 10.1023/A:1009778005914; Gibbons LE, 2012, BRAIN IMAGING BEHAV, V6, P517, DOI 10.1007/s11682-012-9176-1; Gomes S, 2014, J NEUROENDOCRINOL, V26, P176, DOI 10.1111/jne.12138; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Jack C, ALZHEIMERS DEMENTIA, V9, pP521; Jack CR, 2017, ALZHEIMERS DEMENT, V13, P205, DOI 10.1016/j.jalz.2016.08.005; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kaminsky YG, 2015, FRONT BIOSCI-LANDMRK, V20, P173, DOI 10.2741/4304; Kim YJ, 2014, J ALZHEIMERS DIS; Kline R, 2016, Int J Anesthesiol Res, V4, P313, DOI 10.19070/2332-2780-1600065; Lama RK, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/5485080; Lebedev AV, 2014, NEUROIMAGE-CLIN, V6, P115, DOI 10.1016/j.nicl.2014.08.023; Louppe G., 2014, ARXIV14077502, DOI [10. 13140/2.1.1570.5928, DOI 10.13140/2.1.1570.5928]; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Mosconi L, 2007, EUR J NUCL MED MOL I, V34, P1467, DOI 10.1007/s00259-007-0406-5; Mosconi L, 2007, EXP GERONTOL, V42, P129, DOI 10.1016/j.exger.2006.05.016; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Rusinek H, 2004, NEUROLOGY, V63, P2354, DOI 10.1212/01.WNL.0000148602.30175.AC; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Varma VR, 2017, MOL PSYCHIATR, V22, P13, DOI 10.1038/mp.2016.206	39	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0235663	10.1371/journal.pone.0235663	http://dx.doi.org/10.1371/journal.pone.0235663			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716914	Green Published, gold			2022-12-26	WOS:000556674500039
J	Colonna, JG; Carvalho, JRH; Rosso, OA				Colonna, Juan G.; Carvalho, Jose R. H.; Rosso, Osvaldo A.			Estimating ecoacoustic activity in the Amazon rainforest through Information Theory quantifiers	PLOS ONE			English	Article							ACOUSTIC INDEXES; SOUNDSCAPE; BIODIVERSITY; LANDSCAPE	Automatic monitoring of biodiversity by acoustic sensors has become an indispensable tool to assess environmental stress at an early stage. Due to the difficulty in recognizing the Amazon's high acoustic diversity and the large amounts of raw audio data recorded by the sensors, the labeling and manual inspection of this data is not feasible. Therefore, we propose an ecoacoustic index that allows us to quantify the complexity of an audio segment and correlate this measure with the biodiversity of the soundscape. The approach uses unsupervised methods to avoid the problem of labeling each species individually. The proposed index, named the Ecoacoustic Global Complexity Index (EGCI), makes use of Entropy, Divergence and Statistical Complexity. A distinguishing feature of this index is the mapping of each audio segment, including those of varied lengths, as a single point in a 2D-plane, supporting us in understanding the ecoacoustic dynamics of the rainforest. The main results show a regularity in the ecoacoustic richness of a floodplain, considering different temporal granularities, be it between hours of the day or between consecutive days of the monitoring program. We observed that this regularity does a good job of characterizing the soundscape of the environmental protection area of Mamiraua, in the Amazon, differentiating between species richness and environmental phenomena.	[Colonna, Juan G.; Carvalho, Jose R. H.] Univ Fed Amazonas UFAM, Inst Comp IComp, Manaus, Amazonas, Brazil; [Rosso, Osvaldo A.] Univ Fed Alagoas UFAL, Inst Fis, Maceio, Alagoas, Brazil	Universidade Federal de Amazonas; Universidade Federal de Alagoas	Colonna, JG (corresponding author), Univ Fed Amazonas UFAM, Inst Comp IComp, Manaus, Amazonas, Brazil.	juancolonna@icomp.ufam.edu.br	Colonna, Juan/AAF-1969-2021; Rosso, Osvaldo/O-4929-2019	Rosso, Osvaldo/0000-0002-1288-2528; Colonna, Juan/0000-0002-1740-2618	Instituto de Desenvolvimento Sustentavel Mamiraua; Gordon and Betty Moore Foundation; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)-PAPAC Project [005/2019]	Instituto de Desenvolvimento Sustentavel Mamiraua; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)-PAPAC Project	The authors would like to thank the Instituto de Desenvolvimento Sustentavel Mamiraua for their support in coordinating the Providence Project. The authors thank the Gordon and Betty Moore Foundation for their grant support and scholarships. We are grateful to all the institutions that took part in the Providence Project, including the Commonwealth Scientific and Industrial Research Organization (CSIRO), The Sense of Silence Foundation and the Technical University of Catalonia. We also thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), for the institutional support, and the Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)-PAPAC Project (Public Notice 005/2019).	Affonso AG, 2015, BRAZ J BIOL, V75, pS60, DOI 10.1590/1519-6984.04214; Aide TM, 2013, PEERJ, V1, DOI 10.7717/peerj.103; Alonso JB, 2017, EXPERT SYST APPL, V72, P83, DOI 10.1016/j.eswa.2016.12.019; Bermant P. C., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Bjorck J, 2019, AUTOMATIC DETECTION; Boelman NT, 2007, ECOL APPL, V17, P2137, DOI 10.1890/07-0004.1; Colonna JG, 2018, MACH LEARN, V107, P1651, DOI 10.1007/s10994-018-5739-8; Fairbrass AJ, 2017, ECOL INDIC, V83, P169, DOI 10.1016/j.ecolind.2017.07.064; Farina A, 2016, BIOSEMIOTICS-NETH, V9, P227, DOI 10.1007/s12304-016-9266-3; Farina A., 2017, ECOACOUSTICS ECOLOGI, DOI [10.1002/9781119230724, DOI 10.1002/9781119230724, 10.1002/9781119230724.ch1]; Farina A, 2019, MATHEMATICS-BASEL, V7, DOI 10.3390/math7010021; Ferreira-Ferreira J, 2015, WETL ECOL MANAG, V23, P41, DOI 10.1007/s11273-014-9359-1; Fuller S, 2015, ECOL INDIC, V58, P207, DOI 10.1016/j.ecolind.2015.05.057; Gasc A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065311; Ravetti MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108004; Ivan K, 2018, NEURAL COMPUTING APP; Joo W, 2011, LANDSCAPE URBAN PLAN, V103, P259, DOI 10.1016/j.landurbplan.2011.08.001; Kasten EP, 2012, ECOL INFORM, V12, P50, DOI 10.1016/j.ecoinf.2012.08.001; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Melo-Santos G, 2019, PEERJ, V7, DOI 10.7717/peerj.6670; Oliver RY, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1084; Passerini F, 2012, ARXIV08122597V2; Pieretti N, 2011, ECOL INDIC, V11, P868, DOI 10.1016/j.ecolind.2010.11.005; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Rao KVSNR, 2018, LECT NOTES ARTIF INT, V11320, P160, DOI 10.1007/978-3-030-03991-2_17; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; Rosso OA, 2012, PHYSICA A, V391, P42, DOI 10.1016/j.physa.2011.07.030; Rosso OA, 2010, INT J BIFURCAT CHAOS, V20, P775, DOI 10.1142/S021812741002606X; Shiner JS, 1999, PHYS REV E, V59, P1459, DOI 10.1103/PhysRevE.59.1459; Sueur J, 2019, TRENDS ECOLOGY EVOLU; Sueur J., 2009, PUBLIC LIB SCI, V3, P1; Sueur J, 2014, ACTA ACUST UNITED AC, V100, P772, DOI 10.3813/AAA.918757; Vu TT, 2019, INT J PRIMATOL, V40, P169, DOI 10.1007/s10764-018-0073-3; Tome AM, 2010, STAT INTERFACE, V3, P345; Villanueva-Rivera LJ, 2011, LANDSCAPE ECOL, V26, P1233, DOI 10.1007/s10980-011-9636-9; Wilcox R. R., 2012, INTRO ROBUST ESTIMAT; Wold H., 1938, ANAL STATIONARY TIME; Xie J, 2019, ECOL INFORM, V52, P74, DOI 10.1016/j.ecoinf.2019.05.007; Xie J, 2017, ECOL INDIC, V82, P13, DOI 10.1016/j.ecolind.2017.06.015; Yoon JH, 2010, CLIM DYNAM, V34, P249, DOI 10.1007/s00382-009-0551-6	40	0	0	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0229425	10.1371/journal.pone.0229425	http://dx.doi.org/10.1371/journal.pone.0229425			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716981	Green Published, gold			2022-12-26	WOS:000556674500016
J	Iljicsov, A; Milanovich, D; Ajtay, A; Oberfrank, F; Balint, M; Dobi, B; Bereczki, D; Simo, M				Iljicsov, Anna; Milanovich, Daniel; Ajtay, Andras; Oberfrank, Ferenc; Balint, Monika; Dobi, Balazs; Bereczki, Daniel; Simo, Magdolna			Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data	PLOS ONE			English	Article							INCREASING PREVALENCE; CSONGRAD COUNTY; DISEASE; EPIDEMIOLOGY; DIAGNOSIS; REVISIONS; TUSCANY; TRENDS; IRAN; AGE	Objectives As there were only regional studies in Hungary about the prevalence of multiple sclerosis (MS), we aimed to estimate its epidemiological features using data of Hungary's single-payer health insurance system. Methods Pseudonymized database of claims reported by hospitals and outpatient services between 2004-2016 was analyzed and linked with an independent database of outpatient pharmacy refills between 2010-2016. We established an administrative case definition of MS and validated it on medical records of 309 consecutive patients. A subject was defined as MS-patient if received MS diagnosis (International Classification of Diseases, 10th edition, code G35) on three or more occasions at least in 2 calendar years and at least once documented by a neurologist. Patients were counted as incident cases in the year of the first submitted claim for MS. We allowed a 6-year-long run-in period, so only data between 2010-2015 are discussed. Results Sensitivity of the administrative case definition turned out to be 99%, while specificity was >99%. Crude prevalence of MS has increased from 109.3/100,000 in 2010 to 130.8/100,000 in 2015 (p-value = 0.000003). Crude incidence declined from 7.1/100,000 (2010) to 5.4/100,000 (2015) (p-value = 0.018). Direct standardization - based on European standard population and results of nationwide Hungarian census of 2011 - revealed that age standardized prevalence was 105.2/100,000 (2010), which has grown to 127.2/100,000 (2015) (p-value = 0.000001). Age standardized incidence rate declined from 6.7/100,000 (2010) to 5.1/100,000 (2015) (p-value = 0.016). The ratio of MS-patients receiving >= 1 prescription for disease modifying treatment increased from 0.19 (2010) to 0.29 (2015) (p-value = 0.0051). The female/male ratio of prevalent cases remained 2.6. Discussion The prevalence of MS in Hungary is higher than previously reported, the incidence rate is moderate. The prevalence is rising, the incidence rate shows decline. The proportion of patients receiving disease modifying treatment grows but was still around 30% in 2015.	[Iljicsov, Anna; Milanovich, Daniel; Ajtay, Andras; Bereczki, Daniel; Simo, Magdolna] Semmelweis Univ, Dept Neurol, Budapest, Hungary; [Ajtay, Andras; Bereczki, Daniel] MTA SE Neuroepidemiol Res Grp, Budapest, Hungary; [Oberfrank, Ferenc] Inst Expt Med, Budapest, Hungary; [Balint, Monika] Ctr Econ & Reg Studies, Budapest, Hungary; [Dobi, Balazs] Eotvos Lorand Univ, Dept Probabil Theory & Stat, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies; Eotvos Lorand University	Iljicsov, A; Bereczki, D (corresponding author), Semmelweis Univ, Dept Neurol, Budapest, Hungary.; Bereczki, D (corresponding author), MTA SE Neuroepidemiol Res Grp, Budapest, Hungary.	iljicsov.anna@med.semmelweis-univ.hu; bereczki.daniel@med.semmelweis-univ.hu		Bereczki, Daniel/0000-0002-8374-0500; Dobi, Balazs/0000-0002-1187-4104; Milanovich, Daniel/0000-0002-3182-4067	National Brain Research Program [2017-2-1-NKP-2017-00002]; Ministry of Human Resources of the Government of Hungary [UNKP-17-3]	National Brain Research Program; Ministry of Human Resources of the Government of Hungary	DB, AA and OF were supported by grants from the National Brain Research Program 2017-2-1-NKP-2017-00002 DB and AI by the Higher Education Institutional Excellence Program and the New National Excellence Program (UNKP-17-3) of the Ministry of Human Resources of the Government of Hungary. The Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; Al-Sakran LH, 2018, CAN J NEUROL SCI, V45, P295, DOI 10.1017/cjn.2017.301; [Anonymous], 1995, HUNG POP CENS 2011; Bencsik K, 1998, ACTA NEUROL SCAND, V97, P315, DOI 10.1111/j.1600-0404.1998.tb05959.x; Bencsik K, 2001, EUR NEUROL, V46, P206, DOI 10.1159/000050806; Benjak T, 2018, CROAT MED J, V59, P65, DOI 10.3325/cmj.2018.59.65; Bentzen J, 2010, MULT SCLER J, V16, P520, DOI 10.1177/1352458510364197; Bereczki D, 2011, IDEGGYOGY SZEMLE, V64, P173; Bezzini D, 2020, NEUROL SCI, V41, P397, DOI 10.1007/s10072-019-04090-0; Bezzini D, 2018, NEUROL SCI, V39, P1881, DOI 10.1007/s10072-018-3513-0; Bezzini D, 2016, NEUROEPIDEMIOLOGY, V46, P37, DOI 10.1159/000441567; Biernacki T, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1598; Brola W, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0662-8; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Celius EG, 2009, ACTA NEUROL SCAND, V120, P27, DOI 10.1111/j.1600-0404.2009.01208.x; COMPSTON A, 2005, MCALPINES MULTIPLE S, P71; Culpepper WJ, 2019, NEUROLOGY, V92, pE1016, DOI 10.1212/WNL.0000000000007043; Culpepper WJ, 2006, J REHABIL RES DEV, V43, P17, DOI 10.1682/JRRD.2004.09.0122; Daltrozzo T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00871; DALY L, 1992, COMPUT BIOL MED, V22, P351, DOI 10.1016/0010-4825(92)90023-G; Elhami SR, 2011, NEUROEPIDEMIOLOGY, V36, P141, DOI 10.1159/000324708; European Multiple Sclerosis Platform, 2004, MS BAR 2015 RAIS VOI; EUROSTAT, 2013, METH WORK PAP REV EU; Fay MP, 1997, STAT MED, V16, P791; Giovannoni G, 2016, MULT SCLER RELAT DIS, V9, pS5, DOI 10.1016/j.msard.2016.07.003; Grytten N, 2015, ACTA NEUROL SCAND, V132, P29, DOI 10.1111/ane.12428; Hirst C, 2009, J NEUROL NEUROSUR PS, V80, P386, DOI 10.1136/jnnp.2008.144667; Hoer A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-381; Kapica-Topczewska K, 2018, MULT SCLER RELAT DIS, V21, P51, DOI 10.1016/j.msard.2018.02.016; Kingwell E, 2015, J NEUROL, V262, P2352, DOI 10.1007/s00415-015-7842-0; Koch-Henriksen N, 2018, NEUROLOGY, V90, pE1954, DOI [10.1212/WNL.0000000000005612, 10.1212/wnl.0000000000005612]; Krokki O, 2011, MULT SCLER J, V17, P133, DOI 10.1177/1352458510384012; Lauer K, 1994, MULTIPLE SCLEROSIS E, P279; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; Maghzi AH, 2010, MULT SCLER, V16, P359, DOI 10.1177/1352458509358092; Marrie RA, 2010, NEUROLOGY, V74, P465, DOI 10.1212/WNL.0b013e3181cf6ec0; Marrie RA, 2015, NEUROLOGY, V85, P240, DOI 10.1212/WNL.0000000000001718; Marrie RA, 2013, CAN J NEUROL SCI, V40, P824, DOI 10.1017/S0317167100015961; Marrie RA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-16; Murtonen A, 2020, ACTA NEUROL SCAND, V141, P311, DOI 10.1111/ane.13203; Oberfrank F, 2018, EUR J NEUROL, V25, P984, DOI 10.1111/ene.13645; Otero-Romero S, 2013, MULT SCLER J, V19, P245, DOI 10.1177/1352458512444751; Palffy G, 1994, MULTIPLE SCLEROSIS E, P274; Pentek M, 2012, IDEGGYOGY SZEMLE, V65, P316; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Rotstein DL, 2018, NEUROLOGY, V90, pE1435, DOI 10.1212/WNL.0000000000005331; Roux J, 2019, MULT SCLER J-EXP TRA, V5, DOI 10.1177/2055217319896090; Salhofer-Polanyi S, 2017, NEUROEPIDEMIOLOGY, V49, P40, DOI 10.1159/000479696; Solomon AJ, 2016, NEUROLOGY, V87, P1393, DOI 10.1212/WNL.0000000000003152; Szatmari S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00640; Thompson AJ, 2014, MAPPING MULTIPLE SCL; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Trojano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048078; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Widdifield J, 2015, MULT SCLER J, V21, P1045, DOI 10.1177/1352458514556303; Zsiros V, 2014, ACTA NEUROL SCAND, V130, P277, DOI 10.1111/ane.12219	58	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236432	10.1371/journal.pone.0236432	http://dx.doi.org/10.1371/journal.pone.0236432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716953	Green Published, Green Accepted, gold			2022-12-26	WOS:000556674500041
J	Sandhu, RK; Boyd, NS; Qiu, Q; Guan, ZF				Sandhu, Ravneet K.; Boyd, Nathan S.; Qiu, Qi; Guan, Zhegfei			Optimization of planting dates of Jalapeno pepper (Capsicum annuum'Jalapeno' L.) and cantaloupe (Cucumis melovar.cantalupensisSer.) relay cropped with strawberry (Fragaria x ananassaDuchesne)	PLOS ONE			English	Article							ROOT RESTRICTION; YIELD; PRODUCTIVITY; COMPETITION; QUALITY; GROWTH; SEASON	Florida strawberry growers frequently relay-crop (RC) vegetables with strawberry to offset high input costs. Relay-cropping consists of planting two crops at different times on the same raised bed which helps growers' lower risk due to diversification and maximize economic returns. Four separate experiments on relay cropping strawberry with jalapeno pepper and cantaloupe were conducted at Balm, Florida, in 2016-17 and 2017-18. The objective was to a) determine the effects of relay-cropping on crop yields, b) optimize pepper and cantaloupe planting date, and c) optimize the strawberry termination date when relay cropping with vegetables. Strawberry yields were unaffected by the presence of vegetables. Pepper yields were unaffected by the presence of strawberries, but cantaloupes yields were significantly (p = 0.0250) lower when planted with strawberry. Early January to early-February were the optimum dates to transplant pepper with strawberries transplanted in October but date of planting did not affect cantaloupe yield. Early January to early-February transplant dates for pepper resulted in net profits of around $23000-38000/ha in 2016-17 compared to the baseline treatment (strawberries alone). However, in 2017-18 all of the planting dates of pepper with strawberry except January 4 resulted in losses of $2000-18000/ha. In 2016-17, cantaloupes planted in late January and early February resulted in profits of $2986.3 and 2705.1/ha, respectively. All other planting dates resulted in loses compared to baseline treatment. In 2017-18, all the planting dates resulted in net profits of around $6700-14500/ha. In conclusion, cantaloupe and jalapeno pepper can be relay cropped with strawberry with no negative effects on strawberry yield. However, early planting dates tend to maximize economic return.	[Sandhu, Ravneet K.; Boyd, Nathan S.; Qiu, Qi; Guan, Zhegfei] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL 33598 USA	State University System of Florida; University of Florida	Boyd, NS (corresponding author), Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL 33598 USA.	nsboyd@ufl.edu		Boyd, Nathan/0000-0002-1334-3964	Florida Department of Agriculture and Consumer Services [USDA-AMS-SCBGP-2017]	Florida Department of Agriculture and Consumer Services	NSB received the grant number "USDA-AMS-SCBGP-2017" from Florida Department of Agriculture and Consumer Services. https://freshfromflorida.force.com/grants/s/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade JM, 2014, ANAL CHIM ACTA, V838, P1, DOI 10.1016/j.aca.2014.04.057; [Anonymous], 2014, SECR AGR LIV RUR DEV; Cabello MJ, 2009, AGR WATER MANAGE, V96, P866, DOI 10.1016/j.agwat.2008.11.006; CHANDLER CK, 1992, HORTSCIENCE, V27, P1044, DOI 10.21273/HORTSCI.27.9.1044; D'Emilio A, 2017, T ASABE, V60, P1349, DOI 10.13031/trans.12234; Duval JR, 2005, HORTTECHNOLOGY, V15, P907, DOI 10.21273/HORTTECH.15.4.0907; Erickson AN, 2002, PLANT CELL ENVIRON, V25, P123, DOI 10.1046/j.0016-8025.2001.00807.x; Food and Resource Economics Department, 2008, STRAWB EST PROD COST; Freeman JH, 2018, VEGETABLE PRODUCTION, P55; FUKAI S, 1993, FIELD CROP RES, V34, P247, DOI 10.1016/0378-4290(93)90117-6; Guangyin Z, 2017, POLLUTION CONTROL AND RESOURCE RECOVERY: SEWAGE SLUDGE, P1; Hartz T., 2008, CANTALOUPE PRODUCTIO; Hubbard N.L, 2019, J AM SOC HORTIC SCI, V115, P798; Ismail MR, 1998, SCI HORTIC-AMSTERDAM, V74, P257, DOI 10.1016/S0304-4238(98)00090-9; Karlidag H, 2009, J SUSTAIN AGR, V33, P107, DOI 10.1080/10440040802587462; Kinet J. M., 1997, P207; Kitazawa H, 2005, J HORTIC SCI BIOTECH, V80, P677, DOI 10.1080/14620316.2005.11511997; Kumar S, 2002, IND CROP PROD, V15, P103, DOI 10.1016/S0926-6690(01)00100-5; LAMONT WJ, 1993, HORTSCIENCE, V28, P177, DOI 10.21273/HORTSCI.28.3.177; Liu G, 2018, VEGETABLE PRODUCTION, P3; Ma Ying-jie, 2020, Yingyong Shengtai Xuebao, V31, P1130, DOI 10.13287/j.1001-9332.202004.021; MOORE EL, 1952, P AM SOC HORTIC SCI, V60, P289; Ott MA, 2019, AGRON J, V111, P1281, DOI 10.2134/agronj2018.04.0277; Ozores-Hampton M, 2015, VEGETABLE PRODUCTION, P145; PETERSON TA, 1991, J EXP BOT, V42, P1233, DOI 10.1093/jxb/42.10.1233; Poling E.B., 1997, ADV STRAWB PROD, V10, P60; Pritts MP, 2001, HORTSCIENCE, V36, P729, DOI 10.21273/HORTSCI.36.4.729; Samtani JB, 2019, HORTTECHNOLOGY, V29, P11, DOI 10.21273/HORTTECH04135-18; Sandhu R.K, 2020, HORTSCIENCE, V55, P1; Santos BM, 2008, HORTTECHNOLOGY, V18, P656, DOI 10.21273/HORTTECH.18.4.656; Sato S, 2000, PLANT CELL ENVIRON, V23, P719, DOI 10.1046/j.1365-3040.2000.00589.x; Schaffer A. A., 1996, HOTOASSIMILATE DISTR, P729; Suh DH, 2017, INT FOOD AGRIBUS MAN, V20, P591, DOI [10.22434/ifamr2016.0075, 10.22434/IFAMR2016.0075]; U.S. Department of Labor B. o. L. S., 2017, OCCUPATIONAL EMPLOYM; US Department of Agriculture, 2016, SNAP ED STRAT INT OB, P1; USDA-NASS. United States department of agriculture, 2017, NAT AGR STTA SERV DA; Valantin-Morison M, 2006, J HORTIC SCI BIOTECH, V81, P105, DOI 10.1080/14620316.2006.11512036; Whitaker VM., 2019, VEGETABLE PRODUCTION, P311; Yu JL, 2018, HORTSCIENCE, V53, P445, DOI [10.21273/HORTSCI12658-17, 10.21273/hortsci12658-17]; ZHANG YY, 2012, STRAWBERRY IND OVERV, P17	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236677	10.1371/journal.pone.0236677	http://dx.doi.org/10.1371/journal.pone.0236677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716970	gold, Green Published			2022-12-26	WOS:000556674500036
J	Shava, E; Manyake, K; Mdluli, C; Maribe, K; Monnapula, N; Nkomo, B; Mosepele, M; Moyo, S; Mmalane, M; Barnighausen, T; Makhema, J; Bogart, LM; Lockman, S				Shava, Emily; Manyake, Kutlo; Mdluli, Charlotte; Maribe, Kamogelo; Monnapula, Neo; Nkomo, Bornapate; Mosepele, Mosepele; Moyo, Sikhulile; Mmalane, Mompati; Barnighausen, Till; Makhema, Joseph; Bogart, Laura M.; Lockman, Shahin			Acceptability of oral HIV self-testing among female sex workers in Gaborone, Botswana	PLOS ONE			English	Article							TRANSMISSION; PREVENTION; PREVALENCE; INFECTION; BARRIERS; MODES	Background HIV prevalence among female sex workers (FSW) in sub-Saharan Africa is much higher than in the general population. HIV self-testing (HIVST) may be useful for increasing testing rates in FSW. Methods We conducted semi-structured in-depth interviews among FSW, nurses and lay counsellors providing services to FSWs in Botswana. We aimed to gain understanding of perceived acceptability, anticipated barriers, and preferred approaches to HIVST among FSW. Interviews were audio-recorded, transcribed and translated. Transcripts were reviewed and coded independently by two investigators; high inter-coder agreement was achieved (Kappa = 0.80). Results We interviewed five care providers whose average age was 40 years (SD = 2,64, range = 37-43); three nurses and two counsellors. Thirty FSW were interviewed, with mean age 34 years (range = 20-52). Most (27; 90%) FSW expressed great interest in using HIVST kits. Facilitators of HIVST were: awareness of own risky sexual behaviours, desire to stay healthy, and perceived autonomy over one's healthcare decisions. Perceived advantages of HIVST included convenience, privacy, and perception of decreased stigma. Identified barriers to HIVST included lack of knowledge about the HIVST kit, fear of testing due to anticipated stigma, mistrust of the test's accuracy, doubt of self-competency to perform HIVST, and concerns about not linking to care. Assisting someone to test was noted as good for providing emotional support, but there were concerns about confidentiality breaches. Providers expressed concerns over low literacy among FSWs which could affect comprehension of testing instructions, and competency to perform testing and interpret results. Participants' recommendations for implementation of HIVST included: ensuring wide dissemination of information on HIVST, engaging peers in information-sharing and education, making test kits accessible in FSW-friendly centres, and having clear instructions for linkage to healthcare and support. Conclusion HIVST shows high acceptability among FSWs in Gaborone Botswana, with providers expressing some concerns. Implementation should be peer-driven with healthcare provider oversight.	[Shava, Emily; Manyake, Kutlo; Mdluli, Charlotte; Mosepele, Mosepele; Moyo, Sikhulile; Mmalane, Mompati; Makhema, Joseph; Lockman, Shahin] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Shava, Emily; Mosepele, Mosepele; Moyo, Sikhulile; Barnighausen, Till; Makhema, Joseph; Lockman, Shahin] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Maribe, Kamogelo; Monnapula, Neo] Nkaikela Youth Grp, Gaborone, Botswana; [Nkomo, Bornapate] Minist Hlth & Wellness, Gaborone, Botswana; [Mosepele, Mosepele] Univ Botswana, Gaborone, Botswana; [Barnighausen, Till] Heidelberg Univ, Heidelberg, Germany; [Barnighausen, Till] Wellcome Trust Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Bogart, Laura M.] RAND Corp, Santa Monica, CA USA; [Lockman, Shahin] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; University of Botswana; Ruprecht Karls University Heidelberg; RAND Corporation; Harvard University; Brigham & Women's Hospital	Shava, E (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.; Shava, E (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	emakunike@gmail.com	Moyo, Sikhulile/E-1464-2015; Bärnighausen, Till/Y-2388-2019	Moyo, Sikhulile/0000-0003-3821-4592; Shava, Emily/0000-0001-9288-7881	Harvard University Center for AIDS Research (HU CFAR NIH/NIAID fund) [5P30AI060354-15]; NIH/Fogarty International Center [R21TW011069]; NIH/NIMH [P30MH058107]	Harvard University Center for AIDS Research (HU CFAR NIH/NIAID fund); NIH/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	E.S was supported by Harvard University Center for AIDS Research (HU CFAR NIH/NIAID fund 5P30AI060354-15). L.M.B was supported by NIH/Fogarty International Center R21TW011069 and NIH/NIMH P30MH058107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency BNAC, 2015, PROGR REP NAT RESP 2; Baral S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115465; Burke VM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183280; Case KK, 2012, B WORLD HEALTH ORGAN, V90, P831, DOI 10.2471/BLT.12.102574; Chanda MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002442; Chanda MM, 2017, AIDS PATIENT CARE ST, V31, P290, DOI 10.1089/apc.2017.0016; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Go Malawi, 2017, MALAWI COUNTRY OPERA; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Hargreaves JR, 2016, HEALTH POLICY PLANN, V31, P1342, DOI 10.1093/heapol/czw071; Harichund C, 2019, AIDS CARE, V31, P186, DOI 10.1080/09540121.2018.1503638; Harichund C, 2018, AIDS BEHAV, V22, P560, DOI 10.1007/s10461-017-1848-9; Health BMo, 2013, 2012 MAPP SIZ EST BE; Hladik W, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4428-z; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; Johnson LF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49109-w; Kelvin EA, 2019, AIDS BEHAV, V23, P116, DOI 10.1007/s10461-018-2248-5; Kelvin EA, 2018, AIDS CARE, V30, P47, DOI 10.1080/09540121.2017.1360997; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; King EJ, 2017, GLOB PUBLIC HEALTH, V12, P876, DOI 10.1080/17441692.2015.1124905; Merrigan MB, 2015, AIDS BEHAV, V19, P899, DOI 10.1007/s10461-014-0858-0; MOHW B, 2017, MAPPING SIZE ESTIMAT; Mugo PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170868; Mulubwa C, 2019, LANCET HIV, V6, pE81, DOI 10.1016/S2352-3018(18)30258-3; Nakanwagi S, 2016, J SEX TRANSM DIS, V2016, P1, DOI [10.1155/2016/7673014, DOI 10.1155/2016/7673014]; Njau B, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0230-8; Nnko S, 2018, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6362-0; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Oduetse OK, 2019, AJAR-AFR J AIDS RES, V18, P192, DOI 10.2989/16085906.2019.1638427; Oldenburg CE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014780; Ortblad KF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022652; Ortblad KF, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3415-z; Ortblad KF, 2018, JAIDS-J ACQ IMM DEF, V79, pE42, DOI 10.1097/QAI.0000000000001765; ORUBULOYE IO, 1992, STUD FAMILY PLANN, V23, P343, DOI 10.2307/1966892; Park JN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1220; Qin YL, 2018, AIDS, V32, P371, DOI 10.1097/QAD.0000000000001705; Relief USPsEPFA, 2016, BOTSW COUNTR OP PLAN; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2014, CURR OPIN HIV AIDS, V9, P174, DOI 10.1097/COH.0000000000000042; Stevens DR, 2018, AIDS BEHAV, V22, P497, DOI 10.1007/s10461-017-1707-8; Warren EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198680; WHO, 2016, GUID HIV SELF TEST P	42	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236052	10.1371/journal.pone.0236052	http://dx.doi.org/10.1371/journal.pone.0236052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV9ND	32716966	gold, Green Published			2022-12-26	WOS:000556674500002
J	Nacher, M; Adenis, A; Guarmit, B; Lucarelli, A; Blanchet, D; Demar, M; Djossou, F; Abboud, P; Epelboin, L; Couppie, P				Nacher, Mathieu; Adenis, Antoine; Guarmit, Basma; Lucarelli, Aude; Blanchet, Denis; Demar, Magalie; Djossou, Felix; Abboud, Philippe; Epelboin, Loic; Couppie, Pierre			What is AIDS in the Amazon and the Guianas in the 90-90-90 era?	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; DISSEMINATED HISTOPLASMOSIS; DIAGNOSIS	Introduction In the past decade, new diagnostic methods and strategies have appeared, HIV testing efforts and the generalization of antiretroviral therapy may have influenced the number of opportunistic diagnoses and mortality of HIV-infected patients. To test this hypothesis we compiled data on the top opportunistic infections and causes of early death in the HIV cohort of French Guiana. Methods HIV-infected persons followed in Cayenne, Kourou, and Saint Laurent du Maroni hospitals from 2010 to 2019 were studied. Annual incidence of different opportunistic infections and annual deaths are compiled. For patients with opportunistic infections we calculated the proportion of early deaths. Results At the time of analysis, among 2 459 patients, (treated and untreated) 90% had a viral load < 400 copies, 91% of the patients in the cohort were on antiretroviral treatment, and 94.2% of patients on treatment for over 6 months had undetectable viral loads. Only 9% of patients had CD4 counts under 200 per mm(3). Histoplasmosis clearly remained the most frequent (128 cases) opportunistic infection among HIV-infected persons followed by cerebral toxoplasmosis (63 cases) and esophageal candidiasis (41 cases). Cryptococcal meningitis was ranked 5th most frequent opportunistic infection as was tuberculosis (31 cases). The trend for a sharp decline in early deaths continued (3.9% of patients). Conclusions Despite the successes of antiretrovirals, patients presenting with advanced HIV are still common and they are still at risk of dying. Improved diagnosis, and notably systematic screening with appropriate tools are still important areas of potential progress.	[Nacher, Mathieu; Adenis, Antoine] Ctr Hosp Cayenne, Ctr Invest Clin Antilles Guyane, INSERM 1424, Cayenne, French Guiana; [Nacher, Mathieu; Adenis, Antoine; Guarmit, Basma] Ctr Hosp Cayenne, COREVIH Guyane, Cayenne, French Guiana; [Nacher, Mathieu; Demar, Magalie; Couppie, Pierre] Univ Guyane, DFR Sante, Cayenne, French Guiana; [Lucarelli, Aude] Ctr Hosp Cayenne, Hop Jour Adultes, Cayenne, French Guiana; [Blanchet, Denis; Demar, Magalie] Ctr Hosp Cayenne, Cayenne, French Guiana; [Demar, Magalie] Univ Guyane, UMR TBIP, Cayenne, French Guiana; [Djossou, Felix; Abboud, Philippe; Epelboin, Loic] Ctr Hosp Cayenne, Serv Malad Infect & Trop, Cayenne, French Guiana; [Couppie, Pierre] Ctr Hosp Cayenne, Serv Dermatol Venereol, Cayenne, French Guiana		Nacher, M (corresponding author), Ctr Hosp Cayenne, Ctr Invest Clin Antilles Guyane, INSERM 1424, Cayenne, French Guiana.; Nacher, M (corresponding author), Ctr Hosp Cayenne, COREVIH Guyane, Cayenne, French Guiana.; Nacher, M (corresponding author), Univ Guyane, DFR Sante, Cayenne, French Guiana.	mathieu.nacher@ch-cayenne.fr	nacher, mathieu/AAH-4796-2021; Adenis, Antoine/AAI-1059-2021; Pierre Demar, Magalie/L-4268-2013	nacher, mathieu/0000-0001-9397-3204; Adenis, Antoine/0000-0003-4000-4981; Pierre Demar, Magalie/0000-0003-3414-0821				Adenis A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003100; Adenis AA, 2018, LANCET INFECT DIS, V18, P1150, DOI 10.1016/S1473-3099(18)30354-2; Caceres DH, 2019, CURR FUNGAL INFECT R, V13, P244, DOI 10.1007/s12281-019-00365-3; Caceres DH, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM01959-17, 10.1128/JCM.01959-17]; Caceres DH, 2015, AM J TROP MED HYG, V93, P662, DOI 10.4269/ajtmh.15-0108; Caceres DH, 2014, CLIN VACCINE IMMUNOL, V21, P1364, DOI 10.1128/CVI.00101-14; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Nacher M., 2020, HIV FRENCH GUIANA HI, V9; Nacher M., 2020, GLOBAL HLTH FRENCH G, V10; Nacher Mathieu, 2018, BMC Res Notes, V11, P831, DOI 10.1186/s13104-018-3944-y; Nacher M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006802; Nacher M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197990; Nacher M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002638; Nacher M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002319; Nacher M, 2011, AM J TROP MED HYG, V84, P239, DOI 10.4269/ajtmh.2011.10-0251; Vantilcke V, 2014, INT J STD AIDS, V25, P656, DOI 10.1177/0956462413516299	17	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236368	10.1371/journal.pone.0236368	http://dx.doi.org/10.1371/journal.pone.0236368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706836	Green Published, gold, Green Submitted			2022-12-26	WOS:000579931700034
J	Vashistha, V; Poonnen, PJ; Snowdon, JL; Skinner, HG; McCaffrey, V; Spector, NL; Hintze, B; Duffy, JE; Weeraratne, D; Jackson, GP; Kelley, MJ; Patel, VL				Vashistha, Vishal; Poonnen, Pradeep J.; Snowdon, Jane L.; Skinner, Halcyon G.; McCaffrey, Victoria; Spector, Neil L.; Hintze, Bradley; Duffy, Jill E.; Weeraratne, Dilhan; Jackson, Gretchen P.; Kelley, Michael J.; Patel, Vimla L.			Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program	PLOS ONE			English	Article							LUNG-CANCER; TUMOR; ATTITUDES	Background To support the rising need for testing and to standardize tumor DNA sequencing practices within the U.S. Department of Veterans Affairs (VA)'s Veterans Health Administration (VHA), the National Precision Oncology Program (NPOP) was launched in 2016. We sought to assess oncologists' practices, concerns, and perceptions regarding Next-Generation Sequencing (NGS) and the NPOP. Materials and methods Using a purposive total sampling approach, oncologists who had previously ordered NGS for at least one tumor sample through the NPOP were invited to participate in semi-structured interviews. Questions assessed the following: expectations for the NPOP, procedural requirements, applicability of testing results, and the summative utility of the NPOP. Interviews were assessed using an open coding approach. Thematic analysis was conducted to evaluate the completed codebook. Themes were defined deductively by reviewing the direct responses to interview questions as well as inductively by identifying emerging patterns of data. Results Of the 105 medical oncologists who were invited to participate, 20 (19%) were interviewed from 19 different VA medical centers in 14 states. Five recurrent themes were observed: (1) Educational Efforts Regarding Tumor DNA Sequencing Should be Undertaken, (2) Pathology Departments Share a Critical Role in Facilitating Test Completion, (3) Tumor DNA Sequencing via NGS Serves as the Most Comprehensive Testing Modality within Precision Oncology, (4) The Availability of the NPOP Has Expanded Options for Select Patients, and (5) The Completion of Tumor DNA Sequencing through the NPOP Could Help Improve Research Efforts within VHA Oncology Practices. Conclusion Medical oncologists believe that the availability of tumor DNA sequencing through the NPOP could potentially lead to an improvement in outcomes for veterans with metastatic solid tumors. Efforts should be directed toward improving oncologists' understanding of sequencing, strengthening collaborative relationships between oncologists and pathologists, and assessing the role of comprehensive NGS panels within the battery of precision tests.	[Vashistha, Vishal; Poonnen, Pradeep J.; Spector, Neil L.; Hintze, Bradley; Duffy, Jill E.; Kelley, Michael J.] Dept Vet Affairs, Natl Precis Oncol Program, Durham, NC 27707 USA; [Vashistha, Vishal; Poonnen, Pradeep J.; Spector, Neil L.; Kelley, Michael J.] Duke Canc Inst, Durham, NC 27710 USA; [Vashistha, Vishal; Poonnen, Pradeep J.; Spector, Neil L.; Kelley, Michael J.] Durham Vet Affairs Med Ctr, Dept Hematol & Oncol, Durham, NC 27705 USA; [Snowdon, Jane L.; McCaffrey, Victoria; Weeraratne, Dilhan; Jackson, Gretchen P.] IBM Corp, Watson Hlth, Cambridge, MA USA; [Skinner, Halcyon G.] Lehigh Univ, Coll Hlth, Bethlehem, PA 18015 USA; [Jackson, Gretchen P.] Vanderbilt Univ, Med Ctr, Sect Surg Sci, Nashville, TN USA; [Patel, Vimla L.] New York Acad Med, Ctr Cognit Sci Med & Publ Hlth, New York, NY USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; International Business Machines (IBM); Lehigh University; Vanderbilt University; New York Academy of Medicine	Vashistha, V (corresponding author), Dept Vet Affairs, Natl Precis Oncol Program, Durham, NC 27707 USA.; Vashistha, V (corresponding author), Duke Canc Inst, Durham, NC 27710 USA.; Vashistha, V (corresponding author), Durham Vet Affairs Med Ctr, Dept Hematol & Oncol, Durham, NC 27705 USA.	vishal.vashistha@duke.edu	Kelley, Michael/AAC-8939-2019	Kelley, Michael/0000-0001-9523-6080; Jackson, Gretchen/0000-0002-3242-8058	IBM Watson Health	IBM Watson Health(International Business Machines (IBM))	An affiliation with a funder, IBM Watson Health, was shared among a few of our authors. The funder provided support in the form of salaries for authors [JLS, VM, DW, GPJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder also provided support in the form of previous salary to one author (HGS) and consultative fees for one author (VLP). The specific roles of these authors are articulated in the 'author contributions' section. For the purposes of this study, the funder did provide support in the form of research materials.	Arney Jennifer, 2018, Fed Pract, V35, pS53; Arney J, 2018, LUNG CANCER, V116, P25, DOI 10.1016/j.lungcan.2017.12.006; Bijlsma RM, 2018, PSYCHO-ONCOLOGY, V27, P1327, DOI 10.1002/pon.4676; Bijlsma RM, 2018, FAM CANCER, V17, P309, DOI 10.1007/s10689-017-0033-7; Bode AM, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0055-0; Boland P, 2015, CLIN GENET, V88, P565, DOI 10.1111/cge.12555; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Damodaran Senthilkumar, 2015, Am Soc Clin Oncol Educ Book, pe175, DOI 10.14694/EdBook_AM.2015.35.e175; Davis W, 2019, J ONCOL PRACT, V15, P656, DOI 10.1200/JOP.19.00269; Goedde LN, 2017, J GENET COUNS, V26, P878, DOI 10.1007/s10897-017-0065-z; Gray SW, 2014, J CLIN ONCOL, V32, P1317, DOI 10.1200/JCO.2013.52.4298; Hancock C, 2019, CLIN OUTCOMES NEXT G, V17, pCLO19, DOI [10.6004/jnccn.2018.7169, DOI 10.6004/JNCCN.2018.7169]; Haspel RL, 2014, ARCH PATHOL LAB MED, V138, P498, DOI 10.5858/arpa.2013-0359-SA; Johnson A, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00036; Johnson LM, 2017, CANCER-AM CANCER SOC, V123, P2352, DOI 10.1002/cncr.30581; Kurnit KC, 2018, CLIN CANCER RES, V24, P2719, DOI 10.1158/1078-0432.CCR-17-2494; Lynch JA, 2017, CLIN LUNG CANCER, V18, P401, DOI 10.1016/j.cllc.2016.11.018; Mandelker D, 2017, JAMA-J AM MED ASSOC, V318, P825, DOI 10.1001/jama.2017.11137; Meiser B, 2016, J GENET COUNS, V25, P218, DOI 10.1007/s10897-015-9861-5; Morash M, 2018, J PERS MED, V8, DOI 10.3390/jpm8030030; Nagarajan R, 2017, ARCH PATHOL LAB MED, V141, P1679, DOI 10.5858/arpa.2016-0542-CP; Naidoo J, 2014, AM J HEMATOL-ONCOL, V10, P4; Nass SJ, 2019, ONCOLOGIST, V24, P1287, DOI 10.1634/theoncologist.2019-0261; Ortiz MV, 2016, PEDIATR BLOOD CANCER, V63, P1368, DOI 10.1002/pbc.26002; Poonnen P, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.3074; Schwartzberg L, 2017, PRECISION ONCOLOGY W, P160, DOI [10.1200/edbk_174176, DOI 10.1200/EDBK_174176]; Seebacher NA, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1094-2	27	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0235861	10.1371/journal.pone.0235861	http://dx.doi.org/10.1371/journal.pone.0235861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706774	Green Published, gold			2022-12-26	WOS:000579931700011
J	Zhao, H; Jiang, N; Han, YC; Yang, M; Gao, P; Xiong, XF; Xiong, S; Zeng, LF; Xiao, Y; Wei, L; Li, L; Li, CR; Yang, JF; Tang, CY; Xiao, L; Liu, FY; Liu, Y; Sun, L				Zhao, Hao; Jiang, Na; Han, Yachun; Yang, Ming; Gao, Peng; Xiong, Xiaofen; Xiong, Shan; Zeng, Lingfeng; Xiao, Ying; Wei, Ling; Li, Li; Li, Chenrui; Yang, Jinfei; Tang, Chengyuan; Xiao, Li; Liu, Fuyou; Liu, Yu; Sun, Lin			Aristolochic acid induces renal fibrosis by arresting proximal tubular cells in G2/M phase mediated by HIF-1 alpha	FASEB JOURNAL			English	Article						aristolochic acid nephropathy; G2/M arrest; HIF-1 alpha; p21; renal fibrosis	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; KIDNEY-DISEASE; CYCLE ARREST; NEPHROPATHY; INJURY; INDUCTION; PROLIFERATION; EXPRESSION; P21; HIF	Renal tubulointerstitial fibrosis (TIF) is a common pathological feature of aristolochic acid (AA) nephropathy (AAN). G2/M arrest of proximal tubular cells (PTCs) is implicated in renal fibrosis of AAN, but the upstream regulatory molecule remains unknown. Hypoxia inducible factor-1 alpha (HIF-1 alpha) promotes renal fibrosis in kidney disease, but the role of HIF-1 alpha in AAN is unclear. Evidence shows that HIF-1 alpha and p21, a known inducer of cellular G2/M arrest, are closely related to each other. To investigate the role of HIF-1 alpha in renal fibrosis of AAN and its effects on p21 expression and PTCs G2/M arrest, mice with HIF-1 alpha gene knockout PTCs (PT-HIF-1 alpha-KO) were generated, and AAN was induced by AA. In vitro tests were conducted on the human PTCs line HK-2 and primary mouse PTCs. HIF-1 alpha and p21 expression, fibrogenesis, and G2/M arrest of PTCs were determined. Results showed that HIF-1 alpha was upregulated in the kidneys of wild-type (WT) AAN mice, accompanied by p21 upregulation, PTCs G2/M arrest and renal fibrosis, and these alterations were reversed in PT-HIF-1 alpha-KO AAN mice. Similar results were observed in HK-2 cells and were further confirmed in primary PTCs from PT-HIF-1 alpha-KO and WT mice. Inhibiting p21 in HK-2 cells and primary PTCs did not change the expression of HIF-1 alpha, but G2/M arrest and fibrogenesis were reduced. These data indicate that HIF-1 alpha plays a key role in renal fibrosis in AAN by inducing PTCs G2/M arrest modulated through p21. HIF-1 alpha may serve as a potential therapeutic target for AAN.	[Zhao, Hao; Jiang, Na; Han, Yachun; Yang, Ming; Gao, Peng; Xiong, Xiaofen; Xiong, Shan; Zeng, Lingfeng; Xiao, Ying; Wei, Ling; Li, Li; Li, Chenrui; Yang, Jinfei; Tang, Chengyuan; Xiao, Li; Liu, Fuyou; Liu, Yu; Sun, Lin] Cent South Univ, Xiangya Hosp 2, Hunan Key Lab Kidney Dis & Blood Purificat, Dept Nephrol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China	Central South University	Liu, Y; Sun, L (corresponding author), Cent South Univ, Xiangya Hosp 2, Hunan Key Lab Kidney Dis & Blood Purificat, Dept Nephrol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	rory0423@163.com; sunlin@csu.edu.cn			NSFC \ National Natural Science Foundation of China [81570622]; NSFC \ Key Programme [81730018]; National Key R&D program of China [2018YFC1314002]	NSFC \ National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC \ Key Programme; National Key R&D program of China	NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 81570622; NSFC vertical bar Key Programme, Grant/Award Number: 81730018; National Key R&D program of China, Grant/Award Number: 2018YFC1314002	Bach A, 2010, ANTIOXID REDOX SIGN, V13, P437, DOI 10.1089/ars.2009.3000; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Baudoux T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23565-2; Bonventre JV, 2014, KIDNEY INT SUPPL, V4, P39, DOI 10.1038/kisup.2014.8; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Chen YY, 2010, ONCOL REP, V24, P141, DOI 10.3892/or_00000839; Cho YS, 2008, BBA-MOL CELL RES, V1783, P323, DOI 10.1016/j.bbamcr.2007.11.017; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai XY, 2016, ONCOTARGET, V7, P10841, DOI 10.18632/oncotarget.7460; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Eckardt Kai-Uwe, 2005, Kidney Int Suppl, pS46; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P164, DOI 10.1093/nar/gkv927; Gokmen MR, 2013, ANN INTERN MED, V158, P469, DOI 10.7326/0003-4819-158-6-201303190-00006; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Han JY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00648; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Huang M, 2018, CELL SIGNAL, V51, P139, DOI 10.1016/j.cellsig.2018.08.002; Jadot I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020297; Jeong W, 2018, THERIOGENOLOGY, V115, P9, DOI 10.1016/j.theriogenology.2018.04.016; Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008; Kawakami T, 2014, KIDNEY INT SUPPL, V4, P107, DOI 10.1038/kisup.2014.20; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Liu J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050950; Liu KH, 2013, CANCER LETT, V340, P22, DOI 10.1016/j.canlet.2013.06.024; Liu LM, 2019, J MOL CELL BIOL, V11, P371, DOI 10.1093/jmcb/mjy042; Marin DE, 2018, N-S ARCH PHARMACOL, V391, P1147, DOI 10.1007/s00210-018-1538-9; Nayak BK, 2016, DIABETES, V65, P1387, DOI 10.2337/db15-0519; Reginster F, 1997, NEPHROL DIAL TRANSPL, V12, P81, DOI 10.1093/ndt/12.1.81; Richard DE, 2000, J BIOL CHEM, V275, P26765; Salnikow K, 2000, CANCER RES, V60, P5630; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Wen YJ, 2008, TRANSL RES, V152, P38, DOI 10.1016/j.trsl.2008.05.002; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang SK, 2017, REDOX BIOL, V13, P482, DOI 10.1016/j.redox.2017.07.002; Zhang Y, 2019, AGING-US, V11, P2241, DOI 10.18632/aging.101911; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zhu SH, 2010, FORENSIC SCI INT, V199, pE5, DOI 10.1016/j.forsciint.2010.02.003	43	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12599	12614		10.1096/fj.202000949R	http://dx.doi.org/10.1096/fj.202000949R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32706145	hybrid			2022-12-26	WOS:000556097300001
J	Zou, XL; Ren, Y; Feng, DY; He, XQ; Guo, YF; Yang, HL; Li, X; Fang, J; Li, Q; Ye, JJ; Han, LQ; Zhang, TT				Zou, Xiao-Ling; Ren, Yong; Feng, Ding-Yun; He, Xu-Qi; Guo, Yue-Fei; Yang, Hai-Ling; Li, Xian; Fang, Jia; Li, Quan; Ye, Jun-Jie; Han, Lan-Qing; Zhang, Tian-Tuo			A promising approach for screening pulmonary hypertension based on frontal chest radiographs using deep learning: A retrospective study	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; COMPUTER-AIDED DETECTION; RIGHT HEART; DIAGNOSIS; CLASSIFICATION; GUIDELINES	Background To date, the missed diagnosis rate of pulmonary hypertension (PH) was high, and there has been limited development of a rapid, simple, and effective way to screen the disease. The purpose of this study is to develop a deep learning approach to achieve rapid detection of possible abnormalities in chest radiographs suggesting PH for screening patients suspected of PH. Methods We retrospectively collected frontal chest radiographs and the pulmonary artery systolic pressure (PASP) value measured by Doppler transthoracic echocardiography from 762 patients (357 healthy controls and 405 with PH) from three institutes in China from January 2013 to May 2019. The wohle sample comprised 762 images (641 for training, 80 for internal test, and 41 for external test). We firstly performed a 8-fold cross-validation on the 641 images selected for training (561 for pre-training, 80 for validation), then decided to tune learning rate to 0.0008 according to the best score on validation data. Finally, we used all the pre-training and validation data (561+80 = 641) to train our models (Resnet50, Xception, and Inception V3), evaluated them on internal and external test dataset to classify the images as having manifestations of PH or healthy according to the area under the receiver operating characteristic curve (AUC/ROC). After that, the three deep learning models were further used for prediction of PASP using regression algorithm. Moreover, we invited an experienced chest radiologist to classify the images in the test dataset as having PH or not, and compared the prediction accuracy performed by deep learing models with that of manual classification. Results The AUC performed by the best model (Inception V3) achieved 0.970 in the internal test, and slightly declined in the external test (0.967) when using deep learning algorithms to classify PH from normal based on chest X-rays. The mean absolute error (MAE) of the best model for prediction of PASP value was smaller in the internal test (7.45) compared to 9.95 in the external test. Manual classification of PH based on chest X-rays showed much lower AUCs compared to that performed by deep learning models both in the internal and external test. Conclusions The present study used deep learning algorithms to classify abnormalities suggesting PH in chest radiographs with high accuracy and good generalizability. Once tested prospectively in clinical settings, the technology could provide a non-invasive and easy-to-use method to screen patients suspected of having PH.	[Zou, Xiao-Ling; Feng, Ding-Yun; Yang, Hai-Ling; Zhang, Tian-Tuo] Sun Yat Sen Univ, Inst Resp Dis, Dept Pulm & Crit Care Med, Affiliated Hosp 3, Guangzhou, Peoples R China; [Ren, Yong; Li, Quan; Ye, Jun-Jie; Han, Lan-Qing] Res Inst Tsinghua, Ctr Artificial Intelligence Med, Guangzhou, Peoples R China; [He, Xu-Qi] Sun Yat Sen Univ, Dept Med Ultrasound, Affiliated Hosp 3, Guangzhou, Peoples R China; [Guo, Yue-Fei] Sun Yat Sen Univ, Dept Radiol, Affiliated Hosp 3, Guangzhou, Peoples R China; [Li, Xian] Sun Yat Sen Univ, Yuedong Hosp, Dept Pulm & Crit Care Med, Affiliated Hosp 3, Meizhou, Peoples R China; [Fang, Jia] Dongguan Tangxia Hosp, Dept Pumonary Dis, Dongguan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, TT (corresponding author), Sun Yat Sen Univ, Inst Resp Dis, Dept Pulm & Crit Care Med, Affiliated Hosp 3, Guangzhou, Peoples R China.; Han, LQ (corresponding author), Res Inst Tsinghua, Ctr Artificial Intelligence Med, Guangzhou, Peoples R China.	hanlance@tsinghua-gd.org; zhtituli@163.com	ren, yong/GQP-8426-2022					Abreu Alexandre R, 2004, J Intensive Care Med, V19, P291, DOI 10.1177/0885066604265255; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Chen PHC, 2019, NAT MED, V25, P1453, DOI 10.1038/s41591-019-0539-7; Cicero M, 2017, INVEST RADIOL, V52, P281, DOI 10.1097/RLI.0000000000000341; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Frazier AA, 2012, SEMIN ULTRASOUND CT, V33, P535, DOI 10.1053/j.sult.2012.06.002; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Greiner S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001103; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Hua KL, 2015, ONCOTARGETS THER, V8, P2015, DOI 10.2147/OTT.S80733; Huang C, 2016, PROC CVPR IEEE, P5375, DOI 10.1109/CVPR.2016.580; Kather JN, 2019, NAT MED, V25, P1054, DOI 10.1038/s41591-019-0462-y; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lin ZQ, 2015, ACTA RADIOL, V56, P552, DOI 10.1177/0284185114535209; McCann C, 2012, POSTGRAD MED J, V88, P271, DOI 10.1136/postgradmedj-2011-130292; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Rajpurkar P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002686; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Singh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204155; Song H., 2016, J INT SOC SIMUL SURG, V3, P1, DOI [10.18204/JISSiS.2016.3.1.001, DOI 10.18204/JISSIS.2016.3.1.001]; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Sun R, 2018, LANCET ONCOL, V19, P1180, DOI 10.1016/S1470-2045(18)30413-3; Suzuki K, 2017, RADIOL PHYS TECHNOL, V10, P257, DOI 10.1007/s12194-017-0406-5; Taylor AG, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002697; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang WL, 2015, NEUROIMAGE, V108, P214, DOI 10.1016/j.neuroimage.2014.12.061	37	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236378	10.1371/journal.pone.0236378	http://dx.doi.org/10.1371/journal.pone.0236378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706807	Green Published, gold			2022-12-26	WOS:000579931700037
J	Harnvoravongchai, P; Singwisut, R; Ounjai, P; Aroonnual, A; Kosiyachinda, P; Janvilisri, T; Chankhamhaengdecha, S				Harnvoravongchai, Phurt; Singwisut, Ratiyakorn; Ounjai, Puey; Aroonnual, Amornrat; Kosiyachinda, Pahol; Janvilisri, Tavan; Chankhamhaengdecha, Surang			Isolation and characterization of thermophilic cellulose and hemicellulose degrading bacterium, Thermoanaerobacterium sp. R63 from tropical dry deciduous forest soil	PLOS ONE			English	Article							COMMUNITY STRUCTURE; HOT-SPRINGS; COMB-NOV; GEN-NOV; CELLULASES; METAGENOMICS; CONVERSION; BROCKII; ENZYMES	Thermophilic microorganisms and their enzymes have been utilized in various industrial applications. In this work, we isolated and characterized thermophilic anaerobic bacteria with the cellulose and hemicellulose degrading activities from a tropical dry deciduous forest in northern Thailand. Out of 502 isolated thermophilic anaerobic soil bacteria, 6 isolates, identified as Thermoanaerobacterium sp., displayed an ability to utilize a wide range of oligosaccharides and lignocellulosic substrates. The isolates exhibited significant cellulase and xylanase activities at high temperature (65 degrees C). Among all isolates, Thermoanaerobacterium sp. strain R63 exhibited remarkable hydrolytic properties with the highest cellulase and xylanase activities at 1.15 U/mg and 6.17 U/mg, respectively. Extracellular extract of Thermoanaerobacterium sp. strain R63 was thermostable with an optimal temperature at 65 degrees C and could exhibit enzymatic activities on pH range 5.0-9.0. Our findings suggest promising applications of these thermoanaerobic bacteria and their potent enzymes for industrial purposes.	[Harnvoravongchai, Phurt; Singwisut, Ratiyakorn; Ounjai, Puey; Kosiyachinda, Pahol; Chankhamhaengdecha, Surang] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Aroonnual, Amornrat] Mahidol Univ, Fac Trop Med, Dept Trop Nutr & Food Sci, Bangkok, Thailand; [Janvilisri, Tavan] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University	Chankhamhaengdecha, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand.	surang.cha@mahidol.ac.th			Center of Excellence on Biodiversity [BDC-PG1-160004]	Center of Excellence on Biodiversity	This work is supported by a grant from the Center of Excellence on Biodiversity (BDC-PG1-160004) to SC. The equipment was facilitated by Central Instrument Facility (CIF) at Faculty of Science, Mahidol University.	Abrao FO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183628; Akinosho H, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00066; Alonso DM, 2010, GREEN CHEM, V12, P1493, DOI 10.1039/c004654j; Baharuddin A. S., 2010, American Journal of Applied Sciences, V7, P56; Bhalla A, 2015, FRONT BIOENG BIOTECH, V3, DOI [10.3389/fbioe.2015.00084, 10.3389/fbice.2015.00084]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunner K., 2007, P17; CAYOL JL, 1995, INT J SYST BACTERIOL, V45, P783, DOI 10.1099/00207713-45-4-783; Chakravarty S., 2019, HDB RES CONSERVATION, P193, DOI [10.4018/978-1-7998-0014-9.ch010, DOI 10.4018/978-1-7998-0014-9.CH010]; Chimtong S, 2011, J MICROBIOL BIOTECHN, V21, P284, DOI 10.4014/jmb.1009.09032; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; De Roos A, 2004, ENZYMES IND PRODUCTI, DOI [10.1002/3527602135.ch5a, DOI 10.1002/3527602135.CH5A]; DeAngelis KM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00280; DeAngelis KM, 2013, STAND GENOMIC SCI, V7, P382, DOI 10.4056/sigs.3377516; Demirbas A, 2001, ENERG CONVERS MANAGE, V42, P1357, DOI 10.1016/S0196-8904(00)00137-0; Farinas CS, 2016, NEW AND FUTURE DEVELOPMENTS IN MICROBIAL BIOTECHNOLOGY AND BIOENGINEERING: ASPERGILLUS SYSTEM PROPERTIES AND APPLICATIONS, P141, DOI 10.1016/B978-0-444-63505-1.00010-5; Florencio Camila, 2012, Enzyme Res, V2012, P793708, DOI 10.1155/2012/793708; Fujii K, 2012, BIOSCI BIOTECH BIOCH, V76, P906, DOI 10.1271/bbb.110881; Imchen M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09254-6; Ito N, 2017, GENES GENET SYST, V92, P1, DOI 10.1266/ggs.16-00013; Jaafaru M.I., 2013, ISRN MICROBIOL, V2013, P2013, DOI DOI 10.1155/2013/283423; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; Kitchaicharoen J, 2015, SITUATIONAL ANAL SUP, DOI [10.13140/RG.2.2.23008.89600, DOI 10.13140/RG.2.2.23008.89600]; Kuhad Ramesh Chander, 2011, Enzyme Res, V2011, P280696, DOI 10.4061/2011/280696; Lange JP, 2007, BIOFUEL BIOPROD BIOR, V1, P39, DOI 10.1002/bbb.7; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; LEE YE, 1993, J BACTERIOL, V175, P5890, DOI 10.1128/JB.175.18.5890-5898.1993; LEE YE, 1993, INT J SYST BACTERIOL, V43, P41, DOI 10.1099/00207713-43-1-41; Liang YL, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/512497, 10.1155/2014/371593]; Liu SY, 1996, INT J SYST BACTERIOL, V46, P388, DOI 10.1099/00207713-46-2-388; Loow YL, 2016, CELLULOSE, V23, P1491, DOI 10.1007/s10570-016-0936-8; Lu WJ, 2005, J GEN APPL MICROBIOL, V51, P353, DOI 10.2323/jgam.51.353; Mai V, 2000, APPL ENVIRON MICROB, V66, P4817, DOI 10.1128/AEM.66.11.4817-4821.2000; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Miyashita NT, 2013, GENES GENET SYST, V88, P93, DOI 10.1266/ggs.88.93; Rabinovich ML, 2002, BIOCHEMISTRY-MOSCOW+, V67, P850, DOI 10.1023/A:1019958419032; Rastogi G, 2010, BIORESOURCE TECHNOL, V101, P8798, DOI 10.1016/j.biortech.2010.06.001; Saini JK, 2015, 3 BIOTECH, V5, P337, DOI 10.1007/s13205-014-0246-5; Saroj P, 2018, BIORESOUR BIOPROCESS, V5, DOI 10.1186/s40643-018-0216-6; Schmeisser C, 2007, APPL MICROBIOL BIOT, V75, P955, DOI 10.1007/s00253-007-0945-5; Shang SM, 2013, ARCH MICROBIOL, V195, P439, DOI 10.1007/s00203-013-0895-5; SHAO WL, 1995, APPL ENVIRON MICROB, V61, P937, DOI 10.1128/AEM.61.3.937-940.1995; Sharma A, 2016, APPL BIOCHEM BIOTECH, V179, P1346, DOI 10.1007/s12010-016-2070-3; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; Strakowska J, 2014, J BASIC MICROB, V54, pS2, DOI 10.1002/jobm.201300821; Torres A, 2018, J BIOTECH RES, V9; Tyurin MV, 2006, METHOD MICROBIOL, V35, P309, DOI 10.1016/S0580-9517(05)35013-6; WIEGEL J, 1981, ARCH MICROBIOL, V128, P343, DOI 10.1007/BF00405910; Wilson E.O., 1988, BIODIVERSITY, P119; Yoav S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194701; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755	51	8	9	9	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236518	10.1371/journal.pone.0236518	http://dx.doi.org/10.1371/journal.pone.0236518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702033	Green Published, gold			2022-12-26	WOS:000575913700099
J	Verma, V; Joshi, G; Gupta, A; Chaudhary, VK				Verma, Vaishali; Joshi, Gopal; Gupta, Amita; Chaudhary, Vijay K.			An efficient ORF selection system for DNA fragment libraries based on split beta-lactamase complementation	PLOS ONE			English	Article							OPEN READING FRAMES; PHAGE DISPLAY; IN-VIVO; PROTEIN; EXPRESSION; ENRICHMENT; ALIGNMENT; ANTIGEN; VECTOR	PCR-based amplification of annotated genes has allowed construction of expression clones at genome-scale using classical and recombination-based cloning technologies. However, genome-scale expression and purification of proteins for down-stream applications is often limited by challenges such as poor expression, low solubility, large size of multi-domain proteins, etc. Alternatively, DNA fragment libraries in expression vectors can serve as the source of protein fragments with each fragment encompassing a function of its whole protein counterpart. However, the random DNA fragmentation and cloning result in only 1 out of 18 clones being in the correct open-reading frame (ORF), thus, reducing the overall efficiency of the system. This necessitates the selection of correct ORF before expressing the protein fragments. This paper describes a highly efficient ORF selection system for DNA fragment libraries, which is based on split beta-lactamase protein fragment complementation. The system has been designed to allow seamless transfer of selected DNA fragment libraries into any downstream vector systems using a restriction enzyme-free cloning strategy. The strategy has been applied for the selection of ORF using model constructs to show near 100% selection of the clone encoding correct ORF. The system has been further validated by construction of an ORF-selected DNA fragment library of 30 genes of M. tuberculosis. Further, we have successfully demonstrated the cytosolic expression of ORF-selected protein fragments in E. coli.	[Verma, Vaishali; Joshi, Gopal; Gupta, Amita; Chaudhary, Vijay K.] Univ Delhi, Ctr Innovat Infect Dis Res Educ & Training CIIDRE, South Campus, New Delhi, India; [Gupta, Amita; Chaudhary, Vijay K.] Univ Delhi, Dept Biochem, South Campus, New Delhi, India	University of Delhi; University of Delhi	Chaudhary, VK (corresponding author), Univ Delhi, Ctr Innovat Infect Dis Res Educ & Training CIIDRE, South Campus, New Delhi, India.; Chaudhary, VK (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	vkchaudhary@south.du.ac.in	Verma, Vaishali/ABH-2408-2021	Verma, Vaishali/0000-0001-5076-7435; Joshi, Gopal/0000-0002-6238-9926	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/MED/29/SP19222/2017, BT/INF/22/SP23286/2017]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The work was supported by Grant number BT/MED/29/SP19222/2017 and BT/INF/22/SP23286/2017 to VKC and AG from Department of Biotechnology, Ministry of Science and Technology, Government of India (http://dbtindia.gov.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Cariccio VL, 2016, MABS-AUSTIN, V8, P741, DOI 10.1080/19420862.2016.1158371; Chaudhary VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111538; Connor DO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148986; D'Angelo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S5; Deng JY, 2014, CELL REP, V9, P2317, DOI 10.1016/j.celrep.2014.11.023; Di Niro R, 2005, BIOCHEM J, V388, P889, DOI 10.1042/BJ20041983; Domina M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160702; Domina M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31458; Domina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114159; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; Dyson MR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn151; Faix PH, 2004, BIOTECHNIQUES, V36, P1018, DOI 10.2144/04366RR03; Foit Linda, 2013, Methods Mol Biol, V978, P1, DOI 10.1007/978-1-62703-293-3_1; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Gerth ML, 2004, PROTEIN ENG DES SEL, V17, P595, DOI 10.1093/protein/gzh068; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075212; Gupta S, 1999, BIOTECHNIQUES, V27, P328, DOI 10.2144/99272st04; Hailu TT, 2013, ANAL BIOCHEM, V434, P181, DOI 10.1016/j.ab.2012.11.022; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; Hust M, 2006, BIOTECHNIQUES, V41, P335, DOI 10.2144/000112225; Khurshid S, 2013, TUBERCULOSIS, V93, P654, DOI 10.1016/j.tube.2013.07.005; Kugler J, 2008, APPL MICROBIOL BIOT, V80, P447, DOI 10.1007/s00253-008-1576-1; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu LG, 2014, MOL CELL PROTEOMICS, V13, P897, DOI 10.1074/mcp.M113.032623; Lutz S, 2002, PROTEIN ENG, V15, P1025, DOI 10.1093/protein/15.12.1025; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mersmann M, 2010, NEW BIOTECHNOL, V27, P118, DOI 10.1016/j.nbt.2009.10.007; Pedelacq JD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr548; Pelicic V, 1996, J BACTERIOL, V178, P1197, DOI 10.1128/jb.178.4.1197-1199.1996; Prassler J, 2011, J MOL BIOL, V413, P261, DOI 10.1016/j.jmb.2011.08.012; Quan Shu, 2013, Methods Mol Biol, V966, P359, DOI 10.1007/978-1-62703-245-2_22; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Secco P, 2009, PROTEIN ENG DES SEL, V22, P149, DOI 10.1093/protein/gzn053; SEEHAUS T, 1992, GENE, V114, P235, DOI 10.1016/0378-1119(92)90580-I; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Verma V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191315; Wehrman T, 2002, P NATL ACAD SCI USA, V99, P3469, DOI 10.1073/pnas.062043699; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698; Zacchi P, 2003, GENOME RES, V13, P980, DOI 10.1101/gr.861503; Zantow J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34337; Zhong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139695; Zhou FB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15349	50	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235853	10.1371/journal.pone.0235853	http://dx.doi.org/10.1371/journal.pone.0235853			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701967	Green Published, gold			2022-12-26	WOS:000575913700029
J	Parray, HA; Chiranjivi, AK; Asthana, S; Yadav, N; Shrivastava, T; Mani, S; Sharma, C; Vishwakarma, P; Das, S; Pindari, K; Sinha, S; Samal, S; Ahmed, S; Kumar, R				Parray, Hilal Ahmad; Chiranjivi, Adarsh Kumar; Asthana, Shailendra; Yadav, Naveen; Shrivastava, Tripti; Mani, Shailendra; Sharma, Chandresh; Vishwakarma, Preeti; Das, Supratik; Pindari, Kamal; Sinha, Subrata; Samal, Sweety; Ahmed, Shubbir; Kumar, Rajesh			Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naive semisynthetic library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RBD; scFv; ACE2; mAb; IgG1; monoclonal antibody; virus; phage display; infectious disease; antigen	NEUTRALIZING ANTIBODIES	There is a desperate need for safe and effective vaccines, therapies, and diagnostics for SARS- coronavirus 2 (CoV-2), the development of which will be aided by the discovery of potent and selective antibodies against relevant viral epitopes. Human phage display technology has revolutionized the process of identifying and optimizing antibodies, providing facile entry points for further applications. Herein, we use this technology to search for antibodies targeting the receptor-binding domain (RBD) of CoV-2. Specifically, we screened a naive human semisynthetic phage library against RBD, leading to the identification of a high-affinity single-chain fragment variable region (scFv). The scFv was further engineered into two other antibody formats (scFv-Fc and IgG1). All three antibody formats showed high binding specificity to CoV-2 RBD and the spike antigens in different assay systems. Flow cytometry analysis demonstrated specific binding of the IgG1 format to cells expressing membrane-bound CoV-2 spike protein. Docking studies revealed that the scFv recognizes an epitope that partially overlaps with angiotensin-converting enzyme 2 (ACE2)-interacting sites on the CoV-2 RBD. Given its high specificity and affinity, we anticipate that these anti-CoV-2 antibodies will be useful as valuable reagents for accessing the antigenicity of vaccine candidates, as well as developing antibody-based therapeutics and diagnostics for CoV-2.	[Parray, Hilal Ahmad; Chiranjivi, Adarsh Kumar; Asthana, Shailendra; Yadav, Naveen; Shrivastava, Tripti; Mani, Shailendra; Sharma, Chandresh; Vishwakarma, Preeti; Das, Supratik; Pindari, Kamal; Samal, Sweety; Ahmed, Shubbir; Kumar, Rajesh] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad, Haryana, India; [Sinha, Subrata] All India Inst Med Sci, Dept Biochem, New Delhi, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); All India Institute of Medical Sciences (AIIMS) New Delhi	Ahmed, S; Kumar, R (corresponding author), NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad, Haryana, India.	sahmed@thsti.res.in; rajesh@thsti.res.in	SAMAL, SWEETY/GQS-6704-2022; Sharma, Chandresh/GXF-1910-2022	Sharma, Chandresh/0000-0002-2813-302X; Mani, Shailendra/0000-0001-8541-8315; Das, Supratik/0000-0002-7279-938X; CHIRANJIVI, ADARSH/0000-0003-0687-5900	Department of Biotechnology; Translational Health Science & Technology Institute core grant	Department of Biotechnology; Translational Health Science & Technology Institute core grant	This work was supported by the Department of Biotechnology and by a Translational Health Science & Technology Institute core grant.	Abou El-Magd RM, 2016, J IMMUNOL METHODS, V428, P9, DOI 10.1016/j.jim.2015.11.006; Bagheri S, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695924; Benjathummarak S, 2018, BIOLOGICALS, V56, P54, DOI 10.1016/j.biologicals.2018.10.003; Bertoglio F, 2020, SARS COV 2 NEUTRALIZ, DOI [10.1101/2020.06.05.135921, DOI 10.1101/2020.06.05.135921]; Brown BL, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102790; Burnouf T, 2014, TRANSFUS APHER SCI, V51, P120, DOI 10.1016/j.transci.2014.10.003; Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003; Excler JL, 2014, CLIN VACCINE IMMUNOL, V21, P1023, DOI 10.1128/CVI.00230-14; Felsenstein S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108448; Haynes BF, 2006, VIROLOGY, V345, P44, DOI 10.1016/j.virol.2005.08.042; Hey A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.AID-0026-2014; Kanwal A, 2016, DRUG DES DEV THER, V10, P2929, DOI 10.2147/DDDT.S105482; Kumar R, 2020, APPL MICROBIOL BIOT, V104, P3209, DOI 10.1007/s00253-020-10437-x; Kumar R, 2019, INT J BIOL MACROMOL, V135, P907, DOI 10.1016/j.ijbiomac.2019.06.006; Kumar R, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-87; Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P152, DOI 10.2450/2015.0131-15; Mattapally Saidulu, 2018, Oncotarget, V9, P13713, DOI 10.18632/oncotarget.24459; Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; PRINCE GA, 1987, J VIROL, V61, P1851, DOI 10.1128/JVI.61.6.1851-1854.1987; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Sankhyan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21240; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Spriestersbach A, 2015, METHOD ENZYMOL, V559, P1, DOI 10.1016/bs.mie.2014.11.003; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269	29	36	39	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2020	295	36					12814	12821		10.1074/jbc.AC120.014918	http://dx.doi.org/10.1074/jbc.AC120.014918			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NQ9DL	32727845	hybrid, Green Published			2022-12-26	WOS:000571166700020
J	Gourronc, FA; Markan, KR; Kulhankova, K; Zhu, ZY; Sheehy, R; Quelle, DE; Zingman, LV; Kurago, ZB; Ankrum, JA; Klingelhutz, AJ				Gourronc, Francoise A.; Markan, Kathleen R.; Kulhankova, Katarina; Zhu, Zhiyong; Sheehy, Ryan; Quelle, Dawn E.; Zingman, Leonid, V; Kurago, Zoya B.; Ankrum, James A.; Klingelhutz, Aloysius J.			Pdgfr alpha-Cre mediated knockout of the aryl hydrocarbon receptor protects mice from high-fat diet induced obesity and hepatic steatosis	PLOS ONE			English	Article							ADIPOSE-TISSUE; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; DEPOT DIFFERENCES; DIFFERENTIATION; DEFICIENCY; INHIBITION; ASSOCIATIONS; ACTIVATION; CELLS	Aryl hydrocarbon receptor (AHR) agonists such as dioxin have been associated with obesity and the development of diabetes. Whole-body Ahr knockout mice on high-fat diet (HFD) have been shown to resist obesity and hepatic steatosis. Tissue-specific knockout of Ahr in mature adipocytes via adiponectin-Cre exacerbates obesity while knockout in liver increases steatosis without having significant effects on obesity. Our previous studies demonstrated that treatment of subcutaneous preadipocytes with exogenous or endogenous AHR agonists disrupts maturation into functional adipocytesin vitro. Here, we used platelet-derived growth factor receptor alpha (Pdgfr alpha)-Cre mice, a Cre model previously established to knock out genes in preadipocyte lineages and other cell types, but not liver cells, to further define AHR's role in obesity. We demonstrate that Pdgfr alpha-Cre Ahr-floxed (Ahr(fl/fl)) knockout mice are protected from HFD-induced obesity compared to non-knockout Ahr(fl/fl)mice (control mice). The Pdgfr alpha-Cre Ahr(fl/fl)knockout mice were also protected from increased adiposity, enlargement of adipocyte size, and liver steatosis while on the HFD compared to control mice. On a regular control diet, knockout and non-knockout mice showed no differences in weight gain, indicating the protective phenotype arises only when animals are challenged by a HFD. At the cellular level, cultured cells from brown adipose tissue (BAT) of Pdgfr alpha-Cre Ahr(fl/fl)mice were more responsive than cells from controls to transcriptional activation of the thermogenic uncoupling protein 1 (Ucp1) gene by norepinephrine, suggesting an ability to burn more energy under certain conditions. Collectively, our results show that knockout of Ahr mediated by Pdgfr alpha-Cre is protective against diet-induced obesity and suggest a mechanism by which enhanced UCP1 activity within BAT might confer these effects.	[Gourronc, Francoise A.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Markan, Kathleen R.; Quelle, Dawn E.] Univ Iowa, Dept Neurosci & Pharmacol, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA; [Kulhankova, Katarina] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Zhu, Zhiyong] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Sheehy, Ryan] Kansas City Univ, Dept Pharmacol, Kansas City, KS USA; [Zingman, Leonid, V] Univ Iowa, Dept Internal Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Kurago, Zoya B.] Augusta Univ, Dept Oral Biol & Diagnost Sci, Dept Pathol, Augusta, GA USA; [Ankrum, James A.] Univ Iowa, Roy J Carver Dept Biomed Engn, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA; [Klingelhutz, Aloysius J.] Univ Iowa, Dept Microbiol & Immunol, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University System of Georgia; Augusta University; University of Iowa; University of Iowa	Klingelhutz, AJ (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA.	al-klingelhutz@uiowa.edu	Ankrum, James/N-4175-2014; Zingman, Leonid V/GXG-0136-2022	Ankrum, James/0000-0003-3959-6158; Zingman, Leonid V/0000-0002-7566-4616; Quelle, Dawn/0000-0001-8776-0122; Sheehy, Ryan/0000-0003-2435-7234	University of Iowa Fraternal Order of Eagles Diabetes Research Center Pilot Award; Mark Stinski Department of Microbiology Developmental Award; NIH [K01DK111758]	University of Iowa Fraternal Order of Eagles Diabetes Research Center Pilot Award; Mark Stinski Department of Microbiology Developmental Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a University of Iowa Fraternal Order of Eagles Diabetes Research Center Pilot Award as well as a Mark Stinski Department of Microbiology Developmental Award to AJK and an NIH K01DK111758 awarded to KRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 1998, J CELL SCI, V111, P3311; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Baker NA, 2015, ENVIRON HEALTH PERSP, V123, P944, DOI 10.1289/ehp.1408594; Barouki Robert, 2012, Drug Metabolism and Drug Interactions, V27, P3, DOI 10.1515/dmdi-2011-0035; Benede-Ubieto R, 2020, DIABETES METAB SYNDR, V13, P439, DOI 10.2147/DMSO.S234665; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Bowe JE, 2014, J ENDOCRINOL, V222, pG13, DOI 10.1530/JOE-14-0182; Brulport A, 2017, TOXICOLOGY, V390, P43, DOI 10.1016/j.tox.2017.07.017; Cimafranca MA, 2004, TOXICOL APPL PHARM, V196, P156, DOI 10.1016/j.taap.2003.12.005; Cohen P, 2016, MOL BIOL CELL, V27, P2523, DOI 10.1091/mbc.E15-10-0749; Cohen P, 2015, DIABETES, V64, P2346, DOI 10.2337/db15-0318; Eske K, 2014, ENVIRON SCI POLLUT R, V21, P6354, DOI 10.1007/s11356-013-1591-3; Everett CJ, 2012, ENVIRON RES, V118, P107, DOI 10.1016/j.envres.2012.06.012; Everett CJ, 2011, J ENVIRON MONITOR, V13, P241, DOI 10.1039/c0em00400f; Gadupudi G, 2015, TOXICOL IN VITRO, V29, P132, DOI 10.1016/j.tiv.2014.09.015; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Gao ZG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.155861; Gourronc FA, 2020, ENVIRON SCI POLLUT R, V27, P8897, DOI 10.1007/s11356-019-06663-0; Gourronc FA, 2018, ENVIRON SCI POLLUT R, V25, P16481, DOI 10.1007/s11356-017-9676-z; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Han SG, 2012, TOXICOL APPL PHARM, V261, P181, DOI 10.1016/j.taap.2012.03.024; Hanlon PR, 2005, TOXICOL APPL PHARM, V207, P39, DOI 10.1016/j.taap.2004.12.004; Harrill JA, 2013, TOXICOL APPL PHARM, V272, P503, DOI 10.1016/j.taap.2013.06.024; Huang B, 2016, P NATL ACAD SCI USA, V113, P11883, DOI 10.1073/pnas.1613269113; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Hubbard TD, 2015, DRUG METAB DISPOS, V43, P1522, DOI 10.1124/dmd.115.064246; Jaeger C, 2017, J BIOL RHYTHM, V32, P109, DOI 10.1177/0748730417696786; Jaeger C, 2017, CHRONOBIOL INT, V34, P318, DOI 10.1080/07420528.2016.1256298; Jaeger C, 2016, ENVIRON HEALTH INSIG, V10, P133, DOI 10.4137/EHI.S38343; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kang J, 2008, DEV DYNAM, V237, P692, DOI 10.1002/dvdy.21469; Kerley-Hamilton JS, 2012, ENVIRON HEALTH PERSP, V120, P1252, DOI 10.1289/ehp.1205003; Kim KS, 2014, CHEMOSPHERE, V94, P151, DOI 10.1016/j.chemosphere.2013.09.066; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; Klingelhutz AJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19024-z; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Lahoti TS, 2013, ANN RHEUM DIS, V72, P1708, DOI 10.1136/annrheumdis-2012-202639; Larian N, 2019, FOOD CHEM TOXICOL, V130, P219, DOI 10.1016/j.fct.2019.05.012; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lin YH, 2019, INT J OBESITY, V43, P2407, DOI 10.1038/s41366-019-0340-1; Liu JJ, 2019, CURR OPIN CLIN NUTR, V22, P82, DOI 10.1097/MCO.0000000000000529; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Moyer BJ, 2017, NUTR RES, V44, P38, DOI 10.1016/j.nutres.2017.06.002; Moyer BJ, 2016, TOXICOL APPL PHARM, V300, P13, DOI 10.1016/j.taap.2016.03.011; Mulero-Navarro S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00045; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Natividad JM, 2018, CELL METAB, V28, P737, DOI 10.1016/j.cmet.2018.07.001; Nichols GA, 2011, METAB SYNDR RELAT D, V9, P127, DOI 10.1089/met.2010.0105; Ogden CL, 2014, JAMA-J AM MED ASSOC, V312, P189, DOI [10.1001/jama.2014.6228, 10.1001/jama.2014.6219]; Patel P, 2013, NUTRIENTS, V5, P2019, DOI 10.3390/nu5062019; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Persky V, 2011, ENVIRON RES, V111, P817, DOI 10.1016/j.envres.2011.05.012; PHILLIPS M, 1995, J CELL SCI, V108, P395; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sheka AC, 2020, JAMA-J AM MED ASSOC, V323, P1175, DOI 10.1001/jama.2020.2298; Sorg O, 2014, TOXICOL LETT, V230, P225, DOI 10.1016/j.toxlet.2013.10.039; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Wada T, 2016, J BIOL CHEM, V291, P7004, DOI 10.1074/jbc.M115.693655; Wagner G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40881; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Wang C, 2011, ENVIRON HEALTH PERSP, V119, P1739, DOI 10.1289/ehp.1103593; Wheeler MA, 2017, J BIOL CHEM, V292, P12383, DOI 10.1074/jbc.R116.767723; Xu CX, 2015, INT J OBESITY, V39, P1300, DOI 10.1038/ijo.2015.63	75	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236741	10.1371/journal.pone.0236741	http://dx.doi.org/10.1371/journal.pone.0236741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730300	gold, Green Published			2022-12-26	WOS:000556884700033
J	Oliveira, TRA; Carvalho, HWL; Nascimento, M; Costa, EFN; Oliveira, GHF; Gravina, GA; Amaral, AT; Carvalho, JLS				Oliveira, Tamara Rebecca A.; Carvalho, Helio Wilson L.; Nascimento, Moyses; Costa, Emiliano Fernandes N.; Oliveira, Gustavo Hugo F.; Gravina, Geraldo A.; Amaral Junior, Antonio T.; Carvalho Filho, Jose Luiz S.			Adaptability and stability evaluation of maize hybrids using Bayesian segmented regression models	PLOS ONE			English	Article							CENTROID METHOD; SELECTION; CULTIVAR	The occurrence of genotype by environment interaction (G x E), which is defined as the differential response of genotypes to environmental variation, is frequently reported in maize cultures, making it challenging to recommend cultivars. Methods allowing to study the potential nonlinear pattern of genotype responses to environmental variation allied to prior beliefs on unknown parameters are interesting to evaluate the phenotypic adaptability and stability of genotypes. In this context, the present study aimed to assess the adaptability and stability of maize hybrids, by using the Bayesian segmented regression model, and evaluate the efficacy of using informative and minimally informative prior distributions for the selection of cultivars. Randomized complete-block design experiments were carried out to study the yield (kg/ha) of 25 maize hybrids, in 22 different environments, in Northeastern Brazil. The Bayesian segmented regression model fitted using informative prior distributions presented lower credibility intervals and Deviance Criterium of Information values, compared to those obtained by fitting using minimally informative distributions. Therefore, the model using informative prior distributions was considered for the adaptability and stability evaluation of maize genotypes. Once most northeastern farmers in Brazil have limited capital, the genotype P4285HX should be considered for planting, due to its high yield performance and adaptability to unfavorable environments.	[Oliveira, Tamara Rebecca A.; Oliveira, Gustavo Hugo F.] Univ Fed Sergipe, Nucleo Grad Agron, Campus Sertao, Nossa Senhora Da Gloria, Sergipe, Brazil; [Carvalho, Helio Wilson L.; Costa, Emiliano Fernandes N.] Embrapa Tabuleiros Costeiros, Aracaju, Sergipe, Brazil; [Nascimento, Moyses] Univ Fed Vicosa, Dept Estat, Lab Inteligencia Computac & Aprendizado Estat, Vicosa, MG, Brazil; [Gravina, Geraldo A.; Amaral Junior, Antonio T.] Univ Estadual Norte Fluminense, Ctr Ciencias & Tecnol Agr, Lab Engn Agr, Rio De Janeiro, Brazil; [Carvalho Filho, Jose Luiz S.] Univ Fed Rural Pernambuco, Dept Agron, Recife, PE, Brazil	Universidade Federal de Sergipe; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa; Universidade Estadual do Norte Fluminense; Universidade Federal Rural de Pernambuco (UFRPE)	Oliveira, TRA (corresponding author), Univ Fed Sergipe, Nucleo Grad Agron, Campus Sertao, Nossa Senhora Da Gloria, Sergipe, Brazil.	tamara_rebecca@hotmail.com	do Amaral, Antônio Teixeira/AAD-6291-2021; Nascimento, Moyses/Y-8767-2019	do Amaral, Antônio Teixeira/0000-0003-4831-7878; Nascimento, Moyses/0000-0001-5886-9540; Oliveira, Tamara/0000-0003-4418-1547	Coordination for the Improvement of Higher Education People -Brazil (CAPES) [001]	Coordination for the Improvement of Higher Education People -Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in party by the Coordination for the Improvement of Higher Education People -Brazil (CAPES) -Finance Code 001.	Amaral CB, 2017, CIENC TECNOL, V2017, P1; Carvalho HWL, 2017, RECOMENDACAO CULTIVA, V203, P29; Couto MF, 2015, CROP SCI, V55, P571, DOI 10.2135/cropsci2014.07.0498; CRUZ CD, 1989, REV BRAS GENET, V12, P567; De Carvalho HWL, 2000, PESQUI AGROPECU BRAS, V35, P1417, DOI 10.1590/S0100-204X2000000700016; de Oliveira I, 2017, PESQUI AGROPECU BRAS, V52, P455, DOI [10.1590/s0100-204x2017000600009, 10.1590/S0100-204X2017000600009]; Buso WHD, 2016, REV CAATINGA, V29, P927, DOI 10.1590/1983-21252016v29n418rc; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Ferreira D. F., 2006, CEME LAVRAS, V12, P373; Gamerman D, 1933, INFERENCIA ESTATISTI; Gewek EJ, 1991, EVALUATING ACCURACY, V1, P30; LIN CS, 1988, CAN J PLANT SCI, V68, P193, DOI 10.4141/cjps88-018; Nascimento Moysés, 2015, Rev. Ceres, V62, P30, DOI 10.1590/0034-737X201562010004; Nascimento M, 2020, EUPHYTICA, V216, DOI 10.1007/s10681-020-2564-5; Nascimento M, 2011, PESQUI AGROPECU BRAS, V46, P26, DOI 10.1590/S0100-204X2011000100004; Nascimento M, 2010, PESQUI AGROPECU BRAS, V45, P41, DOI 10.1590/S0100-204X2010000100006; Nascimento M, 2009, PESQUI AGROPECU BRAS, V44, P263, DOI 10.1590/S0100-204X2009000300007; Oliveira T. R. A. de, 2017, Australian Journal of Crop Science, V11, P516, DOI 10.21475/ajcs.17.11.05.p304; R Development Core Team, 2017, R LANG ENV STAT COMP; Resende MDV, 2007, SELEGEN REML BLUP; Smith BJ, 2007, J STAT SOFTW, V21, P1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Teodoro PE, 2015, PESQUI AGROPECU BRAS, V50, P878, DOI 10.1590/S0100-204X2015001000003; VERMA MM, 1978, THEOR APPL GENET, V53, P89, DOI [10.1007/BF00817837, 10.1007/BF00274335]; Villafuerte MBC, 2017, REV ESPAMC, V8, P23; Yan J, 2013, RBUGS FUSING R OPENB	27	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236571	10.1371/journal.pone.0236571	http://dx.doi.org/10.1371/journal.pone.0236571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730284	Green Published, gold			2022-12-26	WOS:000556884700008
J	Pena, MM; Teper, D; Ferreira, H; Wang, N; Sato, KU; Ferro, MIT; Ferro, JA				Pena, Michelle Mendonca; Teper, Doron; Ferreira, Henrique; Wang, Nian; Sato, Kenny Umino; Tiraboschi Ferro, Maria Ines; Ferro, Jesus Aparecido			mCherry fusions enable the subcellular localization of periplasmic and cytoplasmic proteins in Xanthomonas sp.	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; GENE-EXPRESSION; DISCOSOMA SP; CITRI; VECTORS; RED; GFP; TOPOISOMERASES; SECRETION; DIVISION	Fluorescent markers are a powerful tool and have been widely applied in biology for different purposes. The genome sequence ofXanthomonas citrisubsp.citri(X.citri) revealed that approximately 30% of the genes encoded hypothetical proteins, some of which could play an important role in the success of plant-pathogen interaction and disease triggering. Therefore, revealing their functions is an important strategy to understand the bacterium pathways and mechanisms involved in plant-host interaction. The elucidation of protein function is not a trivial task, but the identification of the subcellular localization of a protein is key to understanding its function. We have constructed an integrative vector, pMAJIIc, under the control of the arabinose promoter, which allows the inducible expression of red fluorescent protein (mCherry) fusionsin X.citri, suitable for subcellular localization of target proteins. Fluorescence microscopy was used to track the localization of VrpA protein, which was visualized surrounding the bacterial outer membrane, and the GyrB protein, which showed a diffused cytoplasmic localization, sometimes with dots accumulated near the cellular poles. The integration of the vector into theamylocus ofX.citridid not affect bacterial virulence. The vector could be stably maintained inX.citri, and the disruption of the alpha-amylase gene provided an ease screening method for the selection of the transformant colonies. The results demonstrate that the mCherry-containing vector here described is a powerful tool for bacterial protein localization in cytoplasmic and periplasmic environments.	[Pena, Michelle Mendonca] Sao Paulo State Univ UNESP, Sch Agr & Veterinarian Sci, Agr & Livestock Microbiol Grad Program, Jaboticabal, SP, Brazil; [Teper, Doron; Wang, Nian] Univ Florida, Citrus Res & Educ Ctr, Dept Microbiol & Cell Sci, Lake Alfred, FL USA; [Ferreira, Henrique; Sato, Kenny Umino] Sao Paulo State Univ UNESP, Biosci Inst, Dept Biochem & Microbiol, Rio Claro, SP, Brazil; [Tiraboschi Ferro, Maria Ines; Ferro, Jesus Aparecido] Sao Paulo State Univ UNESP, Sch Agr & Veterinarian Sci, Dept Technol, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; State University System of Florida; University of Florida; Universidade Estadual Paulista; Universidade Estadual Paulista	Ferro, JA (corresponding author), Sao Paulo State Univ UNESP, Sch Agr & Veterinarian Sci, Dept Technol, Jaboticabal, SP, Brazil.	jesus.ferro@unesp.br	FERRO, MARIA INÊS TIRABOSCHI/D-3634-2012; Ferro, Jesus Aparecido A/C-8251-2013; Teper, Doron/AAB-8138-2019; Ferreira, Henrique/AAD-3608-2020; Wang, Nian/HDM-2087-2022	FERRO, MARIA INÊS TIRABOSCHI/0000-0003-3389-9131; Ferro, Jesus Aparecido A/0000-0002-3966-1303; Teper, Doron/0000-0002-5608-1917; Ferreira, Henrique/0000-0002-9183-9420; Wang, Nian/0000-0001-7743-0728; Mendonca Pena, Michelle/0000-0003-4635-9679	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brasil (CNPq) [311783/2015]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work is part of the Ph.D. thesis of MMP and was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001 (the BIGA project) and by a fellowship grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brasil (CNPq) to JAF (Grant No. 311783/2015).	Abe VY, 2016, MOL PLANT PATHOL, V17, P1223, DOI 10.1111/mpp.12359; Behlau F, 2016, PLANT PATHOL, V65, P1390, DOI 10.1111/ppa.12503; Behlau F, 2012, EUR J PLANT PATHOL, V133, P949, DOI 10.1007/s10658-012-9966-8; Beilharz K, 2015, APPL ENVIRON MICROB, V81, P7244, DOI 10.1128/AEM.02033-15; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Costantini LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8670; Cubero J, 2011, PLANT PATHOL, V60, P977, DOI 10.1111/j.1365-3059.2011.02450.x; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Dammeyer T, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210013; Dinh T, 2011, J BACTERIOL, V193, P4984, DOI 10.1128/JB.00315-11; Duellman T, 2015, ANAL BIOCHEM, V473, P34, DOI 10.1016/j.ab.2014.12.010; Feucht A, 2001, GENE, V264, P289, DOI 10.1016/S0378-1119(01)00338-9; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Gottwald T. R., 2002, Plant Health Progress, P1; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Ke N, 2016, J BACTERIOL, V198, P1035, DOI 10.1128/JB.00864-15; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lacerda LA, 2017, PLASMID, V90, P44, DOI 10.1016/j.plasmid.2017.03.005; Laia ML, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-12; Lee N, 1980, OPERON, P389; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Lorenzoni ASG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01352; Martins PMM, 2010, FEMS MICROBIOL LETT, V310, P76, DOI 10.1111/j.1574-6968.2010.02047.x; MorAo LG, 2018, MICROBIOLOGYOPEN, V8, P1; Orce IG, 2016, SCI AGR, V73, P552, DOI 10.1590/0103-9016-2015-0409; Petrocelli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040051; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ransom EM, 2015, APPL ENVIRON MICROB, V81, P1652, DOI 10.1128/AEM.03446-14; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanderson Michael J, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.top071795; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Silva IC, 2013, J BACTERIOL, V195, P85, DOI 10.1128/JB.01442-12; Skoog K, 2012, J BACTERIOL, V194, P584, DOI 10.1128/JB.06091-11; Tadesse S, 2006, J BACTERIOL, V188, P3002, DOI 10.1128/JB.188.8.3002-3011.2006; Ucci AP, 2014, MICROBIOLOGYOPEN, V3, P29, DOI 10.1002/mbo3.145; Wee DH, 2015, P NATL ACAD SCI USA, V112, P4098, DOI 10.1073/pnas.1423492112; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Zhang QX, 2015, PLANT CELL REP, V34, P861, DOI 10.1007/s00299-015-1749-1; Zhang S, 2013, SAUDI J BIOL SCI, V20, P23, DOI 10.1016/j.sjbs.2012.11.001; Zhang YN, 2019, MOL PLANT PATHOL, V20, P1550, DOI 10.1111/mpp.12865; Zhou XF, 2015, MOL PLANT MICROBE IN, V28, P143, DOI 10.1094/MPMI-10-14-0309-R	45	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236185	10.1371/journal.pone.0236185	http://dx.doi.org/10.1371/journal.pone.0236185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730344	Green Published, gold			2022-12-26	WOS:000556884700016
J	Wallace, RL; Bulach, DM; Jennison, AV; Valcanis, M; McLure, A; Smith, JJ; Graham, T; Saputra, T; Firestone, S; Symes, S; Waters, N; Stylianopoulos, A; Kirk, MD; Glass, K				Wallace, Rhiannon L.; Bulach, Dieter M.; Jennison, Amy, V; Valcanis, Mary; McLure, Angus; Smith, James J.; Graham, Trudy; Saputra, Themy; Firestone, Simon; Symes, Sally; Waters, Natasha; Stylianopoulos, Anastasia; Kirk, Martyn D.; Glass, Kathryn			Molecular characterization of Campylobacter spp. recovered from beef, chicken, lamb and pork products at retail in Australia	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; JEJUNI; HUMANS; POULTRY; EPIDEMIOLOGY; PREVALENCE; EXPRESSION; LACTAMASE; MUTATIONS	Australian rates of campylobacteriosis are among the highest in developed countries, yet only limited work has been done to characterizeCampylobacterspp. in Australian retail products. We performed whole genome sequencing (WGS) on 331C.coliand 285C.jejunifrom retail chicken meat, as well as beef, chicken, lamb and pork offal (organs).Campylobacterisolates were highly diverse, with 113 sequence types (STs) including 38 novel STs, identified from 616 isolates. Genomic analysis suggests very low levels (2.3-15.3%) of resistance to aminoglycoside, beta-lactam, fluoroquinolone, macrolide and tetracycline antibiotics. A majority (>90%) of isolates (52/56) possessing the fluoroquinolone resistance-associated T86I mutation in thegyrAgene belonged to ST860, ST2083 or ST7323. The 44 pork offal isolates were highly diverse, representing 33 STs (11 novel STs) and harboured genes associated with resistance to aminoglycosides, lincosamides and macrolides not generally found in isolates from other sources. Prevalence of multidrug resistant genotypes was very low (<5%), but ten-fold higher inC.colithanC.jejuni. This study highlights thatCampylobacterspp. from retail products in Australia are highly genotypically diverse and important differences in antimicrobial resistance exist betweenCampylobacterspecies and animal sources.	[Wallace, Rhiannon L.; McLure, Angus; Kirk, Martyn D.; Glass, Kathryn] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Bulach, Dieter M.] Univ Melbourne, Melbourne Bioinformat, Melbourne, Vic, Australia; [Bulach, Dieter M.; Valcanis, Mary] Peter Doherty Inst, Microbiol Diagnost Unit, Publ Hlth Lab, Melbourne, Vic, Australia; [Jennison, Amy, V; Graham, Trudy] Queensland Hlth, Publ Hlth Microbiol Forens & Sci Serv, Brisbane, Qld, Australia; [Smith, James J.] Queensland Hlth, Hlth Protect Branch, Food Safety Stand & Regulat, Brisbane, Qld, Australia; [Saputra, Themy] NSW Govt, New South Wales Food Author, Sydney, NSW, Australia; [Firestone, Simon] Univ Melbourne, Fac Vet & Agr Sci, Melbourne Vet Sch, Parkville, Vic, Australia; [Symes, Sally; Stylianopoulos, Anastasia] Victoria State Govt, Dept Hlth & Human Serv, Melbourne, Vic, Australia; [Waters, Natasha] Australian Capital Terr Hlth Directorate, Act Govt Analyt Lab, Canberra, ACT, Australia	Australian National University; University of Melbourne; Queensland Health; Queensland Health; University of Melbourne	Glass, K (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	kathryn.glass@anu.edu.au	McLure, Angus/AGQ-6116-2022; Bulach, Dieter M/D-5793-2011	McLure, Angus/0000-0003-2890-2703; Bulach, Dieter M/0000-0001-9823-6078; Wallace, Rhiannon/0000-0001-6978-7604; Glass, Kathryn/0000-0001-5905-1310	National Health and Medical Research Council [NHMRC APP1145997, APP1145997]; AgriFutures; Australian Government Department of Health; Food Standards Australia New Zealand; New South Wales Food Authority; Queensland Health; ACT Health	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); AgriFutures; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Food Standards Australia New Zealand; New South Wales Food Authority; Queensland Health; ACT Health	This work was funded by a National Health and Medical Research Council grant (NHMRC GNT1116294), with partner funding from AgriFutures, Australian Government Department of Health, Food Standards Australia New Zealand, New South Wales Food Authority and Queensland Health. Additional funding was provided by ACT Health. The National Health and Medical Research Council provided research fellowship funding for Martyn D. Kirk (APP1145997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson DA, 2005, ANTIMICROB AGENTS CH, V49, P2515, DOI 10.1128/AAC.49.6.2515-2518.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2020, PIGS CHICKENS OUTLOO; Astridge K, 2015, COMMUN DIS INTELL, V39, pE236; Australia Standards, 2015, CAMPYLOBACTER, V6; Australian Chicken Meat Federation, 2018, AUSTR IND FACTS FIG; Australian Chicken Meat Federation, 2018, SURV ANT RES ENT COM; Australian Government Department of Health, 2020, AUSTR 1991 2019 YEAR; Cantero G, 2018, FOODBORNE PATHOG DIS, V15, P145, DOI 10.1089/fpd.2017.2325; Centers for Disease Control, 2016, ANT ANT RES; Centers for Disease Control and Prevention, 2019, NAT ANT RES MON SYST; Di D, 2020, MICROORGANISMS, V8; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dorai-Raj S, 2014, BINOM BINOMIAL CONDE; Du YJ, 2018, FRONTIERS MICROBIOLO, V9, P8; EFSA ECDC, 2019, EFSA J, V17; European Centre for Disease Prevention and Control, 2020, EUR ANT RES SURV NET; Fabre A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00390-18, 10.1128/jcm.00390-18]; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Government of Canada, 2018, CAN ANT RES SURV SYS; Government of Canada, 2018, 2016 ANN REP; Hakanen A, 2002, ANTIMICROB AGENTS CH, V46, P2644, DOI 10.1128/AAC.46.8.2644-2647.2002; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Helms M, 2005, J INFECT DIS, V191, P1050, DOI 10.1086/428453; Ingram PR, 2013, J MED MICROBIOL, V62, P1743, DOI 10.1099/jmm.0.062729-0; ISO, 2017, 1027212017 ISO, V44, P1; Joensen KG, 2020, EMERG INFECT DIS, V26, P523, DOI 10.3201/eid2603.190947; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kayman T, 2019, J MED MICROBIOL, V68, P136, DOI 10.1099/jmm.0.000890; Khan JA, 2018, FOODBORNE PATHOG DIS, V15, P218, DOI 10.1089/fpd.2017.2344; Kirk M, 2014, EMERG INFECT DIS, V20, P1857, DOI 10.3201/eid2011.131315; Ladely SR, 2009, FOODBORNE PATHOG DIS, V6, P91, DOI 10.1089/fpd.2008.0098; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; Marotta F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223804; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; Molbak K, 2005, CLIN INFECT DIS, V41, P1613, DOI 10.1086/497599; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Noormohamed A, 2013, INT J ENV RES PUB HE, V10, P2058, DOI 10.3390/ijerph10052058; Norstrom M, 2006, EPIDEMIOL INFECT, V134, P127, DOI 10.1017/S0950268805004814; Oh JY, 2017, J MICROBIOL, V55, P13, DOI 10.1007/s12275-017-6308-8; Pfaller MA, 1999, ARCH PATHOL LAB MED, V123, P1007; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rokney A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02432; Saenz Y, 2000, ANTIMICROB AGENTS CH, V44, P267, DOI 10.1128/AAC.44.2.267-271.2000; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Travers K, 2002, CLIN INFECT DIS, V34, pS131, DOI 10.1086/340251; Van Looveren M, 2001, J ANTIMICROB CHEMOTH, V48, P235, DOI 10.1093/jac/48.2.235; Walker LJ, 2019, J FOOD PROTECT, V82, P2126, DOI 10.4315/0362-028X.JFP-19-146; Wallace RL, 2020, CAUSING HUMAN INFECT; Whitehouse CA, 2018, FOOD MICROBIOL, V73, P122, DOI 10.1016/j.fm.2018.01.018; WHO, 2018, WHOL GEN SEQ FOODB D; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wieczorek K, 2017, POULTRY SCI, V96, P703, DOI 10.3382/ps/pew343; Wozniak-Biel A, 2018, MICROB DRUG RESIST, V24, P314, DOI 10.1089/mdr.2016.0249; Wu Z., 2019, ANTIBIOTIC USE ANTIB; Yang YC, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01509; Zeng XM, 2014, J ANTIMICROB CHEMOTH, V69, P1215, DOI 10.1093/jac/dkt515; Zhao S, 2016, APPL ENVIRON MICROB, V82, P459, DOI 10.1128/AEM.02873-15	61	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236889	10.1371/journal.pone.0236889	http://dx.doi.org/10.1371/journal.pone.0236889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730330	Green Published, gold			2022-12-26	WOS:000556884700092
J	Wilfong, JM; Badley, EM; Power, JD; Gandhi, R; Rampersaud, YR; Perruccio, AV				Wilfong, Jessica M.; Badley, Elizabeth M.; Power, J. Denise; Gandhi, Rajiv; Rampersaud, Y. Raja; Perruccio, Anthony, V			Discordance between self-reported and performance-based function among knee osteoarthritis surgical patients: Variations by sex and obesity	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; JOINT REPLACEMENT; PAIN; GENDER; HIP; QUESTIONNAIRE; INFLAMMATION; VALIDATION; DISABILITY; OUTCOMES	Background There is currently no standardized method for measuring functional status in knee osteoarthritis (OA) patients, despite that it is one of the top priorities when determining eligibility for total knee arthroplasty (TKA). The purpose of the current investigation was to identify factors associated with discordance between individual self-report and performance-based measures of function for obese and non-obese men and women with knee OA. Methods In a cohort of 727 knee OA patients scheduled for TKA, physical function prior to surgery was assessed with the self-reported physical function subscale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC-pf), and the performance-based Timed Up and Go (TUG). Data on sociodemographic characteristics, health status, knee pain intensity, symptomatic joint site count, and pain catastrophizing were collected via questionnaire. The primary outcome was the difference in rescaled score between a participant's self-report and performance-based measures of function. Multivariable linear regression stratified by sex and obesity status was used to identify factors associated with discordance. Results The mean age of participants was 65.5 years and 55% were women. With younger age, self-reported scores indicated increasingly worse function compared to performance-based scores, regardless of sex or obesity status. Among non-obese individuals, greater knee pain intensity was associated with a participant's self-report score indicating increasingly worse function compared to their performance-based score. For obese women, pain catastrophizing, and number of symptomatic joints were also associated with discordance as was reporting fewer comorbidities. Conclusions Physical function may be differentially represented by self-reported and performance-based measures depending on a variety of patient factors. Our findings add to the evidence which suggests both measures should be used when assessing functional status prior to TKA.	[Wilfong, Jessica M.; Badley, Elizabeth M.; Power, J. Denise; Perruccio, Anthony, V] Univ Hlth Network, Krembil Res Inst, Hlth Care & Outcomes Res, Toronto, ON, Canada; [Wilfong, Jessica M.; Badley, Elizabeth M.; Power, J. Denise; Gandhi, Rajiv; Rampersaud, Y. Raja; Perruccio, Anthony, V] Univ Hlth Network, Krembil Res Inst, Arthrit Program, Toronto, ON, Canada; [Badley, Elizabeth M.; Perruccio, Anthony, V] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gandhi, Rajiv; Rampersaud, Y. Raja; Perruccio, Anthony, V] Univ Toronto, Fac Med, Dept Surg, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Perruccio, AV (corresponding author), Univ Hlth Network, Krembil Res Inst, Hlth Care & Outcomes Res, Toronto, ON, Canada.; Perruccio, AV (corresponding author), Univ Hlth Network, Krembil Res Inst, Arthrit Program, Toronto, ON, Canada.; Perruccio, AV (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Perruccio, AV (corresponding author), Univ Toronto, Fac Med, Dept Surg, Toronto, ON, Canada.	perruccio@uhnres.utoronto.ca		Wilfong, Jessica/0000-0002-3182-012X; Badley, Elizabeth/0000-0002-6045-2549; Perruccio, Anthony V/0000-0002-4389-0993	Toronto General & Western Hospital Foundation through the University Health Network Arthritis Program	Toronto General & Western Hospital Foundation through the University Health Network Arthritis Program	This study received financial support from the Toronto General & Western Hospital Foundation through the University Health Network Arthritis Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan NS, 2018, HEALTHCARE-J DEL SCI; Baert IAC, 2017, JCR-J CLIN RHEUMATOL, V23, P308, DOI 10.1097/RHU.0000000000000560; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Coman L, 2006, CAN J AGING, V25, P253, DOI 10.1353/cja.2007.0001; Coriolano K, 2015, DISABIL REHABIL, V37, P1152, DOI 10.3109/09638288.2014.956813; Elbaz A, 2011, ARCH PHYS MED REHAB, V92, P1618, DOI 10.1016/j.apmr.2011.05.009; Elboim-Gabyzon M, 2012, ISRN ORTHOPEDICS, V2012; Felson DT, 2004, RADIOL CLIN N AM, V42, P1, DOI 10.1016/S0033-8389(03)00161-1; Gignac MAM, 2006, ARTHRIT RHEUM-ARTHR, V55, P905, DOI 10.1002/art.22338; Gossec L, 2007, J RHEUMATOL, V34, P1432; Jin XZ, 2015, ANN RHEUM DIS, V74, P703, DOI 10.1136/annrheumdis-2013-204494; Keefe FJ, 2000, PAIN, V87, P325, DOI 10.1016/S0304-3959(00)00296-7; Kennedy D, 2002, J ARTHROPLASTY, V17, P70, DOI 10.1054/arth.2002.29324; Louie GH, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-84; Maillefert JF, 2008, ARTHRIT RHEUM-ARTHR, V59, P255, DOI 10.1002/art.23331; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Nelson AE, 2014, DISABIL REHABIL, V36, P300, DOI 10.3109/09638288.2013.790490; Perruccio AV, 2017, OSTEOARTHR CARTILAGE, V25, P53, DOI 10.1016/j.joca.2016.08.001; Petterson SC, 2007, J BONE JOINT SURG AM, V89A, P2327, DOI 10.2106/JBJS.F.01144; Rai MF, 2011, CRIT REV EUKAR GENE, V21, P131, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.30; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; Smith BH, 1997, PAIN, V71, P141, DOI 10.1016/S0304-3959(97)03347-2; Somers TJ, 2009, J PAIN SYMPTOM MANAG, V37, P863, DOI 10.1016/j.jpainsymman.2008.05.009; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Stevens-Lapsley JE, 2011, PM&R, V3, P541, DOI 10.1016/j.pmrj.2011.03.002; Stratford PW, 2006, J CLIN EPIDEMIOL, V59, P160, DOI 10.1016/j.jclinepi.2005.07.012; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Terwee CB, 2006, J CLIN EPIDEMIOL, V59, P724, DOI 10.1016/j.jclinepi.2005.11.019; Toussirot E, 2007, CURR MED CHEM, V14, P1095, DOI 10.2174/092986707780362826; VERBRUGGE LM, 1994, J HEALTH SOC BEHAV, V35, P97, DOI 10.2307/2137359; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236865	10.1371/journal.pone.0236865	http://dx.doi.org/10.1371/journal.pone.0236865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730319	Green Published, gold			2022-12-26	WOS:000556884700019
J	Gitahi, N; Camlin, C; Mwania, V; Ngure, K; Auerswald, C; Bukusi, E				Gitahi, Nyawira; Camlin, Carol; Mwania, Veronica; Ngure, Kenneth; Auerswald, Colette; Bukusi, Elizabeth			Psychosocial needs among older perinatally infected adolescents living with HIV and transitioning to adult care in Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; ACQUIRED HIV; HEALTH; DISCLOSURE; CHILDREN; PREVALENCE	Background Little data is available on the long-term psychosocial effects of disclosure of HIV status that may occur in late adolescence, even when disclosure is timely. Moreover, few studies have described the post-disclosure psychosocial needs of older adolescents who experience delayed disclosure. This study sought to address existing knowledge gaps in the post-disclosure experiences and psychosocial needs of older adolescents living with HIV (ALWHIV). Methods We conducted focus group discussions (FGDs) and in-depth interviews (IDIs) among older perinatally infected adolescents aged 16-19 years We collected socio-demographic data and baseline viral load (copies/ml) results for the preceding six months using interviewer-administered questionnaires and clinical notes abstraction. We analysed data inductively and deductively to identify themes related to the experiences and expectations of adolescents with the disclosure and post-disclosure period. Results Adolescents who reported having received timely disclosure expressed that as they grew older, they began to comprehend the lifelong repercussions of an HIV diagnosis and experienced a re-emergence of the negative feelings similar to those experienced during the post-disclosure period. Those who received the knowledge of their HIV status during late adolescence experienced prolonged periods of negative self-perception and anger at not receiving their HIV status earlier. They also expressed a need for more information during the disclosure process on the prevention of onward transmission of the virus, safe conception practices resulting in HIV negative children, and information on how to disclose their HIV status to sexual partners or peers. Anticipated stigma was experienced universally by these older adolescents and was a major barrier towards adherence and coping with an HIV status. Caregivers or siblings with a similar HIV status were a source of social support. Adolescents felt that the support of peers (ALWHIV) helped them to accept their HIV status and to learn how to develop a positive outlook on life. Conclusion Provision of psychosocial care in late adolescence during the transition to adult care is critical in ensuring the resolution of re-emergent negative emotions. Comprehensive information on HIV prevention and sexual reproductive health should be a crucial component of post-disclosure care for older adolescents. HIV Disclosure and adolescent transition guidelines should include these components to optimize psychosocial care for older adolescents.	[Gitahi, Nyawira; Mwania, Veronica; Bukusi, Elizabeth] Kenya Govt Med Res Ctr, Inst Trop Med & Infect Dis, Nairobi, Kenya; [Gitahi, Nyawira] Jomo Kenyatta Univ Agr & Technol, Dept Environm Hlth & Dis Control, Nairobi, Kenya; [Camlin, Carol] Univ Calif San Francisco, Dept Obstet Gynaecol & Reprod Sci, San Francisco, CA 94143 USA; [Ngure, Kenneth] Jomo Kenyatta Univ Agr & Technol, Dept Community Hlth, Nairobi, Kenya; [Auerswald, Colette] Univ Calif Berkeley, Berkeley Sch Publ Hlth, Innovat Youth & Community Hlth Sci I4Y, Berkeley, CA 94720 USA; [Bukusi, Elizabeth] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya	Kenya Medical Research Institute; Jomo Kenyatta University of Agriculture & Technology; University of California System; University of California San Francisco; Jomo Kenyatta University of Agriculture & Technology; University of California System; University of California Berkeley; Kenya Medical Research Institute	Gitahi, N (corresponding author), Kenya Govt Med Res Ctr, Inst Trop Med & Infect Dis, Nairobi, Kenya.; Gitahi, N (corresponding author), Jomo Kenyatta Univ Agr & Technol, Dept Environm Hlth & Dis Control, Nairobi, Kenya.	gnyawira@gmail.com		, nyawira/0000-0002-5018-0674	Fogarty International Centre of the National Institutes of Health (NIH) [D43TW009343]; University of California Global Health Institute (UCGHI)	Fogarty International Centre of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Global Health Institute (UCGHI)	Support for data collection for this project was provided by the Fogarty International Centre of the National Institutes of Health (NIH) under Award Number D43TW009343 and the University of California Global Health Institute (UCGHI) to NGK. The content is solely the responsibility of the authors and does not represent the official views of the NIH or UCGHI. All the authors declare that they have no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britto C, 2016, J DEV BEHAV PEDIATR, V37, P496, DOI 10.1097/DBP.0000000000000303; Brown B., COMPREHENSIVE CONCEP; Brown B.B., 2009, HDB ADOLESCENT PSYCH, P74, DOI [10.1002/9780470479193.adlpsy002004, DOI 10.1002/9780470479193.ADLPSY002004]; Brown LK, 2000, J CHILD PSYCHOL PSYC, V41, P81, DOI 10.1111/1469-7610.00550; Carrizosa J, 2014, EPILEPSIA, V55, P46, DOI 10.1111/epi.12716; Hawkins A, 2016, AIDS CARE, V28, P68, DOI 10.1080/09540121.2016.1146210; Hodgson I, 2012, AIDS CARE, V24, P1204, DOI 10.1080/09540121.2012.658755; Kidia KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087322; Lam PK, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21506; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Mburu G, 2013, REPROD HEALTH MATTER, V21, P176, DOI 10.1016/S0968-8080(13)41701-9; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Midtbo V, 2012, AJAR-AFR J AIDS RES, V11, P261, DOI 10.2989/16085906.2012.734987; Ngeno B, 2019, J ADOLESCENT HEALTH, V64, P242, DOI 10.1016/j.jadohealth.2018.08.013; Nglazi MD, 2012, BMC INFECT DIS, P12; Okawa S, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00326; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Rudy BJ, 2009, AIDS PATIENT CARE ST, V23, P185, DOI 10.1089/apc.2008.0162; Santamaria EK, 2011, AIDS PATIENT CARE ST, V25, P257, DOI 10.1089/apc.2010.0161; Schenk KD, 2010, PUBLIC HEALTH REP, V125, P325, DOI 10.1177/003335491012500223; Sohn AH, 2013, J INT AIDS SOC, V16; Spicer N., 2015, GLOB HEALTH-SCI PRAC, V42, P89; UNAIDS, 2014, GAP REP; UNAIDS, 2016, END AIDS EP AD AD; Vranda M N, 2013, Indian J Psychol Med, V35, P19, DOI 10.4103/0253-7176.112195; WHO, 2011, IMAI ON DAY OR AD LI; Woollett N, 2016, CROSSCULT R HLTH ILL, P65, DOI 10.1007/978-3-319-29936-5_4; World Health Organisation, 2014, WHO HLTH WORLDS AD 2	29	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0233451	10.1371/journal.pone.0233451	http://dx.doi.org/10.1371/journal.pone.0233451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2YL	32726306	Green Published, gold			2022-12-26	WOS:000556908900064
J	Naz, R; Roberts, TH; Bano, A; Nosheen, A; Yasmin, H; Hassan, MN; Keyani, R; Ullah, S; Khan, W; Anwar, Z				Naz, Rabia; Roberts, Thomas H.; Bano, Asghari; Nosheen, Asia; Yasmin, Humaira; Hassan, Muhammad Nadeem; Keyani, Rumana; Ullah, Sami; Khan, Wajiha; Anwar, Zahid			GC-MS analysis, antimicrobial, antioxidant, antilipoxygenase and cytotoxic activities ofJacaranda mimosifoliamethanol leaf extracts and fractions	PLOS ONE			English	Article							TOTAL FLAVONOID CONTENT; ANTIBACTERIAL ACTIVITIES; CARBON-TETRACHLORIDE; PHENOLIC-COMPOUNDS; STEM BARK; L.; INHIBITION; METABOLISM; SEED; PREVENTION	Jacaranda mimosifoliatrees are grown in frost-free regions globally. The aim of this study was to evaluate the methanol crude extract and various fractions of increasing polarity ofJ.mimosifolialeaves for bioactive metabolites, as well as antimicrobial, antioxidant and anticancer activities. The anti-inflammatory potential of the various fractions ofJ.mimosifolialeaf extract was studied via the lipoxygenase (LOX) inhibitory assay. Methanol crude extract (ME), derived fractions extracted with chloroform (CF) and ethyl acetate (EAF), and residual aqueous extract (AE) of driedJ.mimosifolialeaves were assayed for polyphenolic compounds, their antioxidant, antimicrobial and lipoxygenase (LOX) inhibitory activities, and anticancer properties. Polyphenolic compounds were determined via HPLC while phytochemicals (total phenolics, flavonoids, tannins andortho-diphenol contents), antioxidant activities (DPPH, hydrogen peroxideperoxide, hydroxyl and superoxide radical anions) and LOX were measured via spectrophotometry. Methanol extracts and various fractions were evaluated for antibacterial activities againstBacillus subtilis,Klebsiella pneumonia,Pseudomonas aeruginosaandStaphylococcus aureus. Antifungal potential of the fractions was tested against three species:Aspergillus flavus,Aspergillus fumigatusandFusarium oxysporum. The highest values for total phenolic content (TPC), total flavonoid content (TFC), flavonols, tannins andortho-diphenols were in the ME, followed by CF > EAF > AE. ME also had the highest antioxidant activity with EC(50)values 48 +/- 1.3, 45 +/- 2.4, 42 +/- 1.3 and 46 +/- 1.3 mu g/mL based on the DPPH, hydrogen peroxide, hydroxyl radical and superoxide radical assays, respectively. TPC and TFC showed a significant, strong and positive correlation with the values for each of these antioxidant activities. ME exhibited anti-inflammatory potential based on its LOX inhibitory activity (IC50= 1.3 mu g/mL). ME also had the maximum antibacterial and antifungal potential, followed by EAF > CF > AE. Furthermore, ME showed the strongest cytotoxic effect (EC50= 10.7 and 17.3 mu g/mL) against human hormone-dependent prostate carcinoma (LnCaP) and human lung carcinoma (LU-1) cell lines, respectively. Bioactive compounds present in leaf methanol extracts ofJ.mimosifoliawere identified using gas chromatography-mass spectrometry (GC-MS). Fifteen compounds were identified including phenolic and alcoholic compounds, as well as fatty acids. Our results suggest thatJ.mimosifolialeaves are a good source of natural products with antioxidant, anti-inflammatory and anti-cancer properties for potential therapeutic, nutraceutical and functional food applications.	[Naz, Rabia; Nosheen, Asia; Yasmin, Humaira; Hassan, Muhammad Nadeem; Keyani, Rumana] COMSATS Univ, Dept Biosci, Islamabad, Pakistan; [Roberts, Thomas H.] Univ Sydney, Sydney Inst Agr, Plant Breeding Inst, Sydney, NSW, Australia; [Bano, Asghari] Univ Wah, Dept Biosci, Wah Cantt, Pakistan; [Ullah, Sami] Univ Peshawar, Dept Bot, Peshawar, Pakistan; [Khan, Wajiha] COMSATS Univ Islamabad, Dept Biotechnol, Abbotabad Campus, Abbotabad, Pakistan; [Anwar, Zahid] COMSATS Univ Islamabad, Dept Comp Sci, Vehari Campus, Vehari, Pakistan	COMSATS University Islamabad (CUI); University of Sydney; University of Peshawar; COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Naz, R (corresponding author), COMSATS Univ, Dept Biosci, Islamabad, Pakistan.	rabia.naz@comsats.edu.pk	Roberts, Thomas H/H-2071-2012; Ullah, Sami/ABF-6810-2021; Hassan, Mohammad/GZA-7507-2022; Yasmin, Humaira/ABB-1384-2021; Hassan, Muhammad/GWZ-4054-2022	Roberts, Thomas H/0000-0003-3831-3240; Ullah, Sami/0000-0001-6525-1386; Hassan, Mohammad/0000-0002-1712-0004; Yasmin, Humaira/0000-0002-4220-4808; Naz, Rabia/0000-0002-2716-2267; ullah, sami/0000-0002-3177-7360	Higher Education Commission of Pakistan; HEC [074-0998-Av4-036]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); HEC	Higher Education Commission of Pakistan provided the required financial support for the study to Rabia Naz. The personal identification number (PIN) for this financial support/scholarship from HEC was 074-0998-Av4-036.	Alves CQ, 2010, QUIM NOVA, V33, P2202, DOI 10.1590/S0100-40422010001000033; Amessis-Ouchemoukh N, 2017, IND CROP PROD, V95, P6, DOI 10.1016/j.indcrop.2016.10.007; Amin MU, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0580-0; Torres CA, 2018, J INTEGR MED-JIM, V16, P255, DOI 10.1016/j.joim.2018.04.009; [Anonymous], 1980, MANUAL CLIN MICROBIO; Ao CW, 2008, FOOD CONTROL, V19, P940, DOI 10.1016/j.foodcont.2007.09.007; Aparna V, 2012, CHEM BIOL DRUG DES, V80, P434, DOI 10.1111/j.1747-0285.2012.01418.x; Arruda ALA, 2011, J MED FOOD, V14, P1604, DOI 10.1089/jmf.2010.0251; Backlund MG, 2005, ONCOLOGY-BASEL, V69, P28, DOI 10.1159/000086629; Bagheri G, 2016, JUNDISHAPUR J NAT PH, V11, DOI 10.17795/jjnpp-31129; Banu H. R., 2013, Journal of Chemical and Pharmaceutical Research, V5, P279; Baydar NG, 2004, FOOD CONTROL, V15, P335, DOI 10.1016/S0956-7135(03)00083-5; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Joray MB, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/912484; Cabre M, 2000, CLIN EXP PHARMACOL P, V27, P694, DOI 10.1046/j.1440-1681.2000.03322.x; Casagrande JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112748; Castillo-Espana P, 2009, PHARMACOG REV, V3, P48; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; CHISHOLM MJ, 1962, J ORG CHEM, V27, P3137, DOI 10.1021/jo01056a037; Chlopicka J, 2012, LWT-FOOD SCI TECHNOL, V46, P548, DOI 10.1016/j.lwt.2011.11.009; Clinical and Laboratory Standards Institute (CLSI), 2008, M7A4 CLSI, pM7; Custodio L, 2013, IND CROP PROD, V45, P114, DOI 10.1016/j.indcrop.2012.12.011; Czapski GA, 2012, PHARMACOL REP, V64, P1179, DOI 10.1016/S1734-1140(12)70914-3; de Moraes J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002617; de Oliveira CB, 2012, MOLECULES, V17, P1113, DOI 10.3390/molecules17011113; Department of Agriculture Agricultural Research Service, 1992, DR DUKES PHYTOCHEMIC; Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028; Etuk EU, 2009, AFR J PHARM PHARMACO, V3, P151; Fejes S, 2000, J ETHNOPHARMACOL, V69, P259, DOI 10.1016/S0378-8741(99)00171-3; Feng YC, 2015, SEP SCI TECHNOL, V50, P1785, DOI 10.1080/01496395.2015.1014054; Figueiredo-Rinhel ASG, 2013, J ETHNOPHARMACOL, V150, P655, DOI 10.1016/j.jep.2013.09.019; Gachet MS, 2010, J NAT PROD, V73, P553, DOI 10.1021/np900528m; Gambaro V., 1988, REV LATINOAM QUIM, V19, P17; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd; Hahn EL, 2000, J TRAUMA, V49, P1147, DOI 10.1097/00005373-200012000-00033; Henneberg Railson, 2013, Rev. Bras. Hematol. Hemoter., V35, P52, DOI 10.5581/1516-8484.20130015; Honda T, 2006, J EXP MED, V203, P325, DOI 10.1084/jem.20051310; Hossain MA, 2015, ARAB J CHEM, V8, P66, DOI 10.1016/j.arabjc.2011.01.007; Jiang H, 2008, NAT PROD RES, V22, P1650, DOI 10.1080/14786410701875686; Joselin J., 2013, Journal of Chemical and Pharmaceutical Research, V5, P106; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Kalita Pallab, 2013, Journal of Drug Delivery and Therapeutics, V3, P33; Kesharwani Rajesh Kumar, 2012, Org Med Chem Lett, V2, P12, DOI 10.1186/2191-2858-2-12; Khamsan S, 2012, ACTA PHARMACEUT, V62, P181, DOI 10.2478/v10007-012-0014-1; Kraujalis P, 2013, PLANT FOOD HUM NUTR, V68, P322, DOI 10.1007/s11130-013-0375-8; Kumar P. P., 2010, African Journal of Biochemistry Research, V4, P191; Kumar S., 2015, British Journal of Medicine and Medical Research, V7, P438; Kumar S, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-112; Lavanya Kakarla, 2016, Pharmacognosy Journal, V8, P598; Levick SP, 2007, J IMMUNOL, V178, P641, DOI 10.4049/jimmunol.178.2.641; Li HY, 2015, J FOOD COMPOS ANAL, V37, P75, DOI 10.1016/j.jfca.2014.09.003; Li TY, 2016, FOOD FUNCT, V7, P1147, DOI 10.1039/c5fo01036e; Lim YY, 2007, FOOD CHEM, V103, P734, DOI 10.1016/j.foodchem.2006.09.025; Mabuchi T, 2004, NEUROREPORT, V15, P1395, DOI 10.1097/01.wnr.0000129372.89000.31; MAHRAN G H, 1991, Herba Hungarica, V30, P98; Marrelli M, 2012, FOOD CHEM TOXICOL, V50, P726, DOI 10.1016/j.fct.2011.12.025; Silva FME, 2009, MYCOSES, V52, P511, DOI 10.1111/j.1439-0507.2008.01647.x; MEYER AS, 1995, TRENDS FOOD SCI TECH, V6, P300, DOI 10.1016/S0924-2244(00)89140-2; Moreira L, 2008, FOOD CHEM TOXICOL, V46, P3482, DOI 10.1016/j.fct.2008.08.025; Naz R, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1815-z; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Oktay M, 2003, LEBENSM-WISS TECHNOL, V36, P263, DOI 10.1016/S0023-6438(02)00226-8; Oluyemi Kayode A, 2007, Int. J. Morphol., V25, P609, DOI 10.4067/S0717-95022007000300023; Ouattara L., 2011, Journal of Applied Sciences, V11, P157; Parka EJ, 2011, CHEM-BIOL INTERACT, V189, P37, DOI 10.1016/j.cbi.2010.10.013; Pattanayak S. P., 2011, Comparative Clinical Pathology, V20, P381, DOI 10.1007/s00580-010-1008-3; Peteros NP, 2010, J MED PLANTS RES, V4, P407; Plazonic A, 2009, MOLECULES, V14, P2466, DOI 10.3390/molecules14072466; Rabia Naz, 2013, Asian Pacific Journal of Tropical Disease, V3, P480; Rahuman A. Abdul, 2000, Fitoterapia, V71, P553, DOI 10.1016/S0367-326X(00)00164-7; Rainsford K. D., 2007, V42, P3; Raju Ilavarasan, 2005, African Journal of Traditional, Complementary and Alternative Medicines, V2, P70; Rana A, 2013, NAT PROD RES, V27, P1167, DOI 10.1080/14786419.2012.717290; Ribeiro AB, 2015, PHARM BIOL, V53, P1691, DOI 10.3109/13880209.2014.1001407; Roy S, 2014, ENVIRON TOXICOL PHAR, V37, P234, DOI 10.1016/j.etap.2013.11.008; RUCH RJ, 1989, CARCINOGENESIS, V10, P1003, DOI 10.1093/carcin/10.6.1003; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; Saeed N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-221; Santos Camila Carolina de Menezes Patricio, 2013, Neurosci J, V2013, P949452, DOI 10.1155/2013/949452; Seczyk L, 2016, FOOD CHEM, V194, P637, DOI 10.1016/j.foodchem.2015.08.086; Sekerler T, 2018, ANTICANCER ANTIOXIDA, V2, P1542; Sharifi-Rad J, 2017, MOLECULES, V22, DOI 10.3390/molecules22010070; Sharifi-Rad M, 2017, MOLECULES, V22, DOI 10.3390/molecules22122145; Sharma S, 2013, EXPERT OPIN INV DRUG, V22, P1063, DOI 10.1517/13543784.2013.805744; Sharma UK, 2017, CELL MOL BIOL, V63, P73, DOI 10.14715/cmb/2017.63.6.15; Skehan P, 1990, JNCI-J NATL CANCER I, P82, DOI [10.1093/jnci/82.2.82, DOI 10.1093/JNCI/82.2.82]; Sofi FR, 2016, J FOOD SCI TECH MYS, V53, P104, DOI 10.1007/s13197-015-1983-0; Stankovic M.S., 2011, KRAGUJEVAC J SCI, V33, P63; Subbaramaiah K, 2004, J BIOL CHEM, V279, P12647, DOI 10.1074/jbc.M312972200; Sun BS, 1998, J AGR FOOD CHEM, V46, P4267, DOI 10.1021/jf980366j; Tian B, 2006, DNA SEQUENCE, V17, P143, DOI 10.1080/10425170600699877; Tovar MJ, 2002, J SCI FOOD AGR, V82, P892, DOI 10.1002/jsfa.1122; Trease GE, 1985, PHARMACOGNOSY, P453; Umarani V, 2015, TOXICOL MECH METHOD, V25, P143, DOI 10.3109/15376516.2014.1003359; Valgas C, 2007, BRAZ J MICROBIOL, V38, P369, DOI 10.1590/S1517-83822007000200034; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wagner H., 1984, PLANT DRUG ANAL; Wannes WA, 2010, FOOD CHEM TOXICOL, V48, P1362, DOI 10.1016/j.fct.2010.03.002; WAWERU WR, 2017, J ENTOMOL ZOOL STU B, V5, P110; Wintola OA, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0835-9; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Wu HQ, 1996, J MOL GRAPH MODEL, V14, P331, DOI 10.1016/S0263-7855(97)00006-4; Yedgar S, 2007, TRENDS PHARMACOL SCI, V28, P459, DOI 10.1016/j.tips.2007.07.005; Yu XL, 2015, FOOD FUNCT, V6, P3296, DOI 10.1039/c5fo00500k; Zaghloul AM, 2011, NAT PROD RES, V25, P68, DOI 10.1080/14786419.2010.511217; Zengin G, 2011, REC NAT PROD, V5, P123	106	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236319	10.1371/journal.pone.0236319	http://dx.doi.org/10.1371/journal.pone.0236319			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726328	Green Published, gold			2022-12-26	WOS:000556908900039
J	Ruetten, H; Cole, C; Wehber, M; Wegner, KA; Girardi, NM; Peterson, NT; Scharpf, BR; Romero, MF; Wood, MW; Colopy, SA; Bjorling, DE; Vezina, CM				Ruetten, Hannah; Cole, Clara; Wehber, Marlyse; Wegner, Kyle A.; Girardi, Nicholas M.; Peterson, Nelson T.; Scharpf, Brandon R.; Romero, Michael F.; Wood, Michael W.; Colopy, Sara A.; Bjorling, Dale E.; Vezina, Chad M.			An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction	PLOS ONE			English	Article							TISSUE-REPAIR; HYPERPLASIA; DISEASES; ANATOMY; MODEL; GLAND	Background The identity and spatial distribution of prostatic cell types has been determined in humans but not in dogs, even though aging- and prostate-related voiding disorders are common in both species and mechanistic factors, such as prostatic collagen accumulation, appear to be shared between species. In this publication we characterize the regional distribution of prostatic cell types in the young intact dog to enable comparisons with human and mice and we examine how the cellular source of procollagen 1A1 changes with age in intact male dogs. Methods A multichotomous decision tree involving sequential immunohistochemical stains was validated for use in dog and used to identify specific prostatic cell types and determine their distribution in the capsule, peripheral, periurethral and urethral regions of the young intact canine prostate. Prostatic cells identified using this technique include perivascular smooth muscle cells, pericytes, endothelial cells, luminal, intermediate, and basal epithelial cells, neuroendocrine cells, myofibroblasts, fibroblasts, fibrocytes, and other hematolymphoid cells. To enhance rigor and transparency, all high resolution images (representative images shown in the figures and biological replicates) are available through the GUDMAP database at https://doi.org/ 10.25548/16-WMM4. Results The prostatic peripheral region harbors the largest proportion of epithelial cells. Aging does not change the density of hematolymphoid cells, fibroblasts, and myofibroblasts in the peripheral region or in the fibromuscular capsule, regions where we previously observed aging- and androgen-mediated increases in prostatic collagen abundance Instead, we observed aging-related changes the procollagen 1A1 positive prostatic cell identity from a myofibroblast to a fibroblast. Conclusions Hematolymphoid cells and myofibroblasts are often identified as sources of collagen in tissues prone to aging-related fibrosis. We show that these are not the likely sources of pathological collagen synthesis in older intact male dogs. Instead, we identify an aging-related shift in the prostatic cell type producing procollagen 1A1 that will help direct development of cell type and prostate appropriate therapeutics for collagen accumulation.	[Ruetten, Hannah; Cole, Clara; Wehber, Marlyse; Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biomed Sci, Madison, WI 53706 USA; [Ruetten, Hannah; Cole, Clara; Wehber, Marlyse; Wegner, Kyle A.; Girardi, Nicholas M.; Peterson, Nelson T.; Scharpf, Brandon R.; Vezina, Chad M.] Univ Wisconsin, George M OBrien Benign Urol Ctr, Madison, WI 53706 USA; [Wegner, Kyle A.; Girardi, Nicholas M.; Peterson, Nelson T.; Scharpf, Brandon R.; Vezina, Chad M.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Romero, Michael F.] Mayo Clin, Physiol & Biomed Engn & Nephrol & Hypertens, George M OBrien Urol Res Ctr, Coll Med & Sci, Rochester, MN USA; [Wood, Michael W.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Colopy, Sara A.; Bjorling, Dale E.] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vezina, CM (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biomed Sci, Madison, WI 53706 USA.; Vezina, CM (corresponding author), Univ Wisconsin, George M OBrien Benign Urol Ctr, Madison, WI 53706 USA.; Vezina, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA.	cmvezina@wisc.edu	Vezina, Chad/GRO-2299-2022	Romero, Michael F/0000-0002-1555-7835; Ruetten, Hannah/0000-0001-6263-6221	National Institutes of Health [U54DK104310, U54DK104310S1, U54DK100227, K12DK100022, T32ES007015, F31ES028594, TL1TR002375, F30DK122686]; Mayo Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation	Funded by National Institutes of Health grants: U54DK104310 (HR, CC, MW, KW, NG, NP, BS, DB, CV), Summer Program in Undergraduate Urologic Research (U54DK104310S1; NG), U54DK100227 (HR, CC, MW, KW, NG, NP, BS, DB, CV), K12DK100022 (MW), T32ES007015 (KW), F31ES028594 (KW), TL1TR002375 (HR), F30DK122686 (HR), and the Mayo Foundation (MR). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2008, BRIT J OPHTHALMOL, V92, P699, DOI 10.1136/bjo.2007.134346; Aiello SE, 2016, MERCK VET MANUAL, V11th; Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269; BERG OA, 1958, ACTA ENDOCRINOL-COP, V27, P129, DOI 10.1530/acta.0.0270129; BRENDLER CB, 1983, J CLIN INVEST, V71, P1114, DOI 10.1172/JCI110861; Brenner DA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S17; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Cantiello F, 2013, UROLOGY, V81, P1018, DOI 10.1016/j.urology.2013.01.053; Cheng CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060905; Christensen BW, 2018, VET CLIN N AM-SMALL, V48, P701, DOI 10.1016/j.cvsm.2018.02.012; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Evans H.E., 2013, MILLERS ANATOMY DOG; Fernando Leis-Filho A, 2018, ANATOMY HISTOLOGY PH; Henry GH, 2018, CELL REP, V25, P3530, DOI 10.1016/j.celrep.2018.11.086; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hofmann PG, 2013, J ANAT, V222, P170, DOI 10.1111/joa.12002; Johnston S.D., 2001, CANINE FELINE THERIO, P337; Joseph DB, URETHRAL LUMINAL EPI, DOI [10.1101/2020.02.19.937615, DOI 10.1101/2020.02.19.937615]; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Knittel T, 1999, HISTOCHEM CELL BIOL, V112, P387, DOI 10.1007/s004180050421; Lai CL, 2008, PROSTATE, V68, P498, DOI 10.1002/pros.20721; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Mahapokai W, 2000, PROSTATE CANCER P D, V3, P28, DOI 10.1038/sj.pcan.4500391; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P619, DOI 10.1097/00000478-198808000-00003; OSHEA JD, 1962, J COMP PATHOL THERAP, V72, P321, DOI 10.1016/S0368-1742(62)80037-X; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Polisca A, 2016, THERIOGENOLOGY, V85, P835, DOI 10.1016/j.theriogenology.2015.10.030; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rosenbloom J, 2017, METHODS MOL BIOL, V1627, P1, DOI 10.1007/978-1-4939-7113-8_1; Ruetten H, 2018, PROSTATE, V78, P839, DOI 10.1002/pros.23641; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Smith J, 2008, THERIOGENOLOGY, V70, P375, DOI 10.1016/j.theriogenology.2008.04.039; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Wegner KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188413; Wong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100770; Zambelli D, 2012, REPROD DOMEST ANIM, V47, P229, DOI 10.1111/rda.12084	41	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0232564	10.1371/journal.pone.0232564	http://dx.doi.org/10.1371/journal.pone.0232564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726309	gold, Green Submitted, Green Published			2022-12-26	WOS:000556908900053
J	Fernando, HSD; Hapugoda, M; Perera, R; Black, WC; De Silva, BGDNK				Fernando, H. S. D.; Hapugoda, Menaka; Perera, Rushika; Black, William C.; De Silva, B. G. D. N. K.			Mitochondrial metabolic genes provide phylogeographic relationships of global collections of Aedes aegypti (Diptera: Culicidae)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; YELLOW-FEVER MOSQUITO; ORAL INFECTION; MOLECULAR-IDENTIFICATION; DNA POLYMORPHISM; DENGUE; VECTOR; POPULATION; EVOLUTION; SEQUENCES	Phylogeographic relationships among global collections of the mosquito Aedes aegypti were evaluated using the mitochondrial Cytochrome C Oxidase 1 (CO1) and NADH dehydrogenase subunit 4 (ND4) genes including new sequences from Sri Lanka. Phylogeographic analysis estimated that Ae. aegypti arose as a species similar to 614 thousand years ago (kya) in the late Pleistocene. At 545 kya an "early" East African clade arose that continued to differentiate in East Africa, and eventually gave rise to three lineages one of which is distributed throughout all tropical and subtropical regions, a second that contains Southeast Asian/Sri Lankan mosquitoes and a third that contains mostly New World mosquitoes. West African collections were not represented in this early clade. The late clade continued to differentiate throughout Africa and gave rise to a lineage that spread globally. The most recent branches of the late clade are represented by South-East Asia and India/Pakistan collections. Analysis of migration rates suggests abundant gene flow between India/Pakistan and the rest of the world with the exception of Africa.	[Fernando, H. S. D.; De Silva, B. G. D. N. K.] Univ Sri Jayewardenepura, Dept Zool, Ctr Biotechnol, Nugegoda, Sri Lanka; [Hapugoda, Menaka] Univ Kelaniya, Mol Med Unit, Fac Med, Kelaniya, Sri Lanka; [Perera, Rushika; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University Sri Jayewardenepura; University Kelaniya; Colorado State University	De Silva, BGDNK (corresponding author), Univ Sri Jayewardenepura, Dept Zool, Ctr Biotechnol, Nugegoda, Sri Lanka.	nissanka@sci.sjp.ac.lk	Fernando, Sachini/AAJ-7909-2021	Fernando, Sachini/0000-0002-3941-883X; de Silva, nissanka/0000-0001-8725-4393	World Class University Project, University of Sri Jayewardenepura [WCUP/PhD/17/2012]	World Class University Project, University of Sri Jayewardenepura	This research was funded by World Class University Project, University of Sri Jayewardenepura (https://www.sjp.ac.lk/wcup/), grant number [WCUP/PhD/17/2012]. B.G.D.N.K. De Silva received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajamma YU, 2016, J MED ENTOMOL; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097268; Ballard JWO, 2009, CHIANG MAI J SCI, V36, P188; BALLINGERCRABTREE ME, 1992, AM J TROP MED HYG, V47, P893, DOI 10.4269/ajtmh.1992.47.893; Barraud CP, 1934, FAUNA BRIT INDIA INC; Batovska J, 2016, ECOL EVOL, V6, P3001, DOI 10.1002/ece3.2095; Belkin J.N., 1962, MOSQUITOES S PACIFIC, V2; Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762; Black WC, 2009, INSECT MOL BIOL, V18, P705, DOI 10.1111/j.1365-2583.2009.00925.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; da Cruz Ferreira Danielle Andreza, 2017, Parasites & Vectors, V10, P78, DOI 10.1186/s13071-017-2025-8; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Dickson LB, 2016, G3-GENES GENOM GENET, pg3; Epidemiology unit, DENG UPD; Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196; Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226; Freitas MTS, 2014, GENET MOL RES, V13, P8776, DOI 10.4238/2014.October.27.19; FU YX, 1993, GENETICS, V133, P693; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866; Gorrochotegui-Escalante N, 2000, AM J TROP MED HYG, V62, P200, DOI 10.4269/ajtmh.2000.62.200; Gupta K, 2016, J VECTOR DIS, V53, P149; HARTBERG WK, 1968, ANN ENTOMOL SOC AM, V61, P865, DOI 10.1093/aesa/61.4.865; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11; Jaimes-Duenez J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003553; Kotsakiozi P, 2018, ECOL EVOL, V8, P7835, DOI 10.1002/ece3.4278; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Kumara Y.G., 2014, EUR ACAD RES, V2, P2350; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima RS, 2009, GENET MOL BIOL, V32, P414, DOI 10.1590/S1415-47572009005000036; LORENZ L, 1984, AM J TROP MED HYG, V33, P690, DOI 10.4269/ajtmh.1984.33.690; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; MATTINGLY PF, 1967, B WORLD HEALTH ORGAN, V36, P552; Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020; MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x; MCCLELLAND GAH, 1962, NATURE, V195, P965, DOI 10.1038/195965a0; Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175; Morlais I, 2002, DNA SEQUENCE, V13, P123, DOI 10.1080/10425170290030051; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Nei M., 1987, MOL EVOLUTIONARY GEN; Paduan KD, 2008, J MED ENTOMOL, V45, P59, DOI 10.1603/0022-2585(2008)45[59:MDPAHI]2.0.CO;2; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Sylla M, 2013, J VECTOR ECOL, V38, P237, DOI 10.1111/j.1948-7134.2013.12036.x; TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219; TABACHNICK WJ, 1979, EVOLUTION, V33, P287, DOI [10.1111/j.1558-5646.1979.tb04682.x, 10.2307/2407619]; TAJIMA F, 1983, GENETICS, V105, P437; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Vadivalagan C, 2016, PARASITOL RES, V115, P1149, DOI 10.1007/s00436-015-4847-7; WALLIS GP, 1983, GENET RES, V41, P241, DOI 10.1017/S0016672300021315; WALLIS GP, 1985, AM J TROP MED HYG, V34, P1225, DOI 10.4269/ajtmh.1985.34.1225; Yang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099120	68	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0235430	10.1371/journal.pone.0235430	http://dx.doi.org/10.1371/journal.pone.0235430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722672	Green Published, gold			2022-12-26	WOS:000556916000046
J	Go, YM; Zhang, J; Fernandes, J; Litwin, C; Chen, R; Wensel, TG; Jones, DP; Cai, JY; Chen, Y				Go, Young-Mi; Zhang, Jing; Fernandes, Jolyn; Litwin, Christopher; Chen, Rui; Wensel, Theodore G.; Jones, Dean P.; Cai, Jiyang; Chen, Yan			MTOR-initiated metabolic switch and degeneration in the retinal pigment epithelium	FASEB JOURNAL			English	Article						aging; AMD; lipid; metabolism; Mtor	MACULAR DEGENERATION; LIFE-SPAN; DOCOSAHEXAENOIC ACID; GEOGRAPHIC ATROPHY; MECHANISTIC TARGET; FATTY-ACIDS; MOUSE MODEL; RAPAMYCIN; GROWTH; CELLS	The retinal pigment epithelium (RPE) is a particularly vulnerable tissue to age-dependent degeneration. Over the life span, the RPE develops an expanded endo-lysosomal compartment to maintain the high efficiency of phagocytosis and degradation of photoreceptor outer segments (POS) necessary for photoreceptor survival. As the assembly and activation of the mechanistic target of rapamycin complex 1 (mTORC1) occur on the lysosome surface, increased lysosome mass with aging leads to higher mTORC1 activity. The functional consequences of hyperactive mTORC1 in the RPE are unclear. In the current study, we used integrated high-resolution metabolomic and genomic approaches to examine mice with RPE-specific deletion of the tuberous sclerosis 1 (Tsc1) gene which encodes an upstream suppressor of mTORC1. Our data show that RPE cells with constitutively high mTORC1 activity were reprogramed to be hyperactive in glucose and lipid metabolism. Lipolysis was suppressed, mitochondrial carnitine shuttle was inhibited, while genes involved in fatty acid (FA) biosynthesis were upregulated. The metabolic changes occurred prior to structural changes of RPE and retinal degeneration. These findings have revealed cellular events and intrinsic mechanisms that contribute to lipid accumulation in the RPE cells during aging and age-related degeneration.	[Go, Young-Mi; Fernandes, Jolyn; Jones, Dean P.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Zhang, Jing; Cai, Jiyang; Chen, Yan] Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX 77555 USA; [Fernandes, Jolyn] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Litwin, Christopher; Chen, Yan] Univ Oklahoma, Dean McGee Eye Inst, Hlth Sci Ctr, 608 Stanton L Young Blvd DMEI PB 027, Oklahoma City, OK 73104 USA; [Chen, Rui] Baylor Coll Med, Dept Genet, Houston, TX 77030 USA; [Chen, Rui; Wensel, Theodore G.] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Cai, Jiyang] Univ Oklahoma, Dept Physiol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Chen, Yan] Univ Oklahoma, Dept Biochem, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	Emory University; University of Texas System; University of Texas Medical Branch Galveston; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Baylor College of Medicine; Baylor College of Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Chen, Y (corresponding author), Univ Oklahoma, Dean McGee Eye Inst, Hlth Sci Ctr, 608 Stanton L Young Blvd DMEI PB 027, Oklahoma City, OK 73104 USA.	yan-chen@ouhsc.edu	FERNANDES, JOLYN/J-4034-2019	FERNANDES, JOLYN/0000-0002-4100-5815; Litwin, Christopher/0000-0001-6833-454X	NIH [R01EY026999, R01EY 028773, R01EY025218, R01-026545]; NIEHS [R01ES023485, NIHS10 OD018006]; BrightFocus Foundation [M2017186]; Welch Foundation [Q0035]; NIH/NEI grant [P30EY027125]; Research to Prevent Blindness	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); BrightFocus Foundation(BrightFocus Foundation); Welch Foundation(The Welch Foundation); NIH/NEI grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by NIH grants R01EY026999 (YC), R01EY 028773 (JC), R01EY025218 (TGW), R01-026545 (TGW), NIEHS grants R01ES023485 (DPJ and YMG) and NIHS10 OD018006 (DPJ), BrightFocus Foundation grants M2017186 (YC), and Welch Foundation Q0035 (TGW). The authors will like to acknowledge the Oklahoma University Health Science Center (OUHSC) Vision Research Facilities for the Live Animal Imaging Core, Genotyping Core and Cellular Imaging Core services. The cores are supported by NIH/NEI grant P30EY027125 to Dr Michelle C. Callegan and an unrestricted grant from Research to Prevent Blindness to the Dean McGee Eye Institute. We also will like to thank the Molecular Biology and Cytometry Research Shared Resource at OUHSC which provided the Metabolic Analysis of Live Cells service.	Adijanto J, 2014, EXP EYE RES, V126, P77, DOI 10.1016/j.exer.2014.01.015; Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; Benador IY, 2019, CELL METAB, V29, P827, DOI 10.1016/j.cmet.2019.02.011; Benchorin G, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2218; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; BODENSTEIN L, 1987, DEV BIOL, V121, P205, DOI 10.1016/0012-1606(87)90153-9; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; CHEN HM, 1993, EXP EYE RES, V57, P369, DOI 10.1006/exer.1993.1136; Chen L, 2020, RETINA-J RET VIT DIS, V40, P618, DOI 10.1097/IAE.0000000000002657; Chen M, 2016, AGING CELL, V15, P436, DOI 10.1111/acel.12447; Chen Y, 2010, INVEST OPHTH VIS SCI, V51, P5314, DOI 10.1167/iovs.10-5280; Cheng SY, 2020, P NATL ACAD SCI USA, V117, P13094, DOI 10.1073/pnas.2000339117; Choudhary M, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131928; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Du JH, 2016, P NATL ACAD SCI USA, V113, P14710, DOI 10.1073/pnas.1604572113; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Gambril JA, 2019, INVEST OPHTH VIS SCI, V60, P2481, DOI 10.1167/iovs.19-26949; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Go YM, 2015, TOXICOL SCI, V148, P531, DOI 10.1093/toxsci/kfv198; Go YM, 2015, AM J PHYSIOL-REG I, V308, pR62, DOI 10.1152/ajpregu.00278.2014; Golestaneh N, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1101-8; GORDON WC, 1992, CURR EYE RES, V11, P73, DOI 10.3109/02713689209069169; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guo ZX, 2016, ASIAN AUSTRAL J ANIM, V29, P1646, DOI 10.5713/ajas.15.0660; Handa JT, 2017, BBA-MOL CELL BIOL L, V1862, P430, DOI 10.1016/j.bbalip.2016.07.013; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He LZ, 2014, AM J PATHOL, V184, P1660, DOI 10.1016/j.ajpath.2014.02.007; Huang JC, 2019, THERANOSTICS, V9, P1170, DOI 10.7150/thno.26281; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Im SS, 2009, MOL CELL BIOL, V29, P5974, DOI 10.1128/MCB.01236-09; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kaur G, 2018, P NATL ACAD SCI USA, V115, P9014, DOI 10.1073/pnas.1805039115; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Klein R, 2014, AM J OPHTHALMOL, V158, P513, DOI 10.1016/j.ajo.2014.05.027; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Landowski M, 2019, P NATL ACAD SCI USA, V116, P3703, DOI 10.1073/pnas.1814014116; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Muniz-Feliciano L, 2017, AUTOPHAGY, V13, P2072, DOI 10.1080/15548627.2017.1380124; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Nussenblatt RB, 2010, RETINA-J RET VIT DIS, V30, P1579, DOI 10.1097/IAE.0b013e3181e7978e; Petrou PA, 2015, INVEST OPHTH VIS SCI, V56, P330, DOI 10.1167/iovs.14-15877; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Randle P J, 1978, Biochem Soc Symp, P47; Ratnapriya R, 2019, NAT GENET, V51, P606, DOI 10.1038/s41588-019-0351-9; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shang P, 2017, AGING CELL, V16, P349, DOI 10.1111/acel.12561; Shin Y, 2018, BBA-MOL BASIS DIS, V1864, P2420, DOI 10.1016/j.bbadis.2018.04.014; Souied EH, 2013, OPHTHALMOLOGY, V120, P1619, DOI 10.1016/j.ophtha.2013.01.005; Spaide RF, 2018, SURV OPHTHALMOL, V63, P782, DOI 10.1016/j.survophthal.2018.05.005; Storti F, 2019, ELIFE, V8, DOI 10.7554/eLife.45100; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swarup A, 2019, AM J PHYSIOL-CELL PH, V316, pC121, DOI 10.1152/ajpcell.00410.2018; Tyni T, 2002, PEDIATR RES, V52, P595, DOI 10.1203/01.PDR.0000030874.20888.2D; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Wang YJ, 2012, APOPTOSIS, V17, P1144, DOI 10.1007/s10495-012-0750-1; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Wong WT, 2013, INVEST OPHTH VIS SCI, V54, P2941, DOI 10.1167/iovs.13-11650; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu B, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aag3315; Yu B, 2014, INVEST OPHTH VIS SCI, V55, P8638, DOI 10.1167/iovs.14-14758; Yu TW, 2013, J PROTEOME RES, V12, P1419, DOI 10.1021/pr301053d; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhao ZY, 2017, FASEB J, V31, P4903, DOI 10.1096/fj.201700533R; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456; Zigler JS, 2011, J CELL SCI, V124, P523, DOI 10.1242/jcs.078790; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	91	14	14	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12502	12520		10.1096/fj.202000612R	http://dx.doi.org/10.1096/fj.202000612R		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32721041	Green Accepted			2022-12-26	WOS:000556063300001
J	Ozdas, S; Tastekin, B; Gurgen, SG; Ozdas, T; Pelit, A; Erkan, SO; Tuhanioglu, B; Gulnar, B; Gorgulu, O				Ozdas, Sibel; Tastekin, Bora; Gurgen, Seren G.; Ozdas, Talih; Pelit, Aykut; Erkan, Sanem O.; Tuhanioglu, Birgul; Gulnar, Birgul; Gorgulu, Orhan			Pterostilbene protects cochlea from ototoxicity in streptozotocin-induced diabetic rats by inhibiting apoptosis	PLOS ONE			English	Article							IMPROVES GLYCEMIC CONTROL; HEARING-LOSS; OXIDATIVE STRESS; MELLITUS; RESVERATROL; INSULIN; EXPRESSION; INJURY; MOUSE	Diabetes mellitus (DM) causes ototoxicity by inducing oxidative stress, microangiopathy, and apoptosis in the cochlear sensory hair cells. The natural anti-oxidant pterostilbene (PTS) (trans-3,5-dimethoxy-4-hydroxystylbene) has been reported to relieve oxidative stress and apoptosis in DM, but its role in diabetic-induced ototoxicity is unclear. This study aimed to investigate the effects of dose-dependent PTS on the cochlear cells of streptozotocin (STZ)-induced diabetic rats. The study included 30 albino male Wistar rats that were randomized into five groups: non-diabetic control (Control), diabetic control (DM), and diabetic rats treated with intraperitoneal PTS at 10, 20, or 40 mg/kg/day during the four-week experimental period (DM + PTS10, DM + PTS20, and DM + PTS40). Distortion product otoacoustic emission (DPOAE) tests were performed at the beginning and end of the study. At the end of the experimental period, apoptosis in the rat cochlea was investigated using caspase-8, cytochrome-c, and terminal deoxyribonucleotidyl transferase-mediated dUTP-biotin end labeling (TUNEL). Quantitative real-time polymerase chain reaction was used to assess the mRNA expression levels of the following genes:CASP-3, BCL-associated X protein (BAX), andBCL-2. Body weight, blood glucose, serum insulin, and malondialdehyde (MDA) levels in the rat groups were evaluated. The mean DPOAE amplitude in the DM group was significantly lower than the means of the other groups (0.9-8 kHz; P < 0.001 for all). A dose-dependent increase of the mean DPOAE amplitudes was observed with PTS treatment (P < 0.05 for all). The Caspase-8 and Cytochrome-c protein expressions and the number of TUNEL-positive cells in the hair cells of the Corti organs of the DM rat group were significantly higher than those of the PTS treatment and control groups (DM > DM + PTS10 > DM + PTS20 > DM + PTS40 > Control; P < 0.05 for all). PTS treatment also reduced cell apoptosis in a dose-dependent manner by increasing the mRNA expression of the anti-apoptosisBCL2gene and by decreasing the mRNA expressions of both the pro-apoptosisBAXgene and its effectorCASP-3and the ratio ofBAX/BCL-2in a dose-dependent manner (P < 0.05 compared to DM for all). PTS treatment significantly improved the metabolic parameters of the diabetic rats, such as body weight, blood glucose, serum insulin, and MDA levels, consistent with our other findings (P < 0.05 compared to DM for all). PTS decreased the cochlear damage caused by diabetes, as confirmed by DPOAE, biochemical, histopathological, immunohistochemical, and molecular findings. This study reports the first in vivo findings to suggest that PTS may be a protective therapeutic agent against diabetes-induced ototoxicity.	[Ozdas, Sibel; Gulnar, Birgul] Adana Alparslan Turkes Sci & Technol Univ, Dept Bioengn, Fac Engn Sci, Adana, Turkey; [Tastekin, Bora; Pelit, Aykut] Cukurova Univ, Dept Biophys, Adana, Turkey; [Gurgen, Seren G.] Celal Bayar Univ, Dept Histol & Embriol, Manisa, Turkey; [Ozdas, Talih; Erkan, Sanem O.; Tuhanioglu, Birgul; Gorgulu, Orhan] Hlth Sci Univ, Dept Otorhinolaryngol Head & Neck Surg, Adana City Hosp, Adana, Turkey	Adana Alparslan Turkes Science & Technology University; Cukurova University; Celal Bayar University; Adana Numune Training & Research Hospital; University of Health Sciences Turkey	Ozdas, S (corresponding author), Adana Alparslan Turkes Sci & Technol Univ, Dept Bioengn, Fac Engn Sci, Adana, Turkey.	sozdas@atu.edu.tr	Gürgen, Seren Gülşen/AAT-2326-2021; Tastekin, Bora/I-1533-2016	Tastekin, Bora/0000-0003-0178-8656; OZDAS, Sibel/0000-0003-4610-2785				Aimoni C, 2010, AUDIOL NEURO-OTOL, V15, P111, DOI 10.1159/000231636; Akinpelu OV, 2014, OTOL NEUROTOL, V35, P764, DOI 10.1097/MAO.0000000000000293; Axelsson A, 1978, Acta Otolaryngol Suppl, V356, P1; Bagai A, 2006, JAMA-J AM MED ASSOC, V295, P416, DOI 10.1001/jama.295.4.416; Baquer N Z, 1998, Indian J Clin Biochem, V13, P63, DOI 10.1007/BF02867866; Benwahhoud M, 2001, J ETHNOPHARMACOL, V76, P35, DOI 10.1016/S0378-8741(01)00207-0; Bhakkiyalakshmi E, 2016, EUR J PHARMACOL, V777, P9, DOI 10.1016/j.ejphar.2016.02.054; Bhakkiyalakshmi E, 2014, BRIT J PHARMACOL, V171, P1747, DOI 10.1111/bph.12577; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Bortoli S, 1997, ENDOCRINOLOGY, V138, P4821, DOI 10.1210/en.138.11.4821; Botelho CT, 2014, INT J AUDIOL, V53, P402, DOI 10.3109/14992027.2013.879341; Brosius F., HIGH DOSE STREPTOZOT; Ceriello A, 1997, DIABETES CARE, V20, P194, DOI 10.2337/diacare.20.2.194; Chakraborty A, 2010, TOXICOL IN VITRO, V24, P1215, DOI 10.1016/j.tiv.2010.02.007; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; CULLEN JR, 1993, J LARYNGOL OTOL, V107, P179, DOI 10.1017/S0022215100122571; Dudley J, 2009, J NUTR BIOCHEM, V20, P443, DOI 10.1016/j.jnutbio.2008.05.003; Elango B, 2016, CHEM RES TOXICOL, V29, P47, DOI 10.1021/acs.chemrestox.5b00378; Erdem T, 2003, EUR ARCH OTO-RHINO-L, V260, P62, DOI 10.1007/s00405-002-0519-1; Erkan SO, 2019, LARYNGOSCOPE, V129, pE1, DOI 10.1002/lary.27253; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fukushima H, 2006, ARCH OTOLARYNGOL, V132, P934, DOI 10.1001/archotol.132.9.934; Gomez-Zorita S, 2015, FOOD FUNCT, V6, P1968, DOI [10.1039/C5FO00151J, 10.1039/c5fo00151j]; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Hao J, 2017, ACTA OTO-LARYNGOL, V137, P179, DOI 10.1080/00016489.2016.1223344; Hougee S, 2005, PLANTA MED, V71, P387, DOI 10.1055/s-2005-864130; International Diabetes Federation, IDF DIABETES ATLAS, V10th; Jagadeb Manaswini, 2014, Genomics & Informatics, V12, P283, DOI 10.5808/GI.2014.12.4.283; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kim Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010017; Klimes I, 1998, Endocr Regul, V32, P115; Kosuru R, 2017, LIFE SCI, V182, P112, DOI 10.1016/j.lfs.2017.06.015; Lee SK, 2004, AM J NEURORADIOL, V25, P1342; Li WZ, 2018, SAUDI J BIOL SCI, V25, P500, DOI 10.1016/j.sjbs.2016.11.007; Liu JJ, 2005, ANN ONCOL, V16, P455, DOI 10.1093/annonc/mdi077; Liu J, 2016, CYTOKINE, V77, P88, DOI 10.1016/j.cyto.2015.11.006; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Manickam M, 1997, J NAT PROD, V60, P609, DOI 10.1021/np9607013; McCormack D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/575482; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Nageris B, 1998, AM J OTOL, V19, P63; NAKAE S, 1986, ARCH OTO-RHINO-LARYN, V243, P313, DOI 10.1007/BF00460208; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Pari L, 2006, LIFE SCI, V79, P641, DOI 10.1016/j.lfs.2006.02.036; Patidar A, 2015, INT J BASIC CLIN PHA, V4, P1189, DOI [10.18203/2319-2003.ijbcp20151356, DOI 10.18203/2319-2003.IJBCP20151356]; Pyhu HE, 2016, BR J NUTR, V115, P1911, DOI DOI 10.1017/S0007114516001069; Riche DM, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/463595; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rimando AM, 2002, J AGR FOOD CHEM, V50, P3453, DOI 10.1021/jf0116855; Rizvi SI, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/712092; Rodriguez-Bonilla P, 2011, J CHROMATOGR B, V879, P1091, DOI 10.1016/j.jchromb.2011.03.025; Roh SS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1032-1; Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21; Satheesh MA, 2006, J PHARM PHARMACOL, V58, P1483, DOI 10.1211/jpp.58.11.0009; Seshiah V, 1998, INDIAN J MED RES, V108, P24; SMITH TL, 1995, LARYNGOSCOPE, V105, P236, DOI 10.1288/00005537-199503000-00002; Sun HL, 2019, EUR J PHARMACOL, V859, DOI 10.1016/j.ejphar.2019.172526; TACHIBANA M, 1986, ARCH OTO-RHINO-LARYN, V243, P238, DOI 10.1007/BF00464437; Tsai HY, 2017, J FOOD DRUG ANAL, V25, P134, DOI 10.1016/j.jfda.2016.07.004; WACKYM PA, 1986, AM J OTOL, V7, P176; Warrier PK, 1994, INDIAN MED PLANTS, V46, DOI [10.1111/j.2042-7158.1994.tb05722.x, DOI 10.1111/J.2042-7158.1994.TB05722.X, 10.1111/j.2042-7158.1994.tb05722.x.]; Wojnar W, 2017, PHARMACOL REP, V69, P995, DOI 10.1016/j.pharep.2017.04.005; Yuksel Y, 2016, J INVEST SURG, V29, P389, DOI 10.1080/08941939.2016.1178358	64	3	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0228429	10.1371/journal.pone.0228429	http://dx.doi.org/10.1371/journal.pone.0228429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722679	Green Submitted, Green Published, gold			2022-12-26	WOS:000556916000003
J	Li, JY; Meng, XY; Wang, CZ; Zhang, HJ; Chen, HN; Deng, PY; Liu, J; Huandike, M; Wei, J; Chai, LM				Li, Jinyu; Meng, Xiaoying; Wang, Changzhi; Zhang, Huijie; Chen, Hening; Deng, Peiying; Liu, Juan; Huandike, Meiyier; Wei, Jie; Chai, Limin			Coptidis alkaloids extracted from Coptis chinensis Franch attenuate IFN-gamma-induced destruction of bone marrow cells	PLOS ONE			English	Article							CD4(+) T-CELLS; INTERFERON-GAMMA; IMMUNE-RESPONSES; PATHOPHYSIOLOGY; EXPRESSION; APOPTOSIS; FAS	Coptidis alkaloids are the primary active components of Coptis chinensis Franch. Clinical and pharmacodynamic studies have confirmed that Coptidis alkaloids have multiple therapeutic effects including anti-inflammatory, antioxidant and antitumor effects, and they are usually used to treat various inflammatory disorders and related diseases. Mouse bone marrow cells (BMCs) were isolated from BALB/c mice. Immune-mediated destruction of BMCs was induced by interferon (IFN) -gamma. High-performance liquid chromatography-electrospray ionization/mass spectrometry was used to analyze the ingredients of the aqueous extract from Coptis chinensis Franch. The results confirmed that Coptidis alkaloids were the predominant ingredients in the aqueous extract from Coptis chinensis. The functional mechanism of Coptidis alkaloids in inhibiting immune-mediated destruction of BMCs was studied in vitro. After Coptidis alkaloid treatment, the percentages of apoptotic BMCs and the proliferation and differentiation of helper T (Th) cells and regulatory T (Treg) cells were measured by flow cytometry. The expression and distribution of T-bet in BMCs were observed by immunofluorescence. Western blotting analysis was used to assay the expression of key molecules in the Fas apoptosis and Jak/Stats signaling pathways in BMCs. We identified five alkaloids in the aqueous extract of Coptis chinensis. The apoptotic ratios of BMCs induced by IFN-gamma were decreased significantly after Coptidis alkaloid treatment. The levels of key molecules (Fas, Caspase-3, cleaved Caspase-3, Caspase-8 and Caspase-8) in Fas apoptosis signaling pathways also decreased significantly after treatment with low concentrations of Coptidis alkaloids. Coptidis alkaloids were also found to inhibit the proliferation of Th1 and Th17 cells and induce the differentiation of Th2 and Treg cells; further, the distribution of T-bet in BMCs was decreased significantly. In addition, the levels of Stat-1, phospho-Stat-1 and phospho-Stat-3 were also reduced after Coptidis alkaloid treatment. These results indicate that Coptidis alkaloids extracted by water decoction from Coptis chinensis Franch could inhibit the proliferation and differentiation of T lymphocytes, attenuate the apoptosis of BMCs, and suppress the immune-mediated destruction of the BMCs induced by pro-inflammatory cytokines.	[Li, Jinyu; Meng, Xiaoying; Wang, Changzhi; Zhang, Huijie; Chen, Hening; Deng, Peiying; Liu, Juan; Huandike, Meiyier; Chai, Limin] Beijing Univ Chinese Med, Dongzhimen Hosp, Key Lab Chinese Internal Med, Minist Educ & Beijin, Beijing, Peoples R China; [Wei, Jie] Beijing Univ Chinese Med, Dongzhimen Hosp, Pharmaceut Dept, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Chai, LM (corresponding author), Beijing Univ Chinese Med, Dongzhimen Hosp, Key Lab Chinese Internal Med, Minist Educ & Beijin, Beijing, Peoples R China.; Wei, J (corresponding author), Beijing Univ Chinese Med, Dongzhimen Hosp, Pharmaceut Dept, Beijing, Peoples R China.	weijie952157@126.com; liminchai@hotmail.com	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		Research special for National Chinese Medicine Clinical Research Base of State Administration of Traditional Chinese Medicine of the People's Republic of China [JDZX2015191]	Research special for National Chinese Medicine Clinical Research Base of State Administration of Traditional Chinese Medicine of the People's Republic of China	This work was supported by Research special for National Chinese Medicine Clinical Research Base of State Administration of Traditional Chinese Medicine of the People's Republic of China (Grant number: JDZX2015191, http://www.satcm.gov.cn/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We have uploaded the information of funding on the revised files.	Ahmad W, 2016, FOOD FUNCT, V7, P1380, DOI [10.1039/c5fo01531f, 10.1039/C5FO01531F]; Blanco JCG, 2000, J EXP MED, V191, P2131, DOI 10.1084/jem.191.12.2131; Caldenhoven E, 1999, J LEUKOCYTE BIOL, V65, P391, DOI 10.1002/jlb.65.3.391; Chen JC, 2015, BLOOD, V126, P2621, DOI 10.1182/blood-2015-06-652453; Chen SS, 2017, J EXP MED, V214, P475, DOI 10.1084/jem.20161312; de Latour RP, 2010, BLOOD, V116, P4175, DOI 10.1182/blood-2010-01-266098; Deng PY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180417; Dicay MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118713; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Giannakoulas NC, 2004, BRIT J HAEMATOL, V124, P97, DOI 10.1046/j.1365-2141.2003.04729.x; Hombach A, 2006, J IMMUNOL, V177, P5668, DOI 10.4049/jimmunol.177.8.5668; Hsu YY, 2012, EUR J PHARM SCI, V46, P415, DOI 10.1016/j.ejps.2012.03.004; Jin W, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010217; Kordasti SY, 2009, BRIT J HAEMATOL, V145, P64, DOI 10.1111/j.1365-2141.2009.07593.x; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Li JY, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1526-x; Lou LX, 2016, EXP THER MED, V11, P2054, DOI 10.3892/etm.2016.3136; Lu Y, 2012, BLOOD, V119, P1075, DOI 10.1182/blood-2010-12-322891; MACIEJEWSKI J, 1995, BLOOD, V85, P3183, DOI 10.1182/blood.V85.11.3183.bloodjournal85113183; Omokaro SO, 2009, J IMMUNOL, V182, P3414, DOI 10.4049/jimmunol.0801430; Quan GH, 2015, INT J MOL SCI, V16, P29496, DOI 10.3390/ijms161226179; Sarcon AK, 2009, EXP HEMATOL, V37, P477, DOI 10.1016/j.exphem.2008.12.001; Shi J, 2012, BLOOD, V120, P1624, DOI 10.1182/blood-2011-11-390708; Tan HL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00362; WANG H, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/798093; Wang J, 2018, CHIN MED-UK, V13, DOI 10.1186/s13020-018-0184-y; Yang YF, 2017, J CHROMATOGR SCI, V55, P556, DOI 10.1093/chromsci/bmx009; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687; Zeng Y, 2015, CLIN EXP IMMUNOL, V180, P361, DOI 10.1111/cei.12605; Zhang YL, 2017, CHIN MED-UK, V12, DOI 10.1186/s13020-017-0140-2; Zhou JW, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9786972	33	3	4	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236433	10.1371/journal.pone.0236433	http://dx.doi.org/10.1371/journal.pone.0236433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706801	gold, Green Published			2022-12-26	WOS:000579931700041
J	Ribeiro, TB; Buss, L; Wayant, C; Nobre, MRC				Ribeiro, Tatiane Bomfim; Buss, Lewis; Wayant, Cole; Cuce Nobre, Moacyr Roberto			Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018	PLOS ONE			English	Article							AMERICAN SOCIETY; GUIDELINE; THERAPY; TRIALS	Regulatory agencies around the world have been using flexible requirements for approval of new drugs, especially for cancer drugs. The US Food and Drug Administration (FDA) is mostly the first agency to approve new drugs worldwide, mainly due to the faster terms of the accelerated pathway and breakthrough therapy designation. Surrogate endpoints and preliminary data (e.g. single-arm and phase 2 studies) are used for these new approvals, however larger effect sizes are expected. We aim to compare FDA Accelerated vs Regular Pathway approvals and Breakthrough therapy designations (BTD) for lung cancer treatments between 2006 and 2018 regarding study design, sample size, outcome measures and effect size. We assessed the FDA database to collect data from studies that formed the basis of approvals of new drugs or indications for lung cancer spanning from 2006 to 2018. We found that accelerated pathway approvals are based on significantly more single-arm studies with small sample sizes and surrogate primary endpoints. However, effect size was not different between the pathways. A large proportion of studies used to support regular pathway approvals also showed these characteristics that are related to low quality and uncertain evidence. Compared to other approvals, BTD were more frequently based on single-arm studies. There was no significant difference in use of surrogate endpoints or sample size. 44% of BTD were based on studies demonstrating large effect sizes, proportionally more than approvals not receiving this designation. In conclusion, based on the indicators of evidence quality we extracted, criteria's for granting accelerated approval and breakthrough therapy designation seen not clear. Faster approvals are in the majority full of uncertainties which should be viewed with caution and the patient have to be communicated to allow shared decision making. Post-marketing validation is essential.	[Ribeiro, Tatiane Bomfim; Buss, Lewis; Cuce Nobre, Moacyr Roberto] Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, SP, Brazil; [Wayant, Cole] Oklahoma State Univ, Dept Biomed Sci, Ctr Hlth Sci, Tulsa, OK USA; [Cuce Nobre, Moacyr Roberto] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Inst Coracao,InCor, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Oklahoma State University System; Oklahoma State University Center for Health Sciences; Universidade de Sao Paulo	Ribeiro, TB (corresponding author), Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, SP, Brazil.	tatianeribeiro6@gmail.com		Ribeiro, Tatiane/0000-0003-4434-748X	National Cancer Institute of the National Institutes of Health [F30CA243651-01]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CW is supported by the National Cancer Institute of the National Institutes of Health under award number F30CA243651-01. No additional external funding was received for this study.	Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Beaver JA, 2018, JAMA ONCOL, V4, P849, DOI 10.1001/jamaoncol.2017.5618; Booth CM, 2012, J CLIN ONCOL, V30, P1030, DOI 10.1200/JCO.2011.38.7571; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen EY, 2019, JAMA INTERN MED, V179, P915, DOI 10.1001/jamainternmed.2019.0583; Dagenais GR, 2020, LANCET, V395, P785, DOI 10.1016/S0140-6736(19)32007-0; Djulbegovic B, 2018, J CLIN EPIDEMIOL, V98, P24, DOI 10.1016/j.jclinepi.2018.01.011; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Eberhardt WEE, 2015, ANN ONCOL, V26, P1573, DOI 10.1093/annonc/mdv187; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ettinger DS, 2017, JNCCN J NATL COMPR C, DOI [10.6004/jnccn.2017, DOI 10.6004/JNCCN.2017]; FDA, 2014, DRAFT GUID IND; Fojo T, 2014, JAMA OTOLARYNGOL, V140, P1225, DOI 10.1001/jamaoto.2014.1570; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Gyawali B, 2019, JAMA INTERN MED, V179, P906, DOI 10.1001/jamainternmed.2019.0462; Hanna N, 2017, J CLIN ONCOL, V35, P3484, DOI 10.1200/JCO.2017.74.6065; Haslam A, 2019, EUR J CANCER, V106, P196, DOI 10.1016/j.ejca.2018.11.012; Kalemkerian GP, 2013, JNCCN J NATL COMPR C, DOI [10.6004/jnccn.2013.0011, DOI 10.6004/JNCCN.2013.0011]; Kalemkerian GP, 2018, J CLIN ONCOL, V36, P911, DOI 10.1200/JCO.2017.76.7293; Kendall JM, 2003, EMERG MED J, V20, P164, DOI 10.1136/emj.20.2.164; Ladanie A, 2019, J CLIN EPIDEMIOL, V114, P49, DOI 10.1016/j.jclinepi.2019.05.033; National Cancer Institute, MIL CANC RES DISC; POCOCK SJ, 1976, J CHRON DIS, V29, P175, DOI 10.1016/0021-9681(76)90044-8; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Razavi M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11111; Ribeiro TB, 2019, INT J TECHNOL ASSESS, P1; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Van Norman Gail A, 2016, JACC Basic Transl Sci, V1, P399, DOI 10.1016/j.jacbts.2016.06.003; Wayant C, 2018, ANN ONCOL, V29, P2384, DOI 10.1093/annonc/mdy447; Yao JC, 2013, CLIN CANCER RES, V19, P4305, DOI 10.1158/1078-0432.CCR-13-1428	31	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236345	10.1371/journal.pone.0236345	http://dx.doi.org/10.1371/journal.pone.0236345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706800	gold, Green Published			2022-12-26	WOS:000579931700028
J	Cornejo-Juarez, P; Cevallos, MA; Castro-Jaimes, S; Castillo-Ramirez, S; Velaquez-Acosta, C; Martinez-Oliva, D; Peez-Oseguera, A; Rivera-Buendia, F; Volkow-Fernandez, P				Cornejo-Juarez, Patricia; Angel Cevallos, Miguel; Castro-Jaimes, Semiramis; Castillo-Ramirez, Santiago; Velazquez-Acosta, Consuelo; Martinez-Oliva, David; Perez-Oseguera, Angeles; Rivera-Buendia, Frida; Volkow-Fernandez, Patricia			High mortality in an outbreak of multidrug resistant Acinetobacter baumannii infection introduced to an oncological hospital by a patient transferred from a general hospital	PLOS ONE			English	Article							PNEUMONIA; EVOLUTION; SURVIVAL	Objective To describe the clinical features, outcomes, and molecular epidemiology of an outbreak of multidrug resistant (MDR) A. baumannii. Methods We performed a retrospective analysis of all MDR A. baumannii isolates recovered during an outbreak from 2011 to 2015 in a tertiary care cancer hospital. Cases were classified as colonized or infected. We determined sequence types following the Bartual scheme and plasmid profiles. Results There were 106 strains of A. baumannii isolated during the study period. Sixty-six (62.3%) were considered as infection and 40 (37.7%) as colonization. The index case, identified by molecular epidemiology, was a patient with a drain transferred from a hospital outside Mexico City. Ninety-eight additional cases had the same MultiLocus Sequence Typing (MLST) 758, of which 94 also had the same plasmid profile, two had an extra plasmid, and two had a different plasmid. The remaining seven isolates belonged to different MLSTs. Fifty-three patients (50%) died within 30 days of A. baumanniii isolation: 28 (20%) in colonized and 45 (68.2%) in those classified as infection (p<0.001). In multivariate regression analysis, clinical infection and patients with hematologic neoplasm, predicted 30-day mortality. The molecular epidemiology of this outbreak showed the threat posed by the introduction of MDR strains from other institutions in a hospital of immunosuppressed patients and highlights the importance of adhering to preventive measures, including contact isolation, when admitting patients with draining wounds who have been hospitalized in other institutions.	[Cornejo-Juarez, Patricia; Martinez-Oliva, David; Rivera-Buendia, Frida; Volkow-Fernandez, Patricia] Inst Nacl Cancerol, Dept Infectol, Ciudad De Mexico, Mexico; [Angel Cevallos, Miguel; Castro-Jaimes, Semiramis; Castillo-Ramirez, Santiago; Perez-Oseguera, Angeles] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Evolut, Cuernavaca, Morelos, Mexico; [Velazquez-Acosta, Consuelo] Inst Nacl Cancerol, Lab Microbiol, Ciudad De Mexico, Mexico	Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN)	Volkow-Fernandez, P (corresponding author), Inst Nacl Cancerol, Dept Infectol, Ciudad De Mexico, Mexico.	pvolkowf@gmail.com		Castillo-Ramirez, Santiago/0000-0003-3922-7088; Cornejo-Juarez, Patricia/0000-0001-6331-8372	(PAPIIT:[Programas de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica]-Support program for research and technological innovation projects). Universidad Nacional Autonoma de Mexico [PAPIIT200318]	(PAPIIT:[Programas de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica]-Support program for research and technological innovation projects). Universidad Nacional Autonoma de Mexico	MAC, SCR:This project was partially financed by PAPIIT200318 (PAPIIT:[Programas de Apoyo a Proyectos de Investigacion e Innovacio ' n Tecnologica]-Support program for research and technological innovation projects). Universidad Nacional Autonoma de Mexico.	Abbo A, 2005, EMERG INFECT DIS, V11, P22, DOI 10.3201/eid1101.040001; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Blanco N, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01631-17; Bocanegra-Ibarias P, 2015, INT J ANTIMICROB AG, V45, P309, DOI 10.1016/j.ijantimicag.2014.10.022; Brotfain E, 2017, J INTENSIVE CARE MED, V32, P528, DOI 10.1177/0885066616632193; Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLIN LAB STA; Dettori M, 2014, NEW MICROBIOL, V37, P185; Alcantar-Curiel MD, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02116; ECKHARDT T, 1978, PLASMID, V1, P584, DOI 10.1016/0147-619X(78)90016-1; Gagnaire J, 2017, MED MALADIES INFECT, V47, P279, DOI 10.1016/j.medmal.2017.02.006; Garnacho-Montero J, 2015, EXPERT REV ANTI-INFE, V13, P769, DOI 10.1586/14787210.2015.1032254; Grana-Miraglia L, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00801-19; HYNES MF, 1990, MOL MICROBIOL, V4, P567, DOI 10.1111/j.1365-2958.1990.tb00625.x; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006; Lopez-Leal G, 2019, MICROB DRUG RESIST, V25, P690, DOI 10.1089/mdr.2018.0311; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Vanegas JM, 2015, BIOMEDICA, V35, P522, DOI 10.7705/biomedica.v35i4.2572; Marchaim D, 2017, FUTURE MICROBIOL, V12, P271, DOI 10.2217/fmb-2016-0158; Martinez J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53847-2; Michalopoulos A, 2011, AM J INFECT CONTROL, V39, P396, DOI 10.1016/j.ajic.2010.06.017; Miraglia L, 2017, FRONT MICROBIOL, V8, p1 817, DOI [10.3389/fmicb, DOI 10.3389/FMICB.2016.00817]; Shojaei L, 2016, IRAN J MICROBIOL, V8, P288; Tamayo-Legorreta E M, 2014, New Microbes New Infect, V2, P173, DOI 10.1002/nmi2.60; WARSKOW AL, 1972, J BACTERIOL, V112, P1014, DOI 10.1128/JB.112.2.1014-1016.1972; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Yang SS, 2018, CAN J INFECT DIS MED, V2018, P1, DOI 10.1155/2018/3150965; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0234684	10.1371/journal.pone.0234684	http://dx.doi.org/10.1371/journal.pone.0234684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702006	Green Published, gold			2022-12-26	WOS:000575913700010
J	Eddy, CM; Hansen, PC				Eddy, Clare M.; Hansen, Peter C.			Predictors of performance on the Reading the Mind in the Eyes Test	PLOS ONE			English	Article							TORONTO-ALEXITHYMIA-SCALE; ASPERGER-SYNDROME; SCHIZOPHRENIA; RECOGNITION; EMPATHY; ADULTS; SELF; FACE; VALIDATION; DEFICITS	We explored factors associated with performance on the Reading the Mind in the Eyes Test (RMET). 180 undergraduate students completed the human RMET requiring forced-choice mental state judgment; a control human Age Eyes Test (AET) requiring age judgment; a Cat Eyes Test (CET) requiring mental state judgment; and measures of executive function, empathy and psychopathology. Versions of the CET and AET were created that matched the RMET for difficulty (accuracy 71%). RMET and CET performance were strongly correlated after accounting for AET performance. Working memory, schizotypal personality and empathy predicted RMET accuracy but not CET scores. Liking dogs predicted higher accuracy on all eyes tasks, whereas liking cats predicted greater mentalizing but reduced emotional expression. Importantly, we replicated our core findings relating to accuracy and correlations between the CET and RMET in a second sample of 228 students. In conclusion, people can apply similar skills when interpreting cat and human expressions. As RMET and CET performance were found to be differentially affected by executive function and psychopathology, the use of social cognitive measures featuring non-human animals may be of particular use in future clinical research.	[Eddy, Clare M.] BSMHFT, Natl Ctr Mental Hlth, Birmingham, W Midlands, England; [Eddy, Clare M.] Univ Birmingham, Coll Med & Dent Sci, Inst Clin Sci, Birmingham, W Midlands, England; [Hansen, Peter C.] Univ Birmingham, Coll Life & Environm Sci, Ctr Human Brain Hlth, Birmingham, W Midlands, England; [Hansen, Peter C.] Univ Birmingham, Coll Life & Environm Sci, Sch Psychol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Hansen, PC (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Ctr Human Brain Hlth, Birmingham, W Midlands, England.; Hansen, PC (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Psychol, Birmingham, W Midlands, England.	p.c.hansen@bham.ac.uk	Eddy, Clare/AAC-5909-2021	Eddy, Clare/0000-0001-7821-1121; Hansen, Peter/0000-0002-4948-1007				Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Allain P, 2011, NEUROPSYCHOLOGY, V25, P741, DOI 10.1037/a0024408; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baker CA, 2014, INTELLIGENCE, V44, P78, DOI 10.1016/j.intell.2014.03.001; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2006, BRAIN COGNITION, V61, P122, DOI 10.1016/j.bandc.2005.12.011; Baron-Cohen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136521; Berthoz S, 2013, PSYCHIAT RES, V208, P257, DOI 10.1016/j.psychres.2013.05.014; Brecht M, 2012, CURR OPIN NEUROBIOL, V22, P259, DOI 10.1016/j.conb.2011.12.003; Calkins ME, 2004, SCHIZOPHRENIA BULL, V30, P317, DOI 10.1093/oxfordjournals.schbul.a007081; Castelli I, 2010, NEUROPSYCHOLOGIA, V48, P2586, DOI 10.1016/j.neuropsychologia.2010.05.005; Cook CM, 2010, PERS INDIV DIFFER, V49, P712, DOI 10.1016/j.paid.2010.06.010; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Demers LA, 2015, AM J PSYCHOL, V128, P31, DOI 10.5406/amerjpsyc.128.1.0031; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; Eddy CM, 2017, PSYCHOL MED, V47, P507, DOI 10.1017/S0033291716002725; Eddy CM, 2012, ACTA NEUROL SCAND, V126, P376, DOI 10.1111/j.1600-0404.2012.01659.x; Eddy CM, 2011, COGN NEUROPSYCHIATRY, V16, P326, DOI 10.1080/13546805.2010.538213; Epley N, 2007, PSYCHOL REV, V114, P864, DOI 10.1037/0033-295X.114.4.864; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Gosling SD, 2010, ANTHROZOOS, V23, P213, DOI 10.2752/175303710X12750451258850; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Grandgeorge M., 2016, Human-Animal Interaction Bulletin, V4, P39; Hirao K, 2008, SCHIZOPHR RES, V105, P165, DOI 10.1016/j.schres.2008.07.021; Irani F, 2006, SCHIZOPHR RES, V88, P151, DOI 10.1016/j.schres.2006.07.016; Isernia S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00128; Kirkland R.A., 2013, N AM J PSYCHOL, V15, P121, DOI DOI 10.3389/fpsyg.2015.01503; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lyvers M, 2017, AM J PSYCHOL, V130, P83; Maruyama M., 2011, EFFECTS ANIMALS CHIL; Moor BG, 2012, SOC COGN AFFECT NEUR, V7, P44, DOI 10.1093/scan/nsr020; O'Haire ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057010; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Olderbak S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01503; Paul ES, 2014, ANTHROZOOS, V27, P499, DOI 10.2752/175303714X14023922798192; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Reevy GM, 2015, J APPL ANIM WELF SCI, V18, P239, DOI 10.1080/10888705.2014.988333; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Schiffer B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060278; Spunt RP, 2017, SOC COGN AFFECT NEUR, V12, P95, DOI 10.1093/scan/nsw161; Svensson AS, 2014, IMPACT ANIMALS CHILD, V59, P77; Tsuruya N, 2011, PARKINSONISM RELAT D, V17, P246, DOI 10.1016/j.parkreldis.2010.09.001; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vellante M, 2013, COGN NEUROPSYCHIATRY, V18, P326, DOI 10.1080/13546805.2012.721728; Werheid K, 2002, ARCH CLIN NEUROPSYCH, V17, P547, DOI 10.1016/S0887-6177(01)00134-2; Whyte EM, 2016, DEVELOPMENTAL SCI, V19, P306, DOI 10.1111/desc.12305	49	8	8	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235529	10.1371/journal.pone.0235529	http://dx.doi.org/10.1371/journal.pone.0235529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32701998	gold, Green Published			2022-12-26	WOS:000575913700017
J	Saade, S; Brien, C; Pailles, Y; Berger, B; Shahid, M; Russell, J; Waugh, R; Negrao, S; Tester, M				Saade, Stephanie; Brien, Chris; Pailles, Yveline; Berger, Bettina; Shahid, Mohammad; Russell, Joanne; Waugh, Robbie; Negrao, Sonia; Tester, Mark			Dissecting new genetic components of salinity tolerance in two-row spring barley at the vegetative and reproductive stages	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; NA+ EXCLUSION; SALT STRESS; LINKAGE DISEQUILIBRIUM; GENOME ASSOCIATION; POPULATION; WHEAT; ADAPTATION; EXPRESSION; CANDIDATE	Soil salinity imposes an agricultural and economic burden that may be alleviated by identifying the components of salinity tolerance in barley, a major crop and the most salt tolerant cereal. To improve our understanding of these components, we evaluated a diversity panel of 377 two-row spring barley cultivars during both the vegetative, in a controlled environment, and the reproductive stages, in the field. In the controlled environment, a high-throughput phenotyping platform was used to assess the growth-related traits under both control and saline conditions. In the field, the agronomic traits were measured from plots irrigated with either fresh or saline water. Association mapping for the different components of salinity tolerance enabled us to detect previously known associations, such as HvHKT1;5. Using an "interaction model", which took into account the interaction between treatment (control and salt) and genetic markers, we identified several loci associated with yield components related to salinity tolerance. We also observed that the two developmental stages did not share genetic regions associated with the components of salinity tolerance, suggesting that different mechanisms play distinct roles throughout the barley life cycle. Our association analysis revealed that genetically defined regions containing known flowering genes (Vrn-H3, Vrn-H1, and HvNAM-1) were responsive to salt stress. We identified a salt-responsive locus (7H, 128.35 cM) that was associated with grain number per ear, and suggest a gene encoding a vacuolar H+- translocating pyrophosphatase, HVP1, as a candidate. We also found a new QTL on chromosome 3H (139.22 cM), which was significant for ear number per plant, and a locus on chromosome 2H (141.87 cM), previously identified using a nested association mapping population, which associated with a yield component and interacted with salinity stress. Our study is the first to evaluate a barley diversity panel for salinity stress under both controlled and field conditions, allowing us to identify contributions from new components of salinity tolerance which could be used for marker-assisted selection when breeding for marginal and saline regions.	[Saade, Stephanie; Pailles, Yveline; Tester, Mark] King Abdullah Univ Sci & Technol KAUST, Biol & Environm Sci & Engn BESE, Thuwal, Saudi Arabia; [Brien, Chris; Berger, Bettina; Waugh, Robbie] Univ Adelaide, Sch Agr Food & Wine Waite Res Precinct, Urrbrae, SA, Australia; [Brien, Chris] Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA, Australia; [Brien, Chris; Berger, Bettina] Univ Adelaide, Australian Plant Phen Facil, Plant Accelerator, Waite Res Precinct, Urrbrae, SA, Australia; [Shahid, Mohammad] Int Ctr Biosaline Agr ICBA, Dubai, U Arab Emirates; [Russell, Joanne; Waugh, Robbie] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland; [Waugh, Robbie] Univ Dundee, Sch Life Sci, James Hutton Inst, Div Plant Sci, Dundee, Scotland; [Negrao, Sonia] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin, Ireland	King Abdullah University of Science & Technology; University of Adelaide; University of South Australia; University of Adelaide; James Hutton Institute; James Hutton Institute; University of Dundee; University College Dublin	Saade, S (corresponding author), King Abdullah Univ Sci & Technol KAUST, Biol & Environm Sci & Engn BESE, Thuwal, Saudi Arabia.	stephanie.saade@kaust.edu.sa	Brien, Chris/D-5630-2009; Berger, Bettina/AAH-1190-2021; Tester, Mark/J-2368-2017	Brien, Chris/0000-0003-0581-1817; Berger, Bettina/0000-0003-1195-4478; saade, stephanie/0000-0003-3817-7234; Negrao, Sonia/0000-0001-8059-5240; Tester, Mark/0000-0002-5085-8801	King Abdullah University of Science and Technology (KAUST); National Collaborative Research Infrastructure Strategy (NCRIS) of the Australian Government; BBSRC [BB/M018466/1, BB/L026317/1] Funding Source: UKRI	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); National Collaborative Research Infrastructure Strategy (NCRIS) of the Australian Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research reported in this publication was supported by funding from KAUST to the Baseline of Mark Tester. https://saltlab.kaust.edu.sa.; The research reported in this publication was supported by funding from King Abdullah University of Science and Technology (KAUST) to the baseline of MT. We thank Dr. Ibrahim S. Elbasyoni for helping design the field experiments. We thank the International Center for Biosaline Agriculture for their work in performing the field experiments. We acknowledge the Association Genetics of UK Elite Barley (AGOUEB) consortium for putting together the association mapping population. We would also like to extend our gratitude to the team members at The Plant Accelerator1, who provided assistance with the phenotypic data collection. The Plant Accelerator1, Australian Plant Phenomics Facility, is supported under the National Collaborative Research Infrastructure Strategy (NCRIS) of the Australian Government.	Al-Tamimi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13342; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; Brien C., ASREMLPLUS AUGMENTS; Brien C, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00577-6; Brien CJ, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-5; Brien CJ, 2016, IMAGEDATA AIDS PROCE; Butler DG, 2018, ASREML R REFERENCE M; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Byrt CS, 2014, PLANT J, V80, P516, DOI 10.1111/tpj.12651; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Choi WG, 2014, P NATL ACAD SCI USA, V111, P6497, DOI 10.1073/pnas.1319955111; Cockram J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0359-5; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Coombes NE, 2009, DIGGER DESIGN SEARCH; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Dawson IK, 2015, NEW PHYTOL, V206, P913, DOI 10.1111/nph.13266; Distelfeld A, 2008, MOL BREEDING, V22, P25, DOI 10.1007/s11032-007-9153-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fan Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00946; FAO and ITPS, 2015, STAT WORLDS SOIL RES, P242; Feldman MJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006841; Fernandez G.C.J., 1992, P INT S AD VEG OTH F; Frouin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190964; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gilroy S, 2014, TRENDS PLANT SCI, V19, P623, DOI 10.1016/j.tplants.2014.06.013; Hazzouri KM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00156; Honsdorf N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097047; Houston K, 2020, GRAIN SALT 2020; Houston K, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0990-5; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; James RA, 2006, PLANT CELL ENVIRON, V29, P2185, DOI 10.1111/j.1365-3040.2006.01592.x; James RA, 2011, J EXP BOT, V62, P2939, DOI 10.1093/jxb/err003; Khokhar JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179208; Knoch D, 2020, PLANT BIOTECHNOL J, V18, P68, DOI 10.1111/pbi.13171; Lacerenza JA, 2010, J EXP BOT, V61, P3137, DOI 10.1093/jxb/erq139; Li W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00732; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lonergan PF, 2009, NEW PHYTOL, V184, P168, DOI 10.1111/j.1469-8137.2009.02956.x; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Maurer A, 2016, J EXP BOT, V67, P2507, DOI 10.1093/jxb/erw070; Morton MJL, 2019, PLANT J, V97, P148, DOI 10.1111/tpj.14189; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Neumann K, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1085-4; Neumann K, 2015, PLANT CELL ENVIRON, V38, P1980, DOI 10.1111/pce.12516; Newton AC, 2011, FOOD SECUR, V3, P141, DOI 10.1007/s12571-011-0126-3; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Parent B, 2015, J EXP BOT, V66, P5481, DOI 10.1093/jxb/erv320; Peirone LS, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00587; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Development Team, 2015, R LANG ENV STAT COMP; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; Rivandi J, 2011, J EXP BOT, V62, P1201, DOI 10.1093/jxb/erq346; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Saade S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32586; Schilling RK, 2014, PLANT BIOTECHNOL J, V12, P378, DOI 10.1111/pbi.12145; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shavrukov Y., 2014, VACUOLAR H PPASE HVP, P125; Shavrukov Y, 2010, FUNCT INTEGR GENOMIC, V10, P277, DOI 10.1007/s10142-009-0153-8; Smith A, 2001, BIOMETRICS, V57, P1138, DOI 10.1111/j.0006-341X.2001.01138.x; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; USDA, 2018, GRAIN WORLD MARK TRA; Ward B, 2019, PLANT J, V98, P555, DOI 10.1111/tpj.14225; Xu Y., 2015, J APPL BIOINFORMATIC, V4, DOI [10.4172/2329-9533.1000115, DOI 10.4172/2329-9533.1000115]; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Zhou GF, 2012, MOL BREEDING, V29, P427, DOI 10.1007/s11032-011-9559-9	78	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236037	10.1371/journal.pone.0236037	http://dx.doi.org/10.1371/journal.pone.0236037			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701981	gold, Green Published, Green Accepted			2022-12-26	WOS:000575913700042
J	Shrestha, S; Chaudhary, N; Shrestha, S; Pathak, S; Sharma, A; Shrestha, L; Kurmi, OP				Shrestha, Sandeep; Chaudhary, Nagendra; Shrestha, Saneep; Pathak, Santosh; Sharma, Arun; Shrestha, Laxman; Kurmi, Om P.			Clinical predictors of radiological pneumonia: A cross-sectional study from a tertiary hospital in Nepal	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; GAMBIAN CHILDREN; DIAGNOSIS; ETIOLOGY; RELIABILITY	Background Despite readily availability of vaccines against both Hemophilus influenzae and Pneumococcus, pneumonia remains the most common cause of morbidity and mortality in children under the age of five years in Nepal. With growing antibiotic resistance and a general move towards more rational antibiotic use, early identification of clinical signs for the prediction of radiological pneumonia would help practitioners to start the treatment of patients. The main aim of this study was to reassess the clinical predictors of pneumonia in Nepal. Methods This cross-sectional study was conducted between June 2015 and November 2015 at Tribhuvan University Teaching Hospital, a tertiary hospital in Kathmandu, Nepal. Children aged 3-60 months with a clinical diagnosis of pneumonia by a physician were enrolled in the study. Radiological pneumonia was identified and categorized as per World Health Organization guidelines by an experienced radiologist blinded to patient characteristics. We calculated sensitivity and specificity of clinical signs and symptoms for radiological pneumonia. Results Out of 1021 children with fever, 160 cases were clinically diagnosed as pneumonia and were enrolled for this study. Among the enrolled patients, 61% had radiological pneumonia. Tachypnea had the highest sensitivity of 99%, while bronchial breathing had the highest specificity of 100%. During univariate analysis, grunting, wheezing, nasal discharge, decreased breath sounds, noisy breathing and hypoxemia were associated with radiological pneumonia. Only hypoxemia remained an independent predictor when adjusted for all the factors. Conclusion Tachypnea was the most sensitive sign, whereas bronchial breathing was most specific sign for radiological pneumonia.	[Shrestha, Sandeep; Chaudhary, Nagendra] Universal Coll Med Sci, Dept Pediat, Bhairahawa, Nepal; [Shrestha, Saneep] Universal Coll Med Sci, Dept Community Med, Bhairahawa, Nepal; [Pathak, Santosh] Chitwan Med Coll, Dept Pediat, Bharatpur, Nepal; [Sharma, Arun; Shrestha, Laxman] Tribhuvan Univ, Inst Med, Teaching Hosp, Dept Pediat, Kathmandu, Nepal; [Kurmi, Om P.] McMaster Univ, Dept Med, Div Respirol, Hamilton, ON, Canada	Tribhuvan University; Institute of Medicine (IoM) - Nepal; McMaster University	Chaudhary, N (corresponding author), Universal Coll Med Sci, Dept Pediat, Bhairahawa, Nepal.	enagendra@hotmail.com	Chaudhary, Nagendra/D-9723-2017	Chaudhary, Nagendra/0000-0002-3216-8671; Shrestha, Sandeep/0000-0002-0365-3299; Kurmi, Om Prakash/0000-0002-9518-4716; Shrestha, Saneep/0000-0003-2922-2259				Anadol D, 2001, TURKISH J PEDIATR, V43, P205; Ayieko P, 2007, PEDIATR INFECT DIS J, V26, P432, DOI 10.1097/01.inf.0000260107.79355.7d; Banstola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071311; Basnet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122052; Bilkis MD, 2010, PEDIATR EMERG CARE, V26, P399, DOI 10.1097/PEC.0b013e3181e05779; Brandstetter RD, 1993, PULMONARY DISORDERS, P277; Castro AV, 2005, INDIAN PEDIATR, V42, P773; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; Gupta D, 1996, J TROP PEDIATRICS, V42, P196, DOI 10.1093/tropej/42.4.196; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; KORAN LM, 1975, NEW ENGL J MED, V293, P695, DOI 10.1056/NEJM197510022931405; KORAN LM, 1975, NEW ENGL J MED, V293, P642, DOI 10.1056/NEJM197509252931307; LOZANO JM, 1994, ARCH DIS CHILD, V71, P323, DOI 10.1136/adc.71.4.323; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Lynch T, 2004, PEDIATRICS, V113, pE186, DOI 10.1542/peds.113.3.e186; Lynch T, 2004, ACAD EMERG MED, V11, P625, DOI [10.1197/j.aem.2003.12.019, 10.1111/j.1553-2712.2004.tb00714.x]; Neuman MI, 2012, J HOSP MED, V7, P294, DOI 10.1002/jhm.955; Neuman MI, 2011, PEDIATRICS, V128, P246, DOI 10.1542/peds.2010-3367; Neuman MI, 2011, PEDIATR EMERG CARE, V27, P606, DOI 10.1097/PEC.0b013e3182225578; Palafox M, 2000, ARCH DIS CHILD, V82, P41, DOI 10.1136/adc.82.1.41; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Rothrock SG, 2001, PEDIATR EMERG CARE, V17, P240, DOI 10.1097/00006565-200108000-00003; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; Wingerter SL, 2012, PEDIATR INFECT DIS J, V31, P561, DOI 10.1097/INF.0b013e31824da716; World Health Organization, 2013, PNEUM POCK HOSP CAR, P80	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235598	10.1371/journal.pone.0235598	http://dx.doi.org/10.1371/journal.pone.0235598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702037	Green Published, gold			2022-12-26	WOS:000575913700018
J	Wang, C; Zhang, JG; Zhou, SM; Yu, LM; Han, FX; Ling, R; Ling, J				Wang, Chao; Zhang, Jingui; Zhou, Simin; Yu, Limei; Han, Fangxuan; Ling, Ren; Ling, Jin			Tentative identification of gefitinib metabolites in non-small-cell lung cancer patient plasma using ultra-performance liquid chromatography coupled with triple quadrupole time-of-flight mass spectrometry	PLOS ONE			English	Article							DESMETHYL-GEFITINIB; MAJOR METABOLITES; DRUG-INTERACTIONS; IN-VITRO; INHIBITORS; MS/MS	Background Gefitinib is an orally potent and selective ATP-competitive inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase and is commonly used to treat locally advanced or metastatic non-small-cell lung cancer (NSCLC) with sensitive EGFR mutations. Multiple adverse effects associated with gefitinib, including liver and lung injuries, severe nausea, and diarrhea, have limited its clinical application. Xenobiotic-induced bioactivation is thought to be an important reason for gefitinib toxicity, which encouraged us to clarify the metabolism of gefitinib in NSCLC patients. Materials and methods An ultra-performance liquid chromatography coupled with triple quadrupole time-of-flight mass spectrometry (UPLCQ-TOF-MS) method was established to tentatively identify the metabolites of gefitinib in human plasma. The extracted ion chromatogram peak intensity threshold was set at 1500 cps with minimum MS and MS/MS peak intensities of 400 and 100 cps, respectively. Results A total of 18 tentative metabolites were identified. Eight novel tentative metabolites with metabolic changes in dechlorination, defluorination, and hydrogenation on the quinazoline skeleton; removal of a partial or complete 3-chloro-4-fluoroaniline-substituted group; and sulfate conjugation and taurine conjugation were newly discovered in human plasma. Based on structural analysis of the tentative metabolites, the metabolic pathways were proposed. In addition, the pathways of dechlorination, defluorination, and hydrogenation on the quinazoline skeleton; removal of partial or complete 3-chloro-4-fluoroaniline-substituted groups; and sulfate conjugation and taurine conjugation in humans in vivo indicate that novel metabolic pathways exist in humans. Conclusions In summary, the metabolism of gefitinib in humans in vivo is extensive and complex. Based on in vivo evidence, the propoxy-morpholine ring side chain and O-methyl group are the critical metabolic regions of gefitinib in humans. The novel metabolic pathways differ from those of in vitro studies, suggesting that intestinal floral metabolism might be involved.	[Wang, Chao; Zhou, Simin] Hainan Med Univ, Hainan Gen Hosp, Dept Pharm, Hainan Affiliated Hosp, Haikou, Hainan, Peoples R China; [Zhang, Jingui; Han, Fangxuan] Hainan Med Univ, Hainan Gen Hosp, Phase Clin Trial Ward 1, Dept Pharm,Hainan Affiliated Hosp, Haikou, Hainan, Peoples R China; [Yu, Limei] Childrens Hosp Jiangxi Prov, Dept Funct Examinat, Nanchang, Jiangxi, Peoples R China; [Ling, Ren] Zhejiang Jinhua Guangfu Hosp, Dept Pathol, Jinhua, Zhejiang, Peoples R China; [Ling, Jin] Zhejiang Jinhua Guangfu Hosp, Dept Pharm, Jinhua, Zhejiang, Peoples R China; [Ling, Jin] Fudan Univ, Sch Pharm, Dept Pharmaceut Anal, Shanghai, Peoples R China	Hainan Medical University; Hainan Medical University; Fudan University	Wang, C (corresponding author), Hainan Med Univ, Hainan Gen Hosp, Dept Pharm, Hainan Affiliated Hosp, Haikou, Hainan, Peoples R China.; Ling, J (corresponding author), Zhejiang Jinhua Guangfu Hosp, Dept Pharm, Jinhua, Zhejiang, Peoples R China.; Ling, J (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmaceut Anal, Shanghai, Peoples R China.	wch_22001923@163.com; ttelva@foxmail.com		wang, chao/0000-0002-8592-3781	 [2019-3-023]		Ren Ling Grant number 2019-3-023 Jinhua city science and technology project http://kjj.jinhua.gov.cn/.	Elbastawesy MAI, 2020, BIOORG CHEM, V96, DOI 10.1016/j.bioorg.2020.103628; Guan SX, 2019, J PHARMACEUT BIOMED, V172, P364, DOI 10.1016/j.jpba.2019.03.060; Han SY, 2014, J ETHNOPHARMACOL, V151, P210, DOI 10.1016/j.jep.2013.10.021; Li W, 2015, CANCER CHEMOTH PHARM, V75, P1253, DOI 10.1007/s00280-015-2753-4; Ling J, 2019, J GINSENG RES, V43, P539, DOI 10.1016/j.jgr.2018.03.005; Liu X, 2015, BIOCHEM PHARMACOL, V97, P111, DOI 10.1016/j.bcp.2015.07.010; McKillop D, 2006, XENOBIOTICA, V36, P29, DOI 10.1080/00498250500523253; McKillop D, 2005, XENOBIOTICA, V35, P39, DOI 10.1080/00498250400026464; McKillop D, 2005, MOL CANCER THER, V4, P641, DOI 10.1158/1535-7163.MCT-04-0329; Mckillop D, 2004, XENOBIOTICA, V34, P983, DOI 10.1080/02772240400015222; McKillop D, 2004, XENOBIOTICA, V34, P917, DOI 10.1080/00498250400009171; Miotto K, 2017, ANESTH ANALG, V124, P44, DOI 10.1213/ANE.0000000000001683; Rahman AF, 2014, GEFITINIB, V39, P239, DOI [10.1016/B978-0-12-800173-8.00005-2, DOI 10.1016/B978-0-12-800173-8.00005-2]; Sparidans RW, 2016, J CHROMATOGR B, V1033, P390, DOI 10.1016/j.jchromb.2016.09.012; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1067, DOI 10.2165/00003088-200544100-00005; Wang LZ, 2011, J CHROMATOGR B, V879, P2155, DOI 10.1016/j.jchromb.2011.05.056; WANG XM, 2019, FRONT ONCOL, V9, P31374, DOI DOI 10.3389/FONC.2019; Wang YQ, 2020, ACTA PHARMACOL SIN, V41, P731, DOI 10.1038/s41401-019-0341-6; Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002; Xu ZY, 2019, ONCOTARGETS THER, V12, P5467, DOI 10.2147/OTT.S194870; Zhao C, 2017, CURR DRUG DELIV, V14, P282, DOI 10.2174/1567201813666160709021605; Zheng N, 2016, J CHROMATOGR B, V1011, P215, DOI 10.1016/j.jchromb.2016.01.006	22	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236523	10.1371/journal.pone.0236523	http://dx.doi.org/10.1371/journal.pone.0236523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702075	Green Published, gold			2022-12-26	WOS:000575913700100
J	Wang, GF; Wang, YH; Abdelnabby, H; Xiao, XQ; Huang, WK; Peng, DL; Xiao, YN				Wang, Gaofeng; Wang, Yunhe; Abdelnabby, Hazem; Xiao, Xueqiong; Huang, Wenkun; Peng, Deliang; Xiao, Yannong			Dihydroxyacetone of wheat root exudates serves as an attractant for Heterodera avenae	PLOS ONE			English	Article							SOYBEAN CYST-NEMATODE; PATHWAY MODULATES ATTRACTIVENESS; SIGNALING PATHWAY; CHEMOTAXIS	Heterodera avenae, as an obligate endoparasite, causes severe yield loss in wheat (Triticum aestivum). Investigation on the mechanisms how H. avenae perceives wheat roots is limited. Here, the attractiveness of root exudates from eight plant genotypes to H. avenae were evaluated on agar plates. Results showed that the attraction of H. avenae to the root exudates from the non-host Brachypodium distachyon variety Bd21-3 was the highest, approximately 50 infective second-stage juveniles (J2s) per plate, followed by that from three H. avenae-susceptible wheat varieties, Zhengmai9023, Yanmai84 and Xiangmai25, as well as the resistant one of Xinyuan958, whereas the lowest attractive activity was observed in the two H. avenae-resistant wheat varieties, Xianmai20 (approximately 12 J2s/plate) and Liangxing66 (approximately 11 J2s/plate). Then Bd21-3, Zhengmai9023 and Heng4399 were selected for further assays as their different attractiveness and resistance to H. avenae, and attractants for H. avenae in their root exudates were characterized to be heat-labile and low-molecular compounds (LM) by behavioral bioassay. Based on these properties of the attractants, a principle of identifying attractants for H. avenae was set up. Then LM of six root exudates from the three plants with and without heating were separated and analyzed by HPLC-MS. Finally, dihydroxyacetone (DHA), methylprednisolone succinate, embelin and diethylpropionin in the root exudates were identified to be putative attractants for H. avenae according to the principle, and the attraction of DHA to H. avenae was validated by behavioral bioassay on agar. Our study enhances the recognition to the orientation mechanism of H. avenae towards wheat roots.	[Wang, Gaofeng; Wang, Yunhe; Abdelnabby, Hazem; Xiao, Xueqiong; Xiao, Yannong] Huazhong Agr Univ, Coll Plant Sci & Technol, Key Lab Plant Pathol Hubei Prov, Wuhan, Hubei, Peoples R China; [Huang, Wenkun; Peng, Deliang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Xiao, YN (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Key Lab Plant Pathol Hubei Prov, Wuhan, Hubei, Peoples R China.; Peng, DL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	dlpeng@ippcaas.cn; xiaoyannong@mail.hzau.edu.cn	wang, gaofeng/GZM-5268-2022	Wang, Gaofeng/0000-0003-2231-3254	Special Fund for Agro-Scientific Research in the Public Interest [201503114]; National Nature Science Foundations of China [31571988]; Fundamental Research Funds for the Central Universities [2662017JC031]; Science and Technology Research Fund "STDF" [30369]	Special Fund for Agro-Scientific Research in the Public Interest; National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Research Fund "STDF"	Yannong Xiao gets the financial support of the Special Fund for Agro-Scientific Research in the Public Interest (201503114) and National Nature Science Foundations of China (31571988), and Gaofeng Wang gets the Fundamental Research Funds for the Central Universities (2662017JC031). Science and Technology Research Fund "STDF" provided funding to Hazem Abdelnabby: (Project ID: 30369). The sponsors or funders play none roles in the study.	Ali JG, 2011, J ECOL, V99, P26, DOI 10.1111/j.1365-2745.2010.01758.x; Ali JG, 2010, J CHEM ECOL, V36, P361, DOI 10.1007/s10886-010-9773-7; Bacetty AA, 2009, J CHEM ECOL, V35, P844, DOI 10.1007/s10886-009-9657-x; Caruso MC, 2017, J NEUROSURG-PEDIATR, V20, P567, DOI 10.3171/2017.7.PEDS1756; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Devine KJ, 2003, NEMATOLOGY, V5, P65, DOI 10.1163/156854102765216704; Fudali SL, 2013, MOL PLANT MICROBE IN, V26, P75, DOI 10.1094/MPMI-05-12-0107-R; Gandhi GR, 2013, BBA-GEN SUBJECTS, V1830, P2243, DOI 10.1016/j.bbagen.2012.10.016; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hosoi A, 2017, BIOSCI BIOTECH BIOCH, V81, P1542, DOI 10.1080/09168451.2017.1332980; Hu YF, 2017, SCI REP-UK, V7, DOI 10.1038/srep41282; Huang WK, 2016, MOL PLANT PATHOL, V17, P614, DOI 10.1111/mpp.12316; Huang XF, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0225; Iannucci A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02124; Jones J. P., 2002, BIOL NEMATODES, P369; Kawasaki A., 2016, PLOS ONE, V11; Kirwa HK, 2018, J AGR FOOD CHEM, V66, P11291, DOI 10.1021/acs.jafc.8b05101; MCCALLUM ME, 1992, J CHEM ECOL, V18, P585, DOI 10.1007/BF00987821; Mishra R, 2008, BIOTECHNOL ADV, V26, P293, DOI 10.1016/j.biotechadv.2008.02.001; Pan K, 2013, ALLELOPATHY J, V32, P257; PAPADEMETRIOU MK, 1983, J CHEM ECOL, V9, P387, DOI 10.1007/BF00988457; Qi YongHong, 2015, Agricultural Sciences, V6, P900; Rasmann S, 2012, J CHEM ECOL, V38, P615, DOI 10.1007/s10886-012-0118-6; Reinecke A, 2008, BASIC APPL ECOL, V9, P568, DOI 10.1016/j.baae.2007.10.002; Reynolds AM, 2011, J R SOC INTERFACE, V8, P568, DOI 10.1098/rsif.2010.0417; Riga E, 2001, CAN J PLANT PATHOL, V23, P168, DOI 10.1080/07060660109506926; Shekelle PG, 2004, AHRQ EVIDENCE REPORT, P103; Sikder MM, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01792; Smiley RW, 2017, PLANT DIS, V101, P1692, DOI 10.1094/PDIS-03-17-0355-FE; Spiegel Y, 2003, PHYTOPATHOLOGY, V93, P127, DOI 10.1094/PHYTO.2003.93.1.127; VIGLIERCHIO D R, 1990, Revue de Nematologie, V13, P425; Vos C, 2012, PLANT SOIL, V354, P335, DOI 10.1007/s11104-011-1070-x; Wang CL, 2009, J CHEM ECOL, V35, P1242, DOI 10.1007/s10886-009-9703-8; Warnock ND, 2016, INT J PARASITOL, V46, P473, DOI 10.1016/j.ijpara.2016.02.005; Wesemael WML, 2006, NEMATOLOGY, V8, P895, DOI 10.1163/156854106779799204; Wilschut RA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01861; Wu HW, 2002, J AGR FOOD CHEM, V50, P4567, DOI 10.1021/jf025508v; [吴蕾 WU Lei], 2009, [大豆科学, Soybean Science], V28, P1021; Wuyts N, 2006, PLANT SOIL, V283, P217, DOI 10.1007/s11104-006-0013-4; Xu Z, 2015, NEMATOLOGY, V17, P117, DOI 10.1163/15685411-00002856; Yang GD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154675	41	2	2	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236317	10.1371/journal.pone.0236317	http://dx.doi.org/10.1371/journal.pone.0236317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702002	Green Published, gold			2022-12-26	WOS:000575913700074
J	Marjani, A; Nakhjiri, AT; Adimi, M; Jirandehi, HF; Shirazian, S				Marjani, Azam; Nakhjiri, Ali Taghvaie; Adimi, Maryam; Jirandehi, Hassan Fathinejad; Shirazian, Saeed			Modification of polyethersulfone membrane using MWCNT-NH2 nanoparticles and its application in the separation of azeotropic solutions by means of pervaporation	PLOS ONE			English	Article							MASS-TRANSFER SIMULATION; CO2 SEPARATION; NUMERICAL-SIMULATION; LIQUID ABSORBENTS; MIXTURES; REMOVAL	In this study, functionalized multi-walled carbon nanotubes (MWCNT-NH2) were synthesized as an additive for the preparation of mixed matrix membranes (MMMs) and then were investigated by FTIR and FE-SEM techniques. Polyether sulfone (PES) polymeric membrane modified with functionalized MWCNT-NH(2)carbon nanotubes was prepared by phase inversion method. The effect of MWCNT-NH(2)on the morphology and property of the PES membrane was evaluated using scanning electron microscopy. The flux, enrichment factor and swelling properties of modified membranes were also used to investigate the membranes performance. The results showed that the flux and enrichment factor in modified PES membrane containing 5 wt.% of functionalized MWCNT-NH(2)carbon nanotubes were obtained 1.2 L.m(-2)h(-1)and 3.3, respectively. The influence of methanol concentration on the flux and enrichment factor was investigated. The results corroborated that the flux didn't change significantly, while the enrichment factor was decreased.	[Marjani, Azam] Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam; [Marjani, Azam] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam; [Nakhjiri, Ali Taghvaie] Islamic Azad Univ, Dept Petr & Chem Engn, Sci & Res Branch, Tehran, Iran; [Adimi, Maryam] Islamic Azad Univ, Dept Chem Engn, Farahan Branch, Farmahin, Farahan, Iran; [Jirandehi, Hassan Fathinejad] Islamic Azad Univ, Dept Chem, Farahan Branch, Farmahin, Farahan, Iran; [Shirazian, Saeed] Duy Tan Univ, Inst Res & Dev, Da Nang, Vietnam; [Shirazian, Saeed] Duy Tan Univ, Fac Environm & Chem Engn, Da Nang, Vietnam	Ton Duc Thang University; Ton Duc Thang University; Islamic Azad University; Islamic Azad University; Islamic Azad University; Duy Tan University; Duy Tan University	Shirazian, S (corresponding author), Duy Tan Univ, Inst Res & Dev, Da Nang, Vietnam.; Shirazian, S (corresponding author), Duy Tan Univ, Fac Environm & Chem Engn, Da Nang, Vietnam.	saeedshirazian@duytan.edu.vn	Taghvaie Nakhjiri, Ali/ABG-2176-2021; Fathinejad, Hassan/ABD-9861-2021	Taghvaie Nakhjiri, Ali/0000-0001-6244-3446; Fathinejad, Hassan/0000-0001-6990-345X				Abdallah H, 2013, DESALIN WATER TREAT, V51, P7807, DOI 10.1080/19443994.2013.775077; Ang WL, 2015, DESALINATION, V363, P2, DOI 10.1016/j.desal.2014.03.008; Atchariyawut S, 2007, J MEMBRANE SCI, V304, P163, DOI 10.1016/j.memsci.2007.07.030; Byron Bird R, 2007, TRANSPORT PHENOMENA, V2nd, DOI DOI 10.1002/AIC.690070245; Cannilla C, 2017, CATALYSTS, V7, DOI 10.3390/catal7060187; Fadaei F, 2012, DESALINATION, V284, P316, DOI 10.1016/j.desal.2011.09.018; Ghadiri M, 2019, CHEM ENG TECHNOL, V42, P2358, DOI 10.1002/ceat.201800631; Ghadiri M, 2014, POLYM ENG SCI, V54, P660, DOI 10.1002/pen.23601; Ghadiri M, 2012, CHEM ENG TECHNOL, V35, P2177, DOI 10.1002/ceat.201200289; Hajilary N, 2019, ENVIRON CHEM LETT, V17, P1, DOI 10.1007/s10311-018-0777-9; Joo Y, 2015, ACS NANO, V9, P10203, DOI 10.1021/acsnano.5b03835; Ko JM, 2004, ELECTROCHIM ACTA, V50, P367, DOI 10.1016/j.electacta.2004.01.127; Liu HX, 2018, CHINESE J CHEM ENG, V26, P1, DOI 10.1016/j.cjche.2017.03.006; Liu K, 2014, J MEMBRANE SCI, V451, P24, DOI 10.1016/j.memsci.2013.09.045; Marjani A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58472-y; Marjani A, 2011, ASIAN J CHEM, V23, P3205; McGinnis RL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1700938; Nabipour N, 2020, ACS OMEGA, V5, P3571, DOI 10.1021/acsomega.9b03911; Nakhjiri AT, 2020, J ENVIRON CHEM ENG, V8, DOI 10.1016/j.jece.2020.104130; Nakhjiri AT, 2020, J MOL LIQ, V297, DOI 10.1016/j.molliq.2019.111561; Nakhjiri AT, 2019, J IND ENG CHEM, V78, P106, DOI 10.1016/j.jiec.2019.06.031; Nakhjiri AT, 2018, CHINESE J CHEM ENG, V26, P1845, DOI 10.1016/j.cjche.2017.12.012; Nakhjiri AT, 2018, J MEMBRANE SCI, V565, P1, DOI 10.1016/j.memsci.2018.07.095; Nakhjiri AT, 2018, J ENVIRON CHEM ENG, V6, P1500, DOI 10.1016/j.jece.2018.01.068; Quinones-Bolanos E, 2005, J MEMBRANE SCI, V252, P19, DOI 10.1016/j.memsci.2004.10.038; Ranjbar M, 2013, CHEM ENG TECHNOL, V36, P728, DOI 10.1002/ceat.201300008; Razavi SMR, 2016, ARAB J CHEM, V9, P62, DOI 10.1016/j.arabjc.2015.06.006; Razavi SMR, 2015, POLYM ENG SCI, V55, P598, DOI 10.1002/pen.23924; Rezakazemi M, 2019, J MOL LIQ, V274, P470, DOI 10.1016/j.molliq.2018.11.017; Rezakazemi M, 2018, J MOL LIQ, V271, P24, DOI 10.1016/j.molliq.2018.08.132; Rezakazemi M, 2011, CHEM ENG J, V168, P1217, DOI 10.1016/j.cej.2011.02.019; Rezakazemi M, 2011, CHEM ENG J, V168, P60, DOI 10.1016/j.cej.2010.12.034; Saadati J, 2017, J TAIWAN INST CHEM E, V71, P265, DOI 10.1016/j.jtice.2016.12.024; Shirazian S, 2009, SIMUL MODEL PRACT TH, V17, P708, DOI 10.1016/j.simpat.2008.12.002; Yang ZJ, 2013, SEP PURIF TECHNOL, V109, P48, DOI 10.1016/j.seppur.2013.01.056	35	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236529	10.1371/journal.pone.0236529	http://dx.doi.org/10.1371/journal.pone.0236529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697797	gold, Green Published			2022-12-26	WOS:000555392700020
J	Kanemura, S; Sofia, EF; Hirai, N; Okumura, M; Kadokura, H; Inaba, K				Kanemura, Shingo; Sofia, Elza Firdiani; Hirai, Naoya; Okumura, Masaki; Kadokura, Hiroshi; Inaba, Kenji			Characterization of the endoplasmic reticulum-resident peroxidases GPx7 and GPx8 shows the higher oxidative activity of GPx7 and its linkage to oxidative protein folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); oxidation-reduction (redox); disulfide; protein-disulfide isomerase; protein folding; glutathione peroxidase; hydrogen peroxide	DISULFIDE-ISOMERASE; HYDROGEN-PEROXIDE; STRESS SENSOR; ERO1 FAMILY; GLUTATHIONE; ERO1-ALPHA; REDUCTASE; NPGPX; PDI; PATHWAY	Oxidative protein folding occurs primarily in the mammalian endoplasmic reticulum, enabled by a diverse network comprising more than 20 members of the protein disulfide isomerase (PDI) family and more than five PDI oxidases. Although the canonical disulfide bond formation pathway involving Ero1 alpha and PDI has been well-studied so far, the physiological roles of the newly identified PDI oxidases, glutathione peroxidase-7 (GPx7) and -8 (GPx8), are only poorly understood. We here demonstrated that human GPx7 has much higher reactivity with H(2)O(2)and hence greater PDI oxidation activity than human GPx8. The high reactivity of GPx7 is due to the presence of a catalytic tetrad at the redox-active site, which stabilizes the sulfenylated species generated upon the reaction with H2O2. Although it was previously postulated that GPx7 catalysis involved a highly reactive peroxidatic cysteine that can be sulfenylated by H2O2, we revealed that a resolving cysteine instead regulates the PDI oxidation activity of GPx7. We also determined that GPx7 formed complexes preferentially with PDI and P5 in H2O2-treated cells. Altogether, these results suggest that human GPx7 functions as an H2O2-dependent PDI oxidase in cells, whereas PDI oxidation may not be the central physiological role of human GPx8.	[Kanemura, Shingo; Sofia, Elza Firdiani; Hirai, Naoya; Okumura, Masaki; Kadokura, Hiroshi; Inaba, Kenji] Tohoku Univ, Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi, Japan; [Kanemura, Shingo] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda, Hyogo, Japan; [Kanemura, Shingo; Okumura, Masaki] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University; Kwansei Gakuin University; Tohoku University	Inaba, K (corresponding author), Tohoku Univ, Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi, Japan.	kenji.inaba.a1@tohoku.ac.jp	Kadokura, Hiroshi/AAE-1645-2019	Kanemura, Shingo/0000-0002-7012-8179; Inaba, Kenji/0000-0001-8229-0467; Kadokura, Hiroshi/0000-0001-7308-7141	Japan Society for the Promotion of Science KAKENHI [JP17H06521, JP19K16092, JP19H02881, 26116005, 18H03978]; Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants JP17H06521 (to S. K.), JP19K16092 (to S. K.), and JP19H02881 (to H. K.) and Grants-in-Aid for Scientific Research for Scientific Research 26116005 and 18H03978 from the Ministry of Education, Culture, Sports, Science and Technology (to K. I.).	ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Benham AM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0403; Bosello-Travain V, 2013, BBA-GEN SUBJECTS, V1830, P3846, DOI 10.1016/j.bbagen.2013.02.017; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Byun H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00330; Cao ZB, 2016, BIOCHEM J, V473, P851, DOI 10.1042/BJ20151223; Chang YC, 2013, EMBO MOL MED, V5, P1165, DOI 10.1002/emmm.201302679; Chen YI, 2016, AM J TRANSL RES, V8, P1626; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fujimoto T, 2018, J BIOL CHEM, V293, P18421, DOI 10.1074/jbc.RA118.003694; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kanemura S, 2016, J BIOL CHEM, V291, P23952, DOI 10.1074/jbc.M116.735662; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; Maegawa K, 2017, STRUCTURE, V25, P846, DOI 10.1016/j.str.2017.04.001; Maiorino M, 2015, FREE RADICAL BIO MED, V83, P352, DOI 10.1016/j.freeradbiomed.2015.02.017; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Matsusaki M, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.04.003; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; Okumura M, 2014, J BIOL CHEM, V289, P27004, DOI 10.1074/jbc.M114.564104; Peng DF, 2012, GUT, V61, P1250, DOI 10.1136/gutjnl-2011-301078; Ramming T, 2016, REDOX BIOL, V7, P14, DOI 10.1016/j.redox.2015.11.004; Ramming T, 2015, FREE RADICAL BIO MED, V83, P361, DOI 10.1016/j.freeradbiomed.2015.02.011; Ramming T, 2014, FREE RADICAL BIO MED, V70, P106, DOI 10.1016/j.freeradbiomed.2014.01.018; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Toppo S, 2008, ANTIOXID REDOX SIGN, V10, P1501, DOI 10.1089/ars.2008.2057; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Utomo A, 2004, J BIOL CHEM, V279, P43522, DOI 10.1074/jbc.M407141200; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wei PC, 2012, MOL CELL, V48, P747, DOI 10.1016/j.molcel.2012.10.007; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Zhu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105529; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	51	12	12	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2020	295	36					12772	12785		10.1074/jbc.RA120.013607	http://dx.doi.org/10.1074/jbc.RA120.013607			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NQ9DL	32719007	Green Published, hybrid			2022-12-26	WOS:000571166700017
J	Edwards, TM; Mosie, IJ; Moore, BC; Lobjoit, G; Schiavone, K; Bachman, RE; Murray-Hudson, M				Edwards, Thea M.; Mosie, Ineelo J.; Moore, Brandon C.; Lobjoit, Guy; Schiavone, Kelsie; Bachman, Robert E.; Murray-Hudson, Mike			Low oxygen: A (tough) way of life for Okavango fishes	PLOS ONE			English	Article							SALMON SALMO-SALAR; MELANOMACROPHAGE CENTERS; HYPOXIA TOLERANCE; IRON OVERLOAD; LIVER; DELTA; SYSTEM; CARDIOMYOPATHY; ADAPTATION; PESTICIDES	Botswana's Okavango Delta is a World Heritage Site and biodiverse wilderness. In 2016-2018, following arrival of the annual flood of rainwater from Angola's highlands, and using continuous oxygen logging, we documented profound aquatic hypoxia that persisted for 3.5 to 5 months in the river channel. Within these periods, dissolved oxygen rarely exceeded 3 mg/L and dropped below 0.5 mg/L for up to two weeks at a time. Although these dissolved oxygen levels are low enough to qualify parts of the Delta as a dead zone, the region is a biodiversity hotspot, raising the question of how fish survive. In association with the hypoxia, histological samples, collected from nativeOreochromis andersonii(threespot tilapia),Coptodon rendalli(redbreast tilapia), andOreochromis macrochir(greenhead tilapia), exhibited widespread hepatic and splenic inflammation with marked granulocyte infiltration, melanomacrophage aggregates, and ceroid and hemosiderin accumulations. It is likely that direct tissue hypoxia and polycythemia-related iron deposition caused this pathology. We propose that Okavango cichlids respond to extended natural hypoxia by increasing erythrocyte production, but with significant health costs. Our findings highlight seasonal hypoxia as an important recurring stressor, which may limit fishery resilience in the Okavango as concurrent human impacts rise. Moreover, they illustrate how fish might respond to hypoxia elsewhere in the world, where dead zones are becoming more common.	[Edwards, Thea M.; Moore, Brandon C.; Schiavone, Kelsie] Univ South, Dept Biol, Sewanee, TN 37375 USA; [Mosie, Ineelo J.; Murray-Hudson, Mike] Univ Botswana, Okavango Res Inst, Maun, Botswana; [Lobjoit, Guy] Guma Lagoon Camp, Etsha, Botswana; [Bachman, Robert E.] Univ South, Dept Chem, Sewanee, TN 37375 USA; [Edwards, Thea M.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO 65201 USA	Sewanee: University of the South; University of Botswana; Sewanee: University of the South; United States Department of the Interior; United States Geological Survey	Edwards, TM (corresponding author), Univ South, Dept Biol, Sewanee, TN 37375 USA.; Edwards, TM (corresponding author), US Geol Survey, Columbia Environm Res Ctr, Columbia, MO 65201 USA.	tedwards@usgs.gov	Murray-Hudson, Mike A/N-1140-2013	Murray-Hudson, Mike A/0000-0001-6873-0913; Edwards, Thea/0000-0002-6176-2872; Schiavone, Kelsie/0000-0002-9467-3809	U.S. Department of State Fulbright Scholars Program; Coypu Foundation; University of the South	U.S. Department of State Fulbright Scholars Program; Coypu Foundation; University of the South	Funding was provided by the U.S. Department of State Fulbright Scholars Program (TME), the Coypu Foundation (TME), and start-up funds from the University of the South (TME). https://www.cies.org/program/fulbright-usscholar-program.The Coypu Foundation does not operate a website; they accept applications through a portal operated by JP Morgan: https://www.jpmorgan.com/country/US/en/jpmorgan/private_ banking/foundations/online_grant_application/guidelines_to_apply https://new.sewanee.edu/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Rele Sekotswe, Ronald Mothobi, Kaelo Makati, and Keta Mosepele (Okavango Research Institute) and Dr. John Brock (University of North Carolina, Asheville) for insights, assistance, and support during field expeditions, and Sam Penland, Carrie Martin, and Rebecca Salustri (University of the South) for sample processing. We are indebted to Dr. Wolfgang Vogelbein (Virginia Institute of Marine Science) and Dr. Johan Steyl (University of Pretoria) for initial discussions of the observed pathology. We are grateful to Dr. Susan Fogelson (Fishhead Labs, Stuart, Florida) and Dr. John Bowden (University of Florida) for the normal Oreochromis mossambicus liver histology shown in Fig 7A; Dr. Robert Bringolf (University of Georgia) for aquaculture-raised Nile/blue tilapia hybrids; Dean, Ellen, Adam, and Leah Hatty for help dissecting their farmed threespot tilapia from Pandamatenga, Botswana; and Prof. Jan Myburgh (University of Pretoria) for essential supplies. Finally, we gratefully thank Margaret Manson, Christopher Moore, and Nicholas Moore for moral support and good humor throughout this project. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Abdel-Tawwab M, 2019, FISH PHYSIOL BIOCHEM, V45, P997, DOI 10.1007/s10695-019-00614-9; AGIUS C, 1979, J FISH DIS, V2, P337, DOI 10.1111/j.1365-2761.1979.tb00175.x; Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; Ahmed MK, 2013, EXP TOXICOL PATHOL, V65, P903, DOI 10.1016/j.etp.2013.01.003; Arup Giri, 2017, Indian Journal of Animal Sciences, V87, P723; Atarashi M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020175; Barrow LM, 2006, COPEIA, P552; Bartsch PW, 2019, B ENVIRON CONTAM TOX, V103, P274, DOI 10.1007/s00128-019-02630-0; Calverley PM, 2015, AM REV RESPIR DIS, V125, P507; Cawley KM, 2012, WETLANDS, V32, P475, DOI 10.1007/s13157-012-0281-0; CHAPMAN LJ, 1995, CONSERV BIOL, V9, P1274, DOI 10.1046/j.1523-1739.1995.9051262.x-i1; Chapman LJ, 2002, COMP BIOCHEM PHYS A, V133, P421, DOI 10.1016/S1095-6433(02)00195-2; Chouker A, 2005, J APPL PHYSIOL, V98, P640, DOI 10.1152/japplphysiol.00036.2004; Culling C, CELLULAR PATHOLOGY T; Egners A, 2016, MEDIAT INFLAMM, V2016, P1; Ellery WN, 2003, WETLANDS, V23, P357, DOI 10.1672/11-20; Evelyn T., 1996, THE FISH IMMUNE SYST, P349; Fournie JW, 2001, J AQUAT ANIM HEALTH, V13, P105, DOI 10.1577/1548-8667(2001)013<0105:UOSMAA>2.0.CO;2; Hayashi H, 2017, MED MOL MORPHOL, V50, P205, DOI 10.1007/s00795-017-0163-x; IHC World, 2017, H E STAINING METHOD; Joyner-Matos J, 2013, COMP BIOCHEM PHYS A, V165, P405, DOI 10.1016/j.cbpa.2013.03.032; Kam HY, 1999, J APPL PHYSIOL, V87, P1901, DOI 10.1152/jappl.1999.87.5.1901; Kloppel G, 2005, J PANCREAS, V6, P97; Leknes IL, 2004, ZOOLOGY, V107, P201, DOI 10.1016/j.zool.2004.07.002; Li HL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173478; Li WB, 2015, EXP THER MED, V9, P98, DOI 10.3892/etm.2014.2049; Liu YS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00548; Mandic M, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.161349; Mendelsohn J.M., 2010, OKAVANGO DELTA FLOOD; Mladenov N, 2014, J HYDROL, V518, P326, DOI 10.1016/j.jhydrol.2013.09.026; Mmualefe LC, 2008, WATER SA, V34, P405; Narahara A, 1996, PHYSIOL ZOOL, V69, P1114, DOI 10.1086/physzool.69.5.30164249; Paffett-Lugassy N, 2007, BLOOD, V110, P2718, DOI 10.1182/blood-2006-04-016535; Pelster B, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163709; Pollock MS, 2007, ENVIRON REV, V15, P1, DOI 10.1139/a06-006; Puebla-Osorio N, 2017, METHODS MOL BIOL, V1627, P213, DOI 10.1007/978-1-4939-7113-8_14; Rahman MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184341; Reite OB, 2006, FISH SHELLFISH IMMUN, V20, P192, DOI 10.1016/j.fsi.2005.01.012; Rutjes HA, 2007, AM J PHYSIOL-REG I, V293, pR1376, DOI 10.1152/ajpregu.00536.2006; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Sfacteria A, 2015, MOL IMMUNOL, V63, P3, DOI 10.1016/j.molimm.2014.02.007; Shunthirasingham C, 2010, ENVIRON SCI TECHNOL, V44, P8082, DOI 10.1021/es1024788; Standal H, 1997, BIOL TRACE ELEM RES, V59, P13, DOI 10.1007/BF02783225; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Tubatsi G, 2014, AFR J AQUAT SCI, V39, P351, DOI 10.2989/16085914.2014.960791; Turpie J., 2006, EC VALUE OKAVANGO DE; United States EPA, 1986, AMBIENT WATER QUALIT, V1986th; Valenzuela A, 2005, FISH PHYSIOL BIOCHEM, V31, P65, DOI 10.1007/s10695-005-5288-5; van Dyk JC, 2009, AFR J AQUAT SCI, V34, P273, DOI 10.2989/AJAS.2009.34.3.9.985; Villafuerte FC, 2016, HIGH ALT MED BIOL, V17, P61, DOI 10.1089/ham.2016.0031; Welker AF, 2012, AM J PHYSIOL-REG I, V302, pR1111, DOI 10.1152/ajpregu.00243.2011; Whittaker P, 1996, TOXICOL PATHOL, V24, P558, DOI 10.1177/019262339602400504; World Travel and Tourism Council (WTTC), 2019, BOTSW 2019 ANN RES K; Xiao WH, 2015, SCI CHINA LIFE SCI, V58, P148, DOI 10.1007/s11427-015-4801-z; Yousaf MN, 2013, VET IMMUNOL IMMUNOP, V151, P49, DOI 10.1016/j.vetimm.2012.10.004; Zhabyeyev P, 2018, AM J PHYSIOL-HEART C, V314, pH978, DOI 10.1152/ajpheart.00597.2017; Zhu CD, 2013, J COMP PHYSIOL B, V183, P1005, DOI 10.1007/s00360-013-0762-3	57	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0235667	10.1371/journal.pone.0235667	http://dx.doi.org/10.1371/journal.pone.0235667			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730271	gold, Green Published			2022-12-26	WOS:000556884700081
J	Rossi, NF; Fernandes, C; Moreira, CS; Giacheti, CM; Sichieri, BB; Pinheiro, AP; Sampaio, A				Rossi, Natalia Freitas; Fernandes, Catarina; Moreira, Celia Sofia; Giacheti, Celia Maria; Sichieri, Bianca Bortolai; Pinheiro, Ana Patricia; Sampaio, Adriana			Sentence contexts and cloze probabilities for Brazilian Portuguese children and adolescents	PLOS ONE			English	Article							WORD COMPLETION NORMS; BRAIN POTENTIALS; LANGUAGE; MEMORY; CONSTRAINT; CULTURE; COMPREHENSION; EXPECTANCY; ACTIVATION; RESPONSES	Purpose In this study we investigated a set of 100 sentence contexts and their cloze probabilities to develop a database of linguistic stimuli for Brazilian Portuguese children and adolescents. The study also examined age-related changes on cloze probabilities, and specified the predictor effects of age and cloze probabilities on idiosyncratic responses and errors (semantic, syntactic, and other errors). Finally, the study also aimed to shed light on cultural effects on word generation by comparing Brazilian and Portuguese sentence databases. Method 361 typically developing monolingual Brazilian speakers, with ages ranging from 7 to 18 years, participated in the study. The cloze task was composed by 100 sentence contexts, grounded on the European Portuguese database. Responses were classified as valid (correct) or invalid (semantic, syntactic, and other-type errors). Statistical analyses were based on mixed-effects logistic models. Results Sixty-three sentences met criteria for high cloze probabilities, 30 for medium cloze, and 7 for low cloze. Age was a significant predictor of idiosyncratic responses, semantic and syntactic errors: older participants were less likely to produce idiosyncratic responses, as well as semantic and syntactic errors. Cloze probability values were concordant in the Brazilian and Portuguese databases for 31 out of 49 (83.7%) high-cloze sentences and for 7 low-cloze sentences. Conclusion In this study we have provided a database with cloze probability values for a set of 100 sentence-final word contexts for Brazilian Portuguese children and adolescents. Results showed that both age and sentence contextual level predicted sentence final word completion. Older participants were more likely to choose more consistently the same final word, with the contextual level of a given sentence also contributing to the final word selection. Age should be controlled for in future studies probing semantic processing with this set of sentences.	[Rossi, Natalia Freitas; Giacheti, Celia Maria; Sichieri, Bianca Bortolai] Sao Paulo State Univ UNESP, Fac Philosophy & Sci, Speech Language & Hearing Sci Dept, Campus Marilia, Sao Paulo, Brazil; [Fernandes, Catarina; Pinheiro, Ana Patricia; Sampaio, Adriana] Univ Minho, Sch Psychol, Psychol Neurosci Lab, CIPsi, Braga, Portugal; [Moreira, Celia Sofia] Univ Porto, Fac Sci, Porto, Portugal; [Moreira, Celia Sofia] Univ Porto, Ctr Math FCUP&CMUP, Porto, Portugal; [Pinheiro, Ana Patricia] Univ Lisbon, Fac Psychol, Lisbon, Portugal	Universidade Estadual Paulista; Universidade do Minho; Universidade do Porto; Universidade do Porto; Universidade de Lisboa	Rossi, NF (corresponding author), Sao Paulo State Univ UNESP, Fac Philosophy & Sci, Speech Language & Hearing Sci Dept, Campus Marilia, Sao Paulo, Brazil.	nataliafreitasrossi@yahoo.com.br	Sampaio, Adriana/C-8361-2011; Moreira, Célia Sofia/N-8904-2013; Giacheti, Celia Maria/I-4863-2012	Sampaio, Adriana/0000-0001-7347-1282; Moreira, Célia Sofia/0000-0001-5602-7171; Giacheti, Celia Maria/0000-0001-9691-4672	Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Post-Doctoral Fellowship at the University of Minho [BEX 9573/11-9]; Instituto Nacional de Ciencia e Tecnologia sobre Comportamento, Cognicao e Ensino; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [465686/2014-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/50909-8]; Psychology Research Centre [PSI/01662]; Portuguese Foundation for Science and Technology; Portuguese Ministry of Science, Technology and Higher Education through the national funds (PIDDAC) [UID/PSI/01662/2019]; national funds from the Portuguese Foundation for Science and Technology [PTDC/PSI-PCL/115316/2009]; CMUP [UID/MAT/00144/2013]; national funds through FCT (Portugal) [UIDB/00144/2020]	Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Post-Doctoral Fellowship at the University of Minho; Instituto Nacional de Ciencia e Tecnologia sobre Comportamento, Cognicao e Ensino; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Psychology Research Centre; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Ministry of Science, Technology and Higher Education through the national funds (PIDDAC); national funds from the Portuguese Foundation for Science and Technology; CMUP; national funds through FCT (Portugal)	This research was supported by Grants from Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), and by a Post-Doctoral Fellowship at the University of Minho (Process BEX 9573/11-9). This study was partially conducted at the Psychology Research Centre (PSI/01662), University of Minho, and supported by the Instituto Nacional de Ciencia e Tecnologia sobre Comportamento, Cognicao e Ensino, with funding of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, process no 465686/2014-1), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, process no 2014/50909-8), Portuguese Foundation for Science and Technology and the Portuguese Ministry of Science, Technology and Higher Education (UID/PSI/01662/2019), through the national funds (PIDDAC) and by national funds from the Portuguese Foundation for Science and Technology (Grant PTDC/PSI-PCL/115316/2009). CSM was partially supported by CMUP (UID/MAT/00144/2013), which is financed by national funds through FCT (Portugal) under the project with reference UIDB/00144/2020.	Allison P.D., 2012, LOGISTIC REGRESSION, VSecond edition; Arcuri SM, 2001, BEHAV RES METH INS C, V33, P80, DOI 10.3758/BF03195350; Barreiro A., 1996, INESC J RES DEV, V5, P75; Best JR, 2011, LEARN INDIVID DIFFER, V21, P327, DOI 10.1016/j.lindif.2011.01.007; Biderman MTC, 2001, REV BELGE PHILOLOGIE, V79, P963; Bishop DVM, 2014, PSYCHOL PRESS CLASS, P1; Block CK, 2010, BEHAV RES METHODS, V42, P665, DOI 10.3758/BRM.42.3.665; BLOOM PA, 1980, MEM COGNITION, V8, P631, DOI 10.3758/BF03213783; Brasil C., 2013, CRIT CLASS EC BRAS; Brauer J, 2007, J COGNITIVE NEUROSCI, V19, P1609, DOI 10.1162/jocn.2007.19.10.1609; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Caceres-Assenco AM, 2018, CODAS, V30, DOI 10.1590/2317-1782/20182017113; Canet-Juric L, 2009, INT J PSYCHOL RES, V2, P99, DOI 10.21500/20112084.865; Capellari E. T. C., 2002, REV DA ABRALIN, V1, P185; Carneiro MP, 2004, LAB PSICOLOGIA, V2, P49; Collins A., 1969, RETRIEVAL TIME SEMAN; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Cummings A, 2008, BRAIN RES, V1208, P137, DOI 10.1016/j.brainres.2008.02.015; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Delong KA, 2011, PSYCHOPHYSIOLOGY, V48, P1203, DOI 10.1111/j.1469-8986.2011.01199.x; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Ellis C, 2015, SOC COGN AFFECT NEUR, V10, P1392, DOI 10.1093/scan/nsv028; Federmeier KD, 2007, BRAIN RES, V1146, P75, DOI 10.1016/j.brainres.2006.06.101; Ferreira Sandra Cristina Araújo, 2018, Audiol., Commun. Res., V23, pe2006, DOI 10.1590/2317-6431-2018-2006; Fox J, 2018, J STAT SOFTW, V87, P1, DOI 10.18637/jss.v087.i09; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Frota S, 2015, INTONATION ROMANCE, P235, DOI DOI 10.1093/ACPROF:OSO/9780199685332.003.0007; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; Geeraerts D., 2012, STRUCTURE LEXICAL VA; Hahne A, 2004, J COGNITIVE NEUROSCI, V16, P1302, DOI 10.1162/0898929041920504; Hamberger MJ, 1996, BEHAV RES METH INSTR, V28, P102, DOI 10.3758/BF03203644; HOLCOMB PJ, 1992, DEV NEUROPSYCHOL, V8, P203, DOI 10.1080/87565649209540525; Ji LJ, 2004, J PERS SOC PSYCHOL, V87, P57, DOI 10.1037/0022-3514.87.1.57; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; KELLAS G, 1991, UNDERSTANDING WORD S, P47; Kidd E, 2013, TOP LANG DISORD, V33, P208, DOI 10.1097/TLD.0b013e31829d623e; Kimble MO, 2002, PSYCHIAT RES, V113, P303, DOI 10.1016/S0165-1781(02)00229-9; Kircher TTJ, 2001, SCHIZOPHR RES, V50, P27, DOI 10.1016/S0920-9964(00)00042-6; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Lahar CJ, 2004, J GERONTOL B-PSYCHOL, V59, pP7, DOI 10.1093/geronb/59.1.P7; Larina T, 2015, INT REV PRAGMAT, V7, P195, DOI 10.1163/18773109-00702003; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Lima WF, 2001, ALFA REV LINGUISTICA, V45; Loerts H, 2013, J PSYCHOLINGUIST RES, V42, P551, DOI 10.1007/s10936-012-9234-2; LOFTUS EF, 1973, AM J PSYCHOL, V86, P331, DOI 10.2307/1421441; Macdonald JA, 2014, CHILD NEUROPSYCHOL, V20, P509, DOI 10.1080/09297049.2013.822060; Marsh EJ, 2004, APPL COGNITIVE PSYCH, V18, P491, DOI 10.1002/acp.1001; McGregor KK, 2002, J SPEECH LANG HEAR R, V45, P332, DOI 10.1044/1092-4388(2002/026); Minami M., 2002, CULTURE SPECIFIC LAN; Munson B, 2005, J SPEECH LANG HEAR R, V48, P108, DOI 10.1044/1092-4388(2005/009); NEBES RD, 1991, CORTEX, V27, P237, DOI 10.1016/S0010-9452(13)80128-1; Pinheiro AP, 2010, BEHAV RES METHODS, V42, P1022, DOI 10.3758/BRM.42.4.1022; Principe GF, 2008, APPL COGNITIVE PSYCH, V22, P625, DOI 10.1002/acp.1402; Robichon F, 1996, COMPLETION NORMS 744; Rodriguez-Camacho M, 2011, AV PSICOL LATINOAM, V29, P258; ROSENZWEIG MR, 1984, AM PSYCHOL, V39, P365, DOI 10.1037/0003-066X.39.4.365; Rossi NF, 2016, AVALIACAO FALA LINGU, P109; Schneider W., 2013, MEMORY DEV 2 20, DOI [10.4324/9780203774496, DOI 10.4324/9780203774496]; SCHWANENFLUGEL PJ, 1985, J MEM LANG, V24, P232, DOI 10.1016/0749-596X(85)90026-9; SIMPSON GB, 1989, J EXP PSYCHOL LEARN, V15, P88; Staub A, 2015, J MEM LANG, V82, P1, DOI 10.1016/j.jml.2015.02.004; Storkel HL, 2002, J CHILD LANG, V29, P251, DOI 10.1017/S0305000902005032; Storkel HL, 2009, J CHILD LANG, V36, P291, DOI 10.1017/S030500090800891X; TAYLOR WL, 1956, JOURNALISM QUART, V33, P42, DOI 10.1177/107769905603300106; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Xu F, 2013, PLOS ONE, V8; Yoon C, 2004, PSYCHOL AGING, V19, P379, DOI 10.1037/0882-7974.19.3.379; Zhu ZD, 2019, J NEUROLINGUIST, V52, DOI 10.1016/j.jneuroling.2019.100855	73	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236388	10.1371/journal.pone.0236388	http://dx.doi.org/10.1371/journal.pone.0236388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730342	gold, Green Published			2022-12-26	WOS:000556884700074
J	Sui, J; Luan, S; Dai, P; Fu, Q; Meng, XH; Luo, K; Cao, BX; Kong, J				Sui, Juan; Luan, Sheng; Dai, Ping; Fu, Qiang; Meng, Xianhong; Luo, Kun; Cao, Baoxiang; Kong, Jie			High accuracy of pooled DNA genotyping by 2b-RAD sequencing in the Pacific white shrimp,Litopenaeus vannamei	PLOS ONE			English	Article							NEXT-GENERATION; ALLELE; AQUACULTURE; LINKAGE	Using pooled DNA genotyping to estimate the proportional contributions from multiple families in a pooled sample is of particular interest for selective breeding in aquaculture. We compared different pooled libraries with separate 2b-RAD sequencing ofLitopenaeus vannameiindividuals to assess the effect of different population structures (different numbers of individuals and families) on pooled DNA sequencing, the accuracy of parent sequencing of the DNA pools and the effect of SNP numbers on pooled DNA sequencing. We demonstrated that small pooled DNA genotyping of up to 53 individuals by 2b-RAD sequencing could provide a highly accurate assessment of population allele frequencies. The accuracy increased as the number of individuals and families increased. The allele frequencies of the parents from each pool were highly correlated with those of the pools or the corresponding individuals in the pool. We chose 500-28,000 SNPs to test the effect of SNP number on the accuracy of pooled sequencing, and no linear relationship was found between them. When the SNP number was fixed, increasing the number of individuals in the mixed pool resulted in higher accuracy of each pooled genotyping. Our data confirmed that pooled DNA genotyping by 2b-RAD sequencing could achieve higher accuracy than that of individual-based genotyping. The results will provide important information for shrimp breeding programs.	[Sui, Juan; Luan, Sheng; Dai, Ping; Fu, Qiang; Meng, Xianhong; Luo, Kun; Cao, Baoxiang; Kong, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Peoples R China; [Sui, Juan; Luan, Sheng; Dai, Ping; Fu, Qiang; Meng, Xianhong; Luo, Kun; Cao, Baoxiang; Kong, Jie] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology	Kong, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Peoples R China.; Kong, J (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	kongjie@ysfri.ac.cn			central public-interest scientific institution basal research fund, YSFRI, CAFS [20603022018018]; China agriculture research system [CARS-48]; Shandong province agricultural seed improvement project [2017LZN011]; Projects of international exchange and cooperation in agriculture, ministry of agriculture and rural affairs of China-science, technology and innovation cooperation in aquaculture with tropical countries; National natural science foundation of China [31602151]; Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences [20603022019017]	central public-interest scientific institution basal research fund, YSFRI, CAFS; China agriculture research system; Shandong province agricultural seed improvement project; Projects of international exchange and cooperation in agriculture, ministry of agriculture and rural affairs of China-science, technology and innovation cooperation in aquaculture with tropical countries; National natural science foundation of China(National Natural Science Foundation of China (NSFC)); Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences	This study was supported by central public-interest scientific institution basal research fund, YSFRI, CAFS (NO. 20603022018018) to JS; China agriculture research system (CARS-48) to JK; Shandong province agricultural seed improvement project (2017LZN011) to SL; Projects of international exchange and cooperation in agriculture, ministry of agriculture and rural affairs of China-science, technology and innovation cooperation in aquaculture with tropical countries to SL; National natural science foundation of China (31602151) to QF; Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences (CN) (20603022019017) to PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELRAHMAN H, 2017, BMC GENOMICS, V18, P57220, DOI DOI 10.1186/S12864-017-3557-128219347; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Cui Z, 2015, HEREDITY, V115, P206, DOI 10.1038/hdy.2015.26; Dou JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19244; FAO, 2018, FISHSTATJ TOOL FISH; Fjalestad KT, 1997, 1797 AKVAFORSK, P85; Fu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079960; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Gjedrem T., 1985, Geojournal, V10, P233, DOI 10.1007/BF00462124; Gjedrem T, 2012, AQUACULTURE, V350, P117, DOI 10.1016/j.aquaculture.2012.04.008; Gjedrem T, 2012, AQUACULTURE, V344, P12, DOI 10.1016/j.aquaculture.2012.03.003; Henshall JM, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0051-y; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Jiao WQ, 2014, DNA RES, V21, P85, DOI 10.1093/dnares/dst043; Kinghorn BP, 2010, ACTA AGR SCAND A-AN, V60, P3, DOI 10.1080/09064701003801922; Kofler R, 2016, MOL ECOL RESOUR, V16, P118, DOI 10.1111/1755-0998.12432; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li Y, 2015, J ANIM BREED GENET, V132, P169, DOI 10.1111/jbg.12143; Lind CE, 2012, REPROD DOMEST ANIM, V47, P255, DOI 10.1111/j.1439-0531.2012.02084.x; Ozerov M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-12; Rellstab C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080422; Rowe HC, 2011, MOL ECOL, V20, P3499, DOI 10.1111/j.1365-294X.2011.05197.x; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Tian ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep14852; Wang S, 2016, NAT PROTOC, V11, P2189, DOI 10.1038/nprot.2016.133; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Zhang XJ, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-018-08197-4, 10.1038/s41467-019-13333-9]; Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901	35	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236343	10.1371/journal.pone.0236343	http://dx.doi.org/10.1371/journal.pone.0236343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730349	gold, Green Published			2022-12-26	WOS:000556884700026
J	Yoo, JJ; Lim, YS; Kim, MS; Lee, B; Kim, BY; Kim, Z; Lee, JE; Lee, MH; Kim, SG; Kim, YS				Yoo, Jeong-Ju; Lim, Yong Seok; Kim, Min Sung; Lee, Bora; Kim, Bo-Yeon; Kim, Zisun; Lee, Ji Eun; Lee, Min Hee; Kim, Sang Gyune; Kim, Young Seok			Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer	PLOS ONE			English	Article							MACROVESICULAR HEPATIC STEATOSIS; AROMATASE INHIBITORS; NONALCOHOLIC STEATOHEPATITIS; DISEASE; ASSOCIATION; DIAGNOSIS; THERAPY; DONORS; WOMEN; CT	Background Few studies report the effects of tamoxifen intake and the occurrence ofde novofatty liver and the deterioration of existing fatty liver. The aim of this study was to investigate the effects of tamoxifen on fatty change of liver over time and also the impact of fatty liver on the prognosis of patients with breast cancer. Methods This was a single-center, retrospective study of patients who were diagnosed with primary breast cancer from January 2007 to July 2017. 911 consecutive patients were classified into three groups according to treatment method: tamoxifen group, aromatase inhibitor (AI) group, and control group. Results Median treatment duration was 49 months (interquartile range,IQR; 32-58) and median observational period was 85 months (IQR; 50-118). Long-term use of tamoxifen significantly aggravated fatty liver status compared to AI or control groups [hazard ratio (HR): 1.598, 95% confidence interval (CI): 1.173-2.177,P= 0.003] after adjusting other factors. When analyzed separately depending on pre-existing fatty liver at baseline, tamoxifen was involved in the development ofde novofatty liver [HR: 1.519, 95%CI: 1.100-2.098,P= 0.011) and had greater effect on fatty liver worsening (HR: 2.103, 95%CI: 1.156-3.826,P= 0.015). However, the progression of fatty liver did not significantly affect the mortality of breast cancer patients. Conclusions Tamoxifen had a significant effect on the fatty liver status compared to other treatment modalities in breast cancer patients. Although fatty liver did not affect the prognosis of breast cancer, meticulous attention to cardiovascular disease or other metabolic disease should be paid when used for a long time.	[Yoo, Jeong-Ju; Lim, Yong Seok; Kim, Sang Gyune; Kim, Young Seok] Soonchunhyang Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Bucheon Hosp, Bucheon, South Korea; [Kim, Min Sung] Soonchunhyang Univ, Dept Internal Med, Gumi Hosp, Gumi, South Korea; [Lee, Bora] Chung Ang Univ, Dept Biostat, Grad Sch, Seoul, South Korea; [Kim, Bo-Yeon] Soonchunhyang Univ, Dept Internal Med, Div Endocrinol, Sch Med,Bucheon Hosp, Bucheon, South Korea; [Kim, Zisun] Soonchunhyang Univ, Dept Surg, Sch Med, Bucheon Hosp, Bucheon, South Korea; [Lee, Ji Eun; Lee, Min Hee] Soonchunhyang Univ, Dept Radiol, Sch Med, Bucheon Hosp, Bucheon, South Korea	Soonchunhyang University; Soonchunhyang University; Chung Ang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University	Kim, SG (corresponding author), Soonchunhyang Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Bucheon Hosp, Bucheon, South Korea.	mcnulty@schmc.ac.kr		Kim, Sang gyune/0000-0001-8694-777X; Kim, Young Seok/0000-0002-7113-3623; Yoo, Jeong-Ju/0000-0002-7802-0381				Al-Mubarak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088238; Amir E, 2011, JNCI-J NATL CANCER I, V103, P1299, DOI 10.1093/jnci/djr242; Artz NS, 2012, INVEST RADIOL, V47, P603, DOI 10.1097/RLI.0b013e318261fad0; Bruno S, 2005, BMJ-BRIT MED J, V330, P932, DOI 10.1136/bmj.38391.663287.E0; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chang HT, 2018, CLIN BREAST CANCER, V18, pE677, DOI 10.1016/j.clbc.2017.11.010; Clarke M, 1998, LANCET, V351, P1451; David W., 2011, APPL SURVIVAL ANAL R, P618; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Gradishar WJ, 2018, J NATL COMPR CANC NE, V16, P310, DOI 10.6004/jnccn.2018.0012; Haque R, 2012, CANCER MED-US, V1, P318, DOI 10.1002/cam4.37; Hong N, 2017, EUR J CANCER, V82, P103, DOI 10.1016/j.ejca.2017.05.002; Lee BR, 2020, LIVER INT, V40, P1344, DOI 10.1111/liv.14434; Li Q, 2018, WORLD J HEPATOL, V10, P530, DOI 10.4254/wjh.v10.i8.530; Lim E, 2012, ONCOLOGY-NY, V26, P688; Limanond P, 2004, RADIOLOGY, V230, P276, DOI 10.1148/radiol.2301021176; Lupsor Monica, 2005, Rom J Gastroenterol, V14, P419; Nishino M, 2003, AM J ROENTGENOL, V180, P129, DOI 10.2214/ajr.180.1.1800129; Osman KA, 2007, EXPERT OPIN DRUG SAF, V6, P1, DOI 10.1517/14740338.6.1.1; Palmisano BT, 2017, ADV EXP MED BIOL, V1043, P227, DOI 10.1007/978-3-319-70178-3_12; Pan HJ, 2016, J FORMOS MED ASSOC, V115, P411, DOI 10.1016/j.jfma.2015.05.006; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Perez EA, 2007, ANN ONCOL, V18, P26, DOI 10.1093/annonc/mdm263; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Saba L, 2015, EUR J GASTROEN HEPAT, V27, P290, DOI 10.1097/MEG.0000000000000277; Vohra Sandeep, 2014, Indian J Radiol Imaging, V24, P350, DOI 10.4103/0971-3026.143897; Yang YJ, 2016, BREAST, V28, P67, DOI 10.1016/j.breast.2016.04.017; Zeb I, 2012, ACAD RADIOL, V19, P811, DOI 10.1016/j.acra.2012.02.022	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236506	10.1371/journal.pone.0236506	http://dx.doi.org/10.1371/journal.pone.0236506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730287	gold, Green Published			2022-12-26	WOS:000556884700024
J	Engel, N; Vegvari, Z; Rice, R; Kubelka, V; Szekely, T				Engel, Noemie; Vegvari, Zsolt; Rice, Romy; Kubelka, Vojtech; Szekely, Tamas			Incubating parents serve as visual cues to predators in Kentish plover(Charadrius alexandrinus)	PLOS ONE			English	Article							GROUND-NESTING BIRDS; HABITAT; BEHAVIOR; LAPWINGS; DIFFERS; PLOVERS	Ground-nesting birds face many challenges to reproduce successfully, with nest predation being the main cause of reproductive failure. Visual predators such as corvids and egg-eating raptors, are among the most common causes of nest failure; thus, parental strategies that reduce the risk of visual nest predation should be favored by selection. To date, most research has focused on egg crypsis without considering adult crypsis, although in natural circumstances the eggs are covered by an incubating parent most of the time. Here we use a ground-nesting shorebird, the Kentish plover (Charadrius alexandrinus) as model species to experimentally test whether decoy parents influence nest predation. Using artificial nests with a male decoy, a female decoy or no decoy, we found that the presence of a decoy increased nest predation (N = 107 nests, p < 0.001). However, no difference was found in predation rates between nests with a male versus female decoy (p> 0.05). Additionally, we found that nests in densely vegetated habitats experienced higher survival compared to nests placed in sparsely vegetated habitats. Nest camera images, predator tracks and marks left on eggs identified the brown-necked raven (Corvus ruficollis) as the main visual nest predator. Our study suggests that the presence of incubating parents may enhance nest detectability to visual predators. However, parents may reduce the predation risk by placing a nest in sites where they are covered by vegetation. Our findings highlight the importance of nest site selection not only regarding egg crypsis but also considering incubating adult camouflage.	[Engel, Noemie; Rice, Romy; Kubelka, Vojtech; Szekely, Tamas] Univ Debrecen, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary; [Engel, Noemie; Kubelka, Vojtech; Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath, Avon, England; [Vegvari, Zsolt] Danube Res Inst, Ctr Ecol Res, Budapest, Hungary; [Vegvari, Zsolt] Senckenberg German Entomol Inst, Muncheberg, Germany; [Kubelka, Vojtech] Czech Acad Sci, Global Change Res Inst, Dept Biodivers Res, Prague, Czech Republic; [Kubelka, Vojtech] Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England; [Szekely, Tamas] Maio Biodivers Fdn, Maio, Cape Verde	University of Debrecen; University of Bath; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Senckenberg Gesellschaft fur Naturforschung (SGN); Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; University of Sheffield	Engel, N (corresponding author), Univ Debrecen, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary.; Engel, N (corresponding author), Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath, Avon, England.	nce25@bath.ac.uk	Kubelka, Vojtěch/M-3993-2014; Szekely, Tamas/I-7089-2016	Kubelka, Vojtěch/0000-0002-5015-5890; Engel, Noemie/0000-0001-9893-4693; Szekely, Tamas/0000-0003-2093-0056; Engel, Noemie/0000-0001-9298-8703	Fonds National de la Recherche Luxembourg [13530957]; Ministry of Education, Youth and Sports of Czech Republic [CZ.02.2.69/0.0/0.0/19_074/0014459]; Royal Societly (Wolfson Merit Award) [WM170050, APEX APX \R1\191045]; Hungarian government [ELVONAL-KKP-126949]	Fonds National de la Recherche Luxembourg(Luxembourg National Research Fund); Ministry of Education, Youth and Sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Royal Societly (Wolfson Merit Award); Hungarian government	N.E. was supported by the Fonds National de la Recherche Luxembourg (grant No. 13530957). V.K. was supported by the Ministry of Education, Youth and Sports of Czech Republic (grant No. CZ.02.2.69/0.0/0.0/19_074/0014459). T. S. was supported by the Royal Societly (Wolfson Merit Award) (grant No. WM170050, APEX APX \R1\191045). N.E, V.K, T.S. and R.R. were supported by ELVONAL-KKP-126949 of the Hungarian government.	Gomez-Serrano MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107121; [Anonymous], 2014, R LANG ENV STAT COMP; Gonzalez JA, 2017, CAH BIOL MAR, V58, P137, DOI 10.21411/CBM.A.6C592127; Bennett P. M., 2002, OX ECOL EV; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Carmona-Isunza MC, 2015, BEHAV ECOL SOCIOBIOL, V69, P2035, DOI 10.1007/s00265-015-2014-x; Caro Tim, 2005, pXIII; Carthey AJR, 2018, TRENDS ECOL EVOL, V33, P106, DOI 10.1016/j.tree.2017.10.009; Coates PS, 2010, J WILDLIFE MANAGE, V74, P240, DOI 10.2193/2009-047; Cody M.L., 1985, HABITATS SELECTION B; Colwell MA, 2010, SHOREBIRD ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x; Croze H., 1970, Z. Tierpsychol., V5, P5; Cunningham JA, 2016, AUK, V133, P364, DOI 10.1642/AUK-15-196.1; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Eberhart-Phillips LJ, 2019, POPULATION ECOLOGY C, P60; Ekanayake KB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3026; Evans KL, 2004, IBIS, V146, P1, DOI 10.1111/j.1474-919X.2004.00231.x; Evans P.R., 1984, Behavior of Marine Animals, V5, P83; GOTMARK F, 1995, BEHAV ECOL, V6, P22, DOI 10.1093/beheco/6.1.22; Hastie T, 1992, STAT MODELS S PACIFI; Isaksson D, 2007, BIOL CONSERV, V136, P136, DOI 10.1016/j.biocon.2006.11.015; Kassambara A., 2016, SURVMINER R PACKAGE; Kis J, 2000, ARDEA, V88, P155; Kubelka V., 2018, THESIS; Kubelka V, 2018, SCIENCE, V362, P680, DOI 10.1126/science.aat8695; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lucrezi S, 2014, OCEANOGR MAR BIOL, V52, P201; MacDonald MA, 2008, IBIS, V150, P54, DOI 10.1111/j.1474-919X.2008.00869.x; Mainwaring MC, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P50; MARTIN TE, 1988, P NATL ACAD SCI USA, V85, P2196, DOI 10.1073/pnas.85.7.2196; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 1988, EVOL ECOL, V2, P37, DOI 10.1007/BF02071587; Marzluff JM, 2006, BIOL CONSERV, V130, P301, DOI 10.1016/j.biocon.2005.12.026; MELVIN SM, 1992, WILDLIFE SOC B, V20, P143; Moore RP, 2004, ECOLOGY, V85, P1562, DOI 10.1890/03-0088; Murphy RK, 2003, WATERBIRDS, V26, P150, DOI 10.1675/1524-4695(2003)026[0150:POAPPA]2.0.CO;2; Oliveira A., 2013, CAPE VERDE DESIGNATE; Olsen H, 2004, BIRD STUDY, V51, P87, DOI 10.1080/00063650409461337; Opermanis O, 2004, J AVIAN BIOL, V35, P410, DOI 10.1111/j.0908-8857.2004.03243.x; Pauliny A, 2008, J WILDLIFE MANAGE, V72, P1579, DOI 10.2193/2007-199; Pereira Neves JM, 2016, B OFICIAL REBUBLICA, V1, P152; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; Rees James D., 2015, Australian Field Ornithology, V32, P100; Roodbergen M, 2012, J ORNITHOL, V153, P53, DOI 10.1007/s10336-011-0733-y; Salek M, 2006, FOLIA ZOOL, V55, P43; Salek M, 2014, FOLIA ZOOL, V63, P67; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Stoddard MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep32059; Swanson L, 2012, BIRD STUDY, V59, P96, DOI 10.1080/00063657.2011.645799; Szekely T., 2008, UNPUB; Szekely T., 2019, J ORNITHOL, P1; Therneau T., 2015, PACKAGE SURVIVAL ANA; Therneau T, 2013, MODELING SURVIVAL DA; Trnka A, 2008, BIRD STUDY, V55, P329, DOI 10.1080/00063650809461539; Troscianko J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19966; Vigallon SM, 2005, AUK, V122, P36, DOI 10.1642/0004-8038(2005)122[0036:INPBSJ]2.0.CO;2; WELLINS CA, 1989, J CHEM ECOL, V15, P1161, DOI 10.1007/BF01014819; Whittaker RJ, 2017, SCIENCE, V357, P885, DOI 10.1126/science.aam8326; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wilson-Aggarwal JK, 2016, AM NAT, V188, P231, DOI 10.1086/687254	62	4	4	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236489	10.1371/journal.pone.0236489	http://dx.doi.org/10.1371/journal.pone.0236489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726365	Green Published, gold			2022-12-26	WOS:000556908900062
J	Kohler, A; Morgelin, M; Gebauer, JM; Ocal, S; Imhof, T; Koch, M; Nagata, K; Paulsson, M; Zaucke, F; Baumann, U; Sengle, G				Koehler, Anna; Morgelin, Matthias; Gebauer, Jan M.; Oecal, Sinan; Imhof, Thomas; Koch, Manuel; Nagata, Kazuhiro; Paulsson, Mats; Zaucke, Frank; Baumann, Ulrich; Sengle, Gerhard			New specific HSP47 functions in collagen subfamily chaperoning	FASEB JOURNAL			English	Article						collagen; collagen XVII; FACIT; HSP47; MACIT	MOLECULAR CHAPERONE; TRIPLE-HELIX; ENDOPLASMIC-RETICULUM; RECOGNITION; PROTEIN; CARTILAGE; ACID; PH; MICROFIBRILS; EXPRESSION	Although collagens are the most abundant proteins implicated in various disease pathways, essential mechanisms required for their proper folding and assembly are poorly understood. Heat-shock protein 47 (HSP47), an ER-resident chaperone, was mainly reported to fulfill key functions in folding and secretion of fibrillar collagens by stabilizing pro-collagen triple-helices. In this study, we demonstrate unique functions of HSP47 for different collagen subfamilies. Our results show that HSP47 binds to the N-terminal region of procollagen I and is essential for its secretion. However, HSP47 ablation does not majorly impact collagen VI secretion, but its lateral assembly. Moreover, specific ablation ofHsp47in murine keratinocytes revealed a new role for the transmembrane collagen XVII triple-helix formation. Incompletely folded collagen XVII C-termini protruding from isolated HSP47 null keratinocyte membrane vesicles could be fully restored upon the application of recombinant HSP47. Thus, our study expands the current view regarding the client repertoire and function of HSP47, as well as emphasizes its importance for transmembrane collagen folding.	[Koehler, Anna; Imhof, Thomas; Paulsson, Mats; Sengle, Gerhard] Univ Cologne, Ctr Biochem, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden; [Morgelin, Matthias] Colzyx AB, Lund, Sweden; [Gebauer, Jan M.; Oecal, Sinan; Baumann, Ulrich] Univ Cologne, Inst Biochem, Fac Math & Nat Sci, Zulpicher Str 47, D-50674 Cologne, Germany; [Imhof, Thomas; Koch, Manuel] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Med Fac, Cologne, Germany; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto, Japan; [Paulsson, Mats; Sengle, Gerhard] Cologne Ctr Musculoskeletal Biomech CCMB, Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, Cologne, Germany; [Paulsson, Mats; Sengle, Gerhard] Ctr Mol Med Cologne CMMC, Cologne, Germany; [Zaucke, Frank] Friedrichsheim gGmbh, Orthoped Univ Hosp, Dr Rolf M Schwiete Res Unit Osteoarthritis, Frankfurt, Germany; [Sengle, Gerhard] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Pediat & Adolescent Med, Cologne, Germany	University of Cologne; Lund University; University of Cologne; University of Cologne; Kyoto Sangyo University; University of Cologne; University of Cologne; University of Cologne	Sengle, G (corresponding author), Univ Cologne, Ctr Biochem, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.; Baumann, U (corresponding author), Univ Cologne, Inst Biochem, Fac Math & Nat Sci, Zulpicher Str 47, D-50674 Cologne, Germany.; Zaucke, F (corresponding author), Friedrichsheim gGmbH, Orthopad Univ Klin, Orthoped Univ Hosp, Dr Rolf M Schwiete Res Unit Osteoarthritis, Marienburgstr 2, D-60528 Frankfurt, Germany.	Frank.Zaucke@friedrichsheim.de; ubaumann@uni-koeln.de; gsengle@uni-koeln.de	Zaucke, Frank/E-2077-2012; Baumann, Ulrich/B-1220-2013; Koch, Manuel/AAG-9914-2021; Zaucke, Frank/AAT-2688-2021; Gebauer, Jan/C-3085-2009	Koch, Manuel/0000-0002-2962-7814; Gebauer, Jan/0000-0002-3989-4748	Deutsche Forschungsgemeinschaft (DFG) [73111208, FOR2722/B1,B2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 73111208 and FOR2722/B1,B2,C2,D2	Abdillahi SM, 2018, J IMMUNOL, V201, P1007, DOI 10.4049/jimmunol.1700602; Agarwal P, 2012, J BIOL CHEM, V287, P22549, DOI 10.1074/jbc.M111.335935; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; BJORNSSON S, 1981, BIOCHEM J, V197, P249; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; CHU ML, 1988, J BIOL CHEM, V263, P18601; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; HAYASHI T, 1973, J BIOCHEM-TOKYO, V73, P999, DOI 10.1093/oxfordjournals.jbchem.a130184; Hirako Y, 1996, J BIOL CHEM, V271, P13739, DOI 10.1074/jbc.271.23.13739; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ishikawa Y, 2014, J BIOL CHEM, V289, P18189, DOI 10.1074/jbc.M114.561944; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Knupp C, 2001, EMBO J, V20, P372, DOI 10.1093/emboj/20.3.372; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Koide T, 2000, J BIOL CHEM, V275, P27957; LIAN JB, 1973, BIOCHIM BIOPHYS ACTA, V328, P193, DOI 10.1016/0005-2795(73)90345-0; Lindert U, 2015, J BIOL CHEM, V290, P17679, DOI 10.1074/jbc.M115.661025; Maass T, 2016, J BIOL CHEM, V291, P5247, DOI 10.1074/jbc.M115.705160; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; Masago Y, 2012, J CELL SCI, V125, P1118, DOI 10.1242/jcs.089748; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Oecal S, 2016, J BIOL CHEM, V291, P12612, DOI 10.1074/jbc.M115.706069; Ono T, 2012, J BIOL CHEM, V287, P6810, DOI 10.1074/jbc.M111.280248; Ratanavaraporn J, 2008, J BIOMAT SCI-POLYM E, V19, P945, DOI 10.1163/156856208784613505; SPISSINGER T, 1995, MATRIX BIOL, V14, P499, DOI 10.1016/0945-053X(95)90007-1; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Tasab M, 2002, J BIOL CHEM, V277, P35007, DOI 10.1074/jbc.M202782200; Terajima M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008196; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Zwolanek D, 2014, BIOCHEM J, V459, P217, DOI 10.1042/BJ20130642	44	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12040	12052		10.1096/fj.202000570R	http://dx.doi.org/10.1096/fj.202000570R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716577				2022-12-26	WOS:000556424000001
J	Li, Q; Huyan, T; Cai, SN; Huang, QP; Zhang, MZ; Peng, HR; Zhang, YJ; Liu, NJ; Zhang, W				Li, Qi; Huyan, Ting; Cai, Suna; Huang, Qiuping; Zhang, Mengzhao; Peng, Hourong; Zhang, Yujun; Liu, Ningjing; Zhang, Wei			The role of exosomal miR-375-3p: A potential suppressor in bladder cancer via the Wnt/beta-catenin pathway	FASEB JOURNAL			English	Article						bladder cancer; exosomes; FZD8; miR-375-3p; Wnt/beta-catenin pathway	EXTRACELLULAR VESICLES; CERVICAL-CANCER; CARCINOMA-CELLS; LUNG-CANCER; EXPRESSION; PROLIFERATION; BIOGENESIS; AUTOPHAGY; INVASION; SECRETION	miR-375-3p is a significantly downregulated miRNA in bladder cancer (BC). However, its role in BC regulation is still unclear. In this study, we reported that miR-375-3p overexpression inhibited proliferation and migration and promoted apoptosis in BC cells. Frizzled-8 (FZD8) gene is identified as the direct miR-375-3p targeting gene. miR-375-3p blocks the Wnt/beta-catenin pathway and downstream molecules Cyclin D1 and c-Myc by inhibiting the expression of FZD8 directly, it could increase caspase 1 and caspase 3 expression and promote T24 cell apoptosis as well. miR-375-3p also showed a significant inhibitory effect in vivo in bladder tumor-bearing nude mice, as demonstrated by the reduced tumor volume and Ki67 proliferation index in tumor tissue. Collectively, miR-375-3p is a suppressor of BC that inhibits proliferation and metastasis, and promotes apoptosis in BC cells as well as suppresses tumor growth in a T24 xenograft mouse model, which could be used as a potential therapeutic approach for BC in future.	[Li, Qi; Huyan, Ting; Cai, Suna; Huang, Qiuping; Peng, Hourong; Zhang, Yujun; Liu, Ningjing] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Space Biotechnol, 127 YouyiXilu, Xian 710072, Shaanxi, Peoples R China; [Huyan, Ting] Northwestern Polytech Univ, Inst Flexible Elect, Xian, Peoples R China; [Zhang, Mengzhao] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Urol, Xian, Peoples R China; [Zhang, Wei] Zhengzhou Univ, Henan Prov Peoples Hosp, Peoples Hosp, Dept Anesthesiol, Zhengzhou, Peoples R China	Northwestern Polytechnical University; Northwestern Polytechnical University; Xi'an Jiaotong University; Zhengzhou University	Huyan, T (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Space Biotechnol, 127 YouyiXilu, Xian 710072, Shaanxi, Peoples R China.	huyanting@nwpu.edu.cn		Huyan, Ting/0000-0002-8739-1600	Natural Science Basic Research Program of Shaanxi [2019JM360, 2019JM046]; National Natural Science Foundation of China [81502465, 31500688, 31800781]; China Postdoctoral Science Foundation [2020M673491]; National Training Program of Innovation and Entrepreneurship for Undergraduates [201910699168]	Natural Science Basic Research Program of Shaanxi; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Training Program of Innovation and Entrepreneurship for Undergraduates	Natural Science Basic Research Program of Shaanxi, Grant/Award Number: 2019JM360 and 2019JM046; National Natural Science Foundation of China, Grant/Award Number: 81502465, 31500688 and 31800781; China Postdoctoral Science Foundation Funded Project, Grant/Award Number: 2020M673491; National Training Program of Innovation and Entrepreneurship for Undergraduates, Grant/Award Number: 201910699168	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Anastasiadis A, 2012, THER ADV UROL, V4, P13, DOI 10.1177/1756287211431976; Anding AL, 2015, CURR TOP DEV BIOL, V114, P67, DOI 10.1016/bs.ctdb.2015.07.012; Baumgart S, 2017, ONCOTARGET, V8, P58278, DOI 10.18632/oncotarget.17619; Boyd JL, 2015, CURR BIOL, V25, P772, DOI 10.1016/j.cub.2015.01.041; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown AL, 2019, J ORAL PATHOL MED, V48, P840, DOI 10.1111/jop.12894; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chang Y, 2012, GASTROENTEROLOGY, V143, P177, DOI 10.1053/j.gastro.2012.04.009; Chen FK, 2018, CANCER BIOL THER, V19, P1139, DOI 10.1080/15384047.2018.1480888; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Deng SZ, 2020, CANCER GENE THER, V27, P203, DOI 10.1038/s41417-019-0079-9; Du JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16163; Fan YP, 2017, MOL THER-NUCL ACIDS, V7, P181, DOI 10.1016/j.omtn.2017.03.010; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giallombardo M, 2016, JOVE-J VIS EXP, DOI 10.3791/53900; Grayson M, 2017, NATURE, V551, pS33, DOI 10.1038/551S33a; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; He SM, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.03.004; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Ji H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110314; Jin XC, 2017, CLIN CANCER RES, V23, P5311, DOI 10.1158/1078-0432.CCR-17-0577; Jin Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144187; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kumar S, 2018, CANCERS, V10, DOI 10.3390/cancers10110443; Lee YR, 2019, INT J CANCER, V144, P1444, DOI 10.1002/ijc.31931; Li C, 2019, P NATL ACAD SCI USA, V116, P4548, DOI 10.1073/pnas.1813802116; Li GF, 2019, NEOPLASMA, V66, P350, DOI 10.4149/neo_2018_180714N484; Li LN, 2018, ONCOL LETT, V16, P3319, DOI 10.3892/ol.2018.9011; Li Q, 2019, MOL DIAGN THER, V23, P579, DOI 10.1007/s40291-019-00410-4; Li QJ, 2017, CANCER LETT, V402, P166, DOI 10.1016/j.canlet.2017.05.029; Li WH, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0706-8; Lin J, 2016, TUMOR BIOL, V37, P15835, DOI 10.1007/s13277-016-5410-6; Liu G, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0917-7; Liu JN, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12648; Liu SL, 2016, EUR REV MED PHARMACO, V20, P3223; Liu ZH, 2019, EUR REV MED PHARMACO, V23, P3799, DOI 10.26355/eurrev_201905_17806; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ng L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080826; Nolte-'t Hoen E, 2016, P NATL ACAD SCI USA, V113, P9155, DOI 10.1073/pnas.1605146113; Oltra E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00194; Ou HH, 2019, CANCER SCI, V110, P1169, DOI 10.1111/cas.13949; Pan C, 2018, MOL ONCOL, V12, P1935, DOI 10.1002/1878-0261.12371; PROUT GR, 1992, J UROLOGY, V148, P1413, DOI 10.1016/S0022-5347(17)36924-0; Shen ZY, 2014, EXP THER MED, V7, P1757, DOI 10.3892/etm.2014.1627; Sheng B, 2017, BIOMED PHARMACOTHER, V86, P254, DOI 10.1016/j.biopha.2016.11.147; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Spanjer AIR, 2016, THORAX, V71, P312, DOI 10.1136/thoraxjnl-2015-206958; Terasaki H, 2002, INT J MOL MED, V9, P107; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Wang Y, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0556-9; Weston WW, 2019, BIODRUGS, V33, P137, DOI 10.1007/s40259-019-00338-5; Woolbright BL, 2018, UROL ONCOL-SEMIN ORI, V36, P327, DOI 10.1016/j.urolonc.2018.04.010; Wu QW, 2018, ONCOL REP, V39, P1461, DOI 10.3892/or.2018.6177; Xu H, 2019, EXP THER MED, V17, P1509, DOI 10.3892/etm.2018.7106; Xu LL, 2016, ONCOTARGET, V7, P40644, DOI 10.18632/oncotarget.9811; Xu LL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-714; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Yang QW, 2017, ONCOTARGET, V8, P78989, DOI 10.18632/oncotarget.20742; Yang YZ, 2019, ACTA PHARMACOL SIN, V40, P879, DOI 10.1038/s41401-018-0194-4; Yang Y, 2018, MOL CARCINOGEN, V57, P842, DOI 10.1002/mc.22805; Ye CW, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152478; Yoda S, 2014, LUNG CANCER, V85, P366, DOI 10.1016/j.lungcan.2014.06.009; Yoshii S, 2019, CANCER SCI, V110, P2396, DOI 10.1111/cas.14084; Yu X, 2016, INT J GYNECOL CANCER, V26, P851, DOI 10.1097/IGC.0000000000000711; Zhang HD, 2018, EPIGENOMICS-UK, V10, P1499, DOI 10.2217/epi-2017-0151; Zhao PX, 2018, ACTA BIOMATER, V72, P248, DOI 10.1016/j.actbio.2018.03.022; Zhao X, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012632	80	18	18	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12177	12196		10.1096/fj.202000347R	http://dx.doi.org/10.1096/fj.202000347R		JUL 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716585				2022-12-26	WOS:000556424800001
J	Yagisawa, Y; Suita, K; Ohnuki, Y; Ishikawa, M; Mototani, Y; Ito, A; Matsuo, I; Hayakawa, Y; Nariyama, M; Umeki, D; Saeki, Y; Amitani, Y; Nakamura, Y; Tomonari, H; Okumura, S				Yagisawa, Yuka; Suita, Kenji; Ohnuki, Yoshiki; Ishikawa, Misao; Mototani, Yasumasa; Ito, Aiko; Matsuo, Ichiro; Hayakawa, Yoshio; Nariyama, Megumi; Umeki, Daisuke; Saeki, Yasutake; Amitani, Yasuharu; Nakamura, Yoshiki; Tomonari, Hiroshi; Okumura, Satoshi			Effects of occlusal disharmony on cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage in mice	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MYOSIN HEAVY-CHAIN; CELL-DEATH; MUSCLE MASS; KINASE-II; STRESS; FAILURE; HYPERTROPHY; DISRUPTION; MALOCCLUSION	Occlusal disharmony leads to morphological changes in the hippocampus and osteopenia of the lumbar vertebra and long bones in mice, and causes stress. Various types of stress are associated with increased incidence of cardiovascular disease, but the relationship between occlusal disharmony and cardiovascular disease remain poorly understood. Therefore, in this work, we examined the effects of occlusal disharmony on cardiac homeostasis in bite-opening (BO) mice, in which a 0.7 mm space was introduced by cementing a suitable applicance onto the mandibular incisior. We first examined the effects of BO on the level of serum corticosterone, a key biomarker for stress, and on heart rate variability at 14 days after BO treatment, compared with baseline. BO treatment increased serum corticosterone levels by approximately 3.6-fold and the low frequency/high frequency ratio, an index of sympathetic nervous activity, was significantly increased by approximately 4-fold by the BO treatment. We then examined the effects of BO treatment on cardiac homeostasis in mice treated or not treated with the non-selective beta-blocker propranolol for 2 weeks. Cardiac function was significantly decreased in the BO group compared to the control group, but propranolol ameliorated the dysfunction. Cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage were significantly increased in the BO group, but propranolol blocked these changes. The BO-induced cardiac dysfunction was associated with increased phospholamban phosphorylation at threonine-17 and serine-16, as well as inhibition of Akt/mTOR signaling and autophagic flux. These data suggest that occlusal disharmony might affect cardiac homeostasis via alteration of the autonomic nervous system.	[Yagisawa, Yuka; Suita, Kenji; Ohnuki, Yoshiki; Mototani, Yasumasa; Matsuo, Ichiro; Hayakawa, Yoshio; Saeki, Yasutake; Okumura, Satoshi] Tsurumi Univ, Dept Physiol, Sch Dent Med, Yokohama, Kanagawa, Japan; [Yagisawa, Yuka; Ito, Aiko; Umeki, Daisuke; Nakamura, Yoshiki; Tomonari, Hiroshi] Tsurumi Univ, Dept Orthodont, Sch Dent Med, Yokohama, Kanagawa, Japan; [Ishikawa, Misao] Tsurumi Univ, Dept Oral Anat, Sch Dent Med, Yokohama, Kanagawa, Japan; [Matsuo, Ichiro] Tsurumi Univ, Dept Periodontol, Sch Dent Med, Yokohama, Kanagawa, Japan; [Hayakawa, Yoshio] Tsurumi Univ, Dept Dent Anesthesiol, Sch Dent Med, Yokohama, Kanagawa, Japan; [Nariyama, Megumi] Tsurumi Univ, Dept Pediat Dent, Sch Dent Med, Yokohama, Kanagawa, Japan; [Amitani, Yasuharu] Tsurumi Univ, Dept Math, Sch Dent Med, Yokohama, Kanagawa, Japan	Tsurumi University; Tsurumi University; Tsurumi University; Tsurumi University; Tsurumi University; Tsurumi University; Tsurumi University	Okumura, S (corresponding author), Tsurumi Univ, Dept Physiol, Sch Dent Med, Yokohama, Kanagawa, Japan.	okumura-s@tsurumi-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [20K10305, 20K10304, 17K17342, 17K11977, 19K24109, 18K06862, 19H03657]; MEXT [S1511018]; Pfizer Japan [AC190821]; Society for Tsurumi University School of Dental Medicine [28006]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pfizer Japan(Pfizer); Society for Tsurumi University School of Dental Medicine	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [20K10305 to Dr. Kenji Suita, 20K10304 to Dr. Yoshiki Ohnuki, 17K17342 to Dr. Daisuke Umeki., 17K11977 to Dr. Megumi Nariyama., 19K24109 to Dr. Aiko Ito, 18K06862, 19H03657 to Dr. Satoshi Okumura]; the MEXT Supported Program for the Strategic Research Foundation at Private Universities 2015-2019 (S1511018 to Dr. Satoshi Okumura); an Academic Contribution from Pfizer Japan (AC190821 to Dr. Satoshi Okumura); Research Promotion Grant from the Society for Tsurumi University School of Dental Medicine (28006 to Dr. Yuka Yagisawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors approve of the contents and agree to coauthorship.	Abraham WT, 2015, JACC-HEART FAIL, V3, P487, DOI 10.1016/j.jchf.2015.02.006; Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; [Anonymous], 1996, LANCET, V353, P2001; Arai C, 2005, JPN J PHYSIOL, V55, P173, DOI 10.2170/jjphysiol.R2123; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bai YZ, 2012, J PHARMACOL SCI, V119, P381, DOI 10.1254/jphs.12102FP; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BUDTZJORGENSEN E, 1980, J CLIN PERIODONTOL, V7, P149, DOI 10.1111/j.1600-051X.1980.tb01958.x; BUDTZJORGENSEN E, 1981, J ORAL REHABIL, V8, P1, DOI 10.1111/j.1365-2842.1981.tb00469.x; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Choi SH, 2015, AM J ORTHOD DENTOFAC, V147, P587, DOI 10.1016/j.ajodo.2014.12.025; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; da Silva LC, 2021, CRANIO, V39, P249, DOI 10.1080/08869634.2019.1633492; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Ekuni D, 2011, METHOD INFORM MED, V50, P358, DOI 10.3414/ME10-01-0045; Ekuni D, 2011, EUR J ORTHODONT, V33, P558, DOI 10.1093/ejo/cjq121; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feng N, 2017, J MOL CELL CARDIOL, V103, P102, DOI 10.1016/j.yjmcc.2016.12.007; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Grootendorst J, 2001, EUR J NEUROSCI, V14, P1505, DOI 10.1046/j.0953-816x.2001.01766.x; Grumati Paolo, 2012, Cells, V1, P325, DOI 10.3390/cells1030325; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Ito A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215539; Jin HL, 2017, J MOL CELL CARDIOL, V108, P170, DOI 10.1016/j.yjmcc.2017.05.014; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; Katayama T, 2012, NEUROSCI LETT, V520, P77, DOI 10.1016/j.neulet.2012.05.035; Kawamura N, 2019, J PHYSIOL SCI, V69, P503, DOI 10.1007/s12576-019-00670-z; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Marano G, 2003, PFLUG ARCH EUR J PHY, V446, P429, DOI 10.1007/s00424-003-1059-2; Matsuura N, 2015, AM J PHYSIOL-HEART C, V308, pH1275, DOI 10.1152/ajpheart.00906.2014; Middlekauff HR, 1997, CIRCULATION, V96, P1835, DOI 10.1161/01.CIR.96.6.1835; Miyata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079093; Mori D, 2013, NEUROSCI LETT, V534, P228, DOI 10.1016/j.neulet.2012.12.004; Mototani Y, 2018, PFLUG ARCH EUR J PHY, V470, P937, DOI 10.1007/s00424-018-2124-1; Nagasawa K, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.14; National Research Council Committee for the Update of the Guide for the C. U. o. L., 2011, DRUG DISCOVERY EVALU; Ni M, 2009, AM J PHYSIOL-HEART C, V296, pH1598, DOI 10.1152/ajpheart.01202.2008; Ohnuki Y, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12791; Ohnuki Y, 2014, J PHYSIOL-LONDON, V592, P5461, DOI 10.1113/jphysiol.2014.282996; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Okumura S, 2008, J APPL PHYSIOL, V105, P173, DOI 10.1152/japplphysiol.01166.2007; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Okumura S, 2014, J CLIN INVEST, V124, P2785, DOI 10.1172/JCI64784; Onozuka M, 2002, BEHAV BRAIN RES, V131, P125, DOI 10.1016/S0166-4328(01)00378-3; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Park SE, 2017, PHYSIOL BEHAV, V171, P21, DOI 10.1016/j.physbeh.2016.12.036; Pelliccia F, 2017, CIRCULATION, V135, P2426, DOI 10.1161/CIRCULATIONAHA.116.027121; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Sato M, 2014, DIABETES, V63, P4115, DOI 10.2337/db13-1860; Sciarretta S, 2018, CIRC RES, V122, P489, DOI 10.1161/CIRCRESAHA.117.311147; Shimizu Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18037-y; Tanase M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19311; Umeki D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128263; Umeki D, 2013, J PHARMACOL SCI, V122, P278, DOI 10.1254/jphs.12195FP; Vogelzangs N, 2007, J GERONTOL A-BIOL, V62, P563, DOI 10.1093/gerona/62.5.563; Yagisawa Y, 2020, CIRC CONT, V41, P38; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yoshihara T, 2001, J DENT RES, V80, P2089, DOI 10.1177/00220345010800121301; Yoshihara T, 2011, NEUROSCI LETT, V503, P43, DOI 10.1016/j.neulet.2011.08.004; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020334; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017; Zhang Ziyan, 2016, Curr Protoc Toxicol, V69, DOI 10.1002/cptx.11; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	68	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236547	10.1371/journal.pone.0236547	http://dx.doi.org/10.1371/journal.pone.0236547			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716920	Green Published, gold			2022-12-26	WOS:000556674500017
J	Burgess, M; Chen, UCE; Mapp, S; Blumenthal, A; Mollee, P; Gill, D; Saunders, NA				Burgess, M.; Chen, U. C. E.; Mapp, S.; Blumenthal, A.; Mollee, P.; Gill, D.; Saunders, N. A.			HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SKIN-CANCER; CELLS; INHIBITION; PHAGOCYTOSIS; SELECTIVITY; SURVIVAL	Resistance, to therapeutic antibodies used to treat chronic lymphocytic leukemia (CLL) patients is common. Monocyte-derived macrophages (MDMs) are a major effector of antitumour responses to therapeutic antibodies and we have previously reported that resistance to therapeutic antibodies, by MDMs, increases as CLL disease progresses. In this study, we examine the effect of a Class IIa-selective HDAC inhibitor (TMP195) on the phagocytic response to opsonised tumor cells or non-opsonised targets by MDMs derived from CLL patients. We report that TMP195 enhances phagocytic responses to antibody-opsonised CLL cells andE. coliwithin 30 min of treatment. The enhanced response is phenocopied by knockdown of the Class IIa HDAC, HDAC7, or by low concentrations of the pan-HDAC inhibitor, vorinostat. HDAC7 knockdown and inhibition induces hyperacetylation and hyperphosphorylation of Bruton's tyrosine kinase (BTK). Moreover, BTK inhibitors abrogated the enhanced response to HDAC7 inhibition. Our data show that HDAC7 is an actionable driver of resistance to therapeutic antibodies by MDMs derived from CLL patients.	[Burgess, M.; Chen, U. C. E.; Saunders, N. A.] Univ Queensland, Woolloongabba, Qld, Australia; [Burgess, M.; Mapp, S.; Mollee, P.; Gill, D.] Princess Alexandra Hosp, Dept Haematol, Canc Serv Unit, Woolloongabba, Qld, Australia; [Mapp, S.] Univ Queensland, Translat Res Inst, Sch Med, Woolloongabba, Qld, Australia; [Blumenthal, A.] Univ Queensland, Translat Res Inst, Diamantina Inst, Woolloongabba, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Saunders, NA (corresponding author), Univ Queensland, Woolloongabba, Qld, Australia.	nsaunders@uq.edu.au	saunders, nicholas/E-1544-2014	saunders, nicholas/0000-0002-2478-3420; Chen, Yu Chen Enya/0000-0003-4223-5054	Queensland Health, Princess Alexandra Hospital	Queensland Health, Princess Alexandra Hospital	The authors acknowledge the generosity of the patients who donated their time and blood for this study. This work was supported by a generous donation from Jeff and Fran Maclean and a research support package to DG from Queensland Health, Princess Alexandra Hospital.	Barkal AA, 2019, NATURE, V572, P392, DOI 10.1038/s41586-019-1456-0; Bobrowicz M, 2017, BLOOD, V130, P1628, DOI [10.1182/blood-2016-08-736066, 10.1182/blood-2016-08736066]; Boissard F, 2015, LEUKEMIA LYMPHOMA, V56, P1570, DOI 10.3109/10428194.2014.991731; Bosch F, 2019, NAT REV CLIN ONCOL, V16, P684, DOI 10.1038/s41571-019-0239-8; Burgess M, 2017, ONCOGENE, V36, P2366, DOI 10.1038/onc.2016.387; Burgess M, 2013, CLIN CANCER RES, V19, P5675, DOI 10.1158/1078-0432.CCR-13-1037; Burgess M, 2012, LEUKEMIA LYMPHOMA, V53, P1988, DOI 10.3109/10428194.2012.672735; Chen YCE, 2017, BBA-REV CANCER, V1868, P176, DOI 10.1016/j.bbcan.2017.03.006; Chen YCE, 2020, LEUKEMIA, V34, P451, DOI 10.1038/s41375-019-0556-z; Church AK, 2016, CLIN EXP IMMUNOL, V183, P90, DOI 10.1111/cei.12697; Galletti G, 2016, CELL REP, V14, P1748, DOI 10.1016/j.celrep.2016.01.042; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Gul N, 2014, J CLIN INVEST, V124, P812, DOI 10.1172/JCI66776; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hanna BS, 2016, LEUKEMIA, V30, P570, DOI 10.1038/leu.2015.305; Jung JW, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1479627; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kimbrough D, 2018, J MOL CELL CARDIOL, V119, P51, DOI 10.1016/j.yjmcc.2018.04.011; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Liu ZJ, 2010, J IMMUNOL, V184, P244, DOI 10.4049/jimmunol.0902324; Lobera M, 2013, NAT CHEM BIOL, V9, P319, DOI [10.1038/nchembio.1223, 10.1038/NCHEMBIO.1223]; Marek L, 2013, J MED CHEM, V56, P427, DOI 10.1021/jm301254q; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Qi XB, 2018, J CELL BIOCHEM, V119, P3081, DOI 10.1002/jcb.26446; Ramsay HM, 2002, BRIT J DERMATOL, V147, P950, DOI 10.1046/j.1365-2133.2002.04976.x; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Rogers KA, 2019, LEUKEMIA, V33, P2527, DOI 10.1038/s41375-019-0481-1; Roghanian A, 2015, CANCER CELL, V27, P473, DOI 10.1016/j.ccell.2015.03.005; Salvagno C, 2019, NAT CELL BIOL, V21, P511, DOI 10.1038/s41556-019-0298-1; Uribe-Querol E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01368; Van Damme M, 2014, EPIGENETICS-US, V9, P1374, DOI 10.4161/15592294.2014.969628; VanDerMeid KR, 2018, CANCER IMMUNOL RES, V6, P1150, DOI 10.1158/2326-6066.CIR-18-0319; Varughese T, 2018, CLIN INFECT DIS, V67, P687, DOI 10.1093/cid/ciy175; Veillette A, 2018, TRENDS IMMUNOL, V39, P173, DOI 10.1016/j.it.2017.12.005; Weiskopf K, 2017, EUR J CANCER, V76, P100, DOI 10.1016/j.ejca.2017.02.013	37	7	7	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2020	39	35					5756	5767		10.1038/s41388-020-01394-w	http://dx.doi.org/10.1038/s41388-020-01394-w		JUL 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NF2QB	32709923				2022-12-26	WOS:000552155200001
J	Zizalova, K; Vecka, M; Vitek, L; Lenicek, M				Zizalova, Katerina; Vecka, Marek; Vitek, Libor; Lenicek, Martin			Enzymatic methods may underestimate the total serum bile acid concentration	PLOS ONE			English	Article							CHROMATOGRAPHY	Enzymatic assays based on bacterial 3 alpha-hydroxysteroid dehydrogenase are the method of choice for quantification of total bile acids (BAs) in serum. Although non-specific, it is generally considered precise and robust. The aim of this study was to investigate how changes in the BA spectrum might affect the reliability of the method. We measured standard solutions of twenty-three human and murine BAs using a commercial enzymatic assay and compared the measured vs. expected concentrations. Additionally, total BA concentrations in rat and human cholestatic samples with an abnormal BA spectrum were measured using an enzymatic assay, and a more specific LC-MS/MS method. We observed a great variability in the response of individual BAs in the enzymatic assay. Relative signal intensities ranged from 100% in glycocholic acid (reference) to only 20% in alpha-muricholic acid. The enzymatic assay markedly underestimated the BA concentrations in both human and rat cholestatic sera when compared to the LC-MS/MS assay. Our study indicated that the performance of an enzymatic assay largely depends on the BA spectrum, and the total concentration of BAs can be markedly underestimated. Samples with an atypical BA spectrum (viz. in rodents) should preferably be measured by other methods.	[Zizalova, Katerina; Vecka, Marek; Vitek, Libor; Lenicek, Martin] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Vecka, Marek; Vitek, Libor] Charles Univ Prague, Dept Internal Med 4, Fac Med 1, Prague, Czech Republic	Charles University Prague; Charles University Prague	Lenicek, M (corresponding author), Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic.	martin.lenicek@lf1.cuni.cz	Vitek, Libor/A-2645-2008; Vecka, Marek/AAB-9358-2022; Lenicek, Martin/A-5495-2009; Zizalova, Katerina/I-3797-2017	Vitek, Libor/0000-0002-5318-0151; Lenicek, Martin/0000-0001-6242-3488; Zizalova, Katerina/0000-0003-1155-4351	Charles University, Prague, Czech Republic [GAUK 58217]	Charles University, Prague, Czech Republic(Czech Republic Government)	This research was funded by grant GAUK 58217 given by the Charles University, Prague, Czech Republic.	Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Chiang JYL, 2019, ANNU REV NUTR, V39, P175, DOI 10.1146/annurev-nutr-082018-124344; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Danese E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179200; ENGERT R, 1973, ANAL BIOCHEM, V51, P399, DOI 10.1016/0003-2697(73)90493-4; Galloway D, 2019, JPEN-PARENTER ENTER, V43, P263, DOI 10.1002/jpen.1316; IWATA T, 1964, J BIOCHEM-TOKYO, V56, P424, DOI 10.1093/oxfordjournals.jbchem.a128013; MASHIGE F, 1981, CLIN CHEM, V27, P1352; Muchova L, 2015, J CELL MOL MED, V19, P924, DOI 10.1111/jcmm.12401; Prasnicka A, 2017, BBA-MOL CELL BIOL L, V1862, P1469, DOI 10.1016/j.bbalip.2017.09.003; Trottier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022094; Ye L, 2007, J CHROMATOGR B, V860, P10, DOI 10.1016/j.jchromb.2007.09.031	12	3	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236372	10.1371/journal.pone.0236372	http://dx.doi.org/10.1371/journal.pone.0236372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706797	Green Published, gold			2022-12-26	WOS:000579931700036
J	Keuler, KM; Bron, GM; Griebel, R; Richgels, KLD				Keuler, Krystal M.; Bron, Gebbiena M.; Griebel, Randall; Richgels, Katherine L. D.			An invasive disease, sylvatic plague, increases fragmentation of black-tailed prairie dog (Cynomys ludovicianus) colonies	PLOS ONE			English	Article							YERSINIA-PESTIS; POPULATIONS; GRASSLANDS; OUTBREAKS; DYNAMICS; SPREAD	Context A disease can be a source of disturbance, causing population declines or extirpations, altering species interactions, and affecting habitat structure. This is particularly relevant for diseases that affect keystone species or ecosystem engineers, leading to potentially cascading effects on ecosystems. Objective We investigated the invasion of a non-native disease, plague, to a keystone species, prairie dogs, and documented the resulting extent of fragmentation and habitat loss in western grasslands. Specifically, we assessed how the arrival of plague in the Conata Basin, South Dakota, United States, affected the size, shape, and aggregation of prairie dog colonies, an animal species known to be highly susceptible to plague. Methods Colonies in the prairie dog complex were mapped every 1 to 3 years from 1993 to 2015. Plague was first confirmed in 2008 and we compared prairie dog complex and colony characteristics before and after the arrival of plague. Results As expected the colony complex and the patches in colonies became smaller and more fragmented after the arrival of plague; the total area of each colony and the mean area per patch within a colony decreased, the number of patches per colony increased, and mean contiguity of each patch decreased, leading to habitat fragmentation. Conclusion We demonstrate how an emerging infectious disease can act as a source of disturbance to natural systems and lead to potentially permanent alteration of habitat characteristics. While perhaps not traditionally thought of as a source of ecosystem disturbances, in recent years emerging infectious diseases have shown to be able to have large effects on ecosystems if they affect keystone species.	[Keuler, Krystal M.; Bron, Gebbiena M.; Richgels, Katherine L. D.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; [Griebel, Randall] US Forest Serv, Bridger Teton Natl Forest, Jackson, WY USA; [Bron, Gebbiena M.] Univ Wisconsin, Coll Agr & Life Sci, Madison, WI 53706 USA	United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; University of Wisconsin System; University of Wisconsin Madison	Richgels, KLD (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.	krichgels@usgs.gov		Bron, Gebbiena/0000-0002-4431-2482				Adjemian JZ, 2007, AM J TROP MED HYG, V76, P365, DOI 10.4269/ajtmh.2007.76.365; Antolin MF, 2002, INFLUENCE SYLVATIC P, V57; Antonation KS, 2014, J WILDLIFE DIS, V50, P699, DOI 10.7589/2013-08-215; Augustine DJ, 2008, LANDSCAPE ECOL, V23, P255, DOI 10.1007/s10980-007-9175-6; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brickner KM, 2014, BIOL CONSERV, V169, P1, DOI 10.1016/j.biocon.2013.10.010; Brown NL, 2016, ECOL EVOL, V6, P426, DOI 10.1002/ece3.1874; Buhnerkempe MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022498; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Collinge SK, 2005, LANDSCAPE ECOL, V20, P941, DOI 10.1007/s10980-005-4617-5; Cully JF, 2010, VECTOR-BORNE ZOONOT, V10, P7, DOI 10.1089/vbz.2009.0045; Cully JF, 2001, J MAMMAL, V82, P894, DOI 10.1644/1545-1542(2001)082&lt;0894:ICOSPI&gt;2.0.CO;2; Eads DA, 2018, J WILDLIFE DIS, V54, P745, DOI 10.7589/2017-10-250; Eads DA, 2017, J WILDLIFE MANAGE, V81, P990, DOI 10.1002/jwmg.21281; Eads DA, 2015, CONSERV BIOL, V29, P1086, DOI 10.1111/cobi.12498; Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186; Geaumont Benjamin A., 2016, Rangelands, V38, P38, DOI 10.1016/j.rala.2015.11.002; George DB, 2013, ECOLOGY, V94, P1572, DOI 10.1890/12-0719.1; Griebel RL, 2009, WALL RANGER DISTRICT, P1; Griebel RL, 2008, WALL RANGER DISTRICT; Hoogland J. L., 1995, BLACK TAILED PRAIRIE; Jachowski DS, 2008, NAT AREA J, V28, P14, DOI 10.3375/0885-8608(2008)28[14:IOBPDS]2.0.CO;2; Johnson TL, 2011, J WILDLIFE MANAGE, V75, P357, DOI 10.1002/jwmg.40; Kempema S., 2007, 200707 S DAK DEP GEM; Kotliar NB, 1999, ENVIRON MANAGE, V24, P177, DOI 10.1007/s002679900225; Livieri TM, 2012, W N AM NAT, V72; Lockhart J, 2004, P S STAT BLACK FOOT; Martinez-Lopez V, 2017, URBAN ECOSYST, V20, P1161, DOI 10.1007/s11252-017-0668-z; Matchett MR, 2010, VECTOR-BORNE ZOONOT, V10, P27, DOI 10.1089/vbz.2009.0053; Mcdonald LL, 2011, 20115063 US GEOL SUR, P36; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Menge BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153994; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller BJ, 2007, J WILDLIFE MANAGE, V71, P2801, DOI 10.2193/2007-041; Mize EL, 2016, VECTOR-BORNE ZOONOT, V16, P88, DOI 10.1089/vbz.2015.1825; Ostfeld RS, 2010, INFECT DIS ECOLOGY E; Pauli JN, 2006, J WILDLIFE DIS, V42, P74, DOI 10.7589/0090-3558-42.1.74; R Core Team, 2021, R LANGUAGE ENV STAT; Richgels KLD, 2016, ECOHEALTH, V13, P415, DOI 10.1007/s10393-016-1133-9; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Roach JL, 2001, J MAMMAL, V82, P946, DOI 10.1644/1545-1542(2001)082<0946:GSOAMO>2.0.CO;2; Rocke TE, 2017, ECOHEALTH, V14, P438, DOI 10.1007/s10393-017-1253-x; Salkeld DJ, 2016, BIOSCIENCE, V66, P118, DOI 10.1093/biosci/biv179; Salkeld DJ, 2010, P NATL ACAD SCI USA, V107, P14247, DOI 10.1073/pnas.1002826107; Schenbeck GL, 1986, AERIAL PHOTOGRAPHY A, P1; Seery DB, 2003, J MED ENTOMOL, V40, P718, DOI 10.1603/0022-2585-40.5.718; Sinclair E, 1995, SERENGETI DYNAMICS E; Stapp P, 2004, FRONT ECOL ENVIRON, V2, P235, DOI 10.2307/3868263; SUMPTION KJ, 1985, MAMMAL REV, V15, P151, DOI 10.1111/j.1365-2907.1985.tb00396.x; Tripp DW, 2017, ECOHEALTH, V14, P451, DOI 10.1007/s10393-017-1236-y; USF a W, 2013, SERVICE; Verdolin JL, 2002, CAN J ZOOL, V80, P1197, DOI 10.1139/Z02-097	52	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235907	10.1371/journal.pone.0235907	http://dx.doi.org/10.1371/journal.pone.0235907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701990	Green Published, gold			2022-12-26	WOS:000575913700032
J	Patil, PP; Vass, I; Kodru, S; Szabo, M				Patil, Priyanka Pradeep; Vass, Imre; Kodru, Sandeesha; Szabo, Milan			A multi-parametric screening platform for photosynthetic trait characterization of microalgae and cyanobacteria under inorganic carbon limitation	PLOS ONE			English	Article							A FLUORESCENCE INDUCTION; WATER-OXIDIZING COMPLEX; SYNECHOCYSTIS PCC 6803; CYCLIC ELECTRON FLOW; SP STRAIN PCC-6803; CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; CHLAMYDOMONAS-REINHARDTII; NADPH FLUORESCENCE; QUANTUM YIELD	Microalgae and cyanobacteria are considered as important model organisms to investigate the biology of photosynthesis; moreover, they are valuable sources of biomolecules for several biotechnological applications. Understanding the species-specific traits of photosynthetic electron transport is extremely important, because it contributes to the regulation of ATP/NADPH ratio, which has direct/indirect links to carbon fixation and other metabolic pathways and thus overall growth and biomass production. In the present work, a cuvette-based setup is developed, in which a combination of measurements of dissolved oxygen, pH, chlorophyll fluorescence and NADPH kinetics can be performed without disturbing the physiological status of the sample. The suitability of the system is demonstrated using a model cyanobacterium Synechocystis sp. PCC6803, as well as biofuel-candidate microalgae species, such as Chlorella sorokiniana, Dunaliella salina and Nannochloropsis limnetica undergoing inorganic carbon (Ci) limitation. Inorganic carbon limitation, induced by photosynthetic Ci uptake under continuous illumination, caused a decrease in the effective quantum yield of PSII (Y(II)) and loss of oxygen-evolving capacity in all species investigated here; these effects were largely recovered by the addition of NaHCO3. Detailed analysis of the dark-light and light-dark transitions of NADPH production/uptake and changes in chlorophyll fluorescence kinetics revealed species- and condition-specific responses. These responses indicate that the impact of decreased Calvin-Benson cycle activity on photosynthetic electron transport pathways involving several sections of the electron transport chain (such as electron transfer via the Q(A)-Q(B)-plastoquinone pool, the redox state of the plastoquinone pool) can be analyzed with high sensitivity in a comparative manner. Therefore, the integrated system presented here can be applied for screening for specific traits in several significant species at different stages of inorganic carbon limitation, a condition that strongly impacts primary productivity.	[Patil, Priyanka Pradeep; Vass, Imre; Kodru, Sandeesha; Szabo, Milan] Biol Res Ctr, Inst Plant Biol, Szeged, Hungary; [Kodru, Sandeesha] Univ Szeged, Fac Sci & Informat, Biol PhD Sch, Szeged, Hungary; [Szabo, Milan] Univ Technol Sydney, Climate Change Cluster, Ultimo, Australia	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; University of Technology Sydney	Szabo, M (corresponding author), Biol Res Ctr, Inst Plant Biol, Szeged, Hungary.; Szabo, M (corresponding author), Univ Technol Sydney, Climate Change Cluster, Ultimo, Australia.	szabo.milan@brc.hu	Vass, Imre/AAS-6171-2021; Szabo, Milan/L-9942-2014	Vass, Imre/0000-0003-4987-7842; Szabo, Milan/0000-0001-6235-2894; Patil, Priyanka/0000-0003-2079-6248	Hungarian Academy of Sciences, MTA Premium Postdoctoral Research Program [PREMIUM-2017-38]; National Research, Development and Innovation Office [NKFIH FK 128977]	Hungarian Academy of Sciences, MTA Premium Postdoctoral Research Program; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by the grants of M.S. received from the Hungarian Academy of Sciences, MTA Premium Postdoctoral Research Program, Grant number PREMIUM-2017-38, https://mta.hu/english/mta-premium-postdoctoral-research-program and from the National Research, Development and Innovation Office, Grant number NKFIH FK 128977, https://nkfih.gov.hu/about-the-office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdiyeva Y, 2011, J BIOL CHEM, V286, P24007, DOI 10.1074/jbc.M111.223289; Ananyev G, 2005, PHOTOCH PHOTOBIO SCI, V4, P991, DOI 10.1039/b507519j; Ananyev G, 2018, PHOTOSYNTHETICA, V56, P217, DOI 10.1007/s11099-018-0781-0; Ananyev G, 2016, BBA-BIOENERGETICS, V1857, P1380, DOI 10.1016/j.bbabio.2016.04.056; Artier J, 2018, BBA-BIOENERGETICS, V1859, P1108, DOI 10.1016/j.bbabio.2018.06.015; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Bernat G, 2011, J BACTERIOL, V193, P292, DOI 10.1128/JB.00984-10; Borowitzka M.A., 2013, HDB MICROALGAL CULTU, VSecond, P359; Burnap Robert L., 2015, Life-Basel, V5, P348, DOI 10.3390/life5010348; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P912, DOI 10.1016/j.bbabio.2010.12.004; Clowez S, 2015, J BIOL CHEM, V290, P8666, DOI 10.1074/jbc.M114.632588; Cooley JW, 2001, J BACTERIOL, V183, P4251, DOI 10.1128/JB.183.14.4251-4258.2001; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; De-Bashan LE, 2008, BIORESOURCE TECHNOL, V99, P4980, DOI 10.1016/j.biortech.2007.09.065; Deak Z, 2014, BBA-BIOENERGETICS, V1837, P1522, DOI 10.1016/j.bbabio.2014.01.003; Deng Y, 2003, PLANT CELL PHYSIOL, V44, P534, DOI 10.1093/pcp/pcg067; Dere Sukran, 1998, Turkish Journal of Botany, V22, P13; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hayashi R, 2014, BIOSCI BIOTECH BIOCH, V78, P384, DOI 10.1080/09168451.2014.882745; Holland SC, 2016, ALGAL RES, V20, P87, DOI 10.1016/j.algal.2016.09.021; Holland SC, 2015, BBA-BIOENERGETICS, V1847, P355, DOI 10.1016/j.bbabio.2014.12.001; Huertas IE, 2000, PLANTA, V211, P43, DOI 10.1007/s004250000254; Kaiser E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31252; Kalaji HM, 2014, PHOTOSYNTH RES, V122, P121, DOI 10.1007/s11120-014-0024-6; Kauny J, 2014, BBA-BIOENERGETICS, V1837, P792, DOI 10.1016/j.bbabio.2014.01.009; Kirilovsky D, 2015, PHOTOSYNTH RES, V126, P3, DOI 10.1007/s11120-014-0031-7; Klimov VV, 2001, BBA-BIOENERGETICS, V1503, P187, DOI 10.1016/S0005-2728(00)00222-X; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Krienitz L, 2000, PHYCOLOGIA, V39, P219, DOI 10.2216/i0031-8884-39-3-219.1; Krishna PS, 2019, J EXP BOT, V70, P6321, DOI 10.1093/jxb/erz380; Lucker B, 2013, PHOTOSYNTH RES, V117, P449, DOI 10.1007/s11120-013-9932-0; Lucker BF, 2014, ALGAL RES, V6, P242, DOI 10.1016/j.algal.2013.12.007; Melis A, 1998, J APPL PHYCOL, V10, P515, DOI 10.1023/A:1008076231267; Mi HL, 2000, PLANT CELL PHYSIOL, V41, P1129, DOI 10.1093/pcp/pcd038; Muller S, 2019, ENG LIFE SCI, V19, P955, DOI 10.1002/elsc.201900061; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Papageorgiou GC, 2007, PHOTOSYNTH RES, V94, P275, DOI 10.1007/s11120-007-9193-x; Peltier G, 2016, ANNU REV PLANT BIOL, V67, P55, DOI 10.1146/annurev-arplant-043014-114752; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Raven JA, 2014, PHOTOSYNTH RES, V121, P111, DOI 10.1007/s11120-013-9962-7; Roach T, 2013, BBA-BIOENERGETICS, V1827, P1183, DOI 10.1016/j.bbabio.2013.06.004; ROBINSON HH, 1984, Z NATURFORSCH C, V39, P382; Ruuska S, 1998, AUST J PLANT PHYSIOL, V25, P859, DOI 10.1071/PP98079; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Schreiber U., 2009, PAM APPL NOTES, V2, P1; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Shevela D, 2012, BBA-BIOENERGETICS, V1817, P1134, DOI 10.1016/j.bbabio.2012.04.003; Shimakawa G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00886; Shimakawa G, 2017, SCI REP-UK, V7, DOI 10.1038/srep41022; Shimakawa G, 2016, PHOTOSYNTH RES, V130, P293, DOI 10.1007/s11120-016-0253-y; SHOAF WT, 1976, LIMNOL OCEANOGR, V21, P926, DOI 10.4319/lo.1976.21.6.0926; SPALDING MH, 1984, PHOTOSYNTH RES, V5, P169, DOI 10.1007/BF00028529; Stirbet A, 2018, PHOTOSYNTHETICA, V56, P86, DOI 10.1007/s11099-018-0770-3; Stirbet A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P291, DOI 10.1134/S0006297914040014; Sun ZL, 2016, PLANT BIOTECHNOL J, V14, P557, DOI 10.1111/pbi.12398; Tamburic B, 2018, ALGAL RES, V31, P334, DOI 10.1016/j.algal.2018.02.014; Tamburic B, 2015, CHEMSUSCHEM, V8, P2727, DOI 10.1002/cssc.201500332; Tamburic B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086047; Tsimilli-Michael M, 2020, PHOTOSYNTHETICA, V58, P275, DOI 10.32615/ps.2019.150; van Rensen JJS, 2002, PHOTOSYNTH RES, V73, P185, DOI 10.1023/A:1020451114262; Vermaas W. F. J., 1982, Photosynthesis. Volume II. Development, carbon metabolism, and productivity, P541; White S, 2014, INT J HYDROGEN ENERG, V39, P1640, DOI 10.1016/j.ijhydene.2013.11.016; WYDRZYNSKI T, 1975, BIOCHIM BIOPHYS ACTA, V387, P403, DOI 10.1016/0005-2728(75)90121-8; Xiong J, 1997, BBA-BIOENERGETICS, V1322, P60, DOI 10.1016/S0005-2728(97)00063-7; Xu M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00108; Yamori W, 2012, PLANT J, V71, P871, DOI 10.1111/j.1365-313X.2012.05041.x; Zavrel T, 2018, J PHOTOCH PHOTOBIO B, V181, P31, DOI 10.1016/j.jphotobiol.2018.02.020; Zheng J, 2018, SPIN-SINGAPORE, V8, DOI 10.1142/S2010324718400015	73	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236188	10.1371/journal.pone.0236188	http://dx.doi.org/10.1371/journal.pone.0236188			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701995	Green Published, gold, Green Accepted			2022-12-26	WOS:000575913700057
J	Courrier, E; Maurin, C; Lambert, V; Renault, D; Bourlet, T; Pillet, S; Verhoeven, PO; Forest, F; Perrache, C; He, ZG; Garcin, T; Rousseau, A; Labetoulle, M; Gain, P; Thuret, G				Courrier, Emilie; Maurin, Corantin; Lambert, Victor; Renault, Didier; Bourlet, Thomas; Pillet, Sylvie; Verhoeven, Paul O.; Forest, Fabien; Perrache, Chantal; He, Zhiguo; Garcin, Thibaud; Rousseau, Antoine; Labetoulle, Marc; Gain, Philippe; Thuret, Gilles			Ex vivo model of herpes simplex virus type I dendritic and geographic keratitis using a corneal active storage machine	PLOS ONE			English	Article							HSV-1; OPTIMIZATION; INOCULATION; FLUORESCEIN; RESISTANT; CELLS	Background Herpetic keratitis (HK) models using whole human corneas are essential for studying virus-host relationships, because of high species specificity and the role of interactions between corneal cell populations that cell culture cannot reproduce. Nevertheless, the two current corneal storage methods (hypothermia and organ culture (OC)) do not preserve corneas in good physiological condition, as they are characterized by epithelial abrasion, stromal oedema, and excessive endothelial mortality. Methods To rehabilitate human corneas intended for scientific use, we used an active storage machine (ASM) that restores two physiological parameters that are essential for corneal homeostasis: intraocular pressure and storage medium renewal (21mmHg and 2.6 mu L/min, respectively). ASM storage regenerates a normal multilayer epithelium in 2 weeks. We infected six pairs of corneas unsuitable for graft by inoculating the epithelium with herpes simplex virus type 1 (HSV-1), and compared each ASM-stored cornea with the other cornea stored in the same medium using the conventional OC method. Results Only corneas in the ASM developed a dendritic (n = 3) or geographic (n = 2) epithelial ulcer reproducing typical HSV-1-induced clinical lesions. Corneas in OC showed only extensive desquamations. None of the uninfected controls showed epithelial damage. Histology, immunohistochemistry, transmission electron microscopy and polymerase chain reaction on corneal tissue confirmed infection in all cases (excluding negative controls). Conclusions The ASM provides an innovativeex vivomodel of HK in whole human cornea that reproduces typical epithelial lesions.	[Courrier, Emilie; Maurin, Corantin; Renault, Didier; Perrache, Chantal; He, Zhiguo; Garcin, Thibaud; Gain, Philippe; Thuret, Gilles] Jean Monnet Univ, Fac Med, Corneal Graft Biol Engn & Imaging Lab, Hlth Innovat Campus, St Etienne, France; [Lambert, Victor; Garcin, Thibaud; Gain, Philippe; Thuret, Gilles] Univ Hosp, Dept Ophthalmol, St Etienne, France; [Bourlet, Thomas; Pillet, Sylvie; Verhoeven, Paul O.] Univ Hosp, Lab Infect Agents & Hyg GIMAP EA3064, St Etienne, France; [Bourlet, Thomas; Pillet, Sylvie; Verhoeven, Paul O.] Univ Jean Monnet, St Etienne, France; [Forest, Fabien] Univ Hosp, Dept Pathol, St Etienne, France; [Rousseau, Antoine; Labetoulle, Marc] South Paris Univ, Bicetre Hosp, AP HP, Dept Ophthalmol, Le Kremlin Bicetre, France; [Rousseau, Antoine; Labetoulle, Marc] South Paris Univ, Ctr Immunol Viral Infect & Autoimmune Dis, CEA, INSERM,IMVA,UMR, Fontenay Aux Roses, France; [Thuret, Gilles] Inst Univ France, Paris, France	CHU de St Etienne; CHU de St Etienne; CHU de St Etienne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut Universitaire de France	Thuret, G (corresponding author), Jean Monnet Univ, Fac Med, Corneal Graft Biol Engn & Imaging Lab, Hlth Innovat Campus, St Etienne, France.; Thuret, G (corresponding author), Univ Hosp, Dept Ophthalmol, St Etienne, France.; Thuret, G (corresponding author), Inst Univ France, Paris, France.	gilles.thuret@univ-st-etienne.fr	Verhoeven, Paul/GSD-7404-2022; Forest, Fabien/O-7054-2019; Labetoulle, Marc/AAC-6741-2022; Verhoeven, Paul/AAD-5651-2020; GARCIN, Thibaud/C-1524-2018	Verhoeven, Paul/0000-0003-4352-1263; Forest, Fabien/0000-0001-7582-3923; Verhoeven, Paul/0000-0003-4352-1263; GARCIN, Thibaud/0000-0001-7676-4080; rousseau, antoine/0000-0003-2355-2804				Alekseev O, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.2.2; Alekseev O, 2012, JOVE-J VIS EXP, DOI 10.3791/3631; Berdugo M, 2012, ANTIMICROB AGENTS CH, V56, P1390, DOI 10.1128/AAC.05145-11; Chang EJ, 1996, INT OPHTHALMOL CLIN, V36, P17, DOI 10.1097/00004397-199603630-00004; Childress JF, 2017, JAMA-J AM MED ASSOC, V318, P2177, DOI 10.1001/jama.2017.16442; Courrier E, 2018, ACTA OPHTHALMOL, V96, pe140, DOI 10.1111/aos.13559; Crewe JM, 2001, INVEST OPHTH VIS SCI, V42, P1757; Dhillon VK, 2018, ACTA OPHTHALMOL, V96, pE334, DOI 10.1111/aos.13614; Drevets P, 2015, GRAEF ARCH CLIN EXP, V253, P1721, DOI 10.1007/s00417-015-3073-4; Dua HS, 2018, PROG RETIN EYE RES, V66, P107, DOI 10.1016/j.preteyeres.2018.04.003; Farooq AV, 2012, SURV OPHTHALMOL, V57, P448, DOI 10.1016/j.survophthal.2012.01.005; Field HJ, 2013, ANTIVIR RES, V100, P297, DOI 10.1016/j.antiviral.2013.08.024; Forest F, 2015, MOL VIS, V21, P1345; Frobert E, 2013, J CLIN VIROL, V58, P265, DOI 10.1016/j.jcv.2013.04.019; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Garcin T, 2020, TRANSPLANTATION, V104, P1159, DOI 10.1097/TP.0000000000003109; Garcin T, 2019, AM J TRANSPLANT, V19, P1641, DOI 10.1111/ajt.15238; Green Laura K., 2006, International Ophthalmology Clinics, V46, P27, DOI 10.1097/00004397-200604620-00005; GREEN MT, 1984, INVEST OPHTH VIS SCI, V25, P1436; Guindolet D, 2020, TRANSLATIONAL VISION; Guindolet D, 2017, INVEST OPHTH VIS SCI, V58, P5899, DOI 10.1167/iovs.17-22218; Harman RM, 2014, J VIROL, V88, P13669, DOI 10.1128/JVI.02135-14; He ZG, 2011, MOL VIS, V17, P3494; Hill GM, 2014, DM-DIS MON, V60, P239, DOI 10.1016/j.disamonth.2014.03.003; Hill JM, 2013, ANTIVIR RES, V100, P14, DOI 10.1016/j.antiviral.2013.07.002; Hsiung G D, 1984, Clin Dermatol, V2, P67, DOI 10.1016/0738-081X(84)90067-1; Kamiya K, 2000, EXP EYE RES, V70, P737, DOI 10.1006/exer.2000.0841; Knickelbein JE, 2014, INVEST OPHTH VIS SCI, V55, P1118, DOI 10.1167/iovs.13-13523; Komuro A, 1999, INVEST OPHTH VIS SCI, V40, P2827; Kongyingyoes B, 2016, ANTIVIR RES, V132, P281, DOI 10.1016/j.antiviral.2016.07.012; Labetoulle M, 2005, OPHTHALMOLOGY, V112, P888, DOI 10.1016/j.ophtha.2004.11.052; Labetoulle M, 2003, INVEST OPHTH VIS SCI, V44, P217, DOI 10.1167/iovs.02-0464; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Novitskaya ES, 2009, CORNEA, V28, P421, DOI 10.1097/ICO.0b013e31818a7dba; Park PJ, 2013, INVEST OPHTH VIS SCI, V54, P6373, DOI 10.1167/iovs.13-12832; Pels E, 1984, Cornea, V3, P231; Pennington MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110349; Rowe AM, 2013, PROG RETIN EYE RES, V32, P88, DOI 10.1016/j.preteyeres.2012.08.002; Sawtell NM, 1998, J VIROL, V72, P5343, DOI 10.1128/JVI.72.7.5343-5350.1998; Shah A, 2010, MOL VIS, V16, P2476; Simon M, 2004, OPHTHALMOLOGY, V111, P1534, DOI 10.1016/j.ophtha.2003.12.060; Taylor TJ, 2002, FRONT BIOSCI-LANDMRK, V7, pD752, DOI 10.2741/taylor; Thakkar N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42559; Webre JM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/612316; Wilhelmus KR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002898.pub2; Young RC, 2010, ARCH OPHTHALMOL-CHIC, V128, P1178, DOI 10.1001/archophthalmol.2010.187; Zhang M, 1998, EYE SCI, V14, P48	47	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236183	10.1371/journal.pone.0236183	http://dx.doi.org/10.1371/journal.pone.0236183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697805	Green Published, gold			2022-12-26	WOS:000555392700013
J	Ettinger, CL; Eisen, JA				Ettinger, Cassandra L.; Eisen, Jonathan A.			Fungi, bacteria and oomycota opportunistically isolated from the seagrass,Zostera marina	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SEAGRASS POSIDONIA-OCEANICA; EELGRASS ZOSTERA-MARINA; NITROGEN-FIXATION; ENDOPHYTIC FUNGI; PHYLOGENETIC-RELATIONSHIPS; HABITAT GENERALISTS; SP NOV.; DIVERSITY; ROOTS	Fungi in the marine environment are often neglected as a research topic, despite that fungi having critical roles on land as decomposers, pathogens or endophytes. Here we used culture-dependent methods to survey the fungi associated with the seagrass,Zostera marina, also obtaining bacteria and oomycete isolates in the process. A total of 108 fungi, 40 bacteria and 2 oomycetes were isolated. These isolates were then taxonomically identified using a combination of molecular and phylogenetic methods. The majority of the fungal isolates were classified as belonging to the classes Eurotiomycetes, Dothideomycetes, and Sordariomycetes. Most fungal isolates were habitat generalists likePenicilliumsp. andCladosporiumsp., but we also cultured a diverse set of rare taxa including possible habitat specialists likeColletotrichumsp. which may preferentially associate withZ.marinaleaf tissue. Although the bulk of bacterial isolates were identified as being from known ubiquitous marine lineages, we also obtained several Actinomycetes isolates and aPhyllobacteriumsp. We identified two oomycetes, another understudied group of marine microbial eukaryotes, asHalophytophthorasp. which may be opportunistic pathogens or saprophytes ofZ.marina. Overall, this study generates a culture collection of fungi which adds to knowledge ofZ.marinaassociated fungi and highlights a need for more investigation into the functional and evolutionary roles of microbial eukaryotes associated with seagrasses.	[Ettinger, Cassandra L.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ettinger, Cassandra L.; Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ettinger, CL (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Ettinger, CL (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	clettinger@ucdavis.edu	Ettinger, Cassandra/I-3073-2019; Eisen, Jonathan A./H-2706-2019	Ettinger, Cassandra/0000-0001-7334-403X; Eisen, Jonathan A./0000-0002-0159-2197	UC Davis H. A. Lewin Family Fellowship; UC Davis Center for Population Biology	UC Davis H. A. Lewin Family Fellowship; UC Davis Center for Population Biology	This work was supported by grants from the UC Davis H. A. Lewin Family Fellowship and the UC Davis Center for Population Biology to CLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhitya A, 2007, MICROB ECOL, V54, P587, DOI 10.1007/s00248-006-9175-0; Alexiev A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00010-16; Alexiev A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00116-16; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alva P, 2002, FUNG DIVERS RES SER, V7, P167; Amend A, 2019, MBIO, V10, DOI 10.1128/mBio.01189-18; Bagwell CE, 2002, FEMS MICROBIOL ECOL, V39, P113, DOI 10.1111/j.1574-6941.2002.tb00912.x; BAI LJ, 2018, MOL BIOL EVOL, P441, DOI DOI 10.1093/MOLBEV/MSY19430351396; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Bengtsson MM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01312; Borovec O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28989-4; Bourret TB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192502; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CAPONE DG, 1982, MAR ECOL PROG SER, V10, P67, DOI 10.3354/meps010067; CAPONE DG, 1982, PLANT PHYSIOL, V70, P1601, DOI 10.1104/pp.70.6.1601; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cromey M.G, 2002, P 2 INT WORKSH BARL; Crump BC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00388; CUBETA MA, 1991, PHYTOPATHOLOGY, V81, P1395, DOI 10.1094/Phyto-81-1395; Cucio C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00440; CUOMO V, 1985, T BRIT MYCOL SOC, V84, P35, DOI 10.1016/S0007-1536(85)80217-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Silva DD, 2017, FUNGAL BIOL REV, V31, P155, DOI 10.1016/j.fbr.2017.05.001; Devarajan PT, 2002, INDIAN J MAR SCI, V31, P73; Dieguez-Uribeondo J, 2009, FUNGAL GENET BIOL, V46, P365, DOI 10.1016/j.fgb.2009.02.004; Dunitz MI, 2015, PEERJ, V3, DOI 10.7717/peerj.960; Elliott JK, 2019, PROTIST, V170, P64, DOI 10.1016/j.protis.2018.12.001; Ettinger C, 2020, PHYLOGENIES FUNGI IS, DOI [10.25338/B8HS5Z, DOI 10.25338/B8HS5Z]; Ettinger CL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02476; Ettinger CL, 2017, PEERJ, V5, DOI 10.7717/peerj.3674; Ettinger CL, 2017, PEERJ, V5, DOI 10.7717/peerj.3246; Fahimipour AK, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03391-16; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Gnavi G, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-508; Govers LL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0812; Grossart HP, 2019, NAT REV MICROBIOL, V17, P339, DOI 10.1038/s41579-019-0175-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; HOLGUIN G, 1992, FEMS MICROBIOL ECOL, V101, P207; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurtado-McCormick V, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01011; Imhoff JF, 2011, BIOTECHNOL ADV, V29, P468, DOI 10.1016/j.biotechadv.2011.03.001; in't Veld WAM, 2019, EUR J PLANT PATHOL, V153, P341, DOI 10.1007/s10658-018-1561-1; In't Veld WAM, 2011, FUNGAL BIOL-UK, V115, P724, DOI 10.1016/j.funbio.2011.05.006; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jones EBG, 2015, FUNGAL DIVERS, V73, P1, DOI 10.1007/s13225-015-0339-4; Jones EBG, 2011, BOT MAR, V54, P343, DOI 10.1515/BOT.2011.043; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirichuk NN, 2015, RUSS J MAR BIOL+, V41, P351, DOI 10.1134/S1063074015050053; Kress WJ, 2012, DNA BARCODES METHODS, DOI [10.1007/978-1-61779-591-6_122684949, DOI 10.1007/978-1-61779-591-6_122684949]; KUO J, 1984, PROTOPLASMA, V121, P1, DOI 10.1007/BF01279746; Kurilenko VV, 2010, INT J SYST EVOL MICR, V60, P972, DOI 10.1099/ijs.0.013516-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lee R. D., 2016, Genome Announcements, V4, pe00092; Lee RD, 2015, GENOME ANNOUNCEMENTS, V3, DOI [DOI 10.1128/genomeA.01276-15, DOI 10.1128/GENOMEA.01276-15]; Lee RD, 2016, GENOME ANNOUNCEMENTS, V4, DOI [DOI 10.1128/genomeA.01769-15, DOI 10.1128/GENOMEA.01769-15]; Lee RD, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01376-15; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Ling J, 2015, INT J MOL SCI, V16, P14039, DOI 10.3390/ijms160614039; Lujan KM, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00023-17; Lujan KM, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01120-16; Mantelin S, 2006, INT J SYST EVOL MICR, V56, P827, DOI 10.1099/ijs.0.63911-0; Mata JL, 2013, BOT MAR, V56, P541, DOI 10.1515/bot-2013-0047; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller M.A., 2010, P GAT COMP ENV WORKS; MUEHLSTEIN LK, 1991, MYCOLOGIA, V83, P180, DOI 10.2307/3759933; Nakagiri Akira, 2000, Fungal Diversity, V5, P153; NEWELL SY, 1981, APPL ENVIRON MICROB, V41, P1219, DOI 10.1128/AEM.41.5.1219-1224.1981; Nielsen JT, 1999, INT J SYST BACTERIOL, V49, P859, DOI 10.1099/00207713-49-2-859; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Panno L, 2013, NEW BIOTECHNOL, V30, P685, DOI 10.1016/j.nbt.2013.01.010; Park D, 2018, PLANT PATHOLOGY J, V34, P150, DOI 10.5423/PPJ.NT.11.2017.0243; Petersen LE, 2019, MAR DRUGS, V17, DOI 10.3390/md17070419; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Rodriguez G. A., 2008, THESIS; Rojas A, 2001, FEMS MICROBIOL ECOL, V35, P181, DOI 10.1111/j.1574-6941.2001.tb00802.x; Sakayaroj J, 2010, FUNGAL DIVERS, V42, P27, DOI 10.1007/s13225-009-0013-9; Sandberg DC, 2014, MICROB ECOL, V67, P735, DOI 10.1007/s00248-013-0324-y; Selosse MA, 2018, NEW PHYTOL, V217, P968, DOI 10.1111/nph.14983; Shoemaker G, 2013, AQUAT BOT, V111, P71, DOI 10.1016/j.aquabot.2013.05.010; Singh R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01767; Sun FF, 2015, APPL ENVIRON MICROB, V81, P6901, DOI 10.1128/AEM.01382-15; Supaphon P, 2014, INDIAN J GEO-MAR SCI, V43, P785; Supaphon P, 2017, BOT MAR, V60, P489, DOI 10.1515/bot-2016-0089; Supaphon P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072520; Szekely AJ, 2014, FEMS MICROBIOL ECOL, V87, P102, DOI 10.1111/1574-6941.12195; Torta L, 2015, PLANT BIOLOGY, V17, P505, DOI 10.1111/plb.12246; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; Venkatachalam A, 2015, MYCOSPHERE, V6, P345, DOI 10.5943/mycosphere/6/3/10; Venkatachalam A, 2015, FUNGAL ECOL, V13, P60, DOI 10.1016/j.funeco.2014.07.003; Videira SIR, 2016, STUD MYCOL, P49, DOI 10.1016/j.simyco.2016.06.001; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vohnik M, 2019, MYCOKEYS, P59, DOI 10.3897/mycokeys.55.35682; Vohnik M, 2017, MAR ECOL PROG SER, V583, P107, DOI 10.3354/meps12337; Vohnik M, 2016, MICROB ECOL, V71, P442, DOI 10.1007/s00248-015-0640-5; Vohnik M, 2015, MYCORRHIZA, V25, P663, DOI 10.1007/s00572-015-0642-7; Wainwright BJ, 2019, ECOL EVOL, V9, P11288, DOI 10.1002/ece3.5631; Wainwright BJ, 2018, J BIOGEOGR, V45, P762, DOI 10.1111/jbi.13168; Wang LG, 2020, MOL BIOL EVOL, V37, P599, DOI 10.1093/molbev/msz240; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welsh DT, 2000, ECOL LETT, V3, P58, DOI 10.1046/j.1461-0248.2000.00111.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Yang GuiLiu, 2015, Journal of Agricultural Biotechnology, V23, P894; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2016.01.33	120	14	14	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236135	10.1371/journal.pone.0236135	http://dx.doi.org/10.1371/journal.pone.0236135			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697800	gold, Green Published, Green Submitted			2022-12-26	WOS:000555392700010
J	Smit-McBride, Z; Nguyen, AT; Yu, AK; Modjtahedi, SP; Hunter, AA; Rashid, S; Moisseiev, E; Morse, LS				Smit-McBride, Zeljka; Nguyen, Anthony T.; Yu, Alfred K.; Modjtahedi, Sara P.; Hunter, Allan A.; Rashid, Saadia; Moisseiev, Elad; Morse, Lawrence S.			Unique molecular signatures of microRNAs in ocular fluids and plasma in diabetic retinopathy	PLOS ONE			English	Article							SAMPLE-SIZE; ENDOTHELIAL-CELLS; SERUM MICRORNAS; EXPRESSION; BIOMARKERS; CANCER; IDENTIFICATION; ANGIOGENESIS; MIR-320; GENE	The main objective of this pilot study was to identify circulatory microRNAs in aqueous or plasma that were reflecting changes in vitreous of diabetic retinopathy patients. Aqueous, vitreous and plasma samples were collected from a total of 27 patients undergoing vitreoretinal surgery: 11 controls (macular pucker or macular hole patients) and 16 with diabetes mellitus(DM): DM-Type I with proliferative diabetic retinopathy(PDR) (DMI-PDR), DM Type II with PDR(DMII-PDR) and DM Type II with nonproliferative DR(DMII-NPDR). MicroRNAs were isolated using Qiagen microRNeasy kit, quantified on BioAnalyzer, and profiled on Affymetrix GeneChip miRNA 3.0 microarrays. Data were analyzed using Expression Console, Transcriptome Analysis Console, and Ingenuity Pathway Analysis. The comparison analysis of circulatory microRNAs showed that out of a total of 847 human microRNA probes on the microarrays, common microRNAs present both in aqueous and vitreous were identified, and a large number of unique microRNA, dependent on the DM type and severity of retinopathy. Most of the dysregulated microRNAs in aqueous and vitreous of DM patients were upregulated, while in plasma, they were downregulated. Dysregulation of miRNAs in aqueous did not appear to be a good representative of the miRNA abundance in vitreous, or plasma, although a few potential candidates for common biomarkers stood out: let-7b, miR-320b, miR-762 and miR-4488. Additionally, each of the DR subtypes showed miRNAs that were uniquely dysregulated in each fluid (i.e. aqueous: for DMII-NPDR was miR-455-3p; for DMII-PDR was miR-296, and for DMI-PDR it was miR-3202). Pathway analysis identified TGF-beta and VEGF pathways affected. The comparative profiling of circulatory miRNAs showed that a small number of them displayed differential presence in diabetic retinopathy vs. controls. A pattern is emerging of unique molecular microRNA signatures in bodily fluids of DR subtypes, offering promise for the use of ocular fluids and plasma for diagnostic and therapeutic purposes.	[Smit-McBride, Zeljka; Nguyen, Anthony T.; Yu, Alfred K.; Modjtahedi, Sara P.; Hunter, Allan A.; Rashid, Saadia; Moisseiev, Elad; Morse, Lawrence S.] Univ Calif Davis, Sch Med, Vitreoretinal Res Lab, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA; [Nguyen, Anthony T.] Western Univ Hlth Sci, Pomona, CA USA; [Yu, Alfred K.] Univ Calif San Francisco, Koret Vis Res Lab, San Francisco, CA 94143 USA; [Modjtahedi, Sara P.] Sacramento Med Ctr, Permanente Med Grp, Dept Ophthalmol, Sacramento, CA USA; [Hunter, Allan A.] Eugene Main Clin, Oregon Eye Consultants, Eugene, OR USA; [Rashid, Saadia] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Moisseiev, Elad] Tel Aviv Univ, Sackler Sch Med, Meir Med Ctr, Dept Ophthalmol, Kefar Sava, Israel	University of California System; University of California Davis; Western University of Health Sciences; University of California System; University of California San Francisco; Permanente Medical Groups; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Smit-McBride, Z (corresponding author), Univ Calif Davis, Sch Med, Vitreoretinal Res Lab, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA.	zsmcbride@ucdavis.edu		Yu, Alfred/0000-0002-3475-6901; Rashid, Saadia/0000-0003-3640-9257	NIH Grant from NEI [5R01EY021537]; Innovative Development Grant from UC Davis; Research to Prevent Blindness (RPB); Barr Family Foundation	NIH Grant from NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Development Grant from UC Davis; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Barr Family Foundation	This research was supported by NIH Grant from NEI to ZSM (5R01EY021537), Innovative Development Grant from UC Davis to ZSM, and an unrestricted grant from Research to Prevent Blindness (RPB) to UCD Dept. of Ophthalmology, and Barr Family Foundation grant to Department of Ophthalmology at UC Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON JS, 2012, ISRN ENDOCRINOLOGY, V120, DOI DOI 10.5402/2012/549875; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Argyropoulos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054662; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BATTEGAY EJ, 1995, J MOL MED, V73, P333; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Chen JJ, 2007, PHARMACOGENOMICS J, V7, P212, DOI 10.1038/sj.tpj.6500412; Dobbin K, 2005, BIOSTATISTICS, V6, P27, DOI 10.1093/biostatistics/kxh015; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fasanaro P, 2010, PHARMACOL THERAPEUT, V125, P92, DOI 10.1016/j.pharmthera.2009.10.003; Gong QY, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/4727942; Harti M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00051; Hikami K, 2011, ARTHRITIS RHEUM-US, V63, P755, DOI 10.1002/art.30188; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Hua JP, 2005, BIOINFORMATICS, V21, P1509, DOI 10.1093/bioinformatics/bti171; Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang LQ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1359, DOI 10.1152/ajpendo.00236.2013; Jung SH, 2005, BIOINFORMATICS, V21, P3097, DOI 10.1093/bioinformatics/bti456; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kubiczkova L, 2014, HAEMATOLOGICA, V99, P511, DOI 10.3324/haematol.2013.093500; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kumar MM, 2017, CURR TOP MED CHEM, V17, P1750, DOI 10.2174/1568026617666161116144744; Lee CS, 2019, ALZHEIMERS DEMENT, V15, P34, DOI 10.1016/j.jalz.2018.06.2856; Li ZM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00531; Liang Z, 2018, AM J PHYSIOL-ENDOC M, V315, pE374, DOI 10.1152/ajpendo.00021.2018; Ling HY, 2009, CLIN EXP PHARMACOL P, V36, pe32, DOI 10.1111/j.1440-1681.2009.05207.x; Liu HN, 2018, INT J OPHTHALMOL-CHI, V11, P1889, DOI 10.18240/ijo.2018.12.02; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094160; Liu P, 2007, BIOINFORMATICS, V23, P739, DOI 10.1093/bioinformatics/btl664; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Martinez B, 2019, NEURAL REGEN RES, V14, P1858, DOI 10.4103/1673-5374.259602; Martinez B, 2017, NEURAL REGEN RES, V12, P865, DOI 10.4103/1673-5374.208540; Nunes I, 1998, J Am Optom Assoc, V69, P643; Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008; Patel D, 2013, SURGERY, V154, P1224, DOI 10.1016/j.surg.2013.06.022; Pfeiffer A, 1997, DIABETES, V46, pS26, DOI 10.2337/diab.46.2.S26; Romano GL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00168; Ruan LH, 2018, EUR J OBSTET GYN R B, V222, P31, DOI 10.1016/j.ejogrb.2018.01.006; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Slattery ML, 2017, ONCOTARGET, V8, P16765, DOI 10.18632/oncotarget.14508; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tay Y, 2014, CELL REP, V8, P714, DOI 10.1016/j.celrep.2014.06.064; Ueno K, 2016, SCI REP-UK, V6, DOI 10.1038/srep36758; University of Maryland SoPH, POW AN MICR; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Wang Y, 2013, CANCER GENET-NY, V206, P340, DOI 10.1016/j.cancergen.2013.09.005; Welten SMJ, 2016, CARDIOVASC RES, V110, P6, DOI 10.1093/cvr/cvw039; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Wu YY, 2014, ANGIOGENESIS, V17, P247, DOI 10.1007/s10456-013-9394-1; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang J, 2013, MOL CELL ENDOCRINOL, V375, P53, DOI 10.1016/j.mce.2013.04.022; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	54	11	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0235541	10.1371/journal.pone.0235541	http://dx.doi.org/10.1371/journal.pone.0235541			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692745	Green Published, gold			2022-12-26	WOS:000554606400012
J	Le, T; Le, SC; Zhang, Y; Liang, PF; Yang, HH				Le, Trieu; Le, Son C.; Zhang, Yang; Liang, Pengfei; Yang, Huanghe			Evidence that polyphenols do not inhibit the phospholipid scramblase TMEM16F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TMEM16F; ANO6; phospholipid scramblase; CaPLSase; ion channels; pharmacology; tannic acid; epigallocatechin gallate (EGCG); membrane transport; fluorescence; ion channel; membrane lipid; phospholipid; polyphenol; scramblase	TANNIC-ACID; PHOSPHATIDYLSERINE EXPOSURE; ION-CHANNEL; MUTATIONS; PROTEIN; ATAXIA	TMEM16 Ca2+-activated phospholipid scramblases (CaPLSases) mediate rapid transmembrane phospholipid flip-flop and as such play essential roles in various physiological and pathological processes such as blood coagulation, skeletal development, viral infection, cell-cell fusion, and ataxia. Pharmacological tools specifically targeting TMEM16 CaPLSases are urgently needed to understand these novel membrane transporters and their contributions to health and disease. Tannic acid (TA) and epigallocatechin gallate (EGCG) were recently reported as promising TMEM16F CaPLSase inhibitors. However, our present study shows that TA and EGCG do not inhibit the phospholipid-scrambling or ion conduction activities of the dual-functional TMEM16F. Instead, we found that TA and EGCG mainly acted as fluorescence quenchers that rapidly suppress the fluorophores conjugated to annexin V, a phosphatidylserine-binding probe commonly used to report on TMEM16 CaPLSase activity. These data demonstrate the false positive effects of TA and EGCG on inhibiting TMEM16F phospholipid scrambling and discourage the use of these polyphenols as CaPLSase inhibitors. Appropriate controls as well as a combination of both fluorescence imaging and electrophysiological validation are necessary in future endeavors to develop TMEM16 CaPLSase inhibitors.	[Le, Trieu; Le, Son C.; Zhang, Yang; Liang, Pengfei; Yang, Huanghe] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Yang, Huanghe] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Yang, HH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; Yang, HH (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	huanghe.yang@duke.edu		Yang, Huanghe/0000-0001-9521-9328; Le, Son/0000-0002-7647-5307	National Institutes of Health [NIH-DP2-GM126898]; American Heart Association Predoctoral Fellowships [20PRE35120162, 19PRE3438456]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowships(American Heart Association)	This work was supported by National Institutes of Health Grant NIH-DP2-GM126898 (to H. Y.) and American Heart Association Predoctoral Fellowships 20PRE35120162 (to T. L.) and 19PRE3438456 (to S. C. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed GHG, 2015, TALANTA, V132, P252, DOI 10.1016/j.talanta.2014.09.028; Alvadia C, 2019, ELIFE, V8, DOI 10.7554/eLife.44365; Balreira A, 2014, J NEUROL, V261, P2192, DOI 10.1007/s00415-014-7476-7; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Chakrawarti L, 2016, EXPERT OPIN THER PAT, V26, P907, DOI 10.1080/13543776.2016.1203419; Chen RLC, 2005, J AGR FOOD CHEM, V53, P8443, DOI 10.1021/jf051077f; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Feng SJ, 2019, CELL REP, V28, P567, DOI 10.1016/j.celrep.2019.06.023; Gyobu S, 2016, MOL CELL BIOL, V36, P645, DOI 10.1128/MCB.00919-15; HERZ F, 1968, NATURE, V217, P1259; Hicks D, 2011, BRAIN, V134, P171, DOI 10.1093/brain/awq294; Le T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09778-7; Le T, 2019, J BIOL CHEM, V294, P4529, DOI 10.1074/jbc.AC118.006530; Liu XN, 2019, MICROCHIM ACTA, V186, DOI 10.1007/s00604-019-3311-2; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Ohlinger T, 2020, BLOOD CELL MOL DIS, V83, DOI 10.1016/j.bcmd.2020.102426; Ousingsawat J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0373-8; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Penttila S, 2012, NEUROLOGY, V78, P897, DOI 10.1212/WNL.0b013e31824c4682; Renaud M, 2014, JAMA NEUROL, V71, P1305, DOI 10.1001/jamaneurol.2014.193; Scudieri P, 2015, J PHYSIOL-LONDON, V593, P3829, DOI 10.1113/JP270691; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; SHRAGER PG, 1969, J CELL PHYSIOL, V74, P77, DOI 10.1002/jcp.1040740111; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; Tsai TY, 2020, BIOCHEM BIOPH RES CO, V526, P117, DOI 10.1016/j.bbrc.2020.03.078; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; Watanabe R, 2018, P NATL ACAD SCI USA, V115, P3066, DOI 10.1073/pnas.1717956115; Whitlock JM, 2018, J GEN PHYSIOL, V150, P1498, DOI 10.1085/jgp.201812097; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901; Zhang LL, 2019, FOOD CHEM, V301, DOI 10.1016/j.foodchem.2019.125294; Zhang LL, 2017, FOOD CHEM, V237, P39, DOI 10.1016/j.foodchem.2017.05.048	43	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2020	295	35					12537	12544		10.1074/jbc.AC120.014872	http://dx.doi.org/10.1074/jbc.AC120.014872			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NL7DH	32709749	Green Published, hybrid			2022-12-26	WOS:000567571100018
J	Imaizumi, S; Tagami, U; Yang, Y				Imaizumi, Shu; Tagami, Ubuka; Yang, Yi			Fluid movements enhance creative fluency: A replication of Slepian and Ambady (2012)	PLOS ONE			English	Article							AVOIDANCE MOTOR ACTIONS; GENDER-DIFFERENCES; INTELLIGENCE; WARMTH	Bodily movements representing abstract concepts (e.g., fluidity) can affect divergent creative thinking. A recent study showed that participants who performed fluid arm movements by tracing curved line-drawings (the fluid condition) subsequently generated a larger number of more original alternative uses for newspapers than did those who traced angular line-drawings (the non-fluid condition). This suggests that fluid movements enhance fluency and originality in divergent creative thinking. To replicate these findings, we employed the same task with a larger Japanese sample. Participants in the fluid condition generated more uses for newspapers than in the non-fluid condition, regardless of confounding variables: mood, subjective difficulty of the tracing, and daily use of newspapers. In contrast to previous findings, there were no effects on originality. Our results suggest that fluidity enacted by arm movements robustly enhances creative fluency, although other factors (e.g., culture) could interfere with its effect on originality.	[Imaizumi, Shu] Ochanomizu Univ, Inst Educ & Human Dev, Tokyo, Japan; [Tagami, Ubuka; Yang, Yi] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo, Japan	Ochanomizu University; Ochanomizu University	Imaizumi, S (corresponding author), Ochanomizu Univ, Inst Educ & Human Dev, Tokyo, Japan.	imaizumi.shu@ocha.ac.jp	Imaizumi, Shu/N-7069-2018	Imaizumi, Shu/0000-0002-8978-4125	Japan Society for the Promotion of Science [20K20144]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Early-Career Scientists (20K20144) to SI from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RE, 1952, J EXP PSYCHOL, V44, P288, DOI 10.1037/h0062487; Agogue M, 2014, J CREATIVE BEHAV, V48, P1, DOI 10.1002/jocb.37; Andolfi VR, 2017, THINK SKILLS CREAT, V24, P20, DOI 10.1016/j.tsc.2017.02.012; [Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Baas M, 2008, PSYCHOL BULL, V134, P779, DOI 10.1037/a0012815; Baer J, 2008, J CREATIVE BEHAV, V42, P75, DOI 10.1002/j.2162-6057.2008.tb01289.x; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Borghi AM, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0121; Casasanto D, 2010, COGNITION, V115, P179, DOI 10.1016/j.cognition.2009.11.002; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colquhoun D, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171085; Era V, 2019, PHYS LIFE REV, V28, P43, DOI 10.1016/j.plrev.2019.01.022; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fini C, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00838; Forstmeier W, 2017, BIOL REV, V92, P1941, DOI 10.1111/brv.12315; FRIEDMAN H, 1968, PSYCHOL BULL, V70, P245, DOI 10.1037/h0026258; Friedman RS, 2003, CREATIVITY RES J, V15, P277, DOI 10.1207/S15326934CRJ152&3_18; Friedman RS, 2002, J EXP SOC PSYCHOL, V38, P41, DOI 10.1006/jesp.2001.1488; Friedman RS, 2000, J PERS SOC PSYCHOL, V79, P477, DOI 10.1037//0022-3514.79.4.477; Frith E, 2020, J CREATIVE BEHAV, V54, P767, DOI 10.1002/jocb.406; Guilford J.P., 1967, NATURE HUMAN INTELLI; GUILFORD JP, 1959, AM PSYCHOL, V14, P469, DOI 10.1037/h0046827; Hofstadter D.R., 1995, FLUID CONCEPTS CREAT; IJzerman H, 2014, ACTA PSYCHOL, V148, P136, DOI 10.1016/j.actpsy.2014.01.013; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Kato T, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01927; Kuo CY, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01580; LAKOFF G, 1980, COGNITIVE SCI, V4, P195, DOI 10.1207/s15516709cog0402_4; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Leung AKY, 2012, PSYCHOL SCI, V23, P502, DOI 10.1177/0956797611429801; Malinin LH, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02372; Matud MP, 2007, PERS INDIV DIFFER, V43, P1137, DOI 10.1016/j.paid.2007.03.006; Nagai M, 2019, JPN J PSYCHOL, V90, P294; Niu WH, 2002, J CREATIVE BEHAV, V36, P269, DOI 10.1002/j.2162-6057.2002.tb01069.x; Oppezzo M, 2014, J EXP PSYCHOL LEARN, V40, P1142, DOI 10.1037/a0036577; Rohatgi A., 2019, WEBPLOTDIGITIZER; Saeki N, 2001, J CREATIVE BEHAV, V35, P24, DOI 10.1002/j.2162-6057.2001.tb01219.x; Sasaki K, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.0690; Slepian ML, 2012, J EXP PSYCHOL GEN, V141, P625, DOI 10.1037/a0027395; Sligh AC, 2005, J CREATIVE BEHAV, V39, P123, DOI 10.1002/j.2162-6057.2005.tb01254.x; STERNBERG RJ, 1985, J PERS SOC PSYCHOL, V49, P607, DOI 10.1037/0022-3514.49.3.607; Thomas LE, 2009, PSYCHON B REV, V16, P719, DOI 10.3758/PBR.16.4.719; Torrance EP, 1979, CREATIVE CHILD ADULT, V4, P145; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; YAGATI AK, 2016, EDUC PSYCHOL MEAS, V55, DOI DOI 10.1177/0013164495055001006; Yang S.-Y., 1997, J THEORETICAL PHILOS, V17, P101, DOI DOI 10.1037/H0091164; Yuan H, 2018, PERS INDIV DIFFER, V131, P93, DOI 10.1016/j.paid.2018.04.027	49	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236825	10.1371/journal.pone.0236825	http://dx.doi.org/10.1371/journal.pone.0236825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730311	Green Published, Green Submitted, gold			2022-12-26	WOS:000556884700066
J	Degrie, L; de Casterle, BD; Gastmans, C; Denier, Y				Degrie, Liesbet; Dierckx de Casterle, Bernadette; Gastmans, Chris; Denier, Yvonne			'Can you please hold my hand too, not only my breast?' The experiences of Muslim women from Turkish and Moroccan descent giving birth in maternity wards in Belgium	PLOS ONE			English	Article							CULTURAL COMPETENCE; MIDWIVES VIEWS; HEALTH; CARE; PREGNANCY; POPULATION; IMMIGRANTS; SERVICES; FLANDERS; QUALITY	Objectives To reach nuanced understanding of the perinatal experiences of ethnic minority women from Turkish and Moroccan descent giving birth in maternity wards in Belgium thereby gaining insight into the underlying challenges of providing intercultural care for ethnic minority persons in a hospital setting. Methods A qualitative study design was used by conducting In-depth interviews with 24 women from Turkish and Moroccan descent who gave birth during the past three years in maternity wards in Flanders, Belgium. The interviews were analysed using a Grounded Theory Approach. Results This study shows that the women's care experiences were shaped by the care interactions with their caregivers, more specifically on the attention that was given by the caregivers towards two essential dimensions of the care relationship, viz.Ereignis(attention towhathappens) andErlebnis(attention tohowit happens). These two dimensions were interrelated in four different ways, which defined the women's care experiences as being either 'uncaring', 'protocolized', 'embraced' or 'ambiguous'. Moreover, these experiences were fundamentally embedded within the women'sculturalcontext, which has to be understood as a relational process in which an emotional and moral meaning was given to the women's care expectations, interactions and interpretations of care. Conclusions The findings reveal that the quality of intercultural care depends on the nature and quality of care interactions between ethnic minority patients and caregivers much more than on the way in which cultural questions and tensions are being handled or dealt with in a practical way. As such, the importance of establishing a meaningful care relationship should be the priority when providing intercultural care. In this, a shift in perspective on 'culture' from being an 'individual culture-in-isolation' towards an understanding of culture as being inter-relational and emerging from within these care relationships is necessary.	[Degrie, Liesbet; Gastmans, Chris; Denier, Yvonne] Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Biomed Eth & Law, Leuven, Belgium; [Dierckx de Casterle, Bernadette] Univ Leuven, Acad Ctr Nursing & Midwifery, Dept Publ Hlth & Primary Care, Leuven, Belgium	KU Leuven; KU Leuven	Denier, Y (corresponding author), Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Biomed Eth & Law, Leuven, Belgium.	Yvonne.Denier@kuleuven.be	Gastmans, Chris/GWZ-3728-2022	Denier, Yvonne/0000-0002-3715-4236; Dierckx de Casterle, Bernadette/0000-0002-1887-8407	Fund for Scientific Research Flanders [G0B0914N]	Fund for Scientific Research Flanders(FWO)	This work was supported by the Fund for Scientific Research Flanders [grant number: G0B0914N]. The funding source had no involvement in decision during the study design, collection, analysis, writing or submission for publication.	Ahaddour C, 2018, J RELIG HEALTH, V57, DOI 10.1007/s10943-017-0466-1; [Anonymous], 2002, CULTURAL COMPETENCE; Balaam MC, 2013, J ADV NURS, V69, P1919, DOI 10.1111/jan.12139; Bollini P, 2009, SOC SCI MED, V68, P452, DOI 10.1016/j.socscimed.2008.10.018; Broom A, 2019, BMJ OPEN, V9; Campinha-Bacote Josepha, 2002, J Transcult Nurs, V13, P181, DOI 10.1177/10459602013003003; Christiaens W, 2009, MIDWIFERY, V25, pE11, DOI 10.1016/j.midw.2007.02.001; Cortis J D, 2000, J Transcult Nurs, V11, P111, DOI 10.1177/104365960001100205; Cortis J D, 2000, Int Nurs Rev, V47, P53, DOI 10.1046/j.1466-7657.2000.00006.x; Cortis JD, 2003, NURS ETHICS, V10, P77, DOI 10.1191/0969733003ne576oa; Dauvrin M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-726; de Casterle BD, 2012, INT J NURS STUD, V49, P360, DOI 10.1016/j.ijnurstu.2011.09.012; De Schutter S., 2017, MOROCCAN MIGRATION B; Degrie L, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-016-0163-8; Denier Y, 2013, SOC SCI MED, V93, P38, DOI 10.1016/j.socscimed.2013.03.045; Derluyn I., 2011, NAAR INTERCULTURELE, DOI https://www.unia.be/files/Documenten/Publicaties_docs/2012_12_16_eindrapport_NL.pdf; Deville W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-699; Gailly A., 2004, CULTUURGEVOELIGE HUL; Gastmans C, 1998, KENNEDY INST ETHIC J, V8, P43, DOI 10.1353/ken.1998.0002; Gastmans C, 2013, NURS ETHICS, V20, P142, DOI 10.1177/0969733012473772; Higginbottom GMA, 2014, MIDWIFERY, V30, P544, DOI 10.1016/j.midw.2013.06.004; HOye S, INTENSIVE CRITICAL C, V26, P24; Hultsjo S, 2005, INT NURS REV, V52, P276, DOI 10.1111/j.1466-7657.2005.00418.x; Kleiman A, 2006, J LIFELONG LEARNING, VIV; Kleinman A, 2006, PLOS MED, V3, P1673, DOI 10.1371/journal.pmed.0030294; Leininger M M, 1988, Nurs Sci Q, V1, P152, DOI 10.1177/089431848800100408; Lodewijcks N., 2012, GEKLEURDE SAMENLEVIN; Martinsen Hakonsen E., 2014, CARING MED GENTLEMAN; Mathers N, 2016, FAM MED COMMUNITY HE, V4, P1, DOI 10.15212/FMCH.2016.0123; Mead M, 2007, MIDWIFERY, V23, P361, DOI 10.1016/j.midw.2006.05.003; Metraux JC, 2018, MIGRATIE ALS METAFOO; Minsart AF, 2013, EUR J PUBLIC HEALTH, V23, P269, DOI 10.1093/eurpub/cks032; Mohammadi N, 2008, INT NURS REV, V55, P393, DOI 10.1111/j.1466-7657.2008.00647.x; Muaygil RA, 2018, HEC FORUM, V30, P13, DOI 10.1007/s10730-017-9336-1; Papadopoulos I, 2008, CONTEMP NURSE, V28, P45, DOI 10.5172/conu.673.28.1-2.45; Priebe S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-187; Raven JH, 2012, MIDWIFERY, V28, pE676, DOI 10.1016/j.midw.2011.09.003; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Santana MJ, 2018, PRACTICE PERSON CTR, P429; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Small R, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-152; Strauss, 2015, BASICS QUALITATIVE R; Timmerman C, 2003, INT MIGR REV, V37, P1065, DOI 10.1111/j.1747-7379.2003.tb00170.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tronto J., 1993, MORAL BOUNDARIES POL; Tronto JoanC., 2013, CARING DEMOCRACY; Tsianakas V, 2002, MIDWIFERY, V18, P25, DOI 10.1054/midw.2002.0296; TUNCALP, 2015, BJOG, V122, P1045, DOI DOI 10.1111/1471-0528.13451; van Bussel JCH, 2006, BIRTH-ISS PERINAT C, V33, P297, DOI 10.1111/j.1523-536X.2006.00122.x; van Bussel JCH, 2009, J AFFECT DISORDERS, V114, P232, DOI 10.1016/j.jad.2008.07.018; van Eechoud IJ, 2016, INT J NURS STUD, V53, P379, DOI 10.1016/j.ijnurstu.2015.09.007; Van Keer RL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1158-4; Van Kelst L., 2012, PERSPECTIVES MATERNI; Van Kelst L, 2013, J ADV NURS, V69, P600, DOI 10.1111/j.1365-2648.2012.06042.x; Van Kelst L, 2013, MIDWIFERY, V29, pE9, DOI 10.1016/j.midw.2011.10.002; Vassart C., 2005, GEZONDHEIDSZORG DIVE; Vause S., 2014, MIGRATIES MIGRANTENP; WHO, 2004, EUR MFH PROJ GROUP; Wikberg A, 2010, PATIENT PERSPECTIVE; Williamson M, 2010, INT J NURS STUD, V47, P761, DOI 10.1016/j.ijnurstu.2009.12.012; World Health Organization, 2006, QUAL CAR PROC MAK ST; World Health Organization, 2018, REC ANT CAR POS PREG; World Health Organization, 2010, HLTH MIGR THE WAY FO	64	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236008	10.1371/journal.pone.0236008	http://dx.doi.org/10.1371/journal.pone.0236008			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2YL	32726359	Green Published, gold			2022-12-26	WOS:000556908900054
J	Smith, SJ; Towers, N; Demetriou, K; Mohun, TJ				Smith, Stuart J.; Towers, Norma; Demetriou, Kim; Mohun, Timothy J.			Defective heart chamber growth and myofibrillogenesis after knockout of adprhl1 gene function by targeted disruption of the ancestral catalytic active site	PLOS ONE			English	Article							XENOPUS; CELLS; ENDONUCLEASE; ZEBRAFISH; INSIGHTS; PROVIDES; MODEL; CAS9	ADP-ribosylhydrolase-like 1 (Adprhl1) is a pseudoenzyme expressed in the developing heart myocardium of all vertebrates. In the amphibianXenopus laevis, knockdown of the two cardiac Adprhl1 protein species (40 and 23 kDa) causes failure of chamber outgrowth but this has only been demonstrated using antisense morpholinos that interfere with RNA-splicing. Transgenic production of 40 kDa Adprhl1 provides only part rescue of these defects. CRISPR/Cas9 technology now enables targeted mutation of theadprhl1gene in G0-generation embryos with routine cleavage of all alleles. Testing multiple gRNAs distributed across the locus reveals exonic locations that encode critical amino acids for Adprhl1 function. The gRNA recording the highest frequency of a specific ventricle outgrowth phenotype directs Cas9 cleavage of an exon 6 sequence, where microhomology mediated end-joining biases subsequent DNA repairs towards three small in-frame deletions. Mutant alleles encode discrete loss of 1, 3 or 4 amino acids from a di-arginine (Arg271-Arg272) containing peptide loop at the centre of the ancestral ADP-ribosylhydrolase site. Thus despite lacking catalytic activity, it is the modified (adenosine-ribose) substrate binding cleft of Adprhl1 that fulfils an essential role during heart formation. Mutation results in striking loss of myofibril assembly in ventricle cardiomyocytes. The defects suggest Adprhl1 participation from the earliest stage of cardiac myofibrillogenesis and are consistent with previous MO results and Adprhl1 protein localization to actin filament Z-disc boundaries. A single nucleotide change to the gRNA sequence renders it inactive. Mice lackingAdprhl1exons 3-4 are normal but production of the smaller ADPRHL1 species is unaffected, providing further evidence that cardiac activity is concentrated at the C-terminal protein portion.	[Smith, Stuart J.; Towers, Norma; Mohun, Timothy J.] Francis Crick Inst, Heart Format Vertebrates Lab, London, England; [Demetriou, Kim] Francis Crick Inst, Aquat STP, London, England	Francis Crick Institute; Francis Crick Institute	Smith, SJ (corresponding author), Francis Crick Inst, Heart Format Vertebrates Lab, London, England.	stuart.smith@adprhl1.org; tim.mohun@crick.ac.uk		Smith, Stuart/0000-0001-7266-6790; Smith, Stuart/0000-0002-4556-2707	Francis Crick Institute; Cancer Research UK; UK Medical Research Council [U117562103]; Wellcome Trust	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	All authors and this work were supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council (TJM grant U117562103) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Boogerd CJJ, 2009, ANN ANAT, V191, P505, DOI 10.1016/j.aanat.2009.06.004; Bornhorst D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12068-x; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Carlisle C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010032; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Desgrange A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162776; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Du AP, 2008, DEV BIOL, V318, P236, DOI 10.1016/j.ydbio.2008.03.011; Dubaissi E, 2014, DEVELOPMENT, V141, P1514, DOI 10.1242/dev.102426; Fenix AM, 2018, ELIFE, V7, DOI 10.7554/eLife.42144; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Fukuda R, 2019, DEV CELL, V51, P62, DOI 10.1016/j.devcel.2019.08.006; Gautel M, 2016, J EXP BIOL, V219, P135, DOI 10.1242/jeb.124941; Gunthel M, 2018, MOL THER, V26, P1599, DOI 10.1016/j.ymthe.2018.05.022; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karimi K, 2018, NUCLEIC ACIDS RES, V46, pD861, DOI 10.1093/nar/gkx936; Kelly RG, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015750; Kernstock S, 2009, ACTA CRYSTALLOGR F, V65, P529, DOI 10.1107/S1744309109014067; Laing S, 2011, AMINO ACIDS, V41, P257, DOI 10.1007/s00726-010-0676-2; Lin YF, 2012, DEV BIOL, V362, P242, DOI 10.1016/j.ydbio.2011.12.005; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Mashimo M, 2014, DNA REPAIR, V23, P88, DOI 10.1016/j.dnarep.2014.03.005; Matic I, 2012, NAT METHODS, V9, P771, DOI 10.1038/nmeth.2106; MOSS J, 1992, J BIOL CHEM, V267, P10481; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; Naert Thomas, 2018, Drug Discov Today Technol, V28, P41, DOI 10.1016/j.ddtec.2018.07.001; Norland K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12682-9; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Pourfarjam Y, 2018, J BIOL CHEM, V293, P12350, DOI 10.1074/jbc.RA118.003586; Rack JGM, 2018, CELL CHEM BIOL, V25, P1533, DOI 10.1016/j.chembiol.2018.11.001; Ramsdell AF, 2006, DEVELOPMENT, V133, P1399, DOI 10.1242/dev.02292; Ribeiro AJM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat9797; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; Seol JH, 2018, MUTAT RES-FUND MOL M, V809, P81, DOI 10.1016/j.mrfmmm.2017.07.002; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Sidhwani P, 2019, CURR TOP DEV BIOL, V132, P395, DOI 10.1016/bs.ctdb.2018.12.009; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith SJ, 2016, DEV BIOL, V416, P373, DOI 10.1016/j.ydbio.2016.05.006; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Tandon P, 2017, DEV BIOL, V426, P325, DOI 10.1016/j.ydbio.2016.04.009; Uribe V, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164194; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; WEGNER A, 1988, J BIOL CHEM, V263, P13739; Wilson LOW, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00749; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	54	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235433	10.1371/journal.pone.0235433	http://dx.doi.org/10.1371/journal.pone.0235433			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726316	gold, Green Published, Green Submitted			2022-12-26	WOS:000556908900063
J	Desmarets, M; Ayav, C; Diallo, K; Bayer, F; Imbert, F; Sauleau, EA; Monnet, E				Desmarets, Maxime; Ayav, Carole; Diallo, Kadiatou; Bayer, Florian; Imbert, Frederic; Sauleau, Erik Andre; Monnet, Elisabeth		VIGIE Study Grp	Fine-scale geographic variations of rates of renal replacement therapy in northeastern France: Association with the socioeconomic context and accessibility to care	PLOS ONE			English	Article							INFORMATION NETWORK REIN; SOCIAL INEQUALITIES; DISEASE; EPIDEMIOLOGY; POVERTY; URBAN; ESRD; DIALYSIS; PATTERNS; REGISTRY	Background The strong geographic variations in the incidence rates of renal replacement therapy (RRT) for end-stage renal disease are not solely related to variations in the population's needs, such as the prevalence of diabetes or the deprivation level. Inequitable geographic access to health services has been involved in different countries but never in France, a country with a generous supply of health services and where the effect of the variability of medical practices was highlighted in an analysis conducted at the geographic scale of districts. Our ecological study, performed at the finer scale of townships in a French area of 8,370,616 inhabitants, investigated the association between RRT incidence rates, socioeconomic environment and geographic accessibility to healthcare while adjusting for morbidity level and medical practice patterns. Methods Using data from the Renal Epidemiology and Information Network registry, we estimated age-adjusted RRT incidence rates during 2010-2014 for the 282 townships of the area. A hierarchical Bayesian Poisson model was used to examine the association between incidence rates and 18 contextual variables describing population health status, socioeconomic level and health services characteristics. Relative risks (RRs) and 95% credible intervals (95% CrIs) for each variable were estimated for a 1-SD increase in incidence rate. Results During 2010-2014, 6,835 new patients >= 18 years old (4231 men, 2604 women) living in the study area started RRT; the RRT incidence rates by townships ranged from 21 to 499 per million inhabitants. In multivariate analysis, rates were related to the prevalence of diabetes [RR (95% CrI): 1.05 (1.04-1.11)], the median estimated glomerular filtration rate at dialysis initiation [1.14 (1.08-1.20)], and the proportion of incident patients >= 85 years old [1.08 (1.03-1.14)]. After adjusting for these factors, rates in townships increased with increasing French deprivation index [1.05 (1.01-1.08)] and decreased with increasing mean travel time to reach the closest nephrologist [0.92 (0.89-0.95]). Conclusion These data confirm the influence of deprivation level, the prevalence of diabetes and medical practices on RRT incidence rates across a large French area. For the first time, an association was found with the distance to nephrology services. These data suggest possible inequitable geographic access to RRT within the French health system.	[Desmarets, Maxime; Diallo, Kadiatou; Monnet, Elisabeth] Univ Franche Comte, CHU Besancon, INSERM, CIC 1431, Besancon, France; [Desmarets, Maxime] Univ Bourgogne Franche Comte, INSERM, RIGHT UMR1098, EFS, Besancon, France; [Ayav, Carole] Univ Lorraine, CHRU Nancy, CIC Epidemiol Clin 1433, INSERM, Nancy, France; [Bayer, Florian] Agence Biomed, La Plaine St Denis, France; [Imbert, Frederic] Observ Reg Sante Alsace, Strasbourg, France; [Sauleau, Erik Andre] Univ Strasbourg, CNRS, ICube UMR 7357, Lab Biostat, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Monnet, E (corresponding author), Univ Franche Comte, CHU Besancon, INSERM, CIC 1431, Besancon, France.	elisabeth.monnet@univ-fcomte.fr	Desmarets, Maxime/AAB-9897-2022; Monnet, Elisabeth/E-1989-2017	Desmarets, Maxime/0000-0002-3801-5297; Monnet, Elisabeth/0000-0002-3347-2579	French National Agency for Biomedicine [AO REIN 2015]	French National Agency for Biomedicine	This work was supported by a research grant (AO REIN 2015) from the French National Agency for Biomedicine. https://www.agencebiomedecine.fr/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlet M, 2012, LOCAL POTENTIAL ACCE; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Caskey FJ, 2014, NEPHROL DIAL TRANSPL, V29, P1494, DOI 10.1093/ndt/gft390; Caskey FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2604, DOI 10.1093/ndt/gfq781; Castledine CI, 2012, NEPHROL DIAL TRANSPL, V27, P3943, DOI 10.1093/ndt/gfs294; Chevreul K, 2015, HEALT SYST TRANSIT, V17, P1; CLAYTON DG, 1993, INT J EPIDEMIOL, V22, P1193, DOI 10.1093/ije/22.6.1193; Colonna M, 2013, REV EPIDEMIOL SANTE, V61, P559, DOI 10.1016/j.respe.2013.07.686; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Couchoud C, 2012, NEPHROL DIAL TRANSPL, V27, P2312, DOI 10.1093/ndt/gfr639; Couchoud C, 2010, NEPHROL DIAL TRANSPL, V25, P1576, DOI 10.1093/ndt/gfp675; Fan ZJ, 2007, HEALTH PLACE, V13, P179, DOI 10.1016/j.healthplace.2005.12.002; Gomez-Rubio V, 2005, J GEOGR SYST, V7, P189, DOI [10.1007/s10109-005-0156-5, DOI 10.1007/s10109-005-0156-5]; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P2624, DOI 10.1093/ndt/gfq110; Hossain MP, 2009, AM J KIDNEY DIS, V53, P166, DOI 10.1053/j.ajkd.2007.10.047; Judge A, 2012, NEPHROL DIAL TRANSPL, V27, P1598, DOI 10.1093/ndt/gfr466; Kihal-Talantikite W, 2015, CLIN KIDNEY J, V8, P7, DOI 10.1093/ckj/sfu131; Ladin K, 2018, CLIN J AM SOC NEPHRO, V13, P1188, DOI 10.2215/CJN.01740218; Lassalle M, 2015, NEPHROL THER, V11, P78, DOI 10.1016/j.nephro.2014.08.002; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Occelli F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110132; OECD, 2014, GEOGRAPHIC VARIATION, DOI [DOI 10.23062/2010.11.6, 10.1787/9789264216594-en]; Peterson LE, 2010, J RURAL HEALTH, V26, P373, DOI 10.1111/j.1748-0361.2010.00309.x; Pippias M, 2017, CLIN KIDNEY J, V10, P154, DOI 10.1093/ckj/sfw135; QGIS Development Team, 2017, QGIS GEOGRAPHIC INFO; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Richardson S, 2004, ENVIRON HEALTH PERSP, V112, P1016, DOI 10.1289/ehp.6740; Rogerson PA, 2016, CH CRC HANDB MOD STA, P161; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Temam S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4967-3; Touraine M, 2014, LANCET, V383, P1101, DOI 10.1016/S0140-6736(14)60423-2; Udayaraj UP, 2010, J EPIDEMIOL COMMUN H, V64, P535, DOI 10.1136/jech.2009.093518; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; van de Luijtgaarden MWM, 2013, NEPHROL DIAL TRANSPL, V28, P1264, DOI 10.1093/ndt/gft053; van de Luijtgaarden MWM, 2012, AM J KIDNEY DIS, V60, P940, DOI 10.1053/j.ajkd.2012.07.015; Vigneron E, 2012, B ACAD NAT MED PARIS, V196, P939, DOI 10.1016/S0001-4079(19)31781-9; Volkova N, 2008, J AM SOC NEPHROL, V19, P356, DOI 10.1681/ASN.2006080934; Yan GF, 2013, CLIN J AM SOC NEPHRO, V8, P610, DOI 10.2215/CJN.07780812	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236698	10.1371/journal.pone.0236698	http://dx.doi.org/10.1371/journal.pone.0236698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722704	gold, Green Published			2022-12-26	WOS:000556916000011
J	Manion, KP; Baglaenko, Y; Chang, NH; Talaei, N; Wither, JE				Manion, Kieran P.; Baglaenko, Yuriy; Chang, Nan-Hua; Talaei, Nafiseh; Wither, Joan E.			Impaired B cell anergy is not sufficient to breach tolerance to nuclear antigen in V kappa 8/3H9 lupus-prone mice	PLOS ONE			English	Article							NEW-ZEALAND BLACK; REGULATORY T-CELLS; EXPANDED POPULATION; SUSCEPTIBILITY LOCI; ACTIVATION; INDUCTION; CHAIN; AUTOIMMUNITY; DISSECTION; SURVIVAL	Background Systemic lupus erythematosus (SLE) is a severe autoimmune disease in which immune tolerance defects drive production of pathogenic anti-nuclear autoantibodies. Anergic B cells are considered a potential source of these autoantibodies due to their autoreactivity and overrepresentation in SLE patients. Studies of lupus-prone mice have shown that genetic defects mediating autoimmunity can breach B cell anergy, but how this breach occurs with regards to endogenous nuclear antigen remains unclear. We investigated whether B and T cell defects in congenic mice (c1) derived from the lupus-prone New Zealand Black strain can breach tolerance to nuclear self-antigen in the presence of knock-in genes (V kappa 8/3H9; dKI) that generate a ssDNA-reactive, anergic B cell population. Methods Flow cytometry was used to assess splenic B and T cells from 8-month-old c1 dKI mice and serum autoantibodies were measured by ELISA. dKI B cells stimulated in vitro with anti-IgM were assessed for proliferation and activation by examining CFSE decay and CD86. Cytokine-producing T cells were identified by flow cytometry following culture of dKI splenocytes with PMA and ionomycin. dKI B cells from 6-8-week-old mice were adoptively transferred into 4-month-old wild type recipients and assessed after 7 days via flow cytometry and immunofluorescence microscopy. Results c1 dKI mice exhibited B cell proliferation indicative of impaired anergy, but had attenuated autoantibodies and germinal centres compared to wild type littermates. This attenuation appeared to stem from a decrease in PD-1(hi)T helper cells in the dKI strains, as c1 dKI B cells were recruited to germinal centres when adoptively transferred into c1 wild type mice. Conclusion Anergic, DNA-specific autoreactive B cells only seem to drive profound autoimmunity in the presence of concomitant defects in the T cell subsets that support high-affinity plasma cell production.	[Manion, Kieran P.; Baglaenko, Yuriy; Chang, Nan-Hua; Talaei, Nafiseh; Wither, Joan E.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Wither, Joan E.] Univ Toronto, Dept Med & Immunol, Toronto, ON, Canada; [Wither, Joan E.] Univ Hlth Network, Div Rheumatol, Toronto, ON, Canada; [Baglaenko, Yuriy] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Baglaenko, Yuriy] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Baglaenko, Yuriy] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol, Dept Med Immunol & Allergy, Boston, MA 02115 USA; [Baglaenko, Yuriy] Harvard Med Sch, Brigham & Womens Hosp, Ctr Data Sci, Boston, MA 02115 USA	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wither, JE (corresponding author), Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Toronto, Dept Med & Immunol, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Hlth Network, Div Rheumatol, Toronto, ON, Canada.	Joan.Wither@uhnresearch.ca		Wither, Joan/0000-0001-5961-9228; Baglaenko, Yuriy/0000-0002-9020-6824; Manion, Kieran/0000-0001-8945-9384	Canadian Institutes of Health Research [MOP37886]; Ontario Graduate Scholarship; Queen Elizabeth II Graduate Scholarship in Science and Technology; University of Toronto Doctoral Completion Award; Canadian Institutes of Health Research Doctoral Research Award; University of Toronto Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Queen Elizabeth II Graduate Scholarship in Science and Technology; University of Toronto Doctoral Completion Award; Canadian Institutes of Health Research Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); University of Toronto Fellowship Award	JW received funding from the Canadian Institutes of Health Research, grant number MOP37886 (https://cihr-irsc.gc.ca/).KM was the recipient of a Ontario Graduate Scholarship (https://www.sgs.utoronto.ca/awards/ontariograduate-scholarship/), a Queen Elizabeth II Graduate Scholarship in Science and Technology (https://www.deptmedicine.utoronto.ca/queenelizabeth-ii-graduate-scholarships-science-technology-qeii-gsst), and a University of Toronto Doctoral Completion Award (https://www.sgs.utoronto.ca/awards/doctoral-completion-awarddca/).YB was the recipient of a Canadian Institutes of Health Research Doctoral Research Award (https://cihr-irsc.gc.ca/e/38887.html).NT was the recipient of a University of Toronto Fellowship Award (https://www.glse.utoronto.ca/universitytoronto-fellowships), a Ontario Graduate Scholarship (https://www.sgs.utoronto.ca/awards/ontario-graduate-scholarship/) and a University of Toronto Doctoral Completion Award (https://www.sgs.utoronto.ca/awards/doctoral-completionaward-dca/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviszus K, 2012, J IMMUNOL, V189, P4275, DOI 10.4049/jimmunol.1201818; Baglaenko Y, 2017, J IMMUNOL, V198, P3949, DOI 10.4049/jimmunol.1601369; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Chang NH, 2008, J IMMUNOL, V180, P1276, DOI 10.4049/jimmunol.180.2.1276; Chang NH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179506; Chang NH, 2004, J IMMUNOL, V172, P1553, DOI 10.4049/jimmunol.172.3.1553; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Cheung YH, 2011, GENES IMMUN, V12, P251, DOI 10.1038/gene.2010.71; Cheung YH, 2005, J IMMUNOL, V175, P8154, DOI 10.4049/jimmunol.175.12.8154; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Clement RL, 2019, NAT IMMUNOL, V20, P1360, DOI 10.1038/s41590-019-0472-4; Dale BL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129278; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Fan WJ, 2018, J IMMUNOL, V200, P3180, DOI 10.4049/jimmunol.1701288; GOIDL EA, 1981, CLIN EXP IMMUNOL, V44, P24; Howie J B, 1968, Adv Immunol, V9, P215, DOI 10.1016/S0065-2776(08)60444-7; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; Jongstra-Bilen J, 1997, J IMMUNOL, V159, P5810; Keszei M, 2013, FASEB J, V27, P3123, DOI 10.1096/fj.12-226951; Keszei M, 2011, J EXP MED, V208, P811, DOI 10.1084/jem.20101653; Lin J, 2019, RHEUMATOLOGY, V58, P2188, DOI 10.1093/rheumatology/kez228; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Makiyama A, 2019, RHEUMATOLOGY, V58, P1861, DOI 10.1093/rheumatology/kez077; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Morlacchi S, 2011, BLOOD, V118, P984, DOI 10.1182/blood-2011-02-336115; Myers DR, 2019, CELL REP, V27, P1858, DOI 10.1016/j.celrep.2019.04.037; Nguyen KAT, 1997, J IMMUNOL, V159, P2633; Nusser A, 2014, EUR J IMMUNOL, V44, P2893, DOI 10.1002/eji.201344408; Pewzner-Jung Y, 1998, J IMMUNOL, V161, P4634; Quach TD, 2011, J IMMUNOL, V186, P4640, DOI 10.4049/jimmunol.1001946; RADIC MZ, 1991, J IMMUNOL, V146, P176; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Roy V, 2005, J IMMUNOL, V175, P7363, DOI 10.4049/jimmunol.175.11.7363; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Szodoray P, 2016, J ALLERGY CLIN IMMUN, V138, P839, DOI 10.1016/j.jaci.2016.01.035; Talaei N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075166; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang L, 2015, MUCOSAL IMMUNOL, V8, P1297, DOI 10.1038/mi.2015.20; Wither JE, 2003, J IMMUNOL, V171, P1697, DOI 10.4049/jimmunol.171.4.1697; Wither JE, 2000, EUR J IMMUNOL, V30, P356, DOI 10.1002/1521-4141(200002)30:2&lt;356::AID-IMMU356&gt;3.0.CO;2-H; Wong EB, 2012, J IMMUNOL, V189, P5667, DOI 10.4049/jimmunol.1201661; Yusuf I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102791; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236664	10.1371/journal.pone.0236664	http://dx.doi.org/10.1371/journal.pone.0236664			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722684	Green Published, gold			2022-12-26	WOS:000556916000022
J	Alemayehu, S; Yigezu, A; Hailemariam, D; Hailu, A				Alemayehu, Senait; Yigezu, Amanuel; Hailemariam, Damen; Hailu, Alemayehu			Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia	PLOS ONE			English	Article								Background In Ethiopia, MDR-TB has become a significant public health threat; therefore, the Ministry of Health introduced two treatment approaches for MDR-TB cases: treatment initiative center (TIC) and treatment follow-up center (TFC). TIC is where patients usually are diagnosed and start the treatment. At TFC, we follow MDR-TB patients until they completed the treatment. However, there is no evidence about the cost-effectiveness of the approaches. Therefore, this study aimed to analyze the cost-effectiveness of MDR-TB treatment in TIC and TFC. Methods In this study, we employed a full economic evaluation from a providers' perspective. We followed a hypothetical cohort of individuals from the age of 15 for a lifetime using a Markov model with five mutually exclusive health states. We used both primary and secondary data sources for the study. Ingredient-based costing approach was used. The costs include healthcare provider costs (recurrent and capital cost) and patient-side costs (direct and indirect). We use a human capital approach to estimate the indirect cost. The cost estimates were reported in the 2017 United States Dollar (US$), and effectiveness was measured using disability-adjusted life-years (DALYs) averted. Both costs and health benefits were discounted using a 3% discount rate. Both average and incremental cost-effectiveness ratios (ICER) were reported calculated. One-way and probabilistic sensitivity analyses were reported to determine the robustness of the estimates. Results The cost per HIV negative patient successfully treated for MDR-TB was $8,416 at TIC and $6,657 at TFC. The average cost-effectiveness ratio per DALY averted at TFC was $671 and $1,417 per DALY averted at TIC. The incremental cost-effectiveness ratio (ICER) of MDR-TB treatment at TIC was $1,641 per DALYs averted. Conclusion This study indicates that the treatment of MDR-TB at both TIC and TFC are cost-effective interventions compared with the willingness to pay threshold of three-times the GDP per capita in Ethiopia.	[Alemayehu, Senait; Yigezu, Amanuel] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Hailemariam, Damen; Hailu, Alemayehu] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Hailu, Alemayehu] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen Ctr Eth & Prior Setting, Bergen, Norway	Addis Ababa University; University of Bergen	Hailu, A (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.; Hailu, A (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen Ctr Eth & Prior Setting, Bergen, Norway.	alemayehu4all@gmail.com	Hailu, Alemayehu/AAZ-5206-2020; Yigezu, Amanuel/ABI-1769-2020	Hailu, Alemayehu/0000-0003-4872-8036; 	Addis Ababa University School of Public Health	Addis Ababa University School of Public Health	This study was funded by Addis Ababa University School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baye M. DW, 2018, J INFECT DIS THERAPY, V6, DOI [10.4172/2161-1068.1000194, DOI 10.4172/2161-1068.1000194]; Belete G. GA, 2013, BRAZ J INFECT DIS, V17, P8; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Donev D, 2010, METHODS TOOLS PUBLIC, V30, P715; Drummond M., 2017, METHODS EC EVALUATIO; Federal Ministry of Health (FMOH), 2013, GUID CLIN PROGR MAN, V5th; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411; FMOH, 2014, GUID PROGR MAN DRUG; Gospodarevskaya E TO, 2014, INT J TUBERC LUNG D, V18, P8; Hailu A. LB, 2014, COST EFFECTIVENESS C; John Denny, 2018, Indian J Tuberc, V65, P208, DOI 10.1016/j.ijtb.2017.08.031; Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lelisa F. CH, 2017, J INFECT DIS, V7; Lopez AD SJ, 2000, LIFE TABLES 191 COUN, V9; Lucy Cunnama, 2019, COSTING GUIDELINES T; Mulualem Agonafir EL DW, 2010, INT J TUBERC LUNG D, V14, P7; Musa BM, 2016, TROP MED INT HEALTH, V21, P176, DOI 10.1111/tmi.12648; Russell LB GM, 1996, ROLE COST EFFECTIVEN, V276, P8; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; WHO, 2016, ETH TUB FIN PROF GRO; WHO, 2017, GLOB TUB REP; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2012, COST EFF STRAT PLANN; World Health Organization, 2016, GLOB TUB REP 2016, P214; World Health Organization, 2013, TUB PRIS	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0235820	10.1371/journal.pone.0235820	http://dx.doi.org/10.1371/journal.pone.0235820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716915	gold, Green Published			2022-12-26	WOS:000556674500028
J	Bronnimann, D; Wimmer, J; Muller-Kissing, M; Stopp, B; Rissanen, H; Spichtig, N				Bronnimann, David; Wimmer, Johannes; Mueller-Kissing, Milena; Stopp, Barbara; Rissanen, Hannele; Spichtig, Norbert			One man's trash is another man's treasure. Interdisciplinary examination of taphonomic aspects of ceramic sherds, animal bones and sediments from the La Tene period settlement at Basel-Gasfabrik	PLOS ONE			English	Article							HISTORY	As part of an interdisciplinary research project on the Late La Tene period settlement at Basel-Gasfabrik, ceramic sherds, animal bones and archaeological sediments from different archaeological structures (one large pit, two ditches and four archaeological layers) were examined in respect of 21 taphonomic features (proxies). These proxies, in turn, were linked to different processes that can leave traces on objects or sediments: primary use, mechanical stress, heat impact, water, redeposition, exposure, covering and postdepositional processes. The different proxies were compared using a statistical procedure. Our results show significant differences between the different features with regard to taphonomic alteration. For example, ceramic sherds and animal bones from archaeological layers show severe alteration due to exposure, whilst a good and uniform preservation within the pit points to its rapid filling. Furthermore, there is evidence of middens which probably served as material depots. Our results suggest that waste was not simply seen as rubbish, but was stored as a resource. Therefore, materials could take different "paths", each of which resulted in specific taphonomic processes (alterations). The interdisciplinary approach taken in this project has provided new insight into the complex but probably clearly defined handling of various materials at Basel-Gasfabrik, thus allowing us to visualise part of thecultural biography of things.	[Bronnimann, David; Stopp, Barbara] Univ Basel, Integrat Prehist & Archaeol Sci, Basel, Switzerland; [Bronnimann, David; Wimmer, Johannes; Mueller-Kissing, Milena; Rissanen, Hannele; Spichtig, Norbert] Archaeol Serv Canton Basel Stadt, Basel, Switzerland; [Wimmer, Johannes] Univ Bern, Inst Archaeol Sci, Dept Prehist Archaeol, Bern, Switzerland; [Mueller-Kissing, Milena] Ruhr Univ Bochum, Inst Archaeol Studies, Fac Hist Sci, Bochum, Germany	University of Basel; University of Bern; Ruhr University Bochum	Bronnimann, D (corresponding author), Univ Basel, Integrat Prehist & Archaeol Sci, Basel, Switzerland.; Bronnimann, D (corresponding author), Archaeol Serv Canton Basel Stadt, Basel, Switzerland.	david.broennimann@unibas.ch		Bronnimann, David/0000-0003-3432-1753	Archaeological Service of the Canton Basel-Stadt	Archaeological Service of the Canton Basel-Stadt	This work was supported by the Archaeological Service of the Canton Basel-Stadt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjea RY, 2015, ARCHAEOL ANTHROP SCI, V7, P89, DOI 10.1007/s12520-013-0160-5; Binford L.R., 1981, J ANTHR RES, V37, P195, DOI DOI 10.1086/JAR.37.3.3629723; Bronnimann D, 2018, J ARCHAEOL SCI, V98, P45, DOI 10.1016/j.jas.2018.08.005; Bronnimann D, 2020, GEOARCHAEOLOGY, P1; Bronnimann D., 2017, INTERDISCIPLINARITE, P93; BRUAND A, 1995, EUR J SOIL SCI, V46, P377, DOI 10.1111/j.1365-2389.1995.tb01334.x; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chapman J., 2000, P PREHIST SOC, V66, P61, DOI DOI 10.1017/S0079497X00001778; Courty M.A., 1989, SOILS MICROMORPHOLOG; de Capitani A, 2002, ARCHAOLOGIE THURGAU, V11, P135; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Driscoll K, 2016, QUATERN INT, V424, P130, DOI 10.1016/j.quaint.2015.04.054; Garrow D, 2012, ARCHAEOL DIALOG, V19, P85, DOI 10.1017/S1380203812000141; Hahn HP, 2015, MORPHOMATA, V31, P11; Hahn HP, 2015, LOST THINGS FRAGEN W, V12, P9; Hecht Y, 2004, JBABBS, V2002, P57; Hecht Y., 2011, ALLTAGSKULTUR TOTENR; Joy J., 2015, MORPHOMATA, V31, P125; Joy J, 2009, WORLD ARCHAEOL, V41, P540, DOI 10.1080/00438240903345530; Jud P, 1995, JAHRESBERICHT ARCHAO, V1992, P19; Jud P, 2004, THESIS, VI; Knipper C, 2017, ARCHAEOL ANTHROP SCI, V9, P1307, DOI 10.1007/s12520-016-0362-8; Kock S, 2009, SWISS J GEOSCI, V102, P307, DOI 10.1007/s00015-009-1325-1; Kopytoff Igor, 1986, SOCIAL LIFE THINGS C, P64, DOI DOI 10.1017/CBO9780511819582.004; KRAMER C, 1985, ANNU REV ANTHROPOL, V14, P77, DOI 10.1146/annurev.an.14.100185.000453; Madgwick R, 2012, INT J OSTEOARCHAEOL, V22, P509, DOI 10.1002/oa.1274; ManiBabu M., 2010, ORIENTAL ANTHR, V10, P155; Martin-Kilcher S, 2013, IMPORTATIONS EN AMPH, V5, P377; Martin-Seijo M, 2017, J ARCHAEOL SCI-REP, V12, P528, DOI 10.1016/j.jasrep.2017.02.024; Miller CE, 2010, PALETHNOLOGIE, V2, P25; Nagy G., 1999, ARCHAOLOGIE THURGAU, V6; Nick M., 2015, INVENTAR FUNDMUNZEN, V12; Nicosia C, 2012, GEOARCHAEOLOGY, V27, P105, DOI 10.1002/gea.21403; NIELSEN AE, 1991, AM ANTIQUITY, V56, P483, DOI 10.2307/280897; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; Pichler S. L., 2015, PALAOWISSENSCHAFTLIC, P257; Pichler SL, 2017, MULTIDISCIPLINARY AP, P240; Poux M., 1997, ANN SOC SUISSE PREHI, V80, P147; Rentzel P, 2017, ARCHAEOLOGICAL SOIL, P281, DOI DOI 10.1002/9781118941065.CH30; Rentzel P., 2015, JAHRESBERICHT ARCHAO, V2014, P108; Rentzel P., 1994, SPATKELTISCHE ZEIT S, P49; Rentzel P., 1997, JAHRESBERICHT ARCHAO, P31; Rentzel P., 1998, JAHRESBERICHT ARCHAO, P35; Roskams S, 2020, INTERNET ARCHAEOLOGY, V34; Schaer N, 2005, MATERIALHEFTE ARCHAO, V19; SCHIFFER MB, 1972, AM ANTIQUITY, V37, P156, DOI 10.2307/278203; SCHIFFER MB, 1983, AM ANTIQUITY, V48, P675, DOI 10.2307/279771; Schiffer MB, 2002, BEHAV ARCHEOLOGY; SKIBO JM, 1987, J ARCHAEOL SCI, V14, P83, DOI 10.1016/S0305-4403(87)80008-0; SKIBO JM, 1989, AM ANTIQUITY, V54, P122, DOI 10.2307/281335; Sommer U., 1991, UPA, V6, P51; Sommer U., 2012, TAPHONOMIE, P15; Stanislawski Michael B., 1969, SW LORE, V35, P11; Steiner S., 2012, BEITRAGE UR FRUHGESC, V65, P145; Stoops G., 2003, GUIDELINES ANAL DESC; Stopp B., 2008, MAT ARCH OLOGIE BASE, V20A, P249; Stopp B, 2005, HOOVES HORNS MOLLUSC, V15, P187; Vindrola-Padros B, 2019, J ARCHAEOL SCI, V104, P19, DOI 10.1016/j.jas.2019.01.008; Wojtczak D., 2017, VOCATION PRE HIST HO, V148, P367; Wolfram S., 2003, MULL FACETTEN STEINZ, V27, P17	60	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236272	10.1371/journal.pone.0236272	http://dx.doi.org/10.1371/journal.pone.0236272			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV9ND	32716947	Green Published, gold			2022-12-26	WOS:000556674500024
J	Kemmerer, CL; Pernpeintner, V; Ruschil, C; Abdelhak, A; Scholl, M; Ziemann, U; Krumbholz, M; Hemmer, B; Kowarik, MC				Kemmerer, C. L.; Pernpeintner, V.; Ruschil, C.; Abdelhak, A.; Scholl, M.; Ziemann, U.; Krumbholz, M.; Hemmer, B.; Kowarik, M. C.			Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab	PLOS ONE			English	Article							MEMORY; THERAPY; TARGETS	Background Several disease modifying drugs (DMDs) have been approved for the treatment of multiple sclerosis (MS), however, little is known about their differential impact on peripheral blood (PB) B cell subsets. Methods We performed a cross sectional study on PB B cells in MS patients treated with interferon-beta (n = 25), glatiramer acetate (n = 19), dimethyl fumarate (n = 15), fingolimod (n = 16) or natalizumab (n = 22), untreated MS patients (n = 20), and in patients with non-inflammatory neurological diseases (n = 12). Besides analyzing routine laboratory data, flow cytometry was performed to analyze naive B cells (CD19+CD20+CD27-IgD+), non-class switched (CD19+CD20+CD27+IgD+) and class-switched memory B cells (CD19+CD20+CD27+IgD-), double negative B cells (CD19+CD20lowCD27-IgD-) and plasmablasts (CD19+CD20lowCD27+CD38++). Results Treatment associated changes were found for the overall B cell pool as well as for all B cell subsets. Natalizumab increased absolute numbers and percentage of all B cells mainly by expanding the memory B cell pool. Fingolimod decreased absolute numbers of all B cell subsets and the percentage of total B cells. Fingolimod, dimethyl fumarate and interferon-beta treatments were associated with an increase in the fraction of naive B cells while class switched and non-class switched memory B cells showed decreased percentages. Conclusion Our results highlight differential effects of DMDs on the PB B cell compartment. Across the examined treatments, a decreased percentage of memory B cells was found in dimethyl fumarate, interferon-beta and fingolimod treated patients which might contribute to the drugs' mode of action in MS. Further studies are necessary to decipher the exact role of B cell subsets during MS pathogenesis.	[Kemmerer, C. L.; Ruschil, C.; Abdelhak, A.; Scholl, M.; Ziemann, U.; Krumbholz, M.; Kowarik, M. C.] Eberhard Karls Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany; [Kemmerer, C. L.; Ruschil, C.; Abdelhak, A.; Scholl, M.; Ziemann, U.; Krumbholz, M.; Kowarik, M. C.] Eberhard Karls Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Pernpeintner, V.; Hemmer, B.; Kowarik, M. C.] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Hemmer, B.] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich; University of Munich	Kowarik, MC (corresponding author), Eberhard Karls Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany.; Kowarik, MC (corresponding author), Eberhard Karls Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany.; Kowarik, MC (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany.	markus.kowarik@uni-tuebingen.de	Hemmer, Bernhard/AAT-8388-2021; Kowarik, Markus/GVU-1351-2022; Hemmer, Bernhard/AAU-3066-2021; Ziemann, Ulf/AAY-9125-2020; Abdelhak, Ahmed/ABA-2764-2020; Hemmer, Bernhard/GPX-8451-2022; Kowarik, Markus/E-8880-2015	Abdelhak, Ahmed/0000-0001-9731-4169; Hemmer, Bernhard/0000-0001-5985-6784; Kowarik, Markus/0000-0003-1389-5539; Ruschil, Christoph/0000-0001-9900-4295	Munich Cluster for Systems Neurology (SyNergy), Munich, Germany	Munich Cluster for Systems Neurology (SyNergy), Munich, Germany	The Munich Cluster for Systems Neurology (SyNergy), Munich, Germany is a non-commercial funding program which provided support in the form of salary and research materials for M.C. Kowarik, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding of B. Hemmer by SyNergy was not related to this study. The specific roles of the authors are articulated in the `author contributions' section.	Aharoni R, 2014, J AUTOIMMUN, V54, P81, DOI 10.1016/j.jaut.2014.05.005; Baker D, 2017, EBIOMEDICINE, V16, P41, DOI 10.1016/j.ebiom.2017.01.042; Boffa G, 2020, CNS DRUGS, V34, P425, DOI 10.1007/s40263-020-00714-8; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Ceronie B, 2018, J NEUROL, V265, P1199, DOI 10.1007/s00415-018-8830-y; Claes N, 2016, J IMMUNOL, V197, P4576, DOI 10.4049/jimmunol.1502448; Claes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111115; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Diaz GM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26519-w; Haas J, 2011, J AUTOIMMUN, V37, P289, DOI 10.1016/j.jaut.2011.08.003; Habib I, 2015, STUD PEOPLES HIST, V2, P2, DOI 10.1177/2348448915577295; Harp CT, 2010, EUR J IMMUNOL, V40, P2942, DOI 10.1002/eji.201040516; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Ireland SJ, 2014, JAMA NEUROL, V71, P1421, DOI 10.1001/jamaneurol.2014.1472; Jelcic I, 2018, CELL, V175, P85, DOI 10.1016/j.cell.2018.08.011; Kappos L, 2014, LANCET NEUROL, V13, P353, DOI 10.1016/S1474-4422(14)70028-6; Kowarik MC, 2011, NEUROLOGY, V76, P1214, DOI 10.1212/WNL.0b013e3182143564; Kowarik MC, 2017, ANN CLIN TRANSL NEUR, V4, P369, DOI 10.1002/acn3.418; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Krumbholz M, 2008, NEUROLOGY, V71, P1350, DOI 10.1212/01.wnl.0000327671.91357.96; Kuerten S, 2018, CNS DRUGS, V32, P1039, DOI 10.1007/s40263-018-0567-8; Li R, 2017, J IMMUNOL, V198, P691, DOI 10.4049/jimmunol.1601649; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Mehta D, 2019, NEUROLOGY, V92, pE1724, DOI 10.1212/WNL.0000000000007262; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Mills EA, 2018, MULT SCLER J, V24, P1014, DOI 10.1177/1352458518775550; Nakamura M, 2014, MULT SCLER J, V20, P1371, DOI 10.1177/1352458514523496; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Planas R, 2012, EUR J IMMUNOL, V42, P790, DOI 10.1002/eji.201142108; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rizzo F, 2016, IMMUNOL CELL BIOL, V94, P886, DOI 10.1038/icb.2016.55; Schwarz A, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000309; Selewski DT, 2010, AM J NEURORADIOL, V31, P1588, DOI 10.3174/ajnr.A2226; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Thomas Saskia, 2012, Inflammopharmacology, V20, P1, DOI 10.1007/s10787-011-0104-6; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Thompson SAJ, 2010, J CLIN IMMUNOL, V30, P99, DOI 10.1007/s10875-009-9327-3; Torring C, 2013, J NEUROIMMUNOL, V262, P92, DOI 10.1016/j.jneuroim.2013.06.002; Traub JW, 2019, J NEUROINFLAMM, V16, P1, DOI [10.1186/s12974-018-1391-2, DOI 10.1186/S12974-018-1391-2]; Tsai HC, 2016, DRUGS, V76, P1067, DOI 10.1007/s40265-016-0603-2; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yong VW, 1998, NEUROLOGY, V51, P682	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0235449	10.1371/journal.pone.0235449	http://dx.doi.org/10.1371/journal.pone.0235449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716916	gold, Green Published			2022-12-26	WOS:000556674500007
J	Krysztofiak, H; Mlynczak, M; Malek, LA; Folga, A; Braksator, W				Krysztofiak, Hubert; Mlynczak, Marcel; Malek, Lukasz A.; Folga, Andrzej; Braksator, Wojciech			Left ventricular mass normalization in child and adolescent athletes must account for sex differences	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-SURFACE AREA; PHYSICAL-ACTIVITY; AMERICAN SOCIETY; EUROPEAN ASSOCIATION; HEALTHY INFANTS; OXYGEN-UPTAKE; HYPERTROPHY; SIZE; ADULTS	Background To assess left ventricular hypertrophy, actual left ventricular mass (LVM) normalized for body size has to be compared to the LVM normative data. However, only some published normative echocardiographic data have been produced separately for girls and boys; numerous normative data for the pediatric population are not sex-specific. Thus, this study aimed to assess whether the LVM normative data should be developed separately for girls and boys practicing sports. Methods Left ventricular mass was computed for 331 girls and 490 boys, 5-19 years old, based on echocardiography. The effect of sex on the relationship between LVM and body size was evaluated using a linear regression model. Seven sets of the LVM normative data were developed, using different methodologies, to test concordance between sex-specific and non-specific normative data. Every set consisted of normative data that was sex-specific and non-specific. Upon these normative data, for every study participant, seven pairs of LVM z-scores were calculated based on her/his actual LVM. Each pair consisted of z-scores computed based on sex-specific and non-specific normative data from the same set. Results The regression lines fitted to the data points corresponding to LVM of boys had a higher slope than of girls, indicating that sex affects the relationship between LVM and body size. The mean differences between the paired LVM z-scores differed significantly from 0. The percentage of discordant indications, depending on the normalization method, ranged from 66.7% to 100% in girls and from 35.4% to 50% in boys. Application of the LVM normative data that were not sex-specific made relative LVM underestimated in girls and overestimated in boys. Conclusion The LVM normative data should be developed separately for girls and boys practicing sports. Application of normative data that are not sex-specific results in an underestimation of relative LVM in girls and overestimation in boys.	[Krysztofiak, Hubert] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland; [Krysztofiak, Hubert; Folga, Andrzej] Natl Ctr Sports Med, Warsaw, Poland; [Mlynczak, Marcel] Warsaw Univ Technol, Inst Metrol & Biomed Engn, Fac Mechatron, Warsaw, Poland; [Malek, Lukasz A.] Natl Inst Cardiol, Dept Epidemiol Cardiovasc Dis Prevent & Hlth Prom, Warsaw, Poland; [Braksator, Wojciech] Med Univ Warsaw, Med Fac 2, Dept Sports Cardiol & Noninvas Cardiovasc Imaging, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Warsaw University of Technology; Institute of Cardiology - Poland; Medical University of Warsaw	Krysztofiak, H (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland.; Krysztofiak, H (corresponding author), Natl Ctr Sports Med, Warsaw, Poland.	hkrysztofiak@imdik.pan.pl	Krysztofiak, Hubert/L-8083-2019; Młyńczak, Marcel/L-1509-2016; Braksator, Wojciech/N-2197-2018	Krysztofiak, Hubert/0000-0003-4567-1433; Młyńczak, Marcel/0000-0001-8549-7973; Malek, Lukasz/0000-0002-9586-0163; Braksator, Wojciech/0000-0003-2201-4887				ALBRECHT GH, 1993, AM J PHYS ANTHROPOL, V91, P441, DOI 10.1002/ajpa.1330910404; ARMSTRONG N, 1991, EUR J APPL PHYSIOL, V62, P369, DOI 10.1007/BF00634975; Barbieri A, 2012, EUR HEART J-CARD IMG, V13, P109, DOI 10.1093/ejechocard/jer176; Barczuk-Falecka M, 2018, PEDIATR CARDIOL, V39, P948, DOI 10.1007/s00246-018-1844-5; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cantinotti M, 2014, J AM SOC ECHOCARDIOG, V27, P339, DOI 10.1016/j.echo.2013.12.002; Chinali M, 2016, J PEDIATR-US, V170, P193, DOI 10.1016/j.jpeds.2015.10.085; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; DANIELS SR, 1988, J AM COLL CARDIOL, V12, P703, DOI 10.1016/S0735-1097(88)80060-3; DANIELS SR, 1995, CIRCULATION, V92, P3249, DOI 10.1161/01.CIR.92.11.3249; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Diaz A, 2019, PEDIATR CARDIOL, V40, P283, DOI 10.1007/s00246-018-2000-y; Eiberg S, 2005, BRIT J SPORT MED, V39, P725, DOI 10.1136/bjsm.2004.015230; Foster BJ, 2008, CIRCULATION, V117, P2769, DOI 10.1161/CIRCULATIONAHA.107.741157; Foster BJ, 2016, J AM SOC ECHOCARDIOG, V29, P441, DOI 10.1016/j.echo.2015.12.011; Foster BJ, 2013, J AM SOC ECHOCARDIOG, V26, P410, DOI 10.1016/j.echo.2012.11.018; Foster BJ, 2012, ANN HUM BIOL, V39, P171, DOI 10.3109/03014460.2012.681800; George K, 2012, BRIT J SPORT MED, V46, P29, DOI 10.1136/bjsports-2012-091141; GOBLE MM, 1992, CIRCULATION, V85, P1661, DOI 10.1161/01.CIR.85.5.1661; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hense HW, 1998, J AM COLL CARDIOL, V32, P451, DOI 10.1016/S0735-1097(98)00240-X; Huang ZZ, 2020, SCAND J MED SCI SPOR, V30, P1033, DOI 10.1111/sms.13645; Kampmann C, 2000, HEART, V83, P667, DOI 10.1136/heart.83.6.667; Khoury PR, 2009, J AM SOC ECHOCARDIOG, V22, P709, DOI 10.1016/j.echo.2009.03.003; Krysztofiak H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225287; Krysztofiak H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217637; Krysztofiak H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205459; Krysztofiak H, 2019, PEDIATR CARDIOL, V40, P204, DOI 10.1007/s00246-018-1982-9; Kuch B, 2001, J HYPERTENS, V19, P135, DOI 10.1097/00004872-200101000-00018; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; LAUER MS, 1994, AM J CARDIOL, V74, P487, DOI 10.1016/0002-9149(94)90909-1; Leon AS, 1997, INT J SPORTS MED, V18, pS208, DOI 10.1055/s-2007-972717; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lopez L, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006979; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Majonga ED, 2017, INT J CARDIOL, V248, P409, DOI 10.1016/j.ijcard.2017.06.109; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Pela G, 2016, EUR J PREV CARDIOL, V23, P777, DOI 10.1177/2047487315608826; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; Pelliccia A, 1996, JAMA-J AM MED ASSOC, V276, P211, DOI 10.1001/jama.276.3.211; Pelliccia A, 2018, EUR HEART J, V39, P1949, DOI 10.1093/eurheartj/ehx532; Pettersen MD, 2008, J AM SOC ECHOCARDIOG, V21, P922, DOI 10.1016/j.echo.2008.02.006; Rowland T, 2016, PEDIATR EXERC SCI, V28, P345, DOI 10.1123/pes.2015-0239; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schieken RM, 1998, CIRCULATION, V97, P1901, DOI 10.1161/01.CIR.97.19.1901; Sesso HD, 2000, CIRCULATION, V102, P975, DOI 10.1161/01.CIR.102.9.975; Sharma S, 2002, J AM COLL CARDIOL, V40, P1431, DOI 10.1016/S0735-1097(02)02270-2; Whalley GA, 2004, J AM COLL CARDIOL, V44, P892, DOI 10.1016/j.jacc.2004.04.051	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236632	10.1371/journal.pone.0236632	http://dx.doi.org/10.1371/journal.pone.0236632			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716972	gold, Green Published			2022-12-26	WOS:000556674500038
J	Gietel-Basten, S; Saucedo, SEG; Scherbov, S				Gietel-Basten, Stuart; Saucedo, Silvia E. Giorguli; Scherbov, Sergei			Prospective measures of aging for Central and South America	PLOS ONE			English	Article							LATIN-AMERICA; LIFE EXPECTANCY; EPIDEMIOLOGIC TRANSITION; PENSION REFORM; EAST-ASIA; OLD-AGE; POPULATION; MORTALITY; HEALTH; DEPENDENCY	By conventional measures, it is often remarked that Central and South America is one of the fastest aging geographic regions in the world. In recent years, however, scholars have sought to problematize the orthodox measures and concepts employed in the aging literature. By not taking dynamic changes in life expectancy into account, measures which hold chronological age constant (e.g. defining a boundary to old age at 60 or 65) represent a very narrow view of population aging. Furthermore, such constant measures may misrepresent differences between territories when performing a comparative analysis. Prospective measures based on the number of years until death present an alternative approach which can adapt to dynamic changes in life expectancy and differences over time and space. The objective of this paper, then, is to apply the new 'prospective' measures of aging to the territories of Central and South America. We calculate prospective median age; an alternative old-age threshold based on the age at which remaining life expectancy is 15 years, and calculate prospective old-age dependency ratio for 1950-2100 using estimated and projected life tables from the latest iteration of the UN's World Population Prospects. These new measures present a very different view of aging in Central and South America. While there are significant differences across countries, the pace and scale of aging are considerably slower and diminished when compared to standard, orthodox measures based on fixed chronological ages. Applying these new measures can not only serve to present a more realistic view of aging which maps onto demographic reality but can also serve to reconceptualize and reframe the issue as something which is far more manageable (e.g. through institutional reform) than is often perceived to be.	[Gietel-Basten, Stuart] Hong Kong Univ Sci & Technol, Div Social Sci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China; [Gietel-Basten, Stuart] Hong Kong Univ Sci & Technol, Div Publ Policy, Kowloon, Clear Water Bay, Hong Kong, Peoples R China; [Saucedo, Silvia E. Giorguli] Colegio Mexico, Mexico City, DF, Mexico; [Scherbov, Sergei] Int Inst Appl Syst Anal, World Populat Program, Laxenburg, Austria; [Scherbov, Sergei] Russian Presidential Acad Natl Econ & Publ Adm, Int Lab Demog & Human Capital, Moscow, Russia	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Colegio de Mexico; International Institute for Applied Systems Analysis (IIASA); Russian Presidential Academy of National Economy & Public Administration	Gietel-Basten, S (corresponding author), Hong Kong Univ Sci & Technol, Div Social Sci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China.; Gietel-Basten, S (corresponding author), Hong Kong Univ Sci & Technol, Div Publ Policy, Kowloon, Clear Water Bay, Hong Kong, Peoples R China.	sgb@ust.hk		Scherbov, Sergei/0000-0002-0881-1073	European Research Council [European Union] [323947]	European Research Council [European Union](European Research Council (ERC))	SS: Grant no. 323947. European Research Council [European Union Seventh Framework Programme (FP7/2007-2013). Project Name: Reassessing Aging from a Population Perspective, Re-Ageing. https://erc.europa.eu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2015, LANCET, V386, P1407, DOI 10.1016/S0140-6736(15)60170-2; Albala C, 1997, REV MED CHILE, V125, P719; Albala C, 1995, PUBLIC HEALTH, V109, P431, DOI 10.1016/S0033-3506(95)80048-4; Alvarez JA, 2020, POP STUD-J DEMOG, V74, P75, DOI 10.1080/00324728.2019.1614651; Andrade F, 2009, REV PANAM SALUD PUBL, V26, P9, DOI 10.1590/S1020-49892009000700002; ARRIAGA EE, 1969, DEMOGRAPHY, V6, P223, DOI 10.2307/2060393; BAHR J, 1993, SOC SCI MED, V36, P1373, DOI 10.1016/0277-9536(93)90230-2; Solano CB, 2019, ROUT STUD LAT AM POL, P29; Barrientos A, 2000, HEALTH POLICY PLANN, V15, P417, DOI 10.1093/heapol/15.4.417; Basten S, 2014, SOCIOECONOMIC IMPACT, P1; Basten S, 2013, FUTURE FERTILITY LOW; Basten S, 2013, ASIAN SOC WORK POLIC, V7, P242, DOI 10.1111/aswp.12015; Basten S, 2013, ASIAN POPUL STUD, V9, P322, DOI 10.1080/17441730.2013.836394; Basten S, 2013, J POPUL RES, V30, P249, DOI 10.1007/s12546-013-9113-1; Basten S, 2013, DEMOGR RES, V28, P1145, DOI 10.4054/DemRes.2013.28.39; Calvo E, 2008, J AGING STUD, V22, P74, DOI 10.1016/j.jaging.2007.02.004; Chik, 2020, SUSTAINABLE DEV GOAL; De Souza LR, 2019, J ECON AGEING, V13, P72, DOI 10.1016/j.jeoa.2018.03.008; Dorling D, 2017, WHY DEMOGRAPHY MATTE; Fanta J., 2018, BUILDING EVIDENCE AC, P385; Flamini Valentina, 2018, GROWING PAINS IS LAT; Frenk J, 1994, Notas Poblacion, V22, P79; Gietel-Basten S, 2019, J POPUL AGEING, P1; Gietel-Basten S, 2019, AUSTRALAS J AGEING, V38, pE98, DOI 10.1111/ajag.12692; Gietel-Basten S, 2015, ASIAN POPUL STUD, V11, P191, DOI 10.1080/17441730.2015.1052201; Graebner W., 1980, HIST RETIREMENT MEAN; Hessel P, 2020, SOC SCI MED, V267, DOI 10.1016/j.socscimed.2019.112378; Huenchuan S., 2003, AGEING SOLIDARITY SO; ILO, 2018, 2018 LAB OV LAT AM C; Kritzer Barbara E, 2011, Soc Secur Bull, V71, P35; Lee RD, 2012, POPULATION AGING GEN, P598; Leeson G., 2013, AGENDA ENVEJECIMIENT, P53; Mc Rose A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-127; Mesa-Lago C, 2002, WORLD DEV, V30, P1309, DOI 10.1016/S0305-750X(02)00048-7; Mesa-Lago C, 2008, REASSEMBLING SOCIAL; Murray CJL, 2018, LANCET, V392, P1995, DOI [10.1016/S0140-6736(18)32278-5, 10.1016/s0140-6736(18)32278-5]; Ofori-Asenso R, 2018, J POPUL AGEING, V11, P367, DOI 10.1007/s12062-017-9203-5; PALLONI A, 1981, POPUL DEV REV, V7, P623, DOI 10.2307/1972801; Palloni A, 2002, INT J EPIDEMIOL, V31, P762, DOI 10.1093/ije/31.4.762; Palloni Alberto, 2014, Int J Sociol Fam, V40, P199; Payne G, 2007, MILBANK Q, V85, P213, DOI 10.1111/j.1468-0009.2007.00485.x; Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109; Rosero-Bixby L, 2011, POPUL DEV REV, V37, P143, DOI 10.1111/j.1728-4457.2011.00381.x; Saad PM, 2011, DIR DEV, P43; Sanderson WC, 2007, DEMOGR RES, V16, P27, DOI 10.4054/DemRes.2007.16.2; Sanderson WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179171; Sanderson WC, 2015, POPUL DEV REV, V41, P687, DOI 10.1111/j.1728-4457.2015.00091.x; Sanderson WC, 2013, POPUL DEV REV, V39, P673, DOI 10.1111/j.1728-4457.2013.00633.x; Sanderson WC, 2010, SCIENCE, V329, P1287, DOI 10.1126/science.1193647; Scherbov S., 2014, PROSPECTIVE MEASURES; Scherbov S, 2014, WORLD POPULATION HUM; Scherbov S, 2016, AUSTRALAS J AGEING, V35, P139, DOI 10.1111/ajag.12267; Social Security Administration, 2017, SOC SEC PROGR THROUG; Steel K, 1997, DISABIL REHABIL, V19, P130, DOI 10.3109/09638289709166516; Steering Committee for the Workshop on Strengthening the Scientific Foundation for Policymaking to Meet the Challenges of Aging in Latin America and the Caribbean Committee on Population Division of Behavioral and Social Sciences and Education The National Academies of Sciences Engineering and Medicine, 2015, STRENGTH SCI FDN POL; United Nations, 2002, POL DECL MADR INT PL; UNPD, 2019, WORLD POPULATION PRO; Wong R., 2009, INT HDB POPULATION A, P231, DOI 10.1007/978-1-4020-8356-3_11; 2014, METAFORMS, V2, P1	59	6	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236280	10.1371/journal.pone.0236280	http://dx.doi.org/10.1371/journal.pone.0236280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OD5ZL	32706837	gold, Green Published, Green Accepted			2022-12-26	WOS:000579931700021
J	Han, DL; Zhang, R; Yu, GL; Jiang, L; Li, D; Li, JQ				Han, Dianlei; Zhang, Rui; Yu, Guolong; Jiang, Lei; Li, Dong; Li, Jianqiao			Study on bio-inspired feet based on the cushioning and shock absorption characteristics of the ostrich foot	PLOS ONE			English	Article							STRUTHIO-CAMELUS; MECHANICAL-PROPERTIES; BIPEDAL LOCOMOTION; AFRICAN ELEPHANTS; WALKING; GAIT; DYNAMICS; JOINT; TISSUE; SPEED	As the main actuator of high-speed running, the ostrich feet are highly capable of cushioning and shock absorption. In this study, based on the elastic modulus scales and assembly order of the 3rd toe soft tissues and the functions of the metatarsophalangeal (MTP) joint, we designed fourteen bio-inspired feet. The impact process on loose sand was simulated on the finite element software Abaqus. Also the stress distributions and deformations of each component of the bio-inspired feet were clarified. With the peak acceleration as the index, the cushioning performances of the bio-inspired feet were compared on both loose sand and solid ground through height-variable impact tests. The 15-15-15 HA (hardness unit) bio-inspired foot showed lower peak acceleration and thereby better cushioning performance, but larger deformation, less-uniform stress distribution and thereby lower stability than the 15-35-55 HA bio-inspired foot. In fact, the silicon rubbers with different hardness degrees (which simulate the elasticity modulus scales of the digital cushions, fascia and skin) and the spring mechanism (which simulates the functions of the MTP joint) work as an "integrated system" of cushioning and shock absorption.	[Han, Dianlei; Zhang, Rui; Yu, Guolong; Li, Jianqiao] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Peoples R China; [Jiang, Lei] China North Vehicle Res Inst, Beijing, Peoples R China; [Li, Dong] Beijing Inst Spacecraft Environm Engn, Beijing, Peoples R China	Jilin University	Zhang, R (corresponding author), Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Peoples R China.	zhangrui@jlu.edu.cn		Zhang, Rui/0000-0001-9933-2475	National Natural Science Foundation of China [51675221, 91748211]; Science and Technology Development Planning Project of Jilin Province of China [20180101077JC]; Science and Technology Research Project in the 13th Five-Year Period of Education Department of Jilin Province [JJKH20190134KJ]; Graduate Innovation Fund of Jilin University [101832018C006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Project of Jilin Province of China; Science and Technology Research Project in the 13th Five-Year Period of Education Department of Jilin Province; Graduate Innovation Fund of Jilin University(Jilin University)	This work was supported by the National Natural Science Foundation of China (No. 51675221, 91748211), the Science and Technology Development Planning Project of Jilin Province of China (No. 20180101077JC), the Science and Technology Research Project in the 13th Five-Year Period of Education Department of Jilin Province (No. JJKH20190134KJ), and the Graduate Innovation Fund of Jilin University (No. 101832018C006).	Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; Aguilar J, 2016, NAT PHYS, V12, P278, DOI 10.1038/NPHYS3568; ALEXANDER RM, 1991, J EXP BIOL, V160, P55; ALEXANDER RM, 1979, J ZOOL, V187, P169; BENNETT MB, 1986, J ZOOL, V209, P537, DOI 10.1111/j.1469-7998.1986.tb03609.x; BENNETT MB, 1988, J ZOOL, V214, P343, DOI 10.1111/j.1469-7998.1988.tb04727.x; Biewener AA, 2006, J EXP ZOOL PART A, V305A, P899, DOI 10.1002/jez.a.334; Cotton S, 2012, IEEE INT CONF ROBOT, P2358, DOI 10.1109/ICRA.2012.6225250; Daley MA, 2016, J EXP BIOL, V219, P3301, DOI [10.1242/jeb.142588, 10.1242/jeb.104646]; Derbalah Amira Eid, 2012, Research Opinions in Animal & Veterinary Sciences, V2, P19; Ding L, 2013, INT J ROBOT RES, V32, P1585, DOI 10.1177/0278364913498122; Egerbacher M, 2005, ANAT HISTOL EMBRYOL, V34, P112, DOI 10.1111/j.1439-0264.2004.00581.x; El-Gendy SAA, 2012, VET RES COMMUN, V36, P129, DOI 10.1007/s11259-012-9522-1; Faramarzi B, 2017, CAN J VET RES, V81, P285; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Genin JJ, 2010, J EXP BIOL, V213, P694, DOI 10.1242/jeb.035436; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Gilardi G, 2002, MECH MACH THEORY, V37, P1213, DOI 10.1016/S0094-114X(02)00045-9; Goldman D, 2009, IEEE SPECTRUM, V46, P30, DOI 10.1109/MSPEC.2009.4808384; [黄晗 Huang Han], 2017, [吉林大学学报. 工学版, Journal of Jilin University. Engineering and Technology Edition], V47, P1194; Hutchinson JR, 2006, J EXP BIOL, V209, P3812, DOI 10.1242/jeb.02443; Hutchinson JR, 2015, PEERJ, V3, DOI 10.7717/peerj.1001; Kang WT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03344-3; Lamas LP, 2014, PEERJ, V2, DOI 10.7717/peerj.716; Li C, 2013, SCIENCE, V339, P1408, DOI 10.1126/science.1229163; Liu JD, 1996, THEORY VEHICLE DRIVI; Miao HB, 2017, BIOL OPEN, V6, P1889, DOI 10.1242/bio.024828; Michael K., 2012, CONVERSATION; Nelson G.M., 2012, J ROBOTICS SOC JAPAN, V30, P372, DOI [DOI 10.7210/JRSJ.30.372, 10.7210/jrsj.30.372]; Neuhaus PD, 2011, INT J ROBOT RES, V30, P216, DOI 10.1177/0278364910390538; Pantelis DI, 2002, SURF COAT TECH, V161, P125, DOI 10.1016/S0257-8972(02)00495-4; Qiu LJ, 1989, FINITE ELEMENT METHO; Raibert M., 2008, IFAC P, V41, P10822, DOI [10.3182/20080706-5-KR-1001.01833, DOI 10.3182/20080706-5-KR-1001.01833]; Rankin JW, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0035; Ren L, 2008, J R SOC INTERFACE, V5, P195, DOI 10.1098/rsif.2007.1095; Ren L, 2010, P NATL ACAD SCI USA, V107, P7078, DOI 10.1073/pnas.0911396107; Rubenson J, 2004, P ROY SOC B-BIOL SCI, V271, P1091, DOI 10.1098/rspb.2004.2702; Rubenson J, 2007, J EXP BIOL, V210, P2548, DOI 10.1242/jeb.02792; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Sakagami Y, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2478, DOI 10.1109/IRDS.2002.1041641; Schaller N.U., 2011, SCI SCH, V21, P12; Schaller NU, 2011, J EXP BIOL, V214, P1123, DOI 10.1242/jeb.043596; [孙卫东 Sun Weidong], 2010, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P2457; Thorpe CT, 2015, EQUINE VET J, V47, P137, DOI 10.1111/evj.12346; Thorpe CT, 2012, J R SOC INTERFACE, V9, P3108, DOI 10.1098/rsif.2012.0362; Tian WJ, 2011, J BIONIC ENG, V8, P18, DOI 10.1016/S1672-6529(11)60002-4; van der Meer D, 2017, ANNU REV FLUID MECH, V49, P463, DOI 10.1146/annurev-fluid-010816-060213; Watson RR, 2011, P ROY SOC B-BIOL SCI, V278, P2040, DOI 10.1098/rspb.2010.2022; Weissengruber GE, 2006, J ANAT, V209, P781, DOI 10.1111/j.1469-7580.2006.00648.x; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zhang R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216141; Zhang R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191986; Zhang R, 2018, J MORPHOL, V279, P302, DOI 10.1002/jmor.20772; Zhang R, 2017, PEERJ, V5, DOI 10.7717/peerj.3613; Zhang R, 2016, BIOMED RES-INDIA, V27, P1416; Zhang R, 2017, PEERJ, V5, DOI 10.7717/peerj.2857; Zhang R, 2016, INDIAN J ANIM RES, V50, P476, DOI 10.18805/ijar.9300; Zhang Xiaopeng, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P1098	59	2	2	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236324	10.1371/journal.pone.0236324	http://dx.doi.org/10.1371/journal.pone.0236324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706841	Green Published, gold			2022-12-26	WOS:000579931700026
J	Remigio-Baker, RA; Kiser, S; Ferdosi, H; Gregory, E; Engel, S; Sebesta, S; Beauchamp, D; Malik, S; Scher, AI; Hinds, II				Remigio-Baker, Rosemay A.; Kiser, Seth; Ferdosi, Hamid; Gregory, Emma; Engel, Scot; Sebesta, Sean; Beauchamp, Daniel; Malik, Saafan; Scher, Ann, I; Hinds, Sidney R., II			Current patterns of primary care provider practices for the treatment of post-traumatic headache in active duty military settings	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PREVALENCE; CONCUSSION; SOLDIERS	Objective To provide a preliminary assessment of the current clinical practice for the treatment of post-traumatic headache following concussion in military primary health care settings. Background Headache is one of the most common symptoms post-concussion; however, little is known of the current clinical practices of primary care providers (on the treatment of post-traumatic headache), particularly in military settings. Methods Study participants were primary care providers (n = 65) who treated active duty Service members suffering from post-traumatic headache at two military installations. Qualitative data gathered via semi-structured interviews were used to describe provider practices and experience in treating patients with post-traumatic headache. Results Some patterns of care across primary care providers treating post-traumatic headache were consistent with the Department of Defense-recommended clinical recommendation (e.g., recommendation of both pharmacological and non-pharmacological treatment [89.4%]; engaging in follow-up care [100%]). Differences existed in timing of follow-up from initial visit [16.9% reporting within 24 hours; 21.5% reporting within 48-72 hours; and 26.2% reporting more than 1 week], the factors contributing to the type of care given (e.g., symptomatology [33.0%], injury characteristic [24.2%], patient characteristic [13.2%]) and the need for referral to higher level of care (e.g., symptomatology [44.6%], treatment failure [25.0%]). These variations may be indicative of individualized treatment which would be compliant with best clinical practice. Conclusion The results of this study demonstrate the current clinical practice in military primary care settings for the treatment of post-traumatic headache which can potentially inform and improve implementation of provider training and education.	[Remigio-Baker, Rosemay A.; Kiser, Seth; Ferdosi, Hamid; Gregory, Emma; Malik, Saafan] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Remigio-Baker, Rosemay A.] Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Remigio-Baker, Rosemay A.] Naval Hosp Camp Pendleton, Camp Pendleton, CA 92055 USA; [Kiser, Seth; Ferdosi, Hamid] Gen Dynam Informat Technol, Falls Church, VA USA; [Engel, Scot] Intrepid Spirit Ctr, Ft Hood, TX USA; [Sebesta, Sean; Beauchamp, Daniel] Intrepid Spirit Ctr, Ft Bliss, TX USA; [Scher, Ann, I] Uniformed Serv Univ Hlth Sci, Prevent Med & Biostat, Bethesda, MD USA; [Hinds, Sidney R., II] Uniformed Serv Univ Hlth Sci, Neurol, Bethesda, MD USA	United States Department of Defense; United States Army; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Remigio-Baker, RA (corresponding author), Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA.; Remigio-Baker, RA (corresponding author), Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.; Remigio-Baker, RA (corresponding author), Naval Hosp Camp Pendleton, Camp Pendleton, CA 92055 USA.	rremigiobaker@gmail.com		Scher, Ann/0000-0003-4599-9834; Remigio-Baker, Rosemay/0000-0002-1713-5839	Defense and Veterans Brain Injury Center; MRMC JPC-6 Neurotrauma [NT160002]	Defense and Veterans Brain Injury Center(US Department of Veterans Affairs); MRMC JPC-6 Neurotrauma	This study was funded by the Defense and Veterans Brain Injury Center and MRMC JPC-6 Neurotrauma (award number NT160002). RR-B was employed by the Henry M. Jackson Foundation for the Advancement of Military Medicine; SK and HF were employed by the General Dynamics Information Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSARA, 2017, DIS EV SYST AN RES A; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Defense and Veterans Brain Injury Center, MAN HEAD FOLL CONC M; Defense and Veterans Brain Injury Center, 2019, CONC MAN TOOL PUID 4; Defense & Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Hinds Ii Sidney R, 2016, US Army Med Dep J, P97; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S., 2015, BRAIN NEUROTRAUMA; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Martins Hugo André de Lima, 2012, Dement. neuropsychol., V6, P53, DOI 10.1590/S1980-57642012DN06010009; Metti A, 2019, NEUROLOGY; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236762	10.1371/journal.pone.0236762	http://dx.doi.org/10.1371/journal.pone.0236762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706834	gold, Green Published			2022-12-26	WOS:000579931700061
J	Tanaka, N; Okuda, M; Nishigaki, T; Tsuchiya, N; Kobayashi, Y; Uemura, T; Kumo, S; Sugimoto, H; Miyata, S; Waku, T				Tanaka, Naoki; Okuda, Michiaki; Nishigaki, Tatsutoshi; Tsuchiya, Nobuhiko; Kobayashi, Yukako; Uemura, Takuya; Kumo, Sayaka; Sugimoto, Hachiro; Miyata, Seiji; Waku, Tomonori			Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; A-BETA-OLIGOMERS; CHAPERONE-LIKE; FUNCTIONAL ELEMENT; IN-VITRO; DELIVERY; MECHANISM; TOXICITY	Alzheimer's disease (AD) is proposed to be induced by abnormal aggregation of amyloid beta in the brain. Here, we designed a brain-permeable peptide nanofiber drug from a fragment of heat shock protein to suppress aggregation of the pathogenic proteins. To facilitate delivery of the nanofiber into the brain, a protein transduction domain from Drosophila Antennapedia was incorporated into the peptide sequence. The resulting nanofiber efficiently suppressed the cytotoxicity of amyloid beta by trapping amyloid beta onto its hydrophobic nanofiber surface. Moreover, the intravenously or intranasally injected nanofiber was delivered into the mouse brain, and improved the cognitive function of an Alzheimer transgenic mouse model. These results demonstrate the potential therapeutic utility of nanofibers for the treatment of AD.	[Tanaka, Naoki; Nishigaki, Tatsutoshi; Tsuchiya, Nobuhiko; Kobayashi, Yukako; Uemura, Takuya; Kumo, Sayaka; Waku, Tomonori] Kyoto Inst Technol, Fac Mol Chem & Engn, Kyoto, Japan; [Okuda, Michiaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Kyoto, Japan; [Sugimoto, Hachiro] Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan; [Miyata, Seiji] Kyoto Inst Technol, Fac Appl Biol, Kyoto, Japan	Kyoto Institute of Technology; Kyoto University; Doshisha University; Kyoto Institute of Technology	Waku, T (corresponding author), Kyoto Inst Technol, Fac Mol Chem & Engn, Kyoto, Japan.	waku1214@kit.ac.jp		Okuda, Michiaki/0000-0002-0211-7144	Japan Society for the Promotion of Science (JSPS) through KAKENHI [16K14034, 19K12800]	Japan Society for the Promotion of Science (JSPS) through KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	NT and TW acknowledges the financial support of the Japan Society for the Promotion of Science (JSPS) through KAKENHI (No. 16K14034 and 19K12800). https://www.jsps.go.jp/, https://www.jsps.go.jp/english/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2011, ARCH MED SCI, V7, P102, DOI 10.5114/aoms.2011.20612; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Banerjee PR, 2015, BIOCHEMISTRY-US, V54, P505, DOI 10.1021/bi5014479; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Dietz GPH, 2005, BRAIN RES BULL, V68, P103, DOI 10.1016/j.brainresbull.2005.08.015; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Doig AJ, 2007, CURR OPIN DRUG DISC, V10, P533; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Fukuhara S, 2012, BIOCHEMISTRY-US, V51, P5394, DOI 10.1021/bi3004236; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Goedert M, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P195; Goto Y, 2008, CURR PHARM DESIGN, V14, P3205, DOI 10.2174/138161208786404146; Hattori M, 2008, BIOCHEM BIOPH RES CO, V374, P158, DOI 10.1016/j.bbrc.2008.07.001; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Kamei N, 2015, J CONTROL RELEASE, V197, P105, DOI 10.1016/j.jconrel.2014.11.004; Kanazawa T, 2013, BIOMATERIALS, V34, P9220, DOI 10.1016/j.biomaterials.2013.08.036; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Konno T, 2001, BIOCHEMISTRY-US, V40, P2148, DOI 10.1021/bi002156h; Kurnellas MP, 2014, J EXP MED, V211, P1847, DOI 10.1084/jem.20140107; Kurnellas MP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005681; Kurnellas MP, 2012, J BIOL CHEM, V287, P36423, DOI 10.1074/jbc.M112.371229; Kurnellas MP, 2015, P NATL ACAD SCI USA, V112, P15016, DOI 10.1073/pnas.1521206112; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Matlack KES, 2014, P NATL ACAD SCI USA, V111, P4013, DOI 10.1073/pnas.1402228111; Mazza M, 2013, ACS NANO, V7, P1016, DOI 10.1021/nn305193d; Minami T, 2016, POLYM J, V48, P197, DOI 10.1038/pj.2015.97; Morita S, 2012, CELL TISSUE RES, V349, P589, DOI 10.1007/s00441-012-1421-9; Nahomi RB, 2013, J BIOL CHEM, V288, P13022, DOI 10.1074/jbc.M112.440214; Tue NT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/252049; Okuyama K, 2008, FEBS J, V275, P1529, DOI 10.1111/j.1742-4658.2008.06312.x; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Parthsarathy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054769; Popiel HA, 2009, NEUROSCI LETT, V449, P87, DOI 10.1016/j.neulet.2008.06.015; Raju M, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201700095; Raju M, 2016, BBA-GEN SUBJECTS, V1860, P246, DOI 10.1016/j.bbagen.2015.06.010; Raju M, 2014, BIOCHEMISTRY-US, V53, P2615, DOI 10.1021/bi4017268; Ryan TM, 2015, J NEUROSCI, V35, P2871, DOI 10.1523/JNEUROSCI.2912-14.2015; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Salloway S, 2011, NEUROLOGY, V77, P1253, DOI 10.1212/WNL.0b013e3182309fa5; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Sharoar MG, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-104; Sreekumar PG, 2013, INVEST OPHTH VIS SCI, V54, P2787, DOI 10.1167/iovs.12-11571; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Thapa A, 2011, BIOCHEMISTRY-US, V50, P2445, DOI 10.1021/bi101731d; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Waku T, 2013, CHEM LETT, V42, P1441, DOI 10.1246/cl.130693; Wang ZR, 2014, ACS CHEM NEUROSCI, V5, P952, DOI 10.1021/cn500119g; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang HN, 2013, NEUROSCI LETT, V556, P63, DOI 10.1016/j.neulet.2013.09.063; Yao TM, 2003, J BIOCHEM, V134, P91, DOI 10.1093/jb/mvg116	62	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0235979	10.1371/journal.pone.0235979	http://dx.doi.org/10.1371/journal.pone.0235979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706773	gold, Green Published			2022-12-26	WOS:000579931700014
J	Osman, MM; Neyrolles, O; Pagan, AJ; Shanahan, JK; Ramakrishnan, L				Osman, Morwan M.; Neyrolles, Olivier; Pagan, Antonio J.; Shanahan, Jonathan K.; Ramakrishnan, Lalita			Mycobacterium marinum phthiocerol dimycocerosates enhance macrophage phagosomal permeabilization and membrane damage	PLOS ONE			English	Article							VIRULENCE GENE-CLUSTER; BOVIS BCG; TUBERCULOSIS; AUTOPHAGY; LOCUS; RD1; REPLICATION; SECRETION; GRANULOMA; VACCINES	Phthiocerol dimycocerosates (PDIMs) are a class of mycobacterial lipids that promote virulence in Mycobacterium tuberculosis and Mycobacterium marinum. It has recently been shown that PDIMs work in concert with the M. tuberculosis Type VII secretion system ESX-1 to permeabilize the phagosomal membranes of infected macrophages. As the zebrafish-M. marinum model of infection has revealed the critical role of PDIM at the host-pathogen interface, we set to determine if PDIMs contributed to phagosomal permeabilization in M. marinum. Using an Delta mmpL7 mutant defective in PDIM transport, we find the PDIM-ESX-1 interaction to be conserved in an M. marinum macrophage infection model. However, we find PDIM and ESX-1 mutants differ in their degree of defect, with the PDIM mutant retaining more membrane damaging activity. Using an in vitro hemolysis assay-a common surrogate for cytolytic activity, we find that PDIM and ESX-1 differ in their contributions: the ESX-1 mutant loses hemolytic activity while PDIM retains it. Our observations confirm the involvement of PDIMs in phagosomal permeabilization in M. marinum infection and suggest that PDIM enhances the membrane disrupting activity of pathogenic mycobacteria and indicates that the role they play in damaging phagosomal and red blood cell membranes may differ.	[Osman, Morwan M.; Neyrolles, Olivier; Pagan, Antonio J.; Shanahan, Jonathan K.; Ramakrishnan, Lalita] Univ Cambridge, MRC, Lab Mol Biol, Dept Med,Mol Immun Unit, Cambridge, England	MRC Laboratory Molecular Biology; University of Cambridge	Ramakrishnan, L (corresponding author), Univ Cambridge, MRC, Lab Mol Biol, Dept Med,Mol Immun Unit, Cambridge, England.	lr404@cam.ac.uk		Shanahan, Jonathan/0000-0002-8833-7630; Ramakrishnan, Lalita/0000-0003-0692-5533; Osman, Morwan/0000-0002-5361-743X	NIH [R37AI054503]; Wellcome Trust [103950/Z/14/Z, 105388/Z/14/Z]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)	Dr. Osman, Dr. Pagan, and Dr. Shanahan were supported by both the NIH R37AI054503 and Wellcome Trust 103950/Z/14/Z awards to Prof. Ramakrishnan. In addition, Dr. Shanahan had his own Wellcome Trust Grant 105388/Z/14/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates LS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005190; Augenstreich J, 2019, P NATL ACAD SCI USA, V116, P25649, DOI 10.1073/pnas.1910368116; Augenstreich J, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12726; Barczak AK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006363; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bosserman RE, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00760-18; Boyle KB, 2019, METHODS MOL BIOL, V1880, P679, DOI 10.1007/978-1-4939-8873-0_45; Boyle KB, 2013, CURR OPIN MICROBIOL, V16, P339, DOI 10.1016/j.mib.2013.03.010; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cambier C., 2019, SPREADING VIRULENCE, DOI [10.1101/845081, DOI 10.1101/845081]; Cambier CJ, 2014, CELL, V159, P1497, DOI 10.1016/j.cell.2014.11.024; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Chauhan S, 2016, DEV CELL, V39, P13, DOI 10.1016/j.devcel.2016.08.003; Cohen SB, 2018, CELL HOST MICROBE, V24, P439, DOI 10.1016/j.chom.2018.08.001; Conrad WH, 2017, P NATL ACAD SCI USA, V114, P1371, DOI 10.1073/pnas.1620133114; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Jia JY, 2018, MOL CELL, V70, P120, DOI 10.1016/j.molcel.2018.03.009; Keller C, 2013, JOVE-J VIS EXP, DOI 10.3791/50116; Kennedy GM, 2014, J BACTERIOL, V196, P1877, DOI 10.1128/JB.01502-14; KING CH, 1993, INFECT IMMUN, V61, P2708, DOI 10.1128/IAI.61.6.2708-2712.1993; Lerner TR, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0471-6; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lienard J, 2020, P NATL ACAD SCI USA, V117, P1160, DOI 10.1073/pnas.1911646117; Lopez-Jimenez AT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007501; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Mittal E, 2018, MBIO, V9, DOI 10.1128/mBio.01765-18; Moreira-Teixeira L, 2018, J EXP MED, V215, P1273, DOI 10.1084/jem.20180325; Phan TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007247; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Quigley J, 2017, MBIO, V8, DOI 10.1128/mBio.00148-17; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Speer A, 2015, MOL MICROBIOL, V97, P881, DOI 10.1111/mmi.13073; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x	44	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0233252	10.1371/journal.pone.0233252	http://dx.doi.org/10.1371/journal.pone.0233252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701962	gold, Green Submitted, Green Published			2022-12-26	WOS:000575913700007
J	Kaliszewski, K; Diakowska, D; Wojtczak, B; Rudnicki, J				Kaliszewski, Krzysztof; Diakowska, Dorota; Wojtczak, Beata; Rudnicki, Jerzy			Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution	PLOS ONE			English	Article							FINE-NEEDLE ASPIRATIONS; INCREASES; TRENDS; GUIDELINES; OPERATIONS; RADIATION; DIAGNOSES; SURGERY; WELL	Background It is estimated that one of the potential cause of the increasing prevalence of thyroid cancer (TC) is the easier and widespread access to diagnostic tools. If an individual evaluates the thyroid gland due to a mentioned mechanism without considering TC risk factors or symptoms, we can describe this phenomenon as cancer screening activity (CSA). Aim of the study We 1) estimated what types of TC were diagnosed due to CSA, 2) analyzed what clinicopathological features were characteristic of TCs diagnosed by CSA, 3) determined if these features were characteristic of indolent cases, and finally we 4) assessed whether CSA could have resulted in the increasing incidence of potentially indolent papillary thyroid cancer (PTC). Materials and methods A retrospective review of 4,701 medical records of patients admitted and surgically treated at one surgical center between 2008 and 2017 was performed. Among the enrolled patients, 569 (12.1%) had thyroid malignancy, and 514 (10.9%) were diagnosed with PTC. We divided these patients into two groups: 1) patients in whom TC diagnostics were performed without considering any TC risk factors or symptoms (CSA-yes) and 2) those in whom TC was diagnosed due to TC risk factors or symptoms (CSA-no). We then compared the clinicopathological features of these two groups. Results The most common type of TC diagnosed in the CSA-group was PTC (p = 0.024). CSA-yes patients showed a significantly lower degree of Tumor-Node-Metastasis (TNM) staging and demonstrated a significantly lower rate of multifocality, but not of bilaterality (p<0.0001 and p = 0.198, respectively). In the CSA-yes group, the number of TC foci was significantly lower than that in the CSA-no group (p<0.0001). All clinicopathological features characteristic of aggressive cases of TC were absent in CSA-yes patients (p<0.0001), while all features observed in CSA-yes patients were characteristic of indolent cases (p<0.0001). Conclusions The use of CSA results in the diagnosis of indolent cases of PTC and may be one of the potential causes of overdiagnosis and overtreatment of this malignancy.	[Kaliszewski, Krzysztof; Wojtczak, Beata; Rudnicki, Jerzy] Wroclaw Med Univ, Dept Gen Minimally Invas & Endocrine Surg, Wroclaw, Poland; [Diakowska, Dorota] Wroclaw Med Univ, Dept Nervous Syst Dis, Fac Hlth Sci, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University	Kaliszewski, K (corresponding author), Wroclaw Med Univ, Dept Gen Minimally Invas & Endocrine Surg, Wroclaw, Poland.	krzysztofkali@wp.pl		Kaliszewski, Krzysztof/0000-0002-3291-5294; Diakowska, Dorota/0000-0002-1377-5601; Wojtczak, Beata/0000-0002-9953-0460; Rudnicki, Jerzy/0000-0001-8575-7595				Ahn HS, 2016, THYROID, V26, P1535, DOI 10.1089/thy.2016.0075; Ahn HS, 2015, NEW ENGL J MED, V373, P2389, DOI 10.1056/NEJMc1507622; Barratt A, 1999, JAMA-J AM MED ASSOC, V281, P2029, DOI 10.1001/jama.281.21.2029; Bosetti C, 2013, ANN ONCOL, V24, P2657, DOI 10.1093/annonc/mdt301; Brawley OW, 2017, ANN INTERN MED, V166, P364, DOI 10.7326/M16-2850; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Carter SM, 2017, PUBLIC HEALTH RES PR, V27, DOI 10.17061/phrp2731722; Carter SM, 2016, J MED ETHICS, V42, P705, DOI 10.1136/medethics-2015-102928; Carter SM, 2015, AM J PREV MED, V49, P274, DOI 10.1016/j.amepre.2015.01.009; Cherenfant J, 2013, SURGERY, V154, P1016, DOI 10.1016/j.surg.2013.04.055; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Evans DGR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0442-6; Fagin JA, 2016, NEW ENGL J MED, V375, P1054, DOI 10.1056/NEJMra1501993; Francis A, 2015, EUR J CANCER, V51, P2296, DOI 10.1016/j.ejca.2015.07.017; Hall P, 1998, ACTA ONCOL, V37, P325, DOI 10.1080/028418698430539; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Jegerlehner S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179387; Kaliszewski K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44931-8; Kaliszewski K, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-019-1638-0; Kaliszewski K, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015609; Kaliszewski K, 2019, CANCER MANAG RES, V11, P2441, DOI 10.2147/CMAR.S198514; Kaliszewski K, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013339; Kaliszewski K, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/4735436; Kaliszewski K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168654; Kaliszewski K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146883; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lewinski A, 2014, ANN AGR ENV MED, V21, P1; Loyo M, 2013, LARYNGOSCOPE, V123, P2056, DOI 10.1002/lary.23923; Marcus PM, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv014; Perrier ND, 2018, CA-CANCER J CLIN, V68, P56, DOI 10.3322/caac.21439; PHAROAH PDP, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2618; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Schnadig VJ, 2018, ARCH PATHOL LAB MED, V142, P1018, DOI 10.5858/arpa.2017-0510-ED; Sosa JA, 2013, SURGERY, V154, P1420, DOI 10.1016/j.surg.2013.07.006; Takamura N, 2016, LANCET DIABETES ENDO, V4, P647, DOI 10.1016/S2213-8587(16)30112-7; UN Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2011, UNSCEAR 2008 REP; Van den Bruel A, 2013, J CLIN ENDOCR METAB, V98, P4063, DOI 10.1210/jc.2013-1705; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wilhelm SM, 2013, SURGERY, V154, P1426; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	42	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236257	10.1371/journal.pone.0236257	http://dx.doi.org/10.1371/journal.pone.0236257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692768	Green Published, gold			2022-12-26	WOS:000554606400011
J	Li, Q; Wang, DP; Bai, DH; Cai, C; Li, J; Yan, CX; Zhang, S; Wu, ZJ; Hao, JJ; Yu, GL				Li, Qiong; Wang, Depeng; Bai, Donghui; Cai, Chao; Li, Jia; Yan, Chengxiu; Zhang, Shuai; Wu, Zhijun; Hao, Jiejie; Yu, Guangli			Photoprotective effect of Astragalus membranaceus polysaccharide on UVA-induced damage in HaCaT cells	PLOS ONE			English	Article							DNA-DAMAGE; ULTRAVIOLET-RADIATION; CHLORELLA-PYRENOIDOSA; OXIDATIVE DAMAGE; SKIN; CANCER; MITOCHONDRIA; RESVERATROL; EXPOSURE; PROTEIN	Background The skin provides a predominant barrier against chemical, physical and microbial incursion. The intemperate exposure to ultraviolet A (UVA) radiation can cause excessive cellular oxidative stress, leading to skin damage, proteins damage and mitochondrial dysfunction. There is sufficient evidences supporting the proposal that mitochondria is highly implicated in skin photo-damage. Methods In the present study, a polysaccharide isolated fromAstragalus membranaceuswas further purified to be an alpha-glucan, which was further investigated its beneficial influence on UVA-induced photo-damage in HaCaT cells. Results Our results showed that the purifiedAstragalus membranaceuspolysaccharide (AP) can protect HaCaT cells from UVA-induced photo-damage through reducing UVA-induced intracellular ROS production and mitochondrial membrane potential, thereby altering ATP content. It was found that the UVA induced damage in HaCaT cells could be effectively restored by co-treatment with AP. Conclusions AP exhibited promising potential for advanced application as multifunctional skin care products and drugs.	[Li, Qiong; Wang, Depeng; Bai, Donghui; Cai, Chao; Li, Jia; Yan, Chengxiu; Zhang, Shuai; Hao, Jiejie; Yu, Guangli] Ocean Univ China, Sch Med & Pharm, Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Li, Qiong; Wang, Depeng; Bai, Donghui; Cai, Chao; Li, Jia; Yan, Chengxiu; Zhang, Shuai; Hao, Jiejie; Yu, Guangli] Ocean Univ China, Sch Med & Pharm, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Peoples R China; [Cai, Chao; Hao, Jiejie; Yu, Guangli] Pilot Natl Lab Marine Sci & Technol Qingdao, Lab Marine Drugs & Bioprod, Qingdao, Peoples R China; [Wu, Zhijun] Infinitus China Co Ltd, Guangzhou, Peoples R China	Ocean University of China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Hao, JJ; Yu, GL (corresponding author), Ocean Univ China, Sch Med & Pharm, Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China.; Hao, JJ; Yu, GL (corresponding author), Ocean Univ China, Sch Med & Pharm, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Peoples R China.; Hao, JJ; Yu, GL (corresponding author), Pilot Natl Lab Marine Sci & Technol Qingdao, Lab Marine Drugs & Bioprod, Qingdao, Peoples R China.	2009haojie@ouc.edu.cn; glyu@ouc.edu.cn		Cai, Chao/0000-0003-4377-3989	National Natural Science Foundation of China [81973231, 81402982]; National Science and Technology Major Project for Significant New Drugs Development [2018ZX09735004]; Taishan Scholar Project Special Fund [TS201511011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project for Significant New Drugs Development; Taishan Scholar Project Special Fund	This work was supported by National Natural Science Foundation of China (81973231, 81402982), National Science and Technology Major Project for Significant New Drugs Development (2018ZX09735004), Taishan Scholar Project Special Fund (TS201511011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Berneburg M, 2005, J INVEST DERMATOL, V125, P213, DOI 10.1111/j.0022-202X.2005.23806.x; [卞云云 BIAN Yunyun], 2006, [中国药学杂志, Chinese Pharmaceutical Journal], V41, P1217; Birch-Machin MA, 2013, BRIT J DERMATOL, V169, P9, DOI 10.1111/bjd.12207; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen YX, 2018, CARBOHYD POLYM, V185, P120, DOI 10.1016/j.carbpol.2017.12.077; Chiang HM, 2015, J AGR FOOD CHEM, V63, P4551, DOI 10.1021/jf502500t; Chiang HM, 2014, FOOD CHEM TOXICOL, V72, P154, DOI 10.1016/j.fct.2014.07.007; Cho S, 2010, DERMATOLOGY, V221, P160, DOI 10.1159/000305548; Chu Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010164; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; de Oliveira MR, 2016, BBA-GEN SUBJECTS, V1860, P727, DOI 10.1016/j.bbagen.2016.01.017; de Oliveira MR, 2015, PHARMACOL RES, V100, P296, DOI 10.1016/j.phrs.2015.08.021; Del Giudice R, 2017, J SCI FOOD AGR, V97, P1622, DOI 10.1002/jsfa.7910; Farris P, 2014, J DRUGS DERMATOL, V13, P1467; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Fisher DE, 2010, NEW ENGL J MED, V363, P901, DOI 10.1056/NEJMp1005999; Ganceviciene R, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.22804; Griesbach U, 2005, GOOGLE PATENTS; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harbottle A, 2006, BRIT J CANCER, V94, P1887, DOI 10.1038/sj.bjc.6603178; HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; He DW, 2011, J FORMOS MED ASSOC, V110, P153, DOI 10.1016/S0929-6646(11)60025-9; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kammeyer A, 2015, AGEING RES REV, V21, P16, DOI 10.1016/j.arr.2015.01.001; Kim KH, 2015, BASIC CLIN PHARMACOL, V116, P73, DOI 10.1111/bcpt.12288; Lamore SD, 2013, J PHOTOCH PHOTOBIO B, V123, P1, DOI 10.1016/j.jphotobiol.2013.03.007; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Liu GY, 2017, J BIOL CHEM, V292, P10672, DOI 10.1074/jbc.M117.783068; Ma JW, 2011, J MED PLANTS RES, V5, P855; Mammone T, 2006, CELL BIOL INT, V30, P903, DOI 10.1016/j.cellbi.2006.06.010; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Naidoo K, 2018, EXP DERMATOL, V27, P124, DOI 10.1111/exd.13476; Park K, 2008, ONCOL REP, V19, P413; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Petruk G, 2016, J PHOTOCH PHOTOBIO B, V163, P284, DOI 10.1016/j.jphotobiol.2016.08.047; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Qin Y, 2018, J APPL TOXICOL, V38, P564, DOI 10.1002/jat.3563; Quiroga RM, 2005, COSMETIC DERMATOLOGY, P1, DOI 10.1007/3-540-27333-6_1; Roding J, 2007, GOOGLE PATENTS; Ruenger TM., 2014, PHOTODERMATOLOGY PHO; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0; Tirosh O, 2000, NEUROSCIENCE, V97, P531, DOI 10.1016/S0306-4522(00)00028-2; Trocoli A, 2011, AM J CANCER RES, V1, P629; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Tyrrell RM, 2012, PHOTOCH PHOTOBIO SCI, V11, P135, DOI 10.1039/c1pp05222e; Tyrrell RM, 2004, ANTIOXID REDOX SIGN, V6, P835, DOI 10.1089/1523086041798033; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wolfle U, 2011, FREE RADICAL BIO MED, V50, P1081, DOI 10.1016/j.freeradbiomed.2011.01.027; Wu PY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040782; Zhang RL, 2018, BIORESOURCE TECHNOL, V247, P267, DOI 10.1016/j.biortech.2017.09.087; Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816	59	7	8	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0235515	10.1371/journal.pone.0235515	http://dx.doi.org/10.1371/journal.pone.0235515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692781	Green Published, gold			2022-12-26	WOS:000554606400015
J	Zhu, YY; Weisshaar, JC; Mustafi, M				Zhu, Yanyu; Weisshaar, James C.; Mustafi, Mainak			Long-term effects of the proline-rich antimicrobial peptide Oncocin112 on theEscherichia colitranslation machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proline-rich antimicrobial peptides; oncocin112 mechanism; ribosome and EF-Tu diffusion; superresolution single-molecule localization and tracking; translation elongation factor; translation regulation; antimicrobial peptide (AMP); fluorescence; microscopy; superresolution imaging	ELONGATION-FACTOR-TU; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; TRANSFER-RNA; TRANSLATION; TRANSCRIPTION; INHIBITION; MICROSCOPY; INITIATION; MECHANISM	Proline-rich antimicrobial peptides (PrAMPs) are cationic antimicrobial peptides unusual for their ability to penetrate bacterial membranes and kill cells without causing membrane permeabilization. Structural studies show that many such PrAMPs bind deep in the peptide exit channel of the ribosome, near the peptidyl transfer center. Biochemical studies of the particular synthetic PrAMP oncocin112 (Onc112) suggest that on reaching the cytoplasm, the peptide occupies its binding site prior to the transition from initiation to the elongation phase of translation, thus blocking further initiation events. We present a superresolution fluorescence microscopy study of the long-term effects of Onc112 on ribosome, elongation factor-Tu (EF-Tu), and DNA spatial distributions and diffusive properties in intactEscherichia colicells. The new data corroborate earlier mechanistic inferences from studiesin vitro. Comparisons with the diffusive behavior induced by the ribosome-binding antibiotics chloramphenicol and kasugamycin show how the specific location of each agent's ribosomal binding site affects the long-term distribution of ribosomal species between 30S and 50S subunitsversus70S polysomes. Analysis of the single-step displacements from ribosome and EF-Tu diffusive trajectories before and after Onc112 treatment suggests that the act of codon testing of noncognate ternary complexes (TCs) at the ribosomal A-site enhances the dissociation rate of such TCs from their L7/L12 tethers. Testing and rejection of noncognate TCs on a sub-ms timescale is essential to enable incorporation of the rare cognate amino acids into the growing peptide chain at a rate of similar to 20 aa/s.	[Zhu, Yanyu; Weisshaar, James C.; Mustafi, Mainak] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Mustafi, Mainak] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; Columbia University	Mustafi, M (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	mm5701@cumc.columbia.edu	Mustafi, Mainak/GNP-7849-2022	Mustafi, Mainak/0000-0003-2698-8048; Zhu, Yanyu/0000-0001-8681-976X	National Institutes of Health [NIGMS R01-GM094510]; National Science Foundation [MCB-1512946]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health Grant NIGMS R01-GM094510 (to J. C. W.) and by the National Science Foundation Grant MCB-1512946 (to J. C. W.). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal A, 2018, BBA-BIOMEMBRANES, V1860, P1470, DOI 10.1016/j.bbamem.2018.04.009; Babitzke P, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00295-17; Bakshi S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00636; Bakshi S, 2014, MOL MICROBIOL, V94, P871, DOI 10.1111/mmi.12805; Bakshi S, 2012, MOL MICROBIOL, V85, P21, DOI 10.1111/j.1365-2958.2012.08081.x; Bakshi S, 2011, BIOPHYS J, V101, P2535, DOI 10.1016/j.bpj.2011.10.013; Berg, 2018, RANDOM WALKS BIOL; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; CASTEELS P, 1994, BIOCHEM BIOPH RES CO, V199, P339, DOI 10.1006/bbrc.1994.1234; Choi H, 2016, TRENDS MICROBIOL, V24, P111, DOI 10.1016/j.tim.2015.11.004; Choi H, 2015, P NATL ACAD SCI USA, V112, pE303, DOI 10.1073/pnas.1417703112; Chongsiriwatana NP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16180-0; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; DENNIS PP, 1974, J MOL BIOL, V84, P407, DOI 10.1016/0022-2836(74)90449-5; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Edelstein Arthur D, 2014, J Biol Methods, V1; Graf M, 2019, ADV EXP MED BIOL, V1117, P72, DOI 10.1007/978-981-13-3588-4_6; Graf M, 2017, NAT PROD REP, V34, P702, DOI 10.1039/c7np00020k; Gray WT, 2019, CELL, V177, P1632, DOI 10.1016/j.cell.2019.05.017; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Knappe D, 2011, INT J ANTIMICROB AG, V37, P166, DOI 10.1016/j.ijantimicag.2010.10.028; Knappe D, 2010, J MED CHEM, V53, P5240, DOI 10.1021/jm100378b; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; Mardirossian M, 2018, CELL CHEM BIOL, V25, P530, DOI 10.1016/j.chembiol.2018.02.004; Matsuzaki K., 2019, ANTIMICROBIAL PEPTID; Mattiuzzo M, 2007, MOL MICROBIOL, V66, P151, DOI 10.1111/j.1365-2958.2007.05903.x; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Morse JC, 2020, P NATL ACAD SCI USA, V117, P3610, DOI 10.1073/pnas.1904469117; Mustafi M, 2019, J MOL BIOL, V431, P2343, DOI 10.1016/j.jmb.2019.04.037; Mustafi M, 2018, MBIO, V9, DOI 10.1128/mBio.02143-17; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Polikanov YS, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00048; Roy RN, 2015, NAT STRUCT MOL BIOL, V22, P466, DOI 10.1038/nsmb.3031; Rudorf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134994; Rudorf S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003909; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Schuwirth BS, 2006, NAT STRUCT MOL BIOL, V13, P879, DOI 10.1038/nsmb1150; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Seefeldt AC, 2016, NUCLEIC ACIDS RES, V44, P2429, DOI 10.1093/nar/gkv1545; Seefeldt AC, 2015, NAT STRUCT MOL BIOL, V22, P470, DOI 10.1038/nsmb.3034; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Thiel A, 2012, PLOS GENET, V8, P564, DOI 10.1371/journal.pgen.1002672; Traut RR, 1995, BIOCHEM CELL BIOL, V73, P949, DOI 10.1139/o95-102; Weaver J, 2019, MBIO, V10, DOI 10.1128/mBio.02819-18; Wohlgemuth I, 2011, PHILOS T R SOC B, V366, P2979, DOI 10.1098/rstb.2011.0138; Yamamoto H, 2016, P NATL ACAD SCI USA, V113, pE1180, DOI 10.1073/pnas.1524554113; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu YY, 2020, MBIO, V11, DOI 10.1128/mBio.00143-20; Zhu YY, 2019, P NATL ACAD SCI USA, V116, P1017, DOI 10.1073/pnas.1814924116	53	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13314	13325		10.1074/jbc.RA120.013587	http://dx.doi.org/10.1074/jbc.RA120.013587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32727850	Green Published, hybrid			2022-12-26	WOS:000574483500015
J	Kriss, M; Golden-Mason, L; Kaplan, J; Mirshahi, F; Setiawan, VW; Sanyal, AJ; Rosen, HR				Kriss, Michael; Golden-Mason, Lucy; Kaplan, Jeffrey; Mirshahi, Faridoddin; Setiawan, V. Wendy; Sanyal, Arun J.; Rosen, Hugo R.			Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS NASH; FIBROSIS; INFLAMMATION; PROGRESSION; INSIGHTS; CELLS	Background & aims Non-alcoholic steatohepatitis (NASH), a subtype of non-alcoholic fatty liver disease (NAFLD) that can lead to fibrosis, cirrhosis, and hepatocellular carcinoma, is characterized by hepatic inflammation. Despite evolving therapies aimed to ameliorate inflammation in NASH, the transcriptional changes that lead to inflammation progression in NAFLD remain poorly understood. The aim of this pilot study was to define transcriptional changes in early, non-fibrotic NAFLD using two independent biopsy-proven NAFLD cohorts. Methods We extracted RNA from liver tissue of 40 patients with biopsy-proven NAFLD based on NAFLD Activity Score (NAS) (23 patients with NAS <= 3, 17 with NAS >= 5) and 21 healthy controls, and we compared changes in expression of 594 genes involved in innate immune function. Using plasma from an independent cohort of 67 patients with NAFLD and 15 healthy controls, we validated the gene changes observed using a multiplex protein assay. Results Compared to healthy controls, NAFLD patients with NAS >= 5 had differential expression of 211 genes, while those with NAS <= 3 had differential expression of only 14 genes. Notably, osteopontin (SPP1) (3.74-fold in NAS <= 3, 8.28-fold in NAS >= 5) and CXCL10 (2.27-fold in NAS <= 3, 8.28-fold in NAS >= 5) gene expression were significantly upregulated with histologic progression of NAFLD. Plasma osteopontin (SPP1) and CXCL10 are significantly increased in the presence of NAFLD, regardless of histologic grade. In addition, the plasma levels of these two proteins distinguish clearly between the presence or absence of NAFLD (AUC>0.90). Conclusions Osteopontin (SPP1) and CXCL10 are upregulated early in non-fibrotic NAFLD and may serve as valuable non-invasive biomarkers.	[Kriss, Michael] Univ Colorado, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Aurora, CO USA; [Kriss, Michael] Univ Colorado, GI & Liver Innate Immune Program, Sch Med, Aurora, CO USA; [Golden-Mason, Lucy; Setiawan, V. Wendy; Rosen, Hugo R.] Univ Southern Calif USC, Keck Sch Med, Dept Med, Los Angeles, CA 90007 USA; [Golden-Mason, Lucy; Setiawan, V. Wendy; Rosen, Hugo R.] USC Res Ctr Liver Dis RCLD, Los Angeles, CA 90033 USA; [Kaplan, Jeffrey] Univ Colorado, Dept Pathol, Sch Med, Aurora, CO USA; [Mirshahi, Faridoddin; Sanyal, Arun J.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Setiawan, V. Wendy] Univ Southern Calif USC, Dept Prevent Med, Keck Sch Med, Los Angeles, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Virginia Commonwealth University	Rosen, HR (corresponding author), Univ Southern Calif USC, Keck Sch Med, Dept Med, Los Angeles, CA 90007 USA.; Rosen, HR (corresponding author), USC Res Ctr Liver Dis RCLD, Los Angeles, CA 90033 USA.	hugo.rosen@med.usc.edu	Kriss, Michael/AAA-9959-2021	Golden-Mason, Lucy/0000-0002-2087-4405	National Institutes of Health (NIH) [RO1 DK117004, RO1 DK106491, P30 DK48522]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health (NIH) https://www.nih.gov/grants-funding RO1 DK117004 (HRR) RO1 DK106491 (LG-M) P30 DK48522 (HRR) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chu X, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1490-y; Coombes JD, 2015, GUT, V64, P1120, DOI 10.1136/gutjnl-2013-306484; Coombes JD, 2016, BBA-MOL BASIS DIS, V1862, P135, DOI 10.1016/j.bbadis.2015.10.028; Friedman SL, 2018, HEPATOLOGY, V67, P1754, DOI 10.1002/hep.29477; Gao B, 2016, GASTROENTEROLOGY, V150, P1704, DOI 10.1053/j.gastro.2016.01.025; Glass O, 2018, HEPATOL COMMUN, V2, P1344, DOI 10.1002/hep4.1237; Honda M, 2020, J CELL COMMUN SIGNAL, V14, P223, DOI 10.1007/s12079-020-00554-7; Ibrahim SH, 2016, HEPATOLOGY, V63, P731, DOI 10.1002/hep.28252; Iida T, 2017, INT J MOL SCI, V19, DOI [10.3390/ijms19010007 29267211, DOI 10.3390/IJMS19010007 29267211]; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kruger AJ, 2018, HEPATOL COMMUN, V2, P529, DOI 10.1002/hep4.1160; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Ma XF, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-1165-z; McGettigan B, 2018, HEPATOLOGY, DOI [10.1002/hep.30401 30516830, DOI 10.1002/HEP.30401 30516830]; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Schattenberg JM, 2011, CURR OPIN LIPIDOL, V22, P479, DOI 10.1097/MOL.0b013e32834c7cfc; Schuppan D, 2018, J HEPATOL, V68, P238, DOI 10.1016/j.jhep.2017.11.012; Tomita K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28786; Verma S, 2013, LIVER INT, V33, P1398, DOI 10.1111/liv.12226; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Yilmaz Y, 2013, DIGEST LIVER DIS, V45, P58, DOI 10.1016/j.dld.2012.08.017; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; 2016, J HEPATOL, V59, P1121, DOI DOI 10.1016/J.JHEP.2015.11.00427062661	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236353	10.1371/journal.pone.0236353	http://dx.doi.org/10.1371/journal.pone.0236353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730345	gold, Green Published			2022-12-26	WOS:000556884700085
J	Pourghasemi, HR; Pouyan, S; Farajzadeh, Z; Sadhasivam, N; Heidari, B; Babaei, S; Tiefenbacher, JP				Pourghasemi, Hamid Reza; Pouyan, Soheila; Farajzadeh, Zakariya; Sadhasivam, Nitheshnirmal; Heidari, Bahram; Babaei, Sedigheh; Tiefenbacher, John P.			Assessment of the outbreak risk, mapping and infection behavior of COVID-19: Application of the autoregressive integrated-moving average (ARIMA) and polynomial models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; SUSCEPTIBILITY; DYNAMICS; CHINA	Infectious disease outbreaks pose a significant threat to human health worldwide. The outbreak of pandemic coronavirus disease 2019 (COVID-19) has caused a global health emergency. Thus, identification of regions with high risk for COVID-19 outbreak and analyzing the behaviour of the infection is a major priority of the governmental organizations and epidemiologists worldwide. The aims of the present study were to analyze the risk factors of coronavirus outbreak for identifying the areas having high risk of infection and to evaluate the behaviour of infection in Fars Province, Iran. A geographic information system (GIS)-based machine learning algorithm (MLA), support vector machine (SVM), was used for the assessment of the outbreak risk of COVID-19 in Fars Province, Iran whereas the daily observations of infected cases were tested in the-polynomial and the autoregressive integrated moving average (ARIMA) models to examine the patterns of virus infestation in the province and in Iran. The results of the disease outbreak in Iran were compared with the data for Iran and the world. Sixteen effective factors were selected for spatial modelling of outbreak risk. The validation outcome reveals that SVM achieved an AUC value of 0.786 (March 20), 0.799 (March 29), and 86.6 (April 10) that displays a good prediction of outbreak risk change detection. The results of the third-degree polynomial and ARIMA models in the province revealed an increasing trend with an evidence of turning, demonstrating extensive quarantines has been effective. The general trends of virus infestation in Iran and Fars Province were similar, although a more volatile growth of the infected cases is expected in the province. The results of this study might assist better programming COVID-19 disease prevention and control and gaining sorts of predictive capability would have wide-ranging benefits.	[Pourghasemi, Hamid Reza; Pouyan, Soheila; Babaei, Sedigheh] Shiraz Univ, Dept Nat Resources & Environm Engn, Coll Agr, Shiraz, Iran; [Farajzadeh, Zakariya] Shiraz Univ, Coll Agr, Dept Agr Econ, Shiraz, Iran; [Sadhasivam, Nitheshnirmal] Bharathidasan Univ, Sch Earth Sci, Dept Geog, Tiruchirappalli, Tamil Nadu, India; [Heidari, Bahram] Shiraz Univ, Sch Agr, Dept Plant Prod & Genet, Shiraz, Iran; [Tiefenbacher, John P.] Texas State Univ, Dept Geog, San Marcos, TX USA	Shiraz University; Shiraz University; Bharathidasan University; Shiraz University; Texas State University System; Texas State University San Marcos	Pourghasemi, HR (corresponding author), Shiraz Univ, Dept Nat Resources & Environm Engn, Coll Agr, Shiraz, Iran.; Heidari, B (corresponding author), Shiraz Univ, Sch Agr, Dept Plant Prod & Genet, Shiraz, Iran.	hr.pourghasemi@shirazu.ac.ir; bheidari@shirazu.ac.ir	Pourghasemi, Hamid Reza/G-9926-2014; Sadhasivam, Nitheshnirmal/AAC-1678-2019	Pourghasemi, Hamid Reza/0000-0003-2328-2998; Sadhasivam, Nitheshnirmal/0000-0001-6502-8985; babaei, Sedigheh/0000-0002-4138-0658	Shiraz University [96GRD1M271143]	Shiraz University	A grant with number 96GRD1M271143 was initially defined by Shiraz University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi S, 2019, B ENG GEOL ENVIRON, V78, P4017, DOI 10.1007/s10064-018-1403-6; Aik J, 2018, SCI TOTAL ENVIRON, V639, P1261, DOI 10.1016/j.scitotenv.2018.05.254; Alberts CJ, 2019, VACCINE, V37, P2849, DOI 10.1016/j.vaccine.2019.03.048; Arab-Mazar Z, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101630; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Baltagi B.H., 2008, ECONOMETRIC ANAL PAN; BAQUERO OS, 2019, SCI REPORTS, V9, DOI DOI 10.1038/S41598-018-37186-2; Behzad M, 2010, J COMPUT CIVIL ENG, V24, P408, DOI 10.1061/(ASCE)CP.1943-5487.0000043; Benvenuto D, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2020.105340; Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8; Carvajal TM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3066-0; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Chen W, 2018, B ENG GEOL ENVIRON, V77, P647, DOI 10.1007/s10064-017-1010-y; Ayram CAC, 2017, ECOL INDIC, V72, P895, DOI 10.1016/j.ecolind.2016.09.007; Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020; Dodangeh E, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135983; Enders W, 2008, APPL ECONOMETRIC TIM; Garosi Y, 2019, SCI TOTAL ENVIRON, V664, P1117, DOI 10.1016/j.scitotenv.2019.02.093; Gayen A, 2019, SCI TOTAL ENVIRON, V668, P124, DOI 10.1016/j.scitotenv.2019.02.436; Gigovic L, 2019, FORESTS, V10, DOI 10.3390/f10050408; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Gujarati D. N, 2003, BASIC ECONOMETRICS, V4th; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang Y, 2018, CATENA, V165, P520, DOI 10.1016/j.catena.2018.03.003; Jiang D, 2018, ACTA TROP, V185, P391, DOI 10.1016/j.actatropica.2018.06.021; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Leonenko VN, 2016, PROCEDIA COMPUT SCI, V80, P2402, DOI 10.1016/j.procs.2016.05.538; Ma YL, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138226; McCloskey B, 2020, LANCET, V395, P1096, DOI 10.1016/S0140-6736(20)30681-4; Mohammadinia A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4580-4; Nyakarahuka Luke, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.07992a87522e1f229c7cb023270a2af1; Pourghasemi HR, 2020, INT J INFECT DIS, V98, P90, DOI 10.1016/j.ijid.2020.06.058; Pourghasemi HR, 2020, GEOSCI FRONT, V11, P2207, DOI 10.1016/j.gsf.2020.03.005; Pourghasemi HR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60191-3; Bui QT, 2019, GEOCARTO INT, V34, P1300, DOI 10.1080/10106049.2018.1478890; Reeves Tarian, 2015, BMC Res Notes, V8, P801, DOI 10.1186/s13104-015-1789-1; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Saba AI, 2020, PROCESS SAF ENVIRON, V141, P1, DOI 10.1016/j.psep.2020.05.029; Ahmar AS, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138883; Sanchez-Vizcaino F, 2013, VET MICROBIOL, V165, P71, DOI 10.1016/j.vetmic.2013.03.016; Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082; Singh AK, 2020, DIABETES METAB SYND, V14, P241, DOI 10.1016/j.dsx.2020.03.011; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Takian A, 2020, LANCET, V395, P1035, DOI 10.1016/S0140-6736(20)30668-1; Tan JG, 2005, J EPIDEMIOL COMMUN H, V59, P186, DOI 10.1136/jech.2004.020180; Tarwater Patrick M., 2001, Complexity, V6, P29, DOI 10.1002/cplx.10003; Tikhonov AN, 1995, NUMERICAL METHODS SO, P7, DOI [DOI 10.1007/978-94-015-8480-7_2, 10.1007/978-94-015-8480-7_2]; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang M., 2020, MEDRXIV, P1, DOI DOI 10.1101/2020.02.22.20025791; WHO, 2020, WHO CHAR COVID 19 PA, V2020; Wong G, 2008, J URBAN ECON, V63, P74, DOI 10.1016/j.jue.2006.12.007; World Health Organization (WHO), 2020, COR DIS 2019 COVID 1; Xie JG, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138201; Yao X, 2008, GEOMORPHOLOGY, V101, P572, DOI 10.1016/j.geomorph.2008.02.011; Yousefi S, 2020, MEASUREMENT, V157, DOI 10.1016/j.measurement.2020.107652; Zhou CH, 2020, GEOGR SUSTAIN, V1, P77, DOI 10.1016/j.geosus.2020.03.005	58	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236238	10.1371/journal.pone.0236238	http://dx.doi.org/10.1371/journal.pone.0236238			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722716	gold, Green Submitted, Green Published			2022-12-26	WOS:000556916000028
J	Christensen, TK; Balsby, TJS				Christensen, Thomas Kjaer; Balsby, Thorsten Johannes Skovbjerg			Condition dependent strategies of egg size variation in the Common EiderSomateria mollissima	PLOS ONE			English	Article							CLUTCH-SIZE; INTRACLUTCH VARIATION; OFFSPRING SURVIVAL; HATCHING SYNCHRONY; BROOD PARASITISM; PARENTAL CARE; LAYING DATE; FEMALE AGE; EIDER; CONSEQUENCES	We analysed intraclutch egg-size variation over the laying sequence in relation to clutch size, and the relation between clutch size and female body condition, in the Common EiderSomateria mollissimaduring an 8-year period. The aim was to assess if eiders adjusted egg size within the laying sequence depending on clutch sizes in response to body condition, as such an adjustment could have adaptive implications on reproductive success through a size advantage for the hatchlings. The analyses were performed on a population level; and then at the individual level using data from recaptured females that changed clutch size between years. Based on 1,099 clutches from 812 individual females, population clutch size averaged 4.13 eggs (range: 1-6), with 4- and 5-egg clutchesconstitutingc.70% of all clutches, taking turns in being the most represented clutch size. Clutch size was positively related to female pre-laying body condition at both the population and individual levels. Egg size varied significantly within and between clutch sizes and changes were significantly related to the laying sequence. First eggs were significantly larger in 4-egg clutches and second eggs marginally smaller than in 5-egg clutches, a pattern also found among individual females changing clutch size between years. The relationship between female pre-laying body condition and clutch size, and the intraclutch egg-size pattern indicate that both clutch size and egg size are actively adapted to the pre-breeding body condition of the female. As egg size potentially optimise reproductive success through a size advantage in hatchlings, the observed pattern of intraclutch egg-size variation suggests that female eiders possesses a finely tuned conditional dependent mechanism that may optimize reproductive output in years were females are in suboptimal body condition for breeding.	[Christensen, Thomas Kjaer; Balsby, Thorsten Johannes Skovbjerg] Aarhus Univ, Dept Biosci, Ronde, Denmark	Aarhus University	Christensen, TK (corresponding author), Aarhus Univ, Dept Biosci, Ronde, Denmark.	tk@bios.au.dk		Balsby, Thorsten J. S./0000-0001-6855-4040				Anderson VR, 2002, AUK, V119, P62, DOI 10.1642/0004-8038(2002)119[0062:CAGOKE]2.0.CO;2; Anderson VR, 2001, CONDOR, V103, P195, DOI 10.1650/0010-5422(2001)103[0195:ESBSLA]2.0.CO;2; Andersson M, 2006, OECOLOGIA, V148, P350, DOI 10.1007/s00442-006-0374-7; ANKNEY CD, 1978, AUK, V95, P459; ANKNEY CD, 1980, J WILDLIFE MANAGE, V44, P174, DOI 10.2307/3808363; Aparicio JM, 1999, AUK, V116, P825, DOI 10.2307/4089345; ARCESE P, 1988, J ANIM ECOL, V57, P119, DOI 10.2307/4768; ARNOLD TW, 1991, CONDOR, V93, P19, DOI 10.2307/1368601; ASTHEIMER LB, 1985, CONDOR, V87, P256, DOI 10.2307/1366891; BAILLIE SR, 1982, BIRD STUDY, V29, P55, DOI 10.1080/00063658209476738; Barrionuevo M, 2016, BIRD STUDY, V63, P353, DOI 10.1080/00063657.2016.1184617; Bernardo J, 1996, AM ZOOL, V36, P216; BIRKHEAD M, 1984, CONDOR, V86, P489, DOI 10.2307/1366838; Boonstra TA, 2010, CONDOR, V112, P304, DOI 10.1525/cond.2010.090043; Bosman DS, 2014, J FIELD ORNITHOL, V85, P379, DOI 10.1111/jofo.12077; BUSTNES JO, 1991, CAN J ZOOL, V69, P1538, DOI 10.1139/z91-216; Butler MW, 2013, FUNCT ECOL, V27, P1176, DOI 10.1111/1365-2435.12123; Christensen T.K., 2001, MONITORING BREEDING; Christensen TK, 1999, J AVIAN BIOL, V30, P302, DOI 10.2307/3677356; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Dawson RD, 2000, CONDOR, V102, P930, DOI 10.1650/0010-5422(2000)102[0930:EOHDAE]2.0.CO;2; Descamps S, 2011, FUNCT ECOL, V25, P671, DOI 10.1111/j.1365-2435.2010.01824.x; Eichholz MW, 2010, CONDOR, V112, P696, DOI 10.1525/cond.2010.100029; Erikstad KE, 1998, J AVIAN BIOL, V29, P3, DOI 10.2307/3677334; ERIKSTAD KE, 1993, AUK, V110, P623, DOI 10.2307/4088426; Flint Paul L., 1994, Wildfowl, V45, P248; FLINT PL, 1992, AUK, V109, P896, DOI 10.2307/4088164; Flint PL, 1996, CONDOR, V98, P162, DOI 10.2307/1369519; GABRIELSEN G W, 1991, Norsk Polarinstitutt Skrifter, P51; GORMAN M L, 1972, Ornis Scandinavica, V3, P21, DOI 10.2307/3676162; Guild BL, 1974, THESIS; Hanssen SA, 2003, P ROY SOC B-BIOL SCI, V270, P531, DOI 10.1098/rspb.2002.2262; Hanssen SA, 2002, BEHAV ECOL SOCIOBIOL, V52, P282, DOI 10.1007/s00265-002-0523-x; JARVINEN A, 1986, AUK, V103, P235; Kilpi M, 2001, ANIM BEHAV, V62, P527, DOI 10.1006/anbe.2001.1784; Krist M, 2011, BIOL REV, V86, P692, DOI 10.1111/j.1469-185X.2010.00166.x; Laurila T., 1988, Finnish Game Research, V45, P19; LEBLANC Y, 1987, CAN J ZOOL, V65, P3044, DOI 10.1139/z87-461; Maddox JD, 2008, AM NAT, V171, P358, DOI 10.1086/527500; MUNRO J, 1977, AUK, V94, P759, DOI 10.2307/4085272; Ost M, 2003, ANIM BEHAV, V66, P1069, DOI 10.1006/anbe.2003.2300; Ost M, 2002, ANIM BEHAV, V64, P223, DOI 10.1006/anbe.2002.3064; Ost M, 2008, J ANIM ECOL, V77, P315, DOI 10.1111/j.1365-2656.2007.01348.x; OWEN M, 1988, ORNIS SCAND, V19, P58, DOI 10.2307/3676528; PARKER H, 1990, AUK, V107, P660, DOI 10.2307/4087996; PARSONS J, 1976, CONDOR, V78, P481, DOI 10.2307/1367097; Pelayo JT, 2003, AUK, V120, P384, DOI 10.1642/0004-8038(2003)120[0384:COESFO]2.0.CO;2; Pick JL, 2016, HEREDITY, V116, P542, DOI 10.1038/hdy.2016.16; QUINN JS, 1986, CAN J ZOOL, V64, P2116, DOI 10.1139/z86-324; RHYMER JM, 1988, OECOLOGIA, V75, P20, DOI 10.1007/BF00378809; ROBERTSON GJ, 1995, CAN J ZOOL, V73, P1579, DOI 10.1139/z95-188; ROBERTSON GJ, 1993, CAN J ZOOL, V71, P544, DOI 10.1139/z93-075; ROBERTSON GJ, 1994, J AVIAN BIOL, V25, P149, DOI 10.2307/3677034; ROHWER FC, 1989, ORNIS SCAND, V20, P43, DOI 10.2307/3676706; Rollinson N, 2016, BIOL REV, V91, P1134, DOI 10.1111/brv.12214; Sedinger JS, 2017, OECOLOGIA, V183, P431, DOI 10.1007/s00442-016-3772-5; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SLAGSVOLD T, 1984, AUK, V101, P685, DOI 10.2307/4086895; SPURR E, 1976, Ornis Scandinavica, V7, P85, DOI 10.2307/3676177; SWENNEN C, 1993, ORNIS SCAND, V24, P48, DOI 10.2307/3676409; SWENNEN C, 1992, ARDEA, V80, P363; Vinuela J, 1997, J ANIM ECOL, V66, P781, DOI 10.2307/5995; Waldeck P, 2004, BEHAVIOUR, V141, P725, DOI 10.1163/1568539042245132; Waldeck P, 2011, J AVIAN BIOL, V42, P231, DOI 10.1111/j.1600-048X.2010.05288.x; Waldeck P, 2011, OECOLOGIA, V165, P707, DOI 10.1007/s00442-010-1762-6; WILLIAMS TD, 1993, OIKOS, V67, P250, DOI 10.2307/3545469; Williams TD, 1996, IBIS, V138, P499, DOI 10.1111/j.1474-919X.1996.tb08070.x; WILLIAMS TD, 1993, OECOLOGIA, V96, P331, DOI 10.1007/BF00317502; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x	69	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0226532	10.1371/journal.pone.0226532	http://dx.doi.org/10.1371/journal.pone.0226532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716933	Green Submitted, Green Published, gold			2022-12-26	WOS:000556674500043
J	Yamada, K; Yamaguchi, I; Urata, H; Hayashida, N				Yamada, Koji; Yamaguchi, Izumi; Urata, Hideko; Hayashida, Naomi			Survey of awareness of radiation disasters among firefighters in a Japanese prefecture without nuclear power plants	PLOS ONE			English	Article							PREPAREDNESS; WILLINGNESS; WORK	Japanese firefighting organisations are essentially run as village, town, or city units. The Great Hanshin Earthquake of 1995 led to the establishment of emergency support teams to ensure rapid action in response to disasters beyond the capacities of local fire departments. The 2011 Great East Japan Earthquake involved both a tsunami and a radiation disaster caused by a nuclear reactor meltdown, underscoring the need for responses in complex disasters. This study aimed to assess Nagasaki Prefecture firefighters' preparedness for, awareness of, and anxiety regarding radiation disaster response with the aim of elucidating the factors affecting individuals' decisions to accept or reject assignment to a radiation disaster response team. A questionnaire survey was carried out with 1,122 firefighters in three firefighting departments in Nagasaki Prefecture, which does not have nuclear power plants. In total, 920 questionnaires were returned, and the 784 that were valid were analysed. Among the participants, 39% replied that they would have no difficulty accepting assignment to a radiation disaster response team; most of them were under 30 years old and unmarried. This group also included significantly higher percentages of participants who were confident about radiation disaster response or, if anxious, believed things would turn out fine, as well as those who replied that they were able to use the necessary equipment. Furthermore, this group had significantly higher percentages of participants who replied that they would definitely participate in seminars and those who replied that their level of preparedness for radiation disasters was sufficient. The willingness to be assigned to a radiation disaster response team was linked to confidence about radiation disaster response and about handling materials and/or equipment. Therefore, it is considered that measures to increase firefighters' confidence regarding response to radiation disasters will be linked to more proactive measures if and when such disasters occur.	[Yamada, Koji; Yamaguchi, Izumi; Urata, Hideko; Hayashida, Naomi] Nagasaki Univ, Grad Sch Biomed Sci, Div Disaster & Radiat Med Sci, Nagasaki, Japan; [Yamada, Koji] Nagasaki City Fire Dept, Nagasaki, Japan; [Yamada, Koji; Yamaguchi, Izumi; Hayashida, Naomi] Nagasaki Univ, Div Strateg Collaborat Res, Atom Bomb Dis Inst, Nagasaki, Japan; [Urata, Hideko] Nagasaki Univ, Atom Bomb Dis Inst, Dept Mol Med, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Hayashida, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Div Disaster & Radiat Med Sci, Nagasaki, Japan.; Hayashida, N (corresponding author), Nagasaki Univ, Div Strateg Collaborat Res, Atom Bomb Dis Inst, Nagasaki, Japan.	naomin@nagasaki-u.ac.jp						Ahayalimudin N, 2016, AUSTRALAS EMERG NURS, V19, P203, DOI 10.1016/j.aenj.2016.08.001; Ben Natan M, 2014, J NURS MANAGE, V22, P931, DOI 10.1111/jonm.12058; Calamai F, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2364-2; Chi CH, 2001, AM J EMERG MED, V19, P433, DOI 10.1053/ajem.2001.24467; DORIGATTI ALCIR ESCOCIA, 2018, Rev. Col. Bras. Cir., V45, pe1710, DOI 10.1590/0100-6991e-20181710; Fire and Disaster Management Agency, 2018, 2018 WHIT PAP FIR SE; Headquarters for Disaster Control Fire and Disaster Management Agency, 2020, 160 HEADQ DIS CONTR; Headquarters for Disaster Control Fire and Disaster Management Agency, 2012, 114 HEADQ DIS CONTR; Hoffmann R, 2017, WORLD DEV, V96, P32, DOI 10.1016/j.worlddev.2017.02.016; International Fire Service Information Center, 2000, GUID MAINT FIR SERV; Kasai Y, 2017, JPN J HLTH PHYS, V52, P55; Kaya E, 2018, PREHOSP DISASTER MED, V33, P13, DOI 10.1017/S1049023X17007087; Kobe Municipal Fire Dept, 2007, MEM COOP TIM SPEC DI; Kobe University, 2012, SIGN AGR MEM DIS KOB; Labrague LJ, 2018, INT NURS REV, V65, P41, DOI 10.1111/inr.12369; Ministry of Internal Affairs and Communications, 2014, MAN FIR ACT NUCL POW; Ministry of Internal Affairs and Communications, 2015, START RI119 BAS KNOW; Miyamoto M., 2013, ISOTOPE NEWS; Nagasaki City Fire Department, 1998, HIST NAG FIR SERV; Pedersen MJB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156536; Shoaf E, 2016, AORN J, V104, P453, DOI 10.1016/j.aorn.2016.09.009; Uhm D, 2019, ASIAN NURS RES, V13, P264, DOI 10.1016/j.anr.2019.09.005; Yasuda Y., 2009, HOBUTSU SEMINAR	23	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236640	10.1371/journal.pone.0236640; 10.1371/journal.pone.0236640.r001; 10.1371/journal.pone.0236640.r002; 10.1371/journal.pone.0236640.r003; 10.1371/journal.pone.0236640.r004	http://dx.doi.org/10.1371/journal.pone.0236640; 10.1371/journal.pone.0236640.r001; 10.1371/journal.pone.0236640.r002; 10.1371/journal.pone.0236640.r003; 10.1371/journal.pone.0236640.r004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716980	gold, Green Published			2022-12-26	WOS:000556674500049
J	Chikina, M; Pegden, W				Chikina, Maria; Pegden, Wesley			Modeling strict age-targeted mitigation strategies for COVID-19	PLOS ONE			English	Article								We use a simple SIR-like epidemic model integrating known age-contact patterns for the United States to model the effect of age-targeted mitigation strategies for a COVID-19-like epidemic. We find that, among strategies which end with population immunity, strict age-targeted mitigation strategies have the potential to greatly reduce mortalities and ICU utilization for natural parameter choices.	[Chikina, Maria] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Pegden, Wesley] Carnegie Mellon Univ, Dept Math Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Chikina, M (corresponding author), Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	mchikina@pitt.edu			National Science Foundation [DMS-1700365]; NSF [DMS-1700365]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Maria Chikina received no specific funding for this work. Wesley Pegden is funded by the National Science Foundation (DMS-1700365), which in the Mathematical Sciences is expected to be acknowledged in all research projects done during the funding period, through a statement of the form \supported by NSF DMS-1700365", or something similar. Funding statement: The National Science Foundation played no role in study design, data col-lection and analysis, decision to publish, or preparation of the manuscript.	Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Bambery B, 2018, PUBLIC HEALTH ETH-UK, V11, P221, DOI 10.1093/phe/phx021; Bolzoni L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000747; Britton T, 2020, SCIENCE; Chikina Maria, 2020, THESIS; Davies NG, 2020, EFFECT NONPHARMACEUT, DOI DOI 10.1101/2020.04.01.20049908; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Gomes M Gabriela M, 2022, medRxiv, DOI 10.1101/2020.04.27.20081893; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Harris-Kojetin Lauren D, ANAL EPIDEMIOLOGICAL; Highfield R, 2020, CORONAVIRUS HUNTING; Hill AN, 2003, MATH BIOSCI, V181, P85, DOI 10.1016/S0025-5564(02)00129-3; Jones T.C., 2020, ANAL SARS COV 2 VIRA, DOI [10.1101/2020.06.08.20125484, DOI 10.1101/2020.06.08.20125484]; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Lavezzo E., 2020, SUPPRESSION COVID 1, DOI [10.1101/2020.04.17.20053157v1, DOI 10.1101/2020.04.17.20053157V1, 10.1038/s41586-020-2488-1]; Majumder Maimuna Shahnaz, 2018, THESIS; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Myers Laura C., 2020, JAMA-J AM MED ASSOC; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775; Voinsky I, 2020, J INFECTION, V81, pE102, DOI 10.1016/j.jinf.2020.05.026	24	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236237	10.1371/journal.pone.0236237	http://dx.doi.org/10.1371/journal.pone.0236237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706809	Green Published, Green Submitted, gold			2022-12-26	WOS:000579931700019
J	Kouwenberg, M; Rops, A; Bakker-van Benner, M; Diepeveen, L; Gote, M; Hilbrands, L; van der Vlag, J				Kouwenberg, M.; Rops, A.; Bakker-van Benner, M.; Diepeveen, L.; Gotte, M.; Hilbrands, L.; van der Vlag, J.			Role of syndecan-1 in the interaction between dendritic cells and T cells	PLOS ONE			English	Article							HEPARAN-SULFATE; ACUTE REJECTION; CONCANAVALIN-A; ACTIVATION; PROMOTES; LIPOPOLYSACCHARIDE; TRANSPLANTATION; INTERLEUKIN-17; PROLIFERATION; PROTEOGLYCAN	Syndecan-1 (Sdc-1) is a heparan sulfate proteoglycan that can bind cytokines and chemokines via its heparan sulfate side chains, and has immunomodulatory properties in experimental models. Sdc-1 expression has been reported on dendritic cells (DC) and T cells. The potential role of Sdc-1 in DC-T cell interaction has not been investigated yet. We postulate that Sdc-1 is involved in DC-T cell interaction and may influence graft survival in an allogeneic transplant model. Sdc-1 expression on bone marrow-derived DC and T cells was analyzed by flow cytometry. Unstimulated and LPS stimulated Sdc-1 deficient DC were evaluated in vitro for phenotype and stimulatory capacity in mixed lymphocyte reaction. Sdc-1 deficient T cells were evaluated for proliferative capacity and differentiation in a mixed lymphocyte reaction and a proliferation assay. Allograft survival was evaluated in a fully MHC mismatched heterotopic heart transplant model, with either Sdc-1 deficient donors or recipients. Sdc-1 was expressed on the cell surface of unstimulated and LPS matured DC. Sdc-1 deficiency had no effect on expression of co-stimulatory molecules, cytokine production or T cell stimulatory capacity as compared to WT DC. Sdc-1 expression was not detectable on WT T cells, although intracellular Sdc-1 expression could be demonstrated after ConA activation. Sdc-1 deficient T cells showed reduced proliferation upon DC or ConA stimulation and reduced IL-17 production upon ConA stimulation, compared to WT T cells. Sdc-1 deficiency of either allograft or recipient did not prolong allograft survival. In conclusion, Sdc-1 is expressed on the cell surface of DC, where its absence does not affect DC phenotype or T cell stimulatory capacity. Sdc-1 is intracellularly expressed in ConA activated T cells. Sdc-1 deficiency in T cells results in a reduced proliferative response in vitro, as induced by DC and ConA. Sdc-1 deficiency in donor or recipient does not affect allograft survival.	[Kouwenberg, M.; Rops, A.; Bakker-van Benner, M.; Diepeveen, L.; Hilbrands, L.; van der Vlag, J.] Radboud Univ Nijmegen, Dept Nephrol, Med Ctr, Nijmegen, Netherlands; [Gotte, M.] Univ Munster, Dept Gynecol & Obstet, Munster, Germany	Radboud University Nijmegen; University of Munster	van der Vlag, J (corresponding author), Radboud Univ Nijmegen, Dept Nephrol, Med Ctr, Nijmegen, Netherlands.	johan.vandervlag@radboudumc.nl	Hilbrands, Luuk/B-4921-2011; Van der Vlag, Johan/E-4636-2010; Gotte, Martin/G-2254-2018	Hilbrands, Luuk/0000-0002-4935-9765; Van der Vlag, Johan/0000-0001-7843-5918; Gotte, Martin/0000-0003-2360-2496	NWO ZonMw AGIKO [92003567]; Radboud PhD programm 2010	NWO ZonMw AGIKO; Radboud PhD programm 2010	JvdV; LH; MK: NWO ZonMw AGIKO 92003567, Radboud PhD programm 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adepu S, 2015, AM J PHYSIOL-RENAL, V309, pF137, DOI 10.1152/ajprenal.00127.2015; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Angsana J, 2015, ARTERIOSCL THROM VAS, V35, P332, DOI 10.1161/ATVBAHA.114.304720; Averbeck M, 2017, EXP DERMATOL, V26, P1060, DOI 10.1111/exd.13374; Bacsa S, 2011, J GEN VIROL, V92, P733, DOI 10.1099/vir.0.027052-0; Boeddeker SJ, 2014, MOL HUM REPROD, V20, P567, DOI 10.1093/molehr/gau009; Brauer R, 2016, AM J RESP CRIT CARE, V194, P333, DOI 10.1164/rccm.201509-1878OC; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Chen S, 2015, INT J CLIN EXP PATHO, V8, P4903; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2011, EUR J IMMUNOL, V41, P1794, DOI 10.1002/eji.201041233; CORRY RJ, 1973, TRANSPLANT P, V5, P733; Dai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010510; Dai H, 2015, EUR J IMMUNOL, V45, P3045, DOI 10.1002/eji.201545532; Dieker J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0617-2; Duan LH, 2014, INT IMMUNOPHARMACOL, V20, P290, DOI 10.1016/j.intimp.2014.03.010; Emmer PM, 2006, TRANSPLANTATION, V81, P1451, DOI 10.1097/01.tp.0000208801.51222.bd; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gill SE, 2016, AM J RESP CELL MOL, V55, P243, DOI 10.1165/rcmb.2015-0193OC; Gondelaud F, 2019, FEBS J, V286, P2994, DOI 10.1111/febs.14828; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; HAWRYLOWICZ CM, 1984, IMMUNOLOGY, V53, P703; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Henry-Stanley MJ, 2005, SHOCK, V24, P571, DOI 10.1097/01.shk.0000184286.95493.78; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Itoh S, 2011, CIRCULATION, V124, pS187, DOI 10.1161/CIRCULATIONAHA.110.014852; Jaiswal AK, 2018, J IMMUNOL, V201, P1651, DOI 10.4049/jimmunol.1800104; Karasneh GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025252; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kouwenberg M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159986; Kovalszky I, 1998, MOL CELL BIOCHEM, V183, P11, DOI 10.1023/A:1006898920637; Lamorte S, 2012, LEUKEMIA, V26, P1081, DOI 10.1038/leu.2011.290; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lutz MB, 2000, EUR J IMMUNOL, V30, P1048, DOI 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W; Manakil JF, 2007, ORAL MICROBIOL IMMUN, V22, P272, DOI 10.1111/j.1399-302X.2007.00356.x; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; PIGUET PF, 1976, J IMMUNOL, V117, P1817; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; Saleh ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217550; Shi Q, 2013, J VIROL, V87, P6866, DOI 10.1128/JVI.03475-12; Stewart MD, 2014, MATRIX BIOL, V35, P56, DOI 10.1016/j.matbio.2013.10.009; Szatmari T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048091; Wang DZ, 2003, BIOCHEMISTRY-US, V42, P1071, DOI 10.1021/bi026425a; Wu YH, 2012, J IMMUNOL, V188, P2914, DOI 10.4049/jimmunol.1102065; Xiao JT, 2012, ARTERIOSCL THROM VAS, V32, P386, DOI 10.1161/ATVBAHA.111.242198; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang JJ, 2013, WORLD J GASTROENTERO, V19, P682, DOI 10.3748/wjg.v19.i5.682; Zhang JP, 2006, FASEB J, V20, P50, DOI 10.1096/fj.04-3303com; Zhang XL, 2013, J IMMUNOL, V191, P4551, DOI 10.4049/jimmunol.1300931; Zhou YX, 2015, TRANSPLANTATION, V99, P1126, DOI 10.1097/TP.0000000000000666; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	55	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0230835	10.1371/journal.pone.0230835	http://dx.doi.org/10.1371/journal.pone.0230835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701966	Green Submitted, Green Published, gold			2022-12-26	WOS:000575913700004
J	Saller, AM; Werner, J; Reiser, J; Senf, S; Deffner, P; Abendschon, N; Weiss, C; Fischer, J; Schorwerth, A; Miller, R; Zablotski, Y; Bergmann, S; Erhard, MH; Ritzmann, M; Zols, S; Baumgartner, C				Saller, Anna M.; Werner, Julia; Reiser, Judith; Senf, Steffanie; Deffner, Pauline; Abendschoen, Nora; Weiss, Christine; Fischer, Johannes; Schoerwerth, Andrea; Miller, Regina; Zablotski, Yury; Bergmann, Shana; Erhard, Michael H.; Ritzmann, Mathias; Zoels, Susanne; Baumgartner, Christine			Local anesthesia in piglets undergoing castration-A comparative study to investigate the analgesic effects of four local anesthetics on the basis of acute physiological responses and limb movements	PLOS ONE			English	Article							ISOFLURANE-ANESTHESIA; NOXIOUS STIMULI; CHROMOGRANIN-A; SURGICAL CASTRATION; SUCKLING PIGLETS; WEIGHT-GAIN; PAIN; HALOTHANE; INJECTION; BEHAVIOR	Surgical castration of male piglets without analgesia is a painful procedure. This prospective, randomized and double-blinded study aimed to evaluate the analgesic effects of four different local anesthetics for piglet castration during the first week of life. In total, 54 piglets aged 3 to 7 days were distributed into 6 treatment groups: handling (H); castration without pain relief (sodium chloride, NaCl); and castration with a local anesthetic: 4% procaine (P), 2% lidocaine (L), 0.5% bupivacaine (B) or 20 mg/ml mepivacaine (M). By excluding stress and fear as disruptive factors via a minimum anesthesia model, all piglets received individual minimum alveolar concentration (MAC) isoflurane anesthesia. Twenty minutes before castration, all treatment groups except group H received one injection per testis. Then, 0.5 ml of a local anesthetic or NaCl was injected intratesticularly (i.t.), and 0.5 ml was administered subscrotally. Acute physiological responses to noxious stimuli at injection and castration were evaluated by measuring blood pressure (BP), heart rate (HR), cortisol, epinephrine, norepinephrine and chromogranin A (CgA); limb movements were quantified. The results confirm that castration without analgesia is highly painful. Surgical castration without pain relief revealed significant changes in mean arterial blood pressure (MAP) and HR. Local anesthetic administration significantly reduced changes in BP and HR associated with castration. Piglets receiving a preoperative local anesthetic exhibited the fewest limb movements during castration, while the NaCl group exhibited the most. Injection itself was not associated with significant changes in MAP or HR. However, many piglets exhibited limb movements during injection, indicating that the injection itself causes nociceptive pain. No significant differences were found between groups regarding parameters of plasma cortisol, catecholamines and CgA. In conclusion, all four local anesthetics administered are highly effective at reducing signs of nociception during castration under light isoflurane anesthesia. However, injection of a local anesthetic seems to be painful.	[Saller, Anna M.; Werner, Julia; Reiser, Judith; Fischer, Johannes; Baumgartner, Christine] Tech Univ Munich, Ctr Preclin Res, Bavaria, Germany; [Senf, Steffanie; Deffner, Pauline; Abendschoen, Nora; Weiss, Christine; Zablotski, Yury; Ritzmann, Mathias; Zoels, Susanne] Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Clin Swine, Bavaria, Germany; [Schoerwerth, Andrea; Miller, Regina; Bergmann, Shana; Erhard, Michael H.] Ludwig Maximilians Univ Munchen, Chair Anim Welf Ethol Anim Hyg & Husb, Bavaria, Germany; [Baumgartner, Christine] Tech Univ Munich, Klinikum Rechts Isar, Ctr Preclin Res, Munich, Germany	Technical University of Munich; University of Munich; University of Munich; Technical University of Munich	Baumgartner, C (corresponding author), Tech Univ Munich, Ctr Preclin Res, Bavaria, Germany.; Baumgartner, C (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Ctr Preclin Res, Munich, Germany.	christine.baumgartner@tum.de	Bergmann, Shana/AAA-2609-2019	Zablotski, Yury/0000-0001-6928-4089; Erhard, Michael Helmut/0000-0002-2527-0424; Saller, Anna/0000-0001-5724-5701; Werner, Julia/0000-0002-4374-5374; Senf, Steffanie/0000-0002-4463-078X	German Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany by Federal Office for Agriculture and Food (BLE) [2817HS016, 2817HS013]	German Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany by Federal Office for Agriculture and Food (BLE)	This work was funded by the German Federal Ministry of Food and Agriculture (BMEL, https://www.bmel.de) based on a decision of the Parliament of the Federal Republic of Germany, granted by the Federal Office for Agriculture and Food (BLE, https://www.ble.de; grant number: 2817HS016, 2817HS013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOGNINI JF, 1995, ANESTH ANALG, V81, P843, DOI 10.1097/00000539-199510000-00032; Barticciotto LS, 2016, SEMIN-CIENC AGRAR, V37, P1307, DOI 10.5433/1679-0359.2016v37n3p1307; Berchtold S., 2015, THESIS; Bonastre C, 2016, ANIMAL, V10, P1474, DOI 10.1017/S1751731116000586; Bova JF, 2015, J INVEST SURG, V28, P32, DOI 10.3109/08941939.2014.971207; Casal N, 2017, ANIMAL, V11, P1228, DOI 10.1017/S1751731116002561; Courboulay V, 2010, ANN M EUR ASS AN PRO, P138; Eger EI, 2008, ANESTH ANALG, V107, P832, DOI 10.1213/ane.0b013e318182aedb; EGER EI, 1988, ANESTH ANALG, V67, P1174; European Food Safety Authority, 2004, EFSA J, V2, P91, DOI [10.2903/j.efsa.2004.91, DOI 10.2903/J.EFSA.2004.91]; GIBBS NM, 1989, ANESTHESIOLOGY, V70, P503, DOI 10.1097/00000542-198903000-00022; Gutzwiller A., 2003, Agrarforschung, V10, P10; Haga HA, 2005, VET ANAESTH ANALG, V32, P1, DOI 10.1111/j.1467-2995.2004.00225.x; Haga Henning A, 2001, Vet Anaesth Analg, V28, P126, DOI 10.1046/j.1467-2987.2001.00051.x; Hancock TM, 2018, VET ANAESTH ANALG, V45, P858, DOI 10.1016/j.vaa.2018.07.002; Hanna MN, 2009, REGION ANESTH PAIN M, V34, P122, DOI 10.1097/AAP.0b013e31819a12a6; Hansson M, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-34; Herskin MS, 2018, ADV PIG WELFARE, P506; Hofmann K, 2019, TIERAERZTL PRAX G N, V47, P87, DOI 10.1055/a-0861-9640; Hogan ME, 2011, ANN EMERG MED, V58, P86, DOI 10.1016/j.annemergmed.2010.12.001; Horn T, 1999, DEUT TIERARZTL WOCH, V106, P271; Huang YP, 2017, RES VET SCI, V114, P27, DOI 10.1016/j.rvsc.2017.02.023; Hug PJ, 2018, SCHWEIZ ARCH TIERH, V160, P461, DOI 10.17236/sat00169; Ison SH, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00108; Johnson CB, 2009, VET ANAESTH ANALG, V36, P273, DOI 10.1111/j.1467-2995.2009.00448.x; Kluivers-Poodt M, 2013, ANIMAL, V7, P1158, DOI 10.1017/S1751731113000086; Kluivers-Poodt M, 2012, ANIMAL, V6, P1469, DOI 10.1017/S1751731112000547; Leidig MS, 2009, APPL ANIM BEHAV SCI, V116, P174, DOI 10.1016/j.applanim.2008.10.004; Lirk P, 2018, ANESTH ANALG, V126, P1381, DOI 10.1213/ANE.0000000000002665; Lomax S, 2018, TIERARZTL UMSCH, V73; Marsalek P, 2015, CZECH J ANIM SCI, V60, P473, DOI 10.17221/8555-CJAS; MAYFIELD SR, 1989, J DEV PHYSIOL, V11, P331; MCGLONE JJ, 1988, J ANIM SCI, V66, P3049; Merskey H., 1994, CLASSIFICATION CHRON, P207, DOI DOI 10.1002/ANA.20394; Nishiyama T, 2005, J CLIN ANESTH, V17, P586, DOI 10.1016/j.jclinane.2005.03.009; Perez-Pedraza E, 2018, INT J VET SCI MED, V6, P159, DOI 10.1016/j.ijvsm.2018.10.002; Priebe HJ, 2000, CARDIOVASCULAR PHYSL, P213; Prunier A, 2005, J ANIM SCI, V83, P216; R Development Core Team, 2017, LANG ENV STAT COMP; Ranheim B, 2005, J VET PHARMACOL THER, V28, P481, DOI 10.1111/j.1365-2885.2005.00675.x; Rauh A, 2019, TIERAERZTL PRAX G N, V47, P160, DOI 10.1055/a-0866-6694; Rigamonti SM, 2018, SCHWEIZ ARCH TIERH, V160, P469, DOI 10.17236/sat00170; Rittershaus D., 2009, THESIS; Satas S, 1996, ACTA ANAESTH SCAND, V40, P452, DOI 10.1111/j.1399-6576.1996.tb04468.x; Schulz C, 2007, BERL MUNCH TIERARZTL, V120, P177, DOI 10.2376/0005-9366-120-177; Sutherland MA, 2017, J VET BEHAV, V21, P71, DOI 10.1016/j.jveb.2017.07.003; Tavella G., 2016, Atti della Societa Italiana di Patologia ed Allevamento dei Suini, XLII Meeting Annuale, Montichiari, Italia, 10-11 Marzo 2016, P69; Taylor AA, 2000, APPL ANIM BEHAV SCI, V70, P17, DOI 10.1016/S0168-1591(00)00143-X; Taylor AA, 2001, APPL ANIM BEHAV SCI, V73, P35, DOI 10.1016/S0168-1591(01)00123-X; Taylor PM, 1998, EQUINE VET J, V30, P304, DOI 10.1111/j.2042-3306.1998.tb04102.x; Telles FG, 2016, VET ANIM SCI, V1-2, P36, DOI 10.1016/j.vas.2016.11.003; VANLIESHOUT JJ, 1991, CLIN SCI, V81, P575, DOI 10.1042/cs0810575; von Borell E, 2009, ANIMAL, V3, P1488, DOI 10.1017/S1751731109004728; WHITE RG, 1995, J ANIM SCI, V73, P381; Yun J, 2019, RES VET SCI, V125, P36, DOI 10.1016/j.rvsc.2019.05.009; Zankl A, 2007, DEUT TIERARZTL WOCH, V114, P418, DOI 10.2377/0341-6593-114-418; ZBINDEN AM, 1994, ANESTHESIOLOGY, V80, P261, DOI 10.1097/00000542-199402000-00005; Zols S, 2006, BERL MUNCH TIERARZTL, V119, P193; Zols S., 2006, THESIS	59	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236742	10.1371/journal.pone.0236742	http://dx.doi.org/10.1371/journal.pone.0236742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730302	Green Published, gold			2022-12-26	WOS:000556884700031
J	Singh, NK; Bhattacharya, R; Borrok, DM				Singh, Nitin K.; Bhattacharya, Ruchi; Borrok, David M.			A Bayesian framework to unravel food, groundwater, and climate linkages: A case study from Louisiana	PLOS ONE			English	Article							RICE PRODUCTION; CROP PRODUCTION; YIELD RESPONSE; DROUGHT; CHINA; WATER; DEPLETION; WEATHER; TRENDS; ENERGY	Advancing our understanding of the connections among groundwater, food, and climate is critical to meet global food demands while optimizing water resources usage. However, our understanding of the linkages among groundwater, food, and climate is still limited. Here, we offer a Bayesian framework to simulate crop yield at a regional scale and quantify its relationships and associated uncertainty with climate, groundwater, agricultural, and energy-related variables. We implemented the framework in the rice-producing regions of Louisiana from 1960-2015. To build a parsimonious model, we used a probability-based variable selection approach to detect the key drivers of rice yield. Rice yield increased, groundwater declined, and area planted declined or did not change over 56yrs. The number of irrigation wells, groundwater level, air temperature, and area planted were found to be the key drivers of rice yield. The regression coefficients showed that rice yield was positively related to groundwater level, and negatively related to area planted and the number of irrigation wells. The limited influence of N fertilizer was noted on rice yield for the period when fertilizer data were available. The inverse relationship between rice yield and area planted pointed to the adaption of efficient crop management practices that maintained or increased yield, despite the decline in area planted. The farmers' ability to install irrigation wells during droughts sustained the yields over long-term but not short-term. This decline in rice yield in response to drought over the short-term might explain the negative relation between yield and irrigation wells. Overall, this work highlighted the uncertainty in relationships between rice yield and key drivers and quantified the intimate connection between food and groundwater. This work may have implications for managing two highly competing commodities (i.e., groundwater and food) in agricultural regions.	[Singh, Nitin K.; Bhattacharya, Ruchi] Univ Waterloo, Earth & Environm Sci, Waterloo, ON, Canada; [Singh, Nitin K.; Borrok, David M.] Missouri Univ Sci & Technol, Geosci & Geol & Petr Engn, Rolla, MO 65409 USA	University of Waterloo; University of Missouri System; Missouri University of Science & Technology	Singh, NK (corresponding author), Univ Waterloo, Earth & Environm Sci, Waterloo, ON, Canada.; Singh, NK (corresponding author), Missouri Univ Sci & Technol, Geosci & Geol & Petr Engn, Rolla, MO 65409 USA.	nksingh2@ncsu.edu		Singh, Nitin/0000-0002-8495-1908	National Science Foundation [CBET 1360398]	National Science Foundation(National Science Foundation (NSF))	DMB: National Science Foundation (CBET 1360398) https://www.nsf.gov.	[Anonymous], 2013, TEXTS STAT SCI SERIE; Basso B, 2013, P 1 M SCI ADV COMM G, V41; Bhargava A, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaade9; Borrok DM, 2016, J HYDROL, V533, P320, DOI 10.1016/j.jhydrol.2015.12.022; Burke M, 2010, ADV GLOB CHANGE RES, V37, P133, DOI 10.1007/978-90-481-2953-9_8; Cabas J, 2010, CLIMATIC CHANGE, V101, P599, DOI 10.1007/s10584-009-9754-4; Carlson D., 2006, SYSTEMATIC VARIABILI; Cooke B., 2009, INT FOOD POLICY RES; Cotterman KA, 2018, CLIMATIC CHANGE, V146, P187, DOI 10.1007/s10584-017-1947-7; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Dalin C, 2017, NATURE, V543, P700, DOI 10.1038/nature21403; Dobermann A., 2007, FERTILIZER BEST MANA, V1; Duwayri M., 1999, International Rice Commission Newsletter, V48, P13; Dyer J, 2015, J HYDROL, V531, P360, DOI 10.1016/j.jhydrol.2015.07.016; Eldardiry H, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/aa51dc; Espe MB, 2016, FIELD CROP RES, V196, P276, DOI 10.1016/j.fcr.2016.07.011; FAO, 2011, STAT WORLDS LAND WAT; Foster T, 2015, WEATHER CLIM EXTREME, V10, P11, DOI 10.1016/j.wace.2015.07.003; Gage S., 2015, ECOLOGY AGR LANDSCAP, P77; Harrell D, 2018, MORE SUSTAINABLE RIC; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Hoekstra A. Y, 2017, ADV GROUNDWATER GOVE, P353; Horie T, 1995, MODELING IMPACT CLIM, P51; Iizumi T, 2015, GLOB FOOD SECUR-AGR, V4, P46, DOI 10.1016/j.gfs.2014.11.003; Jagermeyr J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/2/025002; Kang YH, 2009, PROG NAT SCI-MATER, V19, P1665, DOI 10.1016/j.pnsc.2009.08.001; Korres N., 2017, WATER RESOUR RURAL D, V9, P12, DOI DOI 10.1016/J.WRR.2016.10.001; Kruschke JK, 2014, JAGS STAN, V2nd, DOI DOI 10.1016/B978-0-12-405888-0.09996-7; Leng GY, 2016, J ADV MODEL EARTH SY, V8, P1912, DOI 10.1002/2016MS000645; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Li T, 2015, GLOBAL CHANGE BIOL, V21, P1328, DOI 10.1111/gcb.12758; Li W., 2009, DEV HYBRID RICE LOUI; Li YP, 2009, CLIM RES, V39, P31, DOI 10.3354/cr00797; Liu L, 2020, FOOD SECUR, V5, P1; Liu ZH, 2013, J GEOGR SCI, V23, P1005, DOI 10.1007/s11442-013-1059-x; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Lobell DB, 2003, SCIENCE, V299, P1032, DOI 10.1126/science.1077838; Ma GN, 2013, MATH COMPUT MODEL, V58, P634, DOI 10.1016/j.mcm.2011.10.038; McBride W.D., 2018, US RICE PRODUCTION N; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Muthayya S, 2014, ANN NY ACAD SCI, V1324, P7, DOI 10.1111/nyas.12540; Naderloo L, 2012, MEASUREMENT, V45, P1406, DOI 10.1016/j.measurement.2012.03.025; Najafi E, 2018, EARTHS FUTURE, V6, P410, DOI 10.1002/2017EF000690; Nalley L, 2016, AGRON J, V108, P1514, DOI 10.2134/agronj2015.0526; Nazlioglu S, 2012, ENERG ECON, V34, P1098, DOI 10.1016/j.eneco.2011.09.008; Nhamo L, 2018, WATER-SUI, V10, DOI 10.3390/w10050567; Palmer W.C., 1965, WEATHER BUREAU RES P; Pei HW, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044013; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Plummer M, 2003, PROC 3 INT WORK DIST, V3, P1; Prabnakorn S, 2018, SCI TOTAL ENVIRON, V621, P108, DOI 10.1016/j.scitotenv.2017.11.136; Rahman M. A., 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-017-0089-5; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Reddy VR, 2000, ENVIRON MODELL SOFTW, V15, P79, DOI 10.1016/S1364-8152(99)00011-0; Ringler C, 2013, CURR OPIN ENV SUST, V5, P617, DOI 10.1016/j.cosust.2013.11.002; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Rossato L, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00073; Russo TA., 2015, SUSTAINABILITY INTEG, P147, DOI [10.1007/978-3-319-12194-9_9, DOI 10.1007/978-3-319-12194-9_9]; Russo TA, 2017, NAT GEOSCI, V10, P105, DOI [10.1038/ngeo2883, 10.1038/NGEO2883]; Sargent B.P., 2011, 17 LOUIS DEP TRANSP, V17, P145; Scanlon BR, 2017, WATER RESOUR RES, V53, P3550, DOI 10.1002/2017WR020889; SINGH N, 2019, SCI REPORTS, V9, P57220, DOI DOI 10.1038/S41598-018-37186-2; Steward DR, 2013, P NATL ACAD SCI USA, V110, pE3477, DOI 10.1073/pnas.1220351110; Stewart WM, 2005, AGRON J, V97, P1, DOI 10.2134/agronj2005.0001; Sun QP, 2011, AGR WATER MANAGE, V98, P808, DOI 10.1016/j.agwat.2010.12.007; Team RC, R PROJECT STAT COMPU; Tebaldi C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033423; Turral H., 2011, FAO WATER REPORTS; van Oort PAJ, 2016, AGR WATER MANAGE, V165, P131, DOI 10.1016/j.agwat.2015.11.005; Vanuytrecht E, 2014, ENVIRON MODELL SOFTW, V62, P351, DOI 10.1016/j.envsoft.2014.08.005; Vories Earl D., 2014, International Journal of Water, V8, P259, DOI 10.1504/IJW.2014.064220; Wada Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044571; Xiong W, 2014, AGR ECOSYST ENVIRON, V196, P125, DOI 10.1016/j.agee.2014.06.014; Yang XG, 2015, AGR FOREST METEOROL, V208, P76, DOI 10.1016/j.agrformet.2015.04.024; Yu YQ, 2012, FIELD CROP RES, V136, P65, DOI 10.1016/j.fcr.2012.07.021; Zeugner S, 2015, J STAT SOFTW, V68, P1; Zhang TY, 2010, AGR FOREST METEOROL, V150, P1128, DOI 10.1016/j.agrformet.2010.04.013; Zhong HL, 2017, AGR WATER MANAGE, V193, P1, DOI 10.1016/j.agwat.2017.07.014	82	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236757	10.1371/journal.pone.0236757	http://dx.doi.org/10.1371/journal.pone.0236757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730317	gold, Green Published			2022-12-26	WOS:000556884700080
J	Vanden Wyngaert, K; Celie, B; Calders, P; Eloot, S; Holvoet, E; Van Biesen, W; Van Craenenbroeck, AH				Vanden Wyngaert, Karsten; Celie, Bert; Calders, Patrick; Eloot, Sunny; Holvoet, Els; Van Biesen, Wim; Van Craenenbroeck, Amaryllis H.			Markers of protein-energy wasting and physical performance in haemodialysis patients: A cross-sectional study	PLOS ONE			English	Article							MINI-NUTRITIONAL ASSESSMENT; CHRONIC KIDNEY-DISEASE; SUBJECTIVE GLOBAL ASSESSMENT; HAND-HELD DYNAMOMETRY; MUSCLE STRENGTH; PERITONEAL-DIALYSIS; INTEROBSERVER AGREEMENT; ELDERLY-PATIENTS; STAND TEST; RISK	Background Physical impairments are common in uraemia, as reflected by the high risk of falls of haemodialysis (HD) patients. Furthermore, these patients often suffer from malnutrition. Objective Up to now, it is unknown which aspects of physical performance are predominantly driven by malnutrition in HD patients. As this answer could steer different interventions, the aim of this study was to evaluate the cross-sectional relationship between nutritional status, muscle strength, exercise capacity and the risk of falls. Methods This study recruited HD patients between December 2016 and March 2018 from two hospital-based and five satellite dialysis units (registration number on clinicaltrial.gov: NCT03910426). The mini-nutritional assessment scale as well as objective measures of protein-energy wasting were obtained (total iron-binding capacity, total protein levels, and CRP). Physical assessment included muscle strength (quadriceps, handgrip force, and sit-to-stand test), exercise capacity (six-minute walking test) and the risk of falls (Tinetti, FICSIT, and dialysis fall index). Their interrelationship was analysed by ridge regression models. Results Out of 113 HD patients (mean age 67 years +/- 16.1, 57.5% male) 36.3% were malnourished according to the mini-nutritional assessment scale and a majority had impaired quadriceps force (86.7%), six-minute walking test (92%), and an increased risk of falls (73.5%). Total protein and CRP levels were identified as relevant nutritional factors in the association with physical performance. Nutritional parameters explained 9.2% of the variance in the risk of falls and 7.6% of the variance in exercise capacity. No conclusive association was found between nutritional status and muscle strength. Conclusion Protein-energy wasting is a determinant ofthe risk of fallsandexercise capacityin patients on HD. The association between malnutrition andmuscle weaknessremains inconclusive.	[Vanden Wyngaert, Karsten; Celie, Bert; Calders, Patrick] Univ Ghent, Fac Med & Hlth Sci, Dept Rehabil Sci, Ghent, Belgium; [Eloot, Sunny; Holvoet, Els; Van Biesen, Wim] Ghent Univ Hosp, Dept Internal Med, Renal Div, Ghent, Belgium; [Van Craenenbroeck, Amaryllis H.] Univ Antwerp, Lab Expt Med & Paediat, Antwerp, Belgium; [Van Craenenbroeck, Amaryllis H.] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Leuven, Belgium	Ghent University; Ghent University; Ghent University Hospital; University of Antwerp; KU Leuven; University Hospital Leuven	Van Craenenbroeck, AH (corresponding author), Univ Antwerp, Lab Expt Med & Paediat, Antwerp, Belgium.; Van Craenenbroeck, AH (corresponding author), Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Leuven, Belgium.	amaryllis.vancraenenbroeck@uzleuven.be		Van Craenenbroeck, Amaryllis/0000-0003-4728-9406; Van Biesen, Wim/0000-0002-4782-5224				Akchurin OM, 2015, BLOOD PURIFICAT, V39, P84, DOI 10.1159/000368940; Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; American Society of Hand T, 1992, CLIN ASSESSMENT RECO; Bao YR, 2012, ARCH INTERN MED, V172, P1071, DOI 10.1001/archinternmed.2012.3020; Bharadwaj S, 2016, GASTROENTEROL REP, V4, P272, DOI 10.1093/gastro/gow013; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Brzosko S, 2013, ARCH MED SCI, V9, P669, DOI 10.5114/aoms.2012.31386; Buatois S, 2008, J AM GERIATR SOC, V56, P1575, DOI 10.1111/j.1532-5415.2008.01777.x; Cacciatore F, 2012, EUR J PREV CARDIOL, V19, P1401, DOI 10.1177/1741826711422991; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; Carvalho EV, 2014, TRANSPL P, V46, P1713, DOI 10.1016/j.transproceed.2014.05.019; Castaneda C, 2004, AM J KIDNEY DIS, V43, P607, DOI 10.1053/j.ajkd.2003.12.025; Valencia VC, 2018, NEFROLOGIA, V38, P57, DOI 10.1016/j.nefro.2017.07.001; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cobo G, 2018, NEPHROL DIAL TRANSPL, V33, P35, DOI 10.1093/ndt/gfy175; Davies SJ, 2002, NEPHROL DIAL TRANSPL, V17, P1085, DOI 10.1093/ndt/17.6.1085; de Arenaza DP, 2010, HEART, V96, P113, DOI 10.1136/hrt.2008.161174; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Duncan MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142463; Elia M, 2017, INT J LOW EXTR WOUND, V16, P230, DOI 10.1177/1534734617733902; Farrington K, 2016, NEPHROL DIAL TRANSPL, V31, P1, DOI 10.1093/ndt/gfw356; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Frih B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00288; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Hermans G, 2012, MUSCLE NERVE, V45, P18, DOI 10.1002/mus.22219; Holvoet E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229722; Ikizler TA, 2006, J AM SOC NEPHROL, V17, P2097, DOI 10.1681/ASN.2006060629; Ikizler TA, 2013, ADV CHRONIC KIDNEY D, V20, P181, DOI 10.1053/j.ackd.2012.12.002; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Johansen KL, 2005, SPORTS MED, V35, P485, DOI 10.2165/00007256-200535060-00003; Jones SE, 2013, THORAX, V68, P1015, DOI 10.1136/thoraxjnl-2013-203576; Kalantar-Zadeh K, 1998, AM J KIDNEY DIS, V31, P263, DOI 10.1053/ajkd.1998.v31.pm9469497; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1343, DOI 10.1053/ajkd.2001.29250; Kegelmeyer DA, 2007, PHYS THER, V87, P1369, DOI 10.2522/ptj.20070007; Koefoed M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150012; Koepke S, 2006, Z GERONTOL GERIATR, V39, P288, DOI 10.1007/s00391-006-0398-y; Kono K, 2018, CLIN EXP NEPHROL, V22, P167, DOI 10.1007/s10157-017-1431-8; Kono K, 2014, THER APHER DIAL, V18, P623, DOI 10.1111/1744-9987.12177; Leal VO, 2011, NEPHROL DIAL TRANSPL, V26, P1354, DOI 10.1093/ndt/gfq487; Maraj M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010069; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Mehrotra R, 2001, ANNU REV NUTR, V21, P343, DOI 10.1146/annurev.nutr.21.1.343; Morley JE, 2002, J GERONTOL A-BIOL, V57, pM698, DOI 10.1093/gerona/57.11.M698; Nakazato Y, 2015, CLIN EXP NEPHROL, V19, P1165, DOI 10.1007/s10157-015-1108-0; Nixon AC, 2018, CLIN KIDNEY J, V11, P236, DOI 10.1093/ckj/sfx134; Oliveira M.C., 2018, NUTRIRE, V43, P14, DOI [10.1186/s41110-018-0073-2, DOI 10.1186/S41110-018-0073-2]; Rodrigues J, 2017, NEPHROL DIAL TRANSPL, V32, P1780, DOI 10.1093/ndt/gfw471; ROSSITERFORNOFF JE, 1995, J GERONTOL A-BIOL, V50, pM29, DOI DOI 10.1093/GERONA/50A.6.M2917583799; Soysal P, 2016, AGEING RES REV, V31, P1, DOI 10.1016/j.arr.2016.08.006; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Takeuchi H, 2018, AGING DIS, V9, P192, DOI 10.14336/AD.2017.0429; Thomas JI, 2005, ARCH PHYS MED REHAB, V86, P1636, DOI 10.1016/j.apmr.2005.03.004; Tsai AC, 2013, INT J NURS STUD, V50, P83, DOI 10.1016/j.ijnurstu.2012.08.015; Tsai AC, 2011, INT J NURS STUD, V48, P1429, DOI 10.1016/j.ijnurstu.2011.05.004; Ullah MI, 2018, R J, V10, P326; Uszko-Lencer NHMK, 2017, INT J CARDIOL, V240, P285, DOI 10.1016/j.ijcard.2017.02.109; Van Craenenbroeck AH, 2016, NEPHROL DIAL TRANSPL, V31, P2064, DOI 10.1093/ndt/gfw303; Vanden Wyngaert K, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-019-1671-9; Vanpee G, 2011, CRIT CARE MED, V39, P1929, DOI 10.1097/CCM.0b013e31821f050b; Vegine Patrícia Marçal, 2011, Braz. J. Nephrol., V33, P55; Wang AY, 2017, NEPHROLOGY, V22, P220, DOI 10.1111/nep.12749	64	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236816	10.1371/journal.pone.0236816	http://dx.doi.org/10.1371/journal.pone.0236816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730305	Green Published, gold			2022-12-26	WOS:000556884700055
J	Arntz, OJ; Pieters, BCH; van Lent, PLEM; Koenders, MI; van der Kraan, PM; van de Loo, FAJ				Arntz, Onno J.; Pieters, Bartijn C. H.; van Lent, Peter L. E. M.; Koenders, Marije I.; van der Kraan, Peter M.; van de Loo, Fons A. J.			An optimized method for plasma extracellular vesicles isolation to exclude the copresence of biological drugs and plasma proteins which impairs their biological characterization	PLOS ONE			English	Article							NANOPARTICLE TRACKING ANALYSIS; RHEUMATOID-ARTHRITIS; EXOSOMES; CLASSIFICATION; MICROVESICLES	Extracellular vesicles (EVs) are cell membrane-derived phospholipid bilayer nanostructures that contain bioactive proteins, enzymes, lipids and polymers of nucleotides. They play a role in intercellular communication and are present in body fluids. EVs can be isolated by methods like ultracentrifugation (UC), polyethylene-glycol-precipitation (PEG) or size exclusion chromatography (SEC). The co-presence of immunoglobulins (Ig) in EV samples isolated from plasma (pEVs) is often reported and this may influence the assessment of the biological function and phenotype of EVs in bio- and immunoassay. Here, we studied the presence of an Ig-based therapeutic (etanercept) in pEV samples isolated from rheumatoid arthritis (RA) patients and improved the isolation method to obtain purer pEVs. From plasma of etanercept (Tumor-necrosis-factor (TNF)-alpha antibodies)-treated RA patients pEVs were isolated by either UC, PEG or SEC. SEC isolated pEVs showed the highest particle-to-protein ratio. Strong TNF-alpha inhibition determined in a TNF-alpha sensitive reporter assay was observed by pEVs isolated by UC and PEG, and to a lesser extent by SEC, suggesting the presence of functional etanercept. SEC isolation of etanercept or labelled immunoglobulin G (IgG) showed co-isolation of these antibodies in the pEV fraction in the presence of plasma or a high protein (albumin) concentration. To minimize the presence of etanercept or immunoglobulins, we extended SEC (eSEC) column length from 56mm to 222mm (total stacking volume unchanged). No effect on the amount of isolated pEVs was observed while protein and IgG content were markedly reduced (90%). Next, from six etanercept- treated RA patients, pEVs were isolated on a eSEC or standard SEC column, in parallel. TNF-alpha inhibition was again observed in pEVs isolated by conventional SEC but not by eSEC. To confirm the purer pEVs isolated by eSEC the basal IL-8 promoter activation in human monocytes was determined and in 4 out of 5 SEC isolated pEVs activation was observed while eSEC isolated pEVs did not. This study shows that extended SEC columns yielded pEVs without detectable biologicals and with low protein and IgG levels. This isolation method will improve the characterization of pEVs as potential biomarkers and mediators of disease.	[Arntz, Onno J.; Pieters, Bartijn C. H.; van Lent, Peter L. E. M.; Koenders, Marije I.; van der Kraan, Peter M.; van de Loo, Fons A. J.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands	Radboud University Nijmegen	van de Loo, FAJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands.	Fons.vandeloo@radboudumc.nl	Arntz, Onno J/A-2354-2016; van de Loo, Fons AJ/A-3425-2014; van der Kraan, Peter M/D-9115-2011	Arntz, Onno J/0000-0001-7064-6067; van de Loo, Fons AJ/0000-0002-5851-099X; 				Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arntz OJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02388; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Boing AN, 2014, J EXTRACELL VESICLES, V1, P1, DOI http://dx.doi.org/10.3402/jev.v3.23430; Brett SI, 2017, PROSTATE, V77, P1335, DOI 10.1002/pros.23393; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Filoti DI, 2015, J PHARM SCI-US, V104, P2123, DOI 10.1002/jps.24454; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Foers AD, 2017, ARTHRITIS RHEUMATOL, V69, P1350, DOI 10.1002/art.40076; Gheinani AH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22142-x; Goyon A, 2017, J CHROMATOGR B, V1065, P119, DOI 10.1016/j.jchromb.2017.09.033; GRUBISIC Z, 1967, J POLYM SCI POL LETT, V5, P753, DOI 10.1002/pol.1967.110050903; Heath N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24163-y; Janson J.C, 2012, PROTEIN PURIFICATION; Karimi N, 2018, CELL MOL LIFE SCI, V75, P2873, DOI 10.1007/s00018-018-2773-4; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Kosanovic M, 2017, BIOTECHNIQUES, V63, P65, DOI 10.2144/000114575; Lim H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030768; Linares R, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29509; Liu ML, 2016, ADV CLIN CHEM, V77, P125, DOI 10.1016/bs.acc.2016.06.005; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Looze C, 2009, BIOCHEM BIOPH RES CO, V378, P433, DOI 10.1016/j.bbrc.2008.11.050; Margolis L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000363; McLellan A., 2009, CRIT REV IMMUNOL, V29; Motrescu I., 2006, SPECTROPHOTOMETRIC A, V16, P215; Pegtel DM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0516; Saunderson SC, 2008, J IMMUNOL, V180, P8146, DOI 10.4049/jimmunol.180.12.8146; Sluijter JPG, 2014, CARDIOVASC RES, V102, P302, DOI 10.1093/cvr/cvu022; Smolarz M, 2019, PROTEOMES, V7, DOI 10.3390/proteomes7020018; Sodar BW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24316; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Vestad B, 2017, J EXTRACELL VESICLES, V6, P1, DOI 10.1080/20013078.2017.1344087; Zhou SY, 2011, J CLIN PHARMACOL, V51, P864, DOI 10.1177/0091270010375961	36	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236508	10.1371/journal.pone.0236508	http://dx.doi.org/10.1371/journal.pone.0236508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726333	Green Published, gold			2022-12-26	WOS:000556908900017
J	Rosa, HS; Ajaz, S; Gnudi, L; Malik, AN				Rosa, Hannah S.; Ajaz, Saima; Gnudi, Luigi; Malik, Afshan N.			A case for measuring both cellular and cell-free mitochondrial DNA as a disease biomarker in human blood	FASEB JOURNAL			English	Article						absolute quantification; circulating nucleic acids; inflammation; mitochondria; qPCR	COPY NUMBER; POTENTIAL BIOMARKER; PLASMA; ASSOCIATION; DAMAGE; RISK; PCR	Circulating mitochondrial DNA (mtDNA), widely studied as a disease biomarker, comprises of mtDNA located within mitochondria, indicative of mitochondrial function, and cell-free (cf) mtDNA linked to inflammation. The purpose of this study was to determine the ranges of, and relationship between, cellular and cf mtDNA in human blood. Whole blood from 23 controls (HC) and 20 patients with diabetes was separated into peripheral blood mononuclear cells (PBMCs), plasma, and serum. Total DNA was isolated and mtDNA copy numbers were determined using absolute quantification. Cellular mtDNA content in PBMCs was higher than in peripheral blood and a surprisingly high level of cf mtDNA was present in serum and plasma of HC, with no direct relationship between cellular and cf mtDNA content within individuals. Diabetes patients had similar levels of cellular mtDNA compared to healthy participants but a significantly higher cf mtDNA content. Furthermore, only in patients with diabetes, we observed a correlation between whole blood and plasma mtDNA levels, indicating that the relationship between cellular and cf mtDNA content is affected by disease status. In conclusion, when evaluating mtDNA in human blood as a biomarker of mitochondrial dysfunction, it is important to measure both cellular and cf mtDNA.	[Rosa, Hannah S.; Ajaz, Saima; Malik, Afshan N.] Kings Coll London, Fac Life Sci & Med, Sch Life Course Sci, Dept Diabet, 2nd Floor Hodgkin Bldg,Guys Campus, London SE1 1UL, England; [Gnudi, Luigi; Malik, Afshan N.] Kings Coll London, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, London, England	University of London; King's College London; University of London; King's College London	Malik, AN (corresponding author), Kings Coll London, Fac Life Sci & Med, Sch Life Course Sci, Dept Diabet, 2nd Floor Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	afshan.malik@kcl.ac.uk		Rosa, Hannah/0000-0003-4624-752X; Ajaz, Saima/0000-0002-1089-1949	European Foundation for the Study of Diabetes (EFSD)	European Foundation for the Study of Diabetes (EFSD)	\European Foundation for the Study of Diabetes (EFSD)	Afrifa J, 2019, MITOCHONDRION, V47, P238, DOI 10.1016/j.mito.2018.12.003; Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arshad O, 2018, JAIDS-J ACQ IMM DEF, V78, P111, DOI 10.1097/QAI.0000000000001650; Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3; Bae JH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040328; Bianco Angelica, 2018, BMC Res Notes, V11, P911, DOI 10.1186/s13104-018-4025-y; Biro O, 2018, BIOMARK MED, V12, P891, DOI 10.2217/bmm-2017-0386; Boyapati RK, 2018, INFLAMM BOWEL DIS, V24, P2113, DOI 10.1093/ibd/izy095; Cao HD, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3131; Cao HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113179; Casula M, 2005, J INFECT DIS, V192, P1794, DOI 10.1086/497140; Canizales YGC, 2018, IRAN J IMMUNOL, V15, P142, DOI IJIv15i2A7; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Cicchillitti L, 2017, ONCOTARGET, V8, DOI [10.18632/oncotar-get.v8i70, DOI 10.18632/ONCOTAR-GET.V8I70]; Cossarizza A, 2003, CURR OPIN INFECT DIS, V16, P5, DOI 10.1097/00001432-200302000-00002; Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002; Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR; Dai Z, 2015, CURR MOL MED, V15, P975, DOI 10.2174/1566524016666151123114401; Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262; Harrington JS, 2019, CHEST, V156, P1120, DOI 10.1016/j.chest.2019.07.014; Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Knez J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181036; Kumar M, 2017, CLIN THER, V39, pe68, DOI DOI 10.1177/1010428317736643; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lei L, 2017, J HUM HYPERTENS, V31, P585, DOI 10.1038/jhh.2017.30; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Liu J, 2015, CLIN LAB, V61, P661, DOI 10.7754/Clin.Lab.2014.141132; Longchamps R.J., 2019, EVALUATION MITOCHOND; Lowes H, 2019, MITOCHONDRION, V46, P307, DOI 10.1016/j.mito.2018.07.008; Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067; Malik AN, 2018, MITOCHONDRIAL BIOL E, P297; McCarthy CG, 2015, CARDIOVASC RES, V107, P119, DOI 10.1093/cvr/cvv137; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Picard M, 2018, BIOL PSYCHIAT, V84, P9, DOI 10.1016/j.biopsych.2018.01.012; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515; Qin CY, 2017, ANATOL J CARDIOL, V17, P224, DOI 10.14744/AnatolJCardiol.2016.7209; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799; Rykova E, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1295-z; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Silzer T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213527; Stertz L, 2015, ACTA PSYCHIAT SCAND, V132, P211, DOI 10.1111/acps.12417; Thurairajah K, 2018, EUR J TRAUMA EMERG S, V44, P325, DOI 10.1007/s00068-018-0954-3; Tripathi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26749; Udomsinprasert W, 2019, MITOCHONDRION, V47, P1, DOI 10.1016/j.mito.2019.04.006; Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008; Workalemahu T, 2017, J MATERN-FETAL NEO M, V30, P2433, DOI 10.1080/14767058.2016.1252747; Yang Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212808; Zhang RY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36097; Zhong F, 2019, TRENDS IMMUNOL, V40, P1120, DOI 10.1016/j.it.2019.10.008	56	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12278	12288		10.1096/fj.202000959RR	http://dx.doi.org/10.1096/fj.202000959RR		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729179	hybrid			2022-12-26	WOS:000556784700001
J	Huang, JR; Li, GP; Lei, HX; Fan, CB; Tian, CH; Chen, Q; Huang, B; Li, HL; Lu, ZC; Feng, HQ				Huang, Jianrong; Li, Guoping; Lei, Haixia; Fan, Chunbin; Tian, Caihong; Chen, Qi; Huang, Bo; Li, Huilong; Lu, Zhaocheng; Feng, Hongqiang			Low-temperature derived temporal change in the vertical distribution ofSesamia inferenslarvae in winter, with links to its latitudinal distribution	PLOS ONE			English	Article							COLD TOLERANCE; OVERWINTERING STRATEGY; CLIMATE-CHANGE; SUPERCOOLING CAPACITY; LEPIDOPTERA; COLEOPTERA; HARDINESS; BEETLE; COCCINELLIDAE; POPULATIONS	To escape or alleviate low temperatures in winter, insects have evolved many behavioral and physiological strategies. The purple stem borer,Sesamia inferens(Walker) is currently reported to be expanding their northern distributions and causing damage to summer maize in Xinxiang, China. However, their method of coping with the lower temperature in the new northern breeding area in winter is largely unknown. This paper investigates the overwinter site ofS.inferens, and identifies the cold hardiness of larvae collected from a new breeding area in winter and explores a potential distribution based on low temperature threshold and on species distribution model MaxEnt. The results show that the overwintering location of theS.inferenspopulation is more likely to be underground with increasing latitude and the population gradually moved down the corn stalk and drilled completely underground in later winter (February) in the north. The cold hardiness test shows the species is a moderate freeze-tolerant one, and Supercooling Points (SCP), Freezing Points (FP) and the incidence of mortality during the middle of winter (January, SCP: -7.653, FP: -6.596) were significantly lower than early winter (October) or late winter (March). Distribution in the new expansion area was predicted and the survival probability area was below N 35 degrees for the Air Lower Lethal Temperature (ALLT(50)) and below N 40 degrees for the Underground Lower Lethal Temperature (ULLT50)(.)The suitable habitat areas forS.inferenswith MaxEnt were also below N 40 degrees. This study suggests the overwinter strategies ofS.inferenshave led to the colonization of up to a five degree more northerly overwintering latitude.	[Huang, Jianrong; Li, Guoping; Tian, Caihong; Huang, Bo; Feng, Hongqiang] Henan Acad Agr Sci, Henan Key Lab Crop Pest Control, MOAs Reg Key Lab Crop IPM Southern Part Northern, Zhengzhou, Peoples R China; [Huang, Jianrong; Li, Guoping; Tian, Caihong; Huang, Bo; Feng, Hongqiang] Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Peoples R China; [Huang, Jianrong] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Lei, Haixia; Li, Huilong; Lu, Zhaocheng] Xinyang Acad Agr Sci, Xinyang, Peoples R China; [Fan, Chunbin] Tianjing Beidagang Wetland Conservat Ctr, Tianjin, Peoples R China; [Chen, Qi] Luohe Acad Agr Sci, Luohe, Peoples R China	Henan Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences; University of Exeter	Huang, JR (corresponding author), Henan Acad Agr Sci, Henan Key Lab Crop Pest Control, MOAs Reg Key Lab Crop IPM Southern Part Northern, Zhengzhou, Peoples R China.; Huang, JR (corresponding author), Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Peoples R China.; Huang, JR (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.	hjr130705@126.com; feng_hq@163.com		Huang, Jianrong/0000-0002-0268-9361	Youth Exchange Funding of Henan Academy of Agricultural sciences; National Natural Science Foundation of China [31401731]; Youth Funding of Henan Academy of Agricultural sciences [2020YQ09]; National Key Research and Development Program of China [2016YFD0300705, 2018YFD0200602, 2018YFD0200605]	Youth Exchange Funding of Henan Academy of Agricultural sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Funding of Henan Academy of Agricultural sciences; National Key Research and Development Program of China	J.H.'s visiting scholarship to the University of Exeter was funded by the Youth Exchange Funding of Henan Academy of Agricultural sciences. This research was supported by the National Natural Science Foundation of China (Grant No. 31401731) and Youth Funding of Henan Academy of Agricultural sciences (No.2020YQ09), Supported by the National Key Research and Development Program of China (Grant Nos. 2016YFD0300705, 2018YFD0200602, and 2018YFD0200605).	Alford L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168693; Andersen JL, 2015, FUNCT ECOL, V29, P55, DOI 10.1111/1365-2435.12310; Aregbesola OZ, 2019, J PEST SCI, V92, P381, DOI 10.1007/s10340-018-1059-9; Bale JS, 1996, EUR J ENTOMOL, V93, P369; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Chen B, 2004, ENVIRON ENTOMOL, V33, P155, DOI 10.1603/0046-225X-33.2.155; David JR, 2003, FUNCT ECOL, V17, P425, DOI 10.1046/j.1365-2435.2003.00750.x; de la Vega GJ, 2015, ECOGRAPHY, V38, P851, DOI 10.1111/ecog.01028; EZCURRA E, 1978, J BIOGEOGR, V5, P149, DOI 10.2307/3038169; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; GILLYBOEUF N, 1994, OECOLOGIA, V99, P366, DOI 10.1007/BF00627750; Gray DR, 2008, CLIMATIC CHANGE, V87, P361, DOI 10.1007/s10584-007-9317-5; Gu L., 2014, THESIS; Gu NH, 1985, ACTA ECOL SIN, V5, P64; [郭慧芳 Guo Huifang], 2002, [江苏农业学报, Journal of Agricultural Sciences], V18, P85; Guo YY, 2017, CROP PESTS DIS; [韩兰芝 Han Lanzhi], 2012, [植物保护, Plant Protection], V38, P9; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Honek A, 2007, EUR J ENTOMOL, V104, P51, DOI 10.14411/eje.2007.008; Hong Bo, 2014, Acta Ecologica Sinica, V34, P4603; Horton B, 2012, SOIL RES, V50, P447, DOI 10.1071/SR12165; Hu CX, 2015, CLIMATIC CHANGE, V132, P337, DOI 10.1007/s10584-015-1427-x; [黄建荣 Huang Jianrong], 2017, [植物保护, Plant Protection], V43, P156; [黄建荣 Huang Jianrong], 2015, [植物保护, Plant Protection], V41, P231; Kleynhans E, 2014, J EVOLUTION BIOL, V27, P1149, DOI 10.1111/jeb.12390; Kostal V, 2014, J INSECT PHYSIOL, V63, P62, DOI 10.1016/j.jinsphys.2014.02.007; Kumar S, 2014, COMPUT ELECTRON AGR, V103, P55, DOI 10.1016/j.compag.2014.02.007; Labrie G, 2008, ANN ENTOMOL SOC AM, V101, P860, DOI 10.1603/0013-8746(2008)101[860:OSOMAL]2.0.CO;2; Leather S. R., 1993, ECOLOGY INSECT OVERW; Liu YQ, 2016, J ECON ENTOMOL, V109, P1619, DOI 10.1093/jee/tow121; Morey AC, 2016, ECOL EVOL, V6, P8267, DOI 10.1002/ece3.2564; Nedved O, 1998, FUNCT ECOL, V12, P816, DOI 10.1046/j.1365-2435.1998.00250.x; PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Reynolds DS, 2016, J ECON ENTOMOL, V109, P240, DOI 10.1093/jee/tov290; Rochefort S, 2011, J INSECT PHYSIOL, V57, P751, DOI 10.1016/j.jinsphys.2011.02.013; Rozsypal J, 2014, J THERM BIOL, V45, P124, DOI 10.1016/j.jtherbio.2014.08.011; Rozsypal J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061745; Stahl K, 2006, CLIM RES, V32, P13, DOI 10.3354/cr032013; Sun M, 2014, FLA ENTOMOL, V97, P1544, DOI 10.1653/024.097.0429; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tian B, 2016, CRYOLETTERS, V37, P206; Ungerer MJ, 1999, J BIOGEOGR, V26, P1133, DOI 10.1046/j.1365-2699.1999.00363.x; Ward SF, 2019, AGR FOREST ENTOMOL, V21, P88, DOI 10.1111/afe.12311; Wheatley CJ, 2017, GLOBAL CHANGE BIOL, V23, P3704, DOI 10.1111/gcb.13759; Wu JG, 2016, CLIMATIC CHANGE, V134, P681, DOI 10.1007/s10584-015-1543-7; Xie DP, 1985, J SICHUAN AGR C, V3, P33; Zhang SM, 1965, ACTA ENTOMOL SIN, V14, P411; Zhang YC, 2019, ENTOMOL NEWS, V128, P460, DOI 10.3157/021.128.0503; Zhao Qian, 2015, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V31, P1171, DOI 10.13865/j.cnki.cjbmb.2015.11.08; Zhou C. B., 1985, ACTA ENTOMOL SINICA, V5, P199	51	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236174	10.1371/journal.pone.0236174	http://dx.doi.org/10.1371/journal.pone.0236174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722719	Green Published, gold			2022-12-26	WOS:000556916000001
J	Ogawa, M; Ishihara, T; Isobe, Y; Kato, T; Kuba, K; Imai, Y; Uchino, Y; Tsubota, K; Arita, M				Ogawa, Mamoru; Ishihara, Tomoaki; Isobe, Yosuke; Kato, Taiga; Kuba, Keiji; Imai, Yumiko; Uchino, Yuichi; Tsubota, Kazuo; Arita, Makoto			Eosinophils promote corneal wound healing via the 12/15-lipoxygenase pathway	FASEB JOURNAL			English	Article						alox15; corneal wound healing; eosinophils; lipid mediator; lipoxygenase; metabolomics	LIPID MEDIATORS; RESOLUTION; RESOLVINS; SIGNALS; 17-HDHA	Lipid mediators play important roles in regulating inflammatory responses and tissue homeostasis. Since 12/15-lipoxygenase (12/15-LOX)-derived lipid mediators such as lipoxin A(4)(LXA(4)) and protectin D1 (PD1) protect against corneal epithelial cell damage, the major cell types that express 12/15-LOX and contribute to the corneal wound healing process are of particular interest. Here, we found that eosinophils were the major cell type expressing 12/15-LOX during the corneal wound healing process. Eosinophils were recruited into the conjunctiva after corneal epithelium wounding, and eosinophil-deficient and/or eosinophil-specific 12/15-LOX knockout mice showed delayed corneal wound healing compared with wild-type mice. Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based mediator lipidomics revealed that a series of 12/15-LOX-derived mediators were significantly decreased in eosinophil-deficient mice and topical application of 17-hydroxydocosahexaenoic acid (17-HDoHE), a major 12/15-LOX-derived product, restored the phenotype. These results indicate that 12/15-LOX-expressing eosinophils, by locally producing pro-resolving mediators, significantly contribute to the corneal wound healing process in the eye.	[Ogawa, Mamoru; Ishihara, Tomoaki; Isobe, Yosuke; Kato, Taiga; Arita, Makoto] RIKEN Ctr Integrat Med Sci IMS, Lab Metabol, Yokohama, Kanagawa, Japan; [Ogawa, Mamoru; Uchino, Yuichi; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Kuba, Keiji] Akita Univ, Dept Biochem & Metab Sci, Grad Sch Med, Akita, Japan; [Imai, Yumiko] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Regulat Intractable Infect Dis, Osaka, Japan; [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan; [Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa, Japan	RIKEN; Keio University; Akita University; Keio University; Yokohama City University	Arita, M (corresponding author), RIKEN Ctr Integrat Med Sci IMS, Lab Metabol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	makoto.arita@riken.jp	Imai, Yumiko/GXW-1144-2022	Arita, Makoto/0000-0001-9902-0463; Ogawa, Mamoru/0000-0003-3416-9843	Japan Society for the Promotion of Science [KAKENHI JP15H05897, 15H05898, 20H00495]; Keio University; RIKEN Junior Research Associate Program; Keio University Doctorate Student Grant-In-Aid Program	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio University; RIKEN Junior Research Associate Program; Keio University Doctorate Student Grant-In-Aid Program	Japan Society for the Promotion of Science, Grant/Award Number: KAKENHI JP15H05897, 15H05898 and 20H00495; Keio University; RIKEN Junior Research Associate Program; Keio University Doctorate Student Grant-In-Aid Program	Ariel A, 2003, J IMMUNOL, V170, P6266, DOI 10.4049/jimmunol.170.12.6266; Carion TW, 2018, FASEB J, V32, P5026, DOI 10.1096/fj.201701502R; Chiu CY, 2012, INFLAMM RES, V61, P967, DOI 10.1007/s00011-012-0489-8; Doyle AD, 2013, J LEUKOCYTE BIOL, V94, P17, DOI 10.1189/jlb.0213089; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P7, DOI 10.1016/bs.pmbts.2015.04.001; Fukuda Ken, 2010, Cornea, V29 Suppl 1, pS62; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Holland EJ, 2015, CORNEA, V34, pS9, DOI 10.1097/ICO.0000000000000534; Iwamoto S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13122-8; Kenchegowda S, 2011, INVEST OPHTH VIS SCI, V52, P2240, DOI 10.1167/iovs.10-6199; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Masterson JC, 2015, GUT, V64, P1236, DOI 10.1136/gutjnl-2014-306998; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Ogawa Mamoru, 2018, Journal of Biological Methods, V5, pe102, DOI 10.14440/jbm.2018.237; Ramon S, 2014, J IMMUNOL, V193, P6031, DOI 10.4049/jimmunol.1302795; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; TSUBOTA K, 1991, CORNEA, V10, P525, DOI 10.1097/00003226-199111000-00011; Weller PF, 2017, NAT REV IMMUNOL, V17, P746, DOI 10.1038/nri.2017.95; Xu ZZ, 2011, BRIT J PHARMACOL, V164, P274, DOI 10.1111/j.1476-5381.2011.01348.x; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yamaguchi T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan3638; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346	27	9	9	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12492	12501		10.1096/fj.202000483R	http://dx.doi.org/10.1096/fj.202000483R		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32721046	hybrid			2022-12-26	WOS:000556061500001
J	Chang, YP; Lee, MS; Wu, DW; Tsai, JH; Ho, PS; Lin, CHR; Chuang, HY				Chang, Yang-Pei; Lee, Min-Sheng; Wu, Da-Wei; Tsai, Jui-Hsiu; Ho, Pei-Shan; Lin, Chun-Hung Richard; Chuang, Hung-Yi			Risk factors for depression in patients with Parkinson's disease: A nationwide nested case-control study	PLOS ONE			English	Article							PROVISIONAL DIAGNOSTIC-CRITERIA; ANXIETY DISORDERS; NEUROPSYCHIATRIC SYMPTOMS; PREVALENCE; DEMENTIA; SYSTEMS	Objectives Patients with Parkinson's disease (PD) have higher prevalence of depression than the general population; however, the risk factors for depression in PD remain uncertain. Methods/Design Using the 2000-2010 Taiwan National Health Insurance Research Database, we selected 1767 patients aged >= 40 years with new-onset PD during 2000-2009. Among them, 324 patients with a new incidence of depression were enrolled as cases and 972 patients without depression were randomly selected as controls. The groups were frequency-matched at a ratio of 1:3 by age, sex, and index year. Thus, this nested case-control study compared differences between the cases and the controls. Logistic regression models were used to identify risk factors for depression in PD. Results Compared with the controls, the odds ratio (OR) of anxiety disorders in the cases was 1.53 (95% confidence interval [95% CI], 1.16-2.02;P= 0.003), after adjusting for the confounding factors of age, sex, index year, geographic region, urban level, monthly income, and other coexisting medical conditions. The OR for sleep disturbances in the cases was 1.49 (95% CI, 1.14-1.96;P= 0.004) compared to the controls, after adjusting these confounding factors. Hence, the risk factors for depression in PD were nonsignificantly associated with physical comorbidities. Conclusions In the present study, depression in PD was significantly associated with anxiety disorders and sleep disturbances. Integrated care for early identification and treatment of neuropsychiatric comorbidities is crucial in patients with new-onset PD so as to prevent further PD degeneration.	[Chang, Yang-Pei] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lee, Min-Sheng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Wu, Da-Wei] Kaohsiung Med Univ, Kaohsiung Municipal Siaogang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wu, Da-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Jui-Hsiu] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Psychiat, Chiayi, Taiwan; [Tsai, Jui-Hsiu; Chuang, Hung-Yi] Taiwan Natl Hlth Res Inst, Program Environm & Occupat Med Taiwan, Kaohsiung, Taiwan; [Tsai, Jui-Hsiu; Chuang, Hung-Yi] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Ho, Pei-Shan] Kaohsiung Med Univ, Dept Oral Hyg, Coll Dent Med, Kaohsiung, Taiwan; [Ho, Pei-Shan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Med Stat & Bioinformat, Dept Med Res, Kaohsiung, Taiwan; [Lin, Chun-Hung Richard] Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung, Taiwan; [Chuang, Hung-Yi] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Chuang, Hung-Yi] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Tsai, JH (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Psychiat, Chiayi, Taiwan.; Tsai, JH (corresponding author), Taiwan Natl Hlth Res Inst, Program Environm & Occupat Med Taiwan, Kaohsiung, Taiwan.; Tsai, JH (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.; Ho, PS (corresponding author), Kaohsiung Med Univ, Dept Oral Hyg, Coll Dent Med, Kaohsiung, Taiwan.; Ho, PS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Med Stat & Bioinformat, Dept Med Res, Kaohsiung, Taiwan.; Lin, CHR (corresponding author), Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung, Taiwan.	faanvangogh@gmail.com; psho@kmu.edu.tw; lin@cse.nsysu.edu.tw	Chuang, H. Y./AAM-3118-2021	Chuang, H. Y./0000-0002-8321-8720; Wu, Da-Wei/0000-0001-5737-6613; Tsai, Jui-Hsiu/0000-0001-7335-4131; Chang, Yang-Pei/0000-0002-1021-2643	Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Taiwan [DMR-99-176]	Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Taiwan	No, this study was supported by Grantin-Hospital-Aid for Financial support by the Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Taiwan (DMR-99-176). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 1999, J NEUROL NEUROSUR PS, V67, P492, DOI 10.1136/jnnp.67.4.492; Aarsland D, 2009, J NEUROL NEUROSUR PS, V80, P928, DOI 10.1136/jnnp.2008.166959; Becker C, 2011, EUR J NEUROL, V18, P448, DOI 10.1111/j.1468-1331.2010.03176.x; Belarbi S, 2010, PARKINSONISM RELAT D, V16, P676, DOI 10.1016/j.parkreldis.2010.09.003; Braak H, 2006, J NEURAL TRANSM-SUPP, P89; Chang YP, 2016, NEUROPSYCH DIS TREAT, V12, P1037, DOI 10.2147/NDT.S99365; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Cologne JB, 2004, INT J EPIDEMIOL, V33, P485, DOI 10.1093/ije/dyh097; Dalle E, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0356-9; Dissanayaka NNW, 2011, J AFFECT DISORDERS, V132, P82, DOI 10.1016/j.jad.2011.01.021; Dissanayaka NNW, 2010, MOVEMENT DISORD, V25, P838, DOI 10.1002/mds.22833; Findley L, 2002, MOVEMENT DISORD, V17, P60; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Hsu YT, 2015, AM J GERIAT PSYCHIAT, V23, P934, DOI 10.1016/j.jagp.2014.10.011; Hughes TA, 2004, ACTA NEUROL SCAND, V110, P118, DOI 10.1111/j.1600-0404.2004.00292.x; Ismail Z, 2016, ALZHEIMERS DEMENT, V12, P195, DOI 10.1016/j.jalz.2015.05.017; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Leentjens AFG, 2004, J GERIATR PSYCH NEUR, V17, P120, DOI 10.1177/0891988704267456; Leentjens AFG, 2002, ACTA PSYCHIAT SCAND, V106, P196, DOI 10.1034/j.1600-0447.2002.02045.x; Leentjens AFG, 2013, NEUROLOGY, V81, P1036, DOI 10.1212/WNL.0b013e3182a4a503; Lindqvist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047387; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Marsh L, 2006, MOVEMENT DISORD, V21, P148, DOI 10.1002/mds.20723; McDonald WA, 2003, BIOL PSYCHIAT, V54, P363, DOI 10.1016/S0006-3223(03)00530-4; Pontone GM, 2009, MOVEMENT DISORD, V24, P1333, DOI 10.1002/mds.22611; Prudon B, 2014, MOVEMENT DISORD, V29, P259, DOI 10.1002/mds.25730; Raggi A, 2013, REV NEUROSCIENCE, V24, P279, DOI 10.1515/revneuro-2013-0002; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Riedel O, 2010, J GERIATR PSYCH NEUR, V23, P27, DOI 10.1177/0891988709351833; Rodriguez-Violante M, 2012, CLIN NEUROL NEUROSUR, V114, P1293, DOI 10.1016/j.clineuro.2012.03.035; Schrag A, 2004, J NEUROL, V251, P795, DOI 10.1007/s00415-004-0483-3; Shiba M, 2000, MOVEMENT DISORD, V15, P669, DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5; Starkstein SE, 2002, PSYCHIAT COGNITIVE D, P88; Swick TJ, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/205471; Tsai CF, 2013, J HEPATOL, V58, P706, DOI 10.1016/j.jhep.2012.12.001; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Wichowicz HM, 2006, EUR PSYCHIAT, V21, P516, DOI 10.1016/j.eurpsy.2006.01.012; Zhu KD, 2016, J NEUROL, V263, P1215, DOI 10.1007/s00415-016-8130-3	40	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236443	10.1371/journal.pone.0236443	http://dx.doi.org/10.1371/journal.pone.0236443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716954	Green Published, gold			2022-12-26	WOS:000556674500057
J	Ditterline, BL; Wade, S; Ugiliweneza, B; Singam, NSV; Harkema, SJ; Stoddard, MF; Hirsch, GA				Ditterline, Bonnie Legg; Wade, Shelley; Ugiliweneza, Beatrice; Singam, Narayana Sarma V.; Harkema, Susan J.; Stoddard, Marcus F.; Hirsch, Glenn A.			Systolic and diastolic function in chronic spinal cord injury	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; HEART-RATE-VARIABILITY; CARDIOVASCULAR-DISEASE; MUSCLE ATROPHY; EXERCISE; DYSFUNCTION; ECHOCARDIOGRAPHY; CONSEQUENCES; INDIVIDUALS; SPACEFLIGHT	Individuals with spinal cord injury develop cardiovascular disease more than age-matched, non-injured cohorts. However, progression of systolic and diastolic dysfunction into cardiovascular disease after spinal cord injury is not well described. We sought to investigate the relationship between systolic and diastolic function in chronic spinal cord injury to describe how biological sex, level, severity, and duration of injury correlate with structural changes in the left ventricle. Individuals with chronic spinal cord injury participated in this study (n = 70). Registered diagnostic cardiac sonographers used cardiac ultrasound to measure dimensions, mass, and systolic and diastolic function of the left ventricle. We found no significant relationship to severity or duration of injury with left ventricle measurements, systolic function outcome, or diastolic function outcome. Moreover, nearly all outcomes measured were within the American Society of Echocardiography-defined healthy range. Similar to non-injured individuals, when indexed by body surface area (BSA) left ventricle mass [-14 (5) g/m2, p < .01], end diastolic volume [-6 (3) mL/m(2), p < .05], and end systolic volume [-4 (1) mL/m(2), p < .01] were significantly decreased in women compared with men. Likewise, diastolic function outcomes significantly worsened with age: E-wave velocity [-5 (2), p < .01], E/A ratio [-0.23 (0.08), p < .01], and e' velocity [lateral: -1.5 (0.3) cm/s, p < .001; septal: -0.9 (0.2), p < .001] decreased with age while A-wave velocity [5 (1) cm/s, p < .001] and isovolumic relaxation time [6 (3) ms, p < .05] increased with age. Women demonstrated significantly decreased cardiac size and volumes compared with men, but there was no biological relationship to dysfunction. Moreover, individuals were within the range of ASE-defined healthy values with no evidence of systolic or diastolic function and no meaningful relationship to level, severity, or duration of injury. Decreases to left ventricular dimensions and mass seen in spinal cord injury may result from adaptation rather than maladaptive myocardial remodeling, and increased incidence of cardiovascular disease may be related to modifiable risk factors.	[Ditterline, Bonnie Legg; Wade, Shelley; Ugiliweneza, Beatrice; Harkema, Susan J.; Hirsch, Glenn A.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Ditterline, Bonnie Legg; Wade, Shelley; Ugiliweneza, Beatrice; Harkema, Susan J.] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Ugiliweneza, Beatrice] Univ Louisville, Dept Hlth Management & Syst Sci, Louisville, KY 40292 USA; [Singam, Narayana Sarma V.; Stoddard, Marcus F.] Univ Louisville, Dept Med, Div Cardiovasc Med, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Hirsch, GA (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.	HirschG@njhealth.org		Singam, Narayana Sarma/0000-0002-6289-2273	Leona M. and Harry B. Helmsley Charitable Trust [2016PG-MED005, 2016PG-MED001]; Craig H. Neilsen Foundation [ES2-CHN-2013]; Christopher and Dana Reeve Foundation [SJH - ES_BI-2017(Harkema)/ES_BI-2016(SH)]	Leona M. and Harry B. Helmsley Charitable Trust; Craig H. Neilsen Foundation; Christopher and Dana Reeve Foundation	SJH -#2016PG-MED005 - The Leona M. and Harry B. Helmsley Charitable Trust https://helmsleytrust.org/SJH -#2016PG-MED001 - The Leona M. and Harry B. Helmsley Charitable Trust https://helmsleytrust.org/SJH - #ES2-CHN-2013 (SH) -Craig H. Neilsen Foundation -https://chnfoundation.org SJH - ES_BI-2017(Harkema)/ES_BI-2016(SH) -Christopher and Dana Reeve Foundation -https://www.christopherreeve.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Samra F, 2016, HEART FAIL REV, V21, P645, DOI 10.1007/s10741-016-9571-6; Arbeille P, 2001, EUR J APPL PHYSIOL, V86, P157, DOI 10.1007/s004210100473; Bartholdy K, 2014, J SPINAL CORD MED, V37, P162, DOI 10.1179/2045772313Y.0000000181; BAUMAN WA, 1994, ARCH PHYS MED REHAB, V75, P946; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Claydon VE, 2006, ARCH PHYS MED REHAB, V87, P1106, DOI 10.1016/j.apmr.2006.05.011; Collier P, 2017, J AM COLL CARDIOL, V69, P1043, DOI 10.1016/j.jacc.2016.12.012; Cragg JJ, 2013, NEUROLOGY, V81, P723, DOI 10.1212/WNL.0b013e3182a1aa68; Cwajg JM, 2000, J AM COLL CARDIOL, V35, P1152, DOI 10.1016/S0735-1097(00)00525-8; de Groot PC, 2006, ARCH PHYS MED REHAB, V87, P1195, DOI 10.1016/j.apmr.2006.05.023; De Rossi G, 2014, MED SCI SPORT EXER, V46, P887, DOI 10.1249/MSS.0000000000000187; DeVeau KM, 2017, AM J PHYSIOL-HEART C, V313, pH861, DOI 10.1152/ajpheart.00046.2017; Driussi C, 2014, J SPINAL CORD MED, V37, P85, DOI 10.1179/2045772313Y.0000000161; EYSMANN SB, 1995, AM J CARDIOL, V75, P201, DOI 10.1016/S0002-9149(00)80082-X; Furlan JC, 2003, J NEUROTRAUM, V20, P1351, DOI 10.1089/089771503322686148; Giangregorio L, 2006, J SPINAL CORD MED, V29, P489, DOI 10.1080/10790268.2006.11753898; GILLEBERT TC, 1991, AM J PHYSIOL, V261, pH805, DOI 10.1152/ajpheart.1991.261.3.H805; Gondim F. A. A., 2004, Current Vascular Pharmacology, V2, P71, DOI 10.2174/1570161043476474; Grigorean Valentin Titus, 2009, J Med Life, V2, P133; Groah SL, 2001, SPINAL CORD, V39, P310, DOI 10.1038/sj.sc.3101162; Guilcher SJT, 2013, DISABIL REHABIL, V35, P894, DOI 10.3109/09638288.2012.721048; Hitzig SL, 2010, SPINAL CORD, V48, P330, DOI 10.1038/sc.2009.135; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Hostettler S, 2012, J REHABIL MED, V44, P131, DOI 10.2340/16501977-0913; Illman A, 2000, SPINAL CORD, V38, P741, DOI 10.1038/sj.sc.3101089; KANNEL WB, 1994, BRIT HEART J, V72, P3; KESSLER KM, 1986, AM J CARDIOL, V58, P525, DOI 10.1016/0002-9149(86)90027-5; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P355, DOI 10.1016/S0003-9993(03)00615-4; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; Liu Katherine A., 2016, Pharmacy Pract (Granada), V14, DOI 10.18549/PharmPract.2016.01.708; Lombardi F, 2001, CARDIOVASC RES, V50, P210, DOI 10.1016/S0008-6363(01)00221-8; Maggioni MA, 2012, SPINAL CORD, V50, P538, DOI 10.1038/sc.2011.189; Martin DS, 2002, AVIAT SPACE ENVIR MD, V73, P532; Matos-Souza JR, 2011, SPINAL CORD, V49, P65, DOI 10.1038/sc.2010.88; Meck JV, 2001, PSYCHOSOM MED, V63, P865, DOI 10.1097/00006842-200111000-00003; Moore CD, 2018, J CLIN DENSITOM, V21, P329, DOI 10.1016/j.jocd.2017.06.001; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; NASH MS, 1991, PARAPLEGIA, V29, P590, DOI 10.1038/sc.1991.87; Negishi K, 2017, J AM SOC ECHOCARDIOG, V30, P1180, DOI 10.1016/j.echo.2017.08.005; Parikh JD, 2016, INT J CARDIOL, V223, P306, DOI 10.1016/j.ijcard.2016.07.252; Piatt Jennifer A, 2016, Top Spinal Cord Inj Rehabil, V22, P165, DOI 10.1310/sci2203-165; Platts SH, 2009, AVIAT SPACE ENVIR MD, V80, pA29, DOI 10.3357/ASEM.BR03.2009; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Savic G, 2017, SPINAL CORD, V55, P891, DOI 10.1038/sc.2017.64; Schreiber R, 2014, CLIN CHIM ACTA, V437, P136, DOI 10.1016/j.cca.2014.07.018; Sessa F, 2018, AGING-US, V10, P166, DOI 10.18632/aging.101386; Shackelford M, 1998, SPINAL CORD, V36, P337, DOI 10.1038/sj.sc.3100510; Sharif H, 2017, SPINAL CORD, V55, P753, DOI 10.1038/sc.2017.30; Squair JW, 2018, J NEUROTRAUM, V35, P424, DOI 10.1089/neu.2017.4984; STODDARD MF, 1989, CIRCULATION, V79, P1226, DOI 10.1161/01.CIR.79.6.1226; Summers RL, 2005, AM J CARDIOL, V95, P1128, DOI 10.1016/j.amjcard.2005.01.033; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848; Theisen D, 2012, EXP PHYSIOL, V97, P319, DOI 10.1113/expphysiol.2011.063016; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Turiel M, 2011, INT J CARDIOL, V149, P323, DOI 10.1016/j.ijcard.2010.02.010; Wecht JM, 2017, AUTONOMIC NEUROSCIEN; West CR, 2016, HYPERTENSION, V68, P1281, DOI 10.1161/HYPERTENSIONAHA.116.07919; Williams AM, 2019, HEART, V105, P217, DOI 10.1136/heartjnl-2018-313585; Wizemann TM, 2001, EXPLORING BIOL CONTR, pxx; Yarar-Fisher Ceren, 2017, Arch Phys Med Rehabil, V98, P1277, DOI 10.1016/j.apmr.2016.10.001	61	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236490	10.1371/journal.pone.0236490	http://dx.doi.org/10.1371/journal.pone.0236490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716921	gold, Green Published			2022-12-26	WOS:000556674500005
J	Liang, H; Yue, Z; Liu, EP; Xiang, N				Liang, Hang; Yue, Zhang; Liu, Erpeng; Xiang, Nan			How does social capital affect individual health among the elderly in rural China?-Mediating effect analysis of physical exercise and positive attitude	PLOS ONE			English	Article							SELF-RATED HEALTH; OLDER-ADULTS; MULTILEVEL ANALYSIS; DEPRESSION; SUPPORT; IMPACT; TRUST	Background The elderly in rural areas comprise over half of the older population in China, and their health problems are a matter of great concern for the Chinese government and society. Among the many factors affecting health, social capital has generated much interest in academic research. Exploring the relationship between social capital and individual health among the elderly in rural China provides ways to improve the health of Chinese people, which has a positive impact on policy. Methods We selected 3719 respondents from the 2016 China Family Panel Studies (CFPS). Structural and cognitive social capital were obtained via exponentiation of variables (mean of zero and a standard deviation of one) and by giving them equal weight. Ordinary least squares (OLS) and two-stage least squares (2SLS) estimators were used to analyze the association between social capital and individual health. We explored the mechanism linking structural and cognitive social capital with individual health through a mediation effect analysis. Results After correcting for endogeneity bias, structural social capital had a positive correlation with individual health among the elderly, with a coefficient of 0.062 (95% CI: 0.020-0.104). Cognitive social capital also had a positive correlation with individual health, with a coefficient of 0.097 (95% CI: 0.060-0.135). Physical exercise and positive attitude were two significant mediating variables of the relationship between social capital and individual health in the study group, with mediating effects of 0.018 and 0.054, respectively. Conclusions Cognitive social capital played a stronger role than structural social capital in promoting individual health among the elderly. Physical exercise and positive attitude mediated the relationship between social capital and individual health. Policymakers should not only build basic medical and health care systems but also consistently cultivate and strengthen structural and cognitive social capital among the elderly in rural China.	[Liang, Hang; Yue, Zhang; Xiang, Nan] Zhongnan Univ Econ & Law, Sch Publ Adm, Wuhan, Hubei, Peoples R China; [Liu, Erpeng] Zhongnan Univ Econ & Law, Inst Income Distribut & Publ Finance, Wuhan, Hubei, Peoples R China	Zhongnan University of Economics & Law; Zhongnan University of Economics & Law	Yue, Z (corresponding author), Zhongnan Univ Econ & Law, Sch Publ Adm, Wuhan, Hubei, Peoples R China.	yuezhang.znufe@163.com		Liu, Erpeng/0000-0003-2207-3756	Planning Fund Project of Humanities and Social Sciences of Ministry of Education of China [19YJA840006]; Surface Project of National Natural Science Foundation of China; "Economic Growth and Environment Pollution of Villagers under the Background of Rural Revitalization: Based on EKC Hypothesis and Evidence from Hubei" [71973154]	Planning Fund Project of Humanities and Social Sciences of Ministry of Education of China; Surface Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Economic Growth and Environment Pollution of Villagers under the Background of Rural Revitalization: Based on EKC Hypothesis and Evidence from Hubei"	This study was supported by the Planning Fund Project of Humanities and Social Sciences of Ministry of Education of China, and the funder name is "A study on the livelihood reconstruction of farmers with expropriated land in the process of urbanization: based on the framework of sustainable livelihood analysis" (grant/award number: 19YJA840006) to ZY. The funder website is http://www.moe.gov.cn/s78/A13/A13_gggs/s8474/201901/t20190129_368523.html.This study was also supported by the Surface Project of National Natural Science Foundation of China, and the funder name is "Economic Growth and Environment Pollution of Villagers under the Background of Rural Revitalization: Based on EKC Hypothesis and Evidence from Hubei" (grant/award number: 71973154) to ZY. The funder website is http://www.nsfc.gov.cn/.The two funders played roles in study design, decision to publish and preparation of manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bian YJ, 1997, AM SOCIOL REV, V62, P366, DOI 10.2307/2657311; BOURDIEU P, 1986, ACTES RECH SCI SOC, P40; Brinkhues S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4948-6; Cao JR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3257-9; Cao WM, 2015, AGING MENT HEALTH, V19, P418, DOI 10.1080/13607863.2014.948805; Chen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142300; Chinese Health Information and Big Data Association, 2018, CHIN FAM HLTH BIG DA; Chuang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122970; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Dauner KN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2437-3; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Flores EC, 2018, SOC PSYCH PSYCH EPID, V53, P107, DOI 10.1007/s00127-017-1469-7; Forsman AK, 2012, AGING MENT HEALTH, V16, P771, DOI 10.1080/13607863.2012.667784; Gilbert KL, 2013, J HEALTH PSYCHOL, V18, P1385, DOI 10.1177/1359105311435983; Gilles I, 2011, EUR J EPIDEMIOL, V26, P203, DOI 10.1007/s10654-011-9577-2; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Harpham T., 2008, SOCIAL CAPITAL HLTH, P51; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Ho CY, 2016, HEALTH ECON, V25, P91, DOI 10.1002/hec.3131; Hu FY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2138-y; Hung N, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8013-5; Hyyppa MT, 2003, HEALTH EDUC RES, V18, P770, DOI 10.1093/her/cyf044; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Kawachi I. TS, 2016, SOCIAL CAPITAL HLTH, DOI [10.1177/1363459315568918, DOI 10.1177/1363459315568918]; Kim YC, 2015, J HEALTH COMMUN, V20, P1084, DOI 10.1080/10810730.2015.1018636; Li QJ, 2017, SOC PSYCH PSYCH EPID, V52, P1513, DOI 10.1007/s00127-017-1439-0; Liu GG, 2016, ECON HUM BIOL, V22, P177, DOI 10.1016/j.ehb.2016.04.003; Ma S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8341-5; Meng TG, 2014, HEALTH PLACE, V27, P38, DOI 10.1016/j.healthplace.2014.01.009; Mohnen SM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-116; Moore S, 2017, J EPIDEMIOL COMMUN H, V71, P513, DOI 10.1136/jech-2016-208313; Mortenson ST, 2009, COMMUN RES, V36, P32, DOI 10.1177/0093650208326460; Muckenhuber J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157909; Murayama H, 2013, SOC SCI MED, V98, P247, DOI 10.1016/j.socscimed.2013.09.026; National Bureau of Statistics of the People's Republic of China, 2018, NAT EC SOC DEV 2018; Norstrand JA, 2012, GERONTOLOGIST, V52, P325, DOI 10.1093/geront/gnr072; Nyqvist F, 2008, HEALTH PLACE, V14, P347, DOI 10.1016/j.healthplace.2007.09.001; Park MJ, 2017, AGING MENT HEALTH, V21, P354, DOI 10.1080/13607863.2015.1088511; Phongsavan P, 2006, SOC SCI MED, V63, P2546, DOI 10.1016/j.socscimed.2006.06.021; Pollack CE, 2004, HEALTH PLACE, V10, P383, DOI 10.1016/j.healthplace.2004.08.008; Prati G, 2011, HEALTH EDUC RES, V26, P761, DOI 10.1093/her/cyr035; PUTNAM RD, 1995, J DEMOCRACY, V0006; Rostila M, 2007, J EUR SOC POLICY, V17, P223, DOI 10.1177/0958928707078366; Scheffler RM, 2008, HEALTH ECON POLICY L, V3, P321, DOI 10.1017/S1744133108004593; Shen YY, 2014, RES AGING, V36, P497, DOI 10.1177/0164027513505624; Sorensen JFL, 2016, REG STUD, V50, P391, DOI 10.1080/00343404.2014.918945; Sun YY, 2017, ARCH PSYCHIAT NURS, V31, P197, DOI 10.1016/j.apnu.2016.09.015; van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575; Veenstra G, 2005, SOC SCI MED, V60, P2059, DOI 10.1016/j.socscimed.2004.08.064; Xie Y, 2010, USERS GUIDE CHINA FA; Yiengprugsawan V, 2018, QUAL LIFE RES, V27, P1277, DOI 10.1007/s11136-017-1655-9; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027; Ziersch AM, 2009, AUST NZ J PUBL HEAL, V33, P7, DOI 10.1111/j.1753-6405.2009.00332.x	54	12	12	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0231318	10.1371/journal.pone.0231318	http://dx.doi.org/10.1371/journal.pone.0231318			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV9ND	32716935	Green Published, gold			2022-12-26	WOS:000556674500006
J	Shalit, Y; Tuvi-Arad, I				Shalit, Yaffa; Tuvi-Arad, Inbal			Side chain flexibility and the symmetry of protein homodimers	PLOS ONE			English	Article							STRUCTURE ALIGNMENT; ENERGY LANDSCAPES; VALIDATION; ALGORITHM; CE	A comprehensive analysis of crystallographic data of 565 high-resolution protein homodimers comprised of over 250,000 residues suggests that amino acids form two groups that differ in their tendency to distort or symmetrize the structure of protein homodimers. Residues of the first group tend to distort the protein homodimer and generally have long or polar side chains. These include: Lys, Gln, Glu, Arg, Asn, Met, Ser, Thr and Asp. Residues of the second group contribute to protein symmetry and are generally characterized by short or aromatic side chains. These include: Ile, Pro, His, Val, Cys, Leu, Trp, Tyr, Phe, Ala and Gly. The distributions of the continuous symmetry measures of the proteins and the continuous chirality measures of their building blocks highlight the role of side chain geometry and the interplay between entropy and symmetry in dictating the conformational flexibility of proteins.	[Shalit, Yaffa; Tuvi-Arad, Inbal] Open Univ Israel, Dept Nat Sci, Raanana, Israel	Open University Israel	Tuvi-Arad, I (corresponding author), Open Univ Israel, Dept Nat Sci, Raanana, Israel.	inbaltu@openu.ac.il	Shalit, Yaffa/AAH-3866-2021		Israel Science Foundation [411/15]	Israel Science Foundation(Israel Science Foundation)	ITA received grant no. 411/15 from the Israel Science Foundation https://www.isf.org.il/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Zapatero C, 2014, ACTA CRYSTALLOGR D, V70, P907, DOI 10.1107/S1399004713032859; Abraham AL, 2009, J MOL BIOL, V394, P522, DOI 10.1016/j.jmb.2009.09.031; Alon G, 2018, J MATH CHEM, V56, P193, DOI 10.1007/s10910-017-0788-y; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; [Anonymous], MOL OP ENV MOE VERS; Baruch-Shpigler Y, 2017, BIOCHEMISTRY-US, V56, P5635, DOI 10.1021/acs.biochem.7b00525; Berchanski A, 2005, PROTEINS, V60, P202, DOI 10.1002/prot.20558; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; Bonjack M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65097-8; Bonjack-Shterengartz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180030; Bonjack-Shterengartz M, 2015, PROTEINS, V83, P722, DOI 10.1002/prot.24706; Boomsma W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003406; Butterfoss GL, 2003, PROTEIN SCI, V12, P2719, DOI 10.1110/ps.03273303; Carugo O, 2013, ACTA CRYSTALLOGR D, V69, P1333, DOI 10.1107/S090744491301158X; Chen HL, 2009, COMPUT BIOL CHEM, V33, P100, DOI 10.1016/j.compbiolchem.2008.07.026; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Do Viet P, 2015, FEBS LETT, V589, P2611, DOI 10.1016/j.febslet.2015.08.025; Dryzun C, 2011, J COMPUT CHEM, V32, P2526, DOI 10.1002/jcc.21828; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Kim C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-303; Kojic-Prodic B, 2010, SYMMETRY-BASEL, V2, P884, DOI 10.3390/sym2020884; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lafita A, 2018, PROTEINS, V86, P247, DOI 10.1002/prot.25408; Levy Y, 2005, P NATL ACAD SCI USA, V102, P2373, DOI 10.1073/pnas.0409572102; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; Martz E., FIRSTGLANCE JMOL VER; Mukherjee S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp318; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; Myers-Turnbull D, 2014, J MOL BIOL, V426, P2255, DOI 10.1016/j.jmb.2014.03.010; Pages G, 2018, J STRUCT BIOL, V203, P185, DOI 10.1016/j.jsb.2018.05.005; Pages G, 2018, J STRUCT BIOL, V203, P142, DOI 10.1016/j.jsb.2018.04.004; Pednekar D, 2010, PROTEINS, V78, P3048, DOI 10.1002/prot.22828; Pinsky M, 2008, J COMPUT CHEM, V29, P2712, DOI 10.1002/jcc.20990; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Schulze B, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2012.0041; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Swapna LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036688; Tai CH, 2014, NUCLEIC ACIDS RES, V42, pW296, DOI 10.1093/nar/gku364; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Tuvi-Arad I, 2019, J CHEMINFORMATICS, V11, DOI 10.1186/s13321-019-0360-9; Tuvi-Arad I, 2016, ISR J CHEM, V56, P1067, DOI 10.1002/ijch.201600045; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Wang H, 2018, BIOCHEMISTRY-US, V57, P6395, DOI 10.1021/acs.biochem.8b00974; Yuan YN, 2014, J PHYS CHEM A, V118, P7876, DOI 10.1021/jp503460m; ZABRODSKY H, 1992, J AM CHEM SOC, V114, P7843, DOI 10.1021/ja00046a033; ZABRODSKY H, 1995, J AM CHEM SOC, V117, P462, DOI 10.1021/ja00106a053; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhu X, 2012, J CHEM INF MODEL, V52, P1559, DOI 10.1021/ci300079j	55	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0235863	10.1371/journal.pone.0235863	http://dx.doi.org/10.1371/journal.pone.0235863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706779	Green Published, gold			2022-12-26	WOS:000579931700012
J	Solomon, H; Moraes, AN; Williams, DB; Fotso, AS; Duong, YT; Ndongmo, CB; Voetsch, AC; Patel, H; Lupoli, K; McAuley, JB; Mulundu, G; Kasongo, W; Mulenga, L				Solomon, Hiwote; Moraes, Albertina Ngomah; Williams, Daniel B.; Fotso, Arlette Simo; Duong, Yen T.; Ndongmo, Clement B.; Voetsch, Andrew C.; Patel, Hetal; Lupoli, Kathryn; McAuley, James B.; Mulundu, Gina; Kasongo, Webster; Mulenga, Lloyd			Prevalence and correlates of active syphilis and HIV co-Infection among sexually active persons aged 15-59 years in Zambia: Results from the Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016	PLOS ONE			English	Article							PREGNANT-WOMEN; TRANSMISSION; INFECTION; TRENDS	Objectives The main objectives of the study are to estimate HIV prevalence, active syphilis prevalence, and correlates of co-infection with HIV in Zambia, among recently sexually active individuals aged 15 to 59 years old. Methods We used data from the 2016 Zambia Population-based HIV Impact Assessment (ZAM-PHIA), a national household survey that included biomarker testing for HIV and syphilis. Chembio DPP (R) Syphilis Screen and Confirm Assay was used to distinguish between active and older syphilis infections. This is the first time Chembio DPP (R) has been used in a national survey. Log-binominal modelling was utilized to understand the risk of acquiring HIV/active syphilis co-infection using select socio-demographic and sexual behavior variables. Multivariable analysis compared those with co-infection and those with no infection. All reported results account for the complex survey design and are weighted. Results A total of 19,114 individuals aged 15-59 years responded to the individual interview and had a valid syphilis and/or HIV test. The prevalence for those sexually active in the 12 months preceding ZAMPHIA 2016 was 3.5% and 13% for active syphilis and HIV, respectively. The prevalence of HIV/active syphilis co-infection was 1.5%. Factors associated with higher prevalence of co-infection versus no infection among females included, but were not limited to, those living in urban areas (adjusted prevalence ratio (aPR) = 3.0, 95% CI = 1.8, 4.8), those had sexual intercourse before age 15 years (aPR = 1.8, 95% CI = 1.1, 2.9), and those who had two or more sexual partners in the 12 months preceding the survey (aPR = 2.7, 95% CI = 1.6, 4.7). Conclusion These findings show high prevalence for both mono-infection with HIV and syphilis, as well as co-infection with HIV/active syphilis in Zambia. There is a need for better screening and partner services, particularly among those engaging in high-risk sexual behaviors (e.g., engaging in transactional sex).	[Solomon, Hiwote] Boston Univ, Sch Publ Hlth, Doctor Publ Hlth Program, Boston, MA 02118 USA; [Solomon, Hiwote; Moraes, Albertina Ngomah; Mulenga, Lloyd] Minist Hlth Zambia, Ndeke House, Lusaka, Zambia; [Solomon, Hiwote] Natl Hlth Res Author, Lusaka, Zambia; [Moraes, Albertina Ngomah] Zambia Natl Publ Hlth Inst, Lusaka, Zambia; [Williams, Daniel B.; Voetsch, Andrew C.; Patel, Hetal; Lupoli, Kathryn] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA USA; [Fotso, Arlette Simo] DPS Univ Witwatersrand, Johannesburg, South Africa; [Fotso, Arlette Simo] Columbia Univ, Mailman Sch Publ Hlth, ICAP, Pretoria, South Africa; [Duong, Yen T.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Ndongmo, Clement B.] US Agcy Int Dev, USAID Global Hlth Supply Chain Program, Arlington, VA USA; [McAuley, James B.] Rush Univ, Med Ctr, Chicago, IL USA; [Mulundu, Gina; Mulenga, Lloyd] Univ Teaching Hosp, Lusaka, Zambia; [Mulundu, Gina; Mulenga, Lloyd] Univ Zambia, Sch Med, Lusaka, Zambia; [Kasongo, Webster] Trop Dis Res Ctr, Ndola, Zambia	Boston University; Centers for Disease Control & Prevention - USA; Columbia University; United States Agency for International Development (USAID); Rush University; University of Zambia; University of Zambia	Solomon, H (corresponding author), Boston Univ, Sch Publ Hlth, Doctor Publ Hlth Program, Boston, MA 02118 USA.; Solomon, H (corresponding author), Minist Hlth Zambia, Ndeke House, Lusaka, Zambia.; Solomon, H (corresponding author), Natl Hlth Res Author, Lusaka, Zambia.	solomohi@bu.edu	Voetsch, Andrew/CAF-1978-2022	Solomon, Hiwote/0000-0001-9125-5217; Voetsch, Andrew/0000-0002-0783-1312; Simo Fotso, Arlette/0000-0002-5006-8105; Ndongmo, Clement Bertin/0000-0003-0177-8458; Ngomah Moraes, Albertina/0000-0002-3435-1170	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GGH001226]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreement #U2GGH001226. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention or other funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, STUD FAMILY PLANN, V41, P230, DOI 10.1111/j.1728-4465.2010.00247.x; Bristow CC, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu015; *CENTR STAT OFF ZA, 2003, ZAMB DEM HLTH SURV 2; Chun HM, 2013, J SEXUALLY TRANSMITT, V2013; Dionne-Odom J, 2013, CLIN INFECT DIS, V56, P1829, DOI 10.1093/cid/cit146; Ginindza TG, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0140-y; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Joseph F, 2009, J HEALTH POPUL NUTR, V27, P704; Kalichman SC, 2011, SEX TRANSM INFECT, V87, P183, DOI 10.1136/sti.2010.047514; Karumudi Usha Rani, 2005, Expert Rev Anti Infect Ther, V3, P825, DOI 10.1586/14787210.3.5.825; Kenyon CR, 2014, INT J INFECT DIS, V29, P54, DOI 10.1016/j.ijid.2014.05.014; Liu JB, 2010, SEX TRANSM INFECT, V86, P292, DOI 10.1136/sti.2009.037549; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Makasa M, 2012, SEX TRANSM DIS, V39, P173, DOI 10.1097/OLQ.0b013e31823b23a4; Ministry of Health and Child Care MOHCC Z, 2017, ZIMB POP BAS HIV IMP; Ministry of Health [Uganda] ICF International Centers for Disease Control and Prevention [Uganda] U. S. Agency for International Development & WHO Uganda, 2012, UG AIDS IND SURV 201; Mutagoma M, 2016, J SEXUALLY TRANSMITT, V2016; Mutagoma M, 2017, INT J STD AIDS, V28, P45, DOI 10.1177/0956462415624058; Oluoch Tom, 2011, Open AIDS J, V5, P125, DOI 10.2174/1874613601105010125; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Zambia Ministry of Health, 2017, ZAMB POP BAS HIV IMP; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236501	10.1371/journal.pone.0236501	http://dx.doi.org/10.1371/journal.pone.0236501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706823	Green Published, gold			2022-12-26	WOS:000579931700049
J	Choi, YJ; Ohn, JH; Kim, N; Kim, W; Park, K; Won, S; Sael, L; Shin, CM; Lee, SM; Lee, S; An, HJ; Jang, DM; Han, BW; Lee, HS; Kang, SJ; Kim, JS; Lee, DH				Choi, Yoon Jin; Ohn, Jung Hun; Kim, Nayoung; Kim, Wonji; Park, Kyungtaek; Won, Sungho; Sael, Lee; Shin, Cheol Min; Lee, Sun Min; Lee, Sejoon; An, Hyun Joo; Jang, Dong Man; Han, Byung Woo; Lee, Hye Seung; Kang, Seung Joo; Kim, Joo Sung; Lee, Dong Ho			Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer	PLOS ONE			English	Article							GENETIC-VARIATION; INCREASED RISK; GLYCOSYLATION; ASSOCIATION; RS4072037; MUTATIONS	Genome-wide association studies of gastric cancer (GC) cases have revealed common gastric cancer susceptibility loci with low effect size. We investigated rare variants with high effect size via whole-exome sequencing (WES) of subjects with familial clustering of gastric cancer. WES of DNAs from the blood of 19 gastric cancer patients and 36 unaffected family members from 14 families with two or more gastric cancer patients were tested. Linkage analysis combined with association tests were performed using Pedigree Variant Annotation, Analysis, and Search Tool (pVAAST) software. Based on the logarithm of odds (LOD) and permutation-based composite likelihood ratio test (CLRT) from pVAAST, MUC4 was identified as a predisposing gene (LOD P-value = 1.9x10(-5); permutation-based P-value of CLRT <= 9.9x10(-9)). In a larger cohort consisting of 597 GC patients and 9,759 healthy controls genotyped with SNP array, we discovered common variants in MUC4 regions (rs148735556, rs11717039, and rs547775645) significantly associated with GC supporting the association of MUC4 with gastric cancer. And the MUC4 variants were found in higher frequency in The Cancer Genome Atlas Study (TCGA) germline samples of patients with multiple cancer types. Immunohistochemistry indicated that MUC4 was downregulated in the noncancerous gastric mucosa of subjects with MUC4 germline missense variants, suggesting that loss of the protective function of MUC4 predisposes an individual to gastric cancer. Rare variants in MUC4 can be novel gastric cancer susceptibility loci in Koreans possessing the familial clustering of gastric cancer.	[Choi, Yoon Jin; Ohn, Jung Hun; Kim, Nayoung; Shin, Cheol Min; Lee, Sun Min; Lee, Dong Ho] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Nayoung; Kim, Joo Sung; Lee, Dong Ho] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Nayoung; Kim, Joo Sung; Lee, Dong Ho] Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea; [Kim, Nayoung; Jang, Dong Man; Han, Byung Woo; Lee, Dong Ho] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Kim, Wonji] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Kim, Wonji] Harvard Med Sch, Boston, MA 02115 USA; [Park, Kyungtaek; Won, Sungho] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Won, Sungho] Seoul Natl Univ, Dept Publ Hlth Sci, Seoul, South Korea; [Won, Sungho] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Sael, Lee] Ajou Univ, Dept Artificial Intelligence & Data Sci, Seoul, South Korea; [Lee, Sejoon; Lee, Hye Seung] Seoul Natl Univ, Dept Pathol, Bundang Hosp, Seongnam, South Korea; [An, Hyun Joo] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon, South Korea; [Kang, Seung Joo; Kim, Joo Sung] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Internal Med, Seoul, South Korea; [Kang, Seung Joo; Kim, Joo Sung] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Healthcare Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ajou University; Seoul National University (SNU); Chungnam National University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, N (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea.	nakim49@snu.ac.kr	Sael, Lee/AAD-9185-2021	Sael, Lee/0000-0002-9066-5756; Choi, Yoon Jin/0000-0002-1922-9388; Kim, Nayoung/0000-0002-9397-0406; Shin, Cheol Min/0000-0003-2265-9845	National Research Foundation (NRF) of Korea - Korean government (MSIP) [20110030001]	National Research Foundation (NRF) of Korea - Korean government (MSIP)	This work was funded by a grant from the National Research Foundation (NRF) of Korea to the Global Core Research Center (GCRC) funded by the Korean government (MSIP) (No. 20110030001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chen H, 2016, AM J HUM GENET, V98, P653, DOI 10.1016/j.ajhg.2016.02.012; Choi YJ, 2016, KOREAN J INTERN MED, V31, P1042, DOI 10.3904/kjim.2016.147; Choi YJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003606; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fewings E, 2018, LANCET GASTROENTEROL, V3, P489, DOI 10.1016/S2468-1253(18)30079-7; Fitzgerald RC, 2010, J MED GENET, V47, P436, DOI 10.1136/jmg.2009.074237; Gupta R, 2002, TECHNIQUES IN MYCORRHIZAL STUDIES, P103; Hansford S, 2015, JAMA ONCOL, V1, P23, DOI 10.1001/jamaoncol.2014.168; Hu H, 2014, NAT BIOTECHNOL, V32, P663, DOI 10.1038/nbt.2895; Hu N, 2016, GUT, V65, P1611, DOI 10.1136/gutjnl-2015-309340; Jayaprakash NG, 2017, BIOCHEM J, V474, P2333, DOI 10.1042/BCJ20170111; Kaurah P, 2007, JAMA-J AM MED ASSOC, V297, P2360, DOI 10.1001/jama.297.21.2360; Kim Nacksung, 2006, Clin Mol Allergy, V4, P4, DOI 10.1186/1476-7961-4-4; LAVECCHIA C, 1992, CANCER, V70, P50, DOI 10.1002/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Luzon-Toro B, 2015, SCI REP-UK, V5, DOI 10.1038/srep16473; Majewski IJ, 2013, J PATHOL, V229, P621, DOI 10.1002/path.4152; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Ng GZ, 2016, GUT, V65, P1087, DOI 10.1136/gutjnl-2014-307175; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Qiu LX, 2016, ONCOTARGET, V7, P15930, DOI 10.18632/oncotarget.7527; Reis CA, 1998, INT J CANCER, V79, P402, DOI 10.1002/(SICI)1097-0215(19980821)79:4<402::AID-IJC16>3.0.CO;2-6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saeki N, 2014, INT J MOL SCI, V15, P7958, DOI 10.3390/ijms15057958; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Sahasrabudhe R, 2017, GASTROENTEROLOGY, V152, P983, DOI 10.1053/j.gastro.2016.12.010; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Senapati S, 2008, BRIT J CANCER, V99, P949, DOI 10.1038/sj.bjc.6604632; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; van der Post S, 2014, J PROTEOME RES, V13, P6013, DOI 10.1021/pr500874f; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wilkins MR, 1999, METH MOL B, V112, P531; Xu Q, 2009, INT J ONCOL, V35, P1313, DOI 10.3892/ijo_00000449; YE Y, 2017, INT J BIOL MARKER, V32, pE28, DOI DOI 10.5301/IJBM.5000270; Yokoyama A, 2007, BIOCHEM BIOPH RES CO, V355, P200, DOI 10.1016/j.bbrc.2007.01.133; ZANGHIERI G, 1990, CANCER, V66, P2047, DOI 10.1002/1097-0142(19901101)66:9<2047::AID-CNCR2820660934>3.0.CO;2-G; Zheng LZ, 2013, MOL BIOL REP, V40, P5791, DOI 10.1007/s11033-013-2682-4	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236197	10.1371/journal.pone.0236197	http://dx.doi.org/10.1371/journal.pone.0236197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701958	gold, Green Published			2022-12-26	WOS:000575913700059
J	Niepel, D; Krishna, B; Siegel, ER; Draganova, R; Preissl, H; Govindan, RB; Eswaran, H				Niepel, Dorothea; Krishna, Bhargavi; Siegel, Eric R.; Draganova, Rossitza; Preissl, Hubert; Govindan, Rathinaswamy B.; Eswaran, Hari			A pilot study: Auditory steady-state responses (ASSR) can be measured in human fetuses using fetal magnetoencephalography (fMEG)	PLOS ONE			English	Article							BEHAVIORAL STATES; FREQUENCY; SOUND; RECORDINGS; POTENTIALS; SIGNATURES; NEWBORNS; AWAKE; AMFR	Background Auditory steady-state responses (ASSRs) are ongoing evoked brain responses to continuous auditory stimuli that play a role for auditory processing of complex sounds and speech perception. Transient auditory event-related responses (AERRs) have previously been recorded using fetal magnetoencephalography (fMEG) but involve different neurological pathways. Previous studies in children and adults demonstrated that the cortical components of the ASSR are significantly affected by state of consciousness and by maturational changes in neonates and young infants. To our knowledge, this is the first study to investigate ASSRs in human fetuses. Methods 47 fMEG sessions were conducted with 24 healthy pregnant women in three gestational age groups (30-32 weeks, 33-35 weeks and 36-39 weeks). The stimulation consisted of amplitude-modulated (AM) tones with a duration of one second, a carrier frequency (CF) of 500 Hz and a modulation frequency (MF) of 27 Hz or 42 Hz. Both tones were presented in a random order with equal probability adding up to 80-100 repetitions per tone. The ASSR across trials was quantified by assessing phase synchrony in the cortical signals at the stimulation frequency. Results and conclusion Ten out of 47 recordings were excluded due to technical problems or maternal movements. Analysis of the included 37 fetal recordings revealed a statistically significant response for the phase coherence between trials for the MF of 27 Hz but not for 42 Hz. An exploratory subgroup analysis moreover suggested an advantage in detectability for fetal behavioral state 2F (active asleep) compared to 1F (quiet asleep) detected using fetal heart rate. In conclusion, this pilot study is the first description of a method to detect human ASSRs in fetuses. The findings warrant further investigations of the developing fetal brain.	[Niepel, Dorothea; Eswaran, Hari] Univ Arkansas Med Sci, Ob Gynecol Dept, SARA Res Ctr, Little Rock, AR 72205 USA; [Niepel, Dorothea] Univ Hosp Tubingen, Dept Internal Med 1, Tubingen, Germany; [Krishna, Bhargavi] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Siegel, Eric R.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Draganova, Rossitza] Univ Tubingen, fMEG Ctr, Tubingen, Germany; [Draganova, Rossitza] Univ Duisburg Essen, Univ Clin Essen, Dept Neurol, Motor Lab, Essen, Germany; [Preissl, Hubert] Univ Tubingen, German Ctr Diabet Res DZD, Inst Diabet Res & Metab Dis, fMEG Ctr,Helmholtz Ctr Munich, Tubingen, Germany; [Govindan, Rathinaswamy B.] Natl Childrens Hosp, Div Fetal & Transit Med, Washington, DC USA	University of Arkansas System; University of Arkansas Medical Sciences; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Arkansas System; University of Arkansas Medical Sciences; Eberhard Karls University of Tubingen; University of Duisburg Essen; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Children's National Health System	Niepel, D (corresponding author), Univ Arkansas Med Sci, Ob Gynecol Dept, SARA Res Ctr, Little Rock, AR 72205 USA.; Niepel, D (corresponding author), Univ Hosp Tubingen, Dept Internal Med 1, Tubingen, Germany.	dorothea.niepel@med.uni-tuebingen.de	Preißl, Hubert/E-9070-2012	Preißl, Hubert/0000-0002-8859-4661; Niepel, Dorothea/0000-0003-2019-5856; Siegel, Eric/0000-0001-9824-6612	National Institutes of Health [1R01EB007826]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was partly funded by National Institutes of Health grant 1R01EB007826. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AL, 2013, NEUROSCI BIOBEHAV R, V37, P2220, DOI 10.1016/j.neubiorev.2013.03.013; AOYAGI M, 1994, ACTA OTO-LARYNGOL, P15; Brandle J, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00147, 10.3389/fnhum.2015.00147]; COHEN LT, 1991, J ACOUST SOC AM, V90, P2467, DOI 10.1121/1.402050; Cone-Wesson B., 2008, AUDITORY STEADY STAT, P109; Dimitrijevic A., 2008, AUDITORY STEADY STAT, P83; Dimitrijevic A., 2008, AUDITORY STEADY STAT, P229; Draganova R, 2018, HEARING RES, V363, P70, DOI 10.1016/j.heares.2018.03.005; Draganova R, 2007, EARLY HUM DEV, V83, P199, DOI 10.1016/j.earlhumdev.2006.05.018; Engelien A, 2000, HEARING RES, V148, P153, DOI 10.1016/S0378-5955(00)00148-9; Eswaran H, 2002, NEUROSCI LETT, V331, P128, DOI 10.1016/S0304-3940(02)00859-5; Frank B, 2006, MED BIOL ENG COMPUT, V44, P179, DOI 10.1007/s11517-005-0015-z; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; GERHARDT KJ, 1990, AM J OBSTET GYNECOL, V162, P282, DOI 10.1016/0002-9378(90)90866-6; Hartkopf J, 2016, EARLY HUM DEV, V100, P61, DOI 10.1016/j.earlhumdev.2016.04.002; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; Holst M, 2005, CLIN NEUROPHYSIOL, V116, P1949, DOI 10.1016/j.clinph.2005.04.008; Jardri R, 2008, NEUROIMAGE, V42, P10, DOI 10.1016/j.neuroimage.2008.04.247; John MS, 2004, EAR HEARING, V25, P539, DOI 10.1097/01.AUD.0000148050.80749.AC; John MS., 2008, AUDITORY STEADY STAT, P11; Kiefer I, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.014; Kiefer-Schmidt I, 2013, J PERINAT MED, V41, P605, DOI 10.1515/jpm-2013-0022; Lengle JM, 2001, CLIN NEUROPHYSIOL, V112, P785, DOI 10.1016/S1388-2457(01)00532-6; LEVI EC, 1993, HEARING RES, V68, P42, DOI 10.1016/0378-5955(93)90063-7; Linder K, 2014, DIABETOLOGIA, V57, P1192, DOI 10.1007/s00125-014-3217-9; Lins OG, 1996, EAR HEARING, V17, P81, DOI 10.1097/00003446-199604000-00001; Lowery CL, 2003, AM J OBSTET GYNECOL, V188, P1491, DOI 10.1067/mob.2003.367; MAURIZI M, 1990, AUDIOLOGY, V29, P322; Moore JK, 2007, INT J AUDIOL, V46, P460, DOI 10.1080/14992020701383019; Morin EC, 2015, BJOG-INT J OBSTET GY, V122, P1184, DOI 10.1111/1471-0528.13347; Muenssinger J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00917; Muenssinger J, 2013, DEVELOPMENTAL SCI, V16, P287, DOI 10.1111/desc.12025; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; Pethe J, 2001, SCAND AUDIOL, V30, P152, DOI 10.1080/010503901300007371; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; PLOURDE G, 1990, ANESTH ANALG, V71, P460; Preissl H, 2005, INT REV NEUROBIOL, V68, P1, DOI 10.1016/S0074-7742(05)68001-4; Purcell D.W, 2008, AUDITORY STEADY STAT, P55; QUERLEU D, 1988, EUR J OBSTET GYN R B, V28, P191, DOI 10.1016/0028-2243(88)90030-5; Rance G., 2008, AUDITORY STEADY STAT, P161; Rance G., 2008, AUDITORY STEADY STAT, P119; Rickards F.W., 2008, AUDITORY STEADY STAT, P1; RICKARDS FW, 1994, BRIT J AUDIOL, V28, P327, DOI 10.3109/03005369409077316; Riquelme R, 2006, EAR HEARING, V27, P104, DOI 10.1097/01.aud.0000201857.99240.24; Ross B, 2003, HEARING RES, V186, P57, DOI 10.1016/S0378-5955(03)00299-5; Ross B, 2002, HEARING RES, V165, P68, DOI 10.1016/S0378-5955(02)00285-X; Schleger F, 2014, DEV NEUROPSYCHOL, V39, P316, DOI 10.1080/87565641.2014.914212; SCHMIDT W, 1985, EARLY HUM DEV, V12, P145, DOI 10.1016/0378-3782(85)90177-X; Schneider U, 2008, J PERINAT MED, V36, P433, DOI 10.1515/JPM.2008.059; Sonanini A, 2014, J PERINAT MED, V42, P307, DOI 10.1515/jpm-2013-0180; STAPELLS DR, 1988, ELECTROEN CLIN NEURO, V71, P289, DOI 10.1016/0168-5597(88)90029-9; SUZUKI T, 1984, AUDIOLOGY, V23, P599; Vrba J, 2004, IEEE T BIO-MED ENG, V51, P1207, DOI 10.1109/TBME.2004.827265; Wilson JD, 2008, IEEE T BIO-MED ENG, V55, P2190, DOI 10.1109/TBME.2008.923916	55	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0235310	10.1371/journal.pone.0235310	http://dx.doi.org/10.1371/journal.pone.0235310			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7SC	32697776	gold, Green Submitted, Green Published			2022-12-26	WOS:000575905100002
J	Obol, CM; Lampic, C; Wettergren, L; Ljungman, L; Eriksson, LE				Obol, Claire Micaux; Lampic, Claudia; Wettergren, Lena; Ljungman, Lisa; Eriksson, Lars E.			Experiences of a web-based psycho-educational intervention targeting sexual dysfunction and fertility distress in young adults with cancer-A self-determination theory perspective	PLOS ONE			English	Article							REPRODUCTIVE CONCERNS; MANAGEMENT	Introduction Sexual and reproductive health are significant aspects of quality of life. Healthcare often fails to provide adequate support for young cancer survivors in this area, hence the need to develop more effective interventions. The present study aimed to describe experiences of participating in a web-based psycho-educational intervention focusing on sexual dysfunction and fertility distress after cancer, and to explore these experiences within the theoretical frame of the basic psychological needs for competence, relatedness and autonomy according to self-determination theory. Methods Individual semi-structured interviews with 24 women and 4 men, age 19-40, were abductively analyzed using the Framework approach for qualitative content analysis. Results Participant experiences corresponded well with the three main deductive themes competence, relatedness and autonomy, divided into a total of nine subthemes illustrating varying degrees of basic need satisfaction with considerable nuance but not without ambiguity. While satisfaction of the need for competence could be linked to the amount of information in relation to participants' cognitive capacity, satisfaction of the need for relatedness seemed to be of special importance for these young adults with cancer experience. Invitation to the program meant a chance at alleviating loneliness and normalizing problems, symptoms and concerns. Participants' descriptions of perceived autonomy support were more challenging and ambiguous, because of the many contradictions in participants' responses to their variable situations. Conclusion Basic psychological needs were confirmed as flexible positions along a continuum rather than discrete and mutually exclusive qualities. Understanding the variety of basic need satisfaction may enhance the design of future web-based interventions to be even more inclusive, tailorable and autonomy-supportive. Further research is warranted to determine the role of basic need satisfaction as a possible mediator for web-based psychoeducational interventions in cancer survivorship care.	[Obol, Claire Micaux; Lampic, Claudia; Wettergren, Lena; Ljungman, Lisa] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Lampic, Claudia] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Ljungman, Lisa] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Eriksson, Lars E.] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Eriksson, Lars E.] City Univ London, Sch Hlth Sci, London, England; [Eriksson, Lars E.] Karolinska Univ Hosp, Dept Infect Dis, Huddinge, Sweden	Karolinska Institutet; Uppsala University; Uppsala University; Karolinska Institutet; City University London; Karolinska Institutet; Karolinska University Hospital	Obol, CM (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	claire.micaux.obol@ki.se		Micaux Obol, Claire/0000-0002-5505-3455	Swedish Cancer Society [CAN 2016/615]; Doctoral School in Health Care Sciences at Karolinska Institutet [3-780/2014]; Swedish Research Council for Health, Working Life and Welfare [2014-4689]; Swedish Childhood Cancer Foundation [TJ2014-0050]; Swedish Research Council [2017-01530]	Swedish Cancer Society(Swedish Cancer Society); Doctoral School in Health Care Sciences at Karolinska Institutet; Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	CMO: The Swedish Cancer Society (CAN 2016/615) https://www.cancerfonden.se/The Doctoral School in Health Care Sciences at Karolinska Institutet (3-780/2014) https://ki.se/nvs/forskarskolan-i-vardvetenskap CL: The Swedish Research Council for Health, Working Life and Welfare (2014-4689) https://forte.se/LW: The Swedish Childhood Cancer Foundation (TJ2014-0050) https://www.barncancerfonden.se/L.L.: The Swedish Research Council (2017-01530) https://www.vr.se/L.E.E.: No specific funding for this work The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts NM, 2018, SUPPORT CARE CANCER, V26, P597, DOI 10.1007/s00520-017-3872-8; Barak A, 2009, ANN BEHAV MED, V38, P4, DOI 10.1007/s12160-009-9130-7; Brouwer W, 2009, HEALTH EDUC, V109, P460, DOI 10.1108/09654280911001149; Deci EL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-24; Desveaux L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0602-z; Fernandez ME, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00209; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gilbert E, 2016, EUR J CANCER CARE, V25, P280, DOI 10.1111/ecc.12216; Goossens J, 2015, ONCOL NURS FORUM, V42, P34, DOI 10.1188/15.ONF.34-43; Gorlick A, 2014, PSYCHO-ONCOLOGY, V23, P452, DOI 10.1002/pon.3443; Gorman JR, 2015, CANCER-AM CANCER SOC, V121, P935, DOI 10.1002/cncr.29133; Haase KR, 2018, CANC NURS, DOI [10.1097/ncc.0000000000000619 29933306, DOI 10.1097/NCC.0000000000000619 29933306]; Kilsdonk E, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12462; Lampic C, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5518-3; Lange M, 2019, ANN ONCOL, V30, P1925, DOI 10.1093/annonc/mdz410; Leykin Y, 2012, PSYCHO-ONCOLOGY, V21, P1016, DOI 10.1002/pon.1993; Ljungman L, 2019, J SEX MED, V16, P1049, DOI 10.1016/j.jsxm.2019.05.005; Logan S, 2019, PSYCHO-ONCOLOGY, V28, P22, DOI 10.1002/pon.4927; Martopullo C, 2020, J CANCER SURVIV, V14, P261, DOI 10.1007/s11764-019-00838-x; McAlpine H, 2015, PATIENT EDUC COUNS, V98, P283, DOI 10.1016/j.pec.2014.11.002; McCann L, 2019, JMIR CANCER, V5, DOI 10.2196/12071; Myall M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0214-y; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Nicholls M.C., 2014, QUALITATIVE RES PRAC, P177, DOI DOI 10.1186/1745-6215-14-166; Olsson M, 2018, J CANCER SURVIV, V12, P450, DOI 10.1007/s11764-018-0684-x; Pingree S, 2010, AM J PREV MED, V38, P103, DOI 10.1016/j.amepre.2009.09.035; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schmidt ME, 2018, QUAL LIFE RES, V27, P2077, DOI 10.1007/s11136-018-1866-8; Schover Leslie R, 2014, EJC Suppl, V12, P41, DOI 10.1016/j.ejcsup.2014.03.004; Smith JN, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1733-1; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ussher J, 2018, INFERTILITY RELATED; Ussher J, 2018, THREAT BIOGRAPHICAL; Van den Broeck A, 2016, J MANAGE, V42, P1195, DOI 10.1177/0149206316632058; Van Leeuwen M, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0920-0; Varela VS, 2013, CURR PROB CANCER, V37, P319, DOI 10.1016/j.currproblcancer.2013.10.009; Vassilakopoulou M, 2016, CRIT REV ONCOL HEMAT, V97, P328, DOI 10.1016/j.critrevonc.2015.08.002; Wettergren L, 2017, PSYCHO-ONCOLOGY, V26, P1632, DOI 10.1002/pon.4181; Wiklander M, 2017, SUPPORT CARE CANCER, V25, P3675, DOI 10.1007/s00520-017-3793-6; Winterling J, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5499	40	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236180	10.1371/journal.pone.0236180	http://dx.doi.org/10.1371/journal.pone.0236180			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU0WZ	32697801	Green Accepted, Green Published, gold			2022-12-26	WOS:000555392700011
J	Sanchez-Teruel, D; Robles-Bello, MA; Camacho-Conde, JA				Sanchez-Teruel, David; Robles-Bello, Maria Auxiliadora; Camacho-Conde, Jose Antonio			Assessment of emotional intelligence in adults with down syndrome: Psychometric properties of the Emotional Quotient Inventory	PLOS ONE			English	Article							HORNS PARALLEL ANALYSIS; COGNITIVE-DEVELOPMENT; SOCIAL INTELLIGENCE; EARLY LANGUAGE; CHILDREN; KNOWLEDGE; VALIDITY; NUMBER; RECOGNITION; ADOLESCENTS	Introduction The Emotional Quotient Inventory: Youth version-EQ-i:YV was developed by Bar-On & Parker in 2000 and later translated and adapted for the general Spanish adolescent population by Ferrandiz et al. in 2012. The Spanish scale presents similar psychometric properties to the original version (54 items and five subdimensions). The Emotional Quotient Inventory assesses a set of personal, emotional, and social skills that influence adaptation to and coping with environmental demands and pressures. These factors can influence an adolescent's success later in life, health, and psychological well-being. Traditionally, research in Down syndrome (DS) has focused on identifying cognitive deficits, relatively little is known about emotional intelligence (EI) and there are no scales that measure EI in people with DS adults. Objectives To validate and analyze the psychometric properties of the scale in the clinical population, specifically in Spanish adults with DS (EQ-i: SVDS). Methods A cross-sectional investigation was carried out in several stages. Descriptive, exploratory factorial (n = 345), confirmatory (n = 397), and scale reliability analyses were performed with better goodness-of-adjustment indices. Results A new scale named Emotional Quotient Inventory: Short Version for DS adults was obtained with a structure of four factors called mood, stress management, interpersonal, and intrapersonal. This new scale was reduced to 25 items. Goodness-of-fit indices were excellent (RMSEA [95% CI] = 02[.01; .03]; CFI = .99; TLI = .98; GFI = .87; AGFI = .89). The internal consistency of the four dimensions and the calculated total score (alpha = .91, omega = .93 and divided halves = .90) yielded high values in this clinical sample. Discussion The results recommend the use of the revised EQ-i: YV, the EQ-i: SVDS, to assess EI in adults with DS. The psychometric properties of this study are satisfactory but have four factors. The findings are discussed in terms of future research and practical implication to gain a more thorough understanding of how this population behaves on both a general and preventive level in order to teach EI properly. Conclusions This new version is a valid and reliable tool to evaluate emotional intelligence in people with intellectual disabilities and specifically in Spanish adults with DS.	[Sanchez-Teruel, David] Univ Cordoba, Dept Psychol, Cordoba, Spain; [Robles-Bello, Maria Auxiliadora] Univ Jaen, Dept Psychol, Jaen, Spain; [Camacho-Conde, Jose Antonio] Univ Malaga, Dept Med, Malaga, Spain	Universidad de Cordoba; Universidad de Jaen; Universidad de Malaga	Robles-Bello, MA (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	marobles@ujaen.es	Teruel, David Sánchez/C-9079-2011; Camacho-Conde, José Antonio/AAA-1096-2019; Camacho-Conde, José Antonio/ABC-1062-2021; Robles-Bello, Maria Auxiliadora/M-4548-2018	Teruel, David Sánchez/0000-0001-8996-0216; Camacho-Conde, José Antonio/0000-0002-6912-8462; Robles-Bello, Maria Auxiliadora/0000-0002-4979-5399				Abbeduto L, 2007, MENT RETARD DEV D R, V13, P247, DOI 10.1002/mrdd.20158; [Anonymous], 1997, BAR ON EMOTIONAL QUO; [Anonymous], 2018, SPAIN MAP OUR ASS SO; [Anonymous], 2017, DOWN SPAIN EMOCIONA; Augusto-Landa J. M., 2006, ANSIEDAD ESTRES, V12, P479; Austin EJ, 2005, PERS INDIV DIFFER, V38, P547, DOI 10.1016/j.paid.2004.05.009; Robles-Bello MA, 2017, REV ARGENT CLIN PSIC, V26, P313, DOI 10.24205/03276716.2017.1023; Baglin J., 2014, PRACTICAL ASSESSMENT, V19; Bar-On R, 2004, MEASURING EMOTIONAL INTELLIGENCE: COMMON GROUND AND CONTROVERSY, P115; Bar-On R, 2003, PERSPECT EDUC, V21, P3; Bar-On R, 2006, LINKING EMOTIONAL INTELLIGENCE AND PERFORMANCE AT WORK: CURRENT RESEARCH EVIDENCE WITH INDIVIDUALS AND GROUPS, P3; Bar-On R., 1988, THESIS; Bar-On R., 2000, EMOTIONAL QUOTIENT I; Bar-On R, 2006, PSICOTHEMA, V18, P13; Barchard KA, 2003, EDUC PSYCHOL MEAS, V63, P840, DOI 10.1177/0013164403251333; Carr J., 1995, DOWNS SYNDROME CHILD; Carvajal F, 2012, RES DEV DISABIL, V33, P783, DOI 10.1016/j.ridd.2011.12.004; Cebula KR, 2010, J INTELL DISABIL RES, V54, P113, DOI 10.1111/j.1365-2788.2009.01215.x; Cebula KR, 2017, AJIDD-AM J INTELLECT, V122, P138, DOI 10.1352/1944-7558-122.2.138; Channell MM, 2014, AJIDD-AM J INTELLECT, V119, P405, DOI 10.1352/1944-7558-119.5.405; Ciarrochi J, 2002, PERS INDIV DIFFER, V32, P197, DOI 10.1016/S0191-8869(01)00012-5; Cleland J, 2010, INT J LANG COMM DIS, V45, P83, DOI 10.3109/13682820902745453; Couzens D, 2012, J APPL RES INTELLECT, V25, P396, DOI 10.1111/j.1468-3148.2011.00673.x; Couzens D, 2011, AJIDD-AM J INTELLECT, V116, P181, DOI 10.1352/1944-7558-116.3.181; Cunningham C., 1996, DOWN SYNDROME RES PR, V4, P87, DOI [10.3104/perspectives.66, DOI 10.3104/PERSPECTIVES.66]; Garrido LE, 2013, PSYCHOL METHODS, V18, P454, DOI 10.1037/a0030005; El Hassan K, 2005, INT J TEST, V5, P301, DOI 10.1207/s15327574ijt0503_7; Erhart M, 2010, CHILD CARE HLTH DEV, V36, P473, DOI 10.1111/j.1365-2214.2009.00998.x; Esnaola I, 2017, AN PSICOL-SPAIN, V33, P327, DOI 10.6018/analesps.33.2.251831; Extremera N., 2004, REV ELECTRON INVEST, V6; Extremera N, 2011, J HAPPINESS STUD, V12, P509, DOI 10.1007/s10902-010-9233-7; Fernandez-Berrocal P, 2006, INDIVIDUAL DIFFERENC, V4, P1; Fernandez-Berrocal P, 2009, REV INTERUNIV FORM P, P85; Ferrandiz C, 2012, REV PSICODIDACT, V17, P309, DOI 10.1387/RevPsicodidact.2814; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; Florez J., 2015, SINDROME NEUROBIOLOG; Garcia Alonso M. I., 2017, REV INFAD PSICOLOGIA, V4, P55; Garcia-Alba J, 2014, REV INFAD PSICOLOGIA, V3, P203; Garcia-Ros R, 2011, REV PSICODIDACT, V16, P231; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; Gohm CL, 2005, PERS INDIV DIFFER, V39, P1017, DOI 10.1016/j.paid.2005.03.018; Goleman D., 1999, PRACTICA INTELIGENCI; Goleman D., 1996, INTELIGENCIA EMOCION; Graham JW., 2012, MISSING DATA; Herrera L, 2015, PROCD SOC BEHV, V203, P4, DOI 10.1016/j.sbspro.2015.08.251; Hippolyte L, 2009, RES DEV DISABIL, V30, P1007, DOI 10.1016/j.ridd.2009.02.004; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Izard CE, 2011, EMOT REV, V3, P44, DOI 10.1177/1754073910380972; JENNRICH RI, 1979, PSYCHOMETRIKA, V44, P173, DOI 10.1007/BF02293969; Kasari C, 2001, AM J MENT RETARD, V106, P59, DOI 10.1352/0895-8017(2001)106<0059:ERBCWD>2.0.CO;2; Kaufman A. S., 1997, TEST BREVE INTELIGEN; Klein AM, 2018, RES DEV DISABIL, V80, P44, DOI 10.1016/j.ridd.2018.05.016; Kline R. B, 2015, PRINCIPLES PRACTICE, DOI DOI 10.1111/j.1467-8721.2009.01598.x; Kun B, 2012, PSYCHOL ASSESSMENT, V24, P518, DOI 10.1037/a0026013; Lanfranchi S, 2012, J INTELL DISABIL RES, V56, P157, DOI 10.1111/j.1365-2788.2011.01444.x; Limonero JT, 2006, PSICOTHEMA, V18, P95; Lloret-Segura S, 2014, AN PSICOL-SPAIN, V30, P1151, DOI 10.6018/analesps.30.3.199361; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Marchal S, 2016, IZA J EUR LABOR STUD, V5, DOI 10.1186/s40174-016-0052-7; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Mason-Apps E, 2018, RES DEV DISABIL, V81, P37, DOI 10.1016/j.ridd.2017.12.021; Mazzone L, 2012, ANN GEN PSYCHIATR, V11, DOI 10.1186/1744-859X-11-16; Mestre JM, 2006, PSICOTHEMA, V18, P112; Moore DF, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-4; Morales G, 2007, SINDROME MUNDO EMOCI; Morgan JK, 2010, SOC DEV, V19, P52, DOI 10.1111/j.1467-9507.2008.00529.x; MUNDY P, 1995, J SPEECH HEAR RES, V38, P157, DOI 10.1044/jshr.3801.157; Naess KAB, 2012, RES DEV DISABIL, V33, P737, DOI 10.1016/j.ridd.2011.09.019; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Parker AR, 2005, CARCINOGENESIS, V26, P2010, DOI 10.1093/carcin/bgi166; Pinar-Chelso M. J., 2011, AVIATION PSYCHOL APP, V1, P21, DOI [10.1027/2192-0923/a00009, DOI 10.1027/2192-0923/A00009]; Pochon R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060055; Potier MC, 2006, J NEUROCHEM, V97, P104, DOI 10.1111/j.1471-4159.2005.03624.x; Pujol J, 2015, CORTEX, V64, P148, DOI 10.1016/j.cortex.2014.10.012; Robles-Bello MA, 2014, 8 S AS MOT EM; Rodriguez M. N., 2008, PSICOLOGICA REV METO, V29, P205; Roper RJ, 2006, PLOS GENETICS, V2; Ruiz E., 2016, TODO MUNDO EMOCIONES; Ruiz E., 2009, REV SINDROME DOWN, V26, P126; Saklofske DH, 2003, PERS INDIV DIFFER, V34, P707, DOI 10.1016/S0191-8869(02)00056-9; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Sanchez-Teruel D, 2015, UNIV PSYCHOL, V14, P645, DOI 10.11144/Javeriana.upsy14-1.rpra; Schalock R., 2021, INTELLECTUAL DISABIL; Schutte NS, 2007, PERS INDIV DIFFER, V42, P921, DOI 10.1016/j.paid.2006.09.003; Shi DX, 2018, STRUCT EQU MODELING, V25, P924, DOI 10.1080/10705511.2018.1449653; Stanimirovic R, 2012, PSYCHOL SPORT EXERC, V13, P44, DOI 10.1016/j.psychsport.2011.07.009; Stern JA, 2014, RES AUTISM SPECT DIS, V8, P1225, DOI 10.1016/j.rasd.2014.06.008; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Tsaousis L, 2005, STRESS HEALTH, V21, P77, DOI 10.1002/smi.1042; Van Riper M, 2001, J Pediatr Health Care, V15, P123, DOI 10.1067/mph.2001.110627; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Zijlmans EAO, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02298	92	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236087	10.1371/journal.pone.0236087	http://dx.doi.org/10.1371/journal.pone.0236087			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MU0WZ	32697810	gold, Green Published			2022-12-26	WOS:000555392700029
J	Elaagip, A; Ahmed, A; Wilson, MD; Boakye, DA; Hamid, MMA				Elaagip, Arwa; Ahmed, Ayman; Wilson, Michael David; Boakye, Daniel A.; Abdel Hamid, Muzamil Mahdi			Studies of host preferences of wild-caughtPhlebotomus orientalisandPh. papatasivectors of leishmaniasis in Sudan	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BLOOD MEAL IDENTIFICATION; PHLEBOTOMUS LARROUSSIUS ORIENTALIS; SANDFLIES DIPTERA PSYCHODIDAE; SAND FLIES DIPTERA; VISCERAL-LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; KALA-AZAR; LUTZOMYIA-LONGIPALPIS; EASTERN SUDAN	Introduction Understanding the feeding behavior and host choice of sand flies provides valuable information on vector-host relationships and elucidates the epidemiological patterns of leishmaniasis transmission. Blood meal analysis studies are essential for estimating the efficiency of pathogen transmission, assessing the relative human disease risk, and assist in identifying the other potential hosts of leishmaniasis. In Sudan and most of East Africa, there are large remaining gaps in knowledge regarding the feeding habits of phlebotomine vectors. The study aimed to identify the blood meal sources and, therefore, the host preferences of the principal vectorsPhlebotomus orientalisandPh.papatasiin leishmaniasis endemic areas of eastern and central Sudan. Materials and methods Sand flies were collected from two endemic villages in eastern and central Sudan using CDC light traps and sticky traps. The phlebotomine sand flies were morphologically and then molecularly identified. The source of blood meal of the engorged females was determined using a multiplex PCR methodology and specific primers of cytochromebgene of mitochondrial DNA for human, goat, cow, and dog. The detection of theLeishmaniaparasite was done using PCR. Results The total number of collected female phlebotomine sand flies was 180. Morphological identification revealed the abundance ofPh.orientalis103 (57.2%),Ph.papatasi42 (23.3%),Ph.bergeroti31 (17.2%),Ph.rodhaini2 (1.1%) andPh.duboscqi2 (1.1%) in the study sites. Out of the 180 collected, 31 (17%) were blood-fed flies. Three species were blood-fed and molecularly identified:Ph.papatasi(N = 7, 22.6%),Ph.bergeroti(N = 9, 26%), andPh.orientalis(N = 15, 48.4%). Blood meal analysis revealed human DNA in twoPh.orientalis(6.4%), hence, the anthropophilic index was 13.3%. Conclusions Multiplex PCR protocol described here allowed the identification of blood meal sources of many vertebrate species simultaneously. The results indicate that wild-caughtPh.orientalisare anthropophilic in the study areas. Further studies on larger blood-fed sample size are required to validate the potential applications of this technique in designing, monitoring and evaluating control programs, particularly in investigating the potential non-human hosts of leishmaniasis.	[Elaagip, Arwa] Univ Khartoum, Fac Med Lab Sci, Dept Parasitol & Med Entomol, Khartoum, Sudan; [Elaagip, Arwa; Ahmed, Ayman; Abdel Hamid, Muzamil Mahdi] Univ Khartoum, Inst Endem Dis, Dept Parasitol & Med Entomol, Khartoum, Sudan; [Wilson, Michael David; Boakye, Daniel A.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Boakye, Daniel A.] END Fund, New York, NY USA	University of Khartoum; University of Khartoum; University of Ghana	Elaagip, A (corresponding author), Univ Khartoum, Fac Med Lab Sci, Dept Parasitol & Med Entomol, Khartoum, Sudan.; Elaagip, A (corresponding author), Univ Khartoum, Inst Endem Dis, Dept Parasitol & Med Entomol, Khartoum, Sudan.	arwalaagip@yahoo.co.uk		Elaagip, Arwa/0000-0003-4091-8345	OWSD (Organization for Women in Science for the Developing World); SIDA (Swedish International Development Cooperation Agency)	OWSD (Organization for Women in Science for the Developing World); SIDA (Swedish International Development Cooperation Agency)	Thanks are extended to Mr. Talal Ahmed from University of Khartoum for assistance in field collection of the sand fly, Dr. Anwar Banaga from Ministry of Health, Gedarif state, Sudan for logistic assistance, to staff of MSF Switzerland at Tabarakallah site for providing accommodation to the study team during field visits, to Dr. Beirag Nazar from Brunel University London for revising the English language of the manuscript and to people of Sirougia and Tabarakallah for their cooperation during field collection. This work is part of the PhD fellowship for Arwa Elaagip from OWSD (Organization for Women in Science for the Developing World) and SIDA (Swedish International Development Cooperation Agency).	Abbasi I, 2009, VECTOR-BORNE ZOONOT, V9, P79, DOI 10.1089/vbz.2008.0064; Abonnenc E, 1965, CAH ORSTOM ENTOMOL M, V5, P1; Alten B, 2015, B ENTOMOL RES, V105, P664, DOI 10.1017/S0007485315000127; Argaw D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002543; Awadallah AH, 2017, INT J INFECT DIS THE, V2, P15, DOI [10.11648/j.ijidt.20170201.14, DOI 10.11648/J.IJIDT.20170201.14]; Balbino VD, 2006, ACTA TROP, V98, P15, DOI 10.1016/j.actatropica.2006.01.007; Balkew M, 2002, ETHIOPIAN MED J, V40, P271; Bari A., 2013, THESIS; Bashaye S, 2009, AM J TROP MED HYG, V81, P34, DOI 10.4269/ajtmh.2009.81.34; Bates PA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0712-x; Baum M, 2015, ACTA TROP, V143, P8, DOI 10.1016/j.actatropica.2014.11.006; BEACH R, 1984, T ROY SOC TROP MED H, V78, P747, DOI 10.1016/0035-9203(84)90006-3; Berdjane-Brouk Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028266; Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x; Cabrera Olga L, 2002, Biomedica, V22, P296; Campino L, 2013, MEM I OSWALDO CRUZ, V108, P516, DOI 10.1590/S0074-02762013000400020; Chaskopoulou A, 2016, ACTA TROP, V158, P170, DOI 10.1016/j.actatropica.2016.03.006; Clements A, 1992, NATURE; Sales KGD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0840-3; Dereure J, 2003, MICROBES INFECT, V5, P1103, DOI 10.1016/j.micinf.2003.07.003; DILLON RJ, 1993, MED VET ENTOMOL, V7, P225, DOI 10.1111/j.1365-2915.1993.tb00681.x; El Hossary S, 2007, NAMRU3 VECT BIOL RES; ELHASSAN AM, 2001, T ROY SOC TROP ME S1, V95, pS; Elnaiem DA, 1997, ANN TROP MED PARASIT, V91, P307, DOI 10.1080/00034989761157; Elnaiem DA, 2001, PARASITOLOGY, V122, P531, DOI 10.1017/S0031182001007594; Elnaiem DA, 1998, ANN TROP MED PARASIT, V92, P877, DOI 10.1080/00034989858925; Elnaiem DEA, 2003, AM J TROP MED HYG, V68, P10, DOI 10.4269/ajtmh.2003.68.1.0680010; Elnaiem DEA, 1998, ACTA TROP, V71, P305, DOI 10.1016/S0001-706X(98)00067-9; Elnaiem DEA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-238; Elnaiem DEA, 2011, J VECTOR ECOL, V36, pS23, DOI 10.1111/j.1948-7134.2011.00109.x; Garlapati RB, 2012, J MED ENTOMOL, V49, P515, DOI 10.1603/ME11115; Gebre-Michael T, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-6; GebreMichael T, 1996, MED VET ENTOMOL, V10, P53, DOI 10.1111/j.1365-2915.1996.tb00082.x; Gebresilassie A, 2015, J TROP MED-US, V2015, DOI 10.1155/2015/710528; Gebresilassie A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0883-5; Gebresilassie A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0807-4; Giantsis I, 2016, J ECON ENTOMOL, P1, DOI [10.1093/jee/tov238, DOI 10.1093/JEE/TOV238]; Gomes LAM, 2001, MEM I OSWALDO CRUZ, V96, P693, DOI 10.1590/S0074-02762001000500020; Gomez B, 1998, J AM MOSQUITO CONTR, V14, P28; Gonzalez C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190686; Haouas N, 2007, AM J TROP MED HYG, V77, P1054, DOI 10.4269/ajtmh.2007.77.1054; Hassan MM, 2008, ANN TROP MED PARASIT, V102, P553, DOI 10.1179/136485908X311803; Hassan MM, 2007, ANN TROP MED PARASIT, V101, P653, DOI 10.1179/136485907X229040; Hassan MM, 2004, ACTA TROP, V92, P77, DOI 10.1016/j.actatropica.2004.06.001; Hassan MM, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-26; Hassan MM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-46; HOOGSTRAAL H, 1969, AM J TROP MED HYG, V18, P1091, DOI 10.4269/ajtmh.1969.18.1091; Ian B, 2010, J MED ENTOMOL, V47, P902, DOI [10.1603/me09184 20939388, DOI 10.1603/ME09184]; Inbar E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004706; Jain S, 2007, INDIAN J ANIM SCI, V77, P880; Jaouadi K, 2013, ANN ENTOMOL SOC AM, V106, P79, DOI 10.1603/AN11186; Kalayou S, 2011, TRANSBOUND EMERG DIS, V58, P255, DOI 10.1111/j.1865-1682.2011.01209.x; Kanjanopas K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-333; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Kenubih A, 2015, TROP MED INT HEALTH, V20, P205, DOI 10.1111/tmi.12418; Khalid N, 2010, MED VET ENTOMOL, V24, P352, DOI 10.1111/j.1365-2915.2010.00893.x; Khalid NM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-249; KILLICKKENDRICK R, 1987, MED VET ENTOMOL, V1, P297, DOI 10.1111/j.1365-2915.1987.tb00358.x; KIRK R., 1951, TRANS ROY ENT SOC LONDON, V102, P383; Lambert M, 2002, ANN TROP MED PARASIT, V96, P631, DOI 10.1179/000349802125001474; Lee JH, 2002, AM J TROP MED HYG, V66, P599, DOI 10.4269/ajtmh.2002.66.599; Macdonald G, 1957, EPIDEMIOLOGY CONTROL; Mahamoud A, 2018, ACTA TROP, V178, P142, DOI 10.1016/j.actatropica.2017.11.010; Maia C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0787-4; Maleki-Ravasan N, 2009, IRAN J ARTHROPOD-BOR, V3, P8; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Mohamed NS, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4608-2; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Mukherjee S, 1997, AM J TROP MED HYG, V57, P423, DOI 10.4269/ajtmh.1997.57.423; Mukhtar MM, 2000, T ROY SOC TROP MED H, V94, P33, DOI 10.1016/S0035-9203(00)90429-2; MUTINGA MJ, 1994, E AFR MED J, V71, P424; Myskova J, 2008, J MED ENTOMOL, V45, P133, DOI 10.1603/0022-2585(2008)45[133:LISFCO]2.0.CO;2; Ngumbi PM, 2010, J VECTOR DIS, V47, P58; Numairy M., 2009, THESIS; Nzelu CO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002630; Oshaghi MA, 2009, AM J TROP MED HYG, V81, P572, DOI 10.4269/ajtmh.2009.08-0469; Paiva BR, 2006, ACTA TROP, V99, P252, DOI 10.1016/j.actatropica.2006.08.009; Parvizi P, 2008, IRAN J VET RES, V9, P9; Pengsakul Theerakamol, 2017, Songklanakarin Journal of Science and Technology, V39, P731; Polanska N., 2014, PARASITE VECTOR, V7, pO5; Pruzinova K, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2613-2; Pruzinova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128203; QUATE LAURENCE W., 1964, J MED ENTOMOL, V1, P213, DOI 10.1093/jmedent/1.3.213; Ramalho-Ortigao M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-300; Ranasinghe S, 2008, T ROY SOC TROP MED H, V102, P875, DOI 10.1016/j.trstmh.2008.04.003; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Soares VYR, 2014, MEM I OSWALDO CRUZ, V109, P379, DOI 10.1590/0074-0276130405; Rohousova I, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0976-1; Sadlova J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-186; Sambrook J, 1989, MOL CLONING LAB MANU, P484; Sant'Anna MRV, 2008, ACTA TROP, V107, P230, DOI 10.1016/j.actatropica.2008.06.003; SCHORSCHER JA, 1992, T ROY SOC TROP MED H, V86, P622, DOI 10.1016/0035-9203(92)90154-5; Seccombe A.K., 1993, Occasional Papers on Systematic Entomology, V8, P1; Tanure A, 2015, REV INST MED TROP SP, V57, P321, DOI 10.1590/S0036-46652015000400008; Townsend R, 2018, PLACENTAL-FETAL GROWTH RESTRICTION, P95; Truppel JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093731; Widaa SO, 2012, MEM I OSWALDO CRUZ, V107, P470, DOI 10.1590/S0074-02762012000400005; World Health Organization, 2003, TDRSWGVEC031 WHO; Yared S, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02132; Yared S, 2017, ACTA TROP, V166, P25, DOI 10.1016/j.actatropica.2016.10.011; Yared S, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0470-1; Zijlstra EE, 2001, T ROY SOC TROP MED H, V95, pS27, DOI 10.1016/S0035-9203(01)90218-4	102	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236253	10.1371/journal.pone.0236253	http://dx.doi.org/10.1371/journal.pone.0236253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692759	Green Published, gold			2022-12-26	WOS:000554606400007
J	Stoean, R; Stoean, C; Becerra-Garcia, R; Garcia-Bermudez, R; Atencia, M; Garcia-Lagos, F; Velazquez-Perez, L; Joya, G				Stoean, Ruxandra; Stoean, Catalin; Becerra-Garcia, Roberto; Garcia-Bermudez, Rodolfo; Atencia, Miguel; Garcia-Lagos, Francisco; Velazquez-Perez, Luis; Joya, Gonzalo			A hybrid unsupervised-Deep learning tandem for electrooculography time series analysis	PLOS ONE			English	Article							DIAGNOSIS; MOVEMENTS	Medical data are often tricky to get mined for patterns even by the generally demonstrated successful modern methodologies of deep learning. This paper puts forward such a medical classification task, where patient registers of two of the categories are sometimes hard to be distinguished because of samples showing characteristics of both labels in turn in several repetitions of the screening procedure. To this end, the current research appoints a pre-processing clustering step (through self-organizing maps) to group the data based on shape similarity and relabel it accordingly. Subsequently, a deep learning approach (a tandem of convolutional and long short-term memory networks) performs the training classification phase on the 'cleaned' samples. The dual methodology was applied for the computational diagnosis of electrooculography tests within spino-cerebral ataxia of type 2. The accuracy obtained for the discrimination into three classes was of 78.24%. The improvement that this duo brings over the deep learner alone does not stem from significantly higher accuracy results when the performance is considered for all classes. The major finding of this combination is that half of the presymptomatic cases were correctly found, in opposition to the single deep model, where this category was sacrificed by the learner in favor of a good accuracy overall. A high accuracy in general is desirable for any medical task, however the correct identification of cases before the symptoms become evident is more important.	[Stoean, Ruxandra; Stoean, Catalin] Univ Craiova, Craiova, Romania; [Becerra-Garcia, Roberto; Atencia, Miguel; Garcia-Lagos, Francisco; Joya, Gonzalo] Univ Malaga, Malaga, Spain; [Garcia-Bermudez, Rodolfo] Univ Tecn Manabi, Portoviejo, Ecuador; [Velazquez-Perez, Luis] Cuban Acad Sci, Havana, Cuba; [Velazquez-Perez, Luis] Ctr Res & Rehabil Hereditary Ataxias, Holguin, Cuba	University of Craiova; Universidad de Malaga; Universidad Tecnica de Manabi; Academia de Ciencias de Cuba	Stoean, C (corresponding author), Univ Craiova, Craiova, Romania.	catalin.stoean@inf.ucv.ro	Stoean, Ruxandra/C-7241-2008; García Bermudez, Rodolfo/A-9200-2013; Stoean, Catalin/C-7242-2008; Atencia, Miguel/A-4734-2009	Stoean, Ruxandra/0000-0002-9849-5712; García Bermudez, Rodolfo/0000-0002-0643-4745; Stoean, Catalin/0000-0001-5917-1857; Joya, Gonzalo/0000-0001-9256-0870; Atencia, Miguel/0000-0002-5158-5905	Romanian Ministry of Research and Innovation, CNCS - UEFISCDI within PNCDI III [298/2019, PN-III-P1-1.1-MC2019-1746, 314/2019, PN-III-P1-1.1-MC2019-1737]; University of Malaga-Andalucia-Tech through the Plan Propio de Investigacion y Transferencia, Project DIATAX: Integracion de nuevas tecnologias para el diagnostico temprano de las Ataxias Hereditarias; Gobierno de Espana Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion [TIN2017-88728-C2-1-R]	Romanian Ministry of Research and Innovation, CNCS - UEFISCDI within PNCDI III(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); University of Malaga-Andalucia-Tech through the Plan Propio de Investigacion y Transferencia, Project DIATAX: Integracion de nuevas tecnologias para el diagnostico temprano de las Ataxias Hereditarias; Gobierno de Espana Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion	This work was partially supported by two mobility grants of the Romanian Ministry of Research and Innovation, CNCS - UEFISCDI: Catalin Stoean received grant No. 298/2019, code PN-III-P1-1.1-MC2019-1746 and Ruxandra Stoean received grant No. 314/2019, code PN-III-P1-1.1-MC2019-1737, both grants within PNCDI III (https://uefiscdi.gov.ro/).The support of the following institutions has consisted of general financing (mainly inventory material, travels, congress assistance) to the different research projects that have given rise, as a partial result, to the current article, but have not consisted of personal grants to individual researchers: University of Malaga-Andalucia-Tech through the Plan Propio de Investigacion y Transferencia, Project DIATAX: Integracion de nuevas tecnologias para el diagnostico temprano de las Ataxias Hereditarias, www.uma.es Involved researchers: Gonzalo Joya, Miguel Atencia, Francisco GarciaLagos, Rodolfo Garcia Bermudez, Roberto Becerra Garcia Ministerio de Ciencia, Innovacion y Universidades, Gobierno de Espana Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion -Project TIN2017-88728-C2-1-R, www.ciencia.gob.es Involved researchers: Gonzalo Joya, Miguel Atencia, Ruxandra Stoean The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaras M, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00103; Arcadu F, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0172-3; Barea R, 2002, IEEE T NEUR SYS REH, V10, P209, DOI 10.1109/TNSRE.2002.806829; Becerra-Garcia RA, 2017, NEUROCOMPUTING, V250, P28, DOI 10.1016/j.neucom.2016.10.077; Benhammou Y, 2020, NEUROCOMPUTING, V375, P9, DOI 10.1016/j.neucom.2019.09.044; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Davidson PR, 2007, IEEE T BIO-MED ENG, V54, P832, DOI 10.1109/TBME.2007.893452; Han ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04075-z; Healthcare MX., 2019, VARA IS GERMANYS 1 A; Kather JN, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002730; Komura D, 2018, COMPUT STRUCT BIOTEC, V16, P34, DOI 10.1016/j.csbj.2018.01.001; Ledezma CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220294; Lichtblau D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209274; Lundervold AS, 2019, Z MED PHYS, V29, P102, DOI 10.1016/j.zemedi.2018.11.002; Min S, 2017, BRIEF BIOINFORM, V18, P851, DOI 10.1093/bib/bbw068; Mirowski P, 2009, CLIN NEUROPHYSIOL, V120, P1927, DOI 10.1016/j.clinph.2009.09.002; Mittal S, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00246; Mostapha M, 2019, MAGN RESON IMAGING, V64, P171, DOI 10.1016/j.mri.2019.06.009; Murtagh F, 2017, WIRES DATA MIN KNOWL, V7, DOI 10.1002/widm.1219; Oh SL, 2019, COMPUT BIOL MED, V105, P92, DOI 10.1016/j.compbiomed.2018.12.012; Petrosian A, 2000, NEUROCOMPUTING, V30, P201, DOI 10.1016/S0925-2312(99)00126-5; Saba L, 2019, EUR J RADIOL, V114, P14, DOI 10.1016/j.ejrad.2019.02.038; Sahlsten J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47181-w; Stoean C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223593; Stoean C, 2019, LECT NOTES COMPUT SC, V11507, P26, DOI 10.1007/978-3-030-20518-8_3; Stoean C, 2019, SOFT COMPUT, V23, P3707, DOI 10.1007/s00500-018-3029-9; Stoean C, 2014, APPL SOFT COMPUT, V25, P159, DOI [10.1016/j.asoc.2014.09.01, 10.1016/j.asoc.2014.09.017]; STOEAN R, 2018, NEURAL COMPUTING APP; Strumberger Ivana, 2019, 2019 International Young Engineers Forum (YEF-ECE). Proceedings, P59, DOI 10.1109/YEF-ECE.2019.8740818; Topol E., 2019, DEEP MED ARTIFICIAL; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; Yang XL, 2020, NEUROCOMPUTING, V396, P514, DOI 10.1016/j.neucom.2018.10.105; Yu Y, 2019, NEURAL COMPUT, V31, P1235, DOI 10.1162/neco_a_01199; Zhao YL, 2015, LECT NOTES COMPUT SC, V9008, P340, DOI 10.1007/978-3-319-16628-5_25; Zhu F, 2019, SCI REPORTS, V9	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236401	10.1371/journal.pone.0236401	http://dx.doi.org/10.1371/journal.pone.0236401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	32692779	Green Published, gold			2022-12-26	WOS:000554606400030
J	Liu, QR; Cui, P; Zheng, K; Wang, JJ; Jiang, W; Liu, GY; Hao, JW; Liu, HJ				Liu, Qingrong; Cui, Pan; Zheng, Kai; Wang, Junjie; Jiang, Wei; Liu, Guiyou; Hao, Junwei; Liu, Haijie			SERPINA1gene expression in whole blood links the rs6647 variant G allele to an increased risk of large artery atherosclerotic stroke	FASEB JOURNAL			English	Article						expression quantitative trait loci; large artery atherosclerotic stroke; rs6647; SERPINA1; whole blood	GENE-EXPRESSION; ISCHEMIC-STROKE; DISEASE; CONTRIBUTE; EQTLS	The rs6647 variant G allele inSERPINA1gene was reported to be associated with the risk of large artery atherosclerotic stroke (LAS), however, the mechanism remains unclear. Here, we performed a functional annotation of the rs6647 variant by using the software HaploReg version 4.1 (HaploReg v4.1). Next, the expression quantitative trait loci (eQTLs) analysis of multiple datasets was conducted for determining the association between the rs6647 andSERPINA1expression in various tissues. Then, a case-control gene expression analysis was done using two independent ischemic stroke (IS) gene expression datasets. Finally,SERPINA1expression in whole blood samples from 8 LAS patients and 14 healthy persons were compared. The functional annotation suggested that the rs6647 regulates gene expression in multiple human tissues especially in brain and blood. The eQTLs analysis revealed a significant association of the rs6647 G allele with increased expression ofSERPINA1gene only in whole blood. Compared with the controls, there was an increased expression ofSERPINA1gene in whole blood in both IS patients and LAS patients.SERPINA1gene expression in whole blood bridges the rs6647 variant G allele with increased LAS risk, providing new insights into the mechanisms underlying role of the rs6647 in determining LAS risk.	[Liu, Qingrong; Hao, Junwei] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, 56 Xinjiannan Rd, Taiyuan, Shanxi, Peoples R China; [Liu, Qingrong; Hao, Junwei] Shanxi Med Univ, Dept Physiol, 56 Xinjiannan Rd, Taiyuan, Shanxi, Peoples R China; [Cui, Pan; Zheng, Kai; Wang, Junjie; Jiang, Wei; Hao, Junwei] Tianjin Med Univ Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Liu, Guiyou; Hao, Junwei; Liu, Haijie] Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing, Peoples R China	Shanxi Medical University; Shanxi Medical University; Tianjin Medical University; Capital Medical University	Hao, JW (corresponding author), Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, 56 Xinjiannan Rd, Taiyuan, Shanxi, Peoples R China.; Hao, JW (corresponding author), Shanxi Med Univ, Dept Physiol, 56 Xinjiannan Rd, Taiyuan, Shanxi, Peoples R China.; Liu, HJ (corresponding author), Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing, Peoples R China.	haojunwei@vip.163.com; haijieliu@163.com			National Natural Science Foundation of China (NSFC) [81825008, 81571600, 81701189, 81801197]; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation) [17JCZDJC35500, 19JCQNJC10500]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81825008, 81571600, 81701189 and 81801197; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation), Grant/Award Number: 17JCZDJC35500 and 19JCQNJC10500	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barr TL, 2010, NEUROLOGY, V75, P1009, DOI 10.1212/WNL.0b013e3181f2b37f; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Chauhan G, 2016, LANCET NEUROL, V15, P695, DOI [10.1016/S1474-4422(16)00102-2, 10.1016/s1474-4422(16)00102-2]; Hu Y, 2017, NEUROL SCI, V38, P1255, DOI 10.1007/s10072-017-2959-9; Inouye M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002907; Liu G, 2018, J ALZHEIMERS DIS, V61, P1077, DOI 10.3233/JAD-170468; Liu GY, 2017, MOL NEUROBIOL, V54, P6820, DOI 10.1007/s12035-016-0208-5; Liu GY, 2017, J ALZHEIMERS DIS, V58, P1121, DOI 10.3233/JAD-170005; Liu GY, 2017, P NATL ACAD SCI USA, V114, pE906, DOI [10.1073/pnas.1618520114, 10.1073/pnas.1712127114]; Liu GY, 2016, P NATL ACAD SCI USA, V113, pE6321, DOI 10.1073/pnas.1614369113; Liu GY, 2015, P NATL ACAD SCI USA, V112, pE3975, DOI 10.1073/pnas.1509048112; Lloyd-Jones LR, 2017, AM J HUM GENET, V100, P228, DOI 10.1016/j.ajhg.2016.12.008; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Malik R, 2017, P NATL ACAD SCI USA, V114, P3613, DOI 10.1073/pnas.1616301114; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; NINDS S, 2016, LANCET NEUROL, V0015; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Stamova B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102550; Traylor M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004469; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Zhang Y, 2018, J NEUROL SCI, V390, P162, DOI 10.1016/j.jns.2018.04.037; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	28	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10107	10116		10.1096/fj.201903197R	http://dx.doi.org/10.1096/fj.201903197R		JUN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725952	Bronze			2022-12-26	WOS:000541772000001
J	Banerjee, S; Ghoshal, S; Stevens, JR; McCommis, KS; Gao, S; Castro-Sepulveda, M; Mizgier, ML; Girardet, C; Kumar, KG; Galgani, JE; Niehoff, ML; Farr, SA; Zhang, JS; Butler, AA				Banerjee, Subhashis; Ghoshal, Sarbani; Stevens, Joseph R.; McCommis, Kyle S.; Gao, Su; Castro-Sepulveda, Mauricio; Mizgier, Maria L.; Girardet, Clemence; Kumar, K. Ganesh; Galgani, Jose E.; Niehoff, Michael L.; Farr, Susan A.; Zhang, Jinsong; Butler, Andrew A.			Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian rhythm; diet; glucagon; insulin; hepatocyte; glucose metabolism; peptide hormone; stress response; signal transduction	PROTEIN-COUPLED RECEPTOR; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; MELANOCORTIN-3 RECEPTORS; METABOLIC DISEASE; MICE LACKING; SENSITIVITY; KINASE; CLOCK; BMAL1	The micropeptide adropin encoded by the clock-controlled energy homeostasis-associated gene is implicated in the regulation of glucose metabolism. However, its links to rhythms of nutrient intake, energy balance, and metabolic control remain poorly defined. Using surveys of Gene Expression Omnibus data sets, we confirm that fasting suppresses liver adropin expression in lean C57BL/6J (B6) mice. However, circadian rhythm data are inconsistent. In lean mice, caloric restriction (CR) induces bouts of compulsive binge feeding separated by prolonged fasting intervals, increasing NAD-dependent deacetylase sirtuin-1 signaling important for glucose and lipid metabolism regulation. CR up-regulates adropin expression and induces rhythms correlating with cellular stress-response pathways. Furthermore, adropin expression correlates positively with phosphoenolpyruvate carboxokinase-1 (Pck1) expression, suggesting a link with gluconeogenesis. Our previous data suggest that adropin suppresses gluconeogenesis in hepatocytes. Liver-specific adropin knockout (LAdrKO) mice exhibit increased glucose excursions following pyruvate injections, indicating increased gluconeogenesis. Gluconeogenesis is also increased in primary cultured hepatocytes derived from LAdrKO mice. Analysis of circulating insulin levels and liver expression of fasting-responsive cAMP-dependent protein kinase A (PKA) signaling pathways also suggests enhanced responses in LAdrKO mice during a glucagon tolerance test (250 mu g/kg intraperitoneally). Fasting-associated changes in PKA signaling are attenuated in transgenic mice constitutively expressing adropin and in fasting mice treated acutely with adropin peptide. In summary, hepatic adropin expression is regulated by nutrient- and clock-dependent extrahepatic signals. CR induces pronounced postprandial peaks in hepatic adropin expression. Rhythms of hepatic adropin expression appear to link energy balance and cellular stress to the intracellular signal transduction pathways that drive the liver fasting response.	[Banerjee, Subhashis; Ghoshal, Sarbani; Stevens, Joseph R.; Girardet, Clemence; Zhang, Jinsong; Butler, Andrew A.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, St Louis, MO 63103 USA; [McCommis, Kyle S.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, Sch Med, St Louis, MO USA; [McCommis, Kyle S.] St Louis Univ, Ctr Cardiovasc Res, Sch Med, St Louis, MO USA; [McCommis, Kyle S.] St Louis Univ, Ctr Cardiovasc Res, Liver Ctr, St Louis, MO USA; [Niehoff, Michael L.; Farr, Susan A.; Butler, Andrew A.] St Louis Univ, Henry & Amelia Nasrallah Ctr Neurosci, Sch Med, St Louis, MO 63103 USA; [Niehoff, Michael L.; Farr, Susan A.] St Louis Univ, Sch Med, Div Geriatr Med, St Louis, MO 63104 USA; [Gao, Su; Kumar, K. Ganesh; Butler, Andrew A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Castro-Sepulveda, Mauricio] Univ Finis Terrae, Fac Med, Lab Ciencias Ejercicio, Santiago, Chile; [Mizgier, Maria L.; Galgani, Jose E.] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Nutr & Dietet, Santiago, Chile; [Mizgier, Maria L.; Galgani, Jose E.] Pontificia Univ Catolica Chile, Fac Med, Dept Nutr Diabet & Metab, Santiago, Chile; [Niehoff, Michael L.; Farr, Susan A.] St Louis Vet Affairs Med Ctr, John Cochran Div, Res Serv, St Louis, MO USA; [Ghoshal, Sarbani] QCC CUNY, Dept Biol Sci & Geol, Bayside, NY USA; [Mizgier, Maria L.] Univ Strasbourg, Unite Mixte Rech, Diabet & Therapeut, Ctr Europeen Etud Diabet, Strasbourg, France; [Girardet, Clemence] Sorbonne Univ, CDR St Antoine UMR S 938, Paris, France; [Kumar, K. Ganesh] Taconic Biosci, Rensselaer, NY USA	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Scripps Research Institute; Universidad Finis Terrae; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Sorbonne Universite	Butler, AA (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol, St Louis, MO 63103 USA.; Butler, AA (corresponding author), St Louis Univ, Henry & Amelia Nasrallah Ctr Neurosci, Sch Med, St Louis, MO 63103 USA.; Butler, AA (corresponding author), Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA.	andrew.butler@health.slu.edu	Girardet, Clemence/GQQ-0627-2022; Mizgier, Maria/AAU-7804-2021	Farr, Susan/0000-0002-0481-2570; Mizgier, Maria Luisa/0000-0002-6396-8823; Zhang, Jinsong/0000-0002-8798-7316; Girardet, Clemence/0000-0002-0302-3350; McCommis, Kyle/0000-0003-2381-1589; Ghoshal, Sarbani/0000-0002-1089-084X	National Institutes of Health [R21NS108138, R00 HL136658]; American Diabetes Association; NovoNordisk	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NovoNordisk(Novo Nordisk)	A. A. B. was supported by National Institutes of Health Grant R21NS108138 and funding from the American Diabetes Association and NovoNordisk. K. S. M. was supported by National Institutes of Health Grant R00 HL136658. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrechtsen NJW, 2019, ENDOCR REV, V40, P1353, DOI 10.1210/er.2018-00251; Altamimi TR, 2019, METABOLISM, V98, P37, DOI 10.1016/j.metabol.2019.06.005; Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Begriche K, 2012, GENES BRAIN BEHAV, V11, P291, DOI 10.1111/j.1601-183X.2012.00766.x; Bremer AA, 2014, J NUTR, V144, P5, DOI 10.3945/jn.113.178061; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Burcelin R, 2004, J BIOL CHEM, V279, P1108, DOI 10.1074/jbc.M307788200; Butler AA, 2020, J LIPID RES, V61, P376, DOI 10.1194/jlr.RA119000423; Butler AA, 2019, J BIOL CHEM, V294, P9706, DOI 10.1074/jbc.RA119.007528; Butler AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14691; Butler AA, 2012, J CLIN ENDOCR METAB, V97, P3783, DOI 10.1210/jc.2012-2194; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Celik E, 2013, J PERINAT MED, V41, P375, DOI 10.1515/jpm-2012-0227; Chang JB, 2018, OBES RES CLIN PRACT, V12, P101, DOI 10.1016/j.orcp.2017.03.001; Chen X, 2020, FASEB J, V34, P10056, DOI 10.1096/fj.202000115RR; Chen X, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101068; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dooley J, 2016, DIABETES, V65, P53, DOI 10.2337/db15-0770; Driessen M, 2015, TOXICOL LETT, V232, P403, DOI 10.1016/j.toxlet.2014.11.020; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Foster SR, 2019, CELL, V179, P895, DOI 10.1016/j.cell.2019.10.010; Gao S, 2019, J BIOL CHEM, V294, P13366, DOI 10.1074/jbc.RA119.008967; Gao S, 2015, MOL METAB, V4, P310, DOI 10.1016/j.molmet.2015.01.005; Gao S, 2014, DIABETES, V63, P3242, DOI 10.2337/db14-0388; Ghoshal S, 2018, MOL METAB, V8, P51, DOI 10.1016/j.molmet.2017.12.002; Girardet C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44444; Havel PJ, 2017, ILAR J, V58, P251, DOI 10.1093/ilar/ilx031; Hughey CC, 2014, MAMM GENOME, V25, P522, DOI 10.1007/s00335-014-9533-z; Hung YH, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01367; Hung YH, 2019, PHYSIOL GENOMICS, V51, P379, DOI 10.1152/physiolgenomics.00037.2019; Kakimoto PA, 2016, REDOX BIOL, V8, P216, DOI 10.1016/j.redox.2016.01.009; Khitun A, 2019, MOL OMICS, V15, P108, DOI 10.1039/c8mo00283e; Kinouchi K, 2018, CELL REP, V25, P3299, DOI 10.1016/j.celrep.2018.11.077; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160; Kumar KG, 2012, OBESITY, V20, P1394, DOI 10.1038/oby.2012.31; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Lee J, 2011, ISLETS, V3, P381, DOI 10.4161/isl.3.6.18157; Lian AJ, 2016, J MOL ENDOCRINOL, V56, P11, DOI 10.1530/JME-15-0207; Liu J, 2016, ENDOCRINOLOGY, V157, P2259, DOI 10.1210/en.2015-2027; Lovren F, 2010, CIRCULATION, V122, pS185, DOI 10.1161/CIRCULATIONAHA.109.931782; Low EXS, 2020, CLIN MOL HEPATOL, V26, P142, DOI 10.3350/cmh.2019.1003; Makarewich CA, 2017, TRENDS CELL BIOL, V27, P685, DOI 10.1016/j.tcb.2017.04.006; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; McGill MR, 2019, BBA-MOL BASIS DIS, V1865, P1031, DOI 10.1016/j.bbadis.2018.08.037; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; Naoumov NV, 2014, J HEPATOL, V61, P1166, DOI 10.1016/j.jhep.2014.07.008; Niswender CM, 2005, GENESIS, V43, P109, DOI 10.1002/gene.20159; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Partridge CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-99; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rao A, 2017, BBA-MOL CELL RES, V1864, P1318, DOI 10.1016/j.bbamcr.2017.05.001; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Roden M, 2019, NATURE, V576, P51, DOI 10.1038/s41586-019-1797-8; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saghatelianr A, 2015, NAT CHEM BIOL, V11, P909, DOI 10.1038/nchembio.1964; Sargsyan A, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1195-5; Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042; St-Onge MP, 2014, OBESITY, V22, P1056, DOI 10.1002/oby.20631; Stein LM, 2016, AM J PHYSIOL-REG I, V310, pR476, DOI 10.1152/ajpregu.00511.2015; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Stern JH, 2019, J ENDOCRINOL, V243, P149, DOI 10.1530/JOE-19-0201; Stevens JR, 2016, OBESITY, V24, P1731, DOI 10.1002/oby.21557; Thapa D, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14043; Thapa D, 2019, J MOL CELL CARDIOL, V129, P174, DOI 10.1016/j.yjmcc.2019.02.012; Thapa D, 2018, REDOX BIOL, V18, P25, DOI 10.1016/j.redox.2018.06.003; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; WAKELAM MJO, 1986, NATURE, V323, P68, DOI 10.1038/323068a0; Wang PC, 2019, NAT CHEM BIOL, V15, P1110, DOI 10.1038/s41589-019-0368-5; Willis BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018772; Wong CM, 2014, J BIOL CHEM, V289, P25976, DOI 10.1074/jbc.M114.576058; Wu LZ, 2019, EXP THER MED, V18, P3307, DOI 10.3892/etm.2019.7937; Yang CJ, 2018, AGING DIS, V9, P322, DOI 10.14336/AD.2017.0523; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zang HH, 2018, ENDOCR J, V65, P685, DOI 10.1507/endocrj.EJ18-0060; Zhang CY, 2020, J ENDOCRINOL, V246, P109, DOI 10.1530/JOE-20-0077; Zhou B, 2014, HEPATOLOGY, V59, P2196, DOI 10.1002/hep.26992	87	10	10	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13753	13768		10.1074/jbc.RA120.014381	http://dx.doi.org/10.1074/jbc.RA120.014381			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32727846	hybrid, Green Published			2022-12-26	WOS:000578444100005
J	Cui, J; Qu, ZP; Harata-Lee, Y; Shen, HY; Aung, TN; Wang, W; Kortschak, D; Adelson, DL				Cui, Jian; Qu, Zhipeng; Harata-Lee, Yuka; Shen, Hanyuan; Aung, Thazin Nwe; Wang, Wei; Kortschak, Daniel; Adelson, David L.			The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; ANTITUMOR ACTIVITIES; GENE-EXPRESSION; MOUSE MODEL; PATHWAY; MATRINE; PROLIFERATION; APOPTOSIS; PACKAGE; GROWTH	Traditional Chinese Medicine (TCM) preparations are often extracts of single or multiple herbs containing hundreds of compounds, and hence it has been difficult to study their mechanisms of action. Compound Kushen Injection (CKI) is a complex mixture of compounds extracted from two medicinal plants and has been used in Chinese hospitals to treat cancer for over twenty years. To demonstrate that a systematic analysis of molecular changes resulting from complex mixtures of bioactives from TCM can identify a core set of differentially expressed (DE) genes and a reproducible set of candidate pathways. We usedin vitrocancer models to measure the effect of CKI on cell cycle phases and apoptosis, and correlated those phenotypes with CKI induced changes in gene expression. We treated two cancer cell lines with or without CKI and assessed the resulting phenotypes by employing cell viability and proliferation assays. Based on these results, we carried out high-throughput transcriptome data analysis to identify genes and candidate pathways perturbed by CKI. We integrated these differential gene expression results with previously reported results and carried out validation of selected differentially expressed genes. CKI induced cell-cycle arrest and apoptosis in the cancer cell lines tested. In these cells CKI also altered the expression of 363 core candidate genes associated with cell cycle, apoptosis, DNA replication/repair, and various cancer pathways. Of these, 7 are clinically relevant to cancer diagnosis or therapy, 14 are cell cycle regulators, and most of these 21 candidates are downregulated by CKI. Comparison of our core candidate genes to a database of plant medicinal compounds and their effects on gene expression identified one-to-one, one-to-many and many-to-many regulatory relationships between compounds in CKI and DE genes. By identifying genes and promising candidate pathways associated with CKI treatment based on our transcriptome-based analysis, we have shown that this approach is useful for the systematic analysis of molecular changes resulting from complex mixtures of bioactives.	[Cui, Jian; Qu, Zhipeng; Harata-Lee, Yuka; Shen, Hanyuan; Aung, Thazin Nwe; Kortschak, Daniel; Adelson, David L.] Univ Adelaide, Dept Mol & Biomed Sci, Adelaide, SA, Australia; [Wang, Wei] Shanxi Zhendong Pharmaceut Co Ltd, Zhendong Res Inst, Beijing, Peoples R China	University of Adelaide	Adelson, DL (corresponding author), Univ Adelaide, Dept Mol & Biomed Sci, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	; Adelson, David/E-5506-2011	Harata-Lee, Yuka/0000-0002-5850-2471; Kortschak, Robert Daniel/0000-0001-8295-2301; Qu, Zhipeng/0000-0002-6841-0773; Cui, Jian/0000-0002-4267-9379; Adelson, David/0000-0003-2404-5636	Chinese National Project for Standardization of Chinese Materia Medica [ZYBZH-C-JIN-43]; Special International Cooperation Project of Traditional Chinese Medicine [GZYYGJ2017035]; University of Adelaide-Zhendong Australia - China Centre for Molecular Chinese Medicine	Chinese National Project for Standardization of Chinese Materia Medica; Special International Cooperation Project of Traditional Chinese Medicine; University of Adelaide-Zhendong Australia - China Centre for Molecular Chinese Medicine	WW: Chinese National Project for Standardization of Chinese Materia Medica (ZYBZH-C-JIN-43), the Special International Cooperation Project of Traditional Chinese Medicine (GZYYGJ2017035) DLA: University of Adelaide-Zhendong Australia - China Centre for Molecular Chinese Medicine. Funders had no control the experiments, study design, data collection and analysis, preparation of the manuscript or decision to publish.	Afar DEH, 2001, CANCER RES, V61, P1686; Anwar-Mohamed A, 2009, CANCER LETT, V275, P93, DOI 10.1016/j.canlet.2008.10.003; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Christensen AG, 2017, ELUCIDATION ALTERED; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cui J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-018-5230-8; Cui M, 2014, J TRADIT CHIN MED, V34, P518, DOI 10.1016/S0254-6272(15)30056-X; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Gao L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18325-7; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hao DC, 2014, DRUG DEVELOP RES, V75, P299, DOI 10.1002/ddr.21214; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hollern DP, 2014, MOL CELL BIOL, V34, P3229, DOI 10.1128/MCB.00737-14; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knowles B.B., 1983, U.S. Patent., Patent No. [4393133A, 4393133, US4393133A]; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Liao CY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/840542; Liu Y, 2014, TUMOR BIOL, V35, P5111, DOI 10.1007/s13277-014-1680-z; Liu Z. Y, 2016, SCI REPORTS, V6; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Ma X, 2016, FRONT PHARMACOL, V7, DOI [10.3389/fphar.2015.00070, 10.3389/fphar.2016.00070]; Mitsui Y, 2016, ONCOTARGET, V7, P49107, DOI 10.18632/oncotarget.9470; Nandekar PP, 2016, EUR J MED CHEM, V115, P82, DOI 10.1016/j.ejmech.2016.02.061; Ninomiya M., 2013, MINOR FLAVONOIDS CHA, P1867, DOI [DOI 10.1007/978-3-642-22144-6_62, 10.1007/978-3-642-22144-6_62]; Ou C, 2016, RELATIONSHIP ALDOSTE; Piotrowska-Kempisty H, 2017, TOXICOL LETT, V267, P59, DOI 10.1016/j.toxlet.2016.12.018; Qu ZP, 2016, ONCOTARGET, V7, P66003, DOI 10.18632/oncotarget.11788; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shu GW, 2014, TOXICOL APPL PHARM, V281, P157, DOI 10.1016/j.taap.2014.06.021; Song YN, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/989618; Sun HX, 2013, HEPATOLOGY, V57, P1088, DOI 10.1002/hep.26188; Wang P, 2013, OMICS, V17, P451, DOI 10.1089/omi.2012.0057; Wang W, 2015, ACTA PHARMACOL SIN, V36, P676, DOI 10.1038/aps.2015.24; WARREN RS, 1995, J CLIN INVEST, V95, P1789, DOI 10.1172/JCI117857; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Wu CZ, 2015, MOL MED REP, V11, P4129, DOI 10.3892/mmr.2015.3338; Yang XZ, 2017, NAT PROD RES, V31, P1150, DOI 10.1080/14786419.2016.1230118; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu PF, 2009, CYTOTECHNOLOGY, V59, P219, DOI 10.1007/s10616-009-9225-9; Zaldua N, 2016, FEBS J, V283, P647, DOI 10.1111/febs.13617; Zhang H, 2016, ONCOGENE; Zhang JQ, 2010, WORLD J GASTROENTERO, V16, P4281, DOI 10.3748/wjg.v16.i34.4281; Zhang LP, 2001, LEUKEMIA RES, V25, P793, DOI 10.1016/S0145-2126(00)00145-4; Zhang XL, 2016, IRAN J PHARM RES, V15, P491; Zhang XL, 2013, PHARMAZIE, V68, P369, DOI 10.1691/ph.2013.2845; Zhao ZZ, 2014, CANCER LETT, V355, P232, DOI 10.1016/j.canlet.2014.08.037; Zhou Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030156	53	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236395	10.1371/journal.pone.0236395	http://dx.doi.org/10.1371/journal.pone.0236395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730293	Green Published, gold			2022-12-26	WOS:000556884700044
J	Gazengel, K; Lebreton, L; Lapalu, N; Amselem, J; Guillerm-Erckelboudt, AY; Tagu, D; Daval, S				Gazengel, Kevin; Lebreton, Lionel; Lapalu, Nicolas; Amselem, Joelle; Guillerm-Erckelboudt, Anne-Yvonne; Tagu, Denis; Daval, Stephanie			pH effect on strain-specific transcriptomes of the take-all fungus	PLOS ONE			English	Article							GRAMINIS VAR. TRITICI; PHYTOPATHOGENIC FUNGUS; GENE-EXPRESSION; FULL VIRULENCE; FACTOR PACC; PATHOGENESIS; WHEAT; MITOCHONDRIA; PROTEINS; LACCASE	The soilborne fungusGaeumannomyces tritici(G.tritici) causes the take-all disease on wheat roots. Ambient pH has been shown to be critical in different steps ofG.triticilife cycle such as survival in bulk soil, saprophytic growth, and pathogenicity on plants. There are however intra-specific variations and we previously found two types ofG.triticistrains that grow preferentially either at acidic pH or at neutral/alkaline pH; gene expression involved in pH-signal transduction pathway and pathogenesis was differentially regulated in two strains representative of these types. To go deeper in the description of the genetic pathways and the understanding of this adaptative mechanism, transcriptome sequencing was achieved on two strains (PG6 and PG38) which displayed opposite growth profiles in two pH conditions (acidic and neutral). PG6, growing better at acidic pH, overexpressed in this condition genes related to cell proliferation. In contrast, PG38, which grew better at neutral pH, overexpressed in this condition genes involved in fatty acids and amino acid metabolisms, and genes potentially related to pathogenesis. This strain also expressed stress resistance mechanisms at both pH, to assert a convenient growth under various ambient pH conditions. These differences in metabolic pathway expression between strains at different pH might buffer the effect of field or soil variation in wheat fields, and explain the success of the pathogen.	[Gazengel, Kevin; Lebreton, Lionel; Guillerm-Erckelboudt, Anne-Yvonne; Tagu, Denis; Daval, Stephanie] Univ Rennes, Inst Agro, IGEPP, INRAE, Le Rheu, France; [Lapalu, Nicolas] Univ Paris Saclay, BIOGER, INRAE, AgroParisTech, Thiverval Grignon, France; [Amselem, Joelle] Univ Paris Saclay, URGI, INRAE, Versailles, France	INRAE; Institut Agro; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gazengel, K (corresponding author), Univ Rennes, Inst Agro, IGEPP, INRAE, Le Rheu, France.	kevin.gazengel@inrae.fr		lebreton, Lionel/0000-0003-1759-5269; GAZENGEL, Kevin/0000-0001-9054-2281				Abu Sadat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100726; Alexa A., 2007, ENCYCL SYST BIOL, V9, P589; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Borghouts C, 1998, MOL GEN GENET, V260, P492, DOI 10.1007/s004380050922; Reis VCB, 2005, GENET MOL RES, V4, P232; CADDICK MX, 1986, MOL GEN GENET, V203, P346, DOI 10.1007/BF00333978; Caracuel Z, 2003, MOL MICROBIOL, V48, P765, DOI 10.1046/j.1365-2958.2003.03465.x; Chadha S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006575; Chen Y, 2018, ENVIRON MICROBIOL, V20, P4063, DOI 10.1111/1462-2920.14453; Cook RJ, 2003, TAKE ALL WHEAT SCIEN; Cui X, 2015, MOL PLANT PATHOL, V16, P847, DOI 10.1111/mpp.12242; Daval S, 2010, PLANT PATHOL, V59, P165, DOI 10.1111/j.1365-3059.2009.02158.x; Daval S, 2013, FUNGAL GENET BIOL, V61, P80, DOI 10.1016/j.fgb.2013.09.009; Daval S, 2011, MOL PLANT PATHOL, V12, P839, DOI [10.1111/J.1364-3703.2011.00715.X, 10.1111/j.1364-3703.2011.00715.x]; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dohmoto M, 2010, BIOSCI BIOTECH BIOCH, V74, P188, DOI 10.1271/bbb.90575; FAHRAEUS G, 1967, ACTA CHEM SCAND, V21, P2367, DOI 10.3891/acta.chem.scand.21-2367; Gutteridge RJ, 2003, PEST MANAG SCI, V59, P215, DOI 10.1002/ps.574; Han YC, 2011, WORLD J MICROB BIOT, V27, P381, DOI 10.1007/s11274-010-0469-5; Henke C, 2016, J BASIC MICROB, V56, P162, DOI 10.1002/jobm.201500381; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; Kang XX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01474; Kwak YS, 2009, PHYTOPATHOLOGY, V99, P472, DOI 10.1094/PHYTO-99-5-0472; Lebreton L, 2004, ENVIRON MICROBIOL, V6, P1174, DOI 10.1111/j.1462-2920.2004.00637.x; Lebreton L, 2014, PLANT PATHOL, V63, P117, DOI 10.1111/ppa.12062; Lebreton L, 2007, ENVIRON MICROBIOL, V9, P492, DOI 10.1111/j.1462-2920.2006.01166.x; Li L, 2017, MOL PLANT PATHOL, V18, P1238, DOI 10.1111/mpp.12487; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Litvintseva AP, 2002, APPL ENVIRON MICROB, V68, P1305, DOI 10.1128/AEM.68.3.1305-1311.2002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Musacchio A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010005; Norvienyeku J, 2017, ENVIRON MICROBIOL, V19, P4256, DOI 10.1111/1462-2920.13888; Okagaki LH, 2015, G3-GENES GENOM GENET, V5, P2539, DOI 10.1534/g3.115.020057; OWNLEY BH, 1992, PHYTOPATHOLOGY, V82, P178, DOI 10.1094/Phyto-82-178; Parisot D, 2002, MOL GENET GENOMICS, V268, P139, DOI 10.1007/s00438-002-0744-8; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penas MM, 2007, EUKARYOT CELL, V6, P960, DOI 10.1128/EC.00047-07; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pham JS, 2014, INT J PARASITOL-DRUG, V4, P1, DOI 10.1016/j.ijpddr.2013.10.001; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rau A, 2015, BIOINFORMATICS, V31, P1420, DOI 10.1093/bioinformatics/btu845; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Roth R, 2017, CURR OPIN PLANT BIOL, V39, P50, DOI 10.1016/j.pbi.2017.05.008; Rzad K, 2018, FUNGAL GENET BIOL, V110, P26, DOI 10.1016/j.fgb.2017.11.009; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; SMILEY RW, 1973, PHYTOPATHOLOGY, V63, P882, DOI 10.1094/Phyto-63-882; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Yang LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120691; You BJ, 2007, MOL PLANT MICROBE IN, V20, P1149, DOI 10.1094/MPMI-20-9-1149; Zhang TY, 2013, APPL MICROBIOL BIOT, V97, P9087, DOI 10.1007/s00253-013-5129-x	53	1	1	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236429	10.1371/journal.pone.0236429	http://dx.doi.org/10.1371/journal.pone.0236429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730288	Green Published, gold, Green Submitted			2022-12-26	WOS:000556884700068
J	Pelster, B; Wood, CM; Campos, DF; Val, AL				Pelster, Bernd; Wood, Chris M.; Campos, Derek F.; Val, Adalberto L.			Cellular oxygen consumption, ROS production and ROS defense in two different size-classes of an Amazonian obligate air-breathing fish (Arapaima gigas)	PLOS ONE			English	Article							OXIDATIVE STRESS; HETEROPNEUSTES-FOSSILIS; METABOLIC DEPRESSION; GAS-EXCHANGE; HYPOXIA; ANTIOXIDANT; TRANSITION; GILLS; PHYSIOLOGY; HYPEROXIA	In air-breathing fish a reduction of gill surface area reduces the danger of losing oxygen taken up in the air-breathing organ (ABO) to hypoxic water, but it also reduces the surface area available for ion exchange, so that ion regulation may at least in part be transferred to other organs, like the kidney or the gut. In the air-breathing Arapaima gigas, gill lamellae regress as development proceeds, and starting as a water-breathing embryo Arapaima turns into an obligate air-breathing fish with proceeding development, suggesting that ion regulation is shifted away from the gills as the fish grows. In Arapaima the kidney projects medially into the ABO and thus, probably a unique situation among fishes, is in close contact to the gas of the ABO. We therefore hypothesized that the kidney would be predestined to adopt an increased importance for ion homeostasis, because the elevated ATP turnover connected to ion transport can easily be met by aerobic metabolism based on the excellent oxygen supply directly from the ABO. We also hypothesized that in gill tissue the reduced ion regulatory activity should result in a reduced metabolic activity. High metabolic activity and exposure to high oxygen tensions are connected to the production of reactive oxygen species (ROS), therefore the tissues exposed to these conditions should have a high ROS defense capacity. Using in vitro studies, we assessed metabolic activity and ROS production of gill, kidney and ABO tissue, and determined the activity of ROS degrading enzymes in small (similar to 5g, 2-3 weeks old) and larger (similar to 670 g, 3-4 months old) A. gigas. Comparing the three tissues revealed that kidney tissue oxygen uptake by far exceeded the uptake measured in gill tissue or ABO. ROS production was particularly high in gill tissue, and all three tissues had a high capacity to degrade ROS. Gill tissue was characterized by high activities of enzymes involved in the glutathione pathway to degrade ROS. By contrast, the tissues of the ABO and in particular the kidney were characterized by high catalase activities, revealing different, tissue-specific strategies in ROS defense in this species. Overall the differences in the activity of cells taken from small and larger fish were not as pronounced as expected, while at the tissue level the metabolic activity of kidney cells by far exceeded the activity of ABO and gill cells.	[Pelster, Bernd] Univ Innsbruck, Inst Zool, Innsbruck, Austria; [Pelster, Bernd] Univ Innsbruck, Ctr Mol Biosci, Innsbruck, Austria; [Wood, Chris M.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Wood, Chris M.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Campos, Derek F.; Val, Adalberto L.] Brazilian Natl Inst Res Amazon, Lab Ecophysiol & Mol Evolut, Manaus, Amazonas, Brazil	University of Innsbruck; University of Innsbruck; University of British Columbia; McMaster University; Institute Nacional de Pesquisas da Amazonia	Pelster, B (corresponding author), Univ Innsbruck, Inst Zool, Innsbruck, Austria.; Pelster, B (corresponding author), Univ Innsbruck, Ctr Mol Biosci, Innsbruck, Austria.	bernd.pelster@uibk.ac.at	Campos, Derek Felipe/AFS-3257-2022	Campos, Derek Felipe/0000-0002-6227-6569; Pelster, Bernd/0000-0002-9170-5086	INCT ADAPTA-CNPq [465540/2014-7]; FAPEAM [062.1187/2017]; CAPES [001]; Brazilian Science Foundation II; Science without Borders (Brazil) III; Brazilian CNPq	INCT ADAPTA-CNPq; FAPEAM; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Science Foundation II; Science without Borders (Brazil) III; Brazilian CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support by INCT ADAPTA-CNPq (465540/2014-7)/FAPEAM (062.1187/2017)/CAPES (finance code 001), Brazilian Science Foundation II. Science without Borders (Brazil) III. ALV is the recipient of a research fellowship from Brazilian CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author received a salary from a funder.	Ali SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036801; Baffy G, 2017, BBA-BIOENERGETICS, V1858, P655, DOI 10.1016/j.bbabio.2017.01.005; Bagnyukova TV, 2006, AQUAT TOXICOL, V78, P325, DOI 10.1016/j.aquatox.2006.04.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauner CJ, 2004, J EXP BIOL, V207, P1433, DOI 10.1242/jeb.00887; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Dawson NJ, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.216762; Doerrier C, 2018, METHODS MOL BIOL, V1782, P31, DOI 10.1007/978-1-4939-7831-1_3; Du SNN, 2016, J EXP BIOL, V219, P1130, DOI 10.1242/jeb.132860; Dymowska AK, 2012, RESP PHYSIOL NEUROBI, V184, P282, DOI 10.1016/j.resp.2012.08.025; Fago A, 2015, PHYSIOLOGY, V30, P116, DOI 10.1152/physiol.00051.2014; FARRELL AP, 1978, CAN J ZOOL, V56, P939, DOI 10.1139/z78-129; Fernandes MN, 2012, MICRON, V43, P961, DOI 10.1016/j.micron.2012.03.018; GILMOUR KM, 1994, J EXP BIOL, V192, P269; Gnaiger E, 2000, LIFE IN THE COLD, P431; Gonzalez RJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P322, DOI 10.1086/648568; Guppy M, 2004, COMP BIOCHEM PHYS B, V139, P435, DOI 10.1016/j.cbpc.2004.02.019; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hermes-Lima M., 2004, FUNCTIONAL METABOLIS, P319, DOI DOI 10.1002/047167558X.CH12; HOCHACHKA PW, 1978, CAN J ZOOL, V56, P820, DOI 10.1139/z78-114; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; Johannsson OE, 2018, COMP BIOCHEM PHYS A, V224, P53, DOI 10.1016/j.cbpa.2018.05.019; Kristensen T, 2010, FISH PHYSIOL BIOCHEM, V36, P1087, DOI 10.1007/s10695-010-9386-7; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Kumai Y, 2012, RESP PHYSIOL NEUROBI, V184, P249, DOI 10.1016/j.resp.2012.06.009; Lushchak VI, 2005, INT J BIOCHEM CELL B, V37, P1670, DOI 10.1016/j.biocel.2005.02.024; Lushchak VI, 2005, INT J BIOCHEM CELL B, V37, P1319, DOI 10.1016/j.biocel.2005.01.006; Lushchak VI, 2014, CHEM-BIOL INTERACT, V224, P164, DOI 10.1016/j.cbi.2014.10.016; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Paital B, 2014, J COMP PHYSIOL B, V184, P65, DOI 10.1007/s00360-013-0778-8; Paital B, 2013, ECOTOX ENVIRON SAFE, V95, P69, DOI 10.1016/j.ecoenv.2013.05.016; Pelster B, 2020, J COMP PHYSIOL B, V190, P569, DOI 10.1007/s00360-020-01286-1; Pelster B, 2018, ACTA HISTOCHEM, V120, P667, DOI 10.1016/j.acthis.2018.08.012; Pelster B, 2018, J COMP PHYSIOL B, V188, P437, DOI 10.1007/s00360-017-1142-1; Pelster B, 2016, J COMP PHYSIOL B, V186, P615, DOI 10.1007/s00360-016-0981-5; Ramos CA, 2013, ANAT REC, V296, P1664, DOI 10.1002/ar.22758; RANDALL DJ, 1981, RESP PHYSIOL, V43, P339, DOI 10.1016/0034-5687(81)90114-6; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Schneebauer G, 2016, J COMP PHYSIOL B, V186, P867, DOI 10.1007/s00360-016-0994-0; Scott GR, 2017, J COMP PHYSIOL B, V187, P117, DOI 10.1007/s00360-016-1024-y; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; SMATRESK NJ, 1982, J EXP BIOL, V96, P263; SMATRESK NJ, 1986, PHYSIOL ZOOL, V59, P385, DOI 10.1086/physzool.59.4.30158592; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Sudha Summarwar, 2012, International Journal of Life Sciences Biotechnology and Pharma Research, V1, P198; Sussarellu R, 2013, J EXP BIOL, V216, P1561, DOI 10.1242/jeb.075879; van Ginneken V, 2009, THERMOCHIM ACTA, V483, P1, DOI 10.1016/j.tca.2008.09.027; Welker AF, 2013, COMP BIOCHEM PHYS A, V165, P384, DOI 10.1016/j.cbpa.2013.04.003; Wood CM, 2016, J COMP PHYSIOL B, V186, P431, DOI 10.1007/s00360-016-0965-5; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	54	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236507	10.1371/journal.pone.0236507	http://dx.doi.org/10.1371/journal.pone.0236507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730281	Green Published, gold			2022-12-26	WOS:000556884700022
J	Seth, EA; Lee, HC; Yusof, HHB; Nordin, N; Cheah, YK; Ho, ETW; Ling, KH; Cheah, PS				Seth, Eryse Amira; Lee, Han-Chung; Yusof, Hadri Hadi bin Md; Nordin, Norshariza; Cheah, Yoke Kqueen; Ho, Eric Tatt Wei; Ling, King-Hwa; Cheah, Pike-See			Phenotype microarrays reveal metabolic dysregulations of neurospheres derived from embryonic Ts1Cje mouse model of Down syndrome	PLOS ONE			English	Article							FEMALE TS65DN MICE; AMINO-ACIDS; L-SERINE; BRAIN; PROLIFERATION; KYNURENINE; CELLS; DISEASE; GLUCOSE	Down syndrome (DS), is the most common cause of intellectual disability, and is characterized by defective neurogenesis during perinatal development. To identify metabolic aberrations in early neurogenesis, we profiled neurospheres derived from the embryonic brain of Ts1Cje, a mouse model of Down syndrome. High-throughput phenotypic microarray revealed a significant decrease in utilisation of 17 out of 367 substrates and significantly higher utilisation of 6 substrates in the Ts1Cje neurospheres compared to controls. Specifically, Ts1Cje neurospheres were less efficient in the utilisation of glucose-6-phosphate suggesting a dysregulation in the energy-producing pathway. T Cje neurospheres were significantly smaller in diameter than the controls. Subsequent preliminary study on supplementation with 6-phosphogluconic acid, an intermediate of glucose-6-phosphate metabolism, was able to rescue the Ts1Cje neurosphere size. This study confirmed the perturbed pentose phosphate pathway, contributing to defects observed in Ts1Cje neurospheres. We show for the first time that this comprehensive energetic assay platform facilitates the metabolic characterisation of Ts1Cje cells and confirmed their distinguishable metabolic profiles compared to the controls.	[Seth, Eryse Amira; Lee, Han-Chung; Yusof, Hadri Hadi bin Md; Nordin, Norshariza; Ling, King-Hwa; Cheah, Pike-See] Univ Putra Malaysia, Fac Med & Hlth Sci, Genet & Regenerat Med Res Ctr GRMRC, Serdang, Selangor, Malaysia; [Seth, Eryse Amira; Cheah, Pike-See] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia; [Lee, Han-Chung; Yusof, Hadri Hadi bin Md; Nordin, Norshariza; Cheah, Yoke Kqueen; Ling, King-Hwa] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang, Selangor, Malaysia; [Ho, Eric Tatt Wei] Univ Teknol Petronas, Ctr Intelligent Signal & Imaging Res, Bandar Seri Iskandar, Perak, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Teknologi Petronas	Cheah, PS (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Genet & Regenerat Med Res Ctr GRMRC, Serdang, Selangor, Malaysia.; Cheah, PS (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia.	cheahpikesee@upm.edu.my	Ling, King-Hwa/M-2349-2018; Ho, Eric Tatt Wei/AAE-6834-2019; Md Yusof, Hadri Hadri/GVS-5481-2022; Cheah, Pike-See/F-4978-2014; Lee, Han Chung/AAD-3686-2019	Ling, King-Hwa/0000-0002-3968-7263; Ho, Eric Tatt Wei/0000-0002-7590-1028; Md Yusof, Hadri Hadri/0000-0002-6702-1952; Cheah, Pike See/0000-0003-2181-2502; Lee, Han Chung/0000-0003-2122-310X	MOHE Fundamental Research Grant Scheme [04-01-15-1663FR]; MOSTI ScienceFund [02-01-04-SF2336]	MOHE Fundamental Research Grant Scheme; MOSTI ScienceFund(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported in part by funding from the MOHE Fundamental Research Grant Scheme (04-01-15-1663FR) awarded to PSC; MOSTI ScienceFund (02-01-04-SF2336) awarded to K-HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197711; Bhattacharyya A, 2009, DEV NEUROSCI-BASEL, V31, P497, DOI 10.1159/000236899; BLOCK A, 2015, BIOL SEX DIFFER, V6, P57220, DOI DOI 10.1186/S13293-014-0019-1; Boccuto L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-16; Bochner BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018147; Brunet JF, 2010, J CEREBR BLOOD F MET, V30, P51, DOI 10.1038/jcbfm.2009.207; Bryn V, 2018, NEUROPSYCHOBIOLOGY, V76, P82, DOI 10.1159/000488157; Busciglio J, 2013, CYTOGENET GENOME RES, V141, P260, DOI 10.1159/000354306; Candelario KM, 2013, J NEUROCHEM, V125, P420, DOI 10.1111/jnc.12204; Cenini G, 2012, BBA-MOL BASIS DIS, V1822, P130, DOI 10.1016/j.bbadis.2011.10.001; Coppus AW, 2007, J NEURAL TRANSM, V114, P1041, DOI 10.1007/s00702-007-0656-1; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Guedj F, 2015, AM J MED GENET A, V167, P1993, DOI 10.1002/ajmg.a.37156; Gulaj E, 2010, ADV MED SCI-POLAND, V55, P204, DOI 10.2478/v10039-010-0023-6; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hewitt CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011561; Horie N, 2004, FEBS LETT, V571, P237, DOI 10.1016/j.febslet.2004.06.085; HSIA DYY, 1971, AM J DIS CHILD, V121, P153, DOI 10.1001/archpedi.1971.02100130107014; Ishihara K, 2019, FREE RADICAL BIO MED, V134, P248, DOI 10.1016/j.freeradbiomed.2019.01.015; Ishihara K, 2009, J NEUROCHEM, V110, P1965, DOI 10.1111/j.1471-4159.2009.06294.x; Jones SP, 2013, INT J TRYPTOPHAN RES, V6, P57, DOI 10.4137/IJTR.S12626; Kaur G, 2014, J NEUROSCI, V34, P5099, DOI 10.1523/JNEUROSCI.5338-13.2014; Kim DY, 2014, CELL MOL LIFE SCI, V71, P4221, DOI 10.1007/s00018-014-1686-0; Kurbat MN, 2009, NEUROCHEM J+, V3, P23, DOI 10.1134/S1819712409010036; Labudova O, 1999, CLIN SCI, V96, P279, DOI 10.1042/CS19980169; Laffaire J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-138; Lee HC, 2019, INT J NEUROSCI, V129, P871, DOI 10.1080/00207454.2019.1580280; Lee HC, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7434191; Lim CL, 2019, JPN J VET RES, V67, P111, DOI 10.14943/jjvr.67.1.111; Ling KH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-624; Luk KC, 2003, J NEUROSCI, V23, P2239; Manoli I, 2016, Transl Sci Rare Dis, V1, P91, DOI 10.3233/TRD-160009; Martinez-Cue C, 2006, GENES BRAIN BEHAV, V5, P413, DOI 10.1111/j.1601-183X.2005.00175.x; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Noctor Stephen C, 2007, Novartis Found Symp, V288, P59; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Oxenkrug GF, 2010, ISR J PSYCHIATR REL, V47, P56; Perluigi M, 2011, PROTEOM CLIN APPL, V5, P167, DOI 10.1002/prca.201000121; Powers RK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12739-9; Rachidi M, 2010, AJIDD-AM J INTELLECT, V115, P83, DOI 10.1352/1944-7558-115.2.83; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richard DM, 2009, INT J TRYPTOPHAN RES, V2, P45; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Scolari MJ, 2007, AMINO ACIDS, V33, P563, DOI 10.1007/s00726-006-0481-0; Shea April, 2012, Methods Mol Biol, V881, P331, DOI 10.1007/978-1-61779-827-6_12; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; Simo M, 2004, INT MED J SYNDR, V8, P23; Smigielska-Kuzia J, 2007, Adv Med Sci, V52 Suppl 1, P183; Sperringer JE, 2017, NEUROCHEM RES, V42, P1697, DOI 10.1007/s11064-017-2261-5; Stagni F, 2018, FREE RADICAL BIO MED, V114, P15, DOI 10.1016/j.freeradbiomed.2017.07.026; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Strisovsky K, 2003, FEBS LETT, V535, P44, DOI 10.1016/S0014-5793(02)03855-3; Sun L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093405; Suzuki M, 2006, EUR J NEUROSCI, V24, P645, DOI 10.1111/j.1460-9568.2006.04957.x; Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396; Vehkala M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118392; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S	59	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236826	10.1371/journal.pone.0236826	http://dx.doi.org/10.1371/journal.pone.0236826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730314	Green Published, gold			2022-12-26	WOS:000556884700065
J	Tesfaye, TS; Zeleke, TM; Alemu, W; Argaw, D; Bedane, TK				Tesfaye, Tinsae Shemelise; Zeleke, Tadesse Mekonen; Alemu, Wagaye; Argaw, Dirshaye; Bedane, Tadesse Kebebe			Dietary diversity and physical activity as risk factors of abdominal obesity among adults in Dilla town, Ethiopia	PLOS ONE			English	Article							ADIPOSITY; URBAN; ASSOCIATION; PREVALENCE; DISEASE	Background Globally, the prevalence of obesity is on the rise and has nearly tripled since 1975. In Ethiopia, despite not having well-documented evidence, abdominal obesity has been increasing dramatically, particularly in urban settings. Therefore, this study is intended to determine the prevalence and risk factors of abdominal obesity among adults in Dilla town, Ethiopia. Methods A community-based cross-sectional study was conducted between January and February 2018 in Dilla Town. A multi-stage sampling technique was employed to recruit 663 adults. The study was conducted in accordance with the World Health Organization (WHO) STEP wise approach. Waist circumference was measured using a flexible metric tape mid-way between the lowest rib and iliac crest with the participant standing at the end of gentle expiration. Abdominal obesity was determined using the International Diabetes Federation cutoff. A logistic regression model was fitted to identify risk factors of abdominal obesity. Adjusted odds ratio (AOR) with corresponding 95% confidence interval (CI) was calculated to show the strength of association. Results A total of 634 adults participated in the study with a response rate of 95.6%. This study revealed that 155 (24.4%) [95% CI: (21.50, 27.80)] adults were abdominally obese. Higher odds of being abdominally obese were noted among adults with a high [AOR = 4.61, 95% CI: (2.51-8.45)] and middle [AOR = 3.22, 95% CI: (1.76-5.88)] wealth rank, consuming less diversified diet [AOR = 2.05, 95% CI: (1.31-3.19)], physical inactivity [AOR = 2.68, 95% CI: (1.70-4.22)] and being female [AOR = 1.92, 95% CI: (1.13-3.28)]. Conclusions The prevalence of abdominal obesity among adults in Dilla town is considerably high, and became an emerging nutrition related problem. Being in the middle and high wealth rank, physical inactivity, consuming less diversified diet, and being female were the risk factors of abdominal obesity.	[Tesfaye, Tinsae Shemelise; Alemu, Wagaye; Argaw, Dirshaye] Dilla Univ, Coll Med & Hlth Sci, Publ Hlth Dept, Dilla, Ethiopia; [Zeleke, Tadesse Mekonen; Bedane, Tadesse Kebebe] Ethiopian Publ Hlth Inst, Food Sci & Nutr Directorate, Addis Ababa, Ethiopia	Dilla University	Zeleke, TM (corresponding author), Ethiopian Publ Hlth Inst, Food Sci & Nutr Directorate, Addis Ababa, Ethiopia.	anguach257@gmail.com	KEBEBE BEDANE, TADESSE/AGK-2861-2022	Zeleke, Tadesse Mekonen/0000-0002-5232-4731	Dilla University	Dilla University	TST and WA received funding from Dilla University, which is provided only for staff. There is no grant number or URL website for this funding. TST, WA and DA received a salary from the funding institution, yet it is not for the purpose of conducting this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amole IO, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.188; Anuradha R, 2012, J CLIN DIAGN RES, V6, P1510, DOI 10.7860/JCDR/2012/4379.2545; Aranceta-Bartrina J, 2016, REV ESP CARDIOL, V69, P579, DOI [10.1016/j.rec.2016.02.009, 10.1016/j.recesp.2016.02.010]; Azadbakht L, 2011, PUBLIC HEALTH NUTR, V14, P62, DOI 10.1017/S1368980010000522; Baszczyk-b E, 2019, INT J ENV RES PUB HE, V16, P1; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Betre M, 1997, E AFR MED J, V74, P376; Ethiopian Public Health Association, 2012, EM PUBL HLTH PROBL E; Fezeu L, 2006, INT J EPIDEMIOL, V35, P105, DOI 10.1093/ije/dyi214; Gbary Akpa R, 2014, GLOBAL EPIDEMIC OBES, V2, P1, DOI [10.7243/2052-5966-2-3, DOI 10.7243/2052-5966-2-3]; Gholizadeh F, 2018, PRIM CARE DIABETES, V12, P338, DOI 10.1016/j.pcd.2018.03.003; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Jayawardena R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-314; Kabwama Steven Ndugwa, 2018, BMC Obes, V5, P40, DOI 10.1186/s40608-018-0217-1; Lopez ALO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156320; Malik SK, 2019, AIMS PUBLIC HEALTH, V6, P334, DOI 10.3934/publichealth.2019.3.334; Mogre V, 2012, J MED BIOMED SCI, V1, P1; Mohamed SF, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2019.1685809; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Owolabi EO, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0133-x; Pradeepa R, 2015, INDIAN J MED RES, V142, P139, DOI 10.4103/0971-5916.164234; Radhika G, 2008, BRIT J NUTR, V99, P398, DOI 10.1017/S0007114507803965; Raimi TH., 2015, J DIAB ENDOCRINOL, V6, P12; Salehi-Abargouei A, 2016, EUR J CLIN NUTR, V70, P1, DOI 10.1038/ejcn.2015.118; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; SEDGWICK P, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H4155; Siddiquee T, 2015, BMC PUBLIC HEALTH, V15, P1; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; Tran A, 2011, INT J HYPERTENS, P1; Vadiveloo M, 2015, J NUTR, V145, P555, DOI 10.3945/jn.114.199067; Wai WS, 2012, OBESITY, V20, P1887, DOI 10.1038/oby.2011.103; Wang H, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-967, 10.1186/1471-2407-12-528]; WHO, WHO STEP WIS APPR CH; World Health Organisation, 2020, OV OB; World Health Organization, 2008, WAIST CIRCUMFERENCE	35	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236671	10.1371/journal.pone.0236671	http://dx.doi.org/10.1371/journal.pone.0236671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730320	gold, Green Published			2022-12-26	WOS:000556884700041
J	Jankowicz-Szymanska, A; Falatowicz, M; Smola, E; Blyszczuk, R; Wodka, K				Jankowicz-Szymanska, Agnieszka; Falatowicz, Michal; Smola, Eliza; Blyszczuk, Renata; Wodka, Katarzyna			Relationship between frontal knee position and the degree of thoracic kyphosis and lumbar lordosis among 10-12-year-old children with normal body weight	PLOS ONE			English	Article							PLANE; MALALIGNMENT; ALIGNMENT; PROFILE; POSTURE; SPINE; ANGLE	Introduction Incorrect positioning of the body in space increases the tension of the myofascial tissue and overloads the skeleton. It is important to look for factors that affect the deterioration of body posture that could be eliminated. Understanding the interrelationship between the positioning of individual body segments should be the key knowledge for those involved in the prevention and correction of faulty body posture. The study aimed to determine the relationship between the degree of physiological curvatures of the spine and the incidence of incorrect knee position. Materials and methods The study involved 685 children aged 10-12. Body height, weight and BMI were measured and calculated. The degree of thoracic kyphosis and lumbar lordosis was assessed using the Zebris Pointer ultrasound system. Valgus and varus knees were diagnosed in an upright position based on the intermalleolar distance with knees together, and intercondylar distance with the feet placed together. The statistical analysis uses descriptive statistics, the Mann-Whitney U test (comparison of girls and boys), the Kruskal-Wallis test, the Tukey's post hoc test (comparison of variables in participants with correct, varus and valgus knees) and Spearman's rank correlation coefficient (the relationship between the position of the spine and knees). Results The examined girls were heavier than the boys and had higher BMI. Spine deformities and incorrect knee position are common among 10-12-year-old children. The girls and boys differed significantly in the spine shape in the sagittal plane and the intermalleolar distance. Round lumbar lordosis is more characteristic for girls, and for boys, round thoracic kyphosis. For both genders, valgus knees occur more often than varus knees and coexist with decreased thoracic kyphosis. The rounder the thoracic kyphosis, the greater distance between the knees and the smaller distance between ankles. Conclusions The frontal knee position significantly correlated with the depth of thoracic kyphosis.	[Jankowicz-Szymanska, Agnieszka; Falatowicz, Michal; Smola, Eliza; Blyszczuk, Renata; Wodka, Katarzyna] Univ Appl Sci Tarnow, Fac Hlth Sci, Tarnow, Poland		Jankowicz-Szymanska, A (corresponding author), Univ Appl Sci Tarnow, Fac Hlth Sci, Tarnow, Poland.	jankowiczszymanska@gmail.com	Jankowicz-Szymańska, Agnieszka/R-7388-2018	Jankowicz-Szymańska, Agnieszka/0000-0002-3111-3468; Smola, Eliza/0000-0003-1499-3069				Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Antonio S, 2013, J BODYW MOV THER, V17, P512, DOI 10.1016/j.jbmt.2013.04.004; Bordoni B, 2014, J MULTIDISCIP HEALTH, V7, P401, DOI 10.2147/JMDH.S68308; Chromik K, 2009, ACTA BIOOPTICA INFOR, V15, P346; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Denys-Struyf G., 1997, CHAINES MUSCULAIRES; Diebo BG, 2015, CLIN NEUROL NEUROSUR, V139, P295, DOI 10.1016/j.clineuro.2015.10.024; Dolphens M, 2012, EUR SPINE J, V21, P2188, DOI 10.1007/s00586-012-2416-7; Erkan S, 2010, ACTA ORTHOP BELG, V76, P675; Espandar Ramin, 2010, Asian J Sports Med, V1, P46; Furian TC, 2013, ORTHOP REV, V5, P29, DOI 10.4081/or.2013.e7; Goldman V, 2010, CURR OPIN PEDIATR, V22, P47, DOI 10.1097/MOP.0b013e328334a600; Griegel-Morris P, 1992, Phys Ther, V72, P425; Heshmatipour M, 2011, J RES MED SCI, V16, P1430; Jankowicz-Szymanska A, 2019, CHILD OBES, V15, P346, DOI 10.1089/chi.2018.0361; Jankowicz-Szymanska A, 2016, PEDIATR PHYS THER, V28, P200, DOI 10.1097/PEP.0000000000000246; Jung SI, 2016, J PHYS THER SCI, V28, P186, DOI [10.1589/jpts.28.186, 10.1589/jpts.28.1816]; Kasperczyk T., 2004, BODY POSTURE DEFECTS; Kjaer P, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-98; Kowalski I., 2013, POLISH ANN MED, V20, P30, DOI [10.1016/j.poamed.2013.07, DOI 10.1016/J.POAMED.2013.07]; Ludwig Oliver, 2017, J Phys Ther Sci, V29, P1154, DOI 10.1589/jpts.29.1154; Maciaczyk-Paprocka K., 2013, EPIDEMIOLOGY POSTURE, P88; Macialczyk-Paprocka K., 2012, PROBL HIG EPIDEMIOL, V93, P309; Macialczyk-Paprocka K, 2017, EUR J PEDIATR, V176, P563, DOI 10.1007/s00431-017-2873-4; Marty C, 2002, EUR SPINE J, V11, P119, DOI 10.1007/s00586-001-0349-7; MELLIN G, 1992, J ORTHOPAED RES, V10, P211, DOI 10.1002/jor.1100100208; Mikoajczyk E, 2010, PHYSIOTHERAPY, V18, P10; Munro A, 2012, J SPORT REHABIL, V21, P7, DOI 10.1123/jsr.21.1.7; Murata Y, 2003, J BONE JOINT SURG BR, V85B, P95, DOI 10.1302/0301-620X.85B1.13389; Myers T.W., 2015, ANATOMY TRAINS MYOFA, V3rd ed.; Navali AM, 2012, BMC SPORTS SCI MED R, V4, DOI 10.1186/1758-2555-4-40; Obeid Ibrahim, 2011, Eur Spine J, V20 Suppl 5, P681, DOI 10.1007/s00586-011-1936-x; Rusek W., 2010, PRZEGLAD MEDYCZNY U, V3, P277; Saini UC, 2010, J CHILD ORTHOP, V4, P579, DOI 10.1007/s11832-010-0297-z; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Shah S., 2012, INT J HLTH SCI RES, P69; Stecco C., 2014, FUNCTIONAL ATLAS HUM, V1st ed.; Stief F, 2014, KNEE, V21, P688, DOI 10.1016/j.knee.2014.03.004; Stief F, 2011, GAIT POSTURE, V33, P490, DOI 10.1016/j.gaitpost.2011.01.001; Takacs M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200245; Takacs M, 2015, ANN BIOMED ENG, V43, P348, DOI 10.1007/s10439-014-1160-z; Tsuji Taichi, 2002, J Orthop Sci, V7, P519, DOI 10.1007/s007760200092; Walicka-Cuprys K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/817913; Wawrzyniak A, 2017, PEDIATR MED RODZ, V13, P72, DOI 10.15557/PiMR.2017.0007; Yanagisawa S, 2015, ASIA-PAC J SPORT MED, V2, P68, DOI 10.1016/j.asmart.2015.01.002; Yoo JH, 2008, J KOREAN MED SCI, V23, P714, DOI 10.3346/jkms.2008.23.4.714; Zebris Medical GmbH, 2009, EX POST SPIN SHAP IT	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236150	10.1371/journal.pone.0236150	http://dx.doi.org/10.1371/journal.pone.0236150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726335	gold, Green Published			2022-12-26	WOS:000556908900032
J	Martin, KR; Johnson, PTJ; Bowerman, J; Li, JC				Martin, Kelly R.; Johnson, Pieter T. J.; Bowerman, Jay; Li, Jingchun			Biogeography of the freshwater gastropod,Planorbella trivolvis, in the western United States	PLOS ONE			English	Article							PHYSA-ACUTA PHYSIDAE; MOLECULAR PHYLOGENY; HELISOMA-DURYI; GENETIC DIFFERENTIATION; GASTROPODA PLANORBIDAE; SELFING RATE; LAND SNAILS; DISPERSAL; POPULATIONS; DIVERSITY	Despite the important roles of freshwater gastropods in aquatic ecosystems, the taxonomic status of many taxa is unclear, which is compounded by a lack of information on species population genetic structuring, distribution, and dispersal patterns. The objective of this study was to address the biogeography of the freshwater snailPlanorbella trivolvis(Gastropoda: Planorbidae) in the western United States. We amplified two genetic markers (16S, COI) from individuals belonging to western USA populations and downloaded genetic data from GenBank. We utilized minimum spanning networks to assess the genetic patterns and performed Analysis of Molecular Variance and linear regression analyses to determine how geographic distance and watershed identity contributed to the observed genetic structuring. For both markers, we found that the majority of genetic variation was associated within and among populations, rather than among watersheds. Correspondingly, there was no significant effect of geographic distance on genetic distance, suggesting that long-distance dispersal was promoting gene flow between populations. The genetic similarity could reflect avian-mediated dispersal of snails along the Pacific Flyway, a major waterfowl migratory corridor. Further analysis of the population structuring across North America revealed East-West genetic structuring, suggesting that across longitudinal gradientsP. trivolvisexperiences significant genetic isolation.	[Martin, Kelly R.; Johnson, Pieter T. J.; Li, Jingchun] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Martin, Kelly R.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Martin, Kelly R.; Li, Jingchun] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Bowerman, Jay] Bend Sci Stn, Bend, OR USA	University of Colorado System; University of Colorado Boulder; Idaho; University of Idaho; University of Colorado System; University of Colorado Boulder	Martin, KR (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.; Martin, KR (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Martin, KR (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.	kell8957@vandals.uidaho.edu		JOHNSON, PIETER/0000-0002-7997-5390; Li, Jingchun/0000-0001-7947-0950	David and Lucile Packard Foundation [1149308]; National Science Foundation [1754171]; University of Colorado Boulder Museum of Natural History; Oregon Community Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); University of Colorado Boulder Museum of Natural History; Oregon Community Foundation	This study was financed in part by the David and Lucile Packard Foundation (1149308) and the National Science Foundation (1754171) to PTJJ. The Museum Student Research Fund and Collie Fund, both awarded by The University of Colorado Boulder Museum of Natural History, provided some financial support to KRM. A grant from the Oregon Community Foundation to the Bend Science Station provided publishing cost assistance to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001835; Appleton CC, 2003, AFR J AQUAT SCI, V28, P669; Baker FC, 1945, MOLLUSCAN FAMILY PLA; Beran Lubos, 2006, Malacologica Bohemoslovaca, V5, P6; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; BOAG DA, 1986, CAN J ZOOL, V64, P904, DOI 10.1139/z86-136; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; BONDESEN P, 1949, OIKOS, V1, P252, DOI 10.2307/3564715; BONNAUD L, 1994, CR ACAD SCI III-VIE, V317, P581; Boss KJ, 1978, PULMONATES, V2; Bousset L, 2004, MOL ECOL, V13, P2023, DOI 10.1111/j.1365-294X.2004.02200.x; BRACKENBURY TD, 1991, J MOLLUS STUD, V57, P461, DOI 10.1093/mollus/57.4.461; Brown KM, 2010, AQUAT ECOL SER, P277, DOI 10.1016/B978-0-12-374855-3.00010-8; Brown RJ, 2007, ARCTIC, V60, P124; Burch J. B, 1982, FRESHWATER SNAILS MO; BURCH JB, 1989, N AM FRESHWATER SNAI; Burlakova LE, 2009, RESTOR ECOL, V17, P433, DOI 10.1111/j.1526-100X.2008.00429.x; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Cianfanelli Simone, 2007, V2, P103, DOI 10.1007/978-1-4020-6029-8_5; CLAMPITT P T, 1970, Malacologia, V10, P113; Clennon JA, 2007, PARASITOLOGY, V134, P683, DOI 10.1017/S0031182006001594; Collado GA, 2012, ZOOL J LINN SOC-LOND, V165, P795, DOI 10.1111/j.1096-3642.2012.00829.x; Cowie R. H., 2002, Molluscs as crop pests, P145, DOI 10.1079/9780851993201.0145; Darwin C., 1959, ORIGIN SPECIES MEANS; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; De WITT R. M., 1959, ANIMAL BEHAVIOR, V7, P81, DOI 10.1016/0003-3472(59)90035-1; Desouky M, 2012, J BASIC APPL ZOOLOGY, V65, P144, DOI [10.1016/j.jobaz.2012.07.009., DOI 10.1016/J.JOBAZ.2012.07.009]; Dillon R.T., 2019, FRESHWATER GASTROPOD, V2, P127; Dillon RT, 2004, AM MALACOL BULL, V19, P69; Ebbs ET, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1208-z; Elejalde MA, 2008, J ZOOL SYST EVOL RES, V46, P193, DOI 10.1111/j.1439-0469.2008.00468.x; Escobar JS, 2011, EVOLUTION, V65, P1233, DOI 10.1111/j.1558-5646.2011.01218.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez MA, 2010, NAUTILUS, V124, P44; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Fiorentino V, 2008, BIOL J LINN SOC, V94, P809, DOI 10.1111/j.1095-8312.2008.01023.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRANDSEN F, 1979, ACTA TROP, V36, P67; Freeland JR, 2000, HEREDITY, V85, P498, DOI 10.1046/j.1365-2540.2000.00780.x; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; HAYNES A, 1985, ARCH HYDROBIOL, V103, P497; Hebert PDN, 1996, FRESHWATER BIOL, V35, P311, DOI 10.1046/j.1365-2427.1996.00501.x; HUBENDICK B., 1955, TRANS ZOOL SOC LONDON, V28, P453; Janssen AW, 2004, NEDERLANDSE ZOETWATE; JARNE P, 1993, BIOL J LINN SOC, V49, P99, DOI 10.1111/j.1095-8312.1993.tb00893.x; JELNES JE, 1982, HEREDITAS, V97, P9, DOI 10.1111/j.1601-5223.1982.tb00704.x; Johnson Michael S., 2013, Records of the Western Australian Museum, P159; Kappes H, 2012, AQUAT SCI, V74, P1, DOI 10.1007/s00027-011-0187-6; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Liu HP, 2009, FRESHWATER BIOL, V54, P1285, DOI 10.1111/j.1365-2427.2009.02175.x; Liu HP, 2003, MOL ECOL, V12, P2771, DOI 10.1046/j.1365-294X.2003.01949.x; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Lydeard C, 1997, MOL PHYLOGENET EVOL, V7, P117, DOI 10.1006/mpev.1996.0377; MADSEN H, 1989, ACTA TROP, V46, P139, DOI 10.1016/0001-706X(89)90030-2; Mahmoud KMA, 2013, AFR J ECOL, V51, P193, DOI 10.1111/aje.12019; MALONE CHARLES R., 1965, NAUTILUS, V78, P135; Malone CR, 1965, THESIS; Minton RL, 2008, HYDROBIOLOGIA, V605, P173, DOI 10.1007/s10750-008-9332-1; Monsutti A, 1999, MOL ECOL, V8, P1076; Morgan JAT, 2002, MOL PHYLOGENET EVOL, V25, P477, DOI 10.1016/S1055-7903(02)00280-4; Norton CG, 2018, AM MALACOL BULL, V36, P153, DOI 10.4003/006.036.0110; PARAENSE W L, 1988, Memorias do Instituto Oswaldo Cruz, V83, P405; Paraense WL, 1996, MEMORIAS I O CRUZ, V83, P405; Perez KE, 2008, J N AM BENTHOL SOC, V27, P471, DOI 10.1899/07-059.1; Pfenninger M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-100; RIBI G, 1986, OECOLOGIA, V69, P60, DOI 10.1007/BF00399038; Roscoe E. J., 1955, Wilson Bulletin, V67, P66; Saito T, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1273-3; Schniebs K, 2019, J CONCHOL, V43, P245; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Strong EE, 2008, HYDROBIOLOGIA, V595, P149, DOI 10.1007/s10750-007-9012-6; TAYLOR D. W., 1966, MALACOLOGIA, V4, P1; Taylor DJ, 1998, EVOLUTION, V52, P1648, DOI 10.1111/j.1558-5646.1998.tb02245.x; Team,R.C, 2018, R LANG ENV STAT COMP; Van Leeuwen CHA, 2013, FRESHWATER BIOL, V58, P88, DOI 10.1111/fwb.12041; Van Riel P, 2005, MOL PHYLOGENET EVOL, V37, P132, DOI 10.1016/j.ympev.2005.03.019; Vanoverbeke J, 1997, HYDROBIOLOGIA, V360, P135, DOI 10.1023/A:1003160903708; Wang SYS, 2019, PHYSIOL BIOCHEM ZOOL, V92, P71, DOI 10.1086/701236; Wethington AR, 2007, J MOLLUS STUD, V73, P241, DOI 10.1093/mollus/eym021; Wethington AR, 2004, AM MALACOL BULL, V19, P135; Whelan NV, 2019, MOL ECOL, V28, P1593, DOI 10.1111/mec.15032; Wilson RM, 2010, SEEKING REFUGE: BIRDS AND LANDSCAPES OF THE PACIFIC FLYWAY, P1; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x; Zukowski S, 2009, MAR FRESHWATER RES, V60, P999, DOI 10.1071/MF08183	88	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0235989	10.1371/journal.pone.0235989	http://dx.doi.org/10.1371/journal.pone.0235989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726356	Green Published, gold			2022-12-26	WOS:000556908900040
J	Wilmink, JM; Ladefoged, S; Jongbloets, A; Vernooij, JCM				Wilmink, Jacintha M.; Ladefoged, Soren; Jongbloets, Angelique; Vernooij, Johannes C. M.			The evaluation of the effect of probiotics on the healing of equine distal limb wounds	PLOS ONE			English	Article							AMYLOID-A SAA; LACTOBACILLUS-PLANTARUM; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; POTENTIAL USE; HORSES; PREVENTION; ACIDOPHILUS; INFECTIONS; EFFICACY	The effect of dressings saturated with either a standardized suspension of probiotic bacteria or saline on healing of traumatic distal limb wounds in horses was evaluated for 24 days, and the systemic inflammatory effect was assessed. The wounds were divided in two groups based on the phase of healing: wounds with an incomplete (ICGB) or a complete granulation bed (CGB). The wound area was expressed as percentage of the wound area at day 0 and defined as relative wound area. The mean relative wound area decreased faster in probiotic than saline treated wounds. The difference was most obvious in CGB and increased rapidly from day 0 until day 12 up to 30%, and stabilized around 25% thereafter until the end of the observation period, but it was not statistically significant because of the large variation within the treatment groups. The mean wound area of CGB decreased to 28.4% (range: 6.3 to 49.3) with probiotic and to 51.9% (range: 29.3 to 81.7) with saline treatment at day 24. Additionally, the rate to 50% healing in CGB was 3.4 faster with probiotic compared to saline treatment, whereas in ICGB this was 1.9 faster. Topical probiotics did not increase serum amyloid A and white blood cell counts. Although the mentioned differences were not statistically significant, the clinical relevance of the effect of treatment with probiotics in CGB wounds is clear, supported by the differences in mean wound area in course of time and the time required to reach 50% healing (day 12 for probiotic vs more than day 24 for saline treated wounds). Thus the probiotic treated wounds reached 50% reduction in wound area in half of the time of the saline treated wounds. The topical use of probiotics can be considered as safe as it did not cause a systemic effect.	[Wilmink, Jacintha M.] Woumarec, Wageningen, Netherlands; [Ladefoged, Soren] Hojgard Hestehosp AS, Morud, Denmark; [Jongbloets, Angelique] Paardenklin West Brabant, Roosendaal, Netherlands; [Vernooij, Johannes C. M.] Univ Utrecht, Fac Vet Med, Dept Populat Hlth Sci, Div Farm Anim Hlth, Utrecht, Netherlands	Utrecht University	Wilmink, JM (corresponding author), Woumarec, Wageningen, Netherlands.	info@woumarec.nl		Vernooij, Johannes/0000-0002-2646-9216	Micuri Aps, Denmark	Micuri Aps, Denmark	The study was funded by Micuri Aps, Denmark. Unfortunately the company does not exist anymore. Micuri has provided the materials required for the study, and payed for the bacteriology and the hematology. Micuri has payed a compensation to the contributing practitioners for their clinical work to treat the wounds of the horses. JW SL AJ have recieved an award for setting up the study and their practical work to perform the study (order of 50%). Analysis of the results and preparation of the manuscript has not been funded. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer E., 2016, RFPERMUTE ESTIMATE P; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Brachkova MI, 2011, J HOSP INFECT, V79, P375, DOI 10.1016/j.jhin.2011.09.003; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Freeman K, 2009, CAN J MICROBIOL, V55, P197, DOI [10.1139/w08-115, 10.1139/W08-115]; Huseini HF, 2012, BURNS, V38, P719, DOI 10.1016/j.burns.2011.12.005; Jacobsen S, 2007, EQUINE VET EDUC, V19, P38, DOI [10.1111/j.2042-3292.2007.tb00550.x, 10.2746/095777307X177235]; Jacobsen S, 2006, VET J, V172, P315, DOI 10.1016/j.tvjl.2005.04.021; Jacobsen S, 2009, VET SURG, V38, P762, DOI 10.1111/j.1532-950X.2009.00564.x; Jebur MS, 2010, N AM J MED SCI, V2, P586, DOI 10.4297/najms.2010.2586; Joint FAO/WHO Working Group, 2002, REP DRAFT GUID EV PR; Mayes T, 2015, J BURN CARE RES, V36, P92, DOI 10.1097/BCR.0000000000000139; Nomoto K, 2005, J BIOSCI BIOENG, V100, P583, DOI 10.1263/jbb.100.583; Oelschlaeger TA, 2010, INT J MED MICROBIOL, V300, P57, DOI 10.1016/j.ijmm.2009.08.005; Peral MC, 2010, CLIN MICROBIOL INFEC, V16, P281, DOI 10.1111/j.1469-0691.2009.02793.x; Peral MC, 2009, INT WOUND J, V6, P73, DOI 10.1111/j.1742-481X.2008.00577.x; Pinheiro J, 2020, R PACKAGE VERSION 31; Ramos AN, 2012, WOUND REPAIR REGEN, V20, P552, DOI 10.1111/j.1524-475X.2012.00798.x; Reid G, 2005, CURR PHARM DESIGN, V11, P11, DOI 10.2174/1381612053382395; Schoster A, 2014, J VET INTERN MED, V28, P1640, DOI 10.1111/jvim.12451; Sekhar MS, 2014, MED HYPOTHESES, V82, P86, DOI 10.1016/j.mehy.2013.11.013; Sikorska H, 2013, INT J ANTIMICROB AG, V42, P475, DOI 10.1016/j.ijantimicag.2013.08.003; Sorensen MA, 2014, WOUND REPAIR REGEN, V22, P647, DOI 10.1111/wrr.12207; Theoret CL, 2013, VET SURG, V42, P783, DOI 10.1111/j.1532-950X.2013.12055.x; Theoret CL, 2013, WOUND REPAIR REGEN, V21, P365, DOI 10.1111/wrr.12018; Theoret CL, 2017, EQUINE WOUND MANAGEM, V3rd, P369; Therneau T., 2021, PACKAGE SURVIVAL ANA, DOI DOI 10.1198/TECH.2004.S740; Valdez JC, 2005, CLIN MICROBIOL INFEC, V11, P472, DOI 10.1111/j.1469-0691.2005.01142.x; Van den Boom R, 2002, WOUND REPAIR REGEN, V10, P188, DOI 10.1046/j.1524-475X.2002.10608.x; Varma P, 2011, J MOL MICROB BIOTECH, V20, P137, DOI 10.1159/000328512; Vuotto C, 2014, INT J ORAL SCI, V6, P189, DOI 10.1038/ijos.2014.52; Walencka E, 2008, FOLIA MICROBIOL, V53, P61, DOI 10.1007/s12223-008-0009-y; Westgate SJ, 2011, VET MICROBIOL, V150, P152, DOI 10.1016/j.vetmic.2011.01.003; Wiegand C, 2011, J MATER SCI-MATER M, V22, P2583, DOI 10.1007/s10856-011-4423-3; Wilmink JM, 2003, EQUINE VET J, V35, P561, DOI 10.2746/042516403775467234; Wilmink JM, 2002, EQUINE VET J, V34, P270, DOI 10.2746/042516402776186047; Wilmink JM, 1999, EQUINE VET J, V31, P61, DOI 10.1111/j.2042-3306.1999.tb03792.x; Wilmink JM, 1999, EQUINE VET J, V31, P53, DOI 10.1111/j.2042-3306.1999.tb03791.x; Wilmink JM, 2017, EQUINE WOUND MANAGEM, V3rd, P21	39	3	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0236761	10.1371/journal.pone.0236761	http://dx.doi.org/10.1371/journal.pone.0236761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726347	gold, Green Published			2022-12-26	WOS:000556908900059
J	Orchard, ER; Ward, PGD; Sforazzini, F; Storey, E; Egan, GF; Jamadar, SD				Orchard, Edwina R.; Ward, Phillip G. D.; Sforazzini, Francesco; Storey, Elsdon; Egan, Gary F.; Jamadar, Sharna D.			Relationship between parenthood and cortical thickness in late adulthood	PLOS ONE			English	Article							NEURAL PLASTICITY; CEREBRAL-CORTEX; MATERNAL BRAIN; PREGNANCY; MEMORY; PARTICIPANTS; HIPPOCAMPAL; BEHAVIOR	Pregnancy and the early postpartum period alter the structure of the brain; particularly in regions related to parental care. However, the enduring effects of this period on human brain structure and cognition in late life is unknown. Here we use magnetic resonance imaging to examine differences in cortical thickness related to parenthood in late life, for both sexes. In 235 healthy older women, we find a positive relationship between parity (number of children parented) and memory performance in mothers. Parity was also associated with differences in cortical thickness in women in the parahippocampus, precuneus, cuneus and pericalcarine sulcus. We also compared non-parents to parents of one child, in a sub-sample of older women (N= 45) and men (N= 35). For females, six regions differed in cortical thickness between parents and non-parents; these regions were consistent with those seen earlier in life in previous studies. For males, five regions differed in cortical thickness between parents and non-parents. We are first to reveal parenthood-related brain differences in late-life; our results are consistent with previously identified areas that are altered during pregnancy and the postpartum period. This study provides preliminary evidence to suggest that neural changes associated with early stages of parenthood persist into older age, and for women, may be related to marginally better cognitive outcomes.	[Orchard, Edwina R.; Ward, Phillip G. D.; Sforazzini, Francesco; Egan, Gary F.; Jamadar, Sharna D.] Monash Univ, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Orchard, Edwina R.; Ward, Phillip G. D.; Egan, Gary F.; Jamadar, Sharna D.] Monash Univ, Monash Biomed Imaging, Melbourne, Vic, Australia; [Orchard, Edwina R.; Ward, Phillip G. D.; Egan, Gary F.; Jamadar, Sharna D.] Australian Res Council, Ctr Excellence Integrat Brain Funct, Clayton, Vic, Australia; [Storey, Elsdon] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Storey, Elsdon] Monash Univ, Dept Neurosci Med, Alfred Hosp Campus, Melbourne, Vic, Australia	Monash University; Monash University; Monash University; Monash University	Jamadar, SD (corresponding author), Monash Univ, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia.; Jamadar, SD (corresponding author), Monash Univ, Monash Biomed Imaging, Melbourne, Vic, Australia.; Jamadar, SD (corresponding author), Australian Res Council, Ctr Excellence Integrat Brain Funct, Clayton, Vic, Australia.	sharna.jamadar@monash.edu		Orchard, Edwina R/0000-0003-4845-8961	Australian National Health and Medical Research Council [APP1086188]; National Institutes of Health [U01AG029824]; National Health and Medical Research Council of Australia [334047, 1127060]; Monash University (Australia); Victorian Cancer Agency (Australia); Australian Research Council (ARC) Centre of Excellence for Integrative Brain Function [CE140100007]; ARC Discovery Early Career Researcher Award [DE150100406]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University (Australia)(Monash University); Victorian Cancer Agency (Australia); Australian Research Council (ARC) Centre of Excellence for Integrative Brain Function(Australian Research Council); ARC Discovery Early Career Researcher Award(Australian Research Council)	This work was supported by an Australian National Health and Medical Research Council Project Grant (APP1086188). ASPREE was supported by the National Institutes of Health (grant number U01AG029824); the National Health and Medical Research Council of Australia (grant numbers 334047, 1127060); Monash University (Australia) and the Victorian Cancer Agency (Australia). ERO, PGDW, GFE and SDJ are supported by the Australian Research Council (ARC) Centre of Excellence for Integrative Brain Function (CE140100007). SJ is supported by an ARC Discovery Early Career Researcher Award (DE150100406). The Principal ASPREE study is registered with the International Standardized Randomized Controlled Trials Register, ASPirin in Reducing Events in the Elderly, Number: ISRCTN83772183 and clinicaltrials.gov number NCT01038583. ASPREE-Neuro trial is registered with Australian New Zealand Clinical Trials Registry ACTRN12613001313729.	Atzil S, 2011, NEUROPSYCHOPHARMACOL, V36, P2603, DOI 10.1038/npp.2011.172; Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Broomhill R, 2005, LABOUR IND, V16, P103, DOI 10.1080/10301763.2005.10722033; Buckwalter J G, 2001, Prog Brain Res, V133, P303; Burgmans S, 2011, NEUROBIOL AGING, V32, P1572, DOI 10.1016/j.neurobiolaging.2009.09.008; Carmona S, 2019, HUM BRAIN MAPP, V40, P2143, DOI 10.1002/hbm.24513; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davies SJ, 2018, MED J AUSTRALIA, V208, P35, DOI 10.5694/mja17.00131; De Carli P, 2019, NEUROSCI BIOBEHAV R, V102, P153, DOI 10.1016/j.neubiorev.2019.04.013; De Lange A-MG, 2020, BIORXIV; de Lange AMG, 2019, P NATL ACAD SCI USA, V116, P22341, DOI 10.1073/pnas.1910666116; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Everette A, 2007, PATERNAL EXPERIENCE; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gatewood JD, 2005, BRAIN RES BULL, V66, P91, DOI 10.1016/j.brainresbull.2005.03.016; Henry NJE, 2016, RN MATERNAL NEWBORN; Hillerer KM, 2014, HIPPOCAMPUS, V24, P673, DOI 10.1002/hipo.22258; Hoekzema E, 2017, NAT NEUROSCI, V20, P287, DOI 10.1038/nn.4458; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Kim P, 2018, BRAIN STRUCT FUNCT, V223, P3267, DOI 10.1007/s00429-018-1688-z; Kim P, 2016, HORM BEHAV, V77, P113, DOI 10.1016/j.yhbeh.2015.08.001; Kim P, 2014, SOC NEUROSCI-UK, V9, P522, DOI 10.1080/17470919.2014.933713; Kim P, 2010, BEHAV NEUROSCI, V124, P695, DOI 10.1037/a0020884; Kinsley CH, 2011, J NEUROENDOCRINOL, V23, P974, DOI 10.1111/j.1365-2826.2011.02194.x; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; Kinsley CH, 2011, BEHAV NEUROBIOLOGY A, P317; Kinsley CH, 2008, J NEUROENDOCRINOL, V20, P515, DOI 10.1111/j.1365-2826.2008.01667.x; Kinsley CH, 2008, ARCH SEX BEHAV, V37, P43, DOI 10.1007/s10508-007-9277-x; Kohler S, 1998, NEUROPSYCHOLOGIA, V36, P901, DOI 10.1016/S0028-3932(98)00017-7; Kozorovitskiy Y, 2006, NAT NEUROSCI, V9, P1094, DOI 10.1038/nn1753; Laurent HK, 2012, SOC COGN AFFECT NEUR, V7, P125, DOI 10.1093/scan/nsq091; Lenzi D, 2009, CEREB CORTEX, V19, P1124, DOI 10.1093/cercor/bhn153; Luders E, 2020, CORTEX, V126, P334, DOI 10.1016/j.cortex.2019.12.029; Maupin AN, 2016, NEW DIR CHILD ADOLES, V153, P73, DOI 10.1002/cad.20169; McNeil JJ, 2017, J GERONTOL A-BIOL, V72, P1586, DOI 10.1093/gerona/glw342; Ning KD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63014-7; Oatridge A, 2002, AM J NEURORADIOL, V23, P19; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Parsons CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01776-3; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Rosen AFG, 2018, NEUROIMAGE, V169, P407, DOI 10.1016/j.neuroimage.2017.12.059; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Seo SW, 2011, NEUROBIOL AGING, V32, P200, DOI 10.1016/j.neurobiolaging.2009.02.004; Smith A., 1982, SYMBOL DIGIT MODALIT; Stolzenberg DS, 2016, HORM BEHAV, V77, P204, DOI 10.1016/j.yhbeh.2015.07.005; Storey AE, 2000, EVOL HUM BEHAV, V21, P79, DOI 10.1016/S1090-5138(99)00042-2; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Troyer AK, 2006, AGING NEUROPSYCHOL C, V13, P20, DOI 10.1080/138255890968187; Veit R, 2014, NEUROIMAGE-CLIN, V6, P307, DOI 10.1016/j.nicl.2014.09.013; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Ward SA, 2017, INT J STROKE, V12, P108, DOI 10.1177/1747493016669848	56	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236031	10.1371/journal.pone.0236031	http://dx.doi.org/10.1371/journal.pone.0236031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722686	Green Published, gold			2022-12-26	WOS:000556916000024
J	Saw, YM; Saw, TN; Than, TM; Khaing, M; Soe, PP; Oo, S; Cho, SM; Win, EM; Mon, AM; Fuchita, E; Kariya, T; Iriyama, S; Hamajima, N				Saw, Yu Mon; Saw, Thu Nandar; Than, Thet Mon; Khaing, Moe; Soe, Pa Pa; Oo, San; Cho, Su Myat; Win, Ei Mon; Mon, Aye Myat; Fuchita, Etsuko; Kariya, Tetsuyoshi; Iriyama, Shigemi; Hamajima, Nobuyuki			Cognitive impairment and its risk factors among Myanmar elderly using the Revised Hasegawa's Dementia Scale: A cross-sectional study in Nay Pyi Taw, Myanmar	PLOS ONE			English	Article							SOCIAL RELATIONSHIPS; GLOBAL PREVALENCE; PHYSICAL-ACTIVITY; HEALTH; EDUCATION; ASSOCIATION; PREVENTION; SMOKING; BURDEN; OLD	Background Globally, elderly population with impaired cognitive function, such as dementia, has been accelerating, and Myanmar is no exception. However, cognitive function among elderly in Myanmar has rarely been assessed. This study aimed to identify the rate of cognitive impairment and its risk factors among the elderly in Myanmar. Methods This cross-sectional study was conducted at rural health centers in Nay Pyi Taw Union Territory, Myanmar, from December 2018 to January 2019. In total, 757 elderly individuals aged 60 years or over (males: 246 [32.5%], females: 511 [67.5%]) were interviewed using a face-to-face method with a pre-tested questionnaire. Descriptive statistics and multivariable logistic regression analyses were performed. Results The rate of impaired cognitive function among participants was 29.9% (males: 23.6%; females: 32.9%). The following participants were more likely to present cognitive impairment: those aged 70-79 years (adjusted odds ratio [AOR] = 1.8; 95% confidence interval [CI]: 1.19-2.70) and 80 years or older (AOR = 3.9; 95% CI: 2.25-6.76); those who were illiterate (AOR = 9.1; 95% CI: 3.82-21.51); and those dependent on family members (AOR = 1.6; 95% CI: 1.04-2.44). The elderly livening with their families and those who reported having good health (AOR = 0.7; 95% CI: 0.44-0.99) were less likely to have cognitive impairment. Conclusion Using the HDS-R Myanmar version, this study reported that there out of five elderly participants had cognitive impairment, and its risk factors, altering policy makers that Myanmar needs to prepare for adequate healthcare services and social support for elderly with cognitive impairment. Future research should be performed not only to detect general cognitive impairment but also to differentiate specific cognitive domains impairments among Myanmar elderly. Longitudinal studies are needed to observe the causal and protective factors associated with cognitive impairments in Myanmar.	[Saw, Yu Mon; Than, Thet Mon; Khaing, Moe; Cho, Su Myat; Kariya, Tetsuyoshi; Hamajima, Nobuyuki] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi, Japan; [Saw, Yu Mon; Kariya, Tetsuyoshi] Nagoya Univ, Asian Satellite Campuses Inst, Nagoya, Aichi, Japan; [Saw, Thu Nandar] Univ Tokyo, Dept Community & Global Hlth, Tokyo, Japan; [Than, Thet Mon; Khaing, Moe; Mon, Aye Myat] Minist Hlth & Sports, Med Care Div, Dept Med Serv, Nay Pyi Taw, Myanmar; [Soe, Pa Pa] Univ Med, Dept Preventat & Social Med, Mandalay, Myanmar; [Oo, San] Yangon Gen Hosp, Dept Neurol, Yangon, Myanmar; [Win, Ei Mon] Minist Hlth & Sports, Dept Publ Hlth, Nay Pyi Taw, Myanmar; [Fuchita, Etsuko; Iriyama, Shigemi] Nagoya Univ, Grad Sch Med, Nursing Sci Div, Dept Integrated Hlth Sci, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; University of Tokyo; Nagoya University	Saw, YM (corresponding author), Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi, Japan.; Saw, YM (corresponding author), Nagoya Univ, Asian Satellite Campuses Inst, Nagoya, Aichi, Japan.	sawyumon@med.nagoya-u.ac.jp	KARIYA, TETSUYOSHI/L-4750-2017	KARIYA, TETSUYOSHI/0000-0002-7757-4251; Saw, Yu Mon/0000-0002-5038-0043; Cho, Su Myat/0000-0002-0118-648X	Ministry of Education, Science, Sports, and Culture of Japan [19K19703]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (No. 19K19703) from the Ministry of Education, Science, Sports, and Culture of Japan. The funder had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Aggarwal Neelum T, 2012, Int J Alzheimers Dis, V2012, P171327, DOI 10.1155/2012/171327; Albert M S, 1995, Ann Epidemiol, V5, P76, DOI 10.1016/1047-2797(94)00044-T; Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; Chtistensen H, 2009, AM J GERIAT PSYCHIAT, V17, P218, DOI 10.1097/JGP.0b013e3181961a84; Conti AA, 2019, NEUROSCI BIOBEHAV R, V96, P143, DOI 10.1016/j.neubiorev.2018.11.017; Cuevas HE, 2019, ETHNIC HEALTH, V24, P512, DOI 10.1080/13557858.2017.1346174; Department of Population Ministry of Labour Immigration and Population, IMM POP REP UN MYANM; Dye L, 2017, P NUTR SOC, V76, P443, DOI 10.1017/S0029665117002014; Etgen T, 2010, ARCH INTERN MED, V170, P186, DOI 10.1001/archinternmed.2009.498; EVERT DL, 1995, ALCOHOL HEALTH RES W, V19, P89; Favieri F, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02126; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FICHTER MM, 1995, BRIT J PSYCHIAT, V166, P621, DOI 10.1192/bjp.166.5.621; Forte G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010034; Gillum RF, 2010, ANN EPIDEMIOL, V20, P251, DOI 10.1016/j.annepidem.2010.01.005; Huang CQ, 2009, COGN BEHAV NEUROL, V22, P190, DOI 10.1097/WNN.0b013e3181b2790b; Imai Y., 1994, J HONG KONG COLL PSY, V4, P20; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Kelley AS, 2015, ANN INTERN MED, V163, P729, DOI 10.7326/M15-0381; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Laws KR, 2016, WORLD J PSYCHIATR, V6, P54, DOI 10.5498/wjp.v6.i1.54; LI G, 1989, ACTA PSYCHIAT SCAND, V79, P557, DOI 10.1111/j.1600-0447.1989.tb10303.x; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lu JJ, 2016, J SPORT HEALTH SCI, V5, P287, DOI 10.1016/j.jshs.2016.07.003; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570; Lyu J, 2016, PSYCHIAT INVEST, V13, P473, DOI 10.4306/pi.2016.13.5.473; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Mohan D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025473; Oung MT, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0153-1; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rao Girish N, 2013, Indian J Public Health, V57, P71, DOI 10.4103/0019-557X.114986; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Ren LB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21983-w; Rosso AL, 2016, AM J EPIDEMIOL, V183, P1088, DOI 10.1093/aje/kwv337; Saw YM, 2018, NAGOYA J MED SCI, V80, P435, DOI 10.18999/nagjms.80.4.435; Scazufca M, 2010, INT PSYCHOGERIATR, V22, P1209, DOI 10.1017/S1041610210001213; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Spoorenberg T, 2013, POPUL DEV REV, V39, P309, DOI 10.1111/j.1728-4457.2013.00593.x; Teerawichitchainan B, 2018, J CROSS-CULT GERONTO, V33, P143, DOI 10.1007/s10823-017-9336-2; Ton TGN, 2017, ALZHEIMERS DEMENT, V13, P217, DOI 10.1016/j.jalz.2016.08.009; Tucker KL, 2016, ANN NY ACAD SCI, V1367, P38, DOI 10.1111/nyas.13062; UHLMANN RF, 1991, J GEN INTERN MED, V6, P126, DOI 10.1007/BF02598307; Wu YT, 2015, INT J GERIATR PSYCH, V30, P793, DOI 10.1002/gps.4297; Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044	45	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236656	10.1371/journal.pone.0236656	http://dx.doi.org/10.1371/journal.pone.0236656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW3BD	32722689	Green Published, gold			2022-12-26	WOS:000556916000008
J	Osborne, TF; Veigulis, ZP; Arreola, DM; Roosli, E; Curtin, CM				Osborne, Thomas F.; Veigulis, Zachary P.; Arreola, David M.; Roosli, Eliane; Curtin, Catherine M.			Automated EHR score to predict COVID-19 outcomes at US Department of Veterans Affairs	PLOS ONE			English	Article								The sudden emergence of COVID-19 has brought significant challenges to the care of Veterans. An improved ability to predict a patient's clinical course would facilitate optimal care decisions, resource allocation, family counseling, and strategies for safely easing distancing restrictions. The Care Assessment Need (CAN) score is an existing risk assessment tool within the Veterans Health Administration (VA), and produces a score from 0 to 99, with a higher score correlating to a greater risk. The model was originally designed for the nonacute outpatient setting and is automatically calculated from structured data variables in the electronic health record. This multisite retrospective study of 6591 Veterans diagnosed with COVID-19 from March 2, 2020 to May 26, 2020 was designed to assess the utility of repurposing the CAN score as objective and automated risk assessment tool to promptly enhance clinical decision making for Veterans diagnosed with COVID-19. We performed bivariate analyses on the dichotomized CAN 1-year mortality score (high vs. low risk) and each patient outcome using Chi-square tests of independence. Logistic regression models using the continuous CAN score were fit to assess its predictive power for outcomes of interest. Results demonstrated that a CAN score greater than 50 was significantly associated with the following outcomes after positive COVID-19 test: hospital admission (OR 4.6), prolonged hospital stay (OR 4.5), ICU admission (3.1), prolonged ICU stay (OR 2.9), mechanical ventilation (OR 2.6), and mortality (OR 7.2). Repurposing the CAN score offers an efficient way to risk-stratify COVID-19 Veterans. As a result of the compelling statistical results, and automation, this tool is well positioned for broad use across the VA to enhance clinical decision-making.	[Osborne, Thomas F.; Arreola, David M.; Curtin, Catherine M.] US Dept Vet Affairs, Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA; [Osborne, Thomas F.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Veigulis, Zachary P.] US Dept Vet Affairs, Cent Iowa Hlth Care Syst, Des Moines, IA USA; [Roosli, Eliane] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Curtin, Catherine M.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Stanford University; Stanford University	Osborne, TF (corresponding author), US Dept Vet Affairs, Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.; Osborne, TF (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	tosborne@stanford.edu		Veigulis, Zachary/0000-0002-9026-1604; Curtin, Catherine/0000-0003-0850-9277; Roosli, Eliane/0000-0003-0557-6239; Osborne, Thomas/0000-0002-8896-2487	VA Palo Alto Healthcare System; VA Central Iowa Health Care System	VA Palo Alto Healthcare System(US Department of Veterans Affairs); VA Central Iowa Health Care System	This material is the result of work supported with resources from VA Palo Alto Healthcare System, and VA Central Iowa Health Care System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Curtis JR, 2020, JAMA-J AM MED ASSOC, V323, P1771, DOI 10.1001/jama.2020.4894; Fihn S, 2016, UPDATE CARE ASSESSME; Finh S, CARE ASSESSMENT NEED; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621; Nelson KM, 2019, J GEN INTERN MED, V34, P1379, DOI 10.1007/s11606-019-04961-4; Osborne Thomas F, 2020, JB JS Open Access, V5, pe0061, DOI 10.2106/JBJS.OA.19.00061; Rentsch CT, 2020, COVID 19 TESTING HOS; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; World Health Organization, 2020, CLIN CAR SEV AC RESP; Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204	13	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236554	10.1371/journal.pone.0236554	http://dx.doi.org/10.1371/journal.pone.0236554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716922	Green Published, gold			2022-12-26	WOS:000556674500040
J	Svendsen, MT; Boggild, H; Skals, RK; Mortensen, RN; Kragholm, K; Hansen, SM; Riddersholm, SJ; Nielsen, G; Torp-Pedersen, C				Svendsen, Majbritt Tang; Boggild, Henrik; Skals, Regitze Kuhr; Mortensen, Rikke Normark; Kragholm, Kristian; Hansen, Steen Moller; Riddersholm, Signe Juel; Nielsen, Gitte; Torp-Pedersen, Christian			Uncertainty in classification of death from fatal myocardial infarction: A nationwide analysis of regional variation in incidence and diagnostic support	PLOS ONE			English	Article							CIVIL REGISTRATION; VITAL-STATISTICS; HEART-DISEASE; DATA QUALITY; MORTALITY; REGISTERS; DENMARK; SYSTEMS; HEALTH; TRENDS	Aims The usefulness of mortality statistics relies on the validity of death certificate diagnosis. However, diagnosing the causal sequence of conditions leading to death is not simple. We examined diagnostic support for fatal acute myocardial infarction (AMI) and investigated its association with regional variation. Methods and results From Danish nationwide registers, we identified the study population (N= 3,244,051) of whom 36,669 individuals were recorded with AMI as the underlying cause-of-death between 2002 and 2015. We included clinical diagnoses, procedures, and claimed prescriptions related to atherosclerotic disease to evaluate the level of diagnostic support for fatal AMI in three diagnostic groups (Definite; Plausible; Uncertain). Adjusted mortality rates, rate ratios, and odds ratios were estimated for each AMI category, stratified by hospital region using multivariable regression models. More than one-third (N= 12,827, 35%) of deaths reported as fatal AMI had uncertain diagnostic support. The largest regional variation in AMI mortality rate ratios, varying from 1.16 (95%CI:1.02;1.31) to 1.62 (95%CI:1.43;1.83), was found among cases with uncertain diagnostic supportive data. Substantial inter-regional differences in the degree to which death occurs outside hospital [OR: 1.01 (95%CI:0.92;1.12) - 1.49 (95%CI:1.36;1.63)] and general practitioners determining the cause-of-death at home were present. Minor regional differences [OR: 0.96 (95%CI:0.85;1.07) - 1.16 (95%CI:1.04;1.29)] in in-hospital AMI mortality were observed. Conclusion There is significant regional variation associated with recording AMI as a cause-of-death. This variation is predominately based on death certificate diagnoses without diagnostic supportive evidence. Studies of fatal AMI should include a stratification on supportive evidence of the diagnosis.	[Svendsen, Majbritt Tang; Nielsen, Gitte] North Denmark Reg Hosp, Dept Cardiol, Hjorring, Denmark; [Svendsen, Majbritt Tang] North Denmark Reg Hosp, Clin Res Ctr, Hjorring, Denmark; [Boggild, Henrik; Skals, Regitze Kuhr; Mortensen, Rikke Normark; Hansen, Steen Moller] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Boggild, Henrik] Aalborg Univ, Dept Hlth Sci & Technol, Publ Hlth & Epidemiol Grp, Aalborg, Denmark; [Kragholm, Kristian; Riddersholm, Signe Juel; Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Riddersholm, Signe Juel] Aalborg Univ Hosp, Dept Anesthesia & Intens care, Aalborg, Denmark; [Torp-Pedersen, Christian] Nordsjaellands Hosp, Dept Clin Res, Hillerod, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Svendsen, MT (corresponding author), North Denmark Reg Hosp, Dept Cardiol, Hjorring, Denmark.; Svendsen, MT (corresponding author), North Denmark Reg Hosp, Clin Res Ctr, Hjorring, Denmark.	majbritt.svendsen@rn.dk	Bøggild, Henrik/O-4385-2019	Bøggild, Henrik/0000-0001-8934-5002; Kragholm, Kristian/0000-0001-9629-8670	Danish Heart Foundation [:15-R99A5893-228918]; Maria Pedersen and Jensine Heiberg Foundation	Danish Heart Foundation; Maria Pedersen and Jensine Heiberg Foundation	This present study was supported by the Danish Heart Foundation [grant number:15-R99A5893-228918] and by the Maria Pedersen and Jensine Heiberg Foundation. The institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; [Anonymous], 1979, MED CERT CAUS DEATH; Antini C, 2015, CAD SAUDE PUBLICA, V31, P1473, DOI 10.1590/0102-311X00099814; Armour A, 1997, ULSTER MED J, V66, P13; ASNAES S, 1980, FORENSIC SCI INT, V15, P191, DOI 10.1016/0379-0738(80)90133-4; Chen Linping, 2002, Aust Health Rev, V25, P189; Danilova I, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0078-0; Dudas K, 2011, CIRCULATION, V123, P46, DOI 10.1161/CIRCULATIONAHA.110.964999; Ersboll AK, 2016, SPAT SPATIO-TEMPORAL, V19, P60, DOI 10.1016/j.sste.2016.06.001; Fernando R, 1990, Ceylon Med J, V35, P71; Gillum RF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-410; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Janssen F, 2004, B WORLD HEALTH ORGAN, V82, P904; Jordan J. M, 1998, CLIN INVESTIG MED, V16, P249; JUEL K, 1995, J CLIN EPIDEMIOL, V48, P467, DOI 10.1016/0895-4356(94)00158-M; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kjaerulff TM, 2019, EUR J PREV CARDIOL, V26, P1828, DOI 10.1177/2047487319852680; LOWEL H, 1991, J CLIN EPIDEMIOL, V44, P249, DOI 10.1016/0895-4356(91)90036-9; Lu TH, 1996, CHIN J PUBLIC HLTH, V15, P376; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Myers KA, 1998, CAN MED ASSOC J, V158, P1317; O'Connor A, 2012, PUBLIC HEALTH, V126, P813, DOI 10.1016/j.puhe.2012.05.029; Olejaz M, 2012, HEALT SYST TRANSIT, V14, P1; Peach H G, 1998, Aust Fam Physician, V27, P178; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; R Core Team, 2019, R LANG ENV STAT COMP; Roffi M, 2015, REV ESP CARDIOL, V68, P1125, DOI 10.1016/j.rec.2015.10.009; Roth GA, 2017, JAMA-J AM MED ASSOC, V317, P1976, DOI 10.1001/jama.2017.4150; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P8, DOI 10.1177/1403494811409654; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Tranberg T, 2017, EUR HEART J, V38, P1645, DOI 10.1093/eurheartj/ehx104; World Health Organization, 1979, MAN INT STAT CLASS D; Ylijoki-Sorensen S, 2014, FORENSIC SCI INT, V244, P289, DOI 10.1016/j.forsciint.2014.09.016	41	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236322	10.1371/journal.pone.0236322	http://dx.doi.org/10.1371/journal.pone.0236322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716962	Green Published, gold			2022-12-26	WOS:000556674500055
J	Zhao, ZH; Ma, JY; Meng, TG; Wang, ZB; Yue, W; Zhou, Q; Li, S; Feng, X; Hou, Y; Schatten, H; Ou, XH; Sun, QY				Zhao, Zheng-Hui; Ma, Jun-Yu; Meng, Tie-Gang; Wang, Zhen-Bo; Yue, Wei; Zhou, Qian; Li, Sen; Feng, Xie; Hou, Yi; Schatten, Heide; Ou, Xiang-Hong; Sun, Qing-Yuan			Single-cell RNA sequencing reveals the landscape of early female germ cell development	FASEB JOURNAL			English	Article						developmental trajectory; meiosis initiation; oocyte; scRNA-seq	PRIMORDIAL FOLLICLE; FATE SPECIFICATION; DNA METHYLATION; MOUSE; DIFFERENTIATION; TROPHECTODERM; SUBUNIT; GENES; TAF4B; CDX2	Meiosis initiation is a crucial step for the production of haploid gametes, which occurs from anterior to posterior in fetal ovaries. The asynchrony of the transition from mitosis to meiosis results in heterogeneity in the female germ cell populations, which limits the studies of meiosis initiation and progression at a higher resolution level. To dissect the process of meiosis initiation, we investigated the transcriptional profiles of 19 363 single germ cells collected from E12.5, E14.5, and E16.5 mouse fetal ovaries. Clustering analysis identified seven groups and defined dozens of corresponding transcription factors, providing a global view of cellular differentiation from primordial germ cells toward meiocytes. Furthermore, we explored the dynamics of gene expression within the developmental trajectory with special focus on the critical state of meiosis. We found that meiosis initiation occurs as early as E12.5 and the cluster of oogonia_4 is the critical state between mitosis and meiosis. Our data provide key insights into the transcriptome features of peri-meiotic female germ cells, which offers new information not only on meiosis initiation and progression but also on screening pathogenic mutations in meiosis-associated diseases.	[Zhao, Zheng-Hui; Meng, Tie-Gang; Wang, Zhen-Bo; Yue, Wei; Zhou, Qian; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Zhao, Zheng-Hui; Wang, Zhen-Bo; Yue, Wei; Zhou, Qian] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Ma, Jun-Yu; Meng, Tie-Gang; Li, Sen; Feng, Xie; Ou, Xiang-Hong; Sun, Qing-Yuan] Guangdong Second Prov Gen Hosp, Fertil Preservat Lab, Reprod Med Ctr, Guangzhou, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Ou, XH; Sun, QY (corresponding author), Guangdong Second Prov Gen Hosp, Fertil Preservat Lab, Reprod Med Ctr, Guangzhou, Peoples R China.	ouxianghong2003@163.com; sunqy@ioz.ac.cn	Zhao, Zhenghui/AAY-6120-2020		National R&D program of China [2018YFA0107701]; National Natural Science Foundation of China (NSFC) [31801245]; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2019GZR110104001]	National R&D program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory	National R&D program of China, Grant/Award Number: 2018YFA0107701; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31801245; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Grant/Award Number: 2019GZR110104001	Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Coto E, 2018, HUM IMMUNOL, V79, P494, DOI 10.1016/j.humimm.2018.03.008; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Falender AE, 2005, DEV BIOL, V288, P405, DOI 10.1016/j.ydbio.2005.09.038; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Guo HS, 2017, CELL RES, V27, P165, DOI 10.1038/cr.2016.128; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jin KX, 2016, DEV NEUROBIOL, V76, P900, DOI 10.1002/dneu.22365; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Korostowski L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002956; Le Bouffant R, 2011, DEVELOPMENT, V138, P5393, DOI 10.1242/dev.068452; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; Nagaoka SI, 2020, SCIENCE, V367, P1089, DOI 10.1126/science.aaw4115; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Onodera K, 2016, BLOOD, V128, P508, DOI 10.1182/blood-2016-02-698118; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Savory JGA, 2014, DEV BIOL, V395, P199, DOI 10.1016/j.ydbio.2014.09.013; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Soh YQS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005531; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Wang J-J, 2019, TRANSCRIPTOME LANDSC; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wen L, 2019, MOL CELL, V76, P320, DOI 10.1016/j.molcel.2019.08.025; Xu YL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0991-1; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yokobayashi S, 2013, NATURE, V495, P236, DOI 10.1038/nature11918; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhao L, 2017, DEV BIOL, V423, P46, DOI 10.1016/j.ydbio.2017.01.013	41	23	23	5	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12634	12645		10.1096/fj.202001034RR	http://dx.doi.org/10.1096/fj.202001034RR		JUL 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716582	Green Submitted			2022-12-26	WOS:000556418400001
J	Halford, EA; Lake, AM; Gould, MS				Halford, Emily A.; Lake, Alison M.; Gould, Madelyn S.			Google searches for suicide and suicide risk factors in the early stages of the COVID-19 pandemic	PLOS ONE			English	Article							INTERNET; EPIDEMIC; TRENDS	A novel coronavirus (SARS-CoV-2), which causes the COVID-19 respiratory illness, emerged in December of 2019 and has since spread globally. The dramatic lifestyle changes and stressors associated with this pandemic pose a threat to mental health and have the potential to exacerbate risk factors for suicide. We used autoregressive integrated moving average (ARIMA) models to assess Google Trends data representing searches in the United States for 18 terms related to suicide and known suicide risk factors following the emergence of COVID-19. Although the relative proportion of Google searches for suicide-related queries was lower than predicted during the early pandemic period, searches for the following queries representative of financial difficulty were dramatically elevated: "I lost my job" (226%; 95%CI, 120%-333%), "laid off" (1164%; 95%CI, 395%-1932%), "unemployment" (1238%; 95%CI, 560%-1915%), and "furlough" (5717%; 95%CI, 2769%-8665%). Searches for the Disaster Distress Helpline, which was promoted as a source of help for those impacted by COVID-19, were also remarkably elevated (3021%; 95%CI, 873%-5169%). Google searches for other queries representative of help-seeking and general mental health concerns were moderately elevated. It appears that some indices of suicidality have fallen in the United States in this early stage of the pandemic, but that COVID-19 may have caused an increase in suicide risk factors that could yield long-term increases in suicidality and suicide rates.	[Halford, Emily A.; Lake, Alison M.; Gould, Madelyn S.] New York State Psychiat Inst & Hosp, Div Child & Adolescent Psychiat, New York, NY 10032 USA; [Gould, Madelyn S.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Gould, Madelyn S.] Columbia Univ, Dept Psychiat, Vagelos Coll Phys & Surg, New York, NY 10027 USA	New York State Psychiatry Institute; Columbia University; Columbia University	Gould, MS (corresponding author), New York State Psychiat Inst & Hosp, Div Child & Adolescent Psychiat, New York, NY 10032 USA.; Gould, MS (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.; Gould, MS (corresponding author), Columbia Univ, Dept Psychiat, Vagelos Coll Phys & Surg, New York, NY 10027 USA.	Madelyn.Gould@nyspi.columbia.edu		Lake, Alison/0000-0002-3288-722X; Gould, Madelyn/0000-0002-2881-9152	Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute	Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute	This project was supported by institutional funds provided by the Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute. There was no additional external funding received for this study.	[Anonymous], LANCET PSYCHIAT; Arora VS, 2016, PUBLIC HEALTH, V137, P147, DOI 10.1016/j.puhe.2015.10.015; Ayers JW, 2017, JAMA INTERN MED, V177, P1527, DOI 10.1001/jamainternmed.2017.3333; Barros JM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173201; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; Cheung YT, 2008, INT J GERIATR PSYCH, V23, P1231, DOI 10.1002/gps.2056; Claassen CA, 2010, BRIT J PSYCHIAT, V196, P359, DOI 10.1192/bjp.bp.109.071928; Gunn JF, 2013, J AFFECT DISORDERS, V148, P411, DOI 10.1016/j.jad.2012.11.004; Hagihara A, 2012, EUR ARCH PSY CLIN N, V262, P39, DOI 10.1007/s00406-011-0212-8; Kristoufek L, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0094-0; Lee JY, 2020, J AFFECT DISORDERS, V262, P155, DOI 10.1016/j.jad.2019.11.014; Ma-Kellams C, 2016, CLIN PSYCHOL SCI, V4, P480, DOI 10.1177/2167702615593475; Parker J, 2017, J AFFECT DISORDERS, V213, P9, DOI 10.1016/j.jad.2016.10.038; REGER MA, JAMA PSYCHIAT; Song TM, 2014, YONSEI MED J, V55, P254, DOI 10.3349/ymj.2014.55.1.254; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; TROUT DL, 1980, SUICIDE LIFE-THREAT, V10, P10; WASSERMAN IM, 1992, SUICIDE LIFE-THREAT, V22, P240; Yang AC, 2011, J AFFECT DISORDERS, V132, P179, DOI 10.1016/j.jad.2011.01.019; Yao H, 2020, LANCET PSYCHIAT, V7, pE21, DOI 10.1016/S2215-0366(20)30090-0	20	35	36	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236777	10.1371/journal.pone.0236777	http://dx.doi.org/10.1371/journal.pone.0236777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OD5ZL	32706835	gold, Green Published			2022-12-26	WOS:000579931700062
J	Mukandavire, Z; Nyabadza, F; Malunguza, NJ; Cuadros, DF; Shiri, T; Musuka, G				Mukandavire, Zindoga; Nyabadza, Farai; Malunguza, Noble J.; Cuadros, Diego F.; Shiri, Tinevimbo; Musuka, Godfrey			Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios	PLOS ONE			English	Article							CORONAVIRUS; CHINA	The emergence and fast global spread of COVID-19 has presented one of the greatest public health challenges in modern times with no proven cure or vaccine. Africa is still early in this epidemic, therefore the extent of disease severity is not yet clear. We used a mathematical model to fit to the observed cases of COVID-19 in South Africa to estimate the basic reproductive number and critical vaccination coverage to control the disease for different hypothetical vaccine efficacy scenarios. We also estimated the percentage reduction in effective contacts due to the social distancing measures implemented. Early model estimates show that COVID-19 outbreak in South Africa had a basic reproductive number of 2.95 (95% credible interval [CrI] 2.83-3.33). A vaccine with 70% efficacy had the capacity to contain COVID-19 outbreak but at very higher vaccination coverage 94.44% (95% Crl 92.44-99.92%) with a vaccine of 100% efficacy requiring 66.10% (95% Crl 64.72-69.95%) coverage. Social distancing measures put in place have so far reduced the number of social contacts by 80.31% (95% Crl 79.76-80.85%). These findings suggest that a highly efficacious vaccine would have been required to contain COVID-19 in South Africa. Therefore, the current social distancing measures to reduce contacts will remain key in controlling the infection in the absence of vaccines and other therapeutics.	[Mukandavire, Zindoga] Coventry Univ, Ctr Data Sci, Coventry, W Midlands, England; [Mukandavire, Zindoga] Coventry Univ, Sch Comp Elect & Math, Coventry, W Midlands, England; [Nyabadza, Farai] Univ Johannesburg, Dept Math & Appl Math, Johannesburg, South Africa; [Malunguza, Noble J.] Natl Univ Sci & Technol, Dept Insurance & Actuarial Sci, Bulawayo, Zimbabwe; [Cuadros, Diego F.] Univ Cincinnati, Dept Geog & Geog Informat Sci, Cincinnati, OH USA; [Cuadros, Diego F.] Univ Cincinnati, Hlth Geog & Dis Modeling Lab, Cincinnati, OH USA; [Shiri, Tinevimbo] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Musuka, Godfrey] Columbia Univ, ICAP, Harare, Zimbabwe	Coventry University; Coventry University; University of Johannesburg; National University of Science & Technology - Zimbabwe; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Liverpool School of Tropical Medicine	Musuka, G (corresponding author), Columbia Univ, ICAP, Harare, Zimbabwe.	gm2660@cumc.columbia.edu	Nyabadza, Farai/AAW-4942-2020	Nyabadza, Farai/0000-0003-3468-5581; Mukandavire, Zindoga/0000-0002-8108-1441; Musuka, Godfrey/0000-0001-9077-4429				Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; [Anonymous], 2020, SSRN; Binti Hamzah FA, 2020, B WHO, DOI 10.2471/BLT.20.255695; Cascella M, 2020, STATPEARLS; Chen ZL, 2020, CHINESE MED J-PEKING, V133, P1044, DOI 10.1097/CM9.0000000000000782; Chutel L., 2020, MOST CORONAVIRUS CAS; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Equils O, 2019, HUM VACC IMMUNOTHER, V15, P637, DOI 10.1080/21645515.2018.1543524; Etbaigha F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202493; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Grant H, 2020, J PUBLIC HEALTH-UK, V42, pE551, DOI 10.1093/pubmed/fdz178; Haffajee F., 2020, FREE STATE RACES CUR; Haider N, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000424; Hansoti B, 2019, ECLINICALMEDICINE, V15, P14, DOI 10.1016/j.eclinm.2019.08.007; Imai N., REPORT 3 TRANSMISSIB; Kolifarhood G, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.620; Kucharski J., 2020, LANCET INFECT DIS; Kwon CM, 2016, INT J MODEL SIMUL SC, V7, DOI 10.1142/S1793962316430030; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Leonenko N. V., 2016, RUSSIAN J NUMERICAL, V31, P1; Li Q., 2020, NEW ENGL J MED, V382, P1199; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442; Liu T., 2020, TRANSMISSION DYNAMIC, DOI 10.1101/2020.01.25.919787; Mukandavire Z., 2020, INT J INFECT DIS; Mukandavire Zindoga, 2011, Proc Natl Acad Sci U S A, V108, P8767, DOI 10.1073/pnas.1019712108; Mukandavire Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep00997; Muniz-Rodriguez K., 2020, EPIDEMIC DOUBLING TI, DOI [10.1101/2020.02.05.20020750v4, DOI 10.1101/2020.02.05.20020750V4]; National Institute for Communicable Diseases, 2020, NAT I COMM DIS COV 1; Nicolson G., 2020, BATTLEGROUND GAUTENG; Paton J., 2020, BLOOMBERG; Peck M., 2019, MMWR-MORBID MORTAL W, P1010; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; Roosa K, 2020, INFECT DIS MODEL, V5, P256, DOI 10.1016/j.idm.2020.02.002; SHEN M, 2020, BIORXIV, DOI [10.1101/2020.01.23.916726, DOI 10.1101/2020.01.23.916726]; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; South African Gorvenment News Agency, 2020, NAT LOCKD EXT BY 2 W; South african government, 2020, 1 CAS COV 19 COR REP; South African Government, 2020, COVID 19 NOV COR; STATS SA, 2019, MID YEAR POP EST 201; STATS SA, 2016, STAT S AFR; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; van den Heever Johann, 2014, OPERATIONAL CHALLENG; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2020, DIR GEN OP REM MED B; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yamey G, 2020, LANCET, V395, P1405, DOI 10.1016/S0140-6736(20)30763-7; Yuen KS, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00404-4; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; Zhao SL, 2020, QUANT BIOL, V8, P11, DOI 10.1007/s40484-020-0199-0; Zhu Z. B., 2020, EPUB, V54, P3	54	41	41	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236003	10.1371/journal.pone.0236003	http://dx.doi.org/10.1371/journal.pone.0236003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706790	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000579931700015
J	Warth, J; Beckmann, N; Puth, MT; Tillmann, J; Porz, J; Zier, U; Weckbecker, K; Weltermann, B; Munster, E				Warth, Jacqueline; Beckmann, Niklas; Puth, Marie-Therese; Tillmann, Judith; Porz, Johannes; Zier, Ulrike; Weckbecker, Klaus; Weltermann, Birgitta; Muenster, Eva			Association between over-indebtedness and antidepressant use: A cross-sectional analysis	PLOS ONE			English	Article							MEDICATION USE; HEALTH; DEBT; DEPRESSION; INEQUALITIES; OLDER; CARE; EPIDEMIOLOGY; ACCESS; RISK	Background Burden of disease caused by depression and its association with socioeconomic status is well documented. However, research on over-indebtedness is scarce although millions of European citizens in all socioeconomic positions are over-indebted. Prior studies suggested that over-indebtedness is associated with poor physical and mental health. Aims Investigate the association between over-indebtedness and antidepressant use in Germany. Method A cross-sectional survey among debt advice agencies' clients was conducted in North Rhine-Westphalia, Germany, in 2017 (OID). Data were merged with the first wave of the German Health Interview and Examination Survey for Adults (DEGS1). Descriptive statistics and logistic regression analysis were used to examine antidepressant use in the previous 7 days (OID: n = 699; DEGS1: n = 7115). Results Prevalence of antidepressant use was higher in the over-indebted (12.3%) than the general population (5.0%). The over-indebted were significantly more likely to use antidepressants than the general population even after controlling for other socioeconomic, demographic and health factors (adjusted odds ratio 1.83; 95% confidence interval 1.35-2.48). Conclusions Stakeholders in health care, debt counselling, research and social policy should consider the link between over-indebtedness and mental illness to advance the understanding of health inequalities and to help those who have mental health and debt problems.	[Warth, Jacqueline; Beckmann, Niklas; Puth, Marie-Therese; Tillmann, Judith; Porz, Johannes; Zier, Ulrike; Weckbecker, Klaus; Weltermann, Birgitta; Muenster, Eva] Univ Bonn, Inst Gen Practice & Family Med, Bonn, Germany; [Puth, Marie-Therese] Univ Hosp Bonn, Dept Med Biometry Informat & Epidemiol IMBIE, Bonn, Germany; [Weckbecker, Klaus] Univ Witten Herdecke, Fac Hlth, Inst Gen Med & Interprofess Care, Dept Med, Herdecke, Germany	University of Bonn; University of Bonn; Witten Herdecke University	Warth, J (corresponding author), Univ Bonn, Inst Gen Practice & Family Med, Bonn, Germany.	jacqueline.warth@ukbonn.de	Weckbecker, Klaus/AGP-8017-2022	Schmitz, Marie-Therese/0000-0003-1351-9381; Warth, Jacqueline/0000-0001-6942-8951; Tillmann, Judith/0000-0002-8142-2015	OID survey Landeszentrum Gesundheit NRW - Centre for Health North Rhine-Westphalia, Germany	OID survey Landeszentrum Gesundheit NRW - Centre for Health North Rhine-Westphalia, Germany	Project manager (EM), OID survey Landeszentrum Gesundheit NRW - Centre for Health North Rhine-Westphalia, Germany - https:// www.lzg.nrw.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2011, AM J PUBLIC HEALTH, V101, P2293, DOI 10.2105/AJPH.2011.300245; Angel S, 2015, J EUR SOC POLICY, V25, P331, DOI 10.1177/0958928715588711; Blomgren J, 2016, INT J PUBLIC HEALTH, V61, P535, DOI 10.1007/s00038-015-0778-4; Boudreau DM, 2004, AM J EPIDEMIOL, V159, P308, DOI 10.1093/aje/kwh038; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Bridges S, 2010, J HEALTH ECON, V29, P388, DOI 10.1016/j.jhealeco.2010.02.003; Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Butterworth P, 2013, J AFFECT DISORDERS, V149, P75, DOI 10.1016/j.jad.2013.01.006; Drentea P, 2012, J AGING HEALTH, V24, P673, DOI 10.1177/0898264311431304; European Commission, 2008, COMM OP EUR DEF OV I; Fryers T, 2003, SOC PSYCH PSYCH EPID, V38, P229, DOI 10.1007/s00127-003-0627-2; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Gathergood J, 2012, ECON J, V122, P1094, DOI 10.1111/j.1468-0297.2012.02519.x; Gnjidic D, 2017, PUBLIC HEALTH RES PR, V27, DOI 10.17061/phrp27341702; Gunasekera CD, 2019, JAMA OPHTHALMOL, V137, P212, DOI 10.1001/jamaophthalmol.2018.5806; Hafferty JD, 2018, J CLIN EPIDEMIOL, V94, P132, DOI 10.1016/j.jclinepi.2017.10.013; Hansen DG, 2004, EUR J CLIN PHARMACOL, V60, P51, DOI 10.1007/s00228-003-0723-y; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P1437, DOI 10.2105/AJPH.2010.300080; Hojman DA, 2016, SOC SCI MED, DOI [10.1001/jama.2016.3445, DOI 10.1001/JAMA.2016.3445]; Jacoby MB, 2002, J LAW MED ETHICS, V30, P560, DOI 10.1111/j.1748-720X.2002.tb00426.x; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Kalousova L, 2014, HEALTH EDUC BEHAV, V41, P155, DOI 10.1177/1090198113493093; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kivimaki M, 2007, PSYCHOL MED, V37, P373, DOI 10.1017/S0033291706009457; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Marcus SC, 2010, ARCH GEN PSYCHIAT, V67, P1265, DOI 10.1001/archgenpsychiatry.2010.151; Meltzer H, 2013, EUR J PUBLIC HEALTH, V23, P108, DOI 10.1093/eurpub/cks021; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Munster E, 2010, GESUNDHEITSWESEN, V72, P67, DOI 10.1055/s-0029-1214397; Munster E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-286; Ochsmann EB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-451; Packness A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020945; R Core Team, 2021, R LANGUAGE ENV STAT; Raymond CB, 2007, PSYCHIAT SERV, V58, P79, DOI 10.1176/appi.ps.58.1.79-a; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Soest T, EPIDEMIOL PSYCH SCI, V21, P87, DOI [10.1017/s2045796011000722, DOI 10.1017/S2045796011000722]; Turunen E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-489; Warth J, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4710-0; Warth J, 2019, PREV MED REP, V16, DOI 10.1016/j.pmedr.2019.100987; WHO WHO, 2018, CAN PEOPL AFF PAY HL; Wong J, 2016, JAMA-J AM MED ASSOC, V315, P2230, DOI 10.1001/jama.2016.3445	43	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236393	10.1371/journal.pone.0236393	http://dx.doi.org/10.1371/journal.pone.0236393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OD5ZL	32706806	gold, Green Published			2022-12-26	WOS:000579931700038
J	Qi, JF; Ding, L; Bao, L; Chen, D				Qi, Junfang; Ding, Li; Bao, Long; Chen, Du			The ratio of shock index to pulse oxygen saturation predicting mortality of emergency trauma patients	PLOS ONE			English	Article							BRAIN-INJURY; SCORE; SEVERITY; AGE	Objective To test the following hypothesis: the ratio of shock index to pulse oxygen saturation can better predict the mortality of emergency trauma patients than shock index. Methods 1723 Patients of trauma admitted to the Emergency Department of the First Affiliated Hospital of Soochow University from 1 November 2016 to 30 November 2019 were retrospectively evaluated. We defined SS as the ratio of SI to SPO2, and the mortality of trauma patients in the emergency department as end-point of outcome. We calculated the crude HR of SS and adjusted HR with the adjustment for risk factors including sex, age, revised trauma score (RTS) by Cox regression model. ROC curve analyses were performed to compare the area under the curve (AUC) of SS and SI. Results The crude HR of SS was: 4.31, 95%CI (2.89-6.42) and adjusted HR: 3.01, 95%CI(1.86-4.88); ROC curve analyses showed that AUC of SS was higher than that of shock index (SI), and the difference was statistically significant: 0.69, 95%CI(0.55-0.83) vs 0.65, 95%CI (0.51-0.79), P = 0.001. Conclusion The ratio of shock index to pulse oxygen saturation is good predictor for emergency trauma patients, which has a better prognostic value than shock index.	[Qi, Junfang; Ding, Li; Bao, Long] Soochow Univ, Dept Emergency Med, Affiliated Hosp 1, Suzhou, Peoples R China; [Chen, Du] Soochow Univ, Dept Crit Care Med, Affiliated Hosp 1, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Chen, D (corresponding author), Soochow Univ, Dept Crit Care Med, Affiliated Hosp 1, Suzhou, Peoples R China.	sdfyycd@suda.edu.cn	Chen, Du/AAM-8789-2021	Chen, Du/0000-0001-6990-3310; Qi, Junfang/0000-0003-0917-4202	First Affiliated Hospital of Soochow University	First Affiliated Hospital of Soochow University	We would like to acknowledge the First Affiliated Hospital of Soochow University for providing database that supported this research.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balhara KS, 2017, EMERG MED J, V34, P89, DOI 10.1136/emermed-2015-205532; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Charry José D., 2015, rev. colomb. cir., V30, P24; Cortés-Samacá Carlos Andrés, 2018, Rev. colomb. anestesiol., V46, P208, DOI 10.1097/cj9.0000000000000064; Huber-Wagner S, 2010, EUR J MED RES, V15, P185, DOI 10.1186/2047-783X-15-5-185; Jeong JH, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0272-4; Jin WYY, 2018, ULUS TRAVMA ACIL CER, V24, P532, DOI 10.5505/tjtes.2018.29434; Kimura A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2014-0; Kimura A, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-9; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Kunitake Ryan C, 2018, Trauma Surg Acute Care Open, V3, pe000131, DOI 10.1136/tsaco-2017-000131; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; Mcnab A, 2013, SURGERY, V154, P384, DOI 10.1016/j.surg.2013.05.007; Mcnab A, 2012, SURGERY, V152, P473, DOI 10.1016/j.surg.2012.07.010; Mitra B, 2014, INJURY, V45, P61, DOI 10.1016/j.injury.2013.01.010; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Raux M, 2006, INTENS CARE MED, V32, P405, DOI 10.1007/s00134-005-0063-8; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Singh A, 2014, N AM J MED SCI, V6, P450, DOI 10.4103/1947-2714.141632; Sloan EP, 2014, WEST J EMERG MED, V15, P795, DOI 10.5811/westjem.2014.7.21304; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Wu SC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112346	25	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236094	10.1371/journal.pone.0236094	http://dx.doi.org/10.1371/journal.pone.0236094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701972	gold, Green Published			2022-12-26	WOS:000575913700049
J	Ekwealor, JTB; Fisher, KM				Ekwealor, Jenna T. B.; Fisher, Kirsten M.			Life under quartz: Hypolithic mosses in the Mojave Desert	PLOS ONE			English	Article							UV-B TOLERANCE; ULTRAVIOLET-RADIATION; SYNTRICHIA-CANINERVIS; MICROBIAL COMMUNITY; SEX-RATIOS; PHOTOSYNTHESIS; BRYOPHYTES; CYANOBACTERIA; COLONIZATION; ASSEMBLAGE	Several species of dryland cyanobacteria are known to occur as hypoliths under semi-translucent rocks. In the Mojave Desert, these organisms find refuge from intense solar radiation under milky quartz where moisture persists for a longer period of time than in adjacent soil surface habitat. Desert mosses, which are extremely desiccation-tolerant, can also occur in these hypolithic spaces, though little is known about this unique moss microhabitat and how species composition compares to that of adjacent soil surface communities. To address this question, we deployed microclimate dataloggers and collected moss samples from under and adjacent to 18 milky quartz rocks (quartz mean center thickness 26 +/- 15 mm) in a western high elevation Mojave Desert site. Light transmission through Mojave quartz rocks may be as low as 1.2%, and data from microclimate loggers deployed for five months support the hypothesis that quartz provides thermal buffering and higher relative humidity compared to the soil surface. Of the 53 samples collected from hypolith and surface microhabitats, 68% wereSyntrichia caninervis, the dominant bryophyte of the Mojave Desert biological soil crust.Tortula inermisaccounted for 28% of the samples and 4% wereBryum argenteum. In a comparison of moss community composition, we found thatS.caninerviswas more likely to be on the soil surface, though it was abundant in both microhabitats, whileT.inermiswas more restricted to hypoliths, perhaps due to protection from temperature extremes. In our study site, the differences between hypolithic and surface microhabitats enable niche partitioning betweenT.inermisandS.caninervis, enhancing alpha diversity. This work points to the need to thoroughly consider microhabitats when assessing bryophyte species diversity and modelling species distributions. This focus is particularly important in extreme environments, where mosses may find refuge from the prevailing macroclimatic conditions in microhabitats such as hypoliths.	[Ekwealor, Jenna T. B.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Fisher, Kirsten M.] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	University of California System; University of California Berkeley; California State University System; California State University Los Angeles	Ekwealor, JTB (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	jtbe@berkeley.edu	Ekwealor, Jenna/K-6733-2019	Ekwealor, Jenna/0000-0001-9014-8786; Fisher, Kirsten/0000-0001-6505-1309	California State University, Los Angeles, Department of Biological Sciences Faculty-Student Achievement Fund; University of California, Berkeley, Department of Integrative Biology Graduate Research Fund; NIH-NIGMS Minority Biomedical Research Support-Research Initiative for Scientific Enhancement program [GM61331]; NSF Dimensions of Biodiversity award [DEB-1638996, DEB-1638956]; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	California State University, Los Angeles, Department of Biological Sciences Faculty-Student Achievement Fund; University of California, Berkeley, Department of Integrative Biology Graduate Research Fund; NIH-NIGMS Minority Biomedical Research Support-Research Initiative for Scientific Enhancement program; NSF Dimensions of Biodiversity award(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	This work was supported by the California State University, Los Angeles, Department of Biological Sciences Faculty-Student Achievement Fund to K.M.F.; the University of California, Berkeley, Department of Integrative Biology Graduate Research Fund to J.T.B.E.; the NIH-NIGMS Minority Biomedical Research Support-Research Initiative for Scientific Enhancement program (GM61331) to J.T.B.E.; and the NSF Dimensions of Biodiversity award (DEB-1638996 and DEB-1638956) to K.M.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication made possible in part by support from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library.	ALPERT P, 1985, ECOLOGY, V66, P660, DOI 10.2307/1940527; ALPERT P, 1979, BRYOLOGIST, V82, P65, DOI 10.2307/3241969; ALPERT P, 1987, AM J BOT, V74, P1787, DOI 10.2307/2443962; [Anonymous], 2001, AM J BOT; Bahl J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1167; BATES JW, 1992, J BRYOL, V17, P223, DOI 10.1179/jbr.1992.17.2.223; Baughman JT, 2017, AM J BOT, V104, P733, DOI 10.3732/ajb.1700045; Belnap J, 2003, BIOSCIENCE, V53, P739, DOI 10.1641/0006-3568(2003)053[0739:BIMTEF]2.0.CO;2; Bowker MA, 2000, AM J BOT, V87, P517, DOI 10.2307/2656595; Chan YK, 2012, ENVIRON MICROBIOL, V14, P2272, DOI 10.1111/j.1462-2920.2012.02821.x; Cockell CS, 2008, J PHOTOCH PHOTOBIO B, V90, P79, DOI 10.1016/j.jphotobiol.2007.11.009; Cockell CS, 2006, ARCT ANTARCT ALP RES, V38, P335, DOI 10.1657/1523-0430(2006)38[335:HCOORI]2.0.CO;2; Coe KK, 2012, ECOLOGY, V93, P1626, DOI 10.1890/11-2247.1; COVE DJ, 1978, PHOTOCHEM PHOTOBIOL, V27, P249, DOI 10.1111/j.1751-1097.1978.tb07596.x; Cowan DA, 2011, ENV MICROBIOL REP, V3, P581, DOI 10.1111/j.1758-2229.2011.00266.x; Cowan DA, 2010, ANTARCT SCI, V22, P714, DOI 10.1017/S0954102010000507; CRIDLAND ARTHUR A., 1959, BRYOLOGIST, V62, P132; Darwin C, 1859, ORIGINS SPECIES MEAN; de los Rios A, 2014, POLAR BIOL, V37, P1823, DOI 10.1007/s00300-014-1564-0; Dunn JL, 2006, GLOBAL CHANGE BIOL, V12, P2282, DOI 10.1111/j.1365-2486.2006.01283.x; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fisher, 2020, FRONT ECOL EVOL, V7, P518, DOI DOI 10.3389/FEVO.2019.00518; Gause G. F., 1934, STRUGGLE EXISTENCE; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Hamerlynck EP, 2002, OECOLOGIA, V131, P498, DOI 10.1007/s00442-002-0925-5; Herrnstadt I, 2005, BRYOLOGIST, V108, P101, DOI 10.1639/0007-2745(2005)108[101:RSOBDI]2.0.CO;2; Johnson N.L., 1934, STAT METHODS RES WOR, V5 Edn; Koch K, 2008, SOFT MATTER, V4, P1943, DOI 10.1039/b804854a; Lacap-Bugler DC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00867; Lin R-G II, 2019, LOS ANGELES TIM 1126; Makhalanyane TP, 2013, ISME J, V7, P2080, DOI 10.1038/ismej.2013.94; Malcolm B., 2009, CALIFORNIA MOSSES; Marschall M, 2004, ANN BOT-LONDON, V94, P593, DOI 10.1093/aob/mch178; Mills SE, 2005, BRYOLOGIST, V108, P86, DOI 10.1639/0007-2745(2005)108[86:FIBAAD]2.0.CO;2; Mishler B. D, 2007, FLORA N AM N MEXICO, V27, P618; Muller G, 2009, GEOGR RES, V47, P449, DOI 10.1111/j.1745-5871.2009.00591.x; Norris Daniel H., 2004, Madrono, V51, P133; Nunez-Olivera E, 2005, BRYOLOGIST, V108, P435, DOI 10.1639/0007-2745(2005)108[0435:ATUTOS]2.0.CO;2; Paasch AE, 2015, INT J PLANT SCI; Pointing S.B., 2016, BIOL SOIL CRUSTS ORG, P199, DOI DOI 10.1007/978-3-319-30214-0; Pointing SB, 2012, NAT REV MICROBIOL, V10, P551, DOI 10.1038/nrmicro2831; Proctor MCF, 2007, BRYOLOGIST, V110, P595, DOI 10.1639/0007-2745(2007)110[595:DIBAR]2.0.CO;2; Robinson SA, 2005, GLOBAL CHANGE BIOL, V11, P476, DOI 10.1111/j.1365-2486.2005.00911.x; Robinson SA, 2014, ADV PHOTOSYNTH RESP, V37, P113, DOI 10.1007/978-94-007-6988-5_7; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Saucedo C, 2019, KTLA5           1223; Schlesinger WH, 2003, ECOLOGY, V84, P3222, DOI 10.1890/02-0549; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Smith MC, 2000, ANTARCT SCI, V12, P177, DOI 10.1017/S0954102000000237; Stark LR, 1997, BRYOLOGIST, V100, P13; Stark LR, 2005, J BRYOL, V27, P231, DOI 10.1179/174328205X69977; Stomeo F, 2013, EXTREMOPHILES, V17, P329, DOI 10.1007/s00792-013-0519-7; Takacs Z, 1999, J PHOTOCH PHOTOBIO B, V48, P210, DOI 10.1016/S1011-1344(99)00029-9; Tracy CR, 2010, ENVIRON MICROBIOL, V12, P592, DOI 10.1111/j.1462-2920.2009.02098.x; Vikram S, 2016, ENVIRON MICROBIOL, V18, P1875, DOI 10.1111/1462-2920.13088; Von Quednow C., 2019, KTLA5           1226; Warren-Rhodes KA, 2006, MICROB ECOL, V52, P389, DOI 10.1007/s00248-006-9055-7; WEBER B, 2013, ECOL PROCESS, V2, pNIL1, DOI DOI 10.1186/2192-1709-2-8; Wei STS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01642; WERGER MJA, 1989, BRYOLOGIST, V92, P411, DOI 10.2307/3243412; Wigglesworth A, 2019, LOS ANGELES TIM 1129; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wong FKY, 2010, MICROB ECOL, V60, P730, DOI 10.1007/s00248-010-9653-2; Wu N, 2014, FUNCT PLANT BIOL, V41, P168, DOI 10.1071/FP13054; WYNNWILLIAMS DD, 1994, ANTAR RES S, V62, P243, DOI DOI 10.1029/AR062P0243; Zhang J, 2009, J HYDROL, V379, P220, DOI 10.1016/j.jhydrol.2009.09.053; Zheng YP, 2011, ARID LAND RES MANAG, V25, P116, DOI 10.1080/15324982.2011.554956	67	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0235928	10.1371/journal.pone.0235928	http://dx.doi.org/10.1371/journal.pone.0235928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697785	Green Submitted, Green Published, gold			2022-12-26	WOS:000555392700015
J	Tariverdi, A; Venkiteswaran, VK; Martinsen, OG; Elle, OJ; Torresen, J; Misra, S				Tariverdi, Abbas; Venkiteswaran, Venkatasubramanian Kalpathy; Martinsen, Orjan Grottem; Elle, Ole Jacob; Torresen, Jim; Misra, Sarthak			Dynamic modeling of soft continuum manipulators using lie group variational integration	PLOS ONE			English	Article							GEOMETRICALLY EXACT MODEL; CATHETER; MECHANICS; ROBOTS; SYSTEM; DEFORMATION; DESIGN	This paper presents the derivation and experimental validation of algorithms for modeling and estimation of soft continuum manipulators using Lie group variational integration. Existing approaches are generally limited to static and quasi-static analyses, and are not sufficiently validated for dynamic motion. However, in several applications, models need to consider the dynamical behavior of the continuum manipulators. The proposed modeling and estimation formulation is obtained from a discrete variational principle, and therefore grants outstanding conservation properties to the continuum mechanical model. The main contribution of this article is the experimental validation of the dynamic model of soft continuum manipulators, including external torques and forces (e.g., generated by magnetic fields, friction, and the gravity), by carrying out different experiments with metal rods and polymer-based soft rods. To consider dissipative forces in the validation process, distributed estimation filters are proposed. The experimental and numerical tests also illustrate the algorithm's performance on a magnetically-actuated soft continuum manipulator. The model demonstrates good agreement with dynamic experiments in estimating the tip position of a Polydimethylsiloxane (PDMS) rod. The experimental results show an average absolute error and maximum error in tip position estimation of 0.13 mm and 0.58 mm, respectively, for a manipulator length of 60.55 mm.	[Tariverdi, Abbas; Martinsen, Orjan Grottem] Univ Oslo, Dept Phys, Oslo, Norway; [Venkiteswaran, Venkatasubramanian Kalpathy; Misra, Sarthak] Univ Twente, Dept Biomech Engn, Enschede, Netherlands; [Martinsen, Orjan Grottem] Oslo Univ Hosp, Dept Clin & Biomed Engn, Oslo, Norway; [Elle, Ole Jacob] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Elle, Ole Jacob; Torresen, Jim] Univ Oslo, Dept Informat, Oslo, Norway; [Misra, Sarthak] Univ Groningen, Dept Biomed Engn, Groningen, Netherlands; [Misra, Sarthak] Univ Med Ctr Groningen, Groningen, Netherlands	University of Oslo; University of Twente; University of Oslo; University of Oslo; University of Oslo; University of Groningen; University of Groningen	Tariverdi, A (corresponding author), Univ Oslo, Dept Phys, Oslo, Norway.	abbast@uio.no	Martinsen, Orjan G/M-4459-2014	Martinsen, Orjan G/0000-0003-1632-4352				Abraham R., 1978, FDN MECH; Bobenko AI, 1999, COMMUN MATH PHYS, V204, P147, DOI 10.1007/s002200050642; Burgner J, 2013, IEEE T BIO-MED ENG, V60, P2567, DOI 10.1109/TBME.2013.2260860; Camarillo DB, 2009, IEEE T ROBOT, V25, P798, DOI 10.1109/TRO.2009.2022426; Camarillo DB, 2008, IEEE T ROBOT, V24, P1262, DOI 10.1109/TRO.2008.2002311; Carpi F, 2009, EXPERT REV MED DEVIC, V6, P487, DOI [10.1586/erd.09.32, 10.1586/ERD.09.32]; Cianchetti M, 2013, IEEE INT C INT ROBOT, P3576, DOI 10.1109/IROS.2013.6696866; Demoures F, 2015, NUMER MATH, V130, P73, DOI 10.1007/s00211-014-0659-4; Grady MS, 2000, J NEUROSURG, V93, P282, DOI 10.3171/jns.2000.93.2.0282; Grazioso S, 2019, SOFT ROBOT, V6, P790, DOI 10.1089/soro.2018.0047; Greigarn T, 2015, IEEE INT CONF ROBOT, P2236, DOI 10.1109/ICRA.2015.7139495; Guo SX, 1996, IEEE INT CONF ROBOT, P2226, DOI 10.1109/ROBOT.1996.506495; Heunis C, 2018, IEEE ROBOT AUTOM MAG, V25, P71, DOI 10.1109/MRA.2017.2787784; Holm D. D., 2011, GEOMETRIC MECH 2; Jones BA, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2659, DOI 10.1109/IROS.2009.5354199; Jung J, 2014, ADV ROBOTICS, V28, P557, DOI 10.1080/01691864.2013.879371; Kesner SB, 2011, IEEE T ROBOT, V27, P1045, DOI 10.1109/TRO.2011.2160467; Laschi C, 2016, SCI ROBOT, V1, DOI 10.1126/scirobotics.aah3690; Lee T., 2008, COMPUTATIONAL GEOMET; Leitz T., 2014, MULTIBODY DYNAMICS, P175, DOI DOI 10.1007/978-3-319-07260-9_8; Lock J, 2010, IEEE INT C INT ROBOT, P2325, DOI 10.1109/IROS.2010.5651240; LU P, 1995, INT J CONTROL, V62, P633, DOI 10.1080/00207179508921561; Mahvash M, 2011, IEEE T ROBOT, V27, P334, DOI 10.1109/TRO.2011.2105410; Marsden J. E., 1994, TEXTS APPL MATH, V17; Pai DK, 2002, COMPUT GRAPH FORUM, V21, P347, DOI 10.1111/1467-8659.00594; Polygerinos P, 2017, ADV ENG MATER, V19, DOI 10.1002/adem.201700016; Roesthuis RJ, 2016, IEEE T ROBOT, V32, P372, DOI 10.1109/TRO.2016.2527047; Rucker DC, 2010, IEEE T ROBOT, V26, P769, DOI 10.1109/TRO.2010.2062570; Rucker DC, 2010, INT J ROBOT RES, V29, P1263, DOI 10.1177/0278364910367543; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Sikorski Jakub, 2017, 2017 IEEE International Conference on Robotics and Automation (ICRA), P3594, DOI 10.1109/ICRA.2017.7989413; Sikorski J, 2019, IEEE T MAGN, V55, DOI 10.1109/TMAG.2019.2917370; SIMO JC, 1985, COMPUT METHOD APPL M, V49, P55, DOI 10.1016/0045-7825(85)90050-7; Tang W, 2012, IEEE T BIO-MED ENG, V59, P2211, DOI 10.1109/TBME.2012.2199319; Thomas TL, 2020, J MECH ROBOT, V12, DOI 10.1115/1.4046838; Tunay I, 2013, IEEE T ROBOT, V29, P297, DOI 10.1109/TRO.2012.2232532; Tunay I, 2011, IEEE ENG MED BIO, P8344, DOI 10.1109/IEMBS.2011.6092058; Venkiteswaran VK, 2019, MECH MACH THEORY, V139, P34, DOI 10.1016/j.mechmachtheory.2019.04.008; Webster RJ, 2010, INT J ROBOT RES, V29, P1661, DOI 10.1177/0278364910368147; Webster RJ, 2009, IEEE T ROBOT, V25, P67, DOI 10.1109/TRO.2008.2006868; Xu K, 2008, IEEE T ROBOT, V24, P576, DOI 10.1109/TRO.2008.924266; Xu K, 2010, J MECH ROBOT, V2, DOI 10.1115/1.4000519; Xu K, 2010, IEEE T ROBOT, V26, P555, DOI 10.1109/TRO.2010.2046924	43	5	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2020	15	7							e0236121	10.1371/journal.pone.0236121	http://dx.doi.org/10.1371/journal.pone.0236121			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MU0WZ	32697813	Green Published, gold			2022-12-26	WOS:000555392700027
J	Szpitalak, M; Polczyk, R				Szpitalak, Malwina; Polczyk, Romuald			Reducing interrogative suggestibility: The role of self-affirmation and positive feedback	PLOS ONE			English	Article							CONFIDENCE; MEMORY; MISINFORMATION; PERFORMANCE; PSYCHOLOGY; RESPONSES	Interrogative suggestibility, as measured with Gudjonsson Suggestibility Scales, consists of an individual's tendency to yield to misleading questions (Yield) and to change answers after negative feedback (Shift). This study aimed to determine whether reinforced self-affirmation (RSA), a technique that aims to boost self-confidence in order to increase the tendency to rely on one's own memory instead of external cues, can reduce interrogative suggestibility. RSA consists of self-affirmation induced by means of writing down one's greatest achievements in life and of manipulated positive feedback. The efficacy of two kinds of positive feedback was explored. Shift was reduced by positive feedback relating both to memory and to the feeling that a person is very independent in their judgements, while only feedback related to memory reduced Yield. The results are discussed in terms of the different mechanisms underlying Yield and Shift. Inducing independence of judgements might not have been effective in the case of Yield because to some extent it taps opinions but not the quality of a cognitive process such as memory. An individual may believe in their own opinions and views but still be unsure about the quality of their own memory.	[Szpitalak, Malwina; Polczyk, Romuald] Jagiellonian Univ, Inst Psychol, Krakow, Poland	Jagiellonian University	Polczyk, R (corresponding author), Jagiellonian Univ, Inst Psychol, Krakow, Poland.	romuald.polczyk@uj.edu.pl			Narodowe Centrum Nauki [National Science Centre], Poland: 'Mechanisms of reinforced self-affirmation effect' [UMO-2016/23/D/HS6/01677]	Narodowe Centrum Nauki [National Science Centre], Poland: 'Mechanisms of reinforced self-affirmation effect'	This study was supported by a grant from the Narodowe Centrum Nauki [National Science Centre], Poland: 'Mechanisms of reinforced self-affirmation effect', Nr UMO-2016/23/D/HS6/01677, for Malwina Szpitalak.	Abele AE, 2007, J PERS SOC PSYCHOL, V93, P751, DOI 10.1037/0022-3514.93.5.751; Adler WP, 1990, EFFECT TASK APPROPRI; [Anonymous], 2012, MOTYWACYJNE MECHANIZ; [Anonymous], 2011, JAPANESE J HLTH PSYC, DOI [10.11560/jahp.24.1_45, DOI 10.11560/JAHP.24.1_45]; [Anonymous], 2017, POL PSYCHOL BULL, DOI [10.1515/PPB-2017-0045, DOI 10.1515/PPB-2017-0045]; Bain S. A., 2000, LEGAL CRIMINOL PSYCH, V5, P123, DOI DOI 10.1348/135532500168029; Bain SA, 2004, LEGAL CRIMINOL PSYCH, V9, P239, DOI 10.1348/1355325041719419; Bakan D ., 1966, DUALITY HUMAN EXISTE; Barber N, 2008, SELF CONFIDENCE KNOW; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Baxter JS, 2006, PERS INDIV DIFFER, V40, P87, DOI 10.1016/j.paid.2005.06.017; Beckmann N, 2009, LEARN INDIVID DIFFER, V19, P277, DOI 10.1016/j.lindif.2008.09.008; BINET Alfred., 1900, LA SUGGESTIBILITE; Blank H, 1998, MEMORY, V6, P481, DOI 10.1080/741943086; Boon J. C. W., 2000, LEGAL CRIMINOL PSYCH, V5, P273, DOI DOI 10.1348/135532500168137; Brewer N, 2011, CURR DIR PSYCHOL SCI, V20, P24, DOI 10.1177/0963721410389169; Clark N. K., 1986, SOCIAL BEHAVIOUR, V1, P83; Elizabeth F., 1996, EYEWITNESS TESTIMONY; Frenda SJ, 2011, CURR DIR PSYCHOL SCI, V20, P20, DOI 10.1177/0963721410396620; Gudjonsson G.H., 2018, PSYCHOL FALSE CONFES; Gudjonsson G.H., 1997, GUDJONSSON SUGGESTIB; Gudjonsson GH, 2003, PSYCHOL INTERROGATIO; Henkel LA, 2017, PSYCHOL CRIME LAW, V23, P97, DOI 10.1080/1068316X.2016.1225051; Hollenbeck GP, 2004, ORGAN DYN, V33, P254, DOI 10.1016/j.orgdyn.2004.06.003; Howe ML, 2013, MEMORY, V21, P576, DOI 10.1080/09658211.2012.725735; Keppel G., 2004, DESIGN AND ANAL; Kleitman S, 2007, LEARN INDIVID DIFFER, V17, P161, DOI 10.1016/j.lindif.2007.03.004; Linton Christopher P., 1994, Australian Journal of Clinical and Experimental Hypnosis, V22, P53; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; Luna K, 2012, APPL COGNITIVE PSYCH, V26, P687, DOI 10.1002/acp.2845; MACBRIDE PD, 1965, J PSYCHOL, V60, P9, DOI 10.1080/00223980.1965.10545258; Mastroberardino S, 2013, LEGAL CRIMINOL PSYCH, V18, P274, DOI 10.1111/j.2044-8333.2012.02048.x; MCCARTY PA, 1986, ACAD MANAGE J, V29, P840, DOI 10.2307/255950; McMurtrie H, 2012, PERS INDIV DIFFER, V53, P958, DOI 10.1016/j.paid.2012.07.008; Morocco PE ., 1978, EFFECTS DESCRIPTIVE; PETRUZZELLO SJ, 1988, J SPORT EXERCISE PSY, V10, P174, DOI 10.1123/jsep.10.2.174; Polczyk R, 2005, PERS INDIV DIFFER, V38, P177, DOI 10.1016/j.paid.2004.03.018; REEDER GD, 1979, PSYCHOL REV, V86, P61, DOI 10.1037/0033-295X.86.1.61; Rosnow R. L., 1985, CONTRASTS ANAL FOCUS; Rosnow RL, 1992, METHODOLOGICAL ISSUE, P337; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schooler J.W., 1986, SOC BEHAV, V1, P105, DOI DOI 10.1006/JESP.1993.1003; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Srivastava S. K., 2013, J PSYCHOSOCIAL RES, V8, P41; Stankov L, 1997, INTELLIGENCE, V25, P93, DOI 10.1016/S0160-2896(97)90047-7; STEELE CM, 1983, J PERS SOC PSYCHOL, V45, P5, DOI 10.1037/0022-3514.45.1.5; Szpitalak M., 2012, STUD PSYCHOL, V50, P63; Szpitalak M., 2011, PROBLEMS FORENSIC SC, V85, P40; Szpitalak M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210987; Szpitalak M, 2016, PSYCHIAT PSYCHOL LAW, V23, P512, DOI 10.1080/13218719.2015.1081088; Szpitalak M, 2015, PSYCHOL CRIME LAW, V21, P911, DOI 10.1080/1068316X.2015.1077243; Thorley C, 2017, PSYCHOL CRIME LAW, V23, P342, DOI 10.1080/1068316X.2016.1258471; TOUSIGNANT JP, 1986, MEM COGNITION, V14, P329, DOI 10.3758/BF03202511; van Bergen S, 2010, APPL COGNITIVE PSYCH, V24, P885, DOI 10.1002/acp.1595; Vealey R.S., 2008, ADV SPORT PSYCHOL, V3rd, P68; Vrij A, 2000, PSYCHOL CRIME LAW, V6, P127, DOI 10.1080/10683160008410837; Wagstaff GF, 2011, J POLICE CRIM PSYCHO, V26, P152, DOI 10.1007/s11896-010-9082-7	57	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0236088	10.1371/journal.pone.0236088	http://dx.doi.org/10.1371/journal.pone.0236088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MS9QL	32692764	gold, Green Published			2022-12-26	WOS:000554606400023
J	Hao, PC; Xia, J; Liu, J; Di Donato, M; Pakula, K; Bailly, A; Jasinski, M; Geisler, M				Hao, Pengchao; Xia, Jian; Liu, Jie; Di Donato, Martin; Pakula, Konrad; Bailly, Aurelien; Jasinski, Michal; Geisler, Markus			Auxin-transporting ABC transporters are defined by a conserved D/E-P motif regulated by a prolylisomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; ABCB; PPIase; FKBP; Twisted Dwarf1; auxin transport; ABC transporter; auxin; plant biochemistry; membrane transport; post-transcriptional regulation; auxin transport	TRANSMEMBRANE CONDUCTANCE REGULATOR; TWISTED DWARF1; LATERAL ROOT; PROTEIN-PHOSPHORYLATION; FUNCTIONALLY INTERACTS; PROLINE RESIDUES; ARABIDOPSIS; GLYCOPROTEIN; PLANT; IMMUNOPHILIN	The plant hormone auxin must be transported throughout plants in a cell-to-cell manner to affect its various physiological functions. ABCB transporters are critical for this polar auxin distribution, but the regulatory mechanisms controlling their function is not fully understood. The auxin transport activity of ABCB1 was suggested to be regulated by a physical interaction with FKBP42/Twisted Dwarf1 (TWD1), a peptidylprolylcis-transisomerase (PPIase), but all attempts to demonstrate such a PPIase activity by TWD1 have failed so far. By using a structure-based approach, we identified several surface-exposed proline residues in the nucleotide binding domain and linker of Arabidopsis ABCB1, mutations of which do not alter ABCB1 protein stability or location but do affect its transport activity. P1008 is part of a conserved signature D/E-P motif that seems to be specific forauxin-transportingABCBs, which we now refer to as ATAs. Mutation of the acidic residue also abolishes auxin transport activity by ABCB1. All higher plant ABCBs for which auxin transport has been conclusively proven carry this conserved motif, underlining its predictive potential. Introduction of this D/E-P motif into malate importer, ABCB14, increases both its malate and its background auxin transport activity, suggesting that this motif has an impact on transport capacity. The D/E-P1008 motif is also important for ABCB1-TWD1 interactions and activation of ABCB1-mediated auxin transport by TWD1. In summary, our data imply a new function for TWD1 acting as a putative activator of ABCB-mediated auxin transport bycis-transisomerization of peptidyl-prolyl bonds.	[Hao, Pengchao; Xia, Jian; Liu, Jie; Di Donato, Martin; Geisler, Markus] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Pakula, Konrad; Jasinski, Michal] Polish Acad Sci, Inst Bioorgan Chem, Dept Plant Mol Physiol, Poznan, Poland; [Pakula, Konrad] Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland; [Bailly, Aurelien] Inst Plant & Microbial Biol, Zurich, Switzerland; [Jasinski, Michal] Poznan Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland	University of Fribourg; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Adam Mickiewicz University; Poznan University of Life Sciences	Geisler, M (corresponding author), Univ Fribourg, Dept Biol, Fribourg, Switzerland.	markus.geisler@unifr.ch	Jasinski, Michal/AAA-3167-2022; Geisler, Markus M/B-3921-2012; Di Donato, Martin/D-7045-2016	Geisler, Markus M/0000-0002-6641-5810; Pakula, Konrad/0000-0003-4189-1981; Jasinski, Michal/0000-0003-0904-5873; Bailly, Aurelien/0000-0001-5546-1945; Di Donato, Martin/0000-0002-5642-2523	Swiss National Fund Grant [31003A-165877/1]; ESA CORA grant LIRAT; Polish National Center for Research and Development Ph.D. program [POWR.03.02.00-00-1032/16]	Swiss National Fund Grant; ESA CORA grant LIRAT; Polish National Center for Research and Development Ph.D. program	This work was supported by Swiss National Fund Grant 31003A-165877/1 and ESA CORA grant LIRAT (to M. G.). This work was also supported by the Polish National Center for Research and Development Ph.D. program POWR.03.02.00-00-1032/16 (to K. P.).	Aryal B, 2015, BIOCHEM SOC T, V43, P966, DOI 10.1042/BST20150128; BAGINSKI E S, 1975, Annals of Clinical and Laboratory Science, V5, P399; Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Bailly A, 2006, PLANT SIGNAL BEHAV, V1, P277, DOI 10.4161/psb.1.6.3531; Bailly A, 2014, PLANT J, V77, P108, DOI 10.1111/tpj.12369; Bailly A, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00108; Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Billet A, 2013, J CYST FIBROS, V12, P737, DOI 10.1016/j.jcf.2013.02.002; Cant N, 2014, INT J BIOCHEM CELL B, V52, P15, DOI 10.1016/j.biocel.2014.02.004; Chang G, 2003, FEBS LETT, V555, P102, DOI 10.1016/S0014-5793(03)01085-8; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; CURRIER SJ, 1992, J BIOL CHEM, V267, P25153; Dacres H, 2010, ANAL CHEM, V82, P432, DOI 10.1021/ac9022956; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2014, PLANT BIOLOGY, V16, P50, DOI 10.1111/plb.12030; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2004, MOL BIOL CELL, V15, P3393, DOI 10.1091/mbc.E03-11-0831; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Geisler M, 2007, TRENDS PLANT SCI, V12, P465, DOI 10.1016/j.tplants.2007.08.015; Geisler M, 2018, CURR OPIN PLANT BIOL, V46, P104, DOI 10.1016/j.pbi.2018.09.005; Geisler M, 2016, PLANT SCI, V245, P1, DOI 10.1016/j.plantsci.2015.12.004; Grones P, 2015, J CELL SCI, V128, P1, DOI 10.1242/jcs.159418; Hemenway CS, 1996, J BIOL CHEM, V271, P18527, DOI 10.1074/jbc.271.31.18527; Henrichs S, 2012, EMBO J, V31, P2965, DOI 10.1038/emboj.2012.120; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hrycyna CA, 1998, BIOCHEMISTRY-US, V37, P13660, DOI 10.1021/bi9808823; Hutt DM, 2012, J BIOL CHEM, V287, P21914, DOI 10.1074/jbc.M112.339788; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Ivanchenko MG, 2015, DEVELOPMENT, V142, P712, DOI 10.1242/dev.113225; Kamimoto Y, 2012, PLANT CELL PHYSIOL, V53, P2090, DOI 10.1093/pcp/pcs149; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kim JY, 2010, J BIOL CHEM, V285, P23307, DOI 10.1074/jbc.M110.105981; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lu XL, 2015, PLANT PHYSIOL, V168, P814, DOI 10.1104/pp.15.00182; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Mravec J, 2008, DEVELOPMENT, V135, P3345, DOI 10.1242/dev.021071; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Naramoto S, 2017, CURR OPIN PLANT BIOL, V40, P8, DOI 10.1016/j.pbi.2017.06.012; Ni ZL, 2011, BIOCHEMISTRY-US, V50, P8057, DOI 10.1021/bi200573t; Ofori PA, 2018, PLANTS-BASEL, V7, DOI 10.3390/plants7030065; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Parizkova B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122736; Park J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0443-x; Pranke IM, 2014, INT J BIOCHEM CELL B, V52, P26, DOI 10.1016/j.biocel.2014.03.020; Rademacher EH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00250; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Santelia D, 2008, J BIOL CHEM, V283, P31218, DOI 10.1074/jbc.M710122200; Sheppard DN, 1996, J BIOL CHEM, V271, P14995, DOI 10.1074/jbc.271.25.14995; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; Wang BJ, 2013, PLANT CELL, V25, P202, DOI 10.1105/tpc.112.105999; Wu GS, 2010, PLANT CELL, V22, P3295, DOI 10.1105/tpc.110.078360; Xi WY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10430; Xu YX, 2014, PLANT J, V79, P106, DOI 10.1111/tpj.12544; Zhang YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06410-y; Zhu JS, 2016, PLANT CELL, V28, P930, DOI 10.1105/tpc.15.00726	66	13	13	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					13094	13105		10.1074/jbc.RA120.014104	http://dx.doi.org/10.1074/jbc.RA120.014104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32699109	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-26	WOS:000572412900018
J	Patil, PR; Vithani, N; Singh, V; Kumar, A; Prakash, B				Patil, Pratik Rajendra; Vithani, Neha; Singh, Virender; Kumar, Ashok; Prakash, Balaji			A revised mechanism for (p)ppGpp synthesis by Rel proteins: The critical role of the 2 '-OH of GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						(p)ppGpp; Rel proteins; (p)ppGpp synthesis; stress response; pyrophosphate transfer; 2 '-OH; GTP; enzyme mechanism; ATP; fluorescence resonance energy transfer (FRET); isothermal titration calorimetry (ITC)	SMALL ALARMONE SYNTHETASE; MOLECULAR-DYNAMICS; PPGPP; ENZYME; HOMOLOG; SUGAR	Bacterial Rel proteins synthesize hyperphosphorylated guanosine nucleotides, denoted as (p)ppGpp, which by inhibiting energy requiring molecular pathways help bacteria to overcome the depletion of nutrients in its surroundings. (p)ppGpp synthesis by Rel involves transferring a pyrophosphate from ATP to the oxygen of 3 '-OH of GTP/GDP. Initially, a conserved glutamate at the active site was believed to generate the nucleophile necessary to accomplish the reaction. Later this role was alluded to a Mg(2+)ion. However, no study has unequivocally established a catalytic mechanism for (p)ppGpp synthesis. Here we present a revised mechanism, wherein for the first time we explore a role for 2 '-OH of GTP and show how it is important in generating the nucleophile. Through a careful comparison of substrate-bound structures of Rel, we illustrate that the active site does not discriminate GTP from dGTP, for a substrate. Using biochemical studies, we demonstrate that both GTP and dGTP bind to Rel, but only GTP (but not dGTP) can form the product. Reactions performed using GTP analogs substituted with different chemical moieties at the 2 ' position suggest a clear role for 2 '-OH in catalysis by providing an indispensable hydrogen bond; preliminary computational analysis further supports this view. This study elucidating a catalytic role for 2 '-OH of GTP in (p)ppGpp synthesis allows us to propose different mechanistic possibilities by which it generates the nucleophile for the synthesis reaction. This study underscores the selection of ribose nucleotides as second messengers and finds its roots in the old RNA world hypothesis.	[Patil, Pratik Rajendra; Vithani, Neha; Singh, Virender; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur, Uttar Pradesh, India; [Prakash, Balaji] Cent Food Technol Res Inst, Council Sci & Ind Res, Dept Mol Nutr, Mysore, Karnataka, India; [Prakash, Balaji] Ahmedabad Univ, Biol & Life Sci, Sch Arts & Sci, Ahmadabad, Gujarat, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Ahmedabad University	Prakash, B (corresponding author), Cent Food Technol Res Inst, Council Sci & Ind Res, Dept Mol Nutr, Mysore, Karnataka, India.; Prakash, B (corresponding author), Ahmedabad Univ, Biol & Life Sci, Sch Arts & Sci, Ahmadabad, Gujarat, India.	bprakashiit@gmail.com	Vithani, Neha/AEA-8375-2022	Singh, Virender/0000-0002-6720-8784	Council of Scientific and Industrial Research-Central Food Technological Research Institute [MLP-234]; Departments of Science and Technology and of Biotechnology, Government of India [EMR/2017/000374/BBM, BT/PR12233/BRB/10/1349/2014]	Council of Scientific and Industrial Research-Central Food Technological Research Institute; Departments of Science and Technology and of Biotechnology, Government of India	This work was supported by Council of Scientific and Industrial Research-Central Food Technological Research Institute Grant MLP-234 (to B. P.) and by Grants EMR/2017/000374/BBM and BT/PR12233/BRB/10/1349/2014 from the Departments of Science and Technology and of Biotechnology, Government of India (to B. P.), respectively.	Ahmad S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8552; Andreoni W, 2000, PARALLEL COMPUT, V26, P819, DOI 10.1016/S0167-8191(00)00014-4; [Anonymous], 2000, AB INITIO MOL DYNAMI; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Avarbock D, 1999, GENE, V233, P261, DOI 10.1016/S0378-1119(99)00114-6; Bag S, 2014, ARCH MICROBIOL, V196, P575, DOI 10.1007/s00203-014-0996-9; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beljantseva J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41839; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; COCHRAN JW, 1974, J BIOL CHEM, V249, P353; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Forconi M, 2011, CHEM BIOL, V18, P949, DOI 10.1016/j.chembiol.2011.07.014; Gaca AO, 2015, J BACTERIOL, V197, P2908, DOI 10.1128/JB.00324-15; Genna V, 2016, J AM CHEM SOC, V138, P14592, DOI 10.1021/jacs.6b05475; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Howard JAK, 1996, TETRAHEDRON, V52, P12613, DOI 10.1016/0040-4020(96)00749-1; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Laio A, 2002, J CHEM PHYS, V116, P6941, DOI 10.1063/1.1462041; Manav MC, 2018, J BIOL CHEM, V293, P3254, DOI 10.1074/jbc.RA117.001374; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Nelson JW, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam8812; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Poole K, 2012, TRENDS MICROBIOL, V20, P227, DOI 10.1016/j.tim.2012.02.004; RICHTER D, 1979, EUR J BIOCHEM, V99, P57, DOI 10.1111/j.1432-1033.1979.tb13230.x; Roitzsch M, 2010, NAT CHEM BIOL, V6, P218, DOI 10.1038/NCHEMBIO.312; Sajish M, 2007, J BIOL CHEM, V282, P34977, DOI 10.1074/jbc.M704828200; Sajish M, 2009, J BIOL CHEM, V284, P9115, DOI 10.1074/jbc.M807187200; Steinchen W, 2015, P NATL ACAD SCI USA, V112, P13348, DOI 10.1073/pnas.1505271112; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; SY J, 1976, BIOCHEMISTRY-US, V15, P4399, DOI 10.1021/bi00665a008; Syal K, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00443-17, 10.1128/aac.00443-17]; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weinger JS, 2006, BIOCHEMISTRY-US, V45, P5939, DOI 10.1021/bi060183n; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925	45	3	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2020	295	37					12851	12867		10.1074/jbc.RA120.013636	http://dx.doi.org/10.1074/jbc.RA120.013636			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NS7BO	32719004	hybrid, Green Published			2022-12-26	WOS:000572412900002
J	Lu, JF; Zhu, MQ; Zhang, H; Liu, H; Xia, B; Wang, YL; Shi, XE; Peng, L; Wu, JW				Lu, Jun Feng; Zhu, Meng Qing; Zhang, Heng; Liu, Hao; Xia, Bo; Wang, Yong Liang; Shi, Xin'e; Peng, Liang; Wu, Jiang Wei			Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice	FASEB JOURNAL			English	Article						fecal microbiota transplantation; flavonoids compound; intestinal microbiota; metabolic syndrome	CITRUS-AURANTIUM L.; INTESTINAL INFLAMMATION; POLYPHENOLS; ACTIVATION; FLAVONOIDS; QUERCETIN; GROWTH	Obesity and related metabolic disorders are associated with intestinal microbiota dysbiosis, disrupted intestinal barrier, and chronic inflammation. Neohesperidin (Neo), a natural polyphenol abundant in citrus fruits, is known for its preventative and therapeutic effects on numerous diseases. Here, we report that Neo administration attenuates weight gain, low-grade inflammation, and insulin resistance in mice fed high-fat diet (HFD). Also, Neo administration substantially restores gut barrier damage, metabolic endotoxemia, and systemic inflammation. Sequencing of 16S rRNA genes in fecal samples revealed that Neo administration reverses HFD-induced intestinal microbiota dysbiosis: an increase in the diversity of gut microbiota and alteration in the composition of intestinal microbiota (particularly in the relative abundances of Bacteroidetes and Firmicutes). Furthermore, systemic antibiotic treatment abolishes the beneficial effects of Neo in body weight control, suggesting that the effect of Neo on obesity attenuation largely depends on the gut microbiota. More importantly, we demonstrate that the impact of Neo on the regulation of obesity could be transferred from Neo-treated mice to HFD-fed mice via fecal microbiota transplantation. Collectively, our data highlight the efficacy of Neo as a prebiotic agent for attenuating obesity, implying a potential mechanism for gut microbiota mediated the beneficial effect of Neo.	[Lu, Jun Feng; Zhu, Meng Qing; Xia, Bo; Wang, Yong Liang; Shi, Xin'e; Wu, Jiang Wei] Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Yangling 712100, Shaanxi, Peoples R China; [Lu, Jun Feng; Zhang, Heng; Liu, Hao; Peng, Liang] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing 10029, Peoples R China	Northwest A&F University - China; China-Japan Friendship Hospital	Wu, JW (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Yangling 712100, Shaanxi, Peoples R China.; Peng, L (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing 10029, Peoples R China.	pengliang8028@163.com; wujiangwei@nwafu.edu.cn	Lu, Junfeng/AFN-9843-2022; Zhu, Mengqing/GLT-5795-2022	Lu, Junfeng/0000-0002-2640-8595; Zhu, Mengqing/0000-0001-9422-6550	National Natural Science Foundation of China (NSFC) [81670758, 81970713]; Beijing Municipal Natural Science Foundation [7182147]; Capital's Funds for Health Improvement and Research [2018-2-4062]; Fundamental Research Funds of the Chinese Academy of Medical Science [2018RC310023]; Special Talent Recruitment Fund of China; Programs for Shaanx Science Technology [2020NY-01]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Capital's Funds for Health Improvement and Research; Fundamental Research Funds of the Chinese Academy of Medical Science; Special Talent Recruitment Fund of China; Programs for Shaanx Science Technology	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670758 and 81970713; Beijing Municipal Natural Science Foundation, Grant/Award Number: 7182147; Capital's Funds for Health Improvement and Research, Grant/Award Number: 2018-2-4062; Fundamental Research Funds of the Chinese Academy of Medical Science, Grant/Award Number: 2018RC310023; Programs for Shaanx Science & Technology: 2020NY-01; Special Talent Recruitment Fund of China to JWW	Anhe FF, 2019, GUT, V68, P453, DOI 10.1136/gutjnl-2017-315565; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Assini JM, 2015, ENDOCRINOLOGY, V156, P2087, DOI 10.1210/en.2014-2003; Bak EJ, 2014, CLIN NUTR, V33, P156, DOI 10.1016/j.clnu.2013.03.013; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Chelakkot C, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0126-x; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gong YL, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104460; Guo JS, 2019, EUR J PHARMACOL, V864, DOI 10.1016/j.ejphar.2019.172712; Hersoug LG, 2016, OBES REV, V17, P297, DOI 10.1111/obr.12370; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Hussain T, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2020.104629; Jia S, 2015, FOOD FUNCT, V6, P878, DOI 10.1039/c4fo00993b; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005; Lee JH, 2009, PHYTOTHER RES, V23, P1748, DOI 10.1002/ptr.2840; Lee P, 2019, DIABETES OBES METAB, V21, P479, DOI 10.1111/dom.13561; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lieber AD, 2019, FASEB J, V33, P1098, DOI [10.1096/fj.201701586R, 10.1096/fj.201701586r]; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Ma XL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00987; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maruvada P, 2017, CELL HOST MICROBE, V22, P589, DOI 10.1016/j.chom.2017.10.005; Moayyedi P, 2008, DIGEST DIS SCI, V53, P2293, DOI 10.1007/s10620-008-0410-z; Moco S, 2012, J PROTEOME RES, V11, P4781, DOI 10.1021/pr300581s; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263; Petersen C, 2019, SCIENCE, V365, P340, DOI 10.1126/science.aat9351; Porras D, 2017, FREE RADICAL BIO MED, V102, P188, DOI 10.1016/j.freeradbiomed.2016.11.037; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sawa T, 1999, J AGR FOOD CHEM, V47, P397, DOI 10.1021/jf980765e; Schneider KM, 2015, HEPATOLOGY, V62, P1405, DOI 10.1002/hep.27982; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen CY, 2017, J AGR FOOD CHEM, V65, P9061, DOI 10.1021/acs.jafc.7b03759; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sinha D., 2019, J DRUG DELIVERY THER, V9, P102, DOI [10.22270/jddt.v9i6.3633, DOI 10.22270/JDDT.V9I6.3633]; Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4; Sun YJ, 2019, FOOD CHEM, V279, P321, DOI 10.1016/j.foodchem.2018.12.019; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tan Z, 2017, MOL CELL ENDOCRINOL, V439, P369, DOI 10.1016/j.mce.2016.09.026; Teng H, 2019, CRIT REV FOOD SCI, V59, P2040, DOI 10.1080/10408398.2018.1437023; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Wang P, 2020, INT J OBESITY, V44, P213, DOI 10.1038/s41366-019-0332-1; Wang WJ, 2018, BRIT J PHARMACOL, V175, P469, DOI 10.1111/bph.14095; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Wu TR, 2019, GUT, V68, P248, DOI 10.1136/gutjnl-2017-315458; Xi WP, 2014, FOOD CHEM, V161, P230, DOI 10.1016/j.foodchem.2014.04.001; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; Yuan C, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00055-20; Zeng SL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6208; Zhang JK, 2012, FOOD CHEM, V135, P1471, DOI 10.1016/j.foodchem.2012.06.004; Zhang L, 2019, FASEB J, V33, P10339, DOI 10.1096/fj.201900488R; Zhao TT, 2019, PHYTOTHER RES, V33, P2034, DOI 10.1002/ptr.6385	68	25	26	7	52	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12053	12071		10.1096/fj.201903102RR	http://dx.doi.org/10.1096/fj.201903102RR		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729978				2022-12-26	WOS:000556800400001
J	Nguyen, PL; van Baalen, M				Phuong Linh Nguyen; van Baalen, Minus			On the difficult evolutionary transition from the free-living lifestyle to obligate symbiosis	PLOS ONE			English	Article							BACILLUS-CEREUS; TRADE-OFF; HETEROGENEOUS ENVIRONMENT; TRICHINELLA-SPIRALIS; PARASITE VIRULENCE; TRANSMISSION MODES; IN-VITRO; MUTUALISM; HOST; COEVOLUTION	Obligate symbiosis evolved from free-living individuals most likely via the intermediate stage of facultative symbiosis. However, why should facultative symbionts, who can live independently but also benefit from their partners if these are available, give up this best of both worlds? Using the adaptive dynamics approach, we analyse a simple model, focusing on one partner of the symbiosis, to gain more insight into the selective forces that make individuals forgo the ability to reproduce in the free-living state. Our results suggest that, similar to the parasitism-mutualism continuum, the free-living way of life and obligate symbiosis are two extremes of a continuum of the ability to reproduce independently of a partner. More importantly, facultative symbiosis should be the rule as for many parameter combinations completely giving up independent reproduction or adopting a pure free-living strategy is not so easy. We also show that if host encounter comes at a cost, individuals that put more effort into increasing the chances to meet with their partners are more likely to give up the ability to reproduce independently. Finally, our model does not specify the ecological interactions between hosts and symbionts but we discuss briefly how the ecological nature of an interaction can influence the transition from facultative to obligate symbiosis.	[Phuong Linh Nguyen; van Baalen, Minus] Ecole Normale Super, Inst Biol, Paris, France; [Phuong Linh Nguyen] Inst Ecol & Sci Environm Paris, Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Nguyen, PL (corresponding author), Ecole Normale Super, Inst Biol, Paris, France.; Nguyen, PL (corresponding author), Inst Ecol & Sci Environm Paris, Paris, France.	lpnguyen@biologie.ens.fr		Nguyen, Linh Phuong/0000-0001-6483-4248	program "Investissements d'Avenir" [ANR-10-LABX-54 MEMOLIFE, ANR-11-IDEX-0001-02 PSL]; Ecole Normale Superieur; PSL Research University	program "Investissements d'Avenir"(French National Research Agency (ANR)); Ecole Normale Superieur; PSL Research University	This work has received support under the program "Investissements d'Avenir" launched by the French Government and implemented by ANR with the references ANR-10-LABX-54 MEMOLIFE and ANR-11-IDEX-0001-02 PSL. Research University. The fund for the author Linh Phuong NGUYEN is under the "Contrat Doctoral no2016-2" by the Ecole Normale Superieur and PSL Research University. The sponsors do not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alizon S, 2005, AM NAT, V165, pE155, DOI 10.1086/430053; Anderson B, 2007, OECOLOGIA, V152, P115, DOI 10.1007/s00442-006-0640-8; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Antonovics J, 2015, EVOL ECOL, V29, P627, DOI 10.1007/s10682-015-9775-6; Ashby B, 2015, P NATL ACAD SCI USA, V112, P13290, DOI 10.1073/pnas.1508397112; Bartoszewicz M, 2017, CAN J MICROBIOL, V63, P939, DOI 10.1139/cjm-2017-0337; Bourret TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001833; BOURTZIS K, 2006, INSECT SYMBIOSIS, V2; Canestrari D, 2014, SCIENCE, V343, P1350, DOI 10.1126/science.1249008; Chaturongakul S, 2008, TRENDS MICROBIOL, V16, P388, DOI 10.1016/j.tim.2008.05.006; Coote JG, 2001, ADV MICROB PHYSIOL, V44, P141, DOI 10.1016/S0065-2911(01)44013-6; Cummins J, 1998, REV REPROD, V3, P172, DOI 10.1530/ror.0.0030172; de Bary Anton, 1879, VORTRAG VERSAMMLUNG, P1; de Mazancourt C, 2004, AM NAT, V164, P765, DOI 10.1086/424762; Denison RF, 2011, CURR BIOL, V21, pR775, DOI 10.1016/j.cub.2011.06.018; Doebeli M, 1998, P NATL ACAD SCI USA, V95, P8676, DOI 10.1073/pnas.95.15.8676; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Ferdy JB, 2005, AM NAT, V166, P613, DOI 10.1086/491799; Ferriere R, 2002, P ROY SOC B-BIOL SCI, V269, P773, DOI 10.1098/rspb.2001.1900; Fisher RM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15973; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Fouts DE, 2006, J BACTERIOL, V188, P3402, DOI 10.1128/JB.188.9.3402-3408.2006; FRANK SA, 1992, TRENDS GENET, V8, P213, DOI 10.1016/0168-9525(92)90236-W; FRANK SA, 1995, J THEOR BIOL, V176, P403, DOI 10.1006/jtbi.1995.0208; Frederick Keebler, 1910, PLANT ANIMALS STUDY; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gagliardo LF, 2002, INFECT IMMUN, V70, P1853, DOI 10.1128/IAI.70.4.1853-1859.2002; Gandon S, 2002, AM NAT, V159, P658, DOI 10.1086/339993; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Greenough WB, 1992, CHOLERA; Hurford A, 2010, J R SOC INTERFACE, V7, P561, DOI 10.1098/rsif.2009.0448; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Law R, 1998, P ROY SOC B-BIOL SCI, V265, P1245, DOI 10.1098/rspb.1998.0426; LAWLOR LR, 1976, AM NAT, V110, P79, DOI 10.1086/283049; Leigh EG, 2010, J EVOLUTION BIOL, V23, P2507, DOI 10.1111/j.1420-9101.2010.02114.x; Leung TLF, 2008, VIE MILIEU, V58, P107; LEVINS R, 1963, AM NAT, V97, P75, DOI 10.1086/282258; LEVINS R, 1962, AM NAT, V96, P361, DOI 10.1086/282245; Lynn Margulis, 2003, SYMBIOSISOURCE EVO, V7; Maharjan R, 2013, ECOL LETT, V16, P1267, DOI 10.1111/ele.12159; MARGULIS L, 1985, Symbiosis, V1, P101; Martin F, 2016, MOL MYCORRHIZAL SYMB; Martinic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025557; MEEROVITCH E, 1965, CAN J ZOOLOG, V43, P81, DOI 10.1139/z65-006; Merezhkowsky C, 1910, BIOL CENTRALBL, V30, P353; Metz Johan J, 1996, P ROYAL DUTCH ACAD S, P183; Michod RE, 1997, AM NAT, V149, P607, DOI 10.1086/286012; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; MONTGOMERY MK, 1994, DEVELOPMENT, V120, P1719; Nuismer SL, 2004, P NATL ACAD SCI USA, V101, P11036, DOI 10.1073/pnas.0403151101; Orlando PA, 2015, THEOR ECOL-NETH, V8, P383, DOI 10.1007/s12080-015-0257-9; Park SF, 2002, INT J FOOD MICROBIOL, V74, P177, DOI 10.1016/S0168-1605(01)00678-X; Percival SL, 2014, MICROBIOLOGY WATERBO, P223; Poinar George O., 1972, ADV PARASIT, V17, P71; Quigley BJZ, 2012, P ROY SOC B-BIOL SCI, V279, P3742, DOI 10.1098/rspb.2012.0769; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Rueffler C, 2006, AM NAT, V167, P81, DOI 10.1086/498275; Sachs JL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2146; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sapp Jan., 1994, EVOLUTION ASS HIST S; Smith J. M., 1997, MAJOR TRANSITIONS EV; STRINGFELLOW F, 1986, J PARASITOL, V72, P339, DOI 10.2307/3281617; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; Udvardi Michael, 1989, ETHOLOGY, V80, P103; van Baalen M, 1998, P ROY SOC B-BIOL SCI, V265, P317, DOI 10.1098/rspb.1998.0298; van Baalen M, 2001, OIKOS, V95, P211, DOI 10.1034/j.1600-0706.2001.950203.x; Vilain S, 2006, APPL ENVIRON MICROB, V72, P4970, DOI 10.1128/AEM.03076-05; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Yamamura N, 2004, J THEOR BIOL, V226, P421, DOI 10.1016/j.jtbi.2003.09.016	70	5	5	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0235811	10.1371/journal.pone.0235811	http://dx.doi.org/10.1371/journal.pone.0235811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730262	gold, Green Published			2022-12-26	WOS:000556884700018
J	Terrens, AF; Soh, SE; Morgan, P				Terrens, Aan Fleur; Soh, Sze-Ee; Morgan, Prue			The safety and feasibility of a Halliwick style of aquatic physiotherapy for falls and balance dysfunction in people with Parkinson's Disease: A single blind pilot trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; FUNCTIONAL MOBILITY; PREVENT FALLS; EXERCISE; GAIT; STRATEGIES; ADHERENCE; EFFICACY; CRITIQUE; THERAPY	Background There is growing evidence that aquatic physiotherapy may be effective for people with Parkinson's Disease (PD) but most studies have investigated land based type exercises in the aquatic environment. Few studies have examined customised aquatic therapies such as the Halliwick concept which focuses on trunk rotation and core stabilisation. Objective The primary aim was to determine the feasibility of a Halliwick style aquatic physiotherapy intervention for people with PD. The secondary aim was to compare the Halliwick intervention with traditional aquatic and land based physiotherapy in terms of disease severity, balance and fear of falling. Methods Halliwick style aquatic, traditional aquatic and land based physiotherapy were trialled in a single blind pilot study. All interventions ran for 60 minutes per week over 12 weeks. Feasibility outcomes were safety, adherence and attrition. Secondary outcomes included the Unified Parkinson's Disease Rating Scale motor subsection (UPDRS-III), Berg Balance Scale (BBS), Mini BESTest and modified Falls Efficacy Scale (mFES). Results 30 participants with moderate PD were recruited. Participant mean age was 72 years (SD 8.4; range 51-86) with moderate disease severity (median Hoehn & Yahr score 3; IQR 1).No falls occurred during intervention sessions, however ten participants reported falls during the study period. No other adverse consequences were reported. All groups had adherence over 85%. No within group significant differences were found in UPDRS-III, BBS or mFES scores post-intervention for all groups, but the Halliwick aquatic group improved significantly in the Mini BESTest post-intervention (p = 0.011, 95% CI -7.36,-1.31,t(10) = -2.98). Conclusions Despite people with PD being a vulnerable population, aquatic physiotherapy, including the Halliwick style is a safe treatment option. Promising results for balance in the Halliwick aquatic group were observed, but further studies with larger sample sizes is required to increase confidence in the results.	[Terrens, Aan Fleur] Peninsula Hlth, Movement Disorder Program, Frankston, Vic, Australia; [Terrens, Aan Fleur; Soh, Sze-Ee; Morgan, Prue] Monash Univ, Dept Physiotherapy, Clayton, Vic, Australia; [Soh, Sze-Ee] Monash Univ, Dept Epidemiol & Preventat Med, Clayton, Vic, Australia	Monash University; Monash University	Terrens, AF (corresponding author), Peninsula Hlth, Movement Disorder Program, Frankston, Vic, Australia.; Terrens, AF (corresponding author), Monash Univ, Dept Physiotherapy, Clayton, Vic, Australia.	fterrens@phcn.vic.gov.au		terrens, aan/0000-0003-3957-9884	Aan F Terrens Lee Silverman Voice Treatment (LSVT)	Aan F Terrens Lee Silverman Voice Treatment (LSVT)	Aan F Terrens Lee Silverman Voice Treatment (LSVT) small student grant [2017] https://www.lsvtglobal.com/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Lee Silverman Voice Treatment (LSVT) for their support with a small student grant [2017].The authors would also like to thank all participants of this trial, and Wendy Toogood who tirelessly assisted in the recruitment and organisation of this trial.	APA, 2015, AUSTR GUID AQ PHYS W; Artigas NR, 2016, ARQ NEURO-PSIQUIAT, V74, P519, DOI 10.1590/0004-282X20160074; Bartels EM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub2; Bartolic A, 2005, EUR J NEUROL, V12, P156, DOI 10.1111/j.1468-1331.2004.00942.x; Beaulne-Seguin Z, 2016, GAIT POSTURE, V49, P443, DOI 10.1016/j.gaitpost.2016.08.002; BERG K, 1989, Physiotherapy Canada, V41, P304; Blandy LM, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00122; Bloem BR, 2016, MOVEMENT DISORD, V31, P1342, DOI 10.1002/mds.26572; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Carroll LM, 2017, ARCH PHYS MED REHAB, V98, P631, DOI 10.1016/j.apmr.2016.12.006; Cugusi L, 2019, J PHYSIOTHER, V65, P65, DOI 10.1016/j.jphys.2019.02.003; Edwards N, 2008, DISABIL REHABIL-ASSI, V3, P193, DOI 10.1080/17483100801897198; Franchignoni F, 2010, J REHABIL MED, V42, P323, DOI 10.2340/16501977-0537; Garcia M.K., 2012, ACTA FISI TRICA, V19, P142, DOI [10.5935/0104-7795.20120022, DOI 10.5935/0104-7795.20120022]; Geytenbeek J., 2002, PHYSIOTHERAPY, V88, P514, DOI [10.1016/S0031-9406(05)60134-4, DOI 10.1016/S0031-9406(05)60134-4]; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Goodwin VA, 2011, J NEUROL NEUROSUR PS, V82, P1232, DOI 10.1136/jnnp-2011-300919; Heisters Daiga, 2011, Br J Nurs, V20, P548; Hirsch L, 2016, NEUROEPIDEMIOLOGY, V46, P292, DOI 10.1159/000445751; Hubble RP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006095; Kalilani L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161689; Karthikbabu S, 2011, NEUROSCIENCE MED, V02, P7; Keus SH., 2014, EUROPEAN PHYSIOTHERA; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; Lim SY, 2018, PARKINSONISM RELAT D, V46, pS47, DOI 10.1016/j.parkreldis.2017.07.029; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834; McMillan J., 1978, FYSIOTERAPEUTEN, V45, P87; McPhate L, 2013, J PHYSIOTHER, V59, P81, DOI 10.1016/S1836-9553(13)70160-7; Morris ME, 2009, MOVEMENT DISORD, V24, P64, DOI 10.1002/mds.22295; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Nilsson MH, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-78; Ossig C, 2015, NEUROL CLIN, V33, P19, DOI 10.1016/j.ncl.2014.09.009; Picillo M, 2017, J NEUROL, V264, P1583, DOI 10.1007/s00415-016-8384-9; Pinto C, 2018, PM R; Pinto C, 2019, PM&R, V11, P278, DOI 10.1016/j.pmrj.2018.09.031; Qutubuddin AA, 2005, ARCH PHYS MED REHAB, V86, P789, DOI 10.1016/j.apmr.2004.11.005; Ramazzina I, 2017, CLIN INTERV AGING, V12, P619, DOI 10.2147/CIA.S131903; Senard JM, 1997, J NEUROL NEUROSUR PS, V63, P584, DOI 10.1136/jnnp.63.5.584; Simek EM, 2012, PREV MED, V55, P262, DOI 10.1016/j.ypmed.2012.07.007; Streiner D, 2001, Evid Based Ment Health, V4, P70; Terrens AF, 2018, DISABIL REHABIL, V40, P2847, DOI 10.1080/09638288.2017.1362710; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tripp F, 2014, CLIN REHABIL, V28, P432, DOI 10.1177/0269215513504942; Zhang HB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004056; Zhu ZZ, 2018, CLIN REHABIL, V32, P29, DOI 10.1177/0269215517715763; Zotz T.G.G., 2013, ADV PARK DIS, V2, P102, DOI [10.4236/apd.2013.24019, DOI 10.4236/APD.2013.24019, DOI 10.4236/apd.2013.24019]	46	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236391	10.1371/journal.pone.0236391	http://dx.doi.org/10.1371/journal.pone.0236391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730325	Green Published, gold			2022-12-26	WOS:000556884700034
J	Martin, M; Girona, MM; Morin, H				Martin, Maxence; Girona, Miguel Montoro; Morin, Hubert			Driving factors of conifer regeneration dynamics in eastern Canadian boreal old-growth forests	PLOS ONE			English	Article							BLACK SPRUCE SEEDLINGS; BALSAM FIR; STAND STRUCTURE; PICEA-MARIANA; ADVANCE REGENERATION; RESTORATION; DISTURBANCE; LANDSCAPE; WINDTHROW; BUDWORM	Old-growth forests play a major role in conserving biodiversity, protecting water resources, and sequestrating carbon, as well as serving as indispensable resources for indigenous societies. Novel silvicultural practices must be developed to emulate the natural dynamics and structural attributes of old-growth forests and preserve the ecosystem services provided by these boreal ecosystems. The success of these forest management strategies depends on developing an accurate understanding of natural regeneration dynamics. Our goal was therefore to identify the main patterns and drivers involved in the regeneration dynamics of old-growth forests with a focus on boreal stands dominated by black spruce (Picea mariana(L.) Mill.) and balsam fir (Abies balsamea(L.) Mill.) in eastern Canada. We sampled 71 stands in a 2 200 km(2)study area located within Quebec's boreal region. For each stand, we noted tree regeneration (seedlings and saplings), structural attributes (diameter distribution, deadwood volume, etc.), and abiotic (slope and soil) factors. The presence of seed-trees located nearby and slopes having moderate to high angles most influenced balsam fir regeneration. In contrast, the indirect indices of recent secondary disturbances (e.g., insect outbreaks or windthrows) and topographic constraints (slope and drainage) most influenced black spruce regeneration. We propose that black spruce regeneration dynamics can be separated into distinct phases: (i) layering within the understory, (ii) seedling growth when gaps open in the canopy, (iii) gradual canopy closure, and (iv) production of new layers once the canopy is closed. These dynamics are not observed in paludified stands or stands where balsam fir is more competitive than black spruce. Overall, this research helps explain the complexity of old-growth forest dynamics, where many ecological factors interact at multiple temporal and spatial scales. This study also improves our understanding of ecological processes within primary old-growth forests and identifies the key factors to consider when ensuring the sustainable management of old-growth boreal stands.	[Martin, Maxence; Morin, Hubert] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Martin, Maxence; Girona, Miguel Montoro; Morin, Hubert] Univ Quebec Montreal, Ctr Etud Foret, Montreal, PQ, Canada; [Girona, Miguel Montoro] Univ Quebec Abitibi Temiscamingue, Inst Rech Forets, Amos, PQ, Canada; [Girona, Miguel Montoro] Swedish Univ Agr Sci SLU, Restorat Ecol Grp, Dept Wildlife Fish & Environm Studies, Umea, Sweden	University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Montreal; University of Quebec; University Quebec Abitibi-Temiscamingue; Swedish University of Agricultural Sciences	Martin, M (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada.; Martin, M (corresponding author), Univ Quebec Montreal, Ctr Etud Foret, Montreal, PQ, Canada.	maxence.martin1@uqac.ca		Martin, Maxence/0000-0002-1384-0514	Chaire de recherche industrielle du CRSNG sur la croissance de l'epinette noire et l'influence de la tordeuse des bourgeons de l'epinette sur la variabilite des paysages en zone boreale; University of Quebec in Abitibi Temiscamingue (UQAT); MRC-Abitibi	Chaire de recherche industrielle du CRSNG sur la croissance de l'epinette noire et l'influence de la tordeuse des bourgeons de l'epinette sur la variabilite des paysages en zone boreale; University of Quebec in Abitibi Temiscamingue (UQAT); MRC-Abitibi	HM: "Chaire de recherche industrielle du CRSNG sur la croissance de l'epinette noire et l'influence de la tordeuse des bourgeons de l'epinette sur la variabilite des paysages en zone boreale,", founded by the Natural Sciences and Engineering Research Council (NSERC) of Canada, the Canada Research Industrial Chairs Program (no grant number; https://www.nserc-crsng.gc.ca/) MMG: professor start-up fund at University of Quebec in Abitibi Temiscamingue (UQAT; no grant number; https://www.uqat.ca/) and silvicultural research grant (MRC-Abitibi; no grant number; https://mrcabitibi.qc.ca/).	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Achard F, 2009, ECOL STUD-ANAL SYNTH, V207, P411, DOI 10.1007/978-3-540-92706-8_18; Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Angers VA, 2010, FOREST ECOL MANAG, V259, P246, DOI 10.1016/j.foreco.2009.09.026; [Anonymous], ECOSYSTEM MANAGEMENT; [Anonymous], 2009, ECOSYSTEM MANAGEMENT; [Anonymous], 2001, OLD GROWTH FOREST DE; BAILEY RL, 1973, FOREST SCI, V19, P97; Basham, 1991, OX408 GREAT LAK FOR; Battles JJ, 1996, FOREST SCI, V42, P131; Bergeron J-F, 1998, RAPPORT CLASSIFICATI; Bergeron Y, 2009, ECOL STUD-ANAL SYNTH, V207, P285, DOI 10.1007/978-3-540-92706-8_13; Bergeron Y, 2012, BOTANY, V90, P509, DOI [10.1139/B2012-034, 10.1139/b2012-034]; Blouin J, 2004, GUIDE DE RECONNAISSA; Bouchard M, 2008, ECOL MODEL, V218, P207, DOI 10.1016/j.ecolmodel.2008.07.001; Boucher D, 2003, FOREST CHRON, V79, P318, DOI 10.5558/tfc79318-2; Boucher Y, 2017, LANDSCAPE ECOL, V32, P361, DOI 10.1007/s10980-016-0448-9; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Cotton-Gagnon A, 2018, FOREST ECOL MANAG, V430, P421, DOI 10.1016/j.foreco.2018.08.011; Couillard P.-L., 2016, DYNAMIQUE VARIABILIT; Cyr D, 2009, FRONT ECOL ENVIRON, V7, P519, DOI 10.1890/080088; De Grandpre L, 2018, FORESTS, V9, DOI 10.3390/f9080471; De Mendiburu F., 2014, AGRICOLAE STAT PROCE, DOI DOI 10.2307/2287932; Desponts M, 2004, CAN J BOT, V82, P830, DOI [10.1139/B04-063, 10.1139/b04-063]; Dolnicar S., 1999, Journal of Travel & Tourism Marketing, V8, P43, DOI 10.1300/J073v08n04_03; Drobyshev I, 2010, ECOSYSTEMS, V13, P556, DOI 10.1007/s10021-010-9340-7; Duchesneau R, 1999, CAN J FOREST RES, V29, P1502, DOI 10.1139/cjfr-29-10-1502; Fenton N, 2005, FOREST ECOL MANAG, V213, P151, DOI 10.1016/j.foreco.2005.03.017; Fenton NJ, 2013, FOREST CHRON, V89, P350, DOI 10.5558/tfc2013-065; Forest Europe, 2015, STAT EUR FOR 2015; Frank R.M., 1990, SILVICS N AM, V654, P26; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Garet J, 2012, ECOL INDIC, V23, P202, DOI 10.1016/j.ecolind.2012.03.032; Garet J, 2009, FOREST ECOL MANAG, V257, P2189, DOI 10.1016/j.foreco.2009.03.001; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; Gauthier S., 2009, ECOSYSTEM MANAGEMENT; Gauthier S, 2010, J VEG SCI, V21, P772, DOI 10.1111/j.1654-1103.2010.01186.x; Girard F, 2014, CAN J FOREST RES, V44, P1165, DOI 10.1139/cjfr-2013-0224; Girona MM, 2019, FRONT FOR GLOB CHANG, V2, DOI 10.3389/ffgc.2019.00004; Girona MM, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00002; Girona MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172653; Girona MM, 2016, FORESTS, V7, DOI 10.3390/f7100240; GIRONA MM, 2018, FRONT PLANT SCI, V9, DOI DOI 10.3389/FPLS.2018.00001; Gold, 1980, INTRO BIVARIATE MULT, DOI DOI 10.2307/2287559; Greene DF, 2007, CAN J FOREST RES, V37, P1012, DOI 10.1139/X06-245; Greene DF, 1999, CAN J FOREST RES, V29, P824, DOI 10.1139/cjfr-29-6-824; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Grondin P, 2018, FOR ECOSYST, V5, DOI 10.1186/s40663-018-0148-9; Halme P, 2013, BIOL CONSERV, V167, P248, DOI 10.1016/j.biocon.2013.08.029; Harrel F. E, 2020, HMISC HARRELL MISCEL; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Harvey BD, 2002, FOREST ECOL MANAG, V155, P369, DOI 10.1016/S0378-1127(01)00573-4; Karjalainen Eeva, 2010, Environmental Health and Preventive Medicine, V15, P1, DOI 10.1007/s12199-008-0069-2; Kneeshaw Daniel, 2003, Environmental Reviews, V11, pS99, DOI 10.1139/a03-010; Kneeshaw DD, 1998, ECOLOGY, V79, P783, DOI 10.1890/0012-9658(1998)079[0783:CGCATR]2.0.CO;2; Kubner R, 2000, SCAND J FOREST RES, V15, P334, DOI 10.1080/028275800447968; Kulha N, 2020, LANDSCAPE ECOL, V35, P843, DOI 10.1007/s10980-020-00979-w; Kulha N, 2019, ECOSYSTEMS, V22, P709, DOI 10.1007/s10021-018-0297-2; Kuuluvainen T, 2018, FOR ECOSYST, V5, DOI 10.1186/s40663-018-0142-2; Larouche C, 2013, LE GUIDE SYLVICOLE D, V2, P10; LAVOIE K, 2019, SPELEOBIOLOGY NOTES, V10, P1; Lawson SS, 2014, J FORESTRY RES, V25, P3, DOI 10.1007/s11676-014-0426-5; LUSSIER JM, 1992, CAN J FOREST RES, V22, P1524, DOI 10.1139/x92-203; Marchand W, 2016, FOREST ECOL MANAG, V369, P47, DOI 10.1016/j.foreco.2016.02.034; Marshall P.L., 2000, USING LINE INTERSECT; Martin M, 2020, FOREST ECOL MANAG, V458, DOI 10.1016/j.foreco.2019.117765; Martin M, 2020, CAN J FOREST RES, V50, P155, DOI 10.1139/cjfr-2019-0177; Martin M, 2019, ANN FOREST SCI, V76, DOI 10.1007/s13595-019-0891-2; Martin M, 2018, FOREST ECOL MANAG, V422, P125, DOI 10.1016/j.foreco.2018.04.007; Martini M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00326; McCarthy JW, 2006, SILVA FENN, V40, P209, DOI 10.14214/sf.339; Menard LP, 2019, FORESTS, V10, DOI 10.3390/f10020177; Messaoud Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P90, DOI 10.1111/j.1466-8238.2006.00277.x; Messaoud Y, 2019, ECOL EVOL, V9, P5118, DOI 10.1002/ece3.5069; Messaoud Y, 2014, FOREST SCI, V60, P57, DOI 10.5849/forsci.12-004; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; [ MFFP] Ministere des Forets de la Faune et des Parcs, 2016, NORM INV EC PLAC ECH; Morin H, 1997, CAN J FOREST RES, V27, P1442, DOI 10.1139/cjfr-27-9-1442; MORIN H, 1992, CAN J FOREST RES, V22, P465, DOI 10.1139/x92-061; MORIN H, 1991, FOREST CHRON, V67, P275, DOI 10.5558/tfc67275-3; Moroni MT, 2015, ECOSYSTEMS, V18, P605, DOI 10.1007/s10021-015-9850-4; Moussaoui L, 2019, ECOL INDIC, V97, P89, DOI 10.1016/j.ecolind.2018.09.059; Muscolo A, 2017, IFOREST, V10, P322, DOI 10.3832/ifor1983-009; Nie ZY, 2018, FOREST ECOL MANAG, V409, P353, DOI 10.1016/j.foreco.2017.11.033; Oboite FO, 2019, FOREST ECOL MANAG, V443, P84, DOI 10.1016/j.foreco.2019.04.017; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oliver C.D., 1996, FOREST STAND DYNAMIC; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P1; Paquin R, 1999, CAN J FOREST RES, V29, P1, DOI 10.1139/cjfr-29-1-1; Pham AT, 2004, CAN J FOREST RES, V34, P353, DOI 10.1139/X03-265; Pollock SL, 2010, J BIOGEOGR, V37, P1684, DOI 10.1111/j.1365-2699.2010.02332.x; Portier J, 2018, J ENVIRON MANAGE, V225, P346, DOI 10.1016/j.jenvman.2018.07.100; POTHIER D, 1995, CAN J FOREST RES, V25, P536, DOI 10.1139/x95-061; Prevost M, 2018, SCAND J FOREST RES, V33, P1; Pureswaran DS, 2019, ECOL EVOL, V9, P576, DOI 10.1002/ece3.4779; R Core Team, 2021, R LANGUAGE ENV STAT; Rossi S, 2009, CAN J FOREST RES, V39, P2307, DOI 10.1139/X09-152; Rossi S, 2009, FOREST ECOL MANAG, V258, P2153, DOI 10.1016/j.foreco.2009.08.023; Ruel JC, 2000, FOREST ECOL MANAG, V135, P169, DOI 10.1016/S0378-1127(00)00308-X; Shorohova E, 2011, SILVA FENN, V45, P785, DOI 10.14214/sf.72; Simard M, 2007, ECOL APPL, V17, P1619, DOI 10.1890/06-1795.1; St-Denis A, 2010, FOREST ECOL MANAG, V259, P469, DOI 10.1016/j.foreco.2009.11.002; Stevens-Rumann CS, 2019, FIRE ECOL, V15, DOI 10.1186/s42408-019-0032-1; Sturtevant BR, 1997, ECOL APPL, V7, P702, DOI 10.1890/1051-0761(1997)007[0702:CWDAAF]2.0.CO;2; Thiffault N, 2004, CAN J FOREST RES, V34, P1657, DOI [10.1139/x04-046, 10.1139/X04-046]; Tukey JW, 1977, EXPLORATORY DATA ANA; Viereck L.A., 1990, AGR HDB, V1, P227; Waldron K, 2013, FORESTRY, V86, P159, DOI 10.1093/forestry/cps061; Wang GG, 2002, FOREST CHRON, V78, P275, DOI 10.5558/tfc78275-2; Wang GG, 2000, CAN J FOREST RES, V30, P573, DOI 10.1139/cjfr-30-4-573; Ward C, 2014, ECOSYSTEMS, V17, P1053, DOI 10.1007/s10021-014-9782-4; Watson JEM, 2018, NAT ECOL EVOL, V2, P599, DOI 10.1038/s41559-018-0490-x; Wilson BF, 2000, AM J BOT, V87, P601, DOI 10.2307/2656846; Wirth C, 2009, ECOL STUD-ANAL SYNTH, V207, P11, DOI 10.1007/978-3-540-92706-8_2; Zhu JJ, 2014, J FORESTRY RES, V25, P501, DOI 10.1007/s11676-014-0489-3	115	17	17	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2020	15	7							e0230221	10.1371/journal.pone.0230221	http://dx.doi.org/10.1371/journal.pone.0230221			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2YL	32726307	gold, Green Submitted, Green Published			2022-12-26	WOS:000556908900052
J	Kelm, NQ; Straughn, AR; Kakar, SS				Kelm, Natia Q.; Straughn, Alex R.; Kakar, Sham S.			Withaferin A attenuates ovarian cancer-induced cardiac cachexia	PLOS ONE			English	Article							II TYPE-2 RECEPTOR; SKELETAL-MUSCLE; HEART-FAILURE; EXPRESSION; ACTIVATION; OVEREXPRESSION; PATHOGENESIS; DYSFUNCTION; INHIBITION; PREVENTION	Cachexia is a common multifactorial syndrome in the advanced stages of cancer and accounts for approximately 20-30% of all cancer-related fatalities. In addition to the progressive loss of skeletal muscle mass, cancer results in impairments in cardiac function. We recently demonstrated that WFA attenuates the cachectic skeletal muscle phenotype induced by ovarian cancer. The purpose of this study was to investigate whether ovarian cancer induces cardiac cachexia, the possible pathway involved, and whether WFA attenuates cardiac cachexia. Xenografting of ovarian cancer induced cardiac cachexia, leading to the loss of normal heart functions. Treatment with WFA rescued the heart weight. Further, ovarian cancer induced systolic dysfunction and diastolic dysfunction Treatment with WFA preserved systolic function in tumor-bearing mice, but diastolic dysfunction was partially improved. In addition, WFA abrogated the ovarian cancer-induced reduction in cardiomyocyte cross-sectional area. Finally, treatment with WFA ameliorated fibrotic deposition in the hearts of tumor-bearing animals. We observed a tumor-induced MHC isoform switching from the adult MHC alpha to the embryonic MHC beta isoform, which was prevented by WFA treatment. Circulating Ang II level was increased significantly in the tumor-bearing, which was lowered by WFA treatment. Our results clearly demonstrated the induction of cardiac cachexia in response to ovarian tumors in female NSG mice. Further, we observed induction of proinflammatory markers through the AT(1)R pathway, which was ameliorated by WFA, in addition to amelioration of the cachectic phenotype, suggesting WFA as a potential therapeutic agent for cardiac cachexia in oncological paradigms.	[Kelm, Natia Q.; Straughn, Alex R.; Kakar, Sham S.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Kakar, Sham S.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Kakar, SS (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.; Kakar, SS (corresponding author), Univ Louisville, Dept Physiol, Louisville, KY 40292 USA.	sham.kakar@louisville.edu		Straughn, Alex/0000-0002-6516-8096	NIH [UO1 CA185148, T32 HL134644]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant UO1 CA185148 sub-award to SSK and T32 HL134644 to SSK.	AMBRUS JL, 1975, J MED, V6, P61; Baba HA, 2008, CURR CARDIOL REV, V4, P157, DOI 10.2174/157340308785160606; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Belloum Y, 2017, ONCOL REP, V37, P2543, DOI 10.3892/or.2017.5542; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Cao YY, 2015, CHINESE MED J-PEKING, V128, P3211, DOI 10.4103/0366-6999.170259; Challa AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042989; Chandrasekaran B, 2018, CARCINOGENESIS, V39, P1537, DOI 10.1093/carcin/bgy109; Chang HW, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00634; Chen Y, 2017, INT J CLIN EXP MED, V10, P14904; Chou DHI, 1996, J IMMUNOL, V156, P4354; Cosper PF, 2011, CANCER RES, V71, P1710, DOI 10.1158/0008-5472.CAN-10-3145; Costelli P, 2001, BRIT J CANCER, V84, P946, DOI 10.1054/bjoc.2001.1696; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; Emmanuel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017617; Ewer MS, 2015, NAT REV CARDIOL, V12, P547, DOI 10.1038/nrcardio.2015.65; Falcon BL, 2004, PHYSIOL GENOMICS, V19, P255, DOI 10.1152/physiolgenomics.00170.2004; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fong MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042265; Gadducci A, 2001, ANTICANCER RES, V21, P2941; Guo R, 2019, CIRC J, V83, P1726, DOI 10.1253/circj.CJ-18-1391; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Helms SA, 2010, INT J BIOL SCI, V6, P475; Heyninck K, 2014, BIOCHEM PHARMACOL, V91, P501, DOI 10.1016/j.bcp.2014.08.004; Ino K, 2006, BRIT J CANCER, V94, P552, DOI 10.1038/sj.bjc.6602961; Kakar SS, 2017, ONCOTARGET, V8, P74494, DOI 10.18632/oncotarget.20170; Kakar Sham S, 2016, J Cancer Stem Cell Res, V4; Kakar SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107596; Kakar SS, 2012, BIOCHEM BIOPH RES CO, V423, P819, DOI 10.1016/j.bbrc.2012.06.047; Kazemi-Bajestani SMR, 2014, J CACHEXIA SARCOPENI, V5, P95, DOI 10.1007/s13539-014-0137-y; Kazemi-Bajestani SMR, 2019, J CACHEXIA SARCOPENI, V10, P1070, DOI 10.1002/jcsm.12451; Kelm NQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202934; KURODA T, 1983, JPN HEART J, V24, P235; Kyakulaga AH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34018-1; La Vecchia C, 2017, EUR J CANCER PREV, V26, P55, DOI 10.1097/CEJ.0000000000000217; Laws MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004230; Le TH, 2003, HYPERTENSION, V42, P507, DOI 10.1161/01.HYP.0000092000.07559.57; Londhe P, 2015, BONE, V80, P131, DOI 10.1016/j.bone.2015.03.015; Manne NDPK, 2013, INT J ONCOL, V42, P2134, DOI 10.3892/ijo.2013.1893; Merz AA, 2016, HEART, V102, P825, DOI 10.1136/heartjnl-2015-308769; Murphy KT, 2016, AM J PHYSIOL-HEART C, V310, pH466, DOI 10.1152/ajpheart.00720.2015; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Nakayama M, 2005, AM J PHYSIOL-HEART C, V288, pH317, DOI 10.1152/ajpheart.00957.2003; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Okoshi MP, 2017, ARQ BRAS CARDIOL, V108, P74, DOI 10.5935/abc.20160142; Penna F, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00041; Pin F, 2018, J CACHEXIA SARCOPENI, V9, P685, DOI 10.1002/jcsm.12311; Pinter M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5616; Qi YF, 2012, EXP PHYSIOL, V97, P89, DOI 10.1113/expphysiol.2011.060673; Royston KJ, 2018, EXP CELL RES, V368, P67, DOI 10.1016/j.yexcr.2018.04.015; Satpathy C, 2006, AM FAM PHYSICIAN, V73, P841; Schnelle M, 2018, J MOL CELL CARDIOL, V114, P20, DOI 10.1016/j.yjmcc.2017.10.006; Schumacher SM, 2018, CURR CARDIOL REP, V20, DOI 10.1007/s11886-018-1067-7; Springer J, 2014, EUR HEART J, V35, P932, DOI 10.1093/eurheartj/eht302; Sriramula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138372; Stevens SCW, 2015, J MOL CELL CARDIOL, V85, P37, DOI 10.1016/j.yjmcc.2015.05.007; Straughn Alex R, 2019, J Ovarian Res, V12, P115, DOI 10.1186/s13048-019-0586-1; Tian M, 2011, INT J ONCOL, V39, P1321, DOI 10.3892/ijo.2011.1150; Tian M, 2010, INT J ONCOL, V37, P347, DOI 10.3892/ijo_00000683; Tournoux F, 2011, J AM SOC ECHOCARDIOG, V24, P465, DOI 10.1016/j.echo.2010.12.019; Utsunomiya H, 2005, REGUL PEPTIDES, V126, P155, DOI 10.1016/j.regpep.2004.09.004; Valentova M, 2020, HEART FAIL CLIN, V16, P61, DOI 10.1016/j.hfc.2019.08.006; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; Wharton J, 1998, J PHARMACOL EXP THER, V284, P323; Xia SX, 2018, BIOCHEM BIOPH RES CO, V503, P2363, DOI 10.1016/j.bbrc.2018.06.162; Xie GZ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0401-3; Xu J, 2014, HYPERTENSION, V63, P1251, DOI 10.1161/HYPERTENSIONAHA.114.03247; Yan XH, 2003, AM J PHYSIOL-HEART C, V285, pH2179, DOI 10.1152/ajpheart.00361.2003; Yoshida T, 2013, INT J BIOCHEM CELL B, V45, P2322, DOI 10.1016/j.biocel.2013.05.035; Zhang CH, 2006, J MOL CELL CARDIOL, V40, P247, DOI 10.1016/j.yjmcc.2005.11.010; Zhang HL, 2017, PHARMACOGN MAG, V13, P523, DOI 10.4103/0973-1296.211042; Zhao YX, 2019, P NATL ACAD SCI USA, V116, P2210, DOI 10.1073/pnas.1818357116	76	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2020	15	7							e0236680	10.1371/journal.pone.0236680	http://dx.doi.org/10.1371/journal.pone.0236680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW3BD	32722688	Green Published, gold			2022-12-26	WOS:000556916000037
J	Babu, SPSP; White, D; Corson, TW				Pran Babu, Sardar Pasha Sheik; White, Darcy; Corson, Timothy W.			Ferrochelatase regulates retinal neovascularization	FASEB JOURNAL			English	Article						angiogenesis; griseofulvin; heme synthesis; retina; vasculature	ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; MOUSE MODEL; ANTI-VEGF; ERYTHROPOIETIC PROTOPORPHYRIA; DIABETIC-RETINOPATHY; THERAPEUTIC TARGET; IN-VIVO; ANGIOGENESIS; INHIBITION	Ferrochelatase (FECH) is the terminal enzyme in heme biosynthesis. We previously showed that FECH is required for endothelial cell growth in vitro and choroidal neovascularization in vivo. But FECH has not been explored in retinal neovascularization, which underlies diseases like proliferative diabetic retinopathy and retinopathy of prematurity. Here, we investigated the inhibition of FECH using genetic and chemical approaches in the oxygen-induced retinopathy (OIR) mouse model. In OIR mice, FECH expression is upregulated and co-localized with neovascular tufts. Partial loss-of-functionFech(m1Pas) mutant mice showed reduced retinal neovascularization and endothelial cell proliferation in OIR. An intravitreal injection of the FECH inhibitorN-methyl protoporphyrin had similar effects. Griseofulvin is an antifungal drug that inhibits FECH as an off-target effect. Strikingly, intravitreal griseofulvin decreased both pathological tuft formation and areas of vasoobliteration compared to vehicle, suggesting potential as a FECH-targeting therapy. Ocular toxicity studies revealed that intravitreal injection of griseofulvin in adult mice does not disrupt retinal vasculature, function, or morphology. In sum, mutation and chemical inhibition ofFechreduces retinal neovascularization and promotes physiological angiogenesis, suggesting a dual effect on vascular repair upon FECH inhibition, without ocular toxicity. These findings suggest that FECH inhibitors could be repurposed to treat retinal neovascularization.	[Pran Babu, Sardar Pasha Sheik; White, Darcy; Corson, Timothy W.] Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Pran Babu, Sardar Pasha Sheik; White, Darcy; Corson, Timothy W.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Corson, TW (corresponding author), Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Dept Ophthalmol, 1160 West Michigan St, Indianapolis, IN 46202 USA.	tcorson@iu.edu	Corson, Timothy W./B-6851-2009	Corson, Timothy W./0000-0002-1402-7875	HHS \ NIH \ National Eye Institute (NEI) [R01EY025641]; BrightFocus Foundation (BrightFocus) [M2019069]	HHS \ NIH \ National Eye Institute (NEI); BrightFocus Foundation (BrightFocus)(BrightFocus Foundation)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: R01EY025641; BrightFocus Foundation (BrightFocus), Grant/Award Number: M2019069	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Aghdam KA, 2016, J AAPOS, V20, P539, DOI 10.1016/j.jaapos.2016.09.013; Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Basavarajappa HD, 2017, EMBO MOL MED, V9, P786, DOI 10.15252/emmm.201606561; Basavarajappa HD, 2015, J MED CHEM, V58, P5015, DOI 10.1021/acs.jmedchem.5b00449; BOULECHFAR S, 1993, GENOMICS, V16, P645, DOI 10.1006/geno.1993.1242; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411; Chang AA, 2003, CLIN EXP OPHTHALMOL, V31, P300, DOI 10.1046/j.1442-9071.2003.00664.x; Chiabrando D, 2014, HAEMATOLOGICA, V99, P973, DOI 10.3324/haematol.2013.091991; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DeNiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022244; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Ferrara N, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.10; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hofer T, 2003, BLOOD, V101, P348, DOI 10.1182/blood-2002-03-0773; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Karl Mike O, 2012, Methods Mol Biol, V884, P213, DOI 10.1007/978-1-61779-848-1_15; Kim CB, 2016, EYE BRAIN, V8, P67, DOI 10.2147/EB.S94447; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Lee B, 2014, ORG BIOMOL CHEM, V12, P7673, DOI 10.1039/c4ob01604a; Liu K, 2015, BIOCHEM PHARMACOL, V98, P493, DOI 10.1016/j.bcp.2015.09.002; Liu YYL, 2004, LIFE SCI, V75, P2035, DOI 10.1016/j.lfs.2004.03.027; Loffler K, 2015, GLIA, V63, P1809, DOI 10.1002/glia.22846; Madan A, 2003, FRONT BIOSCI-LANDMRK, V8, pD1030, DOI 10.2741/1056; Martinez MDC, 2009, CELL MOL BIOL, V55, P127, DOI 10.1170/T862; Moran EP, 2016, AM J PHYSIOL-HEART C, V311, pH738, DOI 10.1152/ajpheart.00005.2016; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Pasha SPBS, 2018, J PHARMACOL EXP THER, V367, P108, DOI 10.1124/jpet.118.248088; Pasha SPBS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09743-8; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Petersen AB, 2014, CHEM REV, V114, P12088, DOI 10.1021/cr400368e; Sankar MJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009734.pub2; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Schmucker C, 2004, VISION RES, V44, P2445, DOI 10.1016/j.visres.2004.05.018; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shetty T, ISCIENCE, DOI [10.1101/836304, DOI 10.1101/836304]; Shetty T, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01015; Shi Z, 2006, BIOCHEM J, V399, P21, DOI 10.1042/BJ20060753; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Smith CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41975; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Sulaiman RS, 2018, ACS CHEM BIOL, V13, P45, DOI 10.1021/acschembio.7b00854; Sulaiman RS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25509; Tsuboi H, 2007, J DERMATOL, V34, P790, DOI 10.1111/j.1346-8138.2007.00386.x; TUTOIS S, 1991, J CLIN INVEST, V88, P1730, DOI 10.1172/JCI115491; van Eeden PE, 2006, ADV EXP MED BIOL, V572, P163; Vandekeere S, 2018, CELL METAB, V28, P573, DOI 10.1016/j.cmet.2018.06.009; VanderVeen DK, 2019, SEMIN PERINATOL, V43, P375, DOI 10.1053/j.semperi.2019.05.011; VanderVeen DK, 2017, OPHTHALMOLOGY, V124, P619, DOI 10.1016/j.ophtha.2016.12.025; Wenzel Andrea A, 2015, Mol Vis, V21, P515; Wu AL, 2018, ASIA-PAC J OPHTHALMO, V7, P145, DOI 10.22608/APO.201837; Wu JH, 2016, J CHEM INF MODEL, V56, P2421, DOI 10.1021/acs.jcim.6b00216; Zhang B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200307; Zhao L, 2009, EXP EYE RES, V88, P1004, DOI 10.1016/j.exer.2008.12.013; Zhao M, 2011, EXP EYE RES, V93, P921, DOI 10.1016/j.exer.2011.10.013	70	11	11	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12419	12435		10.1096/fj.202000964R	http://dx.doi.org/10.1096/fj.202000964R		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716567	Green Submitted, Green Accepted			2022-12-26	WOS:000556423500001
J	Royant-Parola, S; Kovess, V; Brion, A; Dagneaux, S; Hartley, S				Royant-Parola, Sylvie; Kovess, Viviane; Brion, Agnes; Dagneaux, Sylvain; Hartley, Sarah			Do hypnotics increase the risk of driving accidents or near miss accidents due to hypovigilance? The effects of sex, chronic sleepiness, sleep habits and sleep pathology	PLOS ONE			English	Article							MOTOR-VEHICLE COLLISIONS; ROAD TRAFFIC CRASHES; COGNITIVE PERFORMANCE; DAYTIME SLEEPINESS; INSOMNIA PATIENTS; SOCIAL JETLAG; CHRONIC USERS; DRIVERS; DISORDERS; ZOPICLONE	Driving accidents due to hypovigilance are common but the role of hypnotics is unclear in patients suffering from sleep disorders. Our study examined factors influencing accidents and near miss accidents attributed to sleepiness at the wheel (ANMAS). Using data from an online questionnaire aimed at patients with sleep disorders, we analysed the associations between ANMAS, sociodemographic data, symptoms of sleep disorders, severity of insomnia (Insomnia Severity Index (ISI)) symptoms of anxiety and depression (Hospital Anxiety and Depression scale with depression (HADD) and anxiety (HADA) subscales), chronic sleepiness (Epworth sleepiness scale ESS), hypnotic use and information about sleep habits. Hypnotics were hierarchically grouped into Z-drugs, sedative medication, melatonin and over the counter (OTC) alternative treatments. Of 10802 participants; 9.1% reported ANMAS (Men 11.1% women 8.3%) and 24.4% took hypnotics (Z-drugs 8.5%, sedative medication 8%, melatonin 5.6% and alternative treatments 2.5%). Logistic regression analysis identified the following risk factors for ANMAS: moderate (OR 2.4; CI: 2.10-2.79) and severe sleepiness (ESS OR 5.66; CI: 4.74-6.77), depression (HADD OR 1.2; CI: 1.03-1.47), anxiety (HADA OR 1.2;CI: 1.01-1.47), and insufficient sleep (OR1.4; CI: 1.2-1.7). Hypnotics were not associated with an increased risk of ANMAS in patients suffering from insomnia. Risk factors varied according to sex: in females, sex (OR 0.; CI: 0.55-0.74), mild insomnia (OR 0.5; CI: 0.3-0.8) and use of alternative treatments (OR 0.455, CI:0.23-0.89) were protective factors and risk was increased by sleepiness, sleep debt, social jetlag, caffeine use, anxiety and depression. In men no protective factors were identified: sleepiness, sleep debt, and severe insomnia were associated with an increased risk of ANMAS. In clinical practice, all patients with daytime sleepiness and men with severe insomnia should be counselled concerning driving risk and encouraged to avoid sleep debt.	[Royant-Parola, Sylvie; Brion, Agnes; Dagneaux, Sylvain; Hartley, Sarah] Reseau Morphee, Garches, France; [Kovess, Viviane] Paris Descartes Univ, EA 4057, Paris, France; [Hartley, Sarah] Univ Versailles St Quentin Yvelines, Hop Raymond Poincare, APHP, Sleep Ctr,EA 4047, Garches, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Hartley, S (corresponding author), Reseau Morphee, Garches, France.; Hartley, S (corresponding author), Univ Versailles St Quentin Yvelines, Hop Raymond Poincare, APHP, Sleep Ctr,EA 4047, Garches, France.	sarah.hartley@reseau-morphee.fr			French sleep research society (SFRMS: Societe Francaise pour la Recherche et Medecine du Sommeil); Paris region health authority (ARS Ile de France)	French sleep research society (SFRMS: Societe Francaise pour la Recherche et Medecine du Sommeil); Paris region health authority (ARS Ile de France)	This work was supported by the French sleep research society (SFRMS: Societe Francaise pour la Recherche et Medecine du Sommeil) which contributed to the original development of the online questionnaire. The Reseau Morphee is funded by the Paris region health authority (ARS Ile de France). No specific grant for the study was obtained from any funding agency in the public, commercial or not-for-profit sectors.	Ahlner J, 2014, SCAND J PUBLIC HEALT, V42, P177, DOI 10.1177/1403494813510792; *ANSM, 2017, ET LIEUX CONS BENZ F; Bastien CH, 2011, NEUROPSYCHOL REV, V21, P22, DOI 10.1007/s11065-011-9160-3; Bayon V, 2010, MED SOMMEIL, V7, P23; Bertisch SM, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy047; Buscemi N, 2005, J GEN INTERN MED, V20, P1151, DOI 10.1111/j.1525-1497.2005.0243.x; BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003; Clark I, 2017, SLEEP MED REV, V31, P70, DOI 10.1016/j.smrv.2016.01.006; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Curran HV, 2003, PSYCHOL MED, V33, P1223, DOI 10.1017/S0033291703008213; Demos KE, 2016, PHYSIOL BEHAV, V164, P214, DOI 10.1016/j.physbeh.2016.06.003; Dula CS, 2010, ACCIDENT ANAL PREV, V42, P2050, DOI 10.1016/j.aap.2010.06.016; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Garbarino S, 2001, SLEEP, V24, P203; Goncalves M, 2015, J SLEEP RES, V24, P242, DOI 10.1111/jsr.12267; Hill LL, 2017, INJ EPIDEMIOL; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; Hudson AN, 2019, NEUROPSYCHOPHARMACOL; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kalmbach DA, 2018, NAT SCI SLEEP, V10, P193, DOI 10.2147/NSS.S138823; Kyle SD, 2017, SLEEP MED, V38, P85, DOI 10.1016/j.sleep.2017.07.001; Lang CJ, 2018, SLEEP MED, V51, P133, DOI 10.1016/j.sleep.2018.06.014; Leger D, 2014, J SLEEP RES, V23, P143, DOI 10.1111/jsr.12104; LEPINE JP, 1985, LANCET, V2, P1425; Leufkens TRM, 2014, PSYCHOPHARMACOLOGY, V231, P2785, DOI 10.1007/s00213-014-3447-z; Leufkens TRM, 2014, PSYCHOPHARMACOLOGY, V231, P2851, DOI 10.1007/s00213-014-3455-z; Leufkens TRM, 2009, J CLIN PSYCHOPHARM, V29, P432, DOI 10.1097/JCP.0b013e3181b57b43; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100965; Liu JB, 2016, ANNU REV PHARMACOL, V56, P361, DOI 10.1146/annurev-pharmtox-010814-124742; Lowe CJ, 2017, NEUROSCI BIOBEHAV R, V80, P586, DOI 10.1016/j.neubiorev.2017.07.010; Miller CB, 2016, SLEEP, V39, P1993, DOI 10.5665/sleep.6230; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; Nevriana A, 2017, CNS DRUGS, V31, P711, DOI 10.1007/s40263-017-0445-9; Orriols L, 2016, BRIT J CLIN PHARMACO, V82, P1625, DOI 10.1111/bcp.13075; Perrier J, 2014, SLEEP, V37, P1565, DOI 10.5665/sleep.4012; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Philip P, 2019, SLEEP MED CLIN, V14, P407, DOI 10.1016/j.jsmc.2019.07.002; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Quera-Salva MA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012382; Regev S, 2018, J SAFETY RES, V66, P131, DOI 10.1016/j.jsr.2018.07.002; Roehrs TA, 2016, J CLIN SLEEP MED, V12, P319, DOI 10.5664/jcsm.5574; Roehrs TA, 2011, SLEEP, V34, P1647, DOI 10.5665/sleep.1426; Roth T, 2014, TRAFFIC INJ PREV, V15, P439, DOI 10.1080/15389588.2013.830211; Rudisill TM, 2016, ACCIDENT ANAL PREV, V96, P255, DOI 10.1016/j.aap.2016.08.001; Sagberg F, 2006, ACCIDENT ANAL PREV, V38, P28, DOI 10.1016/j.aap.2005.06.018; Salva MAQ, 2014, SLEEP MED, V15, P23, DOI 10.1016/j.sleep.2013.06.018; Shekleton JA, 2010, SLEEP MED REV, V14, P47, DOI 10.1016/j.smrv.2009.06.001; Sivertsen B, 2009, J CLIN SLEEP MED, V5, P349; Staner L, 2005, PSYCHOPHARMACOLOGY, V181, P790, DOI 10.1007/s00213-005-0082-8; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; Verster JC, 2006, CURR DRUG SAF, V1, P63, DOI 10.2174/157488606775252674; Ward KL, 2013, J CLIN SLEEP MED, V9, P1013, DOI 10.5664/jcsm.3072; Wild CJ, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy182; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Woodall KL, 2015, J FORENSIC SCI, V60, P669, DOI 10.1111/1556-4029.12725	61	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236404	10.1371/journal.pone.0236404; 10.1371/journal.pone.0236404.r001; 10.1371/journal.pone.0236404.r002; 10.1371/journal.pone.0236404.r003; 10.1371/journal.pone.0236404.r004	http://dx.doi.org/10.1371/journal.pone.0236404; 10.1371/journal.pone.0236404.r001; 10.1371/journal.pone.0236404.r002; 10.1371/journal.pone.0236404.r003; 10.1371/journal.pone.0236404.r004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MV9ND	32716956	Green Published, gold			2022-12-26	WOS:000556674500047
J	Tullis, JE; Rumian, NL; Brown, CN; Bayer, KU				Tullis, Jonathan E.; Rumian, Nicole L.; Brown, Carolyn Nicole; Bayer, K. Ulrich			The CaMKII K42M and K42R mutations are equivalent in suppressing kinase activity and targeting	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; SYNAPTIC PLASTICITY; II-ALPHA; BINDING; AUTOPHOSPHORYLATION; MECHANISM; CALCIUM; LTP; PHOSPHORYLATION	CaMKII is an important mediator of forms of synaptic plasticity that are thought to underly learning and memory. The CaMKII mutants K42M and K42R have been used interchangeably as research tools, although some reported phenotypic differences suggest that they may differ in the extent to which they impair ATP binding. Here, we directly compared the two mutations at the high ATP concentrations that exist within cells (similar to 4 mM). We found that both mutations equally blocked GluA1 phosphorylationin vitroand GluN2B binding within cells. Both mutations also reduced but did not completely abolish CaMKII T286 autophosphorylationin vitroor CaMKII movement to excitatory synapses in neurons. Thus, despite previously suggested differences, both mutations appear to interfere with ATP binding to the same extent.	[Tullis, Jonathan E.; Rumian, Nicole L.; Brown, Carolyn Nicole; Bayer, K. Ulrich] Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA; [Rumian, Nicole L.; Bayer, K. Ulrich] Univ Colorado, Program Neurosci, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bayer, KU (corresponding author), Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA.; Bayer, KU (corresponding author), Univ Colorado, Program Neurosci, Anschutz Med Campus, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu		Rumian, Nicole/0000-0002-4327-1930; Brown, Carolyn Nicole/0000-0002-3612-1125; Bayer, K. Ulrich/0000-0003-0893-2200	National Institutes of Health [T32GM007635, T32AG000279, R01 NS081248, R01 NS110383]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants T32GM007635 (supporting J.E.T.), T32AG000279 (supporting N. L.R.) and R01s NS081248 and NS110383 (to K.U. B.). The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcomb K, 2016, J BIOL CHEM, V291, P16082, DOI 10.1074/jbc.M116.734822; Barcomb K, 2014, FASEB J, V28, P3810, DOI 10.1096/fj.14-250407; Barcomb K, 2013, MOL PHARMACOL, V84, P834, DOI 10.1124/mol.113.089045; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2019, NEURON, V103, P380, DOI 10.1016/j.neuron.2019.05.033; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Buonarati OR, 2020, CELL REP, V30, P1, DOI 10.1016/j.celrep.2019.11.076; Buonarati OR, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aar6889; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Cook SG, 2019, CELL REP, V27, P658, DOI 10.1016/j.celrep.2019.03.041; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037176; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Fitzgerald ZT, 2020, FRONT SYNAPTIC NEURO, V12, DOI 10.3389/fnsyn.2020.00004; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goodell DJ, 2017, CELL REP, V19, P2231, DOI 10.1016/j.celrep.2017.05.068; Goodell DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096522; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Herring BE, 2016, ANNU REV PHYSIOL, V78, P351, DOI 10.1146/annurev-physiol-021014-071753; Incontro S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04439-7; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Loweth JA, 2013, J NEUROSCI, V33, P1411, DOI 10.1523/JNEUROSCI.4386-13.2013; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Rossetti T, 2017, NEURON, V96, P207, DOI 10.1016/j.neuron.2017.09.010; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Yamagata Y, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0133-18.2018; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009	45	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2020	15	7							e0236478	10.1371/journal.pone.0236478	http://dx.doi.org/10.1371/journal.pone.0236478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV9ND	32716967	gold, Green Published			2022-12-26	WOS:000556674500037
J	Momosaka, D; Togao, O; Hiwatashi, A; Yamashita, K; Kikuchi, K; Tomiyama, H; Nakao, T; Murayama, K; Suzuki, Y; Honda, H				Momosaka, Daichi; Togao, Osamu; Hiwatashi, Akio; Yamashita, Koji; Kikuchi, Kazufumi; Tomiyama, Hirofumi; Nakao, Tomohiro; Murayama, Keitaro; Suzuki, Yuriko; Honda, Hiroshi			A voxel-based analysis of cerebral blood flow abnormalities in obsessive-compulsive disorder using pseudo-continuous arterial spin labeling MRI	PLOS ONE			English	Article							SYMPTOM DIMENSIONS; HUMAN BRAIN; MORPHOMETRY; SPECT	Objective To identify abnormalities of regional cerebral blood flow (rCBF) in individuals with obsessive-compulsive disorder (OCD) by conducting a voxel-based analysis of pseudo-continuous arterial spin labeling (pCASL) perfusion images. Materials and methods This prospective study included 23 OCD patients (nine males, 14 females; age 21-62 years; mean +/- SD 37.2 +/- 10.7 years) diagnosed based on DSM-IV-TR criteria and 64 healthy controls (27 males, 37 females; age 20-64 years; mean +/- SD 38.3 +/- 12.8 years). Subjects were recruited from October 2011 to August 2017. Imaging was performed on a 3T scanner. Quantitative rCBF maps generated from pCASL images were co-registered and resliced with the three-dimensional T1-weighted images, and then spatially normalized to a brain template and smoothed. We used statistical nonparametric mapping to assess the differences in rCBF and gray matter volume between the OCD and control groups. The significance level was set at the p-value < 0.05 with family-wise error rate correction for multiple comparisons. Results Compared to the control group, there were significant rCBF reductions in the right putamen, right frontal operculum, left midcingulate cortex, and right temporal pole in the OCD group. There were no significant between-group differences in the gray matter volume. Conclusion The pCASL imaging noninvasively detected physiologically disrupted areas without structural abnormalities in OCD patients. The rCBF reductions observed in these regions in OCD patients could be associated with the pathophysiology of OCD.	[Momosaka, Daichi; Togao, Osamu; Yamashita, Koji; Kikuchi, Kazufumi; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Japan; [Hiwatashi, Akio] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka, Japan; [Tomiyama, Hirofumi; Nakao, Tomohiro; Murayama, Keitaro] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka, Japan; [Suzuki, Yuriko] Univ Oxford, Inst Biomed Engn, Oxford, England	Kyushu University; Kyushu University; Kyushu University; University of Oxford	Momosaka, D (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Japan.	dmomosaka@icloud.com	Kikuchi, Kazufumi/AAP-4286-2021; Togao, Osamu/AAE-4702-2022	Kikuchi, Kazufumi/0000-0003-1292-1846; Yamashita, Koji/0000-0002-7417-739X	JSPS KAKENHI [JP17K10410, JP20K08111]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grants, no. JP17K10410 and no. JP20K08111 (https://www.jsps.go.jp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alptekin K, 2001, PSYCHIAT RES-NEUROIM, V107, P51, DOI 10.1016/S0925-4927(01)00086-5; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR, Vxii; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Busatto GF, 2000, PSYCHIAT RES-NEUROIM, V99, P15, DOI 10.1016/S0925-4927(00)00050-0; Busatto GF, 2001, J AM ACAD CHILD PSY, V40, P347, DOI 10.1097/00004583-200103000-00015; Chamberlain SR, 2005, NEUROSCI BIOBEHAV R, V29, P399, DOI 10.1016/j.neubiorev.2004.11.006; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056733; Del Casale A, 2016, WORLD J BIOL PSYCHIA, V17, P378, DOI 10.3109/15622975.2015.1102323; Diler RS, 2004, YONSEI MED J, V45, P90, DOI 10.3349/ymj.2004.45.1.90; Duhameau B, 2010, PSYCHIAT RES-NEUROIM, V182, P111, DOI 10.1016/j.pscychresns.2010.01.009; Gao J, 2019, NEUROSCI LETT, V712, DOI 10.1016/j.neulet.2019.134449; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Guo HR, 2014, ARQ NEURO-PSIQUIAT, V72, P44, DOI 10.1590/0004-282X20130205; Harris G J, 1994, Hum Brain Mapp, V1, P237, DOI 10.1002/hbm.460010403; HARRIS GJ, 1993, PSYCHIAT RES-NEUROIM, V50, P57; Hashimoto N, 2011, PSYCHIAT RES, V187, P166, DOI 10.1016/j.psychres.2010.08.001; Karadag F, 2013, PSYCHIAT RES-NEUROIM, V213, P169, DOI 10.1016/j.pscychresns.2012.07.005; Koch K, 2014, J PSYCHIATR RES, V54, P26, DOI 10.1016/j.jpsychires.2014.03.006; Kurth F, 2015, NAT PROTOC, V10, P293, DOI 10.1038/nprot.2015.014; Lacerda ALT, 2003, PSYCHIAT RES-NEUROIM, V123, P125, DOI 10.1016/S0925-4927(03)00061-1; LUCEY JV, 1995, BRIT J PSYCHIAT, V167, P629, DOI 10.1192/bjp.167.5.629; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Moody TD, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.192; Moreira PS, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.189; Nakatani E, 2003, PSYCHIAT RES-NEUROIM, V124, P113, DOI 10.1016/S0925-4927(03)00069-6; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Okada K, 2015, PSYCHIAT CLIN NEUROS, V69, P411, DOI 10.1111/pcn.12269; Ota M, 2013, MAGN RESON IMAGING, V31, P990, DOI 10.1016/j.mri.2013.03.016; Pehrs C, 2017, CEREB CORTEX, V27, P777, DOI 10.1093/cercor/bhv226; Petcharunpaisan S, 2010, WORLD J RADIOL, V2, P384, DOI 10.4329/wjr.v2.i10.384; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Pinkham A, 2011, PSYCHIAT RES-NEUROIM, V194, P64, DOI 10.1016/j.pscychresns.2011.06.013; Piras F, 2015, CORTEX, V62, P89, DOI 10.1016/j.cortex.2013.01.016; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P695; Shibasaki H, 2008, CLIN NEUROPHYSIOL, V119, P731, DOI 10.1016/j.clinph.2007.10.026; Spalletta G, 2014, BRAIN BEHAV, V4, P261, DOI 10.1002/brb3.212; Togao O, 2010, PSYCHIAT RES-NEUROIM, V184, P29, DOI 10.1016/j.pscychresns.2010.06.011; Vogt BA, 2009, CINGULATE NEUROBIOLO, Vxxxiv; Zhong ZX, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1201	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2020	15	7							e0236512	10.1371/journal.pone.0236512	http://dx.doi.org/10.1371/journal.pone.0236512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OD5ZL	32706796	Green Published, gold			2022-12-26	WOS:000579931700050
J	Johnson, AL; Medina, HN; Schlumbrecht, MP; Reis, I; Kobetz, EN; Pinheiro, PS				Johnson, Ariana L.; Medina, Heidy N.; Schlumbrecht, Matthew P.; Reis, Isildinha; Kobetz, Erin N.; Pinheiro, Paulo S.			The role of histology on endometrial cancer survival disparities in diverse Florida	PLOS ONE			English	Article							RACIAL DISPARITIES; POPULATION; MORTALITY; RISK; CARCINOMA; STAGE; HETEROGENEITY; HISPANICS; STATES; MODEL	Background Endometrial cancer (EC) mortality is particularly high among non-Hispanic Blacks and is twice that of non-Hispanic Whites. However, comparisons of EC survival outcomes by race/ethnicity are often confounded by histology and grade. Here, we analyze EC survival disparities in multiracial Florida with a focus on EC types (1 and 2) and subtypes, defined according to histology and grade. Methods All 27,809 cases of EC diagnosed during 2005-2016 were obtained from the Florida Cancer Registry. Age-standardized, 5-year cause-specific survival by race/ethnicity and histological type were calculated. Fine and Gray competing risk regression was used to estimate sub-distribution hazard ratios (sHRs) for associations between risk of death due to EC and potential predictive factors such as histology/grade, age, stage at diagnosis, and insurance. Results Type 2 EC accounted for only 38.7% of all incident EC-cases but 74.6% of all EC-deaths. Blacks were disproportionately affected by type 2 EC (57.6%) compared to Whites, Hispanics, and Asians (35.6%, 37.7%, and 43.0%, respectively). Age-adjusted 5-year survival for types 1 and 2 were 85.3% and 51.6%, respectively; however, there was wide variation within type 2 subtypes, ranging from 60.2% for mixed cell EC to as low as 30.1% for carcinosarcoma. In the multivariable model, Blacks with type 2 EC had a 23% higher risk of death due to EC (sHR: 1.23, 95%CI: 1.12-1.36) compared to Whites. Conclusions Population-based analyses should consider the histological heterogeneity of EC because the less common type 2 EC drives racial/ethnic survival disparities in EC. Black women have a higher proportion of more aggressive histological types and an overall higher risk of death due to EC than Whites. To the extent that some of these histological types may be considered different diseases and require specific treatment approaches, further research on etiology and prognosis for detailed type 2 EC subtypes is warranted.	[Johnson, Ariana L.; Medina, Heidy N.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Schlumbrecht, Matthew P.; Reis, Isildinha; Kobetz, Erin N.; Pinheiro, Paulo S.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Publ Hlth Sci, Miami, FL 33136 USA	University of Miami; University of Miami	Pinheiro, PS (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Publ Hlth Sci, Miami, FL 33136 USA.	ppinheiro@med.miami.edu		Medina, Heidy/0000-0002-1999-6448; Johnson, Ariana/0000-0002-5257-7114				Alkushi A, 2004, INT J GYNECOL PATHOL, V23, P129, DOI 10.1097/00004347-200404000-00007; Amant F, 2018, INT J GYNECOL OBSTET, V143, P37, DOI 10.1002/ijgo.12612; Austin PC, 2017, STAT MED, V36, P4391, DOI 10.1002/sim.7501; Baskovic M, 2018, CANCER MED-US, V7, P4485, DOI 10.1002/cam4.1742; Brinton LA, 2013, GYNECOL ONCOL, V129, P277, DOI 10.1016/j.ygyno.2013.02.023; Buhtoiarova TN, 2016, AM J CLIN PATHOL, V145, P8, DOI [10.1093/AJCP/AQV014, 10.1093/ajcp/aqv014]; Clarke MA, 2019, J CLIN ONCOL, V37, P3466, DOI 10.1200/JCO.19.02109; Clarke MA, 2019, J CLIN ONCOL, V37, P1895, DOI 10.1200/JCO.19.00151; Cook LS, 2013, CANCER CAUSE CONTROL, V24, P61, DOI 10.1007/s10552-012-0090-z; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Cote ML, 2015, CANCER EPIDEM BIOMAR, V24, P1407, DOI 10.1158/1055-9965.EPI-15-0316; Cote ML, 2012, INT J GYNECOL CANCER, V22, P1367, DOI 10.1097/IGC.0b013e31826b1110; Creasman W T, 2006, Int J Gynaecol Obstet, V95 Suppl 1, pS105; Cronin KA, 2018, CANCER-AM CANCER SOC, V124, P2785, DOI [10.1002/cncr.31551, 10.1002/cncr.32802]; Doll KM, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.09.040; Felix AS, 2010, CANCER CAUSE CONTROL, V21, P1851, DOI 10.1007/s10552-010-9612-8; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fritz A, 2000, INT CLASSIFICATION D, DOI DOI 10.1093/AJCP/AGV014; Fryar Cheryl D, 2010, NCHS Data Brief, P1; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Guttery David S, 2018, Oncotarget, V9, P17093, DOI 10.18632/oncotarget.24907; Henley SJ, 2018, MMWR-MORBID MORTAL W, V67, P1333, DOI 10.15585/mmwr.mm6748a1; Howlader N., 2016, SEER CANC STAT REV; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; Jemal A., 2017, J NATL CANC I, V109, DOI [DOI 10.1093/JNCI/DJX030, 10.1093/jnci/djx030]; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Long B, 2013, GYNECOL ONCOL, V130, P652, DOI 10.1016/j.ygyno.2013.05.020; Madison T, 2004, AM J PUBLIC HEALTH, V94, P2104, DOI 10.2105/AJPH.94.12.2104; Mandi H, 2014, GYNECOL ONCOL, V133, P512, DOI 10.1016/j.ygyno.2014.03.562; Maxwell GL, 2008, CANCER, V113, P1431, DOI 10.1002/cncr.23717; McCullough ML, 2008, CANCER EPIDEM BIOMAR, V17, P73, DOI 10.1158/1055-9965.EPI-07-2567; Morales LS, 2002, J HEALTH CARE POOR U, V13, P477, DOI 10.1177/104920802237532; Mukerji B, 2018, GYNECOL ONCOL, V148, P527, DOI 10.1016/j.ygyno.2017.12.032; National Cancer Institute, SURV EP END RES SEER; Pinheiro PS, 2020, ADVANCING THE SCIENCE OF CANCER IN LATINOS, P17, DOI 10.1007/978-3-030-29286-7_2; Pinheiro PS, 2020, CANCER EPIDEMIOL, V66, DOI 10.1016/j.canep.2020.101709; Pinheiro PS, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180529; Pinheiro PS, 2017, CANCER EPIDEM BIOMAR, V26, P376, DOI 10.1158/1055-9965.EPI-16-0684; Pinheiro PS, 2016, CANCER CONTROL, V23, P347, DOI 10.1177/107327481602300406; Pinheiro Paulo S., 2014, Journal of the National Cancer Institute Monographs, P210, DOI 10.1093/jncimonographs/lgu016; Schlumbrecht M, 2019, J CLIN ONCOL, V37, P3464, DOI 10.1200/JCO.19.01720; Schlumbrecht M, 2019, INT J GYNECOL CANCER, V29, P897, DOI 10.1136/ijgc-2019-000347; Schlumbrecht M, 2017, GYNECOL ONCOL, V147, P329, DOI 10.1016/j.ygyno.2017.09.002; Scott OW, 2019, CANCER CAUSE CONTROL, V30, P121, DOI 10.1007/s10552-019-1129-1; Setiawan VW, 2013, J CLIN ONCOL, V31, P2607, DOI 10.1200/JCO.2012.48.2596; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sorosky JI, 2012, OBSTET GYNECOL, V120, P383, DOI 10.1097/AOG.0b013e3182605bf1; Surveillance Epidemiology and End Results (SEER) Program, 2018, SEER 21 REGS LTD FIE; Temkin SM, 2016, FRONT ONCOL, V6, P1, DOI DOI 10.3389/FONC.2016.00089; U.S. Census Bureau, FLOR QUICKFACTS US C; Ward EM, 2019, JNCI-J NATL CANCER I, V111, P1279, DOI 10.1093/jnci/djz106; Weiderpass E, 2014, EUR J CANCER, V50, P1675, DOI 10.1016/j.ejca.2014.02.020; Weir Hannah K., 2014, Journal of the National Cancer Institute Monographs, P198, DOI 10.1093/jncimonographs/lgu018	53	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236402	10.1371/journal.pone.0236402	http://dx.doi.org/10.1371/journal.pone.0236402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX7VK	32701999	gold, Green Published			2022-12-26	WOS:000575913700089
J	Kainz, H; Killen, BA; Wesseling, M; Perez-Boerema, F; Pitto, L; Aznar, JMG; Shefelbine, S; Jonkers, I				Kainz, Hans; Killen, Bryce Adrian; Wesseling, Mariska; Perez-Boerema, Fernando; Pitto, Lorenzo; Aznar, Jose Manuel Garcia; Shefelbine, Sandra; Jonkers, Ilse			A multi-scale modelling framework combining musculoskeletal rigid-body simulations with adaptive finite element analyses, to evaluate the impact of femoral geometry on hip joint contact forces and femoral bone growth	PLOS ONE			English	Article							NECK-SHAFT ANGLE; GAIT PATTERNS; PREDICTION; CHILDREN; ANTEVERSION; KINEMATICS; MUSCLES; CREATE; PLATE	Multi-scale simulations, combining muscle and joint contact force (JCF) from musculoskeletal simulations with adaptive mechanobiological finite element analysis, allow to estimate musculoskeletal loading and predict femoral growth in children. Generic linearly scaled musculoskeletal models are commonly used. This approach, however, neglects subject- and age-specific musculoskeletal geometry, e.g. femoral neck-shaft angle (NSA) and anteversion angle (AVA). This study aimed to evaluate the impact of proximal femoral geometry, i.e. altered NSA and AVA, on hip JCF and femoral growth simulations. Musculoskeletal models with NSA ranging from 120 degrees to 150 degrees and AVA ranging from 20 degrees to 50 degrees were created and used to calculate muscle and hip JCF based on the gait analysis data of a typically developing child. A finite element model of a paediatric femur was created from magnetic resonance images. The finite element model was morphed to the geometries of the different musculoskeletal models and used for mechanobiological finite element analysis to predict femoral growth trends. Our findings showed that hip JCF increase with increasing NSA and AVA. Furthermore, the orientation of the hip JCF followed the orientation of the femoral neck axis. Consequently, the osteogenic index, which is a function of cartilage stresses and defines the growth rate, barely changed with altered NSA and AVA. Nevertheless, growth predictions were sensitive to the femoral geometry due to changes in the predicted growth directions. Altered NSA had a bigger impact on the growth results than altered AVA. Growth simulations based on mechanobiological principles were in agreement with reported changes in paediatric populations.	[Kainz, Hans] Univ Vienna, Dept Biomech Kinesiol & Comp Sci Sport, Vienna, Austria; [Kainz, Hans; Killen, Bryce Adrian; Wesseling, Mariska; Pitto, Lorenzo; Jonkers, Ilse] Katholieke Univ Leuven, Human Movement Biomech Res Grp, Leuven, Belgium; [Perez-Boerema, Fernando] Katholieke Univ Leuven, Dept Mech Engn, Leuven, Belgium; [Aznar, Jose Manuel Garcia] Univ Zaragoza, Dept Mech Engn, Zaragoza, Spain; [Shefelbine, Sandra] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA	University of Vienna; KU Leuven; KU Leuven; University of Zaragoza; Northeastern University	Kainz, H (corresponding author), Univ Vienna, Dept Biomech Kinesiol & Comp Sci Sport, Vienna, Austria.; Kainz, H (corresponding author), Katholieke Univ Leuven, Human Movement Biomech Res Grp, Leuven, Belgium.	hans.kainz@kuleuven.be		Wesseling, Mariska/0000-0002-3347-2130; Killen, Bryce/0000-0001-6389-2497; Kainz, Hans/0000-0001-5296-6040	H2020-MSCA individual fellowship [796120]	H2020-MSCA individual fellowship	HK was funded by a H2020-MSCA individual fellowship (796120). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AS, 2001, ANN BIOMED ENG, V29, P263, DOI 10.1114/1.1355277; Arnold AS, 2001, J BIOMECH, V34, P437, DOI 10.1016/S0021-9290(00)00232-3; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bobroff ED, 1999, CLIN ORTHOP RELAT R, P194; Bosmans L, 2014, J ORTHOP RES, V32, P1406, DOI 10.1002/jor.22698; Carbone V, 2015, J BIOMECH, V48, P734, DOI 10.1016/j.jbiomech.2014.12.034; Carriero A., 2009, MODELLING GAIT ABNOR, DOI [10.25560/4649, DOI 10.25560/4649]; Carriero A, 2014, COMPUT METHOD BIOMEC, V17, P352, DOI 10.1080/10255842.2012.683575; Carriero A, 2011, COMPUT METHOD BIOMEC, V14, P253, DOI 10.1080/10255841003682505; Carter DR, 2003, PHILOS T ROY SOC B, V358, P1461, DOI 10.1098/rstb.2003.1346; CARTER DR, 1987, CLIN ORTHOP RELAT R, P237; Correa TA, 2011, J BIOMECH, V44, P2096, DOI 10.1016/j.jbiomech.2011.05.023; Damsgaard M, 2006, SIMUL MODEL PRACT TH, V14, P1100, DOI 10.1016/j.simpat.2006.09.001; De Groote F, 2008, J BIOMECH, V41, P3390, DOI 10.1016/j.jbiomech.2008.09.035; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Fox AS, 2018, GAIT POSTURE, V61, P169, DOI 10.1016/j.gaitpost.2018.01.010; Germiller JA, 1997, J ORTHOP RES, V15, P362, DOI 10.1002/jor.1100150308; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; Issac B, 1997, CLIN ANAT, V10, P318, DOI 10.1002/(SICI)1098-2353(1997)10:5<318::AID-CA5>3.0.CO;2-M; Jenkins SEM, 2003, GAIT POSTURE, V18, P13, DOI 10.1016/S0966-6362(02)00137-6; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kainz H, 2016, J BIOMECH, V49, P1658, DOI 10.1016/j.jbiomech.2016.03.052; Kainz H, 2019, CLIN BIOMECH, V65, P26, DOI 10.1016/j.clinbiomech.2019.03.014; Kainz H, 2018, GAIT POSTURE, V65, P213, DOI 10.1016/j.gaitpost.2018.07.172; Kainz H, 2017, J APPL BIOMECH, V33, P354, DOI 10.1123/jab.2016-0282; Lenaerts G, 2008, J BIOMECH, V41, P1243, DOI 10.1016/j.jbiomech.2008.01.014; Modenese L, 2018, J BIOMECH, V73, P108, DOI 10.1016/j.jbiomech.2018.03.039; Passmore E, 2018, GAIT POSTURE, V63, P228, DOI 10.1016/j.gaitpost.2018.05.003; Scheys L, 2008, GAIT POSTURE, V28, P358, DOI 10.1016/j.gaitpost.2008.05.002; Scheys L, 2011, GAIT POSTURE, V33, P158, DOI 10.1016/j.gaitpost.2010.11.003; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Shefelbine SJ, 2004, J ORTHOPAED RES, V22, P346, DOI 10.1016/j.orthres.2003.08.004; Shefelbine SJ, 2002, MECH REGULATION BONE; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Taddei F, 2012, CLIN BIOMECH, V27, P273, DOI 10.1016/j.clinbiomech.2011.09.006; Valente G, 2017, COMPUT METH PROG BIO, V152, P85, DOI 10.1016/j.cmpb.2017.09.012; Valente G, 2013, J BIOMECH, V46, P2186, DOI 10.1016/j.jbiomech.2013.06.030; van Arkel RJ, 2013, J ORTHOP RES, V31, P1172, DOI 10.1002/jor.22364; van der Krogt MM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0170-5; van der Meulen MCH, 2002, J BIOMECH, V35, P401, DOI 10.1016/S0021-9290(01)00184-1; Wesseling M, 2016, COMPUT METHOD BIOMEC, V19, P1475, DOI 10.1080/10255842.2016.1154547; Yadav P, 2017, BIOMECH MODEL MECHAN, V16, P1869, DOI 10.1007/s10237-017-0925-3; Yadav P, 2016, J BIOMECH, V49, P1613, DOI 10.1016/j.jbiomech.2016.03.039; Zhang J, 2016, MED ENG PHYS, V38, P450, DOI 10.1016/j.medengphy.2016.02.003	45	17	17	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235966	10.1371/journal.pone.0235966	http://dx.doi.org/10.1371/journal.pone.0235966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702015	Green Published, gold			2022-12-26	WOS:000575913700035
J	Mehdorn, AS; Reuter, S; Suwelack, B; Schutte-Nutgen, K; Becker, F; Senninger, N; Palmes, D; Vogel, T; Bahde, R				Mehdorn, Anne-Sophie; Reuter, Stefan; Suwelack, Barbara; Schuette-Nuetgen, Katharina; Becker, Felix; Senninger, Norbert; Palmes, Daniel; Vogel, Thomas; Bahde, Ralf			Comparison of kidney allograft survival in the Eurotransplant senior program after changing the allocation criteria in 2010-A single center experience	PLOS ONE			English	Article							TRANSPLANT RECIPIENTS; WAITING-LIST; DONOR AGE; RISK; OUTCOMES; COMORBIDITY; CANDIDATES; DEATH; OLDER; TIME	Aims The European Senior Program (ESP) aims to avoid waiting list competition between younger and elderly patients applying for renal transplantation. By listing patients >= 65 years on a separate waiting list and locally allocating of grafts >= 65 years exclusively to this cohort, waiting and cold ischemia times are predicted to be shortened, potentially resulting in improved kidney transplantation outcomes. This study compared a historic cohort of renal transplant recipients being simultaneously listed on the general and the ESP waiting lists with a collective exclusively listed on the ESP list in terms of surrogates of the transplantation outcome. Methods Total 151 eligible patients >= 65 years from Munster transplant Center, Germany, between 1999 and 2014 were included. Graft function, graft and patient survival were compared using surrogate markers of short- and long-term graft function. Patients were grouped according to their time of transplantation. Results Recipients and donors in the newESP (nESP) cohort were significantly older (69.6 +/- 3.5 years vs 67.1 +/- 2 years, p<0.05; 72.0 +/- 5.0 years vs 70.3 +/- 5.0 years, p = 0.039), had significantly shorter dialysis vintage (19.6 +/- 21.7 months vs 60.2 +/- 28.1 months, p<0.001) and suffered from significantly more comorbidities (2.2 +/- 0.9 vs 1.8 +/- 0.8, p = 0.009) than the historic cohort (HC). Five-year death-censored graft survival was better than in the HC, but 5-year graft and patient survival were better in the ESP cohort. After 2005, cold ischemia time between groups was comparable. nESP grafts showed more primary function and significantly better long-term graft function 18 months after transplantation and onwards. Conclusion nESP recipients received significantly older grafts, but experienced significantly shorter time on dialysis. Cold ischemia times were comparable, but graft function in the nESP cohort was significantly better in the long term.	[Mehdorn, Anne-Sophie; Becker, Felix; Senninger, Norbert; Palmes, Daniel; Vogel, Thomas; Bahde, Ralf] Munster Univ Hosp, Dept Gen Visceral & Transplant Surg, Munster, Germany; [Reuter, Stefan; Suwelack, Barbara; Schuette-Nuetgen, Katharina] Munster Univ Hosp, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany	University of Munster; University of Munster	Reuter, S (corresponding author), Munster Univ Hosp, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany.	sreuter@uni-muenster.de		Mehdorn, Anne-Sophie/0000-0003-4415-8371	Open Access Publication Funds of the University of Munster	Open Access Publication Funds of the University of Munster	This work was funded by the Open Access Publication Funds of the University of Munster.	Bahde R, 2014, ANN TRANSPL, V19, P201, DOI 10.12659/AOT.890125; Cippa PE, 2015, CLIN J AM SOC NEPHRO, V10, P2213, DOI 10.2215/CJN.01790215; Concepcion Beatrice P, 2016, World J Transplant, V6, P650, DOI 10.5500/wjt.v6.i4.650; COX DR, 1972, J R STAT SOC B, V34, P187; Dahmen M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47772-7; Dreyer GJ, 2015, TRANSPLANT REV-ORLAN, V29, P205, DOI 10.1016/j.trre.2015.08.003; DSO, 2016, ORG TRANSPL DEUTSCHL; Eurotransplant, KIDN; Filiopoulos Vassilis, 2016, World J Transplant, V6, P103, DOI 10.5500/wjt.v6.i1.103; Frei U, 2008, AM J TRANSPLANT, V8, P50, DOI 10.1111/j.1600-6143.2007.02014.x; Fritsche L, 2003, AM J TRANSPLANT, V3, P1434, DOI 10.1046/j.1600-6135.2003.00251.x; Glorie K, 2014, TRANSPL INT, V27, P333, DOI 10.1111/tri.12202; Heldal K, 2009, TRANSPLANTATION, V87, P1045, DOI 10.1097/TP.0b013e31819cdddd; Hernandez D, 2020, KIDNEY BLOOD PRESS R, V45, P1, DOI 10.1159/000504546; Hwang JK, 2014, TRANSPL P, V46, P431, DOI 10.1016/j.transproceed.2013.11.061; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Jacobi J, 2016, ANN TRANSPL, V21, P94, DOI 10.12659/AOT.895731; Kaplan L. A., 1989, CLIN CHEM THEORY ANA, V2nd; Karim A, 2014, TRANSPLANTATION, V97, P832, DOI 10.1097/01.TP.0000438026.03958.7b; Laging M, 2016, TRANSPLANTATION, V100, P400, DOI 10.1097/TP.0000000000000973; Lehner LJ, 2015, TRANSPLANT REV-ORLAN, V29, P237, DOI 10.1016/j.trre.2015.08.001; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li PKT, 2020, ARCH ARGENT PEDIATR, V118, pE148, DOI 10.5546/aap.2020.eng.e148; Meier-Kriesche HU, 2001, DRUG AGING, V18, P751, DOI 10.2165/00002512-200118100-00004; Neri F, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13036; Oniscu GC, 2004, AM J TRANSPLANT, V4, P2067, DOI 10.1111/j.1600-6143.2004.00622.x; Ponticelli C, 2014, TRANSPLANT REV-ORLAN, V28, P188, DOI 10.1016/j.trre.2014.07.001; Rose C, 2015, J AM SOC NEPHROL, V26, P2483, DOI 10.1681/ASN.2014080771; Schold J, 2009, CLIN J AM SOC NEPHRO, V4, P1239, DOI 10.2215/CJN.01280209; Schutte-Nutgen K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213608; Schutte-Nutgen K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190227; Shi X LJ, 2018, BMC NEPHROL, V19; Singh P, 2016, ADV CHRONIC KIDNEY D, V23, P44, DOI 10.1053/j.ackd.2015.11.002; Smits JMA, 2002, AM J TRANSPLANT, V2, P664, DOI 10.1034/j.1600-6143.2002.20713.x; Summers DM, 2013, LANCET, V381, P727, DOI 10.1016/S0140-6736(12)61685-7; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Tullius SG, 2010, ANN SURG, V252, P662, DOI 10.1097/SLA.0b013e3181f65c7d; Wong G, 2017, TRANSPLANTATION, V101, P1152, DOI 10.1097/TP.0000000000001351; Wu C, 2008, J AM GERIATR SOC, V56, P231, DOI 10.1111/j.1532-5415.2007.01542.x; Yang SS, 2017, YONSEI MED J, V58, P626, DOI 10.3349/ymj.2017.58.3.626; Yang XL, 2010, DIABETES, V59, P1254, DOI 10.2337/db09-1371	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0235680	10.1371/journal.pone.0235680	http://dx.doi.org/10.1371/journal.pone.0235680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702005	gold, Green Published			2022-12-26	WOS:000575913700021
J	Milanovic, V; Osimani, A; Garofalo, C; Belleggia, L; Maoloni, A; Cardinali, F; Mozzon, M; Foligni, R; Aquilanti, L; Clementi, F				Milanovic, Vesna; Osimani, Andrea; Garofalo, Cristiana; Belleggia, Luca; Maoloni, Antonietta; Cardinali, Federica; Mozzon, Massimo; Foligni, Roberta; Aquilanti, Lucia; Clementi, Francesca			Selection of cereal-sourced lactic acid bacteria as candidate starters for the baking industry	PLOS ONE			English	Article							LACTOBACILLUS-PLANTARUM; LEUCONOSTOC-PSEUDOMESENTEROIDES; EXOPOLYSACCHARIDE PRODUCTION; SOURDOUGH FERMENTATIONS; STRUCTURAL-ANALYSIS; PHYTASE ACTIVITY; PURIFICATION; DIVERSITY; STRAINS; DEXTRAN	The quality of sourdough bread mainly depends on metabolic activities of lactic acid bacteria (LAB). The exopolysaccharides (EPS) produced by LAB affect positively the technological and nutritional properties of the bread, while phytases improve the bioavailability of the minerals by reducing its phytate content. In the present study, a pool of 152 cereal-sourced LAB were screened for production of phytases and EPS for potential use as sourdough starter cultures for the baking industry. There was large heterogeneity in the phytase activity observed among the screened isolates, with 95% showing the ability to degrade sodium phytate on plates containing Sourdough Simulation Medium (SSM). The isolates Lactobacillus brevis LD65 and Lactobacillus plantarum PB241 showed the highest enzymatic activity, while the isolates ascribed to Weissella confusa were characterized by low or no phytase activity. Only 18% of the screened LAB produced EPS, which were distinguished as ropy or mucoid phenotypes on SSM supplemented with sucrose. Almost all the EPS producers carried one or more genes (epsD/E and/or epsA) involved in the production of heteropolysaccharides (HePS), whereas the isolates ascribed to Leuconostoc citreum andW. confusa carried genes involved in the production of both HePS and homopolysaccharides (HoPS). Monosaccharide composition analysis of the EPS produced by a selected subset of isolates revealed that all the HePS included glucose, mannose, and galactose, though at different ratios. Furthermore, a few isolates ascribed to L. citreum andW. confusa and carrying the gtf gene produced beta-glucans after fermentation in an ad hoc formulated barley flour medium. Based on the overall results collected, a subset of candidate sourdough starter cultures for the baking industry was selected, including Lb. brevis LD66 and L. citreum PB220, which showed high phytase activity and positive EPS production.	[Milanovic, Vesna; Osimani, Andrea; Garofalo, Cristiana; Belleggia, Luca; Maoloni, Antonietta; Cardinali, Federica; Mozzon, Massimo; Foligni, Roberta; Aquilanti, Lucia; Clementi, Francesca] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy	Marche Polytechnic University	Aquilanti, L; Clementi, F (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy.	l.aquilanti@univpm.it; f.clementi@univpm.it		Milanovic, Vesna/0000-0001-8548-366X; MOZZON, Massimo/0000-0002-5132-5070	Italian Ministry of Education, University and Research (MIUR) program PRIN [2015SSEKFL]	Italian Ministry of Education, University and Research (MIUR) program PRIN(Ministry of Education, Universities and Research (MIUR))	FC. This study was supported by the Italian Ministry of Education, University and Research (MIUR) program PRIN 2015 (grant number 2015SSEKFL) "Processing for healthy cereal foods". The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedfar A, 2018, LWT-FOOD SCI TECHNOL, V96, P686, DOI 10.1016/j.lwt.2018.05.071; Ale EC, 2020, FOOD MICROBIOL, V90, DOI 10.1016/j.fm.2020.103465; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anastasio M, 2010, J FOOD SCI, V75, pM28, DOI 10.1111/j.1750-3841.2009.01402.x; Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Chen LN, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01253; Cizeikiene D, 2015, INT J FOOD SCI NUTR, V66, P736, DOI 10.3109/09637486.2015.1088939; Coda R, 2018, FOOD MICROBIOL, V76, P164, DOI 10.1016/j.fm.2018.05.003; Corsetti A, 2007, SYST APPL MICROBIOL, V30, P561, DOI 10.1016/j.syapm.2007.07.001; Cote GL, 1995, ENCY CHEM TECHNOLOGY; De Angelis M, 2003, INT J FOOD MICROBIOL, V87, P259, DOI 10.1016/S0168-1605(03)00072-2; De Bellis P, 2019, FOODS, V8, DOI 10.3390/foods8020070; De Vuyst L, 2005, TRENDS FOOD SCI TECH, V16, P43, DOI 10.1016/j.tifs.2004.02.012; De Vuyst L, 2014, FOOD MICROBIOL, V37, P11, DOI 10.1016/j.fm.2013.06.002; De Vuyst L., 2007, COMPREHENSIVE GLYCOS, P477; Dertli E, 2018, FOOD CHEM, V242, P45, DOI 10.1016/j.foodchem.2017.09.017; Dertli E, 2016, LWT-FOOD SCI TECHNOL, V71, P116, DOI 10.1016/j.lwt.2016.03.030; Domingos-Lopes MFP, 2017, FOOD MICROBIOL, V63, P178, DOI 10.1016/j.fm.2016.11.014; Du RP, 2018, CARBOHYD POLYM, V198, P529, DOI 10.1016/j.carbpol.2018.06.116; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Febles CI, 2002, J CEREAL SCI, V36, P19, DOI 10.1006/jcrs.2001.0441; Fessard A, 2017, FERMENTATION-BASEL, V3, DOI 10.3390/fermentation3030038; FIGUEROA C, 1995, LETT APPL MICROBIOL, V21, P126, DOI 10.1111/j.1472-765X.1995.tb01023.x; Fossi BT, 2016, EUROPEAN J BIOTECHNO, V4, P34; Ganzle MG, 2014, FOOD MICROBIOL, V37, P2, DOI 10.1016/j.fm.2013.04.007; Garai-Ibabe G, 2010, J AGR FOOD CHEM, V58, P6149, DOI 10.1021/jf904529q; Garofalo C, 2008, J APPL MICROBIOL, V105, P243, DOI 10.1111/j.1365-2672.2008.03768.x; Gobbetti M, 2016, INT J FOOD MICROBIOL, V239, P3, DOI 10.1016/j.ijfoodmicro.2016.05.022; Harris HMB, 2018, MICROBIOL RESOUR ANN, V7, DOI [10.1128/MRA.01072-18, 10.1128/mra.01072-18]; Harth H, 2016, INT J FOOD MICROBIOL, V228, P22, DOI 10.1016/j.ijfoodmicro.2016.04.011; Huang CH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01974; Imran MYM, 2016, INT J BIOL MACROMOL, V93, P731, DOI 10.1016/j.ijbiomac.2016.09.007; Jayachandran M, 2018, J NUTR BIOCHEM, V61, P101, DOI 10.1016/j.jnutbio.2018.06.010; Kearney N, 2011, INT DAIRY J, V21, P561, DOI 10.1016/j.idairyj.2011.03.002; Kim M, 2014, METHOD MICROBIOL, V41, P61, DOI 10.1016/bs.mim.2014.08.001; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; Li JY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00930; Lim SB, 2018, FOOD SCI BIOTECHNOL, V27, P73, DOI 10.1007/s10068-017-0274-0; Lopez HW, 2000, NUTR RES, V20, P141, DOI 10.1016/S0271-5317(99)00146-3; Low D, 1998, APPL ENVIRON MICROB, V64, P2147; Lucci P, 2015, EUR J LIPID SCI TECH, V117, P1027, DOI 10.1002/ejlt.201400599; Malang SK, 2015, FOOD MICROBIOL, V46, P418, DOI 10.1016/j.fm.2014.08.022; Malik A, 2009, FEMS MICROBIOL LETT, V300, P131, DOI 10.1111/j.1574-6968.2009.01772.x; Mandhania MH, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00368-19; Manini F, 2016, LWT-FOOD SCI TECHNOL, V66, P275, DOI 10.1016/j.lwt.2015.10.045; Mariotti M, 2014, LWT-FOOD SCI TECHNOL, V59, P973, DOI 10.1016/j.lwt.2014.06.052; Martensson O, 2002, FOOD RES INT, V35, P775, DOI 10.1016/S0963-9969(02)00074-1; McKevith B., 2004, Nutrition Bulletin, V29, P111, DOI 10.1111/j.1467-3010.2004.00418.x; Minervini F, 2010, INT J FOOD MICROBIOL, V141, P130, DOI 10.1016/j.ijfoodmicro.2010.03.014; Mozzi F, 2006, APPL ENVIRON MICROB, V72, P4431, DOI 10.1128/AEM.02780-05; Neysens P, 2003, INT J FOOD MICROBIOL, V88, P29, DOI 10.1016/S0168-1605(03)00079-5; Nuobariene L, 2015, LWT-FOOD SCI TECHNOL, V63, P766, DOI 10.1016/j.lwt.2015.03.018; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Osimani A, 2009, ITAL J FOOD SCI, V21, P269; Osimani A, 2015, INT J FOOD MICROBIOL, V194, P62, DOI 10.1016/j.ijfoodmicro.2014.11.011; Palomba S, 2012, APPL ENVIRON MICROB, V78, P2737, DOI 10.1128/AEM.07302-11; Raghavendra P, 2009, INT J FOOD MICROBIOL, V133, P129, DOI 10.1016/j.ijfoodmicro.2009.05.006; Reale A, 2019, LWT-FOOD SCI TECHNOL, V99, P468, DOI 10.1016/j.lwt.2018.10.016; Rizzello CG, 2019, INT J FOOD MICROBIOL, V302, P24, DOI 10.1016/j.ijfoodmicro.2018.08.014; Roncolini A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211747; Ruas-Madiedo Patricia, 2009, P279; Ruhmkorf C, 2013, FOOD MICROBIOL, V34, P52, DOI 10.1016/j.fm.2012.11.002; Ruhmkorf C, 2012, EUR FOOD RES TECHNOL, V235, P139, DOI 10.1007/s00217-012-1746-3; Silva LA, 2019, ANN MICROBIOL, V69, P321, DOI 10.1007/s13213-019-01456-9; Smitinont T, 1999, INT J FOOD MICROBIOL, V51, P105, DOI 10.1016/S0168-1605(99)00094-X; Sumengen M, 2012, TURK J BIOL, V36, P533, DOI 10.3906/biy-1111-2; Surayot U, 2014, INT J BIOL MACROMOL, V68, P233, DOI 10.1016/j.ijbiomac.2014.05.005; Taccari M, 2016, J FOOD SCI, V81, pM1996, DOI 10.1111/1750-3841.13372; Tang XJ, 2019, FOOD HYDROCOLLOID, V90, P377, DOI 10.1016/j.foodhyd.2018.10.025; Tieking M, 2003, APPL ENVIRON MICROB, V69, P945, DOI 10.1128/AEM.69.2.945-952.2003; Tinzl-Malang SK, 2015, INT J FOOD MICROBIOL, V214, P91, DOI 10.1016/j.ijfoodmicro.2015.07.025; Torino MI, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00834; TURK M, 1992, J CEREAL SCI, V15, P281; Vakevainen K, 2018, LWT-FOOD SCI TECHNOL, V88, P109, DOI 10.1016/j.lwt.2017.10.004; Van der Meulen R, 2007, INT J FOOD MICROBIOL, V118, P250, DOI 10.1016/j.ijfoodmicro.2007.07.014; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; Vats P, 2004, ENZYME MICROB TECH, V35, P3, DOI 10.1016/j.enzmictec.2004.03.010; Wang J, 2016, OXID MED CELL LONGEV, V3; Wang L, 2014, INT J MOL SCI, V15, P12842, DOI 10.3390/ijms150712842; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang YF, 2018, INT J BIOL MACROMOL, V114, P529, DOI 10.1016/j.ijbiomac.2018.03.162; Yasutake Tetsuya, 2016, Biochem Biophys Rep, V5, P266, DOI 10.1016/j.bbrep.2016.01.004; Ye GB, 2019, CARBOHYD POLYM, V207, P218, DOI 10.1016/j.carbpol.2018.11.092; Zannini E, 2009, FOOD MICROBIOL, V26, P744, DOI 10.1016/j.fm.2009.07.014; Zarour K, 2017, CARBOHYD POLYM, V174, P646, DOI 10.1016/j.carbpol.2017.06.113; Zeidan AA, 2017, FEMS MICROBIOL REV, V41, pS168, DOI 10.1093/femsre/fux017; Zeller E, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2014.62; Zhou K, 2016, CARBOHYD POLYM, V144, P205, DOI 10.1016/j.carbpol.2016.02.067; Ziadi M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1896240	89	11	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236190	10.1371/journal.pone.0236190	http://dx.doi.org/10.1371/journal.pone.0236190			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702068	Green Published, gold			2022-12-26	WOS:000575913700058
J	Phattanawiboon, B; Nonthabenjawan, N; Boonyos, P; Jetsukontorn, C; Towayunanta, W; Chuntrakool, K; Ngaopravet, K; Ruchusatsawat, K; Uppapong, B; Sangkitporn, S; Mekada, E; Matsuura, Y; Tatsumi, M; Mizushima, H				Phattanawiboon, Benjarat; Nonthabenjawan, Nutthawan; Boonyos, Patcharaporn; Jetsukontorn, Chanya; Towayunanta, Worakarn; Chuntrakool, Kobkool; Ngaopravet, Karn; Ruchusatsawat, Kriangsak; Uppapong, Ballang; Sangkitporn, Somchai; Mekada, Eisuke; Matsuura, Yoshiharu; Tatsumi, Masashi; Mizushima, Hiroto			Norovirus transmission mediated by asymptomatic family members in households	PLOS ONE			English	Article							VIRAL LOAD; ACUTE GASTROENTERITIS; PEDIATRIC-PATIENTS; FOOD HANDLERS; RISK-FACTORS; INFECTIONS; PREVALENCE; COMMUNITY; OUTBREAKS; CHILDREN	The transmission of human norovirus excreted from infected persons occasionally causes sporadic infections and outbreaks. Both symptomatic patients and asymptomatic carriers have been reported to contribute to norovirus transmission, but little is known about the magnitude of the contribution of asymptomatic carriers. We carried out a 1-year survey of residents of a district of Bangkok, Thailand to determine the percentage of norovirus transmissions originating from asymptomatic individuals. We screened 38 individuals recruited from 16 families from May 2018 to April 2019 for GI and GII genotypes. Norovirus was detected every month, and 101 of 716 stool samples (14.1%) from individuals with no symptoms of acute gastroenteritis were norovirus-positive. The average infection frequency was 2.4 times per person per year. Fourteen genotypes were identified from the positive samples, with GII.4 being detected most frequently. Notably, 89.1% of the norovirus-positive samples were provided by individuals with no diarrhea episode. Similar to cases of symptomatic infections in Thailand, asymptomatic infections were observed most frequently in December. We detected 4 cases of NV infection caused by household transmission, and 3 of the 4 transmissions originated from asymptomatic individuals. We also identified a case in which norovirus derived from an asymptomatic individual caused diarrhea in a family member. These results suggest that asymptomatic individuals play a substantial role in both the maintenance and spreading of norovirus in a community through household transmission.	[Phattanawiboon, Benjarat; Nonthabenjawan, Nutthawan; Boonyos, Patcharaporn; Jetsukontorn, Chanya; Tatsumi, Masashi; Mizushima, Hiroto] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand; [Towayunanta, Worakarn; Chuntrakool, Kobkool; Ngaopravet, Karn] Publ Hlth Ctr 41, Bangkok, Thailand; [Ruchusatsawat, Kriangsak; Uppapong, Ballang; Sangkitporn, Somchai] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Nonthaburi, Thailand; [Mekada, Eisuke] Res & Educ Promot Fdn, Bangkok, Thailand; [Matsuura, Yoshiharu] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan	Ministry of Public Health - Thailand; Osaka University	Mizushima, H (corresponding author), Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand.	hmizushi@bikeno.osaka-u.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development (J-GRID) [JP18fm0108003]	Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development (J-GRID)	This research was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development (J-GRID, Grant Number, JP18fm0108003) (to YM). The funding agencies had no role in the study design, the data collection or analysis, the decision to publish, or the preparation of the manuscript.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Ahmed SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075922; Allen DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088978; Aoki Y, 2010, J HOSP INFECT, V75, P42, DOI 10.1016/j.jhin.2009.12.016; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2018, CURR OPIN INFECT DIS, V31, P422, DOI [10.1097/QCO.0000000000000476, 10.1097/qco.0000000000000476]; Barclay L, 2014, CLIN MICROBIOL INFEC, V20, P731, DOI 10.1111/1469-0691.12674; Bitler EJ, 2013, EPIDEMIOL INFECT, V141, P1563, DOI 10.1017/S095026881300006X; Bodhidatta L, 2015, J MED VIROL, V87, P664, DOI 10.1002/jmv.24108; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bruggink LD, 2015, J MED VIROL, V87, P961, DOI 10.1002/jmv.24154; Bucardo F, 2017, INFECT GENET EVOL, V55, P305, DOI 10.1016/j.meegid.2017.10.001; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Carmona-Vicente N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1455-9; Chen MY, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3046-5; Cheon DS, 2010, FOODBORNE PATHOG DIS, V7, P1427, DOI 10.1089/fpd.2010.0547; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Chuchaona W, 2019, EMERG INFECT DIS, V25, P1612, DOI 10.3201/eid2508.190365; de Graaf M, 2016, NAT REV MICROBIOL, V14, P421, DOI 10.1038/nrmicro.2016.48; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Enserink R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089496; Fan YM, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819000025; Franck KT, 2015, J INFECT DIS, V211, P563, DOI 10.1093/infdis/jiu479; Fretz R, 2005, EUR J CLIN MICROBIOL, V24, P256, DOI 10.1007/s10096-005-1310-1; Gastanaduy PA, 2015, PEDIATR INFECT DIS J, V34, P1031, DOI 10.1097/INF.0000000000000783; Gladstone BP, 2008, EPIDEMIOL INFECT, V136, P399, DOI 10.1017/S0950268807008709; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Guntapong R, 2004, JPN J INFECT DIS, V57, P276; Hall AJ, 2012, J INFECT DIS, V205, P1622, DOI 10.1093/infdis/jis251; Jensen BH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40077-9; Jeong AY, 2013, J CLIN MICROBIOL, V51, P598, DOI 10.1128/JCM.01856-12; Kabue JP, 2016, J CLIN VIROL, V84, P12, DOI 10.1016/j.jcv.2016.09.005; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Khamrin P, 2017, ARCH VIROL, V162, P3371, DOI 10.1007/s00705-017-3501-3; Kibry AE, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0143759, DOI 10.1371/JOURNAL.PONE.0143759]; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Mathijs E, 2012, FOOD ENVIRON VIROL, V4, P131, DOI 10.1007/s12560-012-9091-z; Matsuyama R, 2018, J INT MED RES, V46, P2866, DOI 10.1177/0300060518776451; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; Siqueira JAM, 2017, J MED VIROL, V89, P1894, DOI 10.1002/jmv.24812; Mori K, 2018, J MED VIROL, V90, P1882, DOI 10.1002/jmv.25079; Newman KL, 2016, CLIN EXP IMMUNOL, V184, P347, DOI 10.1111/cei.12772; Ozawa K, 2007, J CLIN MICROBIOL, V45, P3996, DOI 10.1128/JCM.01516-07; Parron I, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819001146; Partridge DG, 2012, J HOSP INFECT, V81, P25, DOI 10.1016/j.jhin.2012.02.002; Phillips G, 2010, EPIDEMIOL INFECT, V138, P1454, DOI 10.1017/S0950268810000439; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Pongsuwanna Y, 2017, JPN J INFECT DIS, V70, P84, DOI 10.7883/yoken.JJID.2015.440; Qi R, 2018, ECLINICALMEDICINE, V2-3, P50, DOI 10.1016/j.eclinm.2018.09.001; Ramani S, 2015, J INFECT DIS, V212, P397, DOI 10.1093/infdis/jiv053; Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14; Sabria A, 2016, J CLIN VIROL, V82, P119, DOI 10.1016/j.jcv.2016.07.012; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Supadej K, 2019, J MED VIROL, V91, P215, DOI 10.1002/jmv.25261; Supadej K, 2017, INFECT GENET EVOL, V52, P44, DOI 10.1016/j.meegid.2017.04.025; Tang MB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-338; Teunis PFM, 2015, EPIDEMIOL INFECT, V143, P1710, DOI 10.1017/S095026881400274X; Tsang TK, 2018, EPIDEMIOLOGY, V29, P675, DOI [10.1097/EDE.0000000000000855, 10.1097/ede.0000000000000855]; Utsumi T, 2017, INFECT GENET EVOL, V55, P1, DOI 10.1016/j.meegid.2017.08.020; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746; Wu QS, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4205-y	65	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236502	10.1371/journal.pone.0236502	http://dx.doi.org/10.1371/journal.pone.0236502			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32702014	Green Published, gold			2022-12-26	WOS:000575913700097
J	Yang, C; Zhang, YF; Chen, Y; Ragaller, F; Liu, MZ; Corvigno, S; Dahlstrand, H; Carlson, J; Chen, ZH; Nasman, A; Waraky, A; Lin, YB; Larsson, O; Haglund, F				Yang, Chen; Zhang, Yifan; Chen, Yi; Ragaller, Franziska; Liu, Mingzhi; Corvigno, Sara; Dahlstrand, Hanna; Carlson, Joseph; Chen, Zihua; Nasman, Anders; Waraky, Ahmed; Lin, Yingbo; Larsson, Olle; Haglund, Felix			Nuclear IGF1R interact with PCNA to preserve DNA replication after DNA-damage in a variety of human cancers	PLOS ONE			English	Article							STRAND BREAK REPAIR; FACTOR 1 RECEPTOR; HOMOLOGOUS RECOMBINATION; TARGETED THERAPY; TUMOR-CELLS; IGF-1R; RESISTANCE; CHEMOTHERAPY; TRANSLOCATION; CONTRIBUTES	Nuclear IGF1R has been linked to poor outcome in cancer. We recently showed that nuclear IGF1R phosphorylates PCNA and increases DNA damage tolerance. In this paper we aimed to describe this mechanism in cancer tissue as well as in cancer cell lines. In situ proximity ligation assay identified frequent IGF1R and PCNA colocalization in many cancer types. IGF1R/PCNA colocalization was more frequently increased in tumor cells than in adjacent normal, and more prominent in areas with dysplasia and invasion. However, the interaction was often lost in tumors with poor response to neoadjuvant treatment and most metastatic lesions. In two independent cohorts of serous ovarian carcinomas and oropharyngeal squamous cell carcinomas, stronger IGF1R/PCNA colocalization was significantly associated with a higher overall survival. Ex vivo irradiation of ovarian cancer tissue acutely induced IGF1R/PCNA colocalization together with ?H2AX-foci formations. In vitro, RAD18 mediated mono-ubiquitination of PCNA during replication stress was dependent on IGF1R kinase activity. DNA fiber analysis revealed that IGF1R activation could rescue stalled DNA replication forks, but only in cancer cells with baseline IGF1R/PCNA interaction. We believe that the IGF1R/PCNA interaction is a basic cellular mechanism to increase DNA stress tolerance during proliferation, but that this mechanism is lost with tumor progression in conjunction with accumulated DNA damage and aberrant strategies to tolerate genomic instability. To exploit this mechanism in IGF1R targeted therapy, IGF1R inhibitors should be explored in the context of concomitant induction of DNA replication stress as well as in earlier clinical stages than previously tried.	[Yang, Chen; Zhang, Yifan; Chen, Yi; Ragaller, Franziska; Liu, Mingzhi; Corvigno, Sara; Dahlstrand, Hanna; Carlson, Joseph; Nasman, Anders; Lin, Yingbo; Larsson, Olle; Haglund, Felix] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden; [Yang, Chen; Chen, Zihua] Cent South Univ, Dept Gen Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Yang, Chen; Chen, Zihua] Hunan Key Lab Precise Diag & Treatment Gastrointe, Changsha, Hunan, Peoples R China; [Ragaller, Franziska] Heidelberg Univ, Heidelberg, Germany; [Ragaller, Franziska] German Canc Res Ctr, Heidelberg, Germany; [Dahlstrand, Hanna] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Waraky, Ahmed] Gothenburg Univ, Dept Lab Med, Gothenburg, Sweden	Karolinska Institutet; Central South University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Uppsala University; University of Gothenburg	Haglund, F (corresponding author), Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden.	Felix.Haglund@ki.se	Liu, Mingzhi/AAU-7299-2021	Liu, Mingzhi/0000-0001-5842-8307; Carlson, Joseph/0000-0002-3006-4107; Ragaller, Franziska/0000-0002-4148-262X; Yang, Chen/0000-0002-2502-4960; Waraky, Ahmed/0000-0003-4635-021X	Swedish Cancer Society; Swedish Childhood Cancer Foundation; Cancer Society in Stockholm; Stockholm County Council; China Scholarship Council [CSC201706370014]; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Cancer Society in Stockholm; Stockholm County Council(Stockholm County Council); China Scholarship Council(China Scholarship Council); Karolinska Institutet(Karolinska Institutet)	This work is supported by the Swedish Cancer Society, the Swedish Childhood Cancer Foundation, The Cancer Society in Stockholm, the Stockholm County Council and the China Scholarship Council [CSC201706370014] and Karolinska Institutet.	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Amin O, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1803-y; Bhide SA, 2016, BRIT J CANCER, V115, P825, DOI 10.1038/bjc.2016.266; Bi Xin, 2015, World J Biol Chem, V6, P48, DOI 10.4331/wjbc.v6.i3.48; Brand TM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1064; Branzei D, 2016, DNA REPAIR, V44, P68, DOI 10.1016/j.dnarep.2016.05.008; Broustas CG, 2014, RADIAT RES, V181, P111, DOI 10.1667/RR13515.1; Carpenter G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008979; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Chitnis MM, 2014, ONCOGENE, V33, P5262, DOI 10.1038/onc.2013.460; Codony-Servat J, 2017, BRIT J CANCER, V117, P1777, DOI 10.1038/bjc.2017.279; Ferte C, 2013, MOL CANCER THER, V12, P1213, DOI 10.1158/1535-7163.MCT-12-1067; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; Glorieux M, 2017, ONCOTARGET, V8, P81662, DOI 10.18632/oncotarget.20953; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guerard M, 2018, CANCER LETT, V420, P146, DOI 10.1016/j.canlet.2018.01.080; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hjortkjaer M, 2019, INT J GYNECOL CANCER, V29, P166, DOI 10.1136/ijgc-2018-000017; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lodhia KA, 2015, INT J CANCER, V136, P2961, DOI 10.1002/ijc.29327; Packham S, 2015, ONCOGENE, V34, P2227, DOI 10.1038/onc.2014.165; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Tian F, 2013, P NATL ACAD SCI USA, V110, P13558, DOI 10.1073/pnas.1306534110; Turney BW, 2012, RADIOTHER ONCOL, V103, P402, DOI 10.1016/j.radonc.2012.03.009; Waraky A, 2017, J BIOL CHEM, V292, P18227, DOI 10.1074/jbc.M117.781492; Yang SH, 2016, WORLD J GASTROENTERO, V22, P7275, DOI 10.3748/wjg.v22.i32.7275; Yuan JS, 2018, ONCOL LETT, V15, P41, DOI 10.3892/ol.2017.7276; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhou WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083978	32	9	9	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2020	15	7							e0236291	10.1371/journal.pone.0236291	http://dx.doi.org/10.1371/journal.pone.0236291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX7VK	32701997	Green Published, gold			2022-12-26	WOS:000575913700071
